
@ARTICLE{Egger1997629,
author={Egger, M. and Smith, G.D. and Schneider, M. and Minder, C.},
title={Bias in meta-analysis detected by a simple, graphical test},
journal={British Medical Journal},
year={1997},
volume={315},
number={7109},
pages={629-634},
doi={10.1136/bmj.315.7109.629},
note={cited By 32864},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030922816&doi=10.1136%2fbmj.315.7109.629&partnerID=40&md5=25854872ce9d374dc1775303f70c5d97},
affiliation={Department of Social Medicine, University of Bristol, Bristol BSN 2PR, United Kingdom; Department of Social Medicine, University of Berne, CH-3012 Berhe, Switzerland},
abstract={Objective: Funnel plots (plots of effect estimates against sample size) may be useful to detect bias in meta-analyses that were later contradicted by large trials. We examined whether a simple test of asymmetry of funnel plots predicts discordance of results when meta-analyses are compared to large trials, and we assessed the prevalence of bias in published meta-analyses. Design: Medline search to identify pairs consisting of a meta-analysis and a single large trial (concordance of results was assumed if effects were in the same direction and the meta-analytic estimate was within 30% of the trial); analysis of funnel plots from 37 meta-analyses identified from a hand search of four leading general medicine journals 1993-6 and 38 meta-analyses from the second 1996 issue of the Cochrane Database of Systematic Reviews. Main outcome measure: Degree of funnel plot asymmetry as measured by the intercept from regression of standard normal deviates against precision. Results: In the eight pairs of meta-analysis and large trial that were identified (five from cardiovascular medicine, one from diabetic medicine, one from geriatric medicine, one from perinatal medicine) there were four concordant and four discordant pairs. In all cases discordance was due to meta-analyses showing larger effects. Funnel plot asymmetry was present in three out of four discordant pairs but in none of concordant pairs. In 14 (38%) journal meta-analyses and 5 (13%) Cochrane reviews, funnel plot asymmetry indicated that there was bias. Conclusions: A simple analysis of funnel plots provides a useful test for the likely presence of bias in meta-analyses, but as the capacity to detect bias will be limited when meta-analyses are based on a limited number of small trials the results from such analyses should be treated with considerable caution.},
keywords={article;  medical literature;  medical research;  meta analysis;  priority journal;  sample;  statistical analysis},
references={Chalmers, I., Dickersin, K., Chalmers, T.C., Getting to grips with Archie Cochrane's agenda (1992) BMJ, 305, pp. 786-788; Mulrow, C.D., Rationale for systematic reviews (1994) BMJ, 309, pp. 597-599; Huque, M.F., Experiences with meta-analysis in NDA submissions (1988) Proc Biopharmaceutical Section am Statist Assoc, 2, pp. 28-33; Egger, M., Davey Smith, G., Misleading meta-analysis. Lessons from "an effective, sale, simple" intervention that wasn't (1995) BMJ, 310, pp. 752-754; Eysenck, H.J., An exercise in mega-silliness (1978) Am Psychol, 33, p. 517; Easterbrook, P.J., Berlin, J.A., Gopalan, R., Matthews, D.R., Publication bias in clinical research (1991) Lamet, 337, pp. 867-872; Gøtzsche, P.C., Reference bias in reports of drug trials (1987) BMJ, 295, pp. 654-656; Egger, M., Zellweger-Zäluner, T., Schneider, M., Junker, C., Lengeler, C., Antes, G., Language bias in randomised controlled trials published in English and German (1997) Lancet, 350, pp. 326-329; Egger, M., Davey Smith, G., Meta-analysis: Bias in location and selection of studies BMJ, , in press; Light, R.J., Pillemer, D.B., (1984) Summing Up. the Science of Reviewing Research, , Cambridge, MA: Harvard University Press; Villar, J., Piaggio, G., Carroli, G., Donner, A., Factors aflecting the comparability of meta-analyses and largest trials results in perinatology (1997) J Clin Epidemiol, 50, pp. 997-1002; Galbraith, R., A note on graphical presentation of estimated odds ratios from several clinical trials (1988) Stat Med, 7, pp. 889-894; Cappelleri, J.C., Ioannidis, J.P.A., Schmid, C.H., De Ferranti, S.D., Aubert, M., Ghalmers, T.G., Large trials vs meta-analysis of smaller trials. How do their results compare? (1996) JAMA, 276, pp. 1332-1338; Stock, A.K., Sin, A.I., Wieland, G.D., Adams, J., Rubenstein, L.Z., Comprehensive geriatric assessment a meta-analysis of controlled trials (1993) Lancet, 342, pp. 1032-1036; Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure (1991) N Engl Med, 325, pp. 293-302; (1996) The Cochrane Database of Systematic Reviews, , Oxford: Cochrane Collaboration; Yusuf, S., Collins, R., Peto, R., Eurberg, G., Stampfer, M.J., Goldhaber, S.Z., Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials (1985) Eur Heart J, 6, pp. 556-585; Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction (1986) Lancet, 1, pp. 397-402; Yusuf, S., Peto, R., Lewis, J., Collins, R., Sleight, P., Beta blockade during and alter myocardial infarction: An overview of the randomized trials (1985) Progr Cardiovast Dis, 17, pp. 335-371; Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-I (1986) Lancet, 2, pp. 57-66; Wang, P.H., Lau, J., Chalmers, T.C., Mela-analysis of effetts of intensive blood-glucose control on late complications of type 1 diabetes (1993) Lancet, 341, pp. 1306-1309; The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus (1993) N Engl J Med, 329, pp. 977-986; Reuben, D.B., Borok, G.M., Wolde-Tsadik, G., Ershoff, D.H., Fishman, L.K., Ambrosini, V.L., Randomized trial of comprehensive geriatric assessment in the care of hospitalized patients (1995) N Engl J Med, 332, pp. 1345-1350; Yusuf, S., Collins, R., MacMahon, S., Peto, R., Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomised trials (1988) Lancet, 1, pp. 1088-1092; GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction (1994) Lancet, 343, pp. 1115-1122; Mulrow, C.D., Mulrow, J.P., Linn, W.D., Aguilar, C., Ramirez, G., Relative efficacy of vasodilator therapy in chronic congestive heart failure (1988) JAMA, 259, pp. 3422-3426; Teo, K.K., Yusuf, S., Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence (1993) Drugs, 16, pp. 347-359; ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction (1995) Lancet, 345, pp. 669-687; Imperiale, T.F., Stollenwerk Petrullis, A., A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease (1991) JAMA, 266, pp. 264-265; CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women (1994) Lancet, 343, pp. 619-629; Garg, R., Yusuf, S., Overview of randomised trials of angioterisin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure (1995) JAMA, 273, pp. 1450-1456. , for the Collaborative Group on ACE Inhibitor Trials; Collins, R., Antiplatelet agents for IUGR and pre-eclampsia (1994) Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, , Enkin MW. Keirse MJNC, Renfrew MJ, Neilson JP, eds. Oxford: Update Software, Review No 04000, 12 March 1994. Cochrane Updates or Disk, disk issue 3; Chalmers, I., Underreporting research is scientific misconduct (1990) JAMA, 263, pp. 1405-1408; Levy, C., Publication bias: Its implications for clinical pharmacology (1992) Clin Pharmacol Ther, 52, pp. 115-119; Savulescu, J., Chalmers, I., Blunt, J., Are research ethics committees behaving unethically? Some suggestions for improving performances and accountability (1996) BMJ, 313, pp. 1390-1393; Ravnskov, U., Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome (1992) BMJ, 305, pp. 15-19; Huston, P., Moher, D., Redundancy, disaggregaiion, and the integrity of medical research (1996) Lancet, 347, pp. 1024-1026; Chalmers, T.C., Celano, P., Sacks, H.S., Smith, H., Bias in treatment assignment in controlled clinical trials (1983) N Engl J Med, 309, pp. 1358-1601; Schulz, K.F., Chalmers, I., Hayes, R.J., Altman, D.G., Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273, pp. 408-412; Altman, D.G., The scandal of poor medical research (1994) BMJ, 308, pp. 283-284; Egger, M., Davey Smith, C., Phillips, A.N., Meta-analysis: Principles and procedures BMJ, , in press; Davey Smith, G., Egger, M., Who benefits from medical interventions? Treating low risk patients can be a high risk strategy (1994) BMJ, 308, pp. 72-74; Baxter, G.F., Sumeray, M.S., Walker, J.M., Infarct size and magnesium: Insights into LIMIT-2 and ISIS-4 from experimental studies (1996) Lancet, 318, pp. 1424-1426; Collins, R., Peto, R., Magnesium in acute myocardial infarction (1997) Lancet, 349, p. 282; Villar, J., Carroli, G., Belizan, J.M., Hredictive ability of meta-analyses of randomised controlled trials (1995) Lancet, 345, pp. 772-776; Flournoy, N., Olkin, I., Do small trials square with large ones? (1995) Lancet, 345, pp. 741-742; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50, pp. 1088-1099},
correspondence_address1={Egger, M.; Depatment of Social Medicine, , Bristol BS8 2PR, United Kingdom; email: m.eggar@bristol.ac.uk},
publisher={BMJ Publishing Group},
issn={09598146},
coden={BMJOA},
pubmed_id={9310563},
language={English},
abbrev_source_title={BR. MED. J.},
document_type={Article},
source={Scopus},
}

@ARTICLE{DerSimonian1986177,
author={DerSimonian, R. and Laird, N.},
title={Meta-analysis in clinical trials},
journal={Controlled Clinical Trials},
year={1986},
volume={7},
number={3},
pages={177-188},
doi={10.1016/0197-2456(86)90046-2},
note={cited By 28281},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022992740&doi=10.1016%2f0197-2456%2886%2990046-2&partnerID=40&md5=3e9327a4a0e7c13b529a44772a6602a9},
affiliation={Yale University, School of Medicine, New Haven, Connecticut (R.D.), USA, United States; Harvard University, School of Public Health, Boston, Massachusetts (N.L.), USA, United States},
abstract={This paper examines eight published reviews each reporting results from several related trials. Each review pools the results from the relevant trials in order to evaluate the efficacy of a certain treatment for a specified medical condition. These reviews lack consistent assessment of homogeneity of treatment effect before pooling. We discuss a random effects approach to combining evidence from a series of experiments comparing two treatments. This approach incorporates the heterogeneity of effects in the analysis of the overall treatment efficacy. The model can be extended to include relevant covariates which would reduce the heterogeneity and allow for more specific therapeutic recommendations. We suggest a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies. © 1986.},
author_keywords={covariate information;  distribution of treatment effects;  heterogeneity of treatment effects;  random effects model},
keywords={clinical trial;  computer analysis;  covariance;  efficacy;  epidemiology;  heterogeneity;  methodology;  priority journal, Clinical Trials;  Human;  Models, Theoretical;  Research Design;  Statistics;  Support, U.S. Gov't, P.H.S.},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, T32CA009424},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, R01GM029745},
funding_details={Yale UniversityYale University},
funding_details={Harvard UniversityHarvard University},
funding_details={University of Maryland School of Public HealthUniversity of Maryland School of Public Health, SPH, CA09424-03},
funding_text 1={The main difficulty in integrating the results from various studies stems from the sometimes diverse nature of the studies, both in terms of design and methods employed. Some are carefully controlled randomized experi- Yale University, School of Medicine, New Haven, Connecticut (R.D.); Harvard University, School of Public Health, Boston, Massachusetts (N.L.) *This research was supported by grant CA09424-03 from the National Cancer Institute and grant GM-29745 from the National Institute of Health. We are grateful to Frederick Mosteller, Tom Louis, and Katherine Halvorsen for critical readings of various drafts, encouragement, and advice.},
references={Armitage, Controversies and achievements in clinical trials (1984) Controlled Clin Trials, 5, pp. 67-72; DerSimonian, Laird, Evaluating the effect of coaching on SAT Scores: a meta-analysis (1983) Harvard Ed Rev, 53, pp. 1-15; Halvorsen K: Combining results from independent investigations: meta-analysis in medical research. In: Medical Uses of Statistics, Bailar JC, Mosteller F, Eds. Boston: New England Journal of Medicine (in press); Winship, Cimetidine in the treatment of duodenal ulcer (1978) Gastroenterology, 74, pp. 402-406; Conn, Steroid treatment of alcoholic hepatitis (1978) Gastroenterology, 74, pp. 319-326; Miao, Gastric freezing: an example of the evaluation of medical therapy by randomized clinical trials (1977) Costs, Risks, and Benefits of Surgery, pp. 198-211. , JP Bunker, BA Barnes, F Mosteller, Oxford University Press, New York; DeSilva, Hennekens, Lown, Casscells, Lignocaine prophylaxis in acute myocardial infarction: An evaluation of randomized trials (1981) Lancet, 2, pp. 855-858; Stjernsward, Decreased survival related to irradiation post-operatively in early operable breast cancer (1974) Lancet, 2, pp. 1285-1286; Baum, Anish, Chalmers, Sacks, Smith, Fagerstrom, A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls (1981) N Engl J Med, 305, pp. 795-799; Peto, Aspirin after myocardial infarction (1980) Lancet, 1, pp. 1172-1173. , (unsigned editorial); Chalmers, Matta, Smith, Kunzler, Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction (1977) N Engl J Med, 297, pp. 1091-1096; Stampfer, Goldhaber, Yusuf, Peto, Hennekens, Effect of intravenous streptokinase on acute myocardial infarction: Pooled results from randomized trails (1982) N Eng J Med, 307, pp. 1180-1182; Long-term and short-term beta-blockade after myocardial infarction (1982) Lancet, 1, pp. 1159-1161; Wortman, Yeaton, Synthesis of results in controlled trials of coronary artery bypass graft surgery (1983) Evaluation Studies Review Annual; Gilbert, McPeek, Mosteller, Progress in surgery and anesthesia: benefits and risks of innovative therapy (1977) Costs, Risks, and Benefits of Surgery, pp. 124-169. , JP Bunker, BA Barnes, F Mosteller, Oxford University Press, New York; Laird, DerSimonian, Issues in combining evidence from several comparative trials of clinical therapy (1982) Proceeding of the XIth International Biometric Conference, pp. 91-97; Breslow, Day, (1980) Statistical methods in cancer research, pp. 136-146. , International Agency for Research on Cancer; Hedges, Olkin, (1985) Statistical methods for meta-analysis, pp. 122-127. , Academic Press, London; Cochran, Adjusments in analysis (1983) Planning and Analysis of Observational Studies, pp. 102-108. , LE Moses, F Mosteller, Wiley, New York; Rao, Kaplan, Cochran, Estimators for the one-way random effects model with unequal error variances (1981) Journal of the American Statistical Association, 76, pp. 89-97; Harville, Maximum likehood approaches to variance component estimation and to related problems (1977) Journal of the American Statistical Association, 72, pp. 320-338; Dempster, Laird, Rubin, Maximum likehood from incomplete data via the EM algorithm (1977) J R Stat Soc B, 39, pp. 1-38},
correspondence_address1={DerSimonian, R.},
issn={01972456},
coden={CCLTD},
pubmed_id={3802833},
language={English},
abbrev_source_title={Control. Clin. Trials},
document_type={Article},
source={Scopus},
}

@ARTICLE{Moher2009264,
author={Moher, D. and Liberati, A. and Tetzlaff, J. and Altman, D.G. and Altman, D. and Antes, G. and Atkins, D. and Barbour, V. and Barrowman, N. and Berlin, J.A. and Clark, J. and Clarke, M. and Cook, D. and D'Amico, R. and Deeks, J.J. and Devereaux, P.J. and Dickersin, K. and Egger, M. and Ernst, E. and Gøtzsche, P.C. and Grimshaw, J. and Guyatt, G. and Higgins, J. and Ioannidis, J.P.A. and Kleijnen, J. and Lang, T. and Magrini, N. and McNamee, D. and Moja, L. and Mulrow, C. and Napoli, M. and Oxman, A. and Pham, B. and Rennie, D. and Sampson, M. and Schulz, K.F. and Shekelle, P.G. and Tovey, D. and Tugwell, P.},
title={Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement},
journal={Annals of Internal Medicine},
year={2009},
volume={151},
number={4},
pages={264-269},
doi={10.7326/0003-4819-151-4-200908180-00135},
note={cited By 16524},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-69149107165&doi=10.7326%2f0003-4819-151-4-200908180-00135&partnerID=40&md5=c674e69a8be301e4a7a8169d0c2d8db3},
affiliation={Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa Hospital, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada; Università di Modena e Reggio Emilia, Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy; Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Linton Road, Oxford OX2 6UD, United Kingdom; Centre for Statistics in Medicine, Oxford, United Kingdom; University Hospital Freiburg, Freiburg, Germany; Health Services Research and Development Service, Veterans Health Administration, Washington, DC, United States; Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; Johnson and Johnson Pharmaceutical Research and Development, Titusville, NJ, United States; UK Cochrane Centre, Oxford, United Kingdom; School of Nursing and Midwifery, Trinity College, Dublin, Ireland; Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; Università di Modena e Reggio Emilia, Modena, Italy; Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri, Milan, Italy; University of Birmingham, Birmingham, United Kingdom; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Peninsula Medical School, Exeter, United Kingdom; Nordic Cochrane Centre, Copenhagen, Denmark; Ottawa Hospital Research Institute, Ottawa, ON, Canada; MRC Biostatistics Unit, Cambridge, United Kingdom; University of Ioannina Campus, Ioannina, Greece; Kleijnen Systematic Reviews Ltd., York, United Kingdom; School for Public Health and Primary Care (CAPHRI), University of Maastricht, Maastricht, Netherlands; Tom Lang Communications and Training, Davis, CA, United States; NHS Centre for the Evaluation of the Effectiveness of Health Care-CeVEAS, Modena, Italy; Center for Medical Consumers, New York, NY, United States; Norwegian Health Services Research Centre, Oslo, Norway; Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada; GlaxoSmithKline Canada, Mississauga, ON, Canada; University of California, San Francisco, San Francisco, CA, United States; Family Health International, Durham, NC, United States; Southern California Evidence-Based Practice Center, Santa Monica, CA, United States; Cochrane Library, Cochrane Collaboration, Oxford, United Kingdom; Institute of Population Health, University of Ottawa, Ottawa, ON, Canada},
keywords={checklist;  clinical practice;  evidence based medicine;  funding;  health care organization;  meta analysis;  methodology;  nomenclature;  outcome assessment;  practice guideline;  priority journal;  publication;  review;  systematic review;  article;  evidence based practice;  literature;  publishing;  quality control;  standard, Evidence-Based Practice;  Meta-Analysis as Topic;  Publishing;  Quality Control;  Review Literature as Topic;  Terminology as Topic},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_U105285807},
references={Oxman, A.D., Cook, D.J., Guyatt, G.H., Users' guides to the medical literature. VI. How to use an overview (1994) JAMA, 272, pp. 1367-1371. , Evidence-Based Medicine Working Group. PMID: 7933399; Swingler, G.H., Volmink, J., Ioannidis, J.P.A., Number of published systematic reviews and global burden of disease: Database analysis (2003) British Medical Journal, 327 (7423), pp. 1083-1084; (2006) Randomized Controlled Trials Registration/application Checklist, , www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf, December Accessed at on 19 May 2009; Young, C., Horton, R., Putting clinical trials into context (2005) Lancet, 366, pp. 107-108. , PMID: 16005318; Mulrow, C.D., The medical review article: State of the science (1987) Ann Intern Med, 106, pp. 485-488. , PMID: 3813259; Sacks, H.S., Berrier, J., Reitman, D., Ancona-Berk, V.A., Chalmers, T.C., Meta-analyses of randomized controlled trials (1987) N Engl J Med, 316, pp. 450-455. , PMID: 3807986; Sacks, H.S., Reitman, D., Pagano, D., Kupelnick, B., Meta-analysis: An update (1996) Mt Sinai J Med, 63, pp. 216-224. , PMID: 8692168; Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses (1999) Lancet, 354, pp. 1896-1900. , PMID: 10584742; Glossary (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, , www.cochrane.org/resources/glossary.htm, Green S, Higgins J, eds. The Cochrane Collaboration; Accessed at on 19 May 2009; Strech, D., Tilburt, J., Value judgments in the analysis and synthesis of evidence (2008) Journal of Clinical Epidemiology, 61 (6), pp. 521-524. , DOI 10.1016/j.jclinepi.2008.01.001, PII S0895435608000048; Moher, D., Tsertsvadze, A., Systematic reviews: When is an update an update? (2006) Lancet, 367, pp. 881-883. , PMID: 16546523; (2009), www.york.ac.uk/inst/crd/, University of York Centre for Reviews and Dissemination Accessed at on 19 May 2009; (2009) The Joanna Briggs Institute Protocols & Work in Progress, , www.joannabriggs.edu.au/pubs/systematic_reviews_prot.php, Accessed at on 19 May 2009; De Angelis, C., Drazen, J.M., Frizelle, F.A., Haug, C., Hoey, J., Horton, R., Clinical trial registration: A statement from the International Committee of Medical Journal Editors (2004) CMAJ, 171, pp. 606-607. , International Committee of Medical Journal Editors. Editorial. PMID: 15367465; Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., Boddington, E., Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data (2004) Lancet, 363 (9418), pp. 1341-1345. , DOI 10.1016/S0140-6736(04)16043-1, PII S0140673604160431; Bagshaw, S.M., McAlister, F.A., Manns, B.J., Ghali, W.A., Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence (2006) Arch Intern Med, 166, pp. 161-166. , PMID: 16432083; Biondi-Zoccai, G.G.L., Lotrionte, M., Abbate, A., Testa, L., Remigi, E., Burzotta, F., Valgimigli, M., Agostoni, P., Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study (2006) British Medical Journal, 332 (7535), pp. 202-206. , DOI 10.1136/bmj.38693.516782.7C; Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P., Ioannidis, J.P., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration (2009) Ann Intern Med, 151, pp. W-65-94; Altman, D.G., Schulz, K.F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., The revised CONSORT statement for reporting randomized trials: Explanation and elaboration (2001) Ann Intern Med, 134, pp. 663-694. , CONSORT GROUP (Consolidated Standards of Reporting Trials) PMID: 11304107; Bossuyt, P.M., Reitsma, J.B., De Bruns, Gatsonis, C.A., Glasziou, P.P., Irwig, L.M., Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration (2003) Ann Intern Med, 138, pp. W1-12. , PMID: 12513067; Vandenbroucke, J.P., Von Elm, E., Altman, D.G., Gøtzsche, P.C., Mulrow, C.D., Pocock, S.J., Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration (2007) Ann Intern Med, 147, pp. W163-94. , STROBE Initiative. PMID: 17938389; Moher, D., Tetzlaff, J., Tricco, A.C., Sampson, M., Altman, D.G., Epidemiology and reporting characteristics of systematic reviews (2007) PLoS Medicine, 4 (3), pp. 447-455. , http://medicine.plosjournals.org/archive/1549-1676/4/3/pdf/10. 1371_journal.pmed.0040078-S.pdf, DOI 10.1371/journal.pmed.0040078; Bhandari, M., Morrow, F., Kulkarni, A.V., Tornetta III, P., Meta-analyses in orthopaedic surgery. a systematic review of their methodologies (2001) Journal of Bone and Joint Surgery - Series a, 83 (1), pp. 15-24; Kelly, K.D., Travers, A., Dorgan, M., Slater, L., Rowe, B.H., Evaluating the quality of systematic reviews in the emergency medicine literature (2001) Annals of Emergency Medicine, 38 (5), pp. 518-526. , DOI 10.1067/mem.2001.115881; Richards, D., The quality of systematic reviews in dentistry (2004) Evid Based Dent, 5, p. 17. , PMID: 15238972; T-L Choi, P., Halpern, S.H., Malik, N., Jadad, A.R., Tramer, M.R., Walder, B., Examining the evidence in anesthesia literature: A critical appraisal of systematic reviews (2001) Anesthesia and Analgesia, 92 (3), pp. 700-709; Delaney, A., Bagshaw, S.M., Ferland, A., Manns, B., Laupland, K.B., Doig, C.J., A systematic evaluation of the quality of meta-analyses in the critical care literature (2005) Crit Care, 9, pp. R575-82. , PMID: 16277721; Dickersin, K., Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm (2005) Publication Bias in Meta-Analysis - Prevention, Assessment and Adjustments, pp. 11-33. , Rothstein HR, Sutton AJ, Borenstein M, eds. Chichester, UK: J Wiley; Sutton, A.J., Evidence concerning the consequences of publication and related biases (2005) Publication Bias in Meta-Analysis - Prevention, Assessment and Adjustments, pp. 175-192. , Rothstein HR, Sutton AJ, Borenstein M, eds. Chichester, UK: J Wiley; Lau, J., Ioannidis, J.P., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) BMJ, 333, pp. 597-600. , PMID: 16974018; Ladabaum, U., Chopra, C.L., Huang, G., Scheiman, J.M., Chernew, M.E., Fendrick, A.M., Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis (2001) Ann Intern Med, 135, pp. 769-781. , PMID: 11694102; Deeks, J.J., Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests (2001) BMJ, 323, pp. 157-162. , PMID: 11463691; Altman, D.G., Systematic reviews of evaluations of prognostic variables (2001) BMJ, 323, pp. 224-228. , PMID: 11473921; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Contopoulos-Ioannidis, D.G., Replication validity of genetic association studies (2001) Nat Genet, 29, pp. 306-309. , PMID: 11600885; Lavis, J., Davies, H.T.O., Oxman, A., Denis, J.-L., Golden-Biddle, K., Ferlie, E., Towards systematic reviews that inform health care management and policy-making (2005) Journal of Health Services Research and Policy, 10 (SUPPL. 1), pp. 35-48. , DOI 10.1258/1355819054308549; Stewart, L.A., Clarke, M.J., Practical methodology of meta-analyses (overviews) using updated individual patient data (1995) Stat Med, 14, pp. 2057-2079. , Cochrane Working Group. PMID: 8552887; Moja, L.P., Telaro, E., D'Amico, R., Moschetti, I., Coe, L., Liberati, A., Assessment of methodological quality of primary studies by systematic reviews: Results of the metaquality study cross sectional study (2005) British Medical Journal, 330 (7499), pp. 1053-1055. , DOI 10.1136/bmj.38414.515938.8F; Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., GRADE: An emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336, pp. 924-926. , GRADE Working Group PMID: 18436948; Schünemann, H.J., Jaeschke, R., Cook, D.J., Bria, W.F., El-Solh, A.A., Ernst, A., An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations (2006) Am J Respir Crit Care Med, 174, pp. 605-614. , ATS Documents Development and Implementation Committee PMID: 16931644; Chan, A.W., Hróbjartsson, A., Haahr, M.T., Gøtzsche, P.C., Altman, D.G., Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles (2004) JAMA, 291, pp. 2457-2465. , PMID: 15161896; Chan, A.-W., Krleza-Jeric, K., Schmid, I., Altman, D.G., Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research (2004) Canadian Medical Association Journal, 171 (7), pp. 735-740. , DOI 10.1503/cmaj.1041086; Silagy, C.A., Middleton, P., Hopewell, S., Publishing protocols of systematic reviews: Comparing what was done to what was planned (2002) Journal of the American Medical Association, 287 (21), pp. 2831-2834},
correspondence_address1={Moher, D.; Ottawa Methods Centre, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada; email: dmoher@ohri.ca},
publisher={American College of Physicians},
issn={00034819},
coden={AIMEA},
pubmed_id={19622511},
language={English},
abbrev_source_title={Ann. Intern. Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{NoAuthor2009,
title={Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks},
journal={Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks},
year={2009},
note={cited By 4432},
source={Scopus},
}

@ARTICLE{WorldHealthOrganization2015,
author={World Health Organization},
title={World report on ageing and health},
journal={World Report on Ageing and Health},
year={2015},
note={cited By 3768},
source={Scopus},
}

@ARTICLE{Cochran1954101,
author={Cochran, W.G.},
title={The combination of estimates from different experiments},
journal={Biometrics},
year={1954},
volume={10},
number={1},
pages={101-129},
note={cited By 3463},
source={Scopus},
}

@ARTICLE{Shea2017,
author={Shea, B.J. and Reeves, B.C. and Wells, G. and Thuku, M. and Hamel, C. and Moran, J. and Moher, D. and Tugwell, P. and Welch, V. and Kristjansson, E. and Henry, D.A.},
title={AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both},
journal={BMJ (Online)},
year={2017},
volume={358},
doi={10.1136/bmj.j4008},
art_number={j4008},
note={cited By 2657},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029833812&doi=10.1136%2fbmj.j4008&partnerID=40&md5=13e21c05c8fa5e6e76e19b740e5543c3},
affiliation={Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada; Bruyère Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada; School of Clinical Sciences, University of Bristol, Bristol, United Kingdom; University of Ottawa Heart Institute, Ottawa, Canada; Hospital for Sick Children, Genetics and Genome Biology Program, Toronto, Canada; Department of Medicine, Ottawa Hospital, Ottawa, Canada; Centre for Research in Educational and Community Services, School of Psychology, Faculty of Social Sciences, University of Ottawa, Canada; Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Australia; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Institute for Clinical Evaluative Sciences, Toronto, Canada},
abstract={The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.},
keywords={Article;  clinical decision making;  health care delivery;  health care policy;  health care quality;  human;  intervention study;  patient care;  priority journal;  process development;  reliability;  systematic review;  clinical study;  evidence based medicine;  literature;  meta analysis (topic);  observational study;  observer variation;  randomized controlled trial (topic), Clinical Studies as Topic;  Evidence-Based Medicine;  Meta-Analysis as Topic;  Observational Studies as Topic;  Observer Variation;  Randomized Controlled Trials as Topic;  Review Literature as Topic},
funding_details={National Science FoundationNational Science Foundation, NSF, 1002028},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR, MOP-130470},
funding_text 1={We thank for their assistance in the development of the AMSTAR critical appraisal instruments: Lex Bouter, Maarten Boers, Alonso Carrasco-Labra, Jeremy Grimshaw, Ranjeeta Mallick, Jordi Pardo-Pardo, and Larissa Shamseer, and for conducting the reliability studies reported in this manuscript: Brian Hutton, Pauline Barbeau, Fatemeh Yazdi, Vesa Basha, and Roxanne Ward. Contributors: BJS, DAH, GW, and PT conceived the project. BJS and DAH oversaw the project. BJS and DAH led the working group. All authors contributed to the development of AMSTAR 2 and to writing associated guidance. BJS, DAH, BCR, and PT led the drafting and redrafting of the manuscript. All other authors reviewed and commented on drafts of the manuscript. BJS and DAH are the guarantors Funding: This work was supported by an operating grant from the Canadian Institutes for Health Research (grant No MOP-130470). BCR is supported in part by the UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit. Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. Provenance and peer review: Not commissioned; externally peer reviewed.},
references={Bastian, H., Glasziou, P., Chalmers, I., Seventy-five trials and eleven systematic reviews a day: How will we ever keep up? (2010) PLoS Med, 358, p. e1000326. , pmid:20877712; Mulrow, C.D., Rationale for systematic reviews (1994) BMJ, 358, pp. 597-599. , pmid:8086953; Moher, D.A.L., Tetzlaff, J., Altman, D.G., Preferred reporting items for (SR) and meta-Analyses: The PRISMA statement (2009) Ann Intern Med, 358, pp. 264-269. , and the PRISMA Group., pmid:19622511; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group (2000) JAMA, 358, pp. 2008-2012. , pmid:10789670 2008; Higgins, J.P.T., Green, S., (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, , www.handbook.cochrane.org, editors. [updated March 2011]. The Cochrane Collaboration; Dechartres, A., Charles, P., Hopewell, S., Ravaud, P., Altman, D.G., Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed (2011) J Clin Epidemiol, 358, pp. 136-144. , pmid: 20705426; Whiting, P., Rutjes, A.W., Reitsma, J.B., Bossuyt, P.M., Kleijnen, J., The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews (2003) BMC Med Res Methodol, 358, p. 25. , pmid: 14606960; Wong, W.C., Cheung, C.S., Hart, G.J., Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours (2008) Emerg Themes Epidemiol, 358, p. 23. , pmid:19014686; Verhagen, A.P., De Vet, H.C., De Bie, R.A., The Delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus (1998) J Clin Epidemiol, 358, pp. 1235-1241. , pmid:10086815; Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions (1998) J Epidemiol Community Health, 358, pp. 377-384. , pmid:9764259; Murray, J., Farrington, D.P., Eisner, M.P., Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists (2009) J Exp Criminol, 358, pp. 1-23; Terwee, C.B., Mokkink, L.B., Knol, D.L., Ostelo, R.W., Bouter, L.M., De Vet, H.C., Rating the methodological quality in systematic reviews of studies on measurement properties: A scoring system for the COSMIN checklist (2012) Qual Life Res, 358, pp. 651-657. , pmid:21732199; Bérard, A., Andreu, N., Tétrault, J., Niyonsenga, T., Myhal, D., Reliability of Chalmers' scale to assess quality in meta-Analyses on pharmacological treatments for osteoporosis (2000) Ann Epidemiol, 358, pp. 498-503. , pmid:11118928; Thompson, S., Ekelund, U., Jebb, S., A proposed method of bias adjustment for meta-Analyses of published observational studies (2011) Int J Epidemiol, 358, pp. 765-777. , pmid:21186183; Deeks, J.J., Altman, D.G., Bradburn, M.J., (2008) Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis. Systematic Reviews in Health Care: Meta-Analysis in Context, pp. 285-312. , Wiley & Sons; Sacks, H.S., Berrier, J., Reitman, D., Ancona-Berk, V.A., Chalmers, T.C., Meta-Analyses of randomized controlled trials (1987) N Engl J Med, 358, pp. 450-455. , pmid:3807986; Oxman, A.D., Guyatt, G.H., Validation of an index of the quality of review articles (1991) J Clin Epidemiol, 358, pp. 1271-1278. , pmid:1834807; Oxman, A.D., Cook, D.J., Guyatt, G.H., Users' guides to the medical literature. VI. How to use an overview (1994) JAMA, 358, pp. 1367-1371. , Evidence-Based Medicine Working Group., pmid:7933399; Methodology Checklist 1: Systematic Reviews and Meta-Analyses, , www.sign.ac.uk/checklists-And-notes.html, Scottish Intercollegiate Guidelines Network; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Based Healthc, 358, pp. 132-140. , pmid:26360830; Whiting, P., Savović, J., Higgins, J.P., ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 358, pp. 225-234. , pmid:26092286; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 358, p. 10. , pmid:17302989; Shea, B.J., Hamel, C., Wells, G.A., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J Clin Epidemiol, 358, pp. 1013-1020. , pmid:19230606; Shea, B.J., Bouter, L.M., Peterson, J., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS One, 358, p. e1350. , pmid:18159233; Kung, J., Chiappelli, F., Cajulis, O.O., From systematic reviews to clinical recommendations for evidence-based health care: Validation of revised assessment of multiple systematic reviews (R-AMSTAR) for grading of clinical relevance (2010) Open Dent J, 358, pp. 84-91. , pmid:21088686; Pieper, D., Buechter, R.B., Li, L., Prediger, B., Eikermann, M., Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties (2015) J Clin Epidemiol, 358, pp. 574-583. , pmid:25638457; Faggion, C.M., Jr., Critical appraisal of AMSTAR: Challenges, limitations, and potential solutions from the perspective of an assessor (2015) BMC Med Res Methodol, 358, p. 63. , pmid: 26268372; Teich, S.T., Heima, M., Lang, L., Dental students' use of AMSTAR to critically appraise systematic reviews (2015) J Dent Educ, 358, pp. 1031-1039. , pmid:26329027; Burda, B.U., Holmer, H.K., Norris, S.L., Limitations of a measurement tool to assess systematic reviews (amstar) and suggestions for improvement (2016) Syst Rev, 358, p. 58. , pmid:27072548; Wegewitz, U., Weikert, B., Fishta, A., Jacobs, A., Pieper, D., Resuming the discussion of AMSTAR: What can (should) be made better? (2016) BMC Med Res Methodol, 358, p. 111. , pmid:27566440; Dahm, P., Raising the bar for systematic reviews with Assessment of Multiple Systematic Reviews (AMSTAR) (2017) BJU Int, 358, p. 193. , pmid:28090759; Egger, M., Schneider, M., Davey, S.G., Spurious precision? Meta-Analysis of observational studies (1998) BMJ, 358, pp. 140-144. , pmid:9462324; Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body-mass index and incidence of cancer: A systematic review and meta-Analysis of prospective observational studies (2008) Lancet, 358, pp. 569-578. , pmid:18280327; Page, M.J., Shamseer, L., Altman, D.G., Epidemiology and reporting characteristics of systematic reviews of biomedical research: A cross-sectional study (2016) PLoS Med, 358, p. e1002028. , pmid:27218655; Shapiro, S., Shapiro -Analysis/Shmeta-Analysis (1994) Am J Epidemiol, 358, pp. 771-778. , Meta, pmid:7977286; Fleiss, J.L., Gross, A.J., Meta-Analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique (1991) J Clin Epidemiol, 358, pp. 127-139. , pmid: 1995774; Leeflang, M.M., Deeks, J.J., Gatsonis, C., Bossuyt, P.M., Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy (2008) Ann Intern Med, 358, pp. 889-897. , pmid:19075208; Riley, R.D., Lambert, P.C., Abo-Zaid, G., Meta-Analysis of individual participant data: Rationale, conduct, and reporting (2010) BMJ, 358, p. c221. , pmid:20139215; Lumley, T., Network meta-Analysis for indirect treatment comparisons (2002) Stat Med, 358, pp. 2313-2324. , pmid:12210616; Pawson, R., Greenhalgh, T., Harvey, G., Walshe, K., Realist review-A new method of systematic review designed for complex policy interventions (2005) J Health Serv Res Policy, 358, pp. 21-34. , pmid:16053581; Arksey, H., O'Malley, L., Scoping studies: Towards a methodological framework (2005) Int J Soc Res Methodol, 358, pp. 19-32; Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Cochrane Bias Methods Group. Cochrane Statistical Methods Group. The cochrane collaboration's tool for assessing risk of bias in randomized trials (2011) BMJ, 358, p. d5928. , pmid:22008217; Sterne, J.A., Hernán, M.A., Reeves, B.C., ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions (2016) BMJ, 358, p. i4919. , pmid: 27733354; (2017) Appraising the Risk of Bias in Randomized Trials Using the Cochrane Risk of Bias Tool, , http://www.nccmt.ca/resources/search/280, National Collaborating Centre for Methods and Tools . Hamilton, ON: McMaster University. (Updated 1 September, 2017, accessed 7 Sept, 2017; DeAngelis, C.D., Fontanarosa, P.B., Impugning the integrity of medical science: The adverse effects of industry influence (2008) JAMA, 358, pp. 1833-1835. , pmid: 18413880; Lexchin, J., Bero, L.A., Djulbegovic, B., Clark, O., Pharmaceutical industry sponsorship and research outcome and quality: Systematic review (2003) BMJ, 358, pp. 1167-1170. , pmid:12775614; Yaphe, J., Edman, R., Knishkowy, B., Herman, J., The association between funding by commercial interests and study outcome in randomized controlled drug trials (2001) Fam Pract, 358, pp. 565-568. , pmid:11739337; Bilandzic, A., Fitzpatrick, T., Rosella, L., Henry, D., Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 Inhibitors: Application of a new cochrane risk of bias tool (2016) PLoS Med, 358, p. e1001987. , pmid:27046153; Nüesch, E., Trelle, S., Reichenbach, S., Small study effects in meta-Analyses of osteoarthritis trials: Meta-epidemiological study (2010) BMJ, 358, p. c3515. , pmid:20639294; Bero, L., El-Hachem, P., Abou-Haidar, H., Neumann, I., Schünemann, H.J., Guyatt, G.H., What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines (2014) J Clin Epidemiol, 358, pp. 1239-1241. , pmid: 25132356; Code of Conduct and Best Practice Guidelines for Journal Editors, , https://publicationethics.org/files/Code%20of%20Conduct_2.pdf, Committee on Publication Ethics; Salas, M., Hofman, A., Stricker, B.H., Confounding by indication: An example of variation in the use of epidemiologic terminology (1999) Am J Epidemiol, 358, pp. 981-983. , pmid:10355372; Ray, W.A., Evaluating medication effects outside of clinical trials: New-user designs (2003) Am J Epidemiol, 358, pp. 915-920. , pmid:14585769; Suissa, S., Immortal time bias in pharmaco-epidemiology (2008) Am J Epidemiol, 358, pp. 492-499. , pmid:18056625; Greenland, S., O'Rourke, K., On the bias produced by quality scores in meta-Analysis, and a hierarchical view of proposed solutions (2001) Biostatistics, 358, pp. 463-471. , pmid:12933636; Jüni, P., Witschi, A., Bloch, R., Egger, M., The hazards of scoring the quality of clinical trials for meta-Analysis (1999) JAMA, 358, pp. 1054-1060. , pmid: 10493204; Shea, B.J., (2008) Assessing the Methodological Quality of Systematic Reviews: The Development of AMSTAR, p. 70. , https://research.vu.nl/ws/portalfiles/portal/2927023, PhD, Vrije Universiteit Amsterdam; Sanderson, S., Tatt, I.D., Higgins, J.P., Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography (2007) Int J Epidemiol, 358, pp. 666-676. , pmid:17470488; Wells, G.A., Shea, B., O'Connell, D., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Observational Studies in Meta-Analyses, , www.ohri.ca/programs/clinical_epidemiology/oxford.asp; Scottish Intercollegiate Guidelines Network SIGN 50: Methodology Checklist 3: Cohort Studies, , www.sign.ac.uk/checklists-And-notes.html; McGettigan, P., Henry, D., Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies (2011) PLoS Med, 358, p. e1001098. , pmid:21980265; Whiting, P., Savovic, J., Higgins, J.P., ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 358, pp. 225-234. , pmid: 26092286},
correspondence_address1={Shea, B.J.; Ottawa Hospital Research Institute, Canada; email: bevshea@uottawa.ca},
publisher={BMJ Publishing Group},
issn={09598146},
coden={BMJOA},
pubmed_id={28935701},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Article},
source={Scopus},
}

@ARTICLE{NoAuthor2005,
title={Preventing chronic diseases: A vital investment},
journal={Preventing Chronic Diseases: A Vital Investment},
year={2005},
note={cited By 2280},
source={Scopus},
}

@ARTICLE{Lau1997820,
author={Lau, J. and Ioannidis, J.P.A. and Schmid, C.H.},
title={Quantitative synthesis in systematic reviews},
journal={Annals of Internal Medicine},
year={1997},
volume={127},
number={9},
pages={820-826},
doi={10.7326/0003-4819-127-9-199711010-00008},
note={cited By 2122},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030693603&doi=10.7326%2f0003-4819-127-9-199711010-00008&partnerID=40&md5=5f7faa135b5baf73e641383b63765f21},
affiliation={New England Medical Center, Tufts University, School of Medicine, Boston, MA, United States; Division of Clinical Care Research, New England Medical Center, Box 63, 750 Washington Street, Boston, MA 02111, United States; Therapeutics Research Program, Division of AIDS, Natl. Inst. Allerg. and Infect. Dis., Bethesda, MD 20892, United States},
abstract={The final common pathway for most systematic reviews is a statistical summary of the data, or meta-analysis. The complex methods used in meta- analyses should always be complemented by clinical acumen and common sense in designing the protocol of a systematic review, deciding which data can be combined, and determining whether data should be combined. Both continuous and binary data can be pooled. Most meta-analyses summarize data from randomized trials, but other applications, such as the evaluation of diagnostic test performance and observational studies, have also been developed. The statistical methods of meta-analysis aim at evaluating the diversity (heterogeneity) among the results of different studies, exploring and explaining observed heterogeneity, and estimating a common pooled effect with increased precision. Fixed-effects models assume that an intervention has a single true effect, whereas random-effects models assume that an effect may vary across studies. Meta-regression analyses, by using each study rather than each patient as a unit of observation, can help to evaluate the effect of individual variables on the magnitude of an observed effect and thus may sometimes explain why study results differ. It is also important to assess the robustness of conclusions through sensitivity analyses and a formal evaluation of potential sources of bias, including publication bias and the effect of the quality of the studies on the observed effect.},
keywords={data analysis;  meta analysis;  priority journal;  publication;  review;  statistical analysis},
funding_details={National Institute of Allergy and Infectious DiseasesNational Institute of Allergy and Infectious Diseases, NIAID, T32AI007389},
references={Counsell, C., Formulating questions and locating primary studies for inclusion in systematic reviews (1997) Ann Intern Med, 127, pp. 380-387; Meade, M.O., Richardson, W.S., Selecting and appraising studies for a systematic review (1997) Ann Intern Med, 127, pp. 531-537; McQuay, H.J., Moore, R.A., Using numerical results from systematic reviews in clinical practice (1997) Ann Intern Med, 126, pp. 712-720; Sinclair, J.C., Bracken, M.B., Clinically useful measures of effect in binary analyses of randomized trials (1994) J Clin Epidemiol, 47, pp. 881-890; Cooper, H., Hedges, L.V., (1994) The Handbook of Research Synthesis, , New York: Russell Sage Foundation; Fleiss, J.L., (1981) Statistical Methods for Rates and Proportions. 2d Ed., pp. 161-165. , New York: J Wiley; Mantel, N., Haenszel, W., Statistical aspects of the analysis of data from retrospective studies of disease (1959) J Natl Cancer Inst, 22, pp. 719-748; Laird, N.M., Mosteller, F., Some statistical methods for combining experimental results (1990) Int J Technol Assess Health Care, 6, pp. 5-30; Yusuf, S., Peto, R., Lewis, J., Collins, R., Sleight, P., Beta blockade during and after myocardial infarction: An overview of the randomized trials (1985) Prog Cardiovasc Dis, 27, pp. 335-371; Greenland, S., Salvan, A., Bias in the one-step method for pooling study results (1990) Stat Med, 9, pp. 247-252; Fleiss, J.L., The statistical basis of meta-analysis (1993) Stat Methods Med Res, 2, pp. 121-145; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Hedges, L.V., Olkin, I., (1985) Statistical Methods for Meta-Analysis, , Orlando: Academic Pr; Eddy, D.M., Hasselblad, V., Scharter, R.D., (1991) Meta-Analysis by the Confidence Profile Method: The Statistical Synthesis of Evidence, , New York: Academic Pr; Gelman, A., Carlin, J.B., Stern, H.S., Rubin, D.B., (1995) Bayesian Data Analysis, pp. 148-154. , London: Chapman & Hall; Lilford, R.J., Thornton, J.G., Braunholtz, D., Clinical trials and rare diseases: A way out of a conundrum (1995) BMJ, 311, pp. 1621-1625; Dumouchel, W., Meta-analysis for dose-response models (1995) Stat Med, 14, pp. 679-685; Berlin, J.A., Laird, N.M., Sacks, H.S., Chalmers, T.C., A comparison of statistical methods for combining event rates from clinical trials (1989) Stat Med, 8, pp. 141-151; Borzak, S., Ridker, P.M., Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction (1995) Ann Intern Med, 123, pp. 873-877; Lau, J., Antman, E.M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., Chalmers, T.C., Cumulative meta-analysis of therapeutic trials for myocardial infarction (1992) N Engl J Med, 327, pp. 248-254; Lau, J., Schmid, C.H., Chalmers, T.C., Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care (1995) J Clim Epidemiol, 48, pp. 45-57; Berlin, J.A., Antman, E.M., Advantages and limitations of metaanalytic regressions of clinical trials data (1994) Online J Curr Clin Trials, , 4 June Doc. No. 134; Morgenstern, H., Uses of ecologic analysis in epidemiologic research (1982) Am J Public Health, 72, pp. 1336-1344; Ll, L., Lichtman, A.J., (1978) Ecological Inference, , Beverly Hills, CA: Sage; Sage University Paper Series on Quantitative Applications in the Social Sciences. Series no. 07-010; Greenland, S., Robins, J., Invited commentary: Ecologic studies - Biases, misconceptions, and counterexamples (1994) Am J Epidemiol, 139, pp. 747-760; Mclntosh, M., The population risk as an explanatory variable in research synthesis of clinical trials (1996) Stat Med, 15, pp. 1713-1728; Morris, C.N., Normand, S.L., Hierarchical models for combining information and for meta-analyses (1992) Bayesian Statistics, 4. , Bernardo JM, Berger JO, Dawid AP, Smith AF. New York: Oxford Univ Pr; Smith, T.C., Spiegelhalter, D.J., Thomas, A., Bayesian approaches to randomeffects meta-analysis: A comparative study (1995) Stat Med, 14, pp. 2685-2699; Oxman, A.D., Guyatt, G.H., A consumer's guide to subgroup analyses (1992) Ann Intern Med, 116, pp. 78-84; Michels, K.B., Rosner, B.A., Data trawling: To fish or not to fish (1996) Lancet, 348, pp. 1152-1153; Dickersin, K., Chan, S., Chalmers, T.C., Sacks, H.S., Smith Jr., H., Publication bias and clinical trials (1987) Control Clin Trials, 8, pp. 343-353; Dickersin, K., The existence of publication bias and risk factors for its occurrence (1990) JAMA, 263, pp. 1385-1389; Begg, C.B., Publication bias (1994) The Handbook of Research Synthesis, , Cooper H, Hedges L, eds. New York: Russell Sage Foundation; Easterbrook, P.J., Berlin, J.A., Gopalan, R., Matthews, D.R., Publication bias in clinical research (1991) Lancet, 337, pp. 867-872; Light, R.J., Pillemer, D.B., (1984) Summing Up: the Science of Reviewing Research, , Cambridge, MA: Harvard Univ Pr; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50, pp. 1088-1101; Dear, K.B., Begg, C.B., An approach for assessing publication bias prior to performing a meta-analysis (1992) Statistical Science, 7, pp. 237-245; Hedges, L.V., Modeling publication selection effects in random effects models in meta-analysis (1992) Statistical Science, 7, pp. 246-255; Vevea, J.L., Hedges, L.V., A general linear model for estimating effect size in the presence of publication bias (1995) Psychometrika, 60, pp. 419-435; Chalmers, T.C., Smith Jr., H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., A method for assessing the quality of a randomized control trial (1981) Control Clin Trials, 2, pp. 31-49; Mulrow, C.D., Linn, W.D., Gaul, M.K., Pugh, J.A., Assessing quality of a diagnostic test evaluation (1989) J Gen Intern Med, 4, pp. 288-295; Detsky, A.S., Naylor, C.D., O'Rourke, K., McGeer, A.J., L'Abbe, K.A., Incorporating variations in the quality of individual randomized trials into meta-analysis (1992) J Clin Epidemiol, 45, pp. 255-265; Moher, D., Jadad, A.R., Nichol, G., Penman, M., Tugwell, P., Walsh, S., Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists (1995) Control Clin Trials, 16, pp. 62-73; Emerson, J.D., Burdick, E., Hoaglin, D.C., Mosteller, F., Chalmers, T.C., An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials (1990) Control Clin Trials, 11, pp. 339-352; Greenland, S., Invited commentary: A critical look at some popular meta-analytic methods (1994) Am J Epidemiol, 140, pp. 290-296; Schultz, K.F., Chalmers, I., Hayes, R.J., Altman, D.G., Empirical evidence of bias. Dimension of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273, pp. 408-412; Ioannidis, J.P., Cappelleri, J.C., Lau, J., Skolnik, P.R., Melville, B., Chalmers, T.C., Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness (1995) Ann Intern Med, 122, pp. 856-866; Holme, I., Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: Use of meta-analysis (1993) Br Heart J, 69 (1 SUPPL.), pp. S42-7; Irwig, L., Tosteson, A.N., Gatsonis, C., Lau, J., Colditz, G., Chalmers, T.C., Guidelines for meta-analyses evaluating diagnostic tests (1994) Ann Intern Med, 120, pp. 667-676; Moses, L.E., Shapiro, D., Littenberg, B., Combining independent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional considerations (1993) Stat Med, 12, pp. 1293-1316; Tweedie, R.L., Mengersen, K.L., Meta-analytic approaches to dose-response relationships, with application in studies of lung cancer and exposure to environmental tobacco smoke (1995) Stat Med, 14, pp. 545-569; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135, pp. 1301-1309; Smith, S.J., Caudill, S.P., Steinberg, K.K., Thacker, S.B., On combining doseresponse data from epidemiological studies by meta-analysis (1995) Stat Med, 14, pp. 531-544; Stewart, L.A., Clarke, M.J., Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group (1995) Stat Med, 14, pp. 2057-2079; Olkin, I., Statistical and theoretical considerations in meta-analysis (1995) J Clin Epidemiol, 48, pp. 133-146; Cook, D.J., Witt, L.G., Cook, R.J., Guyatt, G.H., Stress ulcer prophylaxis in the critically ill: A meta-analysis (1991) Am J Med, 91, pp. 519-527; Tryba, M., Prophylaxis of stress ulcer bleeding. A meta-analysis (1991) J Clin Gastroenterol, 13 (2 SUPPL.), pp. 544-555; Villar, J., Carroli, G., Belizan, J.M., Predictive ability of meta-analyses of randomised controlled trials (1995) Lancet, 345, pp. 772-776; Cappelleri, J.C., Ioannidis, J.P., Schmid, C.H., De Ferranti, S.D., Aubert, M., Chalmers, T.C., Large trials vs meta-analysis of smaller trials: How do their results compare? (1996) JAMA, 276, pp. 1332-1338; Cook, D.J., Reeve, B.K., Guyatt, G.H., Heyland, D.K., Griffith, L.E., Buckingham, L., Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses (1996) JAMA, 275, pp. 308-314; Ioannidis, J.P., Lau, J., On meta-analyses of meta-analyses (1996) Lancet, 348, p. 756; Altman, D.G., Better reporting of randomised controlled trials: The CONSORT statement (1996) BMJ, 313, pp. 570-571; Begg, C., Cho, M., Eastwood, S., Horton, R., Moher, D., Olkin, I., Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996) JAMA, 276, pp. 637-639},
correspondence_address1={Lau, J.; Division of Clinical Care Research, 750 Washington Street, Boston, MA 02111, United States},
publisher={American College of Physicians},
issn={00034819},
coden={AIMEA},
pubmed_id={9382404},
language={English},
abbrev_source_title={ANN. INTERN. MED.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Chrousos2009374,
author={Chrousos, G.P.},
title={Stress and disorders of the stress system},
journal={Nature Reviews Endocrinology},
year={2009},
volume={5},
number={7},
pages={374-381},
doi={10.1038/nrendo.2009.106},
note={cited By 1737},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-69449108280&doi=10.1038%2fnrendo.2009.106&partnerID=40&md5=63458b08d42a472b1acd7d94ba31dfe3},
affiliation={First Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Thivon and Mikras Asias streets, Athens 11527, Greece},
abstract={All organisms must maintain a complex dynamic equilibrium, or homeostasis, which is constantly challenged by internal or external adverse forces termed stressors. Stress occurs when homeostasis is threatened or perceived to be so; homeostasis is re-established by various physiological and behavioral adaptive responses. Neuroendocrine hormones have major roles in the regulation of both basal homeostasis and responses to threats, and are involved in the pathogenesis of diseases characterized by dyshomeostasis or cacostasis. The stress response is mediated by the stress system, partly located in the central nervous system and partly in peripheral organs. The central, greatly interconnected effectors of this system include the hypothalamic hormones arginine vasopressin, corticotropin-releasing hormone and pro-opiomelanocortin-derived peptides, and the locus ceruleus and autonomic norepinephrine centers in the brainstem. Targets of these effectors include the executive and/or cognitive, reward and fear systems, the wake-sleep centers of the brain, the growth, reproductive and thyroid hormone axes, and the gastrointestinal, cardiorespiratory, metabolic, and immune systems. Optimal basal activity and responsiveness of the stress system is essential for a sense of well-being, successful performance of tasks, and appropriate social interactions. By contrast, excessive or inadequate basal activity and responsiveness of this system might impair development, growth and body composition, and lead to a host of behavioral and somatic pathological conditions. © 2009 Macmillan Publishers Limited. All rights reserved.},
keywords={argipressin;  corticotropin releasing factor;  noradrenalin;  proopiomelanocortin, adaptive behavior;  allostasis;  body composition;  body growth;  brain stem;  cognition;  fear;  gastrointestinal tract;  homeostasis;  hormonal regulation;  human;  immune system;  locus ceruleus;  metabolism;  nonhuman;  pathogenesis;  physical development;  priority journal;  review;  reward;  sleep waking cycle;  social interaction;  stress;  task performance;  wellbeing;  mental stress;  pathophysiology;  physiological stress;  physiology, Corticotropin-Releasing Hormone;  Homeostasis;  Humans;  Norepinephrine;  Stress, Physiological;  Stress, Psychological},
chemicals_cas={argipressin, 113-79-1; corticotropin releasing factor, 9015-71-8; noradrenalin, 1407-84-7, 51-41-2; proopiomelanocortin, 66796-54-1; Corticotropin-Releasing Hormone, 9015-71-8; Norepinephrine, 51-41-2},
references={Raisman, G., An urge to explain the incomprehensible: Geoffrey Harris and the discovery of the neural control of the pituitary gland (1997) Ann. Rev. Neurosci., 20, pp. 533-566; Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis (1992) JAMA, 267, pp. 1244-1252; Charmandari, E., Tsigos, C., Chrousos, G.P., Neuroendocrinology of stress (2005) Ann. Rev. Physiol., (67), pp. 259-284; (1988) Mechanisms of Physical and Emotional Stress (Advances in Experimental Medicine and Biology, 245. , Chrousos, G. P., Loriaux, D. L. Gold, P. w. (eds) (Plenum Press New York); (1996) Stress: Basic Mechanisms and Clinical Implications, , Chrousos, G. P. et al. (eds) (Annals of the New York Academy of Sciences, Vol. 771) (New York Academy of sciences, New York; Chrousos, G.P., The hypothalamic-pituitary- adrenal axis and immune-mediated inflammation (1995) N. Engl. J. Med., 332, pp. 1351-1362; Chrousos, G.P., 1997 Hans selye memorial lecture: Stressors, stress and neuroendocrine integration of the adaptive response (1998) Ann. NY Acad. Sci., 851, pp. 311-335; Chrousos, G.P., The stress response and immune function: Clinical implications; The 1999 Novera H. spector lecture (2000) Ann. NY Acad. Sci., 917, pp. 38-67; Karalis, C., Autocrine or paracrine inflammatory actions of corticotropin releasing hormone in vivo (1991) Science, 254, pp. 421-423; Papanicolaou, D.A., Wilder, R.L., Manolagas, S.C., Chrousos, G.P., The pathophysiologic roles of interleukin-6 in humans (1998) Ann. Intern. Med., 128, pp. 127-137; Vale, W., Spiess, J., Rivier, C., Rivier, J., Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and a-endorphin (1981) Science, 213, pp. 1394-1397; Chrousos G., .P., Organization and integration of the endocrine system: The sleep and wakefulness perspective (2007) Sleep Med. Clin., 2, pp. 125-145; Makino, S., Psychological stress increased corticotropin-releasing hormone mrNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat (1999) Brain Res., 850, pp. 136-143; LeDoux, J.E., Emotion and the amygdala The Amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction, pp. 339-351. , (ed. Aggleton, J. P.) (wiley-Liss, New York 1992); Morgan, M., Romanski, L., Ledoux, J., Extinction of emotional learning: Contribution of medial prefrontal cortex (1993) Neurosci. Lett., 163, pp. 109-113; Morgan, M., LeDoux, J.E., Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear (1995) Behav. Neurosci., 109, pp. 681-688; Sullivan, R.M., Gratton, A., Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats (1999) J. Neurosci., (19), pp. 2834-2840; Fuster, J.M., The prefrontal cortex. An update: Time is of the essence (2001) Neuron, 30, pp. 319-333; Kalivas, P.W., Volkow, N.D., The neural basis of addiction: A pathology of motivation and choice (2005) Am. J. Psychiatry, 162, pp. 1403-1413; Mcewen, B.S., Physiology and neurobiology of stress and adaptation: Central role of the brain (2007) Physiol. Rev., 87, pp. 873-904; Vgontzas, A.N., Sleep deprivation effects on the activity of the hypothalamic-pituitary- adrenal and growth axes: Potential clinical implications (1999) Clin. Endocrinol, 51, pp. 205-215. , (Oxf.); Vgontzas, A.N., Circadian interleukin-6 secretion and quality and depth of sleep (1999) J. Clin. Endocrinol. Metab, 84, pp. 2603-2607; Vgontzas, A.N., Impaired nighttime sleep is associated with elevated plasma iL-6 and cortisol levels in healthy old vs. young adults: Physiologic and therapeutic implications (2003) J. Clin. Endocrinol. Metab, 88, pp. 2087-2095; Vgontzas, A., Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines (2004) J. Clin. Endocrinol. Metab, 89, pp. 2119-2126; Vgontzas, A.N., Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion (2007) Am. J. Physiol. Endocrinol. Metab, 292, pp. e253-e261; Vgontzas, A.N., Chrousos, G.P., Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders (2002) Endocrinol. Metab. Clin. North Am., 31, pp. 15-36; Chrousos, G.P., Torpy, D., Gold, P.W., Interactions between the hypothalamic- pituitary-adrenal axis and the female reproductive system: Clinical implications (1998) Ann. Intern. Med., 129, pp. 229-240; Taché, Y., Bonaz, B., Corticotropin-releasing factor receptors and stress-related alterations of gut motor function (2007) J. Clin. Invest., 117, pp. 33-40; Elenkov, I.J., Papanicolaou, D.A., Wilder, R.L., Chrousos, G.P., Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications (1996) Proc. Assoc. Am. Phys., (108), pp. 374-381; Elenkov, I.J., Chrousos, G.P., Stress hormones, TH1/TH2-patterns, pro/anti- inflammatory cytokines and susceptibility to disease (1999) Trends Endocrinol. Metab, (10), pp. 359-368; Elenkov, I.J., Low versus high baseline epinephrine output shapes opposite innate cytokine profiles: Presence of Lewis- and Fischer-like neurohormonal-immune phenotypes in humans (2008) J. Immunol, 181, pp. 1737-1745; Theoharides, T.C., Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects (1998) Endocrinology, 139, pp. 403-413; Theoharides, T.C., Sress-induced intracranial mast cell degranulation. A corticotropin-releasing hormone-mediated effect (1995) Endocrinology, 136, pp. 5745-5750; Franchimont, D., Kino, T., Galon, J., Meduri, G.U., Chrousos, G.P., Glucocorticoids and inflammation revisited. NiH Clinical staff Conference (2003) Neuroimmunomodulation, 10, pp. 247-260; Chrousos, G.P., Kino, T., Intracellular glucocorticoid signaling: A formerly simple system turns stochastic (2005) Sci. STKE, 304, p. 48; Chrousos, G.P., Kino, T., Glucocorticoid action networks and complex psychiatric and/or somatic disorders (2007) Stress, 10, pp. 213-219; Levine, S., The pituitary-adrenal system and the developing brain (1970) Prog. Brain Res., 32, pp. 79-85; Newport, D.J., Stowe, Z.N., Nemeroff, C.B., Parental depression: Animal models of an adverse life event (2002) Am. J. Psychiatry, 159, pp. 1265-1283; Szyf, M., Weaver, I.C., Champagne, F.A., Diorio, J., Meaney, M.J., Maternal programming of steroid receptor expression in the rat (2005) Front. Neuroendocrinol, (26), pp. 139-162; Champagne, F.A., Maternal care associated with methylation of the estrogen receptor-á1b promoter and estrogen receptor-á expression in the medial preoptic area of female offspring. (2006) Endocrinology, 147, pp. 2909-2915; Gold, P.W., Goodwin, F.K., Chrousos, G.P., Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (First of two parts) (1988) New England Journal of Medicine, 319 (6), pp. 348-353; Gold, P.W., Goodwin, F.K., Chrousos, G.P., Clinical and Biochemical manifestations of depression. Relation to the neurobiology of stress (Second of two parts) (1988) New England Journal of Medicine, 319 (7), pp. 413-420; Gold, P.W., Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia (2005) Proc. Natl Acad. Sci. USA, 102, pp. 8303-8308; Wong, M.-L., Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin releasing hormone (2000) Proc. Natl Acad. Sci. USA, 97, pp. 325-330; Alesci, S., Major depression is associated with significant diurnal elevations in plasma iL-6 levels, a shift of its circadian rhythm, and loss of physiologic complexity in its secretion: Clinical implications (2005) J. Clin. Endocrinol. Metab, 90, pp. 2522-2530; Vgontzas, A., Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis (2001) J. Clin. Endocrinol. Metab, 86, pp. 3787-3794; Vgontzas, A.N., Chronic insomnia is associated with a shift of iL-6 and TNFá Secretion from nighttime to daytime (2002) Metabolism, 29, pp. 1252-1261; Charmandari, E., Kino, T., Souvatzoglou, E., Chrousos, G.P., Pediatric stress: Hormonal mediators and human development (2003) Hormone Res., 59, pp. 161-179; Chrousos, G.P., The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuroendocrine and target tissue-related causes (2000) Int. J. Obes., 24, pp. s50f-s55f. , (London); (2006) Stress, Obesity, and Metabolic Syndrome, 1083. , Chrousos, G. P. Tsigos, C. (eds) Annals of the New York Academy of Sciences, wiley Blackwell, Hoboken; Vgontzas, A.N., Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity (1997) J. Clin. Endocrinol. Metab, 82, pp. 1313-1316; Vgontzas, A.N., Sleep apnea and daytime sleepiness and fatigue: Relations with visceral obesity, insulin resistance, and hypercytokinemia (2000) J. Clin. Endocrinol. Metab, 85, pp. 1151-1158; De Bellis, M.D., Hypothalamic-pituitary- adrenal dysregulation in sexually abused girls J. Clin. Endocrinol. Metab, 78, pp. 249-255; Pervanidou, P., The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTsD) after motor vehicle accidents: Progressive divergence of noradrenaline and cortisol concentrations over time (2007) Biol. Psychiatry, 62, pp. 1095-1102; Pervanidou, P., Elevated morning serum interleukin (iL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident (2007) Psychoneuroendocrinology, 32, pp. 991-999; Grundy, D., Fundamentals of neurogastroenterology: Basic science (2006) Gastroenterology, 130, pp. 1391-1411; Habib, K.E., Oral administration of a CrH receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates (2000) Proc. Natl Acad. Sci. USA, 10, pp. 1073-1079; Webster, E.L., Corticotropin-releasing hormone (CrH) antagonist attenuates adjuvantinduced arthritis: Evidence supporting major role for CrH in peripheral inflammation (2002) J. Rheumatol, (29), pp. 1252-1261; Gabry, K.E., Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs (2002) Mol. Psychiatry, 7, pp. 474-483; Grammatopoulos, D., Chrousos, G.P., Structural and signalling diversity of corticotropin-releasing hormone (CrH) and related peptides and their receptors: Potential clinical applications of CrH receptor antagonists (2002) Trends Endocrinol. Metab, 13, pp. 436-444; Contoreggi, C., Rice, K.C., Chrousos, G.P., Non-peptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders (2004) Neuroendocrinology, 80, pp. 111-123; Zoumakis, E., Grammatopoulos, D., Chrousos, G., Corticotropin-releasing hormone antagonists (2006) Eur. J. Endocrinol, 155 (SUPPL. 1), pp. s85-s90; Clauw, D.J., Chrousos, G.P., Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms (1997) Neuroimmunomodulation, 4, pp. 134-153; Magiakou, M.A., Hypothalamic corticotropin releasing hormone suppression during the postpartum period: Implications for the increase of psychiatric manifestations during this time (1996) J. Clin. Endocrinol. Metab, 81, pp. 1912-1917; Elenkov, I.J., Interleukin 12, tumor necrosis factor-á and hormonal changes during late pregnancy and early postpartum: Implications for autoimmune disease activity during these times (2001) J. Clin. Endocrinol. Metab, (86), pp. 4933-4938; Gold, P.W., Chrousos, G.P., The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences (1999) Proc. Assoc. Am. Physicians, 111, pp. 22-34; Gold, P.W., Gabry, K.E., Yasuda, M.R., Chrousos, G.P., Divergent endocrine abnormalities in melancholic and atypical depression: Clinical and pathophysiologic implications (2002) Endocrinol. Metab. Clin. North Am., 31, pp. 37-62; Chrousos, G.P., The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies (2004) American Journal of Medicine, 117 (3), pp. 204-207. , DOI 10.1016/j.amjmed.2004.05.006, PII S0002934304003055; Brown, G.R., Anderson, B., Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse (1991) Am. J. Psychiatry, 148, pp. 55-61; Smith, G.D., Hart, C., Blane, D., Hole, D., Adverse socioeconomic conditions in childhood and cause specific adult mortality: Prospective observation study (1998) BMJ, 316, pp. 1631-1635; Felitti, V.J., Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults (1998) Am. J. Prevent. Med., (14), pp. 245-258; Repetti, R.L., Taylor, S.E., Seeman, T.E., Risky families: Family social environments and the mental and physical health of offspring (2002) Psych. Bull., (128), pp. 330-366; Banks, J., Marmot, M., Oldfield, Z., Smith, J.P., Disease and disadvantage in the United states and in England (2006) JAMA, 295, pp. 2037-2045; Flegal, K.M., Graubard, B.I., Williamson, D.F., Gail, M.H., Excess deaths associated with underweight, overweight, and obesity (2005) JAMA, 298, pp. 1861-1867; Warren, J., (2007) Presocratics: Natural Philosophers before Socrates, , University of California, Berkeley; Cannon W., .B., (1939) The Wisdom of the Body Edn 2, , w. w. Norton, New York; Cannon W., .B., (1968) The Way of An Investigator, , Hafner, New York; Wolfe, E.L., Barger, A.C., Benison, S., Walter, B., (2000) Cannon: Science and Society, , Harvard University Press, Cambridge; Selye, H., A syndrome produced by diverse nocuous agents (1936) J. Neuropsychiatry Clin. Neurosci, 138, pp. 230-231; Selye, H., (1956) The Stress of Life, , McGraw-Hill, New York; Landau, L.D., Pitaevskii, L.P., Lifshitz, E.M., Kosevich, A.M., (1986) Theory of Elasticity Edn 3, , Butterworth-Heinemann, Oxford},
correspondence_address1={Chrousos, G. P.; First Department of Pediatrics, Thivon and Mikras Asias streets, Athens 11527, Greece; email: chrousge@med.uoa.gr},
issn={17595029},
pubmed_id={19488073},
language={English},
abbrev_source_title={Nat. Rev. Endocrionol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Bertram200717,
author={Bertram, L. and McQueen, M.B. and Mullin, K. and Blacker, D. and Tanzi, R.E.},
title={Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database},
journal={Nature Genetics},
year={2007},
volume={39},
number={1},
pages={17-23},
doi={10.1038/ng1934},
note={cited By 1429},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845892752&doi=10.1038%2fng1934&partnerID=40&md5=b90cb9de079dfafe3eecc9e93eb5d855},
affiliation={MassGeneral Institute for Neurodegenerative Disease (MIND), Department of Neurology, Massachusetts General Hospital, Charlestown, MA 02129, United States; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, United States; Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, United States; Gerontology Research Unit, Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA 02129, United States},
abstract={The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to follow, much less interpret. We have created a publicly available, continuously updated database that comprehensively catalogs all genetic association studies in the field of Alzheimer disease (http://www.alzgene.org). We performed systematic meta-analyses for each polymorphism with available genotype data in at least three case-control samples. In addition to identifying the ε4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11-1.38 for risk alleles and 0.92-0.67 for protective alleles). Our database provides a powerful tool for deciphering the genetics of Alzheimer disease, and it serves as a potential model for tracking the most viable gene candidates in other genetically complex diseases. © 2006 Nature Publishing Group.},
keywords={apolipoprotein C1;  apolipoprotein E;  apolipoprotein E4;  dipeptidyl carboxypeptidase;  tumor necrosis factor, allele;  Alzheimer disease;  article;  chrnb2 gene;  cst3 gene;  data base;  esr1 gene;  gapdhs gene;  gene;  gene frequency;  genetic association;  genetic heterogeneity;  genetic polymorphism;  genotype;  ide gene;  logistic regression analysis;  MTHFR gene;  ncstn gene;  priority journal;  PRNP gene;  psen1 gene;  risk;  statistical significance;  tf gene;  tfam gene, Alzheimer Disease;  Apolipoprotein E4;  Databases, Genetic;  Genetic Heterogeneity;  Genetic Predisposition to Disease;  Humans;  Linkage (Genetics);  Polymorphism, Genetic},
chemicals_cas={dipeptidyl carboxypeptidase, 9015-82-1; Apolipoprotein E4},
funding_details={Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentEunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, R01HD060726},
references={Tanzi, R.E., A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders (1999) J. Clin. Invest, 104, pp. 1175-1179; Saunders, A.M., Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease (1993) Neurology, 43, pp. 1467-1472; Farrer, L.A., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium (1997) J. Am. Med. Assoc, 278, pp. 1349-1356; Bertram, L., Tanzi, R.E., Alzheimer's disease: One disorder, too many genes? (2004) Hum. Mol. Genet, 13, pp. R135-R141; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Contopoulos-Ioannidis, D.G., Replication validity of genetic association studies (2001) Nat. Genet, 29, pp. 306-309; Hirschhorn, J.N., Lohmueller, K., Byrne, E., Hirschhorn, K., A comprehensive review of genetic association studies (2002) Genet. Med, 4, pp. 45-61; Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S., Hirschhorn, J.N., Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease (2003) Nat. Genet, 33, pp. 177-182; Bracken, M.B., Genomic epidemiology of complex disease: The need for an electronic evidence-based approach to research synthesis (2005) Am. J. Epidemiol, 162, pp. 297-301; Colhoun, H.M., McKeigue, P.M., Davey Smith, G., Problems of reporting genetic associations with complex outcomes (2003) Lancet, 361, pp. 865-872; Wu, X., Kan, D., Cooper, R.S., Zhu, X., Identifying genetic variation affecting a complex trait in simulated data: A comparison of meta-analysis with pooled data analysis (2005) BMC Genet, 6 (SUPPL.), p. 97. , S; Zurutuza, L., APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population (2000) Eur. J. Hum. Genet, 8, pp. 713-716; Lehmann, D.J., Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease (2005) Am. J. Epidemiol, 162, pp. 305-317; Del Bo, R. et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol. Aging 27, 770e1-770e5 (2006); Yasuda, M. et al. Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 66, 722-726 (1999); Trikalinos, T.A., Salanti, G., Khoury, M.J., Ioannidis, J.P., Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations (2006) Am. J. Epidemiol, 163, pp. 300-309; Weedon, M.N., Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility (2003) Am. J. Hum. Genet, 73, pp. 1208-1212; Rockhill, B., Newman, B., Weinberg, C., Use and misuse of population attributable fractions (1998) Am. J. Public Health, 88, pp. 15-19; Beffert, U., Arguin, C., Poirier, J., The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease (1999) Neurosci. Lett, 259, pp. 29-32; Lehmann, D.J., Williams, J., McBroom, J. & Smith, A.D. Using meta-analysis to explain the diversity of results in genetic studies of late-onset alzheimer's disease and to identify high-risk subgroups. Neuroscience 108, 541-554 (2001); Rainero, I., Association between the interleukin-1alpha gene and Alzheimer's disease: A meta-analysis (2004) Neurobiol. Aging, 25, pp. 1293-1298; Peters, J.L., Sutton, A.J., Jones, D.R., Abrams, K.R., Rushton, L., Comparison of two methods to detect publication bias in meta-analysis (2006) J. Am. Med. Assoc, 295, pp. 676-680; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Racial' differences in genetic effects for complex diseases (2004) Nat. Genet, 36, pp. 1312-1318; Munafo, M.R., Flint, J., Meta-analysis of genetic association studies (2004) Trends Genet, 20, pp. 439-444; Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., Attia, J., A method for meta-analysis of molecular association studies (2005) Stat. Med, 24, pp. 1291-1306; Ioannidis, J.P., A road map for efficient and reliable human genome epidemiology (2006) Nat. Genet, 38, pp. 3-5; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control. Clin. Trials, 7, pp. 177-188; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) Br. Med. J, 315, pp. 629-634; Lange, C., DeMeo, D., Silverman, E.K., Weiss, S.T., Laird, N.M., PBAT: Tools for family-based association studies (2004) Am. J. Hum. Genet, 74, pp. 367-369; Levin, M.L., The occurrence of lung cancer in man (1953) Acta Unio Int. Contra Cancrum, 9, pp. 531-541; Yang, Q., Khoury, M.J., Friedman, J.M., Flanders, W.D., On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction (2003) Epidemiology, 14, pp. 161-167},
correspondence_address1={Bertram, L.; MassGeneral Institute for Neurodegenerative Disease (MIND), , Charlestown, MA 02129, United States; email: bertram@helix.mgh.harvard.edu},
issn={10614036},
coden={NGENE},
pubmed_id={17192785},
language={English},
abbrev_source_title={Nat. Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Shea20091013,
author={Shea, B.J. and Hamel, C. and Wells, G.A. and Bouter, L.M. and Kristjansson, E. and Grimshaw, J. and Henry, D.A. and Boers, M.},
title={AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews},
journal={Journal of Clinical Epidemiology},
year={2009},
volume={62},
number={10},
pages={1013-1020},
doi={10.1016/j.jclinepi.2008.10.009},
note={cited By 1249},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-67849127882&doi=10.1016%2fj.jclinepi.2008.10.009&partnerID=40&md5=e14310b879c0d80e1635b944f78e8edd},
affiliation={Community Information and Epidemiological Technologies (CIET), Institute of Population Health, Ottawa, Ont., Canada; Institute for Research in Extramural Medicine (EMGO Institute), VU University Medical Center, Amsterdam, Netherlands; Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands; Ottawa Heart Institute, University of Ottawa, Ottawa, Ont., Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont., Canada; Faculty of Social Sciences, School of Psychology, University of Ottawa, Ont., Canada; Clinical Epidemiology Program, Department of Medicine, Ottawa Health Research Institute, Ottawa, Ont., Canada; Institute for Clinical Evaluative Sciences, Toronto, Ont., Canada},
abstract={Objective: Our purpose was to measure the agreement, reliability, construct validity, and feasibility of a measurement tool to assess systematic reviews (AMSTAR). Study Design and Setting: We randomly selected 30 systematic reviews from a database. Each was assessed by two reviewers using: (1) the enhanced quality assessment questionnaire (Overview of Quality Assessment Questionnaire [OQAQ]); (2) Sacks' instrument; and (3) our newly developed measurement tool (AMSTAR). We report on reliability (interobserver kappas of the 11 AMSTAR items), intraclass correlation coefficients (ICCs) of the sum scores, construct validity (ICCs of the sum scores of AMSTAR compared with those of other instruments), and completion times. Results: The interrater agreement of the individual items of AMSTAR was substantial with a mean kappa of 0.70 (95% confidence interval [CI]: 0.57, 0.83) (range: 0.38-1.0). Kappas recorded for the other instruments were 0.63 (95% CI: 0.38, 0.78) for enhanced OQAQ and 0.40 (95% CI: 0.29, 0.50) for the Sacks' instrument. The ICC of the total score for AMSTAR was 0.84 (95% CI: 0.65, 0.92) compared with 0.91 (95% CI: 0.82, 0.96) for OQAQ and 0.86 (95% CI: 0.71, 0.94) for the Sacks' instrument. AMSTAR proved easy to apply, each review taking about 15 minutes to complete. Conclusions: AMSTAR has good agreement, reliability, construct validity, and feasibility. These findings need confirmation by a broader range of assessors and a more diverse range of reviews. © 2009 Elsevier Inc. All rights reserved.},
author_keywords={Feasibility;  Meta-analysis;  Methodological quality;  Reliability;  Systematic reviews;  Validity},
keywords={article;  clinical assessment tool;  confidence interval;  correlation coefficient;  feasibility study;  human;  interrater reliability;  kappa statistics;  measurement;  priority journal;  quality control;  questionnaire;  rank sum test;  reliability;  systematic review;  validity, Evidence-Based Medicine;  Feasibility Studies;  Humans;  Observer Variation;  Quality Control;  Reproducibility of Results;  Research Design;  Review Literature as Topic},
references={Moher, D., Jadad, A.R., Nichol, G., Penman, M., Tugwell, P., Walsh, S., Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists (1995) Control Clin Trials, 16, pp. 62-73; Shea, B., Dubé, C., Moher, D., Assessing the quality of reports of systematic reviews: the QUOROM statement compared to other tools (2001) Systematic reviews in health care: meta-analysis in context, pp. 122-139. , Egger M., Smith G.D., and Altman D.G. (Eds), BMJ Books, London; Oxman, A.D., Guyatt, G.H., Validation of an index of the quality of review articles (1991) J Clin Epidemiol, 44, pp. 1271-1278; Sacks, H., Berrier, J., Reitman, D., Ancona-Berk, V.A., Chalmers, T.C., Meta-analyses of randomized controlled trials (1987) N Engl J Med, 316, pp. 450-455; Shea, B., Grimshaw, J., Wells, G., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Shea, B.J., Bouter, L.M., Peterson, J., Boers, M., Andersson, N., Ortiz, Z., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS ONE, 2 (12), pp. e1350. , 10.1371/journal.pone.0001350 Published online December 26, 2007; Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group (1989) NEJM, 319, pp. 1681-1692; Appel, L.J., Miller, E.R., Seidler, A.J., Whelton, P.K., Does supplementation of diet with "fish oil" reduce blood pressure (1993) Arch Intern Med, 153, pp. 1429-1438; Buring, J.E., Evans, D.A., Mayrent, S.L., Rosner, B., Colton, T., Hennekens, C.H., Randomized trials of aminoglycoside antibiotics: quantitative overview (1988) Rev Inf Dis, 10, pp. 951-957; Chalmers, T.C., Matta, R.J., Smith, H., Kunzler, A.M., Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction (1977) NEJM, 297, pp. 1091-1096; Clagett, G.P., Reisch, J.S., Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis (1988) Ann Surg, 208, pp. 227-240; Counsell, C., Warlow, C., Naylor, R., Different patches in carotoid surgery (1996) Cochrane Library, (issue 3); Daya, S., Comparison of FSH and HMG in IVF (1996) Cochrane Library, (3); Duley, L., Gulmezoglu, A.M., Henderson-Smart, D.J., Anticonvulsants for pre-eclampsia (1996) Cochrane Library, (3); Fanning, J., Bennett, T.Z., Hilgers, R.D., Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma (1992) Obstet Gynecol, 80, pp. 954-960; Gent, M., Roberts, R.S., A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis (1986) Chest, 89, pp. 396S-400S; Gotzsche, P.C., Gjorup, I., Bonnen, H., Brahe, N.E., Becker, U., Burcharth, F., Somatostatin vs placebo in bleeding oesophageal varices: randomised trial and meta-analysis (1995) BMJ, 310, pp. 1495-1498; Graves, P., Malaria vaccines (1996) Cochrane Library, (Issue 3); Henderson, W.G., Goldman, S., Copeland, J., Moritz, T.E., Harker, L.A., Antiplatelet or anticoagulant therapy, after coronary artery bypass surgery: a meta-analysis of clinical trials (1989) Ann Intern Med, 111, pp. 743-750; Hodnett, E.D., Alternative versus conventional delivery settings (1996) Cochrane Library, (3); Hofmeyr, G.J., Abdominal decompression (1996) Cochrane Library, (3); Hopfenmuller, W., Nackweis der therapeutischen Wirksamkeit eines Ginkgo biloba-Spezial extrakes: Meta-Analyse von 11 klinischen Studien bei Patienten mit Hirnleistungsstorungen im Alter (1994) Arzneimittel-Forschung, 44, pp. 1005-1013; Hughes, E., Fedorkow, D.M., Daya, S., Sagle, M.A., van de Kopple, P., Collins, J.A., The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intra-fallopian transfer: a meta-analysis of randomized controlled trials (1992) Fertil Steril, 58, pp. 888-896; Kaufmann, P.G., Jacob, R.G., Ewart, C.K., Chesney, M.A., Muenz, L.R., Doub, N., Hypertension Intervention Pooling Project (1988) Health Psychol, 7 (SUPPL), pp. 209-224; Kramer, M.S., Maternal antigen avoidance as lactation (1996) Cochrane Library, (3); Lycka, B.A., Postherpetic neuralgia and systemic corticosteroid therapy. Efficacy and safety (1990) Int J Dermatol, 29, pp. 523-527; McGrath, J.J., Soares, K.V.S., Tardive dyskinesia and benzodiazepines (1996) Cochrane Library, (3); Mulrow, C.D., Mulrow, J.P., Linn, W.D., Aguilar, C., Ramirez, C., Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials (1988) JAMA, 259, pp. 3422-3426; Ohlsson, A., Treatments of preterm premature rupture of the membranes: a meta-analysis (1989) Am J Obstet Gynecol, 160, pp. 890-906; Perez-Escamilla, R., Pollitt, E., Lonnerdal, B., Dewey, K.G., Infant feeding policies in maternity wards and their effect on breast-feeding success: an analytical overview (1994) Am J Public Health, 84, pp. 89-97; Renfrew, M.J., Lang, S., Breastfeeding and discharge times (1996) Cochrane Library, (3); Renfrew, M.J., Lang, S., Breastfeeding and early contact (1996) Cochrane Library, (3); Soares, K.V.S., McGrath, J.J., Deeks, J.J., Tardive dyskinesia and GABA agonist drugs (1996) Cochrane Library, (3); Thacker, S.B., Quality of controlled clinical trials. The case of imaging ultrasound in obstetrics: a review (1985) BJOG, 92, pp. 437-444; Velanovich, V., Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality (1989) Surgery, 105, pp. 65-71; Wilson, A.P.R., Shrimpton, S., Jaderberg, M., A meta-analysis of the use of amoxycillin-clavulanic acid in surgical prophylaxis (1992) J Hosp Infect, 22, pp. 9-21; Cohen, J., A coefficient of agreement for nominal scales (1960) Educ Psychol Meas, 20, pp. 37-46; Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between two methods of clinical measurement (1986) Lancet, i, pp. 307-310. , http://www-users.york.ac.uk/~mb55/meas/ba.htm; Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between measurements (1987) Biochim Clin, 11, pp. 399-404; Anonymous. This week's citation classic: comparing methods of clinical measurement. Curr Contents 1992; CC/NUMBER 40: 8. Available at http://garfield.library.upenn.edu/classics1992/A1992JN24800001.pdf; Uebersax, J.S., Diversity of decision-making models and the measurement of inter-rater agreement (1987) Psychol Bull, 101, pp. 140-146; Cohen, J., Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit (1968) Psychol Bull, 70, pp. 213-220; Tugwell, P., Bombardier, C., A methodological framework for developing and selecting endpoints in clinical trials (1982) J Rheumatol, 9, pp. 758-762; Singh, S., Bai, A., Lal, A., Yu, C., Ahmed, F., (2006) Developing evidence-based best practices for the prescribing and use of proton pump inhibitors in Canada, , The Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Canada; Balk, E., Bonis, P., Moskowitz, H., Schmid, C., Ioannidis, J., Wang, C., Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials (2002) JAMA, 287, pp. 2973-2982; Jüni, P., Altman, D.G., Egger, M., Assessing the quality of controlled clinical trials (2001) Systematic reviews in health care: meta-analysis in context. 2nd ed, , Egger M., Davey Smith G., and Altman D.G. (Eds), BMJ Books, London; Barnes, D.E., Bero, L.A., Why review articles on the health effects of passive smoking reach different conclusions (1998) JAMA, 279, pp. 1566-1570; Biondi-Zoccai, G., Lotrionte, M., Abbate, A., Testa, L., Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study (2006) BMJ, 332, pp. 202-206; Chou, R., Helfand, M., Challenges in systematic reviews that assess treatment harms (2005) Ann Intern Med, 142, pp. 1090-1099; Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A., Rosenthal, R., Selective Publication of antidepressant trials and its influence on apparent efficacy (2008) N Eng J Med, 358, pp. 252-260; Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., Boddington, E., Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data (2004) Lancet, 363, pp. 1341-1345; McGinn, T., Guyatt, G., Cook, R., Meade, M., Diagnosis: measuring agreement beyond chance (2002) Users' guide to the medical literature. A manual for evidence-based clinical practice, pp. 461-470. , Guyatt G., and Rennie D. (Eds), AMA Press, Chicago, IL; Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup D for the QUOROM group. Improving the reporting quality of meta-analysis of randomized controlled trials: the QUOROM statement (1999) Lancet, 354, pp. 1896-1900; Oxman, A.D., Schünemann, H.J., Fretheim, A., Improving the use of research evidence in guideline development: synthesis and presentation of evidence (2006) Health Res Policy Syst, (4), p. 20. , http://www.health-policy-systems.com/content/4/1/20, 10.1186/1478-4505-4-20 Received April 7, 2006, Accepted December 5, 2006. Available at},
correspondence_address1={Shea, B.J.; Community Information and Epidemiological Technologies (CIET), , Ottawa, Ont., Canada; email: bshea@ciet.org},
issn={08954356},
coden={JCEPE},
pubmed_id={19230606},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Nalls2014989,
author={Nalls, M.A. and Pankratz, N. and Lill, C.M. and Do, C.B. and Hernandez, D.G. and Saad, M. and Destefano, A.L. and Kara, E. and Bras, J. and Sharma, M. and Schulte, C. and Keller, M.F. and Arepalli, S. and Letson, C. and Edsall, C. and Stefansson, H. and Liu, X. and Pliner, H. and Lee, J.H. and Cheng, R. and Ikram, M.A. and Ioannidis, J.P.A. and Hadjigeorgiou, G.M. and Bis, J.C. and Martinez, M. and Perlmutter, J.S. and Goate, A. and Marder, K. and Fiske, B. and Sutherland, M. and Xiromerisiou, G. and Myers, R.H. and Clark, L.N. and Stefansson, K. and Hardy, J.A. and Heutink, P. and Chen, H. and Wood, N.W. and Houlden, H. and Payami, H. and Brice, A. and Scott, W.K. and Gasser, T. and Bertram, L. and Eriksson, N. and Foroud, T. and Singleton, A.B. and Plagnol, V. and Sheerin, U.-M. and Simón-Sánchez, J. and Lesage, S. and Sveinbjörnsdóttir, S. and Barker, R. and Ben-Shlomo, Y. and Berendse, H.W. and Berg, D. and Bhatia, K. and de Bie, R.M.A. and Biffi, A. and Bloem, B. and Bochdanovits, Z. and Bonin, M. and Bras, J.M. and Brockmann, K. and Brooks, J. and Burn, D.J. and Charlesworth, G. and Chinnery, P.F. and Chong, S. and Clarke, C.E. and Cookson, M.R. and Cooper, J.M. and Corvol, J.C. and Counsell, C. and Damier, P. and Dartigues, J.-F. and Deloukas, P. and Deuschl, G. and Dexter, D.T. and van Dijk, K.D. and Dillman, A. and Durif, F. and Dürr, A. and Edkins, S. and Evans, J.R. and Foltynie, T. and Dong, J. and Gardner, M. and Gibbs, J.R. and Gray, E. and Guerreiro, R. and Harris, C. and van Hilten, J.J. and Hofman, A. and Hollenbeck, A. and Holton, J. and Hu, M. and Huang, X. and Wurster, I. and Mätzler, W. and Hudson, G. and Hunt, S.E. and Huttenlocher, J. and Illig, T. and Jónsson, P.V. and Lambert, J.-C. and Langford, C. and Lees, A. and Lichtner, P. and Limousin, P. and Lopez, G. and Lorenz, D. and McNeill, A. and Moorby, C. and Moore, M. and Morris, H.R. and Morrison, K.E. and Mudanohwo, E. and O’sullivan, S.S. and Pearson, J. and Pétursson, H. and Pollak, P. and Post, B. and Potter, S. and Ravina, B. and Revesz, T. and Riess, O. and Rivadeneira, F. and Rizzu, P. and Ryten, M. and Sawcer, S. and Schapira, A. and Scheffer, H. and Shaw, K. and Shoulson, I. and Sidransky, E. and Smith, C. and Spencer, C.C.A. and Stefánsson, H. and Bettella, F. and Stockton, J.D. and Strange, A. and Talbot, K. and Tanner, C.M. and Tashakkori-Ghanbaria, A. and Tison, F. and Trabzuni, D. and Traynor, B.J. and Uitterlinden, A.G. and Velseboer, D. and Vidailhet, M. and Walker, R. and van de Warrenburg, B. and Wickremaratchi, M. and Williams, N. and Williams-Gray, C.H. and Winder-Rhodes, S. and Stefánsson, K. and Hardy, J. and Factor, S. and Higgins, D. and Evans, S. and Shill, H. and Stacy, M. and Danielson, J. and Marlor, L. and Williamson, K. and Jankovic, J. and Hunter, C. and Simon, D. and Ryan, P. and Scollins, L. and Saunders-Pullman, R. and Boyar, K. and Costan-Toth, C. and Ohmann, E. and Sudarsky, L. and Joubert, C. and Friedman, J. and Chou, K. and Fernandez, H. and Lannon, M. and Galvez-Jimenez, N. and Podichetty, A. and Thompson, K. and Lewitt, P. and Deangelis, M. and O'brien, C. and Seeberger, L. and Dingmann, C. and Judd, D. and Marder, K. and Fraser, J. and Harris, J. and Bertoni, J. and Peterson, C. and Rezak, M. and Medalle, G. and Chouinard, S. and Panisset, M. and Hall, J. and Poiffaut, H. and Calabrese, V. and Roberge, P. and Wojcieszek, J. and Belden, J. and Jennings, D. and Marek, K. and Mendick, S. and Reich, S. and Dunlop, B. and Jog, M. and Horn, C. and Uitti, R. and Turk, M. and Ajax, T. and Mannetter, J. and Sethi, K. and Carpenter, J. and Dill, B. and Hatch, L. and Ligon, K. and Narayan, S. and Blindauer, K. and Abou-Samra, K. and Petit, J. and Elmer, L. and Aiken, E. and Davis, K. and Schell, C. and Wilson, S. and Velickovic, M. and Koller, W. and Phipps, S. and Feigin, A. and Gordon, M. and Hamann, J. and Licari, E. and Marotta-Kollarus, M. and Shannon, B. and Winnick, R. and Simuni, T. and Videnovic, A. and Kaczmarek, A. and Williams, K. and Wolff, M. and Rao, J. and Cook, M. and Fernandez, M. and Kostyk, S. and Hubble, J. and Campbell, A. and Reider, C. and Seward, A. and Camicioli, R. and Carter, J. and Nutt, J. and Andrews, P. and Morehouse, S. and Stone, C. and Mendis, T. and Grimes, D. and Alcorn-Costa, C. and Gray, P. and Haas, K. and Vendette, J. and Sutton, J. and Hutchinson, B. and Young, J. and Rajput, A. and Klassen, L. and Shirley, T. and Manyam, B. and Simpson, P. and Whetteckey, J. and Wulbrecht, B. and Truong, D. and Pathak, M. and Frei, K. and Luong, N. and Tra, T. and Tran, A. and Vo, J. and Lang, A. and Kleiner-Fisman, G. and Nieves, A. and Johnston, L. and So, J. and Podskalny, G. and Giffin, L. and Atchison, P. and Allen, C. and Martin, W. and Wieler, M. and Suchowersky, O. and Furtado, S. and Klimek, M. and Hermanowicz, N. and Niswonger, S. and Shults, C. and Fontaine, D. and Aminoff, M. and Christine, C. and Diminno, M. and Hevezi, J. and Dalvi, A. and Kang, U. and Richman, J. and Uy, S. and Sahay, A. and Gartner, M. and Schwieterman, D. and Hall, D. and Leehey, M. and Culver, S. and Derian, T. and Demarcaida, T. and Thurlow, S. and Rodnitzky, R. and Dobson, J. and Lyons, K. and Pahwa, R. and Gales, T. and Thomas, S. and Shulman, L. and Weiner, W. and Dustin, K. and Singer, C. and Zelaya, L. and Tuite, P. and Hagen, V. and Rolandelli, S. and Schacherer, R. and Kosowicz, J. and Gordon, P. and Werner, J. and Serrano, C. and Roque, S. and Kurlan, R. and Berry, D. and Gardiner, I. and Hauser, R. and Sanchez-Ramos, J. and Zesiewicz, T. and Delgado, H. and Price, K. and Rodriguez, P. and Wolfrath, S. and Pfeiffer, R. and Davis, L. and Pfeiffer, B. and Dewey, R. and Hayward, B. and Johnson, A. and Meacham, M. and Estes, B. and Walker, F. and Hunt, V. and O'neill, C. and Racette, B. and Swisher, L. and Dijamco, C. and Conley, E.D. and Dorfman, E. and Tung, J.Y. and Hinds, D.A. and Mountain, J.L. and Wojcicki, A. and Lew, M. and Klein, C. and Golbe, L. and Growdon, J. and Wooten, G.F. and Watts, R. and Guttman, M. and Goldwurm, S. and Saint-Hilaire, M.H. and Baker, K. and Litvan, I. and Nicholson, G. and Nance, M. and Drasby, E. and Isaacson, S. and Burn, D. and Pramstaller, P. and Al-Hinti, J. and Moller, A. and Sherman, S. and Roxburgh, R. and Slevin, J. and Perlmutter, J. and Mark, M.H. and Huggins, N. and Pezzoli, G. and Massood, T. and Itin, I. and Corbett, A. and Chinnery, P. and Ostergaard, K. and Snow, B. and Cambi, F. and Kay, D. and Samii, A. and Agarwal, P. and Roberts, J.W. and Higgins, D.S. and Molho, E. and Rosen, A. and Montimurro, J. and Martinez, E. and Griffith, A. and Kusel, V. and Yearout, D. and Factor, S. and Zabetian, C. and Clark, L.N. and Liu, X. and Lee, J.H. and Cheng Taub, R. and Louis, E.D. and Cote, L.J. and Waters, C. and Ford, B. and Fahn, S. and Vance, J.M. and Beecham, G.W. and Martin, E.R. and Nuytemans, K. and Pericak-Vance, M.A. and Haines, J.L. and Destefano, A. and Seshadri, S. and Choi, S.H. and Frank, S. and Bis, J.C. and Psaty, B.M. and Rice, K. and Longstreth, W.T., Jr. and Ton, T.G.N. and Jain, S. and van Duijn, C.M. and Uitterlinden, A.G. and Verlinden, V.J. and Koudstaal, P.J. and Singleton, A. and Cookson, M. and Gibbs, J.R. and Hernandez, D. and Nalls, M. and Zonderman, A. and Ferrucci, L. and Johnson, R. and Longo, D. and O'brien, R. and Traynor, B. and Troncoso, J. and van der Brug, M. and Zielke, R. and Weale, M. and Ramasamy, A. and Dardiotis, E. and Tsimourtou, V. and Spanaki, C. and Plaitakis, A. and Bozi, M. and Stefanis, L. and Vassilatis, D. and Koutsis, G. and Panas, M. and Hadjigeorgiou, G.M. and Lunnon, K. and Lupton, M. and Powell, J. and Parkkinen, L. and Ansorge, O. and International Parkinson's Disease Genomics Consortium (IPDGC) and Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI) and 23andMe and GenePD and NeuroGenetics Research Consortium (NGRC) and Hussman Institute of Human Genomics (HIHG) and The Ashkenazi Jewish Dataset Investigator and Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE) and North American Brain Expression Consortium (NABEC) and United Kingdom Brain Expression Consortium (UKBEC) and Greek Parkinson's Disease Consortium and Alzheimer Genetic Analysis Group},
title={Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease},
journal={Nature Genetics},
year={2014},
volume={46},
number={9},
pages={989-993},
doi={10.1038/ng.3043},
note={cited By 1224},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939599004&doi=10.1038%2fng.3043&partnerID=40&md5=0660c6c23016ec15637e7dd7916b9dfe},
affiliation={Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, United States; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; 23andMe, Inc, Mountain View, CA, United States; Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, United Kingdom; Department of Biostatistics, University of Washington, Seattle, WA, United States; INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France; Department of Neurology, Boston University School of Medicine, Boston, MA, United States; Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States; National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study, Framingham, MA, United States; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom; Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; deCODE Genetics, Reykjavík, Iceland; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States; The Taub Institute for Alzheimer’s Disease and the Aging Brain, Columbia University Medical Center, New York, NY, United States; Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Radiology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Stanford Prevention Research Center, Stanford University, Stanford, CA, United States; Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, United States; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, United States; Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States; Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States; Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States; Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, NY, United States; Department of Neurology, Columbia University Medical Center, New York, NY, United States; Department of Psychiatry, Columbia University Medical Center, New York, NY, United States; The Michael J. Fox Foundation for Parkinson’s Research, New York, NY, United States; Neuroscience Center, National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States; Department of Neurology, Papageorgiou Hospital, Thessaloniki, Greece; Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle, North Carolina, United States; New York State Department of Health Wadsworth Center, Albany, NY, United States; Sorbonne Université, UPMC Université Paris 06, UM 75, INSERM U1127, Institut du Cerveau et de la Moelle, Paris, France; CNRS, UMR 7225, Paris, France; Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France; Department of Human Genetics, University of Miami School of Medicine, Miami, FL, United States; School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States; Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD  20892, United States; Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, WC1N 3BG, United Kingdom; Department of Biostatistics, University of Washington, Seattle, WA  8195-9460, United States; Department of Neurology, Boston University School of Medicine, Boston, MA, United States; Department of Biostatistics, Boston University School of Public Health, Boston, MA  02118, United States; NHLBI’s Framingham Heart Study, Framingham, MA, United States; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany; deCODE genetics, Sturlugata 8, IS-101, Reykjavík, Iceland; The Taub Institute for Alzheimer’s Disease and the Aging Brain, Columbia University Medical Center, New York, NY  10032, United States; Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Greece; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, United States; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO  63110, United States; Department of Neurology, Washington University School of Medicine, St Louis, MO  63110, United States; Department of Psychiatry, Washington University School of Medicine, St Louis, MO  63110, United States; Department of Genetics, Washington University School of Medicine, St Louis, MO  63110, United States; Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, NY  10032, United States; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina, United States; New York State Department of Health Wadsworth Center, Albany, NY, United States; Sorbonne Université, UPMC Univ Paris 06, UM 75, ICM; Inserm, U 1127, ICM; ICM, Paris, Paris, F-75013, France; Centre National de la Recherche Scientifique, UMR, Paris, 7225, France; AP-HP, Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France; UCL Genetics Institute, London, United Kingdom; INSERM U563, CPTP, Toulouse, France; Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, Netherlands; Université Pierre et Marie Curie-Paris, Centre de Recherche de l’Institut du Cerveau et de la Moelle épinière, Paris, France; Department of Neurology, Landspítali University Hospital, Reykjavík, Iceland; Department of Neurology, MEHT Broomfield Hospital, Chelmsford, Essex, United Kingdom; Department of Neurology, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom; School of Social and Community Medicine, University of Bristol; Department of Neurology and Alzheimer Center, VU University Medical Center; Department of Motor Neuroscience, UCL Institute of Neurology; Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Center for Human Genetic Research and Department of Neurology, Massachusetts General Hospital, Boston, MA, United States; Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; Department of Medical Genetics, Institute of Human Genetics, University of Tübingen, Tübingen, Germany; Newcastle University Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom; Neurology M4104, The Medical School, Framlington Place, Newcastle upon Tyne, United Kingdom; School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Neurosciences, UCL Institute of Neurology; University of Aberdeen, Division of Applied Health Sciences, Population Health Section, Aberdeen, United Kingdom; CHU Nantes, CIC0004, Service de Neurologie, Nantes, France; INSERM U897, Université Victor Segalen, Bordeaux, France; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom; Klinik für Neurologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität Kiel, Kiel, Germany; Parkinson’s Disease Research Group, Faculty of Medicine, Imperial College London, London, United Kingdom; Service de Neurologie, Hôpital Gabriel Montpied, Clermont-Ferrand, France; Cambridge Centre for Brain Repair, Cambridge, United Kingdom; UCL Institute of Neurology; University of Aberdeen; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; AARP, Washington, DC, United States; Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology; Department of Clinical Neurology, John Radcliffe Hospital, Oxford, United Kingdom; Department of Neurology, Pennsylvania State University, Milton S Hershey Medical Center, Hershey, PA, United States; Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Neuherberg, Germany; Department of Geriatrics, Landspítali University Hospital, Reykjavík, Iceland; INSERM U744, Lille, France; Institute of Human Genetics, Helmholtz Zentrum München, German Research Centre for Environmental Health, Neuherberg, Germany; Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, London, United Kingdom; Section on Molecular Neurogenetics, Medical Genetics Branch, NHGRI, National Institutes of Health; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, United Kingdom; Neurogenetics Unit, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery; Department of Neurology, Radiology, and Neurobiology at Washington University, St Louis, United States; Service de Neurologie, CHU de Grenoble, Grenoble, France; Translational Neurology, Biogen IdecMA, United States; Department of Epidemiology, Erasmus University Medical Center; Department of Internal Medicine, Erasmus University Medical Center; University of Cambridge, Department of Clinical Neurosciences, Addenbrooke’s hospital, Cambridge, United Kingdom; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; Department of Neurology, University of Rochester, Rochester, NY, United States; Department of Neurology, University of Washington, Seattle, WA, United States; Department of Pathology, University of Edinburgh, Edinburgh, United Kingdom; Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; University of Oxford, Department of Clinical Neurology, John Radcliffe Hospital, Oxford, United Kingdom; Clinical Research Department, The Parkinson’s Institute and Clinical Center, Sunnyvale, CA, United States; Service de Neurologie, Hôpital Haut-Lévêque, Pessac, France; Department of Psychiatry, University of Cambridge; Medical Research Council, University of Cambridge; Wellcome Trust Behavioural and Clinical Neurosciences Institute, University of Cambridge; INSERM UMR 1043; INSERM UMR S975; Institut Pasteur de Lille, Université de Lille Nord, Lille, France; Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom; Neurosciences Department, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, United States; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Albany Medical College; Barrow Neurological Institute; Baylor College of Medicine; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Brown University (Memorial Hospital of RI); Colorado Neurological Institute; Columbia University Medical Center; Creighton University; Evanston Northwestern Healthcare; Hotel-Dieu Hospital-Chum; Hunter Homes McGuire Veterans Medical Center; Indiana University School of Medicine; Institute For Neurodegenerative Disorders; Johns Hopkins University; London Health Sciences Centre; Mayo Clinic Jacksonville; McFarland Neurosciences; Medical College of Georgia; Medical College of Wisconsin; Medical University of Ohio; Mount Sinai School of Medicine; North Shore-LIJ Health System; Northwestern University; Ochsner Clinic Foundation; Ohio State University; Ottawa Hospital Civic Site; Pacific Neuroscience Medical Group; Saskatoon Dist Health Board Royal Univ Hosp; Scott & White Hospital/Texas A&M University; The Parkinson's & Movement Disorder Institute; Toronto Western Hospital, University Health; UMDNJ-School of Osteopathic Medicine; University of Alabama at Birmingham; University of Alberta; University of Calgary; University of California Irvine; University of California San Diego; University of California San Francisco; University of Chicago; University of Cincinnati; University of Colorado Health Sciences Center; University of Connecticut; University of Kansas Medical Center; University of Maryland School of Medicine; University of Miami; University of Minnesota; University of New Mexico; University of Puerto Rico School of Medicine; University of Rochester; University of South Florida; University of Tennessee Health Science Center; University of Texas Southwestern Medical Center; Wake Forest University School of Medicine; Washington University; University Southern California School of Medicine; University of Lübeck, Germany; UMDNJ-Robert Wood Johnson Medical School; Massachusetts General Hospital, Harvard Medical School; University of Virginia Health System; University of Toronto; Sun Health Research Institute; Parkinson Institute, Istituti Clinici di Perfezionamento, Milano, Italy; Cleveland Clinic Foundation; University of Louisville School of Medicine; University of Sydney ANZAC Research Institute, Concord Hospital, Sydney, Australia; Struthers Parkinson's Center, Minneapolis, United States; Port City Neurology, Scarborough, ME, United States; Parkinson's Disease and Movement Disorder Center of Boca Raton; Newcastle University, Newcastle upon Tyne, United Kingdom; General Regional Hospital Bolzano, Bolzano, Italy; University of Arkansas for Medical Sciences; Aarhus University Hospital, Aarhus, Denmark; University of Arizona; Auckland City Hospital, Auckland, New Zealand; University of Kentucky College of Medicine; VA Puget Sound Health Care System and University of Washington; Oregon Health and Sciences University; Evergreen Hospital Medical Center; Virginia Mason Medical Center; Samuel Stratton VA Medical Center and Albany Medical Center; Emory University; Department of Neurology, Columbia University Medical Center; Miami Udall PD Research Center of Excellence; Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, FL, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States; Department of Health Services, University of Washington, Seattle, WA, United States; Group Health Research Institute, Group Health Cooperative, Seattle, WA, United States; Cardiovascular Health Study, Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States; Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Neurology, Cardiff University, Cardiff, United Kingdom; INSERM CIC-9503, Hôpital Pitié-Salpêtrière, Paris, France; Department of Pathology and Cell Biology, Columbia University Medical Center; Department of Neurology, Gertrude H Sergievsky Center; Department of Epidemiology & Biostatistics and Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, United States; Research Resources Branch, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States; Clinical Research Branch, National Institute on Aging, Baltimore, MD, United States; NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, MD  21201, United States; Lymphocyte Cell Biology Unit, Laboratory of Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States; Brain Resource Center, Johns Hopkins University, Baltimore, MD, United States; Department of Neuroscience, Karolinska Institutet, Stockholm, 171 77, Sweden; Department of Neuropathology, MRC Sudden Death Brain Bank Project, University of Edinburgh, Wilkie Building, Teviot Place, Edinburgh, EH8 9AG, United Kingdom; Department of Genetics, King Faisal Specialist Hospital and Research Centre,  PO Box 3354, Riyadh, 11211, Saudi Arabia; Department of Neurology, Medical School, University of Crete, Heraklion, Crete, Greece; ‘Hygeia’ Hospital, Clinic of Neurodegenerative Disorders, Athens, Greece; Second Department of Neurology, National and Kapodistrian University of Athens Medical School, Athens, Greece; Division of Cell Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Neurogenetics Unit, 1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece; General Hospital of Syros, Syros, Greece; Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Department of Neuroscience, King's College London Institute of Psychiatry, London, United Kingdom; Oxford Parkinson's Disease Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom; Department of Neuropathology, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe HospitalOX3 9DU, United Kingdom; Department of Medical and Molecular Genetics, King’s College London, 8th Floor, Tower Wing, Guy’s Hospital, London, SE1 9RT, United Kingdom; CNRS, Paris, France 228-Pitié-Salpêtrière Hospital; Clinical neuroscience Center, 26400 West Twelve Mile Road, Suite 110, Southfield, MI  48034, United States; Department of Neurology, University Hospital of Larissa, Greece; Queen Mary College, University of London, London, United Kingdom; Neurology M4104, The Medical School, Newcastle upon Tyne, United Kingdom; Boston University School of Medicine, Boston, MA, United States; Washington University School of Medicine},
abstract={We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls. Twenty-six loci were identified as having genome-wide significant association; these and 6 additional previously reported loci were then tested in an independent set of 5,353 cases and 5,551 controls. Of the 32 tested SNPs, 24 replicated, including 6 newly identified loci. Conditional analyses within loci showed that four loci, including GBA, GAK-DGKQ, SNCA and the HLA region, contain a secondary independent risk variant. In total, we identified and replicated 28 independent risk variants for Parkinson's disease across 24 loci. Although the effect of each individual locus was small, risk profile analysis showed substantial cumulative risk in a comparison of the highest and lowest quintiles of genetic risk (odds ratio (OR) = 3.31, 95% confidence interval (CI) = 2.55-4.30; P = 2 × 10-16). We also show six risk loci associated with proximal gene expression or DNA methylation. © 2014 Nature America, Inc. All rights reserved.},
keywords={Article;  DNA methylation;  gene expression;  gene identification;  gene locus;  genetic association;  genetic risk;  genetic variability;  human;  Parkinson disease;  priority journal;  risk assessment;  single nucleotide polymorphism;  case control study;  genetic predisposition;  genetics;  genome-wide association study;  genotype;  meta analysis;  Parkinson disease;  procedures;  risk factor, Case-Control Studies;  Genetic Loci;  Genetic Predisposition to Disease;  Genome-Wide Association Study;  Genotype;  Humans;  Parkinson Disease;  Polymorphism, Single Nucleotide;  Risk Factors},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute on AgingNational Institute on Aging, NIA, K23AG024826, P30AG013846, R01AG008122, R01AG016495, R01AG023629, R01AG025259, R01AG031287, R01AG033193, U24AG021886, ZIAAG000932, ZIAAG000949},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, R01HL120393},
funding_details={National Human Genome Research InstituteNational Human Genome Research Institute, NHGRI, R44HG006981},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, R01CA141668},
funding_details={National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK063491},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, K02NS073836, K23NS070867, P50NS038377, P50NS071674, R01NS017950, R01NS036960, R01NS037167, R01NS075321, R01NS076843, R01NS088538, R21NS050487, R56NS036630},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, ZIAES101986},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, KL2RR024154, UL1RR024156},
funding_details={National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences, NCATS, UL1TR000124, UL1TR001108, UL1TR002529},
funding_details={Medical Research CouncilMedical Research Council, MRC, G0700943, G0701075, G0802462, G0802760, G0901254, G1001253, G108/638, G1100479, MC_G0901330, MC_G1000735, MC_PC_09003, MR/J004758/1, MR/L010305/1, MR/L016400/1},
references={Lill, C.M., Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database (2012) PLoS Genet, 8, p. e1002548; Do, C.B., Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease (2011) PLoS Genet, 7, p. e1002141; International Parkinson Disease Genomics Consortium (2011) Imputation of Sequence Variants for Identification of Genetic Risks for Parkinson's Disease: A Meta-analysis of Genome-wide Association Studies. Lancet, 377, pp. 641-649; A two-stage meta-analysis identifies several new loci for Parkinson's disease (2011) PLoS Genet, 7, p. e1002142. , International Parkinson's Disease Genomics Consortium (IPDGC) & Wellcome Trust Case Control Consortium 2 (WTCCC2; Edwards, T.L., Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease (2010) Ann. Hum. Genet, 74, pp. 97-109; Pankratz, N., Genomewide association study for susceptibility genes contributing to familial Parkinson disease (2009) Hum. Genet, 124, pp. 593-605; Pankratz, N., Meta-analysis of Parkinson's disease: Identification of a novel locus (2012) RIT2. Ann. Neurol, 71, pp. 370-384; Simón-Sánchez, J., Genome-wide association study confirms extant PD risk loci among the Dutch (2011) Eur. J. Hum. Genet, 19, pp. 655-661; Hamza, T.H., Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease (2010) Nat. Genet, 42, pp. 781-785; Liu, X., Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population (2011) BMC Med. Genet, 12 (104); Hernandez, D.G., Genome wide assessment of young onset Parkinson's disease from Finland (2012) PLoS ONE, 7, p. e41859; Pihlstrøm, L., Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease (2013) Neurobiol. Aging, 34, pp. 1708e7-1708e13; Sharma, M., Large-scale replication and heterogeneity in Parkinson disease genetic loci (2012) Neurology, 79, pp. 659-667; Saad, M., Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population (2011) Hum. Mol. Genet, 20, pp. 615-627; Satake, W., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease (2009) Nat. Genet, 41, pp. 1303-1307; Elbaz, A., Independent and joint effects of the MAPT and SNCA genes in Parkinson disease (2011) Ann. Neurol, 69, pp. 778-792; Psaty, B.M., Design of prospective meta-analyses of genome-wide association studies from 5 cohorts (2009) Circ. Cardiovasc. Genet, 2, pp. 73-80. , Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; MacLeod, D.A., RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk (2013) Neuron, 77, pp. 425-439; Keller, M.F., Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease (2012) Hum. Mol. Genet, 21, pp. 4996-5009; Wei, Z., Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease (2013) Am. J. Hum. Genet, 92, pp. 1008-1012; Willems, S.M., Mihaescu, R., Sijbrands, E.J.G., Van Duijn, C.M., Janssens, A.C.J.W., A methodological perspective on genetic risk prediction studies in type 2 diabetes: Recommendations for future research (2011) Curr. Diab. Rep, 11, pp. 511-518; Morrison, A.C., Whole-genome sequence-based analysis of high-density lipoprotein cholesterol (2013) Nat. Genet, 45, pp. 899-901; A Map of Human Genome Variation from Population-scale Sequencing (2010) Nature, 467, pp. 1061-1073. , 1000 Genomes Project Consortium; De Bakker, P.I., Practical aspects of imputation-driven meta-analysis of genome-wide association studies (2008) Hum. Mol. Genet, 17, pp. R122-R128; Van Der Walt, J.M., Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease (2004) Am. J. Hum. Genet, 74, pp. 1121-1127; Gibbs, J.R., Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain (2010) PLoS Genet, 6, p. e1000952; Hofman, A., The Rotterdam Study: 2012 objectives and design update (2011) Eur. J. Epidemiol, 26, pp. 657-686; Ton, T.G., Post hoc Parkinson's disease: Identifying an uncommon disease in the Cardiovascular Health Study (2010) Neuroepidemiology, 35, pp. 241-249; Ikram, M.A., Genomewide association studies of stroke (2009) N. Engl. J. Med, 360, pp. 1718-1728; Eriksson, N., Genetic variant sassociated with breast size also influence breast cancer risk (2012) BMC Med. Genet, 13 (53); Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., Abecasis, G.R., Fast and accurate genotype imputation in genome-wide association studies through pre-phasing (2012) Nat. Genet, 44, pp. 955-959; Willer, C.J., Li, Y., Metal, R.A.G., Fast and efficient meta-analysis of genomewide association scans (2010) Bioinformatics, 26, pp. 2190-2191; Han, B., Eskin, E., Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies (2011) Am. J. Hum. Genet, 88, pp. 586-598; Grove, M.L., Best practices and joint calling of the humanexome beadchip: The charge consortium (2013) PLoS ONE, 8, p. e68095; Ripatti, S., A multilocus genetic risk score for coronary heart disease: Case-control and prospective cohort analyses (2010) Lancet, 376, pp. 1393-1400; Hernandez, D.G., Distinct DNA methylation changes highly correlated with chronological age in the human brain (2011) Hum. Mol. Genet, 20, pp. 1164-1172},
correspondence_address1={Singleton, A.B.; Laboratory of Neurogenetics, United States; email: singleta@mail.nih.gov},
publisher={Nature Research},
issn={10614036},
coden={NGENE},
pubmed_id={25064009},
language={English},
abbrev_source_title={Nat. Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{NoAuthor2017,
journal={Education at a Glance},
year={2017},
note={cited By 1194},
source={Scopus},
}

@ARTICLE{Feigin2017877,
author={Feigin, V.L. and Krishnamurthi, R.V. and Theadom, A.M. and Abajobir, A.A. and Mishra, S.R. and Ahmed, M.B. and Abate, K.H. and Mengistie, M.A. and Wakayo, T. and Abd-Allah, F. and Abdulle, A.M. and Abera, S.F. and Mohammed, K.E. and Abyu, G.Y. and Asgedom, S.W. and Atey, T.M. and Betsu, B.D. and Mezgebe, H.B. and Tuem, K.B. and Woldu, M.A. and Aichour, A.N. and Aichour, I. and Aichour, M.T. and Akinyemi, R.O. and Alabed, S. and Al-Raddadi, R. and Alvis-Guzman, N. and Amare, A.T. and Ansari, H. and Anwari, P. and Ärnlöv, J. and Fereshtehnejad, S. and Weiderpass, E. and Havmoeller, R. and Asayesh, H. and Avila-Burgos, L. and Avokpaho, E.F.G.A. and Afrique, L.E.R.A.S. and Azarpazhooh, M.R. and Barac, A. and Barboza, M. and Barker-Collo, S.L. and Bärnighausen, T. and Farvid, M.S. and Mohammed, S. and Bedi, N. and Beghi, E. and Giussani, G. and Bennett, D.A. and Hay, S.I. and Goulart, A.C. and Santos, I.S. and Bensenor, I.M. and Lotufo, P.A. and Berhane, A. and Jeemon, P. and Bhaumik, S. and Dandona, L. and Dandona, R. and Kumar, G.A. and Birlik, S.M. and Biryukov, S. and Casey, D. and Foreman, K.J. and Goldberg, E.M. and Khalil, I.A. and Kyu, H.H. and Manhertz, T. and Mokdad, A.H. and Naghavi, M. and Nguyen, G. and Nichols, E. and Smith, M. and Murray, C.J.L. and Roth, G.A. and Stanaway, J.D. and Vos, T. and Ellenbogen, R.G. and Jakovljevic, M.B. and Tirschwell, D.L. and Zunt, J.R. and Boneya, D.J. and Hambisa, M. and Bulto, L.N.B. and Carabin, H. and Castañeda-Orjuela, C.A. and Catalá-López, F. and Tabarés-Seisdedos, R. and Chen, H. and Chitheer, A.A. and Chowdhury, R. and Christensen, H. and Deveber, G.A. and Dharmaratne, S.D. and Do, H.P. and Nguyen, C.T. and Nguyen, Q.L. and Nguyen, T.H. and Nong, V.M. and Dokova, K. and Dorsey, E.R. and Eskandarieh, S. and Fischer, F. and Majeed, A. and Steiner, T.J. and Rawaf, S. and Shakir, R. and Shoman, H. and Geleijnse, J.M. and Gillum, R.F. and Gona, P.N. and Gugnani, H.C. and Gupta, R. and Hachinski, V. and Hamadeh, R.R. and Hankey, G.J. and Hareri, H.A. and Heydarpour, P. and Sahraian, M.A. and Kasaeian, A. and Malekzadeh, R. and Roshandel, G. and Sepanlou, S.G. and Hotez, P.J. and Javanbakht, M. and Jonas, J.B. and Kalkonde, Y. and Kandel, A. and Karch, A. and Kastor, A. and Rahman, M.H.U. and Keiyoro, P.N. and Khader, Y.S. and Khan, E.A. and Khang, Y. and Khoja, A.T.A. and Tran, B.X. and Khubchandani, J. and Kim, D. and Kim, Y.J. and Kivimaki, M. and Kokubo, Y. and Kosen, S. and Kravchenko, M. and Piradov, M.A. and Varakin, Y.Y. and Defo, B.K. and Kulkarni, C. and Kumar, R. and Larsson, A. and Lavados, P.M. and Li, Y. and Liang, X. and Liben, M.L. and Lo, W.D. and Logroscino, G. and Loy, C.T. and Mackay, M.T. and Meretoja, A. and Szoeke, C.E.I. and Abd El Razek, H.M. and Mantovani, L.G. and Massano, J. and Mazidi, M. and McAlinden, C. and Mehata, S. and Mehndiratta, M.M. and Memish, Z.A. and Mendoza, W. and Mensah, G.A. and Wijeratne, T. and Miller, T.R. and Mohamed Ibrahim, N. and Mohammadi, A. and Moradi-Lakeh, M. and Velasquez, I.M. and Musa, K.I. and Ngunjiri, J.W. and Ningrum, D.N.A. and Norrving, B. and Stein, D.J. and Noubiap, J.J.N. and Ogbo, F.A. and Renzaho, A.M.N. and Owolabi, M.O. and Pandian, J.D. and Parmar, P.G. and Pereira, D.M. and Petzold, M. and Phillips, M.R. and Poulton, R.G. and Pourmalek, F. and Qorbani, M. and Rafay, A. and Rai, R.K. and Rajsic, S. and Ranta, A. and Rezai, M.S. and Rubagotti, E. and Sachdev, P. and Safiri, S. and Sahathevan, R. and Samy, A.M. and Santalucia, P. and Sartorius, B. and Satpathy, M. and Sawhney, M. and Saylan, M.I. and Shaikh, M.A. and Shamsizadeh, M. and Sheth, K.N. and Shigematsu, M. and Silva, D.A.S. and Sobngwi, E. and Sposato, L.A. and Stovner, L.J. and Stovner, L.J. and Abdulkader, R.S. and Tanne, D. and Thrift, A.G. and Topor-Madry, R. and Truelsen, T. and Ukwaja, K.N. and Uthman, O.A. and Vasankari, T. and Venketasubramanian, N. and Vlassov, V.V. and Wadilo, F. and Wallin, M.T. and Westerman, R. and Wiysonge, C.S. and Wolfe, C.D. and Xavier, D. and Xu, G. and Yano, Y. and Yimam, H.H. and Yonemoto, N. and Yu, C. and Zaidi, Z. and Zaki, M.E.},
title={Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015},
journal={The Lancet Neurology},
year={2017},
volume={16},
number={11},
pages={877-897},
doi={10.1016/S1474-4422(17)30299-5},
note={cited By 1123},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029494753&doi=10.1016%2fS1474-4422%2817%2930299-5&partnerID=40&md5=c96cf08e81b95666e3000a81677a11b1},
affiliation={National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand; School of Public Health, University of Queensland, Brisbane, QLD, Australia; Department of Epidemiology, College of Health Sciences, Jimma University, Jimma, Ethiopia; Department of Neurology, Cairo University, Cairo, Egypt; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates; School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia; School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia; Food Security and Institute for Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart, Germany; University Ferhat Abbas of Setif, Setif, Algeria; National Institute of Nursing Education, Setif, Algeria; High National School of Veterinary Medicine, Algiers, Algeria; University of Ibadan, Ibadan, Nigeria; Newcastle University, Newcastle upon Tyne, United Kingdom; University of Sheffield, Sheffield, United Kingdom; Joint Program of Family and Community Medicine, Jeddah, Saudi Arabia; Universidad de Cartagena, Cartagena de Indias, Colombia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; Health Promotion Research Center, Department of Epidemiology and Biostatistics, Zahedan University of Medical Sciences, Zahedan, Iran; Kabul, Afghanistan; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; School of Health and Social Studies, Dalarna University, Falun, Sweden; Department of Medical Emergency, School of Paramedic, Qom University of Medical Sciences, Qom, Iran; National Institute of Public Health, Cuernavaca, Mexico; Institut de Recherche Clinique du Bénin, Cotonou, Benin; Laboratoire d'Etudes et de Recherche-Action en Santé, Parakou, Benin; Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran; Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Hospital Dr Rafael A Calderón Guardia, CCSS, San José, Costa Rica; Universidad de Costa Rica, San Pedro, Costa Rica; School of Psychology, University of Auckland, Auckland, New Zealand; Department of Global Health and Population, Harvard T H Chan School of Public Health, Department of Nutrition, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, United States; Africa Health Research Institute, Mtubatuba, South Africa; Institute of Public Health, Heidelberg University, Heidelberg, Germany; College of Public Health and Tropical Medicine, Jazan, Saudi Arabia; IRCCS-Istituto di Ricerche Farmacologiche Mario NegriMilan, Italy; Nuffield Department of Population Health, Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom; Center for Clinical and Epidemiological Research Center, Hospital Universitario, Internal Medicine Department, University of São Paulo, São Paulo, Brazil; College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurugram, India; GBS-CIDP International Foundation, Menemen, Turkey; Institute for Health Metrics and Evaluation, Harborview/UW Medicine, Center for Health Trends and Forecasts, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States; Department of Public Health, Debre Markos University, Debre Markos, Ethiopia; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Colombian National Health Observatory, Instituto Nacional de Salud, Bogota, Colombia; Epidemiology and Public Health Evaluation Group, Public Health Department, Universidad Nacional de Colombia, Bogota, Colombia; Department of Medicine, University of Valencia, INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Michigan State University, East Lansing, MI, United States; Ministry of Health, Baghdad, Iraq; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Bispebjerg University Hospital, Copenhagen, Denmark; The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; Department of Community Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka; Institute for Global Health Innovations, Duy Tan University, Da Nang, Viet Nam; Department of Social Medicine, Faculty of Public Health, Medical University-Varna, Varna, Bulgaria; University of Rochester Medical Center, Rochester, NY, United States; Multiple Sclerosis Research Center, Tehran, Iran; Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities, Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, MA, United States; School of Public Health, Bielefeld University, Bielefeld, Germany; Department of Primary Care and Public Health, Division of Brain Sciences, Imperial College London, London, United Kingdom; Division of Human Nutrition, Wageningen University, Wageningen, Netherlands; Howard University, Washington, DC, United States; University of Massachusetts Boston, Boston, MA, United States; Center of Check of Hospital Sirio Libanes, São Paulo, Brazil; Departments of Microbiology and Epidemiology & Biostatistics, Saint James School of Medicine, The Quarter, Anguilla; West Virginia Bureau for Public Health, Charleston, WV, United States; Eternal Heart Care Centre and Research InstituteJaipur, India; Western University, London, ON, Canada; Arabian Gulf University, Manama, Bahrain; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia; Western Australian Neuroscience Research Institute, Nedlands, WA, Australia; Addis Ababa University, Addis Ababa, Ethiopia; Multiple Sclerosis Research Center, Neuroscience Institute, Hematology-Oncology and Stem Cell Transplantation Research Center, Endocrinology and Metabolism Population Sciences Institute, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran; College of Medicine, Baylor University, Houston, TX, United States; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia; University of Aberdeen, Aberdeen, United Kingdom; Centre for Chronic Disease Control, New Delhi, India; Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; Society for Education, Action and Research in Community HealthGadchiroli, India; University at Buffalo, Buffalo, NY, United States; Epidemiological and Statistical Methods Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany; Hannover-Braunschweig Site, German Center for Infection Research, Braunschweig, Germany; International Institute for Population SciencesMumbai, India; Institute of Tropical and Infectious Diseases, Nairobi, Kenya; School of Continuing and Distance Education, Nairobi, Kenya; Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan; Health Services Academy, Islamabad, Pakistan; Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea; Institute of Health Policy and Management, Seoul National University Medical Center, Seoul, South Korea; Department of Public Health and Department of Family Medicine, College of Medicine, Mohammed Ibn Saudi University, Riyadh, Saudi Arabia; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States; Department of Nutrition and Health Science, Ball State University, Muncie, IN, United States; Department of Health Sciences, Northeastern University, Boston, MA, United States; School of Medicine, Xiamen University Malaysia Campus, Sepang, Malaysia; Department of Epidemiology and Public Health, University College London, London, United Kingdom; Faculty of Medicine, University of Helsinki, Clinicum, Helsinki, Finland; Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan; Center for Community Empowerment, Health Policy and Humanities, National Institute of Health Research & Development, Jakarta, Indonesia; Research Center of Neurology, Moscow, Russian Federation; Department of Social and Preventive Medicine, School of Public Health Rajrajeswari Medical College and Hospital, Bangalore, India; Department of Demography and Public Health Research Institute, University of Montreal, Montreal, QC, Canada; King George Medical University, Lucknow, India; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Servicio de Neurologia, Clinica Alemana, Universidad del Desarrollo, Santiago, Chile; San Francisco VA Medical Center, San Francisco, CA, United States; Chinese Center for Disease Control and Prevention, Beijing, China; Samara University, Samara, Ethiopia; Departments of Pediatrics and Neurology, Ohio State University, Columbus, OH, United States; Nationwide Children's Hospital, Columbus, OH, United States; University of Bari, Bari, Italy; The University of Sydney, Sydney, NSW, Australia; Royal Children's Hospital Melbourne, Melbourne, VIC, Australia; Department of Medicine, Institute of Health and Ageing, University of Melbourne, Melbourne, VIC, Australia; Mansoura Faculty of Medicine, Mansoura, Egypt; Aswan University Hospital, Aswan Faculty of Medicine, Aswan, Egypt; University of Milano Bicocca, Monza, Italy; Hospital Pedro Hispano/ULS Matosinhos, Matosinhos, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal; Key State Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; Public Health Wales, Swansea, United Kingdom; Ipas Nepal, Kathmandu, Nepal; Janakpuri Superspecialty Hospital, New Delhi, India; Saudi Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; United Nations Population Fund, Lima, Peru; Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States; Department of Medicine, Institute of Health and Ageing, University of Melbourne, Footscray, VIC, Australia; Department of Neurology, Helsinki University Hospital, Helsinki, Finland; Pacific Institute for Research & Evaluation, Calverton, MD, United States; Centre for Population Health, Curtin University, Perth, WA, Australia; Nepal Development Society, Chitwan, Nepal; Department of Medicine, Universiti Kebangsaan Malaysia Medical Center, Bandar Tun Razak, Malaysia; Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran; Health Systems and Policy Research Unit, Ahmadu Bello University, Zaria, Nigeria; Department of Community Medicine, Preventive Medicine and Public Health Research Center, Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran; Gorgas Memorial Institute for Health Studies, Panama City, Panama; School of Medical Sciences, University of Science Malaysia, Kubang Kerian, Malaysia; University of Nairobi, Nairobi, Kenya; Department of Public Health, Semarang State University, Semarang City, Indonesia; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei City, Taiwan; Skane University Hospital, Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden; Department of Psychiatry, University of Cape Town, Cape Town, South Africa; Medical Diagnostic Centre, Yaounde, Cameroon; Centre for Health Research, Western Sydney University, Penrith, NSW, Australia; Department of Medicine, Ibadan, Nigeria; Blossom Specialist Medical Center, Ibadan, Nigeria; Christian Medical College Ludhiana, Ludhiana, India; Auckland University of Technology, Auckland, New Zealand; REQUIMTE/LAQV, LaboratÓrio de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Health Metrics Unit, University of Gothenburg, Gothenburg, Sweden; University of the Witwatersrand, Johannesburg, South Africa; Shanghai Jiao Tong University School of Medicine, Shanghai, China; Emory University, Atlanta, GA, United States; University of Otago, Dunedin, New Zealand; University of British Columbia, Vancouver, BC, Canada; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Contech International Health Consultants, Lahore, Pakistan; Contech School of Public Health, Lahore, Pakistan; Research and Evaluation Division, BRACDhaka, Bangladesh; Society for Health and Demographic SurveillanceSuri, India; ERAWEB Program, University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria; Capital & Coast District Health Board, Wellington, New Zealand; University of Otago, Wellington, New Zealand; Mazandaran University of Medical Sciences, Sari, Iran; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran; Universidad Tecnica del Norte, Ibarra, Ecuador; University of New South Wales, Randwick, NSW, Australia; Prince of Wales Hospital, Randwick, NSW, Australia; Managerial Epidemiology Research Center, Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, Iran; Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia; Ballarat Health Service, Ballarat, VIC, Australia; Faculty of Science, Ain Shams University, Cairo, Egypt; Fondazione IRCCS Ospedale Maggiore PoliclinicoMilan, Italy; Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa; UKZN Gastrointestinal Cancer Research Centre, South African Medical Research Council, Durban, South Africa; Centre of Advanced Study in Psychology, Utkal University, Bhubaneswar, India; Department of Public Health, Marshall University, Huntington, WV, United States; Bayer Turkey, Istanbul, Turkey; Independent Consultant, Karachi, Pakistan; Department of Medical Surgical Nursing, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran; School of Medicine, Yale University, New Haven, CT, United States; National Institute of Infectious Diseases, Tokyo, Japan; Sandia National Laboratories, Albuquerque, NM, United States; Federal University of Santa Catarina, Florianopolis, Brazil; University of Yaoundé, Yaoundé, Cameroon; Yaoundé Central Hospital, Yaoundé, Cameroon; Department of Clinical Neurological Sciences, Western University, London, ON, Canada; South African Medical Research Council Unit on Anxiety & Stress Disorders, Cape Town, South Africa; Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway; Norwegian Advisory Unit on Headache, St. Olavs Hospital, Trondheim, Norway; Ministry of Health, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia; Chaim Sheba Medical Center, Tel Hashomer, Israel; Tel Aviv University, Tel Aviv, Israel; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia; Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland; Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland; Hanoi Medical University, Hanoi, Viet Nam; Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Internal Medicine, Federal Teaching Hospital, Abakaliki, Nigeria; Warwick Medical School, University of Warwick, Coventry, United Kingdom; UKK Institute for Health Promotion Research, Tampere, Finland; Raffles Neuroscience Centre, Raffles Hospital, Singapore; National Research University Higher School of Economics, Moscow, Russian Federation; Wolaita Sodo University, Wolaita Sodo, Ethiopia; VA Medical Center, Washington, DC, United States; Neurology Department, Georgetown University, Washington, DC, United States; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland; Federal Institute for Population Research, Wiesbaden, Germany; German National Cohort Consortium, Heidelberg, Germany; Western Health, Footscray, VIC, Australia; South African Medical Research Council, Cochrane South Africa, Cape Town, South Africa; Stellenbosch University, Cape Town, South Africa; Division of Health and Social Care Research, King's College London, London, United Kingdom; National Institute for Health Research Comprehensive Biomedical Research Centre, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom; St. John's Medical College and Research Institute, Bangalore, India; Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China; Department of Preventive Medicine, Northwestern University, Chicago, IL, United States; Mizan Tepi University, Mizan Teferi, Ethiopia; Department of Biostatistics, School of Public Health, Kyoto University, Kyoto, Japan; Department of Epidemiology and Biostatistics, School of Public Health, Global Health Institute, Wuhan University, Wuhan, China; University Hospital of Setif, Setif, Algeria; Faculty of Medicine, Mansoura University, Mansoura, Egypt},
abstract={Background Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level. Methods We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development. Findings Neurological disorders ranked as the leading cause group of DALYs in 2015 (250·7 [95% uncertainty interval (UI) 229·1 to 274·7] million, comprising 10·2% of global DALYs) and the second-leading cause group of deaths (9·4 [9·1 to 9·7] million], comprising 16·8% of global deaths). The most prevalent neurological disorders were tension-type headache (1505·9 [UI 1337·3 to 1681·6 million cases]), migraine (958·8 [872·1 to 1055·6] million), medication overuse headache (58·5 [50·8 to 67·4 million]), and Alzheimer's disease and other dementias (46·0 [40·2 to 52·7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36·7%, and the number of DALYs by 7·4%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26·1% and 29·7%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs. Interpretation Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services. Funding Bill & Melinda Gates Foundation. © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY 4.0 license},
keywords={age;  Alzheimer disease;  Article;  brain cancer;  cause of death;  cerebrovascular accident;  cerebrovascular disease;  dementia;  disability-adjusted life year;  disease classification;  drug induced headache;  encephalitis;  epilepsy;  female;  global disease burden;  headache;  human;  major clinical study;  male;  meningitis;  migraine;  mortality;  motor neuron disease;  multiple sclerosis;  nervous system cancer;  neurologic disease;  Parkinson disease;  prevalence;  priority journal;  sex difference;  tension headache;  tetanus;  global health;  Nervous System Diseases;  quality adjusted life year;  trends, Cause of Death;  Female;  Global Burden of Disease;  Global Health;  Humans;  Male;  Nervous System Diseases;  Quality-Adjusted Life Years},
funding_details={Bill and Melinda Gates FoundationBill and Melinda Gates Foundation, BMGF},
funding_details={Wellcome TrustWellcome Trust, WT},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/K013351/1},
funding_details={Health Research Council of New ZealandHealth Research Council of New Zealand, HRC},
funding_text 1={JÄ reports personal fees from AstraZeneca. PJ reports a clinical and public health intermediate fellowship from the Wellcome Trust and Department of Biotechnology, India Alliance. MIS reports other funding from Bayer AG and is an employee of Bayer Pharmaceuticals. CEIS reports grants from the National Medical Health Research Council during the conduct of the study, grants from Lundbeck and Alzheimer's Association, and has a patent issued with the Melbourne Health and Murdoch Children's Research Institute (PCT/AU2008/001556). All other authors declare no competing interests.},
funding_text 2={This research was supported by the Bill & Melinda Gates Foundation and the Health Research Council of New Zealand (VLF, RVK, PGP). VLF was also partly funded by the Brain Research New Zealand Centre of Research Excellence and Ageing Well programme of the National Science Challenge, Ministry of Business, Innovation and Employment of New Zealand. The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the US Department of Health and Human Services.},
references={Aarli, J., Tarun, D., Janca, A., Muscetta, A., (2006) Neurological disorders: public health challenges, , World Health Organization Geneva; Murray, C., Lopez, A., (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020, , Harvard School of Public Health Boston; Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) Lancet, 388, pp. 1603-1658; Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) Lancet, 388, pp. 1545-1602; (2000) Diagnostic and Statistical Manual of Mental Disorders, , 4th edn, text revision American Psychiatric Association Washington DC; The International Classification of Headache Disorders, 3rd edn (beta version) https://www.ichd-3.org/, (accessed July 26, 2017); Flaxman, A.D., Vos, T., Murray, C.J., (2015) An integrative metaregression framework for descriptive epidemiology, , University of Washington Press Seattle; Salomon, J.A., Haagsma, J.A., Davis, A., Disability weights for the Global Burden of Disease 2013 study (2015) Lancet Glob Health, 3, pp. e712-e723; Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) Lancet, 388, pp. 1459-1544; Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 385, pp. 117-171; Foreman, K.J., Lozano, R., Lopez, A.D., Murray, C.J., Modeling causes of death: an integrated approach using CODEm (2012) Popul Health Metr, 10, p. 1; Murray, C.J.L., Ezzati, M., Flaxman, A.D., GBD 2010: design, definitions, and metrics (2012) Lancet, 380, pp. 2063-2066; Lozano, R., Naghavi, M., Foreman, K., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) Lancet, 380, pp. 2095-2128; Stevens, G.A., Alkema, L., Black, R.E., Guidelines for accurate and transparent health estimates reporting: the GATHER statement (2016) PLoS Med, 13, p. e1002056; Stevens, G.A., Alkema, L., Black, R.E., Guidelines for accurate and transparent health estimates reporting: the GATHER statement (2016) Lancet, 388, pp. e19-e23; Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 386, pp. 743-800; Feigin, V.L., Lawes, C.M.M., Bennett, D.A., Barker-Collo, S.L., Parag, V., Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review (2009) Lancet Neurol, 8, pp. 355-369; Grytten, N., Torkildsen, Ø., Myhr, K.-M., Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades (2015) Acta Neurol Scand, 132, pp. 29-36; Alla, S., Pearson, J., Debernard, L., Miller, D., Mason, D., The increasing prevalence of multiple sclerosis in New Zealand (2014) Neuroepidemiology, 42, pp. 154-160; Sander, J.W., Keezer, M.R., Epilepsy: Trends in new-onset epilepsy—the importance of comorbidities (2016) Nat Rev Neurol, 12, pp. 254-256; Lyngberg, A.C., Rasmussen, B.K., Jørgensen, T., Jensen, R., Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey (2005) Eur J Epidemiol, 20, pp. 243-249; Dahlrot, R.H., Poulsen, F.R., Nguyen, N.N.T.T., Trends in tumors in the central nervous system in elderly in Denmark, 2008–2012 (2016) Acta Oncol Stockh Swed, 55, pp. 91-97; Hirsch, L., Jette, N., Frolkis, A., Steeves, T., Pringsheim, T., The incidence of Parkinson's disease: a systematic review and meta-analysis (2016) Neuroepidemiology, 46, pp. 292-300; Pringsheim, T., Jette, N., Frolkis, A., Steeves, T.D.L., The prevalence of Parkinson's disease: a systematic review and meta-analysis (2014) Mov Disord, 29, pp. 1583-1590; Fernández-de-las-Peñas, C., Palacios-Ceña, D., Salom-Moreno, J., Has the prevalence of migraine changed over the last decade (2003–2012)? A Spanish population-based survey (2014) PloS One, 9, p. e110530; Prince, M., Ali, G.-C., Guerchet, M., Prina, A.M., Albanese, E., Wu, Y.-T., Recent global trends in the prevalence and incidence of dementia, and survival with dementia (2016) Alzheimers Res Ther, 8, p. 23; Luepker, R.V., Steffen, L.M., Jacobs, D.R., Zhou, X., Blackburn, H., Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey (2012) Circulation, 126, pp. 1852-1857; Tse, L.A., Fang, X.H., Wang, W.Z., Qiu, H., Yu, I.T.S., Incidence of ischaemic and haemorrhagic stroke and the association with smoking and smoking cessation: a 10-year multicentre prospective study in China (2012) Public Health, 126, pp. 960-966; Rothwell, P.M., Coull, A.J., Giles, M.F., Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) (2004) Lancet, 363, pp. 1925-1933; Ukraintseva, S., Sloan, F., Arbeev, K., Yashin, A., Increasing rates of dementia at time of declining mortality from stroke (2006) Stroke, 37, pp. 1155-1159; Greenberg, D.P., Doemland, M., Bettinger, J.A., Epidemiology of pertussis and Haemophilus influenzae type B disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type B pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States (2009) Pediatr Infect Dis J, 28, pp. 521-528; Divino-Goes, K.G., de Moraes-Pinto, M.I., Dinelli, M.I.S., Prevalence of diphtheria and tetanus antibodies and circulation of Corynebacterium diphtheriae in São Paulo, Brazil (2007) Braz J Med Biol Res, 40, pp. 1681-1687; Mallick, I.H., Winslet, M.C., A review of the epidemiology, pathogenesis and management of tetanus (2004) Int J Surg Lond Engl, 2, pp. 109-112; Turnbull, F., Baker, M., Tsang, B., Jarman, J., Epidemiology of tetanus in New Zealand reinforces value of vaccination (2001) NZ Public Health Rep, 8, pp. 57-60; Halperin, S.A., Bettinger, J.A., Greenwood, B., The changing and dynamic epidemiology of meningococcal disease (2012) Vaccine, 30, pp. B26-B36; Xing, Y., Schmitt, H.-J., Arguedas, A., Yang, J., Tick-borne encephalitis in China: a review of epidemiology and vaccines (2017) Vaccine, 35, pp. 1227-1237; Lopez, A.L., Aldaba, J.G., Roque, V.G., Epidemiology of Japanese encephalitis in the Philippines: a systematic review (2015) PLoS Negl Trop Dis, 9, p. e0003630; Ngugi, A.K., Bottomley, C., Kleinschmidt, I., Sander, J.W., Newton, C.R., Estimation of the burden of active and life-time epilepsy: a meta-analytic approach (2010) Epilepsia, 51, pp. 883-890; Preux, P.-M., Druet-Cabanac, M., Epidemiology and aetiology of epilepsy in sub-Saharan Africa (2005) Lancet Neurol, 4, pp. 21-31; Muangpaisan, W., Hori, H., Brayne, C., Systematic review of the prevalence and incidence of Parkinson's disease in Asia (2009) J Epidemiol, 19, pp. 281-293; Mehta, P., Antao, V., Kaye, W., Prevalence of amyotrophic lateral sclerosis–United States, 2010–2011 (2014) MMWR Suppl, 63, pp. 1-14; Vázquez, M.C., Ketzoián, C., Legnani, C., Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study (2008) Neuroepidemiology, 30, pp. 105-111; Vuković, V., Plavec, D., Pavelin, S., Janculjak, D., Ivanković, M., Demarin, V., Prevalence of migraine, probable migraine and tension-type headache in the Croatian population (2010) Neuroepidemiology, 35, pp. 59-65; Cheung, R.T., Prevalence of migraine, tension-type headache, and other headaches in Hong Kong (2000) Headache, 40, pp. 473-479; Westergaard, M.L., Hansen, E.H., Glümer, C., Olesen, J., Jensen, R.H., Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review (2014) Cephalalgia, 34, pp. 409-425; Stovner, L., Hagen, K., Jensen, R., The global burden of headache: a documentation of headache prevalence and disability worldwide (2007) Cephalalgia, 27, pp. 193-210; Zivadinov, R., Iona, L., Monti-Bragadin, L., The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study (2003) Neuroepidemiology, 22, pp. 65-74; Fiest, K.M., Jetté, N., Roberts, J.I., The prevalence and incidence of dementia: a systematic review and meta-analysis (2016) Can J Neurol Sci, 43, pp. S3-S50; Ezejimofor, M.C., Chen, Y.-F., Kandala, N.-B., Stroke survivors in low- and middle-income countries: a meta-analysis of prevalence and secular trends (2016) J Neurol Sci, 364, pp. 68-76; Koch-Henriksen, N., Sørensen, P.S., The changing demographic pattern of multiple sclerosis epidemiology (2010) Lancet Neurol, 9, pp. 520-532; Wallin, M.T., Page, W.F., Kurtzke, J.F., Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography (2004) Ann Neurol, 55, pp. 65-71; Kantarci, O., Wingerchuk, D., Epidemiology and natural history of multiple sclerosis: new insights (2006) Curr Opin Neurol, 19, pp. 248-254; Kurtzke, J.F., Epidemiologic evidence for multiple sclerosis as an infection (1993) Clin Microbiol Rev, 6, pp. 382-427; Thrift, A.G., Thayabaranathan, T., Howard, G., Global stroke statistics (2017) Int J Stroke, 12, pp. 13-32; Ngugi, A.K., Kariuki, S.M., Bottomley, C., Kleinschmidt, I., Sander, J.W., Newton, C.R., Incidence of epilepsy: a systematic review and meta-analysis (2011) Neurology, 77, pp. 1005-1012; Eskandarieh, S., Heydarpour, P., Minagar, A., Pourmand, S., Sahraian, M.A., Multiple sclerosis epidemiology in east Asia, south east Asia and south Asia: a systematic review (2016) Neuroepidemiology, 46, pp. 209-221; Chiò, A., Logroscino, G., Traynor, B.J., Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature (2013) Neuroepidemiology, 41, pp. 118-130; de Robles, P., Fiest, K.M., Frolkis, A.D., The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis (2015) Neuro-Oncol, 17, pp. 776-783; Arnao, V., Acciarresi, M., Cittadini, E., Caso, V., Stroke incidence, prevalence and mortality in women worldwide (2016) Int J Stroke, 11, pp. 287-301; Banerjee, P.N., Filippi, D., Allen Hauser, W., The descriptive epidemiology of epilepsy–a review (2009) Epilepsy Res, 85, pp. 31-45; Logroscino, G., Traynor, B.J., Hardiman, O., Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues (2008) J Neurol Neurosurg Psychiatry, 79, pp. 6-11; Vetvik, K.G., MacGregor, E.A., Sex differences in the epidemiology, clinical features, and pathophysiology of migraine (2017) Lancet Neurol, 16, pp. 76-87; Janca, A., Aarli, J.A., Prilipko, L., Dua, T., Saxena, S., Saraceno, B., WHO/WFN survey of neurological services: a worldwide perspective (2006) J Neurol Sci, 247, pp. 29-34; Owolabi, M., Miranda, J.J., Yaria, J., Ovbiagele, B., Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism (2016) BMJ Glob Health, 1, p. e000105; Feigin, V.L., Norrving, B., George, M.G., Foltz, J.L., Roth, G.A., Mensah, G.A., Prevention of stroke: a strategic global imperative (2016) Nat Rev Neurol, 12, pp. 501-512; Waisbord, S., Larson, H., Why invest in communication for immunization: evidence and lessons learned. A joint publication of the Health Communication Partnership based at Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (Baltimore) and the United Nations Children's Fund (New York) (2005), https://www.path.org/vaccineresources/details.php?i=136, (accessed Sept 5, 2017); Murray, C.J., Lopez, A.D., Black, R., Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets (2011) Popul Health Metr, 9, p. 27},
publisher={Lancet Publishing Group},
issn={14744422},
coden={LNAEA},
pubmed_id={28931491},
language={English},
abbrev_source_title={Lancet Neurol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{NoAuthor2006,
journal={Neurological Disorders: Public Health Challenges},
year={2006},
note={cited By 1050},
source={Scopus},
}

@ARTICLE{Chesney2014153,
author={Chesney, E. and Goodwin, G.M. and Fazel, S.},
title={Risks of all-cause and suicide mortality in mental disorders: A meta-review},
journal={World Psychiatry},
year={2014},
volume={13},
number={2},
pages={153-160},
doi={10.1002/wps.20128},
note={cited By 922},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901771410&doi=10.1002%2fwps.20128&partnerID=40&md5=7b2c63f667fda8dee783cd7d4cff3809},
affiliation={Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom},
abstract={A meta-review, or review of systematic reviews, was conducted to explore the risks of all-cause and suicide mortality in major mental disorders. A systematic search generated 407 relevant reviews, of which 20 reported mortality risks in 20 different mental disorders and included over 1.7 million patients and over a quarter of a million deaths. All disorders had an increased risk of all-cause mortality compared with the general population, and many had mortality risks larger than or comparable to heavy smoking. Those with the highest all-cause mortality ratios were substance use disorders and anorexia nervosa. These higher mortality risks translate into substantial (10-20 years) reductions in life expectancy. Borderline personality disorder, anorexia nervosa, depression and bipolar disorder had the highest suicide risks. Notable gaps were identified in the review literature, and the quality of the included reviews was typically low. The excess risks of mortality and suicide in all mental disorders justify a higher priority for the research, prevention, and treatment of the determinants of premature death in psychiatric patients. © 2014 World Psychiatric Association.},
author_keywords={anorexia nervosa;  mental disorders;  meta-review;  Mortality;  substance use disorders;  suicide},
keywords={anorexia nervosa;  article;  bipolar disorder;  borderline state;  depression;  human;  life expectancy;  mental disease;  mental patient;  mortality;  priority journal;  risk factor;  smoking;  substance abuse;  suicide;  systematic review},
funding_details={095806},
references={Saha, S., Chant, D., McGrath, J., A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? (2007) Archives of General Psychiatry, 64 (10), pp. 1123-1131. , http://archpsyc.ama-assn.org/cgi/reprint/64/10/1123, DOI 10.1001/archpsyc.64.10.1123; Hoang, U., Stewart, R., Goldacre, M.J., Mortality after hospital discharge for people with schizophrenia or bipolar disorder: Retrospective study of linked English hospital episode statistics, 1999-2006 (2011) BMJ, 343, pp. d5422; Whiteford, H.A., Degenhardt, L., Rehm, J., Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010 (2013) Lancet, 382, pp. 1575-1586; Lozano, R., Naghavi, M., Foreman, K., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010 (2012) Lancet, 380, pp. 2095-2128; Harris, E.C., Barraclough, B., Excess mortality of mental disorder (1998) British Journal of Psychiatry, 173 (JULY), pp. 11-53; Degenhardt, L., Bucello, C., Mathers, B., Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies (2011) Addiction, 106, pp. 32-51; Bland, J.M., Altman, D.G., Statistics notes (2000) The Odds Ratio. BMJ, 320, p. 1468; Viera, A.J., Odds ratios and risk ratios: What's the difference and why does it matter? (2008) South Med J, 101, pp. 730-734; Shea, B.J., Hamel, C., Wells, G.A., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J Clin Epidemiol, 62, pp. 1013-1020; Amato, L., Minozzi, S., Davoli, M., Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome (2011) Cochrane Database Syst Rev, 6, pp. CD008537; Charlson, F., Degenhardt, L., McLaren, J., A systematic review of research examining benzodiazepine-related mortality (2009) Pharmacoepidemiol Drug Saf, 18, pp. 93-103; Pompili, M., Gonda, X., Serafini, G., Epidemiology of suicide in bipolar disorders: A systematic review of the literature (2013) Bipolar Disord, 15, pp. 457-490; James, A., Lai, F.H., Dahl, C., Attention deficit hyperactivity disorder and suicide: A review of possible associations (2004) Acta Psychiatrica Scandinavica, 110 (6), pp. 408-415. , DOI 10.1111/j.1600-0447.2004.00384.x; Wilcox, H.C., Conner, K.R., Caine, E.D., Association of alcohol and drug use disorders and completed suicide: An empirical review of cohort studies (2004) Drug and Alcohol Dependence, 76 (SUPPL.), pp. S11-S19. , DOI 10.1016/j.drugalcdep.2004.08.003, PII S0376871604002108; Singleton, J., Degenhardt, L., Hall, W., Mortality among amphetamine users: A systematic review of cohort studies (2009) Drug Alcohol Depend, 105, pp. 1-8; Degenhardt, L., Singleton, J., Calabria, B., Mortality among cocaine users: A systematic review of cohort studies (2011) Drug Alcohol Depend, 113, pp. 88-95; Arcelus, J., Mitchell, A.J., Wales, J., Mortality rates in patients with anorexia nervosa and other eating disorders (2011) A Meta-analysis of 36 Studies. Arch Gen Psychiatry, 68, pp. 724-731; Preti, A., Rocchi, M.B., Sisti, D., A comprehensive meta-analysis of the risk of suicide in eating disorders (2011) Acta Psychiatr Scand, 124, pp. 6-17; Roerecke, M., Rehm, J., Alcohol use disorders and mortality: A systematic review and meta-analysis (2013) Addiction, 108, pp. 1562-1578; Roerecke, M., Rehm, J., Cause-specific mortality risk in alcohol use disorder treatment patients: A systematic review and meta-analysis Int J Epidemiol, , (in press); Woolfenden, S., Sarkozy, V., Ridley, G., A systematic review of two outcomes in autism spectrum disorder - Epilepsy and mortality (2012) Dev Med Child Neurol, 54, pp. 306-312; Shavelle, R.M., Paculdo, D.R., Strauss, D.J., Smoking habit and mortality: A meta-analysis (2008) J Insur Med, 40, pp. 170-178; Todd, S., Barr, S., Roberts, M., Survival in dementia and predictors of mortality: A review (2013) Int J Geriatr Psychiatry, 28, pp. 1109-1124; Li, D., Yang, X., Ge, Z., Cigarette smoking and risk of completed suicide: A meta-analysis of prospective cohort studies (2012) J Psychiatr Res, 46, pp. 1257-1266; Cuijpers, P., Vogelzangs, N., Twisk, J., Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses Am J Psychiatry, , in press; Neeleman, J., A continuum of premature death. Meta-analysis of competing mortality in the psychosocially vulnerable (2001) International Journal of Epidemiology, 30 (1), pp. 154-162; Baxter, A.J., Page, A., Whiteford, H.A., Factors influencing risk of premature mortality in community cases of depression: A meta-analytic review (2011) Epidemiol Res Int, 2011, pp. 1-12; Calabria, B., Degenhardt, L., Hall, W., Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (2010) Drug Alcohol Rev, 29, pp. 318-330; Pompili, M., Girardi, P., Ruberto, A., Tatarelli, R., Suicide in borderline personality disorder: A meta-analysis (2005) Nordic Journal of Psychiatry, 59 (5), pp. 319-324. , DOI 10.1080/08039480500320025; Li, Z., Page, A., Martin, G., Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: A systematic review (2011) Soc Sci Med, 72, pp. 608-616; Kanwar, A., Malik, S., Prokop, L.J., The association between anxiety disorders and suicidal behaviors: A systematic review and meta-analysis (2013) Depress Anxiety, 30, pp. 917-929; Koedam, E.L., Pijnenburg, Y.A., Deeg, D.J., Early-onset dementia is associated with higher mortality (2008) Dement Geriatr Cogn Disord, 26, pp. 147-152; Appleby, L., Mortensen, P.B., Faragher, E.B., Suicide and other causes of mortality after post-partum psychiatric admission (1998) British Journal of Psychiatry, 173 (SEPT.), pp. 209-211; Kjelsberg, E., Adolescent psychiatric in-patients (2000) A High-risk Group for Premature Death. Br J Psychiatry, 176, pp. 121-125; Callaghan, R.C., Cunningham, J.K., Verdichevski, M., All-cause mortality among individuals with disorders related to the use of methamphetamine: A comparative cohort study (2012) Drug Alcohol Depend, 125, pp. 290-294; Castagnini, A., Foldager, L., Bertelsen, A., Excess mortality of acute and transient psychotic disorders: Comparison with bipolar affective disorder and schizophrenia (2013) Acta Psychiatr Scand, 128, pp. 370-375; Fok, M.L., Hayes, R.D., Chang, C.K., Life expectancy at birth and all-cause mortality among people with personality disorder (2012) J Psychosom Res, 73, pp. 104-107; Talaslahti, T., Alanen, H.M., Hakko, H., Mortality and causes of death in older patients with schizophrenia (2012) Int J Geriatr Psychiatry, 27, pp. 1131-1137; Tyrer, F., McGrother, C., Cause-specific mortality and death certificate reporting in adults with moderate to profound intellectual disability (2009) J Intellect Disabil Res, 53, pp. 898-904; Crump, C., Sundquist, K., Winkleby, M.A., Comorbidities and mortality in bipolar disorder: A Swedish national cohort study (2013) JAMA Psychiatry, 70, pp. 931-939; Barbaresi, W.J., Colligan, R.C., Weaver, A.L., Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: A prospective study (2013) Pediatrics, 131, pp. 637-644; Mykletun, A., Bjerkeset, O., Overland, S., Levels of anxiety and depression as predictors of mortality: The HUNT study (2009) Br J Psychiatry, 195, pp. 118-125; Chang, C.K., Hayes, R.D., Perera, G., Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London (2011) PLoS One, 6, pp. e19590; Nordentoft, M., Wahlbeck, K., Hallgren, J., Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden (2013) PLoS One, 8, pp. e55176; Laursen, T.M., Life expectancy among persons with schizophrenia or bipolar affective disorder (2011) Schizophr Res, 131, pp. 101-104; Kodesh, A., Goldshtein, I., Gelkopf, M., Epidemiology and comorbidity of severe mental illnesses in the community: Findings from a computerized mental health registry in a large Israeli health organization (2012) Soc Psychiatry Psychiatr Epidemiol, 47, pp. 1775-1782; Laursen, T.M., Wahlbeck, K., Hallgren, J., Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries (2013) PLoS One, 8, pp. e67133; Nielsen, R.E., Uggerby, A.S., Jensen, S.O., Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - A Danish nationwide study from 1980 to 2010 (2013) Schizophr Res, 146, pp. 22-27; Crump, C., Winkleby, M.A., Sundquist, K., Comorbidities and mortality in persons with schizophrenia: A Swedish national cohort study (2013) Am J Psychiatry, 170, pp. 324-333; Brodaty, H., Seeher, K., Gibson, L., Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia (2012) Int Psychogeriatr, 24, pp. 1034-1045; Hayes, R.D., Chang, C.K., Fernandes, A., Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service (2011) Drug Alcohol Depend, 118, pp. 56-61; Prescott, E., Osler, M., Hein, H.O., Borch-Johnsen, K., Schnohr, P., Vestbo, J., Life expectancy in Danish women and men related to smoking habits: Smoking may affect women more (1998) Journal of Epidemiology and Community Health, 52 (2), pp. 131-132; Sakata, R., McGale, P., Grant, E.J., Impact of smoking on mortality and life expectancy in Japanese smokers: A prospective cohort study (2012) BMJ, 345, pp. e7093; Al Mamun, A., Peeters, A., Barendregt, J., Willekens, F., Nusselder, W., Bonneux, L., Smoking decreases the duration of life lived with and without cardiovascular disease: A life course analysis of the Framingham Heart Study (2004) European Heart Journal, 25 (5), pp. 409-415. , DOI 10.1016/j.ehj.2003.12.015; Gellert, C., Schottker, B., Brenner, H., Smoking and all-cause mortality in older people: Systematic review and meta-analysis (2012) Arch Intern Med, 172, pp. 837-844; Tollefsen, I.M., Hem, E., Ekeberg, O., The reliability of suicide statistics: A systematic review (2012) BMC Psychiatry, 12, p. 9; Crump, C., Ioannidis, J.P., Sundquist, K., Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses (2013) J Psychiatr Res, 47, pp. 1298-1303; Ioannidis, J.P., Are mortality differences detected by administrative data reliable and actionable? (2013) JAMA, 309, pp. 1410-1411; De Hert, M., Correll, C.U., Bobes, J., Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) World Psychiatry, 10, pp. 52-77; Wittchen, H.U., Jacobi, F., Rehm, J., The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011) Eur Neuropsychopharmacol, 21, pp. 655-679},
publisher={Masson SpA},
issn={17238617},
language={English},
abbrev_source_title={World Psychiatry},
document_type={Article},
source={Scopus},
}

@ARTICLE{Allen2008827,
author={Allen, N.C. and Bagade, S. and McQueen, M.B. and Ioannidis, J.P.A. and Kavvoura, F.K. and Khoury, M.J. and Tanzi, R.E. and Bertram, L.},
title={Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database},
journal={Nature Genetics},
year={2008},
volume={40},
number={7},
pages={827-834},
doi={10.1038/ng.171},
note={cited By 878},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-46249104490&doi=10.1038%2fng.171&partnerID=40&md5=73d333ab1b858464914b8debd828a73e},
affiliation={MassGeneral Institute for Neurodegenerative Disease (MIND), Department of Neurology, Massachusetts General Hospital, Charlestown, MA 02129, United States; Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, United States; Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece; Biomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina 45110, Greece; Department of Medicine, Tufts University School of Medicine, Boston, MA 02110, United States; National Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA 30341, United States},
abstract={In an effort to pinpoint potential genetic risk factors for schizophrenia, research groups worldwide have published over 1,000 genetic association studies with largely inconsistent results. To facilitate the interpretation of these findings, we have created a regularly updated online database of all published genetic association studies for schizophrenia ('SzGene'). For all polymorphisms having genotype data available in at least four independent case-control samples, we systematically carried out random-effects meta-analyses using allelic contrasts. Across 118 meta-analyses, a total of 24 genetic variants in 16 different genes (APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53 and TPH1) showed nominally significant effects with average summary odds ratios of ∼1.23. Seven of these variants had not been previously meta-analyzed. According to recently proposed criteria for the assessment of cumulative evidence in genetic association studies, four of the significant results can be characterized as showing 'strong' epidemiological credibility. Our project represents the first comprehensive online resource for systematically synthesized and graded evidence of genetic association studies in schizophrenia. As such, it could serve as a model for field synopses of genetic associations in other common and genetically complex disorders. © 2008 Nature Publishing Group.},
keywords={4 aminobutyric acid A receptor;  apolipoprotein E;  dao protein;  dopamine 1 receptor;  dopamine 2 receptor;  dopamine 4 receptor;  dysbindin;  flavoprotein;  haptoglobin;  interleukin 1beta;  methylenetetrahydrofolate reductase (NADPH2);  n methyl dextro aspartic acid receptor 2B;  nerve protein;  protein p53;  protein plxna2;  serotonin transporter;  tryptophan hydroxylase, article;  genetic association;  genetic database;  genetic polymorphism;  genetic susceptibility;  genotype;  human;  priority journal;  schizophrenia, Case-Control Studies;  Databases, Genetic;  Gene Frequency;  Genetic Heterogeneity;  Genetic Predisposition to Disease;  Humans;  Linkage (Genetics);  Polymorphism, Single Nucleotide;  Schizophrenia},
chemicals_cas={dopamine 4 receptor, 137750-34-6; haptoglobin, 9087-69-8; methylenetetrahydrofolate reductase (NADPH2), 71822-25-8; tryptophan hydroxylase, 9037-21-2},
funding_details={Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentEunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, R01HD060726},
funding_details={National Alliance for Research on Schizophrenia and DepressionNational Alliance for Research on Schizophrenia and Depression, NARSAD},
funding_details={General Secretariat for Research and TechnologyGeneral Secretariat for Research and Technology, GSRT},
funding_text 1={Funding for this study was provided by the National Alliance on Research in Schizophrenia and Depression (to L.B.). F.K.K. was supported by a PENED training grant co-financed by E.U. European Social Fund and the Greek Ministry of Development, General Secretariat for Research and Technology. We are grateful to the Schizophrenia Research Forum for hosting SzGene on their website. In particular, we would like to thank A. Bumstead, H. Heimer, C. Knep and P. Noyes for the online adaptation of SzGene and many helpful discussions. We would further like to thank the members of the Scientific Advisory Board (currently including W. Byerly, G.D. Smith, J. Kennedy, D.F. Levinson and M. Owen) for their repeated review of the database and their helpful comments and suggestions during the development of this project.},
references={Mueser, K.T., McGurk, S.R., Schizophrenia (2004) Lancet, 363, pp. 2063-2072; Owen, M.J., Craddock, N., O'Donovan, M.C., Schizophrenia: Genes at last? (2005) Trends Genet, 21, pp. 518-525; Sullivan, P.F., Kendler, K.S., Neale, M.C., Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies (2003) Arch. Gen. Psychiatry, 60, pp. 1187-1192; Badner, J.A., Gershon, E.S., Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia (2002) Mol. Psychiatry, 7, pp. 405-411; Lewis, C.M., Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia (2003) Am. J. Hum. Genet, 73, pp. 34-48; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database (2007) Nat. Genet, 39, pp. 17-23; Thakkinstian, A., Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration (2006) Hum. Mol. Genet, 15, pp. 2784-2790; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Racial' differences in genetic effects for complex diseases (2004) Nat. Genet, 36, pp. 1312-1318; Lange, C., DeMeo, D., Silverman, E.K., Weiss, S.T., Laird, N.M., PBAT: Tools for family-based association studies (2004) Am. J. Hum. Genet, 74, pp. 367-369; Ioannidis, J.P., Trikalinos, T.A., Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials (2005) J. Clin. Epidemiol, 58, pp. 543-549; Li, D., He, L., Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis (2007) Genet. Med, 9, pp. 4-8; Mah, S., Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia (2006) Mol. Psychiatry, 11, pp. 471-478; Lencz, T., Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia (2007) Mol. Psychiatry, 12, pp. 572-580; Fujii, T., Failure to confirm an association between the PLXNA2 gene and schizophrenia in a Japanese population (2007) Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, pp. 873-877; Ioannidis, J.P. et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 37, 120-132 (2008); published online 26 September 2007; Ioannidis, J.P., A road map for efficient and reliable human genome epidemiology (2006) Nat. Genet, 38, pp. 3-5; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Contopoulos-Ioannidis, D.G., Replication validity of genetic association studies (2001) Nat. Genet, 29, pp. 306-309; Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S., Hirschhorn, J.N., Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease (2003) Nat. Genet, 33, pp. 177-182; Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007) Nature, 447, pp. 661-678. , Wellcome Trust Case Control Consortium; Missale, C., Fiorentini, C., Busi, C., Collo, G., Spano, P.F., The NMDA/D1 receptor complex as a new target in drug development (2006) Curr. Top. Med. Chem, 6, pp. 801-808; Tauscher, J., Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: Differentiation from other atypical antipsychotics (2004) Am. J. Psychiatry, 161, pp. 1620-1625; Williams, N.M., O'Donovan, M.C., Owen, M.J., Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? (2005) Schizophr. Bull, 31, pp. 800-805; Weickert, C.S., Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain (2004) Arch. Gen. Psychiatry, 61, pp. 544-555; Roffman, J.L., Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia (2008) Biol. Psychiatry, 63, pp. 42-48; Frosst, P., A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase (1995) Nat. Genet, 10, pp. 111-113; van der Put, N.M., A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? (1998) Am. J. Hum. Genet, 62, pp. 1044-1051; Munafo, M.R., Thiselton, D.L., Clark, T.G., Flint, J., Association of the NRG1 gene and schizophrenia: A meta-analysis (2006) Mol. Psychiatry, 11, pp. 539-546; McGorry, P.D., Spurious precision: Procedural validity of diagnostic assessment in psychotic disorders (1995) Am. J. Psychiatry, 152, pp. 220-223; Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., Rothman, N., Assessing the probability that a positive report is false: An approach for molecular epidemiology studies (2004) J. Natl. Cancer Inst, 96, pp. 434-442; Ioannidis, J.P., Why most published research findings are false (2005) PLoS Med, 2, pp. e124; Evangelou, E., Maraganore, D.M., Ioannidis, J.P., Meta-analysis in genome-wide association datasets: Strategies and application in Parkinson disease (2007) PLoS ONE, 2, pp. e196; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control. Clin. Trials, 7, pp. 177-188; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat. Med, 21, pp. 1539-1558; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) Br. Med. J, 327, pp. 557-560; Ioannidis, J.P., Patsopoulos, N., Evangelou, E., Uncertainty in estimates of heterogeneity in meta-analysis (2007) Br. Med. J, 335, pp. 914-916; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) Br. Med. J, 315, pp. 629-634; Harbord, R.M., Egger, M., Sterne, J.A., A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints (2006) Stat. Med, 25, pp. 3443-3457; Lau, J., Ioannidis, J.P., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) Br. Med. J, 333, pp. 597-600; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin. Trials, 4, pp. 245-253},
correspondence_address1={Bertram, L.; MassGeneral Institute for Neurodegenerative Disease (MIND), , Charlestown, MA 02129, United States; email: bertram@helix.mgh.harvard.edu},
issn={10614036},
coden={NGENE},
pubmed_id={18583979},
language={English},
abbrev_source_title={Nat. Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Wirdefeldt2011,
author={Wirdefeldt, K. and Adami, H.-O. and Cole, P. and Trichopoulos, D. and Mandel, J.},
title={Epidemiology and etiology of Parkinson's disease: A review of the evidence},
journal={European Journal of Epidemiology},
year={2011},
volume={26},
number={SUPPL. 1},
pages={S1-S58},
doi={10.1007/s10654-011-9581-6},
note={cited By 776},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959728747&doi=10.1007%2fs10654-011-9581-6&partnerID=40&md5=16a48af259411c918c0da0d6530a25ef},
affiliation={Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm 171 77, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States; School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada},
abstract={The etiology of Parkinson's disease (PD) is not well understood but likely to involve both genetic and environmental factors. Incidence and prevalence estimates vary to a large extent-at least partly due to methodological differences between studies-but are consistently higher in men than in women. Several genes that cause familial as well as sporadic PD have been identified and familial aggregation studies support a genetic component. Despite a vast literature on lifestyle and environmental possible risk or protection factors, consistent findings are few. There is compelling evidence for protective effects of smoking and coffee, but the biologic mechanisms for these possibly causal relations are poorly understood. Uric acid also seems to be associated with lower PD risk. Evidence that one or several pesticides increase PD risk is suggestive but further research is needed to identify specific compounds that may play a causal role. Evidence is limited on the role of metals, other chemicals and magnetic fields. Important methodological limitations include crude classification of exposure, low frequency and intensity of exposure, inadequate sample size, potential for confounding, retrospective study designs and lack of consistent diagnostic criteria for PD. Studies that assessed possible shared etiological components between PD and other diseases show that REM sleep behavior disorder and mental illness increase PD risk and that PD patients have lower cancer risk, but methodological concerns exist. Future epidemiologic studies of PD should be large, include detailed quantifications of exposure, and collect information on environmental exposures as well as genetic polymorphisms. © 2011 Springer Science+Business Media B.V.},
author_keywords={Epidemiology;  Parkinson disease;  Risk factor},
keywords={adenosine triphosphatase;  alpha synuclein;  antioxidant;  cytochrome P450 2D6;  DJ 1 protein;  fungicide;  glucosylceramidase;  herbicide;  insecticide;  leucine rich repeat kinase 2;  metal;  microtubule associated protein;  mineral;  organic solvent;  parkin;  pesticide;  phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase induced putative kinase 1;  protein PARK10;  protein PARK11;  protein PARK12;  protein PARK14;  protein PARK15;  protein PARK16;  protein PARK3;  protein PARK9;  protein serine threonine kinase;  ubiquitin;  ubiquitin carboxy terminal hydrolase L1;  unclassified drug;  uric acid, agricultural worker;  alcohol consumption;  body mass;  coffee;  community living;  dairy product;  dementia;  diabetes mellitus;  diet;  dietary intake;  diffuse Lewy body disease;  ecology;  environmental exposure;  environmental factor;  essential tremor;  gene linkage disequilibrium;  gene locus;  gene mutation;  genetic analysis;  genetic polymorphism;  genetic susceptibility;  gout;  head injury;  heredity;  heterozygosity;  homozygosity;  human;  incidence;  infection;  inflammation;  lifestyle;  macronutrient;  magnetic field;  mental disease;  mortality;  neoplasm;  obesity;  occupational exposure;  olfactory nerve disease;  Parkinson disease;  parkinsonism;  physical activity;  point mutation;  prevalence;  REM sleep;  review;  risk factor;  rural area;  smoking;  tea;  twins;  vascular disease;  vitamin supplementation, Age Factors;  Alcohol Drinking;  Comorbidity;  Diagnosis, Differential;  Diet;  Environmental Exposure;  Genetic Predisposition to Disease;  Humans;  Magnetics;  Metals;  Occupational Exposure;  Organic Chemicals;  Parkinson Disease;  Pesticides;  Polymorphism, Genetic;  Residence Characteristics;  Sex Factors;  Smoking;  Water Supply},
chemicals_cas={adenosine triphosphatase, 37289-25-1, 9000-83-3; alpha synuclein, 154040-18-3; glucosylceramidase, 37228-64-1; parkin, 356136-82-8; ubiquitin, 60267-61-0; uric acid, 69-93-2; Metals; Organic Chemicals; Pesticides},
funding_text 1={Acknowledgments This project was supported by a grant from Syngenta Crop Protection, Inc.},
references={Marsden, C.D., Movement disorders (1996) Oxford Textbook of Medicine, 3, pp. 3998-4022. , Weatherall DJ, Ledingham JGG, Warrell DA, editors. New York: Oxford University Press Inc; Gibb, W.R., Lees, A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease (1988) J Neurol Neurosurg Psychiatry, 51, pp. 745-752; McNaught, K.S., Olanow, C.W., Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease (2003) Ann Neurol, 53, pp. S73-S84; Hoehn, M.M., Yahr, M.D., Parkinsonism: Onset, progression and mortality (1967) Neurology, 17, pp. 427-442; Marttila, R.J., Rinne, U.K., Epidemiology of Parkinson's disease in Finland (1976) Acta Neurol Scand, 53, pp. 81-102; Schoenberg, B.S., Anderson, D.W., Haerer, A.F., Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi (1985) Neurology, 35, pp. 841-845; Calne, D.B., Snow, B.J., Lee, C., Criteria for diagnosing Parkinson's disease (1992) Ann Neurol, 32 (SUPPL.), pp. S125-S127; Gelb, D.J., Oliver, E., Gilman, S., Diagnostic criteria for Parkinson disease (1999) Archives of Neurology, 56 (1), pp. 33-39. , DOI 10.1001/archneur.56.1.33; Ward, C.D., Gibb, W.R., Research diagnostic criteria for Parkinson's disease (1990) Adv Neurol, 53, pp. 245-249; Rajput, A.H., Rozdilsky, B., Rajput, A., Accuracy of clinical diagnosis in parkinsonism-a prospective study (1991) Can J Neurol Sci, 18, pp. 275-278; Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases (1992) J Neurol Neurosurg Psychiatry, 55, pp. 181-184; Hughes, A.J., Ben-Shlomo, Y., Daniel, S.E., Lees, A.J., What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study (1992) Neurology, 42, pp. 1142-1146; Hughes, A.J., Daniel, S.E., Lees, A.J., Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease (2001) Neurology, 57 (8), pp. 1497-1499; Hughes, A.J., Daniel, S.E., Ben-Shlomo, Y., Lees, A.J., The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service (2002) Brain, 125 (4), pp. 861-870; Litvan, I., MacIntyre, A., Goetz, C.G., Wenning, G.K., Jellinger, K., Verny, M., Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study (1998) Arch Neurol, 55, pp. 969-978; Benito-Leon, J., Bermejo-Pareja, F., Rodriguez, J., Molina, J.-A., Gabriel, R., Morales, J.-M., Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain (2003) Movement Disorders, 18 (3), pp. 267-274. , DOI 10.1002/mds.10362; De Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J.F., Baldereschi, M., Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts (2000) Neurology, 54, pp. S21-S23. , Neurologic Diseases in the Elderly Research Group; De Rijk, M.C., Tzourio, C., Breteler, M.M.B., Dartigues, J.F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J.M., Rocca, W.A., Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study (1997) Journal of Neurology Neurosurgery and Psychiatry, 62 (1), pp. 10-15; Claveria, L.E., Duarte, J., Sevillano, M.D., Perez-Sempere, A., Cabezas, C., Rodriguez, F., Prevalence of Parkinson's disease in Cantalejo, Spain: A door-to-door survey (2002) Mov Disord, 17, pp. 242-249; Morgante, L., Rocca, W.A., Di Rosa, A.E., De Domenico, P., Grigoletto, F., Meneghini, F., Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities (1992) Neurology, 42, pp. 1901-1907. , The Sicilian Neuro-Epidemiologic Study (SNES) Group; Schoenberg, B.S., Osuntokun, B.O., Adeuja, A.O., Bademosi, O., Nottidge, V., Anderson, D.W., Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies (1988) Neurology, 38, pp. 645-646; Tison, F., Dartigues, J.F., Dubes, L., Zuber, M., Alperovitch, A., Henry, P., Prevalence of Parkinson's disease in the elderly: A population study in Gironde, France (1994) Acta Neurol Scand, 90, pp. 111-115; Zhang, Z.X., Roman, G.C., Hong, Z., Wu, C.B., Qu, Q.M., Huang, J.B., Parkinson's disease in China: Prevalence in Beijing, Xian, and Shanghai (2005) Lancet, 365, pp. 595-597; Bermejo, F., Gabriel, R., Vega, S., Morales, J.M., Rocca, W.A., Anderson, D.W., Problems and issues with door-to-door, two-phase surveys: An illustration from central spain (2001) Neuroepidemiology, 20 (4), pp. 225-231. , DOI 10.1159/000054794; De Rijk, M.C., Rocca, W.A., Anderson, D.W., Melcon, M.O., Breteler, M.M.B., Maraganore, D.M., A population perspective on diagnostic criteria for Parkinson's disease (1997) Neurology, 48 (5), pp. 1277-1281; Anderson, D.W., Rocca, W.A., De Rijk, M.C., Grigoletto, F., Melcon, M.O., Breteler, M.M.B., Maraganore, D.M., Case ascertainment uncertainties in prevalence surveys of Parkinson's disease (1998) Movement Disorders, 13 (4), pp. 626-632. , DOI 10.1002/mds.870130403; Bower, J.H., Maraganore, D.M., McDonnell, S.K., Rocca, W.A., Influence of strict, intermediate, and broad diagnostic criteria on the age- And sex-specific incidence of Parkinson's disease (2000) Mov Disord, 15, pp. 819-825; Baldereschi, M., Di Carlo, A., Rocca, W.A., Vanni, P., Maggi, S., Perissinotto, E., Parkinson's disease and Parkinsonism in a longitudinal study: Two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging (2000) Neurology, 55, pp. 1358-1363; Benito-Leon, J., Bermejo-Pareja, F., Morales-Gonzalez, J.M., Porta-Etessam, J., Trincado, R., Vega, S., Louis, E.D., Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain (2004) Neurology, 62 (5), pp. 734-741; Bower, J.H., Maraganore, D.M., McDonnell, S.K., Rocca, W.A., Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990 (1999) Neurology, 52, pp. 1214-1220; Brewis, M., Poskanzer, D.C., Rolland, C., Miller, H., Neurological disease in an English city (1966) Acta Neurol Scand, 42 (SUPPL. 24), pp. 1-89; Chen, R.C., Chang, S.F., Su, C.L., Chen, T.H.H., Yen, M.F., Wu, H.M., Chen, Z.Y., Liou, H.H., Prevalence, incidence, and mortality of PD: A door-to-door survey in Ilan County, Taiwan (2001) Neurology, 57 (9), pp. 1679-1686; De Lau, L.M.L., Giesbergen, P.C.L.M., De Rijk, M.C., Hofman, A., Koudstaal, P.J., Breteler, M.M.B., Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study (2004) Neurology, 63 (7), pp. 1240-1244; Driver, J.A., Logroscino, G., Gaziano, J.M., Kurth, T., Incidence and remaining lifetime risk of Parkinson disease in advanced age (2009) Neurology, 72, pp. 432-438; Fall, P.-A., Axelson, O., Fredriksson, M., Hansson, G., Lindvall, B., Olsson, J.-E., Granerus, A.-K., Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community (1996) Journal of Clinical Epidemiology, 49 (6), pp. 637-641. , DOI 10.1016/0895-4356(96)00003-0; Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A., The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study (2004) Brain, 127, pp. 550-560; Granieri, E., Carreras, M., Casetta, I., Govoni, V., Tola, M.R., Paolino, E., Parkinson's disease in Ferrara, Italy, 1967 through 1987 (1991) Arch Neurol, 48, pp. 854-857; Leentjens, A.F.G., Van Den, A.M., Metsemakers, J.F.M., Troost, J., The incidence of Parkinson's disease in the Netherlands: Results from a longitudinal general practice-based registration [1] (2003) Neuroepidemiology, 22 (5), pp. 311-312. , DOI 10.1159/000071195; MacDonald, B.K., Cockerell, O.C., Sander, J.W.A.S., Shorvon, S.D., The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK (2000) Brain, 123 (4), pp. 665-676; Mayeux, R., Marder, K., Cote, L.J., Denaro, J., Hemenegildo, N., Mejia, H., The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993 (1995) Am J Epidemiol, 142, pp. 820-827; Morens, D.M., Davis, J.W., Grandinetti, A., Ross, G.W., Popper, J.S., White, L.R., Epidemiologic observations on Parkinson's disease: Incidence and mortality in a prospective study of middle-aged men (1996) Neurology, 46 (4), pp. 1044-1050; Morioka, S., Sakata, K., Yoshida, S., Nakai, E., Shiba, M., Yoshimura, N., Hashimoto, T., Incidence of Parkinson disease in Wakayama, Japan (2002) Journal of Epidemiology, 12 (6), pp. 403-407; Tan, L.C.S., Venketasubramanian, N., Jamora, R.D.G., Heng, D., Incidence of Parkinson's disease in Singapore (2007) Parkinsonism and Related Disorders, 13 (1), pp. 40-43. , DOI 10.1016/j.parkreldis.2006.07.003, PII S1353802006001520; Taylor, K.S., Counsell, C.E., Harris, C.E., Gordon, J.C., Smith, W.C., Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results (2006) Mov Disord, 21, pp. 976-982; Van Den, E.S.K., Tanner, C.M., Bernstein, A.L., Fross, R.D., Leimpeter, A., Bloch, D.A., Nelson, L.M., Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity (2003) American Journal of Epidemiology, 157 (11), pp. 1015-1022; Wang, Y.S., Shi, Y.M., Wu, Z.Y., He, Y.X., Zhang, B.Z., Parkinson's disease in China. Coordinational Group of Neuroepidemiology (1991) PLA. Chin Med J, 104, pp. 960-964. , Engl; Linder, J., Stenlund, H., Forsgren, L., Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population-based study (2010) Mov Disord, 25, pp. 341-348; Winter, Y., Bezdolnyy, Y., Katunina, E., Avakjan, G., Reese, J.P., Klotsche, J., Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study (2010) Mov Disord, 25, pp. 349-356; Hristova, D., Zachariev, Z., Mateva, N., Grozdev, I., Incidence of Parkinson's disease in Bulgaria (2010) Neuroepidemiology, 34, pp. 76-82; Twelves, D., Perkins, K.S.M., Counsell, C., Systematic review of incidence studies of Parkinson's disease (2003) Movement Disorders, 18 (1), pp. 19-31. , DOI 10.1002/mds.10305; Hirtz, D., Thurman, D.J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A.R., Zalutsky, R., How common are the "common" neurologic disorders? (2007) Neurology, 68, pp. 326-337; Taba, P., Asser, T., Incidence of Parkinson's disease in Estonia (2003) Neuroepidemiology, 22 (1), pp. 41-45. , DOI 10.1159/000067105; Wermuth, L., Bech, S., Petersen, M.S., Joensen, P., Weihe, P., Grandjean, P., Prevalence and incidence of Parkinson's disease in the Faroe Islands (2008) Acta Neurol Scand, 118, pp. 126-131; Elbaz, A., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Peterson, B.J., Ahlskog, J.E., Schaid, D.J., Rocca, W.A., Risk tables for parkinsonism and Parkinson's disease (2002) Journal of Clinical Epidemiology, 55 (1), pp. 25-31. , DOI 10.1016/S0895-4356(01)00425-5, PII S0895435601004255; Wooten, G.F., Currie, L.J., Bovbjerg, V.E., Lee, J.K., Patrie, J., Are men at greater risk for Parkinson's disease than women? (2004) J Neurol Neurosurg Psychiatry, 75, pp. 637-639; Taylor, K.S.M., Cook, J.A., Counsell, C.E., Heterogeneity in male to female risk for Parkinson's disease [1] (2007) Journal of Neurology, Neurosurgery and Psychiatry, 78 (8), pp. 905-906. , DOI 10.1136/jnnp.2006.104695; Barbosa, M.T., Caramelli, P., Maia, D.P., Cunningham, M.C.Q., Guerra, H.L., Lima-Costa, M.F., Cardoso, F., Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambuí Study) (2006) Movement Disorders, 21 (6), pp. 800-808. , DOI 10.1002/mds.20806; Bergareche, A., De La, P.E., Lopez, D.M.A., Sarasqueta, C., De Arce, A., Poza, J.J., Marti-Masso, J.F., Prevalence of Parkinson's disease and other types of Parkinsonism: A door-to-door survey in Bidasoa, Spain (2004) Journal of Neurology, 251 (3), pp. 340-345. , DOI 10.1007/s00415-004-0333-3; Chan, D.K., Cordato, D., Karr, M., Ong, B., Lei, H., Liu, J., Prevalence of Parkinson's disease in Sydney (2005) Acta Neurol Scand, 111, pp. 7-11; De Rijk, M.C., Breteler, M.M.B., Graveland, G.A., Ott, A., Grobbee, D.E., Van Der, M.F.G.A., Hofman, A., Prevalence of Parkinson's disease in the elderly: The Rotterdam study (1995) Neurology, 45 (12), pp. 2143-2146; Kis, B., Schrag, A., Ben-Shlomo, Y., Klein, C., Gasperi, A., Spoegler, F., Novel three-stage ascertainment method: Prevalence of PD and parkinsonism in South Tyrol, Italy (2002) Neurology, 58, pp. 1820-1825; Li, S.-C., Schoenberg, B.S., Wang, C.-C., A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China (1985) Archives of Neurology, 42 (7), pp. 655-657; Melcon, M.O., Anderson, D.W., Vergara, R.H., Rocca, W.A., Prevalence of Parkinson's disease in Junin, Buenos Aires Province, Argentina (1997) Movement Disorders, 12 (2), pp. 197-205. , DOI 10.1002/mds.870120210; Nicoletti, A., Sofia, V., Bartoloni, A., Bartalesi, F., Gamboa, B.H., Giuffrida, S., Reggio, A., Prevalence of Parkinson's disease: A door-to-door survey in rural Bolivia (2003) Parkinsonism and Related Disorders, 10 (1), pp. 19-21. , DOI 10.1016/S1353-8020(03)00066-X; Okada, K., Kobayashi, S., Tsunematsu, T., Prevalence of Parkinson's disease in Izumo City, Japan (1990) Gerontology, 36, pp. 340-344; Tan, L.C.S., Venketasubramanian, N., Hong, C.Y., Sahadevan, S., Chin, J.J., Krishnamoorthy, E.S., Tan, A.K.Y., Saw, S.M., Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians (2004) Neurology, 62 (11), pp. 1999-2004; Wang, S.-J., Fuh, J.-L., Teng, E.L., Liu, C.-Y., Lin, K.-P., Chen, H.-M., Lin, C.-H., Liu, H.-C., A door-to-door survey of Parkinson's disease in a Chinese population in kinmen (1996) Archives of Neurology, 53 (1), pp. 66-71; Wirdefeldt, K., Gatz, M., Bakaysa, S.L., Fiske, A., Flensburg, M., Petzinger, G.M., Complete ascertainment of Parkinson disease in the Swedish Twin Registry (2008) Neurobiol Aging, 29, pp. 1765-1773; Racette, B.A., Good, L.M., Kissel, A.M., Criswell, S.R., Perlmutter, J.S., A population-based study of parkinsonism in an Amish community (2009) Neuroepidemiology, 33, pp. 225-230; Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G., Kieburtz, K., Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 (2007) Neurology, 68, pp. 384-386; Kessler, I.I., Epidemiologic studies of Parkinson's disease. II. A hospital-based survey (1972) Am J Epidemiol, 95, pp. 308-318; Paddison, R.M., Griffith, R.P., Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans (1974) Neurology, 24, pp. 688-690; Lombard, A., Gelfand, M., Parkinson's disease in the African (1978) Central African Journal of Medicine, 24 (1), pp. 5-8; Woo, J., Lau, E., Ziea, E., Chan, D.K.Y., Prevalence of Parkinson's disease in a Chinese population (2004) Acta Neurologica Scandinavica, 109 (3), pp. 228-231. , DOI 10.1034/j.1600-0404.2003.00220.x; Trenkwalder, C., Schwarz, J., Gebhard, J., Ruland, D., Trenkwalder, P., Hense, H.W., Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-todoor survey of inhabitants older than 65 years (1995) Arch Neurol, 52, pp. 1017-1022; Zhang, Z.-X., Roman, G.C., Worldwide occurrence of Parkinson's disease: An updated review (1993) Neuroepidemiology, 12 (4), pp. 195-208; McInerney-Leo, A., Gwinn-Hardy, K., Nussbaum, R.L., Prevalence of Parkinson's disease in populations of African ancestry: A review (2004) Journal of the National Medical Association, 96 (7), pp. 974-979; Romdhane, N.A., Hamida, M.B., Mrabet, A., Larnaout, A., Samoud, S., Hamda, A.B., Hamda, M.B., Oueslati, S., Prevalence study of neurologic disorders in Kelibia (Tunisia) (1993) Neuroepidemiology, 12 (5), pp. 285-299; Ashok, P.P., Radhakrishnan, K., Sridharan, R., Mousa, M.E., Epidemiology of Parkinson's disease in Benghazi, North-East Libya (1986) Clin Neurol Neurosurg, 88, pp. 109-113; Okubadejo, N.U., Bower, J.H., Rocca, W.A., Maraganore, D.M., Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies (2006) Movement Disorders, 21 (12), pp. 2150-2156. , DOI 10.1002/mds.21153; D'Alessandro, R., Gamberini, G., Granieri, E., Benassi, G., Naccarato, S., Manzaroli, D., Prevalence of Parkinson's disease in the Republic of San Marino (1987) Neurology, 37 (10), pp. 1679-1682; Rosati, G., Granieri, E., Pinna, L., Parkinson's disease. Prevalence and incidence in the province of Sassari North Sardinia (1978) Acta Neurologica, 33 (3), pp. 201-207; Rosati, G., Granieri, E., Pinna, L., The risk of Parkinson disease in Mediterranean people (1980) Neurology, 30 (3), pp. 250-255; Rosati, G., Granieri, E., Pinna, L., Devoto, M.C., The frequency of Parkinson's disease in the province of Nuoro (Sardinia) (1979) Acta Neurologica, 34 (4), pp. 303-308; Errea, J.M., Ara, J.R., Aibar, C., De Pedro-Cuesta, J., Prevalence of Parkinson's disease in lower Aragon, Spain (1999) Mov Disord, 14, pp. 596-604; Sutcliffe, R.L., Meara, J.R., Parkinson's disease epidemiology in the Northampton District, England, 1992 (1995) Acta Neurol Scand, 92, pp. 443-450; Berger, K., Breteler, M.M., Helmer, C., Inzitari, D., Fratiglioni, L., Trenkwalder, C., Prognosis with Parkinson's disease in Europe: A collaborative study of population-based cohorts (2000) Neurology, 54, pp. S24-S27. , Neurologic Diseases in the Elderly Research Group; Chen, H., Zhang, S.M., Schwarzschild, M.A., Hernan, M.A., Ascherio, A., Survival of Parkinson's disease patients in a large prospective cohort of male health professionals (2006) Movement Disorders, 21 (7), pp. 1002-1007. , DOI 10.1002/mds.20881; D'Amelio, M., Ragonese, P., Morgante, L., Reggio, A., Callari, G., Salemi, G., Savettieri, G., Long-term survival of Parkinson's disease: A population-based study (2006) Journal of Neurology, 253 (1), pp. 33-37. , DOI 10.1007/s00415-005-0916-7; De Lau, L.M.L., Schipper, C.M.A., Hofman, A., Koudstaal, P.J., Breteler, M.M.B., Prognosis of parkinson disease. Risk of dementia and mortality: The rotterdam study (2005) Archives of Neurology, 62 (8), pp. 1265-1269. , http://archneur.ama-assn.org/cgi/reprint/62/8/1265.pdf, DOI 10.1001/archneur.62.8.1265; Driver, J.A., Kurth, T., Buring, J.E., Gaziano, J.M., Logroscino, G., Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study (2008) Neurology, 70 (16 PART 2), pp. 1423-1430. , DOI 10.1212/01.wnl.0000310414.85144.ee, PII 0000611420080415100010; Ebmeier, K.P., Calder, S.A., Crawford, J.R., Stewart, L., Besson, J.A., Mutch, W.J., Mortality and causes of death in idiopathic Parkinson's disease: Results from the Aberdeen whole population study (1990) Scott Med J, 35, pp. 173-175; Elbaz, A., Bower, J.H., Peterson, B.J., Maraganore, D.M., McDonnell, S.K., Ahlskog, J.E., Survival study of Parkinson disease in Olmsted County, Minnesota (2003) Arch Neurol, 60, pp. 91-96; Fall, P.-A., Saleh, A., Fredrickson, M., Olsson, J.-E., Granerus, A.-K., Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: A 9-year follow-up (2003) Movement Disorders, 18 (11), pp. 1312-1316. , DOI 10.1002/mds.10537; Hely, M.A., Morris, J.G.L., Traficante, R., Reid, W.G.J., O'Sullivan, D.J., Williamson, P.M., The Sydney multicentre study of Parkinson's disease: Progression and mortality at 10 years (1999) Journal of Neurology Neurosurgery and Psychiatry, 67 (3), pp. 300-307; Herlofson, K., Lie, S.A., Arsland, D., Larsen, J.P., Mortality and Parkinson disease: A community based study (2004) Neurology, 62 (6), pp. 937-942; Hughes, T.A., Ross, H.F., Mindham, R.H.S., Spokes, E.G.S., Mortality in Parkinson's disease and its association with dementia and depression (2004) Acta Neurologica Scandinavica, 110 (2), pp. 118-123. , DOI 10.1111/j.1600-0404.2004.00292.x; Louis, E.D., Marder, K., Cote, L., Tang, M., Moyeux, R., Mortality from Parkinson disease (1997) Archives of Neurology, 54 (3), pp. 260-264; Marttila, R.J., Rinne, U.K., Siirtola, T., Sonninen, V., Mortality of patients with Parkinson's disease treated with levodopa (1977) Journal of Neurology, 216 (3), pp. 147-153. , DOI 10.1007/BF00313615; Morgante, L., Salemi, G., Meneghini, F., Di, R.A.E., Epifanio, A., Grigoletto, F., Ragonese, P., Savettieri, G., Parkinson disease survival: A population-based study (2000) Archives of Neurology, 57 (4), pp. 507-512; Vanacore, N., Bonifati, V., Bellatreccia, A., Edito, F., Meco, G., Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987) (1992) Neuroepidemiology, 11, pp. 65-73; Diem-Zangerl, A., Seppi, K., Oberaigner, W., Poewe, W., Mortality in Parkinson's disease, a 20-year follow-up study (2010) Mov Disord, 25, pp. 661-662; Guttman, M., Slaughter, P.M., Theriault, M.-E., DeBoer, D.P., Naylor, C.D., Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study (2001) Neurology, 57 (12), pp. 2278-2282; Ishihara, L.S., Cheesbrough, A., Brayne, C., Schrag, A., Estimated life expectancy of Parkinson's patients compared with the UK population (2007) Journal of Neurology, Neurosurgery and Psychiatry, 78 (12), pp. 1304-1309. , DOI 10.1136/jnnp.2006.100107; Ben-Shlomo, Y., Marmot, M.G., Survival and cause of death in a cohort of patients with parkinsonism: Possible clues to aetiology? (1995) J Neurol Neurosurg Psychiatry, 58, pp. 293-299; Uitti, R.J., Ahlskog, J.E., Maraganore, D.M., Muenter, M.D., Atkinson, E.J., Cha, R.H., O'Brien, P.C., Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project (1993) Neurology, 43 (10), pp. 1918-1926; Roos, R.A.C., Jongen, J.C.F., Van Der, V.E.A., Clinical course of patients with idiopathic Parkinson's disease (1996) Movement Disorders, 11 (3), pp. 236-242. , DOI 10.1002/mds.870110304; Levy, G., Tang, M.-X., Louis, E.D., Cote, L.J., Alfaro, B., Mejia, H., Stern, Y., Marder, K., The association of incident dementia with mortality in PD (2002) Neurology, 59 (11), pp. 1708-1713; Fahn, S., Elton, R.L., Unified Parkinson's disease rating scale (1987) Recent Developments in Parkinson's Disease, 2, pp. 153-163. , the UPDRS Development Committee. Fahn S, Marsden CD, Calne D, Goldstein M, editors. Florham Park, NJ: Macmillan Healthcare Information; Wermuth, L., Stenager, E.N., Stenager, E., Boldsen, J., Mortality in patientswith Parkinson's disease (1995) Acta Neurol Scand, 92, pp. 55-58; Gorell, J.M., Johnson, C.C., Rybicki, B.A., Parkinson's disease and its comorbid disorders: An analysis of Michigan mortality data, 1970 to 1990 (1994) Neurology, 44, pp. 1865-1868; Paulson, G.W., Gill, W.M., Are death certificates reliable to estimate the incidence of Parkinson's disease? (1995) Mov Disord, 10, p. 678; Marsden, C.D., Parkinson's disease in twins (1987) Journal of Neurology Neurosurgery and Psychiatry, 50 (1), pp. 105-106; Marttila, R.J., Kaprio, J., Koskenvuo, M., Rinne, U.K., Parkinson's disease in a nationwide twin cohort (1988) Neurology, 38, pp. 1217-1219; Ward, C.D., Duvoisin, R.C., Ince, S.E., Parkinson's disease in 65 pairs of twins and in a set of quadruplets (1983) Neurology, 33 (7), pp. 815-824; Vieregge, P., Schiffke, K.A., Friedrich, H.J., Muller, B., Ludin, H.P., Parkinson's disease in twins (1992) Neurology, 42, pp. 1453-1461; Vieregge, P., Hagenah, J., Heberlein, I., Klein, C., Ludin, H.-P., Parkinson's disease in twins: A follow-up study (1999) Neurology, 53 (3), pp. 566-572; Johnson, W.G., Hodge, S.E., Duvoisin, R., Twin studies and the genetics of Parkinson's disease - A reappraisal (1990) Movement Disorders, 5 (3), pp. 187-194; Tanner, C.M., Ottman, R., Goldman, S.M., Ellenberg, J., Chan, P., Mayeux, R., Langston, J.W., Parkinson disease in twins: An etiologic study (1999) Journal of the American Medical Association, 281 (4), pp. 341-346. , DOI 10.1001/jama.281.4.341; Wirdefeldt, K., Gatz, M., Schalling, M., Pedersen, N.L., No evidence for heritability of Parkinson disease in Swedish twins (2004) Neurology, 63 (2), pp. 305-311; Morrish, P.K., Rakshi, J.S., Bailey, D.L., Sawle, G.V., Brooks, D.J., Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET (1998) J Neurol Neurosurg Psychiatry, 64, pp. 314-319; Burn, D.J., Mark, M.H., Playford, E.D., Maraganore, D.M., Zimmerman Jr., T.R., Duvoisin, R.C., Parkinson's disease in twins studied with 18F-dopa and positron emission tomography (1992) Neurology, 42, pp. 1894-1900; Piccini, P., Burn, D.J., Ceravolo, R., Maraganore, D., Brooks, D.J., The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins (1999) Annals of Neurology, 45 (5), pp. 577-582. , DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Holthoff, V.A., Vieregge, P., Kessler, J., Pietrzyk, U., Herholz, K., Bonner, J., Wagner, R., Heiss, W.-D., Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits (1994) Annals of Neurology, 36 (2), pp. 176-182. , DOI 10.1002/ana.410360209; Laihinen, A., Ruottinen, H., Rinne, J.O., Haaparanta, M., Bergman, J., Solin, O., Koskenvuo, M., Rinne, U.K., Risk for Parkinson's disease: Twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET (2000) Journal of Neurology, Supplement, 247 (2), pp. 110-113; Martin, W.E., Young, W.I., Anderson, V.E., Parkinson's disease. A genetic study (1973) Brain, 96, pp. 495-506; Barbeau, A., Pourcher, E., New data on the genetics of Parkinson's disease (1982) Canadian Journal of Neurological Sciences, 9 (1), pp. 53-60; Alonso, M.E., Otero, E., D'Regules, R., Figueroa, H.H., Parkinson's disease: A genetic study (1986) Canadian Journal of Neurological Sciences, 13 (3), pp. 248-251; Marttila, R.J., Rinne, U.K., Parkinson's disease and essential tremor in families of patients with early-onset Parkinson's disease (1988) Journal of Neurology Neurosurgery and Psychiatry, 51 (3), pp. 429-431; Mickel, S.F., Broste, S.K., Hiner, B.C., Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease (1997) Neurology, 48, pp. 942-949; Taylor, C.A., Saint-Hilaire, M.H., Cupples, L.A., Thomas, C.A., Burchard, A.E., Feldman, R.G., Environmental,medical, and family history risk factors for Parkinson's disease: A New England-based case control study (1999) Am J Med Genet, 88, pp. 742-749; Semchuk, K.M., Love, E.J., Lee, R.G., Parkinson's disease: A test of the multifactorial etiologic hypothesis (1993) Neurology, 43 (6), pp. 1173-1180; Payami, H., Larsen, K., Bernard, S., Nutt, J., Increased risk of Parkinson's disease in parents and siblings of patients (1994) Annals of Neurology, 36 (4), pp. 659-661. , DOI 10.1002/ana.410360417; Payami, H., Zareparsi, S., James, D., Nutt, J., Familial aggregation of Parkinson disease: A comparative study of early-onset and late-onset disease (2002) Archives of Neurology, 59 (5), pp. 848-850; De La Fuente-Fernandez, R., Maternal effect on Parkinson's disease (2000) Ann Neurol, 48, pp. 782-787; Preux, P.M., Condet, A., Anglade, C., Druet-Cabanac, M., Debrock, C., Macharia, W., Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France (2000) Neuroepidemiology, 19, pp. 333-337; Herishanu, Y.O., Medvedovski, M., Goldsmith, J.R., Kordysh, E., A case-control study of Parkinson's disease in urban population of southern Israel (2001) Canadian Journal of Neurological Sciences, 28 (2), pp. 144-147; Marder, K., Levy, G., Louis, E.D., Mejia-Santana, H., Cote, L., Andrews, H., Harris, J., Ottman, R., Familial aggregation of early- And late-onset Parkinson's disease (2003) Annals of Neurology, 54 (4), pp. 507-513. , DOI 10.1002/ana.10711; Bonifati, V., Fabrizio, E., Vanacore, N., De Mari, M., Meco, G., Familial Parkinson's disease: A clinical genetic analysis (1995) Canadian Journal of Neurological Sciences, 22 (4), pp. 272-279; De Michele, G., Filla, A., Volpe, G., De Marco, V., Gogliettino, A., Ambrosio, G., Marconi, R., Campanella, G., Environmental and genetic risk factors in Parkinson's disease: A case-control study in Southern Italy (1996) Movement Disorders, 11 (1), pp. 17-23. , DOI 10.1002/mds.870110105; McCann, S.J., LeCouteur, D.G., Green, A.C., Brayne, C., Johnson, A.G., Chan, D., McManus, M.E., Pond, S.M., The epidemiology of parkinson's disease in an Australian population (1998) Neuroepidemiology, 17 (6), pp. 310-317. , DOI 10.1159/000026185; Morano, A., Jimenez-Jimenez, F.J., Molina, J.A., Antolin, M.A., Risk-factors for Parkinson's disease: Case-control study in the province of Caceres, Spain (1994) Acta Neurol Scand, 89, pp. 164-170; Behari, M., Srivastava, A.K., Das, R.R., Pandey, R.M., Risk factors of Parkinson's disease in Indian patients (2001) Journal of the Neurological Sciences, 190 (1-2), pp. 49-55. , PII S0022510X01005780; Chan, D.K.Y., Woo, J., Ho, S.C., Pang, C.P., Law, L.K., Ng, P.W., Hung, W.T., Kay, R., Genetic and environmental risk factors for Parkinson's disease in a Chinese population (1998) Journal of Neurology Neurosurgery and Psychiatry, 65 (5), pp. 781-784; Werneck, A.L., Alvarenga, H., Genetics, drugs and environmental factors in Parkinson's disease. A case-control study (1999) Arq Neuropsiquiatr, 57, pp. 347-355; Wang, W.Z., Fang, X.H., Cheng, X.M., Jiang, D.H., Lin, Z.J., A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China (1993) Neuroepidemiology, 12, pp. 209-218; Zorzon, M., Capus, L., Pellegrino, A., Cazzato, G., Zivadinov, R., Familial and environmental risk factors in Parkinson's disease: A case-control study in north-east Italy (2002) Acta Neurologica Scandinavica, 105 (2), pp. 77-82. , DOI 10.1034/j.1600-0404.2002.1o040.x; Rybicki, B.A., Johnson, C.C., Peterson, E.L., Kortshab, G.X., Gorell, J.M., A family history of Parkinson's disease and its effect on other PD risk factors (1999) Neuroepidemiology, 18 (5), pp. 270-278. , DOI 10.1159/000026222; Korchounov, A., Schipper, H.I., Preobrazhenskaya, I.S., Kessler, K.R., Yakhno, N.N., Differences in age at onset and familial aggregation between clinical types of Idiopathic Parkinson's disease (2004) Movement Disorders, 19 (9), pp. 1059-1064. , DOI 10.1002/mds.20061; Spanaki, C., Plaitakis, A., Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance (2004) Neurology, 62 (5), pp. 815-817; Marttila, R.J., Rinne, U.K., Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study (1976) Clin Neurol Neurosurg, 79, pp. 46-56; Rossi, P., Albanese, A., Moro, E., Genvardi, M., Tonali, P., Clinical genetic study of familial Parkinson's disease in Italy (1999) Adv Neurol, 80, pp. 181-186; Butterfield, P.G., Valanis, B.G., Spencer, P.S., Lindeman, C.A., Nutt, J.G., Environmental antecedents of young-onset Parkinson's disease (1993) Neurology, 43 (6), pp. 1150-1158; Seidler, A., Hellenbrand, W., Robra, B.-P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W.H., Schneider, E., Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany (1996) Neurology, 46 (5), pp. 1275-1284; Autere, J.M., Moilanen, J.S., Myllyla, V.V., Majamaa, K., Familial aggregation of Parkinson's disease in a Finnish population (2000) Journal of Neurology Neurosurgery and Psychiatry, 69 (1), pp. 107-109. , DOI 10.1136/jnnp.69.1.107; Duzcan, F., Zencir, M., Ozdemir, F., Cetin, G.O., Bagci, H., Heutink, P., Bonifati, V., Sahiner, T., Familial influence on parkinsonism in a rural area of Turkey (Kizilcaboluk-Denizli): A community-based case-control study (2003) Movement Disorders, 18 (7), pp. 799-804. , DOI 10.1002/mds.10440; Elbaz, A., Grigoletto, F., Baldereschi, M., Breteler, M.M., Manubens-Bertran, J.M., Lopez-Pousa, S., Familial aggregation of Parkinson's disease: A population-based case-control study in Europe (1999) Neurology, 52, pp. 1876-1882. , EUROPARKINSON Study Group; Kuopio, A.-M., Marttila, R.J., Helenius, H., Rinne, U.K., Familial occurrence of Parkinson's disease in a community-based case-control study (2001) Parkinsonism and Related Disorders, 7 (4), pp. 297-303. , DOI 10.1016/S1353-8020(00)00051-1, PII S1353802000000511; Kurz, M., Alves, G., Aarsland, D., Larsen, J.P., Familial Parkinson's disease: A community-based study (2003) European Journal of Neurology, 10 (2), pp. 159-163. , DOI 10.1046/j.1468-1331.2003.00532.x; Marder, K., Tang, M.-X., Mejia, H., Alfaro, B., Cote, L., Louis, E., Groves, J., Mayeux, R., Risk of Parkinson's disease among first-degree relatives: A community- Based study (1996) Neurology, 47 (1), pp. 155-160; Rocca, W.A., McDonnell, S.K., Strain, K.J., Bower, J.H., Ahlskog, J.E., Elbaz, A., Schaid, D.J., Maraganore, D.M., Familial aggregation of Parkinson's disease: The mayo clinic family study (2004) Annals of Neurology, 56 (4), pp. 495-502. , DOI 10.1002/ana.20228; Sundquist, K., Li, X., Hemminki, K., Familial risks of hospitalization for Parkinson's disease in first-degree relatives: A nationwide follow-up study from Sweden (2006) Neurogenetics, 7 (4), pp. 231-237. , DOI 10.1007/s10048-006-0055-z; Sveinbjornsdottir, S., Hicks, A.A., Jonsson, T., Petursson, H., Gugmundsson, G., Frigge, M.L., Familial aggregation of Parkinson's disease in Iceland (2000) N Engl J Med, 343, pp. 1765-1770; Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Brown, G.G., Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease (1999) Neurotoxicology, 20, pp. 239-247; Khoury, M.J., Beaty, T.H., Cohen, B.H., (1993) Fundamentals of Genetic Epidemiology, , New York: Oxford University Press; Elbaz, A., McDonnell, S.K., Maraganore, D.M., Strain, K.J., Schaid, D.J., Bower, J.H., Ahlskog, J.E., Rocca, W.A., Validity of family history data on PD: Evidence for a family information bias (2003) Neurology, 61 (1), pp. 11-17; Thacker, E.L., Ascherio, A., Familial aggregation of Parkinson's disease: A meta-analysis (2008) Mov Disord, 23, pp. 1174-1183; Bonifati, V., Rizzu, P., VanBaren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism (2003) Science, 299, pp. 256-259; Gasser, T., Muller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V., Bereznai, B., Horstmann, R.D., A susceptibility locus for Parkinson's disease maps to chromosome 2p13 (1998) Nature Genetics, 18 (3), pp. 262-265. , DOI 10.1038/ng0398-262; Hicks, A.A., Petursson, H., Jonsson, T., Stefansson, H., Johannsdottir, H.S., Sainz, J., Frigge, M.L., Sveinbjornsdottir, S., A susceptibility gene for late-onset idiopathic Parkinson's disease (2002) Annals of Neurology, 52 (5), pp. 549-555. , DOI 10.1002/ana.10324; Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Shimizu, N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism (1998) Nature, 392 (6676), pp. 605-608. , DOI 10.1038/33416; Lautier, C., Goldwurm, S., Durr, A., Giovannone, B., Tsiaras, W.G., Pezzoli, G., Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease (2008) Am J Hum Genet, 82, pp. 822-833; Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., The ubiquitin pathway in Parkinson's disease (1998) Nature, 395, pp. 451-452; Paisan-Ruiz, C., Bhatia, K.P., Li, A., Hernandez, D., Davis, M., Wood, N.W., Characterization of PLA2G6 as a locus for dystonia-parkinsonism (2009) Ann Neurol, 65, pp. 19-23; Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., Van Der Brug, M., De Munain, A.L., Singleton, A.B., Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease (2004) Neuron, 44 (4), pp. 595-600. , DOI 10.1016/j.neuron.2004.10.023, PII S0896627304006890; Pankratz, N., Nichols, W.C., Uniacke, S.K., Halter, C., Rudolph, A., Shults, C., Conneally, P.M., Hamann, J., Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations (2002) American Journal of Human Genetics, 71 (1), pp. 124-135. , DOI 10.1086/341282; Pankratz, N., Nichols, W.C., Uniacke, S.K., Halter, C., Murrell, J., Rudolph, A., Shults, C.W., Turk, M.F., Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families (2003) Human Molecular Genetics, 12 (20), pp. 2599-2608. , DOI 10.1093/hmg/ddg270; Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Nussbaum, R.L., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease (1997) Science, 276 (5321), pp. 2045-2047. , DOI 10.1126/science.276.5321.2045; Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L.P., Goebel, I., Kubisch, C., Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase (2006) Nature Genetics, 38 (10), pp. 1184-1191. , DOI 10.1038/ng1884, PII NG1884; Shojaee, S., Sina, F., Banihosseini, S.S., Kazemi, M.H., Kalhor, R., Shahidi, G.A., Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays (2008) Am J Hum Genet, 82, pp. 1375-1384; Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Gwinn-Hardy, K., Alpha-Synuclein Locus Triplication Causes Parkinson's Disease (2003) Science, 302 (5646), p. 841. , DOI 10.1126/science.1090278; Strauss, K.M., Martins, L.M., Plun-Favreau, H., Marx, F.P., Kautzmann, S., Berg, D., Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease (2005) Hum Mol Genet, 14, pp. 2099-2111; Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M.K., Harvey, K., Gispert, S., Ali, Z., Wood, N.W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 (2004) Science, 304 (5674), pp. 1158-1160. , DOI 10.1126/science.1096284; Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Gasser, T., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology (2004) Neuron, 44 (4), pp. 601-607. , DOI 10.1016/j.neuron.2004.11.005, PII S0896627304007202; Aharon-Peretz, J., Rosenbaum, H., Gershoni-Baruch, R., Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews (2004) New England Journal of Medicine, 351 (19), pp. 1972-1977. , DOI 10.1056/NEJMoa033277; Payami, H., Nutt, J., Gancher, S., Bird, T., Gonzales, M.N.M., Seltzer, W.K., Hussey, J., Farrer, M., SCA2 may present as levodopa-responsive parkinsonism (2003) Movement Disorders, 18 (4), pp. 425-429. , DOI 10.1002/mds.10375; Berg, D., Niwar, M., Maass, S., Zimprich, A., Moller, J.C., Wuellner, U., Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1, 900 patients (2005) Mov Disord, 20, pp. 1191-1194; Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease (1998) Nat Genet, 18, pp. 106-108; Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., De Yebenes, J.G., The New Mutation, E46K, of alpha-Synuclein Causes Parkinson and Lewy Body Dementia (2004) Annals of Neurology, 55 (2), pp. 164-173. , DOI 10.1002/ana.10795; Golbe, L.I., Di, I.G., Bonavita, V., Miller, D.C., Duvoisin, R.C., A large kindred with autosomal dominant Parkinson's disease (1990) Annals of Neurology, 27 (3), pp. 276-282; Spira, P.J., Sharpe, D.M., Halliday, G., Cavanagh, J., Nicholson, G.A., Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation (2001) Ann Neurol, 49, pp. 313-319; Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Destee, A., Alpha-synuclein locus duplication as a cause of familial Parkinson's disease (2004) Lancet, 364 (9440), pp. 1167-1169. , DOI 10.1016/S0140-6736(04)17103-1, PII S0140673604171031; Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schule, B., Langston, J.W., Farrer, M.J., Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication (2007) Neurology, 68 (12), pp. 916-922. , DOI 10.1212/01.wnl.0000254458.17630.c5; Ibanez, P., Bonnet, A.-M., Debarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Brice, P.A., Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease (2004) Lancet, 364 (9440), pp. 1169-1171. , DOI 10.1016/S0140-6736(04)17104-3, PII S0140673604171043; Nishioka, K., Hayashi, S., Farrer, M.J., Singleton, A.B., Yoshino, H., Imai, H., Kitami, T., Hattori, N., Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease (2006) Annals of Neurology, 59 (2), pp. 298-309. , DOI 10.1002/ana.20753; Ross, O.A., Braithwaite, A.T., Skipper, L.M., Kachergus, J., Hulihan, M.M., Middleton, F.A., Nishioka, K., Farrer, M.J., Genomic investigation of alpha-synuclein multiplication and parkinsonism (2008) Annals of Neurology, 63 (6), pp. 743-750. , DOI 10.1002/ana.21380; Ahn, T.B., Kim, S.Y., Kim, J.Y., Park, S.S., Lee, D.S., Min, H.J., Alpha-Synuclein gene duplication is present in sporadic Parkinson disease (2008) Neurology, 70, pp. 43-49; Brueggemann, N., Odin, P., Gruenewald, A., Tadic, V., Hagenah, J., Seidel, G., Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease (2008) Neurology, 71, p. 1294; Troiano, A.R., Cazeneuve, C., Le Ber, I., Bonnet, A.M., Lesage, S., Brice, A., Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease (2008) Neurology, 71, p. 1295; Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., Goedert, M., Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies (1998) Proceedings of the National Academy of Sciences of the United States of America, 95 (11), pp. 6469-6473. , DOI 10.1073/pnas.95.11.6469; Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., Alpha-synuclein in Lewy bodies (1997) Nature, 388, pp. 839-840; West, A.B., Zimprich, A., Lockhart, P.J., Farrer, M., Singleton, A., Holtom, B., Lincoln, S., Gasser, T., Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes (2001) European Journal of Human Genetics, 9 (9), pp. 659-666. , DOI 10.1038/sj.ejhg.5200698; DeStefano, A.L., Lew, M.F., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Guttman, M., Montgomery, E., Myers, R.H., PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study (2002) American Journal of Human Genetics, 70 (5), pp. 1089-1095. , DOI 10.1086/339814; Pankratz, N., Uniacke, S.K., Halter, C.A., Rudolph, A., Shults, C.W., Conneally, P.M., Foroud, T., Nichols, W.C., Genes influencing Parkinson disease onset: Replication of PARK3 and identification of novel loci (2004) Neurology, 62 (9), pp. 1616-1618; Martinez, M., Brice, A., Vaughan, J.R., Zimprich, A., Breteler, M.M.B., Meco, G., Filla, A., Durr, A., Genome-wide scan linkage analysis for Parkinson's disease: The European genetic study of Parkinson's disease (2004) Journal of Medical Genetics, 41 (12), pp. 900-907. , DOI 10.1136/jmg.2004.022632; Karamohamed, S., DeStefano, A.L., Wilk, J.B., Shoemaker, C.M., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Herbert, A., A haplotype at the PARK3 locus influences onset age for Parkinson's disease: The GenePD study (2003) Neurology, 61 (11), pp. 1557-1561; Sharma, M., Mueller, J.C., Zimprich, A., Lichtner, P., Hofer, A., Leitner, P., Maass, S., Gasser, T., The sepiapterin reductase gene region reveals association in the PARK3 locus: Analysis of familial and sporadic Parkinson's disease in European populations (2006) Journal of Medical Genetics, 43 (7), pp. 557-562. , DOI 10.1136/jmg.2005.039149; Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., Obata, F., A new locus for Parkinson's Disease (PARK8) maps to chromosome 12p11.2-q13.1 (2002) Annals of Neurology, 51 (3), pp. 296-301. , DOI 10.1002/ana.10113; Farrer, M., Stone, J., Mata, I.F., Lincoln, S., Kachergus, J., Hulihan, M., Strain, K.J., Maraganore, D.M., LRRK2 mutations in Parkinson disease (2005) Neurology, 65 (5), pp. 738-740. , DOI 10.1212/01.WNL.0000169023.51764.b0; Lesage, S., Durr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., Brice, A., LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs [13] (2006) New England Journal of Medicine, 354 (4), pp. 422-423. , http://content.nejm.org/cgi/reprint/354/4/422.pdf, DOI 10.1056/NEJMc055540; Paisan-Ruiz, C., Nath, P., Washecka, N., Gibbs, J.R., Singleton, A.B., Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls (2008) Human Mutation, 29 (4), pp. 485-490. , DOI 10.1002/humu.20668; Lesage, S., Brice, A., Parkinson's disease: From monogenic forms to genetic susceptibility factors (2009) Hum Mol Genet, 18, pp. R48-R59; Ozelius, L.J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A.L., Bressman, S.B., LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews [14] (2006) New England Journal of Medicine, 354 (4), pp. 424-425. , http://content.nejm.org/cgi/reprint/354/4/424.pdf, DOI 10.1056/NEJMc055509; Lu, C.S., Simons, E.J., Wu-Chou, Y.H., Fonzo, A.D., Chang, H.C., Chen, R.S., The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease (2005) Parkinsonism Relat Disord, 11, pp. 521-522; Tan, E.K., Shen, H., Tan, L.C.S., Farrer, M., Yew, K., Chua, E., Jamora, R.D., Liu, J.-J., The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients (2005) Neuroscience Letters, 384 (3), pp. 327-329. , DOI 10.1016/j.neulet.2005.04.103, PII S030439400500594X; Okubadejo, N., Britton, A., Crews, C., Akinyemi, R., Hardy, J., Singleton, A., Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3 (2008) PLoS One, 3, pp. e3421; Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study (2008) Lancet Neurol, 7, pp. 583-590; Ishikawa, A., Tsuji, S., Clinical analysis of 17 patients in 12 Japanese families with autosomal- Recessive type juvenile parkinsonism (1996) Neurology, 47 (1), pp. 160-166; Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S., Ikuta, F., Familial juvenile parkinsonism: Clinical and pathologic study in a family (1994) Neurology, 44 (3 I), pp. 437-441; Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Langston, J.W., Lewy bodies and parkinsonism in families with parkin mutations (2001) Annals of Neurology, 50 (3), pp. 293-300. , DOI 10.1002/ana.1132; Pramstaller, P.P., Schlossmacher, M.G., Jacques, T.S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Klein, C., Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers (2005) Annals of Neurology, 58 (3), pp. 411-422. , DOI 10.1002/ana.20587; West, A.B., Maidment, N.T., Genetics of parkin-linked disease (2004) Human Genetics, 114 (4), pp. 327-336. , DOI 10.1007/s00439-003-1074-6; Foroud, T., Uniacke, S.K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Gordon, P., Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease (2003) Neurology, 60 (5), pp. 796-801; Dekker, M.C.J., Bonifati, V., Van Duijn, C.M., Parkinson's disease: Piecing together a genetic jigsaw (2003) Brain, 126 (8), pp. 1722-1733. , DOI 10.1093/brain/awg172; Clark, L.N., Afridi, S., Karlins, E., Wang, Y., Mejia-Santana, H., Harris, J., Case-control study of the parkin gene in early-onset Parkinson disease (2006) Arch Neurol, 63, pp. 548-552; Klein, C., Lohmann-Hedrich, K., Rogaeva, E., Schlossmacher, M.G., Lang, A.E., Deciphering the role of heterozygous mutations in genes associated with parkinsonism (2007) Lancet Neurology, 6 (7), pp. 652-662. , DOI 10.1016/S1474-4422(07)70174-6, PII S1474442207701746; Sun, M., Latourelle, J.C., Wooten, G.F., Lew, M.F., Klein, C., Shill, H.A., Golbe, L.I., Gusella, J.F., Influence of heterozygosity for Parkin mutation on onset age in familial parkinson disease: The genePD study (2006) Archives of Neurology, 63 (6), pp. 826-832. , http://archneur.ama-assn.org/cgi/reprint/63/6/826, DOI 10.1001/archneur.63.6.826; Lesage, S., Lohmann, E., Tison, F., Durif, F., Durr, A., Brice, A., Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls (2008) Journal of Medical Genetics, 45 (1), pp. 43-46. , DOI 10.1136/jmg.2007.051854; Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Selkoe, D.J., Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease (2001) Science, 293 (5528), pp. 263-269. , DOI 10.1126/science.1060627; Valente, E.M., Bentivoglio, A.R., Dixon, P.H., Ferraris, A., Lalongo, T., Frontali, M., Albanese, A., Wood, N.W., Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 (2001) American Journal of Human Genetics, 68 (4), pp. 895-900. , DOI 10.1086/319522; Valente, E.M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A.E., Caputo, V., Romito, L., Bentivoglio, A.R., PINK1 mutations are associated with sporadic early-onset Parkinsonism (2004) Annals of Neurology, 56 (3), pp. 336-341. , DOI 10.1002/ana.20256; Bonifati, V., Rohe, C.F., Breedveld, G.J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Oostra, B.A., Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes (2005) Neurology, 65 (1), pp. 87-95. , DOI 10.1212/01.wnl.0000167546.39375.82; Healy, D.G., Abou-Sleiman, P.M., Gibson, J.M., Ross, O.A., Jain, S., Gandhi, S., Gosal, D., Lynch, T., PINK1 (PARK6) associated Parkinson disease in Ireland (2004) Neurology, 63 (8), pp. 1486-1488; Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Hattori, N., Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism (2005) Neurology, 64 (11), pp. 1955-1957. , DOI 10.1212/01.WNL.0000164009.36740.4E; Rogaeva, E., Johnson, J., Lang, A.E., Gulick, C., Gwinn-Hardy, K., Kawarai, T., Sato, C., Singleton, A.B., Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease (2004) Archives of Neurology, 61 (12), pp. 1898-1904. , DOI 10.1001/archneur.61.12.1898; Tan, E.-K., Yew, K., Chua, E., Puvan, K., Shen, H., Lee, E., Puong, K.-Y., Tan, L., PINK1 mutations in sporadic early-onset Parkinson's Disease (2006) Movement Disorders, 21 (6), pp. 789-793. , DOI 10.1002/mds.20810; Clark, L.N., Afridi, S., Mejia-Santana, H., Harris, J., Louis, E.D., Cote, L.J., Andrews, H., Marder, K., Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations (2004) Movement Disorders, 19 (7), pp. 796-800. , DOI 10.1002/mds.20131; Hedrich, K., Djarmati, A., Schafer, N., Hering, R., Wellenbrock, C., Weiss, P.H., Hilker, R., Klein, C., DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease (2004) Neurology, 62 (3), pp. 389-394; Hering, R., Strauss, K.M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., Petrovic, S., Riess, O., Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7) (2004) Human Mutation, 24 (4), pp. 321-329. , DOI 10.1002/humu.20089; Lockhart, P.J., Lincoln, S., Hulihan, M., Kachergus, J., Wilkes, K., Bisceglio, G., DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function (2004) J Med Genet, 41, pp. e22; Tan, E.-K., Tan, C., Zhao, Y., Yew, K., Shen, H., Chandran, V.R., Teoh, M.-L., Wong, M.-C., Genetic analysis of DJ-1 in a cohort Parkinson's disease patients of different ethnicity (2004) Neuroscience Letters, 367 (1), pp. 109-112. , DOI 10.1016/j.neulet.2004.05.090, PII S0304394004006883; Mitsumoto, A., Nakagawa, Y., DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin (2001) Free Radical Research, 35 (6), pp. 885-893; Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M.M., Takahashi, K., Ariga, H., DJ-1 has a role in antioxidative stress to prevent cell death (2004) EMBO Reports, 5 (2), pp. 213-218. , DOI 10.1038/sj.embor.7400074; Najim Al-Din, A.S., Wriekat, A., Mubaidin, A., Dasouki, M., Hiari, M., Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome (1994) Acta Neurol Scand, 89, pp. 347-352; Ning, Y.P., Kanai, K., Tomiyama, H., Li, Y., Funayama, M., Yoshino, H., Sato, S., Hattori, N., PARK9-linked parkinsonism in eastern asia: Mutation detection in ATP13A2 and clinical phenotype (2008) Neurology, 70 (16 PART 2), pp. 1491-1493. , DOI 10.1212/01.wnl.0000310427.72236.68, PII 0000611420080415100020; Di, F.A., Chien, H.F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Saraiva-Pereira, M.L., ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease (2007) Neurology, 68 (19), pp. 1557-1562. , DOI 10.1212/01.wnl.0000260963.08711.08, PII 0000611420070508000003; Lin, C.H., Tan, E.K., Chen, M.L., Tan, L.C., Lim, H.Q., Chen, G.S., Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore (2008) Neurology, 71, pp. 1727-1732; Li, Y.-J., Scott, W.K., Hedges, D.J., Zhang, F., Gaskell, P.C., Nance, M.A., Watts, R.L., Pericak-Vance, M.A., Age at onset in two common neurodegenerative diseases is genetically controlled (2002) American Journal of Human Genetics, 70 (4), pp. 985-993. , DOI 10.1086/339815; DeStefano, A.L., Latourelle, J., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Replication of association between ELAVL4 and Parkinson disease: The GenePD study (2008) HumGenet, 124, pp. 95-99; Haugarvoll, K., Toft, M., Ross, O.A., Stone, J.T., Heckman, M.G., White, L.R., ELAVL4, PARK10, and the Celts (2007) Mov Disord, 22, pp. 585-587; Noureddine, M.A., Qin, X.-J., Oliveira, S.A., Skelly, T.J., Van Der Walt, J., Hauser, M.A., Pericak-Vance, M.A., Li, Y.-J., Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease (2005) Human Genetics, 117 (1), pp. 27-33. , DOI 10.1007/s00439-005-1259-2; Maraganore, D.M., De Andrade, M., Lesnick, T.C., Strain, K.J., Farrer, M.J., Rocca, W.A., Pant, P.V.K., Ballinger, D.C., High-resolution whole-genome association study of Parkinson disease (2005) American Journal of Human Genetics, 77 (5), pp. 685-693. , DOI 10.1086/496902; Prestel, J., Sharma, M., Leitner, P., Zimprich, A., Vaughan, J.R., Durr, A., Bonifati, V., Gasser, T., PARK11 is not linked with Parkinson's disease in European families (2005) European Journal of Human Genetics, 13 (2), pp. 193-197. , DOI 10.1038/sj.ejhg.5201317; Nichols, W.C., Kissell, D.K., Pankratz, N., Pauciulo, M.W., Elsaesser, V.E., Clark, K.A., Variation in GIGYF2 is not associated with Parkinson disease (2009) Neurology, 72, pp. 1886-1892; Meeus, B., Nuytemans, K., Crosiers, D., Engelborghs, S., Pals, P., Pickut, B., GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population (2011) Neurobiol Aging, 32, pp. 308-312; Bras, J., Simon-Sanchez, J., Federoff, M., Morgadinho, A., Januario, C., Ribeiro, M., Lack of replication of association between GIGYF2 variants and Parkinson disease (2009) Hum Mol Genet, 18, pp. 341-346; Di Fonzo, A., Fabrizio, E., Thomas, A., Fincati, E., Marconi, R., Tinazzi, M., GIGYF2 mutations are not a frequent cause of familial Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. 703-705; Vilarino-Guell, C., Ross, O.A., Soto, A.I., Farrer, M.J., Haugarvoll, K., Aasly, J.O., Reported mutations in GIGYF2 are not a common cause of Parkinson's disease (2009) Mov Disord, 24, pp. 619-620; Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Pericak-Vance, M.A., Complete genomic screen in parkinson disease evidence for multiple genes (2001) Journal of the American Medical Association, 286 (18), pp. 2239-2244; Morgan, N.V., Westaway, S.K., Morton, J.E.V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Hayflick, S.J., PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron (2006) Nature Genetics, 38 (7), pp. 752-754. , DOI 10.1038/ng1826, PII N1826; Di Fonzo, A., Dekker, M.C., Montagna, P., Baruzzi, A., Yonova, E.H., Correia Guedes, L., FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome (2009) Neurology, 72, pp. 240-245; Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease (2009) Nat Genet, 41, pp. 1303-1307; Simon-Sanchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Genome-wide association study reveals genetic risk underlying Parkinson's disease (2009) Nat Genet, 41, pp. 1308-1312; Tan, E.K., Kwok, H.K., Tan, L.C., Zhao, W.T., Prakash, K.M., Au, W.L., Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus (2010) Neurology, 75, pp. 508-512; Lill, C.M., Bagade, S., McQueen, M.B., Roehr, J.T., Kavvoura, F., Schjeide, B.M.M., The PDGene Database Alzheimer Research Forum. 2010, , http://www.pdgene.org/, Accessed 23 Sept 2010; Grabowski, G.A., Gaucher disease. Enzymology, genetics, and treatment (1993) Adv Hum Genet, 21, pp. 377-441; Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Barbosa, E.R., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease (2009) NEngl J Med, 361, pp. 1651-1661; Goker-Alpan, O., Giasson, B.I., Eblan, M.J., Nguyen, J., Hurtig, H.I., Lee, V.M.-Y., Trojanowski, J.Q., Sidransky, E., Glucocerebrosidase mutations are an important risk factor for Lewy body disorders (2006) Neurology, 67 (5), pp. 908-910. , DOI 10.1212/01.wnl.0000230215.41296.18, PII 0000611420060912000047; Goker-Alpan, O., Lopez, G., Vithayathil, J., Davis, J., Hallett, M., Sidransky, E., The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations (2008) Arch Neurol, 65, pp. 1353-1357; McCulloch, C.C., Kay, D.M., Factor, S.A., Samii, A., Nutt, J.G., Higgins, D.S., Exploring gene-environment interactions in Parkinson's disease (2008) Hum Genet, 123, pp. 257-265; Gatto, N.M., Rhodes, S.L., Manthripragada, A.D., Bronstein, J., Cockburn, M., Farrer, M., Alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease (2010) Neuroepidemiology, 35, pp. 191-195; Brighina, L., Frigerio, R., Schneider, N.K., Lesnick, T.G., De Andrade, M., Cunningham, J.M., Farrer, M.J., Maraganore, D.M., Alpha-Synuclein, pesticides, and Parkinson disease: A case-control study (2008) Neurology, 70 (16 PART 2), pp. 1461-1469. , DOI 10.1212/01.wnl.0000304049.31377.f2, PII 0000611420080415100016; Brighina, L., Schneider, N.K., Lesnick, T.G., De Andrade, M., Cunningham, J.M., Mrazek, D., Alpha-Synuclein, alcohol use disorders, and Parkinson disease: A case-control study (2009) Parkinsonism Relat Disord, 15, pp. 430-434; Elbaz, A., Levecque, C., Clavel, J., Vidal, J.-S., Richard, F., Amouyel, P., Alperovitch, A., Tzourio, C., CYP2D6 Polymorphism, Pesticide Exposure, and Parkinson's Disease (2004) Annals of Neurology, 55 (3), pp. 430-434. , DOI 10.1002/ana.20051; Deng, Y., Newman, B., Dunne, M.P., Silburn, P.A., Mellick, G.D., Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease [2] (2004) Annals of Neurology, 55 (6), p. 897. , DOI 10.1002/ana.20143; Dick, F.D., De Palma, G., Ahmadi, A., Osborne, A., Scott, N.W., Prescott, G.J., Bennett, J., Felice, A., Gene-environment interactions in parkinsonism and Parkinson's disease: The Geoparkinson study (2007) Occupational and Environmental Medicine, 64 (10), pp. 673-680. , DOI 10.1136/oem.2006.032078; Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Association of missense and 50-splice-site mutations in tau with the inherited dementia FTDP-17 (1998) Nature, 393, pp. 702-705; Checkoway, H., Franklin, G.M., Costa-Mallen, P., Smith-Weller, T., Dilley, J., Swanson, P.D., Costa, L.G., A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease (1998) Neurology, 50 (5), pp. 1458-1461; Mellick, G.D., McCann, S.J., Le Couter, D.G., Parkinson's disease, MAOB, and smoking (1999) Neurology, 53, p. 658; Hernan, M.A., Checkoway, H., O'Brien, R., Costa-Mallen, P., De Vivo, I., Colditz, G.A., Hunter, D.J., Ascherio, A., MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD (2002) Neurology, 58 (9), pp. 1381-1387; Langston, J.W., Ballard, P., Tetrud, J.W., Irwin, I., Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis (1983) Science, 219, pp. 979-980; Barbeau, A., Roy, M., Bernier, G., Ecogenetics of Parkinson's disease: Prevalence and environmental aspects in rural areas (1987) Canadian Journal of Neurological Sciences, 14 (1), pp. 36-41; Bhatt, M.H., Elias, M.A., Mankodi, A.K., Acute and reversible parkinsonism due to organophosphate pesticide intoxication: Five cases (1999) Neurology, 52 (7), pp. 1467-1471; Meco, G., Bonifati, V., Vanacore, N., Fabrizio, E., Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate) (1994) Scandinavian Journal of Work, Environment and Health, 20 (4), pp. 301-305; Sechi, G.P., Agnetti, V., Piredda, M., Canu, M., Deserra, F., Omar, H.A., Acute and persistent parkinsonism after use of diquat (1992) Neurology, 42, pp. 261-263; Muller-Vahl, K.R., Kolbe, H., Dengler, R., Muller-Vahl, K.R., Transient severe parkinsonism after acute organophosphate poisoning [6] (1999) Journal of Neurology Neurosurgery and Psychiatry, 66 (2), pp. 253-254; Bocchetta, A., Corsini, G.U., Parkinson's disease and pesticides (1986) Lancet, 2 (8516), p. 1163; Sanchez-Ramos, J.R., Hefti, F., Weiner, W.J., Paraquat and Parkinson's disease (1987) Neurology, 37, p. 728; Golbe, L.I., Farrell, T.M., Davis, P.H., Follow-up study of early-life protective and risk factors in Parkinson's disease (1990) Movement Disorders, 5 (1), pp. 66-70; Semchuk, K.M., Love, E.J., Lee, R.G., Parkinson's disease and exposure to agricultural work and pesticide chemicals (1992) Neurology, 42, pp. 1328-1335; Hubble, J.P., Cao, T., Hassanein, R.E.S., Neuberger, J.S., Koller, W.C., Risk factors for Parkinson's disease (1993) Neurology, 43 (9), pp. 1693-1697; Hertzman, C., Wiens, M., Snow, B., Kelly, S., Calne, D., A case-control study of Parkinson's disease in a horticultural region of British Columbia (1994) Movement Disorders, 9 (1), pp. 69-75. , DOI 10.1002/mds.870090111; Liou, H.H., Tsai, M.C., Chen, C.J., Jeng, J.S., Chang, Y.C., Chen, S.Y., Environmental risk factors and Parkinson's disease: A case-control study in Taiwan (1997) Neurology, 48, pp. 1583-1588; Menegon, A., Board, P.G., Blackburn, A.C., Mellick, G.D., Le, C.D.G., Parkinson's disease, pesticides, and glutathione transferase polymorphisms (1998) Lancet, 352 (9137), pp. 1344-1346. , DOI 10.1016/S0140-6736(98)03453-9; Fall, P.-A., Fredrikson, M., Axelson, O., Granerus, A.-K., Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in southeastern Sweden (1999) Movement Disorders, 14 (1), pp. 28-37. , DOI 10.1002/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O; Baldereschi, M., Di, C.A., Vanni, P., Ghetti, A., Carbonin, P., Amaducci, L., Inzitari, D., Lifestyle-related risk factors for Parkinson's disease: A population-based study (2003) Acta Neurologica Scandinavica, 108 (4), pp. 239-244. , DOI 10.1034/j.1600-0404.2003.00128.x; Baldi, I., Cantagrel, A., Lebailly, P., Tison, F., Dubroca, B., Chrysostome, V., Dartigues, J.-F., Brochard, P., Association between Parkinson's disease and exposure to pesticides in southwestern France (2003) Neuroepidemiology, 22 (5), pp. 305-310. , DOI 10.1159/000071194; Galanaud, J.-P., Elbaz, A., Clavel, J., Vidal, J.-S., Correze, J.-R., Alperovitch, A., Tzourio, C., Cigarette smoking and Parkinson's disease: A case-control study in a population characterized by a high prevalence of pesticide exposure (2005) Movement Disorders, 20 (2), pp. 181-189. , DOI 10.1002/mds.20307; Frigerio, R., Sanft, K.R., Grossardt, B.R., Peterson, B.J., Elbaz, A., Bower, J.H., Ahlskog, J.E., Rocca, W.A., Chemical exposures and Parkinson's disease: A population-based case-control study (2006) Movement Disorders, 21 (10), pp. 1688-1692. , DOI 10.1002/mds.21009; Dick, F.D., De Palma, G., Ahmadi, A., Scott, N.W., Prescott, G.J., Bennett, J., Semple, S., Felice, A., Environmental risk factors for Parkinson's disease and parkinsonism: The Geoparkinson study (2007) Occupational and Environmental Medicine, 64 (10), pp. 666-672. , DOI 10.1136/oem.2006.027003; Dhillon, A.S., Tarbutton, G.L., Levin, J.L., Plotkin, G.M., Lowry, L.K., Nalbone, J.T., Pesticide/environmental exposures and Parkinson's disease in East Texas (2008) J Agromed, 13, pp. 37-48; Hancock, D.B., Martin, E.R., Mayhew, G.M., Stajich, J.M., Jewett, R., Stacy, M.A., Pesticide exposure and risk of Parkinson's disease: A family-based case-control study (2008) BMC Neurol, 8, p. 6; Ho, S.C., Woo, J., Lee, C.M., Epidemiologic study of Parkinson's disease in Hong Kong (1989) Neurology, 39 (10), pp. 1314-1318; Tanner, C.M., Ross, G.W., Jewell, S.A., Hauser, R.A., Jankovic, J., Factor, S.A., Occupation and risk of parkinsonism: A multicenter case-control study (2009) Arch Neurol, 66, pp. 1106-1113; Koller, W., Vetere-Overfield, B., Gray, C., Alexander, C., Chin, T., Dolezal, J., Hassanein, R., Tanner, C., Environmental risk factors in Parkinson's disease (1990) Neurology, 40 (8), pp. 1218-1221; Wechsler, L.S., Checkoway, H., Franklin, G.M., Costa, L.G., A pilot study of occupational and environmental risk factors for Parkinson's disease (1991) Neurotoxicology, 12, pp. 387-392; Jimenez-Jimenez, F.J., Mateo, D., Gimenez-Roldan, S., Exposure to well water and pesticides in Parkinson's disease: A case-control study in the Madrid area (1992) Mov Disord, 7, pp. 149-152; Chaturvedi, S., Ostbye, T., Stoessl, A.J., Merskey, H., Hachinski, V., Environmental exposures in elderly Canadians with Parkinson's disease (1995) Can J Neurol Sci, 22, pp. 232-234; Smargiassi, A., Mutti, A., De Rosa, A., De Palma, G., Negrotti, A., Calzetti, S., A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy (1998) NeuroToxicology, 19 (4-5), pp. 709-712; Dong, J.Q., Zhang, Z.X., Zhang, K.L., Parkinson's disease and smoking: An integral part of PD's etiological study (2003) Biomed Environ Sci, 16, pp. 173-179; Nuti, A., Ceravolo, R., Dell'Agnello, G., Gambaccini, G., Bellini, G., Kiferle, L., Rossi, C., Bonuccelli, U., Environmental factors and Parkinson's disease: A case-control study in the Tuscany region of Italy (2004) Parkinsonism and Related Disorders, 10 (8), pp. 481-485. , DOI 10.1016/j.parkreldis.2004.01.008, PII S1353802004000975; Wright, J.M., Keller-Byrne, J., Environmental determinants of Parkinson's disease (2005) Archives of Environmental and Occupational Health, 60 (1), pp. 32-38. , DOI 10.3200/AEOH.60.1.32-38; Petersen, M.S., Halling, J., Bech, S., Wermuth, L., Weihe, P., Nielsen, F., Impact of dietary exposure to food contaminants on the risk of Parkinson's disease (2008) Neurotoxicology, 29, pp. 584-590; Wong, G.F., Gray, C.S., Hassanein, R.S., Koller, W.C., Environmental risk factors in siblings with Parkinson's disease (1991) Arch Neurol, 48, pp. 287-289; Kuopio, A.M., Marttila, R.J., Helenius, H., Rinne, U.K., Environmental risk factors in Parkinson's disease (1999) Mov Disord, 14, pp. 928-939; Firestone, J.A., Smith-Weller, T., Franklin, G., Swanson, P., Longstreth Jr., W.T., Checkoway, H., Pesticides and risk of parkinson disease: A population-based case-control study (2005) Archives of Neurology, 62 (1), pp. 91-95. , DOI 10.1001/archneur.62.1.91; Firestone, J.A., Lundin, J.I., Powers, K.M., Smith-Weller, T., Franklin, G.M., Swanson, P.D., Occupational factors and risk of Parkinson's disease: A population-based case-control study (2010) Am J Ind Med, 53, pp. 217-223; Polder, A., Skaare, J.U., Skjerve, E., Loken, K.B., Eggesbo, M., Levels of chlorinated pesticides and polychlorinated biphenyls in Norwegian breast milk (2002-2006), and factors that may predict the level of contamination (2009) Sci Total Environ, 407, pp. 4584-4590; Baldi, I., Lebailly, P., Mohammed-Brahim, B., Letenneur, L., Dartigues, J.-F., Brochard, P., Neurodegenerative diseases and exposure to pesticides in the elderly (2003) American Journal of Epidemiology, 157 (5), pp. 409-414. , DOI 10.1093/aje/kwf216; Priyadarshi, A., Khuder, S.A., Schaub, E.A., Shrivastava, S., A meta-analysis of Parkinson's disease and exposure to pesticides (2000) Neurotoxicology, 21, pp. 435-440; Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Richardson, R.J., The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living (1998) Neurology, 50 (5), pp. 1346-1350; Gorell, J.M., Peterson, E.L., Rybicki, B.A., Johnson, C.C., Multiple risk factors for Parkinson's disease (2004) Journal of the Neurological Sciences, 217 (2), pp. 169-174. , DOI 10.1016/j.jns.2003.09.014; Costello, S., Cockburn, M., Bronstein, J., Zhang, X., Ritz, B., Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California (2009) Am J Epidemiol, 169, pp. 919-926; Elbaz, A., Clavel, J., Rathouz, P.J., Moisan, F., Galanaud, J.P., Delemotte, B., Professional exposure to pesticides and Parkinson disease (2009) Ann Neurol, 66, pp. 494-504; Stern, M., Dulaney, E., Gruber, S.B., Golbe, L., Bergen, M., Hurtig, H., The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients (1991) Arch Neurol, 48, pp. 903-907; Fleming, L., Mann, J.B., Bean, J., Briggle, T., Sanchez-Ramos, J.R., Parkinson's disease and brain levels of organochlorine pesticides (1994) Annals of Neurology, 36 (1), pp. 100-103. , DOI 10.1002/ana.410360119; Corrigan, F.M., Wienburg, C.L., Shore, R.F., Daniel, S.E., Mann, D., Organochlorine insecticides in substantia nigra in Parkinson's disease (2000) Journal of Toxicology and Environmental Health - Part A, 59 (4), pp. 229-234; Koldkjaer, O.G., Wermuth, L., Bjerregaard, P., Parkinson's disease among Inuit in Greenland: Organochlorines as risk factors (2004) Int J Circumpolar Health, 63 (SUPPL. 2), pp. 366-368; Weisskopf, M.G., Knekt, P., O'Reilly, E.J., Lyytinen, J., Reunanen, A., Laden, F., Persistent organochlorine pesticides in serum and risk of Parkinson disease (2010) Neurology, 74, pp. 1055-1061; Ascherio, A., Chen, H., Weisskopf, M.G., O'Reilly, E., McCullough, M.L., Calle, E.E., Pesticide exposure and risk for Parkinson's disease (2006) Ann Neurol, 60, pp. 197-203; Petrovitch, H., Webster, R.G., Abbott, R.D., Sanderson, W.T., Sharp, D.S., Tanner, C.M., Masaki, K.H., White, L.R., Plantation work and risk of Parkinson disease in a population-based longitudinal study (2002) Archives of Neurology, 59 (11), pp. 1787-1792. , DOI 10.1001/archneur.59.11.1787; Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M., Blair, A., Pesticide exposure and self-reported Parkinson's disease in the agricultural health study (2007) Am J Epidemiol, 165, pp. 364-374; Dosemeci, M., Alavanja, M.C.R., Rowland, A.S., Mage, D., Hoar, Z.S., Rothman, N., Lubin, J.H., Blair, A., A quantitative approach for estimating exposure to pesticides in the agricultural health study (2002) Annals of Occupational Hygiene, 46 (2), pp. 245-260. , DOI 10.1093/annhyg/mef011; Acquavella, J.F., Alexander, B.H., Mandel, J.S., Burns, C.J., Gustin, C., Exposure misclassification in studies of agricultural pesticides: Insights from biomonitoring (2006) Epidemiology, 17, pp. 69-74; Wang, S.J., Fuh, J.L., Liu, C.Y., Lin, K.P., Chang, R., Yih, J.S., Parkinson's disease in Kin-Hu, Kinmen: A community survey by neurologists (1994) Neuroepidemiology, 13, pp. 69-74; Svenson, L.W., Platt, G.H., Woodhead, S.E., Geographic variations in the prevalence rates of Parkinson's disease in Alberta (1993) Canadian Journal of Neurological Sciences, 20 (4), pp. 307-311; Tandberg, E., Larsen, J.P., Nessler, E.G., Riise, T., Aarli, J.A., The epidemiology of Parkinson's disease in the county of Rogaland, Norway (1995) Mov Disord, 10, pp. 541-549; Kuopio, A.-M., Marttila, R.J., Helenius, H., Rinne, U.K., Changing epidemiology of Parkinson's disease in southwestern Finland (1999) Neurology, 52 (2), pp. 302-308; Yesalis III, C.E., Lemke, J.H., Wallace, R.B., Health status of the rural elderly according to farm work history: The Iowa 65+ rural health study (1985) Archives of Environmental Health, 40 (5), pp. 245-253; Imaizumi, Y., Geographical variations in mortality from Parkinson's disease in Japan, 1977-1985 (1995) Acta Neurol Scand, 91, pp. 311-316; Sethi, K.D., Meador, K.J., Loring, D., Meador, M.P., Neuroepidemiology of Parkinson's disease: Analysis of mortality data for the USA and Georgia (1989) Int J Neurosci, 46, pp. 87-92; Strickland, D., Bertoni, J.M., Pfeiffer, R.F., Descriptive epidemiology of Parkinson's disease through proxy measures (1996) Canadian Journal of Neurological Sciences, 23 (4), pp. 279-284; Ritz, B., Yu, F., Parkinson's disease mortality and pesticide exposure in California 1984-1994 (2000) Int J Epidemiol, 29, pp. 323-329; Hertzmann, C., Wiens, M., Bowering, D., Snow, B., Calne, D., Parkinson's disease: A case-control study of occupational and environmental risk factors (1990) American Journal of Industrial Medicine, 17 (3), pp. 349-355; Frigerio, R., Elbaz, A., Sanft, K.R., Peterson, B.J., Bower, J.H., Ahlskog, J.E., Grossardt, B.R., Rocca, W.A., Education and occupations preceding Parkinson disease: A population-based case-control study (2005) Neurology, 65 (10), pp. 1575-1583. , DOI 10.1212/01.wnl.0000184520.21744.a2; Park, J., Yoo, C.-I., Sim, C.S., Kim, H.K., Kim, J.W., Jeon, B.S., Kim, K.-R., Kim, Y., Occupations and Parkinson's disease: A multi-center case-control study in South Korea (2005) NeuroToxicology, 26 (1), pp. 99-105. , DOI 10.1016/j.neuro.2004.07.001, PII S0161813X04000889; Kirkey, K.L., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Gorell, J.M., Occupational categories at risk for Parkinson's disease (2001) Am J Ind Med, 39, pp. 564-571; Tsui, J.K., Calne, D.B., Wang, Y., Schulzer, M., Marion, S.A., Occupational risk factors in Parkinson's disease (1999) Can J Public Health, 90, pp. 334-337; Rocca, W.A., Anderson, D.W., Meneghini, F., Grigoletto, F., Morgante, L., Reggio, A., Savettieri, G., Di, P.R., Occupation, education, and Parkinson's disease: A case-control study in an Italian population (1996) Movement Disorders, 11 (2), pp. 201-206. , DOI 10.1002/mds.870110214; Tanner, C.M., Chen, B., Wang, W., Peng, M., Liu, Z., Liang, X., Kao, L.C., Schoenberg, B.S., Environmental factors and Parkinson's disease: A case-control study in China (1989) Neurology, 39 (5), pp. 660-664; Park, J., Yoo, C.-I., Sim, C.S., Kim, J.-W., Yi, Y., Jung, K.Y., Chung, S.-E., Kim, Y., Occupations and Parkinson's disease: A case-control study in South Korea (2004) Industrial Health, 42 (3), pp. 352-358; Goldman, S.M., Tanner, C.M., Olanow, C.W., Watts, R.L., Field, R.D., Langston, J.W., Occupation and parkinsonism in three movement disorders clinics (2005) Neurology, 65 (9), pp. 1430-1435. , DOI 10.1212/01.wnl.0000180361.74060.70; Lee, E., Burnett, C.A., Lalich, N., Cameron, L.L., Sestito, J.P., Proportionate mortality of crop and livestock farmers in the United States, 1984-1993 (2002) Am J Ind Med, 42, pp. 410-420; Tuchsen, F., Jensen, A.A., Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993 (2000) Scand J Work Environ Health, 26, pp. 359-362; Tsai, C.H., Lo, S.K., See, L.C., Chen, H.Z., Chen, R.S., Weng, Y.H., Chang, F.C., Lu, C.S., Environmental risk factors of young onset Parkinson's disease: A case-control study (2002) Clinical Neurology and Neurosurgery, 104 (4), pp. 328-333. , DOI 10.1016/S0303-8467(02)00027-6, PII S0303846702000276; Semchuk, K.M., Love, E.J., Lee, R.G., Parkinson's disease and exposure to rural environmental factors: A population based case-control study (1991) Can J Neurol Sci, 18, pp. 279-286; Marder, K., Logroscino, G., Alfaro, B., Mejia, H., Halim, A., Louis, E., Cote, L., Mayeux, R., Environmental risk factors for Parkinson's disease in an urban multiethnic community (1998) Neurology, 50 (1), pp. 279-281; Tan, E.-K., Tan, C., Fook-Chong, S.M.C., Lum, S.Y., Chai, A., Chung, H., Shen, H., Wong, M.C., Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: A study in ethnic Chinese (2003) Journal of the Neurological Sciences, 216 (1), pp. 163-167. , DOI 10.1016/j.jns.2003.07.006; Gatto, N.M., Cockburn, M., Bronstein, J., Manthripragada, A.D., Ritz, B., Well-water consumption and Parkinson's disease in rural California (2009) Environ Health Persp, 117, pp. 1912-1918; Rybicki, B.A., Johnson, C.C., Uman, J., Gorell, J.M., Parkinson's disease mortality and the industrial use of heavy metals in Michigan (1993) Movement Disorders, 8 (1), pp. 87-92. , DOI 10.1002/mds.870080116; Hatcher, J.M., Pennell, K.D., Miller, G.W., Parkinson's disease and pesticides: A toxicological perspective (2008) Trends Pharmacol Sci, 29, pp. 322-329; Dick, F.D., Parkinson's disease and pesticide exposures (2006) Br Med Bull, 79-80, pp. 219-231; Brown, T.P., Rumsby, P.C., Capleton, A.C., Rushton, L., Levy, L.S., Pesticides and Parkinson's disease - Is there a link? (2006) Environ Health Persp, 114, pp. 156-164; Li, A.A., Mink, P.J., McIntosh, L.J., Teta, M.J., Finley, B., Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease (2005) Journal of Occupational and Environmental Medicine, 47 (10), pp. 1059-1087. , DOI 10.1097/01.jom.0000174294.58575.3e; Di Monte, D.A., The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins? (2003) Lancet Neurol, 2, pp. 531-538; Sherer, T.B., Betarbet, R., Greenamyre, J.T., Environment, mitochondria, and Parkinson's disease (2002) Neuroscientist, 8 (3), pp. 192-197; Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease (2000) Nat Neurosci, 3, pp. 1301-1306; McCormack, A.L., Thiruchelvam, M., Manning-Bog, A.B., Thiffault, C., Langston, J.W., Cory-Slechta, D.A., Di, M.D.A., Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat (2002) Neurobiology of Disease, 10 (2), pp. 119-127. , DOI 10.1006/nbdi.2002.0507; Thiruchelvam, M., Richfield, E.K., Baggs, R.B., Tank, A.W., Cory-Slechta, D.A., The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease (2000) Journal of Neuroscience, 20 (24), pp. 9207-9214; Uversky, V.N., Li, J., Fink, A.L., Pesticides directly accelerate the rate of alpha-synuclein fibril formation: A possible factor in Parkinson's disease (2001) FEBS Letters, 500 (3), pp. 105-108. , DOI 10.1016/S0014-5793(01)02597-2, PII S0014579301025972; Hatcher, J.M., Richardson, J.R., Guillot, T.S., McCormack, A.L., Di, M.D.A., Jones, D.P., Pennell, K.D., Miller, G.W., Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system (2007) Experimental Neurology, 204 (2), pp. 619-630. , DOI 10.1016/j.expneurol.2006.12.020, PII S0014488606006480; Le, C.D.G., McLean, A.J., Taylor, M.C., Woodham, B.L., Board, P.G., Pesticides and Parkinson's disease (1999) Biomedicine and Pharmacotherapy, 53 (3), pp. 122-130. , DOI 10.1016/S0753-3322(99)80077-8; Di, M.D.A., Lavasani, M., Manning-Bog, A.B., Environmental factors in Parkinson's disease (2002) NeuroToxicology, 23 (4-5), pp. 487-502. , DOI 10.1016/S0161-813X(02)00099-2, PII S0161813X02000992; Elbaz, A., Tranchant, C., Epidemiologic studies of environmental exposures in Parkinson's disease (2007) Journal of the Neurological Sciences, 262 (1-2), pp. 37-44. , DOI 10.1016/j.jns.2007.06.024, PII S0022510X07004388, Environmental Neurology Proceedings of the Meetings of the Environmental Neurology Club, held in Paris, France, 2-3 December 2005 and in Metz, France, 7 February 2007 under the aegis of the French Soc; Jankovic, J., Searching for a relationship between manganese and welding and Parkinson's disease (2005) Neurology, 64 (12), pp. 2021-2028. , DOI 10.1212/01.WNL.0000166916.40902.63; Kuhn, W., Winkel, R., Woitalla, D., Meves, S., Przuntek, H., Muller, T., High prevalence of parkinsonism after occupational exposure to lead- Sulfate batteries (1998) Neurology, 50 (6), pp. 1885-1886; Dexter, D.T., Wells, F.R., Agid, F., Agid, Y., Lees, A.J., Jenner, P., Marsden, C.D., Increased nigral iron content in postmortem Parkinsonian brain (1987) Lancet, 2 (8569), pp. 1219-1220; Dexter, D.T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F.R., Daniel, S.E., Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia (1991) Brain, 114 (PART 4), pp. 1953-1975; Riederer, P., Sofic, E., Rausch, W.-D., Schmidt, B., Reynolds, G.P., Jellinger, K., Youdim, M.B.H., Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains (1989) Journal of Neurochemistry, 52 (2), pp. 515-520. , DOI 10.1111/j.1471-4159.1989.tb09150.x; Ngim, C.-H., Devathasan, G., Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease (1989) Neuroepidemiology, 8 (3), pp. 128-141; McDonnell, L., Maginnis, C., Lewis, S., Pickering, N., Antoniak, M., Hubbard, R., Lawson, I., Britton, J., Occupational exposure to solvents and metals and Parkinson's disease (2003) Neurology, 61 (5), pp. 716-717; Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Brown, G.G., Richardson, R.J., Occupational exposures to metals as risk factors for Parkinson's disease (1997) Neurology, 48 (3), pp. 650-658; Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., Chettle, D., Gorell, J., Whole-body lifetime occupational lead exposure and risk of Parkinson's disease (2006) Environmental Health Perspectives, 114 (12), pp. 1872-1876. , http://www.ehponline.org/members/2006/9102/9102.pdf, DOI 10.1289/ehp.9102; Jimenez-Jimenez, F.J., Molina, J.A., Aguilar, M.V., Arrieta, F.J., Jorge-Santamaria, A., Cabrera-Valdivia, F., Serum and urinary manganese levels in patients with Parkinson's disease (1995) Acta Neurol Scand, 91, pp. 317-320; Park, J., Yoo, C.I., Sim, C.S., Kim, J.W., Yi, Y., Shin, Y.C., A retrospective cohort study of Parkinson's disease in Korean shipbuilders (2006) Neurotoxicology, 27, pp. 445-449; Finkelstein, M.M., Jerrett, M., A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities (2007) Environmental Research, 104 (3), pp. 420-432. , DOI 10.1016/j.envres.2007.03.002, PII S0013935107000540; Fryzek, J.P., Hansen, J., Cohen, S., Bonde, J.P., Llambias, M.T., Kolstad, H.A., Skytthe, A., Olsen, J.H., A cohort study of Parkinson's disease other neurodegenerative disorders in Danish welders (2005) Journal of Occupational and Environmental Medicine, 47 (5), pp. 466-472. , DOI 10.1097/01.jom.0000161730.25913.bf; Fored, C.M., Fryzek, J.P., Brandt, L., Nise, G., Sjogren, B., McLaughlin, J.K., Blot, W.J., Ekbom, A., Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders (2006) Occupational and Environmental Medicine, 63 (2), pp. 135-140. , DOI 10.1136/oem.2005.022921; Stampfer, M.J., Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999 (2009) J Occup Environ Hyg, 6, pp. 267-272; Marsh, G.M., Gula, M.J., Employment as a welder and Parkinson disease among heavy equipment manufacturing workers (2006) Journal of Occupational and Environmental Medicine, 48 (10), pp. 1031-1046. , DOI 10.1097/01.jom.0000232547.74802.d8, PII 0004376420061000000012; Logroscino, G., Chen, H., Wing, A., Ascherio, A., Blood donations, iron stores, and risk of Parkinson's disease (2006) Movement Disorders, 21 (6), pp. 835-838. , DOI 10.1002/mds.20826; Marder, K., Logroscino, G., Tang, M.-X., Graziano, J., Cote, L., Louis, E., Alfaro, B., Mayeux, R., Systemic iron metabolism and mortality from Parkinson's disease (1998) Neurology, 50 (4), pp. 1138-1140; Ohlson, C.G., Hogstedt, C., Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury. A case-referent study (1981) Scandinavian Journal of Work, Environment and Health, 7 (4), pp. 252-256; Savitz, D.A., Checkoway, H., Loomis, D.P., Magnetic field exposure and neurodegenerative disease mortality among electric utility workers (1998) Epidemiology, 9 (4), pp. 398-404; Johansen, C., Exposure to electromagnetic fields and risk of central nervous system disease in utility workers (2000) Epidemiology, 11 (5), pp. 539-543. , DOI 10.1097/00001648-200009000-00009; Noonan, C.W., Reif, J.S., Yost, M., Touchstone, J., Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases (2002) Scandinavian Journal of Work, Environment and Health, 28 (1), pp. 42-48; Li, X., Sundquist, J., Sundquist, K., Socioeconomic and occupational groups and Parkinson's disease: A nationwide study based on hospitalizations in Sweden (2009) Int Arch Occup Environ Health, 82, pp. 235-241; Dorn, H.F., Tobacco consumption and mortality from cancer and other diseases (1959) Public Health Rep, 74, pp. 581-593; Kahn, H.A., The Dorn study of smoking and mortality among U.S. veterans: Report on eight and one-half years of observation (1966) Natl Cancer Inst Monogr, 19, pp. 1-125; Hammond, E.C., Smoking in relation to the death rates of one million men and women (1966) Natl Cancer Inst Monogr, 19, pp. 127-204; Doll, R., Peto, R., Mortality in relation to smoking: 20 years' observations on male British doctors (1976) British Medical Journal, 2 (6051), pp. 1525-1536; Shahi, G.S., Moochhala, S.M., Smoking and Parkinson's disease - A new perspective (1991) Rev Environ Health, 9, pp. 123-136; Morens, D.M., Grandinetti, A., Reed, D., White, L.R., Ross, G.W., Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? (1995) Neurology, 45, pp. 1041-1051; Nefzger, M.D., Quadfasel, F.A., Karl, V.C., A retrospective study of smoking in Parkinson's disease (1968) Am J Epidemiol, 88, pp. 149-158; Kessler, I.I., Diamond, E.L., Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: A survey and explanatory hypothesis (1971) Am J Epidemiol, 94, pp. 16-25; Marttila, R.J., Rinne, U.K., Smoking and Parkinson's disease (1980) Acta Neurologica Scandinavica, 62 (5), pp. 322-325; Haack, D.G., Baumann, R.J., McKean, H.E., Nicotine exposure and parkinson disease (1981) American Journal of Epidemiology, 114 (2), pp. 191-200; Godwin-Austen, R.B., Lee, P.N., Marmot, M.G., Stern, G.M., Smoking and Parkinson's disease (1982) Journal of Neurology Neurosurgery and Psychiatry, 45 (7), pp. 577-581; Rajput, A.H., Offord, K.P., Beard, C.M., Kurland, L.T., A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease (1987) Neurology, 37 (2), pp. 226-232; Mayeux, R., Tang, M.-X., Marder, K., Cote, L.J., Stern, Y., Smoking and Parkinson's disease (1994) Movement Disorders, 9 (2), pp. 207-212; Martyn, C.N., Osmond, C., Parkinson's disease and the environment in early life (1995) J Neurol Sci, 132, pp. 201-206; Hellenbrand, W., Seidler, A., Robra, B.-P., Vieregge, P., Oertel, W.H., Joerg, J., Nischan, P., Ulm, G., Smoking and Parkinson's disease: A case-control study in Germany (1997) International Journal of Epidemiology, 26 (2), pp. 328-339; Gorell, J.M., Rybicki, B.A., Johnson, C.C., Peterson, E.L., Smoking and Parkinson's disease: A dose-response relationship (1999) Neurology, 52 (1), pp. 115-119; Vanacore, N., Bonifati, V., Fabbrini, G., Colosimo, C., Marconi, R., Nicholl, D., Smoking habits in multiple system atrophy and progressive supranuclear palsy (2000) Neurology, 54, pp. 114-119. , European Study Group on Atypical Parkinsonisms; Checkoway, H., Powers, K., Smith-Weller, T., Franklin, G.M., Longstreth Jr., W.T., Swanson, P.D., Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake (2002) American Journal of Epidemiology, 155 (8), pp. 732-738. , DOI 10.1093/aje/155.8.732; Powers, K.M., Kay, D.M., Factor, S.A., Zabetian, C.P., Higgins, D.S., Samii, A., Nutt, J.G., Payami, H., Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk (2008) Movement Disorders, 23 (1), pp. 88-95. , DOI 10.1002/mds.21782; Evans, A.H., Lawrence, A.D., Potts, J., MacGregor, L., Katzenschlager, R., Shaw, K., Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease (2006) J Neurol Neurosurg Psychiatry, 77, pp. 317-321; Elbaz, A., Manubens-Bertran, J.M., Baldereschi, M., Breteler, M.M., Grigoletto, F., Lopez-Pousa, S., Parkinson's disease, smoking, and family history (2000) J Neurol, 247, pp. 793-798. , EUROPARKINSON Study Group; Tanner, C.M., Chen, B., Wang, W.-Z., Peng, M.-L., Liu, Z.-L., Liang, X.-L., Kao, L.C., Schoenberg, B.S., Environmental factors in the etiology of Parkinson's disease (1987) Canadian Journal of Neurological Sciences, 14 (3 SUPPL.), pp. 419-423; Hofman, A., Collette, H.J.A., Bartelds, A.I.M., Incidence and risk factors of Parkinson's disease in the Netherlands (1989) Neuroepidemiology, 8 (6), pp. 296-299; Jimenez-Jimenez, F.J., Mateo, D., Gimenez-Roldan, S., Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study (1992) Mov Disord, 7, pp. 339-344; Tzourio, C., Rocca, W.A., Breteler, M.M., Baldereschi, M., Dartigues, J.F., Lopez-Pousa, S., Smoking and Parkinson's disease. An age-dependent risk effect? (1997) Neurology, 49, pp. 1267-1272. , The EUROPARKINSON Study Group; Benedetti, M.D., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Peterson, B.J., Ahlskog, J.E., Smoking, alcohol, and coffee consumption preceding Parkinson's disease: A case-control study (2000) Neurology, 55, pp. 1350-1358; Ragonese, P., Salemi, G., Morgante, L., Aridon, P., Epifanio, A., Buffa, D., Scoppa, F., Savettieria, G., A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease (2003) Neuroepidemiology, 22 (5), pp. 297-304. , DOI 10.1159/000071193; Duvoisin, R.C., Eldridge, R., Williams, A., Twin study of Parkinson disease (1981) Neurology, 31 (1), pp. 77-80; Bharucha, N.E., Stokes, L., Schoenberg, B.S., A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors (1986) Neurology, 36 (2), pp. 284-288; Tanner, C.M., Goldman, S.M., Aston, D.A., Ottman, R., Ellenberg, J., Mayeux, R., Langston, J.W., Smoking and Parkinson's disease in twins (2002) Neurology, 58 (4), pp. 581-588; Hernan, M.A., Zhang, S.M., Rueda-DeCastro, A.M., Colditz, G.A., Speizer, F.E., Ascherio, A., Cigarette smoking and the incidence of Parkinson's disease in two prospective studies (2001) Annals of Neurology, 50 (6), pp. 780-786. , DOI 10.1002/ana.10028; Thacker, E.L., O'Reilly, E.J., Weisskopf, M.G., Chen, H., Schwarzschild, M.A., McCullough, M.L., Temporal relationship between cigarette smoking and risk of Parkinson disease (2007) Neurology, 68, pp. 764-768; Chen, H., Huang, X., Guo, X., Mailman, R.B., Park, Y., Kamel, F., Smoking duration, intensity, and risk of Parkinson disease (2010) Neurology, 74, pp. 878-884; Tan, L.C., Koh, W.-P., Yuan, J.-M., Wang, R., Au, W.-L., Tan, J.H., Tan, E.-K., Yu, M.C., Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese health study (2008) American Journal of Epidemiology, 167 (5), pp. 553-560. , DOI 10.1093/aje/kwm338; Grandinetti, A., Morens, D.M., Reed, D., MacEachern, D., Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease (1994) American Journal of Epidemiology, 139 (12), pp. 1129-1138; Sasco, A.J., Paffenbarger Jr., R.S., Smoking and Parkinson's disease (1990) Epidemiology, 1, pp. 460-465; Paganini-Hill, A., Risk factors for Parkinson's disease: The Leisure World cohort study (2001) Neuroepidemiology, 20 (2), pp. 118-124. , DOI 10.1159/000054770; Wirdefeldt, K., Gatz, M., Pawitan, Y., Pedersen, N.L., Risk and protective factors for Parkinson's disease: A study in Swedish twins (2005) Annals of Neurology, 57 (1), pp. 27-33. , DOI 10.1002/ana.20307; Hernan, M.A., Takkouche, B., Caamano-Isorna, F., Gestal-Otero, J.J., A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease (2002) Annals of Neurology, 52 (3), pp. 276-284. , DOI 10.1002/ana.10277; Sugita, M., Izuno, T., Tatemichi, M., Otahara, Y., Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson's disease (2001) J Epidemiol, 11, pp. 87-94; Allam, M.F., Campbell, M.J., Hofman, A., Del, C.A.S., Navajas, R.F.-C., Smoking and Parkinson's disease: Systematic review of prospective studies (2004) Movement Disorders, 19 (6), pp. 614-621. , DOI 10.1002/mds.20029; Allam, M.F., Del, C.A.S., Navajas, R.F.-C., Parkinson's disease, smoking and family history: Meta-analysis (2003) European Journal of Neurology, 10 (1), pp. 59-62. , DOI 10.1046/j.1468-1331.2003.00512.x; Ritz, B., Ascherio, A., Checkoway, H., Marder, K.S., Nelson, L.M., Rocca, W.A., Ross, G.W., Gorell, J., Pooled analysis of tobacco use and risk of Parkinson disease (2007) Archives of Neurology, 64 (7), pp. 990-997. , http://archneur.ama-assn.org/cgi/reprint/64/7/990, DOI 10.1001/archneur.64.7.990; Fratiglioni, L., Wang, H.-X., Smoking and Parkinson's and Alzheimer's disease: Review of the epidemiological studies (2000) Behavioural Brain Research, 113 (1-2), pp. 117-120. , DOI 10.1016/S0166-4328(00)00206-0, PII S0166432800002060; Golbe, L.I., Cody, R.A., Duvoisin, R.C., Smoking and Parkinson's disease. Search for a dose-response relationship (1986) Arch Neurol, 43, pp. 774-778; Riggs, J.E., Cigarette smoking and Parkinson disease: The illusion of a neuroprotective effect (1992) Clin Neuropharmacol, 15, pp. 88-99; Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R., Calne, D.B., Parkinson's disease in twins (1984) Adv Neurol, 40, pp. 341-344; Ogawa, T., Personality characteristics of Parkinson's disease (1981) Perceptual and Motor Skills, 52 (2), pp. 375-378; Poewe, W., Gerstenbrand, F., Ransmayr, G., Plorer, S., Premorbid personality of Parkinson patients (1983) J Neural Transm Suppl, 19, pp. 215-224; Scott, W.K., Zhang, F., Stajich, J.M., Scott, B.L., Stacy, M.A., Vance, J.M., Family-based case-control study of cigarette smoking and Parkinson disease (2005) Neurology, 64 (3), pp. 442-447; Hancock, D.B., Martin, E.R., Stajich, J.M., Jewett, R., Stacy, M.A., Scott, B.L., Vance, J.M., Scott, W.K., Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease (2007) Archives of Neurology, 64 (4), pp. 576-580. , http://archneur.ama-assn.org/cgi/reprint/64/4/576.pdf; O'Reilly, E.J., Chen, H., Gardener, H., Gao, X., Schwarzschild, M.A., Ascherio, A., Smoking and Parkinson's disease: Using parental smoking as a proxy to explore causality (2009) Am J Epidemiol, 169, pp. 678-682; Morozova, N., O'Reilly, E.J., Ascherio, A., Variations in gender ratios support the connection between smoking and Parkinson's disease (2008) Mov Disord, 23, pp. 1414-1419; Kandinov, B., Giladi, N., Korczyn, A.D., Smoking and tea consumption delay onset of Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. 41-46; De Reuck, J., De Weweire, M., Van Maele, G., Santens, P., Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease (2005) Journal of the Neurological Sciences, 231 (1-2), pp. 35-39. , DOI 10.1016/j.jns.2004.12.003; Alves, G., Kurz, M., Lie, S.A., Larsen, J.P., Cigarette smoking in Parkinson's disease: Influence on disease progression (2004) Movement Disorders, 19 (9), pp. 1087-1092. , DOI 10.1002/mds.20117; Kandinov, B., Giladi, N., Korczyn, A.D., The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease (2007) Parkinsonism and Related Disorders, 13 (4), pp. 243-245. , DOI 10.1016/j.parkreldis.2006.11.004, PII S1353802006002689; O'Reilly, E.J., McCullough, M.L., Chao, A., Henley, S.J., Calle, E.E., Thun, M.J., Smokeless tobacco use and the risk of Parkinson's disease mortality (2005) Mov Disord, 20, pp. 1383-1384; Quik, M., Smoking, nicotine and Parkinson's disease (2004) Trends in Neurosciences, 27 (9), pp. 561-568. , DOI 10.1016/j.tins.2004.06.008, PII S0166223604001924; Hong, D.P., Fink, A.L., Uversky, V.N., Smoking and Parkinson's disease: Does nicotine affect alpha-synuclein fibrillation? (2009) Biochim Biophys Acta, 1794, pp. 282-290; Hellenbrand, W., Seidler, A., Boeing, H., Robra, B.P., Vieregge, P., Nischan, P., Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study (1996) Neurology, 47, pp. 636-643; Hernan, M.A., Chen, H., Schwarzschild, M.A., Ascherio, A., Alcohol consumption and the incidence of Parkinson's disease (2003) Annals of Neurology, 54 (2), pp. 170-175. , DOI 10.1002/ana.10611; Fertl, E., Doppelbauer, A., Auff, E., Physical activity and sports in patients suffering from Parkinson's disease in comparison with healthy seniors (1993) Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 5 (2), pp. 157-161; Sasco, A.J., Paffenbarger Jr., R.S., Gendre, I., Wing, A.L., The role of physical exercise in the occurrence of Parkinson's disease (1992) Arch Neurol, 49, pp. 360-365; Chen, H., Zhang, S.M., Schwarzschild, M.A., Hernan, M.A., Ascherio, A., Physical activity and the risk of Parkinson disease (2005) Neurology, 64 (4), pp. 664-669; Logroscino, G., Sesso, H.D., Paffenbarger Jr., R.S., Lee, I.-M., Physical activity and risk of Parkinson's disease: A prospective cohort study (2006) Journal of Neurology, Neurosurgery and Psychiatry, 77 (12), pp. 1318-1322. , DOI 10.1136/jnnp.2006.097170; Thacker, E.L., Chen, H., Patel, A.V., McCullough, M.L., Calle, E.E., Thun, M.J., Schwarzschild, M.A., Ascherio, A., Recreational physical activity and risk of Parkinson's disease (2008) Movement Disorders, 23 (1), pp. 69-74. , DOI 10.1002/mds.21772; Ragonese, P., D'Amelio, M., Callari, G., Di Benedetto, N., Palmeri, B., Mazzola, M.A., Body mass index does not change before Parkinson's disease onset (2008) Eur J Neurol, 15, pp. 965-968; Ma, L., Zhang, L., Gao, X.H., Chen, W., Wu, Y.P., Wang, Y., Li, X.F., Qiao, Y.L., Dietary factors and smoking as risk factors for PD in a rural population in China: A nested case-control study (2006) Acta Neurologica Scandinavica, 113 (4), pp. 278-281. , DOI 10.1111/j.1600-0404.2005.00571.x; Abbott, R.D., Ross, G.W., White, L.R., Nelson, J.S., Masaki, K.H., Tanner, C.M., Midlife adiposity and the future risk of Parkinson's disease (2002) Neurology, 59, pp. 1051-1057; Hu, G., Jousilahti, P., Nissinen, A., Antikainen, R., Kivipelto, M., Tuomilehto, J., Body mass index and the risk of Parkinson disease (2006) Neurology, 67 (11), pp. 1955-1959. , DOI 10.1212/01.wnl.0000247052.18422.e5, PII 0000611420061212000013; Chen, H., Zhang, S.M., Schwarzschild, M.A., Hernan, M.A., Willett, W.C., Ascherio, A., Obesity and the Risk of Parkinson's Disease (2004) American Journal of Epidemiology, 159 (6), pp. 547-555. , DOI 10.1093/aje/kwh059; Logroscino, G., Sesso, H.D., Paffenbarger Jr., R.S., Lee, I.-M., Body mass index and risk of Parkinson's disease: A prospective cohort study (2007) American Journal of Epidemiology, 166 (10), pp. 1186-1190. , DOI 10.1093/aje/kwm211; Golbe, L.I., Farrell, T.M., Davis, P.H., Case-control study of early life dietary factors in Parkinson's disease (1988) Arch Neurol, 45, pp. 1350-1353; Vieregge, P., Von Maravic, C., Friedrich, H.J., Life-style and dietary factors early and late in Parkinson's disease (1992) Can J Neurol Sci, 19, pp. 170-173; Kondo, K., Watanabe, K., Lifestyles, risk factors, and inherited predispositions in Parkinson's disease. Preliminary report of a case-control study (1993) Adv Neurol, 60, pp. 346-351; Ayuso-Peralta, L., Jimenez-Jimenez, F.J., Cabrera-Valdivia, F., Molina, J.A., Javier, M.R., Almazan, De Pedro-Cuesta, J., Gimenez-Roldan, S., Premorbid dietetic habits and risk for Parkinson's disease (1997) Parkinsonism and Related Disorders, 3 (1), pp. 55-61. , DOI 10.1016/S1353-8020(96)00047-8, PII S1353802096000478; Ross, G.W., Petrovitch, H., Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease (2001) Drugs and Aging, 18 (11), pp. 797-806; Schwarzschild, M.A., Agnati, L., Fuxe, K., Chen, J.-F., Morelli, M., Targeting adenosine A2A receptors in Parkinson's disease (2006) Trends in Neurosciences, 29 (11), pp. 647-654. , DOI 10.1016/j.tins.2006.09.004, PII S0166223606002219; Ross, G.W., Abbott, R.D., Petrovitch, H., Morens, D.M., Grandinetti, A., Tung, K.-H., Tanner, C.M., White, L.R., Association of coffee and caffeine intake with the risk of Parkinson disease (2000) Journal of the American Medical Association, 283 (20), pp. 2674-2679; Ascherio, A., Zhang, S.M., Hernan, M.A., Kawachi, I., Colditz, G.A., Speizer, F.E., Prospective study of caffeine consumption and risk of Parkinson's disease in men and women (2001) Ann Neurol, 50, pp. 56-63; Ascherio, A., Weisskopf, M.G., O'Reilly, E.J., McCullough, M.L., Calle, E.E., Rodriguez, C., Thun, M.J., Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: The modifying effects of estrogen (2004) American Journal of Epidemiology, 160 (10), pp. 977-984. , DOI 10.1093/aje/kwh312; Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J.F., Ascherio, A., Dluzen, D.E., Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease (2006) J Neurosci, 26, pp. 535-541; Hu, G., Bidel, S., Jousilahti, P., Antikainen, R., Tuomilehto, J., Coffee and tea consumption and the risk of Parkinson's disease (2007) Mov Disord, 22, pp. 2242-2248; Saaksjarvi, K., Knekt, P., Rissanen, H., Laaksonen, M.A., Reunanen, A., Mannisto, S., Prospective study of coffee consumption and risk of Parkinson's disease (2008) European Journal of Clinical Nutrition, 62 (7), pp. 908-915. , DOI 10.1038/sj.ejcn.1602788, PII 1602788; Chen, H., Zhang, S.M., Hernan, M.A., Willett, W.C., Ascherio, A., Diet and Parkinson's disease: A potential role of dairy products in men (2002) Annals of Neurology, 52 (6), pp. 793-801. , DOI 10.1002/ana.10381; Park, M., Ross, G.W., Petrovitch, H., White, L.R., Masaki, K.H., Nelson, J.S., Tanner, C.M., Abbott, R.D., Consumption of milk and calcium in midlife and the future risk of Parkinson disease (2005) Neurology, 64 (6), pp. 1047-1051; Chen, H., O'Reilly, E., McCullough, M.L., Rodriguez, C., Schwarzschild, M.A., Calle, E.E., Consumption of dairy products and risk of Parkinson's disease (2007) Am J Epidemiol, 165, pp. 998-1006; Hellenbrand, W., Boeing, H., Robra, B.P., Seidler, A., Vieregge, P., Nischan, P., Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study (1996) Neurology, 47, pp. 644-650; Logroscino, G., Marder, K., Cote, L., Tang, M.X., Shea, S., Mayeux, R., Dietary lipids and antioxidants in Parkinson's disease: A population-based, case-control study (1996) Ann Neurol, 39, pp. 89-94; Anderson, C., Checkoway, H., Franklin, G.M., Beresford, S., Smith-Weller, T., Swanson, P.D., Dietary factors in Parkinson's disease: The role of food groups and specific foods (1999) Movement Disorders, 14 (1), pp. 21-27. , DOI 10.1002/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y; Johnson, C.C., Gorell, J.M., Rybicki, B.A., Sanders, K., Peterson, E.L., Adult nutrient intake as a risk factor for Parkinson's disease (1999) International Journal of Epidemiology, 28 (6), pp. 1102-1109; Murakami, K., Miyake, Y., Sasaki, S., Tanaka, K., Fukushima, W., Kiyohara, C., Dietary glycemic index is inversely associated with the risk of Parkinson's disease: A case-control study in Japan (2010) Nutrition, 26, pp. 515-521; Chen, H., Zhang, S.M., Hernan, M.A., Willett, W.C., Ascherio, A., Dietary intakes of fat and risk of Parkinson's disease (2003) American Journal of Epidemiology, 157 (11), pp. 1007-1014; Powers, K.M., Smith-Weller, T., Franklin, G.M., Longstreth Jr., W.T., Swanson, P.D., Checkoway, H., Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes (2003) Neurology, 60 (11), pp. 1761-1766; Powers, K.M., Smith-Weller, T., Franklin, G.M., Longstreth Jr., W.T., Swanson, P.D., Checkoway, H., Dietary fats, cholesterol and iron as risk factors for Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. 47-52; De Lau, L.M.L., Bornebroek, M., Witteman, J.C.M., Hofman, A., Koudstaal, P.J., Breteler, M.M.B., Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study (2005) Neurology, 64 (12), pp. 2040-2045. , DOI 10.1212/01.WNL.0000166038.67153.9F; Abbott, R.A., Cox, M., Markus, H., Tomkins, A., Diet, body size and micronutrient status in Parkinson's disease (1992) European Journal of Clinical Nutrition, 46 (12), pp. 879-884; King, D., Playfer, J.R., Roberts, N.B., Concentrations of vitamins A, C and e in elderly patients with Parkinson's disease (1992) Postgrad Med J, 68, pp. 634-637; Fernandez-Calle, P., Jimenez-Jimenez, F.J., Molina, J.A., Cabrera-Valdivia, F., Vazquez, A., Urra, D.G., Bermejo, F., Codocco, R., Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease (1993) Journal of the Neurological Sciences, 118 (1), pp. 25-28. , DOI 10.1016/0022-510X(93)90240-Y; Jimenez-Jimenez, F.J., Molina, J.A., Fernandez-Calle, P., Vazquez, A., Cabrera-Valdivia, F., Catalan, M.J., Garcia-Albea, E., Codoceco, R., Serum levels of beta-carotene and other carotenoids in Parkinson's disease (1993) Neuroscience Letters, 157 (1), pp. 103-106. , DOI 10.1016/0304-3940(93)90653-3; Fernandez-Calle, P., Molina, J.A., Jimenez-Jimenez, F.J., Vazquez, A., Pondal, M., Garcia-Ruiz, P.J., Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease (1992) Neurology, 42, pp. 1064-1066; Jimenez-Jimenez, F.J., Molina, J.A., Fernandez-Calle, P., Vazquez, A., Pondal, M., Del Ser, T., Serum levels of vitamin A in Parkinson's disease (1992) J Neurol Sci, 111, pp. 73-76; Scheider, W.L., Hershey, L.A., Vena, J.E., Holmlund, T., Marshall, J.R., Freudenheim. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease (1997) Mov Disord, 12, pp. 190-196; De Rijk, M.C., Breteler, M.M., Den Breeijen, J.H., Launer, L.J., Grobbee, D.E., Van Der Meche, F.G., Dietary antioxidants and Parkinson disease. The Rotterdam Study (1997) Arch Neurol, 54, pp. 762-765; Morens, D.M., Grandinetti, A., Waslien, C.I., Park, C.B., Ross, G.W., White, L.R., Case-control study of idiopathic Parkinson's disease and dietary vitamin e intake (1996) Neurology, 46 (5), pp. 1270-1274; Zhang, S.M., Hernan, M.A., Chen, H., Spiegelman, D., Willett, W.C., Ascherio, A., Intakes of vitamins e and C, carotenoids, vitamin supplements, and PD risk (2002) Neurology, 59 (8), pp. 1161-1169; Etminan, M., Gill, S.S., Samii, A., Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: A meta-analysis (2005) Lancet Neurology, 4 (6), pp. 362-365. , DOI 10.1016/S1474-4422(05)70097-1, PII S1474442205700971; Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease (1993) N Engl J Med, 328, pp. 176-183. , The Parkinson Study Group N; Evatt, M.L., Delong, M.R., Khazai, N., Rosen, A., Triche, S., Tangpricha, V., Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease (2008) Arch Neurol, 65, pp. 1348-1352; Knekt, P., Kilkkinen, A., Rissanen, H., Marniemi, J., Saaksjarvi, K., Heliovaara, M., Serum vitamin D and the risk of Parkinson disease (2010) Arch Neurol, 67, pp. 808-811; Chen, H., Zhang, S.M., Schwarzschild, M.A., Hernan, M.A., Logroscino, G., Willett, W.C., Ascherio, A., Folate intake and risk of Parkinson's disease (2004) American Journal of Epidemiology, 160 (4), pp. 368-375. , DOI 10.1093/aje/kwh213; De Lau, L.M.L., Koudstaal, P.J., Witteman, J.C.M., Hofman, A., Breteler, M.M.B., Dietary folate, vitamin B12, and vitamin B6and the risk of Parkinson disease (2006) Neurology, 67 (2), pp. 315-318. , DOI 10.1212/01.wnl.0000225050.57553.6d, PII 0000611420060725000031; Logroscino, G., Marder, K., Graziano, J., Freyer, G., Slavkovich, V., Lojacono, N., Dietary iron, animal fats, and risk of Parkinson's disease (1998) Mov Disord, 13 (SUPPL. 1), pp. 13-16; Logroscino, G., Gao, X., Chen, H., Wing, A., Ascherio, A., Dietary iron intake and risk of Parkinson's disease (2008) Am J Epidemiol, 168, pp. 1381-1388; Doty, R.L., Deems, D.A., Stellar, S., Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration (1988) Neurology, 38, pp. 1237-1244; Hawkes, C.H., Shephard, B.C., Daniel, S.E., Olfactory dysfunction in Parkinson's disease (1997) Journal of Neurology Neurosurgery and Psychiatry, 62 (5), pp. 436-446; Berendse, H.W., Booij, J., Francot, C.M.J.E., Bergmans, P.L.M., Hijman, R., Stoof, J.C., Wolters, E.C., Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell (2001) Annals of Neurology, 50 (1), pp. 34-41. , DOI 10.1002/ana.1049; Ponsen, M.M., Stoffers, D., Booij, J., Van Eck-Smit, B.L.F., Wolters, E.C., Berendse, H.W., Idiopathic hyposmia as a preclinical sign of Parkinson's disease (2004) Annals of Neurology, 56 (2), pp. 173-181. , DOI 10.1002/ana.20160; Ponsen, M.M., Stoffers, D., Wolters, E., Booij, J., Berendse, H.W., Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease (2010) J Neurol Neurosurg Psychiatry, 81, pp. 396-399; Ross, G.W., Petrovitch, H., Abbott, R.D., Tanner, C.M., Popper, J., Masaki, K., Launer, L., White, L.R., Association of olfactory dysfunction with risk for future Parkinson's disease (2008) Annals of Neurology, 63 (2), pp. 167-173. , DOI 10.1002/ana.21291; Marras, C., Goldman, S., Smith, A., Barney, P., Aston, D., Comyns, K., Korell, M., Tanner, C.M., Smell identification ability in twin pairs discordant for Parkinson's disease (2005) Movement Disorders, 20 (6), pp. 687-693. , DOI 10.1002/mds.20389; Gagnon, J.F., Postuma, R.B., Mazza, S., Doyon, J., Montplaisir, J., Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases (2006) Lancet Neurol, 5, pp. 424-432; Schenck, C.H., Bundlie, S.R., Mahowald, M.W., Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder (1996) Neurology, 46, pp. 388-393; Iranzo, A., Molinuevo, J.L., Santamaria, J., Serradell, M., Marti, M.J., Valldeoriola, F., Tolosa, E., Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study (2006) Lancet Neurology, 5 (7), pp. 572-577. , DOI 10.1016/S1474-4422(06)70476-8, PII S1474442206704768; Postuma, R.B., Gagnon, J.F., Vendette, M., Fantini, M.L., Massicotte-Marquez, J., Montplaisir, J., Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder (2009) Neurology, 72, pp. 1296-1300; Claassen, D.O., Josephs, K.A., Ahlskog, J.E., Silber, M.H., Tippmann-Peikert, M., Boeve, B.F., REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century (2010) Neurology, 75, pp. 494-499; Gamboa, E.T., Wolf, A., Yahr, M.D., Harter, D.H., Duffy, P.E., Barden, H., Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence (1974) Arch Neurol, 31, pp. 228-232; Ravenholt, R.T., Foege, W.H., 1918 influenza, encephalitis lethargica, parkinsonism (1982) Lancet, 2, pp. 860-864; Poskanzer, D.C., Schwab, R.S., Cohort analysis of Parkinson's syndrome: Evidence for a single etiology related to subclinical infection about 1920 (1963) J Chronic Dis, 16, pp. 961-973; Duvoisin, R.C., Yahr, M.D., Schweitzer, M.D., Merritt, H.H., Parkinsonism before and since the Epidemic of Encephalitis Lethargica (1963) Arch Neurol, 9, pp. 232-236; Schwartz, J., Elizan, T.S., Search for viral particles and virus-specific products in idiopathic Parkinson disease brain material (1979) Annals of Neurology, 6 (3), pp. 261-263; Wetmur, J.G., Schwartz, J., Elizan, T.S., Nucleic acid homology studies of viral nucleic acids in idiopathic Parkinson's disease (1979) Archives of Neurology, 36 (8), pp. 462-464; Takahashi, M., Yamada, T., Nakajima, S., Nakajima, K., Yamamoto, T., Okada, H., The substantia nigra is a major target for neuro-virulent influenza A virus (1995) J Exp Med, 181, pp. 2161-2169; Takahashi, M., Yamada, T., A possible role of influenza A virus infection for Parkinson's disease (2001) Adv Neurol, 86, pp. 91-104; Lai, B.C.L., Marion, S.A., Teschke, K., Tsui, J.K.C., Occupational and environmental risk factors for Parkinson's disease (2002) Parkinsonism and Related Disorders, 8 (5), pp. 297-309. , DOI 10.1016/S1353-8020(01)00054-2, PII S1353802001000542; Fazzini, E., Fleming, J., Fahn, S., Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease (1992) Mov Disord, 7, pp. 153-158; Fiszer, U., Tomik, B., Grzesiowski, P., Krygowska-Wajs, A., Walory, J., Michalowska, M., Palasik, W., The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non-neurological diseases (2004) Acta Neurologica Scandinavica, 110 (2), pp. 113-117. , DOI 10.1111/j.1600-0404.2004.00285.x; Hubble, J.P., Cao, T., Kjelstrom, J.A., Koller, W.C., Beaman, B.L., Nocardia species as an etiologic agent in Parkinson's disease: Serological testing in a case-control study (1995) J Clin Microbiol, 33, pp. 2768-2769; Marttila, R.J., Halonen, P., Rinne, U.K., Influenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls (1977) Arch Neurol, 34, pp. 99-100; Marttila, R.J., Arstila, P., Nikoskelainen, J., Viral antibodies in the sera from patients with Parkinson disease (1977) European Neurology, 15 (1), pp. 25-33; Elizan, T.S., Madden, D.L., Noble, G.R., Viral antibodies in serum and CSF of Parkinsonian patients and controls (1979) Archives of Neurology, 36 (9), pp. 529-534; Powers, K.M., Smith-Weller, T., Franklin, G.M., Longstreth Jr., W.T., Swanson, P.D., Checkoway, H., Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk (2006) Parkinsonism Relat Disord, 12, pp. 185-189; Sasco, A.J., Paffenbarger Jr., R.S., Measles infection and Parkinson's disease (1985) American Journal of Epidemiology, 122 (6), pp. 1017-1031; Mattock, C., Marmot, M., Stern, G., Could Parkinson's disease follow intra-uterine influenza?: A speculative hypothesis (1988) J Neurol Neurosurg Psychiatry, 51, pp. 753-756; Ebmeier, K.P., Mutch, W.J., Calder, S.A., Crawford, J.R., Stewart, L., Besson, J.O., Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza? (1989) J Neurol Neurosurg Psychiatry, 52, pp. 911-913; Logroscino, G., The role of early life environmental risk factors in Parkinson disease: What is the evidence? (2005) Environ Health Persp, 113, pp. 1234-1238; Miura, T., Shimura, M., Kimura, T., Season of birth in parkinsonism (1987) Prog Biometeorol, 6, pp. 157-162; Betemps, E.J., Buncher, C.R., Birthplace as a risk factor in motor neurone disease and Parkinson's disease (1993) Int J Epidemiol, 22, pp. 898-904; Kurtzke, J.F., Goldberg, I.D., Parkinsonism death rates by race, sex, and geography (1988) Neurology, 38, pp. 1558-1561; Liu, B., Gao, H.-M., Hong, J.-S., Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation (2003) Environmental Health Perspectives, 111 (8), pp. 1065-1073; McGeer, P.L., McGeer, E.G., Inflammation and neurodegeneration in Parkinson's disease (2004) Parkinsonism Relat Disord, 10 (SUPPL. 1), pp. S3-S7; McGeer, P.L., Yasojima, K., McGeer, E.G., Inflammation in Parkinson's disease (2001) Adv Neurol, 86, pp. 83-89; Esposito, E., Di, M.V., Benigno, A., Pierucci, M., Crescimanno, G., Di, G.G., Non-steroidal anti-inflammatory drugs in Parkinson's disease (2007) Experimental Neurology, 205 (2), pp. 295-312. , DOI 10.1016/j.expneurol.2007.02.008, PII S0014488607000787; Stypula, G., Kunert-Radek, J., Stepien, H., Zylinska, K., Pawlikowski, M., Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with Parkinson's disease (1996) NeuroImmunoModulation, 3 (2-3), pp. 131-134; Dobbs, R.J., Charlett, A., Purkiss, A.G., Dobbs, S.M., Weller, C., Peterson, D.W., Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism (1999) Acta Neurologica Scandinavica, 100 (1), pp. 34-41; Chen, H., O'Reilly, E.J., Schwarzschild, M.A., Ascherio, A., Peripheral inflammatory biomarkers and risk of Parkinson's disease (2008) Am J Epidemiol, 167, pp. 90-95; Gao, H.-M., Jiang, J., Wilson, B., Zhang, W., Hong, J.-S., Liu, B., Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease (2002) Journal of Neurochemistry, 81 (6), pp. 1285-1297. , DOI 10.1046/j.1471-4159.2002.00928.x; Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R., Lee, C., Wilson, B., Hong, J.-S., MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration (2005) FASEB Journal, 19 (9), pp. 1134-1136. , DOI 10.1096/fj.04-2457fje; Chen, H., Zhang, S.M., Hernan, M.A., Schwarzschild, M.A., Willett, W.C., Colditz, G.A., Speizer, F.E., Ascherio, A., Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease (2003) Archives of Neurology, 60 (8), pp. 1059-1064. , DOI 10.1001/archneur.60.8.1059; Chen, H., Jacobs, E., Schwarzschild, M.A., McCullough, M.L., Calle, E.E., Thun, M.J., Ascherio, A., Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease (2005) Annals of Neurology, 58 (6), pp. 963-967. , DOI 10.1002/ana.20682; Bornebroek, M., De Lau, L.M.L., Haag, M.D.M., Koudstaal, P.J., Hofman, A., Stricker, B.H.C., Breteler, M.M.B., Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease (2007) Neuroepidemiology, 28 (4), pp. 193-196. , DOI 10.1159/000108110; Bower, J.H., Maraganore, D.M., Peterson, B.J., Ahlskog, J.E., Rocca, W.A., Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study (2006) Neurology, 67 (3), pp. 494-496. , DOI 10.1212/01.wnl.0000227906.99570.cc, PII 0000611420060808000030; Ton, T.G., Heckbert, S.R., Longstreth Jr., W.T., Rossing, M.A., Kukull, W.A., Franklin, G.M., Swanson, P.D., Checkoway, H., Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease (2006) Movement Disorders, 21 (7), pp. 964-969. , DOI 10.1002/mds.20856; Hernan, M.A., Logroscino, G., Rodriguez, L.A.G., Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease (2006) Neurology, 66 (7), pp. 1097-1099. , DOI 10.1212/01.wnl.0000204446.82823.28, PII 0000611420060411000027; Gagne, J.J., Power, M.C., Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis (2010) Neurology, 74, pp. 995-1002; Leentjens, A.F.G., Van Den, A.M., Metsemakers, J.F.M., Lousberg, R., Verhey, F.R.J., Higher incidence of depression preceding the onset of parkinson's disease: A register study (2003) Movement Disorders, 18 (4), pp. 414-418. , DOI 10.1002/mds.10387; Schuurman, A.G., Van Den, A.M., Ensinck, K.T.J.L., Metsemakers, J.F.M., Knottnerus, J.A., Leentjens, A.F.G., Buntinx, F., Increased risk of Parkinson's disease after depression: A retrospective cohort study (2002) Neurology, 58 (10), pp. 1501-1504; Shiba, M., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Peterson, B.J., Ahlskog, J.E., Schaid, D.J., Rocca, W.A., Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study (2000) Movement Disorders, 15 (4), pp. 669-677. , DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Nilsson, F.M., Kessing, L.V., Bolwig, T.G., Increased risk of developing Parkinson's disease for patients with major affective disorder: A register study (2001) Acta Psychiatrica Scandinavica, 104 (5), pp. 380-386. , DOI 10.1034/j.1600-0447.2001.00372.x; Li, X., Sundquist, J., Hwang, H., Sundquist, K., Impact of psychiatric disorders on Parkinson's disease: A nationwide follow-up study from Sweden (2008) J Neurol, 255, pp. 31-36; Stern, S.L., Hurtig, H.I., Mendels, J., Balaban, D., Psychiatric illness in relatives of patients with Parkinson's disease: A preliminary report (1977) Am J Psychiatry, 134, pp. 443-444; Fahim, S., VanDuijn, C.M., Baker, F.M., Launer, L., Breteler, M.M., Schudel, W.J., A study of familial aggregation of depression, dementia and Parkinson's disease (1998) Eur J Epidemiol, 14, pp. 233-238; Arabia, G., Grossardt, B.R., Geda, Y.E., Carlin, J.M., Bower, J.H., Ahlskog, J.E., Maraganore, D.M., Rocca, W.A., Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease (2007) Archives of General Psychiatry, 64 (12), pp. 1385-1392. , http://archpsyc.ama-assn.org/cgi/reprint/64/12/1385, DOI 10.1001/archpsyc.64.12.1385; Hofman, A., Schulte, W., Tanja, T.A., Van Duijn, C.M., Haaxma, R., Lameris, A.J., Otten, V.M., Saan, R.J., History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease (1989) Neurology, 39 (12), pp. 1589-1592; Amaducci, L.A., Fratiglioni, L., Rocca, W.A., Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population (1986) Neurology, 36 (7), pp. 922-931; Van Duijn, C.M., Clayton, D., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies (1991) Int J Epidemiol, 20 (SUPPL. 2), pp. S13-S20. , EURODEM Risk Factors Research Group; Huff, F.J., Auerbach, J., Chakravarti, A., Boller, F., Risk of dementia in relatives of patients with Alzheimer's disease (1988) Neurology, 38, pp. 786-790; Li, G., Shen, Y.C., Li, Y.T., Chen, C.H., Zhau, Y.W., Silverman, J.M., A case-control study of Alzheimer's disease in China (1992) Neurology, 42, pp. 1481-1488; Fratiglioni, L., Ahlbom, A., Viitanen, M., Winblad, B., Risk factors for late-onset Alzheimer's disease: A population-based, case- Control study (1993) Annals of Neurology, 33 (3), pp. 258-266; Silverman, J.M., Raiford, K., Edland, S., Fillenbaum, G., Morris, J.C., Clark, C.M., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: A multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls (1994) Neurology, 44, pp. 1253-1259; Marder, K., Tang, M.-X., Alfaro, B., Mejia, H., Cote, L., Louis, E., Stern, Y., Mayeux, R., Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia (1999) Neurology, 52 (4), pp. 719-724; Levy, G., Louis, E.D., Mejia-Santana, H., Cote, L., Andrews, H., Harris, J., Waters, C., Marder, K., Lack of familial aggregation of Parkinson disease and Alzheimer disease (2004) Archives of Neurology, 61 (7), pp. 1033-1039. , DOI 10.1001/archneur.61.7.1033; Rosen, A.R., Steenland, N.K., Hanfelt, J., Factor, S.A., Lah, J.J., Levey, A.I., Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history (2007) Neurogenetics, 8 (4), pp. 263-270. , DOI 10.1007/s10048-007-0100-6; Rocca, W.A., Bower, J.H., Ahlskog, J.E., Elbaz, A., Grossardt, B.R., McDonnell, S.K., Schaid, D.J., Maraganore, D.M., Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease (2007) Archives of Neurology, 64 (10), pp. 1458-1464. , http://archneur.ama-assn.org/cgi/reprint/64/10/1458, DOI 10.1001/archneur.64.10.1458; Costello, S., Bordelon, Y., Bronstein, J., Ritz, B., Familial associations of Alzheimer disease and essential tremor with Parkinson disease (2010) Eur J Neurol, 17, pp. 871-878; Shahed, J., Jankovic, J., Exploring the relationship between essential tremor and Parkinson's disease (2007) Parkinsonism and Related Disorders, 13 (2), pp. 67-76. , DOI 10.1016/j.parkreldis.2006.05.033, PII S1353802006001386; Geraghty, J.J., Jankovic, J., Zetusky, W.J., Association between essential tremor and Parkinson's disease (1985) Annals of Neurology, 17 (4), pp. 329-333. , DOI 10.1002/ana.410170404; Hornabrook, R.W., Nagurney, J.T., Essential tremor in Papua, New Guinea (1976) Brain, 99, pp. 659-672; Rajput, A.H., Offord, K.P., Beard, C.M., Kurland, L.T., Essential tremor in Rochester, Minnesota: A 45-year study (1984) Journal of Neurology Neurosurgery and Psychiatry, 47 (5), pp. 466-470; Larsson, T., Sjogren, T., Essential tremor: A clinical and genetic population study (1960) Acta Psychiatr Scand Suppl, 36, pp. 1-176; Cleeves, L., Findley, L.J., Koller, W., Lack of association between essential tremor and Parkinson's disease (1988) Ann Neurol, 24, pp. 23-26; Louis, E.D., Levy, G., Mejia-Santana, H., Cote, L., Andrews, H., Harris, J., Waters, C., Marder, K., Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD (2003) Neurology, 61 (7), pp. 931-936; Rocca, W.A., Bower, J.H., Ahlskog, J.E., Elbaz, A., Grossardt, B.R., McDonnell, S.K., Schaid, D.J., Maraganore, D.M., Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease (2007) Movement Disorders, 22 (11), pp. 1607-1614. , DOI 10.1002/mds.21584; Benito-Leon, J., Louis, E.D., Bermejo-Pareja, F., Risk of incident Parkinson's disease and parkinsonism in essential tremor: A population based study (2009) J Neurol Neurosurg Psychiatry, 80, pp. 423-425; Westlund, K., Hougen, A., Cancer as a cause of death among patients with other cronic diseases (1956) JAMA, 162, p. 1003; Pritchard III, P.B., Netsky, M.G., Prevalence of neoplasms and causes of death in paralysis agitans. A necropsy study (1973) Neurology, 23, pp. 215-222; Harada, H., Nishikawa, S., Takahashi, K., Epidemiology of Parkinson's disease in a Japanese city (1983) Archives of Neurology, 40 (3), pp. 151-154; Jansson, B., Jankovic, J., Low cancer rates among patients with Parkinson's disease (1985) Annals of Neurology, 17 (5), pp. 505-509. , DOI 10.1002/ana.410170514; Moller, H., Mellemkjaer, L., McLaughlin, J.K., Olsen, J.H., Occurrence of different cancers in patients with Parkinson's disease (1995) BMJ, 310, pp. 1500-1501; Raschetti, R., Spila-Alegiani, S., Vanacore, N., Ancona, C., Meco, G., Mortality in a population-based cohort of patients treated with antiparkinsonian drugs (1998) Acta Neurologica Scandinavica, 97 (1), pp. 20-26; Vanacore, N., Spila-Alegiani, S., Raschetti, R., Meco, G., Mortality cancer risk in parkinsonian patients: A population-based study (1999) Neurology, 52 (2), pp. 395-398; Minami, Y., Yamamoto, R., Nishikouri, M., Fukao, A., Hisamichi, S., Mortality and cancer incidence in patients with Parkinson's disease (2000) Journal of Neurology, 247 (6), pp. 429-434. , DOI 10.1007/s004150070171; D'Amelio, M., Ragonese, P., Morgante, L., Epifanio, A., Callari, G., Salemi, G., Savettiere, G., Tumor diagnosis preceding Parkinson's disease: A case-control study (2004) Movement Disorders, 19 (7), pp. 807-811. , DOI 10.1002/mds.20123; Elbaz, A., Peterson, B.J., Yang, P., Van Gerpen, J.A., Bower, J.H., Maraganore, D.M., McDonnell, S.K., Rocca, W.A., Nonfatal cancer preceding Parkinson's disease: A case-control study (2002) Epidemiology, 13 (2), pp. 157-164. , DOI 10.1097/00001648-200203000-00010; Elbaz, A., Peterson, B.J., Bower, J.H., Yang, P., Maraganore, D.M., McDonnell, S.K., Ahlskog, J.E., Rocca, W.A., Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study (2005) Movement Disorders, 20 (6), pp. 719-725. , DOI 10.1002/mds.20401; Olsen, J.H., Friis, S., Frederiksen, K., McLaughlin, J.K., Mellemkjaer, L., Moller, H., Atypical cancer pattern in patients with Parkinson's disease (2005) British Journal of Cancer, 92 (1), pp. 201-205. , DOI 10.1038/sj.bjc.6602279; Olsen, J.H., Friis, S., Frederiksen, K., Malignant melanoma and other types of cancer preceding parkinson disease (2006) Epidemiology, 17 (5), pp. 582-587. , DOI 10.1097/01.ede.0000229445.90471.5e, PII 0000164820060900000018; Becker, C., Brobert, G.P., Johansson, S., Jick, S.S., Meier, C.R., Cancer risk in association with Parkinson disease: A population-based study (2010) Parkinsonism Relat Disord, 16, pp. 186-190; Driver, J.A., Kurth, T., Buring, J.E., Gaziano, J.M., Logroscino, G., Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease (2007) Cancer Causes and Control, 18 (7), pp. 705-711. , DOI 10.1007/s10552-007-9005-9; Driver, J.A., Logroscino, G., Buring, J.E., Gaziano, J.M., Kurth, T., A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease (2007) Cancer Epidemiology Biomarkers and Prevention, 16 (6), pp. 1260-1265. , http://cebp.aacrjournals.org/cgi/reprint/16/6/1260, DOI 10.1158/1055-9965.EPI-07-0038; Lerner, M.R., Goldman, R.S., Skin colour, MPTP, and Parkinson's disease (1987) Lancet, 2, p. 212; Gao, X., Simon, K.C., Han, J., Schwarzschild, M.A., Ascherio, A., Genetic determinants of hair color and Parkinson's disease risk (2009) Ann Neurol, 65, pp. 76-82; Zanetti, R., Loria, D., Rosso, S., Melanoma, Parkinson's disease and levodopa: Causal or spurious link? A review of the literature (2006) Melanoma Res, 16, pp. 201-206; Vermeij, J.D., Winogrodzka, A., Trip, J., Weber, W.E., Parkinson's disease, levodopa-use and the risk of melanoma (2009) Parkinsonism Relat Disord, 15, pp. 551-553; Zanetti, R., Rosso, S., Loria, D.I., Parkinson's disease and cancer (2007) Cancer Epidemiology Biomarkers and Prevention, 16 (6), p. 1081. , http://cebp.aacrjournals.org/cgi/reprint/16/6/1081, DOI 10.1158/1055-9965.EPI-07-0377; Gao, X., Simon, K.C., Han, J., Schwarzschild, M.A., Ascherio, A., Family history of melanoma and Parkinson disease risk (2009) Neurology, 73, pp. 1286-1291; Herrero Hernandez, E., Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies (2009) Med Hypotheses, 72, pp. 280-284; Bajaj, A., Driver, J.A., Schernhammer, E.S., Parkinson's disease and cancer risk: A systematic review and meta-analysis (2010) Cancer Causes Control, 21, pp. 697-707; West, A.B., Dawson, V.L., Dawson, T.M., To die or grow: Parkinson's disease and cancer (2005) Trends in Neurosciences, 28 (7), pp. 348-352. , DOI 10.1016/j.tins.2005.05.002, PII S0166223605001207; Inzelberg, R., Jankovic, J., Are Parkinson disease patients protected from some but not all cancers? (2007) Neurology, 69, pp. 1542-1550; D'Amelio, M., Ragonese, P., Sconzo, G., Aridon, P., Savettieri, G., Parkinson's disease and cancer: Insights for pathogenesis from epidemiology (2009) Ann N Y Acad Sci, 1155, pp. 324-334; Lacava, G., Boxer's Encephalopathy (1963) J Sports Med Phys Fitness, 168, pp. 87-92; Factor, S.A., Weiner, W.J., Prior history of head trauma in Parkinson's disease (1991) Mov Disord, 6, pp. 225-229; Stern, M.B., Head trauma as a risk factor for Parkinson's disease (1991) Mov Disord, 6, pp. 95-97; Bower, J.H., Maraganore, D.M., Peterson, B.J., McDonnell, S.K., Ahlskog, J.E., Rocca, W.A., Head trauma preceding PD: A case-control study (2003) Neurology, 60 (10), pp. 1610-1615; Goldman, S.M., Tanner, C.M., Oakes, D., Bhudhikanok, G.S., Gupta, A., Langston, J.W., Head injury and Parkinson's disease risk in twins (2006) Ann Neurol, 60, pp. 65-72; Maher, N.E., Golbe, L.I., Lazzarini, A.M., Mark, M.H., Currie, L.J., Wooten, G.F., Saint-Hilaire, M., Myers, R.H., Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study (2002) Neurology, 58 (1), pp. 79-84; Williams, D.B., Annegers, J.F., Kokmen, E., O'Brien, P.C., Kurland, L.T., Brain injury and neurologic sequelae: A cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis (1991) Neurology, 41, pp. 1554-1557; Rugbjerg, K., Ritz, B., Korbo, L., Martinussen, N., Olsen, J.H., Risk of Parkinson's disease after hospital contact for head injury: Population based case-control study (2008) BMJ, 337, pp. a2494; Spangenberg, S., Hannerz, H., Tuchsen, F., Mikkelsen, K.L., A nationwide population study of severe head injury and Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. 12-14; Pressley, J.C., Louis, E.D., Tang, M.-X., Cote, L., Cohen, P.D., Glied, S., Mayeux, R., The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism (2003) Neurology, 60 (1), pp. 87-93; D'Amelio, M., Ragonese, P., Callari, G., Di Benedetto, N., Palmeri, B., Terruso, V., Diabetes preceding Parkinson's disease onset. A case-control study (2009) Parkinsonism Relat Disord, 15, pp. 660-664; Scigliano, G., Musicco, M., Soliveri, P., Piccolo, I., Ronchetti, G., Girotti, F., Reduced risk factors for vascular disorders in Parkinson disease patients: A case-control study (2006) Stroke, 37 (5), pp. 1184-1188. , DOI 10.1161/01.STR.0000217384.03237.9c, PII 0000767020060500000020; Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., Tuomilehto, J., Type 2 diabetes and the risk of Parkinson's disease (2007) Diabetes Care, 30 (4), pp. 842-847. , http://care.diabetesjournals.org/cgi/reprint/30/4/842, DOI 10.2337/dc06-2011; Driver, J.A., Smith, A., Buring, J.E., Gaziano, J.M., Kurth, T., Logroscino, G., Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease (2008) Diabetes Care, 31, pp. 2003-2005; Simon, K.C., Chen, H., Schwarzschild, M., Ascherio, A., Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease (2007) Neurology, 69 (17), pp. 1688-1695. , DOI 10.1212/01.wnl.0000271883.45010.8a; Becker, C., Brobert, G.P., Johansson, S., Jick, S.S., Meier, C.R., Diabetes in patients with idiopathic Parkinson's disease (2008) Diabetes Care, 31, pp. 1808-1812; Becker, C., Jick, S.S., Meier, C.R., Risk of stroke in patients with idiopathic Parkinson disease (2009) Parkinsonism Relat Disord, 16, pp. 31-35; Okello, E., Jiang, X., Mohamed, S., Zhao, Q., Wang, T., Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure (2009) Med Hypotheses, 73, pp. 306-308; Huang, X., Chen, H., Miller, W.C., Mailman, R.B., Woodard, J.L., Chen, P.C., Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease (2007) Mov Disord, 22, pp. 377-381; Huang, X., Abbott, R.D., Petrovitch, H., Mailman, R.B., Ross, G.W., Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study (2008) Mov Disord, 23, pp. 1013-1018; De Lau, L.M.L., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., Serum cholesterol levels and the risk of Parkinson's disease (2006) American Journal of Epidemiology, 164 (10), pp. 998-1002. , DOI 10.1093/aje/kwj283; Hu, G., Antikainen, R., Jousilahti, P., Kivipelto, M., Tuomilehto, J., Total cholesterol and the risk of Parkinson disease (2008) Neurology, 70, pp. 1972-1979; Becker, C., Meier, C.R., Statins and the risk of Parkinson disease: An update on the controversy (2009) Expert Opin Drug Saf, 8, pp. 261-271; Becker, C., Jick, S.S., Meier, C.R., Use of statins and the risk of Parkinson's sisease: A retrospective case-control study in the UK (2008) Drug Safety, 31 (5), pp. 399-407. , DOI 10.2165/00002018-200831050-00004; Shulman, L.M., Is there a connection between estrogen and Parkinson's disease? (2002) Parkinsonism Relat Disord, 8, pp. 289-295; Marder, K., Tang, M.-X., Alfaro, B., Mejia, H., Cote, L., Jacobs, D., Stern, Y., Mayeux, R., Postmenopausal estrogen use and Parkinson's disease with and without dementia (1998) Neurology, 50 (4), pp. 1141-1143; Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H.R., Bressman, S., The effect of estrogen replacement on early Parkinson's disease (1999) Neurology, 52, pp. 1417-1421; Benedetti, M.D., Maraganore, D.M., Bower, J.H., McDonnell, S.K., Peterson, B.J., Ahlskog, J., Schaid, D.J., Rocca, W.A., Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study (2001) Movement Disorders, 16 (5), pp. 830-837. , DOI 10.1002/mds.1170; Ragonese, P., D'Amelio, M., Salemi, G., Aridon, P., Gammino, M., Epifanio, A., Morgante, L., Savettieri, G., Risk of Parkinson disease in women: Effect of reproductive characteristics (2004) Neurology, 62 (11), pp. 2010-2014; Currie, L.J., Harrison, M.B., Trugman, J.M., Bennett, J.P., Wooten, G.F., Postmenopausal estrogen use affects risk for Parkinson disease (2004) Archives of Neurology, 61 (6), pp. 886-888. , DOI 10.1001/archneur.61.6.886; Ascherio, A., Chen, H., Schwarzschild, M.A., Zhang, S.M., Colditz, G.A., Speizer, F.E., Caffeine, postmenopausal estrogen, and risk of Parkinson's disease (2003) Neurology, 60 (5), pp. 790-795; Simon, K.C., Chen, H., Gao, X., Schwarzschild, M.A., Ascherio, A., Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease (2009) Mov Disord, 24, pp. 1359-1365; Rocca, W.A., Bower, J.H., Maraganore, D.M., Ahlskog, J.E., Grossardt, B.R., De Andrade, M., Increased risk of parkinsonism in women who underwent oophorectomy before menopause (2008) Neurology, 70, pp. 200-209; Frigerio, R., Breteler, M.M.B., De Lau, L.M.L., Sanft, K.R., Bower, J.H., Ahlskog, J.E., Grossardt, B.R., Rocca, W.A., Number of children and risk of Parkinson's disease (2007) Movement Disorders, 22 (5), pp. 632-639. , DOI 10.1002/mds.21341; Ames, B.N., Cathcart, R., Schwiers, E., Hochstein, P., Uric acid provides an antioxidant defense in humans against oxidant- And radical-caused aging and cancer: A hypothesis (1981) Proceedings of the National Academy of Sciences of the United States of America, 78 (11 II), pp. 6858-6862; Church, W.H., Ward, V.L., Uric acid is reduced in the substantia nigra in Parkinson's disease: Effect on dopamine oxidation (1994) Brain Res Bull, 33, pp. 419-425; Tohgi, H., Abe, T., Takahashi, S., Kikuchi, T., The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease (1993) Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 6 (2), pp. 119-126. , DOI 10.1007/BF02261005; Ahlskog, J.E., Uitti, R.J., Low, P.A., Tyce, G.M., Nickander, K.K., Petersen, R.C., No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease (1995) Mov Disord, 10, pp. 566-573; Annanmaki, T., Muuronen, A., Murros, K., Low plasma uric acid level in Parkinson's disease (2007) Movement Disorders, 22 (8), pp. 1133-1137. , DOI 10.1002/mds.21502; Davis, J.W., Grandinetti, A., Waslien, C.I., Ross, G.W., White, L.R., Morens, D.M., Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease (1996) American Journal of Epidemiology, 144 (5), pp. 480-484; De Lau, L.M.L., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., Serum uric acid levels and the risk of Parkinson disease (2005) Annals of Neurology, 58 (5), pp. 797-800. , DOI 10.1002/ana.20663; Weisskopf, M.G., O'Reilly, E., Chen, H., Schwarzschild, M.A., Ascherio, A., Plasma urate and risk of Parkinson's disease (2007) American Journal of Epidemiology, 166 (5), pp. 561-567. , DOI 10.1093/aje/kwm127; Chen, H., Mosley, T.H., Alonso, A., Huang, X., Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study (2009) Am J Epidemiol, 169, pp. 1064-1069; Alonso, A., Rodriguez, L.A.G., Logroscino, G., Hernan, M.A., Gout and risk of Parkinson disease: A prospective study (2007) Neurology, 69 (17), pp. 1696-1700. , DOI 10.1212/01.wnl.0000279518.10072.df, PII 0000611420071023000011; De Vera, M., Rahman, M.M., Rankin, J., Kopec, J., Gao, X., Choi, H., Gout and the risk of Parkinson's disease: A cohort study (2008) Arthritis Rheum, 59, pp. 1549-1554; Schwarzschild, M.A., Schwid, S.R., Marek, K., Watts, A., Lang, A.E., Oakes, D., Shoulson, I., Ondrasik, J., Serum urate as a predictor of clinical and radiographic progression in Parkinson disease (2008) Archives of Neurology, 65 (6), pp. 716-723. , http://archneur.ama-assn.org/cgi/reprint/65/6/716, DOI 10.1001/archneur.2008.65.6.nct70003; Ascherio, A., LeWitt, P.A., Xu, K., Eberly, S., Watts, A., Matson, W.R., Urate as a predictor of the rate of clinical decline in Parkinson disease (2009) Arch Neurol, 66, pp. 1460-1468; Bronstein, J., Carvey, P., Chen, H., Cory-Slechta, D., DiMonte, D., Duda, J., Meeting report: Consensus statement-Parkinson's disease and the environment: Collaborative on Health and the Environment and Parkinson's Action Network (CHE PAN) Conference 26-28 June 2007 (2009) Environ Health Persp, 117, pp. 117-121; Vieregge, A., Sieberer, M., Jacobs, H., Hagenah, J.M., Vieregge, P., Transdermal nicotine in PD: A randomized, double-blind, placebo-controlled study (2001) Neurology, 57 (6), pp. 1032-1035; Lemay, S., Chouinard, S., Blanchet, P., Masson, H., Soland, V., Beuter, A., Bedard, M.-A., Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease (2004) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28 (1), pp. 31-39. , DOI 10.1016/S0278-5846(03)00172-6; Xu, K., Bastia, E., Schwarzschild, M., Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease (2005) Pharmacology and Therapeutics, 105 (3), pp. 267-310. , DOI 10.1016/j.pharmthera.2004.10.007; Hauser, R.A., Hubble, J.P., Truong, D.D., Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD (2003) Neurology, 61 (3), pp. 297-303; Hauser, R.A., Shulman, L.M., Trugman, J.M., Roberts, J.W., Mori, A., Ballerini, R., Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations (2008) Mov Disord, 23, pp. 2177-2185; LeWitt, P.A., Guttman, M., Tetrud, J.W., Tuite, P.J., Mori, A., Chaikin, P., Adenosine A2A receptor antagonist istradefylline (KW- 6002) reduces "off" time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005) (2008) Ann Neurol, 63, pp. 295-302; Stacy, M., Silver, D., Mendis, T., Sutton, J., Mori, A., Chaikin, P., A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease (2008) Neurology, 70, pp. 2233-2240; Pankratz, N., Nichols, W.C., Uniacke, S.K., Halter, C., Rudolph, A., Shults, C., Conneally, P.M., Werner, J., Significant linkage of Parkinson disease to chromosome 2q36-37 (2003) American Journal of Human Genetics, 72 (4), pp. 1053-1057. , DOI 10.1086/374383},
correspondence_address1={Wirdefeldt, K.; Department of Medical Epidemiology and Biostatistics, Box 281, Stockholm 171 77, Sweden; email: karin.wirdefeldt@ki.se},
issn={03932990},
coden={EJEPE},
pubmed_id={21626386},
language={English},
abbrev_source_title={Eur. J. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Menche2015841,
author={Menche, J. and Sharma, A. and Kitsak, M. and Ghiassian, S.D. and Vidal, M. and Loscalzo, J. and Barabási, A.-L.},
title={Uncovering disease-disease relationships through the incomplete interactome},
journal={Science},
year={2015},
volume={347},
number={6224},
pages={841},
doi={10.1126/science.1257601},
note={cited By 774},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923306828&doi=10.1126%2fscience.1257601&partnerID=40&md5=4aa2ad5ce8da5e09ef97878a9bd79891},
affiliation={Center for Complex Networks Research, Department of Physics, Northeastern University, 110 Forsyth Street, Boston, MA  02115, United States; Center for Cancer Systems Biology (CCSB), Department of Cancer Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA  02215, United States; Center for Network Science, Central European University, Nador u. 9, Budapest, 1051, Hungary; Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA  02115, United States; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA  02115, United States},
abstract={According to the diseasemodule hypothesis, the cellular components associated with a disease segregate in the same neighborhood of the human interactome, themap of biologically relevant molecular interactions.Yet, given the incompleteness of the interactome and the limited knowledge of disease-associated genes, it is not obvious if the available data have sufficient coverage to map out modules associated with each disease. Here we derive mathematical conditions for the identifiability of disease modules and show that the network-based location of each disease module determines its pathobiological relationship to other diseases. For example, diseases with overlapping network modules show significant coexpression patterns, symptom similarity, and comorbidity, whereas diseases residing in separated network neighborhoods are phenotypically distinct.These tools represent an interactome-based platform to predict molecular commonalities between phenotypically related diseases, even if they do not share primary disease genes.},
keywords={enzyme;  regulator protein;  transcription factor, hypothesis testing;  molecular analysis;  numerical model;  phenotype, Article;  cell component;  cell interaction;  comorbidity;  disease association;  enzyme metabolism;  gene expression;  gene location;  gene mapping;  gene ontology;  genetic association;  genetic risk;  genetic variability;  human;  interactome;  metabolism;  molecular genetics;  molecular interaction;  molecular pathology;  multiple sclerosis;  nonsense mutation;  overlapping gene;  phenotypic variation;  priority journal;  protein binding;  protein DNA interaction;  protein interaction;  protein protein interaction;  risk factor;  Disease;  genetic predisposition;  genetics;  information service;  protein protein interaction, Comorbidity;  Disease;  Genetic Predisposition to Disease;  Humans;  Information Services;  Protein Interaction Maps},
funding_details={UO1-HG007690},
funding_details={P50-HG004233},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, P01HL083069, R37HL061795, RC2HL101543, U01HL108630},
funding_details={National Human Genome Research InstituteNational Human Genome Research Institute, NHGRI, P50HG004233, U01HG007690, U41HG001715},
references={Buchanan, M., Caldarelli, G., De Los Rios, P., (2010) Networks in Cell Biology, , Cambridge Univ. Press, Cambridge; Pawson, T., Linding, R., Network medicine (2008) FEBS Lett., 582, pp. 1266-1270. , pmid: 18282479; Schadt, E.E., Molecular networks as sensors and drivers of common human diseases (2009) Nature, 461, pp. 218-223. , pmid: 19741703; Califano, A., Butte, A.J., Friend, S., Ideker, T., Schadt, E., Leveraging models of cell regulation and GWAS data in integrative network-based association studies (2012) Nat. Genet., 44, pp. 841-847. , pmid: 22836096; Zanzoni, A., Soler-López, M., Aloy, P., A network medicine approach to human disease (2009) FEBS Lett., 583, pp. 1759-1765. , pmid: 19269289; Barabási, A.-L., Gulbahce, N., Loscalzo, J., Network medicine: A network-based approach to human disease (2011) Nat. Rev. Genet., 12, pp. 56-68. , pmid: 21164525; Goh, K.-I., The human disease network (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 8685-8690. , pmid: 17502601; Oti, M., Snel, B., Huynen, M.A., Brunner, H.G., Predicting disease genes using protein-protein interactions (2006) J. Med. Genet., 43, pp. 691-698. , pmid: 16611749; Lage, K., Dissecting spatio-temporal protein networks driving human heart development and related disorders (2010) Mol. Syst. Biol., 6, p. 381. , pmid: 20571530; Chuang, H.-Y., Lee, E., Liu, Y.-T., Lee, D., Ideker, T., Network-based classification of breast cancer metastasis (2007) Mol. Syst. Biol., 3, p. 140. , pmid: 17940530; Mosca, R., Pons, T., Céol, A., Valencia, A., Aloy, P., Towards a detailed atlas of protein-protein interactions (2013) Curr. Opin. Struct. Biol., 23, pp. 929-940. , pmid: 23896349; Rolland, T., A proteome-scale map of the human interactome network (2014) Cell, 159, pp. 1212-1226. , pmid: 25416956; Hart, G.T., Ramani, A.K., Marcotte, E.M., How complete are current yeast and human protein-interaction networks? (2006) Genome Biol., 7, p. 120. , pmid: 17147767; Venkatesan, K., An empirical framework for binary interactome mapping (2009) Nat. Methods, 6, pp. 83-90. , pmid: 19060904; Stumpf, M.P., Estimating the size of the human interactome (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 6959-6964. , pmid: 18474861; Wass, M.N., David, A., Sternberg, M.J., Challenges for the prediction of macromolecular interactions (2011) Curr. Opin. Struct. Biol., 21, pp. 382-390. , pmid: 21497504; Xu, J., Li, Y., Discovering disease-genes by topological features in human protein-protein interaction network (2006) Bioinformatics, 22, pp. 2800-2805. , pmid: 16954137; Feldman, I., Rzhetsky, A., Vitkup, D., Network properties of genes harboring inherited disease mutations (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 4323-4328. , pmid: 18326631; Krauthammer, M., Kaufmann, C.A., Gilliam, T.C., Rzhetsky, A., Molecular triangulation: Bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 15148-15153. , pmid: 15471992; Franke, L., Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes (2006) Am. J. Hum. Genet., 78, pp. 1011-1025. , pmid: 16685651; Köhler, S., Bauer, S., Horn, D., Robinson, P.N., Walking the interactome for prioritization of candidate disease genes (2008) Am. J. Hum. Genet., 82, pp. 949-958. , pmid: 18371930; Chen, Y., Variations in DNA elucidate molecular networks that cause disease (2008) Nature, 452, pp. 429-435. , pmid: 18344982; Baranzini, S.E., Pathway and network-based analysis of genome-wide association studies in multiple sclerosis (2009) Hum. Mol. Genet., 18, pp. 2078-2090. , pmid: 19286671; Wheelock, C.E., Systems biology approaches and pathway tools for investigating cardiovascular disease (2009) Mol. Biosyst., 5, pp. 588-602. , pmid: 19462016; Khalil, A.S., Collins, J.J., Synthetic biology: Applications come of age (2010) Nat. Rev. Genet., 11, pp. 367-379. , pmid: 20395970; Wuchty, S., Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology (2010) J. Biomed. Inform., 43, pp. 945-952. , pmid: 20828632; Lee, I., Blom, U.M., Wang, P.I., Shim, J.E., Marcotte, E.M., Prioritizing candidate disease genes by network-based boosting of genome-wide association data (2011) Genome Res., 21, pp. 1109-1121. , pmid: 21536720; Singh-Blom, U.M., Prediction and validation of genedisease associations using methods inspired by social network analyses (2013) PLOS ONE, 8, p. e58977. , pmid: 23650495; Rzhetsky, A., Wajngurt, D., Park, N., Zheng, T., Probing genetic overlap among complex human phenotypes (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 11694-11699. , pmid: 17609372; Mottaz, A., Yip, Y.L., Ruch, P., Veuthey, A.-L., Mapping proteins to disease terminologies: From UniProt to MeSH (2008) BMC Bioinformatics, 9, p. S3. , pmid: 18460185; Ramos, E.M., Phenotype-Genotype Integrator (PheGenI): Synthesizing genome-wide association study (GWAS) data with existing genomic resources (2014) Eur. J. Hum. Genet., 22, pp. 144-147. , pmid: 23695286; Hakes, L., Pinney, J.W., Robertson, D.L., Lovell, S.C., Protein-protein interaction networks and biology-What's the connection? (2008) Nat. Biotechnol., 26, pp. 69-72; Cusick, M.E., Literature-curated protein interaction datasets (2009) Nat. Methods, 6, pp. 39-46. , pmid: 19116613; Cohen, R., Havlin, S., (2010) Complex Networks. Structure, Robustness and Function, , Cambridge Univ., Cambridge; Bornholdt, S., Schuster, H.G., (2003) Handbook of Graphs and Networks, 2. , Wiley Online Library; Su, A.I., A gene atlas of the mouse and human protein-encoding transcriptomes (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 6062-6067. , pmid: 15075390; Gandhi, T.K., Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets (2006) Nat. Genet., 38, pp. 285-293. , pmid: 16501559; Zhou, X., Menche, J., Barabási, A.-L., Sharma, A., Human symptoms-disease network (2014) Nat. Commun., 5, p. 4212. , pmid: 24967666; Hidalgo, C.A., Blumm, N., Barabási, A.-L., Christakis, N.A., A dynamic network approach for the study of human phenotypes (2009) PLOS Comput. Biol., 5, p. e1000353. , pmid: 19360091; Hunt, K.A., Newly identified genetic risk variants for celiac disease related to the immune response (2008) Nat. Genet., 40, pp. 395-402. , pmid: 18311140; Van Der Windt, D.A., Jellema, P., Mulder, C.J., Kneepkens, C.M., Van Der Horst, H.E., Diagnostic testing for celiac disease among patients with abdominal symptoms: A systematic review (2010) JAMA, 303, pp. 1738-1746. , pmid: 20442390; Pilette, C., Durham, S.R., Vaerman, J.-P., Sibille, Y., Mucosal immunity in asthma and chronic obstructive pulmonary disease: A role for immunoglobulin A? (2004) Proc. Am. Thorac. Soc., 1, pp. 125-135; Shi, J., Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation (2013) Genes Dev., 27, pp. 2648-2662. , pmid: 24285714; Bauer, A., Perras, B., Sufke, S., Horny, H.-P., Kreft, B., Myocardial infarction as an uncommon clinical manifestation of intravascular large cell lymphoma (2005) Acta Cardiol., 60, pp. 551-555. , pmid: 16261789; Hopkins, A.L., Network pharmacology: The next paradigm in drug discovery (2008) Nat. Chem. Biol., 4, pp. 682-690. , pmid: 18936753; Mestres, J., Gregori-Puigjané, E., Valverde, S., Solé, R.V., The topology of drug-target interaction networks: Implicit dependence on drug properties and target families (2009) Mol. Biosyst., 5, pp. 1051-1057. , pmid: 19668871; Kuhn, M., Systematic identification of proteins that elicit drug side effects (2013) Mol. Syst. Biol., 9, p. 663. , pmid: 23632385; Hamosh, A., Scott, A.F., Amberger, J.S., Bocchini, C.A., McKusick, V.A., Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders (2005) Nucleic Acids Res., 33, pp. D514-D517. , pmid: 15608251; Ashburner, M., The Gene Ontology Consortium, Gene ontology: Tool for the unification of biology (2000) Nat. Genet., 25, pp. 25-29. , pmid: 10802651; Subramanian, A., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 15545-15550. , pmid: 16199517},
correspondence_address1={Barabási, A.-L.; Center for Complex Networks Research, 110 Forsyth Street, United States; email: alb@neu.edu},
publisher={American Association for the Advancement of Science},
issn={00368075},
coden={SCIEA},
pubmed_id={25700523},
language={English},
abbrev_source_title={Sci.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Diniz2013329,
author={Diniz, B.S. and Butters, M.A. and Albert, S.M. and Dew, M.A. and Reynolds III, C.F.},
title={Late-life depression and risk of vascular dementia and Alzheimer's disease: Systematic review and meta-analysis of community-based cohort studies},
journal={British Journal of Psychiatry},
year={2013},
volume={202},
number={5},
pages={329-335},
doi={10.1192/bjp.bp.112.118307},
note={cited By 720},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877614564&doi=10.1192%2fbjp.bp.112.118307&partnerID=40&md5=73960f4d379470c87ac17902d4cad0c4},
affiliation={Department of Psychiatry, University of Pittsburgh, School of Medicine, 3811 O'Hara Street, Pittsburgh, PA 15213, United States; Department of Mental Health, School of Medicine, Federal University of Minas Gerais, Brazil; Department of Behavioral and Community Health Sciences, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, United States},
abstract={Background: Late-life depression may increase the risk of incident dementia, in particular of Alzheimer's disease and vascular dementia. Aims: To conduct a systematic review and meta-analysis to evaluate the risk of incident all-cause dementia, Alzheimer's disease and vascular dementia in individuals with late-life depression in population-based prospective studies. Method: A total of 23 studies were included in the meta-analysis. We used the generic inverse variance method with a random-effects model to calculate the pooled risk of dementia, Alzheimer's disease and vascular dementia in older adults with late-life depression. Results: Late-life depression was associated with a significant risk of all-cause dementia (1.85, 95% CI 1.67-2.04, P < 0.001), Alzheimer's disease (1.65, 95% CI 1.42-1.92, P < 0.001) and vascular dementia (2.52, 95% CI 1.77-3.59, P < 0.001). Subgroup analysis, based on five studies, showed that the risk of vascular dementia was significantly higher than for Alzheimer's disease (P = 0.03). Conclusions: Late-life depression is associated with an increased risk for all-cause dementia, vascular dementia and Alzheimer's disease. The present results suggest that it will be valuable to design clinical trials to investigate the effect of late-life depression prevention on risk of dementia, in particular vascular dementia and Alzheimer's disease.},
keywords={Alzheimer disease;  cardiovascular risk;  cohort analysis;  human;  late life depression;  meta analysis;  multiinfarct dementia;  population research;  prospective study;  review;  risk assessment;  systematic review, Adolescent;  Adult;  Aged;  Aged, 80 and over;  Alzheimer Disease;  Child;  Dementia, Vascular;  Depressive Disorder;  Female;  Humans;  Male;  Middle Aged;  Risk Factors;  Young Adult},
funding_details={National Institute of Mental HealthNational Institute of Mental Health, NIMH, P30MH090333, R01MH072947, R01MH080240},
funding_details={National Institute on AgingNational Institute on Aging, NIA, P30AG024827},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, UL1RR024153},
funding_details={National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences, NCATS, UL1TR000005},
references={Byers, A.L., Yaffe, K., Covinsky, K.E., Friedman, M.B., Bruce, M.L., High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication (2010) Arch Gen Psychiatry, 67, pp. 489-496; Butters, M.A., Becker, J.T., Nebes, R.D., Zmuda, M.D., Mulsant, B.H., Pollock, B.G., Changes in cognitive functioning following treatment of late-life depression (2000) Am J Psychiatry, 157, pp. 1949-1954; Butters, M.A., Young, J.B., Lopez, O., Aizenstein, H.J., Mulsant, B.H., Reynolds III, C.F., Pathways linking late-life depression to persistent cognitive impairment and dementia (2008) Dialogues Clin Neurosci, 10, pp. 345-357; Ownby, R.L., Crocco, E., Acevedo, A., John, V., Loewenstein, D., Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis (2006) Arch Gen Psychiatry, 63, pp. 530-538; Lenoir, H., Dufouil, C., Auriacombe, S., Lacombe, J.M., Dartigues, J.F., Ritchie, K., Depression history, depressive symptoms, and incident dementia: The 3C Study (2011) J Alzheimers Dis, 26, pp. 27-38; Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence (2011) Lancet Neurol, 10, pp. 819-828; Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., (2011) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, , http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp; Dal, F.G., Palermo, M.T., Donohue, J.E., Karagiozis, H., Zonderman, A.B., Kawas, C.H., Depressive symptoms, sex, and risk for Alzheimer's disease (2005) Annals of Neurology, 57 (3), pp. 381-387. , DOI 10.1002/ana.20405; Chen, R., Hu, Z., Wei, L., Qin, X., McCracken, C., Copeland, J.R., Severity of depression and risk for subsequent dementia: Cohort studies in China and the UK (2008) Br J Psychiatry, 193, pp. 373-377; Bassuk, S.S., Berkman, L.F., Wypij, D., Depressive symptomatology and incident cognitive decline in an elderly community sample (1998) Archives of General Psychiatry, 55 (12), pp. 1073-1081; Becker, J.T., Chang, Y.F., Lopez, O.L., Yaffe, K., Young, J., Kuller, L., Depressed mood is not a risk factor for incident dementia in a community-based cohort (2009) Am J Geriatr Psychiatry, 17, pp. 653-663; Chen, P., Ganguli, M., Mulsant, B.H., DeKosky, S.T., The temporal relationship between depressive symptoms and dementia: A community-based prospective study (1999) Archives of General Psychiatry, 56 (3), pp. 261-266; Devanand, D.P., Sano, M., Tang, M.-X., Taylor, S., Gurland, B.J., Wilder, D., Stern, Y., Mayeux, R., Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community (1996) Archives of General Psychiatry, 53 (2), pp. 175-182; Fuhrer, R., Dufouil, C., Dartigues, J.F., Exploring sex differences in the relationship between depressive symptoms and dementia incidence: Prospective results from the PAQUID study (2003) Journal of the American Geriatrics Society, 51 (8), pp. 1055-1063. , DOI 10.1046/j.1532-5415.2003.51352.x; Gatz, J.L., Tyas, S.L., John, P.S., Montgomery, P., Do depressive symptoms predict Alzheimer's disease and dementia? (2005) Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 60 (6), pp. 744-747; Geerlings, M.I., Schoevers, R.A., Beekman, A.T.F., Jonker, C., Deeg, D.J.H., Schmand, B., Ader, H.J., Van Tilburg W.Willem, Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands (2000) British Journal of Psychiatry, 176 (JUN.), pp. 568-575. , DOI 10.1192/bjp.176.6.568; Geerlings, M.I., Den, H.T., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease (2008) Neurology, 70 (15), pp. 1258-1264. , DOI 10.1212/01.wnl.0000308937.30473.d1, PII 0000611420080408000008; Goveas, J.S., Espeland, M.A., Woods, N.F., Wassertheil-Smoller, S., Kotchen, J.M., Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: The Women's Health Initiative Memory Study (2011) J Am Geriatr Soc, 59, pp. 57-66; Irie, F., Masaki, K.H., Petrovitch, H., Abbott, R.D., Ross, G.W., Taaffe, D.R., Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: The Honolulu-Asia Aging Study (2008) Arch Gen Psychiatry, 65, pp. 906-912; Kim, J.M., Kim, S.Y., Bae, K.Y., Kim, S.W., Shin, I.S., Yang, S.J., Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older Korean population (2010) Psychiatry Investig, 7, pp. 135-140; Köhler, S., Van Boxtel, M., Jolles, J., Verhey, F., Depressive symptoms and risk for dementia: A 9-year follow-up of the maastricht aging study (2011) Am J Geriatr Psychiatry, 19, pp. 902-905; Hebert, R., Lindsay, J., Verreault, R., Rockwood, K., Hill, G., Dubois, M.-F., Vascular dementia: Incidence and risk factors in the canadian study of health and aging (2000) Stroke, 31 (7), pp. 1487-1493; Li, G., Wang, L.Y., Shofer, J.B., Thompson, M.L., Peskind, E.R., McCormick, W., Temporal relationship between depression and dementia: Findings from a large community-based 15-year follow-up study (2011) Arch Gen Psychiatry, 68, pp. 970-977; Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G.B., McDowell, I., Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging (2002) American Journal of Epidemiology, 156 (5), pp. 445-453. , DOI 10.1093/aje/kwf074; Palmer, K., Berger, A.K., Monastero, R., Winblad, B., Backman, L., Fratiglioni, L., Predictors of progression from mild cognitive impairment to Alzheimer disease (2007) Neurology, 68 (19), pp. 1596-1602. , DOI 10.1212/01.wnl.0000260968.92345.3f, PII 0000611420070508000009; Palsson, S., Aevarsson, O., Skoog, I., Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds (1999) British Journal of Psychiatry, 174 (MAR.), pp. 249-253; Saczynski, J.S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P.A., Au, R., Depressive symptoms and risk of dementia: The Framingham Heart Study (2010) Neurology, 75, pp. 35-41; Spira, A.P., Rebok, G.W., Stone, K.L., Kramer, J.H., Yaffe, K., Depressive symptoms in oldest-old women: Risk of mild cognitive impairment and dementia (2012) Am J Geriatr Psychiatry, 20, pp. 1006-1015; Yaffe, K., Blackwell, T., Gore, R., Sands, L., Reus, V., Browner, W.S., Depressive symptoms and cognitive decline in nondemented elderly women: A prospective study (1999) Archives of General Psychiatry, 56 (5), pp. 425-430. , DOI 10.1001/archpsyc.56.5.425; Barnes, D.E., Yaffe, K., Byers, A.L., McCormick, M., Schaefer, C., Whitmer, R.A., Midlife vs. late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia (2012) Arch Gen Psychiatry, 69, pp. 493-498; Charlson, M., Peterson, J.C., Medical comorbidity and late life depression: What is known and what are the unmet needs? (2002) Biological Psychiatry, 52 (3), pp. 226-235. , DOI 10.1016/S0006-3223(02)01422-1, PII S0006322302014221; Sheline, Y.I., Pieper, C.F., Barch, D.M., Welsh-Bohmer, K., McKinstry, R.C., MacFall, J.R., Support for the vascular depression hypothesis in late-life depression: Results of a 2-site, prospective, antidepressant treatment trial (2010) Arch Gen Psychiatry, 67, pp. 277-285; Laukka, E.J., Fratiglioni, L., Backman, L., The influence of vascular disease on cognitive performance in the preclinical and early phases of Alzheimer's disease (2010) Dement Geriatr Cogn Disord, 29, pp. 498-503; Gold, G., Giannakopoulos, P., Herrmann, F.R., Bouras, C., Kovari, E., Identification of Alzheimer and vascular lesion thresholds for mixed dementia (2007) Brain, 130 (11), pp. 2830-2836. , DOI 10.1093/brain/awm228; Cuijpers, P., Beekman, A.T., Reynolds III, C.F., Preventing depression: A global priority (2012) JAMA, 307, pp. 1033-1034; Reynolds III, C.F., Cuijpers, P., Patel, V., Cohen, A., Dias, A., Chowdhary, N., Early intervention to reduce the global health and economic burden of major depression in older adults (2012) Annu Rev Public Health, 33, pp. 123-135; Dotson, V.M., Beydoun, M.A., Zonderman, A.B., Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment (2010) Neurology, 75, pp. 27-34; Kessing, L.V., Andersen, P.K., Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? (2004) Journal of Neurology, Neurosurgery and Psychiatry, 75 (12), pp. 1662-1666. , DOI 10.1136/jnnp.2003.031773},
correspondence_address1={Butters, M.A.; Department of Psychiatry, 3811 O'Hara Street, Pittsburgh, PA 15213, United States; email: ButtersMA@upmc.edu},
issn={00071250},
coden={BJPYA},
pubmed_id={23637108},
language={English},
abbrev_source_title={Br. J. Psychiatry},
document_type={Review},
source={Scopus},
}

@ARTICLE{Hou2019565,
author={Hou, Y. and Dan, X. and Babbar, M. and Wei, Y. and Hasselbalch, S.G. and Croteau, D.L. and Bohr, V.A.},
title={Ageing as a risk factor for neurodegenerative disease},
journal={Nature Reviews Neurology},
year={2019},
volume={15},
number={10},
pages={565-581},
doi={10.1038/s41582-019-0244-7},
note={cited By 709},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072717929&doi=10.1038%2fs41582-019-0244-7&partnerID=40&md5=5c6c257ffe8be8cb975bd6a219082070},
affiliation={Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, United States; Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark},
abstract={Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD). One in ten individuals aged ≥65 years has AD and its prevalence continues to increase with increasing age. Few or no effective treatments are available for ageing-related neurodegenerative diseases, which tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs. This Review discusses the pathogenesis of AD, PD and other neurodegenerative diseases, and describes their associations with the nine biological hallmarks of ageing: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion and altered intercellular communication. The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD+ precursors, mitophagy inducers and inhibitors of cellular senescence. © 2019, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.},
keywords={nicotinamide adenine dinucleotide, aging;  Alzheimer disease;  cell aging;  cell communication;  cost;  degenerative disease;  disorders of mitochondrial functions;  DNA damage;  epigenetics;  genomic instability;  human;  immunity;  inflammation;  mitophagy;  nonhuman;  nutrient;  Parkinson disease;  prevalence;  priority journal;  protein homeostasis;  proteinosis;  Review;  risk factor;  socioeconomics;  stem cell;  supplementation;  telomere;  aging;  brain;  degenerative disease;  genetic epigenesis;  genetics;  metabolism;  pathology;  physiology;  risk factor, Aging;  Brain;  DNA Damage;  Epigenesis, Genetic;  Humans;  Mitophagy;  Neurodegenerative Diseases;  Risk Factors},
chemicals_cas={nicotinamide adenine dinucleotide, 53-84-9},
funding_details={National Institute on AgingNational Institute on Aging, NIA},
funding_text 1={The authors’ research is supported by the Intramural Research Program of the NIH National Institute on Aging. The authors thank B. Yang and N. B. Fakouri for critical reading of the manuscript. The Bohr laboratory receives nicotinamide riboside as a gift from ChromaDex.},
references={Rose, M.R., Adaptation, aging, and genomic information (2009) Aging (Albany NY), 1, pp. 444-450; Carmona, J.J., Michan, S., Biology of healthy aging and longevity (2016) Rev. Invest. Clin., 68, pp. 7-16. , COI: 1:CAS:528:DC%2BC1cXms1aku7s%3D, PID: 27028172; 2018 Alzheimer’s disease facts and figures (2018) Alzheimers Dement, 14, pp. 367-429; Wyss-Coray, T., Ageing, neurodegeneration and brain rejuvenation (2016) Nature, 539, pp. 180-186. , COI: 1:CAS:528:DC%2BC28XhvVaqs7vI, PID: 5172605; Elobeid, A., Libard, S., Leino, M., Popova, S.N., Alafuzoff, I., Altered proteins in the aging brain (2016) J. Neuropathol. Exp. Neurol., 75, pp. 316-325. , PID: 26979082; Dean, D.C., 3rd, Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study (2014) JAMA Neurol, 71, pp. 11-22. , PID: 24276092; Schaefers, A.T., Teuchert-Noodt, G., Developmental neuroplasticity and the origin of neurodegenerative diseases (2016) World J. Biol. Psychiatry, 17, pp. 587-599. , PID: 23705632; Nussbaum, R.L., Ellis, C.E., Alzheimer's disease and Parkinson's disease (2003) N. Engl. J. Med., 348, pp. 1356-1364. , COI: 1:CAS:528:DC%2BD3sXis1egt7c%3D, PID: 12672864; Hy, L.X., Keller, D.M., Prevalence of AD among whites: a summary by levels of severity (2000) Neurology, 55, pp. 198-204. , COI: 1:STN:280:DC%2BD3czpvVaksw%3D%3D, PID: 10908890; Poewe, W., Parkinson disease (2017) Nat Rev Dis Primers, 3, p. 17013. , PID: 28332488; Mehta, P., Prevalence of amyotrophic lateral sclerosis – United States, 2014 (2018) MMWR Morb. Mortal. Wkly. Rep., 67, pp. 216-218. , PID: 29470458; Robinson, J.L., Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated (2018) Brain, 141, pp. 2181-2193. , PID: 29878075; Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The hallmarks of aging (2013) Cell, 153, pp. 1194-1217. , COI: 1:CAS:528:DC%2BC3sXptFKms78%3D, PID: 23746838; Chow, H.M., Herrup, K., Genomic integrity and the ageing brain (2015) Nat. Rev. Neurosci., 16, pp. 672-684. , COI: 1:CAS:528:DC%2BC2MXhs1eksr7K, PID: 26462757; Madabhushi, R., Pan, L., Tsai, L.H., DNA damage and its links to neurodegeneration (2014) Neuron, 83, pp. 266-282. , COI: 1:CAS:528:DC%2BC2cXhtFyjsrbL, PID: 25033177; Jeppesen, D.K., Bohr, V.A., Stevnsner, T., DNA repair deficiency in neurodegeneration (2011) Prog. Neurobiol., 94, pp. 166-200. , COI: 1:CAS:528:DC%2BC3MXntlGrsLs%3D, PID: 21550379; Thanan, R., Oxidative stress and its significant roles in neurodegenerative diseases and cancer (2015) Int. J. Mol. Sci., 16, pp. 193-217; McKinnon, P.J., Maintaining genome stability in the nervous system (2013) Nat. Neurosci., 16, pp. 1523-1529. , COI: 1:CAS:528:DC%2BC3sXhs1yhs7rJ, PID: 24165679; Maynard, S., Schurman, S.H., Harboe, C., de Souza-Pinto, N.C., Bohr, V.A., Base excision repair of oxidative DNA damage and association with cancer and aging (2009) Carcinogenesis, 30, pp. 2-10. , COI: 1:CAS:528:DC%2BD1MXhtVaqu74%3D, PID: 18978338; Tell, G., Demple, B., Base excision DNA repair and cancer (2015) Oncotarget, 6, pp. 584-585. , PID: 25655644; Leandro, G.S., Sykora, P., Bohr, V.A., The impact of base excision DNA repair in age-related neurodegenerative diseases (2015) Mutat. Res., 776, pp. 31-39. , COI: 1:CAS:528:DC%2BC2MXmslGgtQ%3D%3D, PID: 26255938; Akbari, M., Morevati, M., Croteau, D., Bohr, V.A., The role of DNA base excision repair in brain homeostasis and disease (2015) DNA Repair (Amst), 32, pp. 172-179. , COI: 1:CAS:528:DC%2BC2MXnvFSisrc%3D; Fang, E.F., NAD(+) in aging: molecular mechanisms and translational implications (2017) Trends Mol. Med., 23, pp. 899-916. , COI: 1:CAS:528:DC%2BC2sXhtl2gtLnO, PID: 28899755; Herrmann, M., Pusceddu, I., Marz, W., Herrmann, W., Telomere biology and age-related diseases (2018) Clin. Chem. Lab. Med., 56, pp. 1210-1222. , COI: 1:CAS:528:DC%2BC1cXht1yltbjI, PID: 29494336; Eitan, E., Hutchison, E.R., Mattson, M.P., Telomere shortening in neurological disorders: an abundance of unanswered questions (2014) Trends Neurosci., 37, pp. 256-263. , COI: 1:CAS:528:DC%2BC2cXlt1CntbY%3D, PID: 24698125; Bradley-Whitman, M.A., Lovell, M.A., Epigenetic changes in the progression of Alzheimer's disease (2013) Mech. Ageing Dev., 134, pp. 486-495. , COI: 1:CAS:528:DC%2BC3sXhsV2nu7jJ, PID: 24012631; Hwang, J.Y., Aromolaran, K.A., Zukin, R.S., The emerging field of epigenetics in neurodegeneration and neuroprotection (2017) Nat. Rev. Neurosci., 18, pp. 347-361. , COI: 1:CAS:528:DC%2BC2sXnvFGqu70%3D, PID: 28515491; Tanaka, K., Matsuda, N., Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy (2014) Biochim. Biophys. Acta, 1843, pp. 197-204. , COI: 1:CAS:528:DC%2BC3sXlvVCmsbc%3D, PID: 23523933; Johri, A., Beal, M.F., Mitochondrial dysfunction in neurodegenerative diseases (2012) J. Pharmacol. Exp. Ther., 342, pp. 619-630. , COI: 1:CAS:528:DC%2BC38XhtlShu7zE, PID: 22700435; Keogh, M.J., Chinnery, P.F., Mitochondrial DNA mutations in neurodegeneration (2015) Biochim. Biophys. Acta, 1847, pp. 1401-1411. , COI: 1:CAS:528:DC%2BC2MXpsVygsLY%3D, PID: 26014345; Greene, J.C., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants (2003) Proc. Natl Acad. Sci. USA, 100, pp. 4078-4083. , COI: 1:CAS:528:DC%2BD3sXivFSqu70%3D, PID: 12642658; Pickrell, A.M., Youle, R.J., The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015) Neuron, 85, pp. 257-273. , COI: 1:CAS:528:DC%2BC2MXhsFSjsL4%3D, PID: 25611507; Sliter, D.A., Parkin and PINK1 mitigate STING-induced inflammation (2018) Nature, 561, pp. 258-262. , COI: 1:CAS:528:DC%2BC1cXhsFOgsL3L, PID: 30135585; Fivenson, E.M., Mitophagy in neurodegeneration and aging (2017) Neurochem. Int., 109, pp. 202-209. , COI: 1:CAS:528:DC%2BC2sXktVKhsb8%3D, PID: 28235551; Koentjoro, B., Park, J.S., Sue, C.M., Nix restores mitophagy and mitochondrial function to protect against PINK1/parkin-related Parkinson's disease (2017) Sci. Rep., 7. , PID: 28281653; Di Rita, A., AMBRA1-mediated mitophagy counteracts oxidative stress and apoptosis induced by neurotoxicity in human neuroblastoma SH-SY5Y cells (2018) Front. Cell. Neurosci., 12, p. 92. , PID: 29755319; Yun, J., MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin (2014) Elife, 3. , PID: 24898855; Haynes, C.M., Ron, D., The mitochondrial UPR – protecting organelle protein homeostasis (2010) J. Cell Sci., 123, pp. 3849-3855. , COI: 1:CAS:528:DC%2BC3cXhsF2jsL%2FP, PID: 21048161; Hayflick, L., The limited in vitro lifetime of human diploid cell strains (1965) Exp. Cell Res., 37, pp. 614-636. , COI: 1:STN:280:DyaF2M7hvFOntw%3D%3D, PID: 14315085; Kultz, D., Molecular and evolutionary basis of the cellular stress response (2005) Annu. Rev. Physiol., 67, pp. 225-257. , PID: 15709958; Kuilman, T., Michaloglou, C., Mooi, W.J., Peeper, D.S., The essence of senescence (2010) Genes Dev., 24, pp. 2463-2479. , COI: 1:CAS:528:DC%2BC3cXhsFSgurfK, PID: 21078816; Loaiza, N., Demaria, M., Cellular senescence and tumor promotion: is aging the key? (2016) Biochim. Biophys. Acta, 1865, pp. 155-167. , COI: 1:CAS:528:DC%2BC28XitFCmtb0%3D, PID: 26845683; Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression (2010) Annu. Rev. Pathol., 5, pp. 99-118. , COI: 1:CAS:528:DC%2BC3cXivFekt70%3D, PID: 20078217; Wiley, C.D., Mitochondrial dysfunction induces senescence with a distinct secretory phenotype (2016) Cell Metab., 23, pp. 303-314. , COI: 1:CAS:528:DC%2BC2MXitVSksbrM, PID: 26686024; Nacarelli, T., NAD(+) metabolism governs the proinflammatory senescence-associated secretome (2019) Nat. Cell Biol., 21, pp. 397-407. , COI: 1:CAS:528:DC%2BC1MXmsVyltbs%3D, PID: 30778219; Maynard, S., Fang, E.F., Scheibye-Knudsen, M., Croteau, D.L., Bohr, V.A., DNA Damage, DNA Repair, Aging, and Neurodegeneration (2015) Cold Spring Harbor Perspectives in Medicine, 5 (10), p. a025130; Barrio-Alonso, E., Hernandez-Vivanco, A., Walton, C.C., Perea, G., Frade, J.M., Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons (2018) Sci. Rep., 8. , COI: 1:STN:280:DC%2BB3czis1yisg%3D%3D, PID: 30254284; Fielder, E., von Zglinicki, T., Jurk, D., The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? (2017) J. Alzheimers Dis., 60, pp. S107-S131. , COI: 1:CAS:528:DC%2BC2sXhsFClt7zL, PID: 28436392; Jurk, D., Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response (2012) Aging Cell, 11, pp. 996-1004. , COI: 1:CAS:528:DC%2BC38XhvFWitbrN, PID: 22882466; Vaidya, A., Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age (2014) PLoS Genet., 10. , PID: 25033455; Narita, M., Spatial coupling of mTOR and autophagy augments secretory phenotypes (2011) Science, 332, pp. 966-970. , COI: 1:CAS:528:DC%2BC3MXmtFSgurw%3D, PID: 21512002; Gewirtz, D.A., Autophagy and senescence: a partnership in search of definition (2013) Autophagy, 9, pp. 808-812. , COI: 1:CAS:528:DC%2BC3sXhslars7rO, PID: 23422284; Kang, H.T., Lee, K.B., Kim, S.Y., Choi, H.R., Park, S.C., Autophagy impairment induces premature senescence in primary human fibroblasts (2011) PLoS One, 6. , COI: 1:CAS:528:DC%2BC3MXhtFanur3L, PID: 21858089; Kang, C., The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4 (2015) Science, 349, p. aaa5612. , PID: 26404840; Bhatia-Dey, N., Kanherkar, R.R., Stair, S.E., Makarev, E.O., Csoka, A.B., Cellular senescence as the causal nexus of aging (2016) Front Genet, 7, p. 13. , PID: 26904101; Fontana, L., Partridge, L., Longo, V.D., Extending healthy life span – from yeast to humans (2010) Science, 328, pp. 321-326. , COI: 1:CAS:528:DC%2BC3cXks1Snsro%3D, PID: 20395504; Babbar, M., Sheikh, M.S., Metabolic stress and disorders related to alterations in mitochondrial fission or fusion (2013) Mol. Cell. Pharmacol., 5, pp. 109-133. , PID: 24533171; Oh, J., Lee, Y.D., Wagers, A.J., Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) Nat. Med., 20, pp. 870-880. , COI: 1:CAS:528:DC%2BC2cXht12msrzO, PID: 25100532; Villeda, S.A., Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice (2014) Nat. Med., 20, pp. 659-663. , COI: 1:CAS:528:DC%2BC2cXntlehs7s%3D, PID: 24793238; Amor, S., Woodroofe, M.N., Innate and adaptive immune responses in neurodegeneration and repair (2014) Immunology, 141, pp. 287-291. , COI: 1:CAS:528:DC%2BC2cXitVegsLs%3D, PID: 23758741; He, F., Balling, R., The role of regulatory T cells in neurodegenerative diseases (2013) Wiley Interdiscip. Rev. Syst. Biol. Med., 5, pp. 153-180. , COI: 1:CAS:528:DC%2BC3sXjsFGlsbc%3D, PID: 22899644; Cao, W., Zheng, H., Peripheral immune system in aging and Alzheimer's disease (2018) Mol. Neurodegener., 13, p. 51. , COI: 1:CAS:528:DC%2BC1MXhtFehsLfJ, PID: 30285785; Giunta, S., Is inflammaging an auto[innate]immunity subclinical syndrome? (2006) Immun. Ageing, 3, p. 12. , PID: 17173699; Currais, A., Ageing and inflammation – a central role for mitochondria in brain health and disease (2015) Ageing Res Rev, 21, pp. 30-42. , COI: 1:CAS:528:DC%2BC2MXivVCltr0%3D, PID: 25684584; Lu, T., Gene regulation and DNA damage in the ageing human brain (2004) Nature, 429, pp. 883-891. , COI: 1:CAS:528:DC%2BD2cXltVKltLY%3D, PID: 15190254; Hickman, S., Izzy, S., Sen, P., Morsett, L., El Khoury, J., Microglia in neurodegeneration (2018) Nat. Neurosci., 21, pp. 1359-1369. , COI: 1:CAS:528:DC%2BC1cXhvVSmsbrI, PID: 30258234; Cunningham, C., Microglia and neurodegeneration: the role of systemic inflammation (2013) Glia, 61, pp. 71-90. , PID: 22674585; Youm, Y.H., Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging (2013) Cell Metab., 18, pp. 519-532. , COI: 1:CAS:528:DC%2BC3sXhsFGnsLzF, PID: 24093676; Halle, A., The NALP3 inflammasome is involved in the innate immune response to amyloid-beta (2008) Nat. Immunol., 9, pp. 857-865. , COI: 1:CAS:528:DC%2BD1cXoslCmu74%3D, PID: 18604209; Codolo, G., Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies (2013) PLoS One, 8. , COI: 1:CAS:528:DC%2BC3sXis1yltrw%3D, PID: 23383169; Ona, V.O., Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease (1999) Nature, 399, pp. 263-267. , COI: 1:CAS:528:DyaK1MXjsFyqsrs%3D, PID: 10353249; Johann, S., NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients (2015) Glia, 63, pp. 2260-2273. , PID: 26200799; Meissner, F., Molawi, K., Zychlinsky, A., Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis (2010) Proc. Natl Acad. Sci. USA, 107, pp. 13046-13050. , COI: 1:CAS:528:DC%2BC3cXpsVCrsb0%3D, PID: 20616033; Wang, W.Y., Tan, M.S., Yu, J.T., Tan, L., Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease (2015) Ann Transl Med, 3, p. 136. , PID: 26207229; Wang, W., Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein (2016) Proc. Natl Acad. Sci. USA, 113, pp. 9587-9592. , COI: 1:CAS:528:DC%2BC28Xht1Gru7nN, PID: 27482083; Uchoa, M.F., Moser, V.A., Pike, C.J., Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors (2016) Front. Neuroendocrinol., 43, pp. 60-82. , COI: 1:CAS:528:DC%2BC28XhsFGms7jE, PID: 27651175; Grune, T., Jung, T., Merker, K., Davies, K.J., Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease (2004) Int. J. Biochem. Cell Biol., 36, pp. 2519-2530. , COI: 1:CAS:528:DC%2BD2cXmvFemu7c%3D, PID: 15325589; Nakahira, K., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome (2011) Nat. Immunol., 12, pp. 222-230. , COI: 1:CAS:528:DC%2BC3cXhsFGgtrzE, PID: 21151103; Baker, D.J., Petersen, R.C., Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) J. Clin. Invest., 128, pp. 1208-1216. , PID: 29457783; Pan, M.R., Li, K., Lin, S.Y., Hung, W.C., Connecting the dots: from DNA damage and repair to aging (2016) Int. J. Mol. Sci., 17, p. 685; Frasca, D., Blomberg, B.B., Inflammaging decreases adaptive and innate immune responses in mice and humans (2016) Biogerontology, 17, pp. 7-19. , COI: 1:CAS:528:DC%2BC28XhvV2rsbo%3D, PID: 25921609; Bektas, A., Schurman, S.H., Sen, R., Ferrucci, L., Aging, inflammation and the environment (2018) Exp. Gerontol., 105, pp. 10-18. , COI: 1:CAS:528:DC%2BC1cXntVeqsg%3D%3D, PID: 29275161; Valera, E., Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy (2017) Acta Neuropathol Commun, 5, p. 2. , PID: 28057080; Sevigny, J., The antibody aducanumab reduces Aβ plaques in Alzheimer's disease (2016) Nature, 537, pp. 50-56. , COI: 1:CAS:528:DC%2BC28XhsVCqur%2FJ, PID: 27582220; Van Cauwenberghe, C., Vandendriessche, C., Libert, C., Vandenbroucke, R.E., Caloric restriction: beneficial effects on brain aging and Alzheimer's disease (2016) Mamm. Genome, 27, pp. 300-319. , PID: 27240590; Spielman, L.J., Little, J.P., Klegeris, A., Physical activity and exercise attenuate neuroinflammation in neurological diseases (2016) Brain Res. Bull., 125, pp. 19-29. , COI: 1:CAS:528:DC%2BC28XlsF2htbc%3D, PID: 27021169; Bekris, L.M., Yu, C.E., Bird, T.D., Tsuang, D.W., Genetics of Alzheimer disease (2010) J. Geriatr. Psychiatry Neurol., 23, pp. 213-227. , PID: 21045163; Liu, C.C., Liu, C.C., Kanekiyo, T., Xu, H., Bu, G., Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy (2013) Nat. Rev. Neurol., 9, pp. 106-118. , COI: 1:CAS:528:DC%2BC3sXis1Ggs7Y%3D, PID: 23296339; Bloom, G.S., Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis (2014) JAMA Neurol, 71, pp. 505-508. , PID: 24493463; Wang, J., Gu, B.J., Masters, C.L., Wang, Y.J., A systemic view of Alzheimer disease – insights from amyloid-β metabolism beyond the brain (2017) Nat. Rev. Neurol., 13, pp. 612-623. , COI: 1:CAS:528:DC%2BC2sXhvFCrsL3F, PID: 28960209; Lane, C.A., Hardy, J., Schott, J.M., Alzheimer's disease (2018) Eur. J. Neurol., 25, pp. 59-70. , COI: 1:STN:280:DC%2BC1cbkslGguw%3D%3D, PID: 28872215; Selkoe, D.J., Hardy, J., The amyloid hypothesis of Alzheimer's disease at 25 years (2016) EMBO Mol. Med., 8, pp. 595-608. , COI: 1:CAS:528:DC%2BC28XltVOhtL8%3D, PID: 27025652; Spillantini, M.G., Goedert, M., Tau pathology and neurodegeneration (2013) Lancet Neurol., 12, pp. 609-622. , COI: 1:CAS:528:DC%2BC3sXnvVGkur0%3D, PID: 23684085; Fu, W.Y., Wang, X., Ip, N.Y., Targeting neuroinflammation as a therapeutic strategy for Alzheimer's disease: mechanisms, drug candidates, and new opportunities (2019) ACS Chem. Neurosci., 10, pp. 872-879. , COI: 1:CAS:528:DC%2BC1cXhslWitLnI, PID: 30221933; Hardy, J., The amyloid hypothesis for Alzheimer's disease: a critical reappraisal (2009) J. Neurochem., 110, pp. 1129-1134. , COI: 1:CAS:528:DC%2BD1MXpsFOmu70%3D, PID: 19457065; Hall, A.M., Roberson, E.D., Mouse models of Alzheimer's disease (2012) Brain Res. Bull., 88, pp. 3-12. , COI: 1:CAS:528:DC%2BC38XmsVGlu7c%3D, PID: 22142973; Ewald, C.Y., Li, C., Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system (2010) Brain Struct Funct, 214, pp. 263-283. , COI: 1:CAS:528:DC%2BC3cXktVCnsbk%3D, PID: 20012092; Prussing, K., Voigt, A., Schulz, J.B., Drosophila melanogaster as a model organism for Alzheimer's disease (2013) Mol. Neurodegener., 8, p. 35. , PID: 24267573; Tan, F.H.P., Azzam, G., Drosophila melanogaster: deciphering Alzheimer's disease (2017) Malays. J. Med. Sci., 24, pp. 6-20. , PID: 28894399; Arber, C., Lovejoy, C., Wray, S., Stem cell models of Alzheimer's disease: progress and challenges (2017) Alzheimers Res. Ther., 9, p. 42. , PID: 28610595; Teng, E., Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization (2015) Neurobiol. Dis., 82, pp. 552-560. , COI: 1:CAS:528:DC%2BC2MXhsFeitL3P, PID: 26369878; Lovell, M.A., Gabbita, S.P., Markesbery, W.R., Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF (1999) J. Neurochem., 72, pp. 771-776. , COI: 1:CAS:528:DyaK1MXmt1ylsw%3D%3D, PID: 9930752; Weissman, L., Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment (2007) Nucleic Acids Res., 35, pp. 5545-5555. , COI: 1:CAS:528:DC%2BD2sXht1ygtb%2FE, PID: 17704129; Sykora, P., DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes (2015) Nucleic Acids Res., 43, pp. 943-959. , COI: 1:CAS:528:DC%2BC2MXjtlCjtb4%3D, PID: 25552414; Wang, H.Z., Validating GWAS-identified risk loci for Alzheimer's disease in Han Chinese populations (2016) Mol. Neurobiol., 53, pp. 379-390. , COI: 1:CAS:528:DC%2BC2cXitVWgtL3K, PID: 25452228; Fang, E.F., NAD(+) replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair (2016) Cell Metab., 24, pp. 566-581. , COI: 1:CAS:528:DC%2BC28XhsFKmurjE, PID: 27732836; Hou, Y., NAD(+) supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency (2018) Proc. Natl Acad. Sci. USA, 115, pp. E1876-E1885. , COI: 1:CAS:528:DC%2BC1cXitVaqsbrE, PID: 29432159; Kwon, M.J., Kim, S., Han, M.H., Lee, S.B., Epigenetic changes in neurodegenerative diseases (2016) Mol. Cells, 39, pp. 783-789. , COI: 1:CAS:528:DC%2BC2sXitlSitb8%3D, PID: 27871175; Ow, S.Y., Dunstan, D.E., A brief overview of amyloids and Alzheimer's disease (2014) Protein Sci., 23, pp. 1315-1331. , COI: 1:CAS:528:DC%2BC2cXhsFelsb3E, PID: 25042050; Kerr, J.S., Mitophagy and Alzheimer's disease: cellular and molecular mechanisms (2017) Trends Neurosci., 40, pp. 151-166. , COI: 1:CAS:528:DC%2BC2sXitFeitb8%3D, PID: 28190529; Fang, E.F., Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease (2019) Nat. Neurosci., 22, pp. 401-412. , COI: 1:CAS:528:DC%2BC1MXmsVymt7w%3D, PID: 30742114; Bhat, R., Astrocyte senescence as a component of Alzheimer's disease (2012) PLoS One, 7. , COI: 1:CAS:528:DC%2BC38Xhtl2jt7nI, PID: 22984612; Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., Mecocci, P., From cellular senescence to Alzheimer's disease: the role of telomere shortening (2015) Ageing Res Rev, 22, pp. 1-8. , COI: 1:CAS:528:DC%2BC2MXmslGisb0%3D, PID: 25896211; Chinta, S.J., Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson's disease (2018) Cell Rep, 22, pp. 930-940. , COI: 1:CAS:528:DC%2BC1cXhvFagsb0%3D, PID: 29386135; Turnquist, C., p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration (2016) Cell Death Differ., 23, pp. 1515-1528. , COI: 1:CAS:528:DC%2BC28XmvFChu74%3D, PID: 27104929; He, N., Amyloid-β(1-42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2 (2013) Cell Death Dis., 4. , COI: 1:CAS:528:DC%2BC3sXhvVGgsb3O, PID: 24263098; Kirkland, J.L., Tchkonia, T., Cellular senescence: a translational perspective (2017) EBioMedicine, 21, pp. 21-28. , PID: 28416161; Bussian, T.J., Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline (2018) Nature, 562, pp. 578-582. , COI: 1:CAS:528:DC%2BC1cXhslKjsLzJ, PID: 30232451; Zhang, P., Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model (2019) Nat. Neurosci., 22, pp. 719-728. , COI: 1:CAS:528:DC%2BC1MXosVSjtLw%3D, PID: 30936558; Musi, N., Tau protein aggregation is associated with cellular senescence in the brain (2018) Aging Cell, 17. , PID: 30126037; Talbot, K., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline (2012) J. Clin. Invest., 122, pp. 1316-1338. , COI: 1:CAS:528:DC%2BC38Xlt1egtbY%3D, PID: 22476197; Oddo, S., The role of mTOR signaling in Alzheimer disease (2012) Front Biosci (Schol Ed), 4, pp. 941-952; Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H., Hiltunen, M., AMP-activated protein kinase: a potential player in Alzheimer's disease (2011) J. Neurochem., 118, pp. 460-474. , COI: 1:CAS:528:DC%2BC3MXhtVSit7jP, PID: 21623793; Camandola, S., Mattson, M.P., Brain metabolism in health, aging, and neurodegeneration (2017) EMBO J., 36, pp. 1474-1492. , COI: 1:CAS:528:DC%2BC2sXmsVWht7g%3D, PID: 28438892; De Felice, F.G., Lourenco, M.V., Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease (2015) Front. Aging Neurosci., 7, p. 94. , PID: 26042036; Cai, H., Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders (2012) Curr Alzheimer Res, 9, pp. 5-17. , COI: 1:CAS:528:DC%2BC38Xjt1ChsrY%3D, PID: 22329649; Simons, M., Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons (1998) Proc. Natl Acad. Sci. USA, 95, pp. 6460-6464. , COI: 1:CAS:528:DyaK1cXjtlKgt7o%3D, PID: 9600988; Vivar, C., Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment (2015) Curr. Top. Med. Chem., 15, pp. 2175-2192. , COI: 1:CAS:528:DC%2BC2MXhsFWms7jE, PID: 26059358; McClean, P.L., Parthsarathy, V., Faivre, E., Holscher, C., The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease (2011) J. Neurosci., 31, pp. 6587-6594. , COI: 1:CAS:528:DC%2BC3MXls1Olt7w%3D, PID: 21525299; Ho, L., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (2004) FASEB J., 18, pp. 902-904. , COI: 1:CAS:528:DC%2BD2cXjvVCltr8%3D, PID: 15033922; Takamatsu, Y., Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases (2017) NPJ Parkinsons Dis, 3, p. 4. , PID: 28649604; Heneka, M.T., Reyes-Irisarri, E., Hull, M., Kummer, M.P., Impact and therapeutic potential of PPARs in Alzheimer's disease (2011) Curr. Neuropharmacol., 9, pp. 643-650. , COI: 1:CAS:528:DC%2BC38XhtFWhs74%3D, PID: 22654722; Rotermund, C., Machetanz, G., Fitzgerald, J.C., The therapeutic potential of metformin in neurodegenerative diseases (2018) Front. Endocrinol. (Lausanne), 9, p. 400; Sarlus, H., Heneka, M.T., Microglia in Alzheimer's disease (2017) J. Clin. Invest., 127, pp. 3240-3249. , PID: 28862638; Melki, R., Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases (2015) J. Parkinsons Dis., 5, pp. 217-227. , COI: 1:CAS:528:DC%2BC2MXps12hu7o%3D, PID: 25757830; Rocha, E.M., De Miranda, B., Sanders, L.H., Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease (2018) Neurobiol. Dis., 109, pp. 249-257. , COI: 1:CAS:528:DC%2BC2sXmtVynsbk%3D, PID: 28400134; Dias, V., Junn, E., Mouradian, M.M., The role of oxidative stress in Parkinson's disease (2013) J. Parkinsons Dis., 3, pp. 461-491. , COI: 1:CAS:528:DC%2BC3sXhvV2iur%2FM, PID: 24252804; Hirsch, E.C., Hunot, S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? (2009) Lancet Neurol., 8, pp. 382-397. , COI: 1:CAS:528:DC%2BD1MXks1Sis70%3D, PID: 19296921; Sepe, S., Inefficient DNA repair is an aging-related modifier of Parkinson's disease (2016) Cell Rep, 15, pp. 1866-1875. , COI: 1:CAS:528:DC%2BC28Xotlent78%3D, PID: 27210754; Labbe, C., Lorenzo-Betancor, O., Ross, O.A., Epigenetic regulation in Parkinson's disease (2016) Acta Neuropathol., 132, pp. 515-530. , COI: 1:CAS:528:DC%2BC28XhtFSgsb%2FM, PID: 27358065; Curry, D.W., Stutz, B., Andrews, Z.B., Elsworth, J.D., Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease (2018) J. Parkinsons Dis., 8, pp. 161-181. , PID: 29614701; Alecu, I., Bennett, S.A.L., Dysregulated lipid metabolism and its role in α-synucleinopathy in Parkinson's disease (2019) Front. Neurosci., 13, p. 328. , PID: 31031582; Regensburger, M., Prots, I., Winner, B., Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity (2014) Neural Plast., 2014, p. 454696. , PID: 25110593; Kikuchi, T., Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model (2017) Nature, 548, pp. 592-596. , COI: 1:CAS:528:DC%2BC2sXhsVektrbM, PID: 28858313; McGeer, P.L., Itagaki, S., Boyes, B.E., McGeer, E.G., Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains (1988) Neurology, 38, pp. 1285-1291. , COI: 1:STN:280:DyaL1c3ovVKkuw%3D%3D, PID: 3399080; McKinnon, P.J., ATM and ataxia telangiectasia (2004) EMBO Rep, 5, pp. 772-776. , COI: 1:CAS:528:DC%2BD2cXmtFOhurg%3D, PID: 15289825; Walter, J.T., Alvina, K., Womack, M.D., Chevez, C., Khodakhah, K., Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia (2006) Nat. Neurosci., 9, pp. 389-397. , COI: 1:CAS:528:DC%2BD28Xhslelsbg%3D, PID: 16474392; Valentin-Vega, Y.A., Mitochondrial dysfunction in ataxia-telangiectasia (2012) Blood, 119, pp. 1490-1500. , COI: 1:CAS:528:DC%2BC38XjtVSrs7k%3D, PID: 3286212; Guo, Z., Kozlov, S., Lavin, M.F., Person, M.D., Paull, T.T., ATM activation by oxidative stress (2010) Science, 330, pp. 517-521. , COI: 1:CAS:528:DC%2BC3cXhtlSjsbrO, PID: 20966255; Hardiman, O., Amyotrophic lateral sclerosis (2017) Nat Rev Dis Primers, 3, p. 17071. , PID: 28980624; Bates, G.P., Huntington disease (2015) Nat Rev Dis Primers, 1, p. 15005. , PID: 27188817; Karikkineth, A.C., Scheibye-Knudsen, M., Fivenson, E., Croteau, D.L., Bohr, V.A., Cockayne syndrome: clinical features, model systems and pathways (2017) Ageing Res Rev, 33, pp. 3-17. , COI: 1:CAS:528:DC%2BC28XhslSnsbbK, PID: 27507608; Penndorf, D., Witte, O.W., Kretz, A., DNA plasticity and damage in amyotrophic lateral sclerosis (2018) Neural Regen Res, 13, pp. 173-180. , PID: 29557356; Cai, Z., Yan, L.J., Ratka, A., Telomere shortening and Alzheimer's disease (2013) Neuromolecular Med., 15, pp. 25-48. , COI: 1:CAS:528:DC%2BC3sXjsFKrsr4%3D, PID: 23161153; Linkus, B., Telomere shortening leads to earlier age of onset in ALS mice (2016) Aging (Albany NY), 8, pp. 382-393. , COI: 1:CAS:528:DC%2BC1cXmtFSmtr4%3D; Kota, L.N., Reduced telomere length in neurodegenerative disorders may suggest shared biology (2015) J. Neuropsychiatry Clin. Neurosci., 27, pp. e92-e96. , PID: 25541866; Block, R.C., Dorsey, E.R., Beck, C.A., Brenna, J.T., Shoulson, I., Altered cholesterol and fatty acid metabolism in Huntington disease (2010) J. Clin. Lipidol., 4, pp. 17-23. , PID: 20802793; Allen, D.M., Ataxia telangiectasia mutated is essential during adult neurogenesis (2001) Genes Dev., 15, pp. 554-566. , COI: 1:CAS:528:DC%2BD3MXhvVChs7w%3D, PID: 11238376; Amariglio, N., Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient (2009) PLoS Med., 6. , PID: 19226183; Sapp, E., Early and progressive accumulation of reactive microglia in the Huntington disease brain (2001) J. Neuropathol. Exp. Neurol., 60, pp. 161-172. , COI: 1:STN:280:DC%2BD3M7nt1ymtQ%3D%3D, PID: 11273004; Henkel, J.S., Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue (2004) Ann. Neurol., 55, pp. 221-235. , COI: 1:CAS:528:DC%2BD2cXhs1SgtbY%3D, PID: 14755726; Hui, C.W., Song, X., Ma, F., Shen, X., Herrup, K., Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice (2018) J. Neuroinflammation, 15. , COI: 1:CAS:528:DC%2BC1MXhtFaisLbE, PID: 30400801; Chow, H.M., ATM is activated by ATP depletion and modulates mitochondrial function through NRF1 (2019) J. Cell Biol., 218, pp. 909-928. , COI: 1:CAS:528:DC%2BC1MXpt1eitrs%3D, PID: 30642892; Chen, J., The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment (2016) Mol. Neurodegener., 11, p. 60. , PID: 27538496; Trammell, S.A., Nicotinamide riboside is uniquely and orally bioavailable in mice and humans (2016) Nat Commun, 7. , COI: 1:CAS:528:DC%2BC28Xhs1GnsbfF, PID: 27721479; Zhang, H., NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice (2016) Science, 352, pp. 1436-1443. , COI: 1:CAS:528:DC%2BC28XpslOqsb8%3D, PID: 27127236; Gomes, A.P., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging (2013) Cell, 155, pp. 1624-1638. , COI: 1:CAS:528:DC%2BC3sXhvFylurrJ, PID: 24360282; De Jesus-Cortes, H., Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease (2012) Proc. Natl Acad. Sci. USA, 109, pp. 17010-17015. , PID: 23027934; Phelan, M.J., Mulnard, R.A., Gillen, D.L., Schreiber, S.S., Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer's disease (2017) J Geriatr Med Gerontol, 3, p. 021; Ryu, D., Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents (2016) Nat. Med., 22, pp. 879-888. , COI: 1:CAS:528:DC%2BC28Xht1Klsr7F, PID: 27400265; Georgakopoulos, N.D., Wells, G., Campanella, M., The pharmacological regulation of cellular mitophagy (2017) Nat. Chem. Biol., 13, pp. 136-146. , COI: 1:CAS:528:DC%2BC2sXht1Ortr0%3D, PID: 28103219; Albani, D., Polito, L., Signorini, A., Forloni, G., Neuroprotective properties of resveratrol in different neurodegenerative disorders (2010) Biofactors, 36, pp. 370-376. , COI: 1:CAS:528:DC%2BC3cXhtl2msLjO, PID: 20848560; Heilman, J., Andreux, P., Tran, N., Rinsch, C., Blanco-Bose, W., Safety assessment of urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid (2017) Food Chem. Toxicol., 108, pp. 289-297. , COI: 1:CAS:528:DC%2BC2sXhtlyju7zE, PID: 28757461; Moreira, O.C., Mitochondrial function and mitophagy in the elderly: effects of exercise (2017) Oxid. Med. Cell. Longev., 2017, p. 2012798. , PID: 28900532; Herranz, N., mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype (2015) Nat. Cell Biol., 17, pp. 1205-1217. , COI: 1:CAS:528:DC%2BC2MXhtlCksbzL, PID: 26280535; Walters, H.E., Deneka-Hannemann, S., Cox, L.S., Reversal of phenotypes of cellular senescence by pan-mTOR inhibition (2016) Aging (Albany NY), 8, pp. 231-244. , COI: 1:CAS:528:DC%2BC1cXmtFSmtb4%3D; Katila, N., Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease (2017) Neuropharmacology, 125, pp. 396-407. , COI: 1:CAS:528:DC%2BC2sXhtlOgsbrN, PID: 28807678; Ou, Z., Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice (2018) Brain. Behav. Immun., 69, pp. 351-363. , COI: 1:CAS:528:DC%2BC2sXitVaksb3M, PID: 29253574; Naylor, R.M., Baker, D.J., van Deursen, J.M., Senescent cells: a novel therapeutic target for aging and age-related diseases (2013) Clin. Pharmacol. Ther., 93, pp. 105-116. , COI: 1:CAS:528:DC%2BC38XhvVGms7rL, PID: 23212104; Krimpenfort, P., Berns, A., Rejuvenation by therapeutic elimination of senescent cells (2017) Cell, 169, pp. 3-5. , COI: 1:CAS:528:DC%2BC2sXltVWnsL0%3D, PID: 28340347; Chiti, F., Dobson, C.M., Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade (2017) Annu. Rev. Biochem, 86, pp. 27-68. , COI: 1:CAS:528:DC%2BC2sXns1Wjsr0%3D, PID: 28498720; Jack, C.R., Jr., NIA-AA research framework: toward a biological definition of Alzheimer's disease (2018) Alzheimers Dement, 14, pp. 535-562. , PID: 29653606; Medina, M., An overview on the clinical development of tau-based therapeutics (2018) Int. J. Mol. Sci., 19, p. 1160; Braak, H., Braak, E., Evolution of the neuropathology of Alzheimer's disease (1996) Acta Neurol. Scand. Suppl., 165, pp. 3-12. , COI: 1:STN:280:DyaK283pvVaqtw%3D%3D, PID: 8740983; Cummings, J., Lee, G., Ritter, A., Zhong, K., Alzheimer's disease drug development pipeline: 2018 (2018) Alzheimers Dement (N Y), 4, pp. 195-214; Cao, B., Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: a systematic review and network meta-analysis (2018) Diabetes Obes. Metab., 20, pp. 2467-2471. , PID: 29790638; Miguel-Alvarez, M., Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect (2015) Drugs Aging, 32, pp. 139-147. , COI: 1:CAS:528:DC%2BC2MXitlajt70%3D, PID: 25644018; Rees, K., Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies (2011) Cochrane Database of Systematic Reviews, 9, p. CD008454; (2018), https://clinicaltrials.gov/ct2/show/NCT02588677, ClinicalTrials.gov; Petrov, D., Mansfield, C., Moussy, A., Hermine, O., ALS clinical trials review: 20 years of failure. are we any closer to registering a new treatment? (2017) Front. Aging Neurosci., 9, p. 68. , PID: 28382000; Vaiserman, A.M., Lushchak, O.V., Koliada, A.K., Anti-aging pharmacology: promises and pitfalls (2016) Ageing Res Rev, 31, pp. 9-35. , PID: 27524412; Hernandez-Camacho, J.D., Bernier, M., Lopez-Lluch, G., Navas, P., Coenzyme Q10 supplementation in aging and disease (2018) Front. Physiol., 9, p. 44. , PID: 29459830; Li, T., Chen, Z.J., The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer (2018) J. Exp. Med., 215, pp. 1287-1299. , COI: 1:CAS:528:DC%2BC1cXhvVakt7nO, PID: 29622565; Giraldez-Perez, R., Antolin-Vallespin, M., Munoz, M., Sanchez-Capelo, A., Models of α-synuclein aggregation in Parkinson's disease (2014) Acta Neuropathol Commun, 2, p. 176. , PID: 25497491; Reitz, C., Mayeux, R., Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers (2014) Biochem. Pharmacol., 88, pp. 640-651. , COI: 1:CAS:528:DC%2BC2cXhsFCktbk%3D, PID: 24398425; Vina, J., Lloret, A., Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-β peptide (2010) J. Alzheimers Dis., 20, pp. S527-S533. , PID: 20442496; Luchsinger, J.A., Aggregation of vascular risk factors and risk of incident Alzheimer disease (2005) Neurology, 65, pp. 545-551. , COI: 1:STN:280:DC%2BD2MvkvFChtQ%3D%3D, PID: 16116114; Grant, W.B., Campbell, A., Itzhaki, R.F., Savory, J., The significance of environmental factors in the etiology of Alzheimer's disease (2002) J. Alzheimers Dis., 4, pp. 179-189. , PID: 12226537; Kalia, L.V., Lang, A.E., Parkinson's disease (2015) Lancet, 386, pp. 896-912. , COI: 1:CAS:528:DC%2BC2MXmsl2rtb4%3D, PID: 25904081; Weintraub, D., Stern, M.B., Psychiatric complications in Parkinson disease (2005) Am. J. Geriatr. Psychiatry, 13, pp. 844-851. , PID: 16223962; Mak, E., Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy (2014) J. Neurol. Neurosurg. Psychiatry, 85, pp. 576-580. , PID: 24133286; Talbott, E.O., Malek, A.M., Lacomis, D., The epidemiology of amyotrophic lateral sclerosis (2016) Handb. Clin. Neurol., 138, pp. 225-238. , COI: 1:STN:280:DC%2BC2svhsVOntw%3D%3D, PID: 27637961; Walker, F.O., Huntington's disease (2007) Lancet, 369, pp. 218-228. , COI: 1:CAS:528:DC%2BD2sXntlCntg%3D%3D, PID: 17240289; Subramaniam, S., Sixt, K.M., Barrow, R., Snyder, S.H., Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity (2009) Science, 324, pp. 1327-1330. , COI: 1:CAS:528:DC%2BD1MXms12gur0%3D, PID: 19498170; Duff, K., Psychiatric symptoms in Huntington's disease before diagnosis: the Predict-HD study (2007) Biol. Psychiatry, 62, pp. 1341-1346. , PID: 17481592; Zweig, Y.R., Galvin, J.E., Lewy body dementia: the impact on patients and caregivers (2014) Alzheimers Res. Ther., 6, p. 21. , PID: 25031635; Rothblum-Oviatt, C., Ataxia telangiectasia: a review (2016) Orphanet J. Rare Dis., 11. , PID: 27884168; Kleijer, W.J., Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy (2008) DNA Repair (Amst), 7, pp. 744-750. , COI: 1:CAS:528:DC%2BD1cXls1SgsbY%3D},
correspondence_address1={Bohr, V.A.; Laboratory of Molecular Gerontology, United States; email: vbohr@nih.gov},
publisher={Nature Publishing Group},
issn={17594758},
pubmed_id={31501588},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Theodoratou2014,
author={Theodoratou, E. and Tzoulaki, I. and Zgaga, L. and Ioannidis, J.P.A.},
title={Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials},
journal={BMJ (Online)},
year={2014},
volume={348},
doi={10.1136/bmj.g2035},
art_number={g2035},
note={cited By 680},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897987332&doi=10.1136%2fbmj.g2035&partnerID=40&md5=425e1ebdf4f1058ceed5123085d18de6},
affiliation={Centre for Population Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, United Kingdom; Department of Epidemiology and Biostatistics, Imperial College London, London W2 1PG, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece; Department of Public Health and Primary Care, Trinity College Dublin, Dublin 24, Ireland; Stanford Prevention Research Center, Departments of Medicine and Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305-5411, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, United States},
abstract={Objective: To evaluate the breadth, validity, and presence of biases of the associations of vitamin D with diverse outcomes. Design: Umbrella review of the evidence across systematic reviews and meta-analyses of observational studies of plasma 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D concentrations and randomised controlled trials of vitamin D supplementation. Data sources: Medline, Embase, and screening of citations and references. Eligibility criteria: Three types of studies were eligible for the umbrella review: systematic reviews and meta-analyses that examined observational associations between circulating vitamin D concentrations and any clinical outcome; and meta-analyses of randomised controlled trials assessing supplementation with vitamin D or active compounds (both established and newer compounds of vitamin D). Results: 107 systematic literature reviews and 74 meta-analyses of observational studies of plasma vitamin D concentrations and 87 meta-analyses of randomised controlled trials of vitamin D supplementation were identified. The relation between vitamin D and 137 outcomes has been explored, covering a wide range of skeletal, malignant, cardiovascular, autoimmune, infectious, metabolic, and other diseases. Ten outcomes were examined by both meta-analyses of observational studies and meta-analyses of randomised controlled trials, but the direction of the effect and level of statistical significance was concordant only for birth weight (maternal vitamin D status or supplementation). On the basis of the available evidence, an association between vitamin D concentrations and birth weight, dental caries in children, maternal vitamin D concentrations at term, and parathyroid hormone concentrations in patients with chronic kidney disease requiring dialysis is probable, but further studies and better designed trials are needed to draw firmer conclusions. In contrast to previous reports, evidence does not support the argument that vitamin D only supplementation increases bone mineral density or reduces the risk of fractures or falls in older people. Conclusions: Despite a few hundred systematic reviews and meta-analyses, highly convincing evidence of a clear role of vitamin D does not exist for any outcome, but associations with a selection of outcomes are probable.},
keywords={25 hydroxyvitamin D;  calcitriol;  parathyroid hormone, article;  birth weight;  bone density;  bone disease;  cerebrovascular accident;  chronic kidney disease;  clinical evaluation;  cognitive defect;  colorectal cancer;  dental caries;  fall risk assessment;  human;  hypertension;  metabolic disorder;  non insulin dependent diabetes mellitus;  observational study;  outcome assessment;  pregnancy diabetes mellitus;  priority journal;  prostate cancer;  randomized controlled trial (topic);  rheumatoid arthritis;  rickets;  risk reduction;  systematic review;  vaginitis;  vitamin blood level;  vitamin supplementation, Dietary Supplements;  Humans;  Observational Study as Topic;  Randomized Controlled Trials as Topic;  Vitamin D;  Vitamins},
chemicals_cas={25 hydroxyvitamin D, 64719-49-9; calcitriol, 32222-06-3, 32511-63-0, 66772-14-3; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6},
references={Lips, P., Vitamin D physiology (2006) Progress in Biophysics and Molecular Biology, 92 (1), pp. 4-8. , DOI 10.1016/j.pbiomolbio.2006.02.016, PII S0079610706000083; Holick, M.F., McCollum Award Lecture, 1994: Vitamin D - New horizons for the 21st century (1994) Am J Clin Nutr, 60, pp. 619-630; Tang, B.M., Eslick, G.D., Nowson, C., Smith, C., Bensoussan, A., Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis (2007) Lancet, 370 (9588), pp. 657-666. , DOI 10.1016/S0140-6736(07)61342-7, PII S0140673607613427; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Baron, J.A., Burckhardt, P., Li, R., Spiegelman, D., Specker, B., Willett, W.C., Calcium intake and hip fracture risk in men and women: A meta-analysis of prospective cohort studies and randomized controlled trials (2007) American Journal of Clinical Nutrition, 86 (6), pp. 1780-1790. , http://www.ajcn.org/cgi/reprint/86/6/1780; Bischoff-Ferrari, H.A., Willett, W.C., Wong, J.B., Stuck, A.E., Staehelin, H.B., Orav, E.J., Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials (2009) Arch Intern Med, 169, pp. 551-561; Visser, M., Deeg, D.J.H., Lips, P., Low Vitamin D and High Parathyroid Hormone Levels as Determinants of Loss of Muscle Strength and Muscle Mass (Sarcopenia): The Longitudinal Aging Study Amsterdam (2003) Journal of Clinical Endocrinology and Metabolism, 88 (12), pp. 5766-5772. , DOI 10.1210/jc.2003-030604; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Staehelin, H.B., Orav, J.E., Stuck, A.E., Theiler, R., Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials (2009) BMJ, 339, pp. b3692; Lappe, J.M., Travers-Gustafson, D., Davies, K.M., Recker, R.R., Heaney, R.P., Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial (2007) American Journal of Clinical Nutrition, 85 (6), pp. 1586-1591. , http://www.ajcn.org/cgi/reprint/85/6/1586; Giovannucci, E., Liu, Y., Hollis, B.W., Rimm, E.B., 25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study (2008) Archives of Internal Medicine, 168 (11), pp. 1174-1180. , http://archinte.ama-assn.org/cgi/reprint/168/11/1174, DOI 10.1001/archinte.168.11.1174; Wang, T.J., Pencina, M.J., Booth, S.L., Jacques, P.F., Ingelsson, E., Lanier, K., Vitamin D deficiency and risk of cardiovascular disease (2008) Circulation, 117, pp. 503-511; Pittas, A.G., Lau, J., Hu, F.B., Dawson-Hughes, B., Review: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis (2007) Journal of Clinical Endocrinology and Metabolism, 92 (6), pp. 2017-2029. , http://jcem.endojournals.org/cgi/reprint/92/6/2017.pdf, DOI 10.1210/jc.2007-0298; Yamshchikov, A.V., Desai, N.S., Blumberg, H.M., Ziegler, T.R., Tangpricha, V., Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials (2009) Endocr Pract, 15, pp. 438-449; Cutolo, M., Otsa, K., Uprus, M., Paolino, S., Seriolo, B., Vitamin D in rheumatoid arthritis (2007) Autoimmunity Reviews, 7 (1), pp. 59-64. , DOI 10.1016/j.autrev.2007.07.001, PII S1568997207001140, New Strategies for the Control of Inflmmatory Diseases; Merlino, L.A., Curtis, J., Mikuls, T.R., Cerhan, J.R., Criswell, L.A., Saag, K.G., Vitamin D Intake Is Inversely Associated With Rheumatoid Arthritis: Results From the Iowa Women's Health Study (2004) Arthritis and Rheumatism, 50 (1), pp. 72-77. , DOI 10.1002/art.11434; Myhr, K.M., Vitamin D treatment in multiple sclerosis (2009) J Neurol Sci, 286, pp. 104-108; Melamed, M.L., Michos, E.D., Post, W., Astor, B., 25-hydroxyvitamin D levels and the risk of mortality in the general population (2008) Arch Intern Med, 168, pp. 1629-1637; Zgaga, L., Theodoratou, E., Farrington, S.M., Agakov, F., Tenesa, A., Walker, M., Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient (2011) J Nutr, 141, pp. 1535-1542; Holick, M.F., Vitamin D deficiency (2007) N Engl J Med, 357, pp. 266-281; Maxmen, A., Nutrition advice: The vitamin D-lemma (2011) Nature, 475, pp. 23-25; Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know (2011) J Clin Endocrinol Metab, 96, pp. 53-58; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; Ioannidis, J.P., Patsopoulos, N.A., Rothstein, H.R., Reasons or excuses for avoiding meta-analysis in forest plots (2008) BMJ, 336, pp. 1413-1415; Tzoulaki, I., Siontis, K.C., Evangelou, E., Ioannidis, J.P., Bias in associations of emerging biomarkers with cardiovascular disease (2013) JAMA Intern Med, 173, pp. 664-671; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Tsilidis, K.K., Panagiotou, O.A., Sena, E.S., Aretouli, E., Evangelou, E., Howells, D.W., Evaluation of excess significance bias in animal studies of neurological diseases (2013) PLoS Biol, 11, pp. e1001609; Lau, J., Ioannidis, J.P.A., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Annals of Internal Medicine, 127 (9), pp. 820-826; Ioannidis, J.P.A., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) British Medical Journal, 335 (7626), pp. 914-916; Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) British Medical Journal, 315 (7109), pp. 629-634; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry, 68, pp. 773-780; Kavvoura, F.K., McQueen, M.B., Khoury, M.J., Tanzi, R.E., Bertram, L., Ioannidis, J.P., Evaluation of the potential excess of statistically significant findings in published genetic association studies: Application to Alzheimer's disease (2008) Am J Epidemiol, 168, pp. 855-865; Ioannidis, J.P.A., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clinical Trials, 4 (3), pp. 245-253. , DOI 10.1177/1740774507079441; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Freedman, L.S., Tables of the number of patients required in clinical trials using the logrank test (1982) Statistics in Medicine, 1 (2), pp. 121-129; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Lee, J.E., Li, H., Chan, A.T., Hollis, B.W., Lee, I.M., Stampfer, M.J., Circulating levels of vitamin D and colon and rectal cancer: The Physicians' Health Study and a meta-analysis of prospective studies (2011) Cancer Prev Res (Phila Pa), 4, pp. 735-743; Aghajafari, F., Nagulesapillai, T., Ronksley, P.E., Tough, S.C., O'Beirne, M., Rabi, D.M., Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: Systematic review and meta-analysis of observational studies (2013) BMJ, 346, pp. f1169; Lai, J.K., Lucas, R.M., Clements, M.S., Roddam, A.W., Banks, E., Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: A systematic review and meta-analysis of randomised controlled trials and observational studies (2010) BMC Public Health, 10, p. 331; Saneei, P., Salehi-Abargouei, A., Esmaillzadeh, A., Serum 25-hydroxy vitamin D levels in relation to body mass index: A systematic review and meta-analysis (2013) Obes Rev, 14, pp. 393-404; Sterne, J.A.C., Smith, G.D., Sifting the evidence - Whats wrong with significance tests? (2001) British Medical Journal, 322 (7280), pp. 226-231; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22, pp. 450-456; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci U S A, 110, pp. 19313-19317; Annweiler, C., Allali, G., Allain, P., Bridenbaugh, S., Schott, A.M., Kressig, R.W., Vitamin D and cognitive performance in adults: A systematic review (2009) Eur J Neurol, 16, pp. 1083-1089; Barnard, K., Colon-Emeric, C., Extraskeletal effects of vitamin D in older adults: Cardiovascular disease, mortality, mood, and cognition (2010) Am J Geriatr Pharmacother, 8, pp. 4-33; Buttigliero, C., Monagheddu, C., Petroni, P., Saini, A., Dogliotti, L., Ciccone, G., Prognostic role of vitamin D status and efficacy of vitamin D supplementation in cancer patients: A systematic review (2011) Oncologist, 16, pp. 1215-1227; Christesen, H.T., Elvander, C., Lamont, R.F., Jorgensen, J.S., The impact of vitamin D in pregnancy on extraskeletal health in children: A systematic review (2012) Acta Obstet Gynecol Scand, 91, pp. 1368-1380; Christesen, H.T., Falkenberg, T., Lamont, R.F., Jorgensen, J.S., The impact of vitamin D on pregnancy: A systematic review (2012) Acta Obstet Gynecol Scand, 91, pp. 1357-1367; Chung, M., Balk, E.M., Brendel, M., Ip, S., Lau, J., Lee, J., Vitamin D and calcium: A systematic review of health outcomes (2009) Evid Rep Technol Assess (Full Rep), (183), pp. 1-420; Cranney, A., Horsley, T., O'Donnell, S., Weiler, H., Puil, L., Ooi, D., Effectiveness and safety of vitamin D in relation to bone health (2007) Evid Rep Technol Assess (Full Rep), (158), pp. 1-235; Kriegel, M.A., Manson, J.E., Costenbader, K.H., Does vitamin D affect risk of developing autoimmune disease? A systematic review (2011) Semin Arthritis Rheum, 40, pp. 512e8-531e8; Nassar, N., Halligan, G.H., Roberts, C.L., Morris, J.M., Ashton, A.W., Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy (2011) Am J Obstet Gynecol, 205, pp. 208e1-208e7; Pilz, S., Tomaschitz, A., Ritz, E., Pieber, T.R., Vitamin D status and arterial hypertension: A systematic review (2009) Nat Rev Cardiol, 6, pp. 621-630; Pittas, A.G., Chung, M., Trikalinos, T., Mitri, J., Brendel, M., Patel, K., Systematic review: Vitamin D and cardiometabolic outcomes (2010) Ann Intern Med, 152, pp. 307-314; Renzaho, A.M., Halliday, J.A., Nowson, C., Vitamin D obesity, and obesity-related chronic disease among ethnic minorities: A systematic review (2011) Nutrition, 27, pp. 868-879; Van Der Rhee, H., Coebergh, J.W., De Vries, E., Sunlight, vitamin D and the prevention of cancer: A systematic review of epidemiological studies (2009) Eur J Cancer Prev, 18, pp. 458-475; Yaghjyan, L., Colditz, G.A., Drake, B., Vitamin D and mammographic breast density: A systematic review (2012) Cancer Causes Control, 23, pp. 1-13; Antico, A., Tampoia, M., Tozzoli, R., Bizzaro, N., Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature (2012) Autoimmun Rev, 12, pp. 127-136; Cook, L.S., Neilson, H.K., Lorenzetti, D.L., Lee, R.C., A systematic literature review of vitamin D and ovarian cancer (2010) Am J Obstet Gynecol, 203, pp. 70e1-70e8; Kelly, J.L., Friedberg, J.W., Calvi, L.M., Van Wijngaarden, E., Fisher, S.G., Vitamin D and non-Hodgkin lymphoma risk in adults: A review (2009) Cancer Invest, 27, pp. 942-951; Sakthiswary, R., Raymond, A.A., The clinical significance of vitamin D in systemic lupus erythematosus: A systematic review (2013) PLoS One, 8 (1); Song, G.G., Bae, S.C., Lee, Y.H., Association between vitamin D intake and the risk of rheumatoid arthritis: A meta-analysis (2012) Clin Rheumatol, 31, pp. 1733-1739; Thorne-Lyman, A., Fawzi, W.W., Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: A systematic review and meta-analysis (2012) Paediatr Perinat Epidemiol, 26 (SUPPL. 1), pp. 75-90; Dolinsky, D.H., Armstrong, S., Mangarelli, C., Kemper, A.R., The association between vitamin D and cardiometabolic risk factors in children: A systematic review (2013) Clin Pediatr (Phila), 52, pp. 210-223; Jolliffe, D.A., Griffiths, C.J., Martineau, A.R., Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies (2013) J Steroid Biochem Mol Biol, 136, pp. 321-329; Cao, Y., Winzenberg, T., Nguo, K., Lin, J., Jones, G., Ding, C., Association between serum levels of 25-hydroxyvitamin D and osteoarthritis: A systematic review (2013) Rheumatology, 52, pp. 1323-1334; Balion, C., Griffith, L.E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Vitamin D, cognition, and dementia: A systematic review and meta-analysis (2012) Neurology, 79, pp. 1397-1405; Brondum-Jacobsen, P., Benn, M., Jensen, G.B., Nordestgaard, B.G., 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: Population-based study and meta-analyses of 18 and 17 studies (2012) Arterioscler Thromb Vasc Biol, 32, pp. 2794-2802; Burgaz, A., Orsini, N., Larsson, S.C., Wolk, A., Blood 25-hydroxyvitamin D concentration and hypertension: A meta-analysis (2011) J Hypertens, 29, pp. 636-645; Chen, P., Hu, P., Xie, D., Qin, Y., Wang, F., Wang, H., Meta-analysis of vitamin D, calcium and the prevention of breast cancer (2010) Breast Cancer Res Treat, 121, pp. 469-477; Chowdhury, R., Stevens, S., Ward, H., Chowdhury, S., Sajjad, A., Franco, O.H., Circulating vitamin D, calcium and risk of cerebrovascular disease: A systematic review and meta-analysis (2012) Eur J Epidemiol, 27, pp. 581-591; Chung, M., Lee, J., Terasawa, T., Lau, J., Trikalinos, T.A., Vitamin D with or without calcium supplementation for prevention of cancer and fractures: An updated meta-analysis for the U.S. Preventive Services Task Force (2011) Ann Intern Med, 155, pp. 827-838; Etgen, T., Sander, D., Bickel, H., Sander, K., Forstl, H., Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-analysis (2012) Dement Geriatr Cogn Disord, 33, pp. 297-305; Fedirko, V., Bostick, R.M., Goodman, M., Flanders, W.D., Gross, M.D., Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: A pooled case-control study (2010) Am J Epidemiol, 172, pp. 489-500; Forouhi, N.G., Ye, Z., Rickard, A.P., Khaw, K.T., Luben, R., Langenberg, C., Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies (2012) Diabetologia, 55, pp. 2173-2182; Gallicchio, L., Moore, L.E., Stevens, V.L., Ahn, J., Albanes, D., Hartmuller, V., Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (2010) Am J Epidemiol, 172, pp. 47-57; Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M.J., Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma (2011) Int J Cancer, 128, pp. 1414-1424; Gilbert, R., Martin, R.M., Beynon, R., Harris, R., Savovic, J., Zuccolo, L., Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis (2011) Cancer Causes Control, 22, pp. 319-340; Gorham, E.D., Garland, C.F., Garland, F.C., Grant, W.B., Mohr, S.B., Lipkin, M., Newmark, H.L., Holick, M.F., Optimal Vitamin D Status for Colorectal Cancer Prevention. A Quantitative Meta Analysis (2007) American Journal of Preventive Medicine, 32 (3), pp. 210-216. , DOI 10.1016/j.amepre.2006.11.004, PII S0749379706004983; Grandi, N.C., Breitling, L.P., Brenner, H., Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies (2010) Prev Med, 51, pp. 228-233; Ma, Y., Zhang, P., Wang, F., Yang, J., Liu, Z., Qin, H., Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies (2011) J Clin Oncol, 29, pp. 3775-3782; Mitri, J., Muraru, M.D., Pittas, A.G., Vitamin D and type 2 diabetes: A systematic review (2011) Eur J Clin Nutr, 65, pp. 1005-1015; Mohr, S.B., Gorham, E.D., Alcaraz, J.E., Kane, C.J., Macera, C.A., Parsons, J.K., Serum 25-hydroxyvitamin D and prevention of breast cancer: Pooled analysis [correction in: Anticancer Res 2011;31:3637] (2011) Anticancer Res, 31, pp. 2939-2948; Nnoaham, K.E., Clarke, A., Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis (2008) International Journal of Epidemiology, 37 (1), pp. 113-119. , DOI 10.1093/ije/29.1.113; Parker, J., Hashmi, O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.-B., Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis (2010) Maturitas, 65, pp. 225-236; Pilz, S., Iodice, S., Zittermann, A., Grant, W.B., Gandini, S., Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies (2011) Am J Kidney Dis, 58, pp. 374-382; Poel, Y.H., Hummel, P., Lips, P., Stam, F., Van Der Ploeg, T., Simsek, S., Vitamin D and gestational diabetes: A systematic review and meta-analysis (2012) Eur J Intern Med, 23, pp. 465-469; Purdue, M.P., Freedman, D.M., Gapstur, S.M., Helzlsouer, K.J., Laden, F., Lim, U., Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (2010) Am J Epidemiol, 172, pp. 58-69; Sokol, S.I., Tsang, P., Aggarwal, V., Melamed, M.L., Srinivas, V.S., Vitamin D status and risk of cardiovascular events: Lessons learned via systematic review and meta-analysis (2011) Cardiol Rev, 19, pp. 192-201; Stolzenberg-Solomon, R.Z., Jacobs, E.J., Arslan, A.A., Qi, D., Patel, A.V., Helzlsouer, K.J., Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (2010) Am J Epidemiol, 172, pp. 81-93; Sun, Q., Pan, A., Hu, F.B., Manson, J.E., Rexrode, K.M., 25-hydroxyvitamin D levels and the risk of stroke: A prospective study and meta-analysis (2012) Stroke, 43, pp. 1470-1477; Touvier, M., Chan, D.S., Lau, R., Aune, D., Vieira, R., Greenwood, D.C., Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk (2011) Cancer Epidemiol Biomarkers Prev, 20, pp. 1003-1016; Weatherall, M., A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur (2000) N Z Med J, 113, pp. 137-140; Wei, M.Y., Garland, C.F., Gorham, E.D., Mohr, S.B., Giovannucci, E., Vitamin D and prevention of colorectal adenoma: A meta-analysis (2008) Cancer Epidemiol Biomarkers Prev, 17, pp. 2958-2969; Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk (2009) Aliment Pharmacol Ther, 30, pp. 113-125; Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis: Serum vitamin D and breast cancer risk (2010) Eur J Cancer, 46, pp. 2196-2205; Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis: Serum vitamin D and colorectal adenoma risk (2011) Prev Med, 53, pp. 10-16; Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis: Circulating vitamin D and ovarian cancer risk (2011) Gynecol Oncol, 121, pp. 369-375; Yin, L., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk (2009) Cancer Epidemiol, 33, pp. 435-445; Anglin, R.E., Samaan, Z., Walter, S.D., Sarah, D.M., Vitamin D deficiency and depression in adults: Systematic review and meta-analysis (2013) Br J Psychiatry, 202, pp. 100-107; Annweiler, C., Llewellyn, D.J., Beauchet, O., Low serum vitamin D concentrations in Alzheimer's disease: A systematic review and meta-analysis (2013) J Alzheimers Dis, 33, pp. 659-674; Brondum-Jacobsen, P., Nordestgaard Bo, G., Schnohr, P., Benn, M., 25-hydroxyvitamin D and symptomatic ischemic stroke: An original study and meta-analysis (2013) Ann Neurol, 73, pp. 38-47; Chen, P., Li, M., Gu, X., Liu, Y., Li, X., Li, C., Higher blood 25(OH)D level may reduce the breast cancer risk: Evidence from a Chinese population based case-control study and meta-analysis of the observational studies (2013) PLoS One, 8 (1); Wang, L., Song, Y., Manson, J.E., Pilz, S., Marz, W., Michaelsson, K., Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies (2012) Circ Cardiovasc Qual Outcomes, 5, pp. 819-829; Afzal, S., Bojesen, S.E., Nordestgaard, B.G., Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and metaanalysis (2013) Clin Chem, 59, pp. 381-391; Kunutsor, S.K., Apekey, T.A., Steur, M., Vitamin D and risk of future hypertension: Meta-analysis of 283,537 participants (2013) Eur J Epidemiol, 28, pp. 205-221; Bauer, S.R., Hankinson, S.E., Bertone-Johnson, E.R., Ding, E.L., Plasma vitamin D levels, menopause, and risk of breast cancer: Dose-response meta-analysis of prospective studies (2013) Medicine (Baltimore), 92, pp. 123-131; Autier, P., Gandini, S., Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials (2007) Archives of Internal Medicine, 167 (16), pp. 1730-1737. , http://archinte.ama-assn.org/cgi/reprint/167/16/1730, DOI 10.1001/archinte.167.16.1730; Avenell, A., Gillespie, W.J., Gillespie, L.D., O'Connell, D., Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (2009) Cochrane Database Syst Rev, (2), pp. CD000227; Bergman, G.J., Fan, T., McFetridge, J.T., Sen, S.S., Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: A meta-analysis (2010) Curr Med Res Opin, 26, pp. 1193-1201; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y., Wong, J.B., Effect of Vitamin D on Falls: A Meta-analysis (2004) Journal of the American Medical Association, 291 (16), pp. 1999-2006. , DOI 10.1001/jama.291.16.1999; Bjelakovic, G., Gluud, L.L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R.G., Vitamin D supplementation for prevention of mortality in adults (2011) Cochrane Database Syst Rev, (7), pp. CD007470; Cameron, I.D., Gillespie, L.D., Robertson, M.C., Murray, G.R., Hill, K.D., Cumming, R.G., Interventions for preventing falls in older people in care facilities and hospitals (2012) Cochrane Database Syst Rev, (12), pp. CD005465; De-Regil, L.M., Palacios, C., Ansary, A., Kulier, R., Pena-Rosas, J.P., Vitamin D supplementation for women during pregnancy (2012) Cochrane Database Syst Rev, (2), pp. CD008873; Elamin, M.B., Abu Elnour, N.O., Elamin, K.B., Fatourechi, M.M., Alkatib, A.A., Almandoz, J.P., Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis (2011) J Clin Endocrinol Metab, 96, pp. 1931-1942; George, P.S., Pearson, E.R., Witham, M.D., Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis (2012) Diabet Med, 29, pp. e142-e150; Gillespie, L.D., Robertson, M.C., Gillespie, W.J., Sherrington, C., Gates, S., Clemson, L.M., Interventions for preventing falls in older people living in the community (2012) Cochrane Database Syst Rev, (9), pp. CD007146; Patient level pooled analysis of 68500 patients from seven major vitamin D fracture trials in US and Europe (2010) BMJ, 340, pp. b5463. , DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group; Kalyani, R.R., Stein, B., Valiyil, R., Manno, R., Maynard, J.W., Crews, D.C., Vitamin D treatment for the prevention of falls in older adults: Systematic review and meta-analysis (2010) J Am Geriatr Soc, 58, pp. 1299-1310; Muir, S.W., Montero-Odasso, M., Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: A systematic review and meta-analysis (2011) J Am Geriatr Soc, 59, pp. 2291-2300; Murad, M.H., Elamin, K.B., Abu Elnour, N.O., Elamin, M.B., Alkatib, A.A., Fatourechi, M.M., The effect of vitamin D on falls: A systematic review and meta-analysis (2011) J Clin Endocrinol Metab, 96, pp. 2997-3006; Palmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., Strippoli, G.F., Vitamin D compounds for people with chronic kidney disease not requiring dialysis (2009) Cochrane Database Syst Rev, (4), pp. CD008175; Palmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., Strippoli, G.F., Vitamin D compounds for people with chronic kidney disease requiring dialysis (2009) Cochrane Database Syst Rev, (4), pp. CD005633; Rejnmark, L., Avenell, A., Masud, T., Anderson, F., Meyer, H.E., Sanders, K.M., Vitamin D with calcium reduces mortality: Patient level pooled analysis of 70,528 patients from eight major vitamin D trials (2012) J Clin Endocrinol Metab, 97, pp. 2670-2681; Wang, H., Xia, N., Yang, Y., Peng, D.-Q., Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials (2012) Lipids Health Dis, 11, p. 42; Wang, L., Manson, J.E., Song, Y., Sesso, H.D., Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events (2010) Ann Intern Med, 152, pp. 315-323; Winzenberg, T., Powell, S., Shaw, K.A., Jones, G., Effects of vitamin D supplementation on bone density in healthy children: Systematic review and meta-analysis (2011) BMJ, 342, pp. c7254; Witham, M.D., Nadir, M.A., Struthers, A.D., Effect of vitamin D on blood pressure: A systematic review and meta-analysis (2009) J Hypertens, 27, pp. 1948-1954; Wu, S.H., Ho, S.C., Zhong, L., Effects of vitamin D supplementation on blood pressure (2010) South Med J, 103, pp. 729-737; Hujoel, P.P., Vitamin D and dental caries in controlled clinical trials: Systematic review and meta-analysis (2013) Nutr Rev, 71, pp. 88-97; Kandula, P., Dobre, M., Schold, J.D., Schreiber Jr., M.J., Mehrotra, R., Navaneethan, S.D., Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials (2011) Clin J Am Soc Nephrol, 6, pp. 50-62; Myung, S.K., Ju, W., Cho, B., Oh, S.W., Park, S.M., Koo, B.K., Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials (2013) BMJ, 346, pp. f10; Reid, I.R., Bolland, M.J., Grey, A., Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis (2014) Lancet, 383, pp. 146-155; Autier, P., Boniol, M., Pizot, C., Mullie, P., Vitamin D status and ill health: A systematic review (2014) Lancet Diabetes Endocrinol, 2, pp. 76-89; Bolland, M.J., Grey, A., Gamble, G.D., Reid, I.R., Calcium and vitamin D supplements and health outcomes: A reanalysis of the Women's Health Initiative (WHI) limited-access data set (2011) Am J Clin Nutr, 94, pp. 1144-1149; Bailey, R.L., Dodd, K.W., Goldman, J.A., Gahche, J.J., Dwyer, J.T., Moshfegh, A.J., Estimation of total usual calcium and vitamin D intakes in the United States (2010) J Nutr, 140, pp. 817-822; Bischoff-Ferrari, H.A., Willett, W.C., Wong, J.B., Giovannucci, E., Dietrich, T., Dawson-Hughes, B., Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials (2005) Journal of the American Medical Association, 293 (18), pp. 2257-2264. , DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari, H.A., Willett, W.C., Orav, E.J., Lips, P., Meunier, P.J., Lyons, R.A., A pooled analysis of vitamin D dose requirements for fracture prevention [correction in N Engl J Med 2012;367:481] (2012) N Engl J Med, 367, pp. 40-49; Spedding, S., Vanlint, S., Morris, H., Scragg, R., Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? (2013) Nutrients, 5, pp. 5127-5139; Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline (2011) J Clin Endocrinol Metab, 96, pp. 1911-1930; Hanley, D.A., Cranney, A., Jones, G., Whiting, S.J., Leslie, W.D., Cole, D.E., Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada (2010) CMAJ, 182, pp. E610-E618; Altman, D.G., Bland, J.M., How to obtain the P value from a confidence interval (2011) BMJ, 343, pp. d2304},
correspondence_address1={Theodoratou, E.; Centre for Population Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, United Kingdom; email: e.theodoratou@ed.ac.uk},
publisher={BMJ Publishing Group},
issn={17561833},
coden={BMJOA},
pubmed_id={24690624},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Article},
source={Scopus},
}

@ARTICLE{Aromataris2015132,
author={Aromataris, E. and Fernandez, R. and Godfrey, C.M. and Holly, C. and Khalil, H. and Tungpunkom, P.},
title={Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach},
journal={International Journal of Evidence-Based Healthcare},
year={2015},
volume={13},
number={3},
pages={132-140},
doi={10.1097/XEB.0000000000000055},
note={cited By 644},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966269346&doi=10.1097%2fXEB.0000000000000055&partnerID=40&md5=712e9916a619a2d01218466c9cd4b994},
affiliation={The Joanna Briggs Institute, University of Adelaide, Adelaide, SA, Australia; Centre for Research in Nursing and Health, School of Nursing, St George Hospital, University of Wollongong, Sydney, SA, Australia; Queen's Joanna Briggs Collaboration, Queen's University School of Nursing, Kingston, ON, Canada; Northeast Institute for Evidence Synthesis and Translation Rutgers, University School of Nursing, Newark, NJ, United States; School of Rural Health, Monash UniversityVIC, Australia; Thailand Centre for Evidence Based Nursing, Midwifery and Health Science, A Collaborating Centre of JBI, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand},
abstract={Aims: With the increase in the number of systematic reviews available, a logical next step to provide decision makers in healthcare with the evidence they require has been the conduct of reviews of existing systematic reviews. Syntheses of existing systematic reviews are referred to by many different names, one of which is an umbrella review. An umbrella review allows the findings of reviews relevant to a review question to be compared and contrasted. An umbrella review's most characteristic feature is that this type of evidence synthesis only considers for inclusion the highest level of evidence, namely other systematic reviews and meta-analyses. A methodology working group was formed by the Joanna Briggs Institute to develop methodological guidance for the conduct of an umbrella review, including diverse types of evidence, both quantitative and qualitative. The aim of this study is to describe the development and guidance for the conduct of an umbrella review.Methods: Discussion and testing of the elements of methods for the conduct of an umbrella review were held over a 6-month period by members of a methodology working group. The working group comprised six participants who corresponded via teleconference, e-mail and face-to-face meeting during this development period. In October 2013, the methodology was presented in a workshop at the Joanna Briggs Institute Convention. Workshop participants, review authors and methodologists provided further testing, critique and feedback on the proposed methodology.Results: This study describes the methodology and methods developed for the conduct of an umbrella review that includes published systematic reviews and meta-analyses as the analytical unit of the review. Details are provided regarding the essential elements of an umbrella review, including presentation of the review question in a Population, Intervention, Comparator, Outcome format, nuances of the inclusion criteria and search strategy. A critical appraisal tool with 10 questions to help assess risk of bias in systematic reviews and meta-analyses was also developed and tested. Relevant details to extract from included reviews and how to best present the findings of both quantitative and qualitative systematic reviews in a reader friendly format are provided.Conclusions: Umbrella reviews provide a ready means for decision makers in healthcare to gain a clear understanding of a broad topic area. The umbrella review methodology described here is the first to consider reviews that report other than quantitative evidence derived from randomized controlled trials. The methodology includes an easy to use and informative summary of evidence table to readily provide decision makers with the available, highest level of evidence relevant to the question posed. © 2015 University of Adelaide, Joanna Briggs Institute.},
author_keywords={Overview;  Research synthesis;  Review of reviews;  Systematic review;  Umbrella review;  Umbrella review methodology},
keywords={doctor patient relation;  e-mail;  extract;  human;  meta analysis;  nomenclature;  quantitative study;  synthesis;  systematic review;  teleconference;  empirical research;  evidence based medicine;  literature;  meta analysis (topic);  methodology;  organization and management;  practice guideline;  standards;  statistical bias, Bias (Epidemiology);  Empirical Research;  Evidence-Based Medicine;  Guidelines as Topic;  Humans;  Meta-Analysis as Topic;  Research Design;  Review Literature as Topic},
references={Bastian, H., Glasziou, P., Chalmers, I., Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? (2010) PLoS Med, 7; Hartling, L., Chisholm, A., Thomson, D., Dryden, D.M., A descriptive analysis of overviews of reviews published between 2000 and 2011 (2012) PLoS One, 7; Becker, L.A., Oxman, A.D., Chapter 22: overviews of reviews (2011) Cochrane handbook for systematic reviews of interventions, , www.cochrane-handbook.org, Higgins JPT, Green S, editors, Version 5.1.0 (updated March 2011). The Cochrane Collaboration; Smith, V., Devane, D., Begley, C., Clarke, M., Methodology in conducting a systematic review of systematic reviews of healthcare interventions (2011) BMC Med Res Methodol, 11, pp. 15-20; Khangura, S., Konnyu, K., Cushman, R., Grimshaw, J., Moher, M., Evidence summaries: the evolution of a rapid review approach (2012) Syst Rev, 1, pp. 10-18; Worswick, J., Wayne, S.C., Bennett, R., Improving quality of care for persons with diabetes: an overview of systematic reviews: what does the evidence tell us? (2013) Syst Rev, 2, pp. 26-39; Aromataris, E., Pearson, A., The systematic review: an overview (2014) Am J Nurs, 114, pp. 47-55; Aromataris, E., Fernandez, R., Godfrey, C., Holly, C., Kahlil, H., Tungpunkom, P., Methodology for JBI umbrella reviews, , http://joannabriggs.org/assets/docs/sumari/ReviewersManual-Methodology-JBI_Umbrella%20Reviews-2014.pdf, In Joanna Briggs Institute reviewer's manual 2014. The Joanna Briggs Institute, Adelaide; Stern, C., Jordan, Z., McArthur, A., Developing the review question and inclusion criteria (2014) Am J Nurs, 114, pp. 53-56; Grant, M., Booth, A., A typology of reviews: an analysis of 14 review types and associated methodologies (2009) Health Inform Libraries J, 26, pp. 91-108; Aromataris, E., Riitano, D., Systematic reviews: constructing a search strategy and searching for evidence (2014) Am J Nurs, 114, pp. 49-56; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) PLoS Med, 6 (7); Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, pp. 10-16; Whiting, P., Savovic, J., Higgins, J.P.T., ROBIS: a new tool to assess risk of bias in systematic reviews was developed (2015) J Clin Epidemiology; Kynoch, K., Wu, C.J., Chang, A.M., The effectiveness of interventions in the prevention and management of aggressive behaviours in patients admitted to an acute hospital setting (2009) JBI Library Syst Rev, 7, pp. 175-223; Forbes, D., Forbes, S., Morgan, D.G., Markle-Reid, M., Wood, J., Culum, I., Physical activity programs for people with dementia (2008) Cochrane Database Syst Rev, 3; Finfgeld-Connett, D., Management of aggression among demented or brain-injured patients (2009) Clin Nurs Res, 18, pp. 272-287; Munn, Z., Tufanaru, C., Aromataris, E., JBI's systematic reviews: data extraction and synthesis (2014) Am J Nurs, 114, pp. 49-54},
correspondence_address1={Aromataris, E.; University of AdelaideAustralia; email: ed.aromataris@adelaide.edu.au},
publisher={Lippincott Williams and Wilkins},
issn={17441595},
pubmed_id={26360830},
language={English},
abbrev_source_title={Int. J. Evid.-Based Healthc.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Byers2011323,
author={Byers, A.L. and Yaffe, K.},
title={Depression and risk of developing dementia},
journal={Nature Reviews Neurology},
year={2011},
volume={7},
number={6},
pages={323-331},
doi={10.1038/nrneurol.2011.60},
note={cited By 639},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958234542&doi=10.1038%2fnrneurol.2011.60&partnerID=40&md5=89ba534f4a1cee4f3305b03677e80e15},
affiliation={Department of Psychiatry, University of California, San Francisco, San Francisco Veterans Affairs Medical Center, 4150 Clement Street (116H), San Francisco, CA 94121, United States},
abstract={Depression is highly common throughout the life course and dementia is common in late life. Depression has been linked with dementia, and growing evidence implies that the timing of depression may be important in defining the nature of this association. In particular, earlier-life depression (or depressive symptoms) has consistently been associated with a more than twofold increase in dementia risk. By contrast, studies of late-life depression and dementia risk have been conflicting; most support an association, yet the nature of this association (for example, if depression is a prodrome or consequence of, or risk factor for dementia) remains unclear. The likely biological mechanisms linking depression to dementia include vascular disease, alterations in glucocorticoid steroid levels and hippocampal atrophy, increased deposition of amyloid- 2 plaques, inflammatory changes, and deficits of nerve growth factors. Treatment strategies for depression could interfere with these pathways and alter the risk of dementia. Given the projected increase in dementia incidence in the coming decades, understanding whether treatment for depression alone, or combined with other regimens, improves cognition is of critical importance. In this Review, we summarize and analyze current evidence linking late-life and earlier-life depression and dementia, and discuss the primary underlying mechanisms and implications for treatment. © 2011 Macmillan Publishers Limited. All rights reserved.},
keywords={amyloid beta protein[1-40];  amyloid beta protein[1-42];  antidepressant agent;  brain derived neurotrophic factor;  cholinesterase inhibitor;  glucocorticoid;  hydrocortisone;  interleukin 6;  nerve growth factor;  placebo;  tumor necrosis factor, amyloid plaque;  behavior therapy;  brain atrophy;  brain level;  chronic inflammation;  cognitive defect;  combination chemotherapy;  dementia;  depression;  developmental stage;  disease association;  drug efficacy;  hippocampus;  hormone synthesis;  human;  hypothalamus hypophysis adrenal system;  neuropathology;  onset age;  priority journal;  review;  risk factor;  vascular disease, Adult;  Aged;  Dementia;  Depression;  Hippocampus;  Humans;  Hydrocortisone;  Inflammation;  Middle Aged;  Nerve Growth Factors;  Plaque, Amyloid;  Risk;  Risk Factors;  Vascular Diseases},
chemicals_cas={brain derived neurotrophic factor, 218441-99-7; hydrocortisone, 50-23-7; nerve growth factor, 9061-61-4; Hydrocortisone, 50-23-7; Nerve Growth Factors},
funding_details={National Institute of Mental HealthNational Institute of Mental Health, NIMH, K01MH079093, R01MH086498},
funding_details={National Institute on AgingNational Institute on Aging, NIA, K24AG031155},
funding_text 1={This work was supported by the National Institute of Mental Health (grant K01 MH079093 to A. L. Byers and R01 MH086498 to K. Yaffe) and the National Institute on Aging (grant K24 AG031155 to K. Yaffe).},
references={Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication (2005) Archives of General Psychiatry, 62 (6), pp. 593-602. , http://archpsyc.ama-assn.org/cgi/reprint/62/6/593.pdf, DOI 10.1001/archpsyc.62.6.593; Jorm, A.F., Jolley, D., The incidence of dementia: A meta-analysis (1998) Neurology, 51 (3), pp. 728-733; Corrada, M.M., Brookmeyer, R., Berlau, D., Paganini-Hill, A., Kawas, C.H., Prevalence of dementia after age 90: Results from the 90+ study (2008) Neurology, 71, pp. 337-343; Yaffe, K., Mild cognitive impairment, dementia and subtypes among oldest old women Arch. Neurol., , in press; (2008) An Older and More Diverse Nation by Mid-century, , http://www.census.gov/newsroom/releases/archives/population/cb08-123.html, US Census Bureau Newsroom US Census Bureau [online]; Park, J.H., Lee, S.B., Lee, T.J., Lee, D.Y., Jhoo, J.H., Youn, J.C., Choo, I.H., Kim, K.W., Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease (2007) Dementia and Geriatric Cognitive Disorders, 23 (2), pp. 67-73. , DOI 10.1159/000097039; Ballard, C., Bannister, C., Solis, M., Oyebode, F., Wilcock, G., The prevalence, associations and symptoms of depression amongst dementia sufferers (1996) Journal of Affective Disorders, 36 (3), pp. 135-144. , DOI 10.1016/0165-0327(95)00072-0; Ballard, C., (2000) Anxiety, Depression and Psychosis in Vascular Dementia: Prevalence and Associations. J. Affect. Disord., 59, pp. 97-106; Steffens, D.C., Potter, G.G., Geriatric depression and cognitive impairment (2008) Psychological Medicine, 38 (2), pp. 163-175. , DOI 10.1017/S003329170700102X, PII S003329170700102X; Korczyn, A.D., Halperin, I., Depression and dementia (2009) J. Neurol. Sci., 283, pp. 139-142; Caraci, F., Copani, A., Nicoletti, F., Drago, F., Depression and Alzheimers disease: Neurobiological links and common pharmacological targets (2010) Eur. J. Pharmacol., 626, pp. 64-71; Saczynski, J.S., Depressive symptoms and risk of dementia: The Framingham Heart Study (2010) Neurology, 75, pp. 35-41; Andersen, K., Lolk, A., Kragh-Sorensen, P., Petersen, N.E., Green, A., Depression and the risk of Alzheimer disease (2005) Epidemiology, 16 (2), pp. 233-238. , DOI 10.1097/01.ede.0000152116.32580.24; Gatz, J.L., Tyas, S.L., John, P.S., Montgomery, P., Do depressive symptoms predict Alzheimer's disease and dementia? (2005) Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 60 (6), pp. 744-747; Chen, R., Severity of depression and risk for subsequent dementia: Cohort studies in China and the UK (2008) Br. J. Psychiatry, 193, pp. 373-377; Byers, A.L., Covinsky, K.E., Barnes, D.E., Dysthymia, Y.K., And depression increase risk of dementia and mortality among older veterans Am. J. Geriatr. Psychiatry, , in press; Hebert, R., Lindsay, J., Verreault, R., Rockwood, K., Hill, G., Dubois, M.-F., Vascular dementia: Incidence and risk factors in the canadian study of health and aging (2000) Stroke, 31 (7), pp. 1487-1493; Wilson, R.S., Barnes, L.L., Mendes De Leon, C.F., Aggarwal, N.T., Schneider, J.S., Bach, J., Pilat, J., Bennett, D.A., Depressive symptoms, cognitive decline, and risk of AD in older persons (2002) Neurology, 59 (3), pp. 364-370; Fuhrer, R., Dufouil, C., Dartigues, J.F., Exploring sex differences in the relationship between depressive symptoms and dementia incidence: Prospective results from the PAQUID study (2003) Journal of the American Geriatrics Society, 51 (8), pp. 1055-1063. , DOI 10.1046/j.1532-5415.2003.51352.x; Irie, F., Apolipoprotein e ε4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: The Honolulu-Asia Aging Study (2008) Arch. Gen. Psychiatry, 65, pp. 906-912; Geerlings, M.I., Depressive symptoms and risk of Alzheimers disease in more highly educated older people (2000) J. Am. Geriatr. Soc., 48, pp. 1092-1097; Becker, J.T., Depressed mood is not a risk factor for incident dementia in a community-based cohort (2009) Am. J. Geriatr. Psychiatry, 17, pp. 653-663; Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G.B., McDowell, I., Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging (2002) American Journal of Epidemiology, 156 (5), pp. 445-453. , DOI 10.1093/aje/kwf074; Cankurtaran, M., Yavuz, B.B., Cankurtaran, E.S., Halil, M., Ulger, Z., Ariogul, S., Risk factors and type of dementia: Vascular or Alzheimer? (2008) Archives of Gerontology and Geriatrics, 47 (1), pp. 25-34. , DOI 10.1016/j.archger.2007.06.005, PII S0167494307001422; Zalsman, G., Aizenberg, D., Sigler, M., Nahshony, E., Karp, L., Weizman, A., Increased risk for dementia in elderly psychiatric inpatients with late- onset major depression (2000) Journal of Nervous and Mental Disease, 188 (4), pp. 242-243. , DOI 10.1097/00005053-200004000-00010; Jorm, A.F., History of depression as a risk factor for dementia: An updated review (2001) Australian and New Zealand Journal of Psychiatry, 35 (6), pp. 776-781. , DOI 10.1046/j.1440-1614.2001.00967.x; Ownby, R.L., Depression and risk for Alzheimer Disease: Systematic review, meta-analysis, and metaregression analysis (2006) Arch. Gen. Psychiatry, 63, pp. 530-538; Geerlings, M.I., Den Heijer, T., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease (2008) Neurology, 70 (15), pp. 1258-1264. , DOI 10.1212/01.wnl.0000308937.30473.d1, PII 0000611420080408000008; Dal Forno, G., Palermo, M.T., Donohue, J.E., Karagiozis, H., Zonderman, A.B., Kawas, C.H., Depressive symptoms, sex, and risk for Alzheimer's disease (2005) Annals of Neurology, 57 (3), pp. 381-387. , DOI 10.1002/ana.20405; Dotson, V.M., Beydoun, M.A., Zonderman, A.B., Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment (2010) Neurology, 75, pp. 27-34; Barnes, D.E., Mid-life versus late-life depression and risk of dementia: Differential effects for vascular dementia and Alzheimers disease [abstract] (2010) Alzheimers Dement., 6 (SUPPL. 1), pp. S109; Green, R.C., Cupples, L.A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Farrer, L., Depression as a risk factor for Alzheimer disease: The MIRAGE Study (2003) Archives of Neurology, 60 (5), pp. 753-759. , DOI 10.1001/archneur.60.5.753; Alexopoulos, G.S., Vascular depression hypothesis (1997) Arch. Gen. Psychiatry, 54, pp. 915-922; Krishnan, K.R.R., Hays, J.C., Blazer, D.G., MRI-defined vascular depression (1997) Am. J. Psychiatry, 154, pp. 497-500; Alexopoulos, G.S., Depression in the elderly (2005) Lancet, 365 (9475), pp. 1961-1970. , DOI 10.1016/S0140-6736(05)66665-2, PII S0140673605666652; Alexopoulos, G.S., Vascular disease, depression, and dementia (2003) Journal of the American Geriatrics Society, 51 (8), pp. 1178-1180. , DOI 10.1046/j.1532-5415.2003.51373.x; Camus, V., Kraehenbuhl, H., Preisig, M., Bula, C.J., Waeber, G., Geriatric depression and vascular diseases: What are the links? (2004) Journal of Affective Disorders, 81 (1), pp. 1-16. , DOI 10.1016/j.jad.2003.08.003, PII S0165032703002052; Rao, R., Cerebrovascular disease and late life depression: An age old association revisited (2000) International Journal of Geriatric Psychiatry, 15 (5), pp. 419-433. , DOI 10.1002/(SICI)1099-1166(200005)15:5<419::AID-GPS140>3.0.CO;2-9; De Groot, J.C., Cerebral white matter lesions and depressive symptoms in elderly adults (2000) Arch. Gen. Psychiatry, 57, pp. 1071-1076; Thomas, A.J., Perry, R., Barber, R., Kalaria, R.N., O'Brien, J.T., Pathologies and pathological mechanisms for white matter hyperintensities in depression (2002) Annals of the New York Academy of Sciences, 977, pp. 333-339; Thomas, A.J., Kalaria, R.N., Obrien, J.T., (2004) Depression and Vascular Disease: What Is the Relationship? J. Affect. Disord., 79, pp. 81-95; Butters, M.A., Pathways linking late-life depression to persistent cognitive impairment and dementia (2008) Dialogues Clin. Neurosci., 10, pp. 345-357; Liebetrau, M., Steen, B., Skoog, I., Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds (2008) Stroke, 39, pp. 1960-1965; Herrmann, L.L., Le Masurier, M., Ebmeier, K.P., White matter hyperintensities in late life depression: A systematic review (2008) Journal of Neurology, Neurosurgery and Psychiatry, 79 (6), pp. 619-624. , DOI 10.1136/jnnp.2007.124651; Steffens, D.C., Krishnan, K.R.R., Crump, C., Burke, G.L., Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study (2002) Stroke, 33 (6), pp. 1636-1644. , DOI 10.1161/01.STR.0000018405.59799.D5; Teodorczuk, A., O'Brien, J.T., Firbank, M.J., Pantoni, L., Poggesi, A., Erkinjuntti, T., Wallin, A., Inzitari, D., White matter changes and late-life depressive symptoms: Longitudinal study (2007) British Journal of Psychiatry, 191 (9), pp. 212-217. , DOI 10.1192/bjp.bp.107.036756; Flicker, L., Vascular factors in geriatric psychiatry: Time to take a serious look (2008) Curr. Opin. Psychiatry, 21, pp. 551-554; Flicker, L., Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging (2010) Clin. Geriatr. Med., 26, pp. 17-27; Alexopoulos, G.S., The vascular depression hypothesis: 10 years later (2006) Biological Psychiatry, 60 (12), pp. 1304-1305. , DOI 10.1016/j.biopsych.2006.09.006, PII S0006322306011103; Sheline, Y.I., Price, J.L., Vaishnavi, S.N., Mintun, M.A., Barch, D.M., Epstein, A.A., Wilkins, C.H., McKinstry, R.C., Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors (2008) American Journal of Psychiatry, 165 (4), pp. 524-532. , http://ajp.psychiatryonline.org/cgi/reprint/165/4/524, DOI 10.1176/appi.ajp.2007.07010175; Sapolsky, R.M., Krey, L.C., McEwen, B.S., The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis (1986) Endocr. Rev., 7, pp. 284-301; Sierksma, A.S., Van Den Hove, D.L., Steinbusch, H.W., Prickaerts, J., Major depression, cognitive dysfunction and Alzheimers disease: Is there a link? (2010) Eur. J. Pharmacol., 626, pp. 72-82; Wolkowitz, O.M., Epel, E.S., Reus, V.I., Mellon, S.H., Depression gets old fast: Do stress and depression accelerate cell aging? (2010) Depress. Anxiety, 27, pp. 327-338; Rothman, S.M., Mattson, M.P., Adverse stress, hippocampal networks, and Alzheimers disease (2010) Neuromolecular Med., 12, pp. 56-70; Van De Pol, L.A., Hensel, A., Barkhof, F., Gertz, H.J., Scheltens, P., Van Der Flier, W.M., Hippocampal atrophy in Alzheimer disease: Age matters (2006) Neurology, 66 (2), pp. 236-238. , DOI 10.1212/01.wnl.0000194240.47892.4d, PII 0000611420060124000020; O'Brien, J.T., Lloyd, A., McKeith, I., Gholkar, A., Ferrier, N., A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects (2004) American Journal of Psychiatry, 161 (11), pp. 2081-2090. , DOI 10.1176/appi.ajp.161.11.2081; Videbech, P., Ravnkilde, B., Hippocampal volume and depression: A meta-analysis of MRI studies (2004) American Journal of Psychiatry, 161 (11), pp. 1957-1966. , DOI 10.1176/appi.ajp.161.11.1957; Colla, M., Kronenberg, G., Deuschle, M., Meichel, K., Hagen, T., Bohrer, M., Heuser, I., Hippocampal volume reduction and HPA-system activity in major depression (2007) Journal of Psychiatric Research, 41 (7), pp. 553-560. , DOI 10.1016/j.jpsychires.2006.06.011, PII S002239560600121X; Cereseto, M., Reines, A., Ferrero, A., Sifonios, L., Rubio, M., Wikinski, S., Chronic treatment with high doses of corticosterone decreases cytoskeletal proteins in the rat hippocampus (2006) European Journal of Neuroscience, 24 (12), pp. 3354-3364. , DOI 10.1111/j.1460-9568.2006.05232.x; Park, C.R., Zoladz, P.R., Conrad, C.D., Fleshner, M., Diamond, D.M., Acute predator stress impairs the consolidation and retrieval of hippocampus-dependent memory in male and female rats (2008) Learning and Memory, 15 (4), pp. 271-280. , http://www.learnmem.org/cgi/reprint/15/4/271, DOI 10.1101/lm.721108; Kim, J.J., Song, E.Y., Kosten, T.A., Stress effects in the hippocampus: Synaptic plasticity and memory (2006) Stress, 9 (1), pp. 1-11. , DOI 10.1080/10253890600678004, PII H6488351251672; Pittenger, C., Duman, R.S., Stress, depression, and neuroplasticity: A convergence of mechanisms (2008) Neuropsychopharmacology, 33 (1), pp. 88-109. , DOI 10.1038/sj.npp.1301574, PII 1301574; Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Poulton, R., Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene (2003) Science, 301 (5631), pp. 386-389. , DOI 10.1126/science.1083968; Charney, D.S., Manji, H.K., Life stress genes and depression: Multiple pathways lead to increased risk and new opportunities for intervention (2004) Sci. STKE, 225, pp. re5; Wolkowitz, O.M., Burke, H., Epel, E.S., Reus, V.I., Glucocorticoids. Mood, memory, and mechanisms (2009) Ann. NY Acad. Sci., (1179), pp. 19-40; Swaab, D.F., Bao, A.-M., Lucassen, P.J., The stress system in the human brain in depression and neurodegeneration (2005) Ageing Research Reviews, 4 (2), pp. 141-194. , DOI 10.1016/j.arr.2005.03.003, PII S1568163705000048, Stress, Neuropeptides and Age-Related Diseases; Hickie, I., Naismith, S., Ward, P.B., Turner, K., Scott, E., Mitchell, P., Wilhelm, K., Parker, G., Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression (2005) British Journal of Psychiatry, 186 (MAR.), pp. 197-202. , DOI 10.1192/bjp.186.3.197; Steffens, D.C., McQuoid, D.R., Payne, M.E., Potter, G.G., Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study (2011) Am. J. Geriatr. Psychiatry, 19, pp. 4-12; Steffens, D.C., Payne, M.E., Greenberg, D.L., Byrum, C.E., Welsh-Bohmer, K.A., Wagner, H.R., MacFall, J.R., Hippocampal volume and incident dementia in geriatric depression (2002) American Journal of Geriatric Psychiatry, 10 (1), pp. 62-71. , DOI 10.1176/appi.ajgp.10.1.62; Hastings, R.S., Parsey, R.V., Oquendo, M.A., Arango, V., Mann, J.J., Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression (2004) Neuropsychopharmacology, 29 (5), pp. 952-959. , DOI 10.1038/sj.npp.1300371; Sheline, Y.I., Gado, M.H., Kraemer, H.C., Untreated depression and hippocampal volume loss (2003) American Journal of Psychiatry, 160 (8), pp. 1516-1518. , DOI 10.1176/appi.ajp.160.8.1516; MacQueen, G.M., Campbell, S., McEwen, B.S., Macdonald, K., Amano, S., Joffe, R.T., Nahmias, C., Trevor Young, L., Course of illness, hippocampal function, and hippocampal volume in major depression (2003) Proceedings of the National Academy of Sciences of the United States of America, 100 (3), pp. 1387-1392. , DOI 10.1073/pnas.0337481100; Maes, M., The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression (2009) Metab. Brain Dis., 24, pp. 27-53; Knable, M.B., Barci, B.M., Webster, M.J., Meador-Woodruff, J., Torrey, E.F., Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium (2004) Molecular Psychiatry, 9 (6), pp. 609-620. , DOI 10.1038/sj.mp.4001471; Karege, F., Vaudan, G., Schwald, M., Perroud, N., La Harpe, R., Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs (2005) Molecular Brain Research, 136 (1-2), pp. 29-37. , DOI 10.1016/j.molbrainres.2004.12.020, PII S0169328X04006345; Morishima-Kawashima, M., Ihara, Y., Alzheimer's disease: β-Amyloid protein and tau (2002) Journal of Neuroscience Research, 70 (3), pp. 392-401. , DOI 10.1002/jnr.10355; Rapp, M.A., Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression (2008) Am. J. Geriatr. Psychiatry, 16, pp. 168-174; Rapp, M.A., Schnaider-Beeri, M., Grossman, H.T., Sano, M., Perl, D.P., Purohit, D.P., Gorman, J.M., Haroutunian, V., Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression (2006) Archives of General Psychiatry, 63 (2), pp. 161-167. , http://archpsyc.ama-assn.org/cgi/reprint/63/2/161, DOI 10.1001/archpsyc.63.2.161; Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics (2002) Science, 297 (5580), pp. 353-356. , DOI 10.1126/science.1072994; Leinonen, V., Amyloid and tau proteins in cortical brain biopsy and Alzheimers disease (2010) Ann. Neurol., 68, pp. 446-453; Green, K.N., Billings, L.M., Roozendaal, B., McGaugh, J.L., LaFerla, F.M., Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease (2006) Journal of Neuroscience, 26 (35), pp. 9047-9056. , http://www.jneurosci.org/cgi/reprint/26/35/9047.pdf, DOI 10.1523/JNEUROSCI.2797-06.2006; Cho, S., Hu, Y., Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival (2007) Experimental Neurology, 203 (1), pp. 274-278. , DOI 10.1016/j.expneurol.2006.07.021, PII S0014488606004419; Lezoualch, F., 5-HT4 receptor and Alzheimers disease: The amyloid connection (2007) Exp. Neurol., 205, pp. 325-329; Sun, X., Steffens, D.C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Wei, Q.Q., Amyloid-associated depression: A prodromal depression of Alzheimer disease? (2008) Archives of General Psychiatry, 65 (5), pp. 542-550. , http://archpsyc.ama-assn.org/cgi/reprint/65/5/542, DOI 10.1001/archpsyc.65.5.542; Leonard, B.E., Inflammation, depression and dementia: Are they connected? (2007) Neurochemical Research, 32 (10), pp. 1749-1756. , DOI 10.1007/s11064-007-9385-y; Rojo, L.E., Fernandez, J.A., Maccioni, A.A., Jimenez, J.M., Maccioni, R.B., Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease (2008) Archives of Medical Research, 39 (1), pp. 1-16. , DOI 10.1016/j.arcmed.2007.10.001, PII S0188440907003268; Sorrells, S.F., Sapolsky, R.M., An inflammatory review of glucocorticoid actions in the CNS (2007) Brain, Behavior, and Immunity, 21 (3), pp. 259-272. , DOI 10.1016/j.bbi.2006.11.006, PII S088915910600359X; Yaffe, K., Lindquist, K., Penninx, Simonsick, E.M., Pahor, M., Kritchevsky, S., Launer, L., Harris, T., Inflammatory markers and cognition in well-functioning African-American and white elders (2003) Neurology, 61 (1), pp. 76-80; MacCioni, R.B., Rojo, L.E., Fernández, J.A., Kuljis, R.O., The role of neuroimmunomodulation in Alzheimers disease (2009) Ann. NY Acad. Sci., 1153, pp. 240-246; Okello, A., Microglial activation and amyloid deposition in mild cognitive impairment: A PET study (2009) Neurology, 72, pp. 56-62; Streit, W.J., Braak, H., Xue, Q.S., Dystrophic, B.I., Rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimers disease (2009) Acta Neuropathol., 118, pp. 475-485; Fumagalli, F., Neurotrophic factors in neurodegenerative disorders: Potential for therapy (2008) CNS Drugs, 22, pp. 1005-1019; Krishnan, V., Nestler, E.J., The molecular neurobiology of depression (2008) Nature, 455, pp. 894-902; Angelucci, F., Brenè, S., Mathé, A.A., BDNF in schizophrenia, depression and corresponding animal models (2005) Mol. Psychiatry, 10, pp. 345-352; Murer, M.G., Yan, Q., Raisman-Vozari, R., Brain-derived neurotrophic factor in the control human brain, and in Alzheimers disease and Parkinsons disease (2001) Prog. Neurobiol., 63, pp. 71-124; Cotman, C.W., The role of neurotrophins in brain aging: A perspective in honor of Regino Perez-Polo (2005) Neurochemical Research, 30 (6-7), pp. 877-881. , DOI 10.1007/s11064-005-6960-y; Benjamin, S., The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression (2010) Am. J. Geriatr. Psychiatry, 18, pp. 323-331; Jessen, F., No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression (2009) Psychiatr. Genet., 19, pp. 99-101; Cotman, C.W., Berchtold, N.C., Christie, L.-A., Exercise builds brain health: key roles of growth factor cascades and inflammation (2007) Trends in Neurosciences, 30 (9), pp. 464-472. , DOI 10.1016/j.tins.2007.06.011, PII S0166223607001786; (2010) World Alzheimer Report 2010: The Global Economic Impact of Dementia, , http://www.alz.org/news_and_events_world_alzheimers_day.asp, Alzheimers Disease International Alzheimers Association-World Alzheimers Day [online]; Herrera-Guzman, I., Effects of selective serotonin reuptake and dual serotonergic- noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder (2009) J. Psychiatr. Res., 43, pp. 855-863; Mowla, A., Mosavinasab, M., Pani, A., Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment?: A double-blind, placebo-controlled, clinical trial (2007) Journal of Clinical Psychopharmacology, 27 (1), pp. 67-70. , DOI 10.1097/JCP.0b013e31802e0002, PII 0000471420070200000013; Doraiswamy, P.M., Does antidepressant therapy improve cognition in elderly depressed patients? (2003) Gerontol. A Biol. Sci. Med. Sci., 58, pp. M1137-M1144; Areán, P.A., Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction (2010) Am. J. Psychiatry, 167, pp. 1391-1398; Hashioka, S., McGeer, P.L., Monji, A., Kanba, S., Anti-inflammatory effects of antidepressants: Possibilities for preventives against Alzheimers disease (2009) Cent. Nerv. Syst. Agents Med. Chem., 9, pp. 12-19; Groves, J.O., Is it time to reassess the BDNF hypothesis of depression? (2007) Molecular Psychiatry, 12 (12), pp. 1079-1088. , DOI 10.1038/sj.mp.4002075, PII 4002075; Hashimoto, K., Shimizu, E., Iyo, M., Critical role of brain-derived neurotrophic factor in mood disorders (2004) Brain Research Reviews, 45 (2), pp. 104-114. , DOI 10.1016/j.brainresrev.2004.02.003, PII S0165017304000189; Nebes, R.D., Pollock, B.G., Houck, P.R., Butters, M.A., Mulsant, B.H., Zmuda, M.D., Reynolds III, C.F., Persistence of cognitive impairment in geriatric patients following antidepressant treatment: A randomized, double-blind clinical trial with nortriptyline and paroxetine (2003) Journal of Psychiatric Research, 37 (2), pp. 99-108. , DOI 10.1016/S0022-3956(02)00085-7, PII S0022395602000857; Bhalla, R.K., Persistence of neuropsychologic deficits in the remitted state of late-life depression (2006) Am. J. Geriatr. Psychiatry, 14, pp. 419-427; Devanand, D.P., Pelton, G.H., Marston, K., Camacho, Y., Roose, S.P., Stern, Y., Sackeim, H.A., Sertraline treatment of elderly patients with depression and cognitive impairment (2003) International Journal of Geriatric Psychiatry, 18 (2), pp. 123-130. , DOI 10.1002/gps.802; Modrego, P.J., Ferrandez, J., Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study (2004) Archives of Neurology, 61 (8), pp. 1290-1293. , DOI 10.1001/archneur.61.8.1290; Pelton, G.H., Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: A pilot study (2008) Int. J. Geriatr. Psychiatry, 23, pp. 670-676; Bragin, V., Chemodanova, M., Dzhafarova, N., Bragin, I., Czerniawski, J.L., Aliev, G., Integrated treatment approach improves cognitive function in demented and clinically depressed patients (2005) American Journal of Alzheimer's Disease and other Dementias, 20 (1), pp. 21-26; Lyketsos, C.G., Lee, H.B., Diagnosis and treatment of depression in Alzheimer's disease: A practical update for the clinician (2004) Dementia and Geriatric Cognitive Disorders, 17 (1-2), pp. 55-64. , DOI 10.1159/000074277; Lyketsos, C.G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C.D., Munro, C., Baker, A.S., Rabins, P.V., Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS (2003) Archives of General Psychiatry, 60 (7), pp. 737-746. , DOI 10.1001/archpsyc.60.7.737; Bains, J., Birks, J.S., Dening, T.R., The efficacy of antidepressants in the treatment of depression in dementia (2002) Cochrane Database of Systematic Reviews, , Issue 4 Art. No.: CD003944. doi:10.1002/14651858.CD003944; Weintraub, D., Sertraline for the treatment of depression in Alzheimer disease: Week-24 outcomes (2010) Am. J. Geriatr. Psychiatry, 18, pp. 332-340; Rosenberg, P.B., Sertraline for the treatment of depression in Alzheimer disease (2010) Am. J. Geriatr Psychiatry, 18, pp. 136-145; Zweig, R.M., The neuropathology of aminergic nuclei in Alzheimers disease (1988) Ann. Neurol., 24, pp. 233-242; Zubenko, G.S., Biological correlates of clinical heterogeneity in primary dementia (1992) Neuropsychopharmacology, 6, pp. 77-93; Forstl, H., Burns, A., Luthert, P., Cairns, N., Lantos, P., Levy, R., Clinical and neuropathological correlates of depression in Alzheimer's disease (1992) Psychological Medicine, 22 (4), pp. 877-884; Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., Forecasting the global burden of Alzheimer's disease (2007) Alzheimer's and Dementia, 3 (3), pp. 186-191. , DOI 10.1016/j.jalz.2007.04.381, PII S155252600700475X; Copeland, J.R.M., Dewey, M.E., Griffiths-Jones, H.M., Dementia and depression in elderly persons: Agecat compared with DSM III and pervasive illness (1990) International Journal of Geriatric Psychiatry, 5 (1), pp. 47-51; Radloff, L.S., The CES-D scale: A self-report depression scale for research in the general population (1977) Appl. Psycho. Meas., 1, pp. 385-401; (1994) Diagnostic and Statistical Manual of Mental Disorders, , American Psychiatric Association 4th edn (American Psychiatric Association, Washington, DC); Yesavage, J.A., Brink, T.L., Rose, T.L., Development and validation of a geriatric depression screening scale: A preliminary report (1982) Journal of Psychiatric Research, 17 (1), pp. 37-49. , DOI 10.1016/0022-3956(82)90033-4; Hooijer, C., A standardized interview for the elderly (GMS): Reliability studies comparing the Dutch language version with the original (1991) Int. J. Geriatr. Psychiatry, 6, pp. 71-79; Copeland, J.R., The Geriatric Mental State Examination in the 21st century (2002) Int. J. Geriatr. Psychiatry, 17, pp. 729-732},
correspondence_address1={Byers, A. L.; Department of Psychiatry, 4150 Clement Street (116H), San Francisco, CA 94121, United States; email: amy.byers@ucsf.edu},
issn={17594758},
pubmed_id={21537355},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Beach2010689,
author={Beach, T.G. and Adler, C.H. and Sue, L.I. and Vedders, L. and Lue, L.F. and White III, C.L. and Akiyama, H. and Caviness, J.N. and Shill, H.A. and Sabbagh, M.N. and Walker, D.G.},
title={Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders},
journal={Acta Neuropathologica},
year={2010},
volume={119},
number={6},
pages={689-702},
doi={10.1007/s00401-010-0664-3},
note={cited By 620},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953021942&doi=10.1007%2fs00401-010-0664-3&partnerID=40&md5=07ccd034004465410fee18ecefb55936},
affiliation={Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, United States; Mayo Clinic, Scottsdale, AZ, United States; University of Texas, Southwestern Medical Center, Dallas, TX, United States; Tokyo Institute of Psychiatry, Tokyo, Japan},
abstract={A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated α-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest. © Springer-Verlag 2010.},
author_keywords={α-synuclein;  Adrenal gland;  Alzheimer's disease;  Autonomic nervous system;  Dementia with lewy bodies;  Enteric nervous system;  Esophagus;  Gastrointestinal system;  Heart;  Incidental lewy bodies;  Parkinson's disease;  Parkinsonism;  Peripheral nervous system;  Spinal cord;  Stomach;  Submandibular gland;  Sympathetic nervous system},
keywords={alpha synuclein, adrenal gland;  aged;  Alzheimer disease;  article;  brain region;  brain stem;  colon;  controlled study;  diffuse Lewy body disease;  endocrine gland;  esophagus;  female;  gastrointestinal tract;  histopathology;  human;  human tissue;  immunohistochemistry;  major clinical study;  male;  myenteric plexus;  pancreas;  Parkinson disease;  perikaryon;  priority journal;  protein phosphorylation;  rectum;  spinal cord;  submandibular gland;  sympathetic ganglion;  tissue distribution;  tissue section;  tissue types;  vagus nerve, Aged;  Aged, 80 and over;  alpha-Synuclein;  Alzheimer Disease;  Brain;  Female;  Ganglia, Sympathetic;  Gastrointestinal Tract;  Humans;  Immunohistochemistry;  Lewy Body Disease;  Male;  Parkinson Disease;  Peripheral Nervous System;  Phosphorylation;  Spinal Cord},
chemicals_cas={alpha synuclein, 154040-18-3; alpha-Synuclein},
funding_details={National Institute on AgingNational Institute on Aging, NIA, P30AG019610},
funding_details={Michael J. Fox Foundation for Parkinson's ResearchMichael J. Fox Foundation for Parkinson's Research, MJFF},
funding_details={Arizona Biomedical Research CommissionArizona Biomedical Research Commission, ABRC, 0011, 05-901, 4001},
funding_details={Japan Society for the Promotion of ScienceJapan Society for the Promotion of Science, JSPS, 21591536},
funding_text 1={Acknowledgments This research is supported by Grants to the Sun Health Research Institute Brain and Body Donation Program and the Arizona Parkinson’s Disease Consortium by the Michael J. Fox Foundation for Parkinson’s Research (The Prescott Family Initiative), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901) and the National Institute on Aging (Arizona Alzheimer’s Disease Consortium, P30 AG19610). We would like to thank other members of the Arizona Parkinson’s Disease Consortium, including Erika Driver-Dunckley, MD, Virgilio Evidente, MD, and Donald Connor, PhD.},
references={(1997) Consensus Recommendations for the Postmortem Diagnosis of Alzheimer's Disease, 18, pp. S1-S2. , The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Neurobiol Aging; Abbott, R.D., Petrovitch, H., White, L.R., Masaki, K.H., Tanner, C.M., Curb, J.D., Grandinetti, A., Ross, G.W., Frequency of bowel movements and the future risk of Parkinson's disease (2001) Neurology, 57, pp. 456-462; Abbott, R.D., Ross, G.W., Petrovitch, H., Tanner, C.M., Davis, D.G., Masaki, K.H., Launer, L.J., White, L.R., Bowelmovement frequency in late-life and incidental Lewy bodies (2007) Mov Disord; Adler, C.H., Nonmotor complications in Parkinson's disease (2005) Mov Disord, 20 (SUPPL. 11), pp. S23-S29; Adler, C.H., Hentz, J.G., Joyce, J.N., Beach, T., Caviness, J.N., Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: Longitudinal evaluation of a cohort of prospective brain donors (2002) Parkinsonism Relat Disord, 9, pp. 103-110; Bagheri, H., Damase-Michel, C., Lapeyre-Mestre, M., Cismondo, S., O'Connell, D., Senard, J.M., Rascol, O., Montastruc, J.L., A study of salivary secretion in Parkinson's disease (1999) Clin Neuropharmacol, 22, pp. 213-215; Bateson, M.C., Gibberd, F.B., Wilson, R.S., Salivary symptoms in Parkinson disease (1973) Arch Neurol, 29, pp. 274-275; Beach, T.G., Adler, C.H., Lue, L., Sue, L.I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Walker, D.G., Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009) Acta Neuropathol, 117, pp. 613-634; Beach, T.G., Sue, L.I., Walker, D.G., Roher, A.E., Lue, L., Vedders, L., Connor, D.J., Rogers, J., The sun health research institute brain donation program: Description and experience, 1987-2007 (2008) Cell Tissue Bank, 9, pp. 229-245; Beach, T.G., White, C.L., Hamilton, R.L., Duda, J.E., Iwatsubo, T., Dickson, D.W., Roncaroli, F., Adler, C.H., Evaluation of alpha-synuclein immunohistochemical methods used by invited experts (2008) Acta Neuropathol, 116, pp. 277-288; Beach, T.G., White III, C.L., Hladik, C.L., Sabbagh, M.N., Connor, D.J., Shill, H.A., Sue, L.I., Adler, C.H., Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders (2009) Acta Neuropathol, 117, pp. 169-174; Bloch, A., Probst, A., Bissig, H., Adams, H., Tolnay, M., Alphasynuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects (2006) Neuropathol Appl Neurobiol, 32, pp. 284-295; Bouras, C., Hof, P.R., Giannakopoulos, P., Michel, J.P., Morrison, J.H., Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital (1994) Cereb Cortex, 4, pp. 138-150; Braak, H., Bohl, J.R., Muller, C.M., Rub, U., De Vos, R.A., Del Tredici, K., Stanley fahn lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered (2006) Mov Disord, 21, pp. 2042-2051; Braak, H., Braak, E., Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections (1991) Brain Pathol, 1, pp. 213-216; Braak, H., Braak, E., Neuropathological stageing of Alzheimer- related changes (1991) Acta Neuropathol (Berl), 82, pp. 239-259; Braak, H., De Vos, R.A., Bohl, J., Del Tredici, K., Gastric alphasynuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology (2006) Neurosci Lett, 396, pp. 67-72; Braak, H., Del Tredici, K., Invited Article: Nervous system pathology in sporadic Parkinson disease (2008) Neurology, 70, pp. 1916-1925; Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H., Del Tredici, K., Stages in the development of Parkinson's disease-related pathology (2004) Cell Tissue Res, 318, pp. 121-134; Braak, H., Rub, U., Gai, W.P., Del Tredici, K., Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen (2003) J Neural Transm, 110, pp. 517-536; Braak, H., Sastre, M., Bohl, J.R., De Vos, R.A., Del Tredici, K., Parkinson's disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons (2007) Acta Neuropathol, 113, pp. 421-429; Brait, K., Fahn, S., Schwarz, G.A., Sporadic and familial parkinsonism and motor neuron disease (1973) Neurology, 23, pp. 990-1002; Caviness, J.N., Smith, B.E., Clarke, S.J., Adler, C.H., Caselli, R.J., Hentz, J.G., Manfred, M.S., Muenter, D., Motor unit number estimates in idiopathic Parkinson's disease (2002) Parkinsonism Relat Disord, 8, pp. 161-164; Caviness, J.N., Smith, B.E., Stevens, J.C., Adler, C.H., Caselli, R.J., Reiners, C.A., Hentz, J.G., Muenter, M.D., Motor unit changes in sporadic idiopathic Parkinson's disease (2000) Mov Disord, 15, pp. 238-243; Christensen, J., Stiles, M.J., Rick, G.A., Sutherland, J., Comparative anatomy of the myenteric plexus of the distal colon in eight mammals (1984) Gastroenterology, 86, pp. 706-713; Danzer, K.M., Haasen, D., Karow, A.R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Kostka, M., Different species of alpha-synuclein oligomers induce calcium influx and seeding (2007) J Neurosci, 27, pp. 9220-9232; Danzer, K.M., Krebs, S.K., Wolff, M., Birk, G., Hengerer, B., Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology (2009) J Neurochem, 111, pp. 192-203; Del Tredici, K., Rub, U., De Vos, R.A., Bohl, J.R., Braak, H., Where does parkinson disease pathology begin in the brain? (2002) J Neuropathol Exp Neurol, 61, pp. 413-426; Den Hartog Jager, W.A., Bethlem, J., The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans (1960) J Neurol Neurosurg Psychiatry, 23, pp. 283-290; Desplats, P., Lee, H.J., Bae, E.J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Lee, S.J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein (2009) Proc Natl Acad Sci USA, 106, pp. 13010-13015; Duda, J.E., Giasson, B.I., Mabon, M.E., Lee, V.M., Trojanowski, J.Q., Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases (2002) Ann Neurol, 52, pp. 205-210; Edwards, L.L., Quigley, E.M., Harned, R.K., Hofman, R., Pfeiffer, R.F., Characterization of swallowing and defecation in Parkinson's disease (1994) Am J Gastroenterol, 89, pp. 15-25; Fujishiro, H., Tsuboi, Y., Lin, W.L., Uchikado, H., Dickson, D.W., Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies (2008) Acta Neuropathol, 116, pp. 17-24; Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., Shen, J., Iwatsubo, T., Alpha-synuclein is phosphorylated in synucleinopathy lesions (2002) Nat Cell Biol, 4, pp. 160-164; Fumimura, Y., Ikemura, M., Saito, Y., Sengoku, R., Kanemaru, K., Sawabe, M., Arai, T., Murayama, S., Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease (2007) J Neuropathol Exp Neurol, 66, pp. 354-362; Gelb, D.J., Oliver, E., Gilman, S., Diagnostic criteria for Parkinson disease (1999) Arch Neurol, 56, pp. 33-39; Giasson, B.I., Duda, J.E., Forman, M.S., Lee, V.M., Trojanowski, J.Q., Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons (2001) Exp Neurol, 172, pp. 354-362; Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: A dual-hit hypothesis (2007) Neuropathol Appl Neurobiol, 33, pp. 599-614; Hishikawa, N., Hashizume, Y., Hirayama, M., Imamura, K., Washimi, Y., Koike, Y., Mabuchi, C., Sobue, G., Brainstemtype Lewy body disease presenting with progressive autonomic failure and lethargy (2000) Clin Auton Res, 10, pp. 139-143; Hishikawa, N., Hashizume, Y., Yoshida, M., Sobue, G., Clinical and neuropathological correlates of Lewy body disease (2003) Acta Neuropathol, 105, pp. 341-350; Hladik, C.L., White, C.L., Comparison of digestive enzyme and formic acid pretreatment for optimal immunohistochemical demonstration of alpha-synuclein-immunoreactive cerebral cortical Lewy neurites (2003) J Neuropathol Exp Neurol, 62, p. 554; Hopkins, D.A., Bieger, D., De Vente, J., Steinbusch, W.M., Vagal efferent projections: Viscerotopy, neurochemistry and effects of vagotomy (1996) Prog Brain Res, 107, pp. 79-96; Ikemura, M., Saito, Y., Sengoku, R., Sakiyama, Y., Hatsuta, H., Kanemaru, K., Sawabe, M., Murayama, S., Lewy body pathology involves cutaneous nerves (2008) J Neuropathol Exp Neurol, 67, pp. 945-953; Iseki, E., Marui, W., Kosaka, K., Akiyama, H., Ueda, K., Iwatsubo, T., Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease (1998) Neurosci Lett, 258, pp. 81-84; Iwanaga, K., Wakabayashi, K., Yoshimoto, M., Tomita, I., Satoh, H., Takashima, H., Satoh, A., Takahashi, H., Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases (1999) Neurology, 52, pp. 1269-1271; Jellinger, K.A., Lewy body-related alpha-synucleinopathy in the aged human brain (2004) J Neural Transm, 111, pp. 1219-1235; Kaufmann, H., Nahm, K., Purohit, D., Wolfe, D., Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies (2004) Neurology, 63, pp. 1093-1095; Klos, K.J., Ahlskog, J.E., Josephs, K.A., Apaydin, H., Parisi, J.E., Boeve, B.F., Delucia, M.W., Dickson, D.W., Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals (2006) Neurology, 66, pp. 1100-1102; Knowles, C.H., De, G.R., Kapur, R.P., Bruder, E., Farrugia, G., Geboes, K., Gershon, M.D., Wedel, T., (2009) Acta Neuropathol, 118, pp. 271-301. , Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group; Koike, Y., Takahashi, A., Autonomic dysfunction in Parkinson's disease (1997) Eur Neurol, 38 (SUPPL. 2), pp. 8-12; Kordower, J.H., Brundin, P., Lewy body pathology in longterm fetal nigral transplants: Is Parkinson's disease transmitted from one neural system to another? (2009) Neuropsychopharmacology, 34, p. 254; Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B., Olanow, C.W., Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease (2008) Nat Med, 14, pp. 504-506; Kordower, J.H., Chu, Y., Hauser, R.A., Olanow, C.W., Freeman, T.B., Transplanted dopaminergic neurons develop PD pathologic changes: A second case report (2008) Mov Disord, 23, pp. 2303-2306; Kupsky, W.J., Grimes, M.M., Sweeting, J., Bertsch, R., Cote, L.J., Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells (1987) Neurology, 37, pp. 1253-1255; Langston, J.W., The Parkinson's complex: Parkinsonism is just the tip of the iceberg (2006) Ann Neurol, 59, pp. 591-596; Leopold, N.A., Kagel, M.C., Pharyngo-esophageal dysphagia in Parkinson's disease (1997) Dysphagia, 12, pp. 11-18; Li, J.Y., Englund, E., Holton, J.L., Soulet, D., Hagell, P., Lees, A.J., Lashley, T., Brundin, P., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation (2008) Nat Med, 14, pp. 501-503; McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O'Brien, J.T., Feldman, H., Cummings, J., Yamada, M., Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (2005) Neurology, 65, pp. 1863-1872; Mckeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, L.A., Salmon, D.P., Perry, R.H., (1996) Neurology, 47, pp. 1113-1124. , Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop; Miki, Y., Mori, F., Wakabayashi, K., Kuroda, N., Orimo, S., Incidental Lewy body disease restricted to the heart and stellate ganglia (2009) Mov Disord, 24, pp. 2299-2301; Minguez-Castellanos, A., Chamorro, C.E., Escamilla-Sevilla, F., Ortega-Moreno, A., Rebollo, A.C., Gomez-Rio, M., Concha, A., Munoz, D.G., Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study (2007) Neurology, 68, pp. 2012-2018; Mirra, S.S., Heyman, A., Mckeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Berg, L., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease (1991) Neurology, 41, pp. 479-486; O'sullivan, S.S., Holton, J.L., Massey, L.A., Williams, D.R., Revesz, T., Lees, A.J., Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy (2008) J Neurol Neurosurg Psychiatry, 79, pp. 232-234; Parkkinen, L., Pirttila, T., Alafuzoff, I., Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance (2008) Acta Neuropathol, 115, pp. 399-407; Persson, M., Osterberg, T., Granerus, A.K., Karlsson, S., Influence of Parkinson's disease on oral health (1992) Acta Odontol Scand, 50, pp. 37-42; Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease (2003) Lancet Neurol, 2, pp. 107-116; Pinnington, L.L., Muhiddin, K.A., Ellis, R.E., Playford, E.D., Non-invasive assessment of swallowing and respiration in Parkinson's disease (2000) J Neurol, 247, pp. 773-777; Proulx, M., De Courval, F.P., Wiseman, M.A., Panisset, M., Salivary production in Parkinson's disease (2005) Mov Disord, 20, pp. 204-207; Qualman, S.J., Haupt, H.M., Yang, P., Hamilton, S.R., Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease (1984) Gastroenterology, 87, pp. 848-856; Saito, Y., Kawashima, A., Ruberu, N.N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Murayama, S., Accumulation of phosphorylated alpha-synuclein in aging human brain (2003) J Neuropathol Exp Neurol, 62, pp. 644-654; Saito, Y., Ruberu, N.N., Sawabe, M., Arai, T., Kazama, H., Hosoi, T., Yamanouchi, H., Murayama, S., Lewy body-related alphasynucleinopathy in aging (2004) J Neuropathol Exp Neurol, 63, pp. 742-749; Sica, R.E., Herskovits, E., Aguilera, N., Poch, G., An electrophysiological investigation of skeletal muscle in Parkinson's disease (1973) J Neurol Sci, 18, pp. 411-420; Sica, R.E., Sanz, O.P., An electrophysiological study of the functional changes in the spinal motoneurones in Parkinson's disease (1976) Electromyogr Clin Neurophysiol, 16, pp. 409-417; Siddiqui, M.F., Rast, S., Lynn, M.J., Auchus, A.P., Pfeiffer, R.F., Autonomic dysfunction in Parkinson's disease: A comprehensive symptom survey (2002) Parkinsonism Relat Disord, 8, pp. 277-284; Takeda, S., Yamazaki, K., Miyakawa, T., Arai, H., Parkinson's disease with involvement of the parasympathetic ganglia (1993) Acta Neuropathol, 86, pp. 397-398; Tumilasci, O.R., Cersosimo, M.G., Belforte, J.E., Micheli, F.E., Benarroch, E.E., Pazo, J.H., Quantitative study of salivary secretion in Parkinson's disease (2006) Mov Disord, 21, pp. 660-667; Uchikado, H., Lin, W.L., Delucia, M.W., Dickson, D.W., Alzheimer disease with amygdala Lewy bodies: A distinct form of alpha-synucleinopathy (2006) J Neuropathol Exp Neurol, 65, pp. 685-697; Verbaan, D., Marinus, J., Visser, M., Van Rooden, S.M., Stiggelbout, A.M., Van Hilten, J.J., Patient-reported autonomic symptoms in Parkinson disease (2007) Neurology, 69, pp. 333-341; Wakabayashi, K., Takahashi, H., The intermediolateral nucleus and Clarke's column in Parkinson's disease (1997) Acta Neuropathol, 94, pp. 287-289; Wakabayashi, K., Takahashi, H., Ohama, E., Ikuta, F., Parkinson's disease: An immunohistochemical study of Lewy body-containing neurons in the enteric nervous system (1990) Acta Neuropathol, 79, pp. 581-583; Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., Ikuta, F., Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses (1988) Acta Neuropathol, 76, pp. 217-221; Zaccai, J., Brayne, C., McKeith, I., Matthews, F., Ince, P.G., Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort (2008) Neurology, 70, pp. 1042-1048},
correspondence_address1={Beach, T. G.; Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, United States; email: thomas.beach@bannerhealth.com},
issn={00016322},
coden={ANPTA},
pubmed_id={20306269},
language={English},
abbrev_source_title={Acta Neuropathol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Reynolds2019434,
author={Reynolds, A. and Mann, J. and Cummings, J. and Winter, N. and Mete, E. and Te Morenga, L.},
title={Carbohydrate quality and human health: a series of systematic reviews and meta-analyses},
journal={The Lancet},
year={2019},
volume={393},
number={10170},
pages={434-445},
doi={10.1016/S0140-6736(18)31809-9},
note={cited By 550},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059884906&doi=10.1016%2fS0140-6736%2818%2931809-9&partnerID=40&md5=501575823e175fb596b3096753c0e253},
affiliation={Department of Medicine, University of Otago, Dunedin, Otago, New Zealand; Department of Human Nutrition, University of Otago, Dunedin, Otago, New Zealand; Edgar National Centre for Diabetes and Obesity Research, University of Otago, Dunedin, Otago, New Zealand; Department of Medicine, Riddet Centre of Research Excellence, New Zealand; School of Medicine, University of Dundee, Dundee, United Kingdom; Healthier Lives National Science Challenge, New Zealand},
abstract={Background: Previous systematic reviews and meta-analyses explaining the relationship between carbohydrate quality and health have usually examined a single marker and a limited number of clinical outcomes. We aimed to more precisely quantify the predictive potential of several markers, to determine which markers are most useful, and to establish an evidence base for quantitative recommendations for intakes of dietary fibre. Methods: We did a series of systematic reviews and meta-analyses of prospective studies published from database inception to April 30, 2017, and randomised controlled trials published from database inception to Feb 28, 2018, which reported on indicators of carbohydrate quality and non-communicable disease incidence, mortality, and risk factors. Studies were identified by searches in PubMed, Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials, and by hand searching of previous publications. We excluded prospective studies and trials reporting on participants with a chronic disease, and weight loss trials or trials involving supplements. Searches, data extraction, and bias assessment were duplicated independently. Robustness of pooled estimates from random-effects models was considered with sensitivity analyses, meta-regression, dose-response testing, and subgroup analyses. The GRADE approach was used to assess quality of evidence. Findings: Just under 135 million person-years of data from 185 prospective studies and 58 clinical trials with 4635 adult participants were included in the analyses. Observational data suggest a 15–30% decrease in all-cause and cardiovascular related mortality, and incidence of coronary heart disease, stroke incidence and mortality, type 2 diabetes, and colorectal cancer when comparing the highest dietary fibre consumers with the lowest consumers Clinical trials show significantly lower bodyweight, systolic blood pressure, and total cholesterol when comparing higher with lower intakes of dietary fibre. Risk reduction associated with a range of critical outcomes was greatest when daily intake of dietary fibre was between 25 g and 29 g. Dose-response curves suggested that higher intakes of dietary fibre could confer even greater benefit to protect against cardiovascular diseases, type 2 diabetes, and colorectal and breast cancer. Similar findings for whole grain intake were observed. Smaller or no risk reductions were found with the observational data when comparing the effects of diets characterised by low rather than higher glycaemic index or load. The certainty of evidence for relationships between carbohydrate quality and critical outcomes was graded as moderate for dietary fibre, low to moderate for whole grains, and low to very low for dietary glycaemic index and glycaemic load. Data relating to other dietary exposures are scarce. Interpretation: Findings from prospective studies and clinical trials associated with relatively high intakes of dietary fibre and whole grains were complementary, and striking dose-response evidence indicates that the relationships to several non-communicable diseases could be causal. Implementation of recommendations to increase dietary fibre intake and to replace refined grains with whole grains is expected to benefit human health. A major strength of the study was the ability to examine key indicators of carbohydrate quality in relation to a range of non-communicable disease outcomes from cohort studies and randomised trials in a single study. Our findings are limited to risk reduction in the population at large rather than those with chronic disease. Funding: Health Research Council of New Zealand, WHO, Riddet Centre of Research Excellence, Healthier Lives National Science Challenge, University of Otago, and the Otago Southland Diabetes Research Trust. © 2019 Elsevier Ltd},
keywords={all cause mortality;  Article;  carbohydrate intake;  cardiovascular mortality;  cerebrovascular accident;  cholesterol level;  clinical assessment;  clinical outcome;  colorectal cancer;  dietary reference intake;  disease association;  health status;  human;  incidence;  ischemic heart disease;  low glycemic index diet;  meta analysis;  mortality rate;  non insulin dependent diabetes mellitus;  priority journal;  risk factor;  risk reduction;  systematic review;  systolic blood pressure;  carbohydrate diet;  dietary fiber;  drug therapy;  non communicable disease;  primary prevention, Dietary Carbohydrates;  Dietary Fiber;  Humans;  Noncommunicable Diseases;  Primary Prevention},
chemicals_cas={Dietary Carbohydrates; Dietary Fiber},
funding_details={World Health OrganizationWorld Health Organization, WHO},
funding_details={Health Research Council of New ZealandHealth Research Council of New Zealand, HRC},
funding_text 1={This Article was supported by funding from the Health Research Council of New Zealand; WHO; Riddet Centre of Research Excellence; Healthier Lives National Science Challenge; Department of Medicine, University of Otago, New Zealand; and the Otago Southland Diabetes Research Trust.},
references={Yudkin, J., Pure, white and deadly: the problem of sugar (1972), Davis-Poynter Ltd London; Cleave, T., Campbell, G., Painter, N., Diabetes, coronary thrombosis and saccharine disease (1966), John Wright & Sons, Ltd Bristol; Guideline: sugars intake for adults and children (2015), http://apps.who.int/iris/bitstream/handle/10665/149782/9789241549028_eng.pdf?sequence=1, World Health Organization Geneva (Accessed 1 May 2018); Cummings, J.H., Engineer, A., Denis Burkitt and the origins of the dietary fibre hypothesis (2017) Nutr Res Rev, 31, pp. 1-15; Trowell, H., Burkitt, D., Concluding considerations (1975) Refined carbohydrate foods and disease, pp. 333-345. , Elsevier London; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) PLoS Med, 6, p. e1000097; Te Morenga, L., Mallard, S., Mann, J., Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies (2013) BMJ, 346, p. e7492; Whiting, P., Savović, J., Higgins, J.P., ROBIS: a new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 69, pp. 225-234; Wells, G., Shea, B., O'Connell, D., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (2011), http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, Ottawa Hospital Research Institute Ottawa (Accessed 18 May 2017); Higgins, J.P., Altman, D.G., Gøtzsche, P.C., The Cochrane collaboration's tool for assessing risk of bias in randomised trials (2011) BMJ, 343, p. d5928; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135, pp. 1301-1309; Aune, D., Chan, D.S., Lau, R., Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies (2011) BMJ, 343, p. d6617; Orsini, N., Bellocco, R., Greenland, S., Generalized least squares for trend estimation of summarized dose-response data (2006) Stata J, 6, p. 40; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327, p. 557; The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis (2000) Biometrics, 56, pp. 455-463; Guyatt, G.H., Oxman, A.D., Vist, G.E., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336, p. 924; Stephen, A.M., Champ, M.M., Cloran, S.J., Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health (2017) Nutr Res Rev, 30, pp. 149-190; Englyst, H.N., Kingman, S., Cummings, J.H., Classification and measurement of nutritionally important starch fractions (1992) Eur J Clin Nutr, 46, pp. S33-S50; Aune, D., Keum, N., Giovannucci, E., Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies (2016) BMJ, 353, p. i2716; Aune, D., Chan, D.S., Lau, R., Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies (2011) BMJ, 343, p. d6617; Ye, E.Q., Chacko, S.A., Chou, E.L., Kugizaki, M., Liu, S., Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain (2012) J Nutr, 142, pp. 1304-1313; Liu, L., Wang, S., Liu, J., Fiber consumption and all-cause, cardiovascular, and cancer mortalities: a systematic review and meta-analysis of cohort studies (2015) Mol Nutr Food Res, 59, pp. 139-146; Barclay, A.W., Petocz, P., McMillan-Price, J., Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies (2008) Am J Clin Nutr, 87, pp. 627-637; Dong, J.Y., Zhang, L., Zhang, Y.H., Qin, L.Q., Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies (2011) Br J Nutr, 106, pp. 1649-1654; Bhupathiraju, S.N., Tobias, D.K., Malik, V.S., Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis (2014) Am J Clin Nutr, 100, pp. 218-232; Turati, F., Galeone, C., Gandini, S., High glycemic index and glycemic load are associated with moderately increased cancer risk (2015) Mol Nutr Food Res, 59, pp. 1384-1394; Cai, X., Wang, C., Wang, S., Carbohydrate intake, glycemic index, glycemic load, and stroke: a meta-analysis of prospective cohort studies (2015) Asia Pac J Public Health, 27, pp. 486-496; Fan, J., Song, Y., Wang, Y., Hui, R., Zhang, W., Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis (2012) PLoS One, 7, p. e52182; Mirrahimi, A., de Souza, R.J., Chiavaroli, L., Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts (2012) J Am Heart Assoc, 1, p. e000752; Rossi, M., Turati, F., Lagiou, P., Trichopoulos, D., La Vecchia, C., Trichopoulou, A., Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis (2015) Eur J Nutr, 54, pp. 215-222; Aune, D., Giovannucci, E., Boffetta, P., Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies (2017) Int J Epidemiol, 46, pp. 1029-1056; McCance, R., Lawrence, R., The carbohydrate content of foods. Medical Research Council Special Report Series No 135 (1929), HMS Office London; Cummings, J.H., Dietary fibre (1973) Gut, 14, p. 69; Spiller, G.A., CRC handbook of dietary fiber in human nutrition (2001), Taylor & Francis UK; Clark, M.J., Slavin, J.L., The effect of fiber on satiety and food intake: a systematic review (2013) J Am Coll Nutr, 32, pp. 200-211; Wanders, A.J., van den Borne, J.J., de Graaf, C., Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials (2011) Obes Rev, 12, pp. 724-739; Stephen, A.M., Cummings, J.H., Mechanism of action of dietary fibre in the human colon (1980) Nature, 284, p. 283; Elia, M., Cummings, J.H., Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates (2007) Eur J Clin Nutr, 61, p. S40; Shanahan, F., van Sinderen, D., O'toole, P.W., Stanton, C., Feeding the microbiota: transducer of nutrient signals for the host (2017) Gut, 66, pp. 1709-1717; Gardner, C.D., Trepanowski, J.F., Del Gobbo, L.C., Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial (2018) JAMA, 319, pp. 667-679; Dietary reference values for nutrients: Summary report (2017), https://www.efsa.europa.eu/en/supporting/pub/e15121, (Accessed 21 January 2018); Järvi, A.E., Karlström, B.E., Granfeldt, Y.E., Björck, I.E., Asp, N.G., Vessby, B., Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients (1999) Diabetes Care, 22, pp. 10-18; Hunt, J.R., Bioavailability of iron, zinc, and other trace minerals from vegetarian diets (2003) Am J Clin Nutr, 78, pp. 633S-639S; Atkinson, F.S., Foster-Powell, K., Brand-Miller, J.C., International tables of glycemic index and glycemic load values: 2008 (2008) Diabetes Care, 31, pp. 2281-2283},
correspondence_address1={Mann, J.; Department of Medicine, New Zealand; email: jim.mann@otago.ac.nz},
publisher={Lancet Publishing Group},
issn={01406736},
coden={LANCA},
pubmed_id={30638909},
language={English},
abbrev_source_title={Lancet},
document_type={Article},
source={Scopus},
}

@ARTICLE{Psaltopoulou2013580,
author={Psaltopoulou, T. and Sergentanis, T.N. and Panagiotakos, D.B. and Sergentanis, I.N. and Kosti, R. and Scarmeas, N.},
title={Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis},
journal={Annals of Neurology},
year={2013},
volume={74},
number={4},
pages={580-591},
doi={10.1002/ana.23944},
note={cited By 505},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890119873&doi=10.1002%2fana.23944&partnerID=40&md5=90bd8a819784af89a6d85cc1e95d5862},
affiliation={Department of Hygiene, Epidemiology and Medical Statistics, University of Athens, School of Medicine, 75 M. Asias Str, Goudi 11527, Athens, Greece; Department of Nutrition and Dietetics, Harokopio University, Athens, Greece; Hospital of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland; Department of Neurology, University of Athens, Medical School, Athens, Greece; Department of Neurology, Columbia University, New York, NY, United States},
abstract={Objective: This meta-analysis aims to quantitatively synthesize all studies that examine the association between adherence to a Mediterranean diet and risk of stroke, depression, cognitive impairment, and Parkinson disease. Methods Potentially eligible publications were those providing effect estimates of relative risk (RR) for the association between Mediterranean diet and the aforementioned outcomes. Studies were sought in PubMed up to October 31, 2012. Maximally adjusted effect estimates were extracted; separate analyses were performed for high and moderate adherence. Results: Twenty-two eligible studies were included (11 covered stroke, 9 covered depression, and 8 covered cognitive impairment; only 1 pertained to Parkinson's disease). High adherence to Mediterranean diet was consistently associated with reduced risk for stroke (RR = 0.71, 95% confidence interval [CI] = 0.57-0.89), depression (RR = 0.68, 95% CI = 0.54-0.86), and cognitive impairment (RR = 0.60, 95% CI = 0.43-0.83). Moderate adherence was similarly associated with reduced risk for depression and cognitive impairment, whereas the protective trend concerning stroke was only marginal. Subgroup analyses highlighted the protective actions of high adherence in terms of reduced risk for ischemic stroke, mild cognitive impairment, dementia, and particularly Alzheimer disease. Meta-regression analysis indicated that the protective effects of Mediterranean diet in stroke prevention seemed more sizeable among males. Concerning depression, the protective effects of high adherence seemed independent of age, whereas the favorable actions of moderate adherence seemed to fade away with more advanced age. Interpretation Adherence to a Mediterranean diet may contribute to the prevention of a series of brain diseases; this may be of special value given the aging of Western societies. © 2013 American Neurological Association.},
keywords={article;  cerebrovascular accident;  cognitive defect;  depression;  groups by age;  human;  Mediterranean diet;  Medline;  meta analysis;  outcome assessment;  Parkinson disease;  priority journal;  protection;  publication;  quantitative analysis;  regression analysis;  risk assessment;  risk reduction;  systematic review;  treatment refusal, Cognition Disorders;  Depression;  Diet, Mediterranean;  Humans;  Medication Adherence;  Observation;  Regression Analysis;  Risk;  Stroke},
references={Scarmeas, N., Luchsinger, J.A., Schupf, N., Physical activity, diet, and risk of Alzheimer disease (2009) JAMA, 302, pp. 627-637; Solfrizzi, V., Frisardi, V., Seripa, D., Mediterranean diet in predementia and dementia syndromes (2011) Curr Alzheimer Res, 8, pp. 520-542; Sofi, F., Macchi, C., Abbate, R., Effectiveness of the Mediterranean diet: Can it help delay or prevent Alzheimer's disease? (2010) J Alzheimers Dis, 20, pp. 795-801; Sherzai, A., Heim, L.T., Boothby, C., Stroke, food groups, and dietary patterns: A systematic review (2012) Nutr Rev, 70, pp. 423-435; Appleton, K.M., Rogers, P.J., Ness, A.R., Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood (2010) Am J Clin Nutr, 91, pp. 757-770; Bach-Faig, A., Berry, E.M., Lairon, D., Mediterranean diet pyramid today. Science and cultural updates (2011) Public Health Nutr, 14, pp. 2274-2284; Scientific opinion on the substantiation of health claims related to fruits and/or vegetables and to the "mediterranean diet" pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011) EFSA J, 9, p. 2245. , European Food Safety Authority; Trichopoulou, A., Costacou, T., Bamia, C., Adherence to a Mediterranean diet and survival in a Greek population (2003) N Engl J Med, 348, pp. 2599-2608; Intangible Heritage Lists. Mediterranean Diet, , http://www.unesco.org/culture/ich/index.php?lg=en&pg=00011&RL= 00394, UNESCO Accessed February 1, 2013; Sofi, F., Abbate, R., Gensini, G.F., Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis (2010) Am J Clin Nutr, 92, pp. 1189-1196; Martinez-Gonzalez, M.A., Guillen-Grima, F., De Irala, J., The Mediterranean diet is associated with a reduction in premature mortality among middle-aged adults (2012) J Nutr, 142, pp. 1672-1678; Panagiotakos, D.B., Dimakopoulou, K., Katsouyanni, K., Mediterranean diet and inflammatory response in myocardial infarction survivors (2009) Int J Epidemiol, 38, pp. 856-866; Dai, J., Jones, D.P., Goldberg, J., Association between adherence to the Mediterranean diet and oxidative stress (2008) Am J Clin Nutr, 88, pp. 1364-1370; Carter, S.J., Roberts, M.B., Salter, J., Relationship between Mediterranean diet score and atherothrombotic risk: Findings from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (2010) Atherosclerosis, 210, pp. 630-636; Llorente-Cortes, V., Estruch, R., Mena, M.P., Effect of Mediterranean diet on the expression of pro-atherogenic genes in a population at high cardiovascular risk (2010) Atherosclerosis, 208, pp. 442-450; Vincent-Baudry, S., Defoort, C., Gerber, M., The Medi-RIVAGE study: Reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet (2005) Am J Clin Nutr, 82, pp. 964-971; Psaltopoulou, T., Naska, A., Orfanos, P., Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study (2004) Am J Clin Nutr, 80, pp. 1012-1018; Kastorini, C.M., Milionis, H.J., Esposito, K., The effect of Mediterranean diet on metabolic syndrome and its components: A meta-analysis of 50 studies and 534,906 individuals (2011) J Am Coll Cardiol, 57, pp. 1299-1313; Romaguera, D., Guevara, M., Norat, T., Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: The InterAct project (2011) Diabetes Care, 34, pp. 1913-1918; Esposito, K., Kastorini, C.M., Panagiotakos, D.B., Mediterranean diet and weight loss: Meta-analysis of randomized controlled trials (2011) Metab Syndr Relat Disord, 9, pp. 1-12; Chrysohoou, C., Skoumas, J., Pitsavos, C., Long-term adherence to the Mediterranean diet reduces the prevalence of hyperuricaemia in elderly individuals, without known cardiovascular disease: The Ikaria study (2011) Maturitas, 70, pp. 58-64; Fragopoulou, E., Panagiotakos, D.B., Pitsavos, C., The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: The ATTICA study (2010) J Nutr Biochem, 21, pp. 285-289; Esposito, K., Marfella, R., Ciotola, M., Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial (2004) JAMA, 292, pp. 1440-1446; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group (2000) JAMA, 283, pp. 2008-2012; Panagiotakos, D.B., Pitsavos, C., Stefanadis, C., Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk (2006) Nutr Metab Cardiovasc Dis, 16, pp. 559-568; Higgins, J.P.T., Green, S., (2011) Cochrane Handbook for Systematic Reviews of Interventions, , www.cochrane-handbook.org, version 5.1.0. Updated March. Accessed on March 1, 2013; Scarmeas, N., Stern, Y., Mayeux, R., Mediterranean diet, Alzheimer disease, and vascular mediation (2006) Arch Neurol, 63, pp. 1709-1717; Psaltopoulou, T., Kyrozis, A., Stathopoulos, P., Diet, physical activity and cognitive impairment among elders: The EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition) (2008) Public Health Nutr, 11, pp. 1054-1062; Bountziouka, V., Polychronopoulos, E., Zeimbekis, A., Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: The MEDIS (MEDiterranean ISlands Elderly) epidemiological study (2009) J Aging Health, 21, pp. 864-880; Feart, C., Samieri, C., Rondeau, V., Adherence to a Mediterranean diet, cognitive decline, and risk of dementia (2009) JAMA, 302, pp. 638-648; Fung, T.T., Rexrode, K.M., Mantzoros, C.S., Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women (2009) Circulation, 119, pp. 1093-1100; Sanchez-Villegas, A., Delgado-Rodriguez, M., Alonso, A., Association of the Mediterranean dietary pattern with the incidence of depression: The Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort (2009) Arch Gen Psychiatry, 66, pp. 1090-1098; Scarmeas, N., Stern, Y., Mayeux, R., Mediterranean diet and mild cognitive impairment (2009) Arch Neurol, 66, pp. 216-225; Chrysohoou, C., Tsitsinakis, G., Siassos, G., Fish consumption moderates depressive symptomatology in elderly men and women from the IKARIA study (2010) Cardiol Res Pract, 2011, p. 219578; Roberts, R.O., Geda, Y.E., Cerhan, J.R., Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment (2010) Dement Geriatr Cogn Disord, 29, pp. 413-423; Agnoli, C., Krogh, V., Grioni, S., A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort (2011) J Nutr, 141, pp. 1552-1558; Gardener, H., Wright, C.B., Gu, Y., Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: The Northern Manhattan Study (2011) Am J Clin Nutr, 94, pp. 1458-1464; Kastorini, C.M., Milionis, H.J., Ioannidi, A., Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: A comparative analysis of a case/case-control study (2011) Am Heart J, 162, pp. 717-724; Milaneschi, Y., Bandinelli, S., Penninx, B.W., Depressive symptoms and inflammation increase in a prospective study of older adults: A protective effect of a healthy (Mediterranean-style) diet (2011) Mol Psychiatry, 16, pp. 589-590; Scarmeas, N., Luchsinger, J.A., Stern, Y., Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease (2011) Ann Neurol, 69, pp. 257-268; Yau, W.Y., Hankey, G.J., Which dietary and lifestyle behaviours may be important in the aetiology (and prevention) of stroke? (2011) J Clin Neurosci, 18, pp. 76-80; Antonogeorgos, G., Panagiotakos, D.B., Pitsavos, C., Understanding the role of depression and anxiety on cardiovascular disease risk, using structural equation modeling; The mediating effect of the Mediterranean diet and physical activity: The ATTICA study (2012) Ann Epidemiol, 22, pp. 630-637; Hoevenaar-Blom, M.P., Nooyens, A.C., Kromhout, D., Mediterranean style diet and 12-year incidence of cardiovascular diseases: The EPIC-NL cohort study (2012) PLoS One, 7, pp. e45458; Gardener, S., Gu, Y., Rainey-Smith, S.R., Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population (2012) Transl Psychiatry, 2, pp. e164; Luciano, M., Mottus, R., Starr, J.M., Depressive symptoms and diet: Their effects on prospective inflammation levels in the elderly (2012) Brain Behav Immun, 26, pp. 717-720; Vercambre, M.N., Grodstein, F., Berr, C., Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors (2012) J Acad Nutr Diet, 112, pp. 816-823; Tangney, C.C., Kwasny, M.J., Li, H., Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population (2011) Am J Clin Nutr, 93, pp. 601-607; Christa Maree Stephan, B., Minett, T., Pagett, E., Diagnosing mild cognitive impairment (MCI) in clinical trials: A systematic review (2013) BMJ Open, 3; Tombaugh, T.N., McIntyre, N.J., The mini-mental state examination: A comprehensive review (1992) J Am Geriatr Soc, 40, pp. 922-935; Ownby, R.L., Crocco, E., Acevedo, A., Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis (2006) Arch Gen Psychiatry, 63, pp. 530-538; Willett, W.C., The Mediterranean diet: Science and practice (2006) Public Health Nutr, 9, pp. 105-110; Estruch, R., Ros, E., Salas-Salvado, J., Primary prevention of cardiovascular disease with a Mediterranean diet (2013) N Engl J Med, 368, pp. 1279-1290; Gardener, H., Scarmeas, N., Gu, Y., Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study (2012) Arch Neurol, 69, pp. 251-256; Gu, Y., Scarmeas, N., Dietary patterns in Alzheimer's disease and cognitive aging (2011) Curr Alzheimer Res, 8, pp. 510-519; Knopman, D.S., Mediterranean diet and late-life cognitive impairment: A taste of benefit (2009) JAMA, 302, pp. 686-687; Chrysohoou, C., Panagiotakos, D.B., Pitsavos, C., Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study (2004) J Am Coll Cardiol, 44, pp. 152-158; Trichopoulou, A., Orfanos, P., Norat, T., Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study (2005) BMJ, 330, p. 991; Sofi, F., Cesari, F., Abbate, R., Adherence to Mediterranean diet and health status: Meta-analysis (2008) BMJ, 337, pp. a1344; Mullan, R.J., Flynn, D.N., Carlberg, B., Systematic reviewers commonly contact study authors but do so with limited rigor (2009) J Clin Epidemiol, 62, pp. 138-142; Cherbuin, N., Anstey, K.J., The Mediterranean diet is not related to cognitive change in a large prospective investigation: The PATH Through Life study (2012) Am J Geriatr Psychiatry, 20, pp. 635-639; Gao, X., Chen, H., Fung, T.T., Prospective study of dietary pattern and risk of Parkinson disease (2007) Am J Clin Nutr, 86, pp. 1486-1494; McMillan, L., Owen, L., Kras, M., Behavioural effects of a 10-day Mediterranean diet. Results from a pilot study evaluating mood and cognitive performance (2011) Appetite, 56, pp. 143-147},
correspondence_address1={Psaltopoulou, T.; Department of Hygiene, Epidemiology and Medical Statistics, 75 M. Asias Str, Goudi 11527, Athens, Greece; email: tpsaltop@med.uoa.gr},
issn={03645134},
coden={ANNED},
pubmed_id={23720230},
language={English},
abbrev_source_title={Ann. Neurol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Anstey2011,
author={Anstey, K.J. and Cherbuin, N. and Budge, M. and Young, J.},
title={Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies},
journal={Obesity Reviews},
year={2011},
volume={12},
number={5},
pages={e426-e437},
doi={10.1111/j.1467-789X.2010.00825.x},
note={cited By 491},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954996833&doi=10.1111%2fj.1467-789X.2010.00825.x&partnerID=40&md5=ca209d3de76d288aa428e0ef149a6e92},
affiliation={Ageing Research Unit, Centre for Mental Health Research, Australia; Medical School, Australian National University, Canberra, ACT, Australia},
abstract={The relationship between body mass index (BMI) (in midlife and late-life) and dementia was investigated in meta-analyses of 16 articles reporting on 15 prospective studies. Follow-ups ranged from 3.2 to 36.0 years. Meta-analyses were conducted on samples including 25624 participants evaluated for Alzheimer's disease (AD), 15435 participants evaluated for vascular dementia (VaD) and 30470 followed for any type of dementia (Any Dementia). Low BMI in midlife was associated with 1.96 [95% confidence interval (CI): 1.32, 2.92] times the risk of developing AD. The pooled relative risks for AD, VaD and Any Dementia for overweight BMI in midlife compared with normal BMI were 1.35 (95% CI:1.19, 1.54), 1.33 (95% CI: 1.02, 1.75) and 1.26 (95% CI: 1.10, 1.44), respectively. The pooled relative risks of AD and Any Dementia for obese BMI in midlife compared to normal BMI were 2.04 (95% CI: 1.59, 2.62) and 1.64 (95% CI: 1.34, 2.00), respectively. Continuous BMI in late-life was not associated with dementia. Small numbers of studies included in pooled analyses reduce generalizability of findings, and emphasize the need for publication of additional findings. We conclude that underweight, overweight and obesity in midlife increase dementia risk. Further research evaluating late-life BMI and dementia is required. © 2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.},
author_keywords={Cognitive decline;  Obesity;  Overweight;  Review},
keywords={Alzheimer disease;  article;  body mass;  comparative study;  dementia;  follow up;  human;  meta analysis (topic);  multiinfarct dementia;  obesity;  risk factor},
references={Bagi, Z., Mechanisms of coronary microvascular adaptation to obesity (2009) Am J Physiol Regul Integr Comp Physiol, 297, pp. R556-R567; Reisin, E., Jack, A.V., Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches (2009) Med Clin North Am, 93, pp. 733-751; Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., Vendemiale, G., Panza, F., Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease (2010) Ageing Res Rev 1, 9, pp. 399-417; Solfrizzi, V., Scafato, E., Capurso, C., D'Introno, A., Colacicco, A.M., Frisardi, V., Vendemiale, G., Panza, F., Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing (2010) J Neurol Neurosurg Psychiatry, 81, pp. 433-440; Atti, A.R., Palmer, K., Volpato, S., Winblad, B., De Ronchi, D., Fratiglioni, L., Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project (2008) J Am Geriatr Soc, 56, pp. 111-116; Bagger, Y.Z., Tanko, L.B., Alexandersen, P., Qin, G., Christiansen, C., The implications of body fat mass and fat distribution for cognitive function in elderly women (2004) Obes Res, 9, pp. 1519-1526; Harvey, J., Solovyova, N., Irving, A., Leptin and its role in hippocampal synaptic plasticity (2006) Prog Lipid Res, 45, pp. 369-378; Morrison, C.D., Leptin signaling in brain: a link between nutrition and cognition? (2009) Biochim Biophys Acta, 1792, pp. 401-408; Gunstad, J., Spitznagel, M.B., Keary, T.A., Glickman, E., Alexander, T., Karrer, J., Stanek, K., Juvancic-Heltzel, J., Serum leptin levels are associated with cognitive function in older adults (2008) Brain Res, 1230, pp. 233-236; Whitmer, R.A., Gunderson, E.P., Barrett-Connor, E., Quesenberry Jr, C.P., Yaffe, K., Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study (2005) BMJ, 330, p. 1360; Beydoun, M.A., Beydoun, H.A., Wang, Y., Obesity and central obesity as risk factors for incident dementia and it's subtypes (2008) Obes Rev, 9, pp. 204-218; Gorospe, E.C., Dave, J.K., The risk of dementia with increased BMI (2007) Age Aging, 36, pp. 23-29; Anstey, K.J., Lipnicki, D.M., Low, L.F., Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis (2008) Am J Geriatr Psych, 16, pp. 343-354; Anstey, K.J., Mack, H.A., Cherbuin, N., Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies (2009) Am J Geriatr Psych, 17, pp. 542-555; Anstey, K.J., von Sanden, C., Salim, A., O'Kearney, R., Smoking as a Risk Factor for Dementia and Cognitive Decline: a Meta-Analysis of Prospective Studies (2007) Am J Epidemiol, 166, pp. 367-378; Williams, J.W., Plassman, B.L., Burke, J.R., Holsinger, T., Benjamin, S., (2010), Preventing Alzheimer's disease and cognitive decline. Evidence Report/Technical Assessment No. 193. National Institutes of Health: Durham; Harlein, J., Dassen, T., Halfens, R.J., Heinze, C., Fall risk factors in older people with dementia or cognitive impairment: a systematic review (2009) J Adv Nurs, 65, pp. 922-933; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Thacker, S.B., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group (2000) JAMA, 283, pp. 2008-2012; Rosengren, A., Skoog, I., Gustafson, D., Wilhelmsen, L., Body mass index, other cardiovascular risk factors, and hospitalization for dementia (2005) Arch Intern Med, 165, pp. 321-326; (1987) Diagnostic and Statistical Manual of Mental Disorders, , American Psychiatric Association., 3rd edn. Revised. American Psychiatric Association: Washington, DC; McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, pp. 939-944; Roman, G.C., Tatemichi, T.K., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Amaducci, L., Scheinberg, P., Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop (1993) Neurology, 43, pp. 250-260; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135, pp. 1301-1309; de Craen, A.J., Gussekloo, J., Vrijsen, B., Westendorp, R.G., Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia (2005) Am J Epidemiol, 161, pp. 114-120; Beydoun, M.A., Lhotsky, A., Wang, Y., Dal Forno, G., An, Y., Metter, E.J., Ferrucci, L., Zonderman, A.B., Association of Adiposity status and changes in early to mid adulthood with incidence of Alzheimers's disease (2008) Am J Epidemiol, 168, pp. 1179-1189; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., (2009) Introduction to Meta-Analysis, , John Wiley & Sons: Chichester; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Green, S., (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, , (Higgins JPT, eds). [updated May 2005]. John Wiley & Sons: Chichester; Borenstein Graves, A., Mortimer, J.A., Bowen, J.D., McCormick, W.C., McCurry, S.M., Schellenberg, G.D., Larson, E.B., Head circumference and incident Alzheimer's disease: modification by Apolipoprotein E (2001) Neurology, 57, pp. 1453-1460; Buchman, A.S., Wilson, R.S., Bienias, J.L., Shah, R.C., Evans, D.A., Bennett, D.A., Change in body mass index and risk of incident Alzheimer disease (2005) Neurology, 65, pp. 892-897; Feart, C., Samieri, C., Rondeau, V., Amieva, H., Portet, F., Dartigues, J.F., Scarmeas, N., Barberger-Gateau, P., Adherence to a Mediterranean diet, cognitive decline, and risk of dementia (2009) JAMA, 302, pp. 638-648; Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O'Meara, E.S., Longstreth, W., Luchsinger, J.A., Midlife and late-life obesity and the risk of dementia: cardiovascular Health Study (2009) Arch Neurol, 66, pp. 336-342; Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., Skoog, I., An 18-year follow-up of overweight and risk of Alzheimer disease (2003) Arch Intern Med, 163, pp. 1524-1528; Hayden, K.M., Zandi, P.P., Lyketsos, C.G., Khachaturian, A.S., Bastian, L.A., Charoonruk, G., Tschanz, J.A.T., Welsh-Bohmer, K.A., Vascular risk factors for incident Alzheimer disease and vascular dementia: the cache county study (2006) Alzheimer Dis Assoc Disord, 20, pp. 93-100; Hughes, T.F., Borenstein, A.R., Schofield, E., Wu, Y., Larson, E.B., Association between late-life body mass index and dementia: the Kame Project (2009) Neurology, 72, pp. 1741-1746; Luchsinger, J.A., Patel, B., Tang, M.X., Schupf, N., Mayeux, R., Measures of adiposity and dementia risk in elderly persons (2007) Arch Neurol, 64, pp. 392-398; Minicuci, N., Marzari, C., Maggi, S., Noale, M., Senesi, A., Crepaldi, G., Predictors of transitions in vitality: the Italian longitudinal study on aging (2005) J Gerontol A Biol Sci Med Sci, 60, pp. 566-573; Nourhashemi, F., Deschamps, V., Larrieu, S., Letenneur, L., Dartigues, J.F., Barberger-Gateau, P., Body mass index and incidence of dementia: the PAQUID study (2003) Neurology, 60, pp. 117-119; Scarmeas, N., Luchsinger, J.A., Schupf, N., Brickman, A.M., Cosentino, S., Tang, M.X., Stern, Y., Physical activity, diet, and risk of Alzheimer disease (2009) JAMA, 302, pp. 627-637; Whitmer, R.A., Gunderson, E.P., Quesenberry Jr, C.P., Zhou, J., Yaffe, K., Body mass index in midlife and risk of Alzheimer disease and vascular dementia (2007) Curr Alzheimer Res, 4, pp. 103-109; Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Fujishima, M., Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study (1995) Neurology, 45, pp. 1161-1168; Dahl, A.K., Lopponen, M., Isoaho, R., Berg, S., Kivela, S.L., Overweight and obesity in old age are not associated with greater dementia risk (2008) J Am Geriatr Soc, 56, pp. 2261-2266; Deschamps, V., Astier, X., Ferry, M., Rainfray, M., Emeriau, J.P., Barberger-Gateau, P., Nutritional status of healthy elderly persons living in Dordogne, France, and relation with mortality and cognitive or functional decline (2002) Eur J Clin Nutr, 56, pp. 305-312; Yaffe, K., Fiocco, A.J., Lindquist, K., Vittinghoff, E., Simonsick, E.M., Newman, A.B., Satterfield, S., Harris, T.B., Predictors of maintaining cognitive function in older adults: the Health ABC study (2009) Neurology, 72, pp. 2029-2035; Komulainen, P., Lakka, T.A., Kivipelto, M., Hassinen, M., Helkala, E.-L., Haapala, I., Nissinen, A., Rauramaa, R., Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women (2007) Dement Geriatr Cogn Disord, 23, pp. 29-34; West, N.A., Haan, M.N., Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study (2009) J Gerontol A Biol Sci Med Sci, 64, pp. 103-109; Cournot, M., Marquie, J.C., Ansiau, D., Martinaud, C., Fonds, H., Ferrieres, J., Ruidavets, J.B., Relation between body mass index and cognitive function in healthy middle-aged men and women (2006) Neurology, 67, pp. 1208-1214; Fotuhi, M., Mohassel, P., Yaffe, K., Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association (2009) Nat Clin Pract Neurol, 5, pp. 140-152; Shah, K., Qureshi, S.U., Johnson, M., Parikh, N., Schulz, P.E., Kunik, M.E., Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review (2009) Am J Geriatr Pharmacother, 7, pp. 250-261; Johnson, D.K., Wilkins, C.H., Morris, J.C., Accelerated weight loss may precede diagnosis in Alzheimer disease (2006) Arch Neurol, 63, pp. 1312-1317; Nelson, C., Wengreen, H.J., Munger, R.G., Corcoran, C.D., Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study (2009) J Nutr Health Aging, 13, pp. 899-905; Middleton, L.E., Yaffe, K., Promising strategies for the prevention of dementia (2009) Arch Neurol, 66, pp. 1210-1215; (1997) Obesity: Preventing and Managing the Global Epidemic, , World-Health-Organization. Report of A WHO Consultation. World Health Organization: Geneva; Lau, J., Ioannidis, J.P., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) BMJ, 333, pp. 597-600; Cabrera, C., Wilhelmson, K., Allebeck, P., Wedel, H., Steen, B., Lissner, L., Cohort differences in obesity-related health indicators among 70-year olds with special reference to gender and education (2003) Eur J Epidemiol, 18, pp. 883-890; Gallacher, J., Bayer, A., Fish, M., Pickering, J., Pedro, S., Dunstan, F., Ebrahim, S., Ben-Shlomo, Y., Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study (2009) Psychosom Med, 71, pp. 659-666},
correspondence_address1={Anstey, K.J.; Centre for Mental Health Research, Building 63, Eggleston Rd, Canberra, ACT 0200, Australia; email: kaarin.anstey@anu.edu.au},
publisher={Blackwell Publishing Ltd},
issn={14677881},
coden={ORBEB},
pubmed_id={21348917},
language={English},
abbrev_source_title={Obes. Rev.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Kim2019627,
author={Kim, S. and Kwon, S.-H. and Kam, T.-I. and Panicker, N. and Karuppagounder, S.S. and Lee, S. and Lee, J.H. and Kim, W.R. and Kook, M. and Foss, C.A. and Shen, C. and Lee, H. and Kulkarni, S. and Pasricha, P.J. and Lee, G. and Pomper, M.G. and Dawson, V.L. and Dawson, T.M. and Ko, H.S.},
title={Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease},
journal={Neuron},
year={2019},
volume={103},
number={4},
pages={627-641.e7},
doi={10.1016/j.neuron.2019.05.035},
note={cited By 489},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069056660&doi=10.1016%2fj.neuron.2019.05.035&partnerID=40&md5=4d21c12348099e432146bd5c6e84287a},
affiliation={Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Center for Neurogastroenterology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD  21205, United States; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA  70130, United States},
abstract={Analysis of human pathology led Braak to postulate that α-synuclein (α-syn) pathology could spread from the gut to brain via the vagus nerve. Here, we test this postulate by assessing α-synucleinopathy in the brain in a novel gut-to-brain α-syn transmission mouse model, where pathological α-syn preformed fibrils were injected into the duodenal and pyloric muscularis layer. Spread of pathologic α-syn in brain, as assessed by phosphorylation of serine 129 of α-syn, was observed first in the dorsal motor nucleus, then in caudal portions of the hindbrain, including the locus coeruleus, and much later in basolateral amygdala, dorsal raphe nucleus, and the substantia nigra pars compacta. Moreover, loss of dopaminergic neurons and motor and non-motor symptoms were observed in a similar temporal manner. Truncal vagotomy and α-syn deficiency prevented the gut-to-brain spread of α-synucleinopathy and associated neurodegeneration and behavioral deficits. This study supports the Braak hypothesis in the etiology of idiopathic Parkinson's disease (PD). Gut injection of α-synuclein fibrils converts endogenous α-synuclein to a pathologic species that spreads to the brain. This leads to features of Parkinson's disease, and vagotomy and α-synuclein deficiency prevent the neuropathology and neurobehavioral deficits induced by transmitted pathological α-synuclein. © 2019 Elsevier Inc.},
author_keywords={Braak hypothesis;  gut to brain transmission;  Lewy body pathology;  motor symptoms;  neurodegeneration;  non-motor symptoms;  Parkinson's disease;  pre-formed fibrils;  vagus nerve;  α-synuclein},
keywords={alpha synuclein;  choline acetyltransferase;  dopamine transporter;  ghrelin;  tyrosine 3 monooxygenase;  alpha synuclein;  protein aggregate;  Snca protein, mouse, animal experiment;  animal model;  animal tissue;  Article;  basolateral amygdala;  bioaccumulation;  controlled study;  diffuse Lewy body disease;  disease association;  disease transmission;  dopaminergic nerve cell;  dorsal raphe nucleus;  female;  grip strength;  hormone blood level;  hypothalamus;  immunoreactivity;  latent period;  locus ceruleus;  male;  medulla oblongata;  motoneuron nucleus;  mouse;  neuropathology;  nonhuman;  Parkinson disease;  pons;  prefrontal cortex;  priority journal;  protein misfolding;  protein phosphorylation;  rhombencephalon;  spatial learning;  spatial memory;  substantia nigra;  substantia nigra pars compacta;  synaptic transmission;  synucleinopathy;  vagotomy;  animal;  biological model;  brain chemistry;  C57BL mouse;  duodenum;  human;  innervation;  intramuscular drug administration;  knockout mouse;  Lewy body;  maze test;  memory disorder;  metabolism;  nerve fiber transport;  nesting;  parkinsonism;  pathology;  phosphorylation;  physiology;  protein processing;  psychology;  pylorus;  rotarod test;  smooth muscle;  vagus nerve, alpha-Synuclein;  Animals;  Axonal Transport;  Brain Chemistry;  Dopaminergic Neurons;  Duodenum;  Humans;  Injections, Intramuscular;  Lewy Bodies;  Maze Learning;  Memory Disorders;  Mice;  Mice, Inbred C57BL;  Mice, Knockout;  Models, Neurological;  Muscle, Smooth;  Nesting Behavior;  Parkinsonian Disorders;  Phosphorylation;  Protein Aggregates;  Protein Processing, Post-Translational;  Pylorus;  Rotarod Performance Test;  Vagotomy;  Vagus Nerve},
chemicals_cas={alpha synuclein, 154040-18-3; choline acetyltransferase, 9012-78-6; ghrelin, 304853-26-7; tyrosine 3 monooxygenase, 9036-22-0; alpha-Synuclein; Protein Aggregates; Snca protein, mouse},
funding_details={AG059686},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, P50NS038377, R01NS082205, R01NS107404, R21NS098006},
funding_details={Adrienne Helis Malvin Medical Research FoundationAdrienne Helis Malvin Medical Research Foundation},
funding_details={JPB FoundationJPB Foundation},
funding_details={School of Medicine, Johns Hopkins UniversitySchool of Medicine, Johns Hopkins University, SOM, JHU, M-2014},
funding_text 1={We appreciate Taek-soo Lee, PhD, and Benjamin Tsui, PhD, technical assistance for SPECT-CT analysis. We thank I.-H. Wu for graphic art assistance. This work was supported by grants from the JPB Foundation, NIH/NINDS Morris K. Udall Parkinson's Disease Research Center NS38377, NIH/NINDS NS082205, NS107404, and NS098006 and NIH/NIA AG059686. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Program M-2014. S. Kim and S.-H.K. led the project and contributed to all aspects of the study. T.-I.K. N.P. S.L. W.R.K. M.K. and H.L. contributed to biochemical assay. S.S.K. contributed to HPLC analysis; J.H.L. and S. Kulkarni supported GI injection of PFF; C.A.F. C.S. and M.G.P. contributed to SPEC-CT analysis; P.J.P. G.L. V.L.D. T.M.D. and H.S.K. designed research; S. Kim S.-H.K. V.L.D. T.M.D. and H.S.K. analyzed data; and S. Kim, S.-H.K. V.L.D. T.M.D. and H.S.K. wrote the paper. The authors declare no competing interests.},
funding_text 2={We appreciate Taek-soo Lee, PhD, and Benjamin Tsui, PhD, technical assistance for SPECT-CT analysis. We thank I.-H. Wu for graphic art assistance. This work was supported by grants from the JPB Foundation , NIH /NINDS Morris K. Udall Parkinson’s Disease Research Center NS38377, NIH / NINDS NS082205 , NS107404 , and NS098006 and NIH/NIA AG059686 . The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation’s Parkinson’s Disease Program M-2014.},
references={Anderson, J.P., Walker, D.E., Goldstein, J.M., de Laat, R., Banducci, K., Caccavello, R.J., Barbour, R., Lee, M., Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease (2006) J. Biol. Chem., 281, pp. 29739-29752; Arias, N., Méndez, M., Arias, J.L., The importance of the context in the hippocampus and brain related areas throughout the performance of a fear conditioning task (2015) Hippocampus, 25, pp. 1242-1249; Bernhardt, N., Lieser, M.K., Hlusicka, E.B., Habelt, B., Wieske, F., Edemann-Callesen, H., Garthe, A., Winter, C., Learning deficits in rats overexpressing the dopamine transporter (2018) Sci. Rep., 8, p. 14173; Berthoud, H.R., Carlson, N.R., Powley, T.L., Topography of efferent vagal innervation of the rat gastrointestinal tract (1991) Am. J. Physiol., 260, pp. R200-R207; Bevins, R.A., Besheer, J., Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’ (2006) Nat. Protoc., 1, pp. 1306-1311; Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A., Jansen Steur, E.N., Braak, E., Staging of brain pathology related to sporadic Parkinson's disease (2003) Neurobiol. Aging, 24, pp. 197-211; Braak, H., Rüb, U., Gai, W.P., Del Tredici, K., Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen (2003) J. Neural Transm. (Vienna), 110, pp. 517-536; Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., Del Tredici, K., Stages in the development of Parkinson's disease-related pathology (2004) Cell Tissue Res., 318, pp. 121-134; Braak, H., Sastre, M., Bohl, J.R., de Vos, R.A., Del Tredici, K., Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons (2007) Acta Neuropathol., 113, pp. 421-429; Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., Di Filippo, M., Direct and indirect pathways of basal ganglia: a critical reappraisal (2014) Nat. Neurosci., 17, pp. 1022-1030; Chandra, R., Hiniker, A., Kuo, Y.M., Nussbaum, R.L., Liddle, R.A., α-synuclein in gut endocrine cells and its implications for Parkinson's disease (2017) JCI Insight, 2, p. 92295; Chapman, M.R., Robinson, L.S., Pinkner, J.S., Roth, R., Heuser, J., Hammar, M., Normark, S., Hultgren, S.J., Role of Escherichia coli curli operons in directing amyloid fiber formation (2002) Science, 295, pp. 851-855; Chaudhuri, K.R., Schapira, A.H., Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment (2009) Lancet Neurol., 8, pp. 464-474; Cryan, J.F., Mombereau, C., Vassout, A., The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice (2005) Neurosci. Biobehav. Rev., 29, pp. 571-625; Da Cunha, C., Angelucci, M.E., Canteras, N.S., Wonnacott, S., Takahashi, R.N., The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities (2002) Cell. Mol. Neurobiol., 22, pp. 227-237; Deacon, R.M., Assessing nest building in mice (2006) Nat. Protoc., 1, pp. 1117-1119; Delaville, C., Deurwaerdère, P.D., Benazzouz, A., Noradrenaline and Parkinson's disease (2011) Front. Syst. Neurosci., 5, p. 31; Dodel, R., Csoti, I., Ebersbach, G., Fuchs, G., Hahne, M., Kuhn, W., Oechsner, M., Schulz, J.B., Lewy body dementia and Parkinson's disease with dementia (2008) J. Neurol., 255, pp. 39-47; Eagle, A.L., Wang, H., Robison, A.J., Sensitive assessment of hippocampal learning using temporally dissociated passive avoidance task (2016) Biol. Protoc., 6, p. e1821; El-Salhy, M., Danielsson, A., Axelsson, H., Qian, B.F., Neuroendocrine peptide levels in the gastrointestinal tract of mice after unilateral cervical vagotomy (2000) Regul. Pept., 88, pp. 15-20; Fleming, S.M., Salcedo, J., Fernagut, P.O., Rockenstein, E., Masliah, E., Levine, M.S., Chesselet, M.F., Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein (2004) J. Neurosci., 24, pp. 9434-9440; Fleming, S.M., Tetreault, N.A., Mulligan, C.K., Hutson, C.B., Masliah, E., Chesselet, M.F., Olfactory deficits in mice overexpressing human wildtype alpha-synuclein (2008) Eur. J. Neurosci., 28, pp. 247-256; Forman, M.S., Trojanowski, J.Q., Lee, V.M., Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs (2004) Nat. Med., 10, pp. 1055-1063; Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J.A., Estes, J.D., Keshavarzian, A., Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease (2011) PLoS ONE, 6, p. e28032; Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., Shen, J., Iwatsubo, T., alpha-synuclein is phosphorylated in synucleinopathy lesions (2002) Nat. Cell Biol., 4, pp. 160-164; Furness, J.B., The enteric nervous system and neurogastroenterology (2012) Nat. Rev. Gastroenterol. Hepatol., 9, pp. 286-294; Gelpi, E., Navarro-Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M.J., Martí, M.J., Ribalta, T., Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders (2014) Mov. Disord., 29, pp. 1010-1018; Guo, J.L., Narasimhan, S., Changolkar, L., He, Z., Stieber, A., Zhang, B., Gathagan, R.J., Lee, V.M., Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice (2016) J. Exp. Med., 213, pp. 2635-2654; Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: a dual-hit hypothesis (2007) Neuropathol. Appl. Neurobiol., 33, pp. 599-614; Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson's disease: the dual hit theory revisited (2009) Ann. N Y Acad. Sci., 1170, pp. 615-622; Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.Y., Li, J.Y., Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats (2014) Acta Neuropathol., 128, pp. 805-820; Karpowicz, R.J., Jr., Trojanowski, J.Q., Lee, V.M., Transmission of α-synuclein seeds in neurodegenerative disease: recent developments (2019) Lab. Invest., , Published online February 13, 2019; Karuppagounder, S.S., Brahmachari, S., Lee, Y., Dawson, V.L., Dawson, T.M., Ko, H.S., The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease (2014) Sci. Rep., 4, p. 4874; Klingelhoefer, L., Reichmann, H., Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors (2015) Nat. Rev. Neurol., 11, pp. 625-636; Kuo, Y.M., Li, Z., Jiao, Y., Gaborit, N., Pani, A.K., Orrison, B.M., Bruneau, B.G., Nussbaum, R.L., Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes (2010) Hum. Mol. Genet., 19, pp. 1633-1650; Kwon, S.H., Kim, H.C., Lee, S.Y., Jang, C.G., Loganin improves learning and memory impairments induced by scopolamine in mice (2009) Eur. J. Pharmacol., 619, pp. 44-49; Lee, S.J., Desplats, P., Sigurdson, C., Tsigelny, I., Masliah, E., Cell-to-cell transmission of non-prion protein aggregates (2010) Nat. Rev. Neurol., 6, pp. 702-706; Leonard, B.E., Myint, A., Changes in the immune system in depression and dementia: causal or coincidental effects? (2006) Dialogues Clin. Neurosci., 8, pp. 163-174; Liu, B., Fang, F., Pedersen, N.L., Tillander, A., Ludvigsson, J.F., Ekbom, A., Svenningsson, P., Wirdefeldt, K., Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study (2017) Neurology, 88, pp. 1996-2002; Luk, K.C., Song, C., O'Brien, P., Stieber, A., Branch, J.R., Brunden, K.R., Trojanowski, J.Q., Lee, V.M., Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells (2009) Proc. Natl. Acad. Sci. USA, 106, pp. 20051-20056; Luk, K.C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J.Q., Lee, V.M., Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice (2012) Science, 338, pp. 949-953; Manfredsson, F.P., Luk, K.C., Benskey, M.J., Gezer, A., Garcia, J., Kuhn, N.C., Sandoval, I.M., Kordower, J.H., Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology (2018) Neurobiol. Dis., 112, pp. 106-118; Mao, X., Ou, M.T., Karuppagounder, S.S., Kam, T.I., Yin, X., Xiong, Y., Ge, P., Shin, J.H., Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 (2016) Science, 353, p. aah3374; Marinho-Buzelli, A.R., Bonnyman, A.M., Verrier, M.C., The effects of aquatic therapy on mobility of individuals with neurological diseases: a systematic review (2015) Clin. Rehabil., 29, pp. 741-751; Mayeux, R., The “serotonin hypothesis” for depression in Parkinson's disease (1990) Adv. Neurol., 53, pp. 163-166; Miyoshi, E., Wietzikoski, S., Camplessei, M., Silveira, R., Takahashi, R.N., Da Cunha, C., Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions (2002) Brain Res. Bull., 58, pp. 41-47; O'Leary, O.F., Ogbonnaya, E.S., Felice, D., Levone, B.R., C Conroy, L., Fitzgerald, P., Bravo, J.A., Cryan, J.F., The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus (2018) Eur. Neuropsychopharmacol., 28, pp. 307-316; Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Funk, R.H., Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice (2010) PLoS ONE, 5, p. e8762; Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G.A., Pal, A., Said, J., Rodrigo-Angulo, M., Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice (2012) Sci. Rep., 2, p. 898; Pellow, S., File, S.E., Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat (1986) Pharmacol. Biochem. Behav., 24, pp. 525-529; Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease (2003) Lancet Neurol., 2, pp. 107-116; Phelps, D., Brinkman, N.E., Keely, S.P., Anneken, E.M., Catron, T.R., Betancourt, D., Wood, C.E., Tal, T., Microbial colonization is required for normal neurobehavioral development in zebrafish (2017) Sci. Rep., 7, p. 11244; Ponsen, M.M., Stoffers, D., Booij, J., van Eck-Smit, B.L., Wolters, E.C., Berendse, H.W., Idiopathic hyposmia as a preclinical sign of Parkinson's disease (2004) Ann. Neurol., 56, pp. 173-181; Porsolt, R.D., Anton, G., Blavet, N., Jalfre, M., Behavioural despair in rats: a new model sensitive to antidepressant treatments (1978) Eur. J. Pharmacol., 47, pp. 379-391; Ressler, K.J., Mayberg, H.S., Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic (2007) Nat. Neurosci., 10, pp. 1116-1124; Rey, N.L., Steiner, J.A., Maroof, N., Luk, K.C., Madaj, Z., Trojanowski, J.Q., Lee, V.M., Brundin, P., Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease (2016) J. Exp. Med., 213, pp. 1759-1778; Rogers, R.C., Kita, H., Butcher, L.L., Novin, D., Afferent projections to the dorsal motor nucleus of the vagus (1980) Brain Res. Bull., 5, pp. 365-373; Sakata, K., Jin, L., Jha, S., Lack of promoter IV-driven BDNF transcription results in depression-like behavior (2010) Genes Brain Behav., 9, pp. 712-721; Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Gradinaru, V., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease (2016) Cell, 167, pp. 1469-1480.e12; Santiago, R.M., Barbieiro, J., Lima, M.M., Dombrowski, P.A., Andreatini, R., Vital, M.A., Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine (2010) Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, pp. 1104-1114; Sariñana, J., Tonegawa, S., Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory (2016) Hippocampus, 26, pp. 76-86; Song, N., Liu, J., Shaheen, S., Du, L., Proctor, M., Roman, J., Yu, J., Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice (2015) Sci. Rep., 5, p. 13419; Song, N., Wang, W., Jia, F., Du, X., Xie, A., He, Q., Shen, X., Jiang, H., Assessments of plasma ghrelin levels in the early stages of Parkinson's disease (2017) Mov. Disord., 32, pp. 1487-1491; Steru, L., Chermat, R., Thierry, B., Simon, P., The tail suspension test: a new method for screening antidepressants in mice (1985) Psychopharmacology (Berl.), 85, pp. 367-370; Surmeier, D.J., Obeso, J.A., Halliday, G.M., Selective neuronal vulnerability in Parkinson disease (2017) Nat. Rev. Neurosci., 18, pp. 101-113; Svensson, E., Horváth-Puhó, E., Thomsen, R.W., Djurhuus, J.C., Pedersen, L., Borghammer, P., Sørensen, H.T., Vagotomy and subsequent risk of Parkinson's disease (2015) Ann. Neurol., 78, pp. 522-529; Tadaiesky, M.T., Dombrowski, P.A., Figueiredo, C.P., Cargnin-Ferreira, E., Da Cunha, C., Takahashi, R.N., Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease (2008) Neuroscience, 156, pp. 830-840; Talaga, A.K., Dong, F.N., Reisert, J., Zhao, H., Cilia- and flagella-associated protein 69 regulates olfactory transduction kinetics in mice (2017) J. Neurosci., 37, pp. 5699-5710; Tarutani, A., Suzuki, G., Shimozawa, A., Nonaka, T., Akiyama, H., Hisanaga, S., Hasegawa, M., The effect of fragmented pathogenic α-synuclein seeds on prion-like propagation (2016) J. Biol. Chem., 291, pp. 18675-18688; Taylor, T.N., Greene, J.G., Miller, G.W., Behavioral phenotyping of mouse models of Parkinson's disease (2010) Behav. Brain Res., 211, pp. 1-10; Ter Horst, G.J., Toes, G.J., Van Willigen, J.D., Locus coeruleus projections to the dorsal motor vagus nucleus in the rat (1991) Neuroscience, 45, pp. 153-160; Tysnes, O.B., Kenborg, L., Herlofson, K., Steding-Jessen, M., Horn, A., Olsen, J.H., Reichmann, H., Does vagotomy reduce the risk of Parkinson's disease? (2015) Ann. Neurol., 78, pp. 1011-1012; Uemura, N., Yagi, H., Uemura, M.T., Hatanaka, Y., Yamakado, H., Takahashi, R., Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve (2018) Mol. Neurodegener., 13, p. 21; Ulusoy, A., Rusconi, R., Pérez-Revuelta, B.I., Musgrove, R.E., Helwig, M., Winzen-Reichert, B., Di Monte, D.A., Caudo-rostral brain spreading of α-synuclein through vagal connections (2013) EMBO Mol. Med., 5, pp. 1119-1127; Villageliú, D.N., Rasmussen, S., Lyte, M., A microbial endocrinology-based simulated small intestinal medium for the evaluation of neurochemical production by gut microbiota (2018) FEMS Microbiol. Ecol., 94, p. fiy096; Volpicelli-Daley, L.A., Luk, K.C., Patel, T.P., Tanik, S.A., Riddle, D.M., Stieber, A., Meaney, D.F., Lee, V.M., Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death (2011) Neuron, 72, pp. 57-71; Volpicelli-Daley, L.A., Luk, K.C., Lee, V.M., Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates (2014) Nat. Protoc., 9, pp. 2135-2146; Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory (2006) Nat. Protoc., 1, pp. 848-858; Wakabayashi, K., Mori, F., Tanji, K., Orimo, S., Takahashi, H., Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain (2010) Acta Neuropathol., 120, pp. 1-12; Watabe-Uchida, M., Zhu, L., Ogawa, S.K., Vamanrao, A., Uchida, N., Whole-brain mapping of direct inputs to midbrain dopamine neurons (2012) Neuron, 74, pp. 858-873; Williams, D.L., Grill, H.J., Cummings, D.E., Kaplan, J.M., Vagotomy dissociates short- and long-term controls of circulating ghrelin (2003) Endocrinology, 144, pp. 5184-5187; Wu, C.C., Lien, C.C., Hou, W.H., Chiang, P.M., Tsai, K.J., Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease (2016) Sci. Rep., 6, p. 27358},
correspondence_address1={Dawson, T.M.; Neuroregeneration and Stem Cell Programs, United States; email: tdawson@jhmi.edu},
publisher={Cell Press},
issn={08966273},
coden={NERNE},
pubmed_id={31255487},
language={English},
abbrev_source_title={Neuron},
document_type={Article},
source={Scopus},
}

@ARTICLE{Olsson201626,
author={Olsson, T. and Barcellos, L.F. and Alfredsson, L.},
title={Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis},
journal={Nature Reviews Neurology},
year={2016},
volume={13},
number={1},
pages={26-36},
doi={10.1038/nrneurol.2016.187},
note={cited By 472},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85004147147&doi=10.1038%2fnrneurol.2016.187&partnerID=40&md5=398ed1c88cac27c73204f88d0e637367},
affiliation={Neuroimmunology Unit, Center for Molecular Medicine, L8:04, Karolinska University Hospital (Solna), Stockholm, 17176, Sweden; Genetic Epidemiology and Genomics Laboratory, California Institute for Quantitative Biosciences (QB3), Office: 308D Stanley Hall, University of California, Berkeley, CA  94720-3220, United States; Institute of Environmental Medicine, Karolinska Institutet, Box 210, Stockholm, 171 77, Sweden},
abstract={Genetic predisposition to multiple sclerosis (MS) only explains a fraction of the disease risk; lifestyle and environmental factors are key contributors to the risk of MS. Importantly, these nongenetic factors can influence pathogenetic pathways, and some of them can be modified. Besides established MS-associated risk factors-high latitude, female sex, smoking, low vitamin D levels caused by insufficient sun exposure and/or dietary intake, and Epstein-Barr virus (EBV) infection-strong evidence now supports obesity during adolescence as a factor increasing MS risk. Organic solvents and shift work have also been reported to confer increased risk of the disease, whereas factors such as use of nicotine or alcohol, cytomegalovirus infection and a high coffee consumption are associated with a reduced risk. Certain factors-smoking, EBV infection and obesity-interact with HLA risk genes, pointing at a pathogenetic pathway involving adaptive immunity. All of the described risk factors for MS can influence adaptive and/or innate immunity, which is thought to be the main pathway modulated by MS risk alleles. Unlike genetic risk factors, many environmental and lifestyle factors can be modified, with potential for prevention, particularly for people at the greatest risk, such as relatives of individuals with MS. Here, we review recent data on environmental and lifestyle factors, with a focus on gene-environment interactions. © 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.},
keywords={vitamin D, adaptive immunity;  alcohol consumption;  body mass;  coffee;  cytomegalovirus infection;  dietary intake;  early life stress;  environmental factor;  epigenetics;  Epstein Barr virus infection;  gene interaction;  genetic predisposition;  genetic risk;  genetic variability;  genotype environment interaction;  heredity;  high risk population;  HLA system;  human;  innate immunity;  lifestyle;  microflora;  multiple sclerosis;  nonhuman;  obesity;  priority journal;  prognosis;  Review;  risk assessment;  risk factor;  salt intake;  sex difference;  shift worker;  smoking;  sun exposure;  tobacco use;  ultraviolet radiation;  vitamin blood level;  environmental exposure;  genetic predisposition;  multiple sclerosis;  risk factor, Environmental Exposure;  Gene-Environment Interaction;  Genetic Predisposition to Disease;  Humans;  Life Style;  Multiple Sclerosis;  Risk Factors},
references={Marrie, R.A., Yu, N., Wei, Y., Elliott, L., Blanchard, J., High rates of physician services utilization at least five years before multiple sclerosis diagnosis (2013) Mult. Scler., 19, pp. 1113-1119; Hughes, A.M., Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially (2013) Clin. Exp. Immunol., 172, pp. 466-474; Hedstrom, A.K., Hillert, J., Olsson, T., Alfredsson, L., Reverse causality behind the association between reproductive history and MS (2014) Mult. Scler., 20, pp. 406-411; Nielsen, N.M., Reproductive history and risk of multiple sclerosis (2011) Epidemiology, 22, pp. 546-552; Ascherio, A., Munger, K.L., Lunemann, J.D., The initiation and prevention of multiple sclerosis (2012) Nat. Rev. Neurol., 8, pp. 602-612; Lucas, R.M., Byrne, S.N., Correale, J., Ilschner, S., Hart, P.H., Ultraviolet radiation, Vitamin D and multiple sclerosis (2015) Neurodegener. Dis. Manag., 5, pp. 413-424; Sawcer, S., The complex genetics of multiple sclerosis: Pitfalls and prospects (2008) Brain, 131, pp. 3118-3131; Van Der Mei, I., Population attributable fractions and joint effects of key risk factors for multiple sclerosis (2016) Mult. Scler., 22, pp. 461-469; O'Gorman, C., Lin, R., Stankovich, J., Broadley, S.A., Modelling genetic susceptibility to multiple sclerosis with family data (2013) Neuroepidemiology, 40, pp. 1-12; Westerlind, H., Modest familial risks for multiple sclerosis: A registry-based study of the population of Sweden (2014) Brain, 137, pp. 770-778; Westerlind, H., Identity-by descent mapping in a Scandinavian multiple sclerosis cohort (2015) Eur. J. Hum. Genet., 23, pp. 688-692; Simpson, S., Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 1132-1141; Gale, C.R., Martyn, C.N., Migrant studies in multiple sclerosis (1995) Prog. Neurobiol., 47, pp. 425-448; Berg-Hansen, P., Prevalence of multiple sclerosis among immigrants in Norway (2015) Mult. Scler., 21, pp. 695-702; Ahlgren, C., Oden, A., Lycke, J., A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden (2012) Mult. Scler., 18, pp. 1099-1107; Ahlgren, C., Lycke, J., Oden, A., Andersen, O., High risk of MS in Iranian immigrants in Gothenburg, Sweden (2010) Mult. Scler., 16, pp. 1079-1082; Montgomery, S.M., Lambe, M., Olsson, T., Ekbom, A., Parental age, family size, and risk of multiple sclerosis (2004) Epidemiology, 15, pp. 717-723; Van Der Mei, I.A., Human leukocyte antigen DR15, low infant sibling exposure and multiple sclerosis: Gene-environment interaction (2010) Ann. Neurol., 67, pp. 261-265; Barnett, M.H., McLeod, J.G., Hammond, S.R., Kurtzke, J.F., Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: A reassessment III: Risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania (2016) J. Neurol., 263, pp. 792-798; Koch-Henriksen, N., Sorensen, P.S., The changing demographic pattern of multiple sclerosis epidemiology (2010) Lancet Neurol., 9, pp. 520-532; Westerlind, H., New data identify an increasing sex ratio of multiple sclerosis in Sweden (2014) Mult. Scler., 20, pp. 1578-1583; Ponsonby, A.L., Offspring number, pregnancy, and risk of a first clinical demyelinating event: The AusImmune Study (2012) Neurology, 78, pp. 867-874; Magyari, M., Koch-Henriksen, N., Pfleger, C.C., Sorensen, P.S., Reproduction and the risk of multiple sclerosis (2013) Mult. Scler., 19, pp. 1604-1609; Brodin, P., Variation in the human immune system is largely driven by non-heritable influences (2015) Cell, 160, pp. 37-47; Roshanisefat, H., Bahmanyar, S., Hillert, J., Olsson, T., Montgomery, S., Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis (2012) Mult. Scler., 18, pp. 1430-1436; Sawcer, S., Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) Nature, 476, pp. 214-219; Brynedal, B., HLA A confers an HLA DRB1 independent influence on the risk of multiple sclerosis (2007) PLoS ONE, 2, p. e664; Beecham, A.H., Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) Nat. Genet., 45, pp. 1353-1360; Moutsianas, L., Class II HLA interactions modulate genetic risk for multiple sclerosis (2015) Nat. Genet., 47, pp. 1107-1113; Rothman, K.J., Greenland, S., Walker, A.M., Concepts of interaction (1980) Am. J. Epidemiol., 112, pp. 467-470; Rothman, K.J., Greenland, S., Lash, T.L., (2008) Modern Epidemiology, pp. 71-83. , 3rd edn Ch. 3 Lippincott Williams &Wilkins; Hawkes, C.H., Smoking is a risk factor for multiple sclerosis: A metanalysis (2007) Mult. Scler., 13, pp. 610-615; Handel, A.E., Smoking and multiple sclerosis: An updated meta-analysis (2011) PLoS ONE, 6, p. e16149; Hedstrom, A.K., Baarnhielm, M., Olsson, T., Alfredsson, L., Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis (2009) Neurology, 73, pp. 696-701; Ghadirian, P., Dadgostar, B., Azani, R., Maisonneuve, P., A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis (2001) Can. J. Public Health, 92, pp. 281-285; Salzer, J., Smoking as a risk factor for multiple sclerosis (2013) Mult. Scler., 19, pp. 1022-1027; Hedstrom, A.K., Baarnhielm, M., Olsson, T., Alfredsson, L., Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis (2011) Mult. Scler., 17, pp. 788-793; Heydarpour, P., Potential impact of air pollution on multiple sclerosis in Tehran, Iran (2014) Neuroepidemiology, 43, pp. 233-238; Barragan-Martinez, C., Organic solvents as risk factor for autoimmune diseases: A systematic review and meta-analysis (2012) PLoS ONE, 7, p. e51506; Hedstrom, A., Smokers run increased risk of developing anti-natalizumab antibodies (2013) Mult. Scler., 20, pp. 1081-1085; Hedstrom, A.K., Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a (2014) Mult. Scler., 20, pp. 445-450; Chinoy, H., Interaction of HLA DRB103 and smoking for the development of anti Jo 1 antibodies in adult idiopathic inflammatory myopathies: A European-wide case study (2012) Ann. Rheum. Dis., 71, pp. 961-965; Klareskog, L., Catrina, A.I., Paget, S., Rheumatoid arthritis (2009) Lancet, 373, pp. 659-672; Hedstrom, A.K., Hillert, J., Olsson, T., Alfredsson, L., Nicotine might have a protective effect in the etiology of multiple sclerosis (2013) Mult. Scler., 19, pp. 1009-1013; Nizri, E., Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of TH1 and TH17 responses (2009) J. Immunol., 183, pp. 6681-6688; Shan, M., Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema (2009) Sci. Transl. Med., 1, p. 4ra10; Odoardi, F., T cells become licensed in the lung to enter the central nervous system (2012) Nature, 488, pp. 675-679; Hedstrom, A.K., Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis (2011) Brain, 134, pp. 653-664; Hedstrom, A.K., Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk (2014) Int. J. Epidemiol., 43, pp. 1791-1798; Briggs, F.B., Smoking and risk of multiple sclerosis: Evidence of modification by NAT1 variants (2014) Epidemiology, 25, pp. 605-614; Friese, M.A., Fugger, L., Autoreactive CD8+ T cells in multiple sclerosis: A new target for therapy (2005) Brain, 128, pp. 1747-1763; Friese, M.A., Opposing effects of HLA class i molecules in tuning autoreactive CD8+ T cells in multiple sclerosis (2008) Nat. Med., 14, pp. 1227-1235; Dendrou, C.A., Fugger, L., Friese, M.A., Immunopathology of multiple sclerosis (2015) Nat. Rev. Immunol., 15, pp. 545-558; Mustafa, M., The major histocompatibility complex influences myelin basic protein 63 88 induced T cell cytokine profile and experimental autoimmune encephalomyelitis (1993) Eur. J. Immunol., 23, pp. 3089-3095; Mustafa, M., Protective influences on experimental autoimmune encephalomyelitis by MHC class i and class II alleles (1994) J. Immunol., 153, pp. 3337-3344; Issazadeh, S., Kjellen, P., Olsson, T., Mustafa, M., Holmdahl, R., Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific (1997) Eur. J. Immunol., 27, pp. 1584-1587; Hedstrom, A.K., Olsson, T., Alfredsson, L., Smoking is a major preventable risk factor for multiple sclerosis (2016) Mult. Scler., 22, pp. 1021-1026; Sundstrom, P., Nystrom, L., Smoking worsens the prognosis in multiple sclerosis (2008) Mult. Scler., 14, pp. 1031-1035; Correale, J., Farez, M.F., Smoking worsens multiple sclerosis prognosis: Two different pathways are involved (2015) J. Neuroimmunol., 281, pp. 23-34; Di Pauli, F., Smoking is a risk factor for early conversion to clinically definite multiple sclerosis (2008) Mult. Scler., 14, pp. 1026-1030; Healy, B.C., Smoking and disease progression in multiple sclerosis (2009) Arch. Neurol., 66, pp. 858-864; Hernan, M.A., Cigarette smoking and the progression of multiple sclerosis (2005) Brain, 128, pp. 1461-1465; Pittas, F., Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis (2009) J. Neurol., 256, pp. 577-585; Manouchehrinia, A., Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study (2013) Brain, 136, pp. 2298-2304; Zivadinov, R., Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis (2009) Neurology, 73, pp. 504-510; Manouchehrinia, A., Weston, M., Tench, C.R., Britton, J., Constantinescu, C.S., Tobacco smoking and excess mortality in multiple sclerosis: A cohort study (2014) J. Neurol. Neurosurg. Psychiatry, 85, pp. 1091-1095; Ramanujam, R., Effect of smoking cessation on multiple sclerosis prognosis (2015) JAMA Neurol., 72, pp. 1117-1123; Handel, A.E., An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis (2010) PLoS ONE, 5, p. e12496; Sundstrom, P., Nystrom, M., Ruuth, K., Lundgren, E., Antibodies to specific EBNA 1 domains and HLA DRB11501 interact as risk factors for multiple sclerosis (2009) J. Neuroimmunol., 215, pp. 102-107; Sundqvist, E., Epstein-Barr virus and multiple sclerosis: Interaction with HLA (2012) Genes Immun., 13, pp. 14-20; Levin, L.I., Munger, K.L., O'Reilly, E.J., Falk, K.I., Ascherio, A., Primary infection with the Epstein-Barr virus and risk of multiple sclerosis (2010) Ann. Neurol., 67, pp. 824-830; Ascherio, A., Munger, K.L., EBV and autoimmunity (2015) Curr. Top. Microbiol. Immunol., 390, pp. 365-385; Makhani, N., Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination (2016) Mult. Scler., 22, pp. 385-388; Zhou, Y., Genetic loci for Epstein-Barr virus nuclear antigen 1 are associated with risk of multiple sclerosis (2016) Mult. Scler.; Nielsen, T.R., Effects of infectious mononucleosis and HLA DRB115 in multiple sclerosis (2009) Mult. Scler., 15, pp. 431-436; Hedstrom, A.K., Lima, B.I., Hillert, J., Olsson, T., Alfredsson, L., Obesity interacts with infectious mononucleosis in risk of multiple sclerosis (2015) Eur. J. Neurol., 22, p. 578; Serafini, B., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain (2007) J. Exp. Med., 204, pp. 2899-2912; Lassmann, H., Niedobitek, G., Aloisi, F., Middeldorp, J.M., Epstein-Barr virus in the multiple sclerosis brain: A controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria (2011) Brain, 134, pp. 2772-2786; Hauser, S.L., B Cell depletion with rituximab in relapsing-remitting multiple sclerosis (2008) N. Engl. J. Med., 358, pp. 676-688; Sundqvist, E., JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants (2014) PLoS Pathog., 10, p. e1004084; Staras, S.A., Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 (2006) Clin. Infect. Dis., 43, pp. 1143-1151; Waubant, E., Common viruses associated with lower pediatric multiple sclerosis risk (2011) Neurology, 76, pp. 1989-1995; Waubant, E., Antibody response to common viruses and human leukocyte antigen DRB1 in pediatric multiple sclerosis (2013) Mult. Scler., 19, pp. 891-895; Sundqvist, E., Cytomegalovirus seropositivity is negatively associated with multiple sclerosis (2014) Mult. Scler., 20, pp. 165-173; Ascherio, A., Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study (2001) JAMA, 286, pp. 3083-3088; Levin, L.I., Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis (2005) JAMA, 293, pp. 2496-2500; DeLorenze, G.N., Epstein-Barr virus and multiple sclerosis: Evidence of association from a prospective study with long-term follow up (2006) Arch. Neurol., 63, pp. 839-844; Chidrawar, S., Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals (2009) Clin. Exp. Immunol., 155, pp. 423-432; Munger, K.L., Molecular mechanism underlying the impact of Vitamin D on disease activity of MS (2014) Ann. Clin. Transl. Neurol., 1, pp. 605-617; Kampman, M.T., Wilsgaard, T., Mellgren, S.I., Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle (2007) J. Neurol., 254, pp. 471-477; Baarnhielm, M., Sunlight is associated with decreased multiple sclerosis risk: No interaction with human leukocyte antigen DRB115 (2012) Eur. J. Neurol., 19, pp. 955-962; Becklund, B.R., Severson, K.S., Vang, S.V., DeLuca, H.F., UV radiation suppresses experimental autoimmune encephalomyelitis independent of Vitamin D production (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 6418-6423; Rana, S., Rogers, L.J., Halliday, G.M., Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms (2011) Am. J. Pathol., 178, pp. 2783-2791; Breuer, J., Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity (2014) Ann. Neurol., 75, pp. 739-758; Navid, F., The aryl hydrocarbon receptor is involved in UVR-induced immunosuppression (2013) J. Invest. Dermatol., 133, pp. 2763-2770; Correale, J., Farez, M.F., Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid (2013) J. Neuroimmunol., 261, pp. 134-140; Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S., Ascherio, A., Serum 25 hydroxyvitamin D levels and risk of multiple sclerosis (2006) JAMA, 296, pp. 2832-2838; Cortese, M., Timing of use of cod liver oil, a Vitamin D source, and multiple sclerosis risk: The EnvIMS study (2015) Mult. Scler., 21, pp. 1856-1864; Bjornevik, K., Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study (2014) Mult. Scler., 20, pp. 1042-1049; Baarnhielm, M., Olsson, T., Alfredsson, L., Fatty fish intake is associated with decreased occurrence of multiple sclerosis (2014) Mult. Scler., 20, pp. 726-732; Sandberg, L., Vitamin D and axonal injury in multiple sclerosis (2015) Mult. Scler., 22, pp. 1027-1031; Ueda, P., Neonatal Vitamin D status and risk of multiple sclerosis (2014) Ann. Neurol., 76, pp. 338-346; Adzemovic, M.Z., Zeitelhofer, M., Hochmeister, S., Gustafsson, S.A., Jagodic, M., Efficacy of Vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage (2013) Exp. Neurol., 249, pp. 39-48; Munger, K.L., Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort (2016) JAMA Neurol., 73, pp. 515-519; Staples, J., Ponsonby, A.L., Lim, L., Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis (2010) BMJ, 340, p. c1640; Sundqvist, E., Confirmation of association between multiple sclerosis and CYP27B1 (2010) Eur. J. Hum. Genet., 18, pp. 1349-1352; Rhead, B., Mendelian randomization shows a causal effect of low Vitamin D on multiple sclerosis risk (2016) Neurol. Genet., 2, p. e97; Mokry, L.E., Vitamin D and risk of multiple sclerosis: A Mendelian randomization study (2015) PLoS Med., 12, p. e1001866; Handunnetthi, L., Ramagopalan, S.V., Ebers, G.C., Multiple sclerosis, Vitamin D, and HLA DRB115 (2010) Neurology, 74, pp. 1905-1910; Ascherio, A., Vitamin D as an early predictor of multiple sclerosis activity and progression (2014) JAMA Neurol., 71, pp. 306-314; Fitzgerald, K.C., Association of Vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon Beta 1b (2015) JAMA Neurol., 72, pp. 1458-1465; Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women (2009) Neurology, 73, pp. 1543-1550; Munger, K.L., Childhood body mass index and multiple sclerosis risk: A long-term cohort study (2013) Mult. Scler., 19, pp. 1323-1329; Hedstrom, A.K., Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis (2014) Neurology, 82, pp. 865-872; Gianfrancesco, M.A., Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors (2014) Obes. Res. Clin. Pract., 8, pp. e435-447; Langer-Gould, A., Brara, S.M., Beaber, B.E., Koebnick, C., Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome (2013) Neurology, 80, pp. 548-552; Hedstrom, A.K., Olsson, T., Alfredsson, L., Body mass index during adolescence, rather than childhood, is critical in determining MS risk (2016) Mult. Scler., 22, pp. 878-883; Wesnes, K., Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study (2015) Mult. Scler., 21, pp. 388-395; Mokry, L.E., Obesity and multiple sclerosis: A Mendelian randomization study (2016) PLoS Med., 13, p. e1002053; Gianfrancesco, M.A., Genetic variants associated with body mass index demonstrate a causal effect on multiple sclerosis susceptibility (2016) Am. J. Epidemiol, , http://dx.doi.org/10.1093/aje/kww120, In press; Lumeng, C.N., Bodzin, J.L., Saltiel, A.R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization (2007) J. Clin. Invest., 117, pp. 175-184; Procaccini, C., Pucino, V., Mantzoros, C.S., Matarese, G., Leptin in autoimmune diseases (2015) Metabolism, 64, pp. 92-104; Matarese, G., Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells (2005) Proc. Natl Acad. Sci. USA., 102, pp. 5150-5155; Matarese, G., Carrieri, P.B., Montella, S., De Rosa, V., La Cava, A., Leptin as a metabolic link to multiple sclerosis (2010) Nat. Rev. Neurol., 6, pp. 455-461; Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z., Holick, M.F., Decreased bioavailability of Vitamin D in obesity (2000) Am. J. Clin. Nutr., 72, pp. 690-693; Karlsson, E.A., Beck, M.A., The burden of obesity on infectious disease (2010) Exp. Biol. Med. (Maywood), 235, pp. 1412-1424; Paich, H.A., Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus (2013) Obesity (Silver Spring), 21, pp. 2377-2386; Magrini, A., Shift work and autoimmune thyroid disorders (2006) Int. J. Immunopathol. Pharmacol., 19, pp. 31-36; Hedstrom, A.K., Akerstedt, T., Hillert, J., Olsson, T., Alfredsson, L., Shift work at young age is associated with increased risk for multiple sclerosis (2011) Ann. Neurol., 70, pp. 733-741; Hedstrom, A., Akerstedt, T., Olsson, T., Alfredsson, L., Shift work influences multiple sclerosis risk (2015) Mult. Scler., 21, pp. 1195-1199; Hansson, I., Holmdahl, R., Mattsson, R., Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice (1990) J. Neuroimmunol., 27, pp. 79-84; Farez, M.F., Melatonin contributes to the seasonality of multiple sclerosis relapses (2015) Cell, 162, pp. 1338-1352; Hansson, I., Holmdahl, R., Mattsson, R., Pinealectomy ameliorates collagen II induced arthritis in mice (1993) Clin. Exp. Immunol., 92, pp. 432-436; Massa, J., O'Reilly, E.J., Munger, K.L., Ascherio, A., Caffeine and alcohol intakes have no association with risk of multiple sclerosis (2013) Mult. Scler., 19, pp. 53-58; Hedstrom, A.K., Hillert, J., Olsson, T., Alfredsson, L., Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk (2014) JAMA Neurol., 71, pp. 300-305; Kallberg, H., Alcohol consumption is associated with decreased risk of rheumatoid arthritis: Results from two Scandinavian case-control studies (2009) Ann. Rheum. Dis., 68, pp. 222-227; Hedstrom, A.K., High consumption of coffee is associated with decreased multiple sclerosis risk; Results from two independent studies (2016) J. Neurol. Neurosurg. Psychiatry, 87, pp. 454-460; Chen, G.Q., Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by Guinea pig spinal cord homogenates in Wistar rats (2010) Brain Res., 1309, pp. 116-125; Horrigan, L.A., Kelly, J.P., Connor, T.J., Immunomodulatory effects of caffeine: Friend or foe (2006) Pharmacol. Ther., 111, pp. 877-892; Kleinewietfeld, M., Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells (2013) Nature, 496, pp. 518-522; Wu, C., Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 (2013) Nature, 496, pp. 513-517; Farez, M.F., Fiol, M.P., Gaitan, M.I., Quintana, F.J., Correale, J., Sodium intake is associated with increased disease activity in multiple sclerosis (2015) J. Neurol. Neurosurg. Psychiatry, 86, pp. 26-31; Berer, K., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination (2011) Nature, 479, pp. 538-541; Correale, J., Farez, M.F., The impact of environmental infections (parasites) on MS activity (2011) Mult. Scler., 17, pp. 1162-1169; Zhang, D., Genetic control of individual differences in gene-specific methylation in human brain (2010) Am. J. Hum. Genet., 86, pp. 411-419; Liu, Y., GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease (2014) Am. J. Hum. Genet., 94, pp. 485-495; Gao, X., Jia, M., Zhang, Y., Breitling, L.P., Brenner, H., DNA methylation changes of whole blood cells in response to active smoking exposure in adults: A systematic review of DNA methylation studies (2015) Clin. Epigenetics, 7, p. 113; Mastronardi, F.G., Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: A role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation (2006) J. Neurosci., 26, pp. 11387-11396; Baranzini, S.E., Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis (2010) Nature, 464, pp. 1351-1356; Pedre, X., Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions (2011) J. Neurosci., 31, pp. 3435-3445; Graves, M.C., Methylation differences at the HLA DRB1 locus in CD4+ T Cells are associated with multiple sclerosis (2014) Mult. Scler., 20, pp. 1033-1041; Huynh, J.L., Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains (2014) Nat. Neurosci., 17, pp. 121-130; Bos, S.D., Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis (2015) PLoS ONE, 10, p. e0117403; Maltby, V.E., Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients (2015) Clin. Epigenetics, 7, p. 118},
correspondence_address1={Olsson, T.; Neuroimmunology Unit, Sweden; email: tomas.olsson@ki.se},
publisher={Nature Publishing Group},
issn={17594758},
pubmed_id={27934854},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Trichopoulos1990939,
author={Trichopoulos, D.},
title={Hypothesis: does breast cancer originate in utero?},
journal={The Lancet},
year={1990},
volume={335},
number={8695},
pages={939-940},
doi={10.1016/0140-6736(90)91000-Z},
note={cited By 442},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025214007&doi=10.1016%2f0140-6736%2890%2991000-Z&partnerID=40&md5=204464fa18987a5360a6b3246ef5b383},
affiliation={Department of Epidemiology, School of Public Health, Harvard University, 677 Huntington Avenue, Boston, MA 02115, United States},
abstract={Factors that increase the risk of cancer during adult life may also increase the risk of cancer when they act in utero (eg, ionising radiation and diethylstilboestrol in human beings and chemicals in animals). The existing empirical data seem to be compatible with the hypothesis that increased concentrations of oestrogens in pregnancy increase the probability of future occurrence of breast cancer in daughters. © 1990.},
keywords={estrogen, breast cancer;  cancer risk;  carcinogenesis;  human;  pregnancy;  priority journal;  review;  uterus, Adult;  Breast Neoplasms;  Diet;  Diethylstilbestrol;  Estrogens;  Female;  Human;  Neoplasms, Radiation-Induced;  Pregnancy;  Prenatal Exposure Delayed Effects;  Risk Factors},
chemicals_cas={Diethylstilbestrol, 56-53-1; Estrogens},
references={Boyle, Epidemiology of breast cancer (1988) Baillière's clinical oncology, 2, pp. 1-57. , Jw Yorbro, Rs Bornstein, Mj Mastrangelo, Saunders, Eastbourne; Kelsey, Hildreth, (1983) Breast and gynecologic cancer epidemiology, , CRC Press, Boca Raton, Florida, 5-70; Seshadri, Matthews, Dobrovic, Horsfall, The significance of oncogene amplification in primary breast cancer (1989) Int J Cancer, 43, pp. 270-272; Kelsey, Berkowitz, Breast cancer epidemiology (1988) Cancer Res, 48, pp. 5615-5623; Bergkvist, Adami, Persson, Hoover, Schairer, The risk of breast cancer after estrogen and estrogen-progestin replacement (1989) N Engl J Med, 321, pp. 293-297; Buell, Changing incidence of breast cancer in Japanese-American women (1973) J Natl Cancer Inst, 51, pp. 1479-1483; Trichopoulos, Yen, Brown, Cole, MacMahon, The effect of westernization on urine estrogens, frequency of ovulation and breast risk. A study of ethnic Chinese in the Orient and the USA (1984) Cancer, 53, pp. 187-192; Committee on Diet, Nutrition on Cancer, Assembly of Life Sciences, National Research Council, (1982) Diet, Nutrition and Cancer, , National Academy Press, Washington, DC; Rogers, Longnecker, Dietary and nutritional influences on cancer: a review of epidemiologic and experimental data (1988) Lab Invest, 59, pp. 729-759; Cole, MacMahon, Oestrogen fractions during early reproductive life in the aetiology of breast cancer (1969) Lancet, 1, pp. 604-606; Simpson, Candlish, Pauson, McArdle, Griffiths, Small, Genesis of breast cancer is in the premenopause (1988) Lancet, 2, pp. 74-76; deWaard, Breast cancer incidence and nutritional status with particular reference to body weight and height (1975) Cancer Res, 35, pp. 3351-3356; Micozzi, (1985) Nutrition, body size, and breast cancer. Yearbook of Physical Anthropology, 128. , 175-206; Micozzi, Schatzkin, International correlation of anthropometric variables and adolescent growth patterns with breast cancer incidence (1985) Am J Phys Anthropol, 66, pp. 206-207; Valaoras, MacMahon, Trichopoulos, Polychronopoulou, Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965-67 (1969) Int J Cancer, 4, pp. 350-363; Tretli, Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway (1989) Int J Cancer, 44, pp. 23-30; deWaard, Body size and breast cancer risk (1981) Banbury Report 8. Hormones and breast cancer, pp. 21-29. , Mc Pike, Pk Siiteri, Cw Welsch, Cold Spring Harbor Laboratory, Cold Spring Harbor; Willett, The search for the causes of breast and colon cancer (1989) Nature, 338, pp. 389-394; Albanes, Winick, Are cell number and cell proliferation risk factors for cancer? (1988) JNCI Journal of the National Cancer Institute, 80, pp. 772-775; deWaard, Trichopoulos, A unifying concept of the aetiology of breast cancer (1988) International Journal of Cancer, 41, pp. 666-669; Law, The production of tumours by injection of a carcinogen into the amniotic fluid of mice (1940) Science, 91, pp. 96-97; Tomatis, Prenatal exposure to chemical carcinogens and its effect on subsequent generations (1979) Natl Cancer Inst Monog, 51, pp. 159-184; MacMahon, Prenatal X-ray exposure and childhood cancer (1962) J Natl Cancer Inst, 28, pp. 1173-1191; Kneale, Stewart, Preconception X-rays and childhood cancers (1980) Br J Cancer, 41, pp. 222-226; Greenwald, Barlow, Nasca, Burnett, Vaginal cancer after maternal treatment with synthetic estrogens (1971) N Engl J Med, 285, pp. 390-392; Tomatis, Overview of perinatal and multi-generation carcinogenesis (1989) Perinatal and multigeneration carcinogenesis, pp. 1-15. , Np Napalkov, Jm Rice, L. Tomatis, H. Yamasaki, International Agency for Research on Cancer, Lyon, IARC Scientific Publications No 96; Kato, Yoshimoto, Schull, Risk of cancer among children exposed to atomic bomb radiation in utero: a review (1986) Perinatal and Multigeneration Carcinogenesis, pp. 365-374. , Np Napalkov, Jm Rice, L. Tomatis, H. Yamasaki, International Agency for Research on Cancer, Lyon, IARC Scientific Publications No. 96; Vessey, Epidemiological studies of the effects of diethylstilbestrol (1989) Perinatal and multigeneration carcinogenesis, pp. 335-348. , Np Napalkov, Jm Rice, L. Tomatis, H. Yamasaki, International Agency for Research on Cancer, Lyon, IARC Scientific Publications No. 96; Depue, Pike, Henderson, Estrogen exposure during gestation and risk of testicular cancer (1983) J Natl Cancer Inst, 71, pp. 1151-1155; Walker, Ross, Haile, Henderson, Hormonal factors and risk of ovarian germ cell cancer in young women (1988) Br J Cancer, 57, pp. 418-422; Genuth, The reproductive glands (1983) Physiology, pp. 1069-1115. , Rm Berne, Mn Levy, CV Mosby Co, St. Louis; MacMahon, Cole, Brown, Urine oestrogen profiles of Asian and North American women (1974) Int J Cancer, 14, pp. 161-167; Petridou, Panagiotopoulou, Katsouyanni, Spanos, Trichopoulos, Tobacco smoking, pregnancy estrogens and birth weight (1990) Epidemiology, 1, pp. 247-250; Rothman, MacMahon, Lin, Maternal age and birth rank of women with breast cancer (1980) J Natl Cancer Inst, 65, pp. 719-722; Walker, Tumors in female offspring of control and diethystilbestrol-exposed mice fed high-fat diets (1990) J Natl Cancer Inst, 82, pp. 50-54},
correspondence_address1={Trichopoulos, D.; Department of Epidemiology, School of Public Health, Harvard University, 677 Huntington Avenue, Boston, MA 02115, United States},
issn={01406736},
coden={LANCA},
pubmed_id={1970028},
language={English},
abbrev_source_title={Lancet},
document_type={Article},
source={Scopus},
}

@ARTICLE{Lill2012,
author={Lill, C.M. and Roehr, J.T. and McQueen, M.B. and Kavvoura, F.K. and Bagade, S. and Schjeide, B.-M.M. and Schjeide, L.M. and Meissner, E. and Zauft, U. and Allen, N.C. and Liu, T. and Schilling, M. and Anderson, K.J. and Beecham, G. and Berg, D. and Biernacka, J.M. and Brice, A. and DeStefano, A.L. and Do, C.B. and Eriksson, N. and Factor, S.A. and Farrer, M.J. and Foroud, T. and Gasser, T. and Hamza, T. and Hardy, J.A. and Heutink, P. and Hill-Burns, E.M. and Klein, C. and Latourelle, J.C. and Maraganore, D.M. and Martin, E.R. and Martinez, M. and Myers, R.H. and Nalls, M.A. and Pankratz, N. and Payami, H. and Satake, W. and Scott, W.K. and Sharma, M. and Singleton, A.B. and Stefansson, K. and Toda, T. and Tung, J.Y. and Vance, J. and Wood, N.W. and Zabetian, C.P. and Young, P. and Tanzi, R.E. and Khoury, M.J. and Zipp, F. and Lehrach, H. and Ioannidis, J.P.A. and Bertram, L.},
title={Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDgene database},
journal={PLoS Genetics},
year={2012},
volume={8},
number={3},
doi={10.1371/journal.pgen.1002548},
art_number={e1002548},
note={cited By 424},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859339977&doi=10.1371%2fjournal.pgen.1002548&partnerID=40&md5=f82c97209bb553743d64c76ddfe75f7a},
affiliation={Neuropsychiatric Genetics Group, Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Department of Neurology, Massachusetts General Hospital, Charlestown, MA, United States; Department of Neurology, Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Department of Neurology, University Hospital, Münster, Germany; Department of Mathematics and Computer Science, Free University, Berlin, Germany; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, United States; Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Centre for Diabetes and Endocrinology, Royal Berkshire Hospital, Reading, United Kingdom; Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, University of Oxford, Oxford, United Kingdom; Max Planck Institute for Human Development, Berlin, Germany; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; INSERM, UMR-S975, Paris, France; Université Pierre et Marie Curie-Paris, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975, Paris, France; CNRS, UMR 7225, Paris, France; AP-HP, Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France; Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, United States; Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States; 23andMe, Mountain View, CA, United States; Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; Indiana University School of Medicine, Indianapolis, IN, United States; New York State Department of Health Wadsworth Center, Albany, NY, United States; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom; Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, Netherlands; Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lübeck, Lübeck, Germany; Department of Neurology, NorthShore University Health System, Evanston, IL, United States; INSERM UMR 1043, CPTP, Toulouse, France; Paul Sabatier University, Toulouse, France; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States; Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan; DeCODE genetics, Reykjavik, Iceland; UCL Genetics Institute, University College London, London, United Kingdom; VA Puget Sound Health Care System and Department of Neurology, University of Washington, Seattle, WA, United States; Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA, United States; Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece; Center for Genetic Epidemiology and Modeling and Tufts Clinical, Translational Science Institute, Tufts University School of Medicine, Boston, MA, United States; Stanford Prevention Research Center, Department of Medicine and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States},
abstract={More than 800 published genetic association studies have implicated dozens of potential risk loci in Parkinson's disease (PD). To facilitate the interpretation of these findings, we have created a dedicated online resource, PDGene, that comprehensively collects and meta-analyzes all published studies in the field. A systematic literature screen of ~27,000 articles yielded 828 eligible articles from which relevant data were extracted. In addition, individual-level data from three publicly available genome-wide association studies (GWAS) were obtained and subjected to genotype imputation and analysis. Overall, we performed meta-analyses on more than seven million polymorphisms originating either from GWAS datasets and/or from smaller scale PD association studies. Meta-analyses on 147 SNPs were supplemented by unpublished GWAS data from up to 16,452 PD cases and 48,810 controls. Eleven loci showed genome-wide significant (P&gt;5×10-8) association with disease risk: BST1, CCDC62/HIP1R, DGKQ/GAK, GBA, LRRK2, MAPT, MCCC1/LAMP3, PARK16, SNCA, STK39, and SYT11/RAB25. In addition, we identified novel evidence for genome-wide significant association with a polymorphism in ITGA8 (rs7077361, OR 0.88, P = 1.3×10-8). All meta-analysis results are freely available on a dedicated online database (www.pdgene.org), which is cross-linked with a customized track on the UCSC Genome Browser. Our study provides an exhaustive and up-to-date summary of the status of PD genetics research that can be readily scaled to include the results of future large-scale genetics projects, including next-generation sequencing studies.},
keywords={article;  data analysis;  data base;  data extraction;  gene locus;  gene sequence;  genetic association;  genotype;  human;  information processing;  meta analysis (topic);  online system;  Parkinson disease;  PDGene database;  single nucleotide polymorphism;  web browser;  genetic database;  genetics;  human genome;  Internet;  meta analysis, Databases, Genetic;  Genome, Human;  Genome-Wide Association Study;  Humans;  Internet;  Parkinson Disease;  Polymorphism, Single Nucleotide},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute on AgingNational Institute on Aging, NIA, ZIAAG000949},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, R01CA141668},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, P50NS071674, R01NS036711, R01NS036960, R01NS037167},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, R01ES010751, Z01ES101986},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, UL1RR025752},
funding_details={Michael J. Fox Foundation for Parkinson's ResearchMichael J. Fox Foundation for Parkinson's Research, MJFF},
funding_details={Mayo ClinicMayo Clinic},
funding_details={MedtronicMedtronic},
funding_details={Alnylam PharmaceuticalsAlnylam Pharmaceuticals},
funding_details={Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentEunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, R01HD060726},
funding_details={Medical Research CouncilMedical Research Council, MRC, G0701075, G0901254},
funding_details={EisaiEisai},
funding_text 1={CB Do, N Eriksson, and JY Tung are employed by 23andMe and own stock options in the company. MJ Farrer and Mayo Foundation received royalties from H.Lundbeck A/S and Isis Pharmaceuticals. In addition, MJ Farrer has received an honorarium for a seminar at Genzyme. T Gasser has received consultancy fees from Cephalon and Merck-Serono, grants from Novartis, payments for lectures including service on speakers' bureaus from Boehringer Ingelheim, Merck-Serono, UCB, and Valean, and holds patents NGFN2 and KASPP. JA Hardy has received consulting fees or honoraria from Eisai and his institute has received consulting fees or honoraria from Merck-Serono. DM Maraganore has received extramural research funding support from the National Institutes of Health (2R01 ES10751), the Michael J. Fox Foundation (Linked Efforts to Accelerate Parkinson Solutions Award, Edmond J. Safra Global Genetics Consortia Award), and from Alnylam Pharmaceuticals and Medtronic (observational studies of Parkinson's disease). DM Maraganore has also received intramural research funding support from the Mayo Clinic and from NorthShore University Health System. DM Maraganore filed a provisional patent for a method to predict Parkinson's disease. This provisional patent is unlicensed. He also filed a provisional patent for a method to treat neurodegenerative disorders. That provisional patent has been licensed to Alnylam Pharmaceuticals and DM Maraganore has received royalty payments in total of less than $20,000. K Stefansson has received grants from deCODE.},
references={de Lau, L.M.L., Breteler, M.M.B., Epidemiology of Parkinson's disease (2006) Lancet Neurol, 5, pp. 525-535. , doi:10.1016/S1474-4422(06)70471-9; Hardy, J., Lewis, P., Revesz, T., Lees, A., Paisan-Ruiz, C., The genetics of Parkinson's syndromes: a critical review (2009) Curr Opin Genet Dev, 19, pp. 254-265. , doi:10.1016/j.gde.2009.03.008; Vilariño-Güell, C., Wider, C., Ross, O.A., Dachsel, J.C., Kachergus, J.M., VPS35 mutations in Parkinson disease (2011) Am J Hum Genet, 89, pp. 162-167. , doi:10.1016/j.ajhg.2011.06.001; Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S.H., A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease (2011) Am J Hum Genet, 89, pp. 168-175. , doi:10.1016/j.ajhg.2011.06.008; Chartier-Harlin, M.-C., Dachsel, J.C., Vilariño-Güell, C., Lincoln, S.J., Leprêtre, F., Translation initiator EIF4G1 mutations in familial Parkinson disease (2011) Am J Hum Genet, 89, pp. 398-406. , doi:10.1016/j.ajhg.2011.08.009; Maraganore, D.M., de Andrade, M., Elbaz, A., Farrer, M.J., Ioannidis, J.P., Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease (2006) JAMA, 296, pp. 661-670. , doi:10.1001/jama.296.6.661; Zabetian, C.P., Yamamoto, M., Lopez, A.N., Ujike, H., Mata, I.F., LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease (2009) Mov Disord, 24, pp. 1034-1041. , doi:10.1002/mds.22514; Goris, A., Williams-Gray, C.H., Clark, G.R., Foltynie, T., Lewis, S.J.G., Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease (2007) Ann Neurol, 62, pp. 145-153. , doi:10.1002/ana.21192; Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease (2009) N Engl J Med, 361, pp. 1651-1661. , doi:10.1056/NEJMoa0901281; Maraganore, D.M., de Andrade, M., Lesnick, T.G., Strain, K.J., Farrer, M.J., High-resolution whole-genome association study of Parkinson disease (2005) Am J Hum Genet, 77, pp. 685-693. , doi:10.1086/496902; Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data (2006) Lancet Neurol, 5, pp. 911-916. , doi:10.1016/S1474-4422(06)70578-6; Pankratz, N., Wilk, J.B., Latourelle, J.C., DeStefano, A.L., Halter, C., Genomewide association study for susceptibility genes contributing to familial Parkinson disease (2009) Hum Genet, 124, pp. 593-605. , doi:10.1007/s00439-008-0582-9; Simón-Sánchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Genome-wide association study reveals genetic risk underlying Parkinson's disease (2009) Nat Genet, 41, pp. 1308-1312. , doi:10.1038/ng.487; Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease (2009) Nat Genet, 41, pp. 1303-1307. , doi:10.1038/ng.485; Edwards, T.L., Scott, W.K., Almonte, C., Burt, A., Powell, E.H., Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease (2010) Ann Hum Genet, 74, pp. 97-109. , doi:10.1111/j.1469-1809.2009.00560.x; Hamza, T.H., Zabetian, C.P., Tenesa, A., Laederach, A., Montimurro, J., Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease (2010) Nat Genet, 42, pp. 781-785. , doi:10.1038/ng.642; Spencer, C.C.A., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21 (2011) Hum Mol Genet, 20, pp. 345-353. , doi:10.1093/hmg/ddq469; Saad, M., Lesage, S., Saint-Pierre, A., Corvol, J.-C., Zelenika, D., Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population (2011) Hum Mol Genet, 20, pp. 615-627. , doi:10.1093/hmg/ddq497; Simón-Sánchez, J., van Hilten, J.J., van de Warrenburg, B., Post, B., Berendse, H.W., Genome-wide association study confirms extant PD risk loci among the Dutch (2011) Eur J Hum Genet, 19, pp. 655-661. , doi:10.1038/ejhg.2010.254; Evangelou, E., Maraganore, D.M., Ioannidis, J.P.A., Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease (2007) PLoS ONE, 2, pp. e196. , doi:10.1371/journal.pone.0000196; Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.-M., Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies (2011) Lancet, 377, pp. 641-649. , doi:10.1016/S0140-6736(10)62345-8; Do, C.B., Tung, J.Y., Dorfman, E., Kiefer, A.K., Drabant, E.M., Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease (2011) PLoS Genet, 7, pp. e1002141. , doi:10.1371/journal.pgen.1002141; Sharma, M., Ioannidis, J.P.A., Aasly, J.O., Annesi, G., Brice, A., Large-scale replication and heterogeneity in Parkinson disease genetic loci Neurology in press, n.d; Lin, D.-Y., Sullivan, P.F., Meta-analysis of genome-wide association studies with overlapping subjects (2009) Am J Hum Genet, 85, pp. 862-872. , doi:10.1016/j.ajhg.2009.11.001; Ioannidis, J.P.A., Effect of formal statistical significance on the credibility of observational associations (2008) Am J Epidemiol, 168, pp. 374-383. , doi:10.1093/aje/kwn156, discussion 384-390; Ioannidis, J.P.A., Boffetta, P., Little, J., O'Brien, T.R., Uitterlinden, A.G., Assessment of cumulative evidence on genetic associations: interim guidelines (2008) Int J Epidemiol, 37, pp. 120-132. , doi:10.1093/ije/dym159; Khoury, M.J., Bertram, L., Boffetta, P., Butterworth, A.S., Chanock, S.J., Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases (2009) Am J Epidemiol, 170, pp. 269-279. , doi:10.1093/aje/kwp119; Kent, W.J., Zweig, A.S., Barber, G., Hinrichs, A.S., Karolchik, D., BigWig and BigBed: enabling browsing of large distributed datasets (2010) Bioinformatics, 26, pp. 2204-2207. , doi:10.1093/bioinformatics/btq351; Myers, A.J., Gibbs, J.R., Webster, J.A., Rohrer, K., Zhao, A., A survey of genetic human cortical gene expression (2007) Nat Genet, 39, pp. 1494-1499. , doi:10.1038/ng.2007.16; Varnum-Finney, B., Venstrom, K., Muller, U., Kypta, R., Backus, C., The integrin receptor alpha 8 beta 1 mediates interactions of embryonic chick motor and sensory neurons with tenascin-C (1995) Neuron, 14, pp. 1213-1222; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Harbord, R.M., Egger, M., Sterne, J.A.C., A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints (2006) Stat Med, 25, pp. 3443-3457. , doi:10.1002/sim.2380; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database (2007) Nat Genet, 39, pp. 17-23. , doi:10.1038/ng1934; Allen, N.C., Bagade, S., McQueen, M.B., Ioannidis, J.P.A., Kavvoura, F.K., Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database (2008) Nat Genet, 40, pp. 827-834. , doi:10.1038/ng.171},
correspondence_address1={Bertram, L.; Neuropsychiatric Genetics Group, , Berlin, Germany; email: lbertram@molgen.mpg.de},
issn={15537390},
pubmed_id={22438815},
language={English},
abbrev_source_title={PLoS Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{NoAuthor2019,
title={Risk Reduction of Cognitive Decline and Dementia},
journal={Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines},
year={2019},
note={cited By 420},
source={Scopus},
}

@ARTICLE{Ioannidis2007245,
author={Ioannidis, J.P.A. and Trikalinos, T.A.},
title={An exploratory test for an excess of significant findings},
journal={Clinical Trials},
year={2007},
volume={4},
number={3},
pages={245-253},
doi={10.1177/1740774507079441},
note={cited By 418},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548642946&doi=10.1177%2f1740774507079441&partnerID=40&md5=400df4bfbfa8b4a6d455c3652270d050},
affiliation={Clinical Trials and Evidence Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, United States; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece},
abstract={Background: The published clinical research literature may be distorted by the pursuit of statistically significant results. Purpose: We aimed to develop a test to explore biases stemming from the pursuit of nominal statistical significance. Methods: The exploratory test evaluates whether there is a relative excess of formally significant findings in the published literature due to any reason (e.g., publication bias, selective analyses and outcome reporting, or fabricated data). The number of expected studies with statistically significant results is estimated and compared against the number of observed significant studies. The main application uses α = 0.05, but a range of α thresholds is also examined. Different values or prior distributions of the effect size are assumed. Given the typically low power (few studies per research question), the test may be best applied across domains of many meta-analyses that share common characteristics (interventions, outcomes, study populations, research environment). Results: We evaluated illustratively eight meta-analyses of clinical trials with >50 studies each and 10 meta-analyses of clinical efficacy for neuroleptic agents in schizophrenia; the 10 meta-analyses were also examined as a composite domain. Different results were obtained against commonly used tests of publication bias. We demonstrated a clear or possible excess of significant studies in 6 of 8 large meta-analyses and in the wide domain of neuroleptic treatments. Limitations: The proposed test is exploratory, may depend on prior assumptions, and should be applied cautiously. Conclusions: An excess of significant findings may be documented in some clinical research fields. © Society for Clinical Trials 2007.},
keywords={chlorpromazine;  clozapine;  haloperidol;  loxapine;  neuroleptic agent;  pimozide;  placebo;  risperidone;  sulpiride;  thioridazine, analytical research;  article;  clinical research;  clinical trial;  drug effect;  drug efficacy;  exploratory research;  human;  medical literature;  outcome assessment;  priority journal;  publication;  schizophrenia;  statistical significance, Antipsychotic Agents;  Bias (Epidemiology);  Clinical Trials as Topic;  Data Interpretation, Statistical;  Humans;  Meta-Analysis as Topic;  Probability;  Schizophrenia},
chemicals_cas={chlorpromazine, 50-53-3, 69-09-0; clozapine, 5786-21-0; haloperidol, 52-86-8; loxapine, 1977-10-2; pimozide, 2062-78-4; risperidone, 106266-06-2; sulpiride, 15676-16-1; thioridazine, 130-61-0, 50-52-2; Antipsychotic Agents},
references={Neslon, N., Rosenthal, R., Rosnow, R.L., Interpretation of significance levels by psychological researchers (1986) Am Psychol, 41, pp. 1299-1301; Cohen, J., The earth is round (p-less-than .05) (1994) Am Psychol, 49, pp. 997-1003; Rosenthal, R., Gaito, J., The interpretation of levels of significance by psychological researchers (1963) J Psychol, 55, pp. 33-38; Rosenthal, R., Gaito, J., Further evidence for the cliff effect in the interpretation of levels of significance (1964) Psychol Rep, 15, p. 570; Ioannidis, J.P., Why most published research findings are false (2005) PLoS Med, 2, pp. e124; Dickersin, K., Min, Y.I., Publication bias: The problem that won't go away (1993) Ann N Y Acad Sci, 703, pp. 135-146; Dickersin, K., Min, Y.I., Meinert, C.L., Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards (1992) JAMA, 267, pp. 374-378; Dickersin, K., The existence of publication bias and risk factors for its occurrence (1990) JAMA, 263, pp. 1385-1389; Chalmers, I., Underreporting research is scientific misconduct (1990) JAMA, 263, pp. 1405-1408; Easterbrook, P.J., Berlin, J.A., Gopalan, R., Matthews, D.R., Publication bias in clinical research (1991) Lancet, 337, pp. 867-872; Ioannidis, J.P., Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials (1998) JAMA, 279, pp. 281-286; Light, R.J., Pillemer, D.B., (1984) Summing up. The science of reviewing research, , London: Harvard University Press; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50, pp. 1088-1101; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Sterne, J.A., Egger, M., Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis (2001) J Clin Epidemiol, 54, pp. 1046-1055; Sterne, J.A., Gavaghan, D., Egger, M., Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature (2000) J Clin Epidemiol, 53, pp. 1119-1129; Hedges, L.V., Modeling publication selection effects in meta-analysis (1992) Stat Sci, 7, pp. 246-255; Copas, J.B., What works?: Selectivity models and meta-analysis (1999) J Royal Stat Assoc, 162, pp. 95-109; Hedges, L.V., Vevea, J.L., Estimating effect size under publication bias: Small sample properties and robustness of a random effects selection model (1996) J Educ Behav Stat, 21, pp. 299-332; Vevea, J.L., Hedges, L.V., A general linear model for estimating effect size in the presence of publication bias (1995) Psychometrika, 60, pp. 419-435; Iyengar, S., Zhao, P.L., Maximum likelihood estimation for weighted distributions (1994) Stat Probab Lett, 50, pp. 438-460; Ioannidis, J.P., Differentiating biases from genuine heterogeneity: Distinguishing artifactual from substantive effects (2005) Publication bias in meta-analysis - Prevention, assessment and adjustments, , Rothstein HR, Sutton AJ, Borenstein M eds, Sussex: John Wiley; Chan, A.W., Hrobjartsson, A., Haahr, M.T., Gotzsche, P.C., Altman, D.G., Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles (2004) JAMA, 291, pp. 2457-2465; Chan, A.W., Krleza-Jeric, K., Schmid, I., Altman, D.G., Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research (2004) CMAJ, 171, pp. 735-740; Kyzas, P.A., Loizou, K.T., Ioannidis, J.P., Selective reporting biases in cancer prognostic factor studies (2005) J Natl Cancer Inst, 97, pp. 1043-1055; Michels, K.B., Rosner, B.A., Data trawling: To fish or not to fish (1996) Lancet, 348, pp. 1152-1153; Weiss, R.B., Gill, G.G., Hudis, C.A., An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications (2001) J Clin Oncol, 19, pp. 2771-2777; Ransam, J., Buyse, M., George, S.L., Fraud in medical research: An international survey of biostatisticians (2000) Control Clin Trials, 21, pp. 415-427; Gardner, W., Lidz, C.W., Hartwig, K.C., Authors' reports about research integrity in clinical trials (2005) Contemp Clin Trials, 26, pp. 244-251; Al-Marzouki, S., Evans, S., Marshall, T., Robert, I., Are these data real? Statistical methods for the detection of data fabrication in clinical trials (2005) BMJ, 331, pp. 267-270; Lau, J., Ioannidis, J.P.A., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826; Engels, E.A., Schmid, C.H., Terrin, N., Olkin, I., Lau, J., Heterogeneity and statistical significance in meta-analysis: An empirical study of 125 meta-analyses (2000) Stat Med, 19, pp. 1707-1728; Terrin, N., Schmid, C.H., Lau, J., Olkin, I., Adjusting for publication bias in the presence of heterogeneity (2003) Stat Med, 22, pp. 2113-2126; Lau, J., Ioannidis, J.P.A., Schmid, C.H., Summing up evidence: One answer is not always enough (1998) Lancet, 351, pp. 123-127; Preston, C., Ashby, D., Smith, R., Adjusting for publication bias: Modelling the selection process (2004) J Eval Clin Pract, 10, pp. 313-322; Spiegelhalter, D.J., Myles, J.P., Jones, D.R., Abrams, K.R., Bayesian methods in health technology assessment: A review (2000) Health Technol Assess, 4, pp. 1-130; Sutton, A.J., Abrams, K.R., Jones, D.R., Generalized synthesis of evidence and the threat of dissemination bias: The example of electronic fetal heart rate monitoring (EFM) (2002) J Clin Epidemiol, 55, pp. 1013-1024; Trikalinos, T.A., Churchill, R., Ferri, M., Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time (2004) J Clin Epidemiol, 57, pp. 1124-1130; Ioannidis, J.P.A., Lau, J., Evolution of treatment effects over time: Empirical evidence from recursive cumulative meta-analyses (2001) Proc Natl Acad Sci USA, 98, pp. 831-836; Counsell, C., Formulating questions and locating primary studies for inclusion in systematic reviews (1997) Ann Intern Med, 127, pp. 380-387; Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., Rothman, N., Assessing the probability that a positive report is false: An approach for molecular epidemiology studies (2004) J Natl Cancer Inst, 96, pp. 434-442; Efron, B., Tibshirani, R., Empirical Bayes methods and false discovery rates for microarrays (2002) Genet Epidemiol, 23, pp. 70-86; Spiegelhalter, D.J., Abrams, K.R., Myles, J.P., (2004) Bayesian approaches to clinical trials and health-care evaluation, , Chichester: John Wiley & Sons; Lilford, R.J., Braunholtz, D., The statistical basis of public policy (1996) BMJ, 313, pp. 603-607; Carlin, B.P., Louis, T.A., (2000) Bayes and empirical Bayes methods for data analysis, , Boca Raton: Chapman and Hall/CRC; Greenland, S., Power, sample size and smallest detectable effect determination for multivariate studies (1985) Stat Med, 4, pp. 117-127; Lui, K.J., Sample size determination for case-control studies: The influence of the joint distribution of exposure and confounder (1990) Stat Med, 9, pp. 1485-1493; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am J Epidemiol, 131, pp. 552-566; Pan, Z., Trikalinos, T.A., Kavvoura, F.K., Lau, J., Ioannidis, J.P., Local literature bias in genetic epidemiology: An empirical evaluation of the Chinese literature (2005) PLoS Med, 2, pp. e334; Oxman, A.D., Guyatt, G.H., A consumer's guide to subgroup analyses (1992) Ann Intern Med, 116, pp. 78-84; Ioannidis, J.P.A., Rosenberg, P.S., Goedert, J.J., O'Brien, T.R., Meta-analysis of individual participants' data in genetic epidemiology (2002) Am J Epidemiol, 156, pp. 204-210; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558},
correspondence_address1={Ioannidis, J.P.A.; Department of Hygiene and Epidemiology, , Ioannina 45110, Greece; email: jioannid@cc.uoi.gr},
issn={17407745},
pubmed_id={17715249},
language={English},
abbrev_source_title={Clin. Trials},
document_type={Article},
source={Scopus},
}

@ARTICLE{Dinu201830,
author={Dinu, M. and Pagliai, G. and Casini, A. and Sofi, F.},
title={Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomised trials},
journal={European Journal of Clinical Nutrition},
year={2018},
volume={72},
number={1},
pages={30-43},
doi={10.1038/ejcn.2017.58},
note={cited By 407},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040356827&doi=10.1038%2fejcn.2017.58&partnerID=40&md5=baa4b39524adef99d04a8cb10424c6bf},
affiliation={Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 3, Florence, 50134, Italy; Unit of Clinical Nutrition, University Hospital of Careggi, Florence, Italy; Don Carlo Gnocchi Foundation Italy, Onlus IRCCS, Florence, Italy},
abstract={Research has shown that a greater adherence to the Mediterranean diet is associated with a reduced risk of major chronic disease. However, the existing literature leads to debate for different issues, such as the measurement of the adherence to the Mediterranean diet, the use of a wide variety of dietary indices with various food components and the large heterogeneity across the studies. In order to summarise the evidence and evaluate the validity of the association between the adherence to the Mediterranean diet and multiple health outcomes, an umbrella review of the evidence across meta-analyses of observational studies and randomised clinical trials (RCTs) was performed. Thirteen meta-analyses of observational studies and 16 meta-analyses of RCTs investigating the association between the adherence to the Mediterranean diet and 37 different health outcomes, for a total population of over than 12 800 000 subjects, were identified. A robust evidence, supported by a P-value<0.001, a large simple size, and not a considerable heterogeneity between studies, for a greater adherence to the Mediterranean diet and a reduced the risk of overall mortality, cardiovascular diseases, coronary heart disease, myocardial infarction, overall cancer incidence, neurodegenerative diseases and diabetes was found. For most of the site-specific cancers, as well as for inflammatory and metabolic parameters, the evidence was only suggestive or weak and further studies are needed to draw firmer conclusions. No evidence, on the other hand, was reported for bladder, endometrial and ovarian cancers, as well as for LDL (low density lipoprotein)-cholesterol levels. © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.},
keywords={antioxidant;  polyphenol, adult;  cohort analysis;  connor davidson psychological resilience scale;  cross-sectional study;  dietary pattern;  female;  food frequency questionnaire;  food intake;  fruit vegetable;  human;  major clinical study;  male;  Mediterranean diet;  prospective study;  psychologic assessment;  psychological resilience;  Review;  socioeconomics;  cardiovascular disease;  coronary artery disease;  degenerative disease;  diabetes mellitus;  evidence based medicine;  heart infarction;  incidence;  meta analysis (topic);  mortality;  neoplasm;  observational study;  patient compliance;  randomized controlled trial (topic);  reproducibility, Cardiovascular Diseases;  Coronary Disease;  Diabetes Mellitus;  Diet, Mediterranean;  Evidence-Based Medicine;  Humans;  Incidence;  Meta-Analysis as Topic;  Mortality;  Myocardial Infarction;  Neoplasms;  Neurodegenerative Diseases;  Observational Studies as Topic;  Patient Compliance;  Randomized Controlled Trials as Topic;  Reproducibility of Results;  Systematic Reviews as Topic},
chemicals_cas={polyphenol, 37331-26-3},
references={García-Fernández, E., Rico-Cabanas, L., Rosgaard, N., Estruch, R., Bach-Faig, A., Mediterranean diet and cardiodiabesity: A review (2014) Nutrients, 6, pp. 3474-3500; Vivancos, M., Moreno, J.J., Effect of resveratrol, tyrosol and beta-sitosterol on oxidised low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages (2008) Br J Nutr, 99, pp. 1199-1207; Sofi, F., MacChi, C., Abbate, R., Gensini, G.F., Casini, A., Mediterranean diet and health status: An updated meta-analysis and a proposal for a literature-based adherence score (2014) Public Health Nutr, 17, pp. 2769-2782; Hernández-Ruiz, A., García-Villanova, B., Guerra Hernández, E.J., Amiano, P., Azpiri, M., Molina-Montes, E., Description of indexes based on the adherence to the Mediterranean dietary pattern: A review (2015) Nutr Hosp, 32, pp. 1872-1884; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Based Healthc, 13, pp. 132-140; Riley, R.D., Higgins, J.P., Deeks, J.J., Interpretation of random effects meta-analyses (2011) BMJ, 342, p. d549; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Lau, J., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkin-sonism Relat Disord, 23, pp. 1-9; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci USA, 110, pp. 19313-19317; Huedo-Medina, T.B., Garcia, M., Bihuniak, J.D., Kenny, A., Kerstetter, J., Methodologic quality of meta-analyses and systematic reviews on the Mediterranean diet and cardiovascular disease outcomes: A review (2016) Am J Clin Nutr, 103, pp. 841-850; Ma, M., Bes-Rastrollo, M., Dietary patterns, Mediterranean diet, and cardiovascular disease (2014) Curr Opin Lipidol, 25, pp. 20-26; Grosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., A comprehensive meta-analysis on evidence of mediterranean diet and cardiovascular disease: Are individual components equal? (2015) Crit Rev Food Sci Nutr, , e-pub ahead of print 3 November 2015; Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scar-Meas, N., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis (2013) Ann Neurol, 74, pp. 580-591; Kastorini, C.M., Milionis, H.J., Esposito, K., Giugliano, D., Goudevenos, J.A., Panagiotakos, D.B., The effect of Mediterranean diet on metabolic syndrome and its components: A meta-analysis of 50 studies and 534, 906 individuals (2011) J Am Coll Cardiol, 57, pp. 1299-1313; Schwingshackl, L., Hoffmann, G., Adherence to Mediterranean diet and risk of cancer: An updated systematic review and meta-analysis of observational studies (2015) Cancer Med, 4, pp. 1933-1947; Bloomfield, H.E., Koeller, E., Greer, N., MacDonald, R., Kane, R., Wilt, T.J., Effects on health outcomes of a Mediterranean diet with no restriction on fat intake: A systematic review and meta-analysis (2016) Ann Intern Med, 165, pp. 491-500; Wu, L., Sun, D., Adherence to Mediterranean diet and risk of developing cognitive disorders: An updated systematic review and meta-analysis of prospective cohort studies (2017) Sci Rep, 7, p. 41317; Singh, B., Parsaik, A.K., Mielke, M.M., Erwin, P.J., Knopman, D.S., Petersen, R.C., Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis (2014) J Alzheimers Dis, 39, pp. 271-282; Cao, L., Tan, L., Wang, H.F., Jiang, T., Zhu, X.C., Lu, H., Dietary patterns and risk of dementia: A systematic review and meta-analysis of cohort studies (2016) Mol Neurobiol, 53, pp. 6144-6154; Godos, J., Zappalà, G., Bernardini, S., Giambini, I., Bes-Rastrollo, M., Martinez-Gonzalez, M., Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: A meta-analysis of observational studies (2017) Int J Food Sci Nutr, 68, pp. 138-148; Koloverou, E., Esposito, K., Giugliano, D., Panagiotakos, D., The effect of Mediterranean diet on the development of type 2 diabetes mellitus: A meta-analysis of 10 pro-spective studies and 136, 846 participants (2014) Metabolism, 63, pp. 903-911; Schwingshackl, L., Missbach, B., König, J., Hoffmann, G., Adherence to a Mediterranean diet and risk of diabetes: A systematic review and meta-analysis (2015) Public Health Nutr, 18, pp. 1292-1299; Liyanage, T., Ninomiya, T., Wang, A., Neal, B., Jun, M., Wong, M.G., Effects of the Mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis (2016) PLoS One, 11, p. e0159252; Nordmann, A.J., Suter-Zimmermann, K., Bucher, H.C., Shai, I., Tuttle, K.R., Estruch, R., Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors (2011) Am J Med, 124, pp. 841-851; Rees, K., Hartley, L., Flowers, N., Clarke, A., Hooper, L., Thorogood, M., 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease (2013) Cochrane Database Syst Rev, 8, p. CD009825; Huo, R., Du, T., Xu, Y., Xu, W., Chen, X., Sun, K., Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: A meta-analysis (2015) Eur J Clin Nutr, 69, pp. 1200-1208; Nissensohn, M., Román-Viñas, B., Sánchez-Villegas, A., Piscopo, S., Serra-Majem, L., The effect of the Mediterranean diet on hypertension: A systematic review and meta-analysis (2016) J Nutr Educ Behav, 48, pp. 42-53; Garcia, M., Bihuniak, J.D., Shook, J., Kenny, A., Kerstetter, J., Huedo-Medina, T.B., The effect of the traditional Mediterranean-style diet on metabolic risk factors: A meta-analysis (2016) Nutrients, 8, p. 168; Gay, H.C., Rao, S.G., Vaccarino, V., Ali, M.K., Effects of different dietary interventions on blood pressure: Systematic review and meta-analysis of randomized controlled trials (2016) Hypertension, 67, pp. 733-739; Ndanuko, R.N., Tapsell, L.C., Charlton, K.E., Neale, E.P., Batterham, M.J., Dietary patterns and blood pressure in adults: A systematic review and meta-analysis of randomized controlled trials (2016) Adv Nutr, 7, pp. 76-89; Schwingshackl, L., Hoffmann, G., Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials (2014) Nutr Metab Cardiovasc Dis, 24, pp. 929-939; Esposito, K., Kastorini, C.M., Panagiotakos, D.B., Giugliano, D., Mediterranean diet and weight loss: Meta-analysis of randomized controlled trials (2011) Metab Syndr Relat Disord, 9, pp. 1-12; Ajala, O., English, P., Pinkney, J., Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes (2013) Am J Clin Nutr, 97, pp. 505-516; Esposito, K., Maiorino, M.I., Bellastella, G., Chiodini, P., Panagiotakos, D., Giugliano, D., A journey into a Mediterranean diet and type 2 diabetes: A systematic review with meta-analyses (2015) BMJ Open, 5, p. e008222; Gajendragadkar, P.R., Hubsch, A., Mäki-Petäjä, K.M., Serg, M., Wilkinson, I.B., Cheriyan, J., Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: A randomised controlled trial (2014) PLoS One, 9, p. e99070; Casas, R., Sacanella, E., Urpí-Sardà, M., Chiva-Blanch, G., Ros, E., Ma, M., The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease (2014) PLoS One, 9, p. e100084; Storniolo, C.E., Roselló-Catafau, J., Pintó, X., Mitjavila, M.T., Moreno, J.J., Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1 (2014) Redox Biol, 2, pp. 971-977; Estruch, R., Anti-inflammatory effects of the Mediterranean diet: The experience of the PREDIMED study (2010) Proc Nutr Soc, 69, pp. 333-340; Storniolo, C.E., Casillas, R., Bulló, M., Castañer, O., Ros, E., Sáez, G.T., A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women (2017) Eur J Nutr, 56, pp. 89-97; Sedgwick, P., Cross sectional studies: Advantages and disadvantages (2014) BMJ, 348, p. g2276; Mann, C.J., Observational research methods. Research design II: Cohort, cross sectional, and case-control studies (2003) Emerg Med J, 20, pp. 54-60; Flegal, K.M., Evaluating epidemiologic evidence of the effects of food and nutrient exposures (1999) Am J Clin Nutr, 69, pp. 1339S-1344S; Cherbuin, N., Anstey, K.J., The Mediterranean diet is not related to cognitive change in a large prospective investigation: The PATH Through Life study (2012) Am J Geriatr Psychiatry, 20, pp. 635-639},
correspondence_address1={Dinu, M.; Department of Experimental and Clinical Medicine, Largo Brambilla, 3, Italy; email: mdinu@unifi.it},
publisher={Nature Publishing Group},
issn={09543007},
coden={EJCNE},
pubmed_id={28488692},
language={English},
abbrev_source_title={Eur. J. Clin. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Belbasis2015263,
author={Belbasis, L. and Bellou, V. and Evangelou, E. and Ioannidis, J.P.A. and Tzoulaki, I.},
title={Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses},
journal={The Lancet Neurology},
year={2015},
volume={14},
number={3},
pages={263-273},
doi={10.1016/S1474-4422(14)70267-4},
note={cited By 396},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923285215&doi=10.1016%2fS1474-4422%2814%2970267-4&partnerID=40&md5=4418cf1f8aaca07b5c811cff8eb65af8},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Biostatistics and Epidemiology, Imperial College London, London, United Kingdom; MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={Background: The cause of multiple sclerosis is believed to involve environmental exposure and genetic susceptibility. We aimed to summarise the environmental risk factors that have been studied in relation to onset of multiple sclerosis, assess whether there is evidence for diverse biases in this literature, and identify risk factors without evidence of biases. Methods: We searched PubMed from inception to Nov 22, 2014, to identify systematic reviews and meta-analyses of observational studies that examined associations between environmental factors and multiple sclerosis. For each meta-analysis we estimated the summary effect size by use of random-effects and fixed-effects models, the 95% CI, and the 95% prediction interval. We estimated the between-study heterogeneity expressed by I2 (defined as large for I2≥50%), evidence of small-study effects (ie, large studies had significantly more conservative results than smaller studies), and evidence of excess significance bias (ie, more studies than expected with significant results). Findings: Overall, 44 unique meta-analyses including 416 primary studies of different risk factors and multiple sclerosis were examined, covering a wide range of risk factors: vaccinations, comorbid diseases, surgeries, traumatic events and accidents, exposure to environmental agents, and biochemical, infectious, and musculoskeletal biomarkers. 23 of 44 meta-analyses had results that were significant at p values less than ·05 and 11 at p values less than ·001 under the random-effects model. Only three of the 11 significant meta-analyses (p&lt;·001) included more than 1000 cases, had 95% prediction intervals excluding the null value, and were not suggestive of large heterogeneity (I2&lt;50%), small-study effects (p for Egger's test &gt;·10), or excess significance (p&gt;·05). These were IgG seropositivity to Epstein-Barr virus nuclear antigen (EBNA) (random effects odds ratio [OR] 4·46, 95% CI 3·26-6·09; p for effect size=1·5 × 10-19; I2=43%), infectious mononucleosis (2·17, 1·97-2·39; p=3·1 × 10-50; I2=0%), and smoking (1·52, 1·39-1·66; p=1·7 × 10-18; I2=0%). Interpretation: Many studies on environmental factors associated with multiple sclerosis have caveats casting doubts on their validity. Data from more and better-designed studies are needed to establish robust evidence. A biomarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking showed the strongest consistent evidence of an association. Funding: None. © 2015 Elsevier Ltd.},
keywords={Epstein Barr virus antigen;  immunoglobulin G;  prolactin;  uric acid;  virus capsid antigen;  virus DNA;  vitamin D, accident;  Article;  BCG vaccination;  bone density;  chronic cerebrospinal venous insufficiency;  comorbidity;  cytomegalovirus infection;  diphtheria;  disease association;  environmental exposure;  environmental factor;  Epstein Barr virus infection;  femur neck;  folic acid blood level;  hepatitis B;  human;  meta analysis (topic);  mononucleosis;  multiple sclerosis;  priority journal;  prolactin blood level;  risk factor;  smoking;  social status;  systematic review (topic);  tetanus;  tonsillectomy;  vitamin blood level;  adverse effects;  literature;  meta analysis (topic);  multiple sclerosis;  observational study, Environmental Exposure;  Humans;  Meta-Analysis as Topic;  Multiple Sclerosis;  Observational Study as Topic;  Review Literature as Topic;  Risk Factors},
chemicals_cas={immunoglobulin G, 97794-27-9; prolactin, 12585-34-1, 50647-00-2, 9002-62-4; uric acid, 69-93-2},
references={Gilden, D.H., Infectious causes of multiple sclerosis (2005) Lancet Neurol, 4, pp. 195-202; (2013) Atlas of MS 2013: mapping multiple sclerosis around the world, , Multiple Sclerosis International Federation, Multiple Sclerosis International Federation, London; Kingwell, E., Marriott, J.J., Jette, N., Incidence and prevalence of multiple sclerosis in Europe: a systematic review (2013) BMC Neurol, 13, p. 128; Evans, C., Beland, S.G., Kulaga, S., Incidence and prevalence of multiple sclerosis in the Americas: a systematic review (2013) Neuroepidemiology, 40, pp. 195-210; Handel, A.E., Williamson, A.J., Disanto, G., Handunnetthi, L., Giovannoni, G., Ramagopalan, S.V., An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis (2010) PLoS One, 5; Handel, A.E., Williamson, A.J., Disanto, G., Dobson, R., Giovannoni, G., Ramagopalan, S.V., Smoking and multiple sclerosis: an updated meta-analysis (2011) PLoS One, 6; Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., Taylor, B., Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis (2011) J Neurol Neurosurg Psychiatry, 82, pp. 1132-1141; Ramagopalan, S.V., Dobson, R., Meier, U.C., Giovannoni, G., Multiple sclerosis: risk factors, prodromes, and potential causal pathways (2010) Lancet Neurol, 9, pp. 727-739; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A, 172, pp. 137-159; Higgins, J.P., Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Cochran, W., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335, pp. 914-916; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am J Epidemiol, 131, pp. 552-566; Bagos, P.G., Nikolopoulos, G., Ioannidis, A., Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis (2006) Mult Scler, 12, pp. 397-411; Sundqvist, E., Bergstrom, T., Daialhosein, H., Cytomegalovirus seropositivity is negatively associated with multiple sclerosis (2014) Mult Scler, 20, pp. 165-173; Liu, B., Shen, Y., Xiao, K., Tang, Y., Cen, L., Wei, J., Serum uric acid levels in patients with multiple sclerosis: a meta-analysis (2012) Neurol Res, 34, pp. 163-171; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22, pp. 450-456; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci USA, 110, pp. 19313-19317; Laupacis, A., Lillie, E., Dueck, A., Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis (2011) CMAJ, 183, pp. E1203-E1212; Zwischenberger, B.A., Beasley, M.M., Davenport, D.L., Xenos, E.S., Meta-analysis of the correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis (2013) Vasc Endovasc Surg, 47, pp. 620-624; Ascherio, A., Munch, M., Epstein-Barr virus and multiple sclerosis (2000) Epidemiology, 11, pp. 220-224; Pakpoor, J., Disanto, G., Gerber, J.E., The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis (2013) Mult Scler, 19, pp. 162-166; Demicheli, V., Rivetti, A., Di Pietrantonj, C., Clements, C.J., Jefferson, T., Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review (2003) J Viral Hepat, 10, pp. 343-344; Martinez-Sernandez, V., Figueiras, A., Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production (2013) J Neurol, 260, pp. 1951-1959; Rutschmann, O.T., McCrory, D.C., Matchar, D.B., Immunization and MS: a summary of published evidence and recommendations (2002) Neurology, 59, pp. 18343-18370; Thacker, E.L., Mirzaei, F., Ascherio, A., Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis (2006) Ann Neurol, 59, pp. 499-503; Hernan, M.A., Alonso, A., Hernandez-Diaz, S., Tetanus vaccination and risk of multiple sclerosis: a systematic review (2006) Neurology, 67, pp. 212-215; Landtblom, A.M., Flodin, U., Soderfeldt, B., Wolfson, C., Axelson, O., Organic solvents and multiple sclerosis: a synthesis of the current evidence (1996) Epidemiology, 7, pp. 429-433; Hawkes, C.H., Smoking is a risk factor for multiple sclerosis: a metanalysis (2007) Mult Scler, 13, pp. 610-615; Zhu, Y., Liu, H.N., Zhang, C.D., Liang, H.Y., [Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis] (2009) Zhonghua Yi Xue Za Zhi, 89, pp. 3055-3057; Lunny, C.A., Fraser, S.N., Knopp-Sihota, J.A., Physical trauma and risk of multiple sclerosis: a systematic review and meta-analysis of observational studies (2014) J Neurol Sci, 336, pp. 13-23; Warren, S.A., Olivo, S.A., Contreras, J.F., Traumatic injury and multiple sclerosis: a systematic review and meta-analysis (2013) Can J Neurol Sci, 40, pp. 168-176; Artemiadis, A.K., Anagnostouli, M.C., Alexopoulos, E.C., Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review (2011) Neuroepidemiology, 36, pp. 109-120; Goulden, R., Ibrahim, T., Wolfson, C., Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review (2014) Eur J Neurol, , published online Nov 5; Zhornitsky, S., Yong, V.W., Weiss, S., Metz, L.M., Prolactin in multiple sclerosis (2013) Mult Scler, 19, pp. 15-23; Duan, S., Lv, Z., Fan, X., Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis (2014) Neurosci Lett, 570, pp. 108-113; Zhu, Y., He, Z.Y., Liu, H.N., Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis (2011) J Clin Neurosci, 18, pp. 933-938; Huang, Z., Qi, Y., Du, S., Chen, G., Yan, W., Bone mineral density levels in adults with multiple sclerosis: a meta-analysis (2014) Int J Neurosci, , published online Dec 18; Aminzadeh, K.K., Etminan, M., Dental amalgam and multiple sclerosis: a systematic review and meta-analysis (2007) J Public Health Dent, 67, pp. 64-66; Barragan-Martinez, C., Speck-Hernandez, C.A., Montoya-Ortiz, G., Mantilla, R.D., Anaya, J.M., Rojas-Villarraga, A., Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis (2012) PLoS One, 7; Almohmeed, Y.H., Avenell, A., Aucott, L., Vickers, M.A., Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis (2013) PLoS One, 8; Farez, M.F., Correale, J., Immunizations and risk of multiple sclerosis: systematic review and meta-analysis (2011) J Neurol, 258, pp. 1197-1206; Santiago, O., Gutierrez, J., Sorlozano, A., de Dios Luna, J., Villegas, E., Fernandez, O., Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production (2010) Eur J Clin Microbiol Infect Dis, 29, pp. 857-866; Lunny, C., Knopp-Sihota, J.A., Fraser, S.N., Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies (2013) BMC Neurol, 13, p. 41; Monteiro, L., Souza-Machado, A., Menezes, C., Melo, A., Association between allergies and multiple sclerosis: a systematic review and meta-analysis (2011) Acta Neurol Scand, 123, pp. 1-7; Tsivgoulis, G., Sergentanis, T.N., Chan, A., Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies (2014) Ther Adv Neurol Disord, 7, pp. 114-136; Tsilidis, K.K., Panagiotou, O.A., Sena, E.S., Evaluation of excess significance bias in animal studies of neurological diseases (2013) PLoS Biol, 11; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Tzoulaki, I., Siontis, K.C., Evangelou, E., Ioannidis, J.P., Bias in associations of emerging biomarkers with cardiovascular disease (2013) JAMA Intern Med, 173, pp. 664-671; Compston, A., Coles, A., Multiple sclerosis (2008) Lancet, 372, pp. 1502-1517; Cohen, J.I., Fauci, A.S., Varmus, H., Nabel, G.J., Epstein-Barr virus: an important vaccine target for cancer prevention (2011) Sci Transl Med, 3. , 107fs7; Ascherio, A., Munger, K.L., Lunemann, J.D., The initiation and prevention of multiple sclerosis (2012) Nat Rev Neurol, 8, pp. 602-612; Lunemann, J.D., Tintore, M., Messmer, B., Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis (2010) Ann Neurol, 67, pp. 159-169; He, D., Guo, R., Zhang, F., Zhang, C., Dong, S., Zhou, H., Rituximab for relapsing-remitting multiple sclerosis (2013) Cochrane Database Syst Rev, 12; van der Mei, I.A., Simpson, S., Stankovich, J., Taylor, B.V., Individual and joint action of environmental factors and risk of MS (2011) Neurol Clin, 29, pp. 233-255; Monteyne, P., Andre, F.E., Is there a causal link between hepatitis B vaccination and multiple sclerosis? (2000) Vaccine, 18, pp. 1994-2001; Hernan, M.A., Jick, S.S., Olek, M.J., Jick, H., Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study (2004) Neurology, 63, pp. 838-842; Touze, E., Fourrier, A., Rue-Fenouche, C., Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study (2002) Neuroepidemiology, 21, pp. 180-186; Mikaeloff, Y., Caridade, G., Rossier, M., Suissa, S., Tardieu, M., Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis (2007) Arch Pediatr Adolesc Med, 161, pp. 1176-1182; Sadovnick, A.D., Scheifele, D.W., School-based hepatitis B vaccination programme and adolescent multiple sclerosis (2000) Lancet, 355, pp. 549-550; Zamboni, P., The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis (2006) J R Soc Med, 99, pp. 589-593; Zamboni, P., Galeotti, R., Menegatti, E., Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (2009) J Neurol Neurosurg Psychiatry, 80, pp. 392-399; Zamboni, P., Galeotti, R., Menegatti, E., A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency (2009) J Vasc Surg, 50, pp. 1348-1358. , e1-e3; Zamboni, P., Bertolotto, A., Boldrini, P., Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial (2012) Trials, 13, p. 183; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348; Tzoulaki, I., Siontis, K.C., Ioannidis, J.P., Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study (2011) BMJ, 343; Gallo, V., Egger, M., McCormack, V., STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement (2011) PLoS Med, 8; von Elm, E., Altman, D.G., Egger, M., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007) PLoS Med, 4; Dal-Re, R., Ioannidis, J.P., Bracken, M.B., Making prospective registration of observational research a reality (2014) Sci Transl Med, 6. , 224cm1; Ioannidis, J.P., The importance of potential studies that have not existed and registration of observational data sets (2012) JAMA, 308, pp. 575-576},
correspondence_address1={Tzoulaki, I.; Department of Biostatistics and Epidemiology, United Kingdom; email: i.tzoulaki@imperial.ac.uk},
publisher={Lancet Publishing Group},
issn={14744422},
coden={LNAEA},
pubmed_id={25662901},
language={English},
abbrev_source_title={Lancet Neurol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Patel2010,
author={Patel, C.J. and Bhattacharya, J. and Butte, A.J.},
title={An environment-wide association study (EWAS) on type 2 diabetes mellitus},
journal={PLoS ONE},
year={2010},
volume={5},
number={5},
doi={10.1371/journal.pone.0010746},
art_number={e10746},
note={cited By 395},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953886372&doi=10.1371%2fjournal.pone.0010746&partnerID=40&md5=5bf79837bc01f788286d047e2958c748},
affiliation={Department of Pediatrics and Medicine, Stanford University School of Medicine, Stanford, CA, United States; Stanford Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, United States; Lucile Packard Children's Hospital, Palo Alto, CA, United States; Center For Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA, United States},
abstract={Background: Type 2 Diabetes (T2D) and other chronic diseases are caused by a complex combination of many genetic and environmental factors. Few methods are available to comprehensively associate specific physical environmental factors with disease. We conducted a pilot Environmental-Wide Association Study (EWAS), in which epidemiological data are comprehensively and systematically interpreted in a manner analogous to a Genome Wide Association Study (GWAS). Methods and Findings: We performed multiple cross-sectional analyses associating 266 unique environmental factors with clinical status for T2D defined by fasting blood sugar (FBG) concentration ≥126 mg/dL. We utilized available Centers for Disease Control (CDC) National Health and Nutrition Examination Survey (NHANES) cohorts from years 1999 to 2006. Within cohort sample numbers ranged from 503 to 3,318. Logistic regression models were adjusted for age, sex, body mass index (BMI), ethnicity, and an estimate of socioeconomic status (SES). As in GWAS, multiple comparisons were controlled and significant findings were validated with other cohorts. We discovered significant associations for the pesticide-derivative heptachlor epoxide (adjusted OR in three combined cohorts of 1.7 for a 1 SD change in exposure amount; p<0.001), and the vitamin γ-tocopherol (adjusted OR 1.5; p<0.001). Higher concentrations of polychlorinated biphenyls (PCBs) such as PCB170 (adjusted OR 2.2; p<0.001) were also found. Protective factors associated with T2D included β-carotenes (adjusted OR 0.6; p<0.001). Conclusions and Significance: Despite difficulty in ascertaining causality, the potential for novel factors of large effect associated with T2D justify the use of EWAS to create hypotheses regarding the broad contribution of the environment to disease. Even in this study based on prior collected epidemiological measures, environmental factors can be found with effect sizes comparable to the best loci yet found by GWAS. © 2010 Patel et al.},
keywords={alpha tocopherol;  beta carotene;  glucose;  heptachlor epoxide;  organochlorine pesticide;  polychlorinated biphenyl derivative;  carotenoid;  gamma tocopherol;  pesticide;  polychlorinated biphenyl, age;  article;  body mass;  causal attribution;  concentration (parameters);  controlled study;  disease association;  environmental exposure;  environmental factor;  epidemiological data;  ethnicity;  glucose blood level;  human;  non insulin dependent diabetes mellitus;  pilot study;  sex difference;  social status;  validation process;  blood;  cohort analysis;  environment;  health survey;  population genetics;  reproducibility, Carotenoids;  Cohort Studies;  Diabetes Mellitus, Type 2;  Environment;  gamma-Tocopherol;  Genetics, Population;  Health Surveys;  Humans;  Pesticides;  Polychlorinated Biphenyls;  Reproducibility of Results},
chemicals_cas={alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; beta carotene, 7235-40-7; glucose, 50-99-7, 84778-64-3; heptachlor epoxide, 1024-57-3; gamma tocopherol, 7616-22-0; Carotenoids, 36-88-4; Pesticides; Polychlorinated Biphenyls; gamma-Tocopherol},
funding_details={National Institute on AgingNational Institute on Aging, NIA, K02AG024237},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, R01GM079719},
funding_details={U.S. National Library of MedicineU.S. National Library of Medicine, NLM, R01LM009719, T15LM007033},
references={Schwartz, D., Collins, F., Medicine. Environmental biology and human disease (2007) Science, 316, pp. 695-696; Hirschhorn, J.N., Daly, M.J., Genome-wide association studies for common diseases and complex traits (2005) Nat Rev Genet, 6, pp. 95-108; Hindorff, L., Junkins, H., Mehta, J., Manolio, T., (2009) A Catalog of Published Genome-Wide Association Studies, , www.genome.gov/gwastudies, Available Accessed7/28/2009; Manolio, T.A., Brooks, L.D., Collins, F.S., A HapMap harvest of insights into the genetics of common disease (2008) J Clin Invest, 118, pp. 1590-1605; Goldstein, D.B., Common genetic variation and human traits (2009) N Engl J Med, 360, pp. 1696-1698; Kraft, P., Hunter, D.J., Genetic risk prediction-are we there yet? (2009) N Engl J Med, 360, pp. 1701-1703; Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Clinical risk factors, DNA variants, and the development of type 2 diabetes (2008) N Engl J Med, 359, pp. 2220-2232; Meigs, J.B., Shrader, P., Sullivan, L.M., McAteer, J.B., Fox, C.S., Genotype score in addition to common risk factors for prediction of type 2 diabetes (2008) N Engl J Med, 359, pp. 2208-2219; Klein, B.E., Klein, R., Moss, S.E., Cruickshanks, K.J., Parental history of diabetes in a population-based study (1996) Diabetes Care, 19, pp. 827-830; Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widen, E., Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus (1989) N Engl J Med, 321, pp. 337-343; Schulz, L.O., Bennett, P.H., Ravussin, E., Kidd, J.R., Kidd, K.K., Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S (2006) Diabetes Care, 29, pp. 1866-1871; Carpenter, D.O., Environmental contaminants as risk factors for developing diabetes (2008) Rev Environ Health, 23, pp. 59-74; Judson, R.S., Houck, K.A., Kavlock, R.J., Knudsen, T.B., Martin, M.T., In vitro screening of environmental chemicals for targeted testing prioritization - The toxcast project (2009) Environ Health Perspect; Gong, K.W., Zhao, W., Li, N., Barajas, B., Kleinman, M., Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells (2007) Genome Biol, 8, p. 149; (2009) National Health and Nutrition Examination Survey, , http://www.cdc.gov/nchs/nhanes/, Centers for Disease Control and Prevention (CDC), Available Accessed 9/1/2009; (2009) Diabetes Information - All About Diabetes, , http://www.diabetes.org/about-diabetes.jsp, ADA, Available Accessed6/1/2009; Lumley, T., (2009) Survey: Analysis of Complex Survey Samples, , 3.14 ed; (2009) R: A Language for Statistical Computing, , R Development Core Team. 2.8.1 ed. Vienna, Austria: R Foundation for Statistical Computing; (2007) Stata Statistical Software: Release 10, , StataCorp, 10 ed. College Station, TX: StataCorp LP; Storey, J.D., Tibshirani, R., Statistical significance for genomewide studies (2003) Proc Natl Acad Sci U S A, 100, pp. 9440-9445; (2003) National Health and Nutrition Examination Survey Analytic Guidelines, , http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005.pdf, CDC, National Center for Health Statistics (NCHS), Available, Accessed 2/19/2010; Cowie, C.C., Rust, K.F., Byrd-Holt, D.D., Eberhardt, M.S., Flegal, K.M., Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002 (2006) Diabetes Care, 29, pp. 1263-1268; Abahusain, M.A., Wright, J., Dickerson, J.W., de Vol, E.B., Retinol, alphatocopherol and carotenoids in diabetes (1999) Eur J Clin Nutr, 53, pp. 630-635; Polidori, M.C., Mecocci, P., Stahl, W., Parente, B., Cecchetti, R., Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes (2000) Diabetes Metab Res Rev, 16, pp. 15-19; Arnlov, J., Zethelius, B., Riserus, U., Basu, S., Berne, C., Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: Report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study (2009) Diabetologia, 52, pp. 97-105; Ford, E.S., Will, J.C., Bowman, B.A., Narayan, K.M., Diabetes mellitus and serum carotenoids: Findings from the Third National Health and Nutrition Examination Survey (1999) Am J Epidemiol, 149, pp. 168-176; Ylonen, K., Alfthan, G., Groop, L., Saloranta, C., Aro, A., Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: The Botnia Dietary Study (2003) Am J Clin Nutr, 77, pp. 1434-1441; Wang, L., Liu, S., Pradhan, A.D., Manson, J.E., Buring, J.E., Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women (2006) Am J Epidemiol, 164, pp. 576-585; Montonen, J., Knekt, P., Jarvinen, R., Reunanen, A., Dietary antioxidant intake and risk of type 2 diabetes (2004) Diabetes Care, 27, pp. 362-366; Song, Y., Cook, N.R., Albert, C.M., van Denburgh, M., Manson, J.E., Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: A randomized controlled trial (2009) Am J Clin Nutr, 90, pp. 429-437; Kataja-Tuomola, M., Sundell, J.R., Mannisto, S., Virtanen, M.J., Kontto, J., Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes (2008) Diabetologia, 51, pp. 47-53; Codru, N., Schymura, M.J., Negoita, S., Rej, R., Carpenter, D.O., Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans (2007) Environ Health Perspect, 115, pp. 1442-1447; Uemura, H., Arisawa, K., Hiyoshi, M., Satoh, H., Sumiyoshi, Y., Associations of environmental exposure to dioxins with prevalent diabetes among general inhabitants in Japan (2008) Environ Res, 108, pp. 63-68; Rignell-Hydbom, A., Rylander, L., Hagmar, L., Exposure to persistent organochlorine pollutants and type 2 diabetes mellitus (2007) Hum Exp Toxicol, 26, pp. 447-452; Wang, S.L., Tsai, P.C., Yang, C.Y., Guo, Y.L., Increased risk of diabetes and polychlorinated biphenyls and dioxins: A 24-year follow-up study of the Yucheng cohort (2008) Diabetes Care, 31, pp. 1574-1579; Jiang, Q., Christen, S., Shigenaga, M.K., Ames, B.N., Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention (2001) Am J Clin Nutr, 74, pp. 714-722; Burton, G.W., Traber, M.G., Acuff, R.V., Walters, D.N., Kayden, H., Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin (1998) E. Am J Clin Nutr, 67, pp. 669-684; Campbell, S., Stone, W., Whaley, S., Krishnan, K., Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent (2003) Crit Rev Oncol Hematol, 47, pp. 249-259; (2007) Heptachlor and Heptachlor Epoxide, , http://www.atsdr.cdc.gov/tfacts12.html, Agency for Toxic Substances and Disease Registry, Available Accessed 8/1/2009; (1980) Ambient Water Quality Criteria for Heptachlor; Agency USEP, , Office of Water Regulations and Standards, editor. Washington, DC: United States Environmental Production Agency; Montgomery, M.P., Kamel, F., Saldana, T.M., Alavanja, M.C., Sandler, D.P., Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003 (2008) Am J Epidemiol, 167, pp. 1235-1246; Kitao, Y., Inada, T., Arinami, T., Hirotsu, C., Aoki, S., A contribution to genome-wide association studies: Search for susceptibility loci for schizophrenia using DNA microsatellite markers on chromosomes 19, 20, 21 and 22 (2000) Psychiatr Genet, 10, pp. 139-143; Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H., A highthroughput SNP typing system for genome-wide association studies (2001) J Hum Genet, 46, pp. 471-477; David, E.D., (2009) Experimental Man: What One Man's Body Reveals About His Future, Your Health, and Our Toxic World, , Hoboken, NJ: Wiley; Lang, I.A., Galloway, T.S., Scarlett, A., Henley, W.E., Depledge, M., Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults (2008) JAMA, 300, pp. 1303-1310; Navas-Acien, A., Silbergeld, E.K., Pastor-Barriuso, R., Guallar, E., Arsenic exposure and prevalence of type 2 diabetes in US adults (2008) JAMA, 300, pp. 814-822; Everett, C.J., Frithsen, I.L., Diaz, V.A., Koopman, R.J., Simpson Jr., W.M., Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey (2007) Environ Res, 103, pp. 413-418; Lee, D.H., Lee, I.K., Jin, S.H., Steffes, M., Jacobs Jr., D.R., Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: Results from the National Health and Nutrition Examination Survey 1999-2002 (2007) Diabetes Care, 30, pp. 622-628; Lee, D.H., Lee, I.K., Porta, M., Steffes, M., Jacobs Jr., D.R., Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: Results from the National Health and Nutrition Examination Survey 1999-2002 (2007) Diabetologia, 50, pp. 1841-1851; Ioannidis, J., Loy, E.Y., Poulton, R., Chia, K.S., Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification (2009) Sci Transl Med, 1, p. 8; Smith, G.D., Ebrahim, S., Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) Int J Epidemiol, 32, pp. 1-22; Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes (2008) Nat Genet, 40, pp. 638-645; Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels (2007) Science, 316, pp. 1331-1336; Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes (2007) Science, 316, pp. 1336-1341; Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., A genome-wide association study identifies novel risk loci for type 2 diabetes (2007) Nature, 445, pp. 881-885; Salonen, J.T., Uimari, P., Aalto, J.M., Pirskanen, M., Kaikkonen, J., Type 2 diabetes whole-genome association study in four populations: The DiaGen consortium (2007) Am J Hum Genet, 81, pp. 338-345; Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity (2007) Science, 316, pp. 889-894; Commonweal EWG II Human Toxome Project, , http://www.ewg.org/sites/humantoxome/, Environmental Working Group, Available Accessed11/11/2009; Toscano, W.A., Oehlke, K.P., Systems biology: New approaches to old environmental health problems (2005) Int J Environ Res Public Health, 2, pp. 4-9},
correspondence_address1={Butte, A. J.; Department of Pediatrics and Medicine, , Stanford, CA, United States; email: abutte@stanford.edu},
issn={19326203},
pubmed_id={20505766},
language={English},
abbrev_source_title={PLoS ONE},
document_type={Article},
source={Scopus},
}

@ARTICLE{Beydoun2014,
author={Beydoun, M.A. and Beydoun, H.A. and Gamaldo, A.A. and Teel, A. and Zonderman, A.B. and Wang, Y.},
title={Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis},
journal={BMC Public Health},
year={2014},
volume={14},
number={1},
doi={10.1186/1471-2458-14-643},
art_number={643},
note={cited By 389},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904348791&doi=10.1186%2f1471-2458-14-643&partnerID=40&md5=81d917d8ecd3ef0ccd4c905c6b648e17},
affiliation={Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, 251 Bayview Blvd., Baltimore, MD 21224, United States; Graduate Program in Public Health, Eastern Virginia Medical School, Norfolk, VA, United Kingdom; Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, New York, United States; John Hopkins Global Center on Childhood Obesity, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States},
abstract={Background: Cognitive impairment, including dementia, is a major health concern with the increasing aging population. Preventive measures to delay cognitive decline are of utmost importance. Alzheimer's disease (AD) is the most frequent cause of dementia, increasing in prevalence from <1% below the age of 60 years to >40% above 85 years of age. Methods. We systematically reviewed selected modifiable factors such as education, smoking, alcohol, physical activity, caffeine, antioxidants, homocysteine (Hcy), n-3 fatty acids that were studied in relation to various cognitive health outcomes, including incident AD. We searched MEDLINE for published literature (January 1990 through October 2012), including cross-sectional and cohort studies (sample sizes > 300). Analyses compared study finding consistency across factors, study designs and study-level characteristics. Selecting studies of incident AD, our meta-analysis estimated pooled risk ratios (RR), population attributable risk percent (PAR%) and assessed publication bias. Results: In total, 247 studies were retrieved for systematic review. Consistency analysis for each risk factor suggested positive findings ranging from ∼38.9% for caffeine to ∼89% for physical activity. Education also had a significantly higher propensity for "a positive finding" compared to caffeine, smoking and antioxidant-related studies. Meta-analysis of 31 studies with incident AD yielded pooled RR for low education (RR = 1.99; 95% CI: 1.30-3.04), high Hcy (RR = 1.93; 95% CI: 1.50-2.49), and current/ever smoking status (RR = 1.37; 95% CI: 1.23-1.52) while indicating protective effects of higher physical activity and n-3 fatty acids. Estimated PAR% were particularly high for physical activity (PAR% = 31.9; 95% CI: 22.7-41.2) and smoking (PAR%=31.09%; 95% CI: 17.9-44.3). Overall, no significant publication bias was found. Conclusions: Higher Hcy levels, lower educational attainment, and decreased physical activity were particularly strong predictors of incident AD. Further studies are needed to support other potential modifiable protective factors, such as caffeine. © 2014 Beydoun et al.; licensee BioMed Central Ltd.},
author_keywords={Alzheimer's disease;  Cognition;  Dementia;  Meta-analysis;  Nutrition;  Risk factor},
keywords={antioxidant;  caffeine;  homocysteine;  omega 3 fatty acid, Alzheimer disease;  blood;  cognition;  Cognition Disorders;  dementia;  diet;  drinking behavior;  educational status;  exercise;  female;  human;  male;  meta analysis;  metabolism;  smoking, Alcohol Drinking;  Alzheimer Disease;  Antioxidants;  Caffeine;  Cognition;  Cognition Disorders;  Dementia;  Diet;  Educational Status;  Exercise;  Fatty Acids, Omega-3;  Female;  Homocysteine;  Humans;  Male;  Smoking},
chemicals_cas={caffeine, 58-08-2; homocysteine, 454-28-4, 6027-13-0; Antioxidants; Caffeine; Fatty Acids, Omega-3; Homocysteine},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute on AgingNational Institute on Aging, NIA, ZIAAG000195},
funding_details={International Foundation for Research in ParaplegiaInternational Foundation for Research in Paraplegia, IRP},
funding_text 1={This study was supported by the Intramural Research Program of the National Institute on Aging, NIA/NIH/IRP. The authors would like to thank Mr. James Byrnes, NIA/NIH/IRP, for help with literature search and retrieval. Special thanks also go to Drs. Lori L. Beason-Held and Madhav Thambisetty, NIA/NIH/IRP, for their review and comments on the manuscript.},
references={De Champlain, J., Wu, R., Girouard, H., Karas, M., Midaoui, A.E.L., Laplante, M.-A., Wu, L., Oxidative stress in hypertension (2004) Clinical and Experimental Hypertension, 26 (7-8), pp. 593-601. , DOI 10.1081/CEH-200031904; Verhaeghen, P., Salthouse, T.A., Meta-analyses of age-cognition relations in adulthood: Estimates of linear and nonlinear age effects and structural models (1997) Psychological Bulletin, 122 (3), pp. 231-249; Moritz, D.J., Kasl, S.V., Berkman, L.F., Cognitive functioning and the incidence of limitations in activities of daily living in an elderly community sample (1995) Am J Epidemiol, 141, pp. 41-49; Lobo, A., Launer, L.J., Fratiglioni, L., Andersen, K., Di Carlo, A., Breteler, M.M., Copeland, J.R., Hofman, A., Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group (2000) Neurology, 54, pp. 194-199; Li, G., Shen, Y.C., Chen, C.H., Zhao, Y.W., Li, S.R., Lu, M., An epidemiological survey of age-related dementia in an urban area of Beijing (1989) Acta Psychiatrica Scandinavica, 79 (6), pp. 557-563; Fichter, M.M., Meller, I., Schroppel, H., Steinkirchner, R., Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity (1995) Br J Psychiatry, 166, pp. 621-629; Ankri, J., Poupard, M., Prevalence and incidence of dementia among the very old. Review of the literature (2003) Revue d'Epidemiologie et de Sante Publique, 51 (3), pp. 349-360; Jorm, A.F., Jolley, D., The incidence of dementia: A meta-analysis (1998) Neurology, 51 (3), pp. 728-733; Ott, A., Breteler, M.M., Van Harskamp, F., Claus, J.J., Van Der Cammen, T.J., Grobbee, D.E., Hofman, A., Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study (1995) BMJ, 310, pp. 970-973; Liu, H.C., Lin, K.N., Teng, E.L., Wang, S.J., Fuh, J.L., Guo, N.W., Chou, P., Chiang, B.N., Prevalence and subtypes of dementia in Taiwan: A community survey of 5297 individuals (1995) J Am Geriatr Soc, 43, pp. 144-149; McKhann, G., Drachman, D., Folstein, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease (1984) Neurology, 34 (7), pp. 939-944; McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack Jr., R.C., Kawas, C.H., Klunk, W.E., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 263-269; Roman, G.C., Tatemichi, T.K., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Amaducci, L., Kokmen, E., Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop (1993) Neurology, 43 (2), pp. 250-260; Hachinski, V.C., Iliff, L.D., Zilhka, E., Du Boulay, G.H., McAllister, V.L., Marshall, J., Russell, R.W., Symon, L., Cerebral blood flow in dementia (1975) Arch Neurol, 32, pp. 632-637; Lund, T., Groups, M., Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups (1994) J Neurol Neurosurg Psychiatry, 57, pp. 416-418; McKeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, L.A., Salmon, D.P., Perry, R.H., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop (1996) Neurology, 47 (5), pp. 1113-1124; Crecelius, C., Diagnosis and treatment of non-Alzheimer's dementias (2003) J Am Med Dir Assoc, 4, pp. 825-829; Zekry, D., Hauw, J.J., Gold, G., Mixed dementia: Epidemiology, diagnosis, and treatment (2002) J Am Geriatr Soc, 50, pp. 1431-1438; Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Seshadri, S., Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association (2011) Stroke, 42, pp. 2672-2713. , Heart Association Stroke Council Council On Epidemiology A.Council On Cardiovascular Nursing Council On Cardiovascular Radiology P.Intervention On Cardiovascular Surgery C.Anesthesia; Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence (2011) Lancet Neurol, 10, pp. 819-828; Zhang, M., Katzman, R., Salmon, D., Jin, H., Cai, G., Wang, Z., Qu, G., Liu, W.T., The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender and education (1990) Annals of Neurology, 27 (4), pp. 428-437; Ogunniyi, A., Lekwauwa, U.G., Osuntokun, B.O., Influence of education on aspects of cognitive functions in non-demented elderly Nigerians (1991) Neuroepidemiology, 10, pp. 246-250; Dealberto, M.J., Gagnon, M., Barberger-Gateau, P., Dartigues, J.F., Alperovitch, A., [Influence of educational status on a screening test for dementia, the mini-mental state examination] (1992) Rev Epidemiol Sante Publique, 40, pp. 93-101; Koivisto, K., Helkala, E.L., Reinikainen, K.J., Hanninen, T., Mykkanen, L., Laakso, M., Pyorala, K., Riekkinen, P.J., Population-based dementia screening program in Kuopio: The effect of education, age, and sex on brief neuropsychological tests (1992) J Geriatr Psychiatry Neurol, 5, pp. 162-171; Evans, D.A., Beckett, L.A., Albert, M.S., Hebert, L.E., Scherr, P.A., Funkenstein, H.H., Taylor, J.O., Level of education and change in cognitive function in a community population of older persons (1993) Annals of Epidemiology, 3 (1), pp. 71-77; Paykel, E.S., Brayne, C., Huppert, F.A., Gill, C., Barkley, C., Gehlhaar, E., Beardsall, L., O'Connor, D., Incidence of dementia in a population older than 75 years in the United Kingdom (1994) Archives of General Psychiatry, 51 (4), pp. 325-332; White, L., Katzman, R., Losonczy, K., Salive, M., Wallace, R., Berkman, L., Taylor, J., Havlik, R., Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly (1994) Journal of Clinical Epidemiology, 47 (4), pp. 363-374. , DOI 10.1016/0895-4356(94)90157-0; Cobb, J.L., Wolf, P.A., Au, R., White, R., D'Agostino, R.B., The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study (1995) Neurology, 45, pp. 1707-1712; Farmer, M.E., Kittner, S.J., Rae, D.S., Bartko, J.J., Regier, D.A., Education and change in cognitive function. The epidemiologic catchment area study (1995) Ann Epidemiol, 5, pp. 1-7; Callahan, C.M., Hall, K.S., Hui, S.L., Musick, B.S., Unverzagt, F.W., Hendrie, H.C., Relationship of age, education, and occupation with dementia among a community-based sample of African Americans (1996) Archives of Neurology, 53 (2), pp. 134-140; Hanninen, T., Koivisto, K., Reinikainen, K.J., Helkala, E.-L., Soininen, H., Mykkanen, L., Laakso, M., Riekkinen, P.J., Prevalence of ageing-associated cognitive decline in an elderly population (1996) Age and Ageing, 25 (3), pp. 201-205. , DOI 10.1093/ageing/25.3.201; Christensen, H., Korten, A.E., Jorm, A.F., Henderson, A.S., Jacomb, P.A., Rodgers, B., Mackinnon, A.J., Education and decline in cognitive performance: Compensatory but not protective (1997) International Journal of Geriatric Psychiatry, 12 (3), pp. 323-330. , DOI 10.1002/(SICI)1099-1166(199703)12:3<323::AID-GPS492>3.0.CO;2-N; Evans, D.A., Hebert, L.E., Beckett, L.A., Scherr, P.A., Albert, M.S., Chown, M.J., Pilgrim, D.M., Taylor, J.O., Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons (1997) Archives of Neurology, 54 (11), pp. 1399-1405; Freidl, W., Schmidt, R., Stronegger, W.J., Reinhart, B., The impact of sociodemographic, environmental, and behavioral factors, and cerebrovascular risk factors as potential predictors of the mattis dementia rating scale (1997) J Gerontol A Biol Sci Med Sci, 52, pp. 13111-13116; Kalmijn, S., Feskens, E.J.M., Launer, L.J., Kromhout, D., Longitudinal study of the effect of apolipoprotein e4 allele on the association between education and cognitive decline in elderly men (1997) British Medical Journal, 314 (7073), pp. 34-35; Kilander, L., Nyman, H., Boberg, M., Lithell, H., Cognitive function, vascular risk factors and education. A cross- sectional study based on a cohort of 70-year-old men (1997) Journal of Internal Medicine, 242 (4), pp. 313-321; Schmand, B., Smit, J., Lindeboom, J., Smits, C., Hooijer, C., Janker, C., Deelman, B., Low education is a genuine risk factor for accelerated memory decline and dementia (1997) Journal of Clinical Epidemiology, 50 (9), pp. 1025-1033. , DOI 10.1016/S0895-4356(97)00121-2, PII S0895435697001212; Schmand, B., Smit, J.H., Geerlings, M.I., Lindeboom, J., The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis (1997) Psychological Medicine, 27 (6), pp. 1337-1344. , DOI 10.1017/S0033291797005461; Cerhan, J.R., Folsom, A.R., Mortimer, J.A., Shahar, E., Knopman, D.S., McGovern, P.G., Hays, M.A., Heiss, G., Correlates of cognitive function in middle-aged adults. Atherosclerosis risk in communities (ARIC) study investigators (1998) Gerontology, 44, pp. 95-105; De Ronchi, D., Fratiglioni, L., Rucci, P., Paternico, A., Graziani, S., Dalmonte, E., The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status (1998) Neurology, 50 (5), pp. 1231-1238; Lin, R.T., Lai, C.L., Tai, C.T., Liu, C.K., Yen, Y.Y., Howng, S.L., Prevalence and subtypes of dementia in southern Taiwan: Impact of age, sex, education, and urbanization (1998) J Neurol Sci, 160, pp. 67-75; Lyketsos, C.G., Chen, L.-S., Anthony, J.C., Cognitive decline in adulthood: An 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study (1999) American Journal of Psychiatry, 156 (1), pp. 58-65; Letenneur, L., Gilleron, V., Commenges, D., Helmer, C., Orgogozo, J.M., Dartigues, J.F., Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project (1999) Journal of Neurology Neurosurgery and Psychiatry, 66 (2), pp. 177-183; Ott, A., Van Rossum, C.T.M., Van Harskamp, F., Van De Mheen, H., Hofman, A., Breteler, M.M.B., Education and the incidence of dementia in a large population-based study: The Rotterdam study (1999) Neurology, 52 (3), pp. 663-666; Aevarsson, O., Skoog, I., A longitudinal population study of the Mini-Mental State Examination in the very old: Relation to dementia and education (2000) Dementia and Geriatric Cognitive Disorders, 11 (3), pp. 166-175; Qiu, C., Backman, L., Winblad, B., Aguero-Torres, H., Fratiglioni, L., The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project (2001) Archives of Neurology, 58 (12), pp. 2034-2039; Alvarado, B.E., Zunzunegui, M.-V., Del Ser, T., Beland, F., Cognitive decline is related to education and occupation in a Spanish elderly cohort (2002) Aging - Clinical and Experimental Research, 14 (2), pp. 132-142; Cagney, K.A., Lauderdale, D.S., Education, wealth, and cognitive function in later life (2002) J Gerontol B Psychol Sci Soc Sci, 57, pp. 16163-16172; Herrera Jr., E., Caramelli, P., Silveira, A.S.B., Nitrini, R., Epidemiologic survey of dementia in a community-dwelling Brazilian population (2002) Alzheimer Disease and Associated Disorders, 16 (2), pp. 103-108. , DOI 10.1097/00002093-200204000-00007; Ravaglia, G., Forti, P., Maioli, F., Sacchetti, L., Mariani, E., Nativio, V., Talerico, T., Macini, P.L., Education, occupation, and prevalence of dementia: Findings from the Conselice Study (2002) Dementia and Geriatric Cognitive Disorders, 14 (2), pp. 90-100. , DOI 10.1159/000064930; Wight, R.G., Aneshensel, C.S., Seeman, T.E., Educational attainment, continued learning experience, and cognitive function among older men (2002) Journal of Aging and Health, 14 (2), pp. 211-236; Lee, S., Kawachi, I., Berkman, L.F., Grodstein, F., Education, other socioeconomic indicators, and cognitive function (2003) American Journal of Epidemiology, 157 (8), pp. 712-720. , DOI 10.1093/aje/kwg042; Seeman, T.E., Huang, M.H., Bretsky, P., Crimmins, E., Launer, L., Guralnik, J.M., Education and APOE-e4 in longitudinal cognitive decline: MacArthur studies of successful aging (2005) J Gerontol B Psychol Sci Soc Sci, 60, pp. 1674-1683; Lee, S., Buring, J.E., Cook, N.R., Grodstein, F., The relation of education and income to cognitive function among professional women (2006) Neuroepidemiology, 26 (2), pp. 93-101. , DOI 10.1159/000090254; Shadlen, M.-F., Siscovick, D., Fitzpatrick, A.L., Dulberg, C., Kuller, L.H., Jackson, S., Education, cognitive test scores, and black-white differences in dementia risk (2006) Journal of the American Geriatrics Society, 54 (6), pp. 898-905. , DOI 10.1111/j.1532-5415.2006.00747.x; Zhang, Z.-X., Zahner, G.E.P., Roman, G.C., Liu, X.-H., Wu, C.-B., Hong, Z., Hong, X., Li, H., Socio-demographic variation of dementia subtypes in China: Methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian (2006) Neuroepidemiology, 27 (4), pp. 177-187. , DOI 10.1159/000096131; Zhou, D.F., Wu, C.S., Qi, H., Fan, J.H., Sun, X.D., Como, P., Qiao, Y.L., Kieburtz, K., Prevalence of dementia in rural China: Impact of age, gender and education (2006) Acta Neurologica Scandinavica, 114 (4), pp. 273-280. , DOI 10.1111/j.1600-0404.2006.00641.x; Galasko, D., Salmon, D., Gamst, A., Olichney, J., Thal, L.J., Silbert, L., Kaye, J., Borenstein, A.R., Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE (2007) Neurology, 68 (21), pp. 1772-1781. , DOI 10.1212/01.wnl.0000262028.16738.64, PII 0000611420070522000004; Van Hooren, S.A.H., Valentijn, A.M., Bosma, H., Ponds, R.W.H.M., Van Boxtel, M.P.J., Jolles, J., Cognitive functioning in healthy older adults aged 64-81: A cohort study into the effects of age, sex, and education (2007) Aging, Neuropsychology, and Cognition, 14 (1), pp. 40-54. , DOI 10.1080/138255890969483, PII R5U35R0380527X23; Christensen, H., Batterham, P.J., Mackinnon, A.J., Anstey, K.J., Wen, W., Sachdev, P.S., Education, atrophy, and cognitive change in an epidemiological sample in early old age (2009) Am J Geriatr Psychiatry, 17, pp. 218-226; Dotson, V.M., Kitner-Triolo, M.H., Evans, M.K., Zonderman, A.B., Effects of race and socioeconomic status on the relative influence of education and literacy on cognitive functioning (2009) J Int Neuropsychol Soc, 15, pp. 580-589; Gavrila, D., Antunez, C., Tormo, M.J., Carles, R., Garcia Santos, J.M., Parrilla, G., Fortuna, L., Navarro, C., Prevalence of dementia and cognitive impairment in Southeastern Spain: The Ariadna study (2009) Acta Neurol Scand, 120, pp. 300-307; Peters, R., Beckett, N., Geneva, M., Tzekova, M., Lu, F.H., Poulter, R., Gainsborough, N., Bulpitt, C., Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET (2009) Age Ageing, 38, pp. 521-527; Wilson, R.S., Hebert, L.E., Scherr, P.A., Barnes, L.L., De Leon Cf, M., Evans, D.A., Educational attainment and cognitive decline in old age (2009) Neurology, 72, pp. 460-465; Hamid, T.A., Krishnaswamy, S., Abdullah, S.S., Momtaz, Y.A., Sociodemographic risk factors and correlates of dementia in older Malaysians (2010) Dement Geriatr Cogn Disord, 30, pp. 533-539; Mathuranath, P.S., Cherian, P.J., Mathew, R., Kumar, S., George, A., Alexander, A., Ranjith, N., Sarma, P.S., Dementia in Kerala, South India: Prevalence and influence of age, education and gender (2010) Int J Geriatr Psychiatry, 25, pp. 290-297; Scazufca, M., Almeida, O.P., Menezes, P.R., The role of literacy, occupation and income in dementia prevention: The Sao Paulo ageing & health study (SPAH) (2010) Int Psychogeriatr, 22, pp. 1209-1215; Castro-Costa, E., Dewey, M.E., Uchoa, E., Firmo, J.O., Lima-Costa, M.F., Stewart, R., Trajectories of cognitive decline over 10 years in a Brazilian elderly population: The Bambui cohort study of aging (2011) Cad Saude Publica, 27 (SUPPL.. 3), pp. 19345-19350; Marengoni, A., Fratiglioni, L., Bandinelli, S., Ferrucci, L., Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: The population-based aging in the Chianti area (InCHIANTI) study (2011) J Alzheimers Dis, 24, pp. 559-568; Mejia-Arango, S., Gutierrez, L.M., Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: Data from the Mexican health and aging study (2011) J Aging Health, 23, pp. 1050-1074; Zahodne, L.B., Glymour, M.M., Sparks, C., Bontempo, D., Dixon, R.A., Macdonald, S.W., Manly, J.J., Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal study (2011) J Int Neuropsychol Soc, 17, pp. 1039-1046; Hebert, L.E., Scherr, P.A., Beckett, L.A., Albert, M.S., Rosner, B., Taylor, J.O., Evans, D.A., Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: A longitudinal study in a defined community of older persons (1993) American Journal of Epidemiology, 137 (8), pp. 881-891; Letenneur, L., Dartigues, J.-F., Commenges, D., Barberger-Gateau, P., Tessier -, J.F., Orgogozo, J.-M., Tobacco consumption and cognitive impairment in elderly people: A population-based study (1994) Annals of Epidemiology, 4 (6), pp. 449-454; Ford, A.B., Mefrouche, Z., Friedland, R.P., Debanne, S.M., Smoking and cognitive impairment: A population-based study (1996) Journal of the American Geriatrics Society, 44 (8), pp. 905-909; Galanis, D.J., Petrovitch, H., Launer, L.J., Harris, T.B., Foley, D.J., White, L.R., Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men: The Honolulu-Asia Aging Study (1997) American Journal of Epidemiology, 145 (6), pp. 507-515; Broe, G.A., Creasey, H., Jorm, A.F., Bennett, H.P., Casey, B., Waite, L.M., Grayson, D.A., Cullen, J., Health habits and risk of cognitive impairment and dementia in old age: A prospective study on the effects of exercise, smoking and alcohol consumption (1998) Australian and New Zealand Journal of Public Health, 22 (5), pp. 621-623; Edelstein, S.L., Kritz-Silverstein, D., Barrett-Connor, E., Prospective association of smoking and alcohol use with cognitive function in an elderly cohort (1998) J Womens Health, 7, pp. 1271-1281; Ott, A., Slooter, A.J.C., Hofman, A., Van Harskamp, F., Witteman, J.C.M., Van Broeckhoven, C., Van Duijn, C.M., Breteler, M.M.B., Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam Study (1998) Lancet, 351 (9119), pp. 1840-1843. , DOI 10.1016/S0140-6736(97)07541-7; Carmelli, D., Swan, G.E., Reed, T., Schellenberg, G.D., Christian, J.C., The effect of apolipoprotein E ε4 in the relationships of smoking and drinking to cognitive function (1999) Neuroepidemiology, 18 (3), pp. 125-133; Elwood, P.C., Gallacher, J.E.J., Hopkinson, C.A., Pickering, J., Rabbitt, P., Stollery, B., Brayne, C., Bayer, A., Smelting, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort (1999) Journal of Epidemiology and Community Health, 53 (1), pp. 9-14; Cervilla, J.A., Prince, M., Mann, A., Smoking, drinking, and incident cognitive impairment: A cohort community based study included in the Gospel Oak project (2000) Journal of Neurology Neurosurgery and Psychiatry, 68 (5), pp. 622-626. , DOI 10.1136/jnnp.68.5.622; Doll, R., Peto, R., Boreham, J., Sutherland, I., Smoking and dementia in male British doctors: Prospective study (2000) British Medical Journal, 320 (7242), pp. 1097-1102; Kalmijn, S., Van Boxtel, M.P.J., Verschuren, M.W.M., Jolles, J., Launer, L.J., Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age (2002) American Journal of Epidemiology, 156 (10), pp. 936-944. , DOI 10.1093/aje/kwf135; Chen, W.T., Wang, P.N., Wang, S.J., Fuh, J.L., Lin, K.N., Liu, H.C., Smoking and cognitive performance in the community elderly: A longitudinal study (2003) J Geriatr Psychiatry Neurol, 16, pp. 18-22; Richards, M., Jarvis, M.J., Thompson, N., Wadsworth, M.E.J., Cigarette Smoking and Cognitive Decline in Midlife: Evidence from a Prospective Birth Cohort Study (2003) American Journal of Public Health, 93 (6), pp. 994-998; Tyas, S.L., White, L.R., Petrovitch, H., Ross, G.W., Foley, D.J., Heimovitz, H.K., Launer, L.J., Mid-life smoking and late-life dementia: The Honolulu-Asia Aging study (2003) Neurobiology of Aging, 24 (4), pp. 589-596. , DOI 10.1016/S0197-4580(02)00156-2, PII S0197458002001562; Zhou, H., Deng, J., Li, J., Wang, Y., Zhang, M., He, H., Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in China (2003) Age Ageing, 32, pp. 205-210; Juan, D., Zhou, D.H.D., Li, J., Wang, J.Y.J., Gao, C., Chen, M., A 2-year follow-up study of cigarette smoking and risk of dementia (2004) European Journal of Neurology, 11 (4), pp. 277-282. , DOI 10.1046/j.1468-1331.2003.00779.x; Ott, A., Andersen, K., Dewey, M.E., Letenneur, L., Brayne, C., Copeland, J.R.M., Dartigues, J.-F., Launer, L.J., Effect of smoking on global cognitive function in nondemented elderly (2004) Neurology, 62 (6), pp. 920-924; Solfrizzi, V., Panza, F., Colacicco, A.M., D'Introno, A., Capurso, C., Torres, F., Grigoletto, F., Capurso, A., Vascular risk factors, incidence of MCI, and rates of progression to dementia (2004) Neurology, 63 (10), pp. 1882-1891; Aleman, A., Muller, M., De Haan, E.H.F., Van Der Schouw, Y.T., Vascular risk factors and cognitive function in a sample of independently living men (2005) Neurobiology of Aging, 26 (4), pp. 485-490. , DOI 10.1016/j.neurobiolaging.2004.05.005, PII S0197458004002015; Reitz, C., Luchsinger, J., Tang, M.-X., Mayeux, R., Effect of smoking and time on cognitive function in the elderly without dementia (2005) Neurology, 65 (6), pp. 870-875. , DOI 10.1212/01.wnl.0000176057.22827.b7; Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C., Yaffe, K., Midlife cardiovascular risk factors and risk of dementia in late life (2005) Neurology, 64, pp. 277-281; Stewart, M.C.W., Deary, I.J., Fowkes, F.G.R., Price, J.F., Relationship between lifetime smoking, smoking status at older age and human cognitive function (2006) Neuroepidemiology, 26 (2), pp. 83-92. , DOI 10.1159/000090253; Reitz, C., Den Heijer, T., Van Duijn, C., Hofman, A., Breteler, M.M.B., Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study (2007) Neurology, 69 (10), pp. 998-1005. , DOI 10.1212/01.wnl.0000271395.29695.9a, PII 0000611420070904000011; Nooyens, A.C., Van Gelder, B.M., Verschuren, W.M., Smoking and cognitive decline among middle-aged men and women: The Doetinchem cohort study (2008) Am J Public Health, 98, pp. 2244-2250; Sabia, S., Marmot, M., Dufouil, C., Singh-Manoux, A., Smoking history and cognitive function in middle age from the Whitehall II study (2008) Archives of Internal Medicine, 168 (11), pp. 1165-1173. , http://archinte.ama-assn.org/cgi/reprint/168/11/1165, DOI 10.1001/archinte.168.11.1165; Alonso, A., Mosley Jr., H.T., Gottesman, R.F., Catellier, D., Sharrett, A.R., Coresh, J., Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: The Atherosclerosis risk in communities (ARIC) study (2009) J Neurol Neurosurg Psychiatry, 80, pp. 1194-1201; Collins, N., Sachs-Ericsson, N., Preacher, K.J., Sheffield, K.M., Markides, K., Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans (2009) Am J Geriatr Psychiatry, 17, pp. 934-942; Huang, C.Q., Dong, B.R., Zhang, Y.L., Wu, H.M., Liu, Q.X., Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenarians (2009) Cogn Behav Neurol, 22, pp. 190-196; Rusanen, M., Rovio, S., Ngandu, T., Nissinen, A., Tuomilehto, J., Soininen, H., Kivipelto, M., Midlife smoking, apolipoprotein e and risk of dementia and Alzheimer's disease: A population-based cardiovascular risk factors, aging and dementia study (2010) Dement Geriatr Cogn Disord, 30, pp. 277-284; Wang, C.C., Lu, T.H., Liao, W.C., Yuan, S.C., Kuo, P.C., Chuang, H.L., Lee, M.C., Yen, C.H., Cigarette smoking and cognitive impairment: A 10-year cohort study in Taiwan (2010) Arch Gerontol Geriatr, 51, pp. 143-148; Ronnemaa, E., Zethelius, B., Lannfelt, L., Kilander, L., Vascular risk factors and dementia: 40-year follow-up of a population-based cohort (2011) Dement Geriatr Cogn Disord, 31, pp. 460-466; Rusanen, M., Kivipelto, M., Quesenberry Jr., P.C., Zhou, J., Whitmer, R.A., Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia (2011) Arch Intern Med, 171, pp. 333-339; Sabia, S., Elbaz, A., Dugravot, A., Head, J., Shipley, M., Hagger-Johnson, G., Kivimaki, M., Singh-Manoux, A., Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study (2012) Arch Gen Psychiatry, 69, pp. 627-635; Hendrie, H.C., Gao, S., Hall, K.S., Hui, S.L., Unverzagt, F.W., The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black Americans (1996) Journal of the American Geriatrics Society, 44 (10), pp. 1158-1165; Dufouil, C., Ducimetiere, P., Alperovitch, A., Sex differences in the association between alcohol consumption and cognitive performance (1997) American Journal of Epidemiology, 146 (5), pp. 405-412; Elias, P.K., Elias, M.F., D'Agostino, R.B., Silbershatz, H., Wolf, P.A., Alcohol consumption and cognitive performance in the Framingham Heart Study (1999) American Journal of Epidemiology, 150 (6), pp. 580-589; Bond, G.E., Burr, R., McCurry, S.M., Graves, A.B., Larson, E.B., Alcohol, aging, and cognitive performance in a cohort of Japanese Americans aged 65 and older: The Kame Project (2001) International Psychogeriatrics, 13 (2), pp. 207-223. , DOI 10.1017/S1041610201007591; Zuccala, G., Onder, G., Pedone, C., Cesari, M., Landi, F., Bernabei, R., Cocchi, A., Dose-related impact of alcohol consumption on cognitive function in advanced age: Results of a multicenter survey (2001) Alcoholism: Clinical and Experimental Research, 25 (12), pp. 1743-1748; Leroi, I., Sheppard, J.-M., Lyketsos, C.G., Cognitive function after 11.5 years of alcohol use: Relation to alcohol use (2002) American Journal of Epidemiology, 156 (8), pp. 747-752. , DOI 10.1093/aje/kwf107; Krahn, D., Freese, J., Hauser, R., Barry, K., Goodman, B., Alcohol use and cognition at mid-life: The importance of adjusting for baseline cognitive ability and educational attainment (2003) Alcoholism: Clinical and Experimental Research, 27 (7), pp. 1162-1166. , DOI 10.1097/01.ALC.0000078060.18662.C1; Anttila, T., Helkala, E.L., Viitanen, M., Kareholt, I., Fratiglioni, L., Winblad, B., Soininen, H., Kivipelto, M., Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: A prospective population based study (2004) BMJ, 329, p. 539; Bond, G.E., Burr, R., McCurry, S.M., Rice, M.M., Borenstein, A.R., Kukull, W.A., Teri, L., Larson, E.B., Alcohol, gender, and cognitive performance: A longitudinal study comparing older Japanese and non-Hispanic white Americans (2004) J Aging Health, 16, pp. 615-640; Britton, A., Singh-Manoux, A., Marmot, M., Alcohol consumption and cognitive function in the Whitehall II study (2004) American Journal of Epidemiology, 160 (3), pp. 240-247. , DOI 10.1093/aje/kwh206; Bond, G.E., Burr, R.L., McCurry, S.M., Rice, M.M., Borenstein, A.R., Larson, E.B., Alcohol and cognitive performance: A longitudinal study of older Japanese Americans. The Kame Project (2005) International Psychogeriatrics, 17 (4), pp. 653-668. , DOI 10.1017/S1041610205001651; Ganguli, M., Vander Bilt, J., Saxton, J.A., Shen, C., Dodge, H.H., Alcohol consumption and cognitive function in late life: A longitudinal community study (2005) Neurology, 65 (8), pp. 1210-1217. , DOI 10.1212/01.wnl.0000180520.35181.24; Richards, M., Hardy, R., Wadsworth, M.E.J., Alcohol consumption and midlife cognitive change in the British 1946 birth cohort study (2005) Alcohol and Alcoholism, 40 (2), pp. 112-117. , DOI 10.1093/alcalc/agh126; Rodgers, B., Windsor, T.D., Anstey, K.J., Dear, K.B.G., Jorm, A.F., Christensen, H., Non-linear relationships between cognitive function and alcohol consumption in young, middle-aged and older adults: The PATH through life project (2005) Addiction, 100 (9), pp. 1280-1290. , DOI 10.1111/j.1360-0443.2005.01158.x; Stampfer, M.J., Jae, H.K., Chen, J., Cherry, R., Grodstein, F., Effects of moderate alcohol consumption on cognitive function in women (2005) New England Journal of Medicine, 352 (3), pp. 245-253. , DOI 10.1056/NEJMoa041152; Reid, M.C., Van Ness, P.H., Hawkins, K.A., Towle, V., Concato, J., Guo, Z., Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care (2006) Journal of Geriatric Psychiatry and Neurology, 19 (2), pp. 98-105. , DOI 10.1177/0891988706286513; Wright, C.B., Elkind, M.S.V., Luo, X., Paik, M.C., Sacco, R.L., Reported alcohol consumption and cognitive decline: The Northern Manhattan Study (2006) Neuroepidemiology, 27 (4), pp. 201-207. , DOI 10.1159/000096300; Ngandu, T., Helkala, E.-L., Soininen, H., Winblad, B., Tuomilehto, J., Nissinen, A., Kivipelto, M., Alcohol drinking and cognitive functions: Findings from the cardiovascular risk factors aging and dementia (CAIDE) study (2007) Dementia and Geriatric Cognitive Disorders, 23 (3), pp. 140-149. , DOI 10.1159/000097995; Solfrizzi, V., D'Introno, A., Colacicco, A.M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Panza, F., Alcohol consumption, mild cognitive impairment, and progression to dementia (2007) Neurology, 68 (21), pp. 1790-1799. , DOI 10.1212/01.wnl.0000262035.87304.89, PII 0000611420070522000006; Xu, G., Liu, X., Yin, Q., Zhu, W., Zhang, R., Fan, X., Alcohol consumption and transition of mild cognitive impairment to dementia (2009) Psychiatry Clin Neurosci, 63, pp. 43-49; Au Yeung, S.L., Jiang, C., Zhang, W., Lam, T.H., Cheng, K.K., Leung, G.M., Schooling, C.M., Moderate alcohol use and cognitive function in the Guangzhou Biobank cohort study (2010) Ann Epidemiol, 20, pp. 873-882; Chan, K.K., Chiu, K.C., Chu, L.W., Association between alcohol consumption and cognitive impairment in Southern Chinese older adults (2010) Int J Geriatr Psychiatry, 25, pp. 1272-1279; Corley, J., Jia, X., Brett, C.E., Gow, A.J., Starr, J.M., Kyle, J.A., McNeill, G., Deary, I.J., Alcohol intake and cognitive abilities in old age: The Lothian birth cohort 1936 study (2011) Neuropsychology, 25, pp. 166-175; Gross, A.L., Rebok, G.W., Ford, D.E., Chu, A.Y., Gallo, J.J., Liang, K.Y., Meoni, L.A., Klag, M.J., Alcohol consumption and domain-specific cognitive function in older adults: Longitudinal data from the Johns Hopkins precursors study (2011) J Gerontol B Psychol Sci Soc Sci, 66, pp. 39-47; Sabia, S., Gueguen, A., Berr, C., Berkman, L., Ankri, J., Goldberg, M., Zins, M., Singh-Manoux, A., High alcohol consumption in middle-aged adults is associated with poorer cognitive performance only in the low socio-economic group. Results from the GAZEL cohort study (2011) Addiction, 106, pp. 93-101; Zanjani, F., Downer, B.G., Kruger, T.M., Willis, S.L., Schaie, K.W., Alcohol effects on cognitive change in middle-aged and older adults (2013) Aging Ment Health, 17 (1), pp. 12-23; Ho, S.C., Woo, J., Sham, A., Chan, S.G., Yu, A.L.M., A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairement in a Chinese older cohort (2001) International Journal of Epidemiology, 30 (6), pp. 1389-1396; Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., Rockwood, K., Physical activity and risk of cognitive impairment and dementia in elderly persons (2001) Archives of Neurology, 58 (3), pp. 498-504; Schuit, A.J., Feskens, E.J.M., Launer, L.J., Kromhout, D., Physical activity and cognitive decline, the role of the apolipoprotein e4 allele (2001) Medicine and Science in Sports and Exercise, 33 (5), pp. 772-777; Yaffe, K., Barnes, D., Nevitt, M., Lui, L.-Y., Covinsky, K., A prospective study of physical activity and cognitive decline in elderly women women who walk (2001) Archives of Internal Medicine, 161 (14), pp. 1703-1708; Verghese, J., Lipton, R.B., Katz, M.J., Hall, C.B., Derby, C.A., Kuslansky, G., Ambrose, A.F., Buschke, H., Leisure activities and the risk of dementia in the elderly (2003) New England Journal of Medicine, 348 (25), pp. 2508-2516. , DOI 10.1056/NEJMoa022252; Abbott, R.D., White, L.R., Ross, G.W., Masaki, K.H., Curb, J.D., Petrovitch, H., Walking and dementia in physically capable elderly men (2004) Journal of the American Medical Association, 292 (12), pp. 1447-1453. , DOI 10.1001/jama.292.12.1447; Lytle, M.E., Vander Bilt, J., Pandav, R.S., Dodge, H.H., Ganguli, M., Exercise level and cognitive decline: The MoVIES project (2004) Alzheimer Disease and Associated Disorders, 18 (2), pp. 57-64. , DOI 10.1097/01.wad.0000126614.87955.79; Van Gelder, B.M., Tijhuis, M.A.R., Kalmijn, S., Giampaoli, S., Nissinen, A., Kromhout, D., Physical activity in relation to cognitive decline in elderly men: The FINE study (2004) Neurology, 63 (12), pp. 2316-2321; Weuve, J., Kang, J.H., Manson, J.E., Breteler, M.M.B., Ware, J.H., Grodstein, F., Physical activity, including walking, and cognitive function in older women (2004) Journal of the American Medical Association, 292 (12), pp. 1454-1461. , DOI 10.1001/jama.292.12.1454; Podewils, L.J., Guallar, E., Kuller, L.H., Fried, L.P., Lopez, O.L., Carlson, M., Lyketsos, C.G., Physical activity, APOE genotype, and dementia risk: Findings from the Cardiovascular Health Cognition Study (2005) American Journal of Epidemiology, 161 (7), pp. 639-651. , DOI 10.1093/aje/kwi092; Rovio, S., Kareholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Kivipelto, M., Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease (2005) Lancet Neurology, 4 (11), pp. 705-711. , DOI 10.1016/S1474-4422(05)70198-8, PII S1474442205701988; Sturman, M.T., Morris, M.C., Mendes De Leon, C.F., Bienias, J.L., Wilson, R.S., Evans, D.A., Physical activity, cognitive activity, and cognitive decline in a biracial community population (2005) Archives of Neurology, 62 (11), pp. 1750-1754. , http://archneur.ama-assn.org/cgi/reprint/62/11/1750, DOI 10.1001/archneur.62.11.1750; Karp, A., Paillard-Borg, S., Wang, H.-X., Silverstein, M., Winblad, B., Fratiglioni, L., Mental, physical and social components in leisure activities equally contribute to decrease dementia risk (2006) Dementia and Geriatric Cognitive Disorders, 21 (2), pp. 65-73. , DOI 10.1159/000089919; Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P., Kukull, W., Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older (2006) Annals of Internal Medicine, 144 (2), pp. 73-81; Landi, F., Russo, A., Barillaro, C., Cesari, M., Pahor, M., Danese, P., Bernabei, R., Onder, G., Physical activity and risk of cognitive impairment among older persons living in the community (2007) Aging - Clinical and Experimental Research, 19 (5), pp. 410-416; Psaltopoulou, T., Kyrozis, A., Stathopoulos, P., Trichopoulos, D., Vassilopoulos, D., Trichopoulou, A., Diet, physical activity and cognitive impairment among elders: The EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition) (2008) Public Health Nutr, 11, pp. 1054-1062; Taaffe, D.R., Irie, F., Masaki, K.H., Abbott, R.D., Petrovitch, H., Ross, G.W., White, L.R., Physical activity, physical function, and incident dementia in elderly men: The Honolulu-Asia aging study (2008) J Gerontol A Biol Sci Med Sci, 63, pp. 529-535; Gallucci, M., Antuono, P., Ongaro, F., Forloni, P.L., Albani, D., Amici, G.P., Regini, C., Physical activity, socialization and reading in the elderly over the age of seventy: What is the relation with cognitive decline? Evidence from the Treviso Longeva (TRELONG) study (2009) Arch Gerontol Geriatr, 48, pp. 284-286; Scarmeas, N., Luchsinger, J.A., Schupf, N., Brickman, A.M., Cosentino, S., Tang, M.X., Stern, Y., Physical activity, diet, and risk of Alzheimer disease (2009) JAMA, 302, pp. 627-637; Yaffe, K., Fiocco, A.J., Lindquist, K., Vittinghoff, E., Simonsick, E.M., Newman, A.B., Satterfield, S., Harris, T.B., Predictors of maintaining cognitive function in older adults: The Health ABC study (2009) Neurology, 72, pp. 2029-2035; Chang, M., Jonsson, P.V., Snaedal, J., Bjornsson, S., Saczynski, J.S., Aspelund, T., Eiriksdottir, G., Launer, L.J., The effect of midlife physical activity on cognitive function among older adults: AGES-Reykjavik study (2010) J Gerontol A Biol Sci Med Sci, 65, pp. 1369-1374; Etgen, T., Sander, D., Huntgeburth, U., Poppert, H., Forstl, H., Bickel, H., Physical activity and incident cognitive impairment in elderly persons: The INVADE study (2010) Arch Intern Med, 170, pp. 186-193; Gillum, R.F., Obisesan, T.O., Physical activity, cognitive function, and mortality in a US national cohort (2010) Ann Epidemiol, 20, pp. 251-257; Middleton, L.E., Barnes, D.E., Lui, L.Y., Yaffe, K., Physical activity over the life course and its association with cognitive performance and impairment in old age (2010) J Am Geriatr Soc, 58, pp. 1322-1326; Buchman, A.S., Boyle, P.A., Yu, L., Shah, R.C., Wilson, R.S., Bennett, D.A., Total daily physical activity and the risk of AD and cognitive decline in older adults (2012) Neurology, 78, pp. 1323-1329; Lin, F., Friedman, E., Quinn, J., Chen, D.G., Mapstone, M., Effect of leisure activities on inflammation and cognitive function in an aging sample (2012) Arch Gerontol Geriatr, 54, pp. 5398-5404; Norton, M.C., Dew, J., Smith, H., Fauth, E., Piercy, K.W., Breitner, J.C., Tschanz, J., Welsh-Bohmer, K., Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: The Cache county study (2012) J Am Geriatr Soc, 60, pp. 405-412; Jarvis, M.J., Does caffeine intake enhance absolute levels of cognitive performance? (1993) Psychopharmacology, 110 (1-2), pp. 45-52; Johnson-Kozlow, M., Kritz-Silverstein, D., Barrett-Connor, E., Morton, D., Coffee consumption and cognitive function among older adults (2002) American Journal of Epidemiology, 156 (9), pp. 842-850. , DOI 10.1093/aje/kwf119; Van Boxtel, M.P.J., Schmitt, J.A.J., Bosma, H., Jolles, J., The effects of habitual caffeine use on cognitive change: A longitudinal perspective (2003) Pharmacology Biochemistry and Behavior, 75 (4), pp. 921-927. , DOI 10.1016/S0091-3057(03)00171-0; Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Tsuji, I., Green tea consumption and cognitive function: A cross-sectional study from the Tsurugaya Project (2006) American Journal of Clinical Nutrition, 83 (2), pp. 355-361. , http://www.ajcn.org/cgi/reprint/83/2/355; Van Gelder, B.M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., Kromhout, D., Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study (2007) Eur J Clin Nutr, 61, pp. 226-232; Ng, T.-P., Feng, L., Niti, M., Kua, E.-H., Yap, K.-B., Tea consumption and cognitive impairment and decline in older Chinese adults (2008) American Journal of Clinical Nutrition, 88 (1), pp. 224-231. , http://www.ajcn.org/cgi/reprint/88/1/224; Eskelinen, M.H., Ngandu, T., Tuomilehto, J., Soininen, H., Kivipelto, M., Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study (2009) J Alzheimers Dis, 16, pp. 85-91; Laitala, V.S., Kaprio, J., Koskenvuo, M., Raiha, I., Rinne, J.O., Silventoinen, K., Coffee drinking in middle age is not associated with cognitive performance in old age (2009) Am J Clin Nutr, 90, pp. 640-646; Nurk, E., Refsum, H., Drevon, C.A., Tell, G.S., Nygaard, H.A., Engedal, K., Smith, A.D., Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance (2009) J Nutr, 139, pp. 120-127; Smith, A.P., Caffeine, cognitive failures and health in a non-working community sample (2009) Hum Psychopharmacol, 24, pp. 29-34; Corley, J., Jia, X., Kyle, J.A., Gow, A.J., Brett, C.E., Starr, J.M., McNeill, G., Deary, I.J., Caffeine consumption and cognitive function at age 70: The Lothian birth cohort 1936 study (2010) Psychosom Med, 72, pp. 206-214; Feng, L., Gwee, X., Kua, E.H., Ng, T.P., Cognitive function and tea consumption in community dwelling older Chinese in Singapore (2010) J Nutr Health Aging, 14, pp. 433-438; Ritchie, K., Artero, S., Portet, F., Brickman, A., Muraskin, J., Beanino, E., Ancelin, M.L., Carriere, I., Caffeine, cognitive functioning, and white matter lesions in the elderly: Establishing causality from epidemiological evidence (2010) J Alzheimers Dis, 20 (SUPPL. 1), pp. 19161-19166; Santos, C., Lunet, N., Azevedo, A., De Mendonca, A., Ritchie, K., Barros, H., Caffeine intake is associated with a lower risk of cognitive decline: A cohort study from Portugal (2010) J Alzheimers Dis, 20 (SUPPL. 1), pp. 19175-19185; Arab, L., Biggs, M.L., O'Meara, E.S., Longstreth, W.T., Crane, P.K., Fitzpatrick, A.L., Gender differences in tea, coffee, and cognitive decline in the elderly: The cardiovascular health study (2011) J Alzheimers Dis, 27, pp. 553-566; Gelber, R.P., Petrovitch, H., Masaki, K.H., Ross, G.W., White, L.R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates (2011) J Alzheimers Dis, 23, pp. 607-615; Feng, L., Li, J., Ng, T.P., Lee, T.S., Kua, E.H., Zeng, Y., Tea drinking and cognitive function in oldest-old chinese (2012) J Nutr Health Aging, 16, pp. 754-758; Warsama Jama, J., Launer, L.J., Witteman, J.C.M., Den Breeijen, J.H., Breteler, M.M.B., Grobbee, D.E., Hofman, A., Dietary antioxidants and cognitive function in a population-based sample of older persons: The Rotterdam study (1996) American Journal of Epidemiology, 144 (3), pp. 275-280; Mendelsohn, A.B., Belle, S.H., Stoehr, G.P., Ganguli, M., Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: The movies project (1998) American Journal of Epidemiology, 148 (1), pp. 38-44; Morris, M.C., Beckett, L.A., Scherr, P.A., Hebert, L.E., Bennett, D.A., Field, T.S., Evans, D.A., Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease (1998) Alzheimer Disease and Associated Disorders, 12 (3), pp. 121-126; Schmidt, R., Hayn, M., Reinhart, B., Roob, G., Schmidt, H., Schumacher, M., Watzinger, N., Launer, L.J., Plasma antioxidants and cognitive performance in middle-aged and older adults: Results of the Austrian stroke prevention study (1998) Journal of the American Geriatrics Society, 46 (11), pp. 1407-1410; Masaki, K.H., Losonczy, K.G., Izmirlian, G., Foley, D.J., Ross, G.W., Petrovitch, H., Havlik, R., White, L.R., Association of vitamin E and C supplement use with cognitive function and dementia in elderly men (2000) Neurology, 54 (6), pp. 1265-1272; Peacock, J.M., Folsom, A.R., Knopman, D.S., Mosley, T.H., Goff Jr., C.D., Szklo, M., Dietary antioxidant intake and cognitive performance in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigators (2000) Public Health Nutr, 3, pp. 337-343; Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., Van Swieten, J.C., Hofman, A., Witteman, J.C.M., Breteler, M.M.B., Dietary intake of antioxidants and risk of Alzheimer disease (2002) Journal of the American Medical Association, 287 (24), pp. 3223-3229; Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Aggarwal, N., Wilson, R.S., Scherr, P.A., Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study (2002) Journal of the American Medical Association, 287 (24), pp. 3230-3237; Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Wilson, R.S., Vitamin E and cognitive decline in older persons (2002) Archives of Neurology, 59 (7), pp. 1125-1132. , DOI 10.1001/archneur.59.7.1125; Gray, S.L., Hanlon, J.T., Landerman, L.R., Artz, M., Schmader, K.E., Fillenbaum, G.G., Is antioxidant use protective of cognitive function in the community-dwelling elderly? (2003) American Journal Geriatric Pharmacotherapy, 1 (1), pp. 3-10. , DOI 10.1016/S1543-5946(03)80011-9; Grodstein, F., Chen, J., Willett, W.C., High-dose antioxidant supplements and cognitive function in community-dwelling elderly women (2003) Am J Clin Nutr, 77, pp. 975-984; Luchsinger, J.A., Tang, M.-X., Shea, S., Mayeux, R., Antioxidant vitamin intake and risk of Alzheimer disease (2003) Archives of Neurology, 60 (2), pp. 203-208. , DOI 10.1001/archneur.60.2.203; Laurin, D., Masaki, K.H., Foley, D.J., White, L.R., Launer, L.J., Midlife Dietary Intake of Antioxidants and Risk of Late-Life Incident Dementia: The Honolulu-Asia Aging Study (2004) American Journal of Epidemiology, 159 (10), pp. 959-967. , DOI 10.1093/aje/kwh124; Zandi, P.P., Anthony, J.C., Khachaturian, A.S., Stone, S.V., Gustafson, D., Tschanz, J.T., Norton, M.C., Breitner, J.C.S., Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study (2004) Archives of Neurology, 61 (1), pp. 82-88. , DOI 10.1001/archneur.61.1.82; Cherubini, A., Martin, A., Andres-Lacueva, C., Di Iorio, A., Lamponi, M., Mecocci, P., Bartali, B., Ferrucci, L., Vitamin E levels, cognitive impairment and dementia in older persons: The InCHIANTI study (2005) Neurobiology of Aging, 26 (7), pp. 987-994. , DOI 10.1016/j.neurobiolaging.2004.09.002; Engelhart, M.J., Ruitenberg, A., Meijer, J., Kiliaan, A., Van Swieten, J.C., Hofman, A., Witteman, J.C.M., Breteler, M.M.B., Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline: A population-based study (2005) Dementia and Geriatric Cognitive Disorders, 19 (2-3), pp. 134-139. , DOI 10.1159/000082884; Fillenbaum, G.G., Kuchibhatla, M.N., Hanlon, J.T., Artz, M.B., Pieper, C.F., Schmader, K.E., Dysken, M.W., Gray, S.L., Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E (2005) Annals of Pharmacotherapy, 39 (12), pp. 2009-2014. , DOI 10.1345/aph.1G280; Maxwell, C.J., Hicks, M.S., Hogan, D.B., Basran, J., Ebly, E.M., Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia (2005) Dementia and Geriatric Cognitive Disorders, 20 (1), pp. 45-51. , DOI 10.1159/000085074; Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., Wilson, R.S., Aggarwal, N.T., Scherr, P.A., Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change (2005) American Journal of Clinical Nutrition, 81 (2), pp. 508-514; Akbaraly, N.T., Faure, H., Gourlet, V., Favier, A., Berr, C., Plasma carotenoid levels and cognitive performance in an elderly population: Results of the EVA Study (2007) Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 62 (3), pp. 308-316; Dunn, J.E., Weintraub, S., Stoddard, A.M., Banks, S., Serum α-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment (2007) Neurology, 68 (9), pp. 670-676. , DOI 10.1212/01.wnl.0000255940.13116.86, PII 0000611420070227000012; Wengreen, H.J., Munger, R.G., Corcoran, C.D., Zandi, P., Hayden, K.M., Fotuhi, M., Skoog, I., Welsh-Bohmer, K.A., Antioxidant intake and cognitive function of elderly men and women: The Cache County study (2007) Journal of Nutrition, Health and Aging, 11 (3), pp. 230-237; Fotuhi, M., Zandi, P.P., Hayden, K.M., Khachaturian, A.S., Szekely, C.A., Wengreen, H., Munger, R.G., Welsh-Bohmer, K., Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: The Cache County Study (2008) Alzheimer's and Dementia, 4 (3), pp. 223-227. , DOI 10.1016/j.jalz.2008.01.004, PII S1552526008000344; Gray, S.L., Anderson, M.L., Crane, P.K., Breitner, J.C.S., McCormick, W., Bowen, J.D., Teri, L., Larson, E., Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults (2008) Journal of the American Geriatrics Society, 56 (2), pp. 291-295. , DOI 10.1111/j.1532-5415.2007.01531.x; Ravaglia, G., Forti, P., Lucicesare, A., Pisacane, N., Rietti, E., Mangialasche, F., Cecchetti, R., Mecocci, P., Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort (2008) American Journal of Clinical Nutrition, 87 (5), pp. 1306-1313. , http://www.ajcn.org/cgi/reprint/87/5/1306; Devore, E.E., Kang, J.H., Stampfer, M.J., Grodstein, F., Total antioxidant capacity of diet in relation to cognitive function and decline (2010) Am J Clin Nutr, 92, pp. 1157-1164; McNeill, G., Jia, X., Whalley, L.J., Fox, H.C., Corley, J., Gow, A.J., Brett, C.E., Deary, I.J., Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936 (2011) Eur J Clin Nutr, 65, pp. 619-626; Kalmijn, S., Launer, L.J., Lindemans, J., Bots, M.L., Hofman, A., Breteler, M.M.B., Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam study (1999) American Journal of Epidemiology, 150 (3), pp. 283-289; Duthie, S.J., Whalley, L.J., Collins, A.R., Leaper, S., Berger, K., Deary, I.J., Homocysteine, B vitamin status, and cognitive function in the elderly (2002) American Journal of Clinical Nutrition, 75 (5), pp. 908-913; Prins, N.D., Den Heijer, T., Hofman, A., Koudstaal, P.J., Jolles, J., Clarke, R., Breteler, M.M.B., Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study (2002) Neurology, 59 (9), pp. 1375-1380; Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W.F., Wolf, P.A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease (2002) New England Journal of Medicine, 346 (7), pp. 476-483. , DOI 10.1056/NEJMoa011613; Miller, J.W., Green, R., Ramos, M.I., Allen, L.H., Mungas, D.M., Jagust, W.J., Haan, M.N., Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging (2003) American Journal of Clinical Nutrition, 78 (3), pp. 441-447; Ravaglia, G., Forti, P., Maiol, F., Muscari, A., Sacchetti, L., Arnone, G., Nativio, V., Mariani, E., Homocysteine and cognitive function in healthy elderly community dwellers in Italy (2003) American Journal of Clinical Nutrition, 77 (3), pp. 668-673; Luchsinger, J.A., Tang, M.-X., Shea, S., Miller, J., Green, R., Mayeux, R., Plasma homocysteine levels and risk of Alzheimer disease (2004) Neurology, 62 (11), pp. 1972-1976; Ariogul, S., Cankurtaran, M., Dagli, N., Khalil, M., Yavuz, B., Vitamin B12, folate, homocysteine and dementia: Are they really related? (2005) Archives of Gerontology and Geriatrics, 40 (2), pp. 139-146. , DOI 10.1016/j.archger.2004.07.005, PII S0167494304001475; Campbell, A.K., Jagust, W.J., Mungas, D.M., Miller, J.W., Green, R., Haan, M.N., Allen, L.H., Low erythrocyte folate, but not plasma vitamin B-12, or homocysteine, is associated with dementia in elderly latinos (2005) Journal of Nutrition, Health and Aging, 9 (1), pp. 39-43; Elias, M.F., Sullivan, L.M., D'Agostino, R.B., Elias, P.K., Jacques, P.F., Selhub, J., Seshadri, S., Wolf, P.A., Homocysteine and cognitive performance in the Framingham Offspring Study: Age is important (2005) American Journal of Epidemiology, 162 (7), pp. 644-653. , DOI 10.1093/aje/kwi259; Kado, D.M., Karlamangla, A.S., Huang, M.-H., Troen, A., Rowe, J.W., Selhub, J., Seeman, T.E., Homocysteine versus the vitamins folate, B6, and B 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging (2005) American Journal of Medicine, 118 (2), pp. 161-167. , DOI 10.1016/j.amjmed.2004.08.019; Mooijaart, S.P., Gussekloo, J., Frolich, M., Jolles, J., Stott, D.J., Westendorp, R.G.J., De Craen, A.J.M., Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: The Leiden 85-Plus Study (2005) American Journal of Clinical Nutrition, 82 (4), pp. 866-871; Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Tettamanti, M., Lucca, U., Homocysteine and B vitamins in mild cognitive impairment and dementia (2005) Clinical Chemistry and Laboratory Medicine, 43 (10), pp. 1096-1100. , http://www.extenza-eps.com/WDG/doi/abs/10.1515/CCLM.2005.191, DOI 10.1515/CCLM.2005.191; Ramos, M.I., Allen, L.H., Mungas, D.M., Jagust, W.J., Haan, M.N., Green, R., Miller, J.W., Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging (2005) American Journal of Clinical Nutrition, 82 (6), pp. 1346-1352; Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., Licastro, F., Homocysteine and folate as risk factors for dementia and Alzheimer disease (2005) Am J Clin Nutr, 82, pp. 636-643; Schafer, J.H., Glass, T.A., Bolla, K.I., Mintz, M., Jedlicka, A.E., Schwartz, B.S., Homocysteine and cognitive function in a population-based study of older adults (2005) Journal of the American Geriatrics Society, 53 (3), pp. 381-388. , DOI 10.1111/j.1532-5415.2005.53153.x; Tucker, K.L., Qiao, N., Scott, T., Rosenberg, I., Spiro III, A., High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans affairs normative aging study (2005) Am J Clin Nutr, 82, pp. 627-635; Elias, M.F., Robbins, M.A., Budge, M.M., Elias, P.K., Brennan, S.L., Johnston, C., Nagy, Z., Bates, C.J., Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: The Maine-Syracuse study (2006) Psychosomatic Medicine, 68 (4), pp. 547-554. , DOI 10.1097/01.psy.0000221380.92521.51, PII 0000684220060700000006; Feng, L., Ng, T.-P., Chuah, L., Niti, M., Kua, E.-H., Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: Findings from the Singapore Longitudinal Ageing Study (2006) American Journal of Clinical Nutrition, 84 (6), pp. 1506-1512. , http://www.ajcn.org/cgi/reprint/84/6/1506; Van Raamt, A.F., Kalmijn, S., Mali, W.P., Van Zandvoort, M.J., Van Der Graaf, Y., Homocysteine level and cognitive function in patients with arterial disease: The second manifestations of ARTerial disease study (2006) J Am Geriatr Soc, 54, pp. 575-579; Clarke, R., Birks, J., Nexo, E., Ueland, P.M., Schneede, J., Scott, J., Molloy, A., Evans, J.G., Low vitamin B-12 status and risk of cognitive decline in older adults (2007) American Journal of Clinical Nutrition, 86 (5), pp. 1384-1391. , http://www.ajcn.org/cgi/reprint/86/5/1384; Haan, M.N., Miller, J.W., Aiello, A.E., Whitmer, R.A., Jagust, W.J., Mungas, D.M., Allen, L.H., Green, R., Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging (2007) American Journal of Clinical Nutrition, 85 (2), pp. 511-517. , http://www.ajcn.org/cgi/reprint/85/2/511; Kim, J., Park, M.H., Kim, E., Han, C., Jo, S.A., Jo, I., Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population (2007) Journal of Nutrition, 137 (9), pp. 2093-2097. , http://jn.nutrition.org/cgi/reprint/137/9/2093; Elias, M.F., Robbins, M.A., Budge, M.M., Elias, P.K., Dore, G.A., Brennan, S.L., Johnston, C., Nagy, Z., Homocysteine and cognitive performance: Modification by the ApoE genotype (2008) Neurosci Lett, 430, pp. 64-69; Kim, J.M., Kim, S.W., Shin, I.S., Yang, S.J., Park, W.Y., Kim, S.J., Shin, H.Y., Yoon, J.S., Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly (2008) Psychiatry Investig, 5, pp. 36-40; Kim, J.M., Stewart, R., Kim, S.W., Shin, I.S., Yang, S.J., Shin, H.Y., Yoon, J.S., Changes in folate, vitamin B12 and homocysteine associated with incident dementia (2008) J Neurol Neurosurg Psychiatry, 79, pp. 864-868; Reitz, C., Tang, M.X., Miller, J., Green, R., Luchsinger, J.A., Plasma homocysteine and risk of mild cognitive impairment (2009) Dement Geriatr Cogn Disord, 27, pp. 11-17; Redeen, S., Ryberg, A., Petersson, F., Eriksson, O., Nagga, K., Borch, K., Homocysteine levels in chronic gastritis and other conditions: Relations to incident cardiovascular disease and dementia (2010) Dig Dis Sci, 55, pp. 351-358; Van Den Kommer, T.N., Dik, M.G., Comijs, H.C., Jonker, C., Deeg, D.J., Homocysteine and inflammation: Predictors of cognitive decline in older persons? (2010) Neurobiol Aging, 31, pp. 1700-1709; Perneczky, R., Alexopoulos, P., Kurz, A., Bickel, H., Cognitive reserve, homocysteine, and cognition in the Bavarian school sisters study (2011) J Am Geriatr Soc, 59, pp. 1754-1756; Zylberstein, D.E., Lissner, L., Bjorkelund, C., Mehlig, K., Thelle, D.S., Gustafson, D., Ostling, S., Skoog, I., Midlife homocysteine and late-life dementia in women. A prospective population study (2011) Neurobiol Aging, 32, pp. 380-386; Ford, A.H., Flicker, L., Alfonso, H., Hankey, G.J., Norman, P.E., Van Bockxmeer, F.M., Almeida, O.P., Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia (2012) J Neurol Neurosurg Psychiatry, 83, pp. 70-75; Ford, A.H., Flicker, L., Hankey, G.J., Norman, P., Van Bockxmeer, F.M., Almeida, O.P., Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: The health in men study (2012) Mol Psychiatry, 17, pp. 559-566; Kalmijn, S., Feskens, E.J.M., Launer, L.J., Kromhout, D., Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men (1997) American Journal of Epidemiology, 145 (1), pp. 33-41; Kalmijn, S., Launer, L.J., Ott, A., Witteman, J.C.M., Hofman, A., Breteler, M.M.B., Dietary fat intake and the risk of incident dementia in the Rotterdam study (1997) Annals of Neurology, 42 (5), pp. 776-782. , DOI 10.1002/ana.410420514; Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., Van Swieten, J.C., Hofman, A., Witteman, J.C.M., Breteler, M.M.B., Diet and risk of dementia: Does fat matter? The Rotterdam study (2002) Neurology, 59 (12), pp. 1915-1921; Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Wilson, R.S., Aggarwal, N., Schneider, J., Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease (2003) Archives of Neurology, 60 (7), pp. 940-946. , DOI 10.1001/archneur.60.7.940; Kalmijn, S., Van Boxtel, M.P.J., Ocke, M., Verschuren, W.M.M., Kromhout, D., Launer, L.J., Dietary intake of fatty acids and fish in relation to cognitive performance at middle age (2004) Neurology, 62 (2), pp. 275-280; Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., Wilson, R.S., Fish consumption and cognitive decline with age in a large community study (2005) Archives of Neurology, 62 (12), pp. 1849-1853. , http://archneur.ama-assn.org/cgi/reprint/62/12/1849, DOI 10.1001/archneur.62.12.noc50161; Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J.F., Alperovitch, A., Dietary patterns and risk of dementia: The Three-City cohort study (2007) Neurology, 69 (20), pp. 1921-1930. , DOI 10.1212/01.wnl.0000278116.37320.52, PII 0000611420071113000007; Beydoun, M.A., Kaufman, J.S., Satia, J.A., Rosamond, W., Folsom, A.R., Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study (2007) American Journal of Clinical Nutrition, 85 (4), pp. 1103-1111. , http://www.ajcn.org/cgi/reprint/85/4/1103; Cherubini, A., Andres-Lacueva, C., Martin, A., Lauretani, F., Di Iorio, A., Bartali, B., Corsi, A., Ferrucci, L., Low plasma N-3 fatty acids and dementia in older persons: The InCHIANTI study (2007) Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 62 (10), pp. 1120-1126; Dullemeijer, C., Durga, J., Brouwer, I.A., Van De Rest, O., Kok, F.J., Brummer, R.-J.M., Van Boxtel, M.P.J., Verhoef, P., N-3 Fatty acid proportions in plasma and cognitive performance in older adults (2007) American Journal of Clinical Nutrition, 86 (5), pp. 1479-1485. , http://www.ajcn.org/cgi/reprint/86/5/1479; Beydoun, M.A., Kaufman, J.S., Sloane, P.D., Heiss, G., Ibrahim, J., N-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study (2008) Public Health Nutrition, 11 (1), pp. 17-29. , DOI 10.1017/S1368980007000080, PII S1368980007000080; Eskelinen, M.H., Ngandu, T., Helkala, E.L., Tuomilehto, J., Nissinen, A., Soininen, H., Kivipelto, M., Fat intake at midlife and cognitive impairment later in life: A population-based CAIDE study (2008) Int J Geriatr Psychiatry, 23, pp. 741-747; Samieri, C., Feart, C., Letenneur, L., Dartigues, J.F., Peres, K., Auriacombe, S., Peuchant, E., Barberger-Gateau, P., Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk (2008) Am J Clin Nutr, 88, pp. 714-721; Albanese, E., Dangour, A.D., Uauy, R., Acosta, D., Guerra, M., Guerra, S.S., Huang, Y., Prince, M.J., Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 dementia research group population-based study (2009) Am J Clin Nutr, 90, pp. 392-400; Devore, E.E., Grodstein, F., Van Rooij, F.J., Hofman, A., Rosner, B., Stampfer, M.J., Witteman, J.C., Breteler, M.M., Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk (2009) Am J Clin Nutr, 90, pp. 170-176; Kroger, E., Verreault, R., Carmichael, P.H., Lindsay, J., Julien, P., Dewailly, E., Ayotte, P., Laurin, D., Omega-3 fatty acids and risk of dementia: The Canadian study of health and aging (2009) Am J Clin Nutr, 90, pp. 184-192; Van De Rest, O., Spiro III, A., Krall-Kaye, E., Geleijnse, J.M., De Groot, L.C., Tucker, K.L., Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans affairs normative aging study (2009) J Nutr, 139, pp. 2329-2336; Vercambre, M.N., Boutron-Ruault, M.C., Ritchie, K., Clavel-Chapelon, F., Berr, C., Long-term association of food and nutrient intakes with cognitive and functional decline: A 13-year follow-up study of elderly French women (2009) Br J Nutr, 102, pp. 419-427; Gonzalez, S., Huerta, J.M., Fernandez, S., Patterson, A.M., Lasheras, C., The relationship between dietary lipids and cognitive performance in an elderly population (2010) Int J Food Sci Nutr, 61, pp. 217-225; Muldoon, M.F., Ryan, C.M., Sheu, L., Yao, J.K., Conklin, S.M., Manuck, S.B., Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood (2010) J Nutr, 140, pp. 848-853; Gao, Q., Niti, M., Feng, L., Yap, K.B., Ng, T.P., Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studies (2011) J Nutr Health Aging, 15, pp. 32-35; Kesse-Guyot, E., Peneau, S., Ferry, M., Jeandel, C., Hercberg, S., Galan, P., Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function (2011) J Nutr Health Aging, 15, pp. 115-120; Samieri, C., Feart, C., Proust-Lima, C., Peuchant, E., Dartigues, J.F., Amieva, H., Barberger-Gateau, P., Omega-3 fatty acids and cognitive decline: Modulation by ApoEepsilon4 allele and depression (2011) Neurobiol Aging, 32, p. 2317. , e2313-2322; Thomson, T.M., (2010) Endnote X3, , Philadelphia, PA: Thomson Reuters; Petitti, D.B., Statistical methods in meat-analysis (2000) Meta-analysis. Decision Analysis, and Cost-effectiveness Analysis, , New York, NY: Oxford University Press Petitti DB 2000; Hildebrandt, M., Bender, R., Gehrmann, U., Blettner, M., Calculating confidence intervals for impact numbers (2006) BMC Med Res Methodol, 6, p. 32; Egger, M., Smith, G.D., Altman, D.G., (2001) Systematic Reviews in Heatlh Care: Meta-analysis in Context, , London. UK: the BMJ Publishing Group 2; Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) British Medical Journal, 315 (7109), pp. 629-634; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50, pp. 1088-1101; Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) British Medical Journal, 315 (7109), pp. 629-634; Statistics/Data Analysis: Release 11.0 (2009) Book Statistics/Data Analysis: Release 11.0, , City: Stata Corporation Editor ed; Albert, M.S., How does education affect cognitive function? (1995) Ann Epidemiol, 5, pp. 76-78; Wilson, R.S., Bennett, D.A., Beckett, L.A., Morris, M.C., Gilley, D.W., Bienias, J.L., Scherr, P.A., Evans, D.A., Cognitive activity in older persons from a geographically defined population (1999) J Gerontol B Psychol Sci Soc Sci, 54, pp. 16155-16160; Gorelick, P.B., Sacco, R.L., Smith, D.B., Alberts, M., Mustone-Alexander, L., Rader, D., Ross, J.L., Rhew, D.C., Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association (1999) Journal of the American Medical Association, 281 (12), pp. 1112-1120. , DOI 10.1001/jama.281.12.1112; Markesbery, W.R., Carney, J.M., Oxidative alterations in Alzheimer's disease (1999) Brain Pathology, 9 (1), pp. 133-146; (1990) Nicotinic Cholinergic Receptors in Alzheimer's Disease, in Nicotine Psychopharmacology: Molecular, Cellular, and Behavioral Aspects, , Oxford: Oxford University Press Kellar KJ, Wonnacott S; Nordberg, A., Biological markers and the cholinergic hypothesis in Alzheimer's disease (1992) Acta Neurol Scand Suppl, 139, pp. 54-58; Letenneur, L., Larrieu, S., Barberger-Gateau, P., Alcohol and tobacco consumption as risk factors of dementia: A review of epidemiological studies (2004) Biomedicine and Pharmacotherapy, 58 (2), pp. 95-99. , DOI 10.1016/j.biopha.2003.12.004; Rogers, R.L., Meyer, J.S., Mortel, K.F., After reaching retirement age physical activity sustains cerebral perfusion and cognition (1990) Journal of the American Geriatrics Society, 38 (2), pp. 123-128; Dustman, R.E., Ruhling, R.O., Russell, E.M., Aerobic exercise training and improved neuropsychological function of older individuals (1984) Neurobiology of Aging, 5 (1), pp. 35-42. , DOI 10.1016/0197-4580(84)90083-6; Spirduso, W.W., Physical fitness, aging, and psychomotor speed: A review (1980) Journals of Gerontology, 35 (6), pp. 850-865; Gomez-Pinilla, F., Dao, L., So, V., Physical exercise induces FGF-2 and its mRNA in the hippocampus (1997) Brain Research, 764 (1-2), pp. 1-8. , DOI 10.1016/S0006-8993(97)00375-2, PII S0006899397003752; Cotman, C.W., Engesser-Cesar, C., Exercise enhances and protects brain function (2002) Exercise and Sport Sciences Reviews, 30 (2), pp. 75-79; Pignatti, F., Rozzini, R., Trabucchi, M., Yaffe, K., Physical activity and cognitive decline in elderly persons [2] (multiple letters) (2002) Archives of Internal Medicine, 162 (3), pp. 361-362; James, J.E., (1991) Caffeine & Health, , London, England: Academic; Battig, K., Buzzi, R., Effect of coffee on the speed of subject-paced information processing (1986) Neuropsychobiology, 16 (2-3), pp. 126-130; Riedel, W., Hogervorst, E., Leboux, R., Verhey, F., Van Praag, H., Jolles, J., Caffeine attenuates scopolamine-induced memory impairment in humans (1995) Psychopharmacology, 122 (2), pp. 158-168. , DOI 10.1007/BF02246090; Behl, C., Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease (1997) Cell and Tissue Research, 290 (3), pp. 471-480. , DOI 10.1007/s004410050955; Christen, Y., Oxidative stress and Alzheimer disease (2000) American Journal of Clinical Nutrition, 71 (2), pp. 621S-629S; Grundman, M., Vitamin E and Alzheimer disease: The basis for additional clinical trials (2000) American Journal of Clinical Nutrition, 71 (2), pp. 630S-636S; Refsum, H., Ueland, P.M., Nygard, O., Vollset, S.E., Homocysteine and cardiovascular disease (1998) Annual Review of Medicine, 49, pp. 31-62. , DOI 10.1146/annurev.med.49.1.31; Garcia, A., Haron, Y., Pulman, K., Hua, L., Freedman, M., Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: A prospective follow-up study (2004) Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 59 (12), pp. 1323-1327; Teunissen, C.E., Blom, A.H.J., Van Boxtel, M.P.J., Bosma, H., De Bruijn, C., Jolles, J., Wauters, B.A., De Vente, J., Homocysteine: A marker for cognitive performance? A longitudinal follow-up study (2003) Journal of Nutrition, Health and Aging, 7 (3), pp. 153-159; Scott, T.M., Tucker, K.L., Bhadelia, A., Benjamin, B., Patz, S., Bhadelia, R., Liebson, E., Folstein, M.F., Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders (2004) American Journal of Geriatric Psychiatry, 12 (6), pp. 631-638. , DOI 10.1176/appi.ajgp.12.6.631; Dufouil, C., Alperovitch, A., Ducros, V., Tzourio, C., Homocysteine, white matter hyperintensities, and cognition in healthy elderly people (2003) Annals of Neurology, 53 (2), pp. 214-221. , DOI 10.1002/ana.10440; Sachdev, P.S., Valenzuela, M., Wang, X.L., Looi, J.C.L., Brodaty, H., Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals (2002) Neurology, 58 (10), pp. 1539-1541; Bleich, S., Kornhuber, J., Sachdev, P., Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals [1] (multiple letters) (2003) Neurology, 60 (7), p. 1220; Den Heijer, T., Vermeer, S.E., Clarke, R., Oudkerk, M., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., Homocysteine and brain atrophy on MRI of non-demented elderly (2003) Brain, 126 (1), pp. 170-175. , DOI 10.1093/brain/awg006; Bottiglieri, T., Homocysteine and folate metabolism in depression (2005) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29 (7), pp. 1103-1112. , DOI 10.1016/j.pnpbp.2005.06.021, PII S0278584605002174; Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D., Rosenberg, I.H., Vitamin status and intake as primary determinants of homocysteinemia in an elderly population (1993) Journal of the American Medical Association, 270 (22), pp. 2693-2698. , DOI 10.1001/jama.270.22.2693; Li, L., Cao, D., Desmond, R., Rahman, A., Lah, J.J., Levey, A.I., Zamrini, E., Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease (2008) Dement Geriatr Cogn Disord, 26, pp. 384-390; Vidal, J.-S., Dufouil, C., Ducros, V., Tzourio, C., Homocysteine, folate and cognition in a large community-based sample of elderly people - The 3C Dijon study (2008) Neuroepidemiology, 30 (4), pp. 207-214. , DOI 10.1159/000126914; Kruman, I.I., Culmsee, C., Chan, S.L., Kruman, Y., Guo, Z., Penix, L., Mattson, M.P., Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity (2000) J Neurosci, 20, pp. 6920-6926; Parsons, R.B., Waring, R.H., Ramsden, D.B., Williams, A.C., In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines (1998) Neurotoxicology, 19, pp. 599-603; Arab, L., Biomarkers of fat and fatty acid intake (2003) Journal of Nutrition, 133 (3 SUPPL.), pp. 925S-932S; Andreassi, M., Forleo, P., Di Lorio, A., Masci, S., Abate, G., Amerio, P., Efficacy of γ-linolenic acid in the treatment of patients with atopic dermatitis (1997) Journal of International Medical Research, 25 (5), pp. 266-274; Cerolini, S., Kelso, K.A., Noble, R.C., Speake, B.K., Pizzi, F., Cavalchini, L.G., Relationship between spermatozoan lipid composition and fertility during aging of chickens (1997) Biology of Reproduction, 57 (5), pp. 976-980. , DOI 10.1095/biolreprod57.5.976; Zhang, L., The effects of essential fatty acids preparation in the treatment of intrauterine growth retardation (1997) American Journal of Perinatology, 14 (9), pp. 535-537; Bjerve, K.S., Omega 3 fatty acid deficiency in man: Implications for the requirement of alpha-linolenic acid and long-chain omega 3 fatty acids (1991) World Rev Nutr Diet, 66, pp. 133-142; Wainwright, P.E., Dietary essential fatty acids and brain function: A developmental perspective on mechanisms (2002) Proceedings of the Nutrition Society, 61 (1), pp. 61-69; Haag, M., Essential fatty acids and the brain (2003) Canadian Journal of Psychiatry, 48 (3), pp. 195-203; De Wilde, M.C., Hogyes, E., Kiliaan, A.J., Farkas, T., Luiten, P.G.M., Farkas, E., Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats (2003) Brain Research, 988 (1-2), pp. 9-19. , DOI 10.1016/S0006-8993(03)03320-1},
correspondence_address1={Beydoun, M.A.; Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, 251 Bayview Blvd., Baltimore, MD 21224, United States; email: baydounm@mail.nih.gov},
publisher={BioMed Central Ltd.},
issn={14712458},
pubmed_id={24962204},
language={English},
abbrev_source_title={BMC Public Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Zhou2014,
author={Zhou, X. and Menche, J. and Barabási, A.-L. and Sharma, A.},
title={Human symptoms-disease network},
journal={Nature Communications},
year={2014},
volume={5},
doi={10.1038/ncomms5212},
art_number={4212},
note={cited By 375},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903639346&doi=10.1038%2fncomms5212&partnerID=40&md5=3b1550e5e5a75aac6a268d3c6575a4b7},
affiliation={School of Computer and Information Technology, Beijing Key Lab of Traffic Data Analysis and Mining, Beijing Jiaotong University, Beijing 100044, China; Center for Complex Network Research, Northeastern University Physics Department, 110 Forsyth Street, Boston, MA 02115, United States; Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Smith Bldg., 450 Brookline Ave, Boston, MA 02215, United States; Department of Theoretical Physics, Budapest University of Technology and Economics, Budafoki út. 8, 1111 Budapest, Hungary; Center for Network Science, Central European University, Nádor út. 9, 1051 Budapest, Hungary; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, United States},
abstract={In the post-genomic era, the elucidation of the relationship between the molecular origins of diseases and their resulting phenotypes is a crucial task for medical research. Here, we use a large-scale biomedical literature database to construct a symptom-based human disease network and investigate the connection between clinical manifestations of diseases and their underlying molecular interactions. We find that the symptom-based similarity of two diseases correlates strongly with the number of shared genetic associations and the extent to which their associated proteins interact. Moreover, the diversity of the clinical manifestations of a disease can be related to the connectivity patterns of the underlying protein interaction network. The comprehensive, high-quality map of disease-symptom relations can further be used as a resource helping to address important questions in the field of systems medicine, for example, the identification of unexpected associations between diseases, disease etiology research or drug design. © 2014 Macmillan Publishers Limited. All rights reserved.},
keywords={database;  disease incidence;  drug development;  etiology;  genetic analysis;  genome;  mapping;  medicine;  protein;  symptom, article;  clinical feature;  controlled study;  data base;  genetic association;  human;  molecular interaction;  protein protein interaction;  symptom;  diseases;  genetic predisposition;  genetics;  phenotype;  systems theory;  theoretical model, protein, Disease;  Genetic Predisposition to Disease;  Humans;  Models, Theoretical;  Phenotype;  Proteins;  Systems Theory},
chemicals_cas={protein, 67254-75-5; Proteins},
funding_details={Z131110002813118},
funding_details={270086, HL066289},
funding_details={1U01HL108630-01},
funding_details={2013BAI02B01, 2013BAI13B04},
funding_details={2012ZX09503-001-003},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, P01HL105339, R37HL066289},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 61105055, 81230086},
funding_details={National Basic Research Program of China (973 Program)National Basic Research Program of China (973 Program), 2014CB542903},
funding_text 1={We thank Baoyan Liu, Chaoming Song, Dashun Wang and Andrew Michaelson for useful discussions and suggestions, and especially Lili Xu, Guangli Song, Haixun Qi, Minghui Lv, Yiwei Wang, Xiaofeng Zhou and Hongwei Chu for the manual validation of the selected PubMed records. X.Z. was supported by the National Science Foundation of China (61105055, 81230086), National Basic Research Program of China (2014CB542903), National Key Technology R&D Program (2013BAI02B01, 2013BAI13B04), National S&T Major Special Project (2012ZX09503-001-003) and Beijing Municipal S&T Program of China (Z131110002813118). This work was supported by MapGen grant (1U01HL108630-01) and by the EC-FP7 Program, Synergy-COPD, GA no 270086. Additional support was provided by HL066289 and HL105339 grants from the U.S. National Institutes of Health.},
references={Botstein, D., Risch, N., Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease (2003) Nature Genetics, 33 (SUPPL.), pp. 228-237. , DOI 10.1038/ng1090; Vidal, M., Cusick, M.E., Barabasi, A.L., Interactome networks and human disease (2011) Cell, 144, pp. 986-998; McKusick, V.A., The growth and development of human genetics as a clinical discipline (1975) Am. J. Hum. Genet., 27, pp. 261-273; McKusick, V.A., On lumpers and splitters, or the nosology of genetic disease (1969) Perspect. Biol. Med., 12, pp. 298-312; Loscalzo, J., Kohane, I., Barabasi, A.L., Human disease classification in the postgenomic era: A complex systems approach to human pathobiology (2007) Mol. Syst. Biol., 3, p. 124; Barabasi, A.L., Gulbahce, N., Loscalzo, J., Network medicine: A network-based approach to human disease (2011) Nat. Rev. Genet., 12, pp. 56-68; Wang, Q., Community of protein complexes impacts disease association (2012) Eur. J. Hum. Genet., 20, pp. 1162-1167; Park, J., Lee, D.S., Christakis, N.A., Barabasi, A.L., The impact of cellular networks on disease comorbidity (2009) Mol. Syst. Biol., 5, p. 262; Hidalgo, C.A., Blumm, N., Barabasi, A.L., Christakis, N.A., A dynamic network approach for the study of human phenotypes (2009) PLoS. Comput. Biol., 5, pp. e1000353; Lee, D.S., The implications of human metabolic network topology for disease comorbidity Proc (2008) Natl Acad. Sci., 105, pp. 9880-9885. , USA; Brunner, H.G., Van Driel, M.A., From syndrome families to functional genomics (2004) Nature Reviews Genetics, 5 (7), pp. 545-551. , DOI 10.1038/nrg1383; Rzhetsky, A., Wajngurt, D., Park, N., Zheng, T., Probing genetic overlap among complex human phenotypes (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (28), pp. 11694-11699. , DOI 10.1073/pnas.0704820104; Goh, K.I., The human disease network (2007) Proc. Natl Acad. Sci., 104, pp. 8685-8690. , USA; Giot, L., Bader, J.S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y.L., Rothberg, J.M., A Protein Interaction Map of Drosophila melanogaster (2003) Science, 302 (5651), pp. 1727-1736. , DOI 10.1126/science.1090289; Li, S., Armstrong, C.M., Bertin, N., Ge, H., Milstein, S., Boxem, M., Vidalain, P.-O., Vidal, M., A map of the interactome network of the metazoan C. Elegans (2004) Science, 303 (5657), pp. 540-543. , DOI 10.1126/science.1091403; Dudley, A.M., Janse, D.M., Tanay, A., Shamir, R., Church, G.M., A global view of pleiotropy and phenotypically derived gene function in yeast (2005) Mol. Syst. Biol., 1, p. 20050001; Gavin, A.C., Proteome survey reveals modularity of the yeast cell machinery (2006) Nature, 440, pp. 631-636; Freudenberg, J., Propping, P., A similarity-based method for genome-wide prediction of disease-relevant human genes (2002) Bioinformatics, 18 (SUPPL. 2), pp. S110-S115; Van Driel, M.A., Bruggeman, J., Vriend, G., Brunner, H.G., Leunissen, J.A., A text-mining analysis of the human phenome (2006) Eur. J. Hum. Genet., 14, pp. 535-542; Gandhi, T.K., Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets (2006) Nat. Genet., 38, pp. 285-293; Wu, X., Jiang, R., Zhang, M.Q., Li, S., Network-based global inference of human disease genes (2008) Mol. Syst. Biol., 4, p. 189; Vanunu, O., Magger, O., Ruppin, E., Shlomi, T., Sharan, R., Associating genes and protein complexes with disease via network propagation PLoS (2010) Comput. Biol., 6, pp. e1000641; Wang, X., Gulbahce, N., Yu, H., Network-based methods for human disease gene prediction (2011) Brief. Funct. Genomics, 10, pp. 280-293; Moreau, Y., Tranchevent, L.C., Computational tools for prioritizing candidate genes: Boosting disease gene discovery (2012) Nat. Rev. Genet., 13, pp. 523-536; Robinson, P.N., The Human Phenotype Ontology: A tool for annotating and analyzing human hereditary disease (2008) Am. J. Hum. Genet., 83, pp. 610-615; Smith, C.L., Goldsmith, C.A., Eppig, J.T., The mammalian phenotype ontology as a tool for annotating, analyzing and comparing phenotypic information (2005) Genome Biol., 6, pp. R7; Doelken, S.C., Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafish (2013) Dis. Model. Mech., 6, pp. 358-372; Robinson, P.N., Improved exome prioritization of disease genes through cross-species phenotype comparison (2014) Genome Res., 24, pp. 340-348; Little, R.A., Frayn, K.N., Randall, P.E., Plasma catecholamines in the acute phase of the response to myocardial infarction (1986) Archives of Emergency Medicine, 3 (1), pp. 20-27; Knottnerus, J.A., The effects of disease verification and referral on the relationship between symptoms and diseases (1987) Medical Decision Making, 7 (3), pp. 139-148; Lowe, H.J., Barnett, G.O., Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches (1994) Journal of the American Medical Association, 271 (14), pp. 1103-1108. , DOI 10.1001/jama.271.14.1103; Wheeler, D.L., Barrett, T., Benson, D.A., Bryant, S.H., Canese, K., Chetvernin, V., Church, D.M., Yaschenko, E., Database resources of the National Center for Biotechnology Information (2007) Nucleic Acids Research, 35 (SUPPL. 1), pp. D5-D12. , DOI 10.1093/nar/gkl1031; Fisher, R.A.S., Yates, F., (1943), Statistical Tables for Biological Agricultural and Medical Research 2nd edn revised and enlarged (Oliver & Boyd; Comprehensive molecular characterization of human colon and rectal cancer (2012) Nature, 487, pp. 330-337. , The-Cancer-Genome-Atlas-Network; Oti, M., Snel, B., Huynen, M.A., Brunner, H.G., Predicting disease genes using protein-protein interactions (2006) Journal of Medical Genetics, 43 (8), pp. 691-698. , DOI 10.1136/jmg.2006.041376; Warner, T.T., Schapira, A.H., Genetic and environmental factors in the cause of Parkinson's disease (2003) Ann. Neurol., 53 (SUPPL. 3), pp. S16-S23; Duty, S., Jenner, P., Animal models of Parkinson's disease: A source of novel treatments and clues to the cause of the disease (2011) Br. J. Pharmacol., 164, pp. 1357-1391; Sanchez-Betancourt, J., Manganese mixture inhalation is a reliable Parkinson disease model in rats (2012) Neurotoxicology, 33, pp. 1346-1355; Vanduyn, N., Settivari, R., Wong, G., Nass, R., SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity (2010) Toxicol. Sci., 118, pp. 613-624; Serrano, M.A., Boguna, M., Vespignani, A., Extracting the multiscale backbone of complex weighted networks (2009) Proc. Natl Acad. Sci., 106, pp. 6483-6488. , USA; Grivennikov, S.I., Greten, F.R., Karin, M., Immunity inflammation, and cancer (2010) Cell, 140, pp. 883-899; Chapman, S.J., Hill, A.V., Human genetic susceptibility to infectious disease (2012) Nat. Rev. Genet., 13, pp. 175-188; Loscalzo, J., Barabasi, A.L., Systems biology and the future of medicine (2011) Syst. Biol. Med., 3, pp. 619-627. , Wiley interdisciplinary reviews; Molodecky, N.A., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review (2012) Gastroenterology, 142, pp. 46-54; Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease (2011) Nature, 474, pp. 307-317; Jostins, L., Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (2012) Nature, 491, pp. 119-124; Gulbahce, N., Viral perturbations of host networks reflect disease etiology (2012) PLoS. Comput. Biol., 8, pp. e1002531; Yildirim, M.A., Goh, K.I., Cusick, M.E., Barabasi, A.L., Vidal, M., Drugtarget network (2007) Nat. Biotechnol., 25, pp. 1119-1126; Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L.J., Bork, P., Drug target identification using side-effect similarity (2008) Science, 321 (5886), pp. 263-266. , DOI 10.1126/science.1158140; Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J., Bork, P., A side effect resource to capture phenotypic effects of drugs (2010) Mol. Syst. Biol., 6, p. 343; Imfeld, P., Bodmer, M., Schuerch, M., Jick, S.S., Meier, C.R., Seizures in patients with Alzheimer's disease or vascular dementia: A population-based nested case-control analysis (2013) Epilepsia, 54, pp. 700-707; Sanchez, P.E., Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model (2012) Proc. Natl Acad. Sci., 109, pp. E2895-E2903. , USA; Cote, R.A., Robboy, S., Progress in medical information management. Systematized nomenclature of medicine (SNOMED) (1980) Journal of the American Medical Association, 243 (8), pp. 756-762. , DOI 10.1001/jama.243.8.756; Kohane, I.S., Using electronic health records to drive discovery in disease genomics (2011) Nat. Rev. Genet., 12, pp. 417-428; Hripcsak, G., Albers, D.J., Next-generation phenotyping of electronic health records (2013) J. Am. Med. Inform. Assoc., 20, pp. 117-121; Jensen, P.B., Jensen, L.J., Brunak, S., Mining electronic health records: Towards better research applications and clinical care (2012) Nat. Rev. Genet., 13, pp. 395-405; Pathak, J., Kho, A.N., Denny, J.C., Electronic health records-driven phenotyping: Challenges, recent advances, and perspectives (2013) J. Am. Med. Inform. Assoc., 20, pp. e206-e211; Coletti, M.H., Bleich, H.L., Medical subject headings used to search the biomedical literature (2001) Journal of the American Medical Informatics Association, 8 (4), pp. 317-323; Jensen, L.J., Saric, J., Bork, P., Literature mining for the biologist: From information retrieval to biological discovery (2006) Nature Reviews Genetics, 7 (2), pp. 119-129. , DOI 10.1038/nrg1768, PII NRG1768; Salton, G., Wong, A., Yang, C.S., A vector space model for automatic indexing (1975) Commun. ACM, 18, pp. 613-620; Cao, H., Hripcsak, G., Markatou, M., A statistical methodology for analyzing co-occurrence data from a large sample (2007) Journal of Biomedical Informatics, 40 (3), pp. 343-352. , DOI 10.1016/j.jbi.2006.11.003, PII S1532046406001328; Schweder, T., Spjotvoll, E., Plots of p-values to evaluate many tests simultaneously (1982) Biometrika, 69, pp. 493-502; Girvan, M., Newman, M.E.J., Community structure in social and biological networks (2002) Proceedings of the National Academy of Sciences of the United States of America, 99 (12), pp. 7821-7826. , DOI 10.1073/pnas.122653799; Watts, D.J., Strogatz, S.H., Collective dynamics of 'small-world' networks (1998) Nature, 393 (6684), pp. 440-442. , DOI 10.1038/30918; Cormen, T.H., Cormen, T.H.I.T.A., (2001) Introduction to Algorithms, , MIT Press; Newman, M.E.J., (2010), Networks: an introduction Oxford University Press; Liu, Lu., Mining diversity on networks (2010) Database Systems for Advanced Applications, 5981, pp. 384-398; Freeman, L.C., A set of measures of centrality based on betweenness (1977) Sociometry, 40, pp. 35-41; Hwang, W., Kim, T., Ramanathan, M., Zhang, A., (2008) Proceedings of the 14th ACM SIGKDD Internat Conf on Knowledge Discovery and Data Mining, pp. 336-344. , ACM},
correspondence_address1={Sharma, A.; Center for Complex Network Research, Northeastern University Physics Department, 110 Forsyth Street, Boston, MA 02115, United States; email: amitabh.sharma@channing.harvard.edu},
publisher={Nature Publishing Group},
issn={20411723},
pubmed_id={24967666},
language={English},
abbrev_source_title={Nat. Commun.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Ramagopalan2010727,
author={Ramagopalan, S.V. and Dobson, R. and Meier, U.C. and Giovannoni, G.},
title={Multiple sclerosis: risk factors, prodromes, and potential causal pathways},
journal={The Lancet Neurology},
year={2010},
volume={9},
number={7},
pages={727-739},
doi={10.1016/S1474-4422(10)70094-6},
note={cited By 374},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953394241&doi=10.1016%2fS1474-4422%2810%2970094-6&partnerID=40&md5=e89cfad4397dde4702340727a6e40df7},
affiliation={Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Department of Clinical Neurology, Oxford, United Kingdom},
abstract={Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is not yet known, although epidemiological data indicate that both genetic and environmental factors are important. The evidence that the environment acts long before MS becomes clinically evident is well established and suggests the existence of a prodromal phase for the disease. The increasing incidence of MS emphasises the need for strategies to prevent this chronic disorder, and the possibility of a prodrome indicates a window of opportunity to potentially reverse early disease processes before clinical disease becomes evident. Studying a prodrome requires techniques other than clinical observation such as monitoring endophenotypes that result from associated risk factors. However, our current knowledge of causal pathways and endophenotypes in MS is limited. Identifying and studying individuals with a high risk of developing the disease provides a powerful opportunity to understand the MS causal cascade and is highly relevant to strategies that are aimed at preventing this debilitating disease. © 2010 Elsevier Ltd. All rights reserved.},
keywords={vitamin D, birth;  environmental factor;  Epstein Barr virus;  ethnicity;  genetic association;  genetic risk;  genetic susceptibility;  human;  humoral immunity;  immunopathogenesis;  innate immunity;  latitude;  multiple sclerosis;  nonhuman;  phenotype;  priority journal;  review;  risk factor;  sex ratio;  smoking;  vitamin supplementation, Disease Susceptibility;  Environment;  Environmental Exposure;  Humans;  Multiple Sclerosis;  Risk Factors;  Sex Factors},
funding_details={National Multiple Sclerosis SocietyNational Multiple Sclerosis Society, AIMS2CURE},
funding_details={GlaxoSmithKlineGlaxoSmithKline, GSK},
funding_details={NovartisNovartis},
funding_details={Biogen IdecBiogen Idec},
funding_details={Medical Research CouncilMedical Research Council, MRC, G0801975},
funding_details={Guarantors of BrainGuarantors of Brain},
funding_details={University of OxfordUniversity of Oxford},
funding_details={Universidad Complutense de MadridUniversidad Complutense de Madrid},
funding_details={Mauritius Research CouncilMauritius Research Council},
funding_text 1={A comprehensive search of the PubMed/Medline database was undertaken for all publications in English up to February, 2010. The following search terms were used in combination with “multiple sclerosis OR MS”: “vitamin D OR 25-hydroxyvitamin D”, “Epstein-Barr virus OR EBV”, “smoking”, “genet*”, “environment*”, “timing”, “exposure”, “clinically isolated syndrome OR CIS”, “radiologically isolated syndrome OR RIS”, “immunology”, and “migration”. Abstracts were manually searched for relevance, and selected publications were searched for further relevant references. Contributors GG conceived the idea of this Review. SVR, RD, UCM, and GG undertook the literature search and wrote the paper. Conflicts of interest SVR, RD, and UCM have no conflicts of interest. GG has received consulting fees from Bayer-Schering Healthcare, Biogen-Idec, GlaxoSmithKline, Merck-Serono, Novartis, Protein Discovery Laboratories, Teva-Aventis, and UCB Pharma, lecture fees from Bayer-Schering Healthcare, Biogen Idec, and Teva-Aventis, and grant support from Bayer-Schering Healthcare, Biogen-Idec, Merck-Serono, Merz, Novartis, Teva-Aventis, and UCB Pharma. Acknowledgments We thank our colleagues and collaborators. GG is generously funded by grants from the MRC, National MS Society, the MS Society of Great Britain and Northern Ireland, AIMS2CURE, and the Roan Charitable Trust. SVR is funded by the MRC and is a Goodger Scholar at the University of Oxford. UCM is funded by AIMS2CURE and the Roan Charitable Trust. RD is funded by a fellowship from the Guarantors of Brain.},
references={Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., Weinshenker, B.G., Multiple sclerosis (2000) N Engl J Med, 343, pp. 938-952; Giovannoni, G., Ebers, G., Multiple sclerosis: the environment and causation (2007) Curr Opin Neurol, 20, pp. 261-268; White, T., Anjum, A., Schulz, S.C., The schizophrenia prodrome (2006) Am J Psychiatry, 163, pp. 376-380; Paty, D.W., Ebers, G.C., (1998) Multiple sclerosis, , F A Davis Company, Philadelphia; Miller, D., Barkhof, F., Montalban, X., Thompson, A., Filippi, M., Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis (2005) Lancet Neurol, 4, pp. 281-288; Okuda, D.T., Mowry, E.M., Beheshtian, A., Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome (2009) Neurology, 72, pp. 800-805; Flint, J., Munafo, M.R., The endophenotype concept in psychiatric genetics (2007) Psychol Med, 37, pp. 163-180; Dyment, D.A., Ebers, G.C., Sadovnick, A.D., Genetics of multiple sclerosis (2004) Lancet Neurol, 3, pp. 104-110; Robertson, N.P., Fraser, M., Deans, J., Clayton, D., Walker, N., Compston, D.A., Age-adjusted recurrence risks for relatives of patients with multiple sclerosis (1996) Brain, 119, pp. 449-455; Sadovnick, A.D., Baird, P.A., Ward, R.H., Multiple sclerosis: updated risks for relatives (1988) Am J Med Genet, 29, pp. 533-541; Willer, C.J., Dyment, D.A., Risch, N.J., Sadovnick, A.D., Ebers, G.C., Twin concordance and sibling recurrence rates in multiple sclerosis (2003) Proc Natl Acad Sci USA, 100, pp. 12877-12882; Ebers, G.C., Sadovnick, A.D., Dyment, D.A., Yee, I.M., Willer, C.J., Risch, N., Parent-of-origin effect in multiple sclerosis: observations in half-siblings (2004) Lancet, 363, pp. 1773-1774; Jersild, C., Fog, T., Hansen, G.S., Thomsen, M., Svejgaard, A., Dupont, B., Histocompatibility determinants in multiple sclerosis, with special reference to clinical course (1973) Lancet, 2, pp. 1221-1225; Barcellos, L.F., Oksenberg, J.R., Begovich, A.B., HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course (2003) Am J Hum Genet, 72, pp. 710-716; Marrosu, M.G., Murru, R., Murru, M.R., Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia (2001) Hum Mol Genet, 10, pp. 2907-2916; Dyment, D.A., Herrera, B.M., Cader, M.Z., Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance (2005) Hum Mol Genet, 14, pp. 2019-2026; Masterman, T., Ligers, A., Olsson, T., Andersson, M., Olerup, O., Hillert, J., HLA-DR15 is associated with lower age at onset in multiple sclerosis (2000) Ann Neurol, 48, pp. 211-219; Barcellos, L.F., Sawcer, S., Ramsay, P.P., Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis (2006) Hum Mol Genet, 15, pp. 2813-2824; Ramagopalan, S.V., Morris, A.P., Dyment, D.A., The inheritance of resistance alleles in multiple sclerosis (2007) PLoS Genet, 3, pp. e150; Dean, G., Yeo, T.W., Goris, A., HLA-DRB1 and multiple sclerosis in Malta (2008) Neurology, 70, pp. 101-105; Lincoln, M.R., Ramagopalan, S.V., Chao, M.J., Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility (2009) Proc Natl Acad Sci USA, 106, pp. 7542-7547; De Jager, P.L., Jia, X., Wang, J., Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci (2009) Nat Genet, 41, pp. 776-782; Hafler, D.A., Compston, A., Sawcer, S., Risk alleles for multiple sclerosis identified by a genomewide study (2007) N Engl J Med, 357, pp. 851-862; Kurtzke, J.F., Beebe, G.W., Norman Jr., J.E., Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution (1979) Neurology, 29, pp. 1228-1235; Herrera, B.M., Ramagopalan, S.V., Lincoln, M.R., Parent-of-origin effects in MS. Observations from avuncular pairs (2008) Neurology, 71, pp. 799-803; Hoppenbrouwers, I.A., Liu, F., Aulchenko, Y.S., Maternal transmission of multiple sclerosis in a Dutch population (2008) Arch Neurol, 65, pp. 345-348; Ramagopalan, S.V., Yee, I.M., Dyment, D.A., Parent-of-origin effect in multiple sclerosis. Observations from interracial matings (2009) Neurology, 73, pp. 602-605; Handel, A.E., Ebers, G.C., Ramagopalan, S.V., Epigenetics: Molecular mechanisms and implications for disease Trends Mol Med, 16, pp. 7-16; Chao, M.J., Ramagopalan, S.V., Herrera, B.M., Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex (2009) Hum Mol Genet, 18, pp. 261-266; Orton, S.M., Herrera, B.M., Yee, I.M., Sex ratio of multiple sclerosis in Canada: a longitudinal study (2006) Lancet Neurol, 5, pp. 932-936; Wallin, M.T., Page, W.F., Kurtzke, J.F., Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography (2004) Ann Neurol, 55, pp. 65-71; Hirst, C., Ingram, G., Pickersgill, T., Swingler, R., Compston, D.A., Robertson, N.P., Increasing prevalence and incidence of multiple sclerosis in South East Wales (2009) J Neurol Neurosurg Psychiatry, 80, pp. 386-391; Alonso, A., Hernan, M.A., Temporal trends in the incidence of multiple sclerosis: a systematic review (2008) Neurology, 71, pp. 129-135; Whitacre, C.C., Sex differences in autoimmune disease (2001) Nat Immunol, 2, pp. 777-780; Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part I: the role of infection (2007) Ann Neurol, 61, pp. 288-299; Thacker, E.L., Mirzaei, F., Ascherio, A., Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis (2006) Ann Neurol, 59, pp. 499-503; Sundstrom, P., Juto, P., Wadell, G., An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study (2004) Neurology, 62, pp. 2277-2282; Levin, L.I., Munger, K.L., Rubertone, M.V., Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis (2005) JAMA, 293, pp. 2496-2500; Nielsen, T.R., Rostgaard, K., Nielsen, N.M., Multiple sclerosis after infectious mononucleosis (2007) Arch Neurol, 64, pp. 72-75; Ramagopalan, S.V., Valdar, W., Dyment, D.A., Association of infectious mononucleosis with multiple sclerosis. A population-based study (2009) Neuroepidemiology, 32, pp. 257-262; Banwell, B., Krupp, L., Kennedy, J., Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study (2007) Lancet Neurol, 6, pp. 773-781; Yeh, E.A., Chitnis, T., Krupp, L., Pediatric multiple sclerosis (2009) Nat Rev Neurol, 5, pp. 621-631; Pohl, D., Krone, B., Rostasy, K., High seroprevalence of Epstein-Barr virus in children with multiple sclerosis (2006) Neurology, 67, pp. 2063-2065; Hawkes, C.H., Smoking is a risk factor for multiple sclerosis: a metanalysis [sic] (2007) Mult Scler, 13, pp. 610-615; Hernan, M.A., Olek, M.J., Ascherio, A., Cigarette smoking and incidence of multiple sclerosis (2001) Am J Epidemiol, 154, pp. 69-74; Hedstrom, A.K., Baarnhielm, M., Olsson, T., Alfredsson, L., Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis (2009) Neurology, 73, pp. 696-701; Kurtzke, J.F., Geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region (1980) Acta Neurol Scand, 62, pp. 65-80; Hammond, S.R., McLeod, J.G., Millingen, K.S., The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart (1988) Brain, 111, pp. 1-25; Kampman, M.T., Brustad, M., Vitamin D: a candidate for the environmental effect in multiple sclerosis-observations from Norway (2008) Neuroepidemiology, 30, pp. 140-146; Weinstock-Guttman, B., Jacobs, L.D., Brownscheidle, C.M., Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium (2003) Mult Scler, 9, pp. 293-298; Acheson, E.D., Bachrach, C.A., Wright, F.M., Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables (1960) Acta Psychiatr Scand Suppl, 35, pp. 132-147; van der Mei, I.A., Ponsonby, A.L., Dwyer, T., Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study (2003) BMJ, 327, p. 316; Munger, K.L., Zhang, S.M., O'Reilly, E., Vitamin D intake and incidence of multiple sclerosis (2004) Neurology, 62, pp. 60-65; Vieth, R., Cole, D.E., Hawker, G.A., Trang, H.M., Rubin, L.A., Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it (2001) Eur J Clin Nutr, 55, pp. 1091-1097; van Dam, R.M., Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study (2007) Am J Clin Nutr, 85, pp. 755-761; Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S., Ascherio, A., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis (2006) JAMA, 296, pp. 2832-2838; Ascherio, A., Munger, K.L., Simon, K.C., Vitamin D and multiple sclerosis (2010) Lancet Neurol, 9, pp. 599-612; Holick, M.F., Vitamin D deficiency (2007) N Engl J Med, 357, pp. 266-281; Willer, C.J., Dyment, D.A., Sadovnick, A.D., Rothwell, P.M., Murray, T.J., Ebers, G.C., Timing of birth and risk of multiple sclerosis: population based study (2005) BMJ, 330, p. 120; Sotgiu, S., Pugliatti, M., Sotgiu, M.A., Seasonal fluctuation of multiple sclerosis births in Sardinia (2006) J Neurol, 253, pp. 38-44; Bayes, H.K., Weir, C.J., O'Leary, C., Timing of birth and risk of multiple sclerosis in the Scottish population (2009) Eur Neurol, 63, pp. 36-40; Alter, M., Halpern, L., Kurland, L.T., Bornstein, B., Leibowitz, U., Silberstein, J., Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants (1962) Arch Neurol, 7, pp. 253-263; Alter, M., Leibowitz, U., Speer, J., Risk of multiple sclerosis related to age at immigration to Israel (1966) Arch Neurol, 15, pp. 234-237; Dean, G., Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa (1967) BMJ, 2, pp. 724-730; Alter, M., Okihiro, M., Rowley, W., Morris, T., Multiple sclerosis among Orientals and Caucasians in Hawaii (1971) Neurology, 21, pp. 122-130; Dean, G., Kurtzke, J.F., On the risk of multiple sclerosis according to age at immigration to South Africa (1971) BMJ, 3, pp. 725-729; Dean, G., McLoughlin, H., Brady, R., Adelstein, A.M., Tallett-Williams, J., Multiple sclerosis among immigrants in Greater London (1976) BMJ, 1, pp. 861-864; Kurtzke, J.F., Beebe, G.W., Norman Jr., J.E., Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS (1985) Neurology, 35, pp. 672-678; Elian, M., Dean, G., Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies (1987) J Neurol Neurosurg Psychiatry, 50, pp. 327-332; Elian, M., Nightingale, S., Dean, G., Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies (1990) J Neurol Neurosurg Psychiatry, 53, pp. 906-911; Dean, G., Elian, M., Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis (1997) J Neurol Neurosurg Psychiatry, 63, pp. 565-568; Kurtzke, J.F., Delasnerie-Laupretre, N., Wallin, M.T., Multiple sclerosis in North African migrants to France (1998) Acta Neurol Scand, 98, pp. 302-309; Hammond, S.R., English, D.R., McLeod, J.G., The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia (2000) Brain, 123, pp. 968-974; Karni, A., Kahana, E., Zilber, N., Abramsky, O., Alter, M., Karussis, D., The frequency of multiple sclerosis in Jewish and Arab populations in greater Jerusalem (2003) Neuroepidemiology, 22, pp. 82-86; Cabre, P., Signate, A., Olindo, S., Role of return migration in the emergence of multiple sclerosis in the French West Indies (2005) Brain, 128, pp. 2899-2910; Smestad, C., Sandvik, L., Holmoy, T., Harbo, H.F., Celius, E.G., Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway (2008) J Neurol, 255, pp. 49-55; Gale, C.R., Martyn, C.N., Migrant studies in multiple sclerosis (1995) Prog Neurobiol, 47, pp. 425-448; Pugliatti, M., Riise, T., Sotgiu, M.A., Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population (2006) Am J Epidemiol, 164, pp. 326-333; Ramagopalan, S.V., Valdar, W., Criscuoli, M., Age of puberty and the risk of multiple sclerosis: a population based study (2009) Eur J Neurol, 16, pp. 342-347; Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women (2009) Neurology, 73, pp. 1543-1550; Freedman, D.M., Dosemeci, M., Alavanja, M.C., Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates (2000) Occup Environ Med, 57, pp. 418-421; Lyon-Caen, O., Jouvent, R., Hauser, S., Cognitive function in recent-onset demyelinating diseases (1986) Arch Neurol, 43, pp. 1138-1141; Young, A.C., Saunders, J., Ponsford, J.R., Mental change as an early feature of multiple sclerosis (1976) J Neurol Neurosurg Psychiatry, 39, pp. 1008-1013; Engell, T., A clinical patho-anatomical study of clinically silent multiple sclerosis (1989) Acta Neurol Scand, 79, pp. 428-430; Gilbert, J.J., Sadler, M., Unsuspected multiple sclerosis (1983) Arch Neurol, 40, pp. 533-536; Lebrun, C., Bensa, C., Debouverie, M., Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile (2008) J Neurol Neurosurg Psychiatry, 79, pp. 195-198; Barkhof, F., Filippi, M., Miller, D.H., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis (1997) Brain, 120 (PART 11), pp. 2059-2069; Tintore, M., Rovira, A., Martinez, M.J., Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis (2000) Am J Neuroradiol, 21, pp. 702-706; Fisniku, L.K., Brex, P.A., Altmann, D.R., Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis (2008) Brain, 131, pp. 808-817; Dalton, C.M., Chard, D.T., Davies, G.R., Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes (2004) Brain, 127, pp. 1101-1107; Van Au Duong, M., Audoin, B., Le Fur, Y., Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS: a MRSI study (2007) J Neurol, 254, pp. 914-923; Fernando, K.T., Tozer, D.J., Miszkiel, K.A., Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis (2005) Brain, 128, pp. 2911-2925; Rovaris, M., Judica, E., Ceccarelli, A., A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS (2008) J Neurol, 255, pp. 1209-1214; Kasper, L.H., Shoemaker, J., Multiple sclerosis immunology: the healthy immune system vs the MS immune system (2010) Neurology, 74 (SUPPL. 1), pp. S2-S8; van Oosten, B.W., Lai, M., Hodgkinson, S., Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial (1997) Neurology, 49, pp. 351-357; Segal, B.M., Constantinescu, C.S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., Kasper, L.H., Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study (2008) Lancet Neurol, 7, pp. 796-804; Viglietta, V., Baecher-Allan, C., Weiner, H.L., Hafler, D.A., Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis (2004) J Exp Med, 199, pp. 971-979; Haas, J., Hug, A., Viehover, A., Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis (2005) Eur J Immunol, 35, pp. 3343-3352; Michel, L., Berthelot, L., Pettre, S., Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis (2008) J Clin Invest, 118, pp. 3411-3419; Tzartos, J.S., Friese, M.A., Craner, M.J., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis (2008) Am J Pathol, 172, pp. 146-155; Antel, J.P., Rosenkoetter, M., Reder, A., Oger, J.J., Arnason, B.G., Multiple sclerosis: relation of in vitro IgG secretion to T suppressor cell number and function (1984) Neurology, 34, pp. 1155-1160; Jacobsen, M., Cepok, S., Quak, E., Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients (2002) Brain, 125, pp. 538-550; Jilek, S., Schluep, M., Rossetti, A.O., CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis (2007) Clin Immunol, 123, pp. 105-113; Jilek, S., Schluep, M., Meylan, P., Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis (2008) Brain, 131, pp. 1712-1721; Hintzen, R.Q., Giovannoni, G., CSF analysis in suspected MS: do bands aid? (2008) Neurology, 70, pp. 1059-1060; Freedman, M.S., Thompson, E.J., Deisenhammer, F., Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement (2005) Arch Neurol, 62, pp. 865-870; Nilsson, P., Larsson, E.M., Maly-Sundgren, P., Perfekt, R., Sandberg-Wollheim, M., Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up (2005) J Neurol, 252, pp. 396-402; Soderstrom, M., Ya-Ping, J., Hillert, J., Link, H., Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings (1998) Neurology, 50, pp. 708-714; Tintore, M., Rovira, A., Rio, J., Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? (2008) Neurology, 70, pp. 1079-1083; Benczur, M., Petranyl, G.G., Palffy, G., Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor (1980) Clin Exp Immunol, 39, pp. 657-662; Uchida, A., Maida, E.M., Lenzhofer, R., Micksche, M., Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis (1982) Immunobiology, 160, pp. 392-402; Braakman, E., van Tunen, A., Meager, A., Lucas, C.J., Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit (1986) Clin Exp Immunol, 66, pp. 285-294; Vranes, Z., Poljakovic, Z., Marusic, M., Natural killer cell number and activity in multiple sclerosis (1989) J Neurol Sci, 94, pp. 115-123; Kreuzfelder, E., Shen, G., Bittorf, M., Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls (1992) Eur Neurol, 32, pp. 190-194; Munschauer, F.E., Hartrich, L.A., Stewart, C.C., Jacobs, L., Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls (1995) J Neuroimmunol, 62, pp. 177-181; Kastrukoff, L.F., Morgan, N.G., Zecchini, D., A role for natural killer cells in the immunopathogenesis of multiple sclerosis (1998) J Neuroimmunol, 86, pp. 123-133; Takahashi, K., Miyake, S., Kondo, T., Natural killer type 2 bias in remission of multiple sclerosis (2001) J Clin Invest, 107, pp. R23-R29; Kastrukoff, L.F., Lau, A., Wee, R., Zecchini, D., White, R., Paty, D.W., Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity (2003) J Neuroimmunol, 145, pp. 103-114; Takahashi, K., Aranami, T., Endoh, M., Miyake, S., Yamamura, T., The regulatory role of natural killer cells in multiple sclerosis (2004) Brain, 127, pp. 1917-1927; Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis (2006) Proc Natl Acad Sci USA, 103, pp. 5941-5946; Rinaldi, L., Gallo, P., Calabrese, M., Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients (2006) Brain, 129, pp. 1993-2007; Saraste, M., Irjala, H., Airas, L., Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta (2007) Neurol Sci, 28, pp. 121-126; De Jager, P.L., Rossin, E., Pyne, S., Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells (2008) Brain, 131, pp. 1701-1711; Polman, C.H., O'Connor, P.W., Havrdova, E., A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis (2006) N Engl J Med, 354, pp. 899-910. , AFFIRM Investigators; Coles, A.J., Compston, D.A., Selmaj, K.W., Alemtuzumab vs. interferon beta-1a in early multiple sclerosis (2008) N Engl J Med, 359, pp. 1786-1801. , CAMMS223 Trial Investigators; Hauser, S.L., Waubant, E., Arnold, D.L., B-cell depletion with rituximab in relapsing-remitting multiple sclerosis (2008) N Engl J Med, 358, pp. 676-688. , HERMES Trial Group; Bielekova, B., Becker, B.L., Monoclonal antibodies in MS: mechanisms of action (2010) Neurology, 74 (SUPPL. 1), pp. S31-S40; McFarland, H.F., Martin, R., Multiple sclerosis: a complicated picture of autoimmunity (2007) Nat Immunol, 8, pp. 913-919; Friese, M.A., Fugger, L., Pathogenic CD8(+) T cells in multiple sclerosis (2009) Ann Neurol, 66, pp. 132-141; Goodin, D.S., The causal cascade to multiple sclerosis: a model for MS pathogenesis (2009) PLoS One, 4, pp. e4565; Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part II: noninfectious factors (2007) Ann Neurol, 61, pp. 504-513; Healy, B.C., Ali, E.N., Guttmann, C.R., Smoking and disease progression in multiple sclerosis (2009) Arch Neurol, 66, pp. 858-864; Di Pauli, F., Reindl, M., Ehling, R., Smoking is a risk factor for early conversion to clinically definite multiple sclerosis (2008) Mult Scler, 14, pp. 1026-1030; Farrell, R.A., Antony, D., Wall, G.R., Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI (2009) Neurology, 73, pp. 32-38; Lunemann, J.D., Tintore, M., Messmer, B., Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis (2009) Ann Neurol, 67, pp. 159-169; Hasler, G., Drevets, W.C., Gould, T.D., Gottesman, I.I., Manji, H.K., Toward constructing an endophenotype strategy for bipolar disorders (2006) Biol Psychiatry, 60, pp. 93-105; Somma, P., Ristori, G., Battistini, L., Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis (2007) J Leukoc Biol, 81, pp. 696-710; Nuwer, M.R., Visscher, B.R., Packwood, J.W., Namerow, N.S., Evoked potential testing in relatives of multiple sclerosis patients (1985) Ann Neurol, 18, pp. 30-34; De Stefano, N., Cocco, E., Lai, M., Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis (2006) Ann Neurol, 59, pp. 634-639; Corvol, J.C., Pelletier, D., Henry, R.G., Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event (2008) Proc Natl Acad Sci USA, 105, pp. 11839-11844; De Jager, P.L., Simon, K.C., Munger, K.L., Rioux, J.D., Hafler, D.A., Ascherio, A., Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis (2008) Neurology, 70, pp. 1113-1118; Islam, T., Gauderman, W.J., Cozen, W., Hamilton, A.S., Burnett, M.E., Mack, T.M., Differential twin concordance for multiple sclerosis by latitude of birthplace (2006) Ann Neurol, 60, pp. 56-64; Haghighi, S., Andersen, O., Rosengren, L., Bergstrom, T., Wahlstrom, J., Nilsson, S., Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls (2000) J Neurol, 247, pp. 616-622; Celius, E.G., Harbo, H.F., Egeland, T., Vartdal, F., Vandvik, B., Spurkiand, A., Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis (2000) J Neurol Sci, 178, pp. 132-135; Hensiek, A.E., Sawcer, S.J., Feakes, R., HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis (2002) J Neurol Neurosurg Psychiatry, 72, pp. 184-187; Sundstrom, P., Nystrom, L., Jidell, E., Hallmans, G., EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study (2008) Mult Scler, 14, pp. 1120-1122; Nielsen, T.R., Rostgaard, K., Askling, J., Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis (2009) Mult Scler, 15, pp. 431-436; De Jager, P.L., Chibnik, L.B., Cui, J., Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score (2009) Lancet Neurol, 8, pp. 1111-1119; Kelly, M.A., Cavan, D.A., Penny, M.A., The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome (1993) Hum Immunol, 37, pp. 185-191; Hauser, S.L., Oksenberg, J.R., Lincoln, R., Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS (2000) Neurology, 54, pp. 1859-1861},
correspondence_address1={Giovannoni, G.; Blizard Institute of Cell and Molecular Science, , London, United Kingdom; email: g.giovannoni@qmul.ac.uk},
issn={14744422},
coden={LNAEA},
pubmed_id={20610348},
language={English},
abbrev_source_title={Lancet Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Moher2000964,
author={Moher, D. and Pham and Klassen, T.P. and Schulz, K.F. and Berlin, J.A. and Jadad, A.R. and Liberati, A.},
title={What contributions do languages other than English make on the results of meta-analyses?},
journal={Journal of Clinical Epidemiology},
year={2000},
volume={53},
number={9},
pages={964-972},
doi={10.1016/S0895-4356(00)00188-8},
note={cited By 365},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033834484&doi=10.1016%2fS0895-4356%2800%2900188-8&partnerID=40&md5=439120f347ff71dc93338cad847246bd},
affiliation={Thomas C. Chalmers Ctr. Syst. R., Children's Hosp. E. Ontario Res. I., Ottawa, Ont., Canada; Departments of Pediatrics, Epidemiol., Comm. Med., Univ. Ottawa, Ottawa, Ont., Canada; Family Health International, Dept. Obstet. Gynecol., Univ. N. C., Chapel Hill, NC, United States; Ctr. Clin. Epidemiol. Biostatist., Dept. Biostatist. Epidemiol., U., Philadelphia, PA, United States; Health Information Research Unit, Dept. Epidemiol. Biostatist., M., Hamilton, Ont., Canada; Clinical Epidemiology, Mario Negri Institute, Milan, Italy},
abstract={Including only a portion of all available evidence may introduce systematic errors into the meta-analytic process and threaten its validity. We set out to examine whether language restricted meta-analyses, compared to language inclusive meta-analyses, provide different estimates of the effectiveness of interventions evaluated in randomized trials. We identified and retrieved all 79 meta-analyses from several disease areas in which explicit eligibility criteria regarding trial selection were reported. General characteristics and quality of reporting of the meta-analyses were assessed using a validated instrument. We explored the effects of language of publication of the randomized trials on the quantitative results using logistic regression analyses. Language restricted meta-analyses, compared to language inclusive meta-analyses, did not differ with respect to the estimate of benefit of the effectiveness of an intervention (ROR = 0.98; 95% CI: 0.81- 1.17). These results were also robust after a series of sensitivity analyses. This study provides no evidence that language restricted meta-analyses lead to biased estimates of intervention effectiveness. We encourage others to replicate this study using different sampling frames, clinical topics and interventions. (C) 2000 Elsevier Science Inc.},
author_keywords={Bias;  Language of publication;  Meta-analysis;  Methodology;  Randomized controlled trials},
keywords={analytical error;  article;  clinical trial;  controlled clinical trial;  controlled study;  epidemiological data;  human;  language;  meta analysis;  methodology;  priority journal;  quality control;  randomized controlled trial, Humans;  Language;  Logistic Models;  Meta-Analysis;  Outcome Assessment (Health Care);  Randomized Controlled Trials;  Selection Bias},
funding_details={Medical Research Council CanadaMedical Research Council Canada, MRC, 3705},
funding_text 1={We thank Alison Jones, Leah Le Page, and Michael Saginur for helping to coordinate the study. Alejandro R. Jadad, MD, is a National Health Research Scholar, Health Canada. This research was funded by the Medical Research Council of Canada, Grant # 3705.},
references={Grégoire, G., Derderian, F., Lelorier, J., Selecting the language of the publications included in a meta-analysis: Is there a tower of babel bias? (1995) J Clin Epidemiol, 48 (1), pp. 159-163; Moher, D., Fortin, P., Jadad, A.R., Juni, P., Kiassen, T., Le Lorier, J., Liberati, A., Penna, A., Completeness of reporting of trials published in languages other than English: Implications for the conduct and reporting of systematic reviews (1996) Lancet, 347, pp. 363-366; Jadad, A.R., Moore, A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J., McQuay, H.J., Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996) Control Clin Trials, 17, pp. 1-12; Egger, M., Zellweger-Zahner, T., Schneider, M., Junker, C., Lengeler, C., Antes, G., Language bias in randomised controlled trials published in English and German (1997) Lancet, 350, pp. 326-329; Moher, D., Cook, D.J., Jadad, A.R., Tugwell, P., Moher, M., Jones, A., Pham, B., Klassen, T.P., Assessing the quality of randomized controlled trials: Implications for the conduct of meta-analyses (1999) Health Technology Assessment, 3 (12), pp. 1-98; Jadad, A.R., Cook, D.J., Jones, A., Klassen, T.P., Tugwell, P., Moher, M., Moher, D., Methodology and reports of systematic reviews and meta-analyses: A comparison of Cochrane reviews with articles published in paper-based journals (1998) JAMA, 280, pp. 278-280; Moher, D., Pham, B., Jones, A., Cook, D.J., Jadad, A.R., Moher, M., Tugwell, P., Klassen, T.P., Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998) Lancet, 352, pp. 609-613; Oxman, A.D., Guyatt, G.H., Validation of an index of the quality of review articles (1991) J Clin Epidemiol, 44 (11), pp. 1271-1278; Fleiss, J.L., (1986) The Design and Analysis of Clinical Experiments, , New York, NY, USA: John Wiley & Sons; p. 1-32; Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174; Schulz, K.F., Chalmers, I., Hayes, R., Altman, D.G., Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273, pp. 408-412; Poynard, T., Naveau, S., Mory, B., Chaput, J.C., Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome (1994) Aliment Pharmacol Ther, 8, pp. 499-510; Chalmers, T.C., Berrier, J., Sacks, H.S., Levin, H., Reitman, D., Nagalingam, R., Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree (1987) Stat Med, 6, pp. 733-744; Yusuf, S., Peto, R., Lewis, J., Collins, R., Sleight, P., Beta-blockade during and after myocardial infarction: An overview of the randomized trials (1985) Prog Cardiovasc Dis, 27, pp. 335-371; Dickersin, K., Higgins, K., Meinert, C.L., Identification of meta-analyses: The need for standard terminology (1990) Control Clin Trials, 11, pp. 52-66; Tramer, M., Reynolds, D.J.M., Moore, R.A., McQuay, H.J., Impact of covert duplicate publication on meta-analysis: A case study (1997) BMJ, 315, pp. 635-640; Khan, K.S., Daya, S., Collins, J.A., Walter, S., Empirical evidence of bias in infertility research: Overestimation of treatment effect in crossover trials using pregnancy as the outcome measure (1996) Fertil Steril, 65, pp. 939-945; Berlin, J.A., Does blinding of readers affect the results of meta-analyses? (1997) Lancet, 350, pp. 185-186; Barnes, D.E., Bero, L.A., Why review articles on the health effects of passive smoking reach different conclusions (1998) JAMA, 279, pp. 1566-1570; Simes, R.J., Publication bias: The case for an international registry of clinical trials (1986) J Clin Oncol, 4, pp. 1529-1541; Moher, D., Pham, B., Ausejo, M., Saenz, A., Hood, S.C., Barber, G., Pharmacological management of intermittent claudication: A meta-analysis of randomized trials (2000) Drugs, 59, pp. 1057-1070; Shea, B., Dubé, C., Moher, D., Assessing the quality of reports of meta-analyses: A systematic review of scales and checklists Systematic Reviews in Health Care, 2nd Edition, , In: Egger M, Altman D, Smith GD, editors. London, UK: BMJ Publishing Group, In press; Vandenbroucke-Grauls, C.M.J.E., Vandenbroucke, J.P., Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit (1991) Lancet, 338, pp. 859-862; Thülig, B., Hartenauer, U., Diemer, W., Lawin, P., Fegeler, W., Kehrel, R., Ritzerfeld, W., Selektive Florasuppression zur Infektionskontrolle in der Operativen Intensivmedizin (1989) Anästh Intensivther Notfallmed, 24, pp. 345-354; Anonymous, Metaanalysis of randomized controlled trials of selective decontamination of the digestive tract. Selective Decontamination of the Digestive Tract Trialsts' Collaborative Group (1993) BMJ, 307, pp. 525-532; Jadad, A.R., McQuay, H.J., Meta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology (1996) J Clin Epidemiol, 49, pp. 235-243; Shea, B., Moher, D., Pham, B., Tugwell, P., Assessing the quality of reporting of meta-analyses of randomized controlled trials (1999) Poster Presentation at the VII Cochrane Colloquium, , Rome, Italy, 5-9 October; Begg, C.B., Cho, M.K., Eastwood, S., Horton, R., Moher, D., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reporting of randomized controlled trials: The CONSORT statement (1996) JAMA, 276, pp. 637-639; Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D., Improving the quality of reporting of meta-analysis of randomized controlled trials: The QUOROM statement (1999) Lancet, 354, pp. 1896-1900. , for the QUOROM group; Vickers, A., Goyal, N., Harland, R., Rees, R., Do certain countries produce only positive results? A systematic review of controlled trials (1998) Control Clin Trials, 19, pp. 159-166; Tang, J.L., Zhan, S.Y., Ernst, E., Review of randomised controlled trials of traditional Chinese medicine (1999) BMJ, 319, pp. 160-161},
correspondence_address1={Moher, D.; T. C. Chalmers Ctr. for Syst. Rev., , Ottawa, Ont., Canada; email: dmoher@uottawa.ca},
issn={08954356},
coden={JCEPE},
pubmed_id={11004423},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Poole2017j5024,
author={Poole, R. and Kennedy, O.J. and Roderick, P. and Fallowfield, J.A. and Hayes, P.C. and Parkes, J.},
title={Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes},
journal={BMJ (Clinical research ed.)},
year={2017},
volume={359},
pages={j5024},
doi={10.1136/bmj.j5024},
note={cited By 355},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038390579&doi=10.1136%2fbmj.j5024&partnerID=40&md5=40f19fa728c112c074b5a6908f77b7fb},
affiliation={Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, EH16, United Kingdom; Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, EH16, United Kingdom},
abstract={Objectives To evaluate the existing evidence for associations between coffee consumption and multiple health outcomes.Design Umbrella review of the evidence across meta-analyses of observational and interventional studies of coffee consumption and any health outcome.Data sources PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and screening of references.Eligibility criteria for selecting studies Meta-analyses of both observational and interventional studies that examined the associations between coffee consumption and any health outcome in any adult population in all countries and all settings. Studies of genetic polymorphisms for coffee metabolism were excluded.Results The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often associated with benefit than harm for a range of health outcomes across exposures including high versus low, any versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83, 95% confidence interval 0.83 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90). High versus low consumption was associated with an 18% lower risk of incident cancer (0.82, 0.74 to 0.89). Consumption was also associated with a lower risk of several specific cancers and neurological, metabolic, and liver conditions. Harmful associations were largely nullified by adequate adjustment for smoking, except in pregnancy, where high versus low/no consumption was associated with low birth weight (odds ratio 1.31, 95% confidence interval 1.03 to 1.67), preterm birth in the first (1.22, 1.00 to 1.49) and second (1.12, 1.02 to 1.22) trimester, and pregnancy loss (1.46, 1.06 to 1.99). There was also an association between coffee drinking and risk of fracture in women but not in men.Conclusion Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm. Robust randomised controlled trials are needed to understand whether the observed associations are causal. Importantly, outside of pregnancy, existing evidence suggests that coffee could be tested as an intervention without significant risk of causing harm. Women at increased risk of fracture should possibly be excluded. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.},
keywords={caffeine, adult;  cardiovascular disease;  coffee;  female;  fracture;  human;  low birth weight;  meta analysis;  observational study;  pregnancy;  prematurity, Adult;  Caffeine;  Cardiovascular Diseases;  Coffee;  Female;  Fractures, Bone;  Humans;  Infant, Low Birth Weight;  Observational Studies as Topic;  Pregnancy;  Premature Birth},
chemicals_cas={caffeine, 58-08-2; Caffeine; Coffee},
issn={17561833},
pubmed_id={29167102},
language={English},
abbrev_source_title={BMJ},
document_type={Article},
source={Scopus},
}

@ARTICLE{Fewell2007646,
author={Fewell, Z. and Davey Smith, G. and Sterne, J.A.C.},
title={The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study},
journal={American Journal of Epidemiology},
year={2007},
volume={166},
number={6},
pages={646-655},
doi={10.1093/aje/kwm165},
note={cited By 349},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548356858&doi=10.1093%2faje%2fkwm165&partnerID=40&md5=f9c37516895da390b2408187c9b5f1b1},
affiliation={Department of Social Medicine, University of Bristol, Bristol, United Kingdom; Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, United Kingdom},
abstract={Measurement error in explanatory variables and unmeasured confounders can cause considerable problems in epidemiologic studies. It is well recognized that under certain conditions, nondifferential measurement error in the exposure variable produces bias towards the null. Measurement error in confounders will lead to residual confounding, but this is not a straightforward issue, and it is not clear in which direction the bias will point. Unmeasured confounders further complicate matters. There has been discussion about the amount of bias in exposure effect estimates that can plausibly occur due to residual or unmeasured confounding. In this paper, the authors use simulation studies and logistic regression analyses to investigate the size of the apparent exposure-outcome association that can occur when in truth the exposure has no causal effect on the outcome. The authors consider two cases with a normally distributed exposure and either two or four normally distributed confounders. When the confounders are uncorrelated, bias in the exposure effect estimate increases as the amount of residual and unmeasured confounding increases. Patterns are more complex for correlated confounders. With plausible assumptions, effect sizes of the magnitude frequently reported in observational epidemiologic studies can be generated by residual and/or unmeasured confounding alone. © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved.},
author_keywords={Bias (epidemiology);  Computer simulation;  Confounding factors (epidemiology);  Logistic models},
keywords={computer simulation;  epidemiology;  logistics;  measurement method;  regression analysis, article;  causal attribution;  confounding variable;  correlation analysis;  epidemiological data;  exposure;  logistic regression analysis;  measurement error;  observational study;  outcome assessment;  simulation, Bias (Epidemiology);  Confounding Factors (Epidemiology);  Data Interpretation, Statistical;  Epidemiologic Methods;  Humans;  Research Design},
funding_details={Medical Research CouncilMedical Research Council, MRC, G0600705},
references={Beaglehole, R., Bonita, R., Kjellström, T., Causation in epidemiology (1993) Basic epidemiology, pp. 71-81. , Geneva, Switzerland: World Health Organization; Kelsey, J.L., Petitti, D.B., King, A.C., Key methodologic concepts and issues (1998) Applied epidemiology, pp. 35-69. , Brownson RC, Petitti DB, eds, New York, NY: Oxford University Press; Greenland, S., Robins, J.M., Identifiability, exchangeability, and epidemiologic confounding (1986) Int J Epidemiol, 15, pp. 413-419; Jurek, A.M., Greenland, S., Maldonado, G., Proper interpretation of non-differential misclassification effects: Expectations vs observations (2005) Int J Epidemiol, 34, pp. 680-687; Khaw, K.T., Bingham, S., Welch, A., Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study (2001) Lancet, 357, pp. 657-663; Rimm, E.B., Stampfer, M.J., Ascherio, A., Vitamin E consumption and the risk of coronary heart disease in men (1993) N Engl J Med, 328, pp. 1450-1456; Stampfer, M.J., Hennekens, C.H., Manson, J.E., Vitamin E consumption and the risk of coronary disease in women (1993) N Engl J Med, 328, pp. 1444-1449; MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: A randomised placebo-controlled trial (2002) Lancet, 360, pp. 23-33. , Heart Protection Study Collaborative Group; Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice (2001) Lancet, 357, pp. 89-95. , Collaborative Group of the Primary Prevention Project; Davey Smith, G., Reflections on the limitations to epidemiology (2001) J Clin Epidemiol, 54, pp. 325-331; Lawlor, D.A., Davey Smith, G., Bruckdorfer, K.R., Those confounded vitamins: What can we learn from the differences between observational versus randomised trial evidence? (2004) Lancet, 363, pp. 1724-1727; Eidelman, R.S., Hollar, D., Hebert, P.R., Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease (2004) Arch Intern Med, 164, pp. 1552-1556; Poppers, M.A., Kaposi's sarcoma, and HIV infection: Empirical example of a strong confounding effect? (1995) Prev Med, 24, pp. 90-95; Khaw, K.T., Day, N., Bingham, S., Observational versus randomised trial evidence (2004) Lancet, 364, pp. 753-754; Greenland, S., The effect of misclassification in the presence of covariates (1980) Am J Epidemiol, 112, pp. 564-569; Brenner, H., Bias due to nondifferential misclassification of polytomous confounders (1993) J Clin Epidemiol, 46, pp. 57-63; Savitz, D.A., Barón, A.E., Estimating and correcting for confounder misclassification (1989) Am J Epidemiol, 129, pp. 1062-1071; Phillips, A.N., Davey Smith, G., Bias in relative odds estimation owing to imprecise measurement of correlated exposures (1992) Stat Med, 11, pp. 953-961; Marshall, J.R., Hastrup, J.L., Mismeasurement and the resonance of strong confounders: Uncorrelated errors (1996) Am J Epidemiol, 143, pp. 1069-1078; Kipnis, V., Freedman, L.S., Brown, C.C., Effect of measurement error on energy-adjustment models in nutritional epidemiology (1997) Am J Epidemiol, 146, pp. 842-855; Marshall, J.R., Hastrup, J.L., Ross, J.S., Mismeasurement and the resonance of strong confounders: Correlated errors (1999) Am J Epidemiol, 150, pp. 88-96; Prentice, R.L., Covariate measurement errors and parameter-estimation in a failure time regression-model (1982) Biometrika, 69, pp. 331-342; Armstrong, B.G., Whittemore, A.S., Howe, G.R., Analysis of case-control data with covariate measurement error - application to diet and colon cancer (1989) Stat Med, 8, pp. 1151-1163; Spiegelman, D., Rosner, B., Logan, R., Estimation and inference for logistic regression with covariate misclassification and measurement error in main study/validation study designs (2000) J Am Stat Assoc, 95, pp. 51-61; Kirkwood BR, Sterne JAC. Measurement error: assessment and implications. In: Essentials of medical statistics. 2nd ed. London,UnitedKingdom: BlackwellScienceLtd, 2003:429-46; Satia-Abouta, J., Patterson, R.E., King, I.B., Reliability and validity of self-report of vitamin and mineral supplement use in the Vitamins and Lifestyle Study (2003) Am J Epidemiol, 157, pp. 944-954; Schroder, H., Covas, M.I., Marrugat, J., Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population (2001) Clin Nutr, 20, pp. 429-437; Friesema, I.H., Veenstra, M.Y., Zwietering, P.J., Measurement of lifetime alcohol intake: Utility of a self-administered questionnaire (2004) Am J Epidemiol, 159, pp. 809-817; Chinn, S., Schouten, J.P., Reproducibility of non-specific bronchial challenge in adults: Implications for design, analysis and interpretation of clinical and epidemiological studies (2005) Thorax, 60, pp. 395-400; Freeman, R., Chase, K.P., Risk, M.R., Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy (2003) Neurology, 60, pp. 465-470; Gallagher, K.M., Jara, M., Demaria, A., The reliability of passively collected AIDS surveillance data in Massachusetts (2003) Ann Epidemiol, 13, pp. 100-104; Salerno, D.F., Franzblau, A., Armstrong, T.J., Test-retest reliability of the upper extremity questionnaire among keyboard operators (2001) Am J Ind Med, 40, pp. 655-666; Yokoo, E.M., Valente, J.G., Sichieri, R., Validation and calibration of mercury intake through self-referred fish consumption in riverine populations in Pantanal Mato-grossense, Brazil (2001) Environ Res, 86, pp. 88-93; Xu, L.Z., Porteous, J.E., Phillips, M.R., Development and validation of a calcium intake questionnaire for postmenopausal women in China (2000) Ann Epidemiol, 10, pp. 169-175; Osganian, S.K., Stampfer, M.J., Spiegelman, D., Distribution of and factors associated with serum homocysteine levels in children (1999) JAMA, 281, pp. 1189-1196; Sonis, J., A closer look at confounding (1998) Fam Med, 30, pp. 584-588; Hernan, M.A., Hernandez-Diaz, S., Werler, M.M., Causal knowledge as a prerequisite for confounding evaluation: An application to birth defects epidemiology (2002) Am J Epidemiol, 155, pp. 176-184; Gustafson, P., (2004) Measurement error and misclassification in statistics and epidemiology, , London, United Kingdom: Chapman & Hall Ltd; Maldonado, G., Greenland, S., The importance of critically interpreting simulation studies (1997) Epidemiology, 8, pp. 453-456; White, I., Frost, C., Tokunaga, S., Correcting for measurement error in binary and continuous variables using replicates (2001) Stat Med, 20, pp. 3441-3457; Greenland, S., Basic methods for sensitivity analysis of biases (1996) Int J Epidemiol, 25, pp. 1107-1116; Lash, T.L., Fink, A.K., Semi-automated sensitivity analysis to assess systematic errors in observational data (2003) Epidemiology, 14, pp. 451-458; Rubin, D.B., (1987) Multiple imputation for nonresponse in surveys, , New York, NY: John Wiley and Sons, Inc; Schafer, J.L., (1997) Analysis of incomplete multivariate data, , London, United Kingdom: Chapman and Hall Ltd},
correspondence_address1={Sterne, J.A.C.; Department of Social Medicine, Whiteladies Road, Bristol BS8 2PR, United Kingdom; email: Jonathan.Sterne@bristol.ac.uk},
issn={00029262},
coden={AJEPA},
pubmed_id={17615092},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Ioannidis2009488,
author={Ioannidis, J.P.A.},
title={Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses},
journal={CMAJ. Canadian Medical Association Journal},
year={2009},
volume={181},
number={8},
pages={488-493},
doi={10.1503/cmaj.081086},
note={cited By 321},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350214788&doi=10.1503%2fcmaj.081086&partnerID=40&md5=1ef4c2a826923de85d39344b18faf75e},
affiliation={Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts University School of Medicine, Boston, United States},
keywords={medical literature;  meta analysis;  methodology;  outcome assessment;  practice guideline;  publication;  quantitative analysis;  review, Clinical Trials as Topic;  Evidence-Based Medicine;  Humans;  Practice Guidelines as Topic},
references={Patsopoulos, N.A., Analatos, A.A., Ioannidis, J.P., Relative citation impact of various study designs in the health sciences (2005) JAMA, 293, pp. 2362-2366; (2008) Anatomical Therapeutic Chemical (ATC) Classification, , www.whocc.no/atcddd/, Oslo [Norway]: and Norwegian Institute of Public Health; Available: accessed 2009 June 8; Ioannidis, J.P., Effectiveness of antidepressants: An evidence myth constructed from a thousand randomized trials? (2008) Philos Ethics Humanit Med, 3, p. 14; Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., Johnson, B.T., Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration (2008) PLoS Medicine, 5 (2), pp. 260-268. , http://medicine.plosjournals.org/archive/1549-1676/5/2/pdf/10. 1371_journal.pmed.0050045-S.pdf, DOI 10.1371/journal.pmed.0050045; Stettler, C., Allemann, S., Wandel, S., Drug eluting and bare metal stents in people with and without diabetes: Collaborative network meta-analysis (2008) BMJ, 337, pp. a1331; Eisenberg, M.J., Filion, K.B., Yavin, D., Belisle, P., Mottillo, S., Joseph, L., Gervais, A., Pilote, L., Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials (2008) Canadian Medical Association Journal, 179 (2), pp. 135-144. , http://www.cmaj.ca/cgi/reprint/179/2/135, DOI 10.1503/cmaj.070256; Lam, S.K.H., Owen, A., Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials (2007) British Medical Journal, 335 (7626), pp. 925-928. , DOI 10.1136/bmj.39343.511389.BE; Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M.C., Schomig, A., Pfisterer, M.E., Juni, P., Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis (2007) Lancet, 370 (9591), pp. 937-948. , DOI 10.1016/S0140-6736(07)61444-5, PII S0140673607614445; Moe, R.H., Haavardsholm, E.A., Christie, A., Jamtvedt, G., Dahm, K.T., Hagen, K.B., Effectiveness of nonpharmacological and nonsurgical interventions for hip osteoarthritis: An umbrella review of high-quality systematic reviews (2007) Physical Therapy, 87 (12), pp. 1716-1727. , DOI 10.2522/ptj.20070042; Glasziou, P.P., Irwig, L.M., An evidence based approach to individualising treatment (1995) BMJ, 311, pp. 1356-1359; Ioannidis, J.P.A., Lau, J., Completeness of safety reporting in randomized trials: An evaluation of 7 medical areas (2001) Journal of the American Medical Association, 285 (4), pp. 437-443; Papanikolaou, P.N., Ioannidis, J.P., Availability of large-scale evidence on specific harms from systematic reviews of randomized trials (2004) Am J Med, 117, pp. 582-589; Chan, A.W., Altman, D.G., Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors (2005) BMJ, 330, p. 753; Chan, A.W., Krleza-Jeri, K., Schmid, I., Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research (2004) CMAJ, 171, pp. 735-740; Chan, A.-W., Hrobjartsson, A., Haahr, M.T., Gotzsche, P.C., Altman, D.G., Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles (2004) Journal of the American Medical Association, 291 (20), pp. 2457-2465. , DOI 10.1001/jama.291.20.2457; Salanti, G., Kavvoura, F.K., Ioannidis, J.P., Exploring the geometry of treatment networks (2008) Ann Intern Med, 148, pp. 544-553; Salanti, G., Higgins, J.P., Ades, A., Evaluation of networks of randomized trials (2008) Stat Methods Med Res, 17, pp. 279-301; Wu, P., Wilson, K., Dimoulas, P., Effectiveness of smoking cessation therapies: A systematic review and meta-analysis (2006) BMC Public Health, 6, p. 300; Macfadyen, C.A., Acuin, J.M., Gamble, C., Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations (2005) Cochrane Database Syst Rev, (4). , review. CD004618; Lu, G., Ades, A.E., Assessing evidence inconsistency in mixed treatment comparisons (2006) Journal of the American Statistical Association, 101 (474), pp. 447-459. , DOI 10.1198/016214505000001302; Lumley, T., Network meta-analysis for indirect treatment comparisons (2002) Statistics in Medicine, 21 (16), pp. 2313-2324. , DOI 10.1002/sim.1201; Caldwell, D.M., Ades, A.E., Higgins, J.P., Simultaneous comparison of multiple treatments: Combining direct and indirect evidence (2005) BMJ, 331, pp. 897-900; Song, F., Altman, D.G., Glenny, A.-M., Deeks, J.J., Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses (2003) British Medical Journal, 326 (7387), pp. 472-475; Glenny, A.M., Altman, D.G., Song, F., Indirect comparisons of competing interventions (2005) Health Technol Assess, 9, pp. 1-134. , International Stroke Trial Collaborative Group. iii-iv; Ioannidis, J.P., Indirect comparisons: The mesh and mess of clinical trials (2006) Lancet, 368, pp. 1470-1472; Song, F., Harvey, I., Lilford, R., Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions (2008) J Clin Epidemiol, 61, pp. 455-463; Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., Leucht, S., Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics (2006) American Journal of Psychiatry, 163 (2), pp. 185-194. , DOI 10.1176/appi.ajp.163.2.185; Chalmers, I., Matthews, R., What are the implications of optimism bias in clinical research? (2006) Lancet, 367 (9509), pp. 449-450. , DOI 10.1016/S0140-6736(06)68153-1, PII S0140673606681531; Bero, L., Oostvogel, F., Bacchetti, P., Factors associated with findings of published trials of drug-drug comparisons: Why some statins appear more efficacious than others (2007) PLoS Med, 4, pp. e184; Peppercorn, J., Blood, E., Winer, E., Partridge, A., Association between pharmaceutical involvement and outcomes in breast cancer clinical trials (2007) Cancer, 109 (7), pp. 1239-1246. , DOI 10.1002/cncr.22528; Ioannidis, J.P., Perfect study, poor evidence: Interpretation of biases preceding study design (2008) Semin Hematol, 45, pp. 160-166; Golfinopoulos, V., Salanti, G., Pavlidis, N., Ioannidis, J.P., Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: A meta-analysis (2007) Lancet Oncology, 8 (10), pp. 898-911. , DOI 10.1016/S1470-2045(07)70281-4, PII S1470204507702814; Mauri, D., Polyzos, N.P., Salanti, G., Multiple treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer (2008) J Natl Cancer Inst, 100, pp. 1780-1791; Ioannidis, J., Patsopoulos, N., Rothstein, H., Reasons or excuses for avoiding meta-analysis in forest plots (2008) BMJ, 336 (7658), pp. 1413-1415; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Siersma, V., Als-Nielsen, B., Chen, W., Hilden, J., Gluud, L.L., Gluud, C., Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials (2007) Statistics in Medicine, 26 (14), pp. 2745-2758. , DOI 10.1002/sim.2752; Sterne, J.A., Jüni, P., Schulz, K.F., Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research (2002) Stat Med, 21, pp. 1513-1524; Wood, L., Egger, M., Gluud, L.L., Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study (2008) BMJ, 336, pp. 601-605; Shang, A., Huwiler-Muntener, K., Nartey, L., Juni, P., Dorig, S., Sterne, J.A., Pewsner, D., Egger, M., Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy (2005) Lancet, 366 (9487), pp. 726-732. , DOI 10.1016/S0140-6736(05)67177-2, PII S0140673605671772; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Ioannidis, J.P.A., Lau, J., Evolution of treatment effects over time: Empirical insight from recursive cumulative metaanalyses (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (3), pp. 831-836. , DOI 10.1073/pnas.021529998; Schulz, K.F., Chalmers, I., Hayes, R.J., Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273, pp. 408-412; Balk, E.M., Bonis, P.A.L., Moskowitz, H., Schmid, C.H., Ioannidis, J.P.A., Wang, C., Lau, J., Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials (2002) Journal of the American Medical Association, 287 (22), pp. 2973-2982; Moher, D., Pham, B., Jones, A., Cook, D.J., Jadad, A.R., Moher, M., Tugwell, P., Klassen, T.P., Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998) Lancet, 352 (9128), pp. 609-613. , DOI 10.1016/S0140-6736(98)01085-X; Kjaergard, L.L., Villumsen, J., Gluud, C., Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses (2001) Annals of Internal Medicine, 135 (11), pp. 982-989; Juni, P., Altman, D.G., Egger, M., Systematic reviews in health care: Assessing the quality of controlled clinical trials (2001) British Medical Journal, 323 (7303), pp. 42-46; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database (2007) Nature Genetics, 39 (1), pp. 17-23. , DOI 10.1038/ng1934, PII NG1934; Allen, N.C., Bagade, S., McQueen, M.B., Ioannidis, J.P.A., Kavvoura, F.K., Khoury, M.J., Tanzi, R.E., Bertram, L., Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database (2008) Nature Genetics, 40 (7), pp. 827-834. , DOI 10.1038/ng.171, PII NG171; Kyzas, P.A., Denaxa-Kyza, D., Ioannidis, J.P.A., Almost all articles on cancer prognostic markers report statistically significant results (2007) European Journal of Cancer, 43 (17), pp. 2559-2579. , DOI 10.1016/j.ejca.2007.08.030, PII S0959804907006946; Kavvoura, F.K., McQueen, M., Khoury, M.J., Evaluation of the potential excess of statistically significant findings in reported genetic association studies: Application to Alzheimer's disease (2008) Am J Epidemiol, 168, pp. 855-865; Kyzas, P.A., Denaxa-Kyza, D., Ioannidis, J.P., Quality of reporting of cancer prognostic marker studies: Association with reported prognostic effect (2007) J Natl Cancer Inst, 99, pp. 236-243; Lijmer, J.G., Mol, B.W., Heisterkamp, S., Bonsel, G.J., Prins, M.H., Van Der Meulen, J.H.P., Bossuyt, P.M.M., Empirical evidence of design-related bias in studies of diagnostic tests (1999) Journal of the American Medical Association, 282 (11), pp. 1061-1066. , DOI 10.1001/jama.282.11.1061; Rutjes, A.W.S., Reitsma, J.B., Di Nisio, M., Smidt, N., Van Rijn, J.C., Bossuyt, P.M.M., Evidence of bias and variation in diagnostic accuracy studies (2006) Canadian Medical Association Journal, 174 (4), pp. 469-476. , DOI 10.1503/cmaj.050090},
correspondence_address1={Ioannidis, J. P. A.; Clinical and Molecular Epidemiology Unit, , Ioannina, Greece; email: jioannid@cc.uoi.gr},
publisher={Canadian Medical Association},
issn={08203946},
coden={CMAJA},
pubmed_id={19654195},
language={English},
abbrev_source_title={CMAJ},
document_type={Article},
source={Scopus},
}

@ARTICLE{Xu20151299,
author={Xu, W. and Tan, L. and Wang, H.-F. and Jiang, T. and Tan, M.-S. and Tan, L. and Zhao, Q.-F. and Li, J.-Q. and Wang, J. and Yu, J.-T.},
title={Meta-analysis of modifiable risk factors for Alzheimer's disease},
journal={Journal of Neurology, Neurosurgery and Psychiatry},
year={2015},
volume={86},
number={12},
pages={1299-1306},
doi={10.1136/jnnp-2015-310548},
note={cited By 314},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956583739&doi=10.1136%2fjnnp-2015-310548&partnerID=40&md5=fdeea455bad2e8654b53b84e0bd7f113},
affiliation={Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China; Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China; College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China; Department of Neurology, Memory and Aging Center, University of California San Francisco, 675 Nelson Rising Lane, Box 1207, San Francisco, CA  94158, United States},
abstract={Background The aetiology of Alzheimer's disease (AD) is believed to involve environmental exposure and genetic susceptibility. The aim of our present systematic review and meta-analysis was to roundly evaluate the association between AD and its modifiable risk factors. Methods We systematically searched PubMed and the Cochrane Database of Systematic Reviews from inception to July 2014, and the references of retrieved relevant articles. We included prospective cohort studies and retrospective case-control studies. Results 16 906 articles were identified of which 323 with 93 factors met the inclusion criteria for meta-analysis. Among factors with relatively strong evidence (pooled population >5000) in our meta-analysis, we found grade I evidence for 4 medical exposures (oestrogen, statin, antihypertensive medications and non-steroidal antiinflammatory drugs therapy) as well as 4 dietary exposures (folate, vitamin E/C and coffee) as protective factors of AD. We found grade I evidence showing that one biochemical exposure (hyperhomocysteine) and one psychological condition (depression) significantly increase risk of developing AD. We also found grade I evidence indicative of complex roles of pre-existing disease (frailty, carotid atherosclerosis, hypertension, low diastolic blood pressure, type 2 diabetes mellitus (Asian population) increasing risk whereas history of arthritis, heart disease, metabolic syndrome and cancer decreasing risk) and lifestyle (low education, high body mass index (BMI) in mid-life and low BMI increasing the risk whereas cognitive activity, current smoking (Western population), light-to-moderate drinking, stress, high BMI in late-life decreasing the risk) in influencing AD risk. We identified no evidence suggestive of significant association with occupational exposures. Conclusions Effective interventions in diet, medications, biochemical exposures, psychological condition, preexisting disease and lifestyle may decrease new incidence of AD.},
keywords={alpha tocopherol;  antihypertensive agent;  ascorbic acid;  estrogen;  folic acid;  hydroxymethylglutaryl coenzyme A reductase inhibitor;  nonsteroid antiinflammatory agent, Alzheimer disease;  arthritis;  Article;  Asian;  attributable risk;  body mass;  cancer risk;  carotid atherosclerosis;  case control study;  coffee;  cognition;  cohort analysis;  depression;  diastolic blood pressure;  dietary intake;  disease association;  disease predisposition;  drinking behavior;  educational status;  evidence based medicine;  heart disease;  human;  hyperhomocysteinemia;  hypertension;  lifestyle;  metabolic syndrome X;  non insulin dependent diabetes mellitus;  occupational exposure;  priority journal;  prospective study;  retrospective study;  risk factor;  risk reduction;  smoking;  systematic review;  weakness;  aged;  Alzheimer disease;  insurance;  meta analysis;  motor activity;  risk factor;  very elderly, Aged;  Aged, 80 and over;  Alzheimer Disease;  Humans;  Life Style;  Motor Activity;  Preexisting Condition Coverage;  Risk Factors},
chemicals_cas={alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; ascorbic acid, 134-03-2, 15421-15-5, 50-81-7; folic acid, 59-30-3, 6484-89-5},
references={Hurd, M.D., Martorell, P., Langa, K.M., Monetary costs of dementia in the United States (2013) N Engl J Med, 369, pp. 489-490; Roberts, J.S., Tersegno, S.M., Estimating and disclosing the risk of developing Alzheimer's disease: Challenges, controversies and future directions (2010) Future Neurol, 5, pp. 501-517; Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence (2011) Lancet Neurol, 10, pp. 819-828; Christensen, K., Thinggaard, M., Oksuzyan, A., Physical and cognitive functioning of people older than 90 years: A comparison of two Danish cohorts born 10years apart (2013) Lancet, 382, pp. 1507-1513; Matthews, F.E., Arthur, A., Barnes, L.E., A two-decade comparison of prevalence of dementia in individuals aged 65years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study i and II (2013) Lancet, 382, pp. 1405-1412; Moher, D., Liberati, A., Tetzlaff, J., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2010) Int J Surg, 8, pp. 336-341; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology: A proposal for reporting (2000) Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA, 283, pp. 2008-2012; Green, S., McDonald, S., Cochrane collaboration: More than systematic reviews? (2005) Intern Med J, 35, pp. 3-4; Higgins, J.P., Thompson, S.G., Deeks, J.J., Measuring inconsistency in meta-analyses (2003) BMJ, 327, pp. 557-560; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis (2000) Biometrics, 56, pp. 455-463; Yang, B., Fan, S., Zhi, X., Prevalence of hyperhomocysteinemia in China: A systematic review and meta-analysis (2015) Nutrients, 7, pp. 74-90; Kelly, T., Yang, W., Chen, C.S., Global burden of obesity in 2005 and projections to 2030 (2008) Int J Obes (Lond), 32, pp. 1431-1437; Ng, M., Freeman, M.K., Fleming, T.D., Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 (2014) JAMA, 311, pp. 183-192; Prati, P., Vanuzzo, D., Casaroli, M., Prevalence and determinants of carotid atherosclerosis in a general population (1992) Stroke, 23, pp. 1705-1711; Badawi, A., Sayegh, S., Sallam, M., The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012 (2015) Glob J Health Sci, 7, pp. 183-191; Choi, J., Ahn, A., Kim, S., Global prevalence of physical frailty by Fried's criteria in community-dwelling elderly with national population-based surveys (2015) J Am Med Dir Assoc, 16 (7), pp. 548-550; Poels, M.M., Van Oijen, M., Mattace-Raso, F.U., Arterial stiffness, cognitive decline, and risk of dementia: The Rotterdam study (2007) Stroke, 38, pp. 888-892; Van Popele, N.M., Grobbee, D.E., Bots, M.L., Association between arterial stiffness and atherosclerosis: The Rotterdam Study (2001) Stroke, 32, pp. 454-460; Zhou, J., Yu, J.T., Wang, H.F., Association between stroke and Alzheimer's disease: Systematic review and meta-analysis (2015) J Alzheimers Dis, 43, pp. 479-489; Meng, X.F., Yu, J.T., Wang, H.F., Midlife vascular risk factors and the risk of Alzheimer's disease: A systematic review and meta-analysis (2014) J Alzheimers Dis, 42, pp. 1295-1310; Catoni, G.L., S-Adenosylmethionine; A new intermediate formed enzymatically from L-methionine and adenosinetriphosphate (1953) J Biol Chem, 204, pp. 403-416; Schupf, N., Tang, M.X., Fukuyama, H., Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease (2008) Proc Natl Acad Sci U S A, 105, pp. 14052-14057; Radi, E., Formichi, P., Battisti, C., Apoptosis and oxidative stress in neurodegenerative diseases (2014) J Alzheimers Dis, 42, pp. S125-S152; Polidori, M.C., Nelles, G., Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - Challenges and perspectives (2014) Curr Pharm des, 20, pp. 3083-3092; Bhattacharjee, S., Zhao, Y., Hill, J.M., Aluminum and its potential contribution to Alzheimer's disease (AD) (2014) Front Aging Neurosci, 6, p. 62; Saco, T., Parthasarathy, P.T., Cho, Y., Inflammasome: A new trigger of Alzheimer's disease (2014) Front Aging Neurosci, 6, p. 80; Schmidt, R., Schmidt, H., Curb, J.D., Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study (2002) Ann Neurol, 52, pp. 168-174; Xu, W., Tan, L., Wang, H.F., Education and risk of dementia: Dose-response meta-analysis of prospective cohort studies (2015) Mol Neurobiol; Terracciano, A., Sutin, A.R., An, Y., Personality and risk of Alzheimer's disease: New data and meta-analysis (2014) Alzheimers Dement, 10, pp. 179-186; Boyle, P.A., Buchman, A.S., Barnes, L.L., Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons (2010) Arch Gen Psychiatry, 67, pp. 304-310},
correspondence_address1={Yu, J.-T.; Department of Neurology, 675 Nelson Rising Lane, Box 1207, United States; email: yu-jintai@163.com},
publisher={BMJ Publishing Group},
issn={00223050},
coden={JNNPA},
pubmed_id={26294005},
language={English},
abbrev_source_title={J. Neurol. Neurosurg. Psychiatry},
document_type={Article},
source={Scopus},
}

@ARTICLE{Fratiglioni200711,
author={Fratiglioni, L. and Wang, H.-X.},
title={Brain reserve hypothesis in dementia},
journal={Journal of Alzheimer's Disease},
year={2007},
volume={12},
number={1},
pages={11-22},
doi={10.3233/JAD-2007-12103},
note={cited By 313},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548590301&doi=10.3233%2fJAD-2007-12103&partnerID=40&md5=9315ff5e93edf58b199ee16cde0b0175},
affiliation={Dept. NVS, Karolinska Institute, Stockholm Gerontology Research Center, Stockholm, Sweden; Aging Research Center, Department of Neurobiology, Karolinska Institutet, Gävlegatan 16, S-113 30 Stockholm, Sweden},
abstract={The concept of brain reserve refers to the ability to tolerate the age-related changes and the disease related pathology in the brain without developing clear clinical symptoms or signs. A considerable body of biological research has documented that a number of factors including education, work complexity, social network, and leisure activities may contribute to this reserve allowing cognitive function to be maintained in old ages. Epidemiological studies have also related these factors to the development of dementia, suggesting that intellectual challenges experienced across the whole life span may increase the brain reserve and be crucial for the occurrence of dementia symptoms in late life. This paper is a systematic review of the published epidemiological studies on this topic. The availability of numerous epidemiological and biological data investigating the reserve hypothesis in dementia permits some preliminary conclusions. High education, adult-life occupational work complexity, as well as a mentally and socially integrated lifestyle in late life could postpone the onset of clinical dementia and AD. The relevance of physical activity itself remains in debate, as most physical activities include also social and mental stimulation. Leisure activities with all three components - physical, mental and social - seem to have the most beneficial effect. Delaying dementia onset by five years would halve dementia prevalence and substantially decrease the number of dementia cases in the community. © 2007 - IOS Press and the authors. All rights reserved.},
author_keywords={Brain reserve;  Dementia;  Education;  Leisure activities;  Life course approach;  Social network;  Work complexity},
keywords={Alzheimer disease;  brain function;  cognition;  conference paper;  dementia;  disease course;  educational status;  human;  intellect;  leisure;  lifestyle;  mental performance;  physical activity;  prevalence;  priority journal;  social behavior;  socioeconomics;  systematic review;  work},
references={Demenssjukdomar, (2006) En systematisk litteraturöversikt, pp. 22-29. , Stockholm; Abbott, R.D., White, L.R., Ross, G.W., Masaki, K.H., Curb, J.D., Petrovitch, H., Walking and dementia in physically capable elderly men (2004) Jama, 292, pp. 1447-1453; Adlard, P.A., Perreau, V.M., Pop, V., Cotman, C.W., Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease (2005) J Neurosci, 25, pp. 4217-4221; Aguero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M., Winblad, B., Mortality from dementia in advanced age: A 5-year follow-up study of incident dementia cases (1999) J Clin Epidemiol, 52, pp. 737-743; Aguero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M., von Strauss, E., Winblad, B., Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study (1998) Am J Public Health, 88, pp. 1452-1456; Alexander, G.E., Furey, M.L., Grady, C.L., Pietrini, P., Brady, D.R., Mentis, M.J., Schapiro, M.B., Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: Implications for the cognitive reserve hypothesis (1997) Am J Psychiatry, 154, pp. 165-172; Andel, R., Crowe, M., Pedersen, N.L., Mortimer, J., Crimmins, E., Johansson, B., Gatz, M., Complexity of work and risk of Alzheimer's disease: A population-based study of Swedish twins (2005) J Gerontol B Psychol Sci Soc Sci, 60, pp. P251-P258; Anttila, T., Helkala, E.L., Kivipelto, M., Hallikainen, M., Alhainen, K., Heinonen, H., Mannermaa, A., Nissinen, A., Midlife income, occupation, APOE status, and dementia: A population-based study (2002) Neurology, 59, pp. 887-893; Azzimondi, G., D'Alessandro, R., Pandolfo, G., Feruglio, F.S., Comparative study of the prevalence of dementia in two Sicilian communities with different psychosocial backgrounds (1998) Neuroepidemiology, 17, pp. 199-209; Bennett, D.A., Schneider, J.A., Tang, Y., Arnold, S.E., Wilson, R.S., The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: A longitudinal cohort study (2006) The Lancet Neurology, 5, pp. 406-412; Bennett, D.A., Wilson, R.S., Schneider, J.A., Evans, D.A., Mendes de Leon, C.F., Arnold, S.E., Barnes, L.L., Bienias, J.L., Education modifies the relation of AD pathology to level of cognitive function in older persons (2003) Neurology, 60, pp. 1909-1915; Bickel, H., Cooper, B., Incidence and relative risk of dementia in an urban elderly population: Findings of a prospective field study (1994) Psychol Med, 24, pp. 179-192; Bonaiuto, S., Rocca, W.A., Lippi, A., Giannandrea, E., Mele, M., Cavarzeran, F., Amaducci, L., Education and occupation as risk factors for dementia: A population-based case-control study (1995) Neuroepidemiology, 14, pp. 101-109; Bowirrat, A., Treves, T.A., Friedland, R.P., Korczyn, A.D., Prevalence of Alzheimer's type dementia in an elderly Arab population (2001) Eur J Neurol, 8, pp. 119-123; Broe, G.A., Henderson, A.S., Creasey, H., McCusker, E., Korten, A.E., Jorm, A.F., Longley, W., Anthony, J.C., A case-control study of Alzheimer's disease in Australia (1990) Neurology, 40, pp. 1698-1707; Churchill, J.D., Galvez, R., Colcombe, S., Swain, R.A., Kramer, A.F., Greenough, W.T., Exercise, experience and the aging brain (2002) Neurobiol Aging, 23, pp. 941-955; Cobb, J.L., Wolf, P.A., Au, R., White, R., D'Agostino, R.B., The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study (1995) Neurology, 45, pp. 1707-1712; Crowe, M., Andel, R., Pedersen, N.L., Johansson, B., Gatz, M., Does participation in leisure activities lead to reduced risk of Alzheimer's disease? A prospective study of Swedish twins (2003) J Gerontol B Psychol Sci Soc Sci, 58, pp. P249-P255; Crystal, H.A., Dickson, D.W., Sliwinski, M.J., Lipton, R.B., Grober, E., Marks-Nelson, H., Antis, P., Pathological markers associated with normal aging and dementia in the elderly (1993) Ann Neurol, 34, pp. 566-573; De Ronchi, D., Fratiglioni, L., Rucci, P., Paternico, A., Graziani, S., Dalmonte, E., The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status (1998) Neurology, 50, pp. 1231-1238; Del Ser, T., Hachinski, V., Merskey, H., Munoz, D.G., An autopsy-verified study of the effect of education on degenerative dementia (1999) Brain, 122, pp. 2309-2319; Evans, D.A., Hebert, L.E., Beckett, L.A., Scherr, P.A., Albert, M.S., Chown, M.J., Pilgrim, D.M., Taylor, J.O., Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons (1997) Arch Neurol, 54, pp. 1399-1405; Fabrigoule, C., Letenneur, L., Dartigues, J.F., Zarrouk, M., Commenges, D., Barberger-Gateau, P., Social and leisure activities and risk of dementia: A prospective longitudinal study (1995) J Am Geriatr Soc, 43, pp. 485-490; Fratiglioni, L., Aguero-Torres, H., Winblad, B., Demens - ett stort och ökande folalsoproble (2001) Stiftelsen Stockholms läns Äldrecentrum, , Stockholm; Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafstrom, M., Holmen, K., Ericsson, K., Winblad, B., Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education (1991) Neurology, 41, pp. 1886-1892; Fratiglioni, L., Paillard-Borg, S., Winblad, B., An active and socially integrated lifestyle in late life might protect against dementia (2004) Lancet Neurol, 3, pp. 343-353; Fratiglioni, L., Rocca, W., (2001) Epidemiology of dementia, 6, pp. 193-215. , 2 edn, Elsevier Science BV, Oxford; Fratiglioni, L., Wang, H.X., Ericsson, K., Maytan, M., Winblad, B., Influence of social network on occurrence of dementia: A community-based longitudinal study (2000) Lancet, 355, pp. 1315-1319; Fratiglioni, L., von Strauss, E., Qiu, C., Epidemiology of the dementias of old age, Oxford University, London In press; Fritsch, T., Smyth, K.A., Debanne, S.M., Petot, G.J., Friedland, R.P., Participation in novelty-seeking leisure activities and Alzheimer's disease (2005) J Geriatr Psychiatry Neurol, 18, pp. 134-141; Ganguli, M., Dodge, H.H., Chen, P., Belle, S., DeKosky, S.T., Ten-year incidence of dementia in a rural elderly US community population: The MoVIES Project (2000) Neurology, 54, pp. 1109-1116; Gatz, M., Prescott, C.A., Pedersen, N.L., Lifestyle risk and delaying factors (2006) Alzheimer Dis Assoc Disord, 20, pp. S84-S88; Hall, K.S., Gao, S., Unverzagt, F.W., Hendrie, H.C., Low education and childhood rural residence: Risk for Alzheimer's disease in African Americans (2000) Neurology, 54, pp. 95-99; Harmanci, H., Emre, M., Gurvit, H., Bilgic, B., Hanagasi, H., Gurol, E., Sahin, H., Tinaz, S., Risk factors for Alzheimer disease: A population-based case-control study in Istanbul, Turkey (2003) Alzheimer Dis Assoc Disord, 17, pp. 139-145; Helmer, C., Damon, D., Letenneur, L., Fabrigoule, C., Barberger-Gateau, P., Lafont, S., Fuhrer, R., Dartigues, J.F., Marital status and risk of Alzheimer's disease: A French population-based cohort study (1999) Neurology, 53, pp. 1953-1958; Jorm, A.F., Jolley, D., The incidence of dementia: A meta-analysis (1998) Neurology, 51, pp. 728-733; A. Karp et al., Work complexity and risk of dementia, (in progress); Karp, A., Kareholt, I., Qiu, C., Bellander, T., Winblad, B., Fratiglioni, L., Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease (2004) Am J Epidemiol, 159, pp. 175-183; Karp, A., Paillard-Borg, S., Wang, H.X., Silverstein, M., Winblad, B., Fratiglioni, L., Mental, physical and social components in leisure activities equally contribute to decrease dementia risk (2006) Dement Geriatr Cogn Disord, 21, pp. 65-73; Katzman, R., Education and the prevalence of dementia and Alzheimer's disease (1993) Neurology, 43, pp. 13-20; Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., Peck, A., Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques (1988) Ann Neurol, 23, pp. 138-144; Kempermann, G., Kuhn, H.G., Gage, F.H., More hippocampal neurons in adult mice living in an enriched environment (1997) Nature, 386, pp. 493-495; Kidron, D., Black, S.E., Stanchev, P., Buck, B., Szalai, J.P., Parker, J., Szekely, C., Bronskill, M.J., Quantitative MR volumetry in Alzheimer's disease. Topographic markers and the effects of sex and education (1997) Neurology, 49, pp. 1504-1512; Knopman, D.S., Parisi, J.E., Salviati, A., Floriach-Robert, M., Boeve, B.F., Ivnik, R.J., Smith, G.E., Petersen, R.C., Neuropathology of cognitively normal elderly (2003) J Neuropathol Exp Neurol, 62, pp. 1087-1095; Kuh, D., Ben-Shlomo, Y., Lynch, J., Hallqvist, J., Power, C., Life course epidemiology (2003) J Epidemiol Community Health, 57, pp. 778-783; Lam, L.C., Lui, V.W., Chiu, H.F., Chan, S.S., Tam, C.W., Executive function impairment in community elderly subjects with questionable dementia (2005) Dement Geriatr Cogn Disord, 19, pp. 86-90; Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P., Kukull, W., Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older (2006) Ann Intern Med, 144, pp. 73-81; Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., Rockwood, K., Physical activity and risk of cognitive impairment and dementia in elderly persons (2001) Arch Neurol, 58, pp. 498-504; Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I.S., Korade-Mirnics, Z., Lee, V.M.Y., Hersh, L.B., Sisodia, S.S., Environmental Enrichment Reduces A[beta] Levels and Amyloid Deposition in Transgenic Mice (2005) Cell, 120, pp. 701-713; Letenneur, L., Gilleron, V., Commenges, D., Helmer, C., Orgogozo, J.M., Dartigues, J.F., Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project (1999) J Neurol Neurosurg Psychiatry, 66, pp. 177-183; Li, G., Shen, Y.C., Chen, C.H., Zhau, Y.W., Li, S.R., Lu, M., A three-year follow-up study of age-related dementia in an urban area of Beijing (1991) Acta Psychiatr Scand, 83, pp. 99-104; Lin, R.T., Lai, C.L., Tai, C.T., Liu, C.K., Yen, Y.Y., Howng, S.L., Prevalence and subtypes of dementia in southern Taiwan: Impact of age, sex, education, and urbanization (1998) J Neurol Sci, 160, pp. 67-75; Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G.B., McDowell, I., Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging (2002) Am J Epidemiol, 156, pp. 445-453; Mahncke, H.W., Bronstone, A., Merzenich, M.M., Brain plasticity and functional losses in the aged: Scientific bases for a novel intervention (2006) Prog Brain Res, 157, pp. 81-109; Moceri, V.M., Kukull, W.A., Emanual, I., van Belle, G., Starr, J.R., Schellenberg, G.D., McCormick, W.C., Larson, E.B., Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease (2001) Epidemiology, 12, pp. 383-389; Ott, A., Breteler, M.M., van Harskamp, F., Claus, J.J., van der Cammen, T.J., Grobbee, D.E., Hofman, A., Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study (1995) Bmj, 310, pp. 970-973; Perneczky, R., Drzezga, A., Diehl-Schmid, J., Schmid, G., Wohlschlager, A., Kars, S., Grimmer, T., Kurz, A., Schooling mediates brain reserve in Alzheimer's disease: Findings of fluoro-deoxy-glucose-positron emission tomography (2006) J Neurol Neurosurg Psychiatry, 77, pp. 1060-1063; Pham, T.M., Soderstrom, S., Winblad, B., Mohammed, A.H., Effects of environmental enrichment on cognitive function and hippocampal NGF in the non-handled rats (1999) Behav Brain Res, 103, pp. 63-70; Pham, T.M., Winblad, B., Granholm, A.C., Mohammed, A.H., Environmental influences on brain neurotrophins in rats (2002) Pharmacol Biochem Behav, 73, pp. 167-175; Plassman, B.L., Welsh, K.A., Helms, M., Brandt, J., Page, W.F., Breitner, J.C., Intelligence and education as predictors of cognitive state in late life: A 50-year follow-up (1995) Neurology, 45, pp. 1446-1450; Qiu, C., Backman, L., Winblad, B., Aguero-Torres, H., Fratiglioni, L., The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project (2001) Arch Neurol, 58, pp. 2034-2039; Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Dalmonte, E., Mariani, E., Incidence and etiology of dementia in a large elderly Italian population (2005) Neurology, 64, pp. 1525-1530; Richards, M., Deary, I.J., A life course approach to cognitive reserve: A model for cognitive aging and development? (2005) Ann Neurol, 58, pp. 617-622; Riley, K.P., Snowdon, D.A., Markesbery, W.R., Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study (2002) Ann Neurol, 51, pp. 567-577; Rogers, R.L., Meyer, J.S., Mortel, K.F., After reaching retirement age physical activity sustains cerebral perfusion and cognition (1990) J Am Geriatr Soc, 38, pp. 123-128; Rundek, T., Bennett, D.A., Cognitive leisure activities, but not watching TV, for future brain benefits (2006) Neurology, 66, pp. 794-795; Scarmeas, N., Levy, G., Tang, M.X., Manly, J., Stern, Y., Influence of leisure activity on the incidence of Alzheimer's disease (2001) Neurology, 57, pp. 2236-2242; Scarmeas, N., Stern, Y., Cognitive reserve and lifestyle (2003) J Clin Exp Neuropsychol, 25, pp. 625-633; Scarmeas, N., Stern, Y., Cognitive reserve: Implications for diagnosis and prevention of Alzheimer's disease (2004) Curr Neurol Neurosci Rep, 4, pp. 374-380; Scarmeas, N., Zarahn, E., Anderson, K.E., Habeck, C.G., Hilton, J., Flynn, J., Marder, K.S., Stern, Y., Association of life activities with cerebral blood flow in Alzheimer disease: Implications for the cognitive reserve hypothesis (2003) Arch Neurol, 60, pp. 359-365; Schmand, B., Smit, J.H., Geerlings, M.I., Lindeboom, J., The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis (1997) Psychol Med, 27, pp. 1337-1344; Seidler, A., Bernhardt, T., Nienhaus, A., Frolich, L., Association between the psychosocial network and dementia-a case-control study (2003) J Psychiatr Res, 37, pp. 89-98; Seidler, A., Nienhaus, A., Bernhardt, T., Kauppinen, T., Elo, A.L., Frolich, L., Psychosocial work factors and dementia (2004) Occup Environ Med, 61, pp. 962-971; Shadlen, M.F., Siscovick, D., Fitzpatrick, A.L., Dulberg, C., Kuller, L.H., Jackson, S., Education, cognitive test scores, and black-white differences in dementia risk (2006) J Am Geriatr Soc, 54, pp. 898-905; Simons, L.A., Simons, J., McCallum, J., Friedlander, Y., Lifestyle factors and risk of dementia: Dubbo Study of the elderly (2006) Med J Aust, 184, pp. 68-70; Smyth, K.A., Fritsch, T., Cook, T.B., McClendon, M.J., Santillan, C.E., Friedland, R.P., Worker functions and traits associated with occupations and the development of AD (2004) Neurology, 63, pp. 498-503; Snowdon, D.A., Kemper, S.J., Mortimer, J.A., Greiner, L.H., Wekstein, D.R., Markesbery, W.R., Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study (1996) Jama, 275, pp. 528-532; Stern, Y., What is cognitive reserve? Theory and research application of the reserve concept (2002) J Int Neuropsychol Soc, 8, pp. 448-460; Stern, Y., Alexander, G.E., Prohovnik, I., Mayeux, R., Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease (1992) Ann Neurol, 32, pp. 371-375; Stern, Y., Alexander, G.E., Prohovnik, I., Stricks, L., Link, B., Lennon, M.C., Mayeux, R., Relationship between lifetime occupation and parietal flow: Implications for a reserve against Alzheimer's disease pathology (1995) Neurology, 45, pp. 55-60; Stern, Y., Gurland, B., Tatemichi, T.K., Tang, M.X., Wilder, D., Mayeux, R., Influence of education and occupation on the incidence of Alzheimer's disease (1994) Jama, 271, pp. 1004-1010; Stern, Y.P., Cognitive Reserve and Alzheimer Disease (2006) Alzheimer Disease & Associated Disorders, 20, pp. S69-S74; Tognoni, G., Ceravolo, R., Nucciarone, B., Bianchi, F., Dell'Agnello, G., Ghicopulos, I., Siciliano, G., Murri, L., From mild cognitive impairment to dementia: A prevalence study in a district of Tuscany, Italy (2005) Acta Neurologica Scandinavica, 112, pp. 65-71; Tuokko, H., Garrett, D.D., McDowell, I., Silverberg, N., Kristjansson, B., Cognitive decline in high-functioning older adults: Reserve or ascertainment bias? (2003) Aging Ment Health, 7, pp. 259-270; Valenzuela, M.J., Sachdev, P., Brain reserve and dementia: A systematic review (2006) Psychol Med, 36, pp. 441-454; van Praag, H., Kempermann, G., Gage, F.H., Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus (1999) Nat Neurosci, 2, pp. 266-270; Wang, H.X., Karp, A., Winblad, B., Fratiglioni, L., Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A longitudinal study from the Kungsholmen project (2002) Am J Epidemiol, 155, pp. 1081-1087; Verghese, J., Lipton, R.B., Katz, M.J., Hall, C.B., Derby, C.A., Kuslansky, G., Ambrose, A.F., Buschke, H., Leisure activities and the risk of dementia in the elderly (2003) N Engl J Med, 348, pp. 2508-2516; Verhaeghen, P., Salthouse, T.A., Meta-analyses of age-cognition relations in adulthood: Estimates of linear and nonlinear age effects and structural models (1997) Psychol Bull, 122, pp. 231-249; Whalley, L.J., Dick, F.D., McNeill, G., A life-course approach to the aetiology of late-onset dementias (2006) Lancet Neurol, 5, pp. 87-96; Whalley, L.J., Starr, J.M., Athawes, R., Hunter, D., Pattie, A., Deary, I.J., Childhood mental ability and dementia (2000) Neurology, 55, pp. 1455-1459; Wilson, R.S., Mendes De Leon, C.F., Barnes, L.L., Schneider, J.A., Bienias, J.L., Evans, D.A., Bennett, D.A., Participation in cognitively stimulating activities and risk of incident Alzheimer disease (2002) Jama, 287, pp. 742-748; Wilson, R.S., Scherr, P.A., Hoganson, G., Bienias, J.L., Evans, D.A., Bennett, D.A., Early life socioeconomic status and late life risk of Alzheimer's disease (2005) Neuroepidemiology, 25, pp. 8-14; Yamada, M., Kasagi, F., Sasaki, H., Masunari, N., Mimori, Y., Suzuki, G., Association between dementia and midlife risk factors: The Radiation Effects Research Foundation Adult Health Study (2003) J Am Geriatr Soc, 51, pp. 410-414; Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Ueda, K., Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study (1995) Neurology, 45, pp. 1161-1168},
correspondence_address1={Fratiglioni, L.; Aging Research Center, Gävlegatan 16, S-113 30 Stockholm, Sweden; email: laura.fratiglioni@ki.se},
publisher={IOS Press},
issn={13872877},
coden={JADIF},
pubmed_id={17851191},
language={English},
abbrev_source_title={J. Alzheimer's Dis.},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Radua201849,
author={Radua, J. and Ramella-Cravaro, V. and Ioannidis, J.P.A. and Reichenberg, A. and Phiphopthatsanee, N. and Amir, T. and Yenn Thoo, H. and Oliver, D. and Davies, C. and Morgan, C. and McGuire, P. and Murray, R.M. and Fusar-Poli, P.},
title={What causes psychosis? An umbrella review of risk and protective factors},
journal={World Psychiatry},
year={2018},
volume={17},
number={1},
pages={49-66},
doi={10.1002/wps.20490},
note={cited By 261},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040741812&doi=10.1002%2fwps.20490&partnerID=40&md5=7eb2af578e11be4de5500d24294675cb},
affiliation={Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; FIDMAG Germanes Hospitalàries, CIBERSAM, Sant Boi de Llobregat, Spain; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden; Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Meta-Research Innovation Center at Stanford, Stanford University, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Frieman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; National Institute for Health Research (NIHR) Maudsley Biomedical Research Center, London, United Kingdom; OASIS Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom},
abstract={Psychosis is a heterogeneous psychiatric condition for which a multitude of risk and protective factors have been suggested. This umbrella review aimed to classify the strength of evidence for the associations between each factor and psychotic disorders whilst controlling for several biases. The Web of Knowledge database was searched to identify systematic reviews and meta-analyses of observational studies which examined associations between socio-demographic, parental, perinatal, later factors or antecedents and psychotic disorders, and which included a comparison group of healthy controls, published from 1965 to January 31, 2017. The literature search and data extraction followed PRISMA and MOOSE guidelines. The association between each factor and ICD or DSM diagnoses of non-organic psychotic disorders was graded into convincing, highly suggestive, suggestive, weak, or non-significant according to a standardized classification based on: number of psychotic cases, random-effects p value, largest study 95% confidence interval, heterogeneity between studies, 95% prediction interval, small study effect, and excess significance bias. In order to assess evidence for temporality of association, we also conducted sensitivity analyses restricted to data from prospective studies. Fifty-five meta-analyses or systematic reviews were included in the umbrella review, corresponding to 683 individual studies and 170 putative risk or protective factors for psychotic disorders. Only the ultra-high-risk state for psychosis (odds ratio, OR=9.32, 95% CI: 4.91-17.72) and Black-Caribbean ethnicity in England (OR=4.87, 95% CI: 3.96-6.00) showed convincing evidence of association. Six factors were highly suggestive (ethnic minority in low ethnic density area, second generation immigrants, trait anhedonia, premorbid IQ, minor physical anomalies, and olfactory identification ability), and nine were suggestive (urbanicity, ethnic minority in high ethnic density area, first generation immigrants, North-African immigrants in Europe, winter/spring season of birth in Northern hemisphere, childhood social withdrawal, childhood trauma, Toxoplasma gondii IgG, and non-right handedness). When only prospective studies were considered, the evidence was convincing for ultra-high-risk state and suggestive for urbanicity only. In summary, this umbrella review found several factors to be associated with psychotic disorders with different levels of evidence. These risk or protective factors represent a starting point for further etiopathological research and for the improvement of the prediction of psychosis. © 2018 World Psychiatric Association},
author_keywords={antecedents;  Black-Caribbean ethnicity;  environment;  parental factors;  perinatal factors;  psychosis;  risk;  Schizophrenia;  socio-demographic factors;  ultra-high-risk state for psychosis;  urbanicity},
keywords={Diagnostic and Statistical Manual of Mental Disorders;  disease association;  ethnicity;  high risk patient;  human;  immigrant;  International Classification of Diseases;  perinatal period;  practice guideline;  prediction;  priority journal;  psychosis;  psychosocial withdrawal;  psychotrauma;  Review;  risk factor;  sensitivity analysis;  social status;  urban area},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={King’s College LondonKing’s College London, KCL},
funding_details={Medical Research CouncilMedical Research Council, MRC, G0600972, G0700995, G1100583, MR/K013807/1, MR/N026063/1},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII, CP14/00041, PI14/00292},
funding_details={European Regional Development FundEuropean Regional Development Fund, ERDF},
funding_text 1={This study was supported in part by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King's College London, by a 2017 Medical Research Council Confidence in Concept grant to P. Fusar-Poli, and by Instituto de Salud Carlos III and FEDER grants (CP14/00041 and PI14/00292) to J. Radua. The funders had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The views expressed are those of the authors and not necessarily those of the funders. J. Radua and V. Ramella-Cravaro contributed equally to this work.},
funding_text 2={This study was supported in part by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King’s College London, by a 2017 Medical Research Council Confidence in Concept grant to P. Fusar-Poli, and by Instituto de Salud Carlos III and FEDER grants (CP14/00041 and PI14/00292) to J. Radua. The funders had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The views expressed are those of the authors and not necessarily those of the funders. J. Radua and V. Ramella-Cravaro contributed equally to this work.},
references={Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 386, pp. 743-800; Kirkbride, J.B., Errazuriz, A., Croudace, T.J., Incidence of schizophrenia and other psychoses in England, 1950–2009: a systematic review and meta-analyses (2012) PLoS One, 7; Cloutier, M., Aigbogun, M.S., Guerin, A., The economic burden of schizophrenia in the United States in 2013 (2016) J Clin Psychiatry, 77, pp. 764-771; Fusar-Poli, P., McGorry, P.D., Kane, J., Improving outcomes of first-episode psychosis: an overview (2017) World Psychiatry, 16, pp. 251-265; van Os, J., Rutten, B.P.F., Poulton, R., Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr (2008) Bull, 34, pp. 1066-1082; Howes, O.D., Murray, R.M., Schizophrenia: an integrated sociodevelopmental-cognitive model (2014) Lancet, 383, pp. 1677-1687; Matheson, S.L., Shepherd, A.M., Laurens, K.R., A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia (2011) Schizophr Res, 133, pp. 133-142; Laurens, K.R., Luo, L., Matheson, S.L., Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses (2015) BMC Psychiatry, 15, p. 205; Dean, K.M.R., Environmental risk factors for psychosis (2005) Dialogues Clin Neurosci, 7, pp. 69-80; Fusar-Poli, P., The Clinical High-Risk State for Psychosis (CHR-P), Version II (2017) Schizophr Bull, 43, pp. 44-47; Fusar-Poli, P., Schultze-Lutter, F., Predicting the onset of psychosis in patients at clinical high risk: practical guide to probabilistic prognostic reasoning (2016) Evid Based Ment Health, 19, pp. 10-15; Ioannidis, J.P., Munafo, M.R., Fusar-Poli, P., Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention (2014) Trends Cogn Sci, 18, pp. 235-241; van Os, J., Kenis, G., Rutten, B.P.F., The environment and schizophrenia (2010) Nature, 468, pp. 203-212; Aromataris, E., Fernandez, R., Godfrey, C.M., Summarizing systematic reviews: methodological development, conduct and reporting (2015) of an umbrella review approach. Int J Evid Based Health, 13, pp. 132-140; Dinu, M., Pagliai, G., Casini, A., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials Eur J Clin Nutr, , (in press); Bortolato, B., Kohler, C.A., Evangelou, E., Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses (2017) Bipolar Disord, 19, pp. 84-96; Kyrgiou, M., Kalliala, I., Markozannes, G., Adiposity and cancer at major anatomical sites: umbrella review of the literature (2017) BMJ, 356, p. 477; Dragioti, E., Karathanos, V., Gerdle, B., Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials (2017) Acta Psychiatr Scand, 136, pp. 236-246; Markozannes, G., Tzoulaki, I., Karli, D., Diet, body size, physical activity and risk of prostate cancer: an umbrella review of the evidence (2016) Eur J Cancer, 69, pp. 61-69; Belbasis, L., Savvidou, M.D., Kanu, C., Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14, p. 147; Belbasis, L., Stefanaki, I., Stratigos, A.J., Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: an umbrella review of meta-analyses (2016) J Dermatol Sci, 84, pp. 330-339; Papageorgiou, P.N., Deschner, J., Papageorgiou, S.N., Effectiveness and adverse effects of deep brain stimulation: umbrella review of meta-analyses (2017) J Neurol Surg A Cent Eur Neurosurg, 78, pp. 180-190; Bellou, V., Belbasis, L., Tzoulaki, I., Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses (2017) Alzheimers Dement, 13, pp. 406-418; Carvalho, A.F., Kohler, C.A., Fernandes, B.S., Bias in emerging biomarkers for bipolar disorder (2016) Psychol Med, 46, pp. 2287-2297; Bellou, V., Belbasis, L., Tzoulaki, I., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies (2016) Neuroepidemiology, 46, pp. 96-105; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies (2015) BMJ, 350, p. 7607; Theodoratou, E., Tzoulaki, I., Zgaga, L., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. 2035; Tonelli, A.R., Zein, J., Adams, J., Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses (2014) Intensive Care Med, 40, pp. 769-787; Ioannidis, J.P., Zhou, Y., Chang, C.Q., Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses (2014) Ann Oncol, 25, pp. 16-23; Doufas, A.G., Panagiotou, O.A., Ioannidis, J.P., Concordance of sleep and pain outcomes of diverse interventions: an umbrella review (2012) PLoS One, 7; Contopoulos-Ioannidis, D.G., Ioannidis, J.P., Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review (2012) Eur J Clin Invest, 42, pp. 233-244; Fleischhacker, W.W., A meta view on meta-analyses (2017) JAMA Psychiatry, 74, pp. 684-685; Ioannidis, J.P.A., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; Geddes, J.R., Verdoux, H., Takei, N., Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis (1999) Schizophr Bull, 25, pp. 413-423; Cannon, M., Jones, P.B., Murray, R.M., Obstetric complications and schizophrenia: historical and meta-analytic review (2002) Am J Psychiatry, 159, pp. 1080-1092; Woodberry, K.A., Giuliano, A.J., Seidman, L.J., Premorbid IQ in schizophrenia: a meta-analytic review (2008) Am J Psychiatry, 165, pp. 579-587; Khandaker, G.M., Barnett, J.H., White, I.R., A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia (2011) Schizophr Res, 132, pp. 220-227; Cai, L., Wan, C.L., He, L., Gestational influenza increases the risk of psychosis in adults (2015) Med Chem, 11, pp. 676-682; Selten, J.-P., Termorshuizen, F., The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis (2017) Schizophr Res, 183, pp. 2-9; Tarbox, S.I., Pogue-Geile, M.F., Development of social functioning in preschizophrenia children and adolescents: a systematic review (2008) Psychol Bull, 134, pp. 561-583; Matheson, S.L., Vijayan, H., Dickson, H., Systematic meta-analysis of childhood social withdrawal in schizophrenia, and comparison with data from at-risk children aged 9-14 years (2013) J Psychiatr Res, 47, pp. 1061-1068; Biological insights from 108 schizophrenia-associated genetic loci (2014) Nature, 511, pp. 421-427; O'Dushlaine, C., Rossin, L., Lee, P.H., Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) Nat Neurosci, 18, pp. 199-209; Xu, T., Chan, R.C.K., Compton, M.T., Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis (2011) PLoS One, 6; Hirnstein, M., Hugdahl, K., Excess of non-right-handedness in schizophrenia: meta-analysis of gender effects and potential biases in handedness assessment (2014) Br J Psychiatry, 205, pp. 260-267; Golembo-Smith, S., Walder, D.J., Daly, M.P., The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review (2012) Schizophr Res, 142, pp. 1-11; Neelam, K., Garg, D., Marshall, M., A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia (2011) BMC Psychiatry, 11, p. 139; Christesen, H.T., Elvander, C., Lamont, R.F., The impact of vitamin D in pregnancy on extraskeletal health in children: a systematic review (2012) Acta Obstet Gynecol Scand, 91, pp. 1368-1380; Moher, D., Liberati, A., Tetzlaff, J., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) J Clin Epidemiol, 62, pp. 1006-1012; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology - a proposal for reporting (2000) JAMA, 283, pp. 2008-2012; Bourque, F., van der Ven, E., Malla, A., A meta-analysis of the risk for psychotic disorders among first- and second-generation immigrants (2011) Psychol Med, 41, pp. 897-910; Varese, F., Smeets, F., Drukker, M., Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies (2012) Schizophr Bull, 38, pp. 661-671; Kinney, D.K., Teixeira, P., Hsu, D., Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin D deficiency and infections? (2009) Schizophr Bull, 35, pp. 582-595; Saha, S., Chant, D., Welham, J., A systematic review of the prevalence of schizophrenia (2005) PLoS Med, 2, pp. 413-433; Rohatgi, A., WebPlotDigitizer 3.10; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Shea, B.J., Bouter, L.M., Peterson, J., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS One, 2; Pieper, D., Mathes, T., Eikermann, M., Can AMSTAR also be applied to systematic reviews of non-randomized studies? (2014) BMC Res Notes, 7, p. 609; (2011) R: a language and environment for statistical computing, , Vienna, R Foundation for Statistical Computing; Higgins, J.P.T., Green, S., (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0, , (eds)., The Cochrane Collaboration; Moberg, P., Kamath, V., Marchetto, D., Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis (2014) Schizophr Bull, 40, pp. 50-59; Rubia, K., Alegria, A.A., Cubillo, A.I., Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis (2014) Biol Psychiatry, 76, pp. 616-628; Schwarzer, G., Meta: an R package for meta-analysis (2007) R News, 7, pp. 40-45; Higgins, J.P.T., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc A Stat, 172, pp. 137-159; Jackson, D., Kirkbride, J., Croudace, T., Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses (2013) Int J Methods Psychiatr Res, 22, pp. 36-45; Egger, M., Smith, G.D., Schneider, M., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P.A., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Bosqui, T.J., Hoy, K., Shannon, C., A systematic review and meta-analysis of the ethnic density effect in psychotic disorders (2014) Soc Psychiatry Psychiatr Epidemiol, 49, pp. 519-529; Torrey, E.F., Buka, S., Cannon, T.D., Paternal age as a risk factor for schizophrenia: how important is it? (2009) Schizophr Res, 114, pp. 1-5; Kwok, W., Is there evidence that social class at birth increases risk of psychosis? A systematic review (2014) Int J Soc Psychiatry, 60, pp. 801-808; O'Donoghue, B., Roche, E., Lane, A., Neighbourhood level social deprivation and the risk of psychotic disorders: a systematic review (2016) Soc Psychiatry Psychiatr Epidemiol, 51, pp. 941-950; Rasic, D., Hajek, T., Alda, M., Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies (2014) Schizophr Bull, 40, pp. 28-38; Tortelli, A., Errazuriz, A., Croudace, T., Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950–2013 (2015) Soc Psychiatry Psychiatr Epidemiol, 50, pp. 1039-1055; van der Ven, E., Veling, W., Tortelli, A., Evidence of an excessive gender gap in the risk of psychotic disorder among North African immigrants in Europe: a systematic review and meta-analysis (2016) Soc Psychiatry Psychiatr Epidemiol, 51, pp. 1603-1613; Vassos, E., Pedersen, C.B., Murray, R.M., Meta-analysis of the association of urbanicity with schizophrenia (2012) Schizophr Bull, 38, pp. 1118-1123; Davies, G., Welham, J., Chant, D., A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr (2003) Bull, 29, pp. 587-593; McGrath, J.J., Welham, J.L., Season of birth and schizophrenia: a systematic review and meta-analysis of data from the Southern Hemisphere (1999) Schizophr Res, 35, pp. 237-242; Geddes, J.R., Lawrie, S.M., Obstetric complications and schizophrenia: a meta-analysis (1995) Br J Psychiatry, 167, pp. 786-793; Van Lieshout, R.J., Taylor, V.H., Boyle, M.H., Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review (2011) Obes Rev, 12, pp. e548-e559; Arias, I., Sorlozano, A., Villegas, E., Infectious agents associated with schizophrenia: a meta-analysis (2012) Schizophr Res, 136, pp. 128-136; Attademo, L., Bernardini, F., Garinella, R., Environmental pollution and risk of psychotic disorders: a review of the science to date (2017) Schizophr Res, 181, pp. 55-59; Beards, S., Gayer-Anderson, C., Borges, S., Life events and psychosis: a review and meta-analysis (2013) Schizophr Bull, 39, pp. 740-747; Clancy, M.J., Clarke, M.C., Connor, D.J., The prevalence of psychosis in epilepsy; a systematic review and meta-analysis (2014) BMC Psychiatry, 14, p. 75; Cunningham, T., Hoy, K., Shannon, C., Does childhood bullying lead to the development of psychotic symptoms? A meta-analysis and review of prospective studies (2015) Psychosis, 8, pp. 48-59; de Sousa, P., Varese, F., Sellwood, W., Parental communication and psychosis: a meta-analysis (2014) Schizophr Bull, 40, pp. 756-768; Gurillo, P., Jauhar, S., Murray, R.M., Does tobacco use cause psychosis? Systematic review and meta-analysis (2015) Lancet Psychiatry, 2, pp. 718-725; Gutierrez-Fernandez, J., de Dios Luna del Castillo, J., Mananes-Gonzalez, S., Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study (2015) Neuropsychiatr Dis Treat, 11, pp. 843-852; Khandaker, G.M., Zimbron, J., Dalman, C., Childhood infection and adult schizophrenia: a meta-analysis of population-based studies (2012) Schizophr Res, 139, pp. 161-168; Linszen, M.M.J., Brouwer, R.M., Heringa, S.M., Increased risk of psychosis in patients with hearing impairment: review and meta-analyses (2016) Neurosci Biobehav Rev, 62, pp. 1-20; Marconi, A., Di Forti, M., Lewis, C.M., Meta-analysis of the association between the level of cannabis use and risk of psychosis (2016) Schizophr Bull, 42, pp. 1262-1269; Molloy, C., Conroy, R.M., Cotter, D.R., Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies (2011) Schizophr Bull, 37, pp. 1104-1110; Sutterland, A.L., Fond, G., Kuin, A., Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis (2015) Acta Psychiatr Scand, 132, pp. 161-179; Dickson, H., Laurens, K.R., Cullen, A.E., Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia (2012) Psychol Med, 42, pp. 743-755; Filatova, S., Koivumaa-Honkanen, H., Hirvonen, N., Early motor developmental milestones and schizophrenia: a systematic review and meta-analysis (2017) Schizophr Res, 188, pp. 13-20; Fusar-Poli, P., Cappucciati, M., Rutigliano, G., At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction (2015) World Psychiatry, 14, pp. 322-332; Kaymaz, N., Drukker, M., Lieb, R., Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results (2012) Psychol Med, 42, pp. 2239-2253; Koning, J.P.F., Tenback, D.E., van Os, J., Dyskinesia and Parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr (2010) Bull, 36, pp. 723-731; Ohi, K., Hashimoto, R., Yasuda, Y., Personality traits and schizophrenia: evidence from a case-control study and meta-analysis (2012) Psychiatry Res, 198, pp. 7-11; Ohi, K., Shimada, T., Nitta, Y., The Five-Factor Model personality traits in schizophrenia: a meta-analysis (2016) Psychiatry Res, 240, pp. 34-41; Potvin, S., Marchand, S., Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies (2008) Pain, 138, pp. 70-78; Ward, K.E., Friedman, L., Wise, A., Meta-analysis of brain and cranial size in schizophrenia (1996) Schizophr Res, 22, pp. 197-213; Yan, C., Cao, Y., Zhang, Y., Trait and state positive emotional experience in schizophrenia: a meta-analysis (2012) PLoS One, 7; Selten, J.P., Cantor-Graae, E., Nahon, D., No relationship between risk of schizophrenia and prenatal exposure to stress during the Six-Day War or Yom Kippur War in Israel (2003) Schizophr Res, 63, pp. 131-135; O'Rourke, K., An historical perspective on meta-analysis: dealing quantitatively with varying study results (2007) J Roy Soc Med, 100, pp. 579-582; Fusar-Poli, P., Borgwardt, S., Bechdolf, A., The psychosis high-risk state: a comprehensive state-of-the-art review (2013) JAMA Psychiatry, 70, pp. 107-120; Fusar-Poli, P., Rutigliano, G., Stahl, D., Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders (2017) Eur Psychiatry, 42, pp. 49-54; Kempton, M.J., Bonoldi, I., Valmaggia, L., Speed of psychosis progression in people at ultra-high clinical risk: a complementary meta-analysis (2015) JAMA Psychiatry, 72, pp. 622-623; Fusar-Poli, P., Cappucciati, M., De Micheli, A., Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk (2017) Schizophr Bull, 43, pp. 48-56; Fusar-Poli, P., Cappucciati, M., Bonoldi, I., Prognosis of brief psychotic episodes: a meta-analysis (2016) JAMA Psychiatry, 73, pp. 211-220; Falkenberg, I., Valmaggia, L., Byrnes, M., Why are help-seeking subjects at ultra-high risk for psychosis help-seeking? (2015) Psychiatry Res, 228, pp. 808-815; Fusar-Poli, P., Rocchetti, M., Sardella, A., Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis (2015) Br J Psychiatry, 207, pp. 198-206; Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification (2016) JAMA Psychiatry, 73, pp. 113-120; Fusar-Poli, P., Cappucciati, M., Rutigliano, G., Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS (2016) Psychiatry J, 2016, p. 7146341; Fusar-Poli, P., Tantardini, M., De Simone, S., Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk (2017) Eur Psychiatry, 40, pp. 65-75; Fusar-Poli, P., Rutigliano, G., Stahl, D., Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk (2016) JAMA Psychiatry, 73, pp. 1260-1267; Fusar-Poli, P., Schultze-Lutter, F., Cappucciati, M., The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis (2016) Schizophr Bull, 42, pp. 732-743; Fusar-Poli, P., Schultze-Lutter, F., Addington, J., Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution (2016) Lancet Psychiatry, 3, p. 18; Fusar-Poli, P., Palombini, E., Davies, C., Why transition risk to psychosis is not declining at the OASIS ultra high risk service: the hidden role of stable pretest risk enrichment Schizophr Res, , (in press); Fusar-Poli, P., Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it (2017) World Psychiatry, 16, pp. 212-213; Kirkbride, J., Hameed, Y., Ankireddypalli, G., The epidemiology of first-episode psychosis in early intervention in psychosis services: findings from the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study (2017) Am J Psychiatry, 174, pp. 143-153; Heinz, A., Deserno, L., Reininghaus, U., Urbanicity, social adversity and psychosis (2013) World Psychiatry, 12, pp. 187-197; Selten, J.-P., van Os, J., Cantor-Graae, E., The social defeat hypothesis of schizophrenia: issues of measurement and reverse causality (2016) World Psychiatry, 15, pp. 294-295; Mizrahi, R., Social stress and psychosis risk: common neurochemical substrates? (2016) Neuropsychopharmacology, 41, pp. 666-674; Holtzman, C.W., Trotman, H.D., Goulding, S.M., Stress and neurodevelopmental processes in the emergence of psychosis (2013) Neuroscience, 249, pp. 172-191; Steinheuser, V., Ackermann, K., Schonfeld, P., Stress and the city: impact of urban upbringing on the (re)activity of the hypothalamus-pituitary-adrenal axis (2014) Psychosom Med, 76, pp. 678-685; Mewes, R., Reich, H., Skoluda, N., Elevated hair cortisol concentrations in recently fled asylum seekers in comparison to permanently settled immigrants and non-immigrants (2017) Transl Psychiatry, 7; Powell, N.D., Sloan, E.K., Bailey, M.T., Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis (2013) Proc Natl Acad Sci USA, 110, pp. 16574-16579; Akdeniz, C., Tost, H., Streit, F., Neuroimaging evidence for a role of neural social stress processing in ethnic minority-associated environmental risk (2014) JAMA Psychiatry, 71, pp. 672-680; Lederbogen, F., Kirsch, P., Haddad, L., City living and urban upbringing affect neural social stress processing in humans (2011) Nature, 474, pp. 498-501; Haddad, L., Schafer, A., Streit, F., Brain structure correlates of urban upbringing, an environmental risk factor for schizophrenia (2015) Schizophr Bull, 41, pp. 115-122; Selten, J.P., Booij, J., Buwalda, B., Biological mechanisms whereby social exclusion may contribute to the etiology of psychosis: a narrative review Schizophr Bull, , (in press); Egerton, A., Howes, O.D., Houle, S., Elevated striatal dopamine function in immigrants and their children: a risk mechanism for psychosis (2017) Schizophr Bull, 43, pp. 293-301; Frissen, A., van Os, J., Habets, P., No evidence of association between childhood urban environment and cortical thinning in psychotic disorder (2017) PLoS One, 12; Keskinen, E., Marttila, R., Koivumaa-Honkanen, H., Search for protective factors for psychosis - a population-based sample with special interest in unaffected individuals with parental psychosis Early Interv Psychiatry, , (in press); Millan, M.J., Andrieux, A., Bartzokis, G., Altering the course of schizophrenia: progress and perspectives (2016) Nat Rev Drug Discov, 15, pp. 485-515; Uher, R., Zwicker, A., Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness (2017) World Psychiatry, 16, pp. 121-129; Vassos, E., Di Forti, M., Coleman, J., An examination of polygenic score risk prediction in individuals with first episode psychosis (2016) Biol Psychiatry, 81, pp. 470-477; Fusar-Poli, P., Rutigliano, G., Stahl, D., Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis (2017) JAMA Psychiatry, 74, pp. 493-500; Iyegbe, C., Campbell, D., Butler, A., The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research (2014) Soc Psychiatry Psychiatr Epidemiol, 49, pp. 169-182; Hartley, S., Barrowclough, C., Haddock, G., Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms (2013) Acta Psychiatr Scand, 128, pp. 327-346; Mishara, A.L., Fusar-Poli, P., The phenomenology and neurobiology of delusion formation during psychosis onset: Jaspers, Truman symptoms, and aberrant salience (2013) Schizophr Bull, 39, pp. 278-286; Achim, A.M., Maziade, M., Raymond, E., How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association (2011) Schizophr Bull, 37, pp. 811-821; Newton-Howes, G., Tyrer, P., North, B., The prevalence of personality disorder in schizophrenia and psychotic disorders: systematic review of rates and explanatory modelling (2008) Psychol Med, 38, pp. 1075-1082; Gumley, A.I., Taylor, H.E.F., Schwannauer, M., A systematic review of attachment and psychosis: measurement, construct validity and outcomes (2014) Acta Psychiatr Scand, 129, pp. 257-274; Large, M., Sharma, S., Compton, M.T., Cannabis use and earlier onset of psychosis (2011) Arch Gen Psychiatry, 68, pp. 555-561; Murray, R.M., Quigley, H., Quattrone, D., Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (2016) World Psychiatry, 15, pp. 195-204; Bramness, J.G., Rognli, E.B., Psychosis induced by amphetamines (2016) Curr Opin Psychiatry, 29, pp. 236-241; Roncero, C., Ros-Cucurull, E., Daigre, C., Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients (2012) Actas Esp Psiquiatr, 40, pp. 187-197; Reeve, S., Sheaves, B., Freeman, D., The role of sleep dysfunction in the occurrence of delusions and hallucinations: a systematic review (2015) Clin Psychol Rev, 42, pp. 96-115; Folsom, D., Jeste, D.V., Schizophrenia in homeless persons: a systematic review of the literature (2002) Acta Psychiatr Scand, 105, pp. 404-413; Padgett, F.E., Miltsiou, E., Tiffin, P.A., The co-occurrence of nonaffective psychosis and the pervasive developmental disorders: a systematic review (2010) J Intellect Dev Disabil, 35, pp. 187-198; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94, pp. 485-514; Siontis, K.C., Hernandez-Boussard, T., Ioannidis, J.P., Overlapping meta-analyses on the same topic: survey of published studies (2013) BMJ, 347, p. 4501; Millan, M.J., An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy (2013) Neuropharmacology, 68, pp. 2-82},
publisher={Blackwell Publishing Ltd},
issn={17238617},
language={English},
abbrev_source_title={World Psychiatry},
document_type={Review},
source={Scopus},
}

@ARTICLE{Grosso2017131,
author={Grosso, G. and Godos, J. and Galvano, F. and Giovannucci, E.L.},
title={Coffee, Caffeine, and Health Outcomes: An Umbrella Review},
journal={Annual Review of Nutrition},
year={2017},
volume={37},
pages={131-156},
doi={10.1146/annurev-nutr-071816-064941},
note={cited By 254},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017132703&doi=10.1146%2fannurev-nutr-071816-064941&partnerID=40&md5=5adaabf00700f0bbe416bc051ec77f8c},
affiliation={Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Catania, 95123, Italy; NNEdPro, St. John's Innovation Centre, Cambridge, CB40WS, United Kingdom; Biomedical and Biotechnological Sciences, University of Catania, Catania, 95124, Italy; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA  02115, United States; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA  02115, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA  02115, United States},
abstract={To evaluate the associations between coffee and caffeine consumption and various health outcomes, we performed an umbrella review of the evidence from meta-analyses of observational studies and randomized controlled trials (RCTs). Of the 59 unique outcomes examined in the selected 112 meta-analyses of observational studies, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers; cardiovascular disease and mortality; Parkinson's disease; and type-2 diabetes. Of the 14 unique outcomes examined in the 20 selected meta-analyses of observational studies, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes and an increased risk of pregnancy loss. Of the 12 unique acute outcomes examined in the selected 9 meta-analyses of RCTs, coffee was associated with a rise in serum lipids, but this result was affected by significant heterogeneity, and caffeine was associated with a rise in blood pressure. Given the spectrum of conditions studied and the robustness of many of the results, these findings indicate that coffee can be part of a healthful diet. © 2017 by Annual Reviews.},
author_keywords={Caffeine;  Cancer;  Cardiovascular disease;  Coffee;  Diabetes;  Neurodegenerative disease},
keywords={caffeine;  coffee, Cardiovascular Diseases;  coffee;  Diabetes Mellitus, Type 2;  female;  human;  male;  meta analysis;  Neoplasms;  Neurodegenerative Diseases;  observational study;  pregnancy;  randomized controlled trial (topic);  risk, Caffeine;  Cardiovascular Diseases;  Coffee;  Diabetes Mellitus, Type 2;  Female;  Humans;  Male;  Neoplasms;  Neurodegenerative Diseases;  Observational Studies as Topic;  Pregnancy;  Randomized Controlled Trials as Topic;  Risk},
chemicals_cas={caffeine, 58-08-2; Caffeine; Coffee},
references={Bai, K., Cai, Q., Jiang, Y., Lv, L., Coffee consumption and risk of hepatocellular carcinoma: A metaanalysis of eleven epidemiological studies (2016) Onco Targets Ther., 9, pp. 4369-4375; Bohn, S.K., Blomhoff, R., Paur, I., Coffee and cancer risk, epidemiological evidence, and molecular mechanisms (2014) Mol. Nutr. Food Res., 58, pp. 915-930; Botelho, F., Lunet, N., Barros, H., Coffee and gastric cancer: Systematic review and meta-analysis (2006) Cad. Saude Publica, 22, pp. 889-900; Braem, M.G., Onland-Moret, N.C., Schouten, L.J., Tjonneland, A., Hansen, L., Coffee and tea consumption and the risk of ovarian cancer: A prospective cohort study and updated meta-analysis (2012) Am. J. Clin. Nutr., 95, pp. 1172-1181; Bravi, F., Bosetti, C., Tavani, A., Bagnardi, V., Gallus, S., Coffee drinking and hepatocellular carcinoma risk: A meta-analysis (2007) Hepatology, 46, pp. 430-435; Bravi, F., Bosetti, C., Tavani, A., Gallus, S., La Vecchia, C., Coffee reduces risk for hepatocellular carcinoma: An updated meta-analysis (2013) Clin. Gastroenterol. Hepatol., 11, pp. 1413-1421; Bravi, F., Scotti, L., Bosetti, C., Gallus, S., Negri, E., Coffee drinking and endometrial cancer risk: A metaanalysis of observational studies (2009) Am. J. Obstet. Gynecol., 200, pp. 130-135; Bravi, F., Tavani, A., Bosetti, C., Boffetta, P., La Vecchia, C., Coffee and the risk of hepatocellular carcinoma and chronic liver disease: A systematic review and meta-analysis of prospective studies (2017) Eur. J. Cancer Prev., , http://dx.doi.org/10.1097/CEJ.0000000000000252, In press; Brent, R.L., Christian, M.S., Diener, R.M., Evaluation of the reproductive and developmental risks of caffeine (2011) Birth Defects Res. B Dev. Reprod. Toxicol., 92, pp. 152-187; Brown, O.I., Allgar, V., Wong, K.Y., Coffee reduces the risk of death after acute myocardial infarction: A meta-analysis (2016) Coron. Artery Dis., 27, pp. 566-572; Buscemi, S., Marventano, S., Antoci, M., Cagnetti, A., Castorina, G., Coffee and metabolic impairment: An updated review of epidemiological studies (2016) NFS J., 3, pp. 1-7; Cai, L., Ma, D., Zhang, Y., Liu, Z., Wang, P., The effect of coffee consumption on serum lipids: A meta-analysis of randomized controlled trials (2012) Eur. J. Clin. Nutr., 66, pp. 872-877; Caini, S., Cattaruzza, S., Bendinelli, B., Tosti, G., Masala, G., Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: A review of the literature and meta-analysis (2016) Eur. J. Nutr., 56, pp. 1-12; Caldeira, D., Martins, C., Alves, L.B., Pereira, H., Ferreira, J.J., Costa, J., Caffeine does not increase the risk of atrial fibrillation: A systematic review andmeta-analysis of observational studies (2013) Heart, 99, pp. 1383-1389; Cao, S., Liu, L., Yin, X., Wang, Y., Liu, J., Lu, Z., Coffee consumption and risk of prostate cancer: A meta-analysis of prospective cohort studies (2014) Carcinogenesis, 35, pp. 256-261; Chen, J., Long, S., Tea and coffee consumption and risk of laryngeal cancer: A systematic review meta-analysis (2014) PLOS ONE, 9, p. e112006; Chen, L.W., Wu, Y., Neelakantan, N., Chong, M.F., Pan, A., Van Dam, R.M., Maternal caffeine intake during pregnancy is associated with risk of low birth weight: A systematic review and dose-response meta-analysis (2014) BMC Med., 12, p. 174; Chen, L.W., Wu, Y., Neelakantan, N., Chong, M.F., Pan, A., Van Dam, R.M., Maternal caffeine intake during pregnancy and risk of pregnancy loss: A categorical and dose-response meta-analysis of prospective studies (2016) Public Health Nutr., 19, pp. 1233-1244; Chen, S., Teoh, N.C., Chitturi, S., Farrell, G.C., Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection? (2014) J. Gastroenterol. Hepatol., 29, pp. 435-441; Cheng, J., Su, H., Zhu, R., Wang, X., Peng, M., Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: A metaanalysis (2014) Am. J. Obstet. Gynecol., 210 (151), pp. e1-10; Cheng, M., Hu, Z., Lu, X., Huang, J., Gu, D., Caffeine intake and atrial fibrillation incidence: Dose response meta-analysis of prospective cohort studies (2014) Can. J. Cardiol., 30, pp. 448-454; Chiaffarino, F., Bravi, F., Cipriani, S., Parazzini, F., Ricci, E., Coffee and caffeine intake and risk of endometriosis: A meta-analysis (2014) Eur. J. Nutr., 53, pp. 1573-1579; Colussi, G., De Ferrari, M.E., Brunati, C., Civati, G., Medical prevention and treatment of urinary stones (2000) J. Nephrol., 13, pp. S65-70; Cornelis, M.C., El-Sohemy, A., Kabagambe, E.K., Campos, H., Coffee, CYP1A2 genotype, and risk of myocardial infarction (2006) JAMA, 295, pp. 1135-1141; Costa, J., Lunet, N., Santos, C., Santos, J., Vaz-Carneiro, A., Caffeine exposure and the risk of Parkinson's disease: A systematic review and meta-analysis of observational studies (2010) J. Alzheimers Dis., 20, pp. S221-S238; Crippa, A., Discacciati, A., Larsson, S.C., Wolk, A., Orsini, N., Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis (2014) Am. J. Epidemiol., 180, pp. 763-775; Deng, W., Yang, H., Wang, J., Cai, J., Bai, Z., Coffee consumption and the risk of incident gastric cancer- A meta-analysis of prospective cohort studies (2016) Nutr. Cancer, 68, pp. 40-47; Ding, M., Bhupathiraju, S.N., Chen, M., Van Dam, R.M., Hu, F.B., Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis (2014) Diabetes Care, 37, pp. 569-586; Ding, M., Bhupathiraju, S.N., Satija, A., Van Dam, R.M., Hu, F.B., Long-term coffee consumption and risk of cardiovascular disease: A systematic review and a dose-response meta-analysis of prospective cohort studies (2014) Circulation, 129, pp. 643-659; Discacciati, A., Orsini, N., Wolk, A., Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer- A dose-response meta-analysis (2014) Ann. Oncol., 25, pp. 584-591; Dong, J., Zou, J., Yu, X.F., Coffee drinking and pancreatic cancer risk: A meta-analysis of cohort studies (2011) World J. Gastroenterol., 17, pp. 1204-1210; Galarraga, V., Boffetta, P., Coffee drinking and risk of lung cancer-ameta-analysis (2016) Cancer Epidemiol. Biomarkers Prev., 25, pp. 951-957; Galeone, C., Turati, F., La Vecchia, C., Tavani, A., Coffee consumption and risk of colorectal cancer: A meta-analysis of case-control studies (2010) Cancer Causes Control, 21, pp. 1949-1959; Gan, Y., Wu, J., Zhang, S., Li, L., Cao, S., Association of coffee consumption with risk of colorectal cancer: A meta-analysis of prospective cohort studies (2017) Oncotarget, 8, pp. 18699-18711; Giovannucci, E., Meta-analysis of coffee consumption and risk of colorectal cancer (1998) Am. J. Epidemiol., 147, pp. 1043-1052; Godos, J., Pluchinotta, F.R., Marventano, S., Buscemi, S., Li Volti, G., Coffee components and cardiovascular risk: Beneficial and detrimental effects (2014) Int. J. Food Sci. Nutr., 65, pp. 925-936; Greenland, S., A meta-analysis of coffee, myocardial infarction, and coronary death (1993) Epidemiology, 4, pp. 366-374; Greenwood, D.C., Thatcher, N.J., Ye, J., Garrard, L., Keogh, G., Caffeine intake during pregnancy and adverse birth outcomes: A systematic review and dose-response meta-analysis (2014) Eur. J. Epidemiol., 29, pp. 725-734; Grosso, G., Micek, A., Castellano, S., Pajak, A., Galvano, F., Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies (2016) Mol. Nutr. Food Res., 60, pp. 223-234; Hernan, M.A., Takkouche, B., Caamano-Isorna, F., Gestal-Otero, J.J., Ameta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease (2002) Ann. Neurol., 52, pp. 276-284; Higdon, J.V., Frei, B., Coffee and health: A review of recent human research (2006) Crit. Rev. Food Sci. Nutr., 46, pp. 101-123; Higgins, L.G., Cavin, C., Itoh, K., Yamamoto, M., Hayes, J.D., Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein (2008) Toxicol. Appl. Pharmacol., 226, pp. 328-337; Huang, T.B., Guo, Z.F., Zhang, X.L., Zhang, X.P., Liu, H., Coffee consumption and urologic cancer risk: A meta-analysis of cohort studies (2014) Int. Urol. Nephrol., 46, pp. 1481-1493; Huber, W.W., Parzefall, W., Modification of N-acetyltransferases and glutathione S-transferases by coffee components: Possible relevance for cancer risk (2005) Methods Enzymol., 401, pp. 307-341; Huxley, R., Lee, C.M., Barzi, F., Timmermeister, L., Czernichow, S., Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with metaanalysis (2009) Arch. Intern. Med., 169, pp. 2053-2063; Inoue, M., Tsugane, S., Insulin resistance and cancer: Epidemiological evidence (2012) Endocr. Relat. Cancer, 19, pp. F1-8; Jahanfar, S., Jaafar, S.H., Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome (2015) Cochrane Database Syst. Rev., 6, p. CD006965; Je, Y., Giovannucci, E., Coffee consumption and risk of endometrial cancer: Findings from a large up-to-date meta-analysis (2012) Int. J. Cancer, 131, pp. 1700-1710; Je, Y., Giovannucci, E., Coffee consumption and totalmortality: Ameta-analysis of twenty prospective cohort studies (2014) Br. J. Nutr., 111, pp. 1162-1173; Je, Y., Liu, W., Giovannucci, E., Coffee consumption and risk of colorectal cancer: A systematic review and meta-analysis of prospective cohort studies (2009) Int. J. Cancer, 124, pp. 1662-1668; Jee, S.H., He, J., Whelton, P.K., Suh, I., Klag, M.J., The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials (1999) Hypertension, 33, pp. 647-652; Jiang, W., Wu, Y., Jiang, X., Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies (2013) Gynecol. Oncol., 129, pp. 620-629; Jiang, X., Zhang, D., Jiang, W., Coffee and caffeine intake and incidence of type 2 diabetes mellitus: A meta-analysis of prospective studies (2014) Eur. J. Nutr., 53, pp. 25-38; Kawachi, I., Colditz, G.A., Stone, C.B., Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis (1994) Br. Heart J., 72, pp. 269-275; Kennedy, O.J., Roderick, P., Buchanan, R., Fallowfield, J.A., Hayes, P.C., Parkes, J., Systematic review with meta-analysis: Coffee consumption and the risk of cirrhosis (2016) Aliment. Pharmacol. Ther., 43, pp. 562-574; Kim, B., Nam, Y., Kim, J., Choi, H., Won, C., Coffee consumption and stroke risk: A meta-analysis of epidemiologic studies (2012) Korean J. Fam. Med., 33, pp. 356-365; Kim, J., Oh, S.W., Myung, S.K., Kwon, H., Lee, C., Association between coffee intake and gastroesophageal reflux disease: A meta-analysis (2014) Dis. Esophagus, 27, pp. 311-317; Kim, Y.S., Kwak, S.M., Myung, S.K., Caffeine intake from coffee or tea and cognitive disorders: A meta-analysis of observational studies (2015) Neuroepidemiology, 44, pp. 51-63; Kua, K.P., Lee, S.W., Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates (2017) Br. J. Clin. Pharmacol., 83, pp. 180-191; Larsson, S.C., Drca, N., Jensen-Urstad, M., Wolk, A., Coffee consumption is not associated with increased risk of atrial fibrillation: Results from two prospective cohorts and a meta-analysis (2015) BMC Med., 13, p. 207; Larsson, S.C., Orsini, N., Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies (2011) Am. J. Epidemiol., 174, pp. 993-1001; Larsson, S.C., Wolk, A., Coffee consumption and risk of liver cancer: Ameta-analysis (2007) Gastroenterology, 132, pp. 1740-1745; Lee, D.R., Lee, J., Rota, M., Lee, J., Ahn, H.S., Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis (2014) Bone, 63, pp. 20-28; Lee, Y.H., Bae, S.C., Song, G.G., Coffee or tea consumption and the risk of rheumatoid arthritis: A meta-analysis (2014) Clin. Rheumatol., 33, pp. 1575-1583; Li, G., Ma, D., Zhang, Y., Zheng, W., Wang, P., Coffee consumption and risk of colorectal cancer: A meta-analysis of observational studies (2013) Public Health Nutr., 16, pp. 346-357; Li, J., Zhao, H., Song, J.M., Zhang, J., Tang, Y.L., Xin, C.M., A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy (2015) Int. J. Gynaecol. Obstet., 130, pp. 116-122; Li, L., Gan, Y., Wu, C., Qu, X., Sun, G., Lu, Z., Coffee consumption and the risk of gastric cancer: A meta-analysis of prospective cohort studies (2015) BMC Cancer, 15, p. 733; Li, S., Dai, Z., Wu, Q., Effect of coffee intake on hip fracture: A meta-analysis of prospective cohort studies (2015) Nutr. J., 14, p. 38; Li, X.J., Ren, Z.J., Qin, J.W., Zhao, J.H., Tang, J.H., Coffee consumption and risk of breast cancer: An up-to-date meta-analysis (2013) PLOS ONE, 8, p. e52681; Li, X.L., Xu, J.H., Coffee consumption and hip fracture risk: A meta-analysis (2013) J. Nutr. Sci., 2, p. e23; Li, Y.M., Peng, J., Li, L.Z., Coffee consumption associated with reduced risk of oral cancer: A metaanalysis (2016) Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 121, pp. 381-389; Li, Z.X., Gao, Z.L., Wang, J.N., Guo, Q.H., Maternal coffee consumption during pregnancy and neural tube defects in offspring: A meta-analysis (2016) Fetal Pediatr. Pathol., 35, pp. 1-9; Lippi, G., Mattiuzzi, C., Franchini, M., Venous thromboembolism and coffee: Critical review and meta-analysis (2015) Ann. Transl. Med., 3, p. 152; Liu, F., Wang, X., Wu, G., Chen, L., Hu, P., Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: A meta-analysis (2015) PLOS ONE, 10, p. e0142457; Liu, H., Hu, G.H., Wang, X.C., Huang, T.B., Xu, L., Coffee consumption and prostate cancer risk: A meta-analysis of cohort studies (2015) Nutr. Cancer, 67, pp. 392-400; Liu, H., Hua, Y., Zheng, X., Shen, Z., Luo, H., Effect of coffee consumption on the risk of gastric cancer: A systematic review and meta-analysis of prospective cohort studies (2015) PLOS ONE, 10, p. e0128501; Liu, H., Yao, K., Zhang, W., Zhou, J., Wu, T., He, C., Coffee consumption and risk of fractures: A meta-analysis (2012) Arch. Med. Sci., 8, pp. 776-783; Liu, J., Shen, B., Shi, M., Cai, J., Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: A meta-analysis study (2016) PLOS ONE, 11, p. e0147056; Liu, Q.P., Wu, Y.F., Cheng, H.Y., Xia, T., Ding, H., Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies (2016) Nutrition, 32, pp. 628-636; Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R., Caffeine intake, smoking, and risk of Parkinson disease in men and women (2012) Am. J. Epidemiol., (175), pp. 1200-1207; Lu, Y., Zhai, L., Zeng, J., Peng, Q., Wang, J., Coffee consumption and prostate cancer risk: An updated meta-analysis (2014) Cancer Causes Control, 25, pp. 591-604; Ludwig, I.A., Clifford, M.N., Lean, M.E., Ashihara, H., Crozier, A., Coffee: Biochemistry and potential impact on health (2014) Food Funct., 5, pp. 1695-1717; Malerba, S., Galeone, C., Pelucchi, C., Turati, F., Hashibe, M., A meta-analysis of coffee and tea consumption and the risk of glioma in adults (2013) Cancer Causes Control, 24, pp. 267-276; Malerba, S., Turati, F., Galeone, C., Pelucchi, C., Verga, F., A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases (2013) Eur. J. Epidemiol., 28, pp. 527-539; Martini, D., Del Bo, C., Tassotti, M., Riso, P., Del Rio, D., Coffee consumption and oxidative stress: A review of human intervention studies (2016) Molecules, 21, p. 979; Marventano, S., Salomone, F., Godos, J., Pluchinotta, F., Del Rio, D., Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies (2016) Clin. Nutr., 35, pp. 1269-1281; Meng, S., Cao, J., Feng, Q., Peng, J., Hu, Y., Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review (2013) Evid. Based Complement. Altern. Med., 2013, p. 801457; Mesas, A.E., Leon-Munoz, L.M., Rodriguez-Artalejo, F., Lopez-Garcia, E., The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis (2011) Am. J. Clin. Nutr., 94, pp. 1113-1126; Milne, E., Royle, J.A., Bennett, L.C., De Klerk, N.H., Bailey, H.D., Maternal consumption of coffee and tea during pregnancy and risk of childhood ALL: Results from an Australian case-control study (2011) Cancer Causes Control, 22, pp. 207-218; Moco, S., Martin, F.P., Rezzi, S., Metabolomics view on gut microbiome modulation by polyphenolrich foods (2012) J. Proteome Res., 11, pp. 4781-4790; Moreira, A.S., Nunes, F.M., Domingues, M.R., Coimbra, M.A., Coffee melanoidins: Structures, mechanisms of formation and potential health impacts (2012) Food Funct., 3, pp. 903-915; Mostofsky, E., Rice, M.S., Levitan, E.B., Mittleman, M.A., Habitual coffee consumption and risk of heart failure: A dose-response meta-analysis (2012) Circ. Heart Fail., 5, pp. 401-405; Mulak, A., Bonaz, B., Brain-gut-microbiota axis in Parkinson's disease (2015) World J. Gastroenterol., 21, pp. 10609-10620; Myers, M.G., Basinski, A., Coffee and coronary heart disease (1992) Arch. Intern. Med., 152, pp. 1767-1772; Nehlig, A., Effects of coffee/caffeine on brain health and disease: What should I tell my patients? (2016) Pract. Neurol., 16, pp. 89-95; Nie, K., Xing, Z., Huang, W., Wang, W., Liu, W., Coffee intake and risk of pancreatic cancer: An updated meta-analysis of prospective studies (2016) Minerva Med., 107, pp. 270-278; Noordzij, M., Uiterwaal, C.S., Arends, L.R., Kok, F.J., Grobbee, D.E., Geleijnse, J.M., Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials (2005) J. Hypertens., 23, pp. 921-928; Ouyang, Z., Wang, Z., Jin, J., Association between tea and coffee consumption and risk of laryngeal cancer: A meta-analysis (2014) Int. J. Clin. Exp. Med., 7, pp. 5192-5200; Palatini, P., Ceolotto, G., Ragazzo, F., Dorigatti, F., Saladini, F., CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension (2009) J. Hypertens., 27, pp. 1594-1601; Pan, M.H., Tung, Y.C., Yang, G., Li, S., Ho, C.T., Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee (2016) Food Funct., 7, pp. 4481-4491; Park, C.H., Myung, S.K., Kim, T.Y., Seo, H.G., Jeon, Y.J., Coffee consumption and risk of prostate cancer: A meta-analysis of epidemiological studies (2010) BJU Int., 106, pp. 762-769; Park, K.Y., Kim, H.J., Ahn, H.S., Kim, S.H., Park, E.J., Effects of coffee consumption on serum uric acid: Systematic review and meta-analysis (2016) Semin. Arthritis Rheum., 45, pp. 580-586; Qi, H., Li, S., Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease (2014) Geriatr. Gerontol. Int., 14, pp. 430-439; Ran, H.Q., Wang, J.Z., Sun, C.Q., Coffee consumption and pancreatic cancer risk: An update metaanalysis of cohort studies (2016) Pak. J. Med. Sci., 32, pp. 253-259; Ranheim, T., Halvorsen, B., Coffee consumption and human health-beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus (2005) Mol. Nutr. Food Res., 49, pp. 274-284; Rhee, J., Kim, R., Kim, Y., Tam, M., Lai, Y., Maternal caffeine consumption during pregnancy and risk of low birth weight: A dose-response meta-analysis of observational studies (2015) PLOS ONE, 10, p. e0132334; Saab, S., Mallam, D., Cox, G.A., II, Tong, M.J., Impact of coffee on liver diseases: A systematic review (2014) Liver Int., 34, pp. 495-504; Sang, L.X., Chang, B., Li, X.H., Jiang, M., Consumption of coffee associated with reduced risk of liver cancer: A meta-analysis (2013) BMC Gastroenterol., 13, p. 34; Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., Lunet, N., Caffeine intake and dementia: Systematic review and meta-analysis (2010) J. Alzheimers Dis., 20, pp. S187-204; Shaffer, E.A., Gallstone disease: Epidemiology of gallbladder stone disease (2006) Best Pract. Res. Clin. Gastroenterol., 20, pp. 981-996; Shang, F., Li, X., Jiang, X., Coffee consumption and risk of the metabolic syndrome: A meta-analysis (2016) Diabetes Metab., 42, pp. 80-87; Shen, Z., Liu, H., Cao, H., Coffee consumption and risk of gastric cancer: An updated meta-analysis (2015) Clin. Res. Hepatol. Gastroenterol., 39, pp. 245-253; Sheng, J., Qu, X., Zhang, X., Zhai, Z., Li, H., Coffee, tea, and the risk of hip fracture: Ameta-analysis (2014) Osteoporos. Int., 25, pp. 141-150; Shimamoto, T., Yamamichi, N., Kodashima, S., Takahashi, Y., Fujishiro, M., No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: A cross-sectional study of 8, 013 healthy subjects in Japan (2013) PLOS ONE, 8, p. e65996; Sofi, F., Conti, A.A., Gori, A.M., Eliana Luisi, M.L., Casini, A., Coffee consumption and risk of coronary heart disease: A meta-analysis (2007) Nutr. Metab. Cardiovasc. Dis., 17, pp. 209-223; Steevens, J., Schouten, L.J., Verhage, B.A., Goldbohm, R.A., Van Den Brandt, P.A., Tea and coffee drinking and ovarian cancer risk: Results from the Netherlands Cohort Study and a meta-analysis (2007) Br. J. Cancer, 97, pp. 1291-1294; Steffen, M., Kuhle, C., Hensrud, D., Erwin, P.J., Murad, M.H., The effect of coffee consumption on blood pressure and the development of hypertension: A systematic review andmeta-analysis (2012) J. Hypertens., 30, pp. 2245-2254; Tang, N., Wu, Y., Ma, J., Wang, B., Yu, R., Coffee consumption and risk of lung cancer: Ameta-analysis (2010) Lung Cancer, 67, pp. 17-22; Tang, N., Zhou, B., Wang, B., Yu, R., Coffee consumption and risk of breast cancer: A metaanalysis (2009) Am. J. Obstet. Gynecol., 200 (290), pp. e1-9; Thomopoulos, T.P., Ntouvelis, E., Diamantaras, A.A., Tzanoudaki, M., Baka, M., Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: A metaanalysis (2015) Cancer Epidemiol., (39), pp. 1047-1059; Tian, C., Wang, W., Hong, Z., Zhang, X., Coffee consumption and risk of colorectal cancer: A doseresponse analysis of observational studies (2013) Cancer Causes Control, 24, pp. 1265-1268; Timms, J.A., Relton, C.L., Rankin, J., Strathdee, G., McKay, J.A., DNAmethylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia (2016) Epigenomics, 8, pp. 519-536; Turati, F., Galeone, C., Edefonti, V., Ferraroni, M., Lagiou, P., A meta-analysis of coffee consumption and pancreatic cancer (2012) Ann. Oncol., 23, pp. 311-318; Turati, F., Galeone, C., La Vecchia, C., Garavello, W., Tavani, A., Coffee and cancers of the upper digestive and respiratory tracts: Meta-analyses of observational studies (2011) Ann. Oncol., 22, pp. 536-544; Vitaglione, P., Fogliano, V., Pellegrini, N., Coffee, colon function and colorectal cancer (2012) Food Funct., 3, pp. 916-922; Wang, J., Li, X., Zhang, D., Coffee consumption and the risk of cutaneous melanoma: Ameta-analysis (2016) Eur. J. Nutr., 55, pp. 1317-1329; Wang, L., Shen, X., Wu, Y., Zhang, D., Coffee and caffeine consumption and depression: A meta-analysis of observational studies (2016) Aust. N. Z. J. Psychiatry, 50, pp. 228-242; Wang, S., Zhang, Y., Mao, Z., He, X., Zhang, Q., Zhang, D., A meta-analysis of coffee intake and risk of urolithiasis (2014) Urol. Int., 93, pp. 220-228; Wang, Y., Yu, X., Wu, Y., Zhang, D., Coffee and tea consumption and risk of lung cancer: A doseresponse analysis of observational studies (2012) Lung Cancer, 78, pp. 169-170; Welsh, E.J., Bara, A., Barley, E., Cates, C.J., Caffeine for asthma (2010) Cochrane Database Syst. Rev., 1, p. CD001112; Population Nutrient Intake Goals for Preventing Diet-related Chronic Diseases, , http://www.who.int/nutrition/topics/5populationnutrient/en, World Health Organization Accessed November 2015. Geneva:WHO; Wu, J.N., Ho, S.C., Zhou, C., Ling, W.H., Chen, W.Q., Coffee consumption and risk of coronary heart diseases: A meta-analysis of 21 prospective cohort studies (2009) Int. J. Cardiol., 137, pp. 216-225; Wu, L., Sun, D., He, Y., Coffee intake and the incident risk of cognitive disorders: A dose-response meta-analysis of nine prospective cohort studies (2017) Clin. Nutr., 36 (3), pp. 730-736; Wu, W., Tong, Y., Zhao, Q., Yu, G., Wei, X., Lu, Q., Coffee consumption and bladder cancer: A metaanalysis of observational studies (2015) Sci. Rep., 5, p. 9051; Xie, F., Wang, D., Huang, Z., Guo, Y., Coffee consumption and risk of gastric cancer: A large updated meta-analysis of prospective studies (2014) Nutrients, 6, pp. 3734-3746; Xie, Y., Huang, S., He, T., Su, Y., Coffee consumption and risk of gastric cancer: An updated metaanalysis (2016) Asia Pac. J. Clin. Nutr., 25, pp. 578-588; Xie, Y., Qin, J., Nan, G., Huang, S., Wang, Z., Su, Y., Coffee consumption and the risk of lung cancer: An updated meta-analysis of epidemiological studies (2016) Eur. J. Clin. Nutr., 70, pp. 199-206; Xu, C., Zhang, C., Wang, X.L., Liu, T.Z., Zeng, X.T., Self-fluidmanagement in prevention of kidney stones: A PRISMA-compliant systematic review and dose-response meta-analysis of observational studies (2015) Medicine, 94, p. e1042; Yang, T.O., Crowe, F., Cairns, B.J., Reeves, G.K., Beral, V., Tea and coffee and risk of endometrial cancer: Cohort study and meta-analysis (2015) Am. J. Clin. Nutr., 101, pp. 570-578; Yew, Y.W., Lai, Y.C., Schwartz, R.A., Coffee consumption and melanoma: A systematic review and meta-analysis of observational studies (2016) Am. J. Clin. Dermatol., 17, pp. 113-123; Yu, X., Bao, Z., Zou, J., Dong, J., Coffee consumption and risk of cancers: A meta-analysis of cohort studies (2011) BMC Cancer, 11, p. 96; Zeegers, M.P., Tan, F.E., Goldbohm, R.A., Vanden Brandt, P.A., Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis (2001) Int. J. Epidemiol., 30, pp. 353-362; Zeng, S.B., Weng, H., Zhou, M., Duan, X.L., Shen, X.F., Zeng, X.T., Long-term coffee consumption and risk of gastric cancer: A PRISMA-compliant dose-response meta-analysis of prospective cohort studies (2015) Medicine, 94, p. e1640; Zhang, X., Albanes, D., Beeson, W.L., Vanden Brandt, P.A., Buring, J.E., Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: Pooled analysis of prospective cohort studies (2010) J. Natl. Cancer Inst., 102, pp. 771-783; Zhang, Y., Lee, E.T., Cowan, L.D., Fabsitz, R.R., Howard, B.V., Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study (2011) Nutr.Metab. Cardiovasc. Dis., 21, pp. 418-423; Zhang, Y., Wang, X., Cui, D., Association between coffee consumption and the risk of oral cancer: A meta-analysis of observational studies (2015) Int. J. Clin. Exp. Med., 8, pp. 11657-11665; Zhang, Y., Yang, T., Zeng, C., Wei, J., Li, H., Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis (2016) BMJ Open, 6, p. e009809; Zhang, Y.P., Li, W.Q., Sun, Y.L., Zhu, R.T., Wang, W.J., Systematic review with meta-analysis: Coffee consumption and the risk of gallstone disease (2015) Aliment. Pharmacol. Ther., 42, pp. 637-648; Zhao, Y., Wu, K., Zheng, J., Zuo, R., Li, D., Association of coffee drinking with all-cause mortality: A systematic review and meta-analysis (2015) Public Health Nutr., 18, pp. 1282-1291; Zheng, J.S., Yang, J., Fu, Y.Q., Huang, T., Huang, Y.J., Li, D., Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: A systematic review and meta-analysis of observational studies (2013) Nutr. Cancer, 65, pp. 1-16; Zhong, S., Chen, W., Yu, X., Chen, Z., Hu, Q., Zhao, J., Coffee consumption and risk of prostate cancer: An up-to-date meta-analysis (2014) Eur. J. Clin. Nutr., 68, pp. 330-337; Zhou, J., Zhou, S., Zeng, S., Experimental diabetes treated with trigonelline: Effect on? Cell and pancreatic oxidative parameters (2013) Fundam. Clin. Pharmacol., 27, pp. 279-287; Zhou, Q., Luo, M.L., Li, H., Li, M., Zhou, J.G., Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies (2015) Sci. Rep., 5, p. 13410; Zhou, Y., Tian, C., Jia, C., A dose-response meta-analysis of coffee consumption and bladder cancer (2012) Prev. Med., 55, pp. 14-22; Zuchinali, P., Ribeiro, P.A., Pimentel, M., Da Rosa, P.R., Zimerman, L.I., Rohde, L.E., Effect of caffeine on ventricular arrhythmia: A systematic review and meta-analysis of experimental and clinical studies (2016) Europace, 18, pp. 257-266; Zulli, A., Smith, R.M., Kubatka, P., Novak, J., Uehara, Y., Caffeine and cardiovascular diseases: Critical review of current research (2016) Eur. J. Nutr., 55, pp. 1331-1343},
publisher={Annual Reviews Inc.},
issn={01999885},
coden={ARNTD},
pubmed_id={28826374},
language={English},
abbrev_source_title={Annu. Rev. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Heindel20153416,
author={Heindel, J.J. and Balbus, J. and Birnbaum, L. and Brune-Drisse, M.N. and Grandjean, P. and Gray, K. and Landrigan, P.J. and Sly, P.D. and Suk, W. and Slechta, D.C. and Thompson, C. and Hanson, M.},
title={Developmental origins of health and disease: Integrating environmental influences},
journal={Endocrinology (United States)},
year={2015},
volume={156},
number={10},
pages={3416-3421},
doi={10.1210/EN.2015-1394},
note={cited By 224},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943628948&doi=10.1210%2fEN.2015-1394&partnerID=40&md5=4cddcae2bf0624e6148b76f36c899569},
affiliation={National Institute of Environmental Health Sciences, Division of Extramural Research and Training, P O Box 12233, Research Triangle Park, NC  27709-2233, United States; Department of Public Health, Environmental and Social Determinants of Health, World Health Organization, Geneva 27, 1211, Switzerland; Department of Environmental Health, Harvard School of Public Health, Boston, MA  02115, United States; Department of Preventative Medicine, Mount Sinai Hospital, New York, NY  10029, United States; Queensland Children's Medical Research Institute, University of Queensland, Herston, 4006, Australia; Department of Environmental Medicine, University of Rochester, School of Medicine, Rochester, NY  14642, United States; Institute of Developmental Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom},
abstract={There are now robust data supporting the Developmental Origins of Health and Disease (DOHaD) paradigm. This includes human and animal data focusing on nutrition or environmental chemicals during development. However, the term DOHaD has not been generally accepted as the official term to be used when one is concerned with understanding the pathophysiological basis for how environmental influences acting during early development influence the risk of later noncommunicable diseases. Similarly, there is no global research or public health program built around the DOHaDparadigm that encompasses all aspects of environment. To better inform the global health efforts aimed at addressing the growing epidemic of chronic noncommunicable diseases of environmental origin, we propose a two-pronged approach: first, to make it clear that the current concept of DOHaD comprehensively includes a range of environmental factors and their relevance to disease occurrence not just throughout the life span but potentially across several generations; and second, to initiate the discussion of how adoption of DOHaD can promote a more realistic, accurate, and integrative approach to understanding environmental disruption of developmental programming and better inform clinical and policy interventions. © 2015 by the Endocrine Society.},
keywords={environmental chemical;  pollutant, disease predisposition;  environmental factor;  environmental stress;  fetus development;  health;  health care policy;  health program;  human;  lifespan;  medical research;  medical society;  medical terminology;  non communicable disease;  nutrition;  pollutant;  prenatal stress;  priority journal;  public health service;  Review;  risk factor;  animal;  chronic disease;  environment;  environmental exposure;  female;  genetic epigenesis;  male;  maternal nutrition;  nutritional science;  nutritional status;  pregnancy;  prenatal exposure;  public health, Animals;  Chronic Disease;  Environment;  Environmental Exposure;  Environmental Pollutants;  Epigenesis, Genetic;  Female;  Humans;  Male;  Maternal Exposure;  Maternal Nutritional Physiological Phenomena;  Nutritional Sciences;  Nutritional Status;  Pregnancy;  Prenatal Exposure Delayed Effects;  Public Health},
chemicals_cas={Environmental Pollutants},
references={Barouki, R., Gluckman, P.D., Grandjean, P., Hanson, M., Heindel, J.J., Developmental origins of non-communicable disease: Implications for research and public health (2012) Environ Health., 11, p. 42; Gluckman, P.D., Hanson, M.A., Low, F.M., The role of developmental plasticity and epigenetics in human health (2011) Birth Defects Res C Embryo Today., 93 (1), pp. 12-18; Hanson, M.A., Gluckman, P.D., Developmental origins of health and disease-Global public health implications (2015) Best Pract Res Clin Obstet Gynaecol., 29 (1), pp. 24-31; Balbus, J.M., Barouki, R., Birnbaum, L.S., Early-life prevention of non-communicable diseases (2013) Lancet., 381 (9860), pp. 3-4; Hanson, M.A., Gluckman, P.D., Early developmental conditioning of later health and disease: Physiology or pathophysiology? (2014) Physiol Rev., 94 (4), pp. 1027-1076; Gluckman, P.D., Hanson, M.A., Mitchell, M.D., Developmental origins of health and disease: Reducing the burden of chronic disease in the next generation (2010) Genome Med., 2 (2), p. 14; Robboy, S.J., Scully, R.E., Welch, W.R., Herbst, A.L., Intrauterine diethylstilbestrol exposure and its consequences: Pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions (1977) Arch Pathol Lab Med., 101 (1), pp. 1-5; Clarren, S.K., Smith, D.W., The fetal alcohol syndrome (1978) N Engl J Med., 298 (19), pp. 1063-1067; Needleman, H.L., Leviton, A., Bellinger, D., Lead-associated intellectual deficit (1982) N Engl J Med., 306 (6), p. 367; Arai, Y., Mori, T., Suzuki, Y., Bern, H.A., Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals (1983) Int Rev Cytol., 84, pp. 235-268; Grandjean, P., Bellinger, D., Bergman, The faroes statement: Human health effects of developmental exposure to chemicals in our environment (2008) Basic Clin Pharmacol Toxicol., 102 (2), pp. 73-75; Schug, T.T., Janesick, A., Blumberg, B., Heindel, J.J., Endocrine disrupting chemicals and disease susceptibility (2011) J Steroid Biochem Mol Biol., 127 (3-5), pp. 204-215; Harris, A., Seckl, J., Glucocorticoids, prenatal stress and the programming of disease (2011) Horm Behav., 59 (3), pp. 279-289; Entringer, S., Buss, C., Wadhwa, P.D., Prenatal stress and developmental programming of human health and disease risk: Concepts and integration of empirical findings (2010) Curr Opin Endocrinol Diabetes Obes., 17 (6), pp. 507-516; Li, Y., Gonzalez, P., Zhang, L., Fetal stress and programming of hypoxic/ ischemic-sensitive phenotype in the neonatal brain: Mechanisms and possible interventions (2012) Prog Neurobiol., 98 (2), pp. 145-165; Sandman, C.A., Buss, C., Head, K., Davis, E.P., Fetal exposure to maternal depressive symptoms is associated with cortical thickness in late childhood (2015) Biol Psychiatry., 77 (4), pp. 324-334; Pryce, C.R., Aubert, Y., Maier, C., Pearce, P.C., Fuchs, E., The developmental impact of prenatal stress, prenatal dexamethasone and postnatal social stress on physiology, behaviour and neuroanatomy of primate offspring: Studies in rhesus macaque and common marmoset (2011) Psychopharmacology (Berl)., 214 (1), pp. 33-53; Lucassen, P.J., Naninck, E.F., Van Goudoever, J.B., Fitzsimons, C., Joels, M., Korosi, A., Perinatal programming of adult hippocampal structure and function; Emerging roles of stress, nutrition and epigenetics (2013) Trends Neurosci., 36 (11), pp. 621-631; Khulan, B., Drake, A.J., Glucocorticoids as mediators of developmental programming effects (2012) Best Pract Res Clin Endocrinol Metab., 26 (5), pp. 689-700; Maccari, S., Krugers, H.J., Morley-Fletcher, S., Szyf, M., Brunton, P.J., The consequences of early-life adversity: Neurobiological, behavioural and epigenetic adaptations (2014) J Neuroendocrinol., 26 (10), pp. 707-723; Rinaudo, P., Wang, E., Fetal programming and metabolic syndrome (2012) Annu Rev Physiol., 74, pp. 107-130; Bosch, N.M., Riese, H., Reijneveld, S.A., Timing matters: Long term effects of adversities from prenatal period up to adolescence on adolescents' cortisol stress response (2012) The TRAILS Study. Psychoneuroendocrinology., 37 (9), pp. 1439-1447; Koolhaas, J.M., Bartolomucci, A., Buwalda, B., Stress revisited: A critical evaluation of the stress concept (2011) Neurosci Biobehav Rev., 35 (5), pp. 1291-1301; Zoeller, R.T., Brown, T.R., Doan, L.L., Endocrine-disrupting chemicals and public health protection: A statement of principles from the endocrine society (2012) Endocrinology, 153 (9), pp. 4097-4110; Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Endocrine-disrupting chemicals: An Endocrine Society scientific statement (2009) Endocr Rev., 30 (4), pp. 293-342; Exposure to toxic environmental agents (2013) Obstet Gynecol., 122 (4), pp. 931-935. , ACOG Committee Opinion No. 575; Skakkebaek, N.E., Toppari, J., Söder, O., Gordon, C.M., Divall, S., Draznin, M., The exposure of fetuses and children to endocrine disrupting chemicals: A European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) call to action statement (2011) J Clin Endocrinol Metab., 96 (10), pp. 3056-3058},
correspondence_address1={Heindel, J.J.; National Institute of Environmental Health Sciences, P O Box 12233, United States; email: heindelj@niehs.nih.gov},
publisher={Endocrine Society},
issn={00137227},
coden={ENDOA},
pubmed_id={26241070},
language={English},
abbrev_source_title={Endocrinology},
document_type={Review},
source={Scopus},
}

@ARTICLE{Elliott201723,
author={Elliott, J.H. and Synnot, A. and Turner, T. and Simmonds, M. and Akl, E.A. and McDonald, S. and Salanti, G. and Meerpohl, J. and MacLehose, H. and Hilton, J. and Tovey, D. and Shemilt, I. and Thomas, J. and Agoritsas, T. and Perron, C. and Hodder, R. and Pestridge, C. and Albrecht, L. and Horsley, T. and Platt, J. and Armstrong, R. and Nguyen, P.H. and Plovnick, R. and Arno, A. and Ivers, N. and Quinn, G. and Au, A. and Johnston, R. and Rada, G. and Bagg, M. and Jones, A. and Ravaud, P. and Boden, C. and Kahale, L. and Richter, B. and Boisvert, I. and Keshavarz, H. and Ryan, R. and Brandt, L. and Kolakowsky-Hayner, S.A. and Salama, D. and Brazinova, A. and Nagraj, S.K. and Buchbinder, R. and Lasserson, T. and Santaguida, L. and Champion, C. and Lawrence, R. and Santesso, N. and Chandler, J. and Les, Z. and Schünemann, H.J. and Charidimou, A. and Leucht, S. and Chou, R. and Low, N. and Sherifali, D. and Churchill, R. and Maas, A. and Siemieniuk, R. and Cnossen, M.C. and Cossi, M.-J. and Macleod, M. and Skoetz, N. and Counotte, M. and Marshall, I. and Soares-Weiser, K. and Craigie, S. and Marshall, R. and Srikanth, V. and Dahm, P. and Martin, N. and Sullivan, K. and Danilkewich, A. and García, L.M. and Danko, K. and Mavergames, C. and Taylor, M. and Donoghue, E. and Maxwell, L.J. and Thayer, K. and Dressler, C. and McAuley, J. and Egan, C. and Tritton, R. and McKenzie, J. and Tsafnat, G. and Elliott, S.A. and Tugwell, P. and Etxeandia, I. and Merner, B. and Turgeon, A. and Featherstone, R. and Mondello, S. and Foxlee, R. and Morley, R. and van Valkenhoef, G. and Garner, P. and Munafo, M. and Vandvik, P. and Gerrity, M. and Munn, Z. and Wallace, B. and Glasziou, P. and Murano, M. and Wallace, S.A. and Green, S. and Newman, K. and Watts, C. and Grimshaw, J. and Nieuwlaat, R. and Weeks, L. and Gurusamy, K. and Nikolakopoulou, A. and Weigl, A. and Haddaway, N. and Noel-Storr, A. and Wells, G. and Hartling, L. and O'Connor, A. and Wiercioch, W. and Hayden, J. and Page, M. and Wolfenden, L. and Helfand, M. and Pahwa, M. and Yepes Nuñez, J.J. and Higgins, J. and Pardo, J.P. and Yost, J. and Hill, S. and Pearson, L. and Living Systematic Review Network},
title={Living systematic review: 1. Introduction—the why, what, when, and how},
journal={Journal of Clinical Epidemiology},
year={2017},
volume={91},
pages={23-30},
doi={10.1016/j.jclinepi.2017.08.010},
note={cited By 222},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028993474&doi=10.1016%2fj.jclinepi.2017.08.010&partnerID=40&md5=8daf7a2bea2c4909c2f11d91fee24b18},
affiliation={Cochrane Australia, School of Public Health and Preventive Medicine, Monash University, 4th Floor, 553 St Kilda Road, Melbourne, Victoria  3004, Australia; Department of Infectious Diseases, Monash University and Alfred Hospital, 53 Commercial Road, Melbourne, Victoria  3004, Australia; Centre for Health Communication and Participation, School of Psychology and Public Health, Level 4, Health Sciences 2, Science Drive, La Trobe University, Bundoora, Victoria  3086, Australia; Centre for Reviews and Dissemination, A/B Block, Alcuin College, University of York, York YO10 5DD, York, United Kingdom; Department of Internal Medicine, American University of Beirut, Office Gefinor Center Block B, Beirut, Lebanon; Department of Epidemiology and Population Health, American University of Beirut, Office Gefinor Center Block B, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, ON  L8S 4K1, Canada; Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012, Bern, Switzerland; Cochrane Germany, Medical Center—University of Freiburg, Breisacher Str. 153, Freiburg, 79110, Germany; Cochrane Editorial Unit, Cochrane, St Albans House, 57-59 Haymarket, London, SW1Y 4QX, United Kingdom; EPPI-Centre, Institute of Education, University College London, 18 Woburn Square, London, WC1H 0NR, United Kingdom},
abstract={Systematic reviews are difficult to keep up to date, but failure to do so leads to a decay in review currency, accuracy, and utility. We are developing a novel approach to systematic review updating termed “Living systematic review” (LSR): systematic reviews that are continually updated, incorporating relevant new evidence as it becomes available. LSRs may be particularly important in fields where research evidence is emerging rapidly, current evidence is uncertain, and new research may change policy or practice decisions. We hypothesize that a continual approach to updating will achieve greater currency and validity, and increase the benefits to end users, with feasible resource requirements over time. © 2017 Elsevier Inc.},
author_keywords={Evidence synthesis;  Guidelines;  Living guidelines;  Living systematic review;  Systematic review},
keywords={decision making;  human;  machine learning;  medical research;  peer review;  policy;  priority journal;  protocol compliance;  publication;  publishing;  Review;  statistical analysis;  systematic review (topic);  validity;  access to information;  information dissemination;  literature;  practice guideline;  time factor, Access to Information;  Biomedical Research;  Guidelines as Topic;  Humans;  Information Dissemination;  Review Literature as Topic;  Time Factors},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/J005037/1, MR/N015665/1},
references={Macleod, M., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J., Biomedical research: increasing value, reducing waste (2014) Lancet, 383, pp. 101-104; Higgins, J., Lasserson, T., Chandler, J., Tovey, D., Churchill, R., Methodological expectations of cochrane intervention reviews. 2016, Cochrane, London; Moher, D., Liberati, A., Tetzlaff, J., Altman, D., The PRISMA Group. Preferred reporting Items for systematic reviews and meta-analyses: the PRISMA statement (2009) PLoS Med, 6 (7), p. e1000097; Institute of Medicine. Eden, J., et al. (eds.) Finding what works in health care: standards for systematic reviews, 2011, National Acadamies Press, Washington, DC; Tricco, A.C., Brehaut, J., Chen, M.H., Moher, D., Following 411 Cochrane protocols to completion: a retrospective cohort study (2008) PLoS One, 3, p. e3684; Bastian, H., Glasziou, P., Chalmers, I., Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? (2010) PLoS Med, 7 (9), p. e1000326; Shojania, K.G., Sampson, M., Ansari, M.T., Ji, J., Doucette, S., Moher, D., How quickly do systematic reviews go out of date? A survival analysis (2007) Ann Intern Med, 147, pp. 224-233; Garner, P., Hopewell, S., Chandler, J., MacLehose, H., Akl, E., Beyene, J., When and how to update systematic reviews: consensus and checklist (2016) BMJ, 354, p. i3507; Créquit, P., Trinquart, L., Yavchitz, A., Ravaud, P., Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer (2016) BMC Med, 14, p. 8; Elliott, J.H., Turner, T., Clavisi, O., Thomas, J., Higgins, J.P., Mavergames, C., Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap (2014) PLoS Med, 11 (2), p. e1001603; Tricco, A.C., Antony, J., Zarin, W., Strifler, L., Ghassemi, M., Ivory, J., A scoping review of rapid review methods (2015) BMC Med, 13, p. 224; Tricco, A.C., Zarin, W., Antony, J., Hutton, B., Moher, D., Sherifali, D., An international survey and modified Delphi approach revealed numerous rapid review methods (2016) J Clin Epidemiol, 70, pp. 61-67; Higgins, J., Green, S., Cochrane handbook for systematic reviews of interventions. 2008, John Wiley & Sons, Chichester, UK; Higgins, J.P., Whitehead, A., Simmonds, M., Sequential methods for random-effects meta-analysis (2011) Stat Med, 30, pp. 903-921; Cnossen, M., Scholten, A., Lingsma, H., Synnot, A., Tavender, E., Gantner, D., et al. Adherence to guidelines in adult patients with traumatic brain injury: a living systematic review. J Neurotrauma, 2016 [Epub ahead of print]. https://doi.org/10.1089/neu.2015.4121; Living Systematic Review Network. Cochrane living systematic reviews: interim guidance for pilots (Version 0.3, 21 April 2017). 2017, Cochrane, London, UK Available at http://community.cochrane.org/sites/default/files/uploads/inline-files/Transform/LSR Interim guidance_v0.3_20170421.pdf; Akl, E.A., Kahale, L.A., Ballout, R.A., Barba, M., Yosuico, V.E., van Doormaal, F.F., Parenteral anticoagulation in ambulatory patients with cancer (2014) Cochrane Database Syst Rev, p. CD006652; Rahal, A.K., Badgett, R.G., RM, H., Screening coverage needed to reduce Mortality from Prostate cancer: a living systematic review (2016) PLoS One, 11, p. e0153417},
publisher={Elsevier Inc.},
issn={08954356},
coden={JCEPE},
pubmed_id={28912002},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Bellou20161,
author={Bellou, V. and Belbasis, L. and Tzoulaki, I. and Evangelou, E. and Ioannidis, J.P.A.},
title={Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses},
journal={Parkinsonism and Related Disorders},
year={2016},
volume={23},
pages={1-9},
doi={10.1016/j.parkreldis.2015.12.008},
note={cited By 221},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953291577&doi=10.1016%2fj.parkreldis.2015.12.008&partnerID=40&md5=49a39f38faf6e4556c512db997c82d20},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Biostatistics and Epidemiology, Imperial College London, London, United Kingdom; MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={Background: Parkinson's disease is a neurological disorder with complex pathogenesis implicating both environmental and genetic factors. We aimed to summarise the environmental risk factors that have been studied for potential association with Parkinson's disease, assess the presence of diverse biases, and identify the risk factors with the strongest support. Methods: We searched PubMed from inception to September 18, 2015, to identify systematic reviews and meta-analyses of observational studies that examined associations between environmental factors and Parkinson's disease. For each meta-analysis we estimated the summary effect size by random-effects and fixed-effects models, the 95% confidence interval and the 95% prediction interval. We estimated the between-study heterogeneity expressed by I2, evidence of small-study effects and evidence of excess significance bias. Results: Overall, 75 unique meta-analyses on different risk factors for Parkinson's disease were examined, covering diverse biomarkers, dietary factors, drugs, medical history or comorbid diseases, exposure to toxic environmental agents and habits. 21 of 75 meta-analyses had results that were significant at p &lt; 0.001 by random-effects. Evidence for an association was convincing (more than 1000 cases, p &lt; 10-6 by random-effects, not large heterogeneity, 95% prediction interval excluding the null value and absence of hints for small-study effects and excess significance bias) for constipation, and physical activity. Conclusion: Many environmental factors have substantial evidence of association with Parkinson's disease, but several, perhaps most, of them may reflect reverse causation, residual confounding, information bias, sponsor conflicts or other caveats. © 2016.},
author_keywords={Environment;  Epidemiology;  Meta-analysis;  Parkinson's disease;  Risk factors},
keywords={acetylsalicylic acid;  beta adrenergic receptor blocking agent;  biological marker;  cyanocobalamin;  hydrocarbon;  hydroxymethylglutaryl coenzyme A reductase inhibitor;  ibuprofen;  nonsteroid antiinflammatory agent;  organic solvent;  pesticide;  pyridoxine;  uric acid;  vitamin D;  well water;  xanthophyll, agricultural worker;  alcohol consumption;  anxiety;  bone density;  caloric intake;  causal attribution;  coffee;  comorbidity;  constipation;  dairy product;  depression;  disease association;  drug use;  environmental exposure;  environmental factor;  fat intake;  fluid intake;  genetic heterogeneity;  habit;  head injury;  human;  medical history;  observational study;  Parkinson disease;  physical activity;  priority journal;  Review;  risk assessment;  risk factor;  rural population;  smoking;  systematic error;  systematic review (topic);  tea;  uric acid blood level;  vitamin blood level;  vitamin intake;  welding;  environmental exposure;  meta analysis (topic);  Parkinson disease;  risk factor, Environmental Exposure;  Humans;  Meta-Analysis as Topic;  Parkinson Disease;  Risk Factors},
chemicals_cas={acetylsalicylic acid, 493-53-8, 50-78-2, 53663-74-4, 53664-49-6, 63781-77-1; cyanocobalamin, 53570-76-6, 68-19-9, 8064-09-3; ibuprofen, 15687-27-1, 79261-49-7, 31121-93-4, 527688-20-6; pyridoxine, 12001-77-3, 58-56-0, 65-23-6, 8059-24-3; uric acid, 69-93-2; xanthophyll, 127-40-2, 52842-48-5},
references={De Lau, L.M.L., Breteler, M.M.B., Epidemiology of Parkinson's disease (2006) Lancet Neurol., 5, pp. 525-535; Pringsheim, T., Jette, N., Frolkis, A., Steeves, T.D.L., The prevalence of Parkinson's disease: a systematic review and meta-analysis (2014) Mov. Disord., 29, pp. 1583-1590; Kowal, S.L., Dall, T.M., Chakrabarti, R., Storm, M.V., Jain, A., The current and projected economic burden of Parkinson's disease in the United States (2013) Mov. Disord., 28, pp. 311-318; Nalls, M.A., McLean, C.Y., Rick, J., Eberly, S., Hutten, S.J., Gwinn, K., Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study (2015) Lancet Neurol., 14, pp. 1002-1009; Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.-M.M., Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database (2012) PLoS Genet., 8, p. e1002548; Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease (2014) Nat. Genet., 46, pp. 989-993; Ioannidis, J.P.A., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P.A., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol., 14, pp. 263-273; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control. Clin. Trials, 7, pp. 177-188; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann. Intern. Med., 127, pp. 820-826; Higgins, J.P.T., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J. R. Stat. Soc. Ser. A Stat. Soc., 172, pp. 137-159; Higgins, J.P.T., Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified (2008) Int. J. Epidemiol., 37, pp. 1158-1160; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat. Med., 19, pp. 3127-3131; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, p. 101; Higgins, J.P.T., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat. Med., 21, pp. 1539-1558; Sterne, J.A.C., Sutton, A.J., Ioannidis, J.P.A., Terrin, N., Jones, D.R., Lau, J., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P.A., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin. Trials, 4, pp. 245-253; Ioannidis, J.P.A., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J. Math. Psychol., 57, pp. 184-187; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am. J. Epidemiol., 131, pp. 552-566; Van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., Vermeulen, R., Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results (2012) Environ. Health Perspect., 120, pp. 340-347; Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., Hawkes, C.H., Giovannoni, G., Lees, A.J., Meta-analysis of early nonmotor features and risk factors for Parkinson disease (2012) Ann. Neurol., 72, pp. 893-901; Pezzoli, G., Cereda, E., Exposure to pesticides or solvents and risk of Parkinson disease (2013) Neurology, 80, pp. 2035-2041; Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis (2011) Diabetes Care, 34, pp. 2614-2623; Lu, L., Fu, D.-L., Li, H.-Q., Liu, A.-J., Li, J.-H., Zheng, G.-Q., Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies (2014) PLoS One, 9, p. e85781; Ioannidis, J.P.A., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22, pp. 450-456; Johnson, V.E., Revised standards for statistical evidence (2013) Proc. Natl. Acad. Sci. U. S. A., 110, pp. 19313-19317; Allam, M.F., Campbell, M.J., Del Castillo, A.S., Fernández-Crehuet Navajas, R., Parkinson's disease protects against smoking? (2004) Behav. Neurol., 15, pp. 65-71; Allam, M.F., Campbell, M.J., Hofman, A., Del Castillo, A.S., Fernández-Crehuet Navajas, R., Smoking and Parkinson's disease: systematic review of prospective studies (2004) Mov. Disord., 19, pp. 614-621; Allam, M.F., del Castillo, A.S., Navajas, R.F.-C., Parkinson's disease, tobacco and age: meta analysis (2003) Rev. Neurol., 36, pp. 510-513; Allam, M.F., Del Castillo, A.S., Navajas, R.F.-C., Parkinson's disease, smoking and family history: meta-analysis (2003) Eur. J. Neurol., 10, pp. 59-62; Allam, M.F., Serrano del Castillo, A., Fernández-Crehuet Navajas, R., Smoking and Parkinson's disease: explanatory hypothesis (2002) Int. J. Neurosci., 112, pp. 851-854; Ritz, B., Ascherio, A., Checkoway, H., Marder, K.S., Nelson, L.M., Rocca, W.A., Pooled analysis of tobacco use and risk of Parkinson disease (2007) Arch. Neurol., 64, pp. 990-997; Hernán, M.A., Takkouche, B., Caamaño-Isorna, F., Gestal-Otero, J.J., A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease (2002) Ann. Neurol., 52, pp. 276-284; Sugita, M., Izuno, T., Tatemichi, M., Otahara, Y., Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson's disease (2001) J. Epidemiol., 11, pp. 87-94; Kiyohara, C., Kusuhara, S., Cigarette smoking and Parkinson's disease: a meta-analysis (2011) Fukuoka Igaku Zasshi, 102, pp. 254-265; Allen, M.T., Levy, L.S., Parkinson's disease and pesticide exposure-a new assessment (2013) Crit. Rev. Toxicol., 43, pp. 515-534; Priyadarshi, A., Khuder, S.A., Schaub, E.A., Priyadarshi, S.S., Environmental risk factors and Parkinson's disease: a metaanalysis (2001) Environ. Res., 86, pp. 122-127; Priyadarshi, A., Khuder, S.A., Schaub, E.A., Shrivastava, S., A meta-analysis of Parkinson's disease and exposure to pesticides (2000) Neurotoxicology, 21, pp. 435-440; Van Maele-Fabry, G., Hoet, P., Vilain, F., Lison, D., Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies (2012) Environ. Int., 46, pp. 30-43; Freire, C., Koifman, S., Pesticide exposure and Parkinson's disease: epidemiological evidence of association (2012) Neurotoxicology, 33, pp. 947-971; Hamer, M., Chida, Y., Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence (2009) Psychol. Med., 39, pp. 3-11; Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., Physical activities and future risk of Parkinson disease (2010) Neurology, 75, pp. 341-348; Costa, J., Lunet, N., Santos, C., Santos, J., Vaz-Carneiro, A., Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies (2010) J. Alzheimers Dis., 20, pp. S221-S238; Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R., Freedman, N.D., Caffeine intake, smoking, and risk of Parkinson disease in men and women (2012) Am. J. Epidemiol., 175, pp. 1200-1207; Samii, A., Etminan, M., Wiens, M.O., Jafari, S., NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies (2009) Drugs Aging, 26, pp. 769-779; Torsney, K.M., Noyce, A.J., Doherty, K.M., Bestwick, J.P., Dobson, R., Lees, A.J., Bone health in Parkinson's disease: a systematic review and meta-analysis (2014) J. Neurol. Neurosurg. Psychiatry, 85, pp. 1159-1166; Kamel, F., Goldman, S.M., Umbach, D.M., Chen, H., Richardson, G., Barber, M.R., Dietary fat intake, pesticide use, and Parkinson's disease (2014) Parkinsonism Relat. Disord., 20, pp. 82-87; Van der Marck, M.A., Dicke, H.C., Uc, E.Y., Kentin, Z.H.A., Borm, G.F., Bloem, B.R., Body mass index in Parkinson's disease: a meta-analysis (2012) Parkinsonism Relat. Disord., 18, pp. 263-267; Gao, L., Tang, H., Nie, K., Wang, L., Zhao, J., Gan, R., Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis (2015) Int. J. Neurosci., 125, pp. 645-654; Adams-Carr, K.L., Bestwick, J.P., Shribman, S., Lees, A., Schrag, A., Noyce, A.J., Constipation preceding Parkinson's disease: a systematic review and meta-analysis (2015) J. Neurol. Neurosurg. Psychiatry, , jnnp - 2015-311680; Yang, F., Trolle Lagerros, Y., Bellocco, R., Adami, H.-O., Fang, F., Pedersen, N.L., Physical activity and risk of Parkinson's disease in the Swedish National March Cohort (2015) Brain, 138, pp. 269-275; Jafari, S., Etminan, M., Aminzadeh, F., Samii, A., Head injury and risk of Parkinson disease: a systematic review and meta-analysis (2013) Mov. Disord., 28, pp. 1222-1229; Shen, L., Ji, H.-F., Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis (2013) BMJ Open, 3, p. e003620; Lau, J., Ioannidis, J.P.A., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) BMJ Br. Med. J., 333, pp. 597-600; Tanner, C.M., Comella, C.L., When brawn benefits brain: physical activity and Parkinson's disease risk (2015) Brain, 138, pp. 238-239; Palma, J.-A., Kaufmann, H., Autonomic disorders predicting Parkinson's disease (2014) Parkinsonism Relat. Disord., 20, pp. S94-S98; Braak, H., De Vos, R.A.I., Bohl, J., Del Tredici, K., Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology (2006) Neurosci. Lett., 396, pp. 67-72; Beach, T.G., Adler, C.H., Sue, L.I., Vedders, L., Lue, L.F., White, C.L., Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders (2010) Acta Neuropathol., 119, pp. 689-702; Savica, R., Rocca, W.A., Ahlskog, J.E., When does Parkinson disease start? (2010) Arch. Neurol., 67, pp. 798-801; Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., Mandel, J., Epidemiology and etiology of Parkinson's disease: a review of the evidence (2011) Eur. J. Epidemiol., 26, pp. S1-S58; Van der Mark, M., Nijssen, P.C.G., Vlaanderen, J., Huss, A., Mulleners, W.M., Sas, A.M.G., A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking (2014) PLoS One, 9, p. e95297; Ritz, B., Lee, P.-C., Lassen, C.F., Arah, O.A., Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease (2014) Neurology, 83, pp. 1396-1402; Gao, X., Chen, H., Schwarzschild, M.A., Logroscino, G., Ascherio, A., Perceived imbalance and risk of Parkinson's disease (2008) Mov. Disord., 23, pp. 613-616; Rugbjerg, K., Ritz, B., Korbo, L., Martinussen, N., Olsen, J.H., Risk of Parkinson's disease after hospital contact for head injury: population based case-control study (2008) BMJ, 337, p. a2494; Aarsland, D., Påhlhagen, S., Ballard, C.G., Ehrt, U., Svenningsson, P., Depression in Parkinson disease-epidemiology, mechanisms and management (2012) Nat. Rev. Neurol., 8, pp. 35-47; Ascherio, A., LeWitt, P.A., Xu, K., Eberly, S., Watts, A., Matson, W.R., Urate as a predictor of the rate of clinical decline in Parkinson disease (2009) Arch. Neurol., 66, pp. 1460-1468; Ungprasert, P., Srivali, N., Thongprayoon, C., Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis (2015) Parkinsonism Relat. Disord., 21, pp. 1238-1242; Cheng, H.-C., Ulane, C.M., Burke, R.E., Clinical progression in Parkinson disease and the neurobiology of axons (2010) Ann. Neurol., 67, pp. 715-725; Lang, A.E., In pursuit of prodromal Parkinson's disease (2015) Lancet Neurol., 14, pp. 27-28; Schrag, A., Horsfall, L., Walters, K., Noyce, A., Petersen, I., Prediagnostic presentations of Parkinson's disease in primary care: a case-control study (2015) Lancet Neurol., 14, pp. 57-64; Lo, C.K.-L., Mertz, D., Loeb, M., Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments (2014) BMC Med. Res. Methodol., 14, p. 45; Hartling, L., Milne, A., Hamm, M.P., Vandermeer, B., Ansari, M., Tsertsvadze, A., Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers (2013) J. Clin. Epidemiol., 66, pp. 982-993; Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses (2010) Eur. J. Epidemiol., 25, pp. 603-605; Huang, H.-C., Tsai, C.-H., Muo, C.-H., Lin, K.-H., Lu, M.-K., Sung, F.-C., Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study (2015) J. Clin. Psychiatry, 76, pp. e104-e110; Wang, I.-K., Lin, C.-L., Wu, Y.-Y., Chou, C.-Y., Lin, S.-Y., Liu, J.-H., Increased risk of Parkinson's disease in patients with end-stage renal disease: a retrospective cohort study (2014) Neuroepidemiology, 42, pp. 204-210; Goldman, S.M., Environmental toxins and Parkinson's disease (2014) Annu. Rev. Pharmacol. Toxicol., 54, pp. 141-164; Berg, D., Godau, J., Seppi, K., Behnke, S., Liepelt-Scarfone, I., Lerche, S., The PRIPS study: screening battery for subjects at risk for Parkinson's disease (2013) Eur. J. Neurol., 20, pp. 102-108; Zhang, D., Jiang, H., Xie, J., Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies (2014) Mov. Disord., 29, pp. 819-822; Shen, L., Ji, H.-F., Associations between vitamin D status, supplementation, outdoor work and risk of Parkinson's disease: a meta-analysis assessment (2015) Nutrients, 7, pp. 4817-4827; Li, F.-J., Ji, H.-F., Shen, L., A meta-analysis of tea drinking and risk of Parkinson's disease (2012) Sci. World J., 2012, pp. 1-6; Huss, A., Koeman, T., Kromhout, H., Vermeulen, R., Extremely low frequency magnetic field exposure and Parkinson's disease-a systematic review and meta-analysis of the data (2015) Int. J. Environ. Res. Public Health, 12, pp. 7348-7356; Mortimer, J.A., Borenstein, A.R., Nelson, L.M., Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis (2012) Neurology, 79, pp. 1174-1180; Palin, O., Herd, C., Morrison, K.E., Jagielski, A.C., Wheatley, K., Thomas, G.N., Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's disease (2015) Parkinsonism Relat. Disord., 21, pp. 243-248; Etminan, M., Gill, S.S., Samii, A., Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis (2005) Lancet Neurol., 4, pp. 362-365; Jiang, W., Ju, C., Jiang, H., Zhang, D., Dairy foods intake and risk of Parkinson's disease: a dose-response meta-analysis of prospective cohort studies (2014) Eur. J. Epidemiol., 29, pp. 613-619; Shen, L., Associations between B vitamins and Parkinson's disease (2015) Nutrients, 7, pp. 7197-7208; Takeda, A., Nyssen, O.P., Syed, A., Jansen, E., Bueno-de-Mesquita, B., Gallo, V., Vitamin A and carotenoids and the risk of Parkinson's disease: a systematic review and meta-analysis (2014) Neuroepidemiology, 42, pp. 25-38; Wang, A., Lin, Y., Wu, Y., Zhang, D., Macronutrients intake and risk of Parkinson's disease: a meta-analysis (2015) Geriatr. Gerontol. Int., 15, pp. 606-616; Liu, R., Gao, X., Lu, Y., Chen, H., Meta-analysis of the relationship between Parkinson disease and melanoma (2011) Neurology, 76, pp. 2002-2009; Gagne, J.J., Power, M.C., Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis (2010) Neurology, 74, pp. 995-1002; Gao, X., Chen, H., Schwarzschild, M.A., Ascherio, A., Use of ibuprofen and risk of Parkinson disease (2011) Neurology, 76, pp. 863-869; Lang, Y., Gong, D., Fan, Y., Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis (2015) Pharmacoepidemiol. Drug Saf., 24, pp. 559-566; Undela, K., Gudala, K., Malla, S., Bansal, D., Statin use and risk of Parkinson's disease: a meta-analysis of observational studies (2013) J. Neurol., 260, pp. 158-165; Wang, P., Li, J., Qiu, S., Wen, H., Du, J., Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies (2015) Neuropsychiatr. Dis. Treat., 11, pp. 59-66; Chen, J., Guan, Z., Wang, L., Song, G., Ma, B., Wang, Y., Meta-analysis: overweight, obesity, and Parkinson's disease (2014) Int. J. Endocrinol., 2014, pp. 1-7; Gudala, K., Bansal, D., Muthyala, H., Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence (2013) Parkinson's Dis., 3, pp. 363-370; Lv, Z., Qi, H., Wang, L., Fan, X., Han, F., Wang, H., Vitamin D status and Parkinson's disease: a systematic review and meta-analysis (2014) Neurol. Sci., 35, pp. 1723-1730; Mariani, S., Ventriglia, M., Simonelli, I., Donno, S., Bucossi, S., Vernieri, F., Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis (2013) Neurobiol. Aging, 34, pp. 632-633; Sako, W., Murakami, N., Izumi, Y., Kaji, R., MRI can detect nigral volume loss in patients with Parkinson's disease: evidence from a meta-analysis (2014) J. Parkinson's Dis., 4, pp. 405-411; Shen, C., Guo, Y., Luo, W., Lin, C., Ding, M., Serum urate and the risk of Parkinson's disease: results from a meta-analysis (2013) Can. J. Neurol. Sci., 40, pp. 73-79; Wang, Y.-L., Wang, Y.-T., Li, J.-F., Zhang, Y.-Z., Yin, H.-L., Han, B., Body mass index and risk of Parkinson's disease: a dose-response meta-analysis of prospective studies (2015) PLoS One, 10, p. e0131778; Yu, J.-G., Feng, Y.-F., Xiang, Y., Huang, J.-H., Savini, G., Parisi, V., Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis (2014) PLoS One, 9, p. e85718; Zhao, Y., Shen, L., Ji, H.-F., Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: a meta-analysis (2013) Bone, 52, pp. 498-505},
correspondence_address1={Ioannidis, J.P.A.Medical School Office Building, 1265 Welch Rd, United States; email: jioannid@stanford.edu},
publisher={Elsevier Ltd},
issn={13538020},
coden={PRDIF},
pubmed_id={26739246},
language={English},
abbrev_source_title={Parkinsonism Relat. Disord.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Ascherio2012602,
author={Ascherio, A. and Munger, K.L. and Lünemann, J.D.},
title={The initiation and prevention of multiple sclerosis},
journal={Nature Reviews Neurology},
year={2012},
volume={8},
number={11},
pages={602-612},
doi={10.1038/nrneurol.2012.198},
note={cited By 216},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868535570&doi=10.1038%2fnrneurol.2012.198&partnerID=40&md5=595618fa1fe7542d745c5138d3af8a8a},
affiliation={Department of Nutrition, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, United States; Institute of Experimental Immunology, Department of Neuroinflammation, University of Zürich, Winterthurer Strasse 190, 8057 Zurich, Switzerland},
abstract={Although strong genetic determinants of multiple sclerosis (MS) exist, the findings of migration studies support a role for environmental factors in this disease. Through rigorous epidemiological investigation, Epstein-Barr virus infection, vitamin D nutrition and cigarette smoking have been identified as likely causal factors in MS. In this Review, the strength of this evidence is discussed, as well as the potential biological mechanisms underlying the associations between MS and environmental, lifestyle and dietary factors. Both vitamin D nutrition and cigarette smoking are modifiable; as such, increasing vitamin D levels and smoking avoidance have the potential to substantially reduce MS risk and influence disease progression. Improving our understanding of the environmental factors involved in MS will lead to new and more-effective approaches to prevent this disease. © 2012 Macmillan Publishers Limited.},
keywords={Epstein Barr virus antigen 1;  Epstein Barr virus antigen 2;  Epstein Barr virus vaccine;  immunoglobulin G antibody;  vitamin D, age distribution;  allele;  antibody production;  antibody titer;  B lymphocyte;  cancer risk;  cell differentiation;  cell function;  cell survival;  CYP27B1 gene;  demyelinating disease;  diet;  disease activity;  disease association;  disease control;  disease course;  disease predisposition;  environmental exposure;  environmental factor;  Epstein Barr virus;  Epstein Barr virus infection;  evidence based practice;  gene;  gene function;  gene identification;  gene interaction;  gene locus;  genetic association;  genetic resistance;  genetic risk;  geographic distribution;  heredity;  heritability;  heterozygote;  human;  immunostimulation;  innate immunity;  lifestyle;  liver cancer;  medical research;  migration;  multiple sclerosis;  neuropathology;  nutritional status;  priority journal;  public health;  radiation exposure;  review;  risk assessment;  risk factor;  risk reduction;  smoking;  smoking cessation;  therapy effect;  vitamin blood level;  vitamin intake;  vitamin supplementation, Animals;  Epstein-Barr Virus Infections;  Humans;  Multiple Sclerosis;  Risk Factors;  Smoking;  Vitamin D;  Vitamin D Deficiency},
chemicals_cas={Vitamin D, 1406-16-2},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, R01NS046635, R01NS071082, R01NS073633},
funding_details={Schweizerischer Nationalfonds zur F&#x00F6;rderung der Wissenschaftlichen ForschungSchweizerischer Nationalfonds zur F&#x00F6;rderung der Wissenschaftlichen Forschung, SNF, 130524},
funding_text 1={This work was funded by grants R01 NS046635, R01 NS073633 and R01 NS071082 from the NIH. The authors thank L. Unger, Harvard School of Public Health, for her technical assistance in preparing this manuscript.},
references={MacMahon, B., (1996) Trichopoulos D Epidemiology: Principles and Methods, , 2nd Edn Little, Brown Co, Boston; Czeizel, A.E., Dudas, I., Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation (1992) New England Journal of Medicine, 327 (26), pp. 1832-1835; Dwyer, T., Ponsonby, A.L., Blizzard, L., Newman, N.M., Cochrane, J.A., The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania (1995) JAMA, 273, pp. 783-789; McMahon, B.J., Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program (2011) Hepatology, 54, pp. 801-807; Koch-Henriksen, N., The danish multiple sclerosis registry: A 50-year follow-up (1999) Multiple Sclerosis, 5 (4), pp. 293-296; Mayr, W.T., Pittock, S.J., McClelland, R.L., Jorgensen, N.W., Noseworthy, J.H., Rodriguez, M., Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000 (2003) Neurology, 61 (10), pp. 1373-1377; Compston, A., Coles, A., Multiple sclerosis (2002) Lancet, 359 (9313), pp. 1221-1231. , DOI 10.1016/S0140-6736(02)08220-X; Kurtzke, J.F., Beebe, G.W., Norman Jr., J.E., Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution (1979) Neurology, 29 (9), pp. 1228-1235; Wallin, M.T., Page, W.F., Kurtzke, J.F., Multiple sclerosis in US veterans of the vietnam era and later military service: Race, sex, and geography (2004) Annals of Neurology, 55 (1), pp. 65-71. , DOI 10.1002/ana.10788; Wallin, M.T., The Gulf War era multiple sclerosis cohort: Age and incidence rates by race, sex and service (2012) Brain, 135, pp. 1778-1785; Hansen, T., Skytthe, A., Stenager, E., Petersen, H.C., Bronnum-Hansen, H., Kyvik, K., Concordance for multiple sclerosis in Danish twins: An update of a nationwide study (2005) Multiple Sclerosis, 11 (5), pp. 504-510. , DOI 10.1191/1352458505ms1220oa; Willer, C.J., Dyment, D.A., Risch, N.J., Sadovnick, A.D., Ebers, G.C., Paty, D.W., Hashimoto, S.A., Stefanelli, M., Twin concordance and sibling recurrence rates in multiple sclerosis (2003) Proceedings of the National Academy of Sciences of the United States of America, 100 (22), pp. 12877-12882. , DOI 10.1073/pnas.1932604100; Ebers, G.C., Sadovnick, A.D., Risch, N.J., A genetic basis for familial aggregation in multiple sclerosis (1995) Canadian Collaborative Study Group. Nature, 377, pp. 150-151; Schmidt, H., Williamson, D., Ashley-Koch, A., HLA-DR15 haplotype and multiple sclerosis: A HuGE review (2007) American Journal of Epidemiology, 165 (10), pp. 1097-1109. , DOI 10.1093/aje/kwk118; Sadovnick, A.D., Genetic background of multiple sclerosis (2012) Autoimmun. Rev., 11, pp. 163-166; Marrosu, M.G., Murru, M.R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G., Muntoni, F., Multiple sclerosis in sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles [3] (1997) American Journal of Human Genetics, 61 (2), pp. 454-457; Haines, J.L., Terwedow, H.A., Burgess, K., Pericak-Vance, M.A., Rimmler, J.B., Martin, E.R., Oksenberg, J.R., Hauser, S.L., Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity (1998) Human Molecular Genetics, 7 (8), pp. 1229-1234; Lincoln, M.R., Epistasis among HLA-DRB1 HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility (2009) Proc. Natl Acad. Sci. USA, 106, pp. 7542-7547; Patsopoulos, N.A., De Bakker, P.I., Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci (2011) Ann. Neurol., 70, pp. 897-912; Ramagopalan, S.V., Rare variants in the CYP27B1 gene are associated with multiple sclerosis (2011) Ann. Neurol., 70, pp. 881-886; Alonso, A., Hernan, M.A., Ascherio, A., Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis (2008) Acta Neurologica Scandinavica, 117 (1), pp. 15-20. , DOI 10.1111/j.1600-0404.2007.00898.x; Zorzon, M., Zivadinov, R., Nasuelli, D., Dolfini, P., Bosco, A., Bratina, A., Tommasi, M.A., Cazzato, G., Risk factors of multiple sclerosis: A case-control study (2003) Neurological Sciences, 24 (4), pp. 242-247. , DOI 10.1007/s10072-003-0147-6; Acheson, E.D., Bachrach, C.A., Wright, F.M., Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables (1960) Acta Psychiatr. Scand., 147, pp. 132-147; Gale, C.R., Martyn, C.N., Migrant studies in multiple sclerosis (1995) Progress in Neurobiology, 47 (4-5), pp. 425-448. , DOI 10.1016/0301-0082(95)00033-X; McLeod, J.G., Hammond, S.R., Kurtzke, J.F., Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: A reassessment. I. Risk of MS by age at immigration (2011) J. Neurol., 258, pp. 1140-1149; Kurtzke, J.F., Beebe, G.W., Norman Jr., J.E., Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS (1985) Neurology, 35 (5), pp. 672-678; Elian, M., Dean, G., Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and East and West Africa (1993) Journal of Neurology Neurosurgery and Psychiatry, 56 (5), pp. 454-457; Cabre, P., Signate, A., Olindo, S., Merle, H., Caparros-Lefebvre, D., Bera, O., Smadja, D., Role of return migration in the emergence of multiple sclerosis in the French West Indies (2005) Brain, 128 (12), pp. 2899-2910. , DOI 10.1093/brain/awh624; Hernan, M.A., Olek, M.J., Ascherio, A., Geographic variation of MS incidence in two prospective studies of US women (1999) Neurology, 53 (8), pp. 1711-1718; Koch-Henriksen, N., Sorensen, P.S., Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere (2011) J Neurol. Sci., 311, pp. 58-63; Alonso, A., Hernán, M.A., Temporal trends in the incidence of multiple sclerosis: A systematic review (2008) Neurology, 71, pp. 129-135; Simpson Jr., S., Blizzard, L., Otahal, P., Van Der Mei, I., Taylor, B., Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 1132-1141; Taylor, B.V., Latitudinal variation in incidence and type of first central nervous system demyelinating events (2010) Mult. Scler., 16, pp. 398-405; Henle, W., Henle, G., (1979) The EpsteinYBarr Virus, , eds Epstein, M. A. & Achong, B. G.) 61-78 Springer Berlin Heidelberg, New York; Takeuchi, K., Prevalence of EpsteinYBarr virus in Japan: Trends and future prediction (2006) Pathol. Int., 56, pp. 112-116; Hallee, T.J., Evans, A.S., Niederman, J.C., Brooks, C.M., Voegtly, J.H., Infectious mononucleosis at the United States Military Academy A prospective study of a single class over four years (1974) Yale J. Biol. Med., 3, pp. 182-195; Warner, H.B., Carp, R.I., Multiple sclerosis and EpsteinYBarr virus (1981) Lancet, 2, p. 1290; Thacker, E.L., Mirzaei, F., Ascherio, A., Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis (2006) Annals of Neurology, 59 (3), pp. 499-503. , DOI 10.1002/ana.20820; Bach, J.F., The effect of infections on susceptibility to autoimmune and allergic diseases (2002) N. Engl. J. Med., 347, pp. 911-920; Ascherio, A., Munch, M., Epstein-Barr virus and multiple sclerosis (2000) Epidemiology, 11 (2), pp. 220-224. , DOI 10.1097/00001648-200003000-00023; Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part I: The role of infection (2007) Annals of Neurology, 61 (4), pp. 288-299. , DOI 10.1002/ana.21117; Alotaibi, S., Kennedy, J., Tellier, R., Stephens, D., Banwell, B., Epstein-barr virus in pediatric multiple sclerosis (2004) Journal of the American Medical Association, 291 (15), pp. 1875-1879. , DOI 10.1001/jama.291.15.1875; Pohl, D., Krone, B., Rostasy, K., Kahler, E., Brunner, E., Lehnert, M., Wagner, H.-J., Hanefeld, F., High seroprevalence of Epstein-Barr virus in children with multiple sclerosis (2006) Neurology, 67 (11), pp. 2063-2065. , DOI 10.1212/01.wnl.0000247665.94088.8d, PII 0000611420061212000037; Banwell, B., Krupp, L., Kennedy, J., Tellier, R., Tenembaum, S., Ness, J., Belman, A., Bar-Or, A., Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study (2007) Lancet Neurology, 6 (9), pp. 773-781. , DOI 10.1016/S1474-4422(07)70196-5, PII S1474442207701965; Levin, L.I., Munger, K.L., O'Reilly, E.J., Falk, K.I., Ascherio, A., Primary infection with the EpsteinYBarr virus and risk of multiple sclerosis (2010) Ann. Neurol., 67, pp. 824-830; Beasley, R.P., Hepatitis B virus the major etiology of hepatocellular carcinoma (1988) Cancer, 61, pp. 1942-1956; Ascherio, A., Munger, K.L., Lennette, E.T., Spiegelman, D., Hernan, M.A., Olek, M.J., Hankinson, S.E., Hunter, D.J., Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study (2001) Journal of the American Medical Association, 286 (24), pp. 3083-3088; Levin, L.I., Munger, K.L., Rubertone, M.V., Peck, C.A., Lennette, E.T., Spiegelman, D., Ascherio, A., Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis (2005) Journal of the American Medical Association, 293 (20), pp. 2496-2500. , DOI 10.1001/jama.293.20.2496; Sundstrom, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nystrom, L., Dillner, J., Forsgren, L., An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study (2004) Neurology, 62 (12), pp. 2277-2282; Delorenze, G.N., Munger, K.L., Lennette, E.T., Orentreich, N., Vogelman, J.H., Ascherio, A., Epstein-Barr virus and multiple sclerosis: Evidence of association from a prospective study with long-term follow-up (2006) Archives of Neurology, 63 (6), pp. 839-844. , http://archneur.ama-assn.org/cgi/reprint/63/6/839, DOI 10.1001/archneur.63.6.noc50328; Munger, K.L., Levin, L.I., O'Reilly, E.J., Falk, K.I., Ascherio, A., Anti EpsteinYBarr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel (2011) Mult. Scler., 17, pp. 1185-1193; Simon, K.C., Saghafian-Hedengren, S., Sverremark-Ekström, E., Nilsson, C., Ascherio, A., Age at EpsteinYBarr virus infection and EpsteinYBarr virus nuclear antigen 1 antibodies in Swedish children (2012) Mult. Scler. Relat. Disord., 1, pp. 136-138; Lünemann, J.D., Munz, C., EBV in MS: Guilty by association (2009) Trends Immunol., 30, pp. 243-248; Lovett-Racke, A.E., Trotter, J.L., Lauber, J., Perrin, P.J., June, C.H., Racke, M.K., Decreased dependence of myelin basic protein-reactive T cells on CD28- mediated costimulation in multiple sclerosis patients: A marker of activated/memory T cells (1998) Journal of Clinical Investigation, 101 (4), pp. 725-730; Markovic-Plese, S., Cortese, I., Wandinger, K.-P., McFarland, H.F., Martin, R., CD4+CD28- costimulation-independent T cells in multiple sclerosis (2001) Journal of Clinical Investigation, 108 (8), pp. 1185-1194. , DOI 10.1172/JCI200112516; Viglietta, V., Baecher-Allan, C., Weiner, H.L., Hafler, D.A., Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis (2004) Journal of Experimental Medicine, 199 (7), pp. 971-979. , DOI 10.1084/jem.20031579; Lunemann, J.D., Edwards, N., Muraro, P.A., Hayashi, S., Cohen, J.I., Munz, C., Martin, R., Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis (2006) Brain, 129 (6), pp. 1493-1506. , DOI 10.1093/brain/awl067; Munz, C., Bickham, K.L., Subklewe, M., Tsang, M.L., Chahroudi, A., Kurilla, M.G., Zhang, D., Steinman, R.M., Human CD4+ T lymphocytes consistently respond to the latent Epstein- Barr virus nuclear antigen EBNA1 (2000) Journal of Experimental Medicine, 191 (10), pp. 1649-1660. , DOI 10.1084/jem.191.10.1649; Lünemann, J.D., EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL 2 (2008) J. Exp. Med., 205, pp. 1763-1773; Hauser, S.L., Waubant, E., Arnold, D.L., Vollmer, T., Antel, J., Fox, R.J., Bar-Or, A., Smith, C.H., B-cell depletion with rituximab in relapsing-remitting multiple sclerosis (2008) New England Journal of Medicine, 358 (7), pp. 676-688. , http://content.nejm.org/cgi/reprint/358/7/676.pdf, DOI 10.1056/NEJMoa0706383; Thorley-Lawson, D.A., Epstein-Barr virus: Exploiting the immune system (2001) Nature Reviews Immunology, 1 (1), pp. 75-82; Caldwell, R.G., Wilson, J.B., Anderson, S.J., Longnecker, R., Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals (1998) Immunity, 9 (3), pp. 405-411. , DOI 10.1016/S1074-7613(00)80623-8; Pender, M.P., Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases (2003) Trends in Immunology, 24 (11), pp. 584-588. , DOI 10.1016/j.it.2003.09.005; Lassmann, H., Niedobitek, G., Aloisi, F., Middeldorp, J.M., EpsteinYBarr virus in the multiple sclerosis brain: A controversial issue - Report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria (2011) Brain, 134, pp. 2772-2786; Tzartos, J.S., Association of innate immune activation with latent EpsteinYBarr virus in active MS lesions (2012) Neurology, 78, pp. 15-23; Munz, C., Lünemann, J.D., Getts, M.T., Miller, S.D., Antiviral immune responses: Triggers of or triggered by autoimmunity (2009) Nat Rev. Immunol., 9, pp. 246-258; Salmi, A.A., Panelius, M., Halonen, P., Rinne, U.K., Penttinen, K., Measles virus antibody in cerebrospinal fluids from patients with multiple sclerosis (1972) Br. Med. J., 1, pp. 477-479; Vartdal, F., Vandvik, B., Norrby, E., Viral and bacterial antibody responses in multiple sclerosis (1980) Annals of Neurology, 8 (3), pp. 248-255. , DOI 10.1002/ana.410080305; Derfuss, T., Hohlfeld, R., Meinl, E., Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B cell response (2005) J. Neurol., 252, pp. 986-971; Jacobi, C., Lange, P., Reiber, H., Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response (2007) Journal of Neuroimmunology, 187 (1-2), pp. 139-146. , DOI 10.1016/j.jneuroim.2007.04.002, PII S0165572807001269; Jarius, S., Polyspecific antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica (2008) J. Neurol. Neurosurg. Psychiatry, 79, pp. 1134-1136; Sokal, E.M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Leonard, P., Moreels, A., Haumont, M., Denis, M., Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults (2007) Journal of Infectious Diseases, 196 (12), pp. 1749-1753. , DOI 10.1086/523813; Lycke, J., Acyclovir treatment of relapsingYremitting multiple sclerosis A randomized, placebo-controlled, double-blind study (1996) J. Neurol., 243, pp. 214-224; Friedman, J.E., Zabriskie, J.B., Plank, C., Ablashi, D., Whitman, J., Shahan, B., Edgell, R., Sheng, D., A randomized clinical trial of valacyclovir in multiple sclerosis (2005) Multiple Sclerosis, 11 (3), pp. 286-295. , DOI 10.1191/1352458505ms1185oa; Lünemann, J.D., Elevated EpsteinYBarr virus-encoded nuclear antigen 1 immune responses predict conversion to multiple sclerosis (2010) Ann. Neurol., 67, pp. 159-169; Van Der Mei, I.A.F., Ponsonby, A.-L., Blizzard, L., Dwyer, T., Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation (2001) Neuroepidemiology, 20 (3), pp. 168-174. , DOI 10.1159/000054783; Ebers, G.C., Environmental factors and multiple sclerosis (2008) The Lancet Neurology, 7 (3), pp. 268-277. , DOI 10.1016/S1474-4422(08)70042-5, PII S1474442208700425; Handel, A.E., Giovannoni, G., Ebers, G.C., Ramagopalan, S.V., Environmental factors and their timing in adult-onset multiple sclerosis (2010) Nat. Rev. Neurol., 6, pp. 156-166; Swank, R.L., Lerstad, O., Strøm, A., Backer, J., Multiple sclerosis in rural Norway Its geographic and occupational incidence in relation to nutrition (1952) N. Engl. J. Med., 246, pp. 721-728; Antonovsky, A., Epidemiologic study of multiple sclerosis in Israel (1965) Arch. Neurol., 13, pp. 183-193; Cendrowski, W., Epidemiological study of multiple sclerosis in Western Poland (1969) Eur. Neurol., 2, pp. 90-108; Van Der Mei, I.A., Past exposure to sun, skin phenotype and risk of multiple sclerosis: A caseYcontrol study (2003) BMJ, 327, pp. 316-321; Kampman, M.T., Wilsgaard, T., Mellgren, S.I., Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle (2007) Journal of Neurology, 254 (4), pp. 471-477. , DOI 10.1007/s00415-006-0395-5; Munger, K.L., Zhang, S.M., O'Reilly, E., Hernan, M.A., Olek, M.J., Willett, W.C., Ascherio, A., Vitamin D intake and incidence of multiple sclerosis (2004) Neurology, 62 (1), pp. 60-65; Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S., Ascherio, A., Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis (2006) Journal of the American Medical Association, 296 (23), pp. 2832-2838. , http://jama.ama-assn.org/cgi/reprint/296/23/2832, DOI 10.1001/jama.296.23.2832; Lucas, R.M., Sun exposure and vitamin D are independent risk factors for CNS demyelination (2011) Neurology, 76, pp. 540-548; Ascherio, A., Munger, K.L., Simon, K.C., Vitamin D and multiple sclerosis (2010) Lancet Neurol., 9, pp. 599-612; Feskanich, D., Willett, W.C., Colditz, G.A., Calcium, vitamin D, milk consumption, and hip fractures: A prospective study among postmenopausal women (2003) American Journal of Clinical Nutrition, 77 (2), pp. 504-511; Hollis, B.W., Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D (2005) Journal of Nutrition, 135 (2), pp. 317-322; Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T., Dawson-Hughes, B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes (2006) American Journal of Clinical Nutrition, 84 (1), pp. 18-28. , http://www.ajcn.org/cgi/reprint/84/1/18; Yetley, E.A., Assessing the vitamin D status of the US population (2008) Am. J. Clin. Nutr., 88, pp. 558SY564S; Looker, A.C., Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004 (2008) Am. J. Clin. Nutr., 88, pp. 1519-1527; Gozdzik, A., Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: Associations with vitamin D intake and skin pigmentation (2008) BMC Public Health, 8, p. 336; Gonzalez-Gross, M., Vitamin D status among adolescents in Europe: The Healthy Lifestyle in Europe by Nutrition in Adolescence study (2012) Br. J. Nutr., 107, pp. 755-764; Ascherio, A., Marrie, R.A., Vitamin D in MS: A vitamin for 4 seasons (2012) Neurology, 79, pp. 208-210; Lucas, R.M., Ponsonby, A.-L., Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? (2006) Progress in Biophysics and Molecular Biology, 92 (1), pp. 140-149. , DOI 10.1016/j.pbiomolbio.2006.02.019, PII S0079610706000058; Sundqvist, E., Confirmation of association between multiple sclerosis and CYP27B1 (2010) Eur. J. Hum. Genet., 18, pp. 1349-1352; Simon, K.C., Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis (2011) J. Neurol., 258, pp. 1676-1682; Wang, J.T., Lin, C.-J., Burridge, S.M., Fu, G.K., Labuda, M., Portale, A.A., Miller, W.L., Genetics of vitamin D 1α-hydroxylase deficiency in 17 families (1998) American Journal of Human Genetics, 63 (6), pp. 1694-1702. , DOI 10.1086/302156; Torkildsen, O., Knappskog, P.M., Nyland, H.I., Myhr, K.-M., Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis (2008) Archives of Neurology, 65 (6), pp. 809-811. , http://archneur.ama-assn.org/cgi/reprint/65/6/809, DOI 10.1001/archneur.65.6.809; Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women (2009) Neurology, 73, pp. 1543-1550; Hedström, A.K., Olsson, T., Alfredsson, L., High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women (2012) Mult. Scler., 18, pp. 1334-1336; Mirzaei, F., Gestational vitamin D and the risk of multiple sclerosis in offspring (2011) Ann. Neurol., 70, pp. 30-40; Willer, C.J., Timing of birth and risk of multiple sclerosis: Population based study (2005) BMJ, 330, p. 120; Staples, J., Ponsonby, A.L., Lim, L., Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis (1640) BMJ, 340, pp. c; Bock, G., The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: A randomized controlled trial (2011) Diabetes Metab. Res. Rev., 27, pp. 942-945; Mahon, B.D., Gordon, S.A., Cruz, J., Cosman, F., Cantorna, M.T., Cytokine profile in patients with multiple sclerosis following vitamin D supplementation (2003) Journal of Neuroimmunology, 134 (1-2), pp. 128-132. , DOI 10.1016/S0165-5728(02)00396-X, PII S016557280200396X; Burton, J.M., A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (2010) Neurology, 74, pp. 1852-1859; Smolders, J., Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis (2010) PLoS ONE, 5, pp. e15235; Jorde, R., No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects (2010) Cytokine, 50, pp. 175-180; Schleithoff, S.S., Zittermann, A., Tenderich, G., Berthold, H.K., Stehle, P., Koerfer, R., Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial (2006) American Journal of Clinical Nutrition, 83 (4), pp. 754-759. , http://www.ajcn.org/cgi/reprint/83/4/754; Haddad, J.G., Chyu, K.J., Competitive protein-binding radioassay for 25-hydroxycholecalciferol (1971) J. Clin. Endocrinol. Metab., 33, pp. 992-995; Better, O.S., (1980) Phosphate and Minerals in Health and Disease, , eds Massry S. G. Ritz E. & Jahreis G.) 467-472 Plenum Press New York; Knippenberg, S., Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis (2011) Mult. Scler., 17, pp. 1418-1423; Peelen, E., Effects of vitamin D on the peripheral adaptive immune system: A review (2011) Autoimmun. Rev., 10, pp. 733-743; Liu, P.T., Toll-like receptor triggering of a vitamin D mediated human antimicrobial response (2006) Science, 311, pp. 1770-1773; Laaksi, I., Ruohola, J.-P., Tuohimaa, P., Auvinen, A., Haataja, R., Pihlajamaki, H., Ylikomi, T., An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men (2007) American Journal of Clinical Nutrition, 86 (3), pp. 714-717. , http://www.ajcn.org/cgi/reprint/86/3/714; Ginde, A.A., Mansbach, J.M., Camargo Jr., C.A., Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey (2009) Arch. Intern. Med., 169, pp. 384-390; Andersen, O., Lygner, P.-E., Bergstrom, T., Andersson, M., Vahlne, A., Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study (1993) Journal of Neurology, 240 (7), pp. 417-422; Panitch, H.S., Influence of infection on exacerbations of multiple sclerosis (1994) Annals of Neurology, 36 (SUPPL.), pp. S25-S28. , DOI 10.1002/ana.410360709; Buljevac, D., Flach, H.Z., Hop, W.C.J., Hijdra, D., Laman, J.D., Savelkoul, H.F.J., Van Der Meche, F.G.A., Hintzen, R.Q., Prospective study on the relationship between infections and multiple sclerosis exacerbations (2002) Brain, 125 (5), pp. 952-960; Nørgaard, M., Use of penicillin and other antibiotics and risk of multiple sclerosis: A population-based caseYcontrol study (2011) Am. J. Epidemiol., 174, pp. 945-948; Munger, K.L., Pre-clinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel Am. J. Epidemiol., , in press; Camargo Jr., C.A., Rifas-Shiman, S.L., Litonjua, A.A., Rich-Edwards, J.W., Weiss, S.T., Gold, D.R., Kleinman, K., Gillman, M.W., Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age (2007) American Journal of Clinical Nutrition, 85 (3), pp. 788-795. , http://www.ajcn.org/cgi/reprint/85/3/788; Wallace, R.B., Urinary tract stone occurrence in the Women's Health Initiative randomized clinical trial of calcium and vitamin D supplements (2011) Am. J. Clin. Nutr., 94, pp. 270-277; Heaney, R.P., Davies, K.M., Chen, T.C., Holick, M.F., Janet Barger-Lux, M., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol (2003) American Journal of Clinical Nutrition, 77 (1), pp. 204-210; Vieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety (1999) American Journal of Clinical Nutrition, 69 (5), pp. 842-856; Ross, A.C., DRI Dietary Reference Intakes Calcium and Vitamin D, , for the Institute of Medicine of the National Academies. (The National Academies Press, Washington, DC, 2011; Hernan, M.A., Olek, M.J., Ascherio, A., Cigarette smoking and incidence of multiple sclerosis (2001) American Journal of Epidemiology, 154 (1), pp. 69-74. , DOI 10.1093/aje/154.1.69; Hernan, M.A., Jick, S.S., Logroscino, G., Olek, M.J., Ascherio, A., Jick, H., Cigarette smoking and the progression of multiple sclerosis (2005) Brain, 128 (6), pp. 1461-1465. , DOI 10.1093/brain/awh471; Villard-Mackintosh, L., Vessey, M.P., Oral contraceptives and reproductive factors in multiple sclerosis incidence (1993) Contraception, 47 (2), pp. 161-168. , DOI 10.1016/0010-7824(93)90088-O; Thorogood, M., Hannaford, P.C., The influence of oral contraceptives on the risk of multiple sclerosis (1998) British Journal of Obstetrics and Gynaecology, 105 (12), pp. 1296-1299; Hedström, A.K., Bäärnhielm, M., Olsson, T., Alfredsson, L., Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis (2009) Neurology, 73, pp. 696-701; Riise, T., Nortvedt, M.W., Ascherio, A., Smoking is a risk factor for multiple sclerosis (2003) Neurology, 61 (8), pp. 1122-1124; Sundstrom, P., Nystrom, L., Hallmans, G., Smoke exposure increases the risk for multiple sclerosis (2008) European Journal of Neurology, 15 (6), pp. 579-583. , DOI 10.1111/j.1468-1331.2008.02122.x; Orton, S.M., Sex ratio of multiple sclerosis in Canada: A longitudinal study (2006) Lancet Neurol., 5, pp. 932-936; Koch-Henriksen, N., Sørensen, P.S., The changing demographic pattern of multiple sclerosis epidemiology (2010) Lancet Neurol., 9, pp. 520-532; Palacios, N., Alonso, A., Bronnum-Hansen, H., Ascherio, A., Smoking and increased risk of multiple sclerosis: Parallel trends in the sex ratio reinforce the evidence (2011) Ann. Epidemiol., 21, pp. 536-542; Bass, N.H., Pathogenesis of myelin lesions in experimental cyanide encephalopathy A microchemical study (1968) Neurology, 18, pp. 167-177; Lessell, S., Experimental cyanide optic neuropathy (1971) Arch. Ophthalmol., 86, pp. 194-204; Chen, J.L., Nicotine raises the influx of permeable solutes across the rat bloodYbrain barrier with little or no capillary recruitment (1995) J. Cereb. Blood Flow Metab., 15, pp. 687-698; Sopori, M.L., Kozak, W., Immunomodulatory effects of cigarette smoke (1998) Journal of Neuroimmunology, 83 (1-2), pp. 148-156. , DOI 10.1016/S0165-5728(97)00231-2, PII S0165572897002312; Francus, T., Klein, R.F., Staiano-Coico, L., Becker, C.G., Siskind, G.W., Effects of tobacco glycoprotein (TGP) on the immune system II TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells (1988) J. Immunol., 140, pp. 1823-1829; Rejdak, K., Eikelenboom, M.J., Petzold, A., Thompson, E.J., Stelmasiak, Z., Lazeron, R.H.C., Barkhof, F., Giovannoni, G., CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis (2004) Neurology, 63 (8), pp. 1439-1445; Simon, K.C., Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1.*1501 on multiple sclerosis risk (2010) Neurology, 74, pp. 1365-1371; De Jager, P.L., Simon, K.C., Munger, K.L., Rioux, J.D., Hafler, D.A., Ascherio, A., Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis (2008) Neurology, 70 (PART 2), pp. 1113-1118. , DOI 10.1212/01.wnl.0000294325.63006.f8},
correspondence_address1={Ascherio, A.; Department of Nutrition, 677 Huntington Avenue, Boston, MA 02115, United States; email: aascheri@hsph.harvard.edu},
issn={17594758},
pubmed_id={23045241},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Savica2010798,
author={Savica, R. and Rocca, W.A. and Ahlskog, J.E.},
title={When does Parkinson disease start?},
journal={Archives of Neurology},
year={2010},
volume={67},
number={7},
pages={798-801},
doi={10.1001/archneurol.2010.135},
note={cited By 214},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955016727&doi=10.1001%2farchneurol.2010.135&partnerID=40&md5=87ae9d40ce12ae0285dd07696e34e87b},
affiliation={Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States; Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, United States},
abstract={There is convincing evidence that the Parkinson disease neurodegenerative process begins many years before the onset of motor manifestations. Initial estimates based on nigral neuropathological findings or striatal dopamine imaging suggested a 5- to 6-year preclinical period. However, more recent evidence of Lewy body pathology in other neuronal populations preceding nigral involvement suggests that the preclinical phase may be much longer. Epidemiologic studies of nonmotor manifestations, such as constipation, anxiety disorders, rapid eye movement sleep behavior disorder (RBD), and anemia, suggest that the preclinical period extends at least 20 years before the motor manifestations. Olfactory impairment and depression may also precede the onset of motor manifestations; however, the lag time may be shorter. Recognition of a nonmotor preclinical phase spanning 20 or more years should guide the search for predictive biomarkers and the identification of risk or protective factors for Parkinson disease. ©2010 American Medical Association. All rights reserved.},
keywords={biological marker;  dopamine, anemia;  anxiety disorder;  constipation;  depression;  human;  Lewy body;  motor dysfunction;  neuropathology;  Parkinson disease;  priority journal;  REM sleep;  review;  risk assessment;  sleep disorder;  smelling disorder;  striatonigral degeneration, Age of Onset;  Anemia;  Anxiety Disorders;  Constipation;  Disease Progression;  Humans;  Olfaction Disorders;  Parkinson Disease;  REM Sleep Behavior Disorder},
chemicals_cas={dopamine, 51-61-6, 62-31-7},
funding_details={National Institute on AgingNational Institute on Aging, NIA, U01AG006786},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, R01ES010751},
funding_details={National Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, R01AR030582},
references={Elbaz, A., Bower, J.H., Peterson, B.J., Survival study of Parkinson disease in Olmsted County, Minnesota (2003) Arch Neurol, 60 (1), pp. 91-96; Ahlskog, J.E., Beating a dead horse: Dopamine and Parkinson disease (2007) Neurology, 69 (17), pp. 1701-1711; Fearnley, J.M., Lees, A.J., Ageing and Parkinson's disease: Substantia nigra regional selectivity (1991) Brain, 114 (PART 5), pp. 2283-2301; Hilker, R., Schweitzer, K., Coburger, S., Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity (2005) Arch Neurol, 62 (3), pp. 378-382; Morrish, P.K., Sawle, G.V., Brooks, D.J., An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease (1996) Brain, 119 (2), pp. 585-591; Morrish, P.K., Rakshi, J.S., Bailey, D.L., Sawle, G.V., Brooks, D.J., Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET (1998) J Neurol Neurosurg Psychiatry, 64 (3), pp. 314-319; Abbott, R.D., Petrovitch, H., White, L.R., Frequency of bowel movements and the future risk of Parkinson's disease (2001) Neurology, 57 (3), pp. 456-462; Savica, R., Carlin, J.M., Grossardt, B.R., Medical records documentation of constipation preceding Parkinson disease: A case-control study (2009) Neurology, 73 (21), pp. 1752-1758; Weisskopf, M.G., Chen, H., Schwarzschild, M.A., Kawachi, I., Ascherio, A., Prospective study of phobic anxiety and risk of Parkinson's disease (2003) Movement Disorders, 18 (6), pp. 646-651. , DOI 10.1002/mds.10425; Shiba, M., Bower, J.H., Maraganore, D.M., Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study (2000) Mov Disord, 15 (4), pp. 669-677; Bower, J.H., Grossardt, B.R., Maraganore, D.M., Anxious personality predicts an increased risk of Parkinson's disease Mov Disord, , In press; Schenck, C.H., Bundlie, S.R., Mahowald, M.W., Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder (1996) Neurology, 46 (2), pp. 388-393; Uchiyama, M., Isse, K., Tanaka, K., Incidental Lewy body disease in a patient with REM sleep behavior disorder (1995) Neurology, 45 (4), pp. 709-712; Boeve, B.F., Dickson, D.W., Olson, E.J., Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease (2007) Sleep Med, 8 (1), pp. 60-64; Stiasny-Kolster, K., Doerr, Y., Möller, J.C., Combination of "idiopathic" REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT (2005) Brain, 128 (PART 1), pp. 126-137; Savica, R., Grossardt, B.R., Carlin, J.M., Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study (2009) Neurology, 73 (17), pp. 1381-1387; Braak, H., Del Tredici, K., Rüb, U., De Vos, R.A.I., Jansen Steur, E.N.H., Braak, E., Staging of brain pathology related to sporadic Parkinson's disease (2003) Neurobiol Aging, 24 (2), pp. 197-211; Braak, H., De Vos, R.A.I., Bohl, J., Del Tredici, K., Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology (2006) Neuroscience Letters, 396 (1), pp. 67-72. , DOI 10.1016/j.neulet.2005.11.012, PII S0304394005012814; Braak, H., Sastre, M., Bohl, J.R.E., De Vos, R.A.I., Del Tredici, K., Parkinson's disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- And postganglionic neurons (2007) Acta Neuropathol, 113 (4), pp. 421-429; Beach, T.G., Adler, C.H., Lue, L., Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009) Acta Neuropathol, 117 (6), pp. 613-634. , Arizona Parkinson's Disease Consortium; Edwards, L.L., Quigley, E.M., Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology (1992) Neurology, 42 (4), pp. 726-732; Ashraf, W., Pfeiffer, R.F., Park, F., Lof, J., Quigley, E.M., Constipation in Parkinson's disease: Objective assessment and response to psyllium (1997) Mov Disord, 12 (6), pp. 946-951; Petrovitch, H., Abbott, R.D., Ross, G.W., Bowel movement frequency in late-life and substantia nigra neuron density at death (2009) Mov Disord, 24 (3), pp. 371-376; Minguez-Castellanos, A., Chamorro, C.E., Escamilla-Sevilla, F., Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study (2007) Neurology, 68 (23), pp. 2012-2018; Ahlskog, J.E., (2009) Parkinson's Disease Treatment Guide for Physicians, , New York, NY: Oxford University Press; Olson, E.J., Boeve, B.F., Silber, M.H., Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases (2000) Brain, 123 (PART 2), pp. 331-339; Boeve, B.F., Silber, M.H., Ferman, T.J., Lucas, J.A., Parisi, J.E., Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy (2001) Mov Disord, 16 (4), pp. 622-630; Boeve, B.F., Silber, M.H., Saper, C.B., Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease (2007) Brain, 130 (PART 11), pp. 2770-2788; Eisensehr, I., Linke, R., Tatsch, K., Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters: IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls (2003) Sleep, 26 (5), pp. 507-512; Parker Jr., W.D., Boyson, S.J., Parks, J.K., Abnormalities of the electron transport chain in idiopathic Parkinson's disease (1989) Ann Neurol, 26 (6), pp. 719-723; Shinde, S., Pasupathy, K., Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: Preliminary study (2006) Neurology India, 54 (4), pp. 390-393; Bindoff, L.A., Birch-Machin, M.A., Cartlidge, N.E., Parker Jr., W.D., Turnbull, D.M., Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease (1991) J Neurol Sci, 104 (2), pp. 203-208; Peters, R., Burch, L., Warner, J., Beckett, N., Poulter, R., Bulpitt, C., Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review (2008) BMC Geriatr, 8, p. 18; Atti, A.R., Palmer, K., Volpato, S., Zuliani, G., Winblad, B., Fratiglioni, L., Anaemia increases the risk of dementia in cognitively intact elderly (2006) Neurobiol Aging, 27 (2), pp. 278-284; Ross, G.W., Petrovitch, H., Abbott, R.D., Association of olfactory dysfunction with risk for future Parkinson's disease (2008) Ann Neurol, 63 (2), pp. 167-173; Ross, G.W., Abbott, R.D., Petrovitch, H., Association of olfactory dysfunction with incidental Lewy bodies (2006) Mov Disord, 21 (12), pp. 2062-2067; Ponsen, M.M., Stoffers, D., Booij, J., Van Eck-Smit, B.L.F., Wolters, E.C., Berendse, H.W., Idiopathic hyposmia as a preclinical sign of Parkinson's disease (2004) Ann Neurol, 56 (2), pp. 173-181; Ponsen, M.M., Stoffers, D., Twisk, J.W.R., Wolters, E.C., Berendse, H.W., Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study (2009) Mov Disord, 24 (7), pp. 1060-1065; Nilsson, F.M., Kessing, L.V., Sørensen, T.M., Andersen, P.K., Bolwig, T.G., Major depressive disorder in Parkinson's disease: A register-based study (2002) Acta Psychiatr Scand, 106 (3), pp. 202-211; Schuurman, A.G., Van Den Akker, M., Ensinck, K.T.J.L., Metsemakers, J.F.M., Knottnerus, J.A., Leentjens, A.F.G., Buntinx, F., Increased risk of Parkinson's disease after depression: A retrospective cohort study (2002) Neurology, 58 (10), pp. 1501-1504; Leentjens, A.F.G., Van Den Akker, M., Metsemakers, J.F.M., Lousberg, R., Verhey, F.R.J., Higher incidence of depression preceding the onset of Parkinson's disease: A register study (2003) Mov Disord, 18 (4), pp. 414-418; Alonso, A., García Rodriguez, L.A., Logroscino, G., Hernán, M.A., Use of antidepressants and the risk of Parkinson's disease: A prospective study (2009) J Neurol Neurosurg Psychiatry, 80 (6), pp. 671-674; Behari, M., Srivastava, A.K., Das, R.R., Pandey, R.M., Risk factors of Parkinson's disease in Indian patients (2001) J Neurol Sci, 190 (1-2), pp. 49-55; Frigerio, R., Fujishiro, H., Ahn, T.B., Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? (2009) Neurobiol Aging, , published online June 26, doi:10.1016/j.neurobiolaging.2009.05.019; Klos, K.J., Ahlskog, J.E., Josephs, K.A., α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals (2006) Neurology, 66 (7), pp. 1100-1102; Parkkinen, L., Pirttilä, T., Alafuzoff, I., Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance (2008) Acta Neuropathol, 115 (4), pp. 399-407},
correspondence_address1={Rocca, W. A.; Division of Epidemiology, 200 First St SW, Rochester, MN 55905, United States; email: rocca@mayo.edu},
issn={00039942},
coden={ARNEA},
pubmed_id={20625084},
language={English},
abbrev_source_title={Arch. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Abraha2017,
author={Abraha, I. and Rimland, J.M. and Trotta, F.M. and Dell'Aquila, G. and Cruz-Jentoft, A. and Petrovic, M. and Gudmundsson, A. and Soiza, R. and O'Mahony, D. and Guaita, A. and Cherubini, A.},
title={Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. the SENATOR-OnTop series},
journal={BMJ Open},
year={2017},
volume={7},
number={3},
doi={10.1136/bmjopen-2016-012759},
art_number={e012759},
note={cited By 213},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015751619&doi=10.1136%2fbmjopen-2016-012759&partnerID=40&md5=e42540be4cf6121374bf149f26fbc0ce},
affiliation={Geriatrics and Geriatric Emergency Care, Italian National Research Center on Aging (IRCCS-INRCA), Ancona, Italy; Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Madrid, Spain; Department of Internal Medicine (Geriatrics), Ghent University, Ghent, Belgium; Landspitali University Hospital Reykjavik, Reykjavik, Iceland; Department of Medicine for the Elderly, Woodend Hospital, Aberdeen, United Kingdom; Department of Medicine, University College Cork, Cork, Ireland; 'Golgi Cenci' Foundation, Milan, Italy},
abstract={Objective To provide an overview of non-pharmacological interventions for behavioural and psychological symptoms in dementia (BPSD). Design Systematic overview of reviews. Data sources PubMed, EMBASE, Cochrane Database of Systematic Reviews, CINAHL and PsycINFO (2009-March 2015). Eligibility criteria Systematic reviews (SRs) that included at least one comparative study evaluating any non-pharmacological intervention, to treat BPSD. Data extraction Eligible studies were selected and data extracted independently by 2 reviewers. The AMSTAR checklist was used to assess the quality of the SRs. Data analysis Extracted data were synthesised using a narrative approach. Results 38 SRs and 142 primary studies were identified, comprising the following categories of non-pharmacological interventions: (1) sensory stimulation interventions (12 SRs, 27 primary studies) that encompassed: acupressure, aromatherapy, massage/touch therapy, light therapy and sensory garden; (2) cognitive/emotion-oriented interventions (33 SRs; 70 primary studies) that included cognitive stimulation, music/dance therapy, dance therapy, snoezelen, transcutaneous electrical nerve stimulation, reminiscence therapy, validation therapy, simulated presence therapy; (3) behaviour management techniques (6 SRs; 32 primary studies) and (4) other therapies (5 SRs, 12 primary studies) comprising exercise therapy, animal-assisted therapy, special care unit and dining room environment-based interventions. Music therapy was effective in reducing agitation (SMD, -0.49; 95% CI -0.82 to -0.17; p=0.003), and anxiety (SMD, -0.64; 95% CI -1.05 to -0.24; p=0.002). Home-based behavioural management techniques, caregiver-based interventions or staff training in communication skills, person-centred care or dementia care mapping with supervision during implementation were found to be effective for symptomatic and severe agitation. Conclusions A large number of non-pharmacological interventions for BPSD were identified. The majority of the studies had great variation in how the same type of intervention was defined and applied, the follow-up duration, the type of outcome measured, usually with modest sample size. Overall, music therapy and behavioural management techniques were effective for reducing BPSD. © Published by the BMJ Publishing Group Limited.},
author_keywords={Alzheimer's disease;  Behavioral and psychological symptoms in dementia;  BPSD;  Non-pharmacological intervention},
keywords={acupressure;  aged;  agitation;  alternative medicine;  animal assisted therapy;  anxiety;  aromatherapy;  assisted living facility;  behavior disorder;  behaviour management technique;  caregiver based intervention;  checklist;  cognitive therapy;  communication skill;  dance therapy;  dementia;  dining room environment based intervention;  family counseling;  home care;  horticultural therapy;  human;  intensive care unit;  kinesiotherapy;  massage;  music therapy;  person centred care;  phototherapy;  physical medicine;  psychotherapy;  randomized controlled trial (topic);  reminiscence therapy;  residential care;  Review;  sensory garden;  sensory stimulation;  Shiatsu;  simulated presence therapy;  snoezelen multisensory stimulation therapy;  staff training;  systematic review;  systematic review (topic);  touch therapy;  transcutaneous electrical nerve stimulation;  validation therapy;  alternative medicine;  complication;  dementia;  literature;  physiotherapy;  procedures;  psychology;  restlessness;  very elderly, Aged;  Aged, 80 and over;  Anxiety;  Cognitive Therapy;  Complementary Therapies;  Dementia;  Home Care Services;  Humans;  Phototherapy;  Physical Therapy Modalities;  Psychomotor Agitation;  Review Literature as Topic},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, 305930},
references={Prince, M., Bryce, R., Albanese, E., The global prevalence of dementia: A systematic review and metaanalysis (2013) Alzheimers Dement, 9, pp. 63-75. , e2; Grasset, L., Brayne, C., Joly, P., Trends in dementia incidence: Evolution over a 10-year period in France (2016) Alzheimers Dement, 12, pp. 272-280; Rattinger, G.B., Fauth, E.B., Behrens, S., Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study (2016) Alzheimers Dement, 12, pp. 917-924; Wimo, A., Jönsson, L., Bond, J., The worldwide economic impact of dementia 2010 (2013) Alzheimers Dement, 9, pp. 1-11. , e3; Finkel, S.I., Costae Silva, J., Cohen, G., (1996) Behavioral and Psychological Signs and Symptoms of Dementia: A Consensus Statement on Current Knowledge and Implications for Research and Treatment. Int Psychogeriatr, 8, pp. 497-500; Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Neuropsychiatric symptoms in Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 532-539; Geda, Y.E., Schneider, L.S., Gitlin, L.N., Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future (2013) Alzheimers Dement, 9, pp. 602-608; Ismail, Z., Smith, E.E., Geda, Y., Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment (2016) Alzheimers Dement, 12, pp. 195-202; Kales, H.C., Gitlin, L.N., Lyketsos, C.G., Assessment and management of behavioral and psychological symptoms of dementia (2015) BMJ, 350, p. h369; Petrovic, M., Hurt, C., Collins, D., Clustering of behavioural and psychological symptoms in dementia (BPSD): A European Alzheimer's disease consortium (EADC) study (2007) Acta Clin Belg, 62, pp. 426-432; Pawucka, U., Brzyski, P., Kubicz, D., The determinants of behavioral symptoms in long-term care facility residents (2016) Eur Geriatr Med, 7, pp. 157-162; Savva, G.M., Zaccai, J., Matthews, F.E., Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population (2009) Br J Psychiatry, 194, pp. 212-219; Hendriks, S.A., Smalbrugge, M., Galindo-Garre, F., From admission to death: Prevalence and course of pain, agitation, shortness of breath, treatment of these symptoms in nursing home residents with dementia (2015) J Am Med Dir Assoc, 16, pp. 475-481; Ryu, S.H., Katona, C., Rive, B., Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: The LASER-AD study (2005) Am J Geriatr Psychiatry, 13, pp. 976-983; Givens, J.L., Jones, R.N., Mazor, K.M., Development and psychometric properties of the family distress in advanced dementia scale (2015) J Am Med Dir Assoc, 16, pp. 775-780; Wetzels, R.B., Zuidema, S.U., De Jonghe, J.F., Determinants of quality of life in nursing home residents with dementia (2010) Dement Geriatr Cogn Disord, 29, pp. 189-197; Gaugler, J.E., Yu, F., Krichbaum, K., Predictors of nursing home admission for persons with dementia (2009) Med Care, 47, pp. 191-198; Cabrera, E., Sutcliffe, C., Verbeek, H., Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes (2015) A Systematic Review. Eur Geriatr Med, 6, pp. 134-150; Cammisuli, D.M., Danti, S., Bosinelli, F., Non-pharmacological interventions for people with Alzheimer's disease: A critical review of the scientific literature from the last ten years (2016) Eur Geriatr Med, 7, pp. 57-64; Howard, R., McShane, R., Lindesay, J., Donepezil and memantine for moderate-to-severe Alzheimer's disease (2012) N Engl J Med, 366, pp. 893-903; Olin, J., Schneider, L., Galantamine for Alzheimer's disease (2002) Cochrane Database Syst Rev, 3, p. CD001747; Locca, J.F., Büla, C.J., Zumbach, S., Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: Development of practice recommendations in a Swiss canton (2008) J Am Med Dir Assoc, 9, pp. 439-448; Porsteinsson, A.P., Drye, L.T., Pollock, B.G., Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial (2014) JAMA, 311, pp. 682-691; Bierman, E.J., Comijs, H.C., Gundy, C.M., The effect of chronic benzodiazepine use on cognitive functioning in older persons: Good (2007) Bad or Indifferent Int J Geriatr Psychiatry, 22, pp. 1194-1200; Maher, A.R., Maglione, M., Bagley, S., Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis (2011) JAMA, 306, pp. 1359-1369; Berry, S.D., Placide, S.G., Mostofsky, E., Antipsychotic and benzodiazepine drug changes affect acute falls risk differently in the nursing home (2016) J Gerontol A Biol Sci Med Sci, 71, pp. 273-278; Howard, R.J., Juszczak, E., Ballard, C.G., Donepezil for the treatment of agitation in Alzheimer's disease (2007) N Engl J Med, 357, pp. 1382-1392; Matsunaga, S., Kishi, T., Iwata, N., Memantine monotherapy for Alzheimer's disease: A systematic review and meta-analysis (2015) PLoS ONE, 10, p. e0123289; Seitz, D.P., Brisbin, S., Herrmann, N., Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: A systematic review (2012) J Am Med Dir Assoc, 13, pp. 503-506. , e2; Zetteler, J., Effectiveness of simulated presence therapy for individuals with dementia: A systematic review and meta-analysis (2008) Aging Ment Health, 12, pp. 779-785; O'Neil, M.E., Freeman, M., Portland, V., (2011) A Systematic Evidence Review of Non-pharmacological Interventions for Behavioral Symptoms of Dementia, , Washington (DC): Department of Veterans Affairs; Abraha, I., Trotta, F., Rimland, J.M., Efficacy of non-pharmacological interventions to prevent and treat Delirium in older patients: A systematic overview. The SENATOR project ONTOP Series (2015) PLoS ONE, 10, p. e0123090; Vélez-Diáz-Pallarés, M., Lozano-Montoya, I., Correa-Pérez, A., Non-pharmacological interventions to prevent or treat pressure ulcers in older patients: Clinical practice recommendations. The SENATOR-ONTOP series (2016) Eur Geriatr Med, 7, pp. 142-148; Lozano-Montoya, I., Velez-Diaz-Pallares, M., Abraha, I., Nonpharmacologic interventions to prevent pressure ulcers in older patients: An overview of systematic reviews (the software ENgine for the assessment and optimization of drug and non-drug therapy in older peRsons [SENATOR] definition of optimal evidence-based non-drug therapies in older people [ONTOP] series) (2016) J Am Med Dir Assoc, 17, p. 370. , e1-70 e10; Velez-Diaz-Pallares, M., Lozano-Montoya, I., Abraha, I., Nonpharmacologic interventions to heal pressure ulcers in older patients: An overview of systematic reviews (the SENATORONTOP series) (2015) J Am Med Dir Assoc, 16, pp. 448-469; Rimland, J.M., Dell'Aquila, G., O'Mahony, D., Meta-analysis of multifactorial interventions to prevent falls of older adults in care facilities (2015) J Am Geriatr Soc, p. 63; Rimland, J.M., Abraha, I., Dell'Aquila, G., Effectiveness of non-pharmacological interventions to prevent falls in older people: A systematic overview. The SENATOR Project ONTOP Series (2016) PLoS ONE, 11, p. e0161579; Abraha, I., Cruz-Jentoft, A., Soiza, R.L., Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: The SENATOR-ONTOP systematic review protocol (2015) BMJ Open, 5, p. e007488; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Savovic, J., Jones, H.E., Altman, D.G., Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials (2012) Ann Intern Med, 157, pp. 429-438; Abraha, I., Cherubini, A., Cozzolino, F., Deviation from intention to treat analysis in randomised trials and treatment effect estimates: Meta-epidemiological study (2015) BMJ, 350, p. h2445; Chan, A.W., Hróbjartsson, A., Haahr, M.T., Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles (2004) JAMA, 291, pp. 2457-2465; Guyatt, G.H., Oxman, A.D., Vist, G., GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias) (2011) J Clin Epidemiol, 64, pp. 407-415; Robinson, N., Lorenc, A., Liao, X., The evidence for Shiatsu: A systematic review of Shiatsu and acupressure (2011) BMC Complement Altern Med, 11, p. 88; Lin, L.C., Yang, M.H., Kao, C.C., Using acupressure and Montessori-based activities to decrease agitation for residents with dementia: A cross-over trial (2009) J Am Geriatr Soc, 57, pp. 1022-1029; Nguyen, Q.A., Paton, C., The use of aromatherapy to treat behavioural problems in dementia (2008) Int J Geriatr Psychiatry, 23, pp. 337-346; Fung, J.K.K.M., Tsang, H.W.H., Chung, R.C.K., A systematic review of the use of aromatherapy in treatment of behavioral problems in dementia (2012) Geriatr Gerontol Int, 12, pp. 372-382; Forrester, L.T., Maayan, N., Orrell, M., Aromatherapy for dementia (2014) Cochrane Database Syst Rev, 2, p. CD003150; Fu, C.Y., Moyle, W., Cooke, M., A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behaviour in people with dementia (2013) BMC Complement Altern Med, 13, p. 165; Lin, P.W., Chan, W.C., Ng, B.F., Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: A cross-over randomized trial (2007) Int J Geriatr Psychiatry, 22, pp. 405-410; O'Connor, D.W., Eppingstall, B., Taffe, J., A randomized, controlled cross-over trial of dermally-applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia (2013) BMC Complement Altern Med, 13, p. 315; Smallwood, J., Brown, R., Coulter, F., Aromatherapy and behaviour disturbances in dementia: A randomized controlled trial (2001) Int J Geriatr Psychiatry, 16, pp. 1010-1013; Ballard, C.G., O'Brien, J.T., Reichelt, K., Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa (2002) J Clin Psychiatry, 63, pp. 553-558; Burns, A., Perry, E., Holmes, C., A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease (2011) Dement Geriatr Cogn Disord, 31, pp. 158-164; Akhondzadeh, S., Noroozian, M., Mohammadi, M., Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial (2003) J Neurol Neurosurg Psychiatr, 74, pp. 863-866; Burleigh, S., Armstrong, C., On the scent of a useful therapy (1997) J Dement Care, 5, pp. 21-23; Gray, S.G., Clair, A.A., Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges (2002) Am J Alzheimers Dis Other Demen, 17, pp. 169-174; Holmes, C., Hopkins, V., Hensford, C., Lavender oil as a treatment for agitated behaviour in severe dementia: A placebo controlled study (2002) Int J Geriatr Psychiatry, 17, pp. 305-308; Jimbo, D., Kimura, Y., Taniguchi, M., Effect of aromatherapy on patients with Alzheimer's disease (2009) Psychogeriatrics, 9, pp. 173-179; Kilstoff, K., Chenoweth, L., New approaches to health and well-being for dementia day-care clients, family carers and day-care staff (1998) Int J Nurs Pract, 4, pp. 70-83; Cameron, H., Du Toit, S., Richard, G., Using lemon balm oil to reduce aggression and agitation in dementia: Results of a pilot study (2011) J Dement Care, 19, pp. 36-38; Cohen-Mansfield, J., Nonpharmacologic interventions for inappropriate behaviors in dementia: A review, summary, critique (2001) Am J Geriatr Psychiatry, 9, pp. 361-381; Viggo Hansen, N., Jørgensen, T., Ertenblad, L., Massage and touch for dementia (2006) Cochrane Database Syst Rev, 4, p. CD004989; Remington, R., Calming music and hand massage with agitated elderly (2002) Nurs Res, 51, pp. 317-323; Moyle, W., Murfield, J.E., O'Dwyer, S., The effect of massage on agitated behaviours in older people with dementia: A literature review (2013) J Clin Nurs, 22, pp. 601-610; Holliday-Welsh, D.M., Gessert, C.E., Renier, C.M., Massage in the management of agitation in nursing home residents with cognitive impairment (2009) Geriatr Nurs, 30, pp. 108-117; Forbes, D., Blake Catherine, M., Thiessen Emily, J., Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, psychiatric disturbances in dementia (2014) Cochrane Database Syst Rev, 2, p. CD003946; Ancoli-Israel, S., Martin, J.L., Gehrman, P., Effect of light on agitation in institutionalized patients with severe Alzheimer disease (2003) Am J Geriatr Psychiatry, 11, pp. 194-203; Burns, A., Allen, H., Tomenson, B., Bright light therapy for agitation in dementia: A randomized controlled trial (2009) Int Psychogeriatr, 21, pp. 711-721; Dowling, G.A., Mastick, J., Hubbard, E.M., Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease (2005) Int J Geriatr Psychiatry, 20, pp. 738-743; Riemersma-Van Der Lek, R.F., Swaab, D.F., Twisk, J., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial (2008) JAMA, 299, pp. 2642-2655; Chaudhury, H., Hung, L., Badger, M., The role of physical environment in supporting person-centered dining in long-term care: A review of the literature (2013) Am J Alzheimers Dis Other Demen, 28, pp. 491-500; Barrick, A.L., Sloane, P.D., Williams, C.S., Impact of ambient bright light on agitation in dementia (2010) Int J Geriatr Psychiatry, 25, pp. 1013-1021; Padilla, R., Effectiveness of environment-based interventions for people with Alzheimer's disease and related dementias (2011) Am J Occup Ther, 65, pp. 514-522; Hickman, S.E., Barrick, A.L., Williams, C.S., The effect of ambient bright light therapy on depressive symptoms in persons with Dementia (2007) J Am Geriatr Soc, 55, pp. 1817-1824; Whear, R., Coon, J.T., Bethel, A., What is the impact of using outdoor spaces such as gardens on the physical and mental well-being of those with dementia A systematic review of quantitative and qualitative evidence (2014) J Am Med Dir Assoc, 15, pp. 697-705; Luk, K.Y., Kyc, L., Li, C.C., The effect of horticultural activities on agitation in nursing home residents with dementia (2011) Int J Geriatr Psychiatry, 26, pp. 435-436; Gonzalez, M.T., Kirkevold, M., Benefits of sensory garden and horticultural activities in dementia care: A modified scoping review (2014) J Clin Nurs, 23, pp. 2698-2715; Connell, B.R., Sanford, J.A., Lewis, D., Therapeutic effects of an outdoor activity program on nursing home residents with dementia (2007) J Hous Elderly, 21, pp. 194-209; Chatterton, W.B., Baker, F., Morgan, K., The singer or the singing: Who sings individually to persons with dementia and what are the effects (2010) Am J Alzheimers Dis Other Demen, 25, pp. 641-649; McDermott, O.C., Crellin, N., Ridder, H.M., Music therapy in dementia: A narrative synthesis systematic review (2013) Int J Geriatr Psychiatry, 28, pp. 781-794; Ueda, T.S., Suzukamo, Y., Sato, M., Effects of music therapy on behavioral and psychological symptoms of dementia: A systematic review and meta-analysis (2013) Ageing Res Rev, 12, pp. 628-641; Vasionyte, I.M., Madison, G., Musical intervention for patients with dementia: A meta-analysis (2013) J Clin Nurs, 22, pp. 1203-1216; Wall, M., Duffy, A., The effects of music therapy for older people with dementia (2010) Br J Nurs, 19, pp. 108-113; Whear, R., Abbott, R., Thompson-Coon, J., Effectiveness of mealtime interventions on behavior symptoms of people with dementia living in care homes: A systematic review (2014) J Am Med Dir Assoc, 15, pp. 185-193; Groene, R.W., Effectiveness of music therapy 1:1 intervention with individuals having senile dementia of the Alzheimer's type (1993) J Music Ther, 30, pp. 138-157; Guétin, S., Portet, F., Picot, M.C., Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: Randomised, controlled study (2009) Dement Geriatr Cogn Disord, 28, pp. 36-46; Ledger, A.J., Baker, F.A., An investigation of long-term effects of group music therapy on agitation levels of people with Alzheimer's disease (2007) Aging Ment Health, 11, pp. 330-338; Miura, H., Kanayama, Y., Mogi, N., (2005) Effect and Significance of Music Therapy on Elderly Persons with Mild Dementia, 5, pp. 48-57; Sung, H.C., Chang, A.M., Abbey, J., The effects of preferred music on agitation of older people with dementia in Taiwan (2006) Int J Geriatr Psychiatry, 21, pp. 999-1000; Sung, H.C., Chang, A.M., Lee, W.-L., A preferred music listening intervention to reduce anxiety in older adults with dementia in nursing homes (2010) J Clin Nurs, 19, pp. 1056-1064; Suzuki, M., Kanamori, M., Nagasawa, S., Music therapy-induced changes in behavioral evaluations, saliva chromogranin a and immunoglobulin a concentrations in elderly patients with senile dementia (2007) Geriatr Gerontol Int, 7, pp. 61-71; Tuet, R.W.K., Lam, L.C.W., A preliminary study of the effects of music therapy on agitation in Chinese patients with dementia (2006) Hong Kong J Psychiatry, 16, pp. 87-91; Ikeda, M., Suzuki, M., Sawai, D., Effects of nursing intervention using rhythmic exercise for patients with severe senile dementia (2006) Nurs Res, 39, pp. 301-313; Mihara, B., Hosoya, M., Mihara, Y., The effect of music therapy for elderly with dementia: A comparative study between large group and small group sessions (2004) Japanese J Music Ther, 4, pp. 208-216; Raglio, A., Bellelli, G., Traficante, D., Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia (2008) Alzheimer Dis Assoc Disord, 22, pp. 158-162; Sung, H.C., Chang, S.M., Lee, W.L., The effects of group music with movement intervention on agitated behaviours of institutionalized elders with dementia in Taiwan (2006) Complement Ther Med, 14, pp. 113-119; Choi, A.N., Lee, M.S., Cheong, K.J., Effects of group music intervention on behavioral and psychological symptoms in patients with dementia: A pilot-controlled trial (2009) Int J Neurosci, 119, pp. 471-481; Goka, F., The effects of combined music and reminiscence therapy for small groups of the elderly with senile dementia of Alzheimer type, the efficacy of the evaluation method (2005) Japanese J Music Ther, 5, pp. 25-38; Raglio, A., Bellelli, G., Traficante, D., Efficacy of music therapy treatment based on cycles of sessions: A randomised controlled trial (2010) Aging Ment Health, 14, pp. 900-904; Smith, G.H., A comparison of the effects of three treatment interventions on cognitive functioning of Alzheimer patients (1986) Music Ther, 6, pp. 41-56; Suzuki, M., Kanamori, M., Watanabe, M., Behavioral and endocrinological evaluation of music therapy for elderly patients with dementia (2004) Nurs Health Sci, 6, pp. 11-18; Van De Winckel, A., Feys, H., De Weerdt, W., Cognitive and behavioural effects of music-based exercises in patients with dementia (2004) Clin Rehabil, 18, pp. 253-260; Svansdottir, H.B., Snaedal, J., Music therapy in moderate and severe dementia of Alzheimer's type: A case-control study (2006) Int Psychogeriatr, 18, pp. 613-621; Clark, M.E., Lipe, A.W., Bilbrey, M., Use of music to decrease aggressive behaviors in people with dementia (1998) J Gerontol Nurs, 24, pp. 10-17; Cooke, M., Moyle, W., Shum, D., A randomized controlled trial exploring the effect of music on quality of life and depression in older people with Dementia (2010) J Health Psychology, 15, pp. 765-776; Nair, B., Heim, C., Krishnan, C., The effect of Baroque music on behavioural disturbances in patients with dementia (2011) Australas J Ageing, 30, pp. 11-15; Raglio, A., Oasi, O., Gianotti, M., Effects of music therapy on psychological symptoms and heart rate variability in patients with dementia. A pilot study (2010) Current Aging Sci, pp. 242-246; Irish, M., Cunningham, C.J., Walsh, J.B., Investigating the enhancing effect of music on autobiographical memory in mild Alzheimer's disease (2006) Dement Geriatr Cogn Disord, 22, pp. 108-120; Denney, A., Quiet music. An intervention for mealtime agitation (1997) J Gerontol Nurs, 23, pp. 16-23; Hicks-Moore, S.L., Relaxing music at mealtime in nursing homes: Effects on agitated patients with dementia (2005) J Gerontol Nurs, 31, pp. 26-32; Ragneskog, H., Kihlgren, M., Karlsson, I., Dinner music for demented patients: Analysis of video-recorded observations (1996) Clin Nurs Res, 5, pp. 262-277. , Discussion 78-82; Thomas, D.W., Smith, M., The effect of music on caloric consumption among nursing home residents with Dementia of the Alzheimer's type (2009) Act Adapt Aging, 33, pp. 1-16; Kiepe, M.S., Barbara, S., Thomas, K., Effects of dance therapy and ballroom dances on physical and mental illnesses: A systematic review (2012) Arts Psychotherapy, 39, pp. 404-411; Guzman-Garcia, A., Hughes, J.C., James, I.A., Dancing as a psychosocial intervention in care homes: A systematic review of the literature (2013) Int J Geriatr Psychiatry, 28, pp. 914-924; Hokkanen, L., Rantala, L., Remes, A.M., Dance and movement therapeutic methods in management of dementia: A randomized, controlled study (2008) J Am Geriatr Soc, 56, pp. 771-772; Chung, J.C., Lai, C.K., Chung, P.M., Snoezelen for dementia (2002) Cochrane Database Syst Rev, 4, p. CD003152; Baker, R., Bell, S., Baker, E., A randomized controlled trial of the effects of multi-sensory stimulation (MSS) for people with dementia (2001) Br J Clin Psychology, 40, pp. 81-96; Baker, R., Dowling, Z., (1995) INTERACT. A New Measure of Response to Multi-Sensory Environments, , Research Publication. Research and Development Support Unit, Poole Hospital, Dorset; Baker, R., Holloway, J., Holtkamp, C.C.M., Effects of multi-sensory stimulation for people with dementia (2003) J Dv Nurs, 43, pp. 465-477; Van Weert, J.C., Van Dulmen, A.M., Spreeuwenberg, P.M., Effects of snoezelen, integrated in 24 h dementia care, on nurse-patient communication during morning care (2005) Patient Educ Couns, 58, pp. 312-326; Van Weert, J.C., Van Dulmen, A.M., Spreeuwenberg, P.M., Behavioral and mood effects of Snoezelen integrated into 24-hour dementia care (2005) J Am Geriatr Soc, 53, pp. 24-33; Bi, X., Lv, H., Chen, B.L., Effects of transcutaneous electrical nerve stimulation on pain in patients with spinal cord injury: A randomized controlled trial (2015) J Phys Ther Sci, 27, pp. 23-25; Salami, O., Lyketsos, C., Rao, V., Treatment of sleep disturbance in Alzheimer's dementia (2011) Int J Geriatr Psychiatry, 26, pp. 771-782; Cameron, M., Lonergan, E., Lee, H., Transcutaneous electrical nerve stimulation (TENS) for dementia (2003) Cochrane Database Syst Rev, 3, p. CD004032; Scherder, E., Knol, D., Van Someren, E., Effects of low-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease (2003) Neurorehabil Neural Repair, 17, pp. 101-108; Scherder, E.J., Bouma, A., Steen, L., Influence of transcutaneous electrical nerve stimulation on memory in patients with dementia of the Alzheimer type (1992) J Clin Exp Neuropsychol, 14, pp. 951-960; Scherder, E.J., Deijen, J.B., Vreeswijk, S.H., Cranial electrostimulation (CES) in patients with probable Alzheimer's disease (2002) Behav Brain Res, 128, pp. 215-217; Scherder, E.J., Van Someren, E.J., Bouma, A., Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in aging (2000) Behav Brain Res, 111, pp. 223-225; Scherder, E.J., Van Someren, E.J., Swaab, D.F., Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease (1999) Behav Brain Res, 101, pp. 105-107; Van Someren, E.J., Scherder, E.J., Swaab, D.F., Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease (1998) Alzheimer Dis Assoc Disord, 12, pp. 114-118; Hozumi, S., Hori, H., Okawa, M., Favorable effect of transcranial electrostimulation on behavior disorders in elderly patients with dementia: A double-blind study (1996) Int J Neurosci, 88, pp. 1-10; Woods, B., Aguirre, E., Spector, A.E., Cognitive stimulation to improve cognitive functioning in people with dementia (2012) Cochrane Database Syst Rev, 2, p. CD005562; Aguirre, E., Woods, R.T., Spector, A., Cognitive stimulation for dementia: A systematic review of the evidence of effectiveness from randomised controlled trials (2013) Ageing Res Rev, 12, pp. 253-262; Alves, J., Magalhaes, R., Thomas, R.E., Is there evidence for cognitive intervention in Alzheimer disease A systematic review of efficacy, feasibility, cost-effectiveness (2013) Alzheimer Dis Assoc Disord, 27, pp. 195-203; Carrion, C., Aymerich, M., Baillés, E., Cognitive psychosocial intervention in dementia: A systematic review (2013) Dement Geriatr Cogn Disord, 36, pp. 363-375; Yu, F., Rose, K.M., Burgener, S.C., Cognitive training for earlystage Alzheimer's disease and dementia (2009) J Gerontol Nurs, 35, pp. 23-29; Olazarán, J., Reisberg, B., Clare, L., Nonpharmacological therapies in Alzheimer's disease: A systematic review of efficacy (2010) Dement Geriatr Cogn Disord, 30, pp. 161-178; Zientz, J., Rackley, A., Chapman, S.B., Evidence-based practice recommendations for dementia: Educating caregivers on Alzheimer's disease and training communication strategies (2007) J Med Speech Lang Pathol, 15, pp. iii-xiv; Baines, S., Saxby, P., Ehlert, K., Reality orientation and reminiscence therapy. A controlled cross-over study of elderly confused people (1987) Br J Psychiatry, 151, pp. 222-231; Ferrario, E., Cappa, G., Molaschi, M., Reality orientation therapy in institutionalized elderly patients: Preliminary results (1991) Arch Gerontol Geriatr, 12, pp. 139-142; Onder, G., Zanetti, O., Giacobini, E., Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: Randomised controlled trial (2005) Br J Psychiatry, 187, pp. 450-455; Robichaud, L., Hebert, R., Desrosiers, J., Efficacy of a sensory integration program on behaviors of inpatients with dementia (1994) Am J Occup Ther, 48, pp. 355-360; Kim, S.Y., Yoo, E.Y., Jung, M.Y., A systematic review of the effects of occupational therapy for persons with dementia: A meta-analysis of randomized controlled trials (2012) NeuroRehabilitation, 31, pp. 107-115; Kurz, A.F., Leucht, S., Lautenschlager, N.T., The clinical significance of cognition-focused interventions for cognitively impaired older adults: A systematic review of randomized controlled trials (2011) Int Psychogeriatr, 23, pp. 1364-1375; Blake, M., Group reminiscence therapy for adults with dementia: A review (2013) Br J Community Nurs, 18, pp. 228-233; Subramaniam, P., Woods, B., The impact of individual reminiscence therapy for people with dementia: Systematic review (2012) Expert Rev Neurother, 12, pp. 545-555; Deponte, A., Missan, R., Effectiveness of validation therapy (VT) in group: Preliminary results (2007) Arch Gerontol Geriatr, 44, pp. 113-117; Wang, J.J., Yen, M., OuYang, W.C., Group reminiscence intervention in Taiwanese elders with dementia (2009) Arch Gerontol Geriatr, 49, pp. 227-232; Haight, B.K., Gibson, F., Michel, Y., The Northern Ireland life review/life storybook project for people with dementia (2006) Alzheimers Dement, 2, pp. 56-58; Morgan, S., Woods, R., (2010) Life Review with People with Dementia in Care Homes: A Preliminary Randomized Controlled Trial., 1, pp. 43-60; Lai, C.K., Chi, I., Kayser-Jones, J., A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia (2004) Int Psychogeriatr, 16, pp. 33-49; Haslam, C., Haslam, S.A., Jetten, J., The social treatment: The benefits of group interventions in residential care settings (2010) Psychol Aging, 25, pp. 157-167; Politis, A.M., Vozzella, S., Mayer, L.S., A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care (2004) Int J Geriatr Psychiatry, 19, pp. 1087-1094; Neal, M., Barton Wright, P., Validation therapy for dementia (2003) Cochrane Database Syst Rev, 3, p. CD001394; (1982) Validation Therapy, Versus Reality Orientation As Treatment for Disorientated Institutionalised Elderly [Masters Dissertation], , Peoples Akron: College of Nursing, University of Akron; Robb, S.S., Stegman, C.E., Wolanin, M.O., No research versus research with compromised results: A study of validation therapy (1986) Nurs Res, 35, pp. 113-118; Toseland, R.W., Diehl, M., Freeman, K., The impact of validation group therapy on nursing home residents with dementia (1997) J Appl Gerontol, 16, pp. 31-50; Vasse, E., Vernooij-Dassen, M., Spijker, A., A systematic review of communication strategies for people with dementia in residential and nursing homes (2010) Int Psychogeriatr, 22, pp. 189-200; Cohen-Mansfield, J., Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated (1986) J Am Geriatr Soc, 34, pp. 722-727; Abraha, I., Rimland, J.M., Lozano-Montoya, I., Simulated presence therapy for dementia: A systematic review protocol (2016) BMJ Open, 6, p. e011007; Kverno, K.S., Black, B.S., Nolan, M.T., Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies 1998-2008: A systematic literature review (2009) Int Psychogeriatr, 21, pp. 825-843; Teri, L., Logsdon, R.G., McCurry, S.M., Nonpharmacologic treatment of behavioral disturbance in dementia (2002) Med Clin North Am, 86, pp. 641-656. , viii; Teri, L., Gibbons, L.E., McCurry, S.M., Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial (2003) JAMA, 290, pp. 2015-2022; Proctor, R., Burns, A., Powell, H.S., Behavioural management in nursing and residential homes: A randomised controlled trial (1999) Lancet, 354, pp. 26-29; Teri, L., Huda, P., Gibbons, L., STAR: A dementia-specific training program for staff in assisted living residences (2005) Gerontologist, 45, pp. 686-693; McCurry, S.M., Gibbons, L.E., Logsdon, R.G., Nighttime insomnia treatment and education for Alzheimer's disease: A randomized, controlled trial (2005) J Am Geriatr Soc, 53, pp. 793-802; Gitlin, L.N., Winter, L., Dennis, M.P., A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: The COPE randomized trial (2010) JAMA, 304, pp. 983-991; Beck, C.K., Vogelpohl, T.S., Rasin, J.H., Effects of behavioral interventions on disruptive behavior and affect in demented nursing home residents (2002) Nurs Res, 51, pp. 219-228; Suhr, J., Progressive muscle relaxation in the management of behavioural disturbance in Alzheimer's disease (1999) Neuropsychol Rehabil, 9, pp. 31-44; McCallion, P., Toseland, R.W., Freeman, K., An evaluation of a family visit education program (1999) J Am Geriatr Soc, 47, pp. 203-214; Livingston, G., Kelly, L., Lewis-Holmes, E., A systematic review of the clinical effectiveness and cost-effectiveness of sensory psychological and behavioural interventions for managing agitation in older adults with dementia (2014) Health Technol Assess, 18, pp. 1-226. , v-vi; Gormley, N., Lyons, D., Howard, R., Behavioural management of aggression in dementia: A randomized controlled trial (2001) Age Ageing, 30, pp. 141-145; Teri, L., Logsdon, R.G., Peskind, E., Treatment of agitation in AD: A randomized, placebo-controlled clinical trial (2000) Neurology, 55, pp. 1271-1278; Bourgeois, M.S., Burgio, L.D., Schulz, R., Modifying repetitive verbalizations of community-dwelling patients with AD (1997) Gerontologist, 37, pp. 30-39; Moniz Cook, E.D., Swift, K., James, I., Functional analysis-based interventions for challenging behaviour in dementia (2012) Cochrane Database Syst Rev, 2, p. CD006929; Mador, J.E., Giles, L., Whitehead, C., A randomized controlled trial of a behavior advisory service for hospitalized older patients with confusion (2004) Int J Geriatr Psychiatry, 19, pp. 858-863; Burgio, L., Stevens, A., Guy, D., Impact of two psychosocial interventions on white and African American family caregivers of individuals with dementia (2003) Gerontologist, 43, pp. 568-579; Chenoweth, L., King, M.T., Jeon, Y.-H., Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, usual care in dementia: A cluster-randomised trial (2009) Lancet Neurol, 8, pp. 317-325; Farran, C.J., Gilley, D.W., McCann, J.J., Psychosocial interventions to reduce depressive symptoms of dementia caregivers: A randomized clinical trial comparing two approaches (2004) J Mental Health Aging, 10, pp. 337-350; Fossey, J., Ballard, C., Juszczak, E., Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial (2006) BMJ, 332, pp. 756-761; Gitlin, L.N., Winter, L., Corcoran, M., Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative (2003) Gerontologist, 43, pp. 532-546; Gonyea, J.G., O'Connor, M.K., Boyle, P.A., Project CARE: A randomized controlled trial of a behavioral intervention group for Alzheimer's disease caregivers (2006) Gerontologist, 46, pp. 827-832; Huang, H.L., Shyu, Y.I., Chen, M.C., A pilot study on a home-based caregiver training program for improving caregiver self-efficacy and decreasing the behavioral problems of elders with dementia in Taiwan (2003) Int J Geriatr Psychiatry, 18, pp. 337-345; Losada Baltar, A., Izal Fernandez De Troconiz, M., Montorio Cerrato, I., Differential efficacy of two psychoeducational interventions for dementia family caregivers (2004) Rev Neurol, 38, pp. 701-708; Moniz-Cook, E., Elston, C., Gardiner, E., Can training community mental health nurses to support family carers reduce behavioural problems in dementia An exploratory pragmatic randomised controlled trial (2008) Int J Geriatr Psychiatry, 23, pp. 185-191; Zarit, S.H., Anthony, C.R., Boutselis, M., Interventions with care givers of dementia patients: Comparison of two approaches (1987) Psychol Aging, 2, pp. 225-232; Gitlin, L.N., Winter, L., Dennis, M.P., Targeting and managing behavioral symptoms in individuals with dementia: A randomized trial of a nonpharmacological intervention (2010) J Am Geriatr Soc, 58, pp. 1465-1474; Finnema, E., Droës, R.M., Ettema, T., The effect of integrated emotion-oriented care versus usual care on elderly persons with dementia in the nursing home and on nursing assistants: A randomized clinical trial (2005) Int J Geriatr Psychiatry, 20, pp. 330-343; Schrijnemaekers, V., Van Rossum, E., Candel, M., Effects of emotion-oriented care on elderly people with cognitive impairment and behavioral problems (2002) Int J Geriatr Psychiatry, 17, pp. 926-937; Brodaty, H., Arasaratnam, C., Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia (2012) Am J Psychiatry, 169, pp. 946-953; Eggenberger, E., Heimerl, K., Bennett, M.I., Communication skills training in dementia care: A systematic review of effectiveness, training content, didactic methods in different care settings (2013) Int Psychogeriatr, 25, pp. 345-358; Teri, L., McCurry, S.M., Logsdon, R., Training community consultants to help family members improve dementia care: A randomized controlled trial (2005) Gerontologist, 45, pp. 802-811; Burgio, L.D., Stevens, A., Burgio, K.L., Teaching and maintaining behavior management skills in the nursing home (2002) Gerontologist, 42, pp. 487-496; Burgio, L.D., Allen-Burge, R., Roth, D.L., Come talk with me: Improving communication between nursing assistants and nursing home residents during care routines (2001) Gerontologist, 41, pp. 449-460; Done, D.J., Thomas, J.A., Training in communication skills for informal carers of people suffering from dementia: A cluster randomized clinical trial comparing a therapist led workshop and a booklet (2001) Int J Geriatr Psychiatry, 16, pp. 816-821; Magai, C., Cohen, C.I., Gomberg, D., Impact of training dementia caregivers in sensitivity to nonverbal emotion signals (2002) Int Psychogeriatr, 14, pp. 25-38; Staal, J.A., Sacks, A., Matheis, R., The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit (2007) Int J Psychiatry Med, 37, pp. 357-370; Clare, L., Linden, D.E., Woods, R.T., Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: A single-blind randomized controlled trial of clinical efficacy (2010) Am J Geriatr Psychiatry, 18, pp. 928-939; Gitlin, L.N., Winter, L., Burke, J., Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: A randomized pilot study (2008) Am J Geriatr Psychiatry, 16, pp. 229-239; Gitlin, L.N., Corcoran, M., Winter, L., A randomized, controlled trial of a home environmental intervention: Effect on efficacy and upset in caregivers and on daily function of persons with dementia (2001) Gerontologist, 41, pp. 4-14; Gaugler, J.E., Kane, R.L., Families and assisted living (2007) Gerontologist, 47, pp. 83-99; Collet, J., De Vugt, M.E., Verhey, F.R., Efficacy of integrated interventions combining psychiatric care and nursing home care for nursing home residents: A review of the literature (2010) Int J Geriatr Psychiatry, 25, pp. 3-13; Zimmerman, S., Anderson, W.L., Brode, S., Systematic review: Effective characteristics of nursing homes and other residential long-term care settings for people with dementia (2013) J Am Geriatr Soc, 61, pp. 1399-1409; Whall, A.L., Black, M.E., Groh, C.J., The effect of natural environments upon agitation and aggression in late stage dementia patients (1997) Am J Alzheimers Dis Other Demen, 12, pp. 216-220; Hicks-Moore, S.L., Robinson, B.A., Favorite music and hand massage: Two interventions to decrease agitation in residents with dementia (2008) Dementia, 7, pp. 95-108; Potter, R., Ellard, D., Rees, K., A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia (2011) Int J Geriatr Psychiatry, 26, pp. 1000-1011; Thuné-Boyle, I.C., Iliffe, S., The effect of exercise on behavioral and psychological symptoms of dementia: Towards a research agenda (2012) Int Psychogeriatr, 24, pp. 1046-1057; Burgener, S.C., Yang, Y., Gilbert, R., The effects of a multimodal intervention on outcomes of persons with early-stage dementia (2008) Am J Alzheimers Dis Other Demen, 23, pp. 382-394; Rolland, Y., Pillard, F., Klapouszczak, A., Exercise program for nursing home residents with Alzheimer's disease: A 1-year randomized, controlled trial (2007) J Am Geriatr Soc, 55, pp. 158-165; Steinberg, M., Leoutsakos, J.M., Podewils, L.J., Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: The Maximizing Independence in Dementia (MIND) study (2009) Int J Geriatr Psychiatry, 24, pp. 680-685; Bernabei, V., De Ronchi, D., La Ferla, T., Animal-assisted interventions for elderly patients affected by dementia or psychiatric disorders: A review (2013) J Psychiatr Res, 47, pp. 762-773; Churchill, M., Safaoui, J., McCabe, B.W., Using a therapy dog to alleviate the agitation and desocialization of people with Alzheimer's disease (1999) J Psychosoc Nurs Ment Health Serv, 37, pp. 16-22; McCabe, B.W., Baun, M.M., Speich, D., Resident dog in the Alzheimer's special care unit (2002) West J Nurs Res, 24, pp. 684-696; Richeson, N.E., Effects of animal-assisted therapy on agitated behaviors and social interactions of older adults with dementia (2003) Am J Alzheimers Dis Other Demen, 18, pp. 353-358; Libin, A., Cohen-Mansfield, J., Therapeutic robocat for nursing home residents with dementia: Preliminary inquiry (2004) Am J Alzheimers Dis Other Demen, 19, pp. 111-116; Motomura, N., Yagi, T., Ohyama, H., Animal assisted therapy for people with dementia (2004) Psychogeriatrics, 4, pp. 40-42; Sellers, D.M., The evaluation of an animal assisted therapy intervention for elders with dementia in long-term care (2006) Act Adapt Aging, 30, pp. 61-77; Brush, J.A., Meehan, R.A., Calkins, M.P., Using the environment to improve intake for people with dementia (2002) Alzheimer's Care Today, 3, pp. 330-338; Koss, E., Gilmore, G., Environmental interventions and functional ability of AD patients (1998) Research and Practice in Alzheimer's Disease, pp. 185-191. , In: Vellas, B., Fitten, J. and Frisoni, G. eds Paris: Springer; Frisoni, G.B., Gozzetti, A., Bignamini, V., Special care units for dementia in nursing homes: A controlled study of effectiveness (1998) Arch Gerontol Geriatr, 26, pp. 215-224; Fontana Gasio, P., Kraüchi, K., Cajochen, C., Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly (2003) Exp Gerontol, 38, pp. 207-216},
correspondence_address1={Abraha, I.; Geriatrics and Geriatric Emergency Care, Italy; email: iosief_a@yahoo.it},
publisher={BMJ Publishing Group},
issn={20446055},
pubmed_id={28302633},
language={English},
abbrev_source_title={BMJ Open},
document_type={Review},
source={Scopus},
}

@ARTICLE{Chrousos2007213,
author={Chrousos, G.P. and Kino, T.},
title={Glucocorticoid action networks and complex psychiatric and/or somatic disorders},
journal={Stress},
year={2007},
volume={10},
number={2},
pages={213-219},
doi={10.1080/10253890701292119},
note={cited By 212},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249002259&doi=10.1080%2f10253890701292119&partnerID=40&md5=464975cde32177a82f44187182a435a9},
affiliation={First Department of Pediatrics, Athens University Medical School, 11527 Athens, Greece; Pediatric Endocrinology Section, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1109, United States; National Institutes of Health, Clinical Research Center, Building 10, 10 Center Drive, Bethesda, MD 20892-1109, United States},
abstract={Glucocorticoids contribute fundamentally to the maintenance of basal and stress-related homeostasis in all higher organisms. These hormones influence a large percentage of the expressed human genome and their effects spare almost no organs or tissues. Glucocorticoids influence many functions of the central nervous system, such as arousal, cognition, mood and sleep, the activity and direction of intermediary metabolism, the maintenance of a normal cardiovascular tone, the activity and quality of the immune and inflammatory reaction, including the manifestations of the sickness syndrome, as well as growth and reproduction. The numerous actions of glucocorticoids are mediated by a set of at least 16 glucocorticoid receptor (GR) isoforms forming homo- or hetero-dimers. The GRs consist of multifunctional domain proteins operating as ligand-dependent transcription factors that interact with many other cell signaling systems. The presence of multiple GR monomers and dimers expressed in a cell-specific fashion at different quantities with quantitatively and qualitatively different transcriptional activities suggests that the glucocorticoid signaling system is highly stochastic. Based on ample evidence, we present our conception that glucocorticoids are heavily involved in human pathophysiology and influence life expectancy. Common psychiatric and/or somatic complex disorders, such as anxiety, depression, insomnia, chronic pain and fatigue syndromes, obesity, the metabolic syndrome, essential hypertension, diabetes type 2, atherosclerosis with its cardiovascular sequelae, and osteoporosis, as well as autoimmune inflammatory and allergic disorders, all appear to have a glucocorticoid component. © 2007 Informa UK Ltd.},
author_keywords={Chronic stress;  Cortisol;  Cushing's syndrome;  Hypothalamic-pituitary-adrenal axis;  Inflammation;  Insulin resistance},
keywords={glucocorticoid;  glucocorticoid receptor, allergic disease;  anxiety;  arousal;  atherosclerosis;  cardiovascular disease;  cardiovascular system;  central nervous system;  chronic fatigue syndrome;  chronic pain;  cognition;  depression;  DNA polymorphism;  essential hypertension;  genome;  growth;  homeostasis;  human;  immunity;  inflammation;  inflammatory disease;  insomnia;  life expectancy;  mental disease;  metabolic syndrome X;  metabolism;  mood;  non insulin dependent diabetes mellitus;  obesity;  osteoporosis;  pathophysiology;  priority journal;  reproduction;  review;  sleep;  stress, Glucocorticoids;  Humans;  Hypothalamo-Hypophyseal System;  Mental Disorders;  Metabolic Syndrome X;  Pituitary-Adrenal System;  Receptors, Glucocorticoid;  Stress, Psychological},
chemicals_cas={Glucocorticoids; Receptors, Glucocorticoid},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute of Child Health and Human DevelopmentNational Institute of Child Health and Human Development, NICHD},
funding_details={Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentEunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, Z01HD000615, Z01HD008732, ZIAHD000618},
funding_text 1={The work that has led to this article was funded by the Intramural Research Program of the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.},
references={Alevizaki, M., Cimponeriu, A., Lekakis, J., Papamichael, C., Chrousos, G.P., High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography (2007) Metabolism, 56 (2), pp. 222-226; Buemann, B., Black, E., Holst, C., Toubro, S., Echwald, S., Pedersen, O., Astrup, A., Sorensen, T., The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in men (2005) Obes Res, 13 (5), pp. 862-867; Buemann, B., Vohl, M.C., Chagnon, M., Chagnon, Y.C., Gagnon, J., Perusse, L., Dionne, F., Bouchard, C., Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus (1997) Obes Res, 5 (3), pp. 186-192; Charmandari, E., Kino, T., Chrousos, G.P., Glucocorticoids and their actions: An introduction (2004) Ann NY Acad Sci, 1024, pp. 1-8; Chrousos, G.P., The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation (1995) N Engl J Med, 332 (20), pp. 1351-1362; Chrousos, G.P., Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture (1998) Ann NY Acad Sci, 851, pp. 311-335; Chrousos, G.P., The role of stress and the hypothalamic-pituitary- adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue-related causes (2000) Int J Obes Relat Metab Disord, 24 (SUPPL. 2), pp. S50-S55; Chrousos, G.P., The stress response and immune function: Clinical implications. The 1999 Novera H. Spector lecture (2000) Ann NY Acad Sci, 917, pp. 38-67; Chrousos, G.P., Glucocorticoid therapy (2001) Endocrinology and metabolism, pp. 609-632. , Flig P, Frohman L, editors, 4th ed. New York: McGraw-Hill. p; Chrousos, G.P., The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies (2004) Am J Med, 117 (3), pp. 204-207; Chrousos, G.P., Kino, T., Intracellular glucocorticoid signaling: A formerly simple system turns stochastic (2005) Sci STKE 2005(304):pe48; Chrousos, G.P., Charmandari, E., Kino, T., Glucocorticoid action networks - an introduction to systems biology (2004) J Clin Endocrinol Metab, 89 (2), pp. 563-564; Chrousos, G.P., Detera-Wadleigh, S.D., Karl, M., Syndromes of glucocorticoid resistance (1993) Ann Intern Med, 119 (11), pp. 1113-1124; DeRijk, R., de Kloet, E.R., Corticosteroid receptor genetic polymorphisms and stress responsivity (2005) Endocrine, 28 (3), pp. 263-270; Dobson, M.G., Redfern, C.P., Unwin, N., Weaver, J.U., The N363S polymorphism of the glucocorticoid receptor: Potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus (2001) J Clin Endocrinol Metab, 86 (5), pp. 2270-2274; Franchimont, D., Kino, T., Galon, J., Meduri, G.U., Chrousos, G., Glucocorticoids and inflammation revisited: The state of the art (2003) NIH clinical staff conference Neuroimmunomodulation, 10 (5), pp. 247-260; Friedman, T.C., Mastorakos, G., Newman, T.D., Mullen, N.M., Horton, E.G., Costello, R., Papadopoulos, N.M., Chrousos, G.P., Carbohydrate and lipid metabolism in endogenous hypercortisolism: Shared features with metabolic syndrome X and NIDDM (1996) Endocr J, 43 (6), pp. 645-655; Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Bornstein, S.R., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells (2002) FASEB J, 16 (1), pp. 61-71; Gold, P.W., Chrousos, G.P., Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs. low CRH/NE states (2002) Mol Psychiatry, 7 (3), pp. 254-275; Huizenga, N.A., Koper, J.W., De Lange, P., Pols, H.A., Stolk, R.P., Burger, H., Grobbee, D.E., Lamberts, S.W., A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo (1998) J Clin Endocrinol Metab, 83 (1), pp. 144-151; Ichijo, T., Voutetakis, A., Cotrim, A.P., Bhattachryya, N., Fujii, M., Chrousos, G.P., Kino, T., The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: Potential clinical implications (2005) J Biol Chem, 280 (51), pp. 42067-42077; Kino, T., Chrousos, G.P., Tumor necrosis factor alpha receptor-and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators (2003) J Biol Chem, 278 (5), pp. 3023-3029; Kino, T., Chrousos, G.P., Glucocorticoid and mineralocorticoid receptors and associated diseases (2004) Essays Biochem, 40, pp. 137-155; Kino, T., Charmandari, E., Chrousos, G.P., Basic and clinical implications of glucocorticoid action -focus on development. National Institutes of Health, Bethesda, Maryland, USA. june 17-18, 2003. Introduction and abstracts (2003) Horm Metab Res, 35 (10), pp. 628-648; Kino, T., De Martino, M.U., Charmandari, E., Mirani, M., Chrousos, G.P., Tissue glucocorticoid resistance/hypersensitivity syndromes (2003) J Steroid Biochem Mol Biol, 85 (2-5), pp. 457-467; Kino, T., Ichijo, T., Chrousos, G.P., FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors (2004) J Steroid Biochem Mol Biol, 92 (5), pp. 357-363; Kino, T., Souvatzoglou, E., De Martino, M.U., Tsopanomihalu, M., Wan, Y., Chrousos, G.P., Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway (2003) J Biol Chem, 278 (28), pp. 25651-25656; Kino, T., Souvatzoglou, E., Charmandari, E., Ichijo, T., Driggers, P., Mayers, C., Alatsatianos, A., Segars, J.H., Rho family guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system (2006) J Biol Chem, 281 (14), pp. 9118-9126; Kino, T., Vottero, A., Chrousos, G.P., Mineralocorticoid and glucocorticoid receptors (2001) Nuclear receptor and genetic disease, pp. 297-307. , Burris TP, McCabe ERB, editors, London: Academic Press. p; Lanz, R.B., McKenna, N.J., Onate, S.A., Albrecht, U., Wong, J., Tsai, S.Y., Tsai, M.J., O'Malley, B.W., A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex (1999) Cell, 97 (1), pp. 17-27; Lin, R.C., Wang, W.Y., Morris, B.J., High penetrance, overweight, and glucocorticoid receptor variant: Case-control study (1999) BMJ, 319 (7221), pp. 1337-1338; Lu, N.Z., Cidlowski, J.A., Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes (2005) Mol Cell, 18 (3), pp. 331-342; Marti, A., Ochoa, M.C., Sanchez-Villegas, A., Martinez, J.A., Martinez-Gonzalez, M.A., Hebebrand, J., Hinney, A., Vedder, H., Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity (2006) BMC Med Genet, 7, pp. 50-60; McEwen, B.S., Protective and damaging effects of stress mediators (1998) N Engl J Med, 338 (3), pp. 171-179; Miller, W.L., Chrousos, G.P., The adrenal cortex (2001) Endocrinology and metabolism, pp. 387-524. , Felig P, Frohman LA, editors, 4th ed, New York: McGraw-Hill. p; Panarelli, M., Holloway, C.D., Fraser, R., Connell, J.M., Ingram, M.C., Anderson, N.H., Kenyon, C.J., Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects (1998) J Clin Endocrinol Metab, 83 (6), pp. 1846-1852; Papanicolaou, D.A., Wilder, R.L., Manolagas, S.C., Chrousos, G.P., The pathophysiologic roles of interleukin-6 in human disease (1998) Ann Intern Med, 128 (2), pp. 127-137; Phillips, D.I., Barker, D.J., Fall, C.H., Seckl, J.R., Whorwood, C.B., Wood, P.J., Walker, B.R., Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome? (1998) J Clin Endocrinol Metab, 83 (3), pp. 757-760; Rosmond, R., Chagnon, Y.C., Holm, G., Chagnon, M., Perusse, L., Lindell, K., Carlsson, B., Bjorntorp, P., A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis (2000) Obes Res, 8 (3), pp. 211-218; Stevens, A., Ray, D.W., Zeggini, E., John, S., Richards, H.L., Griffiths, C.E., Donn, R., Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype (2004) J Clin Endocrinol Metab, 89 (2), pp. 892-897; Syed AA, Irving JA, Redfern CP, Hall AG, Unwin NC, White M, Bhopal RS, Weaver JU. 2006. Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 14(5):759-764; Ukkola, O., Rosmond, R., Tremblay, A., Bouchard, C., Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding (2001) Atherosclerosis, 157 (1), pp. 221-224; van Rossum, E.F., Lamberts, S.W., Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition (2004) Recent Prog Horm Res, 59, pp. 333-357; van Rossum, E.F., Koper, J.W., Huizenga, N.A., Uitterlinden, A.G., Janssen, J.A., Brinkmann, A.O., Grobbee, D.E., Lamberts, S.W., A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels (2002) Diabetes, 51 (10), pp. 3128-3134; van Rossum, E.F., Voorhoeve, P.G., te Velde, S.J., Koper, J.W., Delemarrevan de Waal, H.A., Kemper, H.C., Lamberts, S.W., The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults (2004) J Clin Endocrinol Metab, 89 (8), pp. 4004-4009; Weaver, J.U., Hitman, G.A., Kopelman, P.G., An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women (1992) J Mol Endocrinol, 9 (3), pp. 295-300; Wust, S., Van Rossum, E.F., Federenko, I.S., Koper, J.W., Kumsta, R., Hellhammer, D.H., Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress (2004) J Clin Endocrinol Metab, 89 (2), pp. 565-573},
correspondence_address1={Chrousos, G.P.; National Institutes of Health, 10 Center Drive, Bethesda, MD 20892-1109, United States; email: chrousog@mail.nih.gov},
issn={10253890},
coden={STREF},
pubmed_id={17514590},
language={English},
abbrev_source_title={Stress},
document_type={Review},
source={Scopus},
}

@ARTICLE{Ham20031978,
author={Ham, C.},
title={Improving the performance of health services: The role of clinical leadership},
journal={Lancet},
year={2003},
volume={361},
number={9373},
pages={1978-1980},
doi={10.1016/S0140-6736(03)13593-3},
note={cited By 199},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037529065&doi=10.1016%2fS0140-6736%2803%2913593-3&partnerID=40&md5=bb6dae71db4e0fd09bb6ae95aca75d71},
affiliation={Health Services Management Centre, University of Birmingham, Birmingham B15 2RT, United Kingdom},
keywords={clinical practice;  health care distribution;  health care personnel;  health care system;  human;  leadership;  priority journal;  public health service;  review},
references={Mintzberg, H., (1979) The structuring of organisations, , Englewood Cliffs: Prentice-Hall; Eisenberg, J.M., (1988) Doctors' decisions and the cost of medical care, , Ann Arbor: Health Administration Press; (1999) Effective health care, getting evidence into practice, , York: University of York; Graham, A., Steele, J., (2001) Optimising value, , London: Public Management Foundation; McNulty, T., Ferlie, E., (2002) Reengineering health care, , Oxford: Oxford University Press; Bowns, I.R., McNulty, T., (1999) Reengineering Leicester Royal Infirmary: An independent evaluation of implementation and impact, , Sheffield: School of Health and Related Research, University of Sheffield; Joss, R., Kogan, M., (1995) Advancing quality, , Buckingham: Open University Press; Denis, J.-L., Lamothe, L., Langley, A., Valette, A., The struggle to redefine boundaries in health care systems (1999) Restructuring the professional organisation, pp. 105-130. , D. Brock, M. Powell, & C.R. Hinings. London: Routledge; Grol, R., Beliefs and evidence in changing clinical practice (1997) BMJ, 315, pp. 418-421; Rundall, T., Starkweather, D., Norrish, B., (1998) After restructuring, , San Francisco: Jossey-Bass; Langley, G., Nolan, K., Nolan, T., Norman, C., Provost, L., (1996) The improvement guide, , San Francisco: Jossey-Bass; Ham, C., Kipping, R., McLeod, H., Meredith, P., (2002) Capacity, culture and leadership: Lessons from experience of improving access to hospital services, , Birmingham: Health Services Management Centre, University of Birmingham; Bate, S.P., Robert, G., McLeod, H., (2002) Report on the 'Breakthrough' Collaborative approach to quality and service improvement within four regions of the NHS", , Birmingham: Health Services Management Centre, University of Birmingham; (2002) The first two years, , Manchester: National Primary Care Development Team; Wright, O., Freedom more important than a rise in pay, says surgeon (2002) The Times, p. 4. , (London), Oct 29; Silversin, J., Kornacki, M.J., (2000) Leading physicians through change, , Tampa: American College of Physician Executives; Shortell, S., Developing individual leaders is not enough (2002) J Health Serv Res Policy, 7, pp. 193-194; Denis, J.-L., Lamothe, L., Langley, A., The dynamics of collective leadership and strategic change in pluralistic organisations (2001) Acad Manage J, 44, pp. 809-837; Denis, J.-L., Langley, A., Cazale, L., Leadership and strategic change under ambiguity (1996) Organ Stud, 17, pp. 673-699; Berwick, D., Eleven worthy aims for clinical leadership of health system reform (1994) JAMA, 272, pp. 797-802},
correspondence_address1={Ham, C.; Health Services Management Centre, , Birmingham B15 2RT, United Kingdom; email: chris.ham@doh.gsi.gov.uk},
publisher={Elsevier B.V.},
issn={01406736},
coden={LANCA},
pubmed_id={12801754},
language={English},
abbrev_source_title={Lancet},
document_type={Note},
source={Scopus},
}

@ARTICLE{Gusev2018538,
author={Gusev, A. and Mancuso, N. and Won, H. and Kousi, M. and Finucane, H.K. and Reshef, Y. and Song, L. and Safi, A. and McCarroll, S. and Neale, B.M. and Ophoff, R.A. and O'Donovan, M.C. and Crawford, G.E. and Geschwind, D.H. and Katsanis, N. and Sullivan, P.F. and Pasaniuc, B. and Price, A.L.},
title={Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights},
journal={Nature Genetics},
year={2018},
volume={50},
number={4},
pages={538-548},
doi={10.1038/s41588-018-0092-1},
note={cited By 195},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045327964&doi=10.1038%2fs41588-018-0092-1&partnerID=40&md5=b72e8c17e80ab0a861eb94c427a01f62},
affiliation={Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United States; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; Department of Pathology and Lab Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United States; Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, United States; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, United States; Department of Mathematics, Massachusetts Institute of Technology, Cambridge, MA, United States; Department of Computer Science, Harvard University, Cambridge, MA, United States; Center for Genomic and Computational Biology, Duke University, Durham, NC, United States; Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC, United States; Department of Genetics, Harvard Medical School, Boston, MA, United States; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, United States; Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, United States; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands; MRC Centre for Psychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, United States; Program in Neurobehavioral Genetics, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, United States; Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, NC, United States; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden},
abstract={Genome-wide association studies (GWAS) have identified over 100 risk loci for schizophrenia, but the causal mechanisms remain largely unknown. We performed a transcriptome-wide association study (TWAS) integrating a schizophrenia GWAS of 79,845 individuals from the Psychiatric Genomics Consortium with expression data from brain, blood, and adipose tissues across 3,693 primarily control individuals. We identified 157 TWAS-significant genes, of which 35 did not overlap a known GWAS locus. Of these 157 genes, 42 were associated with specific chromatin features measured in independent samples, thus highlighting potential regulatory targets for follow-up. Suppression of one identified susceptibility gene, mapk3, in zebrafish showed a significant effect on neurodevelopmental phenotypes. Expression and splicing from the brain captured most of the TWAS effect across all genes. This large-scale connection of associations to target genes, tissues, and regulatory features is an essential step in moving toward a mechanistic understanding of GWAS. © 2018 The Author(s).},
keywords={deoxyribonuclease I;  histone H3;  RNA polymerase II;  transcriptome;  ubiquitin protein ligase COP1;  kinesin light-chain proteins;  MAPK3 protein, human;  microtubule associated protein;  mitogen activated protein kinase 3;  phosphoprotein phosphatase 2;  PPP2R3C protein, human;  zebrafish protein, ACTR5 gene;  adipose tissue;  ANP32E gene;  Article;  AS3MT gene;  blood;  brain;  CBR3 gene;  chromatin;  DND1 gene;  dorsolateral prefrontal cortex;  DUS2 gene;  expression quantitative trait locus;  follow up;  gene;  gene expression;  gene linkage disequilibrium;  genetic association;  genome-wide association study;  GFOD2 gene;  GLT8D1 gene;  GLYCTK gene;  GNL3 gene;  GRAP gene;  human;  human tissue;  KCTD13 gene;  KIAA0391 gene;  major clinical study;  MAP7D1 gene;  mapk3 gene;  MED8 gene;  MPHOSPH9 gene;  MRPS21 gene;  NDUFA2 gene;  NEK4 gene;  nonhuman;  NT5DC2 gene;  PCCB gene;  PCDHA2 gene;  phenotype;  PPM1M gene;  PPP2R3C gene;  priority journal;  PRMT7 gene;  RERE gene;  RNA splicing;  RNF112 gene;  schizophrenia;  single nucleotide polymorphism;  SLC45A1 gene;  TBC1D5 gene;  TMEM110 gene;  TSNAXIP1 gene;  zebra fish;  ZMAT2 gene;  animal;  chromatin;  gene dosage;  gene expression profiling;  genetic predisposition;  genetics;  genome-wide association study;  growth, development and aging;  metabolism;  multifactorial inheritance;  procedures;  quantitative trait locus;  schizophrenia, Animals;  Brain;  Chromatin;  Gene Dosage;  Gene Expression Profiling;  Genetic Predisposition to Disease;  Genome-Wide Association Study;  Humans;  Microtubule-Associated Proteins;  Mitogen-Activated Protein Kinase 3;  Multifactorial Inheritance;  Protein Phosphatase 2;  Quantitative Trait Loci;  Schizophrenia;  Zebrafish;  Zebrafish Proteins},
chemicals_cas={deoxyribonuclease I, 9003-98-9; mitogen activated protein kinase 3, 137632-07-6; Chromatin; kinesin light-chain proteins; MAPK3 protein, human; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 3; PPP2R3C protein, human; Protein Phosphatase 2; Zebrafish Proteins},
funding_details={National Institutes of HealthNational Institutes of Health, NIH, HHSN271201300031C, MH06692, P50M096891},
funding_details={National Institute of Mental HealthNational Institute of Mental Health, NIMH, K99MH113823, P50MH066392, P50MH084053, P50MH094268, P50MH106934, R01MH075916, R01MH080405, R01MH085542, R01MH093725, R01MH094714, R01MH097276, R01MH105472, R01MH105898, R01MH107649, R01MH109978, R01MH110927, R21MH102791, R21MH103877, R21MH105881, R37MH057881, U01MH103339, U01MH103340, U01MH103346, U01MH103365, U01MH103392},
funding_details={National Institute on AgingNational Institute on Aging, NIA, P01AG002219, P50AG005138},
funding_details={National Human Genome Research InstituteNational Human Genome Research Institute, NHGRI, R01HG009120, U01HG009379},
funding_details={NIH Office of the DirectorNIH Office of the Director, OD, S10OD018164},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, F32GM106584, R01GM105857, T32GM007753},
funding_details={Hertz FoundationHertz Foundation},
funding_details={University of North CarolinaUniversity of North Carolina, UNC},
funding_details={University of California, Los AngelesUniversity of California, Los Angeles, UCLA},
funding_details={Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai, ISMMS},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/L010305/1},
funding_text 1={We acknowledge M. Gandal, B. van de Geijn, A. Ko, P.-R. Loh, L. O'Connor, P. Pajukanta, and N. Zaitlen for helpful discussions. This research was funded by NIH grants F32GM106584 (A.G.), R01GM105857 (A.L.P.), R01MH109978 (A.L.P.), R01MH107649 (B.M.N.), R01MH105472 (G.E.C. and P.F.S.), R01HG009120 (B.P.), U01 MH103339-03S2 (D.H.G.), and R01 MH110927-02 (D.H.G.). H.K.F. was supported by the Fannie and John Hertz Foundation. The project described was also supported by award no. T32GM007753 from the National Institute of General Medical Sciences. This study was supported by a P50MH094268 grant (to N.K.). N.K. is suported as a distinguished Jean and George Brumley Professor. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We are grateful to the CommonMind Consortium and the PsychENCODE Consortium for making data publicly and readily available. Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd.; and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimers Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories, and the NIMH Human Brain Collection Core. CMC Leadership: P. Sklar, J. Buxbaum (Icahn School of Medicine at Mount Sinai), B. Devlin, D. Lewis (University of Pittsburgh), R. Gur, C.-G. Hahn (University of Pennsylvania), K. Hirai, H. Toyoshiba (Takeda Pharmaceuticals Company Limited), E. Domenici, L. Essioux (F. Hoffman-La Roche Ltd.), L. Mangravite, M. Peters (Sage Bionetworks), T. Lehner, and B. Lipska (NIMH). Data were generated as part of the PsychENCODE Consortium, supported by U01MH103339, U01MH103365, U01MH103392, U01MH103340, U01MH103346, R01MH105472, R01MH094714, R01MH105898, R21MH102791, R21MH105881, R21MH103877, and P50MH106934 awarded to S. Akbarian (Icahn School of Medicine at Mount Sinai), G. Crawford (Duke), S. Dracheva (Icahn School of Medicine at Mount Sinai), P. Farnham (USC), M. Gerstein (Yale), D. Geschwind (UCLA), T. M. Hyde (LIBD), A. Jaffe (LIBD), J. A. Knowles (USC), C. Liu (UIC), D. Pinto (Icahn School of Medicine at Mount Sinai), N. Sestan (Yale), P. Sklar (Icahn School of Medicine at Mount Sinai), M. State (UCSF), P. Sullivan (UNC), F. Vaccarino (Yale), S. Weissman (Yale), K. White (University of Chicago), and P. Zandi (JHU).},
funding_text 2={We acknowledge M. Gandal, B. van de Geijn, A. Ko, P.-R. Loh, L. O’Connor, P. Pajukanta, and N. Zaitlen for helpful discussions. This research was funded by NIH grants F32GM106584 (A.G.), R01GM105857 (A.L.P.), R01MH109978 (A.L.P.), R01MH107649 (B.M.N.), R01MH105472 (G.E.C. and P.F.S.), R01HG009120 (B.P.), U01 MH103339-03S2 (D.H.G.), and R01 MH110927-02 (D.H.G.). H.K.F. was supported by the Fannie and John Hertz Foundation. The project described was also supported by award no. T32GM007753 from the National Institute of General Medical Sciences. This study was supported by a P50MH094268 grant (to N.K.). N.K. is suported as a distinguished Jean and George Brumley Professor. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We are grateful to the CommonMind Consortium and the PsychENCODE Consortium for making data publicly and readily available. Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd.; and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimers Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories, and the NIMH Human Brain Collection Core. CMC Leadership: P. Sklar, J. Buxbaum (Icahn School of Medicine at Mount Sinai), B. Devlin, D. Lewis (University of Pittsburgh), R. Gur, C.-G. Hahn (University of Pennsylvania), K. Hirai, H. Toyoshiba (Takeda Pharmaceuticals Company Limited), E. Domenici, L. Essioux (F. Hoffman-La Roche Ltd.), L. Mangravite, M. Peters (Sage Bionetworks), T. Lehner, and B. Lipska (NIMH). Data were generated as part of the PsychENCODE Consortium, supported by U01MH103339, U01MH103365, U01MH103392, U01MH103340, U01MH103346, R01MH105472, R01MH094714, R01MH105898, R21MH102791, R21MH105881, R21MH103877, and P50MH106934 awarded to S. Akbarian (Icahn School of Medicine at Mount Sinai), G. Crawford (Duke), S. Dracheva (Icahn School of Medicine at Mount Sinai), P. Farnham (USC), M. Gerstein (Yale), D. Geschwind (UCLA), T. M. Hyde (LIBD), A. Jaffe (LIBD), J. A. Knowles (USC), C. Liu (UIC), D. Pinto (Icahn School of Medicine at Mount Sinai), N. Sestan (Yale), P. Sklar (Icahn School of Medicine at Mount Sinai), M. State (UCSF), P. Sullivan (UNC), F. Vaccarino (Yale), S. Weissman (Yale), K. White (University of Chicago), and P. Zandi (JHU).},
references={Biological insights from 108 schizophrenia-associated genetic loci (2014) Nature, 511, pp. 421-427; Price, A.L., Spencer, C.C., Donnelly, P., Progress and promise in understanding the genetic basis of common diseases (2015) Proc. R. Soc.B, 282, p. 20151684; Soldner, F., Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression (2016) Nature, 533, pp. 95-99; Sekar, A., Schizophrenia risk from complex variation of complement component 4 (2016) Nature, 530, pp. 177-183; Claussnitzer, M., FTO obesity variant circuitry and adipocyte browning in humans (2015) N. Engl. J. Med, 373, pp. 895-907; Grubert, F., Genetic control of chromatin states in humans involves local and distal chromosomal interactions (2015) Cell, 162, pp. 1051-1065; Maurano, M.T., Systematic localization of common disease-associated variation in regulatory DNA (2012) Science, 337, pp. 1190-1195; Trynka, G., Chromatin marks identify critical cell types for fine mapping complex trait variants (2013) Nat. Genet, 45, pp. 124-130; Pickrell, J.K., Joint analysis of functional genomic data and genome-wide association studies of 18 human traits (2014) Am. J. Hum. Genet, 94, pp. 559-573; Gusev, A., Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases (2014) Am. J. Hum. Genet, 95, pp. 535-552; Kichaev, G., Integrating functional data to prioritize causal variants in statistical fine-mapping studies (2014) PLoS Genet, 10, p. e1004722; Won, H.-H., Disproportionate contributions of select genomic compartments and cell types to genetic risk for coronary artery disease (2015) PLoS Genet, 11, p. e1005622; Finucane, H.K., Partitioning heritability by functional annotation using genome-wide association summary statistics (2015) Nat. Genet, 47, pp. 1228-1235; Degner, J.F., DNase i sensitivity QTLs are a major determinant of human expression variation (2012) Nature, 482, pp. 390-394; McVicker, G., Identification of genetic variants that affect histone modifications in human cells (2013) Science, 342, pp. 747-749; Kasowski, M., Extensive variation in chromatin states across humans (2013) Science, 342, pp. 750-752; Kilpinen, H., Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription (2013) Science, 342, pp. 744-747; Waszak, S.M., Population variation and genetic control of modular chromatin architecture in humans (2015) Cell, 162, pp. 1039-1050; Taudt, A., Colomé-Tatché, M., Johannes, F., Genetic sources of population epigenomic variation (2016) Nat. Rev. Genet, 17, pp. 319-332; Farh, K.K.-H., Genetic and epigenetic fine mapping of causal autoimmune disease variants (2015) Nature, 518, pp. 337-343; Moyerbrailean, G.A., Which genetics variants in DNase-seq footprints are more likely to alter binding? (2016) PLoS Genet, 12, p. e1005875; Gamazon, E.R., A gene-based association method for mapping traits using reference transcriptome data (2015) Nat. Genet, 47, pp. 1091-1098; Gusev, A., Integrative approaches for large-scale transcriptome-wide association studies (2016) Nat. Genet, 48, pp. 245-252; Zhu, Z., Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets (2016) Nat. Genet, 48, pp. 481-487; Fromer, M., Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) Nat. Neurosci, 19, pp. 1442-1453; Wright, F.A., Heritability and genomics of gene expression in peripheral blood (2014) Nat. Genet, 46, pp. 430-437; Li, Y.I., RNA splicing is a primary link between genetic variation and disease (2016) Science, 352, pp. 600-604; Zhou, X., Carbonetto, P., Stephens, M., Polygenic modeling with Bayesian sparse linear mixed models (2013) PLoS Genet, 9, p. e1003264; Nicolae, D.L., Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS (2010) PLoS Genet, 6, p. e1000888; Yang, J., Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits (2012) Nat. Genet, 44, pp. 369-375. , S1-S3; Nica, A.C., Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations (2010) PLoS Genet, 6, p. e1000895; Giambartolomei, C., Bayesian test for colocalisation between pairs of genetic association studies using summary statistics (2014) PLoS Genet, 10, p. e1004383; Won, H., Chromosome conformation elucidates regulatory relationships in developing human brain (2016) Nature, 538, pp. 523-527; Purcell, S.M., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder (2009) Nature, 460, pp. 748-752; Vilhjálmsson, B.J., Modeling linkage disequilibrium increases accuracy of polygenic risk scores (2015) Am. J. Hum. Genet, 97, pp. 576-592; Palla, L., Dudbridge, F., A fast method that uses polygenic scores to estimate the variance explained by genome-wide marker panels and the proportion of variants affecting a trait (2015) Am. J. Hum. Genet, 97, pp. 250-259; Daetwyler, H.D., Villanueva, B., Woolliams, J.A., Accuracy of predicting the genetic risk of disease using a genome-wide approach (2008) PLoS One, 3, p. e3395; The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans (2015) Science, 348, pp. 648-660; Ongen, H., Buil, A., Brown, A.A., Dermitzakis, E.T., Delaneau, O., Fast and efficient QTL mapper for thousands of molecular phenotypes (2016) Bioinformatics, 32, pp. 1479-1485; Ryan, J., Saffery, R., Crucial timing in schizophrenia: Role of DNA methylation in early neurodevelopment (2014) Genome Biol, 15, p. 495; Akbarian, S., The PsychENCODE project (2015) Nat. Neurosci, 18, pp. 1707-1712; Van De Geijn, B., McVicker, G., Gilad, Y., Pritchard, J.K., WASP: Allelespecific software for robust molecular quantitative trait locus discovery (2015) Nat. Methods, 12, pp. 1061-1063; Reilly, S.K., Evolutionary changes in promoter and enhancer activity during human corticogenesis (2015) Science, 347, pp. 1155-1159; Golzio, C., KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant (2012) Nature, 485, pp. 363-367; Maillard, A.M., The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity (2015) Mol. Psychiatry, 20, pp. 140-147; McCarthy, S.E., Microduplications of 16p11.2 are associated with schizophrenia (2009) Nat. Genet, 41, pp. 1223-1227; Migliavacca, E., A potential contributory role for ciliary dysfunction in the 16p11.2 600kb BP4-BP5 pathology (2015) Am. J. Hum. Genet, 96, pp. 784-796; Föcking, M., Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia (2015) Mol. Psychiatry, 20, pp. 424-432; Sibley, C.R., Blazquez, L., Ule, J., Lessons from non-canonical splicing (2016) Nat. Rev. Genet, 17, pp. 407-421; Nelson, C.E., In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy (2016) Science, 351, pp. 403-407; Li, Y.I., Annotation-free quantification of RNA splicing using LeafCutter (2018) Nat. Genet, 50, pp. 151-158; Chen, C.-Y., Improved ancestry inference using weights from external reference panels (2013) Bioinformatics, 29, pp. 1399-1406; Yang, J., Lee, S.H., Goddard, M.E., Visscher, P.M., GCTA: A tool for genome-wide complex trait analysis (2011) Am. J. Hum. Genet, 88, pp. 76-82; Yang, J., Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index (2015) Nat. Genet, 47, pp. 1114-1120; Hormozdiari, F., Kostem, E., Kang, E.Y., Pasaniuc, B., Eskin, E., Identifying causal variants at loci with multiple signals of association (2014) Genetics, 198, pp. 497-508; Bulik-Sullivan, B., An atlas of genetic correlations across human diseases and traits (2015) Nat. Genet, 47, pp. 1236-1241; Jordan, D.M., Identification of cis-suppression of human disease mutations by comparative genomics (2015) Nature, 524, pp. 225-229},
publisher={Nature Publishing Group},
issn={10614036},
coden={NGENE},
pubmed_id={29632383},
language={English},
abbrev_source_title={Nat. Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Husain2018470,
author={Husain, M. and Roiser, J.P.},
title={Neuroscience of apathy and anhedonia: A transdiagnostic approach},
journal={Nature Reviews Neuroscience},
year={2018},
volume={19},
number={8},
pages={470-484},
doi={10.1038/s41583-018-0029-9},
note={cited By 192},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049061018&doi=10.1038%2fs41583-018-0029-9&partnerID=40&md5=fb291e5e51be024d0b598ea224acda22},
affiliation={Nuffield Department of Clinical Neurosciences, Department of Experimental Psychology, University of Oxford. John Radcliffe Hospital, Oxford, United Kingdom; Institute of Cognitive Neuroscience, University College London, London, United Kingdom},
abstract={Apathy and anhedonia are common syndromes of motivation that are associated with a wide range of brain disorders and have no established therapies. Research using animal models suggests that a useful framework for understanding motivated behaviour lies in effort-based decision making for reward. The neurobiological mechanisms underpinning such decisions have now begun to be determined in individuals with apathy or anhedonia, providing an important foundation for developing new treatments. The findings suggest that there might be some shared mechanisms between both syndromes. A transdiagnostic approach that cuts across traditional disease boundaries provides a potentially useful means for understanding these conditions. © 2018 Macmillan Publishers Ltd., part of Springer Nature.},
keywords={dopamine;  serotonin, anhedonia;  apathy;  brain disease;  brain region;  decision making;  human;  learning;  neuroscience;  nonhuman;  priority journal;  Review;  syndrome;  anhedonia;  animal;  apathy;  brain;  motivation;  nerve cell;  physiology;  reward, Anhedonia;  Animals;  Apathy;  Brain;  Decision Making;  Humans;  Motivation;  Neurons;  Reward},
chemicals_cas={dopamine, 51-61-6, 62-31-7; serotonin, 50-67-9},
funding_details={Wellcome TrustWellcome Trust, WT},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR},
funding_details={Leverhulme TrustLeverhulme Trust},
funding_text 1={M.H. and J.P.R. are supported by awards from the Wellcome Trust. M.H. is also supported by the UK National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the Wellcome Trust Centre for Integrative Neuroimaging, Oxford. J.P.R. is also supported by the Leverhulme Trust.},
references={Caeiro, L., Ferro, J.M., Costa, J., Apathy secondary to stroke: A systematic review and meta-analysis (2013) Cerebrovasc. Dis., 35, pp. 23-39; Starkstein, S.E., Pahissa, J., Apathy following traumatic brain injury (2014) Psychiatr. Clin. North Am., 37, pp. 103-112; Seel, R.T., Depression after traumatic brain injury: A National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation (2003) Arch. Phys. Med. Rehabil., 84, pp. 177-184; Zhao, Q.-F., The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis (2016) J. Affect. Disord., 190, pp. 264-271; Lopez, O.L., Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease (2003) J. Neuropsychiatry Clin. Neurosci., 15, pp. 346-353; Den Brok, M.G.H.E., Apathy in Parkinson's disease: A systematic review and meta-analysis (2015) Mov. Disord., 30, pp. 759-769; Lemke, M.R., Brecht, H.M., Koester, J., Kraus, P.H., Reichmann, H., Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole (2005) J. Neuropsychiatry Clin. Neurosci., 17, pp. 214-220; Staekenborg, S.S., Behavioural and psychological symptoms in vascular dementia; Differences between small-and large-vessel disease (2010) J. Neurol. Neurosurg. Psychiatry, 81, pp. 547-551; Chow, T.W., Apathy symptom profile and behavioral associations in frontotemporal dementia versus dementia of Alzheimer type (2009) Arch. Neurol., 66, pp. 888-893; Van Duijn, E., Neuropsychiatric symptoms in A European Huntington's disease cohort (REGISTRY) (2014) J. Neurol. Neurosurg. Psychiatry, 85, pp. 1411-1418; Pelizza, L., Ferrari, A., Anhedonia in schizophrenia and major depression: State or trait? (2009) Ann. Gen. Psychiatry, 8, p. 22; Yuen, G.S., Apathy in late-life depression: Common, persistent, and disabling (2015) Am. J. Geriatr. Psychiatry, 23, pp. 488-494; Horan, W.P., Kring, A.M., Blanchard, J.J., Anhedonia in schizophrenia: A review of assessment strategies (2006) Schizophr. Bull., 32, pp. 259-273; Yazbek, H., The Lille Apathy Rating Scale (LARS): Exploring its psychometric properties in schizophrenia (2014) Schizophr. Res., 157, pp. 278-284; Brown, R.G., Pluck, G., Negative symptoms: The 'pathology' of motivation and goal-directed behaviour (2000) Trends Neurosci., 23, pp. 412-417; Prange, S., Historical crossroads in the conceptual delineation of apathy in Parkinson's disease (2018) Brain, 141, pp. 613-619; Starkstein, S.E., Leentjens, A.F.G., The nosological position of apathy in clinical practice (2008) J. Neurol. Neurosurg. Psychiatry, 79, pp. 1088-1092; Lanctôt, K.L., Apathy associated with neurocognitive disorders: Recent progress and future directions (2017) Alzheimers Dement., 13, pp. 84-100; Robert, P., Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders (2009) Eur. Psychiatry, 24, pp. 98-104; Thomsen, K.R., Whybrow, P.C., Kringelbach, M.L., Reconceptualizing anhedonia: Novel perspectives on balancing the pleasure networks in the human brain (2015) Front. Behav. Neurosci., 9, p. 49; Foussias, G., Remington, G., Negative symptoms in schizophrenia: Avolition and Occam's razor (2010) Schizophr. Bull., 36, pp. 359-369; Treadway, M.T., Zald, D.H., Reconsidering anhedonia in depression: Lessons from translational neuroscience (2011) Neurosci. Biobehav. Rev., 35, pp. 537-555; Berridge, K.C., Robinson, T.E., Parsing reward (2003) Trends Neurosci., 26, pp. 507-513; Barch, D.M., Pagliaccio, D., Luking, K., Mechanisms underlying motivational deficits in psychopathology: Similarities and differences in depression and schizophrenia (2016) Curr. Top. Behav. Neurosci., 27, pp. 411-449; Der-Avakian, A., Barnes, S.A., Markou, A., Pizzagalli, D.A., Translational assessment of reward and motivational deficits in psychiatric disorders (2015) Curr. Top. Behav. Neurosci., 28, pp. 231-262; Salamone, J.D., Yohn, S.E., López-Cruz, L., San Miguel, N., Correa, M., Activational and effort-related aspects of motivation: Neural mechanisms and implications for psychopathology (2016) Brain, 139, pp. 1325-1347; Le Heron, C., Apps, M.A.J., Husain, M., The anatomy of apathy: A neurocognitive framework for amotivated behaviour (2017) Neuropsychologia, , https://doi.org/10.1016/j.neuropsychologia.2017.07.003; Marin, R.S., Apathy: A neuropsychiatric syndrome (1991) J. Neuropsychiatry Clin. Neurosci., 3, pp. 243-254; Starkstein, S.E., Petracca, G., Chemerinski, E., Kremer, J., Syndromic validity of apathy in Alzheimer's disease (2001) Am. J. Psychiatry, 158, pp. 872-877; Sockeel, P., The Lille apathy rating scale (LARS), A new instrument for detecting and quantifying apathy: Validation in Parkinson's disease (2006) J. Neurol. Neurosurg. Psychiatry, 77, pp. 579-584; Ang, Y.-S., Lockwood, P., Apps, M.A.J., Muhammed, K., Husain, M., Distinct subtypes of apathy revealed by the apathy motivation index (2017) PLoS ONE, 12, p. e0169938; Németh, G., Hegedüs, K., Molnár, L., Akinetic mutism associated with bicingular lesions: Clinicopathological and functional anatomical correlates (1988) Eur. Arch. Psychiatry Neurol. Sci., 237, pp. 218-222; Rizvi, S.J., Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in A community sample and individuals with major depression (2015) Psychiatry Res., 229, pp. 109-119; (2013) Diagnostic and Statistical Manual of Mental Disorders: DSM-5, , American Psychiatric Association & American Psychiatric Association American Psychiatric Association, WA; Shankman, S.A., (2014) Anhedonia: A Comprehensive Handbook, 1, pp. 3-22. , ed. Ritsner, M Springer, Netherlands; Assogna, F., Cravello, L., Caltagirone, C., Spalletta, G., Anhedonia in Parkinson's disease: A systematic review of the literature (2011) Mov. Disord., 26, pp. 1825-1834; Blanchard, J.J., Cohen, A.S., The structure of negative symptoms within schizophrenia: Implications for assessment (2006) Schizophr. Bull., 32, pp. 238-245; Foussias, G., Agid, O., Fervaha, G., Remington, G., Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders (2014) Eur. Neuropsychopharmacol., 24, pp. 693-709; Kaiser, S., Individual negative symptoms and domains-relevance for assessment, pathomechanisms and treatment (2017) Schizophr. Res., 186, pp. 39-45; Bischof, M., The brief negative symptom scale: Validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy (2016) BMC Psychiatry, 16, p. 415; Hartmann, M.N., Apathy in schizophrenia as A deficit in the generation of options for action (2015) J. Abnorm. Psychol., 124, pp. 309-318; Isella, V., Physical anhedonia in Parkinson's disease (2003) J. Neurol. Neurosurg. Psychiatry, 74, pp. 1308-1311; Skorvanek, M., The associations between fatigue, apathy, and depression in Parkinson's disease (2015) Acta Neurol. Scand., 131, pp. 80-87; Lampe, I.K., Kahn, R.S., Heeren, T.J., Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals (2001) J. Geriatr. Psychiatry Neurol., 14, pp. 11-16; Brodaty, H., Altendorf, A., Withall, A., Sachdev, P., Do people become more apathetic as they grow older? A longitudinal study in healthy individuals (2010) Int. Psychogeriatr., 22, pp. 426-436; Bonnelle, V., Manohar, S., Behrens, T., Husain, M., Individual differences in premotor brain systems underlie behavioral apathy (2016) Cereb. Cortex, 26, p. bhv247; Lavretsky, H., The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia (2008) Int. J. Geriatr. Psychiatry, 23, pp. 1040-1050; Grool, A.M., Structural MRI correlates of apathy symptoms in older persons without dementia: AGESReykjavik Study (2014) Neurology, 82, pp. 1628-1635; Kawagoe, T., Onoda, K., Yamaguchi, S., Apathy and executive function in healthy elderly-resting state fMRI study (2017) Front. Aging Neurosci., 9, p. 124; Rzepa, E., Fisk, J., McCabe, C., Blunted neural response to anticipation, effort and consummation of reward and aversion in adolescents with depression symptomatology (2017) J. Psychopharmacol., 31, pp. 303-311; Pessiglione, M., Vinckier, F., Bouret, S., Daunizeau, J., Le Bouc, R., Why not try harder? Computational approach to motivation deficits in neuro-psychiatric diseases (2017) Brain, , https://doi.org/10.1093/brain/awx278; Sinha, N., Manohar, S., Husain, M., Impulsivity and apathy in Parkinson's disease (2013) J. Neuropsychol., 7, pp. 255-283; Ang, Y.-S., Dopamine modulates option generation for behaviour (2018) Curr. Biol., 28, pp. 1561-1569; Robinson, G., Shallice, T., Bozzali, M., Cipolotti, L., The differing roles of the frontal cortex in fluency tests (2012) Brain, 135, pp. 2202-2214; Glimcher, P.W., Fehr, E., Camerer, C., (2014) Neuroeconomics: Decision Making and the Brain, , Elsevier Academic Press, London; Le Bouc, R., Computational dissection of dopamine motor and motivational functions in humans (2016) J. Neurosci., 36, pp. 6623-6633; Le Heron, C., Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease (2018) Brain, 141, pp. 1455-1469; Brehm, J.W., Self, E.A., The intensity of motivation (1989) Annu. Rev. Psychol., 40, pp. 109-131; Muhammed, K., Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease (2016) Brain, 139, pp. 2706-2721; Salamone, J.D., Cousins, M.S., Bucher, S., Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in A T-maze cost/benefit procedure (1994) Behav. Brain Res., 65, pp. 221-229; Treadway, M.T., Bossaller, N.A., Shelton, R.C., Zald, D.H., Effort-based decision-making in major depressive disorder: A translational model of motivational anhedonia (2012) J. Abnorm. Psychol., 121, pp. 553-558; Chong, T.T.-J., Dopamine enhances willingness to exert effort for reward in Parkinson's disease (2015) Cortex, 69, pp. 40-46; Murray, G.K., Incentive motivation in first-episode psychosis: A behavioural study (2008) BMC Psychiatry, 8, p. 34; Hosking, J.G., Cocker, P.J., Winstanley, C.A., Dissociable contributions of anterior cingulate cortex and basolateral amygdala on A rodent cost/benefit decision-making task of cognitive effort (2014) Neuropsychopharmacology, 39, pp. 1558-1567; Schmidt, L., Lebreton, M., Cléry-Melin, M.-L., Daunizeau, J., Pessiglione, M., Neural mechanisms underlying motivation of mental versus physical effort (2012) PLoS Biol., 10, p. e1001266; Chong, T.T.-J., Neurocomputational mechanisms underlying subjective valuation of effort costs (2017) PLoS Biol., 15, p. e1002598; Berridge, K.C., Robinson, T.E., What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? (1998) Brain Res. Rev., 28, pp. 309-369; Huys, Q.J.M., The specificity of Pavlovian regulation is associated with recovery from depression (2016) Psychol. Med., 46, pp. 1027-1035; Willner, P., The chronic mild stress (CMS) model of depression: History, evaluation and usage (2017) Neurobiol. Stress, 6, pp. 78-93; Huys, Q.J.M., Daw, N.D., Dayan, P., Depression: A decision-theoretic analysis (2015) Annu. Rev. Neurosci., 38, pp. 1-23; Bechara, A., Damasio, H., Tranel, D., Damasio, A.R., Deciding advantageously before knowing the advantageous strategy (1997) Science, 275, pp. 1293-1295; Evens, R., Hoefler, M., Biber, K., Lueken, U., The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication (2016) Neuropsychologia, 91, pp. 163-172; Adams, R.A., Huys, Q.J.M., Roiser, J.P., Computational psychiatry: Towards A mathematically informed understanding of mental illness (2016) J. Neurol. Neurosurg. Psychiatry, 87, pp. 53-63; Henriques, J.B., Glowacki, J.M., Davidson, R.J., Reward fails to alter response bias in depression (1994) J. Abnorm. Psychol., 103, pp. 460-466; Huys, Q.J., Pizzagalli, D.A., Bogdan, R., Dayan, P., Mapping anhedonia onto reinforcement learning: A behavioural meta-analysis (2013) Biol. Mood Anxiety Disord., 3, p. 12; Collins, A.G.E., Brown, J.K., Gold, J.M., Waltz, J.A., Frank, M.J., Working memory contributions to reinforcement learning impairments in Schizophrenia (2014) J. Neurosci., 34, pp. 13747-13756; Meyniel, F., A specific role for serotonin in overcoming effort cost (2016) ELife, 5, p. e17282; Levy, R., Dubois, B., Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits (2005) Cereb. Cortex, 16, pp. 916-928; Barris, R.W., Schuman, H.R., Bilateral anterior cingulate gyrus lesions; Syndrome of the anterior cingulate gyri (1953) Neurology, 3, pp. 44-52; Laplane, D., Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study (1989) Brain, 112, pp. 699-725; Adam, R., Dopamine reverses reward insensitivity in apathy following globus pallidus lesions (2013) Cortex, 49, pp. 1292-1303; Kang, S.Y., Kim, J.S., Anterior cerebral artery infarction: Stroke mechanism and clinical-imaging study in 100 patients (2008) Neurology, 70, pp. 2386-2393; Manohar, S.G., Husain, M., Human ventromedial prefrontal lesions alter incentivisation by reward (2016) Cortex, 76, pp. 104-120; Heath, R.G., Pleasure and brain activity in man. Deep and surface electroencephalograms during orgasm (1972) J. Nerv. Ment. Dis., 154, pp. 3-18; Berridge, K.C., Kringelbach, M.L., Pleasure systems in the brain (2015) Neuron, 86, pp. 646-664; Parvizi, J., Rangarajan, V., Shirer, W.R., Desai, N., Greicius, M.D., The will to persevere induced by electrical stimulation of the human cingulate gyrus (2013) Neuron, 80, pp. 1359-1367; Mayberg, H.S., Deep brain stimulation for treatment-resistant depression (2005) Neuron, 45, pp. 651-660; Holtzheimer, P.E., Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multisite, randomised, sham-controlled trial (2017) Lancet Psychiatry, 4, pp. 839-849; Rudebeck, P.H., Walton, M.E., Smyth, A.N., Bannerman, D.M., Rushworth, M.F.S., Separate neural pathways process different decision costs (2006) Nat. Neurosci., 9, pp. 1161-1168; Walton, M.E., Kennerley, S.W., Bannerman, D.M., Phillips, P.E.M., Rushworth, M.F.S., Weighing up the benefits of work: Behavioral and neural analyses of effort-related decision making (2006) Neural Netw., 19, pp. 1302-1314; Floresco, S.B., Ghods-Sharifi, S., Amygdalaprefrontal cortical circuitry regulates effort-based decision making (2007) Cereb. Cortex, 17, pp. 251-260; Hauber, W., Sommer, S., Prefrontostriatal circuitry regulates effort-related decision making (2009) Cereb. Cortex, 19, pp. 2240-2247; Worbe, Y., Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum (2009) Cereb. Cortex, 19, pp. 1844-1856; Wise, R.A., Addictive drugs and brain stimulation reward (1996) Annu. Rev. Neurosci., 19, pp. 319-340; Ferenczi, E.A., Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior (2016) Science, 351, p. aac9698; Croxson, P.L., Walton, M.E., O'Reilly, J.X., Behrens, T.E.J., Rushworth, M.F.S., Effort-based cost-benefit valuation and the human brain (2009) J. Neurosci., 29, pp. 4531-4541; Skvortsova, V., Palminteri, S., Pessiglione, M., Learning to minimize efforts versus maximizing rewards: Computational principles and neural correlates (2014) J. Neurosci., 34, pp. 15621-15630; Klein-Flugge, M.C., Kennerley, S.W., Friston, K., Bestmann, S., Neural signatures of value comparison in human cingulate cortex during decisions requiring an effort-reward trade-off (2016) J. Neurosci., 36, pp. 10002-10015; Zenon, A., Sidibe, M., Olivier, E., Disrupting the supplementary motor area makes physical effort appear less effortful (2015) J. Neurosci., 35, pp. 8737-8744; Kroemer, N.B., Balancing reward and work: Anticipatory brain activation in NAcc and VTA predict effort differentially (2014) Neuroimage, 102, pp. 510-519; Kurniawan, I.T., Guitart-Masip, M., Dayan, P., Dolan, R.J., Effort and valuation in the brain: The effects of anticipation and execution (2013) J. Neurosci., 33, pp. 6160-6169; Lau, H.C., Rogers, R.D., Haggard, P., Passingham, R.E., Attention to intention (2004) Science, 303, pp. 1208-1210; Nachev, P., Kennard, C., Husain, M., Functional role of the supplementary and pre-supplementary motor areas (2008) Nat. Rev. Neurosci., 9, pp. 856-869; Pizzagalli, D.A., Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder (2009) Am. J. Psychiatry, 166, pp. 702-710; Knutson, B., Bhanji, J.P., Cooney, R.E., Atlas, L.Y., Gotlib, I.H., Neural responses to monetary incentives in major depression (2008) Biol. Psychiatry, 63, pp. 686-692; Gorka, S.M., Neural response to reward anticipation in those with depression with and without panic disorder (2014) J. Affect. Disord., 164, pp. 50-56; Rutledge, R.B., Association of neural and emotional impacts of reward prediction errors with major depression (2017) JAMA Psychiatry, 74, p. 790; Stringaris, A., The brain's response to reward anticipation and depression in adolescence: Dimensionality, specificity, and longitudinal predictions in A community-based sample (2015) Am. J. Psychiatry, 172, pp. 1215-1223; Ziauddeen, H., Murray, G.K., The relevance of reward pathways for schizophrenia (2010) Curr. Opin. Psychiatry, 23, pp. 91-96; Zhang, B., Mapping anhedonia-specific dysfunction in A transdiagnostic approach: An ALE meta-analysis (2016) Brain Imaging Behav., 10, pp. 920-939; Howe, M.W., Tierney, P.L., Sandberg, S.G., Phillips, P.E.M., Graybiel, A.M., Prolonged dopamine signalling in striatum signals proximity and value of distant rewards (2013) Nature, 500, pp. 575-579; Robbins, T.W., Roberts, D.C., Koob, G.F., Effects of D-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens (1983) J. Pharmacol. Exp. Ther., 224, pp. 662-673; Taylor, J.R., Robbins, T.W., Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens (1984) Psychopharmacology., 84, pp. 405-412; Cador, M., Taylor, J.R., Robbins, T.W., Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens (1991) Psychopharmacoloy, 104, pp. 377-385; Salamone, J.D., Correa, M., The mysterious motivational functions of mesolimbic dopamine (2012) Neuron, 76, pp. 470-485; Schultz, W., Dayan, P., Montague, P.R., A neural substrate of prediction and reward (1997) Science, 275, pp. 1593-1599; Chang, C.Y., Brief optogenetic inhibition of dopamine neurons mimics endogenous negative reward prediction errors (2016) Nat. Neurosci., 19, pp. 111-116; Steinberg, E.E., A causal link between prediction errors, dopamine neurons and learning (2013) Nat. Neurosci., 16, pp. 966-973; Niv, Y., Daw, N.D., Joel, D., Dayan, P., Tonic dopamine: Opportunity costs and the control of response vigor (2007) Psychopharmacology, 191, pp. 507-520; Hamid, A.A., Mesolimbic dopamine signals the value of work (2015) Nat. Neurosci., 19, pp. 117-126; Syed, E.C.J., Action initiation shapes mesolimbic dopamine encoding of future rewards (2015) Nat. Neurosci., 19, pp. 34-36; Collins, A.G.E., Frank, M.J., Surprise! Dopamine signals mix action, value and error (2016) Nat. Neurosci., 19, pp. 3-5; Martins, D., Mehta, M.A., Prata, D., The "highs and lows" of the human brain on dopaminergics: Evidence from neuropharmacology (2017) Neurosci. Biobehav. Rev., 80, pp. 351-371; Leyton, M., Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men (2003) Neuropsychopharmacology, 29, pp. 427-432; Roiser, J.P., The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression (2005) Neuropsychopharmacology, 30, pp. 775-785; Robinson, O.J., Standing, H.R., DeVito, E.E., Cools, R., Sahakian, B.J., Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males (2010) Psychopharmacology, 211, pp. 187-195; Bjork, J.M., Grant, S.J., Chen, G., Hommer, D.W., Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing (2014) Neuropsychopharmacology, 39, pp. 595-604; Guitart-Masip, M., Action controls dopaminergic enhancement of reward representations (2012) Proc. Natl Acad. Sci. USA, 109, pp. 7511-7516; Zenon, A., Devesse, S., Olivier, E., Dopamine manipulation affects response vigor independently of opportunity cost (2016) J. Neurosci., 36, pp. 9516-9525; Rutledge, R.B., Skandali, N., Dayan, P., Dolan, R.J., Dopaminergic modulation of decision making and subjective well-being (2015) J. Neurosci., 35, pp. 9811-9822; Chowdhury, R., Dopamine restores reward prediction errors in old age (2013) Nat. Neurosci., 16, pp. 648-653; Argyropoulos, S.V., Nutt, D.J., Anhedonia revisited: Is there A role for dopamine-targeting drugs for depression? (2013) J. Psychopharmacol., 27, pp. 869-877; Di Giannantonio, M., Martinotti, G., Anhedonia and major depression: The role of agomelatine (2012) Eur. Neuropsychopharmacol., 22, pp. S505-S510; Thobois, S., Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil (2013) Brain, 136, pp. 1568-1577; Devos, D., Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: A double-blind, placebocontrolled, randomised clinical trial (2014) J. Neurol. Neurosurg. Psychiatry, 85, pp. 668-674; McGirr, A., A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes (2015) Psychol. Med., 45, pp. 693-704; Kokkinou, M., Ashok, A.H., Howes, O.D., The effects of ketamine on dopaminergic function: Meta-analysis and review of the implications for neuropsychiatric disorders (2017) Mol. Psychiatry, 23, pp. 59-69; Lally, N., Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression (2014) Transl Psychiatry 4, e469; Peciña, M., Striatal dopamine D2/3 receptormediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response (2017) Eur. Neuropsychopharmacol., 27, pp. 977-986; Remy, P., Doder, M., Lees, A., Turjanski, N., Brooks, D., Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system (2005) Brain, 128, pp. 1314-1322; Sarchiapone, M., Dopamine transporter binding in depressed patients with anhedonia (2006) Psychiatry Res., 147, pp. 243-248; Bloomfield, M.A.P., Morgan, C.J.A., Kapur, S., Curran, H.V., Howes, O.D., The link between dopamine function and apathy in cannabis users: An [18F]-DOPA PET imaging study (2014) Psychopharmacology, 231, pp. 2251-2259; Felger, J.C., Treadway, M.T., Inflammation effects on motivation and motor activity: Role of dopamine (2017) Neuropsychopharmacology, 42, pp. 216-241; Felger, J.C., Miller, A.H., Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise (2012) Front. Neuroendocrinol., 33, pp. 315-327; Kapur, S., Remington, G., Serotonin-dopamine interaction and its relevance to schizophrenia (1996) Am. J. Psychiatry, 153, pp. 466-476; Bailey, M.R., The effects of pharmacological modulation of the serotonin 2C receptor on goaldirected behavior in mice (2016) Psychopharmacology, 233, pp. 615-624; Deakin, J.F.W., Graeff, F.G., 5-HT and mechanisms of defence (1991) J. Psychopharmacol, 5, pp. 305-315; Maier, S.F., Watkins, L.R., Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor (2005) Neurosci. Biobehav. Rev., 29, pp. 829-841; Daw, N.D., Kakade, S., Dayan, P., Opponent interactions between serotonin and dopamine (2002) Neural Netw., 15, pp. 603-616; Boureau, Y.-L., Dayan, P., Opponency revisited: Competition and cooperation between dopamine and serotonin (2011) Neuropsychopharmacology, 36, pp. 74-97; Kranz, G.S., Kasper, S., Lanzenberger, R., Reward and the serotonergic system (2010) Neuroscience, 166, pp. 1023-1035; Nakamura, K., Matsumoto, M., Hikosaka, O., Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus (2008) J. Neurosci., 28, pp. 5331-5343; Fonseca, M.S., Murakami, M., Mainen, Z.F., Activation of dorsal raphe serotonergic neurons promotes waiting but is not reinforcing (2015) Curr. Biol., 25, pp. 306-315; Luo, M., Zhou, J., Liu, Z., Reward processing by the dorsal raphe nucleus: 5-HT and beyond (2015) Learn. Mem., 22, pp. 452-460; Faulkner, P., Deakin, J.F.W., The role of serotonin in reward, punishment and behavioural inhibition in humans: Insights from studies with acute tryptophan depletion (2014) Neurosci. Biobehav. Rev., 46, pp. 365-378; Macoveanu, J., Serotonergic modulation of reward and punishment: Evidence from pharmacological fMRI studies (2014) Brain Res., 1556, pp. 19-27; Seymour, B., Daw, N.D., Roiser, J.P., Dayan, P., Dolan, R., Serotonin selectively modulates reward value in human decision-making (2012) J. Neurosci., 32, pp. 5833-5842; Cools, R., Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as A function of trait impulsivity (2005) Neuropsychopharmacology, 30, pp. 1362-1373; Maillet, A., The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease (2016) Brain, 139, pp. 2486-2502; Da Silva, S., Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls (2017) Psychiatry Res., 254, pp. 112-117; Richards, D.A., Cost and outcome of behavioural activation versus Cognitive Behavioural Therapy for Depression (COBRA): A randomised, controlled, non-inferiority trial (2016) Lancet, 388, pp. 871-880; Lutgens, D., Gariepy, G., Malla, A., Psychological and psychosocial interventions for negative symptoms in psychosis: Systematic review and meta-analysis (2017) Br. J. Psychiatry, 210, pp. 324-332; Rizvi, S.J., Pizzagalli, D.A., Sproule, B.A., Kennedy, S.H., Assessing anhedonia in depression: Potentials and pitfalls (2016) Neurosci. Biobehav. Rev., 65, pp. 21-35; Strauss, G.P., Gold, J.M.A., Psychometric comparison of the clinical assessment interview for negative symptoms and the brief negative symptom scale (2016) Schizophr. Bull., 42, pp. 1384-1394; Kaji, Y., Hirata, K., Apathy and anhedonia in Parkinson's disease (2011) ISRN Neurol., 2011, p. 219427; Haarasilta, L., Marttunen, M., Kaprio, J., Aro, H., The 12-month prevalence and characteristics of major depressive episode in A representative nationwide sample of adolescents and young adults (2001) Psychol. Med., 31, pp. 1169-1179; Keller, M.B., Results of the DSM-IV mood disorders field trial (1995) Am. J. Psychiatry, 152, pp. 843-849; Kiwanuka, J.N., Strauss, G.P., McMahon, R.P., Gold, J.M., Psychological predictors of functional outcome in people with schizophrenia (2014) Schizophr. Res., 157, pp. 299-304; Daw, N.D., (2011) Decision Making, Affect, and Learning, pp. 3-38. , eds Delgado, M R., Phelps, E. A. & Robbins, T. W Oxford Univ. Press, Oxford; Anticevic, A., Murray, J.D., (2017) Computational Psychiatry: Mathematical Modeling of Mental Illness, , Academic Press, Elsevier, London; Gelman, A., Shalizi, C.R., Philosophy and the practice of Bayesian statistics (2013) Br. J. Math. Stat. Psychol., 66, pp. 8-38; Pessiglione, M., Seymour, B., Flandin, G., Dolan, R.J., Frith, C.D., Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans (2006) Nature, 442, pp. 1042-1045; Sutton, R.S., Barto, A.G., Reinforcement Learning: An Introduction (MIT Press, Cambridge, 1998; Assadi, S.M., Yücel, M., Pantelis, C., Dopamine modulates neural networks involved in effort-based decision-making (2009) Neurosci. Biobehav. Rev., 33, pp. 383-393},
publisher={Nature Publishing Group},
issn={1471003X},
coden={NRNAA},
pubmed_id={29946157},
language={English},
abbrev_source_title={Nat. Rev. Neurosci.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Tsilidis2013,
author={Tsilidis, K.K. and Panagiotou, O.A. and Sena, E.S. and Aretouli, E. and Evangelou, E. and Howells, D.W. and Salman, R.A.-S. and Macleod, M.R. and Ioannidis, J.P.A.},
title={Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases},
journal={PLoS Biology},
year={2013},
volume={11},
number={7},
doi={10.1371/journal.pbio.1001609},
art_number={e1001609},
note={cited By 186},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880934207&doi=10.1371%2fjournal.pbio.1001609&partnerID=40&md5=c4e1da1cf9dfeaa4eb0ac81b869bbeaf},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, VIC, Australia; Department of Methods and Experimental Psychology, University of Deusto, Bilbao, Spain; Laboratory of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece; Stanford Prevention Research Center, Department of Medicine, Department of Health Research and Policy, Stanford University School of Medicine, Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={Animal studies generate valuable hypotheses that lead to the conduct of preventive or therapeutic clinical trials. We assessed whether there is evidence for excess statistical significance in results of animal studies on neurological disorders, suggesting biases. We used data from meta-analyses of interventions deposited in Collaborative Approach to Meta-Analysis and Review of Animal Data in Experimental Studies (CAMARADES). The number of observed studies with statistically significant results (O) was compared with the expected number (E), based on the statistical power of each study under different assumptions for the plausible effect size. We assessed 4,445 datasets synthesized in 160 meta-analyses on Alzheimer disease (n = 2), experimental autoimmune encephalomyelitis (n = 34), focal ischemia (n = 16), intracerebral hemorrhage (n = 61), Parkinson disease (n = 45), and spinal cord injury (n = 2). 112 meta-analyses (70%) found nominally (p≤0.05) statistically significant summary fixed effects. Assuming the effect size in the most precise study to be a plausible effect, 919 out of 4,445 nominally significant results were expected versus 1,719 observed (p&lt;10-9). Excess significance was present across all neurological disorders, in all subgroups defined by methodological characteristics, and also according to alternative plausible effects. Asymmetry tests also showed evidence of small-study effects in 74 (46%) meta-analyses. Significantly effective interventions with more than 500 animals, and no hints of bias were seen in eight (5%) meta-analyses. Overall, there are too many animal studies with statistically significant results in the literature of neurological disorders. This observation suggests strong biases, with selective analysis and outcome reporting biases being plausible explanations, and provides novel evidence on how these biases might influence the whole research domain of neurological animal literature. © 2013 Tsilidis et al.},
keywords={bromocriptine;  melatonin;  minocycline;  myelin basic protein;  nicotinamide;  nitric oxide;  quinpirole, accuracy;  allergic encephalomyelitis;  Alzheimer disease;  article;  brain hemorrhage;  brain ischemia;  controlled study;  data analysis;  disease association;  effect size;  neurologic disease;  nonhuman;  Parkinson disease;  spinal cord injury;  statistical significance;  stem cell;  systematic error;  uncertainty, Animals;  Bias (Epidemiology);  Disease Models, Animal;  Nervous System Diseases;  Research Design},
chemicals_cas={bromocriptine, 25614-03-3; melatonin, 73-31-4; minocycline, 10118-90-8, 11006-27-2, 13614-98-7; nicotinamide, 11032-50-1, 98-92-0; nitric oxide, 10102-43-9; quinpirole, 73625-62-4, 80373-22-4, 85760-75-4, 85798-08-9},
funding_details={Medical Research CouncilMedical Research Council, MRC, G1002605, G108/613},
references={van der Worp, H.B., Howells, D.W., Sena, E.S., Porritt, M.J., Rewell, S., Can animal models of disease reliably inform human studies? (2010) PLoS Med, 7, pp. e1000245. , doi:10.1371/journal.pmed.1000245; Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Comparison of treatment effects between animal experiments and clinical trials: systematic review (2007) BMJ, 334, p. 197; Pound, P., Ebrahim, S., Sandercock, P., Bracken, M.B., Roberts, I., Where is the evidence that animal research benefits humans? (2004) BMJ, 328, pp. 514-517; O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., 1,026 experimental treatments in acute stroke (2006) Ann Neurol, 59, pp. 467-477; Sena, E., van der Worp, H.B., Howells, D., Macleod, M., How can we improve the pre-clinical development of drugs for stroke? (2007) Trends Neurosci, 30, pp. 433-439; Macleod, M.R., O'Collins, T., Horky, L.L., Howells, D.W., Donnan, G.A., Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke (2005) J Cereb Blood Flow Metab, 25, pp. 713-721; Macleod, M.R., van der Worp, H.B., Sena, E.S., Howells, D.W., Dirnagl, U., Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality (2008) Stroke, 39, pp. 2824-2829; Ioannidis, J.P., Extrapolating from animals to humans (2012) Sci Transl Med, 4, pp. 151ps115; Sena, E.S., van der Worp, H.B., Bath, P.M., Howells, D.W., Macleod, M.R., Publication bias in reports of animal stroke studies leads to major overstatement of efficacy (2010) PLoS Biol, 8, pp. e1000344. , doi:10.1371/journal.pbio.1000344; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, pp. d4002; Ioannidis, J.P., Trikalinos, T.A., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey (2007) CMAJ, 176, pp. 1091-1096; Lau, J., Ioannidis, J.P., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) BMJ, 333, pp. 597-600; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry, 68, pp. 773-780; Kavvoura, F.K., McQueen, M.B., Khoury, M.J., Tanzi, R.E., Bertram, L., Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease (2008) Am J Epidemiol, 168, pp. 855-865; Hackam, D.G., Redelmeier, D.A., Translation of research evidence from animals to humans (2006) JAMA, 296, pp. 1731-1732; Macleod, M.R., O'Collins, T., Howells, D.W., Donnan, G.A., Pooling of animal experimental data reveals influence of study design and publication bias (2004) Stroke, 35, pp. 1203-1208; Crossley, N.A., Sena, E., Goehler, J., Horn, J., van der Worp, B., Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach (2008) Stroke, 39, pp. 929-934; Bebarta, V., Luyten, D., Heard, K., Emergency medicine animal research: does use of randomization and blinding affect the results? (2003) Acad Emerg Med, 10, pp. 684-687; O'Collins, V.E., Macleod, M.R., Cox, S.F., Van Raay, L., Aleksoska, E., Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing (2011) J Cereb Blood Flow Metab, 31, pp. 962-975; Freedman, M.S., Bar-Or, A., Oger, J., Traboulsee, A., Patry, D., A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS (2011) Neurology, 77, pp. 1551-1560; Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Minocycline treatment in acute stroke: an open-label, evaluator-blinded study (2007) Neurology, 69, pp. 1404-1410; Padma Srivastava, M.V., Bhasin, A., Bhatia, R., Garg, A., Gaikwad, S., Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial (2012) Neurol India, 60, pp. 23-28; Macleod, M.R., O'Collins, T., Horky, L.L., Howells, D.W., Donnan, G.A., Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke (2005) J Pineal Res, 38, pp. 35-41; Kucukakin, B., Wilhelmsen, M., Lykkesfeldt, J., Reiter, R.J., Rosenberg, J., No effect of melatonin to modify surgical-stress response after major vascular surgery: a randomised placebo-controlled trial (2010) Eur J Vasc Endovasc Surg, 40, pp. 461-467; Whitney, E.J., Krasuski, R.A., Personius, B.E., Michalek, J.E., Maranian, A.M., A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events (2005) Ann Intern Med, 142, pp. 95-104; Ono, H., Osanai, T., Ishizaka, H., Hanada, H., Kamada, T., Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation (2004) Am Heart J, 148, pp. E15; Sugimoto, K., Ito, H., Iwakura, K., Ikushima, M., Kato, A., Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction (2003) Circ J, 67, pp. 295-300; England, T.J., Abaei, M., Auer, D.P., Lowe, J., Jones, D.R., Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial (2012) Stroke, 43, pp. 405-411; Shyu, W.C., Lin, S.Z., Lee, C.C., Liu, D.D., Li, H., Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial (2006) CMAJ, 174, pp. 927-933; Rooke, E.D., Vesterinen, H.M., Sena, E.S., Egan, K.J., Macleod, M.R., Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis (2011) Parkinsonism Relat Disord, 17, pp. 313-320; Libman, I., Gawel, M.J., Riopelle, R.J., Bouchard, S., A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients (1987) Can J Neurol Sci, 14, pp. 576-580; Landis, S.C., Amara, S.G., Asadullah, K., Austin, C.P., Blumenstein, R., A call for transparent reporting to optimize the predictive value of preclinical research (2012) Nature, 490, pp. 187-191; Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., Altman, D.G., Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research (2010) PLoS Biol, 8, pp. e1000412. , doi:10.1371/journal.pbio.1000412; Recommendations for standards regarding preclinical neuroprotective and restorative drug development (1999) Stroke, 30, pp. 2752-2758. , Stroke Therapy Academic Industry Roundtable (STAIR); Macleod, M.R., Fisher, M., O'Collins, V., Sena, E.S., Dirnagl, U., Good laboratory practice: preventing introduction of bias at the bench (2009) Stroke, 40, pp. e50-e52; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335, pp. 914-916; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Sena, E.S., Briscoe, C.L., Howells, D.W., Donnan, G.A., Sandercock, P.A., Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis (2010) J Cereb Blood Flow Metab, 30, pp. 1905-1913; Sena, E.S., van der Worp, H.B., Bath, P.M., Howells, D.W., Macleod, M.R., Publication bias in reports of animal stroke studies leads to major overstatement of efficacy (2010) PLoS Biol, 8, pp. e1000344. , doi:10.1371/journal.pbio.1000344; Vesterinen, H.M., Sena, E.S., ffrench-Constant, C., Williams, A., Chandran, S., Improving the translational hit of experimental treatments in multiple sclerosis (2010) Mult Scler, 16, pp. 1044-1055; Higgins, J., Green, S., (2008) Cochrane Handbook for Systematic Reviews of Interventions, , Editors, Chichester, England: The Cochrane Collaboration and John Wiley & Sons Ltd; Erdfelder, E., Faul, F., Buchner, A., GPOWER: A general power analysis program (1996) Behav Res Methods Instrum Comput, 28, pp. 1-11; Heller, G., Power calculations for preclinical studies using a K-sample rank test and the Lehmann alternative hypothesis (2006) Stat Med, 25, pp. 2543-2553; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327, pp. 557-560},
correspondence_address1={Ioannidis, J. P. A.; Stanford Prevention Research Center, Department of Medicine, , Stanford, CA, United States; email: jioannid@stanford.edu},
issn={15449173},
coden={PBLIB},
pubmed_id={23874156},
language={English},
abbrev_source_title={PloS Biol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Rosengren2019e748,
author={Rosengren, A. and Smyth, A. and Rangarajan, S. and Ramasundarahettige, C. and Bangdiwala, S.I. and AlHabib, K.F. and Avezum, A. and Bengtsson Boström, K. and Chifamba, J. and Gulec, S. and Gupta, R. and Igumbor, E.U. and Iqbal, R. and Ismail, N. and Joseph, P. and Kaur, M. and Khatib, R. and Kruger, I.M. and Lamelas, P. and Lanas, F. and Lear, S.A. and Li, W. and Wang, C. and Quiang, D. and Wang, Y. and Lopez-Jaramillo, P. and Mohammadifard, N. and Mohan, V. and Mony, P.K. and Poirier, P. and Srilatha, S. and Szuba, A. and Teo, K. and Wielgosz, A. and Yeates, K.E. and Yusoff, K. and Yusuf, R. and Yusufali, A.H. and Attaei, M.W. and McKee, M. and Yusuf, S.},
title={Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study},
journal={The Lancet Global Health},
year={2019},
volume={7},
number={6},
pages={e748-e760},
doi={10.1016/S2214-109X(19)30045-2},
note={cited By 176},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065465541&doi=10.1016%2fS2214-109X%2819%2930045-2&partnerID=40&md5=3024b2ea3783aabc235736d619daa523},
affiliation={Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; HRB Clinical Research Facility Galway, National University of Ireland, Galway, Ireland; Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada; Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Dante Pazzanese Institute of Cardiology and University Santo Amaro, São Paulo, Brazil; R&D Centre Skaraborg Primary Care, Skövde, Sweden; Department of Physiology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe; Cardiology Department, Ankara University School of Medicine, Ankara, Turkey; Eternal Heart Care Centre and Research Institute, Jaipur, India; School of Public Health, University of the Western Cape, Bellville, South Africa; Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia; School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Public Health Sciences, Stritch School of Medicine, Maywood, IL, United States; Africa Unit for Transdisciplinary Health Research, North-West University, Potchefstroom, South Africa; Universidad de La Frontera, Temuco, Chile; Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Wujin District Center for Disease Control and Prevention, Changzhou, China; Research Institute, FOSCAL International Clinic, Bucaramanga, Colombia; Eugenio Espejo Medical School, Universidad UTE, Quito, Ecuador; Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran; Madras Diabetes Research Foundation and Dr Mohan's Diabetes Specialities Centre, Chennai, India; St John's Medical College & Research Institute, Bangalore, India; Faculté de pharmacie, Université Laval, Institut universitaire de cardiologie et de pneumologie de Québec, Québec City, QC, Canada; Health Action by People, Kerala, India; Division of Angiology, Wroclaw Medical University, Wroclaw, Poland; Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada; Department of Medicine, Queen's University, Kingston, ON, Canada; Universiti Teknologi MARA, Selayang Campus, Selangor, Malaysia; UCSI University, Kuala Lumpur, Malaysia; School of Life Sciences, Independent University, Dhaka, Bangladesh; Hatta Hospital, Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates; London School of Hygiene & Tropical Medicine, London, United Kingdom},
abstract={Background: Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel differences in risk factor levels or differences in management. Methods: In this large-scale prospective cohort study, we recruited adults aged between 35 years and 70 years from 367 urban and 302 rural communities in 20 countries. We collected data on families and households in two questionnaires, and data on cardiovascular risk factors in a third questionnaire, which was supplemented with physical examination. We assessed socioeconomic status using education and a household wealth index. Education was categorised as no or primary school education only, secondary school education, or higher education, defined as completion of trade school, college, or university. Household wealth, calculated at the household level and with household data, was defined by an index on the basis of ownership of assets and housing characteristics. Primary outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction, and heart failure), cardiovascular mortality, and all-cause mortality. Information on specific events was obtained from participants or their family. Findings: Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data and were eligible for inclusion. After exclusion of 6130 (3·8%) participants without complete baseline or follow-up data, 154 169 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income countries. Participants were followed-up for a mean of 7·5 years. Major cardiovascular events were more common among those with low levels of education in all types of country studied, but much more so in low-income countries. After adjustment for wealth and other factors, the HR (low level of education vs high level of education) was 1·23 (95% CI 0·96–1·58) for high-income countries, 1·59 (1·42–1·78) in middle-income countries, and 2·23 (1·79–2·77) in low-income countries (pinteraction&lt;0·0001). We observed similar results for all-cause mortality, with HRs of 1·50 (1·14–1·98) for high-income countries, 1·80 (1·58–2·06) in middle-income countries, and 2·76 (2·29–3·31) in low-income countries (pinteraction&lt;0·0001). By contrast, we found no or weak associations between wealth and these two outcomes. Differences in outcomes between educational groups were not explained by differences in risk factors, which decreased as the level of education increased in high-income countries, but increased as the level of education increased in low-income countries (pinteraction&lt;0·0001). Medical care (eg, management of hypertension, diabetes, and secondary prevention) seemed to play an important part in adverse cardiovascular disease outcomes because such care is likely to be poorer in people with the lowest levels of education compared to those with higher levels of education in low-income countries; however, we observed less marked differences in care based on level of education in middle-income countries and no or minor differences in high-income countries. Interpretation: Although people with a lower level of education in low-income and middle-income countries have higher incidence of and mortality from cardiovascular disease, they have better overall risk factor profiles. However, these individuals have markedly poorer health care. Policies to reduce health inequities globally must include strategies to overcome barriers to care, especially for those with lower levels of education. Funding: Full funding sources are listed at the end of the paper (see Acknowledgments). © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license},
keywords={adult;  all cause mortality;  Article;  assessment of humans;  cardiovascular disease;  cardiovascular mortality;  cardiovascular risk;  cohort analysis;  education;  female;  food frequency questionnaire;  high income country;  household wealth index;  human;  low income country;  major clinical study;  male;  middle aged;  middle income country;  priority journal;  prospective study;  questionnaire;  social status;  cardiovascular disease;  developing country;  economics;  risk factor;  rural population;  social class;  urban population, Cardiovascular Diseases;  Developed Countries;  Developing Countries;  Female;  Humans;  Male;  Middle Aged;  Risk Factors;  Rural Population;  Social Class;  Urban Population},
funding_details={07-05-IFN-BPH 010, 100-IRDC/BIOTEK 16/6/21 [13/2007},
funding_details={290/W-PURE/2008/0},
funding_details={GlaxoSmithKlineGlaxoSmithKline, GSK},
funding_details={SanofiSanofi},
funding_details={Heart and Stroke Foundation of CanadaHeart and Stroke Foundation of Canada, HSFC},
funding_details={Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS), 6517-777-58228, 6566-04-18062},
funding_details={AstraZeneca CanadaAstraZeneca Canada},
funding_details={Boehringer IngelheimBoehringer Ingelheim},
funding_details={Public Health Agency of CanadaPublic Health Agency of Canada, PHAC},
funding_details={Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical SciencesSheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences},
funding_details={International Development Research CentreInternational Development Research Centre, IDRC},
funding_details={Ontario Ministry of Health and Long-Term CareOntario Ministry of Health and Long-Term Care, MOHLTC},
funding_details={Indian Council of Medical ResearchIndian Council of Medical Research, ICMR},
funding_details={Saudi Heart AssociationSaudi Heart Association, SHA},
funding_details={AFA FörsäkringAFA Försäkring},
funding_details={Ministry of Higher Education, MalaysiaMinistry of Higher Education, Malaysia, MOHE, 600-RMI/LRGS/5/3 [2/2011},
funding_details={VetenskapsrådetVetenskapsrådet, VR},
funding_details={Universiti Kebangsaan MalaysiaUniversiti Kebangsaan Malaysia, UKM-Hejim-Komuniti-15-2010},
funding_details={Universiti Teknologi MARAUniversiti Teknologi MARA, UiTM},
funding_details={North-West UniversityNorth-West University, NWU},
funding_details={Universidad de La FronteraUniversidad de La Frontera, UFRO},
funding_details={Uniwersytet Medyczny im. Piastów Slaskich we WroclawiuUniwersytet Medyczny im. Piastów Slaskich we Wroclawiu},
funding_details={Philippine Council for Health Research and DevelopmentPhilippine Council for Health Research and Development, PCHRD},
funding_details={Deanship of Scientific Research, King Saud UniversityDeanship of Scientific Research, King Saud University, RG-1436-013},
funding_details={ServierServier},
funding_details={Independent University, BangladeshIndependent University, Bangladesh, IUB},
funding_text 1={SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from the Canadian Institutes of Health Research Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and various national or local organisations in participating countries. These various national or local organisations include: Argentina: Fundacion ECLA (Estudios Clínicos Latino America); Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant nos 6566-04-18062 and 6517-777-58228 ); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant no 100-IRDC/BIOTEK 16/6/21 [13/2007 and 07-05-IFN-BPH 010 ), Ministry of Higher Education of Malaysia (grant no 600-RMI/LRGS/5/3 [2/2011] ), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia ( UKM-Hejim-Komuniti-15-2010 ); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant no 290/W-PURE/2008/0 ), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (research group no RG-1436-013 ); South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi-Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.},
references={Havranek, E.P., Mujahid, M.S., Barr, D.A., Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association (2015) Circulation, 132, pp. 873-898; Veronesi, G., Tunstall-Pedoe, H., Ferrario, M.M., Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: Implications for prevention (2017) Eur J Prev Cardiol, 24, pp. 437-445; Stringhini, S., Carmeli, C., Jokela, M., Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women (2017) Lancet, 389, pp. 1229-1237; Roth, G.A., Huffman, M.D., Moran, A.E., Global and regional patterns in cardiovascular mortality from 1990 to 2013 (2015) Circulation, 132, pp. 1667-1678; Gupta, R., Gupta, K.D., Coronary heart disease in low socioeconomic status subjects in India: “an evolving epidemic” (2009) Indian Heart J, 61, pp. 358-367; Reddy, K.S., Prabhakaran, D., Jeemon, P., Educational status and cardiovascular risk profile in Indians (2007) Proc Natl Acad Sci USA, 104, pp. 16263-16268; Subramanian, S.V., Corsi, D.J., Subramanyam, M.A., Smith, G.D., Jumping the gun: the problematic discourse on socioeconomic status and cardiovascular health in India (2013) Int J Epidemiol, 42, pp. 1410-1426; Braveman, P.A., Cubbin, C., Egerter, S., Socioeconomic status in health research: one size does not fit all (2005) JAMA, 294, pp. 2879-2888; Pednekar, M.S., Gupta, R., Gupta, P.C., Illiteracy, low educational status, and cardiovascular mortality in India (2011) BMC Public Health, 11, p. 567; Vathesatogkit, P., Batty, G.D., Woodward, M., Socioeconomic disadvantage and disease-specific mortality in Asia: systematic review with meta-analysis of population-based cohort studies (2014) J Epidemiol Community Health, 68, pp. 375-383; Stringhini, S., Rousson, V., Viswanathan, B., Gedeon, J., Paccaud, F., Bovet, P., Association of socioeconomic status with overall and cause specific mortality in the Republic of Seychelles: results from a cohort study in the African region (2014) PLoS One, 9, p. e102858; Goyal, A., Bhatt, D.L., Steg, P.G., Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries (2010) Circulation, 122, pp. 1167-1175; Woodward, M., Peters, S.A., Batty, G.D., Socioeconomic status in relation to cardiovascular disease and cause-specific mortality: a comparison of Asian and Australasian populations in a pooled analysis (2015) BMJ Open, 5, p. e006408; Kumar, A., Prasad, M., Kathuria, P., Low socioeconomic status is an independent risk factor for ischemic stroke: a case-control study in North Indian population (2015) Neuroepidemiology, 44, pp. 138-143; Teo, K., Chow, C.K., Vaz, M., Rangarajan, S., Yusuf, S., The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries (2009) Am Heart J, 158, pp. 1-7; Yusuf, S., Rangarajan, S., Teo, K., Cardiovascular risk and events in 17 low-, middle-, and high-income countries (2014) N Engl J Med, 371, pp. 818-827; How does the World Bank classify countries? https://datahelpdesk.worldbank.org/knowledgebase/articles/378834-how-does-the-world-bank-classify-countries, (Accessed 3 April 2019); Corsi, D.J., Subramanian, S.V., Chow, C.K., Prospective Urban Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries (2013) Am Heart J, 166, pp. 636-646; McGorrian, C., Yusuf, S., Islam, S., Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score (2011) Eur Heart J, 32, pp. 581-589; Gupta, R., Islam, S., Mony, P., Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: the PURE study (2015) Eur J Prev Cardiol, 22, pp. 1261-1271; Erreygers, G., Van Ourti, T., Measuring socioeconomic inequality in health, health care and health financing by means of rank-dependent indices: a recipe for good practice (2011) J Health Econ, 30, pp. 685-694; Wagstaff, A., The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality (2005) Health Econ, 14, pp. 429-432; Mackenbach, J.P., Stirbu, I., Roskam, A.J., Socioeconomic inequalities in health in 22 European countries (2008) N Engl J Med, 358, pp. 2468-2481; Avendano, M., Kunst, A.E., Huisman, M., Socioeconomic status and ischaemic heart disease mortality in 10 western European populations during the 1990s (2006) Heart, 92, pp. 461-467; Moran, A.E., Tzong, K.Y., Forouzanfar, M.H., Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study (2014) Glob Heart, 9, pp. 91-99; Kreatsoulas, C., Anand, S.S., The impact of social determinants on cardiovascular disease (2010) Can J Cardiol, 26, pp. 8-13; White, M., Adams, J., Heywood, P., How and why do interventions that increase health overall widen inequalities within populations? (2009) Social inequality and public health, pp. 65-81. , SJ Babones Policy Press London; Rosengren, A., Subramanian, S.V., Islam, S., Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study (2009) Heart, 95, pp. 2014-2022; Ross, C.E., Mirowsky, J., Why education is the key to socioeconomic differentials in health (2010) Handbook of medical sociology, pp. 33-51. , CE Bird P Conrad AM Fremont S Timmermans Vanderbilt University Press Nashville; Mirowsky, J., Ross, C.E., Education, learned effectiveness and health (2005) London Rev Educ, 3, pp. 205-220; Berkman, L.F., Glass, T., Brissette, I., From social integration to health: Durkheim in the new millennium (2000) Soc Sci Med, 51, pp. 843-857; Camacho, P.A., Gomez-Arbelaez, D., Molina, D.I., Social disparities explain differences in hypertension prevalence, detection and control in Colombia (2016) J Hypertens, 34, pp. 2344-2352; Khatib, R., McKee, M., Shannon, H., Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2016) Lancet, 387, pp. 61-69; Xavier, D., Pais, P., Devereaux, P.J., Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data (2008) Lancet, 371, pp. 1435-1442; Miller, V., Yusuf, S., Chow, C.K., Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study (2016) Lancet Glob Health, 4, pp. e695-e703; Wallack, L., Thornburg, K., Developmental origins, epigenetics, and equity: moving upstream (2016) Matern Child Health J, 20, pp. 935-940; Eriksson, J.G., Forsén, T., Tuomilehto, J., Winter, P.D., Osmond, C., Barker, D.J.P., Catch-up growth in childhood and death from coronary heart disease: longitudinal study (1999) BMJ, 318, pp. 427-431; Ohlsson, C., Bygdell, M., Sondén, A., Rosengren, A., Kindblom, J.M., Association between excessive BMI increase during puberty and risk of cardiovascular mortality in adult men: a population-based cohort study (2016) Lancet Diabetes Endocrinol, 4, pp. 1017-1024; Rosengren, A., Wilhelmsen, L., Wedel, H., Weight gain from age 20 to middle age and long-term mortality from coronary, cardiovascular and all causes (1999) Eur Heart J, 20, pp. 269-277; Meneton, P., Hoertel, N., Wiernik, E., Work environment mediates a large part of social inequalities in the incidence of several common cardiovascular risk factors: findings from the Gazel cohort (2018) Soc Sci Med, 216, pp. 59-66; Brunner, E.J., Social factors and cardiovascular morbidity (2017) Neurosci Biobehav Rev, 74, pp. 260-268; Kakinami, L., Séguin, L., Lambert, M., Gauvin, L., Nikiema, B., Paradis, G., Comparison of three lifecourse models of poverty in predicting cardiovascular disease risk in youth (2013) Ann Epidemiol, 23, pp. 485-491; Bambra, C., Eikemo, T.A., Welfare state regimes, unemployment and health: a comparative study of the relationship between unemployment and self-reported health in 23 European countries (2009) J Epidemiol Community Health, 63, pp. 92-98; Pollack, C.E., Cubbin, C., Sania, A., Do wealth disparities contribute to health disparities within racial/ethnic groups? (2013) J Epidemiol Community Health, 67, pp. 439-445; Chae, D.H., Clouston, S., Hatzenbuehler, M.L., Association between an internet-based measure of area racism and black mortality (2015) PLoS One, 10, p. e0122963; Kunitz, S.J., McKee, M., Nolte, E., State political cultures and the mortality of African Americans and American Indians (2010) Health Place, 16, pp. 558-566},
correspondence_address1={Rosengren, A.; Sahlgrenska Academy, Sweden; email: annika.rosengren@gu.se},
publisher={Elsevier Ltd},
issn={2214109X},
pubmed_id={31028013},
language={English},
abbrev_source_title={Lancet Global Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Li2017,
author={Li, X. and Meng, X. and Timofeeva, M. and Tzoulaki, I. and Tsilidis, K.K. and Ioannidis, P.A. and Campbell, H. and Theodoratou, E.},
title={Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies},
journal={BMJ (Online)},
year={2017},
volume={357},
doi={10.1136/bmj.j2376},
art_number={j2376},
note={cited By 176},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020442980&doi=10.1136%2fbmj.j2376&partnerID=40&md5=9ce5a675c0118c27ed134927f37130f7},
affiliation={Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, EH8 9AG, United Kingdom; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Stanford Prevention Research Center, Stanford School of Medicine, Stanford, CA, United States; Department of Health Research and Policy, Stanford School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University, Stanford, CA, United States},
abstract={OBJECTIVE: To map the diverse health outcomes associated with serum uric acid (SUA) levels. DESIGN: Umbrella review. DATA SOURCES: Medline, Embase, Cochrane Database of Systematic Reviews, and screening of citations and references. ELIGIBILITY CRITERIA: Systematic reviews and meta-analyses of observational studies that examined associations between SUA level and health outcomes, meta-analyses of randomised controlled trials that investigated health outcomes related to SUA lowering treatment, and Mendelian randomisation studies that explored the causal associations of SUA level with health outcomes. RESULTS: 57 articles reporting 15 systematic reviews and144 meta-analyses of observational studies (76 unique outcomes), 8 articles reporting 31 meta-analyses of randomised controlled trials (20 unique outcomes), and 36 articles reporting 107 Mendelian randomisation studies (56 unique outcomes) met the eligibility criteria. Across all three study types, 136 unique health outcomes were reported. 16 unique outcomes in meta-analyses of observational studies had P&lt;10-6, 8 unique outcomes in meta-analyses of randomised controlled trials had P&lt;0.001, and 4 unique outcomes in Mendelian randomisation studies had P&lt;0.01. Large between study heterogeneity was common (80% and 45% in meta-analyses of observational studies and of randomised controlled trials, respectively). 42 (55%) meta-analyses of observational studies and 7 (35%) meta-analyses of randomised controlled trials showed evidence of small study effects or excess significance bias. No associations from meta-analyses of observational studies were classified as convincing; five associations were classified as highly suggestive (increased risk of heart failure, hypertension, impaired fasting glucose or diabetes, chronic kidney disease, coronary heart disease mortality with high SUA levels). Only one outcome from randomised controlled trials (decreased risk of nephrolithiasis recurrence with SUA lowering treatment) had P&lt;0.001, a 95% prediction interval excluding the null, and no large heterogeneity or bias. Only one outcome from Mendelian randomisation studies (increased risk of gout with high SUA levels) presented convincing evidence. Hypertension and chronic kidney disease showed concordant evidence in meta-analyses of observational studies, and in some (but not all) meta-analyses of randomised controlled trials with respective intermediate or surrogate outcomes, but they were not statistically significant in Mendelian randomisation studies. CONCLUSION: Despite a few hundred systematic reviews, meta-analyses, and Mendelian randomisation studies exploring 136 unique health outcomes, convincing evidence of a clear role of SUA level only exists for gout and nephrolithiasis. © 2017, BMJ Publishing Group. All rights reserved.},
keywords={uric acid;  biological marker;  uric acid, Alzheimer disease;  atrial fibrillation;  cerebrovascular accident;  chronic kidney failure;  controlled study;  diabetes mellitus;  diabetic neuropathy;  diastolic blood pressure;  disorders of higher cerebral function;  estimated glomerular filtration rate;  heart failure;  human;  hypertension;  impaired glucose tolerance;  ischemic heart disease;  malignant neoplasm;  Mendelian randomization analysis;  meta analysis;  metabolic syndrome X;  mild cognitive impairment;  mortality;  nephrolithiasis;  observational study;  priority journal;  purine metabolism;  Review;  risk factor;  systematic review;  systolic blood pressure;  uric acid blood level;  blood;  gout;  Mendelian randomization analysis;  randomized controlled trial (topic), Biomarkers;  Gout;  Humans;  Mendelian Randomization Analysis;  Nephrolithiasis;  Observational Studies as Topic;  Randomized Controlled Trials as Topic;  Uric Acid},
chemicals_cas={uric acid, 69-93-2; Biomarkers; Uric Acid},
funding_details={Cancer Research UKCancer Research UK, CRUK},
funding_details={China Scholarship CouncilChina Scholarship Council, CSC},
funding_text 1={XL and XM are supported by the China Scholarship Council. ET is supported by a CRUK Career Development Fellowship.},
references={Garrod, A.B., Observations on certain pathological conditions of the blood and urine, in gout, rheumatism, and Bright's disease (1848) Med Chir Trans, 31, pp. 83-97; Davis, N.S., Jr., The cardio-vascular and renal relations and manifestations of gout (1897) JAMA, 29, pp. 261-262; Freedman, D.S., Williamson, D.F., Gunter, E.W., Byers, T., Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study (1995) Am J Epidemiol, 141, pp. 637-644; Culleton, B.F., Larson, M.G., Kannel, W.B., Levy, D., Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study (1999) Ann Intern Med, 131, pp. 7-13; Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Serum urate and the risk of major coronary heart disease events (1997) Heart, 78, pp. 147-153; Vaccarino, V., Krumholz, H.M., Risk factors for cardiovascular disease: One down, many more to evaluate (1999) Ann Intern Med, 131, pp. 62-63; Feig, D.I., Kang, D.-H., Johnson, R.J., Uric acid and cardiovascular risk (2008) N Engl J Med, 359, pp. 1811-1821; Khanna, D., Fitzgerald, J.D., Khanna, P.P., 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia (2012) Arthritis Care Res (Hoboken), 64, pp. 1431-1446. , American College of Rheumatology; Stamp, L., Dalbeth, N., Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution (2016) Semin Arthritis Rheum; Nakagawa, T., Kang, D.H., Feig, D., Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease (2006) Kidney Int, 69, pp. 1722-1725; Soltani, Z., Rasheed, K., Kapusta, D.R., Reisin, E., Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: Is it time for reappraisal? (2013) Curr Hypertens Rep, 15, pp. 175-181; George, J., Struthers, A.D., Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress (2009) Vasc Health Risk Manag, 5, pp. 265-272; Meotti, F.C., Jameson, G.N., Turner, R., Urate as a physiological substrate for myeloperoxidase: Implications for hyperuricemia and inflammation (2011) J Biol Chem, 286, pp. 12901-12911; Nakagawa, T., Hu, H., Zharikov, S., A causal role for uric acid in fructose-induced metabolic syndrome (2006) Am J Physiol Renal Physiol, 290, pp. F625-F631; Pasalic, D., Marinkovic, N., Feher-Turkovic, L., Uric acid as one of the important factors in multifactorial disorders - Facts and controversies (2012) Biochem Med (Zagreb), 22, pp. 63-75; Alvarez-Lario, B., Macarrón-Vicente, J., Is there anything good in uric acid? (2011) QJM, 104, pp. 1015-1024; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172, pp. 137-159; Higgins, J.P., Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry, 68, pp. 773-780; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P.A., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Brion, M.J., Shakhbazov, K., Visscher, P.M., Calculating statistical power in Mendelian randomization studies (2013) Int J Epidemiol, 42, pp. 1497-1501; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Kavanagh, B.P., The GRADE system for rating clinical guidelines (2009) PLoS Med, 6; Pierce, B.L., Ahsan, H., Vanderweele, T.J., Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants (2011) Int J Epidemiol, 40, pp. 740-752; Baker, J.F., Krishnan, E., Chen, L., Schumacher, H.R., Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? (2005) Am J Med, 118, pp. 816-826; Strazzullo, P., Puig, J.G., Uric acid and oxidative stress: Relative impact on cardiovascular risk? (2007) Nutr Metab Cardiovasc Dis, 17, pp. 409-414; Barron, E., Lara, J., White, M., Mathers, J.C., Blood-borne biomarkers of mortality risk: Systematic review of cohort studies (2015) PLoS One, 10; Dimitroula, H.V., Hatzitolios, A.I., Karvounis, H.I., The role of uric acid in stroke: The issue remains unresolved (2008) Neurologist, 14, pp. 238-242; Hwu, C.M., Lin, K.H., Uric acid and the development of hypertension (2010) Med Sci Monit, 16, pp. RA224-RA230; Avram, Z., Krishnan, E., Hyperuricaemia - Where nephrology meets rheumatology (2008) Rheumatology (Oxford), 47, pp. 960-964; Feig, D.I., Uric acid: A novel mediator and marker of risk in chronic kidney disease? (2009) Curr Opin Nephrol Hypertens, 18, pp. 526-530; Alonso, A., Sovell, K.A., Gout, hyperuricemia, and Parkinson's disease: A protective effect? (2010) Curr Rheumatol Rep, 12, pp. 149-155; Chang, Y.T., Chang, W.N., Tsai, N.W., The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: A systematic review (2014) Biomed Res Int, 2014, p. 182303; Cnossen, J.S., De Ruyter-Hanhijärvi, H., Van Der Post, J.A., Mol, B.W., Khan, K.S., Ter Riet, G., Accuracy of serum uric acid determination in predicting pre-eclampsia: A systematic review (2006) Acta Obstet Gynecol Scand, 85, pp. 519-525; Zhang, C.H., Huang, D.S., Shen, D., Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk (2016) Cell Physiol Biochem, 38, pp. 1589-1595; Zhao, J., Liu, T., Korantzopoulos, P., Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis (2016) Int J Cardiol, 204, pp. 103-105; Li, M., Hu, X., Fan, Y., Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis (2016) Sci Rep, 6, p. 19520; Qin, T., Zhou, X., Wang, J., Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis (2016) J Clin Hypertens (Greenwich), 18, pp. 1268-1278; Huang, H., Huang, B., Li, Y., Uric acid and risk of heart failure: A systematic review and meta-analysis (2014) Eur J Heart Fail, 16, pp. 15-24; Wang, J., Qin, T., Chen, J., Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies (2014) PLoS One, 9; Jiang, M., Gong, D., Fan, Y., Serum uric acid levels and risk of prehypertension: A meta-analysis (2016) Clin Chem Lab Med; Song, X., Wang, Y., Hou, X., Association between hyperuricemia and clinical adverse outcomes after percutaneous coronary intervention: A meta-analysis (2015) Int J Cardiol, 201, pp. 658-662; Trkulja, V., Car, S., On-admission serum uric acid predicts outcomes after acute myocardial infarction: Systematic review and meta-analysis of prognostic studies (2012) Croat Med J, 53, pp. 162-172; Li, M., Hou, W., Zhang, X., Hu, L., Tang, Z., Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies (2014) Atherosclerosis, 232, pp. 265-270; Kodama, S., Saito, K., Yachi, Y., Association between serum uric acid and development of type 2 diabetes (2009) Diabetes Care, 32, pp. 1737-1742; Jia, Z., Zhang, X., Kang, S., Wu, Y., Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: A meta-analysis of cohort studies (2013) Diabetes Res Clin Pract, 101, pp. 88-96; Xu, Y., Zhu, J., Gao, L., Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: A meta-analysis (2013) PLoS One, 8; Xu, X., Du, N., Wang, R., Wang, Y., Cai, S., Hyperuricemia is independently associated with increased risk of atrial fibrillation: A meta-analysis of cohort studies (2015) Int J Cardiol, 184, pp. 699-702; Yu, S., Chen, Y., Hou, X., Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: A Systematic Review and Meta-analysis (2016) Mol Neurobiol, 53, pp. 1045-1051; Zhu, P., Liu, Y., Han, L., Xu, G., Ran, J.M., Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: A meta-analysis of 15 cohort studies (2014) PLoS One, 9; Li, L., Yang, C., Zhao, Y., Zeng, X., Liu, F., Fu, P., Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies (2014) BMC Nephrol, 15, p. 122; Huang, Y., Li, Y.L., Huang, H., Wang, L., Yuan, W.M., Li, J., Effects of hyperuricemia on renal function of renal transplant recipients: A systematic review and meta-analysis of cohort studies (2012) PLoS One, 7; Du, N., Xu, D., Hou, X., Inverse Association Between Serum Uric Acid Levels and Alzheimer's Disease Risk (2016) Mol Neurobiol, 53, pp. 2594-2599; Khan, A.T.J.Q., Dawson, J., Serum uric acid level and cognitive function; A systematic review and meta-analysis (2013) Cerebrovasc Dis, 35, p. 821; Shen, C., Guo, Y., Luo, W., Lin, C., Ding, M., Serum urate and the risk of Parkinson's disease: Results from a meta-analysis (2013) Can J Neurol Sci, 40, pp. 73-79; Wang, L., Hu, W., Wang, J., Qian, W., Xiao, H., Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis (2016) Mult Scler Relat Disord, 9, pp. 17-22; Abraham, A., Drory, V.E., Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: A meta-analysis (2014) J Neurol, 261, pp. 1133-1138; Flatow, J., Buckley, P., Miller, B.J., Meta-analysis of oxidative stress in schizophrenia (2013) Biol Psychiatry, 74, pp. 400-409; Bartoli, F., Crocamo, C., Mazza, M.G., Clerici, M., Carrà, G., Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis (2016) J Psychiatr Res, 81, pp. 133-139; Yan, S., Zhang, P., Xu, W., Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis (2015) Mediators Inflamm, 2015, p. 764250; Zhao, G., Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies (2014) Cardiology (Switzerland), 129, p. 47; Xia, X., Luo, Q., Li, B., Lin, Z., Yu, X., Huang, F., Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis (2016) Metabolism, 65, pp. 1326-1341; Tamariz, L., Harzand, A., Verma, S., Jones, J., Hare, J., Uric acid as a predictor of mortality in congestive heart failure: A meta-analysis (2009) J Am Coll Cardiol, 53, p. A169; Yan, L., Liu, Z., Zhang, C., Uric acid as a predictor of in-hospital mortality in acute myocardial infarction: A meta-analysis (2014) Cell Biochem Biophys, 70, pp. 1597-1601; Wang, Z., Lin, Y., Liu, Y., Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke (2016) Mol Neurobiol, 53, pp. 1753-1759; Li, X., Miao, X., Wang, H., Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis (2016) Medicine (Baltimore), 95, p. e3676; Zhou, Y., Wei, F., Fan, Y., High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis (2016) Clin Biochem, 49, pp. 636-642; Braga, F., Pasqualetti, S., Ferraro, S., Panteghini, M., Hyperuricemia (HUA) as an independent risk factor for coronary heart disease (CHD) in the general population: A systematic review and meta-analysis (2015) Clin Chem Lab Med, 53, p. S1199; Chen, X., Guo, X., Huang, R., Chen, Y., Zheng, Z., Shang, H., Serum uric acid levels in patients with Alzheimer's disease: A meta-analysis (2014) PLoS One, 9; Grayson, P.C., Kim, S.Y., LaValley, M., Choi, H.K., Hyperuricemia and incident hypertension: A systematic review and meta-analysis (2011) Arthritis Care Res (Hoboken), 63, pp. 102-110; Kim, S.Y., Guevara, J.P., Kim, K.M., Choi, H.K., Heitjan, D.F., Albert, D.A., Hyperuricemia and risk of stroke: A systematic review and meta-analysis (2009) Arthritis Rheum, 61, pp. 885-892; Kim, S.Y., Guevara, J.P., Kim, K.M., Choi, H.K., Heitjan, D.F., Albert, D.A., Hyperuricemia and coronary heart disease: A systematic review and meta-analysis (2010) Arthritis Care Res (Hoboken), 62, pp. 170-180; Li, Y.L., Wang, L., Li, J., Huang, Y., Yuan, W.M., The correlation between uric acid and the incidence and prognosis of kidney diseases: A systematic review and meta-analysis of cohort studies (2011) Zhonghua Nei Ke Za Zhi, 50, pp. 555-561; Liu, B., Shen, Y., Xiao, K., Tang, Y., Cen, L., Wei, J., Serum uric acid levels in patients with multiple sclerosis: A meta-analysis (2012) Neurol Res, 34, pp. 163-171; Lv, Q., Meng, X.F., He, F.F., High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies (2013) PLoS One, 8; Schrag, M., Mueller, C., Zabel, M., Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis (2013) Neurobiol Dis, 59, pp. 100-110; Shen, L., Ji, H.F., Low uric acid levels in patients with Parkinson's disease: Evidence from meta-analysis (2013) BMJ Open, 3, p. e003620; Tamariz, L., Hernandez, F., Bush, A., Palacio, A., Hare, J.M., Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis (2014) Heart Rhythm, 11, pp. 1102-1108; Wheeler, J.G., Juzwishin, K.D.M., Eiriksdottir, G., Gudnason, V., Danesh, J., Serum uric acid and coronary heart disease in 9,458 incident cases and 155 084 controls: Prospective study and meta-analysis (2005) PLoS Med, 2 (3), pp. 0236-0243; Yang, Y., Fan, Y., Li, J., Serum uric acid as a predictor for cardiovascular and all-cause mortality in women versus men (2015) Int J Cardiol, 185, pp. 125-128; Zhang, W., Sun, K., Yang, Y., Zhang, H., Hu, F.B., Hui, R., Plasma uric acid and hypertension in a Chinese community: Prospective study and metaanalysis (2009) Clin Chem, 55, pp. 2026-2034; Fink, H.A., Wilt, T.J., Eidman, K.E., Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline (2013) Ann Intern Med, 158, pp. 535-543; Wang, H., Wei, Y., Kong, X., Xu, D., Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: A meta-analysis (2013) J Ren Nutr, 23, pp. 389-396; Zhang, Y.F., He, F., Ding, H.H., Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis (2014) J Huazhong Univ Sci Technolog Med Sci, 34, pp. 476-481; Bose, B., Badve, S.V., Hiremath, S.S., Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis (2014) Nephrol Dial Transplant, 29, pp. 406-413; Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., Walters, M.R., Xanthine oxidase inhibition for the treatment of cerebrovascular and cardiovascular disease: A systematic review and meta-analysis (2010) Cerebrovasc Dis, 29, p. 321; Kanbay, M., Siriopol, D., Nistor, I., Effects of allopurinol on endothelial dysfunction: A meta-analysis (2014) Am J Nephrol, 39, pp. 348-356; Chaudhari, T., McGuire, W., Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy (2012) Cochrane Database Syst Rev, (7), p. CD006817; Agarwal, V., Hans, N., Messerli, F.H., Effect of allopurinol on blood pressure: A systematic review and meta-analysis (2013) J Clin Hypertens (Greenwich), 15, pp. 435-442; Korostishevsky, M., Steves, C.J., Malkin, I., Spector, T., Williams, F.M., Livshits, G., Genomics and metabolomics of muscular mass in a community-based sample of UK females (2016) Eur J Hum Genet, 24, pp. 277-283; Lyngdoh, T., Vuistiner, P., Marques-Vidal, P., Serum uric acid and adiposity: Deciphering causality using a bidirectional Mendelian randomization approach (2012) PLoS One, 7; White, J., Sofat, R., Hemani, G., Plasma urate concentration and risk of coronary heart disease: A Mendelian randomisation analysis (2016) Lancet Diabetes Endocrinol, 4, pp. 327-336; Dalbeth, N., Topless, R., Flynn, T., Cadzow, M., Bolland, M.J., Merriman, T.R., Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density (2015) J Bone Miner Res, 30, pp. 985-991; Xiong, A., Yao, Q., He, J., Fu, W., Yu, J., Zhang, Z., No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity - A Mendelian randomization study (2016) Osteoporos Int, 27, pp. 1031-1039; Kleber, M.E., Delgado, G., Grammer, T.B., Uric Acid and Cardiovascular Events: A Mendelian Randomization Study (2015) J Am Soc Nephrol, 26, pp. 2831-2838; Keenan, T., Zhao, W., Rasheed, A., Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study (2016) J Am Coll Cardiol, 67, pp. 407-416; Palmer, T.M., Nordestgaard, B.G., Benn, M., Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts (2013) BMJ, 347, p. f4262; Oikonen, M., Wendelin-Saarenhovi, M., Lyytikäinen, L.P., Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study (2012) Atherosclerosis, 223, pp. 497-503; Yan, D., Wang, J., Jiang, F., A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: A Mendelian randomization analysis (2016) Int J Cardiol, 214, pp. 194-199; Mallamaci, F., Testa, A., Leonardis, D., A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: A family-based study (2015) Am J Kidney Dis, 65, pp. 294-302; Sluijs, I., Holmes, M.V., Van Der Schouw, Y.T., A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes (2015) Diabetes, 64, pp. 3028-3036; Yang, Q., Köttgen, A., Dehghan, A., Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors (2010) Circ Cardiovasc Genet, 3, pp. 523-530; Dai, X., Yuan, J., Yao, P., Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population (2013) Eur J Epidemiol, 28, pp. 669-676; Greenberg, K.I., McAdams-DeMarco, M.A., Köttgen, A., Appel, L.J., Coresh, J., Grams, M.E., Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study (2015) Clin J Am Soc Nephrol, 10, pp. 776-783; Testa, A., Mallamaci, F., Spoto, B., Association of a polymorphism in a gene encoding a urate transporter with CKD progression (2014) Clin J Am Soc Nephrol, 9, pp. 1059-1065; Hughes, K., Flynn, T., De Zoysa, J., Dalbeth, N., Merriman, T.R., Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function (2014) Kidney Int, 85, pp. 344-351; Gao, J., Xu, H., Huang, X., Chen, H., Short communication: Genetic variations of SLC2A9 in relation to Parkinson's disease (2013) Transl Neurodegener, 2, p. 5; Facheris, M.F., Hicks, A.A., Minelli, C., Variation in the uric acid transporter gene SLC2A9 and its association with AAO of Parkinson's disease (2011) J Mol Neurosci, 43, pp. 246-250; Lyngdoh, T., Bochud, M., Glaus, J., Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: A population-based study (2013) PLoS One, 8; Houlihan, L.M., Wyatt, N.D., Harris, S.E., Variation in the uric acid transporter gene (SLC2A9) and memory performance (2010) Hum Mol Genet, 19, pp. 2321-2330; Burgess, S., Daniel, R.M., Butterworth, A.S., Thompson, S.G., Network Mendelian randomization: Using genetic variants as instrumental variables to investigate mediation in causal pathways (2015) Int J Epidemiol, 44, pp. 484-495; González-Aramburu, I., Sánchez-Juan, P., Jesús, S., Genetic variability related to serum uric acid concentration and risk of Parkinson's disease (2013) Mov Disord, 28, pp. 1737-1740; González-Aramburu, I., Sánchez-Juan, P., Sierra, M., Serum uric acid and risk of dementia in Parkinson's disease (2014) Parkinsonism Relat Disord, 20, pp. 637-639; Han, X., Gui, L., Liu, B., Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk (2015) BMC Genet, 16, p. 4; Mallamaci, F., Testa, A., Leonardis, D., A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study (2014) J Hypertens, 32, pp. 1621-1628. , discussion 1628; McKeigue, P.M., Campbell, H., Wild, S., Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): Example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome (2010) Int J Epidemiol, 39, pp. 907-918; Parsa, A., Brown, E., Weir, M.R., Genotype-based changes in serum uric acid affect blood pressure (2012) Kidney Int, 81, pp. 502-507; Pfister, R., Barnes, D., Luben, R., No evidence for a causal link between uric acid and type 2 diabetes: A Mendelian randomisation approach (2011) Diabetologia, 54, pp. 2561-2569; Rasheed, H., Hughes, K., Flynn, T.J., Merriman, T.R., Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels (2014) Circ Cardiovasc Genet, 7, pp. 830-837; Sedaghat, S., Pazoki, R., Uitterlinden, A.G., Association of uric acid genetic risk score with blood pressure: The Rotterdam study (2014) Hypertension, 64, pp. 1061-1066; Simon, K.C., Eberly, S., Gao, X., Mendelian randomization of serum urate and parkinson disease progression (2014) Ann Neurol, 76, pp. 862-868; Stark, K., Reinhard, W., Grassl, M., Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease (2009) PLoS One, 4; Sun, X., Zhang, R., Jiang, F., Common variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese population (2015) PLoS One, 10; Tabara, Y., Kohara, K., Kawamoto, R., Association of four genetic loci with uric acid levels and reduced renal function: The J-SHIPP Suita study (2010) Am J Nephrol, 32, pp. 279-286; Voruganti, V.S., Franceschini, N., Haack, K., Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians (2014) Eur J Hum Genet, 22, pp. 938-943; Holme, I., Aastveit, A.H., Hammar, N., Jungner, I., Walldius, G., Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (2009) J Intern Med, 266, pp. 558-570; Mazza, A., Pessina, A.C., Pavei, A., Scarpa, R., Tikhonoff, V., Casiglia, E., Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly (2001) Eur J Epidemiol, 17, pp. 1097-1104; Kuo, C.F., See, L.C., Yu, K.H., Chou, I.J., Chiou, M.J., Luo, S.F., Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality (2013) Rheumatology (Oxford), 52, pp. 127-134; Chen, J.H., Chuang, S.Y., Chen, H.J., Yeh, W.T., Pan, W.H., Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study (2009) Arthritis Rheum, 61, pp. 225-232; Owens, D.K., Lohr, K.N., Atkins, D., AHRQ series paper 5: Grading the strength of a body of evidence when comparing medical interventions - Agency for healthcare research and quality and the effective health-care program (2010) J Clin Epidemiol, 63, pp. 513-523; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: An umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14, p. 147; Krishnan, E., Lessov-Schlaggar, C.N., Krasnow, R.E., Swan, G.E., Nature versus nurture in gout: A twin study (2012) Am J Med, 125, pp. 499-504; Köttgen, A., Albrecht, E., Teumer, A., Genome-wide association analyses identify 18 new loci associated with serum urate concentrations (2013) Nat Genet, 45, pp. 145-154; Richette, P., Doherty, M., Pascual, E., 2016 Updated EULAR evidence-based recommendations for the management of gout (2016) Ann Rheum Dis, 76, pp. 29-42; Chen, H., Mosley, T.H., Alonso, A., Huang, X., Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study (2009) Am J Epidemiol, 169, pp. 1064-1069; Weisskopf, M.G., O'Reilly, E., Chen, H., Schwarzschild, M.A., Ascherio, A., Plasma urate and risk of Parkinson's disease (2007) Am J Epidemiol, 166, pp. 561-567; Kim, T.S., Pae, C.U., Yoon, S.J., Decreased plasma antioxidants in patients with Alzheimer's disease (2006) Int J Geriatr Psychiatry, 21, pp. 344-348; Feig, D.I., Madero, M., Jalal, D.I., Sanchez-Lozada, L.G., Johnson, R.J., Uric acid and the origins of hypertension (2013) J Pediatr, 162, pp. 896-902; Tamariz, L., Hare, J.M., Xanthine oxidase inhibitors in heart failure: Where do we go from here? (2015) Circulation, 131, pp. 1741-1744; Ioannidis, J.P., The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses (2016) Milbank Q, 94, pp. 485-514; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P., Selection in reported epidemiological risks: An empirical assessment (2007) PLoS Med, 4, p. e79; Ioannidis, J.P., Exposure-wide epidemiology: Revisiting Bradford Hill (2016) Stat Med, 35, pp. 1749-1762},
correspondence_address1={Theodoratou, E.; Centre for Global Health Research, United Kingdom; email: E.Theodoratou@ed.ac.uk},
publisher={BMJ Publishing Group},
issn={09598146},
coden={BMJOA},
pubmed_id={28592419},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Review},
source={Scopus},
}

@ARTICLE{Veronese2018436,
author={Veronese, N. and Solmi, M. and Caruso, M.G. and Giannelli, G. and Osella, A.R. and Evangelou, E. and Maggi, S. and Fontana, L. and Stubbs, B. and Tzoulaki, I.},
title={Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses},
journal={American Journal of Clinical Nutrition},
year={2018},
volume={107},
number={3},
pages={436-444},
doi={10.1093/ajcn/nqx082},
note={cited By 175},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044225948&doi=10.1093%2fajcn%2fnqx082&partnerID=40&md5=f25ca45db57dca0c23759a7cadccebac},
affiliation={National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; Ambulatory of Clinical Nutrition, National Institute of Gastroenterology-Research Hospital, Saverio de Bellis, Castellana Grotte, Italy; Department of Neurosciences, University of Padova, Padova, Italy; Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Epidemiology and Biostatistics and MRC-PHE Center for Environment, School of Public Health, Imperial College London, London, United Kingdom; Department of MRC-PHE Center for Environment, School of Public Health, Imperial College London, London, United Kingdom; Department of Clinical and Experimental Sciences, Brescia University Medical School, Brescia, Italy; CEINGE Biotecnologie Avanzate, Naples, Italy; Division of Geriatrics and Nutritional Science, Washington University, St. Louis, MO, United States; Physiotherapy Department, South London and Maudsley National Health System Foundation Trust, London, United Kingdom; Health Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience (IoPPN), King's College London, London, United Kingdom; Faculty of Health, Social Care, and Education, Anglia Ruskin University, Chelmsford, United Kingdom},
abstract={Background Several studies have suggested that higher consumption of dietary fiber is beneficial for a variety of health outcomes. However, many results have been inconclusive and, to our knowledge, there has been no attempt to systematically capture the breadth of outcomes associated with dietary fiber intake or to systematically assess the quality and the strength of the evidence on the associations of dietary fiber intake and different health outcomes or medical conditions. Objective The aim of this study was to describe the diverse health outcomes convincingly associated with dietary fiber consumption. Design This was an umbrella review of systematic reviews with meta-analysis of observational studies. For each association, random-effects summary effect size, 95% CIs, and 95% prediction intervals were estimated. We also assessed heterogeneity, evidence for small-study effect, and evidence for excess significance bias. We used these metrics to evaluate the credibility of the identified evidence. Results Our literature search identified 1351 abstracts. Of these, 18 meta-analyses including a total of 298 prospective observational studies and 21 outcomes were included. Outcomes studied included cancer and precancer lesions (n = 12), cardiovascular diseases (CVDs; n = 3), all-cause and specific-cause mortality (n = 4), type 2 diabetes (n = 1), and Crohn disease (n = 1). Overall, 6 (29%) of the 21 eligible outcomes reported highly significant summary results (P < 1 × 10 ' '6); these included CVD and CVD mortality, coronary artery disease, pancreatic cancer, and gastric cancer. Overall, 3 of 21 (14%) outcomes presented convincing evidence (pancreatic cancer, CVD mortality, and all-cause mortality), but only CVD and all-cause mortality were based on prospective studies. Two other outcomes (10%), CVD and coronary artery disease, presented highly suggestive evidence based on prospective studies. Conclusion Our results support dietary recommendations that promote higher fiber intake as part of a healthy diet. © 2018 American Society for Nutrition. All rights reserved.},
author_keywords={cancer;  cardiovascular disease;  fibers;  meta-analysis, systemati review},
keywords={all cause mortality;  cardiovascular disease;  cardiovascular mortality;  coronary artery disease;  Crohn disease;  dietary fiber;  human;  malignant neoplasm;  meta analysis;  non insulin dependent diabetes mellitus;  outcome assessment;  pancreas cancer;  precancer;  Review;  stomach cancer;  systematic review;  administration and dosage;  diet;  dietary fiber;  factual database;  incidence;  inflammation;  meta analysis (topic);  mortality;  observational study;  randomized controlled trial (topic);  treatment outcome, Cardiovascular Diseases;  Databases, Factual;  Diabetes Mellitus, Type 2;  Diet;  Dietary Fiber;  Humans;  Incidence;  Inflammation;  Meta-Analysis as Topic;  Observational Studies as Topic;  Randomized Controlled Trials as Topic;  Systematic Reviews as Topic;  Treatment Outcome},
chemicals_cas={Dietary Fiber},
references={Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., Franklin, B., Wylie-Rosett, J., Summary of American Heart Association diet and lifestyle recommendations: Revision 2006 (2006) Arterioscler Thromb Vasc Biol., 26 (10), pp. 2186-2191; Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., Franklin, B., Howard, B., Diet and lifestyle recommendations revision 2006 (2006) Circulation, 114 (1), pp. 82-96; Park, Y., Subar, A.F., Hollenbeck, A., Schatzkin, A., Dietary fiber intake and mortality in the NIH-AARP Diet and Health Study (2011) Arch Intern Med, 171 (12), pp. 1061-1068; Anderson, J.W., Baird, P., Davis, R.H., Jr., Ferreri, S., Knudtson, M., Koraym, A., Waters, V., Williams, C.L., Health benefits of dietary fiber (2009) Nutr Rev, 67 (4), pp. 188-205; Guillon, F., Champ, M., Structural and physical properties of dietary fibres, and consequences of processing on human physiology (2000) Food Res Int, 33 (3), pp. 233-245; Xu, H., Huang, X., Riserus, U., Krishnamurthy, V.M., Cederholm, T., Arnlov, J., Lindholm, B., Carrero, J.J., Dietary fiber, kidney function, inflammation, and mortality risk (2014) Clin J Am Soc Nephrol, 9 (12), pp. 2104-2110; Miller, S.J., Batra, A.K., Shearrer, G.E., House, B.T., Cook, L.T., Pont, S.J., Goran, M.I., Davis, J.N., Dietary fibre linked to decreased inflammation in overweight minority youth (2016) Pediatr Obes, 11 (1), pp. 33-39; Madeddu, C., Gramignano, G., Floris, C., Murenu, G., Sollai, G., Maccio, A., Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer (2014) J Cell Mol Med, 18 (12), pp. 2519-2529; Coussens, L.M., Werb, Z., Inflammation and cancer (2002) Nature, 420 (6917), pp. 860-867; Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., Oxidative stress, inflammation, and cancer: How are they linked (2010) Free Radic Biol Med, 49 (11), pp. 1603-1616; Erkkila, A.T., Lichtenstein, A.H., Fiber and cardiovascular disease risk: How strong is the evidence (2006) J Cardiovasc Nurs, 21 (1), pp. 3-8; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Dinu, M., Pagliai, G., Casini, A., Sofi, F., Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomized trials (2017) NutrMetab Cardiovasc Dis, 27 (1), p. e21; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P.A., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks andmultiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) J Evid Based Healthc, 13 (3), pp. 132-140; Da Costa, B.R., Rutjes, A.W., Johnston, B.C., Reichenbach, S., Nuesch, E., Tonia, T., Gemperli, A., Juni, P., Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: Meta-epidemiological study (2012) J Epidemiol, 41 (5), pp. 1445-1459; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127 (9), pp. 820-826; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19 (22), pp. 3127-3131; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc ser A Stat Soc, 172 (1), pp. 137-159; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a metaanalysis (2002) Stat Med, 21 (11), pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335 (7626), pp. 914-916; Egger, M., Davey, S.G., Schneider, M., Minder, C., Bias in metaanalysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Carvalho, A.F., Kohler, C.A., Brunoni, A.R., Miskowiak, K.W., Herrmann, N., Lanctot, K.L., Hyphantis, T.N., Berk, M., Bias in peripheral depression biomarkers (2016) Psychother Psychosom, 85 (2), pp. 81-90; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, P.A., Campbell, H., Theodoratou, E., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7 (1), p. 10; Trock, B., Lanza, E., Greenwald, P., Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiologic evidence (1990) J Natl Cancer Inst, 82 (8), pp. 650-661; Chen, S., Chen, Y., Ma, S., Zheng, R., Zhao, P., Zhang, L., Liu, Y., Zhang, K., Dietary fibre intake and risk of breast cancer: A systematic review and meta-analysis of epidemiological studies (2016) Oncotarget, 7 (49), pp. 80980-80989; Bandera, E.V., Kushi, L.H., Moore, D.F., Gifkins, D.M., McCullough, M.L., Association between dietary fiber and endometrial cancer: A doseresponse meta-analysis (2007) Am J Clin Nutr, 86 (6), pp. 1730-1737; Wu, Y., Qian, Y., Pan, Y., Li, P., Yang, J., Ye, X., Xu, G., Association between dietary fiber intake and risk of coronary heart disease: A meta-analysis (2015) Clin Nutr, 34 (4), pp. 603-611; Bailie, L., Loughrey, M.B., Coleman, H.G., Lifestyle risk factors for serrated colorectal polyps: A systematic review and meta-analysis (2017) Gastroenterology, 152 (1), pp. 92-104; Zhang, Z., Xu, G., Liu, D., Zhu, W., Fan, X., Liu, X., Dietary fiber consumption and risk of stroke (2013) Eur J Epidemiol, 28 (2), pp. 119-130; Zhang, Z., Xu, G., Ma, M., Yang, J., Liu, X., Dietary fiber intake reduces risk for gastric cancer: A meta-analysis (2013) Gastroenterology, 145 (1), pp. 113-120; Yao, B., Fang, H., Xu, W., Yan, Y., Xu, H., Liu, Y., Mo, M., Zhao, Y., Dietary fiber intake and risk of type 2 diabetes: A dose-response analysis of prospective studies (2014) Eur J Epidemiol, 29 (2), pp. 79-88; Ben, Q., Sun, Y., Chai, R., Qian, A., Xu, B., Yuan, Y., Dietary fiber intake reduces risk for colorectal adenoma: A meta-analysis (2014) Gastroenterology, 146 (3), pp. 689-699; Wang, R.J., Tang, J.E., Chen, Y., Gao, J.G., Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer (2015) Onco Targets Ther, 8, pp. 2415-2426; Yang, Y., Zhao, L.G., Wu, Q.J., Ma, X., Xiang, Y.B., Association between dietary fiber and lower risk of all-cause mortality: A meta-analysis of cohort studies (2015) Am J Epidemiol, 181 (2), pp. 83-91; Liu, X., Wu, Y., Li, F., Zhang, D., Dietary fiber intake reduces risk of inflammatory bowel disease: Result from a meta-analysis (2015) Nutr Res, 35 (9), pp. 753-758; Hajishafiee, M., Saneei, P., Benisi-Kohansal, S., Esmaillzadeh, A., Cereal fibre intake and risk of mortality from all causes, CVD, cancer and inflammatory diseases: A systematic review and meta-analysis of prospective cohort studies (2016) Br J Nutr, 116 (2), pp. 343-352; Threapleton, D.E., Greenwood, D.C., Evans, C.E., Cleghorn, C.L., Nykjaer, C., Woodhead, C., Cade, J.E., Burley, V.J., Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis (2013) BMJ, 347, p. f6879; Huang, T.B., Ding, P.P., Chen, J.F., Yan, Y., Zhang, L., Liu, H., Liu, P.C., Yao, X.D., Dietary fiber intake and risk of renal cell carcinoma: Evidence from a meta-analysis (2014) Med Oncol, 31 (8), p. 125; Mao, Q.Q., Lin, Y.W., Chen, H., Qin, J., Zheng, X.Y., Xu, X., Xie, L.P., Dietary fiber intake is inversely associated with risk of pancreatic cancer: A meta-analysis (2017) Asia Pac J Clin Nutr, 26 (1), pp. 89-96; Sun, L., Zhang, Z., Xu, J., Xu, G., Liu, X., Dietary fiber intake reduces risk for Barrett's esophagus and esophageal cancer (2017) Crit Rev Food Sci Nutr, 57 (13), pp. 2749-2757; Kim, Y., Je, Y., Dietary fibre intake and mortality from cardiovascular disease and all cancers: A meta-analysis of prospective cohort studies (2016) Arch Cardiovasc Dis, 109 (1), pp. 39-54; Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: An umbrella reviewof systematic reviews and meta-analyses (2016) BMCMed, 14 (1), p. 147; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci USA, 110 (48), pp. 19313-19317; North, C.J., Venter, C.S., Jerling, J.C., The effects of dietary fibre on Creactive protein, an inflammation marker predicting cardiovascular disease (2009) Eur J Clin Nutr, 63 (8), pp. 921-933; Krishnamurthy, V.M.R., Wei, G., Baird, B.C., Murtaugh, M., Chonchol, M.B., Raphael, K.L., Greene, T., Beddhu, S., High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease (2012) Kidney Int, 81 (3), pp. 300-306; Man, S.F.P., Connett, J.E., Anthonisen, N.R., Wise, R.A., Tashkin, D.P., Sin, D.D., C-reactive protein andmortality in mild to moderate chronic obstructive pulmonary disease (2006) Thorax, 61 (10), pp. 849-853; Demaria, S., Pikarsky, E., Karin, M., Coussens, L.M., Chen, Y.C., El-Omar, E.M., Trinchieri, G., Szabo, E., Cancer and inflammation: Promise for biologic therapy (2010) J Immunother, 33 (4), pp. 335-351; Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation (2008) Nature, 454 (7203), pp. 436-444; Strandberg, T.E., Tilvis, R.S., C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly (2000) Arterioscler Thromb Vasc Biol, 20 (4), pp. 1057-1060; Muegge, B.D., Kuczynski, J., Knights, D., Clemente, J.C., Gonzalez, A., Fontana, L., Henrissat, B., Gordon, J.I., Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans (2011) Science, 332 (6032), pp. 970-974; Kuo, S.-M., The interplay between fiber and the intestinal microbiome in the inflammatory response (2013) Adv Nutr, 4 (1), pp. 16-28; Zhao, L.-G., Shu, X.-O., Li, H.-L., Zhang, W., Gao, J., Sun, J.-W., Zheng, W., Xiang, Y.-B., Dietary antioxidant vitamins intake and mortality: A report from two cohort studies of Chinese adults in Shanghai (2017) J Epidemiol, 27 (3), pp. 89-97; Kaluza, J., Orsini, N., Levitan, E.B., Brzozowska, A., Roszkowski, W., Wolk, A., Dietary calcium and magnesium intake and mortality: A prospective study of men (2010) Am J Epidemiol, 171 (7), pp. 801-807; Slavin, J.L., Martini, M.C., Jacobs, D.R., Marquart, L., Plausible mechanisms for the protectiveness of whole grains (1999) Am J Clin Nutr, 70, pp. 459S-463S; Lattimer, J.M., Haub, M.D., Effects of dietary fiber and its components on metabolic health (2010) Nutrients, 2 (12), pp. 1266-1289; Dikeman, C.L., Fahey, G.C., Viscosity as related to dietary fiber: A review (2006) Crit Rev Food Sci Nutr, 46 (8), pp. 649-663; Ho, H.V.T., Jovanovski, E., Zurbau, A., Blanco, M.S., Sievenpiper, J.L., Au-Yeung, F., Jenkins, A.L., Vuksan, V., A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B (2017) Am J Clin Nutr, 105 (5), pp. 1239-1247; Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M.J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., Tsilidis, K.K., Adiposity and cancer at major anatomical sites: Umbrella review of the literature (2017) BMJ, 356, p. j477; Donohoe, D.R., Holley, D., Collins, L.B., Montgomery, S.A., Whitmore, A.C., Hillhouse, A., Curry, K.P., Ryan, E.P., A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota-and butyratedependent manner (2014) Cancer Discover, 4 (12), pp. 1387-1397; Kinnaird, A., Zhao, S., Wellen, K.E., Michelakis, E.D., Metabolic control of epigenetics in cancer (2016) Nat Rev Cancer, 16 (11), pp. 694-707; Luchini, C., Veronese, N., Yachida, S., Cheng, L., Nottegar, A., Stubbs, B., Solmi, M., Barbareschi, M., Different prognostic roles of tumor suppressor gene BAP1 in Cancer: A systematic review with meta-analysis (2016) Genes Chromosomes Cancer, 55, pp. 741-749; Luchini, C., Veronese, N., Solmi, M., Cho, H., Kim, J.H., Chou, A., Gill, A.J., Netto, G.J., Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis (2015) Oncotarget, 6 (36), pp. 39088-39097; Leonel, A.J., Alvarez-Leite, J.I., Butyrate: Implications for intestinal function (2012) Curr Opin Clin Nutr Metab Care, 15 (5), pp. 474-479; Yao, Y., Suo, T., Andersson, R., Cao, Y., Wang, C., Lu, J., Chui, E., Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas (2017) Cochrane Database Syst Rev, 1, p. CD003430; Luchini, C., Nottegar, A., Pea, A., Solmi, M., Stubbs, B., Capelli, P., Sergi, G., Wood, L.D., Extranodal extension is an important prognostic parameter for both colonic and rectal cancer (2016) Ann Oncol, 27 (5), pp. 955-956; Moen, B., Henjum, K., Måge, I., Knutsen, S.H., Rud, I., Hetland, R.B., Paulsen, J.E., Effect of dietary fibers on cecal microbiota and intestinal tumorigenesis in azoxymethane treated A/J min/+ mice (2016) PloS One, 11 (5), p. e0155402; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P., Selection in reported epidemiological risks: An empirical assessment (2007) PLoS Med, 4 (3), p. e79},
correspondence_address1={Veronese, N.; National Research Council, Aging Branch, Italy; email: ilmannato@gmail.com},
publisher={Oxford University Press},
issn={00029165},
coden={AJCNA},
pubmed_id={29566200},
language={English},
abbrev_source_title={Am. J. Clin. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Khoury2009559,
author={Khoury, M.J. and McBride, C.M. and Schully, S.D. and Ioannidis, J.P.A. and Feero, W.G. and Janssens, A.C.J.W. and Gwinn, M. and Simons-Morton, D.G. and Bernhardt, J.M. and Cargill, M. and Chanock, S.J. and Church, G.M. and Coates, R.J. and Collins, F.S. and Croyle, R.T. and Davis, B.R. and Downing, G.J. and Duross, A. and Friedman, S. and Gail, M.H. and Ginsburg, G.S. and Green, R.C. and Greene, M.H. and Greenland, P. and Gulcher, J.R. and Hsu, A. and Hudson, K.L. and Kardia, S.L.R. and Kimmel, P.L. and Lauer, M.S. and Miller, A.M. and Offit, K. and Ransohoff, D.F. and Roberts, J.S. and Rasooly, R.S. and Stefansson, K. and Terry, S.F. and Teutsch, S.M. and Trepanier, A. and Wanke, K.L. and Witte, J.S. and Xu, J.},
title={The scientific foundation for personal genomics: Recommendations from a national institutes of health-centers for disease control and prevention multidisciplinary workshop},
journal={Genetics in Medicine},
year={2009},
volume={11},
number={8},
pages={559-567},
doi={10.1097/GIM.0b013e3181b13a6c},
note={cited By 173},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-69549126536&doi=10.1097%2fGIM.0b013e3181b13a6c&partnerID=40&md5=f1493ac56a28fd430448e049fd48d184},
affiliation={Office of Public Health Genomics, Centers for Disease Control and Prevention, MS E61, 1600 Clifton Road, Atlanta, GA 30333, United States; National Cancer Institute, National Institutes of Health, Bethesda, MD, United States; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Department of Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece; Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands; National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD, United States; National Center for Health Marketing, Centers for Disease Control and Prevention, Atlanta, GA, United States; Navigenics, Redwood Shores, CA, United States; Department of Genetics, Harvard Medical School, Boston, MA, United States; Department of Biostatistics, University of Texas, School of Public Health, Houston, TX, United States; Personalized Health Care Initiative, United States Department of Health and Human Services, Washington, DC, United States; Facing Our Risk of Cancer Empowered (FORCE), Tampa, FL, United States; Institute for Genome Sciences and Policy, Center for Genomic Medicine, Duke University, Durham, NC, United States; Departments of Neurology, Medicine (Genetics) and Epidemiology, Boston University, Schools of Medicine and Public Health, Boston, MA, United States; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; deCODE Genetics, Reykjavik, Iceland; 23 and Me, Inc., Mountain View, CA, United States; Genetics and Public Policy Center, Johns Hopkins University, Washington, DC, United States; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States; Personalized Medicine Coalition, Washington, DC, United States; Clinical Genetics Service, Memorial Sloan - Kettering Cancer Center, New York, NY, United States; Departments of Medicine, Epidemiology, and Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Health Behavior and Health Education, University of Michigan, School of Public Health, Ann Arbor, MI, United States; Genetic Alliance, Washington, DC, United States; Los Angeles County Department of Public Health, Los Angeles, CA, United States; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, United States; Office of Behavioral and Social Sciences Research, National Institutes of Health, Bethesda, MD, United States; Department of Epidemiology and Biostatistics, Institute of Human Genetics, University of California, San Francisco, CA, United States; Center for Cancer Genomics, Wake Forest University, School of Medicine, Winston-Salem, NC, United States; Tufts University, School of Medicine, Boston, MA, United States},
abstract={The increasing availability of personal genomic tests has led to discussions about the validity and utility of such tests and the balance of benefits and harms. A multidisciplinary workshop was convened by the National Institutes of Health and the Centers for Disease Control and Prevention to review the scientific foundation for using personal genomics in risk assessment and disease prevention and to develop recommendations for targeted research. The clinical validity and utility of personal genomics is a moving target with rapidly developing discoveries but little translation research to close the gap between discoveries and health impact. Workshop participants made recommendations in five domains: (1) developing and applying scientific standards for assessing personal genomic tests; (2) developing and applying a multidisciplinary research agenda, including observational studies and clinical trials to fill knowledge gaps in clinical validity and utility; (3) enhancing credible knowledge synthesis and information dissemination to clinicians and consumers; (4) linking scientific findings to evidence-based recommendations for use of personal genomics; and (5) assessing how the concept of personal utility can affect health benefits, costs, and risks by developing appropriate metrics for evaluation. To fulfill the promise of personal genomics, a rigorous multidisciplinary research agenda is needed. ©2009The American College of Medical Genetics.},
author_keywords={Behavioral sciences;  Epidemiologic methods;  Evidence-based medicine;  Genetic testing;  Genetics;  Genomics;  Medicine;  Public health},
keywords={behavioral research;  conference paper;  controlled study;  evidence based medicine;  genetic association;  genetic procedures;  genomics;  health status;  information dissemination;  national health organization;  prophylaxis;  risk assessment, Genomics;  Humans;  Information Dissemination;  National Institutes of Health (U.S.);  Personal Health Services;  United States},
funding_details={National Institute on AgingNational Institute on Aging, NIA, K24AG027841, P30AG013846},
funding_details={National Human Genome Research InstituteNational Human Genome Research Institute, NHGRI, R01HG002213, R01HG005092, ZIAHG000024, ZIAHG200344},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, M01RR000533},
references={Manolio, T.A., Brooks, L.D., Collins, F.S., A hapmap harvest of insights into the genetics of common diseases (2008) J Clin Invest, 18, pp. 1590-1605; Feero, W.G., Guttmacher, A.E., Collins, F.S., The genome gets personal, almost (2008) JAMA, 299, pp. 1351-1352; Offit, K., Genomic profiles for disease risk: Predictive or premature? (2008) JAMA, 299, pp. 1353-1355; Hunter, D.J., Khoury, M.J., Drazen, J.M., Letting the genome out of the bottle: Will we get our wish? (2008) N Engl J Med, 358, pp. 105-107; McGuire, A.L., Burke, W., An unwelcome side effect of direct-to-consumer personal genome testing: Raiding the medical commons (2008) JAMA, 300, pp. 2669-2671; Prainsack, B., Reardon, J., Hindmarsh, R., Gottweis, H., Naue, U., Lunshof, J.E., Personal genomes: Misdirected precautions (2008) Nature, 456, pp. 34-35; Della, L.J., Eroglu, D., Bernhardt, J.M., Edgerton, E., Nall, J., Looking to the future of new media in health marketing: Deriving propositions based on traditional theories (2008) Health Mark Q, 25, pp. 147-174; McBride, C.M., Alford, S.H., Reid, R.J., Larson, E.B., Baxevanis, A.D., Brody, L.C., Putting science over supposition in the arena of personalized genomics (2008) Nat Genet, 40, pp. 939-942; National Cancer Institute: Public Health Genomics Website, Workshop Page, , http://cancercontrol.cancer.gov/od/phg/workshop.html, Available at: Accessed February 25, 2009; US System of Oversight of Genetic Testing, , http://www4.od.nih.gov/oba/SACGHS/reports/SACGHS_oversight_report.pdf, Secretary's Advisory Committee on Genetics, Health and Society. Available at: Accessed March 4, 2009; Miller, S.M., Bowen, D.J., Croyle, R.T., Rowland, J.H., Overview, current status and future directions (2009) Handbook of Cancer Control and Behavioral Science, pp. 5-22. , Washington, DC: American Psychological Association; Khoury, M.J., McCabe, L.L., McCabe, E.R.B., Population screening in the age of genomic medicine (2003) New England Journal of Medicine, 348 (1), pp. 50-58. , DOI 10.1056/NEJMra013182; Khoury, M.J., Gwinn, M., Yoon, P.W., Dowling, N., Moore, C.A., Bradley, L., The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? (2007) Genetics in Medicine, 9 (10), pp. 665-674. , DOI 10.1097/GIM.0b013e31815699d0, PII 0012581720071000000001; Haddow, J.E., Palomaki, G.E., A model process for the evaluating data on emerging genetic tests (2004) Human Genome Epidemiology: Scope and Strategies, pp. 217-233. , Khoury MJ, Little J, Burke W, editors. New York: Oxford University Press; Teutsch, S.M., Bradley, L.A., Palomaki, G., The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: Methods of the EGAPP working group (2009) Genet Med, 11, pp. 3-14; Recommendations from the EGAPP Working Group: Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors (2007) Genet Med, 9, pp. 799-800. , EGAPP Working group; Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (2009) Genet Med, 11, pp. 15-20. , EGAPP working group; Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives (2009) Genet Med, 11, pp. 35-41. , EGAPP working group; Recommendations from the EGAPP Working Group: Can tumor gene expression profiling improve outcomes in patients with breast cancer? (2009) Genet Med, 11, pp. 66-73. , EGAPP working group; Petitti, D., Teutsch, S.M., Barton, M.B., Sawaya, G.F., Ockene, J.K., DeWitt, T., Update on the Methods of the U.S. Preventive Services Task Force: Insufficient evidence (2009) Ann Intern Med, 150, pp. 199-205. , U.S. Preventive Services Task Force; Evaluation of Genomic Applications in Practice and Prevention Website, , http://www.egappreviews.org/, Available at: Accessed February 25, 2009; Wideroff, L., Phillips, K.A., Randhawa, G., A health services research agenda for cellular, molecular and genetic technologies (2009) Public Health Genomics, 12, pp. 233-244; McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P.A., Hirschhorn, J.N., Genome-wide association studies for complex traits: Consensus, uncertainty and challenges (2008) Nature Reviews Genetics, 9 (5), pp. 356-369. , DOI 10.1038/nrg2344, PII NRG2344; Altshuler, D., Daly, M.J., Lander, E.S., Genetic mapping in human disease (2008) Science, 322, pp. 881-888; Cohen, J.C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G.L., Grundy, S.M., Hobbs, H.H., Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (6), pp. 1810-1815. , DOI 10.1073/pnas.0508483103; Ji, W., Foo, J.N., O'Roak, B.J., Zhao, H., Larson, M.G., Simon, D.B., Newton-Cheh, C., Lifton, R.P., Rare independent mutations in renal salt handling genes contribute to blood pressure variation (2008) Nature Genetics, 40 (5), pp. 592-599. , DOI 10.1038/ng.118, PII NG118; Romeo, S., Yin, W., Kozlitina, J., Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans (2009) J Clin Invest, 119, pp. 70-79; Manolio, T.A., Cohort studies and the genetics of complex disease (2009) Nature, 41, pp. 5-6; Khoury, M.J., The need for a global human genome epidemiology initiative (2004) Nat Genet, 36, pp. 1027-1028; Higgins, J.P.T., Little, J., Ioannidis, J.P.A., Bray, M.S., Manolio, T.A., Smeeth, L., Sterne, J.A., Khoury, M.J., Turning the pump handle: Evolving methods for integrating the evidence on gene-disease association (2007) American Journal of Epidemiology, 166 (8), pp. 863-866. , DOI 10.1093/aje/kwm248; Zeggini, E., Ioannidis, J.P., Meta-analysis in genome-wide association studies (2009) Pharmacogenomics, 10, pp. 191-201; Ioannidis, J.P.A., Boffetta, P., Little, J., O'Brien, T.R., Uitterlinden, A.G., Vineis, P., Balding, D.J., Khoury, M.J., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) International Journal of Epidemiology, 37 (1), pp. 120-132. , DOI 10.1093/ije/dym159; Janssens, A.C.J.W., Gwinn, M., Bradley, L.A., Oostra, B.A., Van Duijn, C.M., Khoury, M.J., A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health Interventions (2008) American Journal of Human Genetics, 82 (3), pp. 593-599. , DOI 10.1016/j.ajhg.2007.12.020, PII S0002929708001456; http://www.timesonline.co.uk/tol/news/uk/science/article4692891.ece, Available at: Accessed June 1, 2009; http://www.bio-itworld.com/issues/2008/nov-dec/cover-story-keeping-score- of-your-sequence.html?terms=SNPedia%3A+A+Wiki+for+Personal+Genomics, Available at: Accessed June 1, 2009; http://oba.od.nih.gov/oba/SACGHS/meetings/july2008/Duncan.pdf, Available at: Accessed June 1, 2009; https://www.23andme.com/, Available at: Accessed February 25, 2009; http://www.navigenics.com/, Available at: Accessed February 25, 2009; http://www.decodeme.com/, Available at: Accessed February 25, 2009; Personalized Medicine Coalition: Personal Genomics and Industry Standards: Scientific Validity, , http://cancercontrol.cancer.gov/od/phg/docs/PMCSciValid.pdf, Available at: Accessed February 25, 2009; Yu, W., Gwinn, M., Clyne, M., Yesupria, A., Khoury, M.J., A navigator for human genome epidemiology (2008) Nat Genet, 40, pp. 124-125. , http://hugenavigator.net/, Available at: Accessed June 1, 2009; http://genome.ucsc.edu/, Available at: Accessed February 25, 2009; http://www.genetests.org/, Available at: Accessed February 25, 2009; http://www.pharmgkb.org/, Available at: Accessed February 25, 2009; Kraft, P., Wacholder, S., Cornelis, M.C., Beyond odds ratios: Communicating disease risks based on genetic profiles (2009) Nat Rev Genet, 10, pp. 264-269; Offit, K., Garber, J.E., Time to check CHEK2 in families with breast cancer? (2008) Journal of Clinical Oncology, 26 (4), pp. 519-520. , http://jco.ascopubs.org/cgi/reprint/26/4/519, DOI 10.1200/JCO.2007.13.8503; Gail, M.H., Pfeiffer, R.M., On criteria for evaluating models of absolute risk (2005) Biostatistics, 6, pp. 227-239; Van Hoek, M., Dehghan, A., Witteman, J.C., Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: A population-based study (2008) Diabetes, 57, pp. 3122-3128; Lango, H., Palmer, C.N., Morris, A.D., Zeggini, E., Hattersley, A.T., McCarthy, M.I., Frayling, T.M., Weedon, M.N., Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk (2008) Diabetes, 57, pp. 3129-3135. , UK Type 2 Diabetes Genetics Consortium; Cook, N.R., Comments on evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (2008) Stat Med, 27, pp. 191-195; Cook, N.R., Use and misuse of the receiver operating characteristic curve in risk prediction (2007) Circulation, 115 (7), pp. 928-935. , DOI 10.1161/CIRCULATIONAHA.106.672402, PII 0000301720070220000018; Janes, H., Pepe, M.S., Gu, W., Assessing the value of risk prediction by using risk stratification tables (2008) Ann Intern Med, 149, pp. 751-760; Pepe, M.S., Janes, H.E., Gauging the performance of SNPs, biomarkers, and clinical factors in predicting risk of breast cancer (2008) J Natl Cancer Inst, 100, pp. 978-979; D'Agostino Sr., R.B., Vasan, R.S., Pencina, M.J., General cardiovascular risk profile for use in primary care: The Framingham Heart Study (2008) Circulation, 117, pp. 743-753; Gail, M.H., Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk (2008) J Natl Cancer Inst, 100, pp. 1037-1041; Jannssens, A.C., VanDujin, C.M., Genome-based prediction of common diseases: Advances and prospects (2008) Hum Mol Genet, 17, pp. R166-R173; Jakobsdottir, J., Gorin, M.B., Conley, Y.P., Ferrell, R.E., Weeks, D.E., Interpretation of genetic association studies: Markers with replicated highly significant odds ratios may be poor classifiers (2009) PLoS Genetics, 5, pp. e1000337; Janssens, A.C.J.W., Moonesinghe, R., Yang, Q., Steyerberg, E.W., Van Duijn, C.M., Khoury, M.J., The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases (2007) Genetics in Medicine, 9 (8), pp. 528-535. , DOI 10.1097/GIM.0b013e31812eece0, PII 0012581720070800000006; Pepe, M.S., Feng, Z., Huang, Y., Longton, G., Prentice, R., Thompson, I.M., Zheng, Y., Integrating the predictiveness of a marker with its performance as a classifier (2008) American Journal of Epidemiology, 167 (3), pp. 362-368. , DOI 10.1093/aje/kwm305; Pencina, M.J., D'Agostino Sr., R.B., D'Agostino Jr., S.R., Vasan, R.S., Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (2008) Stat Med, 30, pp. 157-172; Paynter, N.P., Chasman, D.I., Buring, J.E., Shiffman, D., Cook, N.R., Ridker, P.M., Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 (2009) Ann Intern Med, 150, pp. 65-72; Brautbar, A., Ballantyne, C., Lawson, K., Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Risk Classification for Coronary Heart Disease and Implications for Lipid-Modifying Therapy in the White Population of the Atherosclerosis Risk in Communities (ARIC) Study American Heart Association Meeting 2008, , Abstract 5090; Talmud, P.J., Cooper, J.A., Palmen, J., Lovering, R., Drenos, F., Hingorani, A.D., Humphries, S.E., Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men (2008) Clinical Chemistry, 54 (3), pp. 467-474. , http://www.clinchem.org/cgi/reprint/54/3/467, DOI 10.1373/clinchem.2007.095489; Ioannidis, J.P., Personalized genetic prediction: Too limited, too expensive or too soon (2009) Ann Intern Med, 150, pp. 139-141; Grosse, S.D., Khoury, M.J., What is the clinical utility of genetic testing? (2006) Genetics in Medicine, 8 (7), pp. 448-450. , DOI 10.1097/01.gim.0000227935.26763.c6, PII 0012581720060700000008; Willensky, G.R., Developing a center for comparative effectiveness information (2006) Health Aff, 25, pp. w572-w585; Roberts, J.S., Barber, M., Brown, T.M., Cupples, L.A., Farrer, L.A., Larusse, S.A., Post, S.G., Green, R.C., Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial (2004) Genetics in Medicine, 6 (4), pp. 197-203. , DOI 10.1097/01.GIM.0000132688.55591.77; Larusse, S., Roberts, J.S., Marteau, T.M., Katzen, H., Linnenbringer, E.L., Barber, M., Whitehouse, P., Relkin, N.R., Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease (2005) Genetics in Medicine, 7 (1), pp. 48-53. , DOI 10.1097/01.GIM.0000151157.13716.6C; Zick, C.D., Mathews, C.J., Roberts, J.S., Cook-Deegan, R., Pokorski, R.J., Green, R.C., Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior (2005) Health Affairs, 24 (2), pp. 483-490. , DOI 10.1377/hlthaff.24.2.483; Chao, S., Roberts, J.S., Marteau, T.M., Silliman, R., Cupples, L.A., Green, R.C., Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL study (2008) Alzheimer Disease and Associated Disorders, 22 (1), pp. 94-97. , DOI 10.1097/WAD.0b013e31815a9dcc, PII 0000209320080100000014; Green, R., Roberts, J., Cupples, L., Disclosure of APOE genotype for risk of Alzheimer's Disease N Engl J Med, , for the REVEAL Study. In press; Foster, M.W., Mulvihill, J.J., Sharp, R.R., Evaluating the utility of personal genomic information (2009) Genet Med, 11, pp. 570-574; Lord, S.J., Irwing, L., Simes, R.J., When is measuring sensitivity and specificity sufficient to evaluate a new diagnostic test, and when do we need randomized trials? (2006) Ann Intern Med, 144, pp. 850-855; Wang, L., Weinshilboum, R.M., Pharmacogenomics: Candidate gene identification, functional validation and mechanisms (2008) Hum Mol Genet, 17 (R2), pp. R174-R179; Weinshilboum, R.M., Wang, L., Pharmacogenetics and pharmacogenomics: Development, science, and translation (2006) Annual Review of Genomics and Human Genetics, 7, pp. 223-245. , DOI 10.1146/annurev.genom.6.080604.162315; Shurin, S.B., Nabel, E.G., Pharmacogenomics-ready for prime time (2008) N Engl J Med, 358, pp. 1061-1063; Lackner, T.A., Pharmacogenomic dosing of warfarin: Ready or not? (2008) Consult Pharm, 23, pp. 614-619; Estimation of the warfarin dose with clinical and genetic data (2009) N Engl J Med, 360, pp. 753-764. , International warfarin pharmacogenetics consortium; Woodcock, J., Lesko, L., Pharmacogenetics: Tailoring treatments for the outliers (2009) N Engl J Med, 360, pp. 811-813; Eckman, M.H., Rosand, J., Greenberg, S.M., Gage, B.F., Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation (2009) Ann Intern Med, 150, pp. 73-83; Marteau, T.M., Weinman, J., Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research (2006) Social Science and Medicine, 62 (6), pp. 1360-1368. , DOI 10.1016/j.socscimed.2005.08.005, PII S0277953605004223; Marteau, T., Senior, V., Humphries, S.E., Bobrow, M., Cranston, T., Crook, M.A., Day, L., Wray, R., Psychological impact of genetic testing for familial hyperecholesterolemia within a previously aware population: A randomized controlled trial (2004) American Journal of Medical Genetics, 128 A (3), pp. 285-293; Phelan, J.C., Yang, L.H., Cruz-Rojas, R., Effects of attributing serious mental illnesses to genetic causes on orientations to treatment (2006) Psychiatric Services, 57 (3), pp. 382-387. , DOI 10.1176/appi.ps.57.3.382; Picot, J., Bryant, J., Cooper, K., Psychosocial aspects of DNA testing for hereditary hemochromatosis in at risk individuals: A systematic review (2009) Genet Test, 13, pp. 7-14; Douma, K.F., Aaronson, N.K., Vasen, H.F., Bleiker, E.M., Psychosocial issues in genetic testing for familial adenomatous polyposis: A review of the literature (2008) Psychooncology, 17, pp. 737-745; McBride, C.M., Brody, L.C., Point: Genetic risk feedback for common disease: Time to test the waters (2007) Cancer Epidemiol Biomarkers Prev, 16, pp. 1724-1726; Thompson, P.A., Counterpoint: Genetic risk feedback for common disease: Time to test the waters (2007) Cancer Epidemiol Biomarkers Prev, 16, pp. 1727-1729; McBride, C.M., Blazing a trail: A public health research agenda in genomics and chronic disease (2005) Prev Chron Dis, 2, pp. A04; Snyder, L.B., Hamilton, M.A., Mitchell, E.W., Kiwanuka-Tondo, J., Fleming-Milici, F., Proctor, D., A meta-analysis of the effect of mediated health communication campaigns on behavior change in the United States (2004) Journal of Health Communication, 9 (SUPPL. 1), pp. 71-96; Weitzel, J.A., Bernhardt, J.M., Usdan, S., Mays, D., Glanz, K., Using wireless handheld computers and tailored text messaging to reduce negative consequences of drinking alcohol (2007) Journal of Studies on Alcohol and Drugs, 68 (4), pp. 534-537; Gigerenzer, G., Edwards, A., Simple tools for understanding risks: From innumeracy to insight (2003) British Medical Journal, 327 (7417), pp. 741-744; O'Doherty, K., Suthers, G.K., Risky communication: Pitfalls in counseling about risk, and how to avoid them (2007) Journal of Genetic Counseling, 16 (4), pp. 409-417. , DOI 10.1007/s10897-006-9077-9; O'Neill, S.C., White, D.B., Sanderson, S.C., The feasibility of online genetic testing for lung cancer susceptibility: Uptake of a web-based protocol and decision outcomes (2008) Genet Med, 10, pp. 121-130; Lerman, C., Gold, K., Audrain, J., Lin, T.H., Orleans, C.T., Boyd, N.R., Wilfond, B., Caporaso, N., Incorporating Biomarkers of Exposure and Genetic Susceptibility into Smoking Cessation Treatment: Effects on Smoking-Related Cognitions, Emotions, and Behavior Change (1997) Health Psychology, 16 (1), pp. 87-99; Jelalian, E., Hart, C.N., Mehlenbeck, R.S., Lloyd-Richardson, E.E., Kaplan, J.D., Flynn-O'Brien, K.T., Wing, R.R., Predictors of attrition and weight loss in an adolescent weight control program (2008) Obesity, 16 (6), pp. 1318-1323. , DOI 10.1038/oby.2008.51, PII OBY200851; Shiwaku, K., Nogi, A., Anuurad, E., Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene (2003) Int J Obes Relat Metab Disord, 27, pp. 1028-1036; Burton, P.R., Hanssell, A.L., Fortoer, I., Size matters: Just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology (2009) Int J Epidemiol, 38, pp. 263-273; Genomic Applications in Practice and Prevention Translation Research. Funding Announcement, , http://www.cdc.gov/genomics/activities/fund2007_11_29.htm, Available at: Accessed February 25, 2009; Funding Announcement. Translation of Common Disease Genetics into Clinical Applications, , http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-08-004.html, Available at: Accessed February 25, 2009; Program Announcements on Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis, , http://grants.nih.gov/grants/guide/pa-files/PA-07-021.html, Available at: Accessed June 1, 2009; Program Announcement: Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery, , http://grants.nih.gov/grants/guide/pa-files/PA-07-260.html, Available at: Accessed February 25, 2009; Genomic Applications in Practice and Prevention Translation Programs in Education, Surveillance, Policy. Funding Announcement, , http://www.cdc.gov/od/pgo/funding/GD08-801.htm, Available at: Accessed February 25, 2009; Computer-based Clinical Decision Support (CDS) Tools for Gene-based Tests Used in Breast Cancer, , http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype= nr&ProcessID=68, Available at: Accessed February 25, 2009; Khoury, M.J., Feero, W.G., Reyes, M., The Genomic Applications in Practice and Prevention Network (GAPPNet) (2009) Genet Med, 11, pp. 488-494; Khoury, M.J., Berg, A., Coates, R., Evans, J., Teutsch, S.M., Bradley, L., The evidence dilemma in genomic medicine (2008) Health Aff, 27, pp. 1600-1611},
correspondence_address1={Khoury, M. J.; Office of Public Health Genomics, 1600 Clifton Road, Atlanta, GA 30333, United States; email: mkhoury@cdc.gov},
issn={10983600},
coden={GEMEF},
pubmed_id={19617843},
language={English},
abbrev_source_title={Gen. Med.},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Schwarzschild2014141,
author={Schwarzschild, M.A. and Ascherio, A. and Beal, M.F. and Cudkowicz, M.E. and Curhan, G.C. and Hare, J.M. and Hooper, D.C. and Kieburtz, K.D. and Macklin, E.A. and Oakes, D. and Rudolph, A. and Shoulson, I. and Tennis, M.K. and Espay, A.J. and Gartner, M. and Hung, A. and Bwala, G. and Lenehan, R. and Encarnacion, E. and Ainslie, M. and Castillo, R. and Togasaki, D. and Barles, G. and Friedman, J.H. and Niles, L. and Carter, J.H. and Murray, M. and Goetz, C.G. and Jaglin, J. and Ahmed, A. and Russell, D.S. and Cotto, C. and Goudreau, J.L. and Russell, D. and Parashos, S.A. and Ede, P. and Saint-Hilaire, M.H. and Thomas, C.A. and James, R. and Stacy, M.A. and Johnson, J. and Gauger, L. and Antonelle de Marcaida, J. and Thurlow, S. and Isaacson, S.H. and Carvajal, L. and Rao, J. and Cook, M. and Hope-Porche, C. and McClurg, L. and Grasso, D.L. and Logan, R. and Orme, C. and Ross, T. and Brocht, A.F. and Constantinescu, R. and Sharma, S. and Venuto, C. and Weber, J. and Eaton, K. and Parkinson Study Group SURE-PD Investigators},
title={Inosine to increase serum and cerebrospinal fluid urate in parkinson disease a randomized clinical trial},
journal={JAMA Neurology},
year={2014},
volume={71},
number={2},
pages={141-150},
doi={10.1001/jamaneurol.2013.5528},
note={cited By 172},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893841038&doi=10.1001%2fjamaneurol.2013.5528&partnerID=40&md5=48485a0aacd56eb87f7d3909c1fba411},
abstract={IMPORTANCE: Convergent biological, epidemiological, and clinical data identified urate elevation as a candidate strategy for slowing disability progression in Parkinson disease (PD). OBJECTIVE: To determine the safety, tolerability, and urate-elevating capability of the urate precursor inosine in early PD and to assess its suitability and potential design features for a disease-modification trial. DESIGN, SETTING, AND PARTICIPANTS: The Safety of Urate Elevation in PD (SURE-PD) study, a randomized, double-blind, placebo-controlled, dose-ranging trial of inosine, enrolled participants from 2009 to 2011 and followed them for up to 25 months at outpatient visits to 17 credentialed clinical study sites of the Parkinson Study Group across the United States. Seventy-five consenting adults (mean age, 62 years; 55% women) with early PD not yet requiring symptomatic treatment and a serum urate concentration less than 6 mg/dL (the approximate population median) were enrolled. INTERVENTIONS: Participants were randomized to 1 of 3 treatment arms: placebo or inosine titrated to produce mild (6.1-7.0 mg/dL) or moderate (7.1-8.0 mg/dL) serum urate elevation using 500-mg capsules taken orally up to 2 capsules 3 times per day. They were followed for up to 24 months (median, 18 months) while receiving the study drug plus 1 washout month. MAINOUTCOMESAND MEASURES: The prespecified primary outcomes were absence of unacceptable serious adverse events (safety), continued treatment without adverse event requiring dose reduction (tolerability), and elevation of urate assessed serially in serum and once (at 3 months) in cerebrospinal fluid. RESULTS: Serious adverse events (17), including infrequent cardiovascular events, occurred at the same or lower rates in the inosine groups relative to placebo. No participant developed gout and 3 receiving inosine developed symptomatic urolithiasis. Treatment was tolerated by 95% of participants at 6 months, and no participant withdrew because of an adverse event. Serum urate rose by 2.3 and 3.0 mg/dL in the 2 inosine groups (P <.001 for each) vs placebo, and cerebrospinal fluid urate level was greater in both inosine groups (P =.006 and <.001, respectively). Secondary analyses demonstrated nonfutility of inosine treatment for slowing disability. CONCLUSIONS AND RELEVANCE: Inosine was generally safe, tolerable, and effective in raising serum and cerebrospinal fluid urate levels in early PD. The findings support advancing to more definitive development of inosine as a potential disease-modifying therapy for PD. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00833690 © Copyright 2014 American Medical Association. All rights reserved.},
keywords={inosine;  placebo;  urate, adult;  article;  cardiovascular disease;  cerebrospinal fluid level;  controlled study;  crystalluria;  dose response;  double blind procedure;  drug dose titration;  drug efficacy;  drug fatality;  drug safety;  drug tolerability;  drug withdrawal;  female;  gout;  human;  major clinical study;  male;  middle aged;  morning dosage;  multicenter study;  Parkinson disease;  priority journal;  randomized controlled trial;  United States;  uric acid blood level;  uric acid stone;  urolithiasis, Aged;  Biological Markers;  Double-Blind Method;  Female;  Follow-Up Studies;  Humans;  Inosine;  Male;  Middle Aged;  Parkinson Disease;  Treatment Outcome;  Uric Acid},
chemicals_cas={inosine, 58-63-9; urate, 1198-77-2, 3106-08-9, 59216-10-3},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, K24NS060991},
references={Ames, B.N., Cathcart, R., Schwiers, E., Hochstein, P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis (1981) Proc Natl Acad Sci U S A, 78 (11), pp. 6858-6862; Davies, K.J., Sevanian, A., Muakkassah-Kelly, S.F., Hochstein, P., Uric acid-iron ion complexes: A new aspect of the antioxidant functions of uric acid (1986) Biochem J, 235 (3), pp. 747-754; Cipriani, S., Desjardins, C.A., Burdett, T.C., Xu, Y., Xu, K., Schwarzschild, M.A., Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease (2012) PLoS One, 7 (5), pp. e37331; Gong, L., Zhang, Q.L., Zhang, N., Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: Linking to Akt/GSK3ß signaling pathway (2012) J Neurochem, 123 (5), pp. 876-885; Chen, X., Burdett, T.C., Desjardins, C.A., Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration (2013) Proc Natl Acad Sci U S A, 110 (1), pp. 300-305; Davis, J.W., Grandinetti, A., Waslien, C.I., Ross, G.W., White, L.R., Morens, D.M., Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease (1996) Am J Epidemiol., 144 (5), pp. 480-484; De Lau, L.M., Koudstaal, P.J., Hofman, A., Breteler, M.M., Serum uric acid levels and the risk of Parkinson disease (2005) Ann Neurol., 58 (5), pp. 797-800; Weisskopf, M.G., O'Reilly, E., Chen, H., Schwarzschild, M.A., Ascherio, A., Plasma urate and risk of Parkinson's disease (2007) Am J Epidemiol., 166 (5), pp. 561-567; Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease (2007) Neurology, 69 (15), pp. 1480-1490. , Parkinson Study Group PRECEPT Investigators; Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease (1993) N Engl J Med., 328 (3), pp. 176-183. , Parkinson Study Group; Schwarzschild, M.A., Schwid, S.R., Marek, K., Serum urate as a predictor of clinical and radiographic progression in Parkinson disease (2008) Arch Neurol., 65 (6), pp. 716-723. , Parkinson Study Group PRECEPT Investigators; Ascherio, A., Le Witt, P.A., Xu, K., Urate as a predictor of the rate of clinical decline in Parkinson disease (2009) Arch Neurol., 66 (12), pp. 1460-1468. , Parkinson Study Group DATATOP Investigators; Yamamoto, T., Moriwaki, Y., Cheng, J., Effect of inosine on the plasma concentration of uridine and purine bases (2002) Metabolism, 51 (4), pp. 438-442; Spitsin, S., Hooper, D.C., Leist, T., Streletz, L.J., Mikheeva, T., Koprowskil, H., Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease (2001) Mult Scler., 7 (5), pp. 313-319; Toncev, G., Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis (2006) Vojnosanit Pregl., 63 (10), pp. 879-882; Markowitz, C.E., Spitsin, S., Zimmerman, V., The treatment of multiple sclerosis with inosine (2009) J Altern Complement Med., 15 (6), pp. 619-625; Gonsette, R.E., Sindic, C., D'hooghe, M.B., Boosting endogenous neuroprotection in multiple sclerosis: The ASsociation of Inosine and Interferon beta in relapsing-remitting Multiple Sclerosis (ASIIMS) trial (2010) Mult Scler., 16 (4), pp. 455-462. , ASIIMS study group; Soltani, Z., Rasheed, K., Kapusta, D.R., Reisin, E., Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: Is it time for reappraisal? (2013) Curr Hypertens Rep., 15 (3), pp. 175-181; Safety of Urate Elevation in Parkinson's Disease (SURE-PD), , http://clinicaltrials.gov/show/NCT00833690, Accessed September 25, 2013; Cameron, M.A., Sakhaee, K., Uric acid nephrolithiasis (2007) Urol Clin North Am., 34 (3), pp. 335-346; Siderowf, A., McDermott, M., Kieburtz, K., Blindauer, K., Plumb, S., Shoulson, I., Test-retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial (2002) Mov Disord., 17 (4), pp. 758-763. , Parkinson Study Group; Zadikoff, C., Fox, S.H., Tang-Wai, D.F., A comparison of the mini mental state exam to the Montreal Cognitive Assessment in identifying cognitive deficits in Parkinson's disease (2008) Mov Disord., 23 (2), pp. 297-299; Schrag, A., Barone, P., Brown, R.G., Depression rating scales in Parkinson's disease: Critique and recommendations (2007) Mov Disord., 22 (8), pp. 1077-1092; Tilley, B.C., Palesch, Y.Y., Kieburtz, K., Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs (2006) Neurology, 66 (5), pp. 628-633. , NET-PD Investigators; A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease (2006) Neurology, 66 (5), pp. 664-671. , NINDS NET-PD Investigators; Koski, L., Xie, H., Finch, L., Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive Assessment (2009) J Geriatr Psychiatry Neurol., 22 (3), pp. 151-160; Spitsin, S., Markowitz, C.E., Zimmerman, V., Koprowski, H., Hooper, D.C., Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure (2010) J Hum Hypertens, 24 (5), pp. 359-362; Feig, D.I., Kang, D.H., Johnson, R.J., Uric acid and cardiovascular risk (2008) N Engl J Med., 359 (17), pp. 1811-1821; Elm, J.J., Design innovations and baseline findings in a long-term Parkinson's trial: The National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-term Study-1 (2012) Mov Disord., 27 (12), pp. 1513-1521. , NINDS NET-PD Investigators; Orowan, E., The origin of man (1955) Nature, 175 (4459), pp. 683-684; Kasl, S.V., Brooks, G.W., Rodgers, W.L., Serum uric acid and cholesterol in achievement behavior and motivation, I: The relationship to ability, grades, test performance, and motivation (1970) JAMA, 213 (7), pp. 1158-1164; Kasl, S.V., Brooks, G.W., Rodgers, W.L., Serum uric acid and cholesterol in achievement behavior and motivation, II: The relationship to college attendance, extracurricular and social activities, and vocational aspirations (1970) JAMA, 213 (8), pp. 1291-1299},
correspondence_address1={Schwarzschild, M.A.; 3002, 114 16th St, United States; email: michaels@helix.mgh.harvard.edu},
publisher={American Medical Association},
issn={21686149},
pubmed_id={24366103},
language={English},
abbrev_source_title={JAMA Neurol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Ritchie2010336,
author={Ritchie, K. and Carrière, I. and Ritchie, C.W. and Berr, C. and Artero, S. and Ancelin, M.-L.},
title={Designing prevention programmes to reduce incidence of dementia: Prospective cohort study of modifiable risk factors},
journal={BMJ (Online)},
year={2010},
volume={341},
number={7768},
pages={336},
doi={10.1136/bmj.c3885},
art_number={c3885},
note={cited By 168},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955870204&doi=10.1136%2fbmj.c3885&partnerID=40&md5=41a6819bb695893128191702d5c6c34a},
affiliation={Inserm, U888 Nervous System Pathologies: Epidemiological and Clinical Research, La Colombière Hospital, 34093 Montpellier Cedex 5, France; Université de Montpellier 1, Montpellier, F-34000, France; Faculty of Medicine, Imperial College, St Mary's Hospital, London, United Kingdom},
abstract={Objective: To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated. Design: Prospective seven year cohort study. Setting: General population, Montpellier, France. Participants: 1433 people aged over 65 with a mean baseline age of 72.5 (SD 5.1) years. Main outcome measures: Diagnosis of mild cognitive impairment or dementia established by a standardised neurological examination. Results: Cox models were constructed to derive hazard ratios and determine confounding and interaction effects for potentially modifiable risk factors for dementia. Mean percentage population attributable fractions were calculated with 95% confidence intervals derived from bootstrapping for seven year incidence of mild cognitive impairment or dementia. The final model retained crystallised intelligence (population attributable fraction 18.11%, 95% confidence interval 10.91% to 25.42%), depression (10.31%, 3.66% to 17.17%), fruit and vegetable consumption (6.46%, 0.15% to 13.06%), diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E ε4 allele (7.11%, 2.44% to 11.98%). Conclusions: Increasing crystallised intelligence and fruit and vegetable consumption and eliminating depression and diabetes are likely to have the biggest impact on reducing the incidence of dementia, outweighing even the effect of removing the principal known genetic risk factor. Although causal relations cannot be concluded with certainty, the study suggests priorities that may inform public health programmes.},
keywords={apolipoprotein E, aged;  allele;  article;  dementia;  depression;  diabetes mellitus;  dietary intake;  female;  France;  fruit;  health program;  human;  incidence;  intelligence;  major clinical study;  male;  mild cognitive impairment;  neurologic examination;  preventive health service;  priority journal;  risk factor;  vegetable;  France;  lifestyle;  prospective study;  socioeconomics;  very elderly, Aged;  Aged, 80 and over;  Dementia;  Female;  France;  Humans;  Incidence;  Life Style;  Male;  Neurologic Examination;  Prospective Studies;  Risk Factors;  Socioeconomic Factors},
references={Ferri, C., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Global prevalence of dementia: A Delphi consensus study (2005) Lancet, 17, pp. 2112-2117; Gao, S., Hendrie, H.C., Hall, K.S., Hui, S., The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis (1998) Archives of General Psychiatry, 55 (9), pp. 809-815. , DOI 10.1001/archpsyc.55.9.809; Lautenschlager, N.T., Cupples, L.A., Rao, V.S., Auerbach, S.A., Becker, R., Burke, J., Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? (1996) Neurology, 46, pp. 641-650; Ritchie, K., Kildea, D., Is senile dementia age-related or ageing-related? Evidence from a meta-analysis of dementia prevalence in the oldest old (1995) Lancet, 346, pp. 931-934; Stern, Y., Alexander, G.E., Prohovnik, I., Mayeux, R., Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease (1992) Ann Neurol, 32, pp. 371-375; Hendrie, H.C., Ogunniyi, A., Hall, K.S., Baiyewu, O., Unverzagt, F.W., Gureje, O., Incidence of dementia and Alzheimer disease in two communities: Yoruba residing in Ibadan and African Americans residing in Indianapolis, Indiana (2001) JAMA, 14, pp. 739-747; Seripa, D., Panza, F., Franceschi, M., D'Onofrio, G., Solfrizzi, V., Dallapiccola, B., Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease (2009) Ageing Res Rev, 8, pp. 214-236; Ashford, J.W., APOE genotype effects on Alzheimer's disease onset and epidemiology (2004) J Mol Neurosci, 23, pp. 157-165; Fleminger, S., Oliver, D.L., Lovestone, S., Rabe-Hesketh, S., Giora, A., Head injury as a risk factor for Alzheimer's disease: The evidence 10 years on; a partial replication (2003) Journal of Neurology Neurosurgery and Psychiatry, 74 (7), pp. 857-862. , DOI 10.1136/jnnp.74.7.857; Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.X., Ginsberg, H., Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease (1995) Neurology, 45, pp. 555-557; Peila, R., White, L.R., Petrovich, H., Masaki, K., Ross, G.W., Havlik, R.J., Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia aging study (2001) Stroke, 32, pp. 2882-2889; Razay, G., Williams, J., King, E., Smith, A.D., Wilcock, G., Blood pressure, dementia and Alzheimer's disease: The OPTIMA longitudinal study (2009) Dement Geriatr Cogn Disord, 28, pp. 70-74; Stewart, R., Asonganyi, B., Sherwood, R., Plasma homocysteine and cognitive impairment in an older British African-Caribbean population (2002) Journal of the American Geriatrics Society, 50 (7), pp. 1227-1232. , DOI 10.1046/j.1532-5415.2002.50309.x; White, L., Launer, L., Relevance of cardiovascular risk factors and ischemic cerebrovascular disease to the pathogenesis of Alzheimer disease: A review of accrued findings from the Honolulu-Asia Aging Study (2006) Alzheimer Dis Assoc Disord, 20, pp. 79-83S; Farooki, A., Central obesity and increased risk of dementia more than three decades later (2009) Neurology, 72, pp. 1030-1031; Helzner, E.P., Luchsinger, J.A., Scarmeas, N., Cosentino, S., Brickman, A.M., Glymour, M.M., Contribution of vascular risk factors to the progression in Alzheimer disease (2009) Arch Neurol, 66, pp. 343-348; Jorm, A.F., History of depression as a risk factor for dementia: An updated review (2001) Aust N Z J Psychiatry, 35, pp. 776-781; Eriksson, U.K., Gatz, M., Dickman, P.W., Fratiglioni, L., Pedersen, N.L., Asthma, eczema, rhinitis and the risk for dementia (2008) Dementia and Geriatric Cognitive Disorders, 25 (2), pp. 148-156. , DOI 10.1159/000112729; Itzhaki, R.F., Wozniak, M.A., Appelt, D.M., Balin, B.J., Infiltration of the brain by pathogens causes Alzheimer's disease (2004) Neurobiol Aging, 25, pp. 619-627; Etminan, M., Gill, S., Samii, A., Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: Systematic review and meta-analysis of observational studies (2003) BMJ, 327, p. 128; Ancelin, M.L., Ritchie, K., Lifelong endocrine fluctuations and related cognitive disorders (2005) Current Pharmaceutical Design, 11 (32), pp. 4229-4252. , DOI 10.2174/138161205774913228; Ryan, J., Carriere, I., Scali, J., Dartigues, J.F., Tzourio, C., Poncet, M., Characteristics of hormone therapy, cognitive function, and dementia: The prospective 3C Study (2009) Neurology, 73, pp. 1729-1737; Baranov, D., Bickler, P., Crosby, G., Culley, D.J., Eckenhoff, M.F., Eckenhoff, R.G., Consensus statement: First international workshop on anesthetics and Alzheimer'sdisease (2009) Anesth and Analg, 108, pp. 1627-1630; Ancelin, M.L., Artero, S., Portet, F., Dupuy, A.M., Touchon, J., Ritchie, K., Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study (2006) BMJ, 332, pp. 455-459; Carriere, I., Fourrier-Reglat, A., Dartigues, J.F., Rouaud, O., Pasquier, F., Ritchie, K., Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study (2009) Arch Intern Med, 169, pp. 1317-1324; Hall, C.B., Lipton, R.B., Sliwinski, M., Katz, M.J., Derby, C.A., Verghese, J., Cognitive activities delay onset of memory decline in persons who develop dementia (2009) Neurology, 73, pp. 356-361; Akbaraly, T.N., Portet, F., Fustinoni, S., Dartigues, J.F., Artero, S., Rouaud, O., Leisure activities and the risk of dementia in the elderly: Results from the Three-City Study (2009) Neurology, 73, pp. 854-861; Fratiglioni, L., Paillard-Borg, S., Winblad, B., An active and socially integrated lifestyle in late life might protect against dementia (2004) Lancet Neurology, 3 (6), pp. 343-353. , DOI 10.1016/S1474-4422(04)00767-7, PII S1474442204007677; Scarmeas, N., Luchsinger, J.A., Schupf, N., Brickman, A.M., Cosentino, S., Tang, M.X., Physical activity, diet, and risk of Alzheimer disease (2009) JAMA, 302, pp. 627-637; Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Wilson, R.S., Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease (2003) Arch Neurol, 60, pp. 940-946; Anstey, K.J., Mack, H.A., Cherbuin, N., Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies (2009) Am J Geriatr Psychiatry, 17, pp. 542-555; Luchsinger, J.A., Tang, M.X., Siddiqui, M., Shea, S., Mayeux, R., Alcohol intake and risk of dementia (2004) J Am Geriatr Soc, 52, pp. 540-546; Harwood, D.G., Kalechstein, A., Barker, W.W., Strauman, S., St George-Hyslop, P., Iglesias, C., The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease (2010) Int J Geriatr Psychiatry, 25, pp. 511-518; Ritchie, K., Artero, S., Portet, F., Brickman, A., Muraskin, J., Beanino, E., Caffeine, cognitive functioning and white matter lesions in the elderly: Establishing causality from epidemiological evidence (2010) J Alzheimer's Dis, 20 (SUPPL. 1), pp. S161-6; Gharibzadeh, S., Hoseini, S.S., Chronic dehydration may be a preventable risk factors for Alzheimer's disease (2007) Medical Hypotheses, 68 (3), p. 718. , DOI 10.1016/j.mehy.2006.08.019, PII S0306987706006141; Van Duijn, C.M., Hofman, A., Relation between nicotine intake and Alzheimer's disease (1991) BMJ, 22, pp. 1491-1494; Lee, Y., Back, J.H., Kim, J., Kim, S.H., Na, D.L., Cheong, H.K., Systematic review of health behavioral risks and cognitive health in older adults (2009) Int Psychogeriatr, 9, pp. 1-14; Artero, S., Petersen, R., Touchon, J., Ritchie, K., Revised criteria for mild cognitive impairment: Validation within a longitudinal population study (2006) Dementia and Geriatric Cognitive Disorders, 22 (5-6), pp. 465-470. , DOI 10.1159/000096287; Blair, J.R., Spreen, O., Predicting premorbid IQ: A revision of the National Adult Reading Test (1989) Clin Neuropsychol, 3, pp. 129-136; Radloff, L., The CES-D scale: A self-report depression scale for research in the general population (1977) Appl Psychol Measurement, 1, pp. 385-401; Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Janavs, J., Weiller, E., The Mini International Neuropsychiatric Interview (MINI), a short diagnostic interview: Reliability and validity according to the CIDI (1997) European Psychiatry, 12, pp. 232-241; Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement (2005) Circulation, 112, pp. 2735-2752; Steenland, K., Armstrong, B., An overview of methods for calculating the burden of disease due to specific risk factors (2006) Epidemiology, 17 (5), pp. 512-519. , DOI 10.1097/01.ede.0000229155.05644.43, PII 0000164820060900000008; Rockhill, B., Newman, B., Weinberg, C., Use and misuse of population attributable fractions (1998) Am J Public Health, 88, pp. 15-19; Ritchie, K., Gilham, C., Ledesert, B., Touchon, J., Kotzki, P.-O., Depressive illness, depressive symptomatology and regional cerebral blood flow in elderly people with sub-clinical cognitive impairment (1999) Age and Ageing, 28 (4), pp. 385-391. , DOI 10.1093/ageing/28.4.385; Middleton, L., Yaffe, K., Promising strategies for the prevention of dementia (2009) Arch Neurol, 66, pp. 1210-1215; Gammanpila, U.P., Burns, A., Heller, R., Purandare, N., What are the benefits of cognitive enhancers for Alzheimer's disease: Use of population impact measures (2007) BMC Geriatr, 6, pp. 7-25; Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial (2008) Lancet Neurol, 7, pp. 683-689; Li, N.-C., Lee, A., Whitmer, R.A., Kivipelto, M., Lawlor, E., Kazis, L.E., Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis (2010) BMJ, 340, pp. b5465; Duron, E., Hanon, O., Vascular risk factors, cognitve decline, and dementia (2008) Vascular Health and Risk Management, 4 (2), pp. 363-381; Stewart, R., White, L.R., Xue, Q.-L., Launer, L.J., Twenty-six-year change in total cholesterol levels and incident dementia: The Honolulu-Asia aging study (2007) Archives of Neurology, 64 (1), pp. 103-107. , http://archneur.ama-assn.org/cgi/reprint/64/1/103, DOI 10.1001/archneur.64.1.103; Murray, C.J.L., Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S., Comparative quantification of health risks: Conceptual framework and methodological issues (2003) Popul Health Metr, 1, pp. 1-20},
correspondence_address1={Ritchie, K.; Inserm, , 34093 Montpellier Cedex 5, France; email: karen.ritchie@inserm.fr},
issn={17561833},
coden={BMJOA},
pubmed_id={20688841},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Article},
source={Scopus},
}

@ARTICLE{Chiavaroli2019,
author={Chiavaroli, L. and Viguiliouk, E. and Nishi, S.K. and Mejia, S.B. and Rahelić, D. and Kahleová, H. and Salas-Salvadó, J. and Kendall, C.W.C. and Sievenpiper, J.L.},
title={DASH dietary pattern and cardiometabolic outcomes: An umbrella review of systematic reviews and meta-analyses},
journal={Nutrients},
year={2019},
volume={11},
number={2},
doi={10.3390/nu11020338},
art_number={338},
note={cited By 161},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061584848&doi=10.3390%2fnu11020338&partnerID=40&md5=a693d1bd3aff8a67ab55a865cb3b01d3},
affiliation={Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Center, St. Michael’s Hospital, Toronto, ON  M5C 2T2, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON  M5S 1A8, Canada; Department of Endocrinology, Diabetes and Clinical Pharmacology, Dubrava University Hospital, Zagreb, 10000, Croatia; School of Medicine, University of Zagreb, Zagreb, 10000, Croatia; Institute for Clinical and Experimental Medicine, Diabetes Centre, Prague, 140 21, Czech Republic; Physicians Committee for Responsible Medicine, Washington, DC, 20016-4131, United States; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, 28029, Spain; Human Nutrition Unit, Biochemistry and Biotechnology Department, Hospital Universitari de Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Reus, 43201, Spain; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK  S7N 2Z4, Canada; Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto, ON  M5C 2T2, Canada; Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON  M5C 2T2, Canada},
abstract={Background: The Dietary Approaches to Stop Hypertension (DASH) dietary pattern, which emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and limits saturated fat, cholesterol, red and processed meats, sweets, added sugars, salt and sugar-sweetened beverages, is widely recommended by international diabetes and heart association guidelines. Objective: To summarize the available evidence for the update of the European Association of the Study of Diabetes (EASD) guidelines, we conducted an umbrella review of existing systematic reviews and meta-analyses using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach of the relation of the DASH dietary pattern with cardiovascular disease and other cardiometabolic outcomes in prospective cohort studies and its effect on blood pressure and other cardiometabolic risk factors in controlled trials in individuals with and without diabetes. Methods: MEDLINE and EMBASE were searched through 3 January 2019. We included systematic reviews and meta-analyses assessing the relation of the DASH dietary pattern with cardiometabolic disease outcomes in prospective cohort studies and the effect on cardiometabolic risk factors in randomized and non-randomized controlled trials. Two independent reviewers extracted relevant data and assessed the risk of bias of individual studies. The primary outcome was incident cardiovascular disease (CVD) in the prospective cohort studies and systolic blood pressure in the controlled trials. Secondary outcomes included incident coronary heart disease, stroke, and diabetes in prospective cohort studies and other established cardiometabolic risk factors in controlled trials. If the search did not identify an existing systematic review and meta-analysis on a pre-specified outcome, then we conducted our own systematic review and meta-analysis. The evidence was summarized as risk ratios (RR) for disease incidence outcomes and mean differences (MDs) for risk factor outcomes with 95% confidence intervals (95% CIs). The certainty of the evidence was assessed using GRADE. Results: We identified three systematic reviews and meta-analyses of 15 unique prospective cohort studies (n = 942,140) and four systematic reviews and meta-analyses of 31 unique controlled trials (n = 4,414) across outcomes. We conducted our own systematic review and meta-analysis of 2 controlled trials (n = 65) for HbA1c. The DASH dietary pattern was associated with decreased incident cardiovascular disease (RR, 0.80 (0.76–0.85)), coronary heart disease (0.79 (0.71–0.88)), stroke (0.81 (0.72–0.92)), and diabetes (0.82 (0.74–0.92)) in prospective cohort studies and decreased systolic (MD, -5.2 mmHg (95% CI, -7.0 to -3.4)) and diastolic (-2.60 mmHg (-3.50 to -1.70)) blood pressure, Total-C (-0.20 mmol/L (-0.31 to -0.10)), LDL-C (-0.10 mmol/L (-0.20 to -0.01)), HbA1c (-0.53% (-0.62, -0.43)), fasting blood insulin (-0.15 µU/mL (-0.22 to -0.08)), and body weight (-1.42 kg (-2.03 to -0.82)) in controlled trials. There was no effect on HDL-C,triglycerides, fasting blood glucose, HOMA-IR, or CRP. The certainty of the evidence was moderate for SBP and low for CVD incidence and ranged from very low to moderate for the secondary outcomes. Conclusions: Current evidence allows for the conclusion that the DASH dietary pattern is associated with decreased incidence of cardiovascular disease and improves blood pressure with evidence of other cardiometabolic advantages in people with and without diabetes. More research is needed to improve the certainty of the estimates. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.},
author_keywords={Cardiometabolic health;  Cardiovascular disease;  DASH;  Dietary approaches to stop hypertension;  GRADE;  Review},
keywords={C reactive protein;  hemoglobin A1c;  high density lipoprotein cholesterol;  insulin;  low density lipoprotein cholesterol, body weight;  caloric intake;  cardiometabolic risk;  cardiovascular disease;  cerebrovascular accident;  clinical trial (topic);  DASH diet;  diabetes mellitus;  diastolic blood pressure;  diet;  dietary pattern;  follow up;  food intake;  glucose blood level;  glycemic control;  GRADE approach;  homeostasis model assessment;  incidence;  inflammation;  insulin resistance;  ischemic heart disease;  meta analysis (topic);  obesity;  outcome assessment;  practice guideline;  quality control;  randomized controlled trial (topic);  Review;  risk factor;  systematic review (topic);  total cholesterol level;  cardiovascular disease;  diet therapy;  human;  hypertension;  metabolic disorder, Cardiovascular Diseases;  Dietary Approaches To Stop Hypertension;  Humans;  Hypertension;  Meta-Analysis as Topic;  Metabolic Diseases;  Systematic Reviews as Topic},
chemicals_cas={C reactive protein, 9007-41-4; hemoglobin A1c, 62572-11-6; insulin, 9004-10-8},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={Division of Computer and Network SystemsDivision of Computer and Network Systems, CNS},
funding_details={Ontario Research FoundationOntario Research Foundation, ORF},
funding_details={National Dried Fruit Trade AssociationNational Dried Fruit Trade Association, NDFTA},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR, 129920},
funding_details={Canada Foundation for InnovationCanada Foundation for Innovation, CFI},
funding_details={Physicians' Services Incorporated FoundationPhysicians' Services Incorporated Foundation, PSI},
funding_details={European CommissionEuropean Commission, EC},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={International Nut and Dried Fruit CouncilInternational Nut and Dried Fruit Council, INC},
funding_text 1={Cardiovascular disease (CVD) continues to be a leading cause of mortality in people with and without diabetes globally [1–3]. Clinical practice guidelines recommend dietary strategies as the cornerstone of therapy to prevent and manage cardiovascular disease [4–9]. The dietary approaches to stop hypertension (DASH) dietary pattern, which emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and limits total and saturated fat, cholesterol, red and processed meats, sweets, added sugars, and sugar-sweetened beverages, was originally developed through research sponsored by the US National Institutes of Health (NIH) to treat hypertension without medication and successfully demonstrated a clinically meaningful blood pressure lowering effect [10].},
funding_text 2={Funding: The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) commissioned this systematic review and meta-analysis and provided funding and logistical support for meetings as part of the development of the EASD Clinical Practice Guidelines for Nutrition Therapy. This work was also supported by the Canadian Institutes of Health Research (funding reference number, 129920) through the Canada-wide Human Nutrition Trialists' Network (NTN). The Diet, Digestive tract, and Disease (3-D) Centre, funded through the Canada Foundation for Innovation (CFI) and the Ministry of Research and Innovation's Ontario Research Fund (ORF), provided the infrastructure for the conduct of this project. Laura Chiavaroli was funded by a Toronto 3D Knowledge Synthesis and Clinical Trials foundation Postdoctoral Fellowship Award. Effie Viguiliouk was supported by a Toronto 3D Knowledge Synthesis and Clinical Trials foundation Internship Award. John L Sievenpiper was funded by a PSI Graham Farquharson Knowledge Translation Fellowship, Diabetes Canada Clinician Scientist award, CIHR INMD/CNS New Investigator Partnership Prize, and Banting and Best Diabetes Centre Sun Life Financial New Investigator Award. With the exception of the Clinical Practice Guidelines Committee of the DNSG of the EASD, none of the sponsors had a role in any aspect of the present study, including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, approval of the manuscript or decision to publish.},
funding_text 3={Conflicts of Interest: D.R. has served as principal investigator or co-investigator in clinical trials of AstraZeneca, Eli Lilly, MSD, Novo Nordisk, Sanofi Aventis, Solvay and Trophos. He received honoraria for speaking or advisory board engagements and consulting fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Lifescan–Johnson and Johnson, Novartis, Novo Nordisk, MSD, Merck Sharp and Dohme, Pfizer, Pliva, Roche, Salvus, Sanofi Aventis and Takeda. He served as a Board member and Secretary of IDF Europe in biennium 2015–2017. He is a president of Croatian Society for Diabetes and Metabolic Disorders of Croatian Medical Association, chair of IDF Young Leaders in Diabetes Programme, Executive committee member of Diabetes and Cardiovascular Disease Study Group of EASD, Croatian Endocrine Society, Croatian Society for Obesity and Croatian Society for Endocrine Oncology. J.S.S. reports serving on the board of and receiving grant support through his institution from the International Nut and Dried Fruit Council, and Eroski Foundation and serving on the Executive Committee of the Instituto Danone Spain and on the Scientific Committee of the Danone International Institute. Has received research support from the Instituto de Salud Carlos III, Spain; Ministerio de Educación y Ciencia, Spain; Departament de Salut Pública de la Generalitat de Catalunya, Catalonia, Spain; European Commission. He has received research support from California Walnut Commission, Sacramento CA, USA; Patrimonio Comunal Olivarero, Spain; La Morella Nuts, Spain; and Borges S.A., Spain. Reports receiving consulting fees or travel expenses from Danone; California Walnut Commission, Eroski Foundation, Instituto Danone–Spain, Nuts for Life, Australian Nut Industry Council, Nestlé, Abbot Laboratories, and Font Vella Lanjarón. He is on the Clinical Practice Guidelines Expert Committee of the European Association for the study of Diabetes (EASD), and served in the Scientific Committee of the Spanish Food and Safety Agency, and the Spanish Federation of the Scientific Societies of Food, Nutrition and Dietetics. He is a member of the International Carbohydrate Quality Consortium (ICQC), and Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD. C.W.C.K. has received grant grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada (AAFC), Almond Board of California, American Pistachio Growers, Barilla, California Strawberry Commission, Calorie Control Council, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd., Pulse Canada, Saskatchewan Pulse Growers and Unilever. He has received in-kind research support from the Almond Board of California, California Walnut Council, American Peanut Council, Barilla, Unilever, Unico/Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Kellogg Canada, WhiteWave Foods. He has received travel support and/or honoraria from the American Peanut Council, American Pistachio Growers, Barilla, Bayer, California Walnut Commission, Canola Council of Canada, General Mills, International Tree Nut Council, Loblaw Brands Ltd., Nutrition Foundation of Italy, Oldways Preservation Trust, Orafti, Paramount Farms, Peanut Institute, Pulse Canada, Sabra Dipping Co., Saskatchewan Pulse Growers, Sun-Maid, Tate and Lyle, Unilever and White Wave Foods. He has served on the scientific advisory board for the International Tree Nut Council, McCormick Science Institute, Oldways Preservation Trust, Paramount Farms and Pulse Canada. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the EASD and is a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. J.L.S. has received research support from the Canadian Institutes of health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), Canadian Nutrition Society (CNS), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers) and the Nutrition Trialists Fund at the University of Toronto (a fund established by the Calorie Control Council). He has received in-kind research support from the Almond Board of California, California Walnut Commission, American Peanut Council, Barilla, Unilever, Unico/Primo, Loblaw Companies, Quaker (Pepsico), Kellogg Canada, WhiteWave Foods. He has received travel support, speaker fees and/or honoraria from Diabetes Canada, Canadian Nutrition Society (CNS), Mott’s LLP, Dairy Farmers of Canada, FoodMinds LLC, Memac Ogilvy & Mather LLC, PepsiCo, The Ginger Network LLC, International Sweeteners Association, Nestlé, Pulse Canada, Canadian Society for Endocrinology and Metabolism (CSEM), GI Foundation, Abbott, Biofortis, American Society for Nutrition (ASN), and Physicians Committee for Responsible Medicine. He has ad hoc consulting arrangements with Perkins Coie LLP, Tate and Lyle, and Wirtschaftliche Vereinigung Zucker e.V. He is a member of the European Fruit Juice Association Scientific Expert Panel. He is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada. He serves as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of the International Life Science Institute (ILSI) North America. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. No competing interests were declared by L.C., E.V., S.K.N., S.B.M., and H.K.},
references={(2015) IDF Diabetes Atlas, , http://www.diabetesatlas.org/resources/2015-atlas.html, 7th ed, Available online:, (accessed on 30 January 2018); O’Rourke, K., Vanderzanden, A., Shepard, D., Leach-Kemon, K., Cardiovascular disease worldwide, 1990–2013 (2015) JAMA, 1905, p. 314. , [CrossRef]; (2018) Obesity, , http://www.who.int/gho/ncd/riskfactors/obesity_text/en/, Available online, accessed on 30 January; Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jr., Jones, D.W., Wright, J.T., Jr., The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report (2003) JAMA, 289, pp. 2560-2572; Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., Franklin, B., Kris-Etherton, P., Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee (2006) Circulation, 114, pp. 82-96. , [CrossRef] [PubMed]; Anderson, T.J., Gregoire, J., Pearson, G.J., Barry, A.R., Couture, P., Dawes, M., Francis, G.A., Gupta, M., 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult (2016) Can. J. Cardiol., 32, pp. 1263-1282; Evert, A.B., Boucher, J.L., Cypress, M., Dunbar, S.A., Franz, M.J., Mayer-Davis, E.J., Neumiller, J.J., Urbanski, P., Nutrition therapy recommendations for the management of adults with diabetes (2014) Diabetes Care, 37. , Suppl. 1), S120–S143. [CrossRef; Dworatzek, P.D., Arcudi, K., Gougeon, R., Husein, N., Sievenpiper, J.L., Williams, S.L., (2013) Nutrition Therapy. Can. J. Diabetes, 37, pp. S45-S55. , [CrossRef] [PubMed]; Nerenberg, K.A., Zarnke, K.B., Leung, A.A., Dasgupta, K., Butalia, S., McBrien, K., Harris, K.C., Gelfer, M., Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children (2018) Can. J. Cardiol., 34, pp. 506-525; Sacks, F.M., Svetkey, L.P., Vollmer, W.M., Appel, L.J., Bray, G.A., Harsha, D., Obarzanek, E., Simons-Morton, D.G., Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group (2001) N. Engl. J. Med., 344, pp. 3-10. , [CrossRef] [PubMed]; Siervo, M., Lara, J., Chowdhury, S., Ashor, A., Oggioni, C., Mathers, J.C., Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: A systematic review and meta-analysis (2015) Br. J. Nutr., 113, pp. 1-15; Jannasch, F., Kroger, J., Schulze, M.B., Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies (2017) J. Nutr., 147, pp. 1174-1182; Schwingshackl, L., Hoffmann, G., Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: A systematic review and meta-analysis of cohort studies (2015) J. Acad. Nutr. Diet, 115, pp. 780-800; (2015) 2015–2020 Dietary Guidelines for Americans, , http://health.gov/dietaryguidelines/2015/guidelines/, 8th ed.; December, Available online, accessed on 27 November 2018; Sievenpiper, J.L., Chan, C.B., Dworatzek, P.D., Freeze, C., Williams, S.L., Nutrition Therapy (2018) Can. J. Diabetes, 42, pp. S64-S79. , [CrossRef] [PubMed]; Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., Cooney, M.T., Deaton, C., European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) (2016) Eur. Heart J., 201, pp. 2315-2381. , [PubMed]; Eckel, R.H., Jakicic, J.M., Ard, J.D., de Jesus, J.M., Houston Miller, N., Hubbard, V.S., Lee, I.M., Millen, B.E., 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) J. Am. Coll. Cardiol., 63, pp. 2960-2984. , [CrossRef] [PubMed]; Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. Cochrane Collaboration; Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., Norris, S., Debeer, H., GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables (2011) J. Clin. Epidemiol., 64, pp. 383-394; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2010) Int. J. Surg., 8, pp. 336-341; Wells, G.A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., (2014) The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses; Ottawa Hospital Research Institute: Ottawa, Canada, , www.ohri.ca/programs/clinical_epidemiology/oxford.asp, accessed on 30 January 2018; Higgins, J.P., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., Savovic, J., Sterne, J.A., The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials (2011) BMJ, 343, p. 5928; Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., Vist, G.E., Norris, S., GRADE guidelines: 3. Rating the quality of evidence (2011) J. Clin. Epidemiol., 64, pp. 401-406; Brunetti, M., Shemilt, I., Pregno, S., Vale, L., Oxman, A.D., Lord, J., Sisk, J., Guyatt, G.H., GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence (2013) J. Clin. Epidemiol., 66, pp. 140-150; Guyatt, G., Oxman, A.D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Jaeschke, R., GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes (2013) J. Clin. Epidemiol., 66, pp. 151-157; Guyatt, G.H., Oxman, A.D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Schunemann, H.J., GRADE guidelines: 2. Framing the question and deciding on important outcomes (2011) J. Clin. Epidemiol., 64, pp. 395-400; Guyatt, G.H., Oxman, A.D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P.J., Vist, G., GRADE guidelines 6. Rating the quality of evidence–imprecision (2011) J. Clin. Epidemiol., 64, pp. 1283-1293; Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Vist, G., GRADE guidelines: 8. Rating the quality of evidence–indirectness (2011) J. Clin. Epidemiol., 64, pp. 1303-1310; Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Akl, E.A., GRADE guidelines: 7. Rating the quality of evidence–inconsistency (2011) J. Clin. Epidemiol., 64, pp. 1294-1302; Guyatt, G.H., Oxman, A.D., Montori, V., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Falck-Ytter, Y., GRADE guidelines: 5. Rating the quality of evidence—Publication bias (2011) J. Clin. Epidemiol., 64, pp. 1277-1282; Guyatt, G.H., Oxman, A.D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Djulbegovic, B., GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes (2013) J. Clin. Epidemiol., 66, pp. 158-172; Guyatt, G.H., Oxman, A.D., Sultan, S., Glasziou, P., Akl, E.A., Alonso-Coello, P., Atkins, D., Montori, V., GRADE guidelines: 9. Rating up the quality of evidence (2011) J. Clin. Epidemiol., 64, pp. 1311-1316; Guyatt, G.H., Oxman, A.D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Montori, V., Falck-Ytter, Y., GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias) (2011) J. Clin. Epidemiol., 64, pp. 407-415; Guyatt, G.H., Thorlund, K., Oxman, A.D., Walter, S.D., Patrick, D., Furukawa, T.A., Johnston, B.C., Vist, G., GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes (2013) J. Clin. Epidemiol., 66, pp. 173-183; Agnoli, C., Krogh, V., Grioni, S., Sieri, S., Palli, D., Masala, G., Sacerdote, C., Frasca, G., A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort (2011) J. Nutr., 141, pp. 1552-1558; Bertoia, M.L., Triche, E.W., Michaud, D.S., Baylin, A., Hogan, J.W., Neuhouser, M.L., Tinker, L.F., Li, W., Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women (2014) Am. J. Clin. Nutr., 99, pp. 344-351; Fitzgerald, K.C., Chiuve, S.E., Buring, J.E., Ridker, P.M., Glynn, R.J., Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism (2012) J. Thromb. Haemost., 10, pp. 189-198; Folsom, A.R., Parker, E.D., Harnack, L.J., Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease (2007) Am. J. Hypertens., 20, pp. 225-232; Fung, T.T., Chiuve, S.E., McCullough, M.L., Rexrode, K.M., Logroscino, G., Hu, F.B., Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women (2008) Arch. Intern. Med., 168, pp. 713-720; Levitan, E.B., Wolk, A., Mittleman, M.A., Consistency with the DASH diet and incidence of heart failure (2009) Arch. Intern. Med., 169, pp. 851-857; Lin, P.H., Yeh, W.T., Svetkey, L.P., Chuang, S.Y., Chang, Y.C., Wang, C., Pan, W.H., Dietary intakes consistent with the DASH dietary pattern reduce blood pressure increase with age and risk for stroke in a Chinese population (2013) Asia Pac. J. Clin. Nutr., 22, pp. 482-491; Reedy, J., Krebs-Smith, S.M., Miller, P.E., Liese, A.D., Kahle, L.L., Park, Y., Subar, A.F., Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults (2014) J. Nutr., 144, pp. 881-889; Salehi-Abargouei, A., Maghsoudi, Z., Shirani, F., Azadbakht, L., Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—incidence: A systematic review and meta-analysis on observational prospective studies (2013) Nutrition, 29, pp. 611-618; de Koning, L., Chiuve, S.E., Fung, T.T., Willett, W.C., Rimm, E.B., Hu, F.B., Diet-quality scores and the risk of type 2 diabetes in men (2011) Diabetes Care, 34, pp. 1150-1156; Otto, M.C., Padhye, N.S., Bertoni, A.G., Jacobs, D.R., Jr., Mozaffarian, D., Everything in Moderation—Dietary Diversity and Quality, Central Obesity and Risk of Diabetes (2015) Plos ONE, 10; Jacobs, S., Harmon, B.E., Boushey, C.J., Morimoto, Y., Wilkens, L.R., Le Marchand, L., Kroger, J., Maskarinec, G., A priori-defined diet quality indexes and risk of type 2 diabetes: The Multiethnic Cohort (2015) Diabetologia, 58, pp. 98-112; Interact, C., Adherence to predefined dietary patterns and incident type 2 diabetes in European populations: EPIC-InterAct Study (2014) Diabetologia, 57, pp. 321-333; Liese, A.D., Nichols, M., Sun, X., D’Agostino, R.B., Jr., Haffner, S.M., Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: The insulin resistance atherosclerosis study (2009) Diabetes Care, 32, pp. 1434-1436; Appel, L.J., Moore, T.J., Obarzanek, E., Vollmer, W.M., Svetkey, L.P., Sacks, F.M., Bray, G.A., Windhauser, M.M., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group (1997) N. Engl. J. Med., 336, pp. 1117-1124; Appel, L.J., Champagne, C.M., Harsha, D.W., Cooper, L.S., Obarzanek, E., Elmer, P.J., Stevens, V.J., Svetkey, L.P., Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial (2003) JAMA, 289, pp. 2083-2093. , [PubMed]; Conlin, P.R., Erlinger, T.P., Bohannon, A., Miller, E.R., III, Appel, L.J., Svetkey, L.P., Moore, T.J., The DASH diet enhances the blood pressure response to losartan in hypertensive patients (2003) Am. J. Hypertens., 16, pp. 337-342; Lopes, H.F., Martin, K.L., Nashar, K., Morrow, J.D., Goodfriend, T.L., Egan, B.M., DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity (2003) Hypertension, 41, pp. 422-430; Nowson, C.A., Wattanapenpaiboon, N., Pachett, A., Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women (2009) Nutr. Res., 29, pp. 8-18; Nowson, C.A., Worsley, A., Margerison, C., Jorna, M.K., Frame, A.G., Torres, S.J., Godfrey, S.J., Blood pressure response to dietary modifications in free-living individuals (2004) J. Nutr., 134, pp. 2322-2329; Nowson, C.A., Worsley, A., Margerison, C., Jorna, M.K., Godfrey, S.J., Booth, A., Blood pressure change with weight loss is affected by diet type in men (2005) Am. J. Clin. Nutr., 81, pp. 983-989; Azadbakht, L., Mirmiran, P., Esmaillzadeh, A., Azizi, T., Azizi, F., Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome (2005) Diabetes Care, 28, pp. 2823-2831; Azadbakht, L., Surkan, P.J., Esmaillzadeh, A., Willett, W.C., The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients (2011) J. Nutr., 141, pp. 1083-1088; Al-Solaiman, Y., Jesri, A., Mountford, W.K., Lackland, D.T., Zhao, Y., Egan, B.M., DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre (2010) J. Hum. Hypertens., 24, pp. 237-246; Blumenthal, J.A., Babyak, M.A., Hinderliter, A., Watkins, L.L., Craighead, L., Lin, P.H., Caccia, C., Sherwood, A., Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study (2010) Arch. Intern. Med., 170, pp. 126-135; Malloy-McFall, J., Barkley, J.E., Gordon, K.L., Burzminski, N., Glickman, E.L., Effect of the DASH Diet on Pre-and Stage 1 Hypertensive Individuals in a Free-Living Environment (2010) Nutr. Metab. Insights, 3, pp. 15-23; Edwards, K.M., Wilson, K.L., Sadja, J., Ziegler, M.G., Mills, P.J., Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure (2011) Acta Physiol. (Oxf.), 203, pp. 343-350; Lin, P.H., Allen, J.D., Li, Y.J., Yu, M., Lien, L.F., Svetkey, L.P., Blood Pressure-Lowering Mechanisms of the DASH Dietary Pattern (2012) J. Nutr. Metab, 472, p. 2012. , [CrossRef]; Asemi, Z., Tabassi, Z., Samimi, M., Fahiminejad, T., Esmaillzadeh, A., Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: A randomised clinical trial (2013) Br. J. Nutr., 109, pp. 2024-2030; Shirani, F., Salehi-Abargouei, A., Azadbakht, L., Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: A systematic review and meta-analysis on controlled clinical trials (2013) Nutrition, 29, pp. 939-947; Soltani, S., Shirani, F., Chitsazi, M.J., Salehi-Abargouei, A., The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: A systematic review and meta-analysis of randomized controlled clinical trials (2016) Obes. Rev., 17, pp. 442-454; Soltani, S., Chitsazi, M.J., Salehi-Abargouei, A., The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: A systematic review and meta-analysis of randomized trials (2018) Clin. Nutr., 37, pp. 542-550; Harsha, D.W., Sacks, F.M., Obarzanek, E., Svetkey, L.P., Lin, P.H., Bray, G.A., Aickin, M., Appel, L.J., Effect of dietary sodium intake on blood lipids: Results from the DASH-sodium trial (2004) Hypertension, 43, pp. 393-398; Chen, S.T., Maruthur, N.M., Appel, L.J., The effect of dietary patterns on estimated coronary heart disease risk: Results from the Dietary Approaches to Stop Hypertension (DASH) trial (2010) Circ. Cardiovasc. Qual. Outcomes, 3, pp. 484-489; Ard, J.D., Grambow, S.C., Liu, D., Slentz, C.A., Kraus, W.E., Svetkey, L.P., Study, P., The effect of the PREMIER interventions on insulin sensitivity (2004) Diabetes Care, 27, pp. 340-347; Lien, L.F., Brown, A.J., Ard, J.D., Loria, C., Erlinger, T.P., Feldstein, A.C., Lin, P.H., McGuire, H.L., Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome (2007) Hypertension, 50, pp. 609-616; Al-Solaiman, Y., Jesri, A., Zhao, Y., Morrow, J.D., Egan, B.M., Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans (2009) J. Hum. Hypertens., 23, pp. 826-835; Hodson, L., Harnden, K.E., Roberts, R., Dennis, A.L., Frayn, K.N., Does the DASH diet lower blood pressure by altering peripheral vascular function? (2010) J. Hum. Hypertens., 24, pp. 312-319; Ard, J.D., Coffman, C.J., Lin, P.H., Svetkey, L.P., One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants (2004) Am. J. Hypertens., 17, pp. 1156-1162; Elmer, P.J., Obarzanek, E., Vollmer, W.M., Simons-Morton, D., Stevens, V.J., Young, D.R., Lin, P.H., Svetkey, L.P., Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial (2006) Ann. Intern. Med., 144, pp. 485-495; Lima, S.T., da Silva Nalin de Souza, B., Franca, A.K., Salgado Filho, N., Sichieri, R., Dietary approach to hypertension based on low glycaemic index and principles of DASH (Dietary Approaches to Stop Hypertension): A randomised trial in a primary care service (2013) Br. J. Nutr, 110, pp. 1472-1479; Rifai, L., Pisano, C., Hayden, J., Sulo, S., Silver, M.A., Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure (2015) Bayl. Univ. Med. Cent. Proc., 28, pp. 151-156; Asemi, Z., Samimi, M., Tabassi, Z., Esmaillzadeh, A., The effect of DASH diet on pregnancy outcomes in gestational diabetes: A randomized controlled clinical trial (2014) Eur. J. Clin. Nutr., 68, pp. 490-495; Razavi Zade, M., Telkabadi, M.H., Bahmani, F., Salehi, B., Farshbaf, S., Asemi, Z., The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: A randomized clinical trial (2016) Liver Int, 36, pp. 563-571; Jenkins, D.J., Jones, P.J., Frohlich, J., Lamarche, B., Ireland, C., Nishi, S.K., Srichaikul, K., Faulkner, D., The effect of a dietary portfolio compared to a DASH-type diet on blood pressure (2015) Nutr. Metab. Cardiovasc. Dis., 25, pp. 1132-1139; King, D.E., Egan, B.M., Woolson, R.F., Mainous, A.G., III, Al-Solaiman, Y., Jesri, A., Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level (2007) Arch. Intern. Med., 167, pp. 502-506; Roussell, M.A., Hill, A.M., Gaugler, T.L., West, S.G., Heuvel, J.P., Alaupovic, P., Gillies, P.J., Kris-Etherton, P.M., Beef in an Optimal Lean Diet study: Effects on lipids, lipoproteins, and apolipoproteins (2012) Am. J. Clin. Nutr, 95, pp. 9-16. , [CrossRef] [PubMed]; Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., Hu, F.B., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies (2014) BMJ, 349, p. 4490; Tang, G., Wang, D., Long, J., Yang, F., Si, L., Meta-analysis of the association between whole grain intake and coronary heart disease risk (2015) Am. J. Cardiol., 115, pp. 625-629; Reynolds, A.N., Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple? (2018) Lancet, 391, p. 1676; Viguiliouk, E., Blanco Mejia, S., Kendall, C.W., Sievenpiper, J.L., Can pulses play a role in improving cardiometabolic health? Evidence from systematic reviews and meta-analyses (2017) Ann. N. Y. Acad. Sci., 1392, pp. 43-57; Aune, D., Keum, N., Giovannucci, E., Fadnes, L.T., Boffetta, P., Greenwood, D.C., Tonstad, S., Norat, T., Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies (2016) BMC Med, 14, p. 207; Abete, I., Romaguera, D., Vieira, A.R., Lopez de Munain, A., Norat, T., Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: A meta-analysis of cohort studies (2014) Br. J. Nutr., 112, pp. 762-775; Wang, X., Lin, X., Ouyang, Y.Y., Liu, J., Zhao, G., Pan, A., Hu, F.B., Red and processed meat consumption and mortality: Dose-response meta-analysis of prospective cohort studies (2016) Public Health Nutr, 19, pp. 893-905; Threapleton, D.E., Greenwood, D.C., Evans, C.E., Cleghorn, C.L., Nykjaer, C., Woodhead, C., Cade, J.E., Burley, V.J., Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis (2013) BMJ, 347, p. 6879; Arts, I.C., Hollman, P.C., Polyphenols and disease risk in epidemiologic studies (2005) Am. J. Clin. Nutr., 81, pp. 317S-325S; Perez-Cano, F.J., Castell, M., Flavonoids, Inflammation and Immune System (2016) Nutrients, 8, p. 659; Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., Amann, M., Aryee, M., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010 (2012) A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet, 380, pp. 2224-2260. , [CrossRef]; Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., Prospective Studies, Collaboration (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies. Lancet, 360, pp. 1903-1913; Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., Peto, R., Keech, A., Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials (2010) Lancet, 376, pp. 1670-1681; Fulcher, J., O’Connell, R., Voysey, M., Emberson, J., Blackwell, L., Mihaylova, B., Simes, J., Kirby, A., Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials (2015) Lancet, 385, pp. 1397-1405; Cannon, C.P., Blazing, M.A., Giugliano, R.P., McCagg, A., White, J.A., Theroux, P., Darius, H., Jukema, J.W., Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes (2015) N. Engl. J. Med., 372, pp. 2387-2397; Johnston, B.C., Kanters, S., Bandayrel, K., Wu, P., Naji, F., Siemieniuk, R.A., Ball, G.D., Guyatt, G., Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis (2014) JAMA, 312, pp. 923-933; Haslam, D.W., James, W.P., Obesity (2005) Lancet, 366, pp. 1197-1209; Sotos-Prieto, M., Bhupathiraju, S.N., Mattei, J., Fung, T.T., Li, Y., Pan, A., Willett, W.C., Hu, F.B., Association of Changes in Diet Quality with Total and Cause-Specific Mortality (2017) N. Engl. J. Med., 377, pp. 143-153; Li, M., Fan, Y., Zhang, X., Hou, W., Tang, Z., Fruit and vegetable intake and risk of type 2 diabetes mellitus: Meta-analysis of prospective cohort studies (2014) BMJ Open, 4; Gijsbers, L., Ding, E.L., Malik, V.S., de Goede, J., Geleijnse, J.M., Soedamah-Muthu, S.S., Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies (2016) Am. J. Clin. Nutr., 103, pp. 1111-1124; Wei, G.S., Coady, S.A., Goff, D.C., Jr., Brancati, F.L., Levy, D., Selvin, E., Vasan, R.S., Fox, C.S., Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study (2011) Diabetes Care, 34, pp. 873-879; Emdin, C.A., Anderson, S.G., Woodward, M., Rahimi, K., Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies (2015) J. Am. Coll. Cardiol, 66, pp. 1552-1562; Marott, S.C., Nordestgaard, B.G., Tybjaerg-Hansen, A., Benn, M., Components of the Metabolic Syndrome and Risk of Type 2 Diabetes (2016) J. Clin. Endocrinol. Metab., 101, pp. 3212-3221; Post, R.E., Mainous, A.G., III, King, D.E., Simpson, K.N., Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis (2012) J. Am. Board Fam. Med., 25, pp. 16-23; Evans, C.E., Greenwood, D.C., Threapleton, D.E., Cleghorn, C.L., Nykjaer, C., Woodhead, C.E., Gale, C.P., Burley, V.J., Effects of dietary fibre type on blood pressure: A systematic review and meta-analysis of randomized controlled trials of healthy individuals (2015) J. Hypertens., 33, pp. 897-911; Hou, Q., Li, Y., Li, L., Cheng, G., Sun, X., Li, S., Tian, H., The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis (2015) Nutrients, 7, pp. 10369-10387; Sievenpiper, J.L., Kendall, C.W., Esfahani, A., Wong, J.M., Carleton, A.J., Jiang, H.Y., Bazinet, R.P., Jenkins, D.J., Effect of non-oil-seed pulses on glycaemic control: A systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes (2009) Diabetologia, 52, pp. 1479-1495; Choo, V.L., Viguiliouk, E., Blanco Mejia, S., Cozma, A.I., Khan, T.A., Ha, V., Wolever, T.M.S., Kendall, C.W.C., Food sources of fructose-containing sugars and glycaemic control: Systematic review and meta-analysis of controlled intervention studies (2018) BMJ, 363. , [CrossRef] [PubMed]; Dietary fibre and incidence of type 2 diabetes in eight European countries: The EPIC-InterAct Study and a meta-analysis of prospective studies (2015) Diabetologia, 58, pp. 1394-1408; Aune, D., Norat, T., Romundstad, P., Vatten, L.J., Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies (2013) Eur. J. Epidemiol., 28, pp. 845-858; Kotchen, T.A., Kotchen, J.M., Dietary sodium and blood pressure: Interactions with other nutrients (1997) Am. J. Clin. Nutr., 65, pp. 708S-711S; Whelton, P.K., He, J., Cutler, J.A., Brancati, F.L., Appel, L.J., Follmann, D., Klag, M.J., Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials (1997) JAMA, 277, pp. 1624-1632; Petrov, V., Lijnen, P., Modification of intracellular calcium and plasma renin by dietary calcium in men (1999) Am. J. Hypertens., 12, pp. 1217-1224; Kanbay, M., Bayram, Y., Solak, Y., Sanders, P.W., Dietary potassium: A key mediator of the cardiovascular response to dietary sodium chloride (2013) J. Am. Soc. Hypertens., 7, pp. 395-400; Haddy, F.J., Vanhoutte, P.M., Feletou, M., Role of potassium in regulating blood flow and blood pressure (2006) Am. J. Physiol. Regul. Integr. Comp. Physiol., 290, pp. R546-R552; Zacchia, M., Abategiovanni, M.L., Stratigis, S., Capasso, G., Potassium: From Physiology to Clinical Implications (2016) Kidney Dis. (Basel), 2, pp. 72-79; Siervo, M., Lara, J., Ogbonmwan, I., Mathers, J.C., Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: A systematic review and meta-analysis (2013) J. Nutr., 143, pp. 818-826; Jayalath, V.H., de Souza, R.J., Sievenpiper, J.L., Ha, V., Chiavaroli, L., Mirrahimi, A., Di Buono, M., Kris-Etherton, P.M., Effect of dietary pulses on blood pressure: A systematic review and meta-analysis of controlled feeding trials (2014) Am. J. Hypertens., 27, pp. 56-64; Huang, H., Chen, G., Liao, D., Zhu, Y., Xue, X., Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials (2016) Sci. Rep., 6; Khan, K., Jovanovski, E., Ho, H.V.T., Marques, A.C.R., Zurbau, A., Mejia, S.B., Sievenpiper, J.L., Vuksan, V., The effect of viscous soluble fiber on blood pressure: A systematic review and meta-analysis of randomized controlled trials (2018) Nutr. Metab. Cardiovasc. Dis, 28, pp. 3-13; Ho, H.V., Sievenpiper, J.L., Zurbau, A., Blanco Mejia, S., Jovanovski, E., Au-Yeung, F., Jenkins, A.L., Vuksan, V., The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials (2016) Br. J. Nutr., 116, pp. 1369-1382; Hollaender, P.L., Ross, A.B., Kristensen, M., Whole-grain and blood lipid changes in apparently healthy adults: A systematic review and meta-analysis of randomized controlled studies (2015) Am. J. Clin. Nutr., 102, pp. 556-572; Ha, V., Sievenpiper, J.L., de Souza, R.J., Jayalath, V.H., Mirrahimi, A., Agarwal, A., Chiavaroli, L., Di Buono, M., Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic review and meta-analysis of randomized controlled trials (2014) CMAJ, 186, pp. E252-E262; Hooper, L., Martin, N., Abdelhamid, A., Davey Smith, G., Reduction in saturated fat intake for cardiovascular disease (2015) Cochrane Database Syst. Rev.; Chiavaroli, L., Nishi, S.K., Khan, T.A., Braunstein, C.R., Glenn, A.J., Mejia, S.B., Rahelic, D., Jenkins, D.J.A., Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials (2018) Prog. Cardiovasc. Dis., 61, pp. 43-53; Mytton, O.T., Nnoaham, K., Eyles, H., Scarborough, P., Ni Mhurchu, C., Systematic review and meta-analysis of the effect of increased vegetable and fruit consumption on body weight and energy intake (2014) BMC Public Health, 14, p. 886; Howarth, N.C., Saltzman, E., Roberts, S.B., Dietary fiber and weight regulation (2001) Nutr. Rev., 59, pp. 129-139; Kim, S.J., de Souza, R.J., Choo, V.L., Ha, V., Cozma, A.I., Chiavaroli, L., Mirrahimi, A., Bernstein, A.M., Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials (2016) Am. J. Clin. Nutr., 103, pp. 1213-1223; Li, S.S., Kendall, C.W., de Souza, R.J., Jayalath, V.H., Cozma, A.I., Ha, V., Mirrahimi, A., Blanco Mejia, S., Dietary pulses, satiety and food intake: A systematic review and meta-analysis of acute feeding trials (2014) Obesity (Silver Spring), 22, pp. 1773-1780; Oh, S.W., Han, K.H., Han, S.Y., Koo, H.S., Kim, S., Chin, H.J., Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat (2015) Medicine (Baltimore), 94; Jiao, J., Xu, J.Y., Zhang, W., Han, S., Qin, L.Q., Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: A meta-analysis of randomized controlled trials (2015) Int. J. Food Sci. Nutr., 66, pp. 114-119; Estruch, R., Martinez-Gonzalez, M.A., Corella, D., Basora-Gallisa, J., Ruiz-Gutierrez, V., Covas, M.I., Fiol, M., Escoda, R., Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk (2009) J. Epidemiol. Community Health, 63, pp. 582-588; Kanauchi, O., Mitsuyama, K., Araki, Y., Andoh, A., Modification of intestinal flora in the treatment of inflammatory bowel disease (2003) Curr. Pharm Des., 9, pp. 333-346; Scheppach, W., Wiggins, H.S., Halliday, D., Self, R., Howard, J., Branch, W.J., Schrezenmeir, J., Cummings, J.H., Effect of gut-derived acetate on glucose turnover in man (1988) Clin. Sci. (Lond.), 75, pp. 363-370; Lee, Y., Kang, D., Lee, S.A., Effect of dietary patterns on serum C-reactive protein level (2014) Nutr. Metab. Cardiovasc. Dis., 24, pp. 1004-1011; Watzl, B., Kulling, S.E., Moseneder, J., Barth, S.W., Bub, A., A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men (2005) Am. J. Clin. Nutr., 82, pp. 1052-1058; Dibaba, D.T., Xun, P., He, K., Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review (2014) Eur. J. Clin. Nutr., 68, p. 971; Almoznino-Sarafian, D., Berman, S., Mor, A., Shteinshnaider, M., Gorelik, O., Tzur, I., Alon, I., Cohen, N., Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration? (2007) Eur. J. Nutr., 46, pp. 230-237; Chen, X., Touyz, R.M., Park, J.B., Schiffrin, E.L., Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR (2001) Hypertension, 38, pp. 606-611; Yang, Y., Gao, M., Nie, W., Yuan, J., Zhang, B., Wang, Z., Wu, Z., Dietary magnesium sulfate supplementation protects heat stress-induced oxidative damage by restoring the activities of anti-oxidative enzymes in broilers (2012) Biol. Trace Elem. Res., 146, pp. 53-58; Blanco Mejia, S., Kendall, C.W., Viguiliouk, E., Augustin, L.S., Ha, V., Cozma, A.I., Mirrahimi, A., Leiter, L.A., Effect of tree nuts on metabolic syndrome criteria: A systematic review and meta-analysis of randomised controlled trials (2014) BMJ Open, 4; Ho, H.V., Sievenpiper, J.L., Zurbau, A., Blanco Mejia, S., Jovanovski, E., Au-Yeung, F., Jenkins, A.L., Vuksan, V., A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction(I-iv) (2016) Eur. J. Clin. Nutr, 70, p. 1340; Health Promotion and Disease Prevention: Fruit and Vegetables, , https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/fruit-vegetables#_jrc2018, Available online, accessed on 28 November 2018; Dietary Fats. European Commission, , https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/fats#_Toctb5b, Available online, accessed on 28 November 2018; Hjartaker, A., Lagiou, A., Slimani, N., Lund, E., Chirlaque, M.D., Vasilopoulou, E., Zavitsanos, X., Ocke, M.C., Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: Data from 35,955 24-hour dietary recalls in 10 European countries (2002) Public Health Nutr, 5, pp. 1259-1271; Lee-Kwan, S.H., Moore, L.V., Blanck, H.M., Harris, D.M., Galuska, D., Disparities in State-Specific Adult Fruit and Vegetable Consumption—United States, 2015 (2017) MMWR Morb. Mortal Wkly. Rep., 66, pp. 1241-1247; (2013) Food Patterns Equivalents Intakes from Food: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat in America, NHANES 2009–2010, , www.ars.usda.gov/ba/bhnrc/fsrg, (accessed on 27 November 2018); Nielsen, S.J., Kit, B.K., Ogden, C.L., Nut Consumption Among U.S. Adults, 2009–2010 (2014) NCHS Data Brief, 176, pp. 1-8},
correspondence_address1={Sievenpiper, J.L.; Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Canada; email: john.sievenpiper@utoronto.ca},
publisher={MDPI AG},
issn={20726643},
pubmed_id={30764511},
language={English},
abbrev_source_title={Nutrients},
document_type={Review},
source={Scopus},
}

@ARTICLE{Pingault2018566,
author={Pingault, J.-B. and O’Reilly, P.F. and Schoeler, T. and Ploubidis, G.B. and Rijsdijk, F. and Dudbridge, F.},
title={Using genetic data to strengthen causal inference in observational research},
journal={Nature Reviews Genetics},
year={2018},
volume={19},
number={9},
pages={566-580},
doi={10.1038/s41576-018-0020-3},
note={cited By 159},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048031133&doi=10.1038%2fs41576-018-0020-3&partnerID=40&md5=7ee540e243aa3171cc1309eb8a7bb380},
affiliation={Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom; Social, Genetic, and Developmental Psychiatry, King’s College London, De Crespigny Park, London, United Kingdom; Centre for Longitudinal Studies, Department of Social Science, UCL Institute of Education, University College London, London, United Kingdom; Department of Health Sciences, University of Leicester, Leicester, United Kingdom},
abstract={Causal inference is essential across the biomedical, behavioural and social sciences.By progressing from confounded statistical associations to evidence of causal relationships, causal inference can reveal complex pathways underlying traits and diseases and help to prioritize targets for intervention. Recent progress in genetic epidemiology — including statistical innovation, massive genotyped data sets and novel computational tools for deep data mining — has fostered the intense development of methods exploiting genetic data and relatedness to strengthen causal inference in observational research. In this Review, we describe how such genetically informed methods differ in their rationale, applicability and inherent limitations and outline how they should be integrated in the future to offer a rich causal inference toolbox. © 2018, Macmillan Publishers Ltd., part of Springer Nature.},
keywords={causal inference;  causality;  genetic analysis;  genetic association;  genetic epidemiology;  human;  Mendelian randomization analysis;  priority journal;  Review;  study design;  data mining;  genetic database;  genotype;  genotyping technique;  procedures, Data Mining;  Databases, Genetic;  Genotype;  Genotyping Techniques;  Humans},
funding_details={King’s College LondonKing’s College London, KCL},
funding_details={Wellcome TrustWellcome Trust, WT, 109863/Z/15/Z},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/N015746/1},
funding_details={Economic and Social Research CouncilEconomic and Social Research Council, ESRC, ES/M008584/1},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR},
funding_details={Newcastle upon Tyne Hospitals NHS Foundation TrustNewcastle upon Tyne Hospitals NHS Foundation Trust},
funding_text 1={The authors thank S. Gage and J. M. Vink for cannabis initiation summary statistics and syntax and J. Rees for multivariable Mendelian randomization (MR) syntax. J.-B.P. is a fellow of MQ: Transforming Mental Health (MQ16IP16) and affiliated with the Centre for Research in Epidemiology and Population Health (CESP), French National Institute for Health and Medical Research (INSERM), Université de Paris-Sud, Université de Versailles-Saint Quentin, and Université Paris-Saclay, Paris, France. P.F.O. receives funding from the UK Medical Research Council (MR/N015746/1) and the Wellcome Trust (109863/Z/15/Z). This report represents independent research (partly) funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.},
references={Glass, T.A., Goodman, S.N., Hernán, M.A., Samet, J.M., Causal inference in public health (2013) Annu. Rev. Public Health, 34, pp. 61-75. , PID: 23297653; Rimm, E.B., Vitamin E consumption and the risk of coronary heart disease in men (1993) N. Engl. J. Med., 328, pp. 1450-1456. , PID: 8479464; Stampfer, M.J., Vitamin E consumption and the risk of coronary disease in women (1993) N. Engl. J. Med., 328, pp. 1444-1449. , PID: 8479463; Millen, A.E., Dodd, K.W., Subar, A.F., Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results (2004) J. Am. Diet Assoc., 104, pp. 942-950. , PID: 15175592; Eidelman, R.S., Hollar, D., Hebert, P.R., Lamas, G.A., Hennekens, C.H., Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease (2004) Arch. Intern. Med., 164, pp. 1552-1556. , PID: 15277288; Imai, K., King, G., Stuart, E.A., Misunderstandings between experimentalists and observationalists about causal inference (2008) J. Royal Stat. Soc. A Stat. Methodol., 171, pp. 481-502; Jaffee, S.R., Price, T.S., The implications of genotype-environment correlation for establishing causal processes in psychopathology (2012) Dev. Psychopathol., 24, pp. 1253-1264. , PID: 23062295; Deaton, A., Cartwright, N., Understanding and misunderstanding randomized controlled trials (2017) Soc. Sci. Med.; DiMasi, J.A., Grabowski, H.G., Hansen, R.W., Innovation in the pharmaceutical industry: new estimates of R&D costs (2016) J. Health Econ., 47, pp. 20-33. , PID: 26928437; McGue, M., Osler, M., Christensen, K., Causal inference and observational research: the utility of twins (2010) Perspect. Psychol. Sci., 5, pp. 546-556. , PID: 21593989, This study is an introduction to the twin model from a causal inference perspective. It includes a discussion of concepts, estimations and limitations; Davey Smith, G., Ebrahim, S., What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? (2005) BMJ, 330, pp. 1076-1079. , PID: 15879400; Davey Smith, G., Hemani, G., Mendelian randomization: genetic anchors for causal inference in epidemiological studies (2014) Hum. Mol. Genet., 23, pp. R89-R98. , PID: 25064373; Burgess, S., Timpson, N.J., Ebrahim, S., Davey Smith, G., Mendelian randomization: where are we now and where are we going? (2015) Int. J. Epidemiol., 44, pp. 379-388. , PID: 26085674; Nikpay, M., A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) Nat. Genet., 47, pp. 1121-1130. , PID: 26343387; Sudlow, C., UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age (2015) PLoS Med., 12. , PID: 25826379; Bulik-Sullivan, B., An atlas of genetic correlations across human diseases and traits (2015) Nat. Genet., 47, pp. 1236-1241. , PID: 26414676; Hemani, G., (2016) MR-Base: A platform for systematic causal inference across the phenome using billions of genetic associations, p. 78972; Stuart, E.A., Matching methods for causal inference: a review and a look forward (2010) Stat. Sci., 25, pp. 1-21. , PID: 20871802; Angrist, J.D., Imbens, G.W., Rubin, D.B., Identification of causal effects using instrumental variables (1996) J. Am. Stat. Assoc., 91, pp. 444-455; Tenesa, A., Haley, C.S., The heritability of human disease: estimation, uses and abuses (2013) Nat. Rev. Genet., 14, pp. 139-149. , PID: 23329114; Speed, D., Cai, N., Johnson, M.R., Nejentsev, S., Balding, D.J., Reevaluation of SNP heritability in complex human traits (2017) Nat. Genet., 49, pp. 986-992. , PID: 28530675; Hernán, M.A., A definition of causal effect for epidemiological research (2004) J. Epidemiol. Commun. Health, 58, pp. 265-271. , This study is a pedagogical introduction to the counterfactual or potential outcomes framework for causal inference. It includes mathematical notations and a discussion of key concepts, such as association, causation and exchangeability; Imbens, G.W., Rubin, D.B., (2015) Causal Inference for Statistics, Social, and Biomedical Sciences, , Cambridge Univ. Press, Cambridge; Pearl, J., (2009) Causality, , Cambridge Univ. Press, Cambridge; Rice, F., Disentangling prenatal and inherited influences in humans with an experimental design (2009) Proc. Natl Acad. Sci. USA, 106, pp. 2464-2467. , PID: 19188591, This is an example of the application of the IVF design to examine the effect of smoking during pregnancy on birthweight; Mezuk, B., Myers, J.M., Kendler, K.S., Integrating social science and behavioral genetics: testing the origin of socioeconomic disparities in depression using a genetically informed design (2013) Am. J. Publ. Heal., 103, pp. S145-S151; Kendler, K.S., Gardner, C.O., Dependent stressful life events and prior depressive episodes in the prediction of major depression: the problem of causal inference in psychiatric epidemiology (2010) Arch. Gen. Psychiatry, 67, pp. 1120-1127. , PID: 21041613; Bruder, C.E.G., Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles (2008) Am. J. Hum. Genet., 82, pp. 763-771. , PID: 18304490; Carlin, J.B., Gurrin, L.C., Sterne, J.A., Morley, R., Dwyer, T., Regression models for twin studies: a critical review (2005) Int. J. Epidemiol., 34, pp. 1089-1099. , PID: 16087687; Vitaro, F., Brendgen, M., Arseneault, L., The discordant MZ-twin method: one step closer to the holy grail of causality (2009) Int. J. Behav. Dev., 33, pp. 376-382; Fletcher, J.M., Lehrer, S.F., Genetic lotteries within families (2011) J. Heal. Econ., 30, pp. 647-659. , This paper provides a model combining family fixed effects and genetic instruments, with a discussion of important concepts, such as dynastic effects; Kohler, H.-P., Behrman, J.R., Schnittker, J., Social science methods for twins data: integrating causality, endowments, and heritability (2011) Biodemogr. Soc. Biol., 57, pp. 88-141; Hjelmborg, J., Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer (2017) Thorax, 72, pp. 1021-1027. , PID: 29054888; Bröckerman, P., Hyytinen, A., Kaprio, J., Smoking and long-term labour market outcomes (2015) Tob. Control, 24, pp. 348-353; Cohen-Cline, H., Turkheimer, E., Duncan, G.E., Access to green space, physical activity and mental health: a twin study (2015) J. Epidemiol. Commun. Health, 69, pp. 523-529; Singham, T., Concurrent and longitudinal contribution of exposure to bullying in childhood to mental health: the role of vulnerability and resilience (2017) JAMA Psychiatry, 74, pp. 1112-1119. , PID: 28979965; Taylor, M.J., Developmental associations between traits of autism spectrum disorder and attention deficit hyperactivity disorder: a genetically informative, longitudinal twin study (2013) Psychol. Med., 43, pp. 1735-1746. , PID: 23158218; Frisell, T., Öberg, S., Kuja-Halkola, R., Sjölander, A., Sibling comparison designs: bias from non-shared confounders and measurement error (2012) Epidemiology, 23, pp. 713-720. , PID: 22781362; Heath, A.C., Testing hypotheses about direction of causation using cross-sectional family data (1993) Behav. Genet., 23, pp. 29-50. , PID: 8476389; Neale, M.C., Cardon, L.R., (1992) Methodology for Genetic Studies of Twins and Families, , Kluwer Academic; D’Onofrio, B.M., Paternal age at childbearing and offspring psychiatric and academic morbidity (2014) JAMA Psychiatry, 71, pp. 432-438. , PID: 24577047; Tully, E.C., Iacono, W.G., McGue, M., An adoption study of parental depression as an environmental liability for adolescent depression and childhood disruptive disorders (2008) Am. J. Psychiatry, 165, p. 1148. , PID: 18558644; Duffy, D.L., Martin, N.G., Inferring the direction of causation in cross-sectional twin data: theoretical and empirical considerations (1994) Genet. Epidemiol., 11, pp. 483-502. , PID: 7713391; Wood, A.C., Rijsdijk, F., Asherson, P., Kuntsi, J., Inferring causation from cross-sectional data: examination of the causal relationship between hyperactivity-impulsivity and novelty seeking (2011) Front. Genet., 2, p. 6. , PID: 22303305; Toulopoulou, T., Reciprocal causation models of cognitive versus volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort (2015) Mol. Psychiatry, 20, p. 1386. , PID: 25450228; Katan, M.B., Apolipoprotein E isoforms, serum cholesterol, and cancer (1986) Lancet, 1, pp. 507-508. , PID: 2869248; Davey Smith, G., Mendelian randomization for strengthening causal inference in observational studies: application to gene x environment interactions (2010) Perspect. Psychol. Sci., 5, pp. 527-545; Brion, M.-J.A., Benyamin, B., Visscher, P.M., Smith, G.D., Beyond the single SNP: emerging developments in Mendelian randomization in the ‘Omics’ era (2014) Curr. Epidemiol. Rep., 1, pp. 228-236; Nitsch, D., Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials (2006) Am. J. Epidemiol., 163, pp. 397-403. , PID: 16410347; Davey Smith, G., Genetic epidemiology and public health: hope, hype, and future prospects (2005) Lancet, 366, pp. 1484-1498. , PID: 16243094; Davey Smith, G., Association of C-reactive protein with blood pressure and hypertension: life course confounding and Mendelian randomization tests of causality (2005) Arter. Thromb. Vasc. Biol., 25, pp. 1051-1056; Hartwig, F.P., Borges, M.C., Horta, B.L., Bowden, J., Davey Smith, G., Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study (2017) JAMA Psychiatry, 74, p. 1226. , PID: 29094161; Wensley, F., Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data (2011) BMJ, 342, p. d548. , PID: 21325005; Bolton, C.E., The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study (2011) Clin. Sci., 120, pp. 347-355. , PID: 21080913; Pingault, J.-B., Cecil, C.M., Murray, J., Munafo, M., Viding, E., Causal inference in psychopathology: a systematic review of Mendelian randomisation studies aiming to identify environmental risk factors for psychopathology (2017) Psychopathol. Rev., 4, pp. 4-25; Manousaki, D., Mokry, L.E., Ross, S., Goltzman, D., Richards, J.B., Mendelian randomization studies do not support a role for vitamin D in coronary artery disease (2016) Circ. Cardiovasc. Genet., 9, pp. 349-356. , PID: 27418593; Mokry, L.E., Vitamin D and risk of multiple sclerosis: a Mendelian randomization study (2015) PLoS Med., 12. , PID: 26305103; Sheehan, N.A., Didelez, V., Commentary: Can ‘many weak’ instruments ever be ‘strong’? (2011) Int. J. Epidemiol., 40, pp. 752-754. , PID: 21310719; Visscher, P.M., Yang, J., A plethora of pleiotropy across complex traits (2016) Nat. Genet., 48, p. 707. , PID: 27350602; Bowden, J., Davey Smith, G., Burgess, S., Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression (2015) Int. J. Epidemiol., 44, pp. 512-525. , PID: 26050253, This study introduces the use of a meta-analytical method known as Egger regression to MR analysis. Under certain assumptions, this approach enables causal estimation even when all instruments are invalid; Bowden, J., Davey Smith, G., Haycock, P.C., Burgess, S., Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator (2016) Genet. Epidemiol., 40, pp. 304-314. , PID: 27061298; Rees, J.M.B., Wood, A.M., Burgess, S., Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy (2017) Stat. Med., 36, pp. 4705-4718. , PID: 28960498, This study provides the analytical framework to combine multivariable-MR and MR-Egger methods, which yields causal estimates robust to invalid genetic instruments; Brion, M.-J.A., Shakhbazov, K., Visscher, P.M., Calculating statistical power in Mendelian randomization studies (2013) Int. J. Epidemiol., 42, pp. 1497-1501. , PID: 24159078; Burgess, S., Thompson, S.G., Bias in causal estimates from Mendelian randomization studies with weak instruments (2011) Stat. Med., 30, pp. 1312-1323. , PID: 21432888; Burgess, S., Thompson, S.G., Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes (2012) Stat. Med., 31, pp. 1582-1600. , PID: 22374818; Gage, S.H., Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study (2017) Psychol. Med., 47, pp. 971-980. , PID: 27928975; Stringer, S., Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium (2016) Transl Psychiatry, 6. , PID: 27023175; Burgess, S., Thompson, S.G., Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects (2015) Am. J. Epidemiol., 181, pp. 251-260. , PID: 25632051; Burgess, S., Freitag, D.F., Khan, H., Gorman, D.N., Thompson, S.G., Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions (2014) PLoS ONE, 9. , PID: 25302496; Liu, D.J., Exome-wide association study of plasma lipids in >300,000 individuals (2017) Nat. Genet., 49, p. 1758. , PID: 29083408; Tyrrell, J., Genetic evidence for causal relationships between maternal obesity-related traits and birth weight (2016) JAMA, 315, pp. 1129-1140. , PID: 26978208; Richmond, R.C., Using genetic variation to explore the causal effect of maternal pregnancy adiposity on future offspring adiposity:a Mendelian randomisation study (2017) PLoS Med., 14. , PID: 28118352; Zhang, G., Assessing the causal relationship of maternal height on birth size and gestational age at birth: a Mendelian randomization analysis (2015) PLoS Med., 12. , PID: 26284790, This study introduces intergenerational MR by computing allelic scores the mother containing variants either transmitted or non-transmitted to the offspring. The method enables the estimation of the effect of maternal risk factors on the offspring free from passive gene–environment correlation; Evans, D.M., Mining the human phenome using allelic scores that index biological intermediates (2013) PLoS Genet., 9. , PID: 24204319; Krapohl, E., Widespread covariation of early environmental exposures and trait-associated polygenic variation (2017) Proc. Natl Acad. Sci. USA, 114, pp. 11727-11732. , PID: 29078306; Fletcher, J.M., The promise and pitfalls of combining genetic and economic research (2011) Health Econ., 20, pp. 889-892. , PID: 21612001; Minica, C.C., Dolan, C.V., Boomsma, D.I., de Geus, E., Neale, M.C., (2017) Extending causality tests with genetic instruments: An integration of Mendelian randomization and the classical twin design; Davey Smith, G., Ebrahim, S., ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) Int. J. Epidemiol., 32, pp. 1-22; Davey Smith, G., Capitalizing on Mendelian randomization to assess the effects of treatments (2007) J. R. Soc. Med., 100, pp. 432-435. , PID: 17766918; Pasaniuc, B., Price, A.L., Dissecting the genetics of complex traits using summary association statistics (2017) Nat. Rev. Genet., 18, pp. 117-127. , PID: 27840428; Gill, D., Age at menarche and lung function: a Mendelian randomization study (2017) Eur. J. Epidemiol., 32, pp. 701-710. , PID: 28624884; Bush, W.S., Oetjens, M.T., Crawford, D.C., Unravelling the human genome-phenome relationship using phenome-wide association studies (2016) Nat. Rev. Genet., 17, p. 129. , PID: 26875678; O’Reilly, P.F., MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS (2012) PLoS ONE, 7. , PID: 22567092; Porter, H.F., O’Reilly, P.F., Multivariate simulation framework reveals performance of multi-trait GWAS methods (2017) Sci. Rep., 7. , PID: 28287610; Pickrell, J.K., Detection and interpretation of shared genetic influences on 42 human traits (2016) Nat. Genet., 48, p. 709. , PID: 27182965, This study introduces a method to detect shared genetic influences on multiple traits. It includes a test of asymmetry, which helps to identify pairs of phenotypes that are causally related and which phenotype influences the other (that is, direction of causation; Zhu, Z., Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets (2016) Nat. Genet., 48, pp. 481-487. , PID: 27019110, This study applies summary Mendelian randomization (SMR) methods to expression data and enables the distinction between shared aetiology between expression and phenotypes owing to shared causal variants or distinct variants LD; Richardson, T.G., Mendelian Randomization analysis identifies CpG sites as putative mediators for genetic influences on cardiovascular disease risk (2017) Am. J. Hum. Genet., 101, pp. 590-602. , PID: 28985495; Wallace, C., Statistical testing of shared genetic control for potentially related traits (2013) Genet. Epidemiol., 37, pp. 802-813. , PID: 24227294; Giambartolomei, C., Bayesian test for colocalisation between pairs of genetic association studies using summary statistics (2014) PLoS Genet., 10. , PID: 24830394, This paper introduces a Bayesian colocalization method to identify shared causal variants between phenotypes; Walter, S., Revisiting mendelian randomization studies of the effect of body mass index on depression (2015) Am. J. Med. Genet. B. Neuropsychiatr. Genet., 168B, pp. 108-115. , PID: 25656382; Hemani, G., (2017) Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome; Davey Smith, G., Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial (2005) Ann. Intern. Med., 142, pp. 313-322. , PID: 15738450; Åsvold, B.O., Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway (2014) Int. J. Epidemiol., 43, pp. 1458-1470. , PID: 24867305; Burgess, S., Daniel, R.M., Butterworth, A.S., Thompson, S.G., Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways (2015) Int. J. Epidemiol., 44, pp. 484-495. , PID: 25150977; Chen, W.-M., Abecasis, G.R., Family-based association tests for genomewide association scans (2007) Am. J. Hum. Genet., 81, pp. 913-926. , PID: 17924335; Dudbridge, F., Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data (2008) Hum. Hered., 66, pp. 87-98. , PID: 18382088; Dudbridge, F., Power and predictive accuracy of polygenic risk scores (2013) PLoS Genet., 9. , PID: 23555274; Moayyeri, A., Hammond, C.J., Valdes, A.M., Spector, T.D., Cohort Profile: TwinsUK and healthy ageing twin study (2013) Int. J. Epidemiol., 42, pp. 76-85. , PID: 22253318; Haworth, C.M.A., Davis, O.S.P., Plomin, R., Twins Early Development Study (TEDS): a genetically sensitive investigation of cognitive and behavioral development from childhood to young adulthood (2013) Twin Res. Hum. Genet., 16, pp. 117-125. , PID: 23110994; Magnus, P., Cohort profile update: The Norwegian Mother and Child Cohort Study (MoBa) (2016) Int. J. Epidemiol., 45, pp. 382-388. , PID: 27063603; Fraser, A., Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort (2013) Int. J. Epidemiol., 42, pp. 97-110. , PID: 22507742; Walker, V.M., Davey Smith, G., Davies, N.M., Martin, R.M., Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities (2017) Int. J. Epidemiol., 46, pp. 2078-2089. , PID: 29040597; Scott, R.A., A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease (2016) Sci. Transl Med., 8, p. 341ra76. , PID: 27252175; Lehrer, S.F., Ding, W., Are genetic markers of interest for economic research? (2017) IZA J. Labor Policy, 6; Glymour, M.M., Tchetgen Tchetgen, E.J., Robins, J.M., Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions (2012) Am. J. Epidemiol., 175, pp. 332-339. , PID: 22247045; Lawlor, D.A., Tilling, K., Davey Smith, G., Triangulation in aetiological epidemiology (2016) Int. J. Epidemiol., 45, pp. 1866-1886. , PID: 28108528; Munafò, M.R., Davey Smith, G., Robust research needs many lines of evidence (2018) Nature, 553, pp. 399-401. , PID: 29368721; Fisher, R.A., Alleged dangers of cigarette-smoking (1957) BMJ, 2, pp. 297-298; Knopik, V.S., Neiderhiser, J.M., DeFries, J.C., Plomin, R., (2016) Behavioral Genetics, , Worth Publishers, New York; Okbay, A., Genome-wide association study identifies 74 loci associated with educational attainment (2016) Nature, 533, pp. 539-542. , PID: 27225129; Kendler, K.S., Baker, J.H., Genetic influences on measures of the environment: a systematic review (2007) Psychol. Med., 37, pp. 615-626. , PID: 17176502; Krapohl, E., Plomin, R., Genetic link between family socioeconomic status and children’s educational achievement estimated from genome-wide SNPs (2016) Mol. Psychiatry, 21, pp. 437-443. , PID: 25754083; Munafò, M.R., Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure (2012) J. Natl Cancer Inst., 104, pp. 740-748. , PID: 22534784; Genome-wide meta-analyses identify multiple loci associated with smoking behavior (2010) Nat. Genet., 42, pp. 441-447; Morral, A.R., McCaffrey, D.F., Paddock, S.M., Reassessing the marijuana gateway effect (2002) Addiction, 97, pp. 1493-1504. , PID: 12472629; Rutter, M., Proceeding from observed correlation to causal inference: the use of natural experiments (2007) Perspect. Psychol. Sci., 2, pp. 377-395. , PID: 26151974; Greenland, S., Quantifying biases in causal models: classical confounding versus collider-stratification bias (2003) Epidemiology, 14, pp. 300-306. , PID: 12859030; Sheehan, N.A., Didelez, V., Burton, P.R., Tobin, M.D., Mendelian randomisation and causal inference in observational epidemiology (2008) PLoS Med., 5. , PID: 18752343; Didelez, V., Sheehan, N., Mendelian randomization as an instrumental variable approach to causal inference (2007) Stat. Methods Med. Res., 16, pp. 309-330. , PID: 17715159; Burgess, S., Thompson, S.G., (2015) Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation, , CRC Press, Boca Raton; Davey Smith, G., Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology (2007) PLoS Med., 4; Pierce, B.L., Burgess, S., Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators (2013) Am. J. Epidemiol., 178, pp. 1177-1184. , PID: 23863760; Hu, J.X., Thomas, C.E., Brunak, S., Network biology concepts in complex disease comorbidities (2016) Nat. Rev. Genet., 17, pp. 615-629. , PID: 27498692; Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M., Smoller, J.W., Pleiotropy in complex traits: challenges and strategies (2013) Nat. Rev. Genet., 14, pp. 483-495. , PID: 23752797; Paaby, A.B., Rockman, M.V., The many faces of pleiotropy (2013) Trends Genet., 29, pp. 66-73. , PID: 23140989; Kong, A., The nature of nurture: effects of parental genotypes (2018) Science, 359, pp. 424-428. , PID: 29371463; Bates, T.C., The nature of nurture: using a virtual-parent design to test parenting effects on children’s educational attainment in genotyped families (2018) Twin Res. Hum. Genet., 21, pp. 73-83. , PID: 29530109; Euesden, J., Lewis, C.M., O’Reilly, P.F., PRSice: Polygenic Risk Score software (2015) Bioinformatics, 31, pp. 1466-1468. , PID: 25550326; Burgess, S., Butterworth, A., Thompson, S.G., Mendelian randomization analysis with multiple genetic variants using summarized data (2013) Genet. Epidemiol., 37, pp. 658-665. , PID: 24114802; Hartwig, F.P., Davey Smith, G., Bowden, J., Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption (2017) Int. J. Epidemiol., 46, pp. 1985-1998. , PID: 29040600; Burgess, S., Zuber, V., Gkatzionis, A., Rees, J.M.B., Foley, C., (2017) Improving on a modal-based estimation method: Model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid; Bowden, J., A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization (2017) Stat. Med., 36, pp. 1783-1802. , PID: 28114746},
correspondence_address1={Pingault, J.-B.; Department of Clinical, United Kingdom; email: j.pingault@ucl.ac.uk},
publisher={Nature Publishing Group},
issn={14710056},
coden={NRGAA},
pubmed_id={29872216},
language={English},
abbrev_source_title={Nat. Rev. Gen.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Michelson1994848,
author={Michelson, D. and Stone, L. and Galliven, E. and Magiakou, M.A. and Chrousos, G.P. and Sternberg, E.M. and Gold, P.W.},
title={Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function},
journal={Journal of Clinical Endocrinology and Metabolism},
year={1994},
volume={79},
number={3},
pages={848-853},
doi={10.1210/jcem.79.3.8077372},
note={cited By 155},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027968587&doi=10.1210%2fjcem.79.3.8077372&partnerID=40&md5=deac9fe068fedd61c42f0ad384ada42c},
affiliation={Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, 20892, United States; Neuroimmunology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, United States; TheDevelopmental Endocrinology Branch, National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD, 20892, United States},
abstract={In the LEW/N rat model, a decreased hypothalamic-pituitary-adrenal (HPA) axis response to inflammatory and immune mediators confers susceptibility to the development of a variety of inflammatory and immune diseases, including experimental allergic encephalomyelitis. In humans with optic neuritis, early intervention with steroids is associated with a decrease in the number of patients who go on to develop multiple sclerosis (MS). The current study was designed to determine whether patients with MS show evidence of a hypoactive HPA axis. Thirteen patients with MS were studied at baseline and with provocative tests of HPA axis function [ovine CRH, arginine vasopressin (AVP), and ACTH stimulation]. Compared to matched controls, patients with MS had significantly higher plasma cortisol levels at baseline. Despite this hypercortisolism and in contrast to patients with depression who had similar elevations in plasma cortisol levels, patients with MS showed normal, rather than blunted, plasma ACTH responses to ovine CRH, suggesting that the pathophysiology of hypercortisolism in MS is different from that in depression. Patients with MS also showed blunted ACTH responses to AVP stimulation and normal cortisol responses to high and low dose ACTH stimulation. Taken together, these findings are compatible with data from studies of experimental animals exposed to chronic inflammatory stress, which showed mild increased activation of the HPA axis with increased relative activity of AVP in the regulation of the pituitary-adrenal axis. These data do not support a role for hypocortisolism in MS once the disease is established. © 1994 by The Endocrine Society.},
keywords={argipressin;  corticotropin;  corticotropin releasing factor, adult;  allergic encephalomyelitis;  article;  clinical article;  controlled study;  female;  human;  hydrocortisone blood level;  hypercortisolism;  hypothalamus hypophysis adrenal system;  inflammation;  male;  multiple sclerosis;  optic nerve disease;  pathophysiology;  priority journal;  provocation test, Adrenal Glands;  Argipressin;  Corticotropin;  Corticotropin-Releasing Hormone;  Cytokines;  Female;  Human;  Hydrocortisone;  Hypothalamus;  Male;  Multiple Sclerosis;  Pituitary Gland;  Recurrence;  Remission Induction, Animalia;  Ovis},
chemicals_cas={Argipressin, 113-79-1; Corticotropin, 9002-60-2; Corticotropin-Releasing Hormone, 9015-71-8; Cytokines; Hydrocortisone, 50-23-7},
references={Sternberg, E.M., Young, W.S., Bernardini, R., Calogero, A.E., Chrousos, G.P., Wilder, R.L., A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats (1989) Proc Natl Acad Sci USA, 86, pp. 4771-4775; Sternberg, E.M., Hill, J.M., Chousos, G.P., Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats (1989) Proc Natl Acad Sci USA, 86, pp. 2374-2378; Mason, D., Macphee, I., Antoni, F., The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat (1990) Immunology, 70, pp. 1-5; Macphee, I., Antoni, F.A., Mason, D.W., Spontaneous recovery of rats from experimental allergic encephalomyelitits is dependent on regulation of the immune system by endogenous adrenal corticosteroids (1989) J Exp Med, 169, pp. 431-435; Beck, R.W., Leary, P.A., Tobe, J.D., The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis (1993) N Eng J Med, 329, pp. 1764-1769; Poser, C.M., Paty, D.W., Scheinberg, L., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols (1983) Ann Neurol, 13, pp. 227-231; Kurtzke, J.F., Rating neurological impairment in multiple sclerosis: An expanded disability status score (EDSS) (1983) Neurology, 33, pp. 1444-1452; Demitrak, M.A., Dale, J.K., Straus, S.E., Evidence for impaired activation of the hypothalamic pituitary adrenal axis in patients with chronic fatigue syndrome (1991) J Clin Endocrinol Metab, 73, pp. 1224-1234; Rittmaster, R.S., Cutler, G., Gold, P.W., The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone stimulated adrenocorticotropin and cortisol secretion in man (1987) J Clin Endocrinol Metab, 64, pp. 371-376; Klapps, P., Seyfert, S., Fischer, T., Scherbaum, W.A., Endocrine function in multiple sclerosis (1992) Acta Neurol Scand, 85, pp. 353-357; Teasdale, G.M., Smith, P.A., Wilkinson, R., Latner, A.L., Miller, H., Endocrine activity in multiple sclerosis (1967) Lancet, 1, pp. 64-68; Millac, P., Cook, D.B., Chase, K., Endocrine function in multiple sclerosis (1969) J Neurol Neurosurg Psychiatry, 32, pp. 414-418; Reder, A.T., Makowiec, R.L., Lowy, M.T., Adrenal size is increased in multiple sclerosis (1994) Arch Neurol, 51, pp. 151-154; Reder, A.T., Lowy, M.T., Meltzer, H.Y., Antel, J.P., Dexamethasone suppression test abnormalities in multiple sclerosis in relation to ACTH therapy (1987) Neurology, 37, pp. 849-853; Maimone, D., Gregory, S., Arnason, B.G., Reder, A.T., Cytokine levels in the cerebrospinal fluid of patients with multiple sclerosis (1991) J Neuroimmunol, 32, pp. 67-74; Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H., Dinarello, C.A., Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6 (1990) Neurology, 40, pp. 1735-1739; Frei, K., Leist, T.P., Meager, A., Production of B cell stimulating factor-3 and interferon gamma in the central nervous system during viral meningitis and encephalitis: Evaluation in a murine model and in patients (1988) J Exp Med, 168, pp. 449-453; Houssiau, F.A., Bukasa, K., Sindic, C., Elevated levels of the 26K human hybridoma growth factor (Interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system (1988) Clin Exp Immunol, 71, pp. 320-323; Yehuda, R., Resnick, H., Kahana, B., Giller, E.L., Long lasting hormonal alterations to extreme stress in humans: Normative or maladaptive (1993) Psychosom Med, 55, pp. 287-297; Schaeffer, M.A., Baum, A., Adrenal cortical response to stress at Three Mile Island (1984) Psychosom Med, 46, pp. 175-181; Gold, P.W., Loriaux, D.L., Roy, A., Response to corticotropiin releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications (1986) N Engl J Med, 314, pp. 1329-1335; Gold, P.W., Gwirtzman, H., Avgerinos, P.C., Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: Pathophysiologic mechanisms in undercorrected and weight corrected patients (1986) N Engl J Med, 314, pp. 1335-1342; Harbuz, M.S., Rees, R.G., Eckland, D., Jessop, D.S., Brewerton, D., Lightman, S.L., Paradoxical responses of hypothalamic corticotropin releasing factor (CRF) messenger RNA (m-RNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress (1992) Endocrinology, 130, pp. 1394-1400; Debold, C.R., Sheldon, W.R., Decherney, G.S., Arginine vasopresin potentiates adrenocorticotropin release induced by corticotropin releasing factor (1985) J Clin Invest, 75, pp. 533-538; Bilezikjian, V.M., Blount, A.L., Vale, W.W., The cellular actions of vasopressin in corticotrophs of the anterior pituitary: Resistance to glucocorticoid actions (1987) Mol Endocrinol, 1, pp. 451-458; Perraudin, V., Delarue, C., Lefebvre, H., Contesse, V., Kuhn, J.M., Vaudry, H., Vasopressin stimulates cortisol secretion from human adrenocortical tissues through activation of VI receptors (1993) J Clin Endocrinol Metab, 76, pp. 1522-1528; Altemus, M., Licinio, J., Jolkovsky, L., Gold, P.W., Stimulation of the hypothalamic-pituitary-adenal axis by bulimic behaviors (1992) 145Th Assembly of the am Psychiatric Assoc, p. 378},
correspondence_address1={Michelson, D.; Clinical Neuroendocrinology Branch, Building 10, Room 3S231, 9000 Rockville Pike, Bethesda, MD, 20892, United States},
issn={0021972X},
pubmed_id={8077372},
language={English},
abbrev_source_title={J. Clin. Endocrinol. Metab.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Fusar-Poli201895,
author={Fusar-Poli, P. and Radua, J.},
title={Ten simple rules for conducting umbrella reviews},
journal={Evidence-Based Mental Health},
year={2018},
volume={21},
number={3},
pages={95-100},
doi={10.1136/ebmental-2018-300014},
note={cited By 151},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050193490&doi=10.1136%2febmental-2018-300014&partnerID=40&md5=7bff7347fc0fe56c2f312b7cbe94cad8},
affiliation={Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Psychology and Neuroscience, London, SE58AF, United Kingdom; OASIS Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; FIDMAG Germanes Hospitalaries, CIBERSAM, Barcelona, Spain; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden},
abstract={Objective Evidence syntheses such as systematic reviews and meta-Analyses provide a rigorous and transparent knowledge base for translating clinical research into decisions, and thus they represent the basic unit of knowledge in medicine. Umbrella reviews are reviews of previously published systematic reviews or meta-Analyses. Therefore, they represent one of the highest levels of evidence synthesis currently available, and are becoming increasingly influential in biomedical literature. However, practical guidance on how to conduct umbrella reviews is relatively limited. Methods We present a critical educational review of published umbrella reviews, focusing on the essential practical steps required to produce robust umbrella reviews in the medical field. Results The current manuscript discusses 10 key points to consider for conducting robust umbrella reviews. The points are: ensure that the umbrella review is really needed, prespecify the protocol, clearly define the variables of interest, estimate a common effect size, report the heterogeneity and potential biases, perform a stratification of the evidence, conduct sensitivity analyses, report transparent results, use appropriate software and acknowledge the limitations. We illustrate these points through recent examples from umbrella reviews and suggest specific practical recommendations. Conclusions The current manuscript provides a practical guidance for conducting umbrella reviews in medical areas. Researchers, clinicians and policy makers might use the key points illustrated here to inform the planning, conduction and reporting of umbrella reviews in medicine. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.},
keywords={article;  clinical research;  effect size;  human;  knowledge base;  language;  meta analysis;  publication;  scientist;  sensitivity analysis;  software;  stratification;  synthesis;  systematic review;  meta analysis (topic);  practice guideline;  statistics, Guidelines as Topic;  Humans;  Meta-Analysis as Topic;  Statistics as Topic;  Systematic Reviews as Topic},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_PC_16048, MS14/00041},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={European Regional Development FundEuropean Regional Development Fund, FEDER},
funding_text 1={Acknowledgements This work is supported by a King’s College London Confidence in Concept award (MC_PC_16048) from the Medical Research Council (MRC) to PFP and a Miguel Servet Research Contract (MS14/00041) to JR from the Instituto de Salud Carlos III and the European Regional Development Fund (FEDER).},
references={Ioannidis, J.P., Khoury, M.J., Km, J., Improving validation practices in omics" research (2011) Science, 334, pp. 1230-1232; Szucs, D., Ioannidis, J.P., Ijp, A., Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature (2017) PLoS Biol, 15, p. e2000797; Ioannidis, J.P., Evolution and translation of research findings: From bench to where? (2006) PLoS Clin Trials, 1, p. e36; Ioannidis, J.P., Munafò, M.R., Fusar-Poli, P., Publication and other reporting biases in cognitive sciences: Detection, prevalence, and prevention (2014) Trends Cogn Sci, 18, pp. 235-241; Ioannidis, J.P., Integration of evidence from multiple meta-Analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-Analyses (2009) CMAJ, 181, pp. 488-493; Elliott, J., Kelly, S.E., Bai, Z., Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: Protocol for an umbrella review (2017) BMJ Open, 7, p. e015421; Catalá-López, F., Hutton, B., Driver, J.A., Cancer and central nervous system disorders: Protocol for an umbrella review of systematic reviews and updated metaanalyses of observational studies (2017) Syst Rev, 6, p. 69; Dinsdale, S., Azevedo, L.B., Shucksmith, J., Effectiveness of weight management, smoking cessation and alcohol reduction interventions in changing behaviors during pregnancy: An umbrella review protocol (2016) JBI Database System Rev Implement Rep, 14, pp. 29-47; Jadczak, A., Makwana, N., Luscombe-Marsh, N.D., Effectiveness of exercise interventions on physical function in community-dwelling frail older people: An umbrella review protocol (2016) JBI Database System Rev Implement Rep, 14, pp. 93-102; Chai, L.K., Burrows, T., May, C., Effectiveness of family-based weight management interventions in childhood obesity: An umbrella review protocol (2016) JBI Database System Rev Implement Rep, 14, pp. 32-39; Thomson, K., Bambra, C., McNamara, C., The effects of public health policies on population health and health inequalities in European welfare states: Protocol for an umbrella review (2016) Syst Rev, 5, p. 57; Krause, D., Roupas, P., Dietary interventions as a neuroprotective therapy for the delay of the onset of cognitive decline in older adults: An umbrella review protocol (2015) JBI Database System Rev Implement Rep, 13, pp. 74-83; Radua, J., Ramella-Cravaro, V., Jpa, I., What causes psychosis? An umbrella review of risk and protective factors (2018) World Psychiatry, 17, pp. 49-66; Schmidt, A., Cappucciati, M., Radua, J., Improving prognostic accuracy in subjects at clinical high risk for psychosis: Systematic review of predictive models and metaanalytical sequential testing simulation (2017) Schizophr Bull, 43, pp. 375-388; Fusar-Poli, P., Cappucciati, M., Bonoldi, I., Prognosis of brief psychotic episodes: A meta-Analysis (2016) JAMA Psychiatry, 73, pp. 211-220; Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-Analytical stratification (2016) JAMA Psychiatry, 73, pp. 113-120; Siontis, K.C., Hernandez-Boussard, T., Ioannidis, J.P., Overlapping meta-Analyses on the same topic: Survey of published studies (2013) BMJ, 347, p. f4501; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-Analyses (2016) Milbank Q, 94, pp. 485-514; Moher, D., Liberati, A., Tetzlaff, J., Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement (2009) J Clin Epidemiol, 62, pp. 1006-1012; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-Analysis of observational studies in epidemiology-A proposal for reporting (2000) JAMA, 283, pp. 2008-2012; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Shea, B.J., Bouter, L.M., Peterson, J., External validation of a measurement tool to assess systematic reviews (AMSTAR (2007) PLoS One, 2, p. 5; Chinn, S., A simple method for converting an odds ratio to effect size for use in metaanalysis (2000) Stat Med, 19, pp. 3127-3131; Bellou, V., Belbasis, L., Tzoulaki, I., Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-Analyses (2017) Alzheimers Dement, 13; Bellou, V., Belbasis, L., Tzoulaki, I., Environmental risk factors and Parkinson's disease: An umbrella review of meta-Analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-Analyses (2015) Lancet Neurol, 14, pp. 263-273; Schwarzer, G., Meta: An R package for meta-Analysis (2007) R News, 7, pp. 40-45; Viechtbauer, W., Conducting meta-Analyses in R with the metafor package (2010) J Stat Softw, 36, pp. 1-48; Radua, J., Schmidt, A., Borgwardt, S., Ventral striatal activation during reward processing in psychosis: A neurofunctional meta-Analysis (2015) JAMA Psychiatry, 72, pp. 1243-1251; Viechtbauer, W., Bias and efficiency of meta-Analytic variance estimators in the random-effects model (2005) Journal of Educational and Behavioral Statistics, 30, pp. 261-293; Veroniki, A.A., Jackson, D., Viechtbauer, W., Methods to estimate the betweenstudy variance and its uncertainty in meta-Analysis (2016) Res Synth Methods, 7, pp. 55-79; Petropoulou, M., Mavridis, D., A comparison of 20 heterogeneity variance estimators in statistical synthesis of results from studies: A simulation study (2017) Stat Med, 36, pp. 4266-4280},
correspondence_address1={Fusar-Poli, P.; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, United Kingdom; email: paolo.fusar-poli@kcl.ac.uk},
publisher={BMJ Publishing Group},
issn={13620347},
pubmed_id={30006442},
language={English},
abbrev_source_title={Evid. -Based Ment. Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Chrousos2009153,
author={Chrousos, G.P. and Kino, T.},
title={Glucocorticoid signaling in the cell: Expanding clinical implications to complex human behavioral and somatic disorders},
journal={Annals of the New York Academy of Sciences},
year={2009},
volume={1179},
pages={153-166},
doi={10.1111/j.1749-6632.2009.04988.x},
note={cited By 151},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449417568&doi=10.1111%2fj.1749-6632.2009.04988.x&partnerID=40&md5=4f8f2fc35064dc9e2a4bde52f0992ba4},
affiliation={First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, 115 27 Athens, Greece; Pediatric Endocrinology Section, Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States},
abstract={Glucocorticoids contribute to the maintenance of basal and stress-related homeostasis in all higher organisms, and influence a large proportion of the expressed human genome, and their effects spare almost no organs or tissues. Glucocorticoids regulate many functions of the central nervous system, such as arousal, cognition, mood, sleep, the activity and direction of intermediary metabolism, the maintenance of a proper cardiovascular tone, the activity and quality of the immune and inflammatory reaction, including the manifestations of the sickness syndrome, and growth and reproduction. The numerous actions of glucocorticoids are mediated by a set of at least 16 glucocorticoid receptor (GR) isoforms forming homo- or hetero-dimers. The GRs consist of multifunctional domain proteins operating as ligand-dependent transcription factors that interact with many other cell signaling systems, including large and small G proteins. The presence of multiple GR monomers and homo- or hetero-dimers expressed in a cell-specific fashion at different quantities with quantitatively and qualitatively different transcriptional activities suggest that the glucocorticoid signaling system is highly stochastic. Glucocorticoids are heavily involved in human pathophysiology and influence life expectancy. Common behavioral andor somatic complex disorders, such as anxiety, depression, insomnia, chronic pain and fatigue syndromes, obesity, the metabolic syndrome, essential hypertension, diabetes type 2, atherosclerosis with its cardiovascular sequelae, and osteoporosis, as well as autoimmune inflammatory and allergic disorders, all appear to have a glucocorticoid-regulated component. © 2009 New York Academy of Sciences.},
author_keywords={CDK5;  Glucocorticoid hypersensitivity;  Glucocorticoid resistance;  GR phosphorylation;  Metabolic syndrome;  Osteoporosis;  Stress system},
keywords={cyclin dependent kinase 5;  glucocorticoid;  glucocorticoid receptor;  guanine nucleotide binding protein;  interleukin 6;  mitogen activated protein kinase p38;  stress activated protein kinase, allergic disease;  atherosclerosis;  behavior;  brain;  chronic fatigue syndrome;  chronic pain;  conference paper;  Cushing syndrome;  cytokine release;  depression;  DNA polymorphism;  essential hypertension;  human;  hypothalamus hypophysis adrenal system;  insomnia;  life expectancy;  metabolic syndrome X;  non insulin dependent diabetes mellitus;  nonhuman;  obesity;  osteoporosis;  pathophysiology;  protein phosphorylation;  signal transduction;  stress, Cells;  Cyclin-Dependent Kinase 5;  Feedback, Physiological;  Gene Expression Regulation;  Glucocorticoids;  Humans;  Mental Disorders;  Metabolic Syndrome X;  Models, Biological;  Phosphorylation;  Receptors, Glucocorticoid;  Signal Transduction;  Stress, Psychological},
chemicals_cas={stress activated protein kinase, 155215-87-5},
references={Chrousos, G.P., Glucocorticoid therapy (2001) Endocrinology and Metabolism, pp. 609-632. , P. Flig & L. Frohman, Eds. McGraw-Hill. New York, NY; Franchimont, D., Glucocorticoids and inflammation revisited: The state of the art (2003) NIH Clinical Staff Conference. Neuroimmunomodulation, 10, pp. 247-260; Galon, J., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells (2002) FASEB J., 16, pp. 61-71; Chrousos, G.P., Stressors, stress, and neuroendocrine integration of the adaptive response (1998) The 1997 Hans Selye Memorial Lecture. Ann. N. Y. Acad. Sci., 851, pp. 311-335; Ẅust, S., Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress (2004) J. Clin. Endocrinol. Metab., 89, pp. 565-573; Buemann, B., Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus (1997) Obes. Res., 5, pp. 186-192; Dobson, M.G., TheN363S polymorphism of the glucocorticoid receptor: Potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus (2001) J. Clin. Endocrinol. Metab., 86, pp. 2270-2274; Huizenga, N.A., A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo (1998) J. Clin. Endocrinol. Metab., 83, pp. 144-151; Lin, R.C., Wang, W.Y., Morris, B.J., High penetrance, overweight, and glucocorticoid receptor variant: Case-control study (1999) BMJ, 319, pp. 1337-1338; Panarelli, M., Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects (1998) J. Clin. Endocrinol. Metab., 83, pp. 1846-1852; Rosmond, R., A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamicpituitary- adrenal axis (2000) Obes. Res., 8, pp. 211-218; Ukkola, O., Glucocorticoid receptor Bcl i variant is associated with an increased atherogenic profile in response to long-term overfeeding (2001) Atherosclerosis, 157, pp. 221-224; Weaver, J.U., Hitman, G.A., Kopelman, P.G., An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women (1992) J. Mol. Endocrinol., 9, pp. 295-300; Chrousos, G.P., The stress response and immune function: Clinical implications (2000) The 1999 Novera H. Spector Lecture. Ann. N. Y. Acad. Sci., 917, pp. 38-67; Chrousos, G.P., The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of themetabolic syndrome: Neuro-endocrine and target tissue-related causes (2000) Int. J. Obes. Relat. Metab. Disord., 24, pp. S50-S55; Chrousos, G.P., Detera-Wadleigh, S.D., Karl, M., Syndromes of glucocorticoid resistance (1993) Ann. Intern. Med., 119, pp. 1113-1124; Mc Ewen, B.S., Protective and damaging effects of stress mediators (1998) N. Engl. J. Med., 338, pp. 171-179; Kino, T., Tissue glucocorticoid resistance/ hypersensitivity syndromes (2003) J. Steroid Biochem. Mol. Biol., 85, pp. 457-467; Charmandari, E., Generalized glucocorticoid resistance: Clinical aspects, molecular mechanisms, and implications of a rare genetic disorder (2008) J. Clin. Endocrinol. Metab., 93, pp. 1563-1572; Charmandari, E., A novel point mutation in the DNA-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance (2008) Endocrine, 90, p. 280; Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders Overview of physical and behavioral homeostasis (1992) JAMA, 267, pp. 1244-1252; Gold, P.W., Chrousos, G.P., Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states (2002) Mol. Psychiatry, 7, pp. 254-275; Alevizaki, M., High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography (2007) Metabolism, 56, pp. 222-226; Chrousos, G.P., Kino, T., Intracellular glucocorticoid signaling: A formerly simple system turns stochastic (2005) Sci. STKE 2005, p. 48; Kino, T., Charmandari, E., Chrousos, G.P., Basic and clinical implications of glucocorticoid action-focus on development (2003) Horm. Metab. Res., 35, pp. 628-648. , National Institutes of Health, Bethesda, Maryland, USA. June 17-18, 2003 Introduction and abstracts; Kino, T., G protein â interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus (2005) J. Cell Biol., 169, pp. 885-896; Kino, T., Rho family guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system (2006) J. Biol. Chem., 281, pp. 9118-9126; Kino, T., Chrousos, G.P., Tumor necrosis factor á receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators (2003) J. Biol. Chem., 278, pp. 3023-3029; Kino, T., Protein 14-3-3ó interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway (2003) J. Biol. Chem., 278, pp. 25651-25656; Kino, T., TheHIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor (1999) J. Exp. Med., 189, pp. 51-62; Kino, T., Human immunodeficiency virus type-1 accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators (2002) J. Virol., 76, pp. 9724-9734; Ichijo, T., The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: Potential clinical implications (2005) J. Biol. Chem., 280, pp. 42067-42077; Kino, T., Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: Clinical implications for the nervous system response to glucocorticoids and stress (2007) Mol. Endocrinol., 21, pp. 1552-1568; Kino, T., Tissue glucocorticoid sensitivity: Beyond stochastic regulation on the diverse actions of glucocorticoids (2007) Horm. Metab. Res., 39, pp. 420-424; Krstic, M.D., Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor (1997) Mol. Cell Biol., 17, pp. 3947-3954; Ismaili, N., Garabedian, M.J., Modulation of glucocorticoid receptor function via phosphorylation (2004) Ann. N. Y. Acad. Sci., 1024, pp. 86-101; Wang, Z., Frederick, J., Garabedian, M.J., Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo (2002) J. Biol. Chem., 277, pp. 26573-26580; Miller, A.L., P38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and sitespecific phosphorylation of the human glucocorticoid receptor at serine 211 (2005) Mol. Endocrinol., 19, pp. 1569-1583; Itoh, M., Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinasemediated phosphorylation (2002) Mol. Endocrinol., 16, pp. 2382-2392; Ismaili, N., Blind, R., Garabedian, M.J., Stabilization of the unliganded glucocorticoid receptor by TSG101 (2005) J. Biol. Chem., 280, pp. 11120-11126; Kesavapany, S., Li, B.S., Pant, H.C., Cyclindependent kinase 5 in neurofilament function and regulation (2003) Neurosignals, 12, pp. 252-264; Ohshima, T., Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 11173-11178; Dhavan, R., Tsai, L.H., A decade of CDK5 (2001) Nat. Rev. Mol. Cell Biol., 2, pp. 749-759; Tsai, L.H., P35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 (1994) Nature, 371, pp. 419-423; Tang, D., Wang, J.H., Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators (1996) Prog. Cell Cycle Res., 2, pp. 205-216; Lau, L.F., Cdk5 as a drug target for the treatment of Alzheimer's disease (2002) J. Mol. Neurosci., 19, pp. 267-273; Lee, M.S., Neurotoxicity induces cleavage of p35 to p25 by calpain (2000) Nature, 405, pp. 360-364; Kusakawa, G., Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25 (2000) J. Biol. Chem., 275, pp. 17166-17172; Sun, Z., Tumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300 (1999) Cancer, 86, pp. 689-696; Chrousos, G.P., The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation (1995) N. Engl. J. Med., 332, pp. 1351-136251; Kino, T., Chrousos, G.P., Glucocorticoid effects on gene expression (2005) In Handbook of Stress and the Brain, pp. 295-311. , T. Steckler,N.H.Kalin & J.M.H.M.Reul, Eds. Elsevier B.V. Amsterdam, Netherlands; Holsboer, F., Barden, N., Antidepressants and hypothalamic-pituitary-adrenocortical regulation (1996) Endocr. Rev., 17, pp. 187-205; Ahlijanian, M.K., Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 2910-2915; Patrick, G.N., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration (1999) Nature, 402, pp. 615-622; Friedman, T.C., Carbohydrate and lipid metabolism in endogenous hypercortisolism: Shared features with metabolic syndrome X and NIDDM (1996) Endocr. J., 43, pp. 645-655; Miller, W.L., Chrousos, G.P., The adrenal cortex (2001) Endocrinology & Metabolism, pp. 387-524. , P. Felig & L.A. Frohman, Eds. McGraw-Hill. New York, NY; Buemann, B., The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in men (2005) Obes. Res., 13, pp. 862-867; De Rijk, R., Dec Kloet, E.R., Corticosteroid receptor genetic polymorphisms and stress responsivity (2005) Endocrine, 28, pp. 263-270; Marti, A., Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity (2006) BMC Med. Genet., 7, pp. 50-60; Stevens, A., Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype (2004) J. Clin. Endocrinol. Metab., 89, pp. 892-897; Chrousos, G.P., The glucocorticoid receptor gene, longevity, and the complex disorders ofWestern societies (2004) Am. J. Med., 117, pp. 204-207; Phillips, D.I., Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome? (1998) J. Clin. Endocrinol. Metab., 83, pp. 757-760; Manenschijn, L., Van Den Akker, E.L.T., Lamberts, S.W.J., Van Rossum, E.F.C., Clinical features associated with glucocorticoid receptor polymorphisms: An overview (2009) Ann. N. Y. Acad. Sci. Glucocorticoids and Mood. Clinical Manifestations, Risk Factors, and Molecular Mechanisms, , In Press; Spijker, A.T., Van Rossum, E.F.C., Glucocorticoid receptor polymorphisms in major depression: Focus on glucocorticoid sensitivity and neurocognitive functioning (2009) Ann. N. Y. Acad. Sci. Glucocorticoids AndMood: Clinical Manifestations, Risk Factors, and Molecular Mechanisms, , In press; Syed, A.A., Association of glucocorticoid receptor polymorphism A3669G in exon 9â with reduced central adiposity in women (2006) Obesity (Silver Spring), 14, pp. 759-764; Van Rossum, E.F., A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels (2002) Diabetes, 51, pp. 3128-3134; Van Rossum, E.F., Lamberts, S.W., Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition (2004) Recent Prog. Horm. Res., 59, pp. 333-357; Van Rossum, E.F., The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition andmuscle strength in young adults (2004) J. Clin. Endocrinol. Metab., 89, pp. 4004-4009; Papanicolaou, D.A., The pathophysiologic roles of interleukin-6 in human disease (1998) Ann. Intern. Med., 128, pp. 127-137; Chrousos, G.P., Kino, T., Glucocorticoid action networks and complex psychiatric and/or somatic disorders (2007) Stress, 10, pp. 213-219; Kino, T., Ichijo, T., Chrousos, G.P., FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors (2004) J. Steroid Biochem. Mol. Biol., 92, pp. 357-363; Lanz, R.B., A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC- 1 complex (1999) Cell, 97, pp. 17-27; Kino, T., Chrousos, G.P., Glucocorticoid and mineralocorticoid receptors and associated diseases (2004) Essays Biochem, 40, pp. 137-155; De Martino, M.U., The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: Implications for intermediary metabolism (2004) Mol. Endocrinol., 18, pp. 820-833; Charmandari, E., Kino, T., Chrousos, G.P., Glucocorticoids and their actions: An introduction (2004) Ann. N. Y. Acad. Sci., 1024, pp. 1-8; Kino, T., Vottero, A., Chrousos, G.P., Mineralocorticoid and glucocorticoid receptors (2001) Nuclear Receptor and Genetic Disease, pp. 297-307. , T.P. Burris & E.R.B. McCabe, Eds. Academic Press. London, England; Nader, N., Chrousos, G.P., Kino, T., Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: Potential physiologic implications (2009) FASEB J., 23, pp. 1572-1583},
correspondence_address1={Chrousos, G. P.; First Department of Pediatrics, , 115 27 Athens, Greece; email: chrousge@med.uoa.gr},
publisher={Blackwell Publishing Inc.},
issn={00778923},
isbn={9781573317481},
coden={ANYAA},
pubmed_id={19906238},
language={English},
abbrev_source_title={Ann. New York Acad. Sci.},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Paez-Colasante2015266,
author={Paez-Colasante, X. and Figueroa-Romero, C. and Sakowski, S.A. and Goutman, S.A. and Feldman, E.L.},
title={Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era},
journal={Nature Reviews Neurology},
year={2015},
volume={11},
number={5},
pages={266-279},
doi={10.1038/nrneurol.2015.57},
note={cited By 150},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929264163&doi=10.1038%2fnrneurol.2015.57&partnerID=40&md5=8c602051bceac7dc3a95b9fdb12ad812},
affiliation={Department of Neurology, University of Michigan, 1914 Taubman Centre SPC 5316, 1500 East Medical Centre Drive, Ann Arbor, MI  48109, United States; A. Alfred Taubman Medical Research Institute, University of Michigan, 109 Zina Pitcher Place, 5017 A. Alfred Taubman Biomedical Science Research Building, Ann Arbor, MI  48109, United States},
abstract={Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of the motor neurons, which results in weakness and atrophy of voluntary skeletal muscles. Treatments do not modify the disease trajectory effectively, and only modestly improve survival. A complex interaction between genes, environmental exposure and impaired molecular pathways contributes to pathology in patients with ALS. Epigenetic mechanisms control the hereditary and reversible regulation of gene expression without altering the basic genetic code. Aberrant epigenetic patterns - including abnormal microRNA (miRNA) biogenesis and function, DNA modifications, histone remodeling, and RNA editing - are acquired throughout life and are influenced by environmental factors. Thus, understanding the molecular processes that lead to epigenetic dysregulation in patients with ALS might facilitate the discovery of novel therapeutic targets and biomarkers that could reduce diagnostic delay. These achievements could prove crucial for successful disease modification in patients with ALS. We review the latest findings regarding the role of miRNA modifications and other epigenetic mechanisms in ALS, and discuss their potential as therapeutic targets. © 2015 Macmillan Publishers Limited. All rights reserved.},
keywords={4 phenylbutyric acid;  antisense oligonucleotide;  complementary RNA;  copper zinc superoxide dismutase;  isis 333611;  microRNA;  miravirsen;  riluzole;  RNA binding protein;  TAR DNA binding protein;  unclassified drug;  antisense oligonucleotide;  histone;  microRNA, amyotrophic lateral sclerosis;  biogenesis;  C9orf72 gene;  cytotoxicity;  delayed diagnosis;  DNA methylation;  DNA modification;  environmental exposure;  environmental factor;  epigenetics;  FUS gene;  gene;  gene expression regulation;  gene interaction;  gene mutation;  genetic code;  histone modification;  human;  inflammation;  molecular pathology;  neuromuscular synapse;  nonhuman;  phase 1 clinical trial (topic);  phase 2 clinical trial (topic);  priority journal;  protein metabolism;  protein targeting;  Review;  RNA editing;  RNA metabolism;  signal transduction;  SOD1 gene;  TARDBP gene;  amyotrophic lateral sclerosis;  antagonists and inhibitors;  chromatin assembly and disassembly;  early diagnosis;  epigenetics;  genetic epigenesis;  genetics;  genotype environment interaction;  mutation;  physiology, Amyotrophic Lateral Sclerosis;  Chromatin Assembly and Disassembly;  DNA Methylation;  Early Diagnosis;  Epigenesis, Genetic;  Epigenomics;  Gene-Environment Interaction;  Histones;  Humans;  MicroRNAs;  Mutation;  Oligonucleotides, Antisense;  RNA Editing},
chemicals_cas={copper zinc superoxide dismutase, 149394-67-2; miravirsen, 1072874-90-8; riluzole, 1744-22-5; histone, 9062-68-4; Histones; MicroRNAs; Oligonucleotides, Antisense},
tradenames={isis 333611; spc 3649},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, R01NS077982},
funding_details={Agency for Toxic Substances and Disease RegistryAgency for Toxic Substances and Disease Registry, ATSDR, 200-2013-56,856},
funding_details={A. Alfred Taubman Medical Research InstituteA. Alfred Taubman Medical Research Institute},
funding_text 1={Funding support during the preparation of this Review was provided by the Program for Neurology Research & Discovery, the A. Alfred Taubman Medical Research Institute, the Agency for Toxic Substances and Disease Registry (contract # 200-2013-56,856 to E.L.F. and S.G.), and the National Institutes of Health (R01 NS077982 to E.L.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would also like to thank Dr Dana Carter for critically reviewing the manuscript.},
references={Robberecht, W., Philips, T., The changing scene of amyotrophic lateral sclerosis (2013) Nat. Rev. Neurosci., 14, pp. 248-264; Hardiman, O., Van Den Berg, L.H., Kiernan, M.C., Clinical diagnosis and management of amyotrophic lateral sclerosis (2011) Nat. Rev. Neurol., 7, pp. 639-649; Kurian, K.M., Forbes, R.B., Colville, S., Swingler, R.J., Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register (2009) J. Neurol. Neurosurg. Psychiatry, 80, pp. 84-87; Mitchell, J.D., Borasio, G.D., Amyotrophic lateral sclerosis (2007) Lancet, 369, pp. 2031-2041; Al-Chalabi, A., Hardiman, O., The epidemiology of ALS: A conspiracy of genes, environment and time (2013) Nat. Rev. Neurol., 9, pp. 617-628; Traxinger, K., Kelly, C., Johnson, B.A., Lyles, R.H., Glass, J.D., Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011 (2013) Neurology, 3, pp. 313-320; Blackhall, L.J., Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead (2012) Muscle Nerve, 45, pp. 311-318; Chiò, A., Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 740-746; Vinsant, S., Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part I, background and methods (2013) Brain Behav., 3, pp. 335-350; Simon, N.G., Quantifying disease progression in amyotrophic lateral sclerosis (2014) Ann. Neurol., 76, pp. 643-657; Ling, S.C., Polymenidou, M., Cleveland, D.W., Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis (2013) Neuron, 79, pp. 416-438; Murphy, J.M., Continuum of frontal lobe impairment in amyotrophic lateral sclerosis (2007) Arch. Neurol., 64, pp. 530-534; Ringholz, G.M., Prevalence and patterns of cognitive impairment in sporadic ALS (2005) Neurology, 65, pp. 586-590; Dion, P.A., Daoud, H., Rouleau, G.A., Genetics of motor neuron disorders: New insights into pathogenic mechanisms (2009) Nat. Rev. Genet., 10, pp. 769-782; Diekstra, F.P., C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis (2014) Ann. Neurol., 76, pp. 120-133; Matus, S., Medinas, D.B., Hetz, C., Common ground: Stem cell approaches find shared pathways underlying ALS (2014) Cell Stem Cell, 14, pp. 697-699; Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics (2014) Nat. Neurosci., 17, pp. 17-23; Vucic, S., Rothstein, J.D., Kiernan, M.C., Advances in treating amyotrophic lateral sclerosis: Insights from pathophysiological studies (2014) Trends Neurosci.; Ahmed, A., Wicklund, M.P., Amyotrophic lateral sclerosis: What role does environment play? (2011) Neurol. Clin., 29, pp. 689-711; Al-Chalabi, A., Genetic and epigenetic studies of amyotrophic lateral sclerosis (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 14, pp. 44-52; Figueroa-Romero, C., Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis (2012) PLoS ONE, 7, p. e52672; Kanekura, K., Suzuki, H., Aiso, S., Matsuoka, M., ER stress and unfolded protein response in amyotrophic lateral sclerosis (2009) Mol. Neurobiol., 39, pp. 81-89; Moloney, E.B., De Winter, F., Verhaagen, J., ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease (2014) Front. Neurosci., 8, p. 252; Strong, M.J., TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein (2007) Mol. Cell. Neurosci., 35, pp. 320-327; He, C.Z., Hays, A.P., Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis (2004) J. Neurol. Sci., 217, pp. 47-54; Corbo, M., Hays, A.P., Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease (1992) J. Neuropathol. Exp. Neurol., 51, pp. 531-537; Ishtiaq, M., Campos-Melo, D., Volkening, K., Strong, M.J., Analysis of novel NEFL mRNA targeting microRNAs in amyotrophic lateral sclerosis (2014) PLoS ONE, 9, p. e85653; Voigt, A., TDP-43-mediated neuron loss in vivo requires RNA-binding activity (2010) PLoS ONE, 5, p. e12247; Narayanan, R.K., Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 14, pp. 252-260; Meyerowitz, J., C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress (2011) Mol. Neurodegener., 6, p. 57; Freibaum, B.D., Chitta, R.K., High, A.A., Taylor, J.P., Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery (2010) J. Proteome Res., 9, pp. 1104-1120; Neumann, M., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2006) Science, 314, pp. 130-133; Yamazaki, T., FUS-SMN protein interactions link the motor neuron diseases ALS and SMA (2012) Cell Rep., 2, pp. 799-806; Marangi, G., Traynor, B.J., Genetic causes of amyotrophic lateral sclerosis: New genetic analysis methodologies entailing new opportunities and challenges (2015) Brain Res., 1607, pp. 75-93; Boillee, S., Onset and progression in inherited ALS determined by motor neurons and microglia (2006) Science, 312, pp. 1389-1392; Niikura, T., Kita, Y., Abe, Y., SUMO3 modification accelerates the aggregation of ALS-linked SOD1 mutants (2014) PLoS ONE, 9, p. e101080; Su, X.W., Broach, J.R., Connor, J.R., Gerhard, G.S., Simmons, Z., Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research (2014) Muscle Nerve, 49, pp. 786-803; Okado-Matsumoto, A., Fridovich, I., Amyotrophic lateral sclerosis: A proposed mechanism (2002) Proc. Natl Acad. Sci. USA, 99, pp. 9010-9014; Turner, B.J., Ackerley, S., Davies, K.E., Talbot, K., Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice (2010) Hum. Mol. Genet., 19, pp. 815-824; Lobsiger, C.S., Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice (2009) Proc. Natl Acad. Sci. USA, 106, pp. 4465-4470; Liu, J., Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria (2004) Neuron, 43, pp. 5-17; Polymenidou, M., Cleveland, D.W., Prion-like spread of protein aggregates in neurodegeneration (2012) J. Exp. Med., 209, pp. 889-893; Araki, T., Misfolded SOD1 forms high-density molecular complexes with synaptic molecules in mutant SOD1-linked familial amyotrophic lateral sclerosis cases (2012) J. Neurol. Sci., 314, pp. 92-96; Toivonen, J.M., MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis (2014) PLoS ONE, 9, p. e89065; Honda, D., The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons (2013) FEBS Open Bio, 4, pp. 1-10; Buratti, E., TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing (2005) J. Biol. Chem., 280, pp. 37572-37584; Johnson, B.S., TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity (2009) J. Biol. Chem., 284, pp. 20329-20339; Kim, S.H., Shanware, N.P., Bowler, M.J., Tibbetts, R.S., Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA (2010) J. Biol. Chem., 285, pp. 34097-34105; Vance, C., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 (2009) Science, 323, pp. 1208-1211; Kwiatkowski, T.J., Jr., Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis (2009) Science, 323, pp. 1205-1208; Brown, J.A., SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: A United States clinical testing lab experience (2012) Amyotroph. Lateral Scler., 13, pp. 217-222; Lattante, S., Rouleau, G.A., Kabashi, E., TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: Summary and update (2013) Hum. Mutat., 34, pp. 812-826; Groen, E.J., ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN (2013) Hum. Mol. Genet., 22, pp. 3690-3704; Paez-Colasante, X., Improvement of neuromuscular synaptic phenotypes without enhanced survival and motor function in severe spinal muscular atrophy mice selectively rescued in motor neurons (2013) PLoS ONE, 8, p. e75866; Droppelmann, C.A., Campos-Melo, D., Ishtiaq, M., Volkening, K., Strong, M.J., RNA metabolism in ALS: When normal processes become pathological (2014) Amyotroph. Lateral Scler. Frontotemporal Degener., 15, pp. 321-336; Dewey, C.M., TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor (2011) Mol. Cell. Bio., 31, pp. 1098-1108; Liu-Yesucevitz, L., Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue (2010) PLoS ONE, 5, p. e13250; Volkening, K., Leystra-Lantz, C., Yang, W., Jaffee, H., Strong, M.J., Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) (2009) Brain Res., 1305, pp. 168-182; Renton, A.E., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2011) Neuron, 72, pp. 257-268; DeJesus-Hernandez, M., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS (2011) Neuron, 72, pp. 245-256; Wicks, P., SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis (2009) J. Neurol., 256, pp. 234-241; Borroni, B., Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease (2009) Hum. Mut., 30, pp. E974-E983; Broustal, O., FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis (2010) J. Alzheimer Dis., 22, pp. 765-769; Xi, Z., Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion (2013) Am. J. Hum. Genet., 92, pp. 981-989; Sareen, D., Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion (2013) Sci. Transl. Med., 5, p. 208ra149; Ash, P.E., Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS (2013) Neuron, 77, pp. 639-646; Zhang, Y.J., Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress (2014) Acta Neuropathol., 128, pp. 505-524; Donnelly, C.J., RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention (2013) Neuron, 80, pp. 415-428; Kwon, I., Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells (2014) Science, 345, pp. 1139-1145; Morris, H.R., Waite, A.J., Williams, N.M., Neal, J.W., Blake, D.J., Recent advances in the genetics of the ALS-FTLD complex (2012) Curr. Neurol. Neurosci. Rep., 12, pp. 243-250; Johnson, J.O., Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis (2014) Nat. Neurosci., 17, pp. 664-666; Takanashi, K., Yamaguchi, A., Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation (2014) Biochem. Biophys. Res. Commun., 452, pp. 600-607; D'Ambrogio, A., Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo (2009) Nucleic Acids Res., 37, pp. 4116-4126; Kim, H.J., Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS (2013) Nature, 495, pp. 467-473; Hirano, M., Senataxin mutations and amyotrophic lateral sclerosis (2011) Amyotroph. Lateral Scler., 12, pp. 223-227; Bannwarth, S., Reply: Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis (2014) Brain, 137, p. e312; Muller, K., Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease (2014) Brain, 137, p. e309; Baker, M., Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 (2006) Nature, 442, pp. 916-919; Gellera, C., Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis (2008) Neurogenetics, 9, pp. 33-40; Giordana, M.T., Dementia and cognitive impairment in amyotrophic lateral sclerosis: A review (2011) Neurol. Sci., 32, pp. 9-16; Wu, C.H., Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis (2012) Nature, 488, pp. 499-503; Johnson, J.O., Exome sequencing reveals VCP mutations as a cause of familial ALS (2010) Neuron, 68, pp. 857-864; Al-Chalabi, A., An estimate of amyotrophic lateral sclerosis heritability using twin data (2010) J. Neurol. Neurosurg. Psychiatry, 81, pp. 1324-1326; Al-Chalabi, A., Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study (2014) Lancet Neurol., 13, pp. 1108-1113; Conradi, S., Ronnevi, L.O., Nise, G., Vesterberg, O., Abnormal distribution of lead in amyotrophic lateral sclerosis - Reestimation of lead in the cerebrospinal fluid (1980) J. Neurol. Sci., 48, pp. 413-418; Conradi, S., Ronnevi, L.O., Vesterberg, O., Lead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects (1978) J. Neurol. Neurosurg. Psychiatry, 41, pp. 1001-1004; Conradi, S., Ronnevi, L.O., Vesterberg, O., Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry (1978) J. Neurol. Neurosurg. Psychiatry, 41, pp. 389-393; Fang, F., Association between blood lead and the risk of amyotrophic lateral sclerosis (2010) Am. J. Epidemiol., 171, pp. 1126-1133; Petkau, A., Sawatzky, A., Hillier, C.R., Hoogstraten, J., Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: Case report and other considerations (1974) Br. J. Ind. Med., 31, pp. 275-287; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis (2014) J. Occup. Environ. Med., 56, pp. 1235-1242; Callaghan, B., Feldman, D., Gruis, K., Feldman, E., The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications (2011) Neurodegener. Dis., 8, pp. 1-8; Perl, D.P., Gajdusek, D.C., Garruto, R.M., Yanagihara, R.T., Gibbs, C.J., Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam (1982) Science, 217, pp. 1053-1055; Kihira, T., Yoshida, S., Yase, Y., Ono, S., Kondo, T., Chronic low-Ca/Mg high-Al diet induces neuronal loss (2002) Neuropathology, 22, pp. 171-179; Giagheddu, M., Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy (1983) Acta Neurol. Scand., 68, pp. 394-404; Chio, A., Meineri, P., Tribolo, A., Schiffer, D., Risk factors in motor neuron disease: A case-control study (1991) Neuroepidemiology, 10, pp. 174-184; Granieri, E., Motor neuron disease in the province of Ferrara, Italy, in 1964-1982 (1988) Neurology, 38, pp. 1604-1608; Yu, Y., Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in Michigan (2014) PLoS ONE, 9, p. e101186; Desplats, P., Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's disease (2012) Mol. Neurodegener., 7, p. 49; Kong, M., 5′-Aza-dC sensitizes paraquat toxic effects on PC12 cell (2012) Neurosci. Lett., 524, pp. 35-39; Nelson, L.M., McGuire, V., Longstreth, W.T., Jr., Matkin, C., Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption (2000) Am. J. Epidemiol., 151, pp. 156-163; Wang, H., Smoking and risk of amyotrophic lateral sclerosis: A pooled analysis of 5 prospective cohorts (2011) Arch. Neurol., 68, pp. 207-213; De Jong, S.W., Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: A population-based study (2012) Am. J. Epidemiol., 176, pp. 233-239; Alonso, A., Logroscino, G., Hernan, M.A., Smoking and the risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis (2010) J. Neurol. Neurosurg. Psychiatry, 81, pp. 1249-1252; Alonso, A., Logroscino, G., Jick, S.S., Hernan, M.A., Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: A prospective study (2010) BMC Neurol., 10, p. 6; Horner, R.D., Occurrence of amyotrophic lateral sclerosis among Gulf War veterans (2003) Neurology, 61, pp. 742-749; Bird, A., Perceptions of epigenetics (2007) Nature, 447, pp. 396-398; Qureshi, I.A., Mehler, M.F., Epigenetic mechanisms governing the process of neurodegeneration (2013) Mol. Aspects Med., 34, pp. 875-882; Staszewski, O., Prinz, M., Glial epigenetics in neuroinflammation and neurodegeneration (2014) Cell Tissue Res., 356, pp. 609-616; Chestnut, B.A., Epigenetic regulation of motor neuron cell death through DNA methylation (2011) J. Neurosci., 31, pp. 16619-16636; Choy, M.K., Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated (2010) BMC Genomics, 11, p. 519; Urdinguio, R.G., Sanchez-Mut, J.V., Esteller, M., Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies (2009) Lancet Neurol., 8, pp. 1056-1072; Chen, P.Y., Feng, S., Joo, J.W., Jacobsen, S.E., Pellegrini, M., A comparative analysis of DNA methylation across human embryonic stem cell lines (2011) Genome Bio., 12, p. R62; Gavin, D.P., Chase, K.A., Sharma, R.P., Active DNA demethylation in post-mitotic neurons: A reason for optimism (2013) Neuropharmacology, 75, pp. 233-245; Laurent, L., Dynamic changes in the human methylome during differentiation (2010) Genome Res., 20, pp. 320-331; Feng, J., Fouse, S., Fan, G., Epigenetic regulation of neural gene expression and neuronal function (2007) Pediatric Res., 61, pp. 58R-63R; Tremolizzo, L., Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 15, pp. 98-105; Morahan, J.M., Yu, B., Trent, R.J., Pamphlett, R., A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis (2009) Amyotroph. Lateral Scler., 10, pp. 418-429; Tibshirani, M., Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1 (2014) Hum. Mol. Genet., 24, pp. 773-786; Xi, Z., Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients (2014) Hum. Mol. Genet., 23, pp. 5630-5637; Belzil, V.V., Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients (2014) Brain Res., 1584, pp. 15-21; Liu, E.Y., C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD (2014) Acta Neuropathol., 128, pp. 525-541; Dion, V., Lin, Y., Hubert, L., Jr., Waterland, R.A., Wilson, J.H., Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline (2008) Hum. Mol. Genet., 17, pp. 1306-1317; Jowaed, A., Schmitt, I., Kaut, O., Wullner, U., Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains (2010) J. Neurosci., 30, pp. 6355-6359; Fuso, A., Nicolia, V., Cavallaro, R.A., Scarpa, S., DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models (2011) J. Nutr. Biochem., 22, pp. 242-251; Lagali, P.S., Picketts, D.J., Matters of life and death: The role of chromatin remodeling proteins in retinal neuron survival (2011) J. Ocular Bio., 4, pp. 111-120; Lazo-Gomez, R., Ramirez-Jarquin, U.N., Tovar, Y.R., Tapia, R., Histone deacetylases and their role in motor neuron degeneration (2013) Front. Cell. Neurosci., 7, p. 243; Martin, C., Zhang, Y., The diverse functions of histone lysine methylation (2005) Nat. Rev. Mol. Cell Bio., 6, pp. 838-849; Bardai, F.H., D'Mello, S.R., Selective toxicity by HDAC3 in neurons: Regulation by Akt and GSK3beta (2011) J. Neurosci., 31, pp. 1746-1751; Janssen, C., Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis (2010) J. Neuropathol. Exp. Neurol., 69, pp. 573-581; Valle, C., Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: Pharmacological characterization of SIRT1 and SIRT2 pathways (2014) Cell Death Dis., 5, p. e1296; Teyssou, E., Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis (2014) Neurobiol. Aging, 35, pp. 1213.e19-1213.e12; Simpson, C.L., Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration (2009) Hum. Mol. Genet., 18, pp. 472-481; Kwak, S., Hideyama, T., Yamashita, T., Aizawa, H., AMPA receptor-mediated neuronal death in sporadic ALS (2010) Neuropathology, 30, pp. 182-188; Hideyama, T., Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons (2012) Neurobiol. Dis., 45, pp. 1121-1128; Kawahara, Y., Glutamate receptors: RNA editing and death of motor neurons (2004) Nature, 427, p. 801; Yamashita, T., Kwak, S., The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients (2014) Brain Res., 1584, pp. 28-38; Yamashita, T., Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons (2013) EMBO Mol. Med., 5, pp. 1710-1719; Lagos-Quintana, M., Rauhut, R., Lendeckel, W., Tuschl, T., Identification of novel genes coding for small expressed RNAs (2001) Science, 294, pp. 853-858; Bartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function (2004) Cell, 116, pp. 281-297; Lee, R.C., Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans (2001) Science, 294, pp. 862-864; Selbach, M., Widespread changes in protein synthesis induced by microRNAs (2008) Nature, 455, pp. 58-63; Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets (2005) Cell, 120, pp. 15-20; Lau, N.C., Lim, L.P., Weinstein, E.G., Bartel, D.P., An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans (2001) Science, 294, pp. 858-862; University of Manchester, (2014), http://www.mirbase.org/, online; Ponomarev, E.D., Veremeyko, T., Barteneva, N., Krichevsky, A.M., Weiner, H.L., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway (2011) Nat. Med., 17, pp. 64-70; Engels, B.M., Hutvagner, G., Principles and effects of microRNA-mediated posttranscriptional gene regulation (2006) Oncogene, 25, pp. 6163-6169; Lau, P., De Strooper, B., Dysregulated microRNAs in neurodegenerative disorders (2010) Semin. Cell Dev. Bio., 21, pp. 768-773; Mondanizadeh, M., MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by targeting Sp1 mRNA (2015) J. Cell. Biochem.; Lagos-Quintana, M., Identification of tissue-specific microRNAs from mouse (2002) Curr. Bio., 12, pp. 735-739; Coolen, M., Katz, S., Bally-Cuif, L., miR-9: A versatile regulator of neurogenesis (2013) Front. Cell. Neurosci., 7, p. 220; Lee, Y., MicroRNA genes are transcribed by RNA polymerase II (2004) EMBO J., 23, pp. 4051-4060; Winter, J., Jung, S., Keller, S., Gregory, R.I., Diederichs, S., Many roads to maturity: MicroRNA biogenesis pathways and their regulation (2009) Nat. Cell Bio., 11, pp. 228-234; Lee, Y., Jeon, K., Lee, J.T., Kim, S., Kim, V.N., MicroRNA maturation: Stepwise processing and subcellular localization (2002) EMBO J., 21, pp. 4663-4670; Lee, Y., The nuclear RNase III Drosha initiates microRNA processing (2003) Nature, 425, pp. 415-419; Yi, R., Qin, Y., Macara, I.G., Cullen, B.R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs (2003) Genes Devel., 17, pp. 3011-3016; Hutvagner, G., A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA (2001) Science, 293, pp. 834-838; Pillai, R.S., Artus, C.G., Filipowicz, W., Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis (2004) RNA, 10, pp. 1518-1525; Zhang, R., Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) (2005) J. Neuroimmunol., 159, pp. 215-224; Koval, E.D., Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice (2013) Hum. Mol. Genet., 22, pp. 4127-4135; Miyoshi, K., Miyoshi, T., Siomi, H., Many ways to generate microRNA-like small RNAs: Non-canonical pathways for microRNA production (2010) Mol. Genet. Genomics, 284, pp. 95-103; Okamura, K., Hagen, J.W., Duan, H., Tyler, D.M., Lai, E.C., The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila (2007) Cell, 130, pp. 89-100; Ruby, J.G., Jan, C.H., Bartel, D.P., Intronic microRNA precursors that bypass Drosha processing (2007) Nature, 448, pp. 83-86; Diederichs, S., Haber, D.A., Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression (2007) Cell, 131, pp. 1097-1108; Hansen, T.B., miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA (2011) EMBO J., 30, pp. 4414-4422; Haramati, S., miRNA malfunction causes spinal motor neuron disease (2010) Proc. Natl Acad. Sci. USA, 107, pp. 13111-13116; Tan, L., Yu, J.T., Causes and consequences of microRNA dysregulation in neurodegenerative diseases Mol. Neurobio., , http://dx.doi.org/10.1007/s12035-014-8803-9; Kawahara, Y., Mieda-Sato, A., TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes (2012) Proc. Natl Acad. Sci. USA, 109, pp. 3347-3352; Ruegger, S., Grosshans, H., MicroRNA turnover: When, how, and why (2012) Trends Biochem. Sci., 37, pp. 436-446; Freischmidt, A., Muller, K., Ludolph, A.C., Weishaupt, J.H., Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis (2013) Acta Neuropathol. Commun., 1, p. 42; De Felice, B., miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients (2014) Neurogenetics, 15, pp. 243-253; Morel, L., Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1 (2013) J. Biol. Chem., 288, pp. 7105-7116; Russell, A.P., Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis (2013) Neurobiol. Dis., 49, pp. 107-117; Williams, A.H., MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice (2009) Science, 326, pp. 1549-1554; Campos-Melo, D., Droppelmann, C.A., He, Z., Volkening, K., Strong, M.J., Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels (2013) Mol. Brain, 6, p. 26; Butovsky, O., Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS (2012) J. Clin. Invest., 122, pp. 3063-3087; Parisi, C., Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation (2013) Cell Death Dis., 4, p. e959; Jobe, E.M., McQuate, A.L., Zhao, X., Crosstalk among epigenetic pathways regulates neurogenesis (2012) Front. Neurosci., 6, p. 59; Goodall, E.F., Heath, P.R., Bandmann, O., Kirby, J., Shaw, P.J., Neuronal dark matter: The emerging role of microRNAs in neurodegeneration (2013) Front. Cell. Neurosci., 7, p. 178; Rossi, J.J., A novel nuclear miRNA mediated modulation of a non-coding antisense RNA and its cognate sense coding mRNA (2011) EMBO J., 30, pp. 4340-4341; Bruneteau, G., Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression (2013) Brain, 136, pp. 2359-2368; Dini Modigliani, S., Morlando, M., Errichelli, L., Sabatelli, M., Bozzoni, I., An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA-FUS regulatory circuitry (2014) Nat. Commun., 5, p. 4335; Kabashi, E., FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis (2011) PLoS Genet., 7, p. e1002214; Gascon, E., Gao, F.B., The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders (2014) J. Neurogenet., 28, pp. 30-40; Jiao, J., Herl, L.D., Farese, R.V., Gao, F.B., MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia (2010) PLoS ONE, 5, p. e10551; Buratti, E., Nuclear factor TDP-43 can affect selected microRNA levels (2010) FEBS J., 277, pp. 2268-2281; King, I.N., The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex (2014) J. Biol. Chem., 289, pp. 14263-14271; Bensimon, G., Lacomblez, L., Meininger, V., A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group (1994) N. Engl. J. Med., 330, pp. 585-591; Miller, T.M., An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study (2013) Lancet Neurol., 12, pp. 435-442; Lagier-Tourenne, C., Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration (2013) Proc. Natl Acad. Sci. USA, 110, pp. E4530-E4539; Bader, A.G., Brown, D., Winkler, M., The promise of microRNA replacement therapy (2010) Cancer Res., 70, pp. 7027-7030; Lanford, R.E., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection (2010) Science, 327, pp. 198-201; Corbett, G.T., Roy, A., Pahan, K., Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): Implications for Alzheimer disease therapy (2013) J. Biol. Chem., 288, pp. 8299-8312; Del Signore, S.J., Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice (2009) Amyotroph. Lateral Scler., 10, pp. 85-94; Cudkowicz, M.E., Phase 2 study of sodium phenylbutyrate in ALS (2009) Amyotroph. Lateral Scler., 10, pp. 99-106; Ho, A.S., Turcan, S., Chan, T.A., Epigenetic therapy: Use of agents targeting deacetylation and methylation in cancer management (2013) Onco Targets Ther., 6, pp. 223-232; Veerappan, C.S., Sleiman, S., Coppola, G., Epigenetics of Alzheimer's disease and frontotemporal dementia (2013) Neurotherapeutics, 10, pp. 709-721; Zhang, Z., Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations (2013) PloS ONE, 8, p. e76055; Kye, M.J., Goncalves Ido, C., The role of miRNA in motor neuron disease (2014) Front. Cell. Neurosci., 8, p. 15; Waddington, C.H., Preliminary notes on the development of the wings in normal and mutant strains of Drosophila (1939) Proc. Natl Acad. Sci. USA, 25, pp. 299-307; Riggs, A.D., Martienssen, R.A., Russo, V.E., (1996) Epigenetic Mechanisms of Gene Regulation, pp. 1-4. , (Eds Russo, V. E.et al.) Cold Spring Harbor Laboratory Press; Berger, S.L., Kouzarides, T., Shiekhattar, R., Shilatifard, A., An operational definition of epigenetics (2009) Genes Dev., 23, pp. 781-783; Wong, A.H., Gottesman, I.I., Petronis, A., Phenotypic differences in genetically identical organisms: The epigenetic perspective (2005) Hum. Mol. Genet., 14, pp. R11-R18},
correspondence_address1={Feldman, E.L.; Department of Neurology, 1500 East Medical Centre Drive, United States},
publisher={Nature Publishing Group},
issn={17594758},
pubmed_id={25896087},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Killinger2018,
author={Killinger, B.A. and Madaj, Z. and Sikora, J.W. and Rey, N. and Haas, A.J. and Vepa, Y. and Lindqvist, D. and Chen, H. and Thomas, P.M. and Brundin, P. and Brundin, L. and Labrie, V.},
title={The vermiform appendix impacts the risk of developing Parkinson’s disease},
journal={Science Translational Medicine},
year={2018},
volume={10},
number={465},
doi={10.1126/scitranslmed.aar5280},
art_number={aar5280},
note={cited By 148},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055838515&doi=10.1126%2fscitranslmed.aar5280&partnerID=40&md5=3b29c16c318b273c8ab5628c798eae0a},
affiliation={Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, United States; Proteomics Center of Excellence, Northwestern University, Evanston, IL, United States; Paris-Saclay Institute of Neuroscience, Centre National de la Recherche Scientifique, Gif-sur-Yvette, 91190, France; Department of Clinical Sciences, Psychiatry, Faculty of Medicine, Lund University, Lund, Sweden; Psychiatric Clinic, Lund, Division of Psychiatry, Lund, Sweden; Department of Epidemiology and Biostatis-tics, College of Human Medicine, Michigan State University, East Lansing, MI, United States; Centre for Addiction and Mental Health, Toronto, ON, Canada},
abstract={The pathogenesis of Parkinson’s disease (PD) involves the accumulation of aggregated -synuclein, which has been suggested to begin in the gastrointestinal tract. Here, we determined the capacity of the appendix to modify PD risk and influence pathogenesis. In two independent epidemiological datasets, involving more than 1.6 million individuals and over 91 million person-years, we observed that removal of the appendix decades before PD onset was associated with a lower risk for PD, particularly for individuals living in rural areas, and delayed the age of PD onset. We also found that the healthy human appendix contained intraneuronal -synuclein aggregates and an abundance of PD pathology–associated -synuclein truncation products that are known to accumulate in Lewy bodies, the pathological hallmark of PD. Lysates of human appendix tissue induced the rapid cleavage and oligo-merization of full-length recombinant -synuclein. Together, we propose that the normal human appendix contains pathogenic forms of -synuclein that affect the risk of developing PD. Copyright © 2018 The Authors, some rights reserved.},
keywords={alpha synuclein;  alpha synuclein;  mutant protein;  protein aggregate, adult;  age distribution;  aged;  appendectomy;  appendix;  Article;  controlled study;  demography;  disease course;  disease registry;  epidemiological data;  female;  genetic analysis;  human;  human tissue;  Lewy body;  major clinical study;  male;  myenteric plexus;  oligomerization;  onset age;  Parkinson disease;  pathogenesis;  priority journal;  protein aggregation;  risk factor;  rural area;  Sweden;  very elderly;  appendix;  chemistry;  disease exacerbation;  metabolism;  middle aged;  Parkinson disease;  pathology;  risk factor;  surgery, Age of Onset;  Aged;  alpha-Synuclein;  Appendectomy;  Appendix;  Disease Progression;  Humans;  Middle Aged;  Mutant Proteins;  Parkinson Disease;  Protein Aggregates;  Risk Factors;  Sweden},
chemicals_cas={alpha synuclein, 154040-18-3; alpha-Synuclein; Mutant Proteins; Protein Aggregates},
funding_details={National Institute on Deafness and Other Communication DisordersNational Institute on Deafness and Other Communication Disorders, NIDCD, R01DC016519},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, P41GM108569},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, R21NS093993},
references={Postuma, R.B., Berg, D., Stern, M., Poewe, W., Olanow, C.W., Oertel, W., Obeso, J., Deuschl, G., MDS clinical diagnostic criteria for Parkinson’s disease (2015) Mov. Disord., 30, pp. 1591-1601; Fearnley, J.M., Lees, A.J., Ageing and Parkinson’s disease: Substantia nigra regional selectivity (1991) Brain, 114, pp. 2283-2301; Chen, H., Zhao, E.J., Zhang, W., Lu, Y., Liu, R., Huang, X., Ciesielski-Jones, A.J., Peddada, S., Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis (2015) Transl. Neurodegener., 4, p. 1; Savica, R., Carlin, J.M., Grossardt, B.R., Bower, J.H., Ahlskog, J.E., Maraganore, D.M., Bharucha, A.E., Rocca, W.A., Medical records documentation of constipation preceding Parkinson disease: A case-control study (2009) Neurology, 73, pp. 1752-1758; Stokholm, M.G., Danielsen, E.H., Hamilton-Dutoit, S.J., Borghammer, P., Pathological -synuclein in gastrointestinal tissues from prodromal Parkinson disease patients (2016) Ann. Neurol., 79, pp. 940-949; Barrenschee, M., Zorenkov, D., Böttner, M., Lange, C., Cossais, F., Scharf, A.B., Deuschl, G., Wedel, T., Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson’s disease (2017) Acta Neuropathol. Commun., 5, p. 1; Beach, T.G., Corbille, A.G., Letournel, F., Kordower, J.H., Kremer, T., Munoz, D.G., Intorcia, A., Derkinderen, P., Multicenter assessment of immunohistochemical methods for pathological alpha-synuclein in sigmoid colon of autopsied Parkinson’s disease and control subjects (2016) J. Parkinsons Dis., 6, pp. 761-770; Corbillé, A.-G., Letournel, F., Kordower, J.H., Lee, J., Shanes, E., Neunlist, M., Munoz, D.G., Beach, T.G., Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies (2016) Acta Neuropathol. Commun., 4, p. 35; Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Carroll, C., Accumulation of -synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease (2014) Acta Neuropathol, 127, pp. 235-241; Hawkes, C.H., Del Tredici, K., Braak, H., Parkinson’s disease: A dual-hit hypothesis (2007) Neuropathol. Appl. Neurobiol., 33, pp. 599-614; Volpicelli-Daley, L.A., Luk, K.C., Patel, T.P., Tanik, S.A., Riddle, D.M., Stieber, A., Meaney, D.F., Lee, V.M.-Y., Exogenous -synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death (2011) Neuron, 72, pp. 57-71; Mao, X., Ou, M.T., Karuppagounder, S.S., Kam, T.-I., Yin, X., Xiong, Y., Ge, P., Dawson, T.M., Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3 (2016) Science, 353, p. aah3374; Liu, B., Fang, F., Pedersen, N.L., Tillander, A., Ludvigsson, J.F., Ekbom, A., Svenningsson, P., Wirdefeldt, K., Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study (2017) Neurology, 88, pp. 1996-2002; Svensson, E., Horvath-Puho, E., Thomsen, R.W., Djurhuus, J.C., Pedersen, L., Borghammer, P., Sorensen, H.T., Vagotomy and subsequent risk of Parkinson’s disease (2015) Ann. Neurol., 78, pp. 522-529; Tysnes, O.-B., Kenborg, L., Herlofson, K., Steding-Jessen, M., Horn, A., Olsen, J.H., Reichmann, H., Does vagotomy reduce the risk of Parkinson’s disease? (2015) Ann. Neurol., 78, pp. 1011-1012; Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Li, J.-Y., Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats (2014) Acta Neuropathol, 128, pp. 805-820; Ulusoy, A., Rusconi, R., Pérez-Revuelta, B.I., Musgrove, R.E., Helwig, M., Winzen-Reichert, B., Di Monte, D.A., Caudo-rostral brain spreading of -synuclein through vagal connections (2013) EMBO Mol. Med., 5, pp. 1119-1127; Visanji, N.P., Brooks, P.L., Hazrati, L.-N., Lang, A.E., The prion hypothesis in Parkinson’s disease: Braak to the future (2013) Acta Neuropathol. Commun., 1, p. 2; Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Mazmanian, S.K., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease (2016) Cell, 167, pp. 1469-1480; Knudsen, K., Fedorova, T.D., Hansen, A.K., Sommerauer, M., Otto, M., Svendsen, K.B., Nahimi, A., Borghammer, P., In-vivo staging of pathology in REM sleep behaviour disorder: A multimodality imaging case-control study (2018) Lancet Neurol, 17, pp. 618-628; Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O’Sullivan, G.A., Pal, A., Said, J., Reichmann, H., Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice (2012) Sci. Rep., 2, p. 898; Keshavarzian, A., Green, S.J., Engen, P.A., Voigt, R.M., Naqib, A., Forsyth, C.B., Mutlu, E., Shannon, K.M., Colonic bacterial composition in Parkinson’s disease (2015) Mov. Disord., 30, pp. 1351-1360; Stolzenberg, E., Berry, D., Yang, D., Lee, E.Y., Kroemer, A., Kaufman, S., Wong, G.C.L., Zasloff, M.A., A role for neuronal alpha-synuclein in gastrointestinal immunity (2017) J. Innate Immun., 9, pp. 456-463; Gray, M.T., Munoz, D.G., Gray, D.A., Schlossmacher, M.G., Woulfe, J.M., Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects (2014) Mov. Disord., 29, pp. 991-998; Zahid, A., The vermiform appendix: Not a useless organ (2004) J. Coll. Physicians Surg. Pak., 14, pp. 256-258; Masahata, K., Umemoto, E., Kayama, H., Kotani, M., Nakamura, S., Kurakawa, T., Kikuta, J., Takeda, K., Generation of colonic IgA-secreting cells in the caecal patch (2014) Nat. Commun., 5, p. 3704; Luk, K.C., Song, C., O’Brien, P., Stieber, A., Branch, J.R., Brunden, K.R., Trojanowski, J.Q., Lee, V.M.-Y., Exogenous -synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 20051-20056; Giasson, B.I., Murray, I.V., Trojanowski, J.Q., Lee, V.M.-Y., A hydrophobic stretch of 12 amino acid residues in the middle of -synuclein is essential for filament assembly (2001) J. Biol. Chem., 276, pp. 2380-2386; Crowther, R.A., Jakes, R., Spillantini, M.G., Goedert, M., Synthetic filaments assembled from C-terminally truncated -synuclein (1998) FEBS Lett, 436, pp. 309-312; Murray, I.V.Y., Giasson, B.I., Quinn, S.M., Koppaka, V., Axelsen, P.H., Ischiropoulos, H., Trojanowski, J.Q., Lee, V.M.-Y., Role of -synuclein carboxy-terminus on fibril formation in vitro (2003) Biochemistry, 42, pp. 8530-8540; Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V.M., Trojanowski, J.Q., Iwatsubo, T., Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies (1998) Am. J. Pathol., 152, pp. 879-884; Li, W., West, N., Colla, E., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, T.M., Lee, M.K., Aggregation promoting C-terminal truncation of -synuclein is a normal cellular process and is enhanced by the familial Parkinson’s disease-linked mutations (2005) Proc. Natl. Acad. Sci. U.S.A., 102, pp. 2162-2167; Choi, D.-H., Kim, Y.-J., Kim, Y.-G., Joh, T.H., Beal, M.F., Kim, Y.-S., Role of matrix metalloproteinase 3-mediated -synuclein cleavage in dopaminergic cell death (2011) J. Biol. Chem., 286, pp. 14168-14177; Wang, W., Nguyen, L.T.T., Burlak, C., Chegini, F., Guo, F., Chataway, T., Ju, S., Hoang, Q.Q., Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein -synuclein (2016) Proc. Natl. Acad. Sci. U.S.A., 113, pp. 9587-9592; Zhang, Z., Kang, S.S., Liu, X., Ahn, E.H., Zhang, Z., He, L., Iuvone, P.M., Ye, K., Asparagine endopeptidase cleaves -synuclein and mediates pathologic activities in Parkinson’s disease (2017) Nat. Struct. Mol. Biol., 24, pp. 632-642; Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Richardson, R.J., The risk of Parkinson’s disease with exposure to pesticides, farming, well water, and rural living (1998) Neurology, 50, pp. 1346-1350; Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson’s disease (2000) Nat. Neurosci., 3, pp. 1301-1306; Savica, R., Rocca, W.A., Ahlskog, J.E., When does Parkinson disease start? (2010) Arch. Neurol., 67, pp. 798-801; Neumann, M., Müller, V., Kretzschmar, H.A., Haass, C., Kahle, P.J., Regional distribution of proteinase K-resistant -synuclein correlates with Lewy body disease stage (2004) J. Neuropathol. Exp. Neurol., 63, pp. 1225-1235; Lee, H.-J., Lee, S.-J., Characterization of cytoplasmic -synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells (2002) J. Biol. Chem., 277, pp. 48976-48983; Tsigelny, I.F., Crews, L., Desplats, P., Shaked, G.M., Sharikov, Y., Mizuno, H., Spencer, B., Masliah, E., Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases (2008) PLOS ONE, 3, p. e3135; Zhou, J., Broe, M., Huang, Y., Anderson, J.P., Gai, W.-P., Milward, E.A., Porritt, M., Halliday, G.M., Changes in the solubility and phosphorylation of -synuclein over the course of Parkinson’s disease (2011) Acta Neuropathol, 121, pp. 695-704; Mendes, A., Gonçalves, A., Vila-Chã, N., Moreira, I., Fernandes, J., Dámasio, J., Teixeira-Pinto, A., Cavaco, S., Appendectomy may delay Parkinson’s disease onset (2015) Mov. Disord., 30, pp. 1404-1407; Marras, C., Lang, A.E., Austin, P.C., Lau, C., Urbach, D.R., Appendectomy in mid and later life and risk of Parkinson’s disease: A population-based study (2016) Mov. Disord., 31, pp. 1243-1247; Yilmaz, R., Bayram, E., Ulukan, C., Altinok, M.K., Akbostanci, M.C., Appendectomy history is not related to Parkinson’s disease (2017) J. Parkinsons Dis., 7, pp. 347-352; Svensson, E., Horváth-Puhó, E., Stokholm, M.G., Sørensen, H.T., Henderson, V.W., Borghammer, P., Appendectomy and risk of Parkinson’s disease: A nationwide cohort study with more than 10 years of follow-up (2016) Mov. Disord., 31, pp. 1918-1922; Barbeau, A., Roy, M., Bernier, G., Campanella, G., Paris, S., Ecogenetics of Parkinson’s disease: Prevalence and environmental aspects in rural areas (1987) Can. J. Neurol. Sci., 14, pp. 36-41; Angot, E., Steiner, J.A., Hansen, C., Li, J.Y., Brundin, P., Are synucleinopathies prion-like disorders? (2010) Lancet Neurol, 9, pp. 1128-1138; Braak, H., Braak, E., Pathoanatomy of Parkinson’s disease (2000) J. Neurol., 247, pp. II3-II10; Beach, T.G., Adler, C.H., Sue, L.I., Vedders, L., Lue, L., White, C.L., III, Akiyama, H., Walker, D.G., Multi-organ distribution of phosphorylated -synuclein histopathology in subjects with Lewy body disorders (2010) Acta Neuropathol, 119, pp. 689-702; Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Neunlist, M., Pathological lesions in colonic biopsies during Parkinson’s disease (2008) Gut, 57, pp. 1741-1743; Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., Ikuta, F., Parkinson’s disease: The presence of Lewy bodies in Auerbach’s and Meissner’s plexuses (1988) Acta Neuropathol, 76, pp. 217-221; Games, D., Valera, E., Spencer, B., Rockenstein, E., Mante, M., Adame, A., Patrick, C., Masliah, E., Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson’s disease-like models (2014) J. Neurosci., 34, pp. 9441-9454; Kellie, J.F., Higgs, R.E., Ryder, J.W., Major, A., Beach, T.G., Adler, C.H., Merchant, K., Knierman, M.D., Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson’s disease brain tissue by intact protein mass spectrometry (2014) Sci. Rep., 4, p. 5797; Grassi, D., Howard, S., Zhou, M., Diaz-Perez, N., Urban, N.T., Guerrero-Given, D., Kamasawa, N., Lasmézas, C.I., Identification of a highly neurotoxic -synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease (2018) Proc. Natl. Acad. Sci. U.S.A., 115, pp. E2634-E2643; Ulusoy, A., Febbraro, F., Jensen, P.H., Kirik, D., Romero-Ramos, M., Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology (2010) Eur. J. Neurosci., 32, pp. 409-422; Bartels, T., Ahlstrom, L.S., Leftin, A., Kamp, F., Haass, C., Brown, M.F., Beyer, K., The N-terminus of the intrinsically disordered protein -synuclein triggers membrane binding and helix folding (2010) Biophys. J., 99, pp. 2116-2124; Terada, M., Suzuki, G., Nonaka, T., Kametani, F., Tamaoka, A., Hasegawa, M., The effect of truncation on prion-like properties of -synuclein (2018) J. Biol. Chem., 293, pp. 13910-13920; Dufty, B.M., Warner, L.R., Hou, S.T., Jiang, S.X., Gomez-Isla, T., Leenhouts, K.M., Oxford, J.T., Rohn, T.T., Calpain-cleavage of -synuclein: Connecting proteolytic processing to disease-linked aggregation (2007) Am. J. Pathol., 170, pp. 1725-1738; Peelaerts, W., Bousset, L., Van Der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van Den Haute, C., Baekelandt, V., Synuclein strains cause distinct synucleinopathies after local and systemic administration (2015) Nature, 522, pp. 340-344; Borghammer, P., How does Parkinson’s disease begin? Perspectives on neuroanatomical pathways, prions, and histology (2018) Mov. Disord., 33, pp. 48-57; Feldman, A.L., Johansson, A.L.V., Gatz, M., Flensburg, M., Petzinger, G.M., Widner, H., Lew, M.F., Wirdefeldt, K., Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers (2012) Neuroepidemiology, 38, pp. 186-193; Parkinson progression marker: The Parkinson progression marker initiative (PPMI) (2011) Prog. Neurobiol., 95, pp. 629-635. , Initiative; Short, M.E., Goetzel, R.Z., Pei, X., Tabrizi, M.J., Ozminkowski, R.J., Gibson, T.B., Dejoy, D.M., Wilson, M.G., How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data (2009) J. Occup. Environ. Med., 51, pp. 786-796; Richards, W., Watson, D., Lynch, G., Reed, G.W., Olsen, D., Spaw, A., Holcomb, W., Sharp, K., A review of the results of laparoscopic versus open appendectomy (1993) Surg. Gynecol. Obstet., 177, pp. 473-480; Ferris, M., Quan, S., Kaplan, B.S., Molodecky, N., Ball, C.G., Chernoff, G.W., Bhala, N., Kaplan, G.G., The global incidence of appendicitis: A systematic review of population-based studies (2017) Ann. Surg., 266, pp. 237-241; Hardin, D.M., Jr., Acute appendicitis: Review and update (1999) Am. Fam. Physician, 60, pp. 2027-2034; Stewart, B., Khanduri, P., McCord, C., Ohene-Yeboah, M., Uranues, S., Vega Rivera, F., Mock, C., Global disease burden of conditions requiring emergency surgery (2014) Br. J. Surg., 101, pp. e9-e22; Khan, M.N., Fayyad, T., Cecil, T.D., Moran, B.J., Laparoscopic versus open appendectomy: The risk of postoperative infectious complications (2007) JSLS, 11, pp. 363-367; Guller, U., Hervey, S., Purves, H., Muhlbaier, L.H., Peterson, E.D., Eubanks, S., Pietrobon, R., Laparoscopic versus open appendectomy: Outcomes comparison based on a large administrative database (2004) Ann. Surg., 239, pp. 43-52; Mentes, O., Eryilmaz, M., Harlak, A., Ozer, T., Balkan, M., Kozak, O., Tufan, T., Can d-dimer become a new diagnostic parameter for acute appendicitis? (2009) Am. J. Emerg. Med., 27, pp. 765-769; Lionnet, A., Leclair-Visonneau, L., Neunlist, M., Murayama, S., Takao, M., Adler, C.H., Derkinderen, P., Beach, T.G., Does Parkinson’s disease start in the gut? (2018) Acta Neuropathol, 135, pp. 1-12; Hui, K.Y., Fernandez-Hernandez, H., Hu, J., Schaffner, A., Pankratz, N., Hsu, N.-Y., Chuang, L.-S., Peter, I., Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease (2018) Sci. Transl. Med., 10, p. eaai7795; Peter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., Wang, A., Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease (2018) JAMA Neurol, 75, pp. 939-946; Andersson, R.E., Olaison, G., Tysk, C., Ekbom, A., Appendectomy and protection against ulcerative colitis (2001) N. Engl. J. Med., 344, pp. 808-814; Brundin, P., Dave, K.D., Kordower, J.H., Therapeutic approaches to target alpha-synuclein pathology (2017) Exp. Neurol., 298, pp. 225-235; El-Agnaf, O.M., Paleologou, K.E., Greer, B., Abogrein, A.M., King, J.E., Salem, S.A., Fullwood, N.J., Allsop, D., A strategy for designing inhibitors of -synuclein aggregation and toxicity as a novel treatment for Parkinson’s disease and related disorders (2004) FASEBJ, 18, pp. 1315-1317; Zucker, S., Cao, J., Chen, W.-T., Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment (2000) Oncogene, 19, pp. 6642-6650; Beatman, E.L., Massey, A., Shives, K.D., Burrack, K.S., Chamanian, M., Morrison, T.E., Beckham, J.D., Alpha-synuclein expression restricts RNA viral infections in the brain (2015) J. Virol., 90, pp. 2767-2782; Chen, S.G., Stribinskis, V., Rane, M.J., Demuth, D.R., Gozal, E., Roberts, A.M., Jagadapillai, R., Friedland, R.P., Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans (2016) Sci. Rep., 6, p. 34477; Scheperjans, F., Aho, V., Pereira, P.A.B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Auvinen, P., Gut microbiota are related to Parkinson’s disease and clinical phenotype (2015) Mov. Disord., 30, pp. 350-358; Rey, N.L., Steiner, J.A., Maroof, N., Luk, K.C., Madaj, Z., Trojanowski, J.Q., Lee, V.M.-Y., Brundin, P., Widespread transneuronal propagation of -synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease (2016) J. Exp. Med., 213, pp. 1759-1778; Beach, T.G., Adler, C.H., Lue, L., Sue, L.I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Walker, D.G., Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009) Acta Neuropathol, 117, pp. 613-634; (2017) The National Patient Register, , www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish; Ludvigsson, J.F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., Olausson, P.O., External review and validation of the Swedish national inpatient register (2011) BMC Public Health, 11, p. 450; Ho, D., Imai, K., King, G., Stuart, E.A., Matchit: Nonparametric preprocessing for parametric causal inference (2011) J. Stat Softw., 42, pp. 1-28; (2016) Functional Urban Areas in OECD Countries: Sweden, , www.oecd.org/cfe/regional-policy/functional-urbanareas-all-sweden.pdf; George, B., Seals, S., Aban, I., Survival analysis and regression models (2014) J. Nucl. Cardiol., 21, pp. 686-694; Therneau, T., (2015) A Package for Survival Analysis in S, , https://CRAN.R-project.org/package=survival, Version 2.38; Miller, R.G., Jr., Gong, G., Munoz, A., (1981) Survival Analysis, , John Wiley and Sons; Venables, W.N., Ripley, B.D., (2002) Modern Applied Statistics with S, , Springer-Verlag, ed. 4; Friedman, D.B., Quantitative proteomics for two-dimensional gels using difference gel electrophoresis (2007) Methods Mol. Biol., 367, pp. 219-239; Butt, R.H., Coorssen, J.R., Coomassie blue as a near-infrared fluorescent stain: A systematic comparison with Sypro Ruby for in-gel protein detection (2013) Mol. Cell. Proteomics, 12, pp. 3834-3850; Atarashi, R., Satoh, K., Sano, K., Fuse, T., Yamaguchi, N., Ishibashi, D., Matsubara, T., Nishida, N., Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion (2011) Nat. Med., 17, pp. 175-178; Wessel, D., Flügge, U.I., A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids (1984) Anal. Biochem., 138, pp. 141-143; Ntai, I., Toby, T.K., LeDuc, R.D., Kelleher, N.L., A method for label-free, differential top-down proteomics (2016) Methods Mol. Biol., 1410, pp. 121-133},
correspondence_address1={Labrie, V.; Center for Neurodegenerative Science, United States; email: viviane.labrie@vai.org},
publisher={American Association for the Advancement of Science},
issn={19466234},
pubmed_id={30381408},
language={English},
abbrev_source_title={Sci. Transl. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Perkins201560,
author={Perkins, J.M. and Subramanian, S.V. and Christakis, N.A.},
title={Social networks and health: A systematic review of sociocentric network studies in low- and middle-income countries},
journal={Social Science and Medicine},
year={2015},
volume={125},
pages={60-78},
doi={10.1016/j.socscimed.2014.08.019},
note={cited By 146},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919882800&doi=10.1016%2fj.socscimed.2014.08.019&partnerID=40&md5=1f3884a595a4495101c7a4f40a24a64a},
affiliation={Department of Health Policy, Harvard University, 14 Story St., 4th Floor, Cambridge, MA  02138, United States; Department of Social and Behavioral Sciences, Harvard School of Public Health, 677 Huntington Ave., Kresge Building 7th Floor, Boston, MA  02115, United States; Yale Institute for Network Science, 17 Hillhouse Ave., New Haven, CT  06520, United States},
abstract={In low- and middle-income countries (LMICs), naturally occurring social networks may be particularly vital to health outcomes as extended webs of social ties often are the principal source of various resources. Understanding how social network structure, and influential individuals within the network, may amplify the effects of interventions in LMICs, by creating, for example, cascade effects to non-targeted participants, presents an opportunity to improve the efficiency and effectiveness of public health interventions in such settings. We conducted a systematic review of PubMed, Econlit, Sociological Abstracts, and PsycINFO to identify a sample of 17 sociocentric network papers (arising from 10 studies) that specifically examined health issues in LMICs. We also separately selected to review 19 sociocentric network papers (arising from 10 other studies) on development topics related to wellbeing in LMICs. First, to provide a methodological resource, we discuss the sociocentric network study designs employed in the selected papers, and then provide a catalog of 105 name generator questions used to measure social ties across all the LMIC network papers (including both ego- and sociocentric network papers) cited in this review. Second, we show that network composition, individual network centrality, and network structure are associated with important health behaviors and health and development outcomes in different contexts across multiple levels of analysis and across distinct network types. Lastly, we highlight the opportunities for health researchers and practitioners in LMICs to 1) design effective studies and interventions in LMICs that account for the sociocentric network positions of certain individuals and overall network structure, 2) measure the spread of outcomes or intervention externalities, and 3) enhance the effectiveness and efficiency of aid based on knowledge of social structure. In summary, human health and wellbeing are connected through complex webs of dynamic social relationships. Harnessing such information may be especially important in contexts where resources are limited and people depend on their direct and indirect connections for support. © 2014 Elsevier Ltd.},
author_keywords={Centrality;  Name generators;  Network position;  Network type;  Networks;  Social structure;  Sociocentric;  Systematic review},
keywords={developing world;  network analysis;  public health;  social network;  social structure, Article;  behavior change;  disease transmission;  family planning;  health behavior;  health status;  human;  income;  public health;  social environment;  social interaction;  social network;  social status;  social structure;  social support;  systematic review;  wellbeing;  developing country;  economics;  health behavior;  social support, Developing Countries;  Health Behavior;  Humans;  Public Health;  Social Support},
funding_details={National Institute of Mental HealthNational Institute of Mental Health, NIMH, T32MH019733},
references={Adams, A.M., Madhavan, S., Simon, D., Women's social networks and child survival in Mali (2002) Soc. Sci. Med., 54, pp. 165-178; Alatas, V., Banerjee, A., Chandrasekhar, A.G., Hanna, R., Olken, B.A., Network Structure and the Aggregation of Information: Theory and Evidence from Indonesia (2012) National Bureau of Economic Research, No. 18351, , http://www.nber.org/papers/w18351, Last accessed at:, on November 14, 2013; Ali, M.M., Dwyer, D.S., Social network effects in alcohol consumption among adolescents (2010) Addict. Behav., 35, pp. 337-342; Alvergne, A., Gibson, M.A., Gurmu, E., Mace, R., Social transmission and the spread of modern contraception in rural Ethiopia (2011) PLoS ONE, 6, p. e22515; Apicella, C.L., Marlowe, F.W., Fowler, J.H., Christakis, N.A., Social networks and cooperation in hunter-gatherers (2012) Nature, 481, pp. 497-501; Aral, S., Muchnik, L., Sundararajan, A., Distinguishing influence-based contagion from homophily-driven diffusion in dynamic networks (2009) Proc. Natl. Acad. Sci., 106, pp. 21544-21549; Aral, S., Walker, D., Identifying social influence in networks using randomized experiments (2011) Intell. Syst. IEEE, 26, pp. 91-96; Avogo, W., Agadjanian, V., Men's social networks and contraception in Ghana (2008) J.Biosoc. Sci., 40, pp. 413-429; Bignami-Van Assche, S., Network stability in longitudinal data: a case study from rural Malawi (2005) Soc. Netw., 27, pp. 231-247; Banerjee, A., Chandrasekhar, A.G., Duflo, E., Jackson, M.O., The diffusion of microfinance (2013) Science, 341. , 1236498; Bates, S.J., Trostle, J., Cevallos, W.T., Hubbard, A., Eisenberg, J.N., Relating diarrheal disease to social networks and the geographic configuration of communities in rural Ecuador (2007) Am. J. Epidemiol., 166, pp. 1088-1095; Bearman, P.S., Moody, J., Suicide and friendships among American adolescents (2004) Am. J. Public Health, 94, pp. 89-95; Berkman, L.F., Krishna, A., Social network epidemiology (2014) Social Epidemiology, pp. 234-289. , Oxford University Press, New York, L.F. Berkman, I. Kawachi, M. Glymour (Eds.); Berkman, L.F., Glass, T., Brissete, I., Seeman, T.E., From social integration to health: Durkheim in the new millennium (2000) Soc. Sci. Med., 51, pp. 843-857; Bond, R.M., Fariss, C.J., Jones, J.J., Kramer, A.D.I., Marlow, C., Settle, J.F., Fowler, J.H., A61-million person experiment in social influence and political mobilization (2012) Nature, 489, pp. 295-298; Cai, J., De Janvry, A., Sadoulet, E., (2012) Social Networks and the Decision to Insure: Evidence from Randomized Experiments in China, , http://papers.ssrn.com/abstract=2161686, Available at: SSRN 2161686. Last accessed at:, on May 13, 2014; Christakis, N.A., Social networks and collateral health effects (2004) Br. Med. J., 329, pp. 184-185; Christakis, N.A., Fowler, J.H., The spread of obesity in a large social network over 32 years (2007) N. Engl J. Med., 357, pp. 370-379; Christakis, N.A., Fowler, J.H., (2009) Connected: the Surprising Power of Our Social Networks and How They Shape Our Lives, , Little Brown and Company, New York, NY; Christakis, N.A., Fowler, J.H., Social contagion theory: examining dynamic social networks and human behavior (2013) Stat. Med., 32, pp. 556-577; Cohen, S., Willis, T.A., Stress, social support, and the buffering hypothesis (1985) Psychol. Bull., 98, pp. 310-357; Coleman, J.S., Human capital in the creation of social capital (1988) Am. J. Sociol., 94, pp. S95-S120; Comola, M., (2008) Educational Programs in Rural Nepal: Peer Communication and Information Spillovers, , http://ssrn.com/abstract=1019237, Available at: SSRN 1019237. Last accessed at:, on May 13, 2014; Comola, M., (2012) Estimating Local Externalities, , http://ssrn.com/abstract=946093, Available at: SSRN 946093. Last accessed at:, on May 13, 2014; Comola, M., Prina, S., (2013) Intervention-driven Changes in Social Networks and Their Effects on Household Outcomes, , http://ssrn.com/abstract=2250748, Available at: SSRN 2250748. Last accessed at:, on May 13, 2014; Cornwell, B., Schumm, L.P., Laumann, E.O., Graber, J., Social networks in the NSHAP study: rationale, measurement, and preliminary findings (2009) J.Gerontol. Soc. Sci., 64 B, pp. i47-i55; D'Exelle, B., Holvoet, N., Gender and network formation in rural Nicaragua: a village case study (2011) Fem. Econ., 17, pp. 31-61; D'Exelle, B., Riedl, A., (2010) Directed Generosity and Network Formation: Network Dimension Matters. Discussion Paper 5356, , http://ssrn.com/abstract=1723994, IZA, Available at: SSRN 1723994. Last accessed at:, on May 13, 2014; De Weerdt, J., Risk-sharing and endogenous network formation (2004) Insurance against Poverty, pp. 197-216. , (Chapter 10), Oxford University Press, UK, S. Dercon (Ed.); De Weerdt, J., Dercon, S., Risk sharing networks and insurance against illness (2006) J.Dev. Econ., 81, pp. 337-356; De Weerdt, J., Fafchamps, M., Social identity and the formation of health insurance networks (2011) J.Dev. Stud., 47, pp. 1152-1177; Edmonds, J.K., Hruschka, D., Bernard, H.R., Sibley, L., Women's social networks and birth attendant decisions: application of the network-episode model (2012) Soc. Sci. Med., 74, pp. 452-459; Emch, M., Root, E.D., Giebultowicz, S., Ali, M., Perez-Heydrich, C., Yunus, M., Integration of spatial and social network analysis in disease transmission studies (2012) Ann. Assoc. Am. Geogr., 102, pp. 1004-1015; Ennett, S.T., Baumann, K.E., The contribution of influence and selection to adolescent peer group homogeneity: the case of adolescent cigarette smoking (1994) J.Personality Soc. Psychol., 67, pp. 653-663; Ennett, S.T., Baumann, K.E., Hussong, A., Faris, R., Foshee, V.A., Cai, L., DuRant, R.H., The peer context of adolescent substance use: findings from social network analysis (2006) J.Res. Adolesc., 16, pp. 159-186; Ensminger, J., (2011) Roots of Human Sociality Phase II: Social Network Analysis, , http://jee.caltech.edu/files/2011/06/Social-Network-Analysis.pdf, Last accessed at:, on July 2, 2014; Entwisle, B., Faust, K., Rindfuss, R., Kaneda, T., Networks and contexts: variation in the structure of social ties (2007) Am. J. Sociol., 112, pp. 1495-1533; Entwisle, B., Walsh, S.J., Rindfuss, R.R., Chamratrihirong, A., Land use/land-cover and population dynamics, Nang Rong Thailand (1998) People and Pixels, pp. 121-144. , National Academy Press, Washington, D. Liverman (Ed.); Faust, K., Entwisle, B., Rindfuss, R.R., Walsh, S.J., Sawangdee, Y., Spatial arrangement of social and economic networks among villages in Nang Rong District, Thailand (1999) Soc. Netw., 21, pp. 311-337; Fonseca-Becker, F., Valente, T.W., Promoting breastfeeding in Bolivia: do social networks add to the predictive value of traditional socioeconomic characteristics? (2006) J.Health Popul. Nutr., 24, pp. 71-80; Fowler, J.H., Christakis, N.A., Cooperative behavior cascades in human social networks (2010) Proc. Natl. Acad. Sci., 107, pp. 5334-5338; Freeman, L.C., Centrality in social networks conceptual clarification (1979) Soc. Netw., 1, pp. 215-239; Fu, Z., He, N., Duan, S., Jiang, Q., Ye, R., Pu, Y., HIV infection, sexual behaviors, sexual networks, and drug use among rural residents in Yunnan Province, China (2011) AIDS Behav., 15, pp. 1017-1025; Gayen, K., Raeside, R., Social networks and contraception practice of women in rural Bangladesh (2010) Soc. Sci. Med., 71, pp. 1584-1592; Giebultowicz, S., Ali, M., Yunus, M., Emch, M., The simultaneous effects of spatial and social networks on cholera transmission (2011) Interdiscip. Perspect. Infect. Dis., p. 604372; Green, H.D., Atuyambe, L., Ssali, S., Ryan, G.W., Wagner, G.J., Social networks of PLHA in Uganda: implications for mobilizing PLHA as agents for prevention (2011) AIDS Behav., 15, pp. 992-1002; Haas, S.A., Schaefer, D.R., Kornienko, O., Health and the structure of adolescent social networks (2010) J.Health Soc. Behav., 51, pp. 424-439; Helleringer, S., Kohler, H.P., Sexual network structure and the spread of HIV in Africa: evidence from Likoma Island, Malawi (2007) AIDS, 21, pp. 2323-2332; Helleringer, S., Kohler, H.P., Chimbiri, A., Characteristics of external/bridge relationships by partner type and location where sexual relationship took place (2007) AIDS, 21, pp. 2560-2561; Helleringer, S., Kohler, H.-P., Chimbiri, A., Chatonda, P., Mkandawire, J., The Likoma Network Study: context, data collection, and initial results (2009) Demogr. Res., 21, pp. 427-468; Helleringer, S., Mkandawire, J., Kalilani-Phiri, L., Kohler, H.P., Cohort profile: the Likoma Network Study (LNS) (2013) Int. J. Epidemiol., pp. 1-13; Henrich, J., Broesch, J., On the nature of cultural transmission networks: evidence from Fijan villages for adaptive learning biases (2011) Philos. Trans. R. Soc. Biol. Sci., 366, pp. 1139-1148; Honeycutt, T., Making Connections: Using Social Network Analysis for Program Evaluation (2009) Mathematica Issue Brief, , http://files.eric.ed.gov/fulltext/ED507482.pdf, Last accessed at:, on November 14, 2013; House, J.S., Landis, K.R., Umberson, D., Social relationships and health (1988) Science, 241, pp. 540-545; Hurley, E.A., Warren, N.E., Doumbia, S., Winch, P.J., Exploring the connectedness of rural auxiliary midwives to social networks in Koutiala, Mali (2013) Midwifery; Jackson, M.O., Rodriguez-Barraquer, T., Tan, X., Social capital and social quilts: network patterns of favor exchange (2012) Am. Econ. Rev., 102, pp. 1857-1897; Jaimovich, D., (2011) Macrostructure and microstructure: evidence from overlapping village networks in the Gambia, , http://mpra.ub.uni-muenchen.de/38932/, MPRA Working Paper No. 38932. Last accessed at on Aug 25, 2014; Kivela, M., Arenas, A., Barthelemy, M., Gleeson, J.P., Moreno, Y., Porter, M.A., Mutilayer networks (2014) J.Complex Netw.; Kohler, H.P., Behrman, J.R., Watkins, S.C., Social networks and HIV/AIDS risk perceptions (2007) Demography, 44, pp. 1-33; Koster, J., Interhousehold meat sharing among Mayangna and Miskito horticulturalists in Nicaragua (2011) Hum. Nat., 22, pp. 394-415; Laumann, E., Marsden, P., Prensky, D., The boundary specification problem in network analysis (1983) Applied Network Analysis: a Methodological Introduction, pp. 18-34. , Sage Publications, London, R.S. Burt, M.J. Minor (Eds.); Lin, N., Social networks and status attainment (1999) Annu. Rev. Sociol., pp. 467-487; Luke, D.A., Harris, J.K., Network analysis in public health: history, methods, and applications (2007) Annu. Rev. Public Health, 28, pp. 69-93; Manski, C.F., Identification of endogenous social effects: the reflection problem (1993) Rev. Econ. Stud., 60, pp. 531-542; Marin, A., Are respondents more likely to list alters with certain characteristics? Implications for name generator data (2004) Soc. Netw., 26, pp. 289-307; Marin, A., Hampton, K.N., Simplifying the personal network name generator: alternatives to traditional multiple and single name generators (2007) Field Methods, 19, pp. 163-193; Marsden, P.V., Network data and measurement (1990) Annu. Rev. Sociol., 16, pp. 435-463; Marsden, P.V., Egocentric and sociocentric measures of network centrality (2002) Soc. Netw., 24, pp. 407-422; Matous, P., Todo, Y., Mojo, D., Boots are made for walking: interactions across physical and social space in infrastructure-poor regions (2013) J.Transp. Geogr., 31, pp. 226-235; McCarty, C., Killworth, P.D., Rennell, J., Impact of methods for reducing respondent burden on personal network structural measures (2007) Soc. Netw., 29, pp. 300-315; Mertens, F., Saint-Charles, J., Lucotte, M., Mergler, D., Emergence and robustness of a community discussion network on mercury contamination and health in the Brazilian Amazon (2008) Health Educ. Behav., 35, pp. 509-521; Mertens, F., Saint-Charles, J., Mergler, D., Social communication network analysis of the role of participatory research in the adoption of new fish consumption behaviors (2012) Soc. Sci. Med., 75, pp. 643-650; Miguel, E., Kremer, M., (2003) Networks, Social Learning and Technology Adoption: The Case of Deworming Drugs in Kenya, , http://cle.berkeley.edu/wp/wp61.pdf, Working Paper 61. Last accessed at:, on May 13, 2014; Moore, A., Older people living with HIV/AIDS (OPLWHA) in Lome, Togo: personal networks and disclosure of serostatus (2014) Ageing Int., 38, pp. 218-232; Moore, S., Salsberg, J., Leroux, J., Advancing social capital interventions from a network and population health perspective (2013) Global Perspectives on Social Capital and Health, pp. 189-204. , Springer, New York, I. Kawachi, S. Takao, S.V. Subramanian (Eds.); Moser, S., Mosler, H.-J., Differences in influence patterns between groups predicting the adoption of solar disinfection technology for drinking water in Bolivia (2008) Soc. Sci. Med., 67, pp. 497-504; Nolin, D.A., Food-sharing networks in Lamalera, Indonesia: reciprocity, kinship and distance (2010) Hum. Nat., 21, pp. 243-268; Nolin, D.A., Food-sharing networks in Lamalera, Indonesia: status, sharing and signaling (2012) Evol. Hum. Behav., 33, pp. 334-345; O'Malley, A.J., Christakis, N.A., Longitudinal analysis of large social networks: estimating the effects of health traitis on changes in friendship ties (2011) Stat. Med., 30, pp. 950-964; O'Malley, A.J., The analysis of social network data: an exciting frontier for statisticians (2013) Stat. Med., 32, pp. 539-555; O'Malley, A.J., Elwert, F., Rosenquist, J.N., Zaslavsky, A.M., Christakis, N.A., Estimating peer effects in longitudinal dyadic data using instrumental variables (2014) Biometrics; Perez-Heydrich, C., Furgurson, J.M., Giebultowics, S., Winston, J.J., Yunus, M., Streatfield, P.K., Emch, M., Social and spatial processes associated with childhood diarrheal disease in Matlab, Bangladesh (2013) Health Place, 19, pp. 45-52; Perry, B.L., Pescosolido, B.A., Functional specificity in discussion networks: the influence of general and problem-specific networks on health outcomes (2010) Soc. Netw., 32, pp. 345-357; Philipson, T.C., Design of HIV trials for estimating external effects (2002) Quantitative Evaluation of HIV Prevention Programs, , Yale University, New Haven, CT, E.H. Kaplan, R. Brookmeyer (Eds.); Pollard, M.S., Tucker, J.S., Green, H.D., Kennedy, D., Go, M.H., Friendship networks and trajectories of adolescent tobacco use (2010) Addict. Behav., 35, pp. 678-685; Rand, D.G., Arbesman, S., Christakis, N.A., Dynamic social networks promote cooperation in experiments with humans (2011) Proc. Natl. Acad. Sci., 108, pp. 19193-19198; Rasul, I., Hernandez, M., Programme Evaluation and Social Networks (2012) ESRC Research Methods Festival, , http://www.ifs.org.uk/docs/PEPA_RMF_Imran.pdf, Institute for Fiscal Studies, London, UK, Last accessed at:, on November 14, 2013; Ruiz-Casares, M., Kin and youths in social networks of youth-headed households in Namibia (2010) J.Marriage Fam., 72, pp. 1408-1425; Sandberg, J., The influence of network mortality experience on nonnumeric response concerning expected family size: evidence from a Nepalese mountain village (2005) Demography, 42, pp. 737-756; Sandberg, J., Infant mortality, social networks, and subsequent fertility (2006) Am. Sociol. Rev., 71, pp. 288-309; Sandberg, J., Social learning about levels of perinatal and infant mortality in Niakhar, Senegal (2012) Soc. Netw., 34, pp. 264-274; (2011) The Sage Handbook of Social Network Analysis, , SAGE Publications Limited, London, UK, J.P. Scott, P.J. Carrington (Eds.); Seeman, T., Social ties and health: the benefits of social integration (1996) Ann. Epidemiol., 6, pp. 442-451; Seidner, M.J., Lankowski, A., Musinga, D., Jackson, J., Muzoora, C., Hunt, P.W., Martin, J.N., Haberer, J.E., Obtimizing network connectivity for mobile health technologies in sub-Saharan Africa (2012) PLoS One, 7, p. e45643; Shakya, H.B., Christakis, N.A., Fowler, J.H., Social network predictors of latrine ownership (2014) Soc. Sci. Med.; Shakya, H.B., Christakis, N.A., Fowler, J.H., Association between social network communities and health behavior: an observational sociocentric network study of latrine ownership in rural India (2014) Am. J. Public Health; Shalizi, C.R., Thomas, A.C., Homophily and contagion are generically confounded in observational social network studies (2011) Sociol. Methods Res., 40, pp. 211-239; Smith, K., Christakis, N., Social networks and health (2008) Annu. Rev. Sociol., 34, pp. 405-429; Stafford, D., Hughes, A.D., Abel, B., (2010) APictures is Worth a Thousand Words: Photographic Identification in Rural Networks and an Introduction to Netriks, , http://polisci2.ucsd.edu/dhughes/Netriks_Design.pdf, Last accessed at:, on November 14, 2013; Stoebenau, K., Valente, T.W., Using network analysis to understand community-based programs: a case study from highland Madagascar (2003) Int. Fam. Plan. Perspect., 29, pp. 167-173; Trostle, J.A., Hubbard, A., Scott, J., Cevallos, W., Bates, S.J., Eisenberg, J.N.S., Raising the level of analysis of food-borne outbreaks: food-sharing networks in rural coastal Ecuador (2008) Epidemiology, 19, pp. 384-390; Tsai, A.C., Bangsberg, D.R., Weiser, S.D., Harnessing poverty alleviation to reduce stigma of HIV in Sub-Saharan Africa (2013) PLoS Med., 10, p. e1001557; Umberson, D., Crosnoe, R., Rezeck, C., (2010) Annu. Rev. Sociol., 36, pp. 139-157; Valente, T.W., Watkins, S.C., Jato, M.N., Van der Straten, A., Tsitsol, L.M., Social network associations with contraceptive use among Cameroonian women in voluntary associations (1997) Soc. Sci. Med., 45, pp. 677-687; Valente, T.W., (2010) Social Networks and Health: Models, Methods, and Applications, , Oxford University Press, New York; Valente, T.W., Network interventions (2012) Science, 337, pp. 49-53; Van der Poel, M.G.M., Delineating personal networks (1993) Soc. Netw., 15, pp. 49-70; VanderWeele, T.J., Inference for influence over multiple degrees of separation on a social network (2013) Stat. Med., 32, pp. 591-596; Verdery, A.M., Entwisle, B., Faust, K., Rindfuss, R.R., Social and spatial networks: kinship distance and dwelling unit proximity in rural Thailand (2012) Soc. Netw., 34, pp. 112-127; Ware, N.C., Idoko, J., Kaaya, S., Biraro, I.A., Wyatt, M.A., Agbaji, O., Chalamilla, G., Bangsberg, D.R., Explaining adherence success in Sub-Saharan Africa: an ethnographic study (2009) PLoS Med., 6, p. e11; Wasserman, S., Faust, K., (1994) Social Network Analysis: Methods and Applications, , Cambridge University Press, Cambridge, UK; Wellman, B., Which types of ties and networks give what kinds of social support? (1992) Adv. Group Process., 9, pp. 207-235; White, K., Watkins, S., Accuracy, stability and reciprocity in informal conversational networks in rural Kenya (2000) Soc. Netw., 22, pp. 337-355; Wutich, A., McCarty, C., Social networks and infant feeding, in Oaxaca, Mexico (2008) Matern. Child Nutr., 4, pp. 121-135; Zelner, J.L., Trostle, J., Goldstick, J.E., Cevallos, W., House, J.S., Eisenberg, J.N., Social connectedness and disease transmission: social organization, cohesion, village context, and infection risk in rural Ecuador (2012) Am. J. Public Health, 102, pp. 2233-2239; Zhang, T., Cao, W., Lv, J., Wang, N., Reilly, K., Zhu, Q., Size, composition, and strength of ties of personal social support networks among adult people living with HIV/AIDS in Henan and Beijing, China (2012) AIDS Behav., 16, pp. 911-919},
correspondence_address1={Perkins, J.M.; Department of Health Policy, Harvard University, 14 Story St., 4th Floor, United States},
publisher={Elsevier Ltd},
issn={02779536},
coden={SSMDE},
pubmed_id={25442969},
language={English},
abbrev_source_title={Soc. Sci. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Pinnock2017,
author={Pinnock, H. and Parke, H.L. and Panagioti, M. and Daines, L. and Pearce, G. and Epiphaniou, E. and Bower, P. and Sheikh, A. and Griffiths, C.J. and Taylor, S.J.C. and Griffiths, C.J.C. and Greenhalgh, T. and Schwappach, A. and Purushotham, N. and Jacob, S. and Richardson, G. and Murray, E. and Rogers, A. and Kennedy, A. and Newman, S. and Small, N. and PRISMS and RECURSIVE groups},
title={Systematic meta-review of supported self-management for asthma: A healthcare perspective},
journal={BMC Medicine},
year={2017},
volume={15},
number={1},
doi={10.1186/s12916-017-0823-7},
art_number={64},
note={cited By 144},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015700719&doi=10.1186%2fs12916-017-0823-7&partnerID=40&md5=cc9eddba59c2c9a777cc800c24391c76},
affiliation={Usher Institute of Population Health Sciences and Informatics, Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, University of Edinburgh, Doorway 3, Medical School, Teviot Place, Edinburgh, EH8 9AG, United Kingdom; Queen Mary University of London, Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, London, United Kingdom; University of Manchester, NIHR School for Primary Care Research, Centre for Primary Care, Manchester Academic Health Science Centre, Manchester, United Kingdom; Coventry University, Centre for Technology Enabled Health Research (CTEHR), Coventry, United Kingdom},
abstract={Background: Supported self-management has been recommended by asthma guidelines for three decades; improving current suboptimal implementation will require commitment from professionals, patients and healthcare organisations. The Practical Systematic Review of Self-Management Support (PRISMS) meta-review and Reducing Care Utilisation through Self-management Interventions (RECURSIVE) health economic review were commissioned to provide a systematic overview of supported self-management to inform implementation. We sought to investigate if supported asthma self-management reduces use of healthcare resources and improves asthma control; for which target groups it works; and which components and contextual factors contribute to effectiveness. Finally, we investigated the costs to healthcare services of providing supported self-management. Methods: We undertook a meta-review (systematic overview) of systematic reviews updated with randomised controlled trials (RCTs) published since the review search dates, and health economic meta-analysis of RCTs. Twelve electronic databases were searched in 2012 (updated in 2015; pre-publication update January 2017) for systematic reviews reporting RCTs (and update RCTs) evaluating supported asthma self-management. We assessed the quality of included studies and undertook a meta-analysis and narrative synthesis. Results: A total of 27 systematic reviews (n = 244 RCTs) and 13 update RCTs revealed that supported self-management can reduce hospitalisations, accident and emergency attendances and unscheduled consultations, and improve markers of control and quality of life for people with asthma across a range of cultural, demographic and healthcare settings. Core components are patient education, provision of an action plan and regular professional review. Self-management is most effective when delivered in the context of proactive long-term condition management. The total cost (n = 24 RCTs) of providing self-management support is offset by a reduction in hospitalisations and accident and emergency visits (standard mean difference 0.13, 95% confidence interval -0.09 to 0.34). Conclusions: Evidence from a total of 270 RCTs confirms that supported self-management for asthma can reduce unscheduled care and improve asthma control, can be delivered effectively for diverse demographic and cultural groups, is applicable in a broad range of clinical settings, and does not significantly increase total healthcare costs. Informed by this comprehensive synthesis of the literature, clinicians, patient-interest groups, policy-makers and providers of healthcare services should prioritise provision of supported self-management for people with asthma as a core component of routine care. Systematic review registration: RECURSIVE: PROSPERO CRD42012002694 ; PRISMS: PROSPERO does not register meta-reviews © 2017 The Author(s).},
author_keywords={Asthma;  Health economic analysis;  Meta-analysis;  Supported self-management;  Systematic meta-review},
keywords={corticosteroid, Article;  asthma;  clinical effectiveness;  consultation;  cost benefit analysis;  cultural anthropology;  demography;  disease control;  disease marker;  electronic medical record;  emergency care;  health care cost;  health care delivery;  health care utilization;  health economics;  health practitioner;  hospitalization;  human;  meta analysis;  patient care planning;  patient education;  program effectiveness;  quality control;  quality of life;  randomized controlled trial (topic);  risk reduction;  self care;  systematic review;  asthma;  economics;  health care cost;  procedures;  self care;  statistics and numerical data, Asthma;  Delivery of Health Care;  Health Care Costs;  Hospitalization;  Humans;  Quality of Life;  Self Care},
funding_details={11/1014/04, 11/1014/06},
funding_details={Medical Research CouncilMedical Research Council, MRC, G1000758},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR},
funding_text 1={The submitted work was funded by a grant from the National Institute for Health Research Health Services and Delivery Research Programme. None of the authors have financial relationships with any organisations that might have an interest in the submitted work. HP chairs the self-management evidence review group for the British Thoracic Society/Scottish Intercollegiate Guideline Network Asthma guideline; the authors declare that they have no other relationships or activities that could appear to have influenced the submitted work.},
funding_text 2={PRISMS and RECURSIVE were funded by the National Institute for Health Research Health Services and Delivery Research Programme (project numbers 11/1014/04 and 11/1014/06. The funding body had no role in the design of the study, collection, analysis, nor interpretation of data, nor in writing the manuscript. HP was supported by a Primary Care Research Career Award from the Chief Scientist’s Office of the Scottish Government at the time of the study. LD is supported by an Academic Fellowship in General Practice from the Scottish School of Primary Care.},
references={The global asthma report 2014 (2014) Global Asthma Network, , http://www.globalasthmareport.org/resources/Global_Asthma_Report_2014.pdf, Accessed 22 Dec 2016; Mukherjee, M., Stoddart, A., Gupta, R.P., Nwaru, B.I., Farr, A., Heaven, M., The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases (2016) BMC Med., 14, p. 113; National Asthma Campaign. Guidelines for management of asthma in adults: I-chronic persistent asthma (1990) BMJ, 301, pp. 651-653; British guideline on the management of asthma (2016) 2016 update, , http://sign.ac.uk/guidelines/fulltext/153/index.html, Accessed 22 Dec; (2016) Global strategy for asthma management and prevention 2015 update, , http://www.ginasthma.org, Accessed 22 Dec; Pearce, G., Parke, H., Pinnock, H., The PRISMS taxonomy of self-management support: derivation of a novel taxonomy and initial testing of utility (2016) J Health Serv Res Policy., 21, pp. 73-82; (2014) Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report, , London: Royal College of Physicians; Singh, D., Ham, C., Improving care for people with long-term conditions: a review of UK and international frameworks (2006) NHS Institute for Innovation and Improvement, , Department of Health: Birmingham; Innovative care for chronic conditions (2002) Building blocks for action. Global report, , Geneva: WHO; The Mandate (2012) A mandate from the Government to the NHS Commissioning Board, , April 2013 to March 2015. London: Department of Health; Time to take action on asthma, , UK, London: Asthma UK; 2014; Pinnock, H., Epiphaniou, E., Pearce, G., Implementing supported self-management for asthma: a systematic review of implementation studies (2015) BMC Med., 13, p. 127; Taylor, S.J.C., Pinnock, H., Epiphaniou, E., Pearce, G., Parke, H., A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions. (PRISMS Practical Systematic Review of Self-Management Support for long-term conditions) (2014) Health Serv Deliv Res, 2, p. 54; Panagioti, M., Richardson, G., Murray, E., Rogers, A., Kennedy, A., Newman, S., Reducing care utilisation through self-management interventions (RECURSIVE): a systematic review and meta-analysis (2014) Health Serv Deliv Res., 2, p. 54; Higgins, J.P.T., Green, S., (2016) Cochrane handbook for systematic reviews of interventions version 5.1.0, , http://handbook.cochrane.org, Accessed 22 Dec; Adams, K., Greiner, A.C., Corrigan, J.M., (2004) The 1st annual crossing the quality chasm summit - a focus on communities, p. 57. , Washington, D.C: The National Academic Press; Kung, J., Chiappelli, F., Cajulis, O.O., Avezova, R., Kossan, G., Chew, L., From systematic reviews to clinical recommendations for evidence-based health care: validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for grading of clinical relevance (2010) Open Dent J., 4, pp. 84-91; Drumance, G.W., (1997) Methods for the economic evaluation of health care programmes, , 2nd ed. Oxford: Oxford University Press; Drummond, M.F., Sculpher, M.J., Torrance, G.W., O'Brien, B.J., Stoddart, G.L., (2005) Methods for the economic evaluation of health care programmes, , 3rd ed. Oxford: Oxford University Press; Pildal, J., Hrobjartsson, A., Jorgensen, K.J., Hilden, J., Altman, D.G., Gotzsche, P.C., Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials (2007) Int J Epidemiol., 36, pp. 847-857; Nixon, J., Khan, K., Kleijnen, J., Summarising economic evaluations in systematic reviews: a new approach (2001) BMJ., 322, pp. 1596-1598; Greenhalgh, T., Peacock, R., Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources (2005) BMJ., 331, pp. 1064-1065; Bhogal, S.K., Zemek, R.L., Ducharme, F., Written action plans for asthma in children (2006) Cochrane Database Syst Rev., 3; Zemek, R.L., Bhogal, S.K., Ducharme, F.M., Systematic review of randomized controlled trials examining written action plans in children. What is the plan? (2008) Arch Pediatr Adolesc Med, 162, pp. 157-163; Bailey, E.J., Cates, C.J., Kruske, S.G., Morris, P.S., Brown, N., Chang, A.B., Culture-specific programs for children and adults from minority groups who have asthma (2009) Cochrane Database Syst Rev., 2; Bernard-Bonnin, A.C., Stachenko, S., Bonin, D., Charette, C., Rousseau, E., Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis (1995) J Allergy Clin Immunol., 95, pp. 34-41; Boyd, M., Lasserson, T.J., McKean, M.C., Gibson, P.G., Ducharme, F.M., Haby, M., Interventions for educating children who are at risk of asthma-related emergency department attendance (2009) Cochrane Database Syst Rev., 2; Bussey-Smith, K.L., Rossen, R.D., A systematic review of randomized control trials evaluating the effectiveness of interactive computerized asthma patient education programs (2007) Ann Allergy Asthma Immunol., 98, pp. 507-516; Chang, A.B., Taylor, B., Masters, I.B., Laifoo, Y., Brown, A.D.H., Indigenous healthcare worker involvement for Indigenous adults and children with asthma (2010) Cochrane Database Syst Rev., 5; Coffman, J.M., Cabana, M.D., Yelin, E.H., Do school-based asthma education programs improve self-management and health outcomes? (2009) Pediatrics., 124, pp. 729-742; Gibson, P.G., Powell, H., Wilson, A., Abramson, M.J., Haywood, P., Bauman, A., Self management education and regular practitioner review for adults with asthma (2002) Cochrane Database Syst Rev., 3; Gibson, P.G., Powell, H., Written action plans for asthma: an evidence-based review of the key components (2004) Thorax., 59, pp. 94-99; Moullec, G., Gour-Provencal, G., Bacon, S.L., Campbell, T.S., Lavoie, K.L., Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model (2012) Respir Med., 106, pp. 1211-1225; Newman, S., Steed, L., Mulligan, K., Self-management interventions for chronic illness (2004) Lancet., 364, pp. 1523-1537; Postma, J., Karr, C., Kieckhefer, G., Community health workers and environmental interventions for children with asthma: a systematic review (2009) J Asthma., 46, pp. 564-576; Powell, H., Gibson, P.G., Options for self-management education for adults with asthma (2002) Cochrane Database Syst Rev., 3; Ring, N., Malcolm, C., Wyke, S., Promoting the use of personal asthma action plans: a systematic review (2007) Prim Care Respir J., 16, pp. 271-283; Tapp, S., Lasserson, T.J., Rowe, B.H., Education interventions for adults who attend the emergency room for acute asthma (2007) Cochrane Database Syst Rev, 3. , CD003000; Toelle, B., Ram, F.S.F., Written individualised management plans for asthma in children and adults (2004) Cochrane Database Syst Rev., 1; Welsh, E.J., Hasan, M., Li, P., Home-based educational interventions for children with asthma (2011) Cochrane Database Syst Rev, 10; Bravata, D.M., Gienger, A.L., Holty, J.E., Sundaram, V., Khazeni, N., Wise, P.H., Quality improvement strategies for children with asthma: a systematic review (2009) Arch Pediatr Adolesc Med., 163, pp. 572-581; Jongh, T., Gurol-Urganci, I., Vodopivec-Jamsek, V., Car, J., Atun, R., Mobile phone messaging for facilitating self-management of long-term illnesses (2012) Cochrane Database Syst Rev., 12; Denford, S., Taylor, R.S., Campbell, J.L., Greaves, C.J., Effective behavior change techniques in asthma self-care interventions: systematic review and meta-regression (2014) Health Psychol., 33, pp. 577-587; Kirk, S., Beatty, S., Callery, P., Gellatly, J., Milnes, L., Pryjmachuk, S., The effectiveness of self-care support interventions for children and young people with long-term conditions: a systematic review (2012) Child Care Health Dev., 39, pp. 305-324; Marcano Belisario, J.S., Huckvale, K., Greenfield, G., Car, J., Gunn, L.H., Smartphone and tablet self management apps for asthma (2013) Cochrane Database Syst Rev., 11; Press, V.G., Pappalardo, A.A., Conwell, W.D., Pincavage, A.T., Prochaska, M.H., Arora, V.M., Interventions to improve outcomes for minority adults with asthma: a systematic review (2012) J Gen Int Med., 27, pp. 1001-1015; Stinson, J., Wilson, R., Gill, N., Yamada, J., Holt, J., A systematic review of internet-based self-management interventions for youth with health conditions (2009) J Pediatr Psychol., 34, pp. 495-510; Al-sheyab, N., Gallagher, R., Crisp, J., Shah, S., Peer-led education for adolescents with asthma in Jordan: a cluster-randomized controlled trial (2012) Pediatrics., 129, pp. e106-e112; Baptist, A.P., Ross, J.A., Yang, Y., Song, P.X.K., Clark, N.M., A randomized controlled trial of a self-regulation intervention for older adults with asthma (2013) J Am Geriatrics Soc., 61, pp. 747-753; Ducharme, F.M., Zemek, R.L., Chalut, D., McGillivray, D., Noya, F.J., Resendes, S., Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control (2011) Am J Respir Crit Care Med., 183, pp. 195-203; Goeman, D., Jenkins, C., Crane, M., Paul, E., Douglass, J., Educational intervention for older people with asthma: a randomised controlled trial (2013) Pat Ed Counsel., 93, pp. 586-595; Halterman, J.S., Szilagyi, P.G., Fisher, S.G., Fagnano, M., Tremblay, P., Conn, K.M., Randomized controlled trial to improve care for urban children with asthma: results of the school-based asthma therapy trial (2011) Arch Pediatric Adolesc Med., 165, pp. 262-268; Horner, S.D., Brown, A., Evaluating the effect of an asthma self-management intervention for rural families (2013) J Asthma., 51, pp. 168-177; Joseph, C.L., Ownby, D.R., Havstad, S.L., Saltzgaber, J., Considine, S., Johnson, D., Evaluation of a web-based asthma management intervention program for urban teenagers: reaching the hard to reach (2013) J Adolesc Health., 52, pp. 419-426; Khan, R., Maharaj, R., Seerattan, N., Babwah, F., Effectiveness of personalized written asthma action plans in the management of children with partly controlled asthma in Trinidad: a randomized controlled trial (2014) J Trop Pediatr., 60, pp. 17-26; Rhee, H., Belyea, M.J., Hunt, J.F., Brasch, J., Effects of a peer-led asthma self-management program for adolescents (2011) Arch Pediatr Adolesc Med., 165, pp. 513-519; Rikkers Mutsaerts, E.R., Winters, A.E., Bakker, M.J., Stel, H.F., Meer, V., Jongste, J.C., Internet-based self-management compared with usual care in adolescents with asthma: a randomized controlled trial (2012) Pediatr Pulmonol., 47, pp. 1170-1179; Shah, S., Sawyer, S.M., Toelle, B.G., Mellis, C.M., Peat, J.K., Lagleva, M., Improving paediatric asthma outcomes in primary health care: a randomised controlled trial (2011) Med J Aust., 195, pp. 405-409; Gaalen, J.L., Beerthuizen, T., Meer, V., Reisen, P., Redelijkheid, G.W., Snoeck-Stroband, J.B., Long-term outcomes of internet-based self-management support in adults with asthma: randomized controlled trial (2013) J Med Internet Res., 15; Wong, S.S., Nathan, A.M., Bruyne, J., Zaki, R., Tahir, S.Z.M., Does a written asthma action plan reduce unscheduled doctor visits in children? (2011) Indian J Pediatr., 80, pp. 590-595; Coelho, A.C., Cardoso, L.S., Machado, C.S., Machado, A.S., The impacts of educational asthma interventions in schools: a systematic review of the literature (2016) Can Respir J., 2016, p. 8476206; McLean, G., Murray, E., Band, R., Moffat, K.R., Hanlon, P., Bruton, A., Interactive digital interventions to promote self-management in adults with asthma: systematic review and meta-analysis (2016) BMC Pulm Med., 16, p. 83; Morawska, A., Mitchell, A.E., Burgess, S., Fraser, J., Effects of Triple P parenting intervention on child health outcomes for childhood asthma and eczema: randomised controlled trial (2016) Behav Res Ther., 83, pp. 35-44; Yeh, H.Y., Ma, W.F., Huang, J.L., Hsueh, K.C., Chiang, L.C., Evaluating the effectiveness of a family empowerment program on family function and pulmonary function of children with asthma: a randomized control trial (2016) Int J Nurs Stud., 60, pp. 133-144; Hoskins, G., Williams, B., Abhyankar, P., Donnan, P., Duncan, E., Pinnock, H., Achieving Good Outcomes for Asthma Living (GOAL): mixed methods feasibility and pilot cluster randomised controlled trial of a practical intervention for eliciting, setting and achieving goals for adults with asthma (2016) Trials., 17, p. 584; Rice, J.L., Matlack, K.M., Simmons, M.D., Steinfeld, J., Laws, M.A., Dovey, M.E., LEAP: A randomized-controlled trial of a lay-educator inpatient asthma education program (2015) Pat Ed Counsel., 98, pp. 1585-1591; Plaza, V., Peiró, M., Torrejón, M., Fletcher, M., López-Viña, A., Ignacio, J.M., A repeated short educational intervention improves asthma control and quality of life (2015) Eur Respir J., 46, pp. 1298-1307; Zairina, E., Abramson, M.J., McDonald, C.F., Li, J., Dharmasiri, T., Stewart, K., Telehealth to improve asthma control in pregnancy: a randomized controlled trial (2016) Respirology., 21, pp. 867-874; Castro, M., Zimmermann, N.A., Crocker, S., Bradley, J., Leven, C., Schechtman, K.B., Asthma intervention program prevents readmissions in high healthcare users (2003) Am J Respir Crit Care Med., 168, pp. 1095-1099; Clark, N.M., Gong, Z.M., Wang, S.J., Lin, X., Bria, W.F., Johnson, T.R., A randomized trial of a self-regulation intervention for women with asthma (2007) Chest., 132, pp. 88-97; Oliveira, M., Faresin, S., Bruno, V., Bittencourt, A., Fernandes, A., Evaluation of an educational programme for socially deprived asthma patients (1999) Eur Respir J., 14, pp. 908-914; Gallefoss, F., Bakke, P.S., Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial (2001) Eur Respir J., 17, pp. 206-213; Gruffydd-Jones, K., Hollinghurst, S., Ward, S., Taylor, G., Targeted routine asthma care in general practice using telephone triage (2005) Br J Gen Pract., 55, pp. 918-923; Honkoop, P.J., Loijmans, R.J., Termeer, E.H., Snoeck-Stroband, J.B., Hout, W.B., Bakker, M.J., Symptom-and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care (2015) J Allergy Clin Immunol., 135, pp. 682-688; Kauppinen, R., Sintonen, H., Tukiainen, H., One-year economic evaluation of intensive vs conventional patient education and supervision for self-management of new asthmatic patients (1998) Respir Med., 92, pp. 300-307; Krieger, J., Song, L., Philby, M., Community health worker home visits for adults with uncontrolled asthma: the HomeBASE Trial randomized clinical trial (2015) JAMA Intern Med., 175, pp. 109-117; Lahdensuo, A., Haahtela, T., Herrala, J., Kava, T., Kiviranta, K., Kuusisto, P., Randomised comparison of guided self management and traditional treatment of asthma over one year (1996) BMJ., 312, pp. 748-752; Levy, M.L., Robb, M., Allen, J., Doherty, C., Bland, J.M., Winter, R.J., A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma (2000) Respir Med., 94, pp. 900-908; Mancuso, C.A., Peterson, M.G., Gaeta, T.J., Fernández, J.L., Birkhahn, R.H., Melniker, L.A., A randomized controlled trial of self-management education for asthma patients in the emergency department (2011) Ann Emerg Med., 57, pp. 603-612; McLean, W., Gillis, J., Waller, R., The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia (2003) Canadian Respir J., 10, pp. 195-202; Moudgil, H., Marshall, T., Honeybourne, D., Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham (2000) UK. Thorax., 55, pp. 177-183; Pilotto, L.S., Smith, B.J., Heard, A.R., McElroy, H.J., Weekley, J., Bennett, P., Trial of nurse-run asthma clinics based in general practice versus usual medical care (2004) Respirology., 9, pp. 356-362; Pinnock, H., Bawden, R., Proctor, S., Wolfe, S., Scullion, J., Price, D., Accessibility, acceptability and effectiveness of telephone reviews for asthma in primary care: randomised controlled trial (2003) BMJ., 326, pp. 477-479; Price, D., Haughney, J., Lloyd, A., Hutchinson, J., Plumb, J., An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study (2004) Curr Med Res Opin., 20, pp. 1671-1679; Ryan, D., Price, D., Musgrave, S.D., Malhotra, S., Lee, A.J., Ayansina, D., Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial (2012) BMJ., 344; Schermer, T.R., Thoonen, B.P., Boom, G., Akkermans, R.P., Grol, R.P., Folgering, H.T., Randomized controlled economic evaluation of asthma self-management in primary health care (2002) Am J Respir Crit Care Med., 166, pp. 1062-1072; Shelledy, D.C., Legrand, T.S., Gardner, D.D., Peters, J.I., A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care (2009) J Asthma., 46, pp. 194-201; Sundberg, R., Tunsater, A., Palmqvist, M., Ellbjar, S., Lowhagen, O., Toren, K., A randomized controlled study of a computerized limited education program among young adults with asthma (2005) Respir Med., 99, pp. 321-328; Meer, V., Hout, W.B., Bakker, M.J., Rabe, K.F., Sterk, P.J., Assendelft, W.J., Cost-effectiveness of Internet-based self-management compared with usual care in asthma (2011) PLoS One., 6; Yilmaz, A., Akkaya, E., Evaluation of long-term efficacy of an asthma education programme in an out-patient clinic (2002) Respir Med., 96, pp. 519-524; Yoon, R., McKenzie, D.K., Bauman, A., Miles, D.A., Controlled trial evaluation of an asthma education programme for adults (1993) Thorax., 48, pp. 1110-1116; Bodenheimer, T., Wagner, E., Grumbach, K., Improving primary care for patients with chronic illness: the chronic care model (2002) JAMA., 288, pp. 1775-1779; Ring, N., Jepson, R., Hoskins, G., Wilson, C., Pinnock, H., Sheikh, A., Understanding what helps or hinders asthma action plan use: a systematic review and synthesis of the qualitative literature (2011) Pat Ed Counsel., 85, pp. e131-e143; Fleming, E., Gillibrand, W., An exploration of culture, diabetes, and nursing in the South Asian community: a metasynthesis of qualitative studies (2009) J Transcult Nurs., 20, p. 146; Nam, S., Janson, S.L., Stotts, N.A., Chesla, C., Kroon, L., Effect of culturally tailored diabetes education in ethnic minorities with type 2 diabetes: a meta-analysis (2012) J Cardiovasc Nurs., 27, pp. 505-518; Marshall, I.J., Wolfe, C.D.A., McKevitt, C., Lay perspectives on hypertension and drug adherence: systematic review of qualitative research (2012) BMJ., 344; Pérez-Escamilla, R., Hromi-Fiedler, A., Vega-López, S., Bermúdez-Millán, A., Segura-Pérez, S., Impact of peer nutrition education on dietary behaviors and health outcomes among Latinos: a systematic literature review (2008) J Nutr Educ Behav., 40, pp. 208-226; Grading quality of evidence and strength of recommendations (2004) BMJ, 328, pp. 1490-1494; Ayling, K., Brierley, S., Johnson, B., Heller, S., Eiser, C., How standard is standard care? Exploring control group outcomes in behaviour change interventions for young people with type 1 diabetes (2015) Psychol Health., 3, pp. 85-103; Bruin, M., Viechtbauer, W., Schaalma, H.P., Kok, G., Abraham, C., Hospers, H.J., Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials (2010) Arch Intern Med., 170, pp. 240-250},
correspondence_address1={Pinnock, H.; Usher Institute of Population Health Sciences and Informatics, Doorway 3, Medical School, Teviot Place, United Kingdom; email: hilary.pinnock@ed.ac.uk},
publisher={BioMed Central Ltd},
issn={17417015},
pubmed_id={28302126},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Dyer2018295,
author={Dyer, S.M. and Harrison, S.L. and Laver, K. and Whitehead, C. and Crotty, M.},
title={An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia},
journal={International Psychogeriatrics},
year={2018},
volume={30},
number={3},
pages={295-309},
doi={10.1017/S1041610217002344},
note={cited By 141},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034616870&doi=10.1017%2fS1041610217002344&partnerID=40&md5=69d5b43a8d25b694c006aa796033f395},
affiliation={Department of Rehabilitation, Aged and Extended Care, Faculty of Medicine, Nursing and Health Sciences, School of Health Sciences, Flinders University, Repatriation General Hospital, Daws Road, Daw Park, SA  5041, Australia; NHMRC Cognitive Decline Partnership Centre, University of Sydney, Sydney, NSW, Australia},
abstract={Background: This systematic overview reports findings from systematic reviews of randomized controlled trials of pharmacological and non-pharmacological interventions for behavioural and psychological symptoms of dementia (BPSD).Methods: The Cochrane Database of Systematic Reviews, DARE, Medline, EMBASE, and PsycINFO were searched to September 2015.Results: Fifteen systematic reviews of eighteen different interventions were included. A significant improvement in BPSD was seen with: functional analysis-based interventions (GRADE quality of evidence moderate; standardized mean difference (SMD) -0.10, 95%CI -0.20 to 0.00), music therapy (low; SMD -0.49, 95%CI -0.82 to -0.17), analgesics (low; SMD -0.24, 95%CI -0.47 to -0.01), donepezil (high; SMD -0.15 95% CI -0.29 to -0.01), galantamine (high; SMD -0.15, 95%CI -0.28 to -0.03), and antipsychotics (high; SMD -0.13, 95%CI -0.21 to -0.06). The estimate of effect size for most interventions was small.Conclusions: Although some pharmacological interventions had a slightly larger effect size, current evidence suggests functional analysis-based interventions should be used as first line management of BPSD whenever possible due to the lack of associated adverse events. Music therapy may also be beneficial, but further research is required as the quality of evidence to support its use is low. Cholinesterase inhibitors donepezil and galantamine should be trialled for the management of BPSD where non-pharmacological treatments have failed. Low-quality evidence suggests that assessment of pain should be conducted and a stepped analgesic approach trialled when appropriate. Antipsychotics have proven effectiveness but should be avoided where possible due to the high risk of serious adverse events and availability of safer alternatives. Copyright © International Psychogeriatric Association 2017.},
author_keywords={antipsychotics;  behavioral symptoms;  cholinesterase inhibitors;  complementary therapies;  dementia;  systematic review},
keywords={analgesic agent;  atypical antipsychotic agent;  donepezil;  galantamine;  melatonin;  memantine;  neuroleptic agent;  rivastigmine;  sertraline;  valproate semisodium;  cholinesterase inhibitor, adverse event;  aromatherapy;  behavior disorder;  dementia;  drug efficacy;  evidence based medicine;  functional assessment;  human;  memory;  mental disease;  music therapy;  pain assessment;  randomized controlled trial (topic);  Review;  systematic review;  systematic review (topic);  alternative medicine;  behavior;  complication;  dementia;  mental disease;  music therapy;  psychology, Antipsychotic Agents;  Behavioral Symptoms;  Cholinesterase Inhibitors;  Complementary Therapies;  Dementia;  Humans;  Mental Disorders;  Music Therapy;  Randomized Controlled Trials as Topic},
chemicals_cas={donepezil, 120011-70-3, 120014-06-4, 142057-77-0; galantamine, 1953-04-4, 357-70-0; melatonin, 73-31-4; memantine, 19982-08-2, 41100-52-1, 51052-62-1; rivastigmine, 129101-54-8, 123441-03-2; sertraline, 79617-96-2; valproate semisodium, 76584-70-8; Antipsychotic Agents; Cholinesterase Inhibitors},
references={(2009) World Alzheimer Report 2009, , Alzheimer's Disease International; (2015) Alzheimer's Disease International, , World Alzheimer Report 2015; American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults (2015) Journal of the American Geriatrics Society, 63, pp. 2227-2246. , American Geriatrics Society Beers Criteria Update Expert Panel; Azermai, M., Petrovic, M., Elseviers, M.M., Bourgeois, J., Van Bortel, L.M., Vander Stichele, R.H., Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms (2012) Ageing Research Reviews, 11, pp. 78-86; Ballard, C.G., O'Brien, J.T., Reichelt, K., Perry, E.K., Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind placebo-controlled trial with Melissa (2002) Journal of Clinical Psychiatry, 63, pp. 553-558; Burns, A., A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease (2011) Dementia and Geriatric Cognitive Disorders, 31, pp. 158-164; Cerejeira, J., Lagarto, L., Mukaetova-Ladinska, E.B., Behavioral and psychological symptoms of dementia (2012) Frontiers of Neurology, 3, p. 73; Chen, Y., Briesacher, B.A., Field, T.S., Tjia, J., Lau, D.T., Gurwitz, J.H., Unexplained variation across US nursing homes in antipsychotic prescribing rates (2010) Archives of Internal Medicine, 170, pp. 89-95; Collaboration, C., RevMan (2014) Informatics and Knowledge Management Department; Corbett, A., Ballard, C., Antipsychotics and mortality in dementia (2012) American Journal of Psychiatry, 169, pp. 7-9; Douglas, I.J., Smeeth, L., Exposure to antipsychotics and risk of stroke: Self controlled case series study (2008) BMJ, 337, p. a1227; Forbes, D., Forbes, S.C., Blake, C.M., Thiessen, E.J., Forbes, S., Exercise programs for people with dementia (2015) Cochrane Database of Systematic Reviews, 4, p. CD006489; Forrester, L.T., Maayan, N., Orrell, M., Spector, A.E., Buchan, L.D., Soares-Weiser, K., Aromatherapy for dementia (2014) Cochrane Database of Systematic Reviews, 2, p. CD003150; (2016) Clinical Practice Guidelines and Principles of Care for People with Dementia, , http://www.clinicalguidelines.gov.au/portal/2503/clinical-practice-guidelines-and-principles-carepeople-dementia, Guideline Adaptation Committee Sydney: NHMRC Cognitive Decline Partnership Centre; Guyatt, G., GRADE guidelines: 1 Introduction-GRADE evidence profiles and summary of findings tables (2011) Journal of Clinical Epidemiology, 64, pp. 383-394; Higgins, J., Green, S., (2011) Cochrane Handbook for Systematic Reviews of Interventions, , London, UK: The Cochrane Collaboration; Hurt, C., Patient and caregiver perspectives of quality of life in dementia An investigation of the relationship to behavioural and psychological symptoms in dementia (2008) Dementia and Geriatric Cognitive Disorders, 26, pp. 138-146; Jansen, S., Forbes, D., Duncan, V., Morgan Debra, G., Malouf, R., Melatonin for the treatment of dementia (2011) Cochrane Database of Systematic Reviews, 1, p. CD003802; Laver, K., Dyer, S., Whitehead, C., Clemson, L., Crotty, M., Interventions to delay functional decline in people with dementia: A systematic review of systematic reviews (2016) BMJ Open, 6, p. e010767; Lyketsos, C.G., Steinberg, M., Tschanz, J.T., Norton, M.C., Steffens, D.C., Breitner, J.C., Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in aging (2000) American Journal of Psychiatry, 157, pp. 708-714; Ma, H., The efficacy and safety of atypical antipsychotics for the treatment of dementia: A meta-analysis of randomized placebo-controlled trials (2014) Journal of Alzheimer's Disease, 42, pp. 915-937; Moher, D., Altman, D.G., Liberati, A., Tetzlaff, J., PRISMA statement (2011) Epidemiology, 22, p. 128; Moniz Cook, E.D., Swift, K., James, I., Malouf, R., De Vugt, M., Verhey, F., Functional analysis-based interventions for challenging behaviour in dementia (2012) Cochrane Database of Systematic Reviews, 2, p. CD006929; Moore, M., Zhu, C., Clipp, E., Informal costs of dementia care: Estimates from the national longitudinal caregiver study (2001) Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 56, pp. S219-S228; (2007) Dementia A NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, , National Institute for Health and Clinical Excellence-Social Care Institute for Excellence. London, UK: National Clinical Practice Guideline London; Nelson, J., Devanand, D.P., A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia (2011) Journal of the American Geriatrics Society, 59, pp. 577-585; Orgeta, V., Qazi, A., Spector, A.E., Orrell, M., Psychological treatments for depression and anxiety in dementia and mild cognitive impairment (2014) Cochrane Database of Systematic Reviews, 1, p. CD009125; Pieper, M.J.C., Interventions targeting pain or behaviour in dementia: A systematic review (2013) Ageing Research Reviews, 12, pp. 1042-1055; Savva, G.M., Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population (2009) British Journal of Psychiatry, 194, pp. 212-219; Schneider, L.S., Dagerman, K.S., Insel, P., Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials (2005) JAMA, 294, pp. 1934-1943; Seitz, D.P., Adunuri, N., Gill Sudeep, S., Gruneir, A., Herrmann, N., Rochon, P., Antidepressants for agitation and psychosis in dementia (2011) Cochrane Database of Systematic Reviews, 2, p. CD008191; Seitz, D.P., Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: A systematic review (2013) International Psychogeriatrics, 25, pp. 185-203; Shea, B.J., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Medical Research Methodology, 7, p. 10; Steele, C., Rovner, B., Chase, G.A., Folstein, M., Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease (1990) American Journal of Psychiatry, 147, pp. 1049-1051; Tan, C.C., Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: A systematic review and meta-analysis (Provisional abstract) (2014) Journal of Alzheimer's Disease, 41, pp. 615-631; Ueda, T., Suzukamo, Y., Sato, M., Izumi, S., Effects of music therapy on behavioral and psychological symptoms of dementia: A systematic review and meta-analysis (2013) Ageing Research Reviews, 12, pp. 628-641; Van'T Leven, N., Prick, A.E., Groenewoud, J.G., Roelofs, P.D., Lange, J., Pot, A.M., Dyadic interventions for community-dwelling people with dementia and their family caregivers: A systematic review (Provisional abstract) (2013) International Psychogeriatrics, 25, pp. 1581-1603; Woods, B., Aguirre, E., Spector, A.E., AndOrrell, M., Cognitive stimulation to improve cognitive functioning in people with dementia (2012) Cochrane Database of Systematic Reviews, 2, p. CD005562; Woods, B., Spector, A., Jones, C., Orrell, M., Davies, S., Reminiscence therapy for dementia (2005) Cochrane Database of Systematic Reviews, 2, p. CD001120},
correspondence_address1={Dyer, S.M.; Department of Rehabilitation, Daws Road, Australia; email: sue.dyer@flinders.edu.au},
publisher={Cambridge University Press},
issn={10416102},
coden={INPSE},
pubmed_id={29143695},
language={English},
abbrev_source_title={Int. Psychogeriatr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Bellou2017406,
author={Bellou, V. and Belbasis, L. and Tzoulaki, I. and Middleton, L.T. and Ioannidis, J.P.A. and Evangelou, E.},
title={Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses},
journal={Alzheimer's and Dementia},
year={2017},
volume={13},
number={4},
pages={406-418},
doi={10.1016/j.jalz.2016.07.152},
note={cited By 140},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85000470579&doi=10.1016%2fj.jalz.2016.07.152&partnerID=40&md5=428d7e99558fdcd3272824c5e7818fe5},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, United Kingdom; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={Introduction Dementia is a heterogeneous neurodegenerative disease, whose etiology results from a complex interplay between environmental and genetic factors. Methods We searched PubMed to identify meta-analyses of observational studies that examined associations between nongenetic factors and dementia. We estimated the summary effect size using random-effects and fixed-effects model, the 95% CI, and the 95% prediction interval. We assessed the between-study heterogeneity (I-square), evidence of small-study effects, and excess significance. Results A total of 76 unique associations were examined. By applying standardized criteria, seven associations presented convincing evidence. These associations pertained to benzodiazepines use, depression at any age, late-life depression, and frequency of social contacts for all types of dementia; late-life depression for Alzheimer's disease; and type 2 diabetes mellitus for vascular dementia and Alzheimer's disease. Discussion Several risk factors present substantial evidence for association with dementia and should be assessed as potential targets for interventions, but these associations may not necessarily be causal. © 2016 the Alzheimer's Association},
author_keywords={Alzheimer's disease;  Dementia;  Epidemiology;  Risk factors;  Umbrella review},
keywords={Alzheimer disease;  Article;  dementia;  environmental factor;  heredity;  human;  late life depression;  multiinfarct dementia;  neurosis;  non insulin dependent diabetes mellitus;  observational study;  physical activity;  priority journal;  sensitivity analysis;  social behavior;  systematic review;  complication;  dementia;  literature;  meta analysis (topic);  risk factor, Dementia;  Humans;  Meta-Analysis as Topic;  Review Literature as Topic;  Risk Factors},
references={World Alzheimer's report 2015: The global impact of dementia (2015), Alzheimer's Disease International London; Gauthier, S., Albert, M., Fox, N., Goedert, M., Kivipelto, M., Mestre-Ferrandiz, J., Why has therapy development for dementia failed in the last two decades? (2016) Alzheimers Dement, 12, pp. 60-64; G8 Dementia Summit Declaration (2013), G8 Summit London; Norton, S., Matthews, F.E., Barnes, D.E., Yaffe, K., Brayne, C., Potential for primary prevention of Alzheimer's disease: An analysis of population-based data (2014) Lancet Neurol, 13, pp. 788-794; Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence (2011) Lancet Neurol, 10, pp. 819-828; Qiu, C., von Strauss, E., Bäckman, L., Winblad, B., Fratiglioni, L., Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden (2013) Neurology, 80, pp. 1888-1894; Schrijvers, E.M., Verhaaren, B.F., Koudstaal, P.J., Hofman, A., Ikram, M.A., Breteler, M.M., Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study (2012) Neurology, 78, pp. 1456-1463; Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson, L., A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II (2013) Lancet, 382, pp. 1405-1412; Satizabal, C.L., Beiser, A.S., Chouraki, V., Chêne, G., Dufouil, C., Seshadri, S., Incidence of Dementia over Three Decades in the Framingham Heart Study (2016) N Engl J Med, 374, pp. 523-532; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Belbasis, L., Bellou, V., Evangelou, E., Environmental Risk Factors and Amyotrophic Lateral Sclerosis: An Umbrella Review and Critical Assessment of Current Evidence from Systematic Reviews and Meta-Analyses of Observational Studies (2016) Neuroepidemiology, 46, pp. 96-105; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database (2007) Nat Genet, 39, pp. 17-23; Dwyer, R., Skrobot, O.A., Dwyer, J., Munafo, M., Kehoe, P.G., Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment (2013) J Alzheimers Dis, 34, pp. 145-154; Ioannidis, J.P.A., Boffetta, P., Little, J., O'Brien, T.R., Uitterlinden, A.G., Vineis, P., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) Int J Epidemiol, 37, pp. 120-132; Belbasis, L., Panagiotou, O.A., Dosis, V., Evangelou, E., A systematic appraisal of field synopses in genetic epidemiology: a HuGE review (2015) Am J Epidemiol, 181, pp. 1-16; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172, pp. 137-159; Higgins, J.P., Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Cochran, W.G., The Combination of Estimates from Different Experiments (1954) Biometrics, 10, p. 101; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; Sterne, J.A.C., Sutton, A.J., Ioannidis, J.P.A., Terrin, N., Jones, D.R., Lau, J., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am J Epidemiol, 131, pp. 552-566; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22, pp. 450-456; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci U S A, 110, pp. 19313-19317; Anstey, K.J., Mack, H.A., Cherbuin, N., Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies (2009) Am J Geriatr Psychiatry, 17, pp. 542-555; Anstey, K.J., Cherbuin, N., Budge, M., Young, J., Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies (2011) Obes Rev, 12, pp. e426-e437; Beckett, M.W., Ardern, C.I., Rotondi, M.A., A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer's disease in older adults (2015) BMC Geriatr, 15, p. 9; Cataldo, J.K., Prochaska, J.J., Glantz, S.A., Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation (2010) J Alzheimers Dis, 19, pp. 465-480; Chang-Quan, H., Hui, W., Chao-Min, W., Zheng-Rong, W., Jun-Wen, G., Yong-Hong, L., The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies (2011) Int J Clin Pract, 65, pp. 1295-1305; da Silva, J., Goncalves-Pereira, M., Xavier, M., Mukaetova-Ladinska, E.B., Affective disorders and risk of developing dementia: systematic review (2013) Br J Psychiatry, 202, pp. 177-186; Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A., Reynolds, C.F., Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies (2013) Br J Psychiatry, 202, pp. 329-335; García, A.M., Sisternas, A., Hoyos, S.P., Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: A meta-analysis (2008) Int J Epidemiol, 37, pp. 329-340; Gudala, K., Bansal, D., Schifano, F., Bhansali, A., Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies (2013) J Diabetes Investig, 4, pp. 640-650; Kim, Y.S., Kwak, S.M., Myung, S.K., Caffeine intake from coffee or tea and cognitive disorders: a meta-analysis of observational studies (2015) Neuroepidemiology, 44, pp. 51-63; Li, F.J., Shen, L., Ji, H.F., Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis (2012) J Alzheimers Dis, 31, pp. 253-258; Maheshwari, P., Eslick, G.D., Bacterial infection and Alzheimer's disease: a meta-analysis (2015) J Alzheimers Dis, 43, pp. 957-966; Meng, X., D'Arcy, C., Education and Dementia in the Context of the Cognitive Reserve Hypothesis: A Systematic Review with Meta-Analyses and Qualitative Analyses (2012) PLoS One, 7, p. e38268; Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis (2014) J Alzheimers Dis, 42, pp. 1295-1310; O'Brien, J., Jackson, J.W., Grodstein, F., Blacker, D., Weuve, J., Postmenopausal Hormone Therapy Is Not Associated With Risk of All-Cause Dementia and Alzheimer's Disease (2014) Epidemiol Rev, 36, pp. 83-103; Perry, D.C., Sturm, V.E., Peterson, M.J., Pieper, C.F., Bullock, T., Boeve, B.F., Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis (2016) J Neurosurg, 124, pp. 511-526; Peters, R., Booth, A., Peters, J., A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly (2014) J Hypertens, 32, pp. 1945-1957. , discussion 1957–8; Power, M.C., Weuve, J., Gagne, J.J., McQueen, M.B., Viswanathan, A., Blacker, D., The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis (2011) Epidemiology, 22, pp. 646-659; Richardson, K., Schoen, M., French, B., Umscheid, C.A., Mitchell, M.D., Arnold, S.E., Statins and cognitive function: a systematic review (2013) Ann Intern Med, 159, pp. 688-697; Seitz, D.P., Shah, P.S., Herrmann, N., Beyene, J., Siddiqui, N., Exposure to general anesthesia and risk of alzheimer's disease: a systematic review and meta-analysis (2011) BMC Geriatr, 11, p. 83; Steel, A.J., Eslick, G.D., Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis (2015) J Alzheimers Dis, 47, pp. 351-364; Terracciano, A., Sutin, A.R., An, Y., O'Brien, R.J., Ferrucci, L., Zonderman, A.B., Personality and risk of Alzheimer's disease: New data and meta-analysis (2014) Alzheimers Dement, 10, pp. 179-186; Virk, S.A., Eslick, G.D., Brief Report: Meta-analysis of Antacid Use and Alzheimer's Disease: Implications for the Aluminum Hypothesis (2015) Epidemiology, 26, pp. 769-773; Wang, J., Tan, L., Wang, H.-F., Tan, C.-C., Meng, X.-F., Wang, C., Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis (2015) J Alzheimers Dis, 44, pp. 385-396; Wang, Z., Wei, X., Yang, J., Suo, J., Chen, J., Liu, X., Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis (2016) Neurosci Lett, 610, pp. 200-206; Zhang, Q., Guo, S., Zhang, X., Tang, S., Shao, W., Han, X., Inverse relationship between cancer and Alzheimer's disease: a systemic review meta-analysis (2015) Neurol Sci, 36, pp. 1987-1994; Zhang, Y., Chen, J., Qiu, J., Li, Y., Wang, J., Jiao, J., Intakes of fish and PUFAs and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies (2016) Am J Clin Nutr, 103, pp. 330-340; Zhou, J., Yu, J.T., Wang, H.-F., Meng, X.-F., Tan, C.-C., Wang, J., Association between stroke and Alzheimer's disease: systematic review and meta-analysis (2015) J Alzheimers Dis, 43, pp. 479-489; Blondell, S.J., Hammersley-Mather, R., Veerman, J., Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies (2014) BMC Public Health, 14, p. 510; Kuiper, J.S., Zuidersma, M., Oude Voshaar, R.C., Zuidema, S.U., van den Heuvel, E.R., Stolk, R.P., Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies (2015) Ageing Res Rev, 22, pp. 39-57; Levi Marpillat, N., Macquin-Mavier, I., Tropeano, A.I., Bachoud-Levi, A.C., Maison, P., Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis (2013) J Hypertens, 31, pp. 1073-1082; Loef, M., Walach, H., Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China (2013) Obesity (Silver Spring), 21, pp. E51-E55; Pedditizi, E., Peters, R., Beckett, N., The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies (2016) Age Ageing, 45, pp. 14-21; Russ, T.C., Batty, G.D., Hearnshaw, G.F., Fenton, C., Starr, J.M., Geographical variation in dementia: Systematic review with meta-analysis (2012) Int J Epidemiol, 41, pp. 1012-1032; Santangeli, P., Di Biase, L., Bai, R., Mohanty, S., Pump, A., Cereceda Brantes, M., Atrial fibrillation and the risk of incident dementia: A meta-analysis (2012) Heart Rhythm, 9, pp. 1761-1768.e2; Shen, T., Lv, J., Wang, L., Wang, W., Zhang, D., Association between tooth loss and dementia among older people: a meta-analysis (2016) Int J Geriatr Psychiatry, 31, pp. 953-955; Ungprasert, P., Wijarnpreecha, K., Thongprayoon, C., Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis (2016) Neurol India, 64, pp. 56-61; Wu, S., Ding, Y., Wu, F., Li, R., Hou, J., Mao, P., Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: A meta-analysis (2015) Neurosci Biobehav Rev, 48, pp. 1-9; Zhong, G., Wang, Y., Zhang, Y., Zhao, Y., Association between Benzodiazepine Use and Dementia: A Meta-Analysis (2015) PLoS One, 10, p. e0127836; Zhong, G., Wang, Y., Zhang, Y., Guo, J.J., Zhao, Y., Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers (2015) PLoS One, 10, p. e0118333; Aarsland, D., Sardahaee, F.S., Anderssen, S., Ballard, C., Is physical activity a potential preventive factor for vascular dementia? A systematic review (2010) Aging Ment Health, 14, pp. 386-395; Beydoun, M.A., Beydoun, H.A., Wang, Y., Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis (2008) Obes Rev, 9, pp. 204-218; Sharp, S.I., Aarsland, D., Day, S., Sønnesyn, H., Ballard, C., Hypertension is a potential risk factor for vascular dementia: systematic review (2011) Int J Geriatr Psychiatry, 26, pp. 661-669; McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, pp. 939-944; McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Kawas, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 263-269; Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, J.R., Dartigues, J.F., Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group (2000) Neurology, 54, pp. S10-S15; Schneider, J.A., Arvanitakis, Z., Bang, W., Bennett, D.A., Mixed brain pathologies account for most dementia cases in community-dwelling older persons (2007) Neurology, 69, pp. 2197-2204; Byers, A.L., Yaffe, K., Depression and risk of developing dementia (2011) Nat Rev Neurol, 7, pp. 323-331; Barnes, D.E., Yaffe, K., Byers, A.L., McCormick, M., Schaefer, C., Whitmer, R.A., Midlife vs Late-Life Depressive Symptoms and Risk of Dementia: Differential Effects for Alzheimer Disease and Vascular Dementia (2012) Arch Gen Psychiatry, 69, pp. 493-498; O'Brien, J.T., Thomas, A., Vascular dementia (2015) Lancet, 386, pp. 1698-1706; Jellinger, K.A., Morphologic diagnosis of ‘vascular dementia’ - a critical update (2008) J Neurol Sci, 270, pp. 1-12; Gorelick, P.B., Scuteri, A., Black, S.E., DeCarli, C., Greenberg, S.M., Iadecola, C., Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) Stroke, 42, pp. 2672-2713; Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial (2015) Lancet, 385, pp. 2255-2263; Lautenschlager, N.T., Cox, K.L., Flicker, L., Foster, J.K., van Bockxmeer, F.M., Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease (2008) JAMA, 300, pp. 1027-1037; Fratiglioni, L., Wang, H.X., Brain reserve hypothesis in dementia (2007) J Alzheimers Dis, 12, pp. 11-22; Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Benzodiazepine use and risk of Alzheimer's disease: case-control study (2014) BMJ, 349, p. g5205; Barbui, C., Gastaldon, C., Cipriani, A., Benzodiazepines and risk of dementia: true association or reverse causation? (2013) Epidemiol Psychiatr Sci, 22, pp. 307-308; Gray, S.L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R.A., Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study (2016) BMJ, 352, p. i90; Prasad, V., Jorgenson, J., Ioannidis, J.P., Cifu, A., Observational studies often make clinical practice recommendations: an empirical evaluation of authors’ attitudes (2013) J Clin Epidemiol, 66. , 361-366.e4},
correspondence_address1={Evangelou, E.; Department of Hygiene and Epidemiology, Greece; email: vangelis@cc.uoi.gr},
publisher={Elsevier Inc.},
issn={15525260},
pubmed_id={27599208},
language={English},
abbrev_source_title={Alzheimer's Dementia},
document_type={Article},
source={Scopus},
}

@ARTICLE{O'Sullivan2018,
author={O'Sullivan, J.W. and Muntinga, T. and Grigg, S. and Ioannidis, J.P.A.},
title={Prevalence and outcomes of incidental imaging findings: Umbrella review},
journal={BMJ (Online)},
year={2018},
volume={361},
doi={10.1136/bmj.k2387},
art_number={k2387},
note={cited By 137},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048756545&doi=10.1136%2fbmj.k2387&partnerID=40&md5=3731aac8a3899f64ee65669fc04ca316},
affiliation={Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, United Kingdom; University of MelbourneVIC, Australia; Stanford Prevention Research Center, Stanford University, School of Medicine, Stanford, CA, United States; Department of Health Research and Policy, Stanford University, School of Medicine, Stanford, CA, United States; Department of Biomedical Data Science, Stanford University, School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University, School of Humanities and Sciences, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, United States},
abstract={Objective To provide an overview of the evidence on prevalence and outcomes of incidental imaging findings. Design Umbrella review of systematic reviews. Data sources Searches of MEDLINE, EMBASE up to August 2017; screening of references in included papers. Eligibility criteria Criteria included systematic reviews and meta-analyses of observational studies that gave a prevalence of incidental abnormalities ("incidentalomas"). An incidental imaging finding was defined as an imaging abnormality in a healthy, asymptomatic patient or an imaging abnormality in a symptomatic patient, where the abnormality was not apparently related to the patient's symptoms. Primary studies that measured the prevalence of incidentalomas in patients with a history of malignancy were also considered in sensitivity analyses. Results 20 systematic reviews (240 primary studies) were identified from 7098 references from the database search. Fifteen systematic reviews provided data to quantify the prevalence of incidentalomas, whereas 18 provided data to quantify the outcomes of incidentalomas (13 provided both). The prevalence of incidentalomas varied substantially between imaging tests; it was less than 5% for chest computed tomography for incidental pulmonary embolism in patients with and without cancer and whole body positron emission tomography (PET) or PET/computed tomography (for patients with and without cancer). Conversely, incidentalomas occurred in more than a third of images in cardiac magnetic resonance imaging (MRI), chest computed tomography (for incidentalomas of thorax, abdomen, spine, or heart), and computed tomography colonoscopy (for extra-colonic incidentalomas). Intermediate rates occurred with MRI of the spine (22%) and brain (22%). The rate of malignancy in incidentalomas varied substantially between organs; the prevalence of malignancy was less than 5% in incidentalomas of the brain, parotid, and adrenal gland. Extra-colonic, prostatic, and colonic incidentalomas were malignant between 10% and 20% of the time, whereas renal, thyroid, and ovarian incidentalomas were malignant around a quarter of the time. Breast incidentalomas had the highest percentage of malignancy (42%, 95% confidence interval 31% to 54%). Many assessments had high between-study heterogeneity (15 of 20 meta-analyses with I 2 >50%). Conclusions There is large variability across different imaging techniques both in the prevalence of incidentalomas and in the prevalence of malignancy for specific organs. This umbrella review will aid clinicians and patients weigh up the pros and cons of requesting imaging scans and will help with management decisions after an incidentaloma diagnosis. Our results can underpin the creation of guidelines to assist these decisions. Systematic review registration PROSPERO: CRD42017075679. © Published by the BMJ Publishing Group Limited.},
keywords={abdominal cancer;  adrenal cancer;  Article;  brain cancer;  cardiovascular magnetic resonance;  colon cancer;  colonoscopy;  computer assisted tomography;  heart cancer;  human;  imaging;  incidental finding;  incidental imaging finding;  incidentaloma;  kidney cancer;  lung embolism;  medical history;  meta analysis;  outcome assessment;  ovary cancer;  parotid gland cancer;  positron emission tomography;  positron emission tomography-computed tomography;  practice guideline;  prevalence;  priority journal;  prostate cancer;  sensitivity analysis;  spine cancer;  systematic review;  thorax cancer;  thorax radiography;  thyroid cancer;  diagnostic imaging;  statistics and numerical data;  treatment outcome, Diagnostic Imaging;  Humans;  Incidental Findings;  Prevalence;  Treatment Outcome},
funding_details={Laura and John Arnold FoundationLaura and John Arnold Foundation, LJAF},
funding_text 1={Funding: This study did not receive any specific funding. The Meta-Research Innovation Center at Stanford (METRICS) has been funded by the Laura and John Arnold Foundation. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: Not required. Data sharing: We extracted data from published systematic reviews, all of which are available and accessible. The manuscript’s guarantor affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.},
references={Freda, P.U., Beckers, A.M., Katznelson, L., Pituitary incidentaloma: An endocrine society clinical practice guideline (2011) J Clin Endocrinol Metab, 96, pp. 894-904. , Endocrine Society; Young, W.F., Jr., Clinical practice the incidentally discovered adrenal mass (2007) N Engl J Med, 356, pp. 601-610; Hitzeman, N., Cotton, E., Incidentalomas: Initial management (2014) Am Fam Physician, 90, pp. 784-789; Weiner, C., Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues) (2014) Am J Epidemiol, 180, pp. 562-564; Smith-Bindman, R., Miglioretti, D.L., Larson, E.B., Rising use of diagnostic medical imaging in a large integrated health system (2008) Health Aff (Millwood), 27, pp. 1491-1502; O'Sullivan, J.W., Albasri, A., Nicholson, B.D., Overtesting and undertesting in primary care: A systematic review and meta-analysis (2018) BMJ Open, 8, p. e018557; Morris, Z., Whiteley, W.N., Longstreth, W.T., Jr., Incidental findings on brain magnetic resonance imaging: Systematic review and metaanalysis (2009) BMJ, 339, p. b3016; Flor, N., Di Leo, G., Squarza, S.A.C., Malignant incidental extracardiac findings on cardiac CT: Systematic review and metaanalysis (2013) AJR Am J Roentgenol, 201, pp. 555-564; Xiong, T., Richardson, M., Woodroffe, R., Halligan, S., Morton, D., Lilford, R.J., Incidental lesions found on CT colonography: Their nature and frequency (2005) Br J Radiol, 78, pp. 22-29; Powell, D.K., Patient explanation guidelines for incidentalomas: Helping patients not to fear the delayed surveillance (2014) AJR Am J Roentgenol, 202, p. W602; Kole, J., Fiester, A., Incidental findings and the need for a revised informed consent process (2013) AJR Am J Roentgenol, 201, pp. 1064-1068; Sexton, S.M., How should we manage incidentalomas? (2014) Am Fam Physician, 90, pp. 758-759. , https://www.aafp.org/afp/2014/1201/p758.html#afp20141201p758-b2; Zeiger, M.A., Thompson, G.B., Duh, Q.-Y., American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas: Executive summary of recommendations (2009) Endocr Pract, 15, pp. 450-453. , American Association of Clinical Endocrinologists, American Association of Endocrine Surgeons; Fassnacht, M., Arlt, W., Bancos, I., Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors (2016) Eur J Endocrinol, 175, pp. G1-34; Patel, M.D., Ascher, S.M., Paspulati, R.M., Managing incidental findings on abdominal and pelvic CT and MRI, part 1: White paper of the ACR Incidental Findings Committee II on adnexal findings (2013) J Am Coll Radiol, 10, pp. 675-681; Hoang, J.K., Langer, J.E., Middleton, W.D., Managing incidental thyroid nodules detected on imaging: White paper of the ACR Incidental Thyroid Findings Committee (2015) J Am Coll Radiol, 12, pp. 143-150; Smith, A.D., Remer, E.M., Cox, K.L., Bosniak category IIF and III cystic renal lesions: Outcomes and associations (2012) Radiology, 262, pp. 152-160; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826. , http://annals.org/article.aspx?articleid=710939; Barendregt, J.J., Doi, S.A., Lee, Y.Y., Norman, R.E., Vos, T., Meta-analysis of prevalence (2013) J Epidemiol Community Health, 67, pp. 974-978; Doi, S.A.R., Barendregt, J.J., Khan, S., Thalib, L., Williams, G.M., Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model (2015) Contemp Clin Trials, 45, pp. 130-138; Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327, pp. 557-560; Higgins, J.P.T., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc ser A Stat Soc, 172, pp. 137-159; IntHout, J., Ioannidis, J.P., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) BMJ Open, 6, p. e010247; Patsopoulos, N.A., Evangelou, E., Jpa, I., Sensitivity of between-study heterogeneity in meta-analysis: Proposed metrics and empirical evaluation (2008) Int J Epidemiol, 37, pp. 1148-1157; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Nayan, S., Ramakrishna, J., Gupta, M.K., The proportion of malignancy in incidental thyroid lesions on 18-FDG PET Study (2014) Otolaryngol Head Neck Surg, 151, pp. 190-200; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Treglia, G., Taralli, S., Salsano, M., Muoio, B., Sadeghi, R., Giovanella, L., Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: A meta-analysis (2014) Radiol Oncol, 48, pp. 99-104; Kousgaard, S.J., Thorlacius-Ussing, O., Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: A systematic review (2017) Tech Coloproctol, 21, pp. 521-529; Treglia, G., Bertagna, F., Sadeghi, R., Muoio, B., Giovanella, L., Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: A meta-analysis (2015) Eur Arch Otorhinolaryngol, 272, pp. 3617-3626; Bertagna, F., Treglia, G., Orlando, E., Prevalence and clinical significance of incidental F18-FDG breast uptake: A systematic review and meta-analysis (2014) Jpn J Radiol, 32, pp. 59-68; Takashima, K., Takimoto, Y., Nakazawa, E., Discovery and informing research participants of incidental findings detected in brain magnetic resonance imaging studies: Review and multiinstitutional study (2017) Brain Behav, 7, p. e00676; Dunet, V., Schwitter, J., Meuli, R., Beigelman-Aubry, C., Incidental extracardiac findings on cardiac MR: Systematic review and metaanalysis (2016) J Magn Reson Imaging, 43, pp. 929-939; Dentali, F., Ageno, W., Becattini, C., Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: A meta-analysis (2010) Thromb Res, 125, pp. 518-522; Donadini, M.P., Dentali, F., Squizzato, A., Guasti, L., Ageno, W., Unsuspected pulmonary embolism in cancer patients: A narrative review with pooled data (2014) Intern Emerg Med, 9, pp. 375-384; Jacobs, P.C., Wptm, M., Grobbee, D.E., Van Der Graaf, Y., Prevalence of incidental findings in computed tomographic screening of the chest: A systematic review (2008) J Comput Assist Tomogr, 32, pp. 214-221; Ramadorai, U., Hire, J., DeVine, J.G., Brodt, E.D., Dettori, J.R., Incidental findings on magnetic resonance imaging of the spine in the asymptomatic pediatric population: A systematic review (2014) Evid Based Spine Care J, 5, pp. 95-100; Anthoulakis, C., Nikoloudis, N., Pelvic MRI as the gold standard in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: A systematic review (2014) Gynecol Oncol, 132, pp. 661-668; Volpe, A., The role of active surveillance of small renal masses (2016) Int J Surg, 36, pp. 518-524; Bach, A.G., Abbas, J., Jasaabuu, C., Schramm, D., Wienke, A., Surov, A., Comparison between incidental malignant and benign breast lesions detected by computed tomography: A systematic review (2013) J Med Imaging Radiat Oncol, 57, pp. 529-533; Fernández-Balsells, M.M., Murad, M.H., Barwise, A., Natural history of nonfunctioning pituitary adenomas and incidentalomas: A systematic review and metaanalysis (2011) J Clin Endocrinol Metab, 96, pp. 905-912; Loh, H.H., Yee, A., Loh, H.S., Sukor, N., Kamaruddin, N.A., The natural progression and outcomes of adrenal incidentaloma: A systematic review and meta-analysis (2017) Minerva Endocrinol, 42, pp. 77-87; Bertagna, F., Sadeghi, R., Giovanella, L., Incidental uptake of 18F-fluoro-deoxyglucose in the prostate gland (2014) Nucl Med (Stuttg), 53, pp. 249-258; Smith-Bindman, R., Lipson, J., Marcus, R., Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer (2009) Arch Intern Med, 169, pp. 2078-2086; Katzberg, R.W., Lamba, R., Contrast-induced nephropathy after intravenous administration: Fact or fiction (2009) Radiol Clin North Am, 47, pp. 789-800. , vt; Neptune, S.M., Hopper, K.D., Matthews, Y.L., Risks associated with the use of IV contrast material: Analysis of patients' awareness (1994) AJR Am J Roentgenol, 162, pp. 451-454; Booth, T.C., Jackson, A., Wardlaw, J.M., Taylor, S.A., Waldman, A.D., Incidental findings found in healthy volunteers during imaging performed for research: Current legal and ethical implications (2010) Br J Radiol, 83, pp. 456-465; Montori, V.M., Big Science for patient centred care (2017) BMJ, 359, p. j5600; Berger, Z.D., Brito, J.P., Ospina, N.S., Patient centred diagnosis: Sharing diagnostic decisions with patients in clinical practice (2017) BMJ, 359, p. j4218; Elwyn, G., Durand, M.A., Song, J., A three-talk model for shared decision making: Multistage consultation process (2017) BMJ, 359, p. j4891; Elwyn, G., Wieringa, S., Greenhalgh, T., Clinical encounters in the post-guidelines era (2016) BMJ, 353, p. i3200; Bosniak, M.A., Diagnosis and management of patients with complicated cystic lesions of the kidney (1997) AJR Am J Roentgenol, 169, pp. 819-821; Levine, D., Brown, D.L., Andreotti, R.F., Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement (2010) Radiology, 256, pp. 943-954; Busby, J., Schroeder, K., Woltersdorf, W., Temporal growth and geographic variation in the use of laboratory tests by NHS general practices: Using routine data to identify research priorities (2013) Br J Gen Pract, 63, pp. e256-e266; Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: An umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14, p. 147; Pereira, T.V., Patsopoulos, N.A., Salanti, G., Ioannidis, J.P., Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity (2010) Res Synth Methods, 1, pp. 149-161; Leeflang, M.M.G., Systematic reviews and meta-analyses of diagnostic test accuracy (2014) Clin Microbiol Infect, 20, pp. 105-113; Paterson, F., Theodoraki, A., Amajuoyi, A., Bouloux, P.M., Maclachlan, J., Khoo, B., Radiology reporting of adrenal incidentalomas-who requires further testing? (2014) Clin Med (Lond), 14, pp. 16-21; Lumbreras, B., Donat, L., Hernández-Aguado, I., Incidental findings in imaging diagnostic tests: A systematic review (2010) Br J Radiol, 83, pp. 276-289; Sihvonen, R., Paavola, M., Malmivaara, A., Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear (2013) N Engl J Med, 369, pp. 2515-2524. , Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group; Wartolowska, K., Judge, A., Hopewell, S., Use of placebo controls in the evaluation of surgery: Systematic review (2014) BMJ, 348, p. g3253; Jørgensen, K.J., Gøtzsche, P.C., Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends (2009) BMJ, 339, p. b2587; Park, S., Oh, C.-M., Cho, H., Association between screening and the thyroid cancer epidemic South Korea: Evidence from a nationwide study (2016) BMJ, 355, p. i5745; Brodersen, J., Schwartz, L.M., Heneghan, C., O'Sullivan, J.W., Aronson, J.K., Woloshin, S., Overdiagnosis: What it is and what it isn't (2018) BMJ Evid Based Med, 23, pp. 1-3},
correspondence_address1={O'Sullivan, J.W.; Centre for Evidence-Based Medicine, United Kingdom; email: jack.osullivan@phc.ox.ac.uk},
publisher={BMJ Publishing Group},
issn={09598146},
coden={BMJOA},
pubmed_id={29914908},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Article},
source={Scopus},
}

@ARTICLE{Wallace20202174,
author={Wallace, T.C. and Bailey, R.L. and Blumberg, J.B. and Burton-Freeman, B. and Chen, C.-Y.O. and Crowe-White, K.M. and Drewnowski, A. and Hooshmand, S. and Johnson, E. and Lewis, R. and Murray, R. and Shapses, S.A. and Wang, D.D.},
title={Fruits, vegetables, and health: A comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake},
journal={Critical Reviews in Food Science and Nutrition},
year={2020},
volume={60},
number={13},
pages={2174-2211},
doi={10.1080/10408398.2019.1632258},
note={cited By 134},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087434056&doi=10.1080%2f10408398.2019.1632258&partnerID=40&md5=1f94c27328af41f28e9825865442f6e4},
affiliation={Department of Nutrition and Food Studies, George Mason University, Fairfax, VA, United States; Think Healthy Group, Inc., Washington, DC, United States; Department of Nutrition Science, Purdue University, West Lafayette, IN, United States; Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, United States; Biofortis Research, Merieux NutriSciences, Addison, IL, United States; Center for Nutrition Research, Institute for Food Safety and Health, Illinois Institute of Technology, Bedford Park, IL, United States; Department of Human Nutrition, University of Alabama, Tuscaloosa, AL, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States; School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, United States; Bone and Body Composition Laboratory, College of Family and Consumer Sciences, University of Georgia, Athens, GA, United States; College of Education and Human Ecology, The Ohio State University, Columbus, OH, United States; Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ, United States; D&V Systematic Evidence Review, Bronx, NY, United States},
abstract={Fruit and vegetables (F&V) have been a cornerstone of healthy dietary recommendations; the 2015–2020 U.S. Dietary Guidelines for Americans recommend that F&V constitute one-half of the plate at each meal. F&V include a diverse collection of plant foods that vary in their energy, nutrient, and dietary bioactive contents. F&V have potential health-promoting effects beyond providing basic nutrition needs in humans, including their role in reducing inflammation and their potential preventive effects on various chronic disease states leading to decreases in years lost due to premature mortality and years lived with disability/morbidity. Current global intakes of F&V are well below recommendations. Given the importance of F&V for health, public policies that promote dietary interventions to help increase F&V intake are warranted. This externally commissioned expert comprehensive narrative, umbrella review summarizes up-to-date clinical and observational evidence on current intakes of F&V, discusses the available evidence on the potential health benefits of F&V, and offers implementation strategies to help ensure that public health messaging is reflective of current science. This review demonstrates that F&V provide benefits beyond helping to achieve basic nutrient requirements in humans. The scientific evidence for providing public health recommendations to increase F&V consumption for prevention of disease is strong. Current evidence suggests that F&V have the strongest effects in relation to prevention of CVDs, noting a nonlinear threshold effect of 800 g per day (i.e., about 5 servings a day). A growing body of clinical evidence (mostly small RCTs) demonstrates effects of specific F&V on certain chronic disease states; however, more research on the role of individual F&V for specific disease prevention strategies is still needed in many areas. Data from the systematic reviews and mostly observational studies cited in this report also support intake of certain types of F&V, particularly cruciferous vegetables, dark-green leafy vegetables, citrus fruits, and dark-colored berries, which have superior effects on biomarkers, surrogate endpoints, and outcomes of chronic disease. © 2019, © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.},
author_keywords={Fruit;  health;  nutrition;  produce;  vegetable},
keywords={Citrus fruits;  Clinical research;  Nutrients;  Nutrition;  Public health;  Public policy;  Vegetables, Cruciferous vegetables;  Fruit and vegetables;  Green leafy vegetables;  Implementation strategies;  Non-linear thresholds;  Nutrient requirement;  Observational study;  Premature mortality, Diseases, eating;  fruit;  human;  nutrition policy;  observational study;  United States;  vegetable, Diet, Healthy;  Eating;  Fruit;  Humans;  Nutrition Policy;  Observational Studies as Topic;  Systematic Reviews as Topic;  United States;  Vegetables},
funding_text 1={Funding for this manuscript was provided through an unrestricted educational grant from the Produce for Better Health Foundation ( www.pbhfoundation.org ). The funding body had no role in the design, analysis, interpretation, or presentation of the data and results.},
references={Abar, L., Vieira, A.R., Aune, D., Stevens, C., Vingeliene, S., Navarro Rosenblatt, D.A., Chan, D., Norat, T., Blood concentrations of carotenoids and retinol and lung cancer risk: An update of the WCRF-AICR systematic review of published prospective studies (2016) Cancer Medicine, 5 (8), pp. 2069-2083; Abushita, A.A., Daood, H.G., Biacs, P.A., Change in carotenoids and antioxidant vitamins in tomato as a function of varietal and technological factors (2000) Journal of Agricultural and Food Chemistry, 48 (6), pp. 2075-2081; Adebawo, O., Salau, B., Ezima, E., Oyefuga, O., Ajani, E., Idowu, G., Famodu, A., Osilesi, O., Fruits and vegetables moderate lipid cardiovascular risk factor in hypertensive patients (2006) Lipids in Health and Disease, 5 (1), p. 14; Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report Number 3 (2000) Ophthalmology, 107 (12), pp. 2224-2232; Akbaraly, T.N., Brunner, E.J., Ferrie, J.E., Marmot, M.G., Kivimaki, M., Singh-Manoux, A., Dietary pattern and depressive symptoms in middle age (2009) British Journal of Psychiatry, 195 (5), pp. 408-413; Al-Solaiman, Y., Jesri, A., Mountford, W.K., Lackland, D.T., Zhao, Y., Egan, B.M., DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre (2010) Journal of Human Hypertension, 24 (4), pp. 237-246; Al-Zalabani, A.H., Stewart, K.F.J., Wesselius, A., Schols, A.M.W.J., Zeegers, M.P., Modifiable risk factors for the prevention of bladder cancer: A systematic review of meta-analyses (2016) European Journal of Epidemiology, 31 (9), pp. 811-851; Allen, S., Britton, J.R., Leonardi-Bee, J.A., Association between antioxidant vitamins and asthma outcome measures: Systematic review and meta-analysis (2009) Thorax, 64 (7), pp. 610-619; Angeloni, C., Spencer, J.P.E., Leoncini, E., Biagi, P.L., Hrelia, S., Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress (2007) Biochimie, 89 (1), pp. 73-82; Anstee, Q.M., Targher, G., Day, C.P., Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (2013) Nature Reviews Gastroenterology & Hepatology, 10 (6), pp. 330-344; Appel, L.J., Moore, T.J., Obarzanek, E., Vollmer, W.M., Svetkey, L.P., Sacks, F.M., Bray, G.A., Windhauser, M.M., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group (1997) New England Journal of Medicine, 336 (16), pp. 1117-1124; Arjmandi, B.H., Johnson, S.A., Pourafshar, S., Navaei, N., George, K.S., Hooshmand, S., Chai, S.C., Akhavan, N.S., Bone-protective effects of dried plum in postmenopausal women: Efficacy and possible mechanisms (2017) Nutrients, 9 (5), p. 496; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) International Journal of Evidence-Based Healthcare, 13 (3), pp. 132-140; Aronow, P.M., Karlan, D., Pinson, L.E., The effect of images of Michelle Obama’s face on trick-or-treaters’ dietary choices: A randomized control trial (2018) PLoS One, 13 (1); Aune, D., Chan, D.S.M., Vieira, A.R., Rosenblatt, D.A.N., Vieira, R., Greenwood, D.C., Norat, T., Fruits, vegetables and breast cancer risk: A systematic review and meta-analysis of prospective studies (2012) Breast Cancer Research and Treatment, 134 (2), pp. 479-493; Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L.T., Keum, N., Norat, T., Greenwood, D.C., Tonstad, S., Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—A systematic review and dose-response meta-analysis of prospective studies (2017) International Journal of Epidemiology, 46 (3), pp. 1029-1056; Aune, D., Keum, N., Giovannucci, E., Fadnes, L.T., Boffetta, P., Greenwood, D.C., Tonstad, S., Norat, T., Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: Systematic review and dose-response meta-analysis of prospective studies (2016) BMJ, 353, p. i2716; Aune, D., Lau, R., Chan, D.S.M., Vieira, R., Greenwood, D.C., Kampman, E., Norat, T., Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies (2011) Gastroenterology, 141 (1), pp. 106-118; Bahadori, S., Salamzadeh, J., Kamalinejad, M., Shams Ardekani, M.R., Keshavarz, M., Ahmadzadeh, A., Study of the effect of an oral formulation of fig and olive on rheumatoid arthritis (RA) remission indicators: A randomized clinical trial (2016) Iranian Journal of Pharmaceutical Research, 15 (3), pp. 537-545; Bailey, R.L., Parker, E.A., Rhodes, D.G., Goldman, J.D., Clemens, J.C., Moshfegh, A.J., Thuppal, S.V., Weaver, C.M., Estimating sodium and potassium intakes and their ratio in the American Diet: Data from the 2011–2012 NHANES (2016) The Journal of Nutrition, 146 (4), pp. 745-750; Baldrick, F.R., Elborn, J.S., Woodside, J.V., Treacy, K., Bradley, J.M., Patterson, C.C., Schock, B.C., McKinley, M.C., Effect of fruit and vegetable intake on oxidative stress and inflammation in COPD: A randomised controlled trial (2012) European Respiratory Journal, 39 (6), pp. 1377-1384; Bandera, E.V., Kushi, L.H., Moore, D.F., Gifkins, D.M., McCullough, M.L., Fruits and vegetables and endometrial cancer risk: A systematic literature review and meta-analysis (2007) Nutrition and Cancer, 58 (1), pp. 6-21; Barbaresko, J., Koch, M., Schulze, M.B., Nöthlings, U., Dietary pattern analysis and biomarkers of low-grade inflammation: A systematic literature review (2013) Nutrition Reviews, 71 (8), pp. 511-527; Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J.F., Alperovitch, A., Dietary patterns and risk of dementia: The three-city cohort study (2007) Neurology, 69 (20), pp. 1921-1930; Barcelo, S., Gardiner, J.M., Gescher, A., Chipman, J.K., CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane (1996) Carcinogenesis, 17 (2), pp. 277-282; Basu, A., Rhone, M., Lyons, T.J., Berries: Emerging impact on cardiovascular health (2010) Nutrition Reviews, 68 (3), pp. 168-177; Basu, A., Schell, J., Scofield, R.H., Dietary fruits and arthritis (2018) Food & Function, 9 (1), pp. 70-77; Bauer, U.E., Briss, P.A., Goodman, R.A., Bowman, B.A., Prevention of chronic disease in the 21st century: Elimination of the leading preventable causes of premature death and disability in the USA (2014) Lancet, 384 (9937), pp. 45-52; Bazzano, L.A., Li, T.Y., Joshipura, K.J., Hu, F.B., Intake of fruit, vegetables, and fruit juices and risk of diabetes in women (2008) Diabetes Care, 31 (7), pp. 1311-1317; Bechthold, A., Boeing, H., Schwedhelm, C., Hoffmann, G., Knüppel, S., Iqbal, K., De Henauw, S., Schwingshackl, L., Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies (2019) Critical Reviews in Food Science and Nutrition, 59 (7), pp. 1071-1090; Ben, Q., Zhong, J., Liu, J., Wang, L., Sun, Y., Yv, L., Yuan, Y., Association between consumption of fruits and vegetables and risk of colorectal adenoma: A PRISMA-compliant meta-analysis of observational studies (2015) Medicine, 94 (42), p. e1599; Benetou, V., Orfanos, P., Feskanich, D., Michaëlsson, K., Pettersson‐Kymmer, U., Eriksson, S., Grodstein, F., Ahmed, L.A., Fruit and vegetable intake and hip fracture incidence in older men and women: The CHANCES Project: Fruit and vegetable intake and hip fracture incidence (2016) Journal of Bone and Mineral Research, 31 (9), pp. 1743-1752; Bhatnagar, S., Taneja, S., Zinc and cognitive development (2001) British Journal of Nutrition, 85 (S2), pp. S139-S145; Biesalski, H.K., Berneburg, M., Grune, T., Kerscher, M., Krutmann, J., Raab, W., Reimann, J., Schwarz, T., Oxidative and premature skin ageing (2003) Experimental Dermatology, 12 (s3), pp. 3-15; Birch, L.L., Ventura, A.K., Preventing childhood obesity: What works? (2009) International Journal of Obesity, 33 (S1), pp. S74-S81; Black, B.S., Rabins, P.V., German, P.S., Predictors of nursing home placement among elderly public housing residents (1999) Gerontologist, 39 (5), pp. 559-568; Blanch, N., Clifton, P.M., Keogh, J.B., A systematic review of vascular and endothelial function: Effects of fruit, vegetable and potassium intake (2015) Nutrition, Metabolism & Cardiovascular Diseases, 25 (3), pp. 253-266; Blumberg, J., Heaney, R.P., Huncharek, M., Scholl, T., Stampfer, M., Vieth, R., Weaver, C.M., Zeisel, S.H., Evidence-based criteria in the nutritional context (2010) Nutrition Reviews, 68 (8), pp. 478-484; Bonaccio, M., Pounis, G., Cerletti, C., Donati, M.B., Iacoviello, L., de Gaetano, G., Mediterranean diet, dietary polyphenols and low grade inflammation: Results from the MOLI-SANI study: Mediterranean diet, polyphenols and low grade inflammation (2017) British Journal of Clinical Pharmacology, 83 (1), pp. 107-113; Bonequi, P., Meneses-Gonzalez, F., Correa, P., Rabkin, C.S., Camargo, M.C., Risk factors for gastric cancer in Latin America: A meta-analysis (2013) Cancer Causes & Control, 24 (2), pp. 217-231; Boone, C.W., Kelloff, G.J., Maolone, W.F., Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review (1990) Cancer Research, 50, pp. 2-9; Bowler, R.P., Oxidative stress in the pathogenesis of asthma (2004) Current Allergy and Asthma Reports, 4 (2), pp. 116-122; Brookie, K.L., Best, G.I., Conner, T.S., Intake of raw fruits and vegetables is associated with better mental health than intake of processed fruits and vegetables (2018) Frontiers in Psychology, 9, p. 487; Brown, L., Rimm, E.B., Seddon, J.M., Giovannucci, E.L., Chasan-Taber, L., Spiegelman, D., Willett, W.C., Hankinson, S.E., A prospective study of carotenoid intake and risk of cataract extraction in US men (1999) The American Journal of Clinical Nutrition, 70 (4), pp. 517-524; Byberg, L., Bellavia, A., Orsini, N., Wolk, A., Michaelsson, K., Fruit and vegetable intake and risk of hip fracture: A cohort study of Swedish men and women (2015) Journal of Bone and Mineral Research, 30 (6), pp. 976-984; Byrd-Bredbenner, C., Ferruzzi, M.G., Fulgoni, V.L., Murray, R., Pivonka, E., Wallace, T.C., Satisfying America’s fruit gap: Summary of an expert roundtable on the role of 100% fruit juice: Filling America’s fruit intake gap with 100% fruit juice (2017) Journal of Food Science, 82 (7), pp. 1523-1534; Calder, P.C., Ahluwalia, N., Albers, R., Bosco, N., Bourdet-Sicard, R., Haller, D., Holgate, S.T., Marcos, A., A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies (2013) British Journal of Nutrition, 109 (S1), pp. S1-S34; Calder, P.C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Lansink, M., Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) British Journal of Nutrition, 106 (S3), pp. S5-S78; Calder, P.C., Boobis, A., Braun, D., Champ, C.L., Dye, L., Einöther, S., Greyling, A., Wopereis, S., Improving selection of markers in nutrition research: Evaluation of the criteria proposed by the ILSI Europe Marker Validation Initiative (2017) Nutrition Research Reviews, 30 (1), pp. 73-81; Calder, P.C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Salvioli, S., Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition (2017) Ageing Research Reviews, 40, pp. 95-119; Campbell, R., Gross, G. A. Grandits, D., Potter, J.D., Plasma carotenoids as biomarkers of vegetable and fruit intake (1994) Cancer Epidemiology, 3, pp. 493-500; Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity (2015) Nature Reviews Endocrinology, 11 (10), pp. 577-591; Cao, L., Tan, L., Wang, H.-F., Jiang, T., Zhu, X.-C., Lu, H., Tan, M.-S., Yu, J.-T., Dietary patterns and risk of dementia: A systematic review and meta-analysis of cohort studies (2016) Molecular Neurobiology, 53 (9), pp. 6144-6154; Carter, P., Gray, L.J., Troughton, J., Khunti, K., Davies, M.J., Fruit and vegetable intake and incidence of type 2 diabetes mellitus: Systematic review and meta-analysis (2010) BMJ, 341 (4), p. c4229; Casas, R., Estruch, R., Sacanella, E., Influence of bioactive nutrients on the atherosclerotic process: A review (2018) Nutrients, 10 (11), p. 1630; Center, J.R., Nguyen, T.V., Schneider, D., Sambrook, P.N., Eisman, J.A., Mortality after all major types of osteoporotic fracture in men and women: An observational study (1999) Lancet, 353 (9156), pp. 878-882; Cerhan, J.R., Saag, K.G., Merlino, L.A., Mikuls, T.R., Criswell, L.A., Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women (2003) American Journal of Epidemiology, 157 (4), pp. 345-354; Cevenini, E., Monti, D., Franceschi, C., Inflamm-ageing (2013) Current Opinion in Clinical Nutrition and Metabolic Care, 16 (1), pp. 14-20; Chadban, S.J., Briganti, E.M., Kerr, P.G., Dunstan, D.W., Welborn, T.A., Zimmet, P.Z., Atkins, R.C., Prevalence of kidney damage in Australian adults: The AusDiab kidney study (2003) Journal of the American Society of Nephrology: JASN, 14 (7), pp. S131-S138; Chai, N.C., Bond, D.S., Moghekar, A., Scher, A.I., Peterlin, B.L., Obesity and headache: Part II–Potential mechanism and treatment considerations (2014) Headache, 54 (3), pp. 459-471; Charytoniuk, T., Drygalski, K., Konstantynowicz-Nowicka, K., Berk, K., Chabowski, A., Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials (2017) Nutrition, 34, pp. 108-117; Chen, G.-C., Lv, D.-B., Pang, Z., Liu, Q.-F., Fruits and vegetables consumption and risk of non-Hodgkin’s lymphoma: A meta-analysis of observational studies (2013) International Journal of Cancer, 133 (1), pp. 190-200; Chen, J., Song, Y., Zhang, L., Lycopene/tomato consumption and the risk of prostate cancer: A systematic review and meta-analysis of prospective studies (2013) Journal of Nutritional Science and Vitaminology, 59 (3), pp. 213-223; (2018), http://dg.en.cnsoc.org/index.html, The Chinese Dietary Guidelines. Accessed July 31, 2018; Christen, W.G., Liu, S., Schaumberg, D.A., Buring, J.E., Fruit and vegetable intake and the risk of cataract in women (2005) The American Journal of Clinical Nutrition, 81 (6), pp. 1417-1422; Chun, O.K., Chung, S.-J., Claycombe, K.J., Song, W.O., Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults (2008) The Journal of Nutrition, 138 (4), pp. 753-760; Clemens, R., Drewnowski, A., Ferruzzi, M.G., Toner, C.D., Welland, D., Squeezing fact from fiction about 100% fruit juice (2015) Advances in Nutrition, 6 (2), pp. 236S-43S; Coleman, A.L., Stone, K.L., Kodjebacheva, G., Yu, F., Pedula, K.L., Ensrud, K.E., Cauley, J.A., Badala, F., Glaucoma risk and the consumption of fruits and vegetables among older women in the Study of Osteoporotic Fractures (2008) American Journal of Ophthalmology, 145 (6), pp. 1081-1089; Colijn, J.M., Buitendijk, G.H.S., Prokofyeva, E., Alves, D., Cachulo, M.L., Khawaja, A.P., Cougnard-Gregoire, A., Erke, M.G., Prevalence of age-related macular degeneration in Europe: The past and the future (2017) Ophthalmology, 124 (12), pp. 1753-1763; Cook, L.T., O'Reilly, G.A., Goran, M.I., Weigensberg, M.J., Spruijt-Metz, D., Davis, J.N., Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth (2014) Journal of the Academy of Nutrition and Dietetics, 114 (11), pp. 1776-1783; Cooke, L.J., Chambers, L.C., Añez, E.V., Croker, H.A., Boniface, D., Yeomans, M.R., Wardle, J., Eating for pleasure or profit: The effect of incentives on children's enjoyment of vegetables (2011) Psychological Science, 22 (2), pp. 190-196; Cooper, A.J., Sharp, S.J., Lentjes, M.A.H., Luben, R.N., Khaw, K.-T., Wareham, N.J., Forouhi, N.G., A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes (2012) Diabetes Care, 35 (6), pp. 1293-1300; Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Galleron, N., Dietary intervention impact on gut microbial gene richness (2013) Nature, 500 (7464), pp. 585-588; Cox, M.A., Jackson, J., Stanton, M., Rojas-Triana, A., Bober, L., Laverty, M., Yang, X., Wang, S., Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines (2009) World Journal of Gastroenterology, 15 (44), pp. 5549-5557; Cremer, J., Segota, I., Yang, C.-Y., Arnoldini, M., Sauls, J.T., Zhang, Z., Gutierrez, E., Hwa, T., Effect of flow and peristaltic mixing on bacterial growth in a gut-like channel (2016) Proceedings of the National Academy of Sciences of the United States of America, 113 (41), pp. 11414-11419; Cross, A.J., Lampe, J.W., Rock, C.L., Boushey, C.J., Biomarkers and their use in nutrition intervention (2017) Nutrition in the prevention and treatment of disease, pp. 217-234. , Coulston A.M., Boushey C.J., Ferruzzi M.G., Delahanty L.M., (eds), London, UK: Elsevier, and,. edited by; Crowe-White, K., O'Neil, C.E., Parrott, J.S., Benson-Davies, S., Droke, E., Gutschall, M., Stote, K.S., Ziegler, P., Impact of 100% fruit juice consumption on diet and weight status of children: An evidence-based review (2016) Critical Reviews in Food Science and Nutrition, 56 (5), pp. 871-884; Crowe-White, K., Parrott, J.S., Stote, K.S., Gutschall, M., Benson-Davies, S., Droke, E., O'Neil, C.E., Ziegler, P., Metabolic impact of 100% fruit juice consumption on antioxidant/oxidant status and lipid profiles of adults: An evidence-based review (2017) Critical Reviews in Food Science and Nutrition, 57 (1), pp. 152-162; Crowe, K.M., Murray, E., Deconstructing a fruit serving: Comparing the antioxidant density of select whole fruit and 100% fruit juices (2013) Journal of the Academy of Nutrition and Dietetics, 113 (10), pp. 1354-1358; da Silva Pereira, A.C., Dionísio, A.P., Wurlitzer, N.J., Alves, R.E., Brito, E.S.D., Silva, A.M.D.O., Brasil, I.M., Mancini Filho, J., Effect of antioxidant potential of tropical fruit juices on antioxidant enzyme profiles and lipid peroxidation in rats (2014) Food Chemistry, 157, pp. 179-185; Dauchet, L., Amouyel, P., Dallongeville, J., Fruit and vegetable consumption and risk of stroke: A meta-analysis of cohort studies (2005) Neurology, 65 (8), pp. 1193-1197; Dauchet, L., Amouyel, P., Hercberg, S., Dallongeville, J., Fruit and vegetable consumption and risk of coronary heart disease: A meta-analysis of cohort studies (2006) The Journal of Nutrition, 136 (10), pp. 2588-2593; Daviglus, M.L., Bell, C.C., Berrettini, W., Bowen, P.E., Connolly, E.S., Cox, N.J., Dunbar-Jacob, J.M., NIH state-of-the-science conference statement: Preventing Alzheimer’s disease and cognitive decline (2010) NIH Consensus and State-of-the-Science Statements, 27 (4), pp. 1-30. , et al; de Koning-Backus, A.P.M., Buitendijk, G.H.S., Kiefte-de Jong, J.C., Colijn, J.M., Hofman, A., Vingerling, J.R., Haverkort, E.B., Klaver, C.C.W., Intake of vegetables, fruit, and fish is beneficial for age-related macular degeneration (2019) American Journal of Ophthalmology, 198, pp. 70-79; de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J.L., Monjaud, I., Guidollet, J., Delaye, J., Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease (1994) Lancet, 343 (8911), pp. 1454-1459; De Rosa, V., Galgani, M., Santopaolo, M., Colamatteo, A., Laccetti, R., Matarese, G., Nutritional control of immunity: Balancing the metabolic requirements with an appropriate immune function (2015) Seminars in Immunology, 27 (5), pp. 300-309; DeChristopher, L.R., Tucker, K.L., Excess free fructose, high-fructose corn syrup and adult asthma: The Framingham offspring cohort (2018) British Journal of Nutrition, 119 (10), pp. 1157-1167; DeChristopher, L.R., Uribarri, J., Tucker, K.L., Intakes of apple juice, fruit drinks and soda are associated with prevalent asthma in US children aged 2–9 years (2016) Public Health Nutrition, 19 (1), pp. 123-130; Deckersbach, T., Das, S.K., Urban, L.E., Salinardi, T., Batra, P., Rodman, A.M., Arulpragasam, A.R., Roberts, S.B., Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention (2014) Nutrition & Diabetes, 4 (9), p. e129; Deehan, E.C., Duar, R.M., Armet, A.M., Perez-Muñoz, M.E., Jin, M., Walter, J., Modulation of the gastrointestinal microbiome with nondigestible fermentable carbohydrates to improve human health (2017) Microbiology Spectrum, 5 (5). , BAD-0019-2017; Delzenne, N.M., Cani, P.D., Everard, A., Neyrinck, A.M., Bindels, L.B., Gut microorganisms as promising targets for the management of type 2 diabetes (2015) Diabetologia, 58 (10), pp. 2206-2217; Dessypris, N., Karalexi, M.A., Ntouvelis, E., Diamantaras, A.-A., Papadakis, V., Baka, M., Hatzipantelis, E., Polychronopoulou, S., Association of maternal and index child’s diet with subsequent leukemia risk: A systematic review and meta-analysis (2017) Cancer Epidemiology, 47, pp. 64-75; (2015) Scientific report of the 2015 Dietary Guidelines Advisory Committee: Advisory report to the Secretary of Health and Human Services and the secretary of agriculture, , Washington, DC: U.S. Department of Agriculture Agricultural Research Service; (2016), http://kyunbound.lib.overdrive.com/ContentDetails.htm?ID=D2E702A6-B2A3-48B1-93ED-B9E085738FC6, Dietary Guidelines for Americans 2015–2020. Accessed August 17, 2018; Di Landro, A., Cazzaniga, S., Cusano, F., Bonci, A., Carla, C., Musumeci, M.L., Patrizi, A., Caproni, M., Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy (2016) Journal of the American Academy of Dermatology, 75 (6), pp. 1134-1141; Dinu, M., Pagliai, G., Casini, A., Sofi, F., Food groups and risk of age-related macular degeneration: A systematic review with meta-analysis (2018) European Journal of Nutrition; Dragsted, L.O., Gao, Q., Praticò, G., Manach, C., Wishart, D.S., Scalbert, A., Feskens, E.J.M., Dietary and health biomarkers-time for an update (2017) Genes & Nutrition, 12 (1), p. 24; Drewnowski, A., Buszkiewicz, J., Aggarwal, A., Soda, salad, and socioeconomic status: Findings from the Seattle Obesity Study (SOS) (2019) SSM - Population Health, 7, p. 100339; Drewnowski, A., Rehm, C.D., Vegetable cost metrics show that potatoes and beans provide most nutrients per penny (2013) PLoS One, 8 (5); Ellwood, K., Balentine, D.A., Dwyer, J.T., Erdman, J.W., Gaine, P.C., Kwik-Uribe, C.L., Considerations on an approach for establishing a framework for bioactive food components (2014) Advances in Nutrition, 5 (6), pp. 693-701; Ersoy, L., Ristau, T., Lechanteur, Y.T., Hahn, M., Hoyng, C.B., Kirchhof, B., den Hollander, A.I., Fauser, S., Nutritional risk factors for age-related macular degeneration (2014) BioMed Research International, 2014, p. 1; (2006), https://www.eufic.org/en/healthy-living/article/the-determinants-of-food-choice, The determinants of food choice. Accessed March 17, 2019; EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease (2016) Journal of Hepatology, 64 (6), pp. 1388-1402; Evans, E.W., Lipton, R.B., Peterlin, B.L., Raynor, H.A., Thomas, J.G., O'Leary, K.C., Pavlovic, J., Bond, D.S., Dietary intake patterns and diet quality in a nationally representative sample of women with and without severe headache or migraine (2015) Headache, 55 (4), pp. 550-561; Fang, X., Wei, J., He, X., An, P., Wang, H., Jiang, L., Shao, D., Wang, F., Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies (2015) European Journal of Cancer, 51 (18), pp. 2820-2832; (2018), http://www.fao.org/nutrition/education/food-dietary-guidelines/home/en/, Food-based dietary guidelines. Accessed May 4, 2018; Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Bray, F., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015) International Journal of Cancer, 136 (5), pp. E359-E386; Fitó, M., Melander, O., Martínez, J., Toledo, E., Carpéné, C., Corella, D., Advances in integrating traditional and omic biomarkers when analyzing the effects of the Mediterranean diet intervention in cardiovascular prevention (2016) International Journal of Molecular Sciences, 17 (9), p. 1469; Ford, E.S., Mokdad, A.H., Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults (2001) Preventive Medicine, 32 (1), pp. 33-39; Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M.P., Scurti, M., Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans (2007) Mechanisms of Ageing and Development, 128 (1), pp. 92-105; Freedman, M.R., Fulgoni, V.L., Canned vegetable and fruit consumption is associated with changes in nutrient intake and higher diet quality in children and adults: National Health and Nutrition Examination Survey 2001–2010 (2016) Journal of the Academy of Nutrition and Dietetics, 116 (6), pp. 940-948; Freedman, M.R., Keast, D.R., Potatoes, including French fries, contribute key nutrients to diets of US adults: NHANES 2003–2006 (2012) Journal of Nutritional Therapeutics, 1 (1), pp. 1-11; Fujioka, N., Ransom, B.W., Carmella, S.G., Upadhyaya, P., Lindgren, B.R., Roper-Batker, A., Hatsukami, D.K., Hecht, S.S., Harnessing the power of cruciferous vegetables: Developing a biomarker for Brassica vegetable consumption using urinary 3,3'-diindolylmethane (2016) Cancer Prevention Research, 9 (10), pp. 788-793; Gan, Y., Tong, X., Li, L., Cao, S., Yin, X., Gao, C., Herath, C., Chen, Y., Consumption of fruit and vegetable and risk of coronary heart disease: A meta-analysis of prospective cohort studies (2015) International Journal of Cardiology, 183, pp. 129-137; Gandini, S., Merzenich, H., Robertson, C., Boyle, P., Meta-analysis of studies on breast cancer risk and diet: The role of fruit and vegetable consumption and the intake of associated micronutrients (2000) European Journal of Cancer, 36 (5), pp. 636-646; Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 385 (9963), pp. 117-171; Geyer, M., Schönfeld, C., Novel insights into the pathogenesis of osteoarthritis (2018) Current Rheumatology Reviews, 14 (2), pp. 98-107; Ghavipour, M., Sotoudeh, G., Tavakoli, E., Mowla, K., Hasanzadeh, J., Mazloom, Z., Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in rheumatoid arthritis patients (2017) European Journal of Clinical Nutrition, 71 (1), pp. 92-96; Giaconi, J.A., Yu, F., Stone, K.L., Pedula, K.L., Ensrud, K.E., Cauley, J.A., Hochberg, M.C., Coleman, A.L., The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the Study of Osteoporotic Fractures (2012) American Journal of Ophthalmology, 154 (4), pp. 635-644; Gillette Guyonnet, S., Abellan Van Kan, G., Andrieu, S., Barberger Gateau, P., Berr, C., Bonnefoy, M., Dartigues, J.F., Galan, P., IANA task force on nutrition and cognitive decline with aging (2007) The Journal of Nutrition, Health and Aging, 11 (2), pp. 132-152; Goldberg, J., Flowerdew, G., Smith, E., Brody, J.A., Tso, M.O., Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey (1988) American Journal of Epidemiology, 128 (4), pp. 700-710; Gomes, J.M.G., Costa, J.D.A., Alfenas, R.D.C.G., Metabolic endotoxemia and diabetes mellitus: A systematic review (2017) Metabolism, 68, pp. 133-144; Gong, G., Qin, Y., Huang, W., Zhou, S., Yang, X., Li, D., Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells (2010) European Journal of Pharmacology, 628 (1-3), pp. 27-35; Gonzalez-Gallego, J., V. Garcia-Mediavilla, S. Sanchez-Campos, M., Tunon, M.J., Fruit polyphenols, immunity and inflammation (2010) British Journal of Nutrition, 104, pp. S15-S27; Gonzalez-Vallinas, M., Gonzalez-Castejon, M., Rodriguez-Casado, A., Ramirez de Molina, A., Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives (2013) Nutrition Reviews, 71, pp. 585-599. , –,. : 10.111.nure.12051; Goraya, N., Simoni, J., Jo, C.-H., Wesson, D.E., A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate (2013) Clinical Journal of the American Society of Nephrology, 8 (3), pp. 371-381; Goraya, N., Simoni, J., Jo, C.-H., Wesson, D.E., Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate (2014) Kidney International, 86 (5), pp. 1031-1038; Goraya, N., Simoni, J., Jo, C., Wesson, D.E., Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy (2012) Kidney International, 81 (1), pp. 86-93; Greene, L.S., Asthma, oxidant stress, and diet (1999) Nutrition, 15 (11-12), pp. 899-907; Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035 (2014) Diabetes Research and Clinical Practice, 103 (2), pp. 137-149; Gunn, C., Weber, J., McGill, A.-T., Kruger, M., Increased intake of selected vegetables, herbs and fruit may reduce bone turnover in post-menopausal women (2015) Nutrients, 7 (4), pp. 2499-2517; Hales, C.M., Fryar, C.D., Carroll, M.D., Freedman, D.S., Ogden, C.L., Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016 (2018) JAMA, 319 (16), pp. 1723-1725; Hamer, M., Chida, Y., Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: Systematic review and meta-analysis (2007) Journal of Hypertension, 25 (12), pp. 2361-2369; Hamidi, M., Boucher, B.A., Cheung, A.M., Beyene, J., Shah, P.S., Fruit and vegetable intake and bone health in women aged 45 years and over: A systematic review (2011) Osteoporosis International, 22 (6), pp. 1681-1693; Han, H.S., Chang, C.B., Lee, D.-C., Lee, J.-Y., Relationship between total fruit and vegetable intake and self-reported knee pain in older adults (2017) The Journal of Nutrition, Health & Aging, 21 (7), pp. 750-758; Han, J.M., Jo, A.N., Lee, S.M., Bae, H.S., Jun, D.W., Cho, Y.K., Suk, K.T., Cho, Y.J., Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults (2014) Journal of Gastroenterology and Hepatology, 29 (6), pp. 1265-1272; Harasym, J., Oledzki, R., Effect of fruit and vegetable antioxidants on total antioxidant capacity of blood plasma (2014) Nutrition, 30 (5), pp. 511-517; Hardcastle, A.C., Aucott, L., Fraser, W.D., Reid, D.M., Macdonald, H.M., Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women (2011) European Journal of Clinical Nutrition, 65 (3), pp. 378-385; Hardcastle, A.C., Aucott, L., Reid, D.M., Macdonald, H.M., Associations between dietary flavonoid intakes and bone health in a Scottish population (2011) Journal of Bone and Mineral Research, 26 (5), pp. 941-947; Harding, A.-H., Wareham, N.J., Bingham, S.A., Khaw, K., Luben, R., Welch, A., Forouhi, N.G., Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: The European prospective investigation of cancer—Norfolk prospective study (2008) Archives of Internal Medicine, 168 (14), pp. 1493-1499; Hawkes, C., Smith, T.G., Jewell, J., Wardle, J., Hammond, R.A., Friel, S., Thow, A.M., Kain, J., Smart food policies for obesity prevention (2015) Lancet, 385 (9985), pp. 2410-2421; He, F.J., Nowson, C.A., Lucas, M., MacGregor, G.A., Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: Meta-analysis of cohort studies (2007) Journal of Human Hypertension, 21 (9), pp. 717-728; He, F.J., Nowson, C.A., MacGregor, G.A., Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies (2006) Lancet, 367 (9507), pp. 320-326; He, J., Gu, Y., Zhang, S., Consumption of vegetables and fruits and breast cancer survival: A systematic review and meta-analysis (2017) Scientific Reports, 7 (1), p. 599; (2014), https://www.canada.ca/en/health-canada/services/canada-food-guides.html, Canada’s Food Guides: Education and awareness. Accessed May 4, 2018; Heyman, M.B., Abrams, S.A., Fruit juice in infants, children, and adolescents: Current recommendations (2017) Pediatrics, 139 (6), p. e20170967; Hodge, A.M., English, D.R., O'Dea, K., Giles, G.G., Glycemic index and dietary fiber and the risk of type 2 diabetes (2004) Diabetes Care, 27 (11), pp. 2701-2706; Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., Buzatu, L., Cherniack, R.M., Coxson, H.O., The nature of small-airway obstruction in chronic obstructive pulmonary disease (2004) New England Journal of Medicine, 350 (26), pp. 2645-2653; Holscher, H.D., Dietary fiber and prebiotics and the gastrointestinal microbiota (2017) Gut Microbes, 8 (2), pp. 172-184; Holt, E.M., Steffen, L.M., Moran, A., Basu, S., Steinberger, J., Ross, J.A., Hong, C.-P., Sinaiko, A.R., Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents (2009) Journal of the American Dietetic Association, 109 (3), pp. 414-421; Hooshmand, S., Chai, S.C., Saadat, R.L., Payton, M.E., Brummel-Smith, K., Arjmandi, B.H., Comparative effects of dried plum and dried apple on bone in postmenopausal women (2011) British Journal of Nutrition, 106 (6), pp. 923-930; Hooshmand, S., Kern, M., Metti, D., Shamloufard, P., Chai, S.C., Johnson, S.A., Payton, M.E., Arjmandi, B.H., The effect of two doses of dried plum on bone density and bone biomarkers in osteopenic postmenopausal women: A randomized, controlled trial (2016) Osteoporosis International, 27 (7), pp. 2271-2279; Hornick, B.A., Weiss, L., Comparative nutrient analysis of commonly consumed vegetables: Support for recommending a nutrition education approach emphasizing specific vegetables to improve nutrient intakes (2011) Nutrition Today, 46 (3), p. 130; Hosseini, B., Berthon, B.S., Saedisomeolia, A., Starkey, M.R., Collison, A., Wark, P.A.B., Wood, L.G., Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: A systematic literature review and meta-analysis (2018) The American Journal of Clinical Nutrition, 108 (1), pp. 136-155; Hosseini, B., Berthon, B.S., Wark, P., Wood, L.G., Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: A systematic review and meta-analysis (2017) Nutrients, 9 (4), p. 341; Howlett, J.F., Betteridge, V.A., Champ, M., Craig, S.A.S., Meheust, A., Jones, J.M., The definition of dietary fiber—Discussions at the Ninth Vahouny Fiber Symposium: Building scientific agreement (2010) Food & Nutrition Research, 54; Hoy, M.K., Goldman, J.D., Dietary fiber intake of the U.S. population: What we eat in America, NHANES 2009–2010 (2014) U. S. Department of Agriculture, 12, p. 6; Hu, D., Cheng, L., Jiang, W., Fruit and vegetable consumption and the risk of postmenopausal osteoporosis: A meta-analysis of observational studies (2018) Food & Function, 9 (5), pp. 2607-2616; Hu, D., Huang, J., Wang, Y., Zhang, D., Qu, Y., Fruits and vegetables consumption and risk of stroke: A meta-analysis of prospective cohort studies (2014) Stroke, 45 (6), pp. 1613-1619; Hu, X.H., Markson, L.E., Lipton, R.B., Stewart, W.F., Berger, M.L., Burden of migraine in the United States: Disability and economic costs (1999) Archives of Internal Medicine, 159 (8), pp. 813-818; Hwang, J., Wang, J., Morazzoni, P., Hodis, H.N., Sevanian, A., The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: An antioxidant mechanism for cell-mediated LDL modification (2003) Free Radical Biology and Medicine, 34 (10), pp. 1271-1282; Hyson, D.A., A review and critical analysis of the scientific literature related to 100% fruit juice and human health (2015) Advances in Nutrition, 6 (1), pp. 37-51; (2014) World cancer report 2014, , Lyon, France: International Agency for Research on Cancer; (2016), http://public.eblib.com/choice/publicfullrecord.aspx?p=4770630, Breast cancer screening. Accessed November 14, 2018; (1998) Dietary reference intakes: Proposed definition and plan for review of dietary antioxidants and related compounds, , Washington, DC: National Academies Press; (2001) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc, , Washington, DC: National Academies Press; (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids, , Washington, DC: National Academies Press; (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients)., , Washington, DC: National Academies Press; Jacka, F.N., Pasco, J.A., Mykletun, A., Williams, L.J., Hodge, A.M., O'Reilly, S.L., Nicholson, G.C., Berk, M., Association of Western and traditional diets with depression and anxiety in women (2010) American Journal of Psychiatry, 167 (3), pp. 305-311; Jenkins, D.J.A., Hu, F.B., Tapsell, L.C., Josse, A.R., Kendall, C.W.C., Possible benefit of nuts in type 2 diabetes (2008) The Journal of Nutrition, 138 (9), pp. 1752S-6S; Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Yang, C.-W., Chronic kidney disease: Global dimension and perspectives (2013) Lancet, 382 (9888), pp. 260-272; Jiang, X., Huang, J., Song, D., Deng, R., Wei, J., Zhang, Z., Increased consumption of fruit and vegetables is related to a reduced risk of cognitive impairment and dementia: Meta-analysis (2017) Frontiers in Aging Neuroscience, 9, p. 18; Jin, J., Ouyang, Z., Wang, Z., Association of fruit and vegetables with the risk of nasopharyngeal cancer: Evidence from a meta-analysis (2014) Scientific Reports, 4, p. 5229; John, J.H., Ziebland, S., Yudkin, P., Roe, L.S., Neil, H.A., Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial (2002) Lancet, 359 (9322), pp. 1969-1974; Johnson, C.M., Wei, C., Ensor, J.E., Smolenski, D.J., Amos, C.I., Levin, B., Berry, D.A., Meta-analyses of colorectal cancer risk factors (2013) Cancer Causes & Control, 24 (6), pp. 1207-1222; Johnson, E.J., Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan (2014) Nutrition Reviews, 72 (9), pp. 605-612; Johnston, K.L., Clifford, M.N., Morgan, L.M., Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans (2002) Journal of the Science of Food and Agriculture, 82 (15), pp. 1800-1805; Jones, J.M., CODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’ (2014) Nutrition Journal, 13, p. 34; Joseph, S.V., Edirisinghe, I., Burton-Freeman, B.M., Fruit polyphenols: A review of anti-inflammatory effects in humans (2016) Critical Reviews in Food Science and Nutrition, 56 (3), pp. 419-444; Jung, S., Spiegelman, D., Baglietto, L., Bernstein, L., Boggs, D.A., van den Brandt, P.A., Buring, J.E., Giles, G.G., Fruit and vegetable intake and risk of breast cancer by hormone receptor status (2013) JNCI: Journal of the National Cancer Institute, 105 (3), pp. 219-236; Kaiser, K.A., Brown, A.W., Bohan Brown, M.M., Shikany, J.M., Mattes, R.D., Allison, D.B., Increased fruit and vegetable intake has no discernible effect on weight loss: A systematic review and meta-analysis (2014) The American Journal of Clinical Nutrition, 100 (2), pp. 567-576; Kalkwarf, H.J., Gilsanz, V., Lappe, J.M., Oberfield, S., Shepherd, J.A., Hangartner, T.N., Huang, X., Zemel, B.S., Tracking of bone mass and density during childhood and adolescence (2010) The Journal of Clinical Endocrinology and Metabolism, 95 (4), pp. 1690-1698; Kaluza, J., Larsson, S.C., Orsini, N., Linden, A., Wolk, A., Fruit and vegetable consumption and risk of COPD: A prospective cohort study of men (2017) Thorax, 72 (6), pp. 500-509; Kang, J.H., Ascherio, A., Grodstein, F., Fruit and vegetable consumption and cognitive decline in aging women (2005) Annals of Neurology, 57 (5), pp. 713-720; Kang, J.H., Willett, W.C., Rosner, B.A., Buys, E., Wiggs, J.L., Pasquale, L.R., Association of dietary nitrate intake with primary open-angle glaucoma: A prospective analysis from the Nurses’ Health Study and Health Professionals Follow-up Study (2016) JAMA Ophthalmology, 134 (3), p. 294; Karlsen, A., Retterstøl, L., Laake, P., Paur, I., Bøhn, S.K., Sandvik, L., Blomhoff, R., Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults (2007) The Journal of Nutrition, 137 (8), pp. 1951-1954; Kelly, J.T., Palmer, S.C., Wai, S.N., Ruospo, M., Carrero, J.-J., Campbell, K.L., Strippoli, G.F.M., Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies (2017) Clinical Journal of the American Society of Nephrology, 12 (2), pp. 272-279; Keranis, E., Makris, D., Rodopoulou, P., Martinou, H., Papamakarios, G., Daniil, Z., Zintzaras, E., Gourgoulianis, K.I., Impact of dietary shift to higher-antioxidant foods in COPD: A randomised trial (2010) European Respiratory Journal, 36 (4), pp. 774-780; Kim, E.-K., Kim, H., Kim, H., Chang, N., Relation of dietary fruit and vegetable intake and smoking to age-related macular degeneration in elderly men in Korea (2017) Advances in Nutrition, 8 (1), p. 3; Kim, E.-K., Kim, H., Kwon, O., Chang, N., Associations between fruits, vegetables, vitamin A, β-carotene and flavonol dietary intake, and age-related macular degeneration in elderly women in Korea: The Fifth Korea National Health and Nutrition Examination Survey (2018) European Journal of Clinical Nutrition, 72 (1), pp. 161-167; Kim, V., Criner, G.J., Chronic bronchitis and chronic obstructive pulmonary disease (2013) American Journal of Respiratory and Critical Care Medicine, 187 (3), pp. 228-237; Kim, Y., Je, Y., Flavonoid intake and mortality from cardiovascular disease and all causes: A meta-analysis of prospective cohort studies (2017) Clinical Nutrition ESPEN, 20, pp. 68-77; Klurfeld, D.M., Davis, C.D., Karp, R.W., Allen-Vercoe, E., Chang, E.B., Chassaing, B., Fahey, G.C., Lampe, J.W., Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome (2018) American Journal of Physiology-Endocrinology and Metabolism, 315 (6), pp. E1087-E1097; Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T., Aromaa, A., Flavonoid intake and risk of chronic diseases (2002) The American Journal of Clinical Nutrition, 76 (3), pp. 560-568; Kong, F., Hua, Y., Zeng, B., Ning, R., Li, Y., Zhao, J., Gut microbiota signatures of longevity (2016) Current Biology, 26 (18), pp. R832-R833; Kong, L.C., Holmes, B.A., Cotillard, A., Habi-Rachedi, F., Brazeilles, R., Gougis, S., Gausserès, N., Bastard, J.-P., Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects (2014) PLoS One, 9 (10); Kootte, R.S., Vrieze, A., Holleman, F., Dallinga-Thie, G.M., Zoetendal, E.G., de Vos, W.M., Groen, A.K., Nieuwdorp, M., The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus (2012) Diabetes, Obesity and Metabolism, 14 (2), pp. 112-120; Koushik, A., Spiegelman, D., Albanes, D., Anderson, K.E., Bernstein, L., van den Brandt, P.A., Bergkvist, L., Fuchs, C.S., Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies (2012) American Journal of Epidemiology, 176 (5), pp. 373-386; Kresty, L.A., Mallery, S.R., Stoner, G.D., Black raspberries in cancer clinical trials: Past, present and future (2016) Journal of Berry Research, 6 (2), pp. 251-261; Krinsky, N.I., Landrum, J.T., Bone, R.A., Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye (2003) Annual Review of Nutrition, 23 (1), pp. 171-201; Kunisawa, J., Kiyono, H., Vitamin-mediated regulation of intestinal immunity (2013) Frontiers in Immunology, 4, p. 189; Kuo, C.-F., Luo, S.-F., See, L.-C., Chou, I.-J., Chang, H.-C., Yu, K.-H., Rheumatoid arthritis prevalence, incidence, and mortality rates: A nationwide population study in Taiwan (2013) Rheumatology International, 33 (2), pp. 355-360; Kurotani, K., Nanri, A., Goto, A., Mizoue, T., Noda, M., Kato, M., Inoue, M., Tsugane, S., Vegetable and fruit intake and risk of type 2 diabetes: Japan Public Health Center-Based Prospective Study (2013) British Journal of Nutrition, 109 (4), pp. 709-717; Kushi, L.H., Doyle, C., McCullough, M., Rock, C.L., Demark-Wahnefried, W., Bandera, E.V., Gapstur, S., Gansler, T., American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity (2012) CA: A Cancer Journal for Clinicians, 62 (1), pp. 30-67; La, V.D., Howell, A.B., Grenier, D., Cranberry proanthocyanidins inhibit MMP production and activity (2009) Journal of Dental Research, 88 (7), pp. 627-632; Lai, J.S., Hiles, S., Bisquera, A., Hure, A.J., McEvoy, M., Attia, J., A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults (2014) The American Journal of Clinical Nutrition, 99 (1), pp. 181-197; Langsetmo, L., Hanley, D.A., Prior, J.C., Barr, S.I., Anastassiades, T., Towheed, T., Goltzman, D., Kreiger, N., Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥50 y: A population-based cohort study (2011) The American Journal of Clinical Nutrition, 93 (1), pp. 192-199; Law, M.R., Morris, J.K., By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? (1998) European Journal of Clinical Nutrition, 52 (8), pp. 549-556; Le Port, A., Gueguen, A., Kesse-Guyot, E., Melchior, M., Lemogne, C., Nabi, H., Goldberg, M., Czernichow, S., Association between dietary patterns and depressive symptoms over time: A 10-year follow-up study of the GAZEL cohort (2012) PLoS One, 7 (12); Ledoux, T.A., Hingle, M.D., Baranowski, T., Relationship of fruit and vegetable intake with adiposity: A systematic review (2011) Obesity Reviews, 12 (5), pp. e143-e150; Lefer, A.M., Prostacyclin, high density lipoproteins, and myocardial ischemia (1990) Circulation, 81 (6), pp. 2013-2015; Lewis, S.J., Heaton, K.W., Stool form scale as a useful guide to intestinal transit time (1997) Scandinavian Journal of Gastroenterology, 32 (9), pp. 920-924; Li, B., Jiang, G., Zhang, G., Xue, Q., Zhang, H., Wang, C., Zhao, T., Intake of vegetables and fruit and risk of esophageal adenocarcinoma: A meta-analysis of observational studies (2014) European Journal of Nutrition, 53 (7), pp. 1511-1521; Li, B., Li, F., Wang, L., Zhang, D., Fruit and vegetables consumption and risk of hypertension: A meta-analysis (2016) The Journal of Clinical Hypertension, 18 (5), pp. 468-476; Li, D., Yang, L., Deng, S., Ling, W., Liu, Z., Yang, L., Chen, Y., Du, Z., Effects of anthocyanins on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials (2017) Advances in Nutrition: An International Review Journal, 8 (5), pp. 684-693; Li, F., Liu, X., Wang, W., Zhang, D., Consumption of vegetables and fruit and the risk of inflammatory bowel disease: A meta-analysis (2015) European Journal of Gastroenterology & Hepatology, 27 (6), pp. 623-630; Li, M., Fan, Y., Zhang, X., Hou, W., Tang, Z., Fruit and vegetable intake and risk of type 2 diabetes mellitus: Meta-analysis of prospective cohort studies (2014) BMJ Open, 4 (11), p. e005497; Li, Y., Association between fruit and vegetable intake and risk for glioma: A meta-analysis (2014) Nutrition, 30 (11-12), pp. 1272-1278; Lin, Y.-C., Wu, T.-C., Chen, P.-Y., Hsieh, L.-Y., Yeh, S.-L., Comparison of plasma and intake levels of antioxidant nutrients in patients with chronic obstructive pulmonary disease and healthy people in Taiwan: A case-control study (2010) Asia Pacific Journal of Clinical Nutrition, 19 (3), pp. 393-401; Liu, H., Wang, X.-C., Hu, G.-H., Guo, Z.-F., Lai, P., Xu, L., Huang, T.-B., Xu, Y.-F., Fruit and vegetable consumption and risk of bladder cancer: An updated meta-analysis of observational studies (2015) European Journal of Cancer Prevention, 24 (6), pp. 508-516; Liu, J., Wang, J., Leng, Y., Lv, C., Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: A meta-analysis of observational studies (2013) International Journal of Cancer, 133 (2), pp. 473-485; Liu, R.H., Potential synergy of phytochemicals in cancer prevention: Mechanism of action (2004) The Journal of Nutrition, 134 (12), pp. 3479S-85S; Liu, R.H., Dietary bioactive compounds and their health implications: Dietary bioactive compounds and health (2013) Journal of Food Science, 78 (s1), pp. A18-A25; Liu, S., Serdula, M., Janket, S.-J., Cook, N.R., Sesso, H.D., Willett, W.C., Manson, J.E., Buring, J.E., A prospective study of fruit and vegetable intake and the risk of type 2 diabetes in women (2004) Diabetes Care, 27 (12), pp. 2993-2996; Liu, X., Yan, Y., Li, F., Zhang, D., Fruit and vegetable consumption and the risk of depression: A meta-analysis (2016) Nutrition, 32 (3), pp. 296-302; Liu, Z., Lin, A., Dietary factors and thyroid cancer risk: A meta-analysis of observational studies (2014) Nutrition and Cancer, 66 (7), pp. 1165-1178; Loef, M., Walach, H., Fruit, vegetables and prevention of cognitive decline or dementia: A systematic review of cohort studies (2012) The Journal of Nutrition, Health & Aging, 16 (7), pp. 626-630; Loke, W.M., Proudfoot, J.M., Stewart, S., McKinley, A.J., Needs, P.W., Kroon, P.A., Hodgson, J.M., Croft, K.D., Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity (2008) Biochemical Pharmacology, 75 (5), pp. 1045-1053; Loomba, R., Sanyal, A.J., The global NAFLD epidemic (2013) Nature Reviews Gastroenterology & Hepatology, 10 (11), pp. 686-690; Lunet, N., Valbuena, C., Vieira, A.L., Lopes, C., Lopes, C., David, L., Carneiro, F., Barros, H., Fruit and vegetable consumption and gastric cancer by location and histological type: Case-control and meta-analysis (2007) European Journal of Cancer Prevention, 16 (4), pp. 312-327; Luo, S.Y., Li, Y., Luo, H., Yin, X.H., Lin, D.R., Zhao, K., Huang, G.L., Song, J.K., Increased intake of vegetables, but not fruits, may be associated with reduced risk of hip fracture: A meta-analysis (2016) Scientific Reports, 6, p. 19783; Lupton, J.R., Atkinson, S.A., Chang, N., Fraga, C.G., Levy, J., Messina, M., Richardson, D.P., Griffiths, J.C., Exploring the benefits and challenges of establishing a DRI-like process for bioactives (2014) European Journal of Nutrition, 53, pp. 1-9; Macdonald, H.M., Black, A.J., Aucott, L., Duthie, G., Duthie, S., Sandison, R., Hardcastle, A.C., Reid, D.M., Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: A randomized controlled trial (2008) The American Journal of Clinical Nutrition, 88 (2), pp. 465-474; Macdonald, H.M., Hardcastle, A.C., Duthie, G.G., Duthie, S.J., Aucott, L., Sandison, R., Shearer, M.J., Reid, D.M., Changes in vitamin biomarkers during a 2-year intervention trial involving increased fruit and vegetable consumption by free-living volunteers (2009) British Journal of Nutrition, 102 (10), pp. 1477-1486; Macready, A.L., George, T.W., Chong, M.F., Alimbetov, D.S., Jin, Y., Vidal, A., Spencer, J.P.E., Minihane, A.-M., Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease—FLAVURS: A randomized controlled trial (2014) The American Journal of Clinical Nutrition, 99 (3), pp. 479-489; Makki, K., Deehan, E.C., Walter, J., Bäckhed, F., The impact of dietary fiber on gut microbiota in host health and disease (2018) Cell Host Microbe, 23 (6), pp. 705-715; Mares, J., Lutein and zeaxanthin isomers in eye health and disease (2016) Annual Review of Nutrition, 36 (1), pp. 571-602; Marques-Vidal, P., Ravasco, P., Ermelinda Camilo, M., Foodstuffs and colorectal cancer risk: A review (2006) Clinical Nutrition, 25 (1), pp. 14-36; Maslowski, K.M., Mackay, C.R., Diet, gut microbiota and immune responses (2011) Nature Immunology, 12 (1), pp. 5-9; Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 (2009) Nature, 461 (7268), pp. 1282-1286. , et al; Mateen, S., Moin, S., Khan, A.Q., Zafar, A., Fatima, N., Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis (2016) PLoS One, 11 (4); Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson, L., Brayne, C., A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II (2013) Lancet, 382 (9902), pp. 1405-1412. , Medical Research Council Cognitive Function and Ageing Collaboration; Mayhew, A.J., de Souza, R.J., Meyre, D., Anand, S.S., Mente, A., A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality (2016) British Journal of Nutrition, 115 (2), pp. 212-225; Mayne, S.T., Antioxidant nutrients and chronic disease: Use of biomarkers of exposure and oxidative stress status in epidemiologic research (2003) The Journal of Nutrition, 133 (3), pp. 933S-40S; Mayne, S.T., Cartmel, B., Scarmo, S., Jahns, L., Ermakov, I.V., Gellermann, W., Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies (2013) Archives of Biochemistry and Biophysics, 539 (2), pp. 163-170; McCall, D.O., McGartland, C.P., McKinley, M.C., Patterson, C.C., Sharpe, P., McCance, D.R., Young, I.S., Woodside, J.V., Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner (2009) Circulation, 119 (16), pp. 2153-2160; McDannell, R., McLean, A.E.M., Chemical and biological properties of indole glucosinolates (glucobrassicins): A review (1988) Food and Chemical Toxicology, 26, pp. 59-70; McDonough, J.E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W.M., Sanchez, P.G., Wright, A.C., Coxson, H.O., Small-airway obstruction and emphysema in chronic obstructive pulmonary disease (2011) New England Journal of Medicine, 365 (17), pp. 1567-1575; McMartin, S.E., Jacka, F.N., Colman, I., The association between fruit and vegetable consumption and mental health disorders: Evidence from five waves of a national survey of Canadians (2013) Preventive Medicine, 56 (3-4), pp. 225-230; McTiernan, A., Wactawski-Wende, J., Wu, L., Rodabough, R.J., Watts, N.B., Tylavsky, F., Freeman, R., Jackson, R., Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: The Women’s Health Initiative Dietary Modification Trial (2009) The American Journal of Clinical Nutrition, 89 (6), pp. 1864-1876; Meng, H., Hu, W., Chen, Z., Shen, Y., Fruit and vegetable intake and prostate cancer risk: A meta-analysis (2014) Asia-Pacific Journal of Clinical Oncology, 10 (2), pp. 133-140; Mente, A., de Koning, L., Shannon, H.S., Anand, S.S., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease (2009) Archives of Internal Medicine, 169 (7), pp. 659-669; Merikangas, K.R., He, J.-P., Burstein, M., Swanson, S.A., Avenevoli, S., Cui, L., Benjet, C., Swendsen, J., Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A) (2010) Journal of the American Academy of Child and Adolescent Psychiatry, 49 (10), pp. 980-989; Mewborn, C.M., Lindbergh, C.A., Robinson, T.L., Gogniat, M.A., Terry, D.P., Jean, K.R., Hammond, B.R., Miller, L.S., Lutein and zeaxanthin are positively associated with visual-spatial functioning in older adults: An fMRI study (2018) Nutrients, 10 (4), p. 458; Mewborn, C.M., Terry, D.P., Renzi-Hammond, L.M., Hammond, B.R., Miller, L.S., Relation of retinal and serum lutein and zeaxanthin to white matter integrity in older adults: A diffusion tensor imaging study (2018) Archives of Clinical Neuropsychology, 33 (7), pp. 861-874; Meyer, K.A., Kushi, L.H., Jacobs, D.R., Slavin, J., Sellers, T.A., Folsom, A.R., Carbohydrates, dietary fiber, and incident type 2 diabetes in older women (2000) The American Journal of Clinical Nutrition, 71 (4), pp. 921-930; Michels, K.B., Mohllajee, A.P., Roset-Bahmanyar, E., Beehler, G.P., Moysich, K.B., Diet and breast cancer: A review of the prospective observational studies (2007) Cancer, 109 (S12), pp. 2712-2749; Minihane, A.M., Vinoy, S., Russell, W.R., Baka, A., Roche, H.M., Tuohy, K.M., Teeling, J.L., Vauzour, D., Low-grade inflammation, diet composition and health: Current research evidence and its translation (2015) British Journal of Nutrition, 114 (7), pp. 999-1012; Misso, N.L.A., Brooks-Wildhaber, J., Ray, S., Vally, H., Thompson, P.J., Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma (2005) European Respiratory Journal, 26 (2), pp. 257-264; Miyake, Y., Sasaki, S., Tanaka, K., Hirota, Y., Consumption of vegetables, fruit, and antioxidants during pregnancy and wheeze and eczema in infants (2010) Allergy, 65 (6), pp. 758-765; Moeller, S.M., Taylor, A., Tucker, K.L., McCullough, M.L., Chylack, L.T., Hankinson, S.E., Willett, W.C., Jacques, P.F., Overall adherence to the Dietary Guidelines for Americans is associated with reduced prevalence of early age-related nuclear lens opacities in women (2004) The Journal of Nutrition, 134 (7), pp. 1812-1819; Moeller, S.M., Voland, R., Tinker, L., Blodi, B.A., Klein, M.L., Gehrs, K.M., Johnson, E.J., Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the carotenoids in the Age-Related Eye Disease Study, an ancillary study of the Women’s Health Initiative (2008) Archives of Ophthalmology, 126 (3), pp. 354-364; Montonen, J., Järvinen, R., Heliövaara, M., Reunanen, A., Aromaa, A., Knekt, P., Food consumption and the incidence of type II diabetes mellitus (2005) European Journal of Clinical Nutrition, 59 (3), pp. 441-448; Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., Wilson, R.S., Associations of vegetable and fruit consumption with age-related cognitive change (2006) Neurology, 67 (8), pp. 1370-1376; Mottaghi, T., Amirabdollahian, F., Haghighatdoost, F., Fruit and vegetable intake and cognitive impairment: A systematic review and meta-analysis of observational studies (2018) European Journal of Clinical Nutrition, 72 (10), pp. 1336-1344; Movassagh, E.Z., Vatanparast, H., Current evidence on the association of dietary patterns and bone health: A scoping review (2017) Advances in Nutrition: An International Review Journal, 8 (1), pp. 12-16; Mukai, Y., Sato, S., Polyphenol-containing azuki bean (vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension (2009) Nutrition, Metabolism & Cardiovascular Diseases, 19 (7), pp. 491-497; Muraki, I., Imamura, F., Manson, J.E., Hu, F.B., Willett, W.C., van Dam, R.M., Sun, Q., Fruit consumption and risk of type 2 diabetes: Results from three prospective longitudinal cohort studies (2013) BMJ, 347 (1), p. f5001; Murphy, L.B., Cisternas, M.G., Greenlund, K.J., Giles, W., Hannan, C., Helmick, C.G., Defining arthritis for public health surveillance: Methods and estimates in four US population health surveys (2017) Arthritis Care & Research, 69 (3), pp. 356-367; Murphy, M.M., Stettler, N., Smith, K.M., Reiss, R., Associations of consumption of fruits and vegetables during pregnancy with infant birth weight or small for gestational age births: A systematic review of the literature (2014) International Journal of Women's Health, 6, pp. 899-912; Murray, C.J.L., The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors (2013) JAMA, 310 (6), pp. 591-606; Mursu, J., Virtanen, J.K., Tuomainen, T.-P., Nurmi, T., Voutilainen, S., Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study (2014) The American Journal of Clinical Nutrition, 99 (2), pp. 328-333; Musso, G., Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis (2003) Hepatology, 37 (4), pp. 909-916; Myasoedova, E., Crowson, C.S., Kremers, H.M., Therneau, T.M., Gabriel, S.E., Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007 (2010) Arthritis & Rheumatology, 62 (6), pp. 1576-1582; Myint, P.K., Welch, A.A., Bingham, S.A., Surtees, P.G., Wainwright, N.W.J., Luben, R.N., Wareham, N.J., Day, N.E., Fruit and vegetable consumption and self-reported functional health in men and women in the European prospective investigation into cancer–norfolk (EPIC–norfolk): A population-based cross-sectional study (2007) Public Health Nutrition, 10 (1), pp. 34-41; Mytton, O.T., Nnoaham, K., Eyles, H., Scarborough, P., Mhurchu, C.N., Systematic review and meta-analysis of the effect of increased vegetable and fruit consumption on body weight and energy intake (2014) BMC Public Health, 14, p. 886; Nanri, A., Yoshida, D., Yamaji, T., Mizoue, T., Takayanagi, R., Kono, S., Dietary patterns and C-reactive protein in Japanese men and women (2008) The American Journal of Clinical Nutrition, 87 (5), pp. 1488-1496; Nantz, M.P., Rowe, C.A., Nieves, C., Percival, S.S., Immunity and antioxidant capacity in humans is enhanced by consumption of a dried, encapsulated fruit and vegetable juice concentrate (2006) The Journal of Nutrition, 136 (10), pp. 2606-2610; Netting, M.J., Middleton, P.F., Makrides, M., Does maternal diet during pregnancy and lactation affect outcomes in offspring? A systematic review of food-based approaches (2014) Nutrition, 30 (11-12), pp. 1225-1241; Neville, C.E., Young, I.S., Gilchrist, S.E.C.M., McKinley, M.C., Gibson, A., Edgar, J.D., Woodside, J.V., Effect of increased fruit and vegetable consumption on bone turnover in older adults: A randomised controlled trial (2014) Osteoporosis International, 25 (1), pp. 223-233; Osteoporosis prevention, diagnosis, and therapy (2001) JAMA, 285 (6), pp. 785-795; (2018), https://ods.od.nih.gov/Research/Bioactive_Food_Components_Initiatives.aspx, Bioactive food components initiatives. Accessed July 20, 2018; Nishida, C., Uauy, R., Kumanyika, S., Shetty, P., The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: Process, product and policy implications (2004) Public Health Nutrition, 7 (1a), pp. 245-250; Nooyens, A.C.J., Bueno-de-Mesquita, H.B., van Boxtel, M.P.J., van Gelder, B.M., Verhagen, H., Verschuren, W.M.M., Fruit and vegetable intake and cognitive decline in middle-aged men and women: The Doetinchem Cohort Study (2011) British Journal of Nutrition, 106 (5), pp. 752-761; Nurk, E., Refsum, H., Drevon, C.A., Tell, G.S., Nygaard, H.A., Engedal, K., Smith, A.D., Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study (2010) British Journal of Nutrition, 104 (8), pp. 1190-1201; Nurmatov, U., Devereux, G., Sheikh, A., Nutrients and foods for the primary prevention of asthma and allergy: Systematic review and meta-analysis (2011) The Journal of Allergy and Clinical Immunology, 127 (3), p. 724. , 33.e1–e30, and; Ogden, C.L., Carroll, M.D., Lawman, H.G., Fryar, C.D., Kruszon-Moran, D., Kit, B.K., Flegal, K.M., Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014 (2016) JAMA, 315 (21), pp. 2292-2299; Okoko, B.J., Burney, P.G., Newson, R.B., Potts, J.F., Shaheen, S.O., Childhood asthma and fruit consumption (2007) European Respiratory Journal, 29 (6), pp. 1161-1168; Palmer, D., The effect of age on thymic function (2013) Frontiers in Immunology, 4, p. 316; Palmer, S.C., Maggo, J.K., Campbell, K.L., Craig, J.C., Johnson, D.W., Sutanto, B., Ruospo, M., Strippoli, G.F., Dietary interventions for adults with chronic kidney disease (2017) Cochrane Database of Systematic Reviews, 2017 (4), p. CD011998; Paluszkiewicz, P., Smolińska, K., Dębińska, I., Turski, W.A., Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies (2012) Cancer Epidemiology, 36 (1), pp. 60-67; Pappas, A., Liakou, A., Zouboulis, C.C., Nutrition and skin (2016) Reviews in Endocrine and Metabolic Disorders, 17 (3), pp. 443-448; Park, S., Kim, M.-Y., Lee, D.H., Lee, S.H., Baik, E.J., Moon, C.-H., Park, S.W., Jung, Y.-S., Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect (2009) European Journal of Nutrition, 48 (4), pp. 235-242; Pascolini, D., Mariotti, S.P., Global estimates of visual impairment: 2010 (2012) British Journal of Ophthalmology, 96 (5), pp. 614-618; Patel, B.D., Dietary antioxidants and asthma in adults (2006) Thorax, 61 (5), pp. 388-393; Pattison, D.J., Symmons, D.P., Lunt, M., Welch, A., Bingham, S.A., Day, N.E., Silman, A.J., Dietary β-cryptoxanthin and inflammatory polyarthritis: Results from a population-based prospective study (2005) The American Journal of Clinical Nutrition, 82 (2), pp. 451-455; Pattison, D.J., Symmons, D.P.M., Lunt, M., Welch, A., Luben, R., Bingham, S.A., Khaw, K.-T., Silman, A.J., Dietary risk factors for the development of inflammatory polyarthritis: Evidence for a role of high level of red meat consumption (2004) Arthritis & Rheumatism, 50 (12), pp. 3804-3812; Pavia, M., Pileggi, C., Nobile, C.G.A., Angelillo, I.F., Association between fruit and vegetable consumption and oral cancer: A meta-analysis of observational studies (2006) The American Journal of Clinical Nutrition, 83 (5), pp. 1126-1134; Peluso, I., Miglio, C., Morabito, G., Ioannone, F., Serafini, M., Flavonoids and immune function in human: A systematic review (2015) Critical Reviews in Food Science and Nutrition, 55 (3), pp. 383-395; Pera, A., Campos, C., López, N., Hassouneh, F., Alonso, C., Tarazona, R., Solana, R., Immunosenescence: Implications for response to infection and vaccination in older people (2015) Maturitas, 82 (1), pp. 50-55; Pereira, S.S., Alvarez-Leite, J.I., Low-grade inflammation, obesity, and diabetes (2014) Current Obesity Reports, 3 (4), pp. 422-431; Pinent, M., Blay, M., Bladé, M.C., Salvadó, M.J., Arola, L., Ardévol, A., Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines (2004) Endocrinology, 145 (11), pp. 4985-4990; Poutanen, K.S., Dussort, P., Erkner, A., Fiszman, S., Karnik, K., Kristensen, M., Marsaux, C.F., A review of the characteristics of dietary fibers relevant to appetite and energy intake outcomes in human intervention trials (2017) The American Journal of Clinical Nutrition, 106 (3), pp. 747-754; Prince, M.J., Wu, F., Guo, Y., Gutierrez Robledo, L.M., O'Donnell, M., Sullivan, R., Yusuf, S., The burden of disease in older people and implications for health policy and practice (2015) Lancet, 385 (9967), pp. 549-562; (2015), http://www.pbhfoundation.org/pdfs/about/res/pbh_res/State_of_the_Plate_2015_WEB_Bookmarked.pdf, State of the Plate: 2015 Study on America’s Consumption of Fruit & Vegetables. Accessed March 17, 2019; Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scarmeas, N., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis (2013) Annals of Neurology, 74 (4), pp. 580-591; Qiu, R., Cao, W.-T., Tian, H.-Y., He, J., Chen, G.-D., Chen, Y.-M., Greater intake of fruit and vegetables is associated with greater bone mineral density and lower osteoporosis risk in middle-aged and elderly adults (2017) PLoS One, 12 (1); Raghavan, R., Dreibelbis, C., Kingshipp, B., Wong, Y.P., Abrams, B., Gernand, A.D., Rasmussen, K.M., Casavale, K.O., Dietary patterns before and during pregnancy and birth outcomes: A systematic review (2019) The American Journal of Clinical Nutrition, 109, pp. 729S-56S; Raghavan, R., Dreibelbis, C., Kingshipp, B., Wong, Y.P., Abrams, B., Gernand, A.D., Rasmussen, K.M., Casavale, K.O., Dietary patterns before and during pregnancy and maternal outcomes: A systematic review (2019) The American Journal of Clinical Nutrition, 109, pp. 705S-28S; Raj Krishnamurthy, V.M., Wei, G., Baird, B.C., Murtaugh, M., Chonchol, M.B., Raphael, K.L., Greene, T., Beddhu, S., High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease (2012) Kidney International, 81 (3), pp. 300-306; Ranard, K.M., Jeon, S., Mohn, E.S., Griffiths, J.C., Johnson, E.J., Erdman, J.W., Dietary guidance for lutein: Consideration for intake recommendations is scientifically supported (2017) European Journal of Nutrition, 56 (S3), pp. 37-42; Renzi-Hammond, L.M., Bovier, E.R., Fletcher, L.M., Miller, L.S., Mewborn, C.M., Lindbergh, C.A., Baxter, J.H., Hammond, B.R., Effects of a lutein and zeaxanthin intervention on cognitive function: A randomized, double-masked, placebo-controlled trial of younger healthy adults (2017) Nutrients, 9 (11), p. 1246; Rickman, J.C., Barrett, D.M., Bruhn, C.M., Nutritional comparison of fresh, frozen and canned fruits and vegetables. Part 1. Vitamins C and B and phenolic compounds (2007) Journal of the Science of Food and Agriculture, 87 (6), pp. 930-944; Rickman, J.C., Bruhn, C.M., Barrett, D.M., Nutritional comparison of fresh, frozen, and canned fruits and vegetables II. Vitamin A and carotenoids, vitamin E, minerals and fiber (2007) Journal of the Science of Food and Agriculture, 87 (7), pp. 1185-1196; Riley, L., Gouda, H., Cowan, M., (2017), Noncommunicable diseases progress monitor, 2017; Rist, P.M., Buring, J.E., Kurth, T., Dietary patterns according to headache and migraine status: A cross-sectional study (2015) Cephalalgia, 35 (9), pp. 767-775; Rosenlund, H., Kull, I., Pershagen, G., Wolk, A., Wickman, M., Bergstrom, A., Fruit and vegetable consumption in relation to allergy: Disease-related modification of consumption? (2011) The Journal of Allergy and Clinical Immunology, 127 (5), pp. 1219-1225; Roth, G.A., Dwyer-Lindgren, L., Bertozzi-Villa, A., Stubbs, R.W., Morozoff, C., Naghavi, M., Mokdad, A.H., Murray, C.J.L., Trends and patterns of geographic variation in cardiovascular mortality among US counties, 1980–2014 (2017) JAMA, 317 (19), pp. 1976-1992; Rybicka, M., Baranowska-Bosiacka, I., Żyluk, B., Nowacki, P., Chlubek, D., The role of magnesium in migraine pathogenesis. Potential use of magnesium compounds in prevention and treatment of migraine headaches (2012) Journal of Elementology, 17 (2), pp. 345-356; Sabia, S., Nabi, H., Kivimaki, M., Shipley, M.J., Marmot, M.G., Singh-Manoux, A., Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II Study (2009) American Journal of Epidemiology, 170 (4), pp. 428-437; Saghafian, F., Malmir, H., Saneei, P., Milajerdi, A., Larijani, B., Esmaillzadeh, A., Fruit and vegetable consumption and risk of depression: Accumulative evidence from an updated systematic review and meta-analysis of epidemiological studies (2018) British Journal of Nutrition, 119 (10), pp. 1087-1101; Salas-Salvadó, J., Garcia-Arellano, A., Estruch, R., Marquez-Sandoval, F., Corella, D., Fiol, M., Gómez-Gracia, E., Herrera, C., Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease (2008) European Journal of Clinical Nutrition, 62 (5), pp. 651-659; Salomone, F., Godos, J., Zelber-Sagi, S., Natural antioxidants for non-alcoholic fatty liver disease: Molecular targets and clinical perspectives (2016) Liver International, 36 (1), pp. 5-20; Sánchez-Villegas, A., Delgado-Rodríguez, M., Alonso, A., Schlatter, J., Lahortiga, F., Serra Majem, L., Martínez-González, M.A., Association of the Mediterranean dietary pattern with the incidence of depression: The Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort (2009) Archives of General Psychiatry, 66 (10), pp. 1090-1098; Sánchez-Villegas, A., Toledo, E., de Irala, J., Ruiz-Canela, M., Pla-Vidal, J., Martínez-González, M.A., Fast-food and commercial baked goods consumption and the risk of depression (2012) Public Health Nutrition, 15 (3), pp. 424-432; Sánchez-Villegas, A., Verberne, L., De Irala, J., Ruíz-Canela, M., Toledo, E., Serra-Majem, L., Martínez-González, M.A., Dietary fat intake and the risk of depression: The SUN project (2011) PLoS One, 6 (1); Sanders, M.G.H., Pardo, L.M., Ginger, R.S., Kiefte-de Jong, J.C., Nijsten, T., Association between diet and seborrheic dermatitis: A cross-sectional study (2019) Journal of Investigative Dermatology, 139 (1), pp. 108-114; Santoro, A., Ostan, R., Candela, M., Biagi, E., Brigidi, P., Capri, M., Franceschi, C., Gut microbiota changes in the extreme decades of human life: A focus on centenarians (2018) Cellular and Molecular Life Sciences, 75 (1), pp. 129-148; Sargeant, L.A., Jaeckel, A., Wareham, N.J., Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC norfolk (2000) European Respiratory Journal, 16 (3), pp. 397-403; Sarkar, D., Sharma, A., Talukder, G., Chlorophyll and chlorophyllin as modifiers of genotoxic effects (1994) Mutation Research, 318 (3), pp. 239-247; Schlesinger, S., Neuenschwander, M., Schwedhelm, C., Hoffmann, G., Bechthold, A., Boeing, H., Schwingshackl, L., Food groups and risk of overweight, obesity, and weight gain: A systematic review and dose-response meta-analysis of prospective studies (2019) Advances in Nutrition, 10 (2), pp. 205-218; Schell, J., Scofield, R., Barrett, J., Kurien, B., Betts, N., Lyons, T., Zhao, Y., Basu, A., Strawberries improve pain and inflammation in obese adults with radiographic evidence of knee osteoarthritis (2017) Nutrients, 9 (9), p. 949; Schoenaker, D.A.J.M., Soedamah-Muthu, S.S., Mishra, G.D., The association between dietary factors and gestational hypertension and pre-eclampsia: A systematic review and meta-analysis of observational studies (2014) BMC Medicine, 12, p. 157; Schwarzenberg, S.J., Georgieff, M.K., Advocacy for improving nutrition in the first 1000 days to support childhood development and adult health (2018) Pediatrics, 141 (2), p. e20173716. , and; Schwingshackl, L., Hoffmann, G., Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: A systematic review and meta-analysis of cohort studies (2015) Journal of the Academy of Nutrition and Dietetics, 115 (5), pp. 780-800; Schwingshackl, L., Hoffmann, G., Lampousi, A.-M., Knuppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Boeing, H., Food groups and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies (2017) European Journal of Epidemiology, 32 (5), pp. 363-375; Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Knuppel, S., Iqbal, K., Andriolo, V., Bechthold, A., Boeing, H., Food groups and risk of hypertension: A systematic review and dose-response meta-analysis of prospective studies (2017) Advances in Nutrition: An International Review Journal, 8 (6), pp. 793-803; Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Knüppel, S., Laure Preterre, A., Iqbal, K., Bechthold, A., Devleesschauwer, B., Food groups and risk of colorectal cancer (2018) International Journal of Cancer, 142 (9), pp. 1748-1758; Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Lampousi, A.-M., Knüppel, S., Iqbal, K., Bechthold, A., Boeing, H., Food groups and risk of all-cause mortality: A systematic review and meta-analysis of prospective studies (2017) The American Journal of Clinical Nutrition, 105 (6), pp. 1462-1473; Seddon, J.M., Ajani, U.A., Sperduto, R.D., Hiller, R., Blair, N., Burton, T.C., Farber, M.D., Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group (1994) JAMA: The Journal of the American Medical Association, 272 (18), pp. 1413-1420. , et al; Seeman, E., Bianchi, G., Khosla, S., Kanis, J.A., Orwoll, E., Bone fragility in men–Where are we? (2006) Osteoporosis International, 17 (11), pp. 1577-1583; Sergentanis, T.N., Psaltopoulou, T., Ntanasis-Stathopoulos, I., Liaskas, A., Tzanninis, I.-G., Dimopoulos, M.-A., Consumption of fruits, vegetables, and risk of hematological malignancies: A systematic review and meta-analysis of prospective studies (2018) Leukemia & Lymphoma, 59 (2), pp. 434-447; Seyedrezazadeh, E., Moghaddam, M.P., Ansarin, K., Vafa, M.R., Sharma, S., Kolahdooz, F., Fruit and vegetable intake and risk of wheezing and asthma: A systematic review and meta-analysis (2014) Nutrition Reviews, 72 (7), pp. 411-428; Sherzai, A., Heim, L.T., Boothby, C., Sherzai, A.D., Stroke, food groups, and dietary patterns: A systematic review (2012) Nutrition Reviews, 70 (8), pp. 423-435; Shi, L., Liu, Z.W., Li, Y., Gong, C., Zhang, H., Song, L.J., Huang, C.Y., Li, M., The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu (2012) Biomedical and Environmental Sciences, 25 (4), pp. 383-391; Shin, J.Y., Kim, J.Y., Kang, H.T., Han, K.H., Shim, J.Y., Effect of fruits and vegetables on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials (2015) International Journal of Food Sciences and Nutrition, 66 (4), pp. 416-425; Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016 (2016) CA: A Cancer Journal for Clinicians, 66 (1), pp. 7-30; Singh, N.P., Ingle, G.K., Saini, V.K., Jami, A., Beniwal, P., Lal, M., Meena, G.S., Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: An observational, cross-sectional study (2009) BMC Nephrology, 10, p. 4; Skoczek-Rubinska, A., Bajerska, J., Menclewicz, K., Effects of fruit and vegetables intake in periodontal diseases: A systematic review (2018) Dental and Medical Problems, 55 (4), pp. 431-439; Slavin, J.L., Lloyd, B., Health benefits of fruits and vegetables (2012) Advances in Nutrition, 3 (4), pp. 506-516; Song, W., Derito, C.M., Liu, M.K., He, X., Dong, M., Liu, R.H., Cellular antioxidant activity of common vegetables (2010) Journal of Agricultural and Food Chemistry, 58 (11), pp. 6621-6629; Spagnuolo, C., Moccia, S., Russo, G.L., Anti-inflammatory effects of flavonoids in neurodegenerative disorders (2018) European Journal of Medicinal Chemistry, 153, pp. 105-115; Stahl, W., Sies, H., β-carotene and other carotenoids in protection from sunlight (2012) The American Journal of Clinical Nutrition, 96 (5), pp. 1179S-84S; Stewart, W.F., Roy, J., Lipton, R.B., Migraine prevalence, socioeconomic status, and social causation (2013) Neurology, 81 (11), pp. 948-955; Stice, E., Burger, K., Neural vulnerability factors for obesity (2019) Clinical Psychology Review, 68, pp. 38-53; Storey, M., Anderson, P., Total fruit and vegetable consumption increases among consumers of frozen fruit and vegetables (2018) Nutrition, 46, pp. 115-121; Storey, M.L., Anderson, P.A., Vegetable consumption and selected nutrient intakes of women of childbearing age (2016) Journal of Nutrition Education and Behavior, 48 (10), pp. 691-696; Sun-Edelstein, C., Mauskop, A., Role of magnesium in the pathogenesis and treatment of migraine (2009) Expert Review of Neurotherapeutics, 9 (3), pp. 369-379; Thom, D.H., Haan, M.N., Van Den Eeden, S.K., Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality (1997) Age and Ageing, 26 (5), pp. 367-374; Tian, Y., Su, L., Wang, J., Duan, X., Jiang, X., Fruit and vegetable consumption and risk of the metabolic syndrome: A meta-analysis (2018) Public Health Nutrition, 21 (4), pp. 756-765; Tursi, A., Dietary pattern and colonic diverticulosis (2017) Current Opinion in Clinical Nutrition & Metabolic Care, 20 (5), pp. 409-413; Government, U.K., (2018) The Eatwell Guide, , https://www.gov.uk/government/publications/the-eatwell-guide, Accessed May 4, 2018; (2010) Older Americans 2010: Key indicators of well-being, , Washington, DC: U.S. Government Printing Office; Ueda, H., Yamazaki, C., Yamazaki, M., A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production (2004) Bioscience, Biotechnology, and Biochemistry, 68 (1), pp. 119-125; (2015), https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/fped/table_1_fped_gen_0910.pdf, What we eat America, NHANES 2009–10: Table 1a. Mean daily food patterns cup equivalents consumed per individual, by gender and age, the United States, 2009–2010; (2018), https://health.gov/dietaryguidelines/2015/, 2015–2020 Dietary Guidelines for Americans. Accessed May 4, 2018; (2018), https://www.ars.usda.gov/research/publications/publication/?seqNo115=350651, Salad consumption the U.S.: What we eat America, NHANES 2011–2014. Accessed July 20, 2018; van Egmond-Fröhlich, A.W.A., Weghuber, D., de Zwaan, M., Association of symptoms of attention-deficit/hyperactivity disorder with physical activity, media time, and food intake in children and adolescents (2012) PLoS One, 7 (11); Vieira, A.R., Abar, L., Chan, D.S.M., Vingeliene, S., Polemiti, E., Stevens, C., Greenwood, D., Norat, T., Foods and beverages and colorectal cancer risk: A systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project (2017) Annals of Oncology, 28 (8), pp. 1788-1802; Vieira, A.R., Abar, L., Vingeliene, S., Chan, D.S.M., Aune, D., Navarro-Rosenblatt, D., Stevens, C., Norat, T., Fruits, vegetables and lung cancer risk: A systematic review and meta-analysis (2016) Annals of Oncology, 27 (1), pp. 81-96; Vieira, A.R., Vingeliene, S., Chan, D.S.M., Aune, D., Abar, L., Navarro Rosenblatt, D., Greenwood, D.C., Norat, T., Fruits, vegetables, and bladder cancer risk: A systematic review and meta-analysis (2015) Cancer Medicine, 4 (1), pp. 136-146; Villegas, R., Shu, X.O., Gao, Y.-T., Yang, G., Elasy, T., Li, H., Zheng, W., Vegetable but not fruit consumption reduces the risk of type 2 diabetes in Chinese women (2008) The Journal of Nutrition, 138 (3), pp. 574-580; Vingeliene, S., Chan, D.S.M., Vieira, A.R., Polemiti, E., Stevens, C., Abar, L., Navarro Rosenblatt, D., Norat, T., An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk (2017) Annals of Oncology, 28 (10), pp. 2409-2419; Wakai, K., Matsuo, K., Nagata, C., Mizoue, T., Tanaka, K., Tsuji, I., Sasazuki, S., Inoue, M., Lung cancer risk and consumption of vegetables and fruit: An evaluation based on a systematic review of epidemiological evidence from Japan (2011) Japanese Journal of Clinical Oncology, 41 (5), pp. 693-708; Wallace, I.J., Worthington, S., Felson, D.T., Jurmain, R.D., Wren, K.T., Maijanen, H., Woods, R.J., Lieberman, D.E., Knee osteoarthritis has doubled in prevalence since the mid-20th century (2017) Proceedings of the National Academy of Sciences of the United States of America, 114 (35), pp. 9332-9336; Wallace, I.R., McEvoy, C.T., Hunter, S.J., Hamill, L.L., Ennis, C.N., Bell, P.M., Patterson, C.C., McKinley, M.C., Dose-response effect of fruit and vegetables on insulin resistance in people at high risk of cardiovascular disease: A randomized controlled trial (2013) Diabetes Care, 36 (12), pp. 3888-3896; Wallace, T., Dried plums, prunes and bone health: A comprehensive review (2017) Nutrients, 9 (4), p. 401; Wallace, T., Slavin, M., Frankenfeld, C., Systematic review of anthocyanins and markers of cardiovascular disease (2016) Nutrients, 8 (1), p. 32; Wallace, T.C., Anthocyanins in cardiovascular disease (2011) Advances in Nutrition, 2 (1), pp. 1-7; Wallace, T.C., Blumberg, J.B., Johnson, E.J., Shao, A., Dietary bioactives: Establishing a scientific framework for recommended intakes (2015) Advances in Nutrition, 6 (1), pp. 1-4; Wallace, T.C., Bultman, S., D’Adamo, C., Daniel, C.R., Debelius, J., Ho, E., Eliassen, H., Seyfried, T.N., Personalized nutrition in disrupting cancer — Proceedings from the 2017 American College of Nutrition Annual Meeting (2019) Journal of the American College of Nutrition, 38 (1), pp. 1-14; Wallace, T.C., Guarner, F., Madsen, K., Cabana, M.D., Gibson, G., Hentges, E., Sanders, M.E., Human gut microbiota and its relationship to health and disease (2011) Nutrition Reviews, 69 (7), pp. 392-403; Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A., Casey, D.C., Coates, M.M., Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) Lancet, 388 (10053), pp. 1459-1544; Wang, M., Qin, S., Zhang, T., Song, X., Zhang, S., The effect of fruit and vegetable intake on the development of lung cancer: A meta-analysis of 32 publications and 20,414 cases (2015) European Journal of Clinical Nutrition, 69 (11), pp. 1184-1192; Wang, P.-Y., Fang, J.-C., Gao, Z.-H., Zhang, C., Xie, S.-Y., Higher intake of fruits, vegetables or their fiber reduces the risk of type 2 diabetes: A meta-analysis (2016) Journal of Diabetes Investigation, 7 (1), pp. 56-69; Wang, Q., Chen, Y., Wang, X., Gong, G., Li, G., Li, C., Consumption of fruit, but not vegetables, may reduce risk of gastric cancer: Results from a meta-analysis of cohort studies (2014) European Journal of Cancer, 50 (8), pp. 1498-1509; Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., Hu, F.B., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies (2014) BMJ, 349 (3), p. g4490; Wang, X., Ouyang, Y.Y., Liu, J., Zhao, G., Flavonoid intake and risk of CVD: A systematic review and meta-analysis of prospective cohort studies (2014) British Journal of Nutrition, 111 (1), pp. 1-11; Wang, Y., Li, F., Wang, Z., Qiu, T., Shen, Y., Wang, M., Fruit and vegetable consumption and risk of lung cancer: A dose-response meta-analysis of prospective cohort studies (2015) Lung Cancer, 88 (2), pp. 124-130; Warrilow, A., Mellor, D., McKune, A., Pumpa, K., Dietary fat, fibre, satiation, and satiety—a systematic review of acute studies (2019) European Journal of Clinical Nutrition, 73, pp. 333-344; Watson, R.R., Preedy, V.R., Bioactive food as dietary interventions for cardiovascular disease (2013) Bioactive foods in chronic disease states, p. 719. , Watson R., Preedy V., (eds), Boston, MA: Elsevier, and,. edited by; Wattenberg, L.W., Effects of dietary constituents on the metabolism of chemical carcinogens (1975) Cancer Research, 35 (11 Pt. 2), pp. 3326-3331; (2018), https://www.wcrf.org/dietandcancer/summary-third-expert-report, Diet, nutrition, physical activity and cancer: A global perspective: A summary of the Third Expert Report; Weaver, C.M., Alexander, D.D., Boushey, C.J., Dawson-Hughes, B., Lappe, J.M., LeBoff, M.S., Liu, S., Wang, D.D., Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation (2016) Osteoporosis International, 27 (1), pp. 367-376; Weaver, C.M., Gordon, C.M., Janz, K.F., Kalkwarf, H.J., Lappe, J.M., Lewis, R., O’Karma, M., Zemel, B.S., The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: A systematic review and implementation recommendations (2016) Osteoporosis International, 27 (4), pp. 1281-1386; Weaver, C.M., Martin, B.R., Jackson, G.S., McCabe, G.P., Peacock, M., Wastney, M., Calcium-41: A technology for monitoring changes in bone mineral (2017) Osteoporosis International, 28 (4), pp. 1215-1223; Wedick, N.M., Pan, A., Cassidy, A., Rimm, E.B., Sampson, L., Rosner, B., Willett, W., van Dam, R.M., Dietary flavonoid intakes and risk of type 2 diabetes in US men and women (2012) The American Journal of Clinical Nutrition, 95 (4), pp. 925-933; (2002) The World Health Report 2002: Reducing risks, promoting healthy life, , Geneva, Switzerland: World Health Organization; Wirth, W., Hunter, D.J., Nevitt, M.C., Sharma, L., Kwoh, C.K., Ladel, C., Eckstein, F., Predictive and concurrent validity of cartilage thickness change as a marker of knee osteoarthritis progression: Data from the Osteoarthritis Initiative (2017) Osteoarthritis Cartilage, 25 (12), pp. 2063-2071; Wong, W.L., Su, X., Li, X., Cheung, C.M.G., Klein, R., Cheng, C.-Y., Wong, T.Y., Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis (2014) The Lancet Global Health, 2 (2), pp. e106-e116; Woo, H.D., Park, S., Oh, K., Kim, H.J., Shin, H.R., Moon, H.K., Kim, J., Diet and cancer risk in the Korean population: A meta-analysis (2014) Asian Pacific Journal of Cancer Prevention: APJCP, 15 (19), pp. 8509-8519; Wood, L.G., Gibson, P.G., Dietary factors lead to innate immune activation in asthma (2009) Pharmacology & Therapeutics, 123 (1), pp. 37-53; Wren, T.A.L., Kalkwarf, H.J., Zemel, B.S., Lappe, J.M., Oberfield, S., Shepherd, J.A., Winer, K.A., Gilsanz, V., Longitudinal tracking of dual-energy X-ray absorptiometry bone measures over 6 years in children and adolescents: Persistence of low bone mass to maturity (2014) The Journal of Pediatrics, 164 (6), pp. 1280-1285; Wright, N.C., Looker, A.C., Saag, K.G., Curtis, J.R., Delzell, E.S., Randall, S., Dawson-Hughes, B., The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine (2014) Journal of Bone and Mineral Research, 29 (11), pp. 2520-2526; Wu, L., Sun, D., He, Y., Fruit and vegetables consumption and incident hypertension: Dose-response meta-analysis of prospective cohort studies (2016) Journal of Human Hypertension, 30 (10), pp. 573-580; Wu, L., Sun, D., Tan, Y., Intake of fruit and vegetables and the incident risk of cognitive disorders: A systematic review and meta-analysis of cohort studies (2017) The Journal of Nutrition, Health & Aging, 21 (10), pp. 1284-1290; Wu, Y.-C., Zheng, D., Sun, J.-J., Zou, Z.-K., Ma, Z.-L., Meta-analysis of studies on breast cancer risk and diet in Chinese women (2015) International Journal of Clinical and Experimental Medicine, 8 (1), pp. 73-85; Wu, Y., Zhang, D., Jiang, X., Jiang, W., Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies (2015) Nutrition, Metabolism & Cardiovascular Diseases, 25 (2), pp. 140-147; Xi, B., Li, S., Liu, Z., Tian, H., Yin, X., Huai, P., Tang, W., Steffen, L.M., Intake of fruit juice and incidence of type 2 diabetes: A systematic review and meta-analysis (2014) PLoS One, 9 (3); Xu, C., Zeng, X.-T., Liu, T.-Z., Zhang, C., Yang, Z.-H., Li, S., Chen, X.-Y., Fruits and vegetables intake and risk of bladder cancer: A PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies (2015) Medicine, 94 (17), p. e759; Yahia, E.M., Maldonado Celis, M.E., Svendsen, M., The contribution of fruit and vegetable consumption to human health (2017) Fruit and vegetable phytochemicals, pp. 1-52. , Yahia E.M., (ed), Chichester, UK: John Wiley & Sons, Ltd, and,. edited by; Yang, Y., Wu, F., Winzenberg, T., Jones, G., Tracking of areal bone mineral density from age eight to young adulthood and factors associated with deviation from tracking: A 17-year prospective cohort study (2018) Journal of Bone and Mineral Research, 33 (5), pp. 832-839; Yang, Y., Zhang, D., Feng, N., Chen, G., Liu, J., Chen, G., Zhu, Y., Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: A meta-analysis (2014) Gastroenterology, 147 (5), pp. 1031-1042; Yao, B., Yan, Y., Ye, X., Fang, H., Xu, H., Liu, Y., Li, S., Zhao, Y., Intake of fruit and vegetables and risk of bladder cancer: A dose-response meta-analysis of observational studies (2014) Cancer Causes & Control, 25 (12), pp. 1645-1658; Zhan, J., Liu, Y.-J., Cai, L.-B., Xu, F.-R., Xie, T., He, Q.-Q., Fruit and vegetable consumption and risk of cardiovascular disease: A meta-analysis of prospective cohort studies (2017) Critical Reviews in Food Science and Nutrition, 57 (8), pp. 1650-1663; Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., Chen, M., Yu, X., Prevalence of chronic kidney disease in China: A cross-sectional survey (2012) Lancet, 379 (9818), pp. 815-822; Zhang, S., Jia, Z., Yan, Z., Yang, J., Consumption of fruits and vegetables and risk of renal cell carcinoma: A meta-analysis of observational studies (2017) Oncotarget, 8 (17), pp. 27892-27903; Zhang, Y., Zhang, D.-Z., Associations of vegetable and fruit consumption with metabolic syndrome. A meta-analysis of observational studies (2018) Public Health Nutrition, 21 (9), pp. 1693-1703; Zhang, L.X., Cooney, R.V., Bertram, J.S., Carotenoids up-regulate connexin-43 gene expression independent of their proviamin A or antioxidant properties (1992) Cancer Research, 52 (20), pp. 5707-5712; Zhang, Y., Talalay, P., Anticarcinogenic activities of organic isothiocyanate: Chemistry and mechanisms (1994) Cancer Research, 54, pp. 1976S-81S; Zhao, L.-G., Sun, J.-W., Yang, Y., Ma, X., Wang, Y.-Y., Xiang, Y.-B., Fish consumption and all-cause mortality: A meta-analysis of cohort studies (2016) European Journal of Clinical Nutrition, 70 (2), pp. 155-161; Zhu, F., Du, B., Xu, B., Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: A review (2018) Critical Reviews in Food Science and Nutrition, 58 (8), pp. 1260-1270},
correspondence_address1={Wallace, T.C.; Department of Nutrition and Food Studies, MS: 1F7, 4400 University Drive, United States; email: taylor.wallace@me.com},
publisher={Taylor and Francis Inc.},
issn={10408398},
coden={CRFND},
pubmed_id={31267783},
language={English},
abbrev_source_title={Crit. Rev. Food Sci. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Prüss-Ustün2017464,
author={Prüss-Ustün, A. and Wolf, J. and Corvalán, C. and Neville, T. and Bos, R. and Neira, M.},
title={Diseases due to unhealthy environments: An updated estimate of the global burden of disease attributable to environmental determinants of health},
journal={Journal of Public Health (United Kingdom)},
year={2017},
volume={39},
number={3},
pages={464-475},
doi={10.1093/pubmed/fdw085},
note={cited By 128},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032297034&doi=10.1093%2fpubmed%2ffdw085&partnerID=40&md5=eb19de12f575a52e3ddd5c35af2a277c},
affiliation={Department of Public Health, Environmental and Social Determinants of Health, World Health Organization, Geneva, 1211, Switzerland; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, 4051, Switzerland; University of Basel, Basel, 4003, Switzerland; Faculty of Health, University of CanberraACT  2617, Australia; World Health Organization, Geneva, Switzerland},
abstract={Background The update of the global burden of disease attributable to the environment is presented. The study focuses on modifiable risks to show the potential health impact from environmental interventions. Methods Systematic literature reviews on 133 diseases and injuries were performed. Comparative risk assessments were complemented by more limited epidemiological estimates, expert opinion and information on disease transmission pathways. Population attributable fractions were used to calculate global deaths and global disease burden from environmental risks. Results Twenty-three percent (95% CI: 13-34%) of global deaths and 22% (95% CI: 13-32%) of global disability adjusted life years (DALYs) were attributable to environmental risks in 2012. Sixty-eight percent of deaths and 56% of DALYs could be estimated with comparative risk assessment methods. The global disease burden attributable to the environment is now dominated by noncommunicable diseases. Susceptible ages are children under five and adults between 50 and 75 years. Country level data are presented. Conclusions Nearly a quarter of global disease burden could be prevented by reducing environmental risks. This analysis confirms that eliminating hazards and reducing environmental risks will greatly benefit our health, will contribute to attaining the recently agreed Sustainable Development Goals and will systematically require intersectoral collaboration to be successful. © The World Health Organization [2016]. Published by Oxford University Press on behalf of The Faculty of Public Health.},
author_keywords={Environment;  Morbidity;  Mortality;  Public health},
keywords={adolescent;  adult;  aged;  child;  communicable disease;  disabled person;  environmental exposure;  female;  global disease burden;  human;  infant;  male;  middle aged;  mortality;  newborn;  non communicable disease;  preschool child;  quality adjusted life year;  risk assessment;  statistics and numerical data;  very elderly;  young adult, Adolescent;  Adult;  Aged;  Aged, 80 and over;  Child;  Child, Preschool;  Communicable Diseases;  Disabled Persons;  Environmental Exposure;  Female;  Global Burden of Disease;  Humans;  Infant;  Infant, Newborn;  Male;  Middle Aged;  Mortality;  Noncommunicable Diseases;  Quality-Adjusted Life Years;  Risk Assessment;  Young Adult},
references={Prüss-Üstün, A., Corvalán, C., (2006) Preventing Disease Through Healthy Environments [internet], , http://cdrwww.who.int/entity/quantifying_ehimpacts/publications/preventingdiseasebegin.pdf, World Health Organization Geneva; (20 December 2015, date last accessed; Global Health Observatory (GHO) Data [internet], , http://www.who.int/gho/en/, World Health Organization WHO. undated. (16 July 2015, date last accessed; GBD 2013, GBD Compare [internet], , http://vizhub.healthdata.org/gbd-compare/, IHME. (13 January 2016, date last accessed; Prüss-Ustün, A., Wolf, J., Corvalán, C., (2016) Preventing Disease Through Healthy Environments: A Global Assessment of The Environmental Burden of Disease from Environmental Risks [internet, , http://www.who.int/quantifying_ehimpacts/publications/preventing-disease/en/, (18 March 2016, date last accessed; Environmental Health [internet], , http://www.who.int/topics/environmental_health/en/, World Health Organization undated. (16 July 2015, date last accessed; Metrics: Population Attributable Fraction (PAF) [internet], , http://www.who.int/healthinfo/global_burden_disease/metrics_paf/en/index.html, undated. (15 Novenber 2015, date last accessed; (2009) Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, , World Health Organization; Forouzanfar, M.H., Alexander, L., Anderson, H.R., Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 386 (10010), pp. 2287-2323; Ezzati, M., Lopez, A.D., Rodgers, A., Selected major risk factors and global and regional burden of disease (2002) Lancet, 360 (9343), pp. 1347-1360; Prüss-Ustün, A., Mathers, C., (2003) Introduction and Methods. Assessing The Environmental Burden of Disease at National and Local Levels, , Geneva, Switzerland: World Health Organization; Prüss-Ustün, A., Bartram, J., Clasen, T., Burden of disease from inadequate water, sanitation and hygiene in low- And middle-income settings: A retrospective analysis of data from 145 countries (2014) Trop Med Int Health, 19 (8), pp. 894-905; (2014) Burden of Disease from Household Air Pollution for 2012, , World Health Organization. Geneva, Switzerland: World Health Organization; (2014) Burden of Disease from Ambient Air Pollution for 2012, , World Health Organization. Geneva, Switzerland: World Health Organization; Naghavi, M., Wang, H., Lozano, R., Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 385 (9963), pp. 117-171; Bonjour, S., Adair-Rohani, H., Wolf, J., Solid fuel use for household cooking: Country and regional estimates for 1980-2010 (2013) Environ Health Perspect, 121 (7), pp. 784-790; Baumgartner, J., Schauer, J.J., Ezzati, M., Indoor air pollution and blood pressure in adult women living in rural China (2011) Environ Health Perspect, 119 (10), pp. 1390-1395; Fuks, K.B., Weinmayr, G., Foraster, M., Arterial blood pressure and long-term exposure to traffic-related air pollution: An analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE) (2014) Environ Health Perspect, 122 (9), pp. 896-905; Abhyankar, L.N., Jones, M.R., Guallar, E., Arsenic exposure and hypertension: A systematic review (2012) Environ Health Perspect, 120 (4), pp. 494-500; Navas-Acien, A., Schwartz, B.S., Rothenberg, S.J., Bone lead levels and blood pressure endpoints: A meta-analysis (2008) Epidemiology, 19 (3), pp. 496-504; Babu, G.R., Jotheeswaran, A.T., Mahapatra, T., Is hypertension associated with job strain? A meta-analysis of observational studies (2014) Occup Env Med, pp. 220-227; Van Kempen, E., Babisch, W., The quantitative relationship between road traffic noise and hypertension: A meta-analysis (2012) J Hypertens, 30 (6), pp. 1075-1086; Murray, C.J.L., Vos, T., Lozano, R., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010 (2012) Lancet, 380 (9859), pp. 2197-2223; Social Determinants of Health [internet], , http://www.who.int/social_determinants/en/, World Health Organization(21 July 2015, date last accessed; Marmot, M., Allen, J., Bell, R., WHO European review of social determinants of health and the health divide (2012) Lancet, 380 (9846), pp. 1011-1029; Sustainable Development Goals [internet], , http://www.un.org/sustainabledevelopment/development-agenda/, United Nations undated cited 2015 Dec 14; 2015 United Nations Climate Change Conference (2015) Wikipedia, The Free Encyclopedia [internet], , https://en.wikipedia.org/w/index.php?title=2015_United_Nations_Climate_Change_Conference&oldid=695179642, (14 December 2015, date last accessed},
correspondence_address1={Prüss-Ustün, A.; Department of Public Health, Switzerland; email: pruessa@who.int},
publisher={Oxford University Press},
issn={17413842},
coden={JPHOC},
pubmed_id={27621336},
language={English},
abbrev_source_title={J. Public Health},
document_type={Review},
source={Scopus},
}

@ARTICLE{Khoury2009269,
author={Khoury, M.J. and Bertram, L. and Boffetta, P. and Butterworth, A.S. and Chanock, S.J. and Dolan, S.M. and Fortier, I. and Garcia-Closas, M. and Gwinn, M. and Higgins, J.P.T. and Janssens, A.C.J.W. and Ostell, J. and Owen, R.P. and Pagon, R.A. and Rebbeck, T.R. and Rothman, N. and Bernstein, J.L. and Burton, P.R. and Campbell, H. and Chockalingam, A. and Furberg, H. and Little, J. and O'Brien, T.R. and Seminara, D. and Vineis, P. and Winn, D.M. and Yu, W. and Ioannidis, J.P.A.},
title={Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases},
journal={American Journal of Epidemiology},
year={2009},
volume={170},
number={3},
pages={269-279},
doi={10.1093/aje/kwp119},
note={cited By 124},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-67749106283&doi=10.1093%2faje%2fkwp119&partnerID=40&md5=73064baeb4076d89c5f4d751f52e7eec},
affiliation={Office of Public Health Genomics, Natl. Ctr. for Chron. Dis. Prev. and Hlth. Prom., Centers for Dis. Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, United States},
abstract={Genome-wide association studies (GWAS) have led to a rapid increase in available data on common genetic variants and phenotypes and numerous discoveries of new loci associated with susceptibility to common complex diseases. Integrating the evidence from GWAS and candidate gene studies depends on concerted efforts in data production, online publication, database development, and continuously updated data synthesis. Here the authors summarize current experience and challenges on these fronts, which were discussed at a 2008 multidisciplinary workshop sponsored by the Human Genome Epidemiology Network. Comprehensive field synopses that integrate many reported gene-disease associations have been systematically developed for several fields, including Alzheimer's disease, schizophrenia, bladder cancer, coronary heart disease, preterm birth, and DNA repair genes in various cancers. The authors summarize insights from these field synopses and discuss remaining unresolved issues - especially in the light of evidence from GWAS, for which they summarize empirical P-value and effect-size data on 223 discovered associations for binary outcomes (142 with P&lt;10 -7). They also present a vision of collaboration that builds reliable cumulative evidence for genetic associations with common complex diseases and a transparent, distributed, authoritative knowledge base on genetic variation and human health. As a next step in the evolution of Human Genome Epidemiology reviews, the authors invite investigators to submit field synopses for possible publication in the American Journal of Epidemiology. American Journal of Epidemiology Published by Oxford University Press 2009.2009This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. © American Journal of Epidemiology Published by Oxford University Press 2009.},
author_keywords={Association;  Database;  Encyclopedias;  Epidemiologic methods;  Genome, human;  Genome-wide association study;  Genomics;  Meta-analysis},
keywords={DNA, cancer;  cardiovascular disease;  cohort analysis;  database;  epidemiology;  genetic variation;  meta-analysis;  nervous system disorder;  phenotype;  public health, Alzheimer disease;  bladder cancer;  disease association;  DNA repair;  genetic epidemiology;  genome;  genome wide association;  human;  human genome;  ischemic heart disease;  prematurity;  review;  schizophrenia, Bayes Theorem;  Bias (Epidemiology);  Disease;  Disease Susceptibility;  Epidemiologic Methods;  Genetic Predisposition to Disease;  Genetic Variation;  Genome, Human;  Genome-Wide Association Study;  Georgia;  Humans;  Interdisciplinary Communication;  Knowledge Bases;  Meta-Analysis as Topic;  Phenotype;  Pilot Projects;  Practice Guidelines as Topic;  Schizophrenia},
chemicals_cas={DNA, 9007-49-2},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, K07CA118412, ZIACP005782},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, UL1RR025752},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_U105285807},
references={Lin, B., Clyne, M., Walsh, M., Tracking the epidemiology of human genes in the literature: The HuGE published literature database (2006) Am J Epidemiol, 164 (1), pp. 1-4; Topol, E.J., Murray, S.S., Frazer, K.A., The genomics gold rush (2007) JAMA, 298 (2), pp. 218-221; Kingsmore, S.F., Lindquist, I.E., Mudge, J., Genome-wide association studies: Progress and potential for drug discovery and development (2008) Nat Rev Drug Discov, 7 (3), pp. 221-230; Hunter, D.J., Khoury, M.J., Drazen, J.M., Letting the genome out of the bottle - will we get our wish? (2008) N Engl J Med, 358 (2), pp. 105-107; (2007) Nat Genet, 39 (12), p. 1415. , Risky business [editorial; (2008) Nat Genet, 40 (2), p. 119. , Positively disruptive [editorial; Chanock SJ, Manolio T. Replicating genotype-phenotype associations (2007) Nature, 447 (7145), pp. 655-660. , NCI-NHGRI Working Group on Replication in Association Studies;; Yu, W., Gwinn, M., Clyne, M., A navigator for human genome epidemiology (2008) Nat Genet, 40 (2), pp. 124-125; National Institutes of Health. Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies (GWAS). (Notice no. NOT-OD-07-088). Bethesda, MD: National Institutes of Health; 2007. (http:// www.grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html). (Accessed April 19, 2008); Homer N, Szelinger S, Redman M, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays [electronic article]. PLoS Genet. 2008;4(8):e1000167; Khoury, M.J., Dorman, J.S., The Human Genome Epidemiology Network (1998) Am J Epidemiol, 148 (1), pp. 1-3; Ioannidis, J.P., Gwinn, M., Little, J., A road map for efficient and reliable human genome epidemiology (2006) Nat Genet, 38 (1), pp. 3-5; Ioannidis, J.P., Bernstein, J., Boffetta, P., A network of investigator networks in human genome epidemiology (2005) Am J Epidemiol, 162 (4), pp. 302-304; Little, J., Higgins, J.P., Ioannidis, J.P., Strengthening the Reporting of Genetic Association Studies (STREGA): An extension of the STROBE statement (2009) Ann Intern Med, 150 (3), pp. 206-215; http://www.hugenet.ca, Little J, Higgins JP, eds. The HuGENet™ HuGE Review Handbook, Version 1.0. Ottawa, Ontario, Canada: HuGENet Canada Coordinating Centre; 2006, Accessed March 10, 2008; (2006) Nat Genet, 38 (1), p. 1. , Embracing risk [editorial; (2006) HuGENet™ Workshop on the Assessment of Cumulative Evidence on Genetic Associations: International Workshop held in Venice (Italy) on 9-10 November 2006, , http://www.cdc.gov/genomics/hugenet/hugewkshp-nov06.htm, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA: Centers for Disease Control and Prevention;, Accessed April 15, 2008; Ioannidis, J.P., Boffetta, P., Little, J., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) Int J Epidemiol, 37 (1), pp. 120-132; Bertram, L., McQueen, M.B., Mullin, K., Systematic metaanalyses of Alzheimer genetic association studies: The AlzGene database (2007) Nat Genet, 39 (1), pp. 17-23; Allen, N.C., Bagade, S., McQueen, M.B., Systematic metaanalyses and field synopsis of genetic association studies in schizophrenia: The SzGene database (2008) Nat Genet, 40 (7), pp. 827-834; Vineis, P., Manuguerra, M., Kavvoura, F.K., A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility (2009) J Natl Cancer Inst, 101 (1), pp. 24-36; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335 (7626), pp. 914-916; García-Closas, M., Malats, N., Silverman, D., NAT2 slow acetylation and GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses (2005) Lancet, 366 (9486), pp. 649-659; Rothman, N., Garcia-Closas, M., Hein, D.W., Commentary: Reflections on G.M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned (2007) Int J Epidemiol, 36 (1), pp. 23-28; Frayling, T.M., Timpson, N.J., Weedon, M.N., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity (2007) Science, 316 (5826), pp. 889-894; Burton, P.R., Palmer, L.J., Jacobs, K., Ascertainment adjustment: Where does it take us? (2000) Am J Hum Genet, 67 (6), pp. 1505-1514; Ioannidis, J.P., Non-replication and inconsistency in the genome-wide association setting (2007) Hum Hered, 64 (4), pp. 203-213; Moonesinghe, R., Khoury, M.J., Liu, T., Required sample size and nonreplicability thresholds for heterogeneous genetic associations (2008) Proc Natl Acad Sci U S A, 105 (2), pp. 617-622; Thomas, G., Jacobs, K.B., Yeager, M., Multiple loci identified in a genome-wide association study of prostate cancer (2008) Nat Genet, 40 (3), pp. 310-315; Ioannidis, J.P., Why most published research findings are false [electronic article] (2005) PLoS Med, 2 (8), pp. e124; Zeggini, E., Weedon, M.N., Lindgren, C.M., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes (2007) Science, 316 (5829), pp. 1336-1341; Wakefield, J., Bayesian measure of the probability of false discovery in genetic epidemiology studies (2007) Am J Hum Genet, 81 (2), pp. 208-227; Wakefield, J., Bayes factors for genome-wide association studies: Comparison with P-values (2008) Genet Epidemiol, 33 (1), pp. 79-86; Wacholder, S., Chanock, S., Garcia-Closas, M., Assessing the probability that a positive report is false: An approach for molecular epidemiology studies (2004) J Natl Cancer Inst, 96 (6), pp. 434-442; Ioannidis, J.P., Calibration of credibility of agnostic genome-wide associations assessing the probability that a positive report is false: An approach for molecular epidemiology studies (2008) Am J Med Genet B Neuropsychiatr Genet, 147 B (6), pp. 964-972; Hoggart, C.J., Clark, T.G., De Iorio, M., Genome-wide significance for dense SNP and resequencing data (2008) Genet Epidemiol, 32 (2), pp. 179-185; Pe'er, I., Yelensky, R., Altshuler, D., Estimation of the multiple testing burden for genomewide association studies of nearly all common variants (2008) Genet Epidemiol, 32 (4), pp. 381-385; Hindorff, L.A., Junkins, H.A., Manolio, T.A., (2008) A Catalog of Published Genome-Wide Association Studies, , http://www.genome.gov/26525384, Bethesda, MD: Office of Population Genomics, National Human Genome Research Institute;, Accessed October 14, 2008; Manolio, T.A., Brooks, L.D., Collins, F.S., A HapMap harvest of insights into the genetics of common disease (2008) J Clin Invest, 118 (5), pp. 1590-1605; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Heterogeneity in meta-analyses of genome-wide association investigations [electronic article] (2007) PLoS ONE, 2 (9), pp. e841; Zollner, S., Pritchard, J.K., Overcoming the winner's curse: Estimating penetrance parameters from case-control data (2007) Am J Hum Genet, 80 (4), pp. 605-615; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19 (5), pp. 640-648; Wright, A.F., Charlesworth, B., Rudan, I., A polygenic basis for late-onset disease (2002) Trends Genet, 19 (2), pp. 97-106; Bodmer, W., Bonilla, C., Common and rare variants in multi-factorial susceptibility to common diseases (2008) Nat Genet, 40 (6), pp. 695-701; Walsh, T., McClellan, J.M., McCarthy, S.E., Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia (2008) Science, 320 (5875), pp. 539-543; Zeggini, E., Scott, L.J., Saxena, R., Meta-analysis of genome-wide association data and large-scale replication identifies several additional susceptibility loci for type 2 diabetes (2008) Nat Genet, 40 (5), pp. 638-645; Willer, C.J., Speliotes, E.K., Loos, R.J., Six new loci associated with body mass index highlight a neuronal influence on body weight regulation (2009) Nat Genet, 41 (1), pp. 25-34; Cotton, R.G., Appelbe, W., Auerbach, A.D., Recommendations of the 2006 Human Variome Project meeting (2007) Nat Genet, 39 (4), pp. 433-436; Klein, T.E., Chang, J.T., Cho, M.K., Integrating genotype and phenotype information: An overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base (2001) Pharmacogenomics J, 1 (3), pp. 167-170; Pagon, R.A., GeneTests: An online genetic information resource for healthcare providers (2006) J Med Libr Assoc, 94 (3), pp. 343-348; (2008) Genes and Disease [electronic book], , http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View.ShowSection&rid=gnd.preface.91, National Center for Biotechnology Information, National Institutes of Health, Be-thesda, MD:, Accessed February 19, 2008; Harbord, R.M., Egger, M., Sterne, J.A., A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints (2006) Stat Med, 25 (20), pp. 3443-3457; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253},
correspondence_address1={Khoury, M. J.; Office of Public Health Genomics, 4770 Buford Highway NE, Atlanta, GA 30341, United States; email: mukl@cdc.gov},
issn={00029262},
coden={AJEPA},
pubmed_id={19498075},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Silagy20022831,
author={Silagy, C.A. and Middleton, P. and Hopewell, S.},
title={Publishing protocols of systematic reviews: Comparing what was done to what was planned},
journal={JAMA},
year={2002},
volume={287},
number={21},
pages={2831-2834},
doi={10.1001/jama.287.21.2831},
note={cited By 121},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037024219&doi=10.1001%2fjama.287.21.2831&partnerID=40&md5=d7a9f417665015517f9e54916ea7adda},
affiliation={Monash Institute of Health Services Research, Monash Medical Centre, Clayton, Vic., Australia; UK Cochrane Centre, Oxford, United Kingdom},
abstract={Context: Publication of research protocols minimizes bias by explicitly stating a priori hypotheses and methods without prior knowledge of results. Methods: We conducted a retrospective comparative study to assess the extent to which the content of published Cochrane reviews had changed compared with their previously published protocols and to assess any potential impact these changes may have had in introducing bias to the study. We identified previously published protocols for new Cochrane reviews appearing in The Cochrane Library; 2000, issue 3. The texts of published protocols and completed reviews were compared. Two raters independently identified changes to the different sections of the protocol and classified the changes as none, minor, or major. Results: Of the 66 new Cochrane reviews, we identified a previously published protocol for 47 reviews. Of these, 43 reviews had at least 1 section that had undergone a major change compared with the most recently published protocol. The greatest variation between protocols and reviews was in the methods section, in which 68% of reviews (n=32) had undergone a major change. Changes made in other sections that may have resulted in the introduction of bias included narrowing of objectives, addition of comparisons or new outcome measures, broadening of criteria for the types of study design included, and narrowing of types of participants included. Conclusions: Research protocols, even if published, are likely to remain, at least to some extent, iterative documents. We found that a large number of changes were made to Cochrane reviews, some of which could be prone to influence by prior knowledge of results. Even if many of the changes between protocol and review improve the overall study, the reasons for making these should be clearly identified and documented within the final review.},
keywords={comparative study;  feedback system;  hypothesis;  outcomes research;  peer review;  planning;  priority journal;  publication;  research;  retrospective study;  review;  statistics;  system analysis},
references={Bias in RCTs: Beyond the sequence generation (1998) Randomised Controlled Trials, pp. 28-44. , Jadad AR. London, England: BMJ Books; Clarke, M., Oxman, A.D., (2001) Cochrane Reviewers Handbook 4.1.2, (2). , Oxford, England: Cochrane Library, Update Software},
correspondence_address1={Hopewell, S.; UK Cochrane Centre, Middle Way, Oxford OX2 7LG, United Kingdom; email: shopewell@cochrane.co.uk},
publisher={American Medical Association},
issn={00987484},
coden={JAMAA},
pubmed_id={12038926},
language={English},
abbrev_source_title={J. Am. Med. Assoc.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Apóstolo20171154,
author={Apóstolo, J. and Cooke, R. and Bobrowicz-Campos, E. and Santana, S. and Marcucci, M. and Cano, A. and Vollenbroek-Hutten, M. and Germini, F. and Holland, C.},
title={Predicting risk and outcomes for frail older adults: An umbrella review of frailty screening tools},
journal={JBI Database of Systematic Reviews and Implementation Reports},
year={2017},
volume={15},
number={4},
pages={1154-1208},
doi={10.11124/JBISRIR-2016-003018},
note={cited By 119},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032747575&doi=10.11124%2fJBISRIR-2016-003018&partnerID=40&md5=8e2167793ffb9335753134c5f64e1e3f},
affiliation={Health Sciences Research Unit, Nursing, Nursing School of Coimbra, Portugal Centre for Evidence-Based Practice, Joanna Briggs Institute Centre of Excellence, Australia; Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, United Kingdom; Department of Economics, Management and Industrial Engineering, University of Aveiro, Aveiro, Portugal; Geriatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Science and Community Health, University of Milan, Milan, Italy; Department of Paediatrics, Obstetrics and Gynaecology, Universitat de Valência, Valência, Spain; Roessingh Research and Development, Netherlands},
abstract={Background A scoping search identified systematic reviews on diagnostic accuracy and predictive ability of frailty measures in older adults. In most cases, research was confined to specific assessment measures related to a specific clinical model. Objectives To summarize the best available evidence from systematic reviews in relation to reliability, validity, diagnostic accuracy and predictive ability of frailty measures in older adults. Inclusion criteria Population Older adults aged 60 years or older recruited from community, primary care, long-term residential care and hospitals. Index test Available frailty measures in older adults. Reference test Cardiovascular Health Study phenotype model, the Canadian Study of Health and Aging cumulative deficit model, Comprehensive Geriatric Assessment or other reference tests. Diagnosis of interest Frailty defined as an age-related state of decreased physiological reserves characterized by an increased risk of poor clinical outcomes. Types of studies Quantitative systematic reviews. Search strategy A three-step search strategy was utilized to find systematic reviews, available in English, published between January 2001 and October 2015. Methodological quality Assessed by two independent reviewers using the Joanna Briggs Institute critical appraisal checklist for systematic reviews and research synthesis. Data extraction Two independent reviewers extracted data using the standardized data extraction tool designed for umbrella reviews. Data synthesis Data were only presented in a narrative form due to the heterogeneity of included reviews. Results Five reviews with a total of 227,381 participants were included in this umbrella review. Two reviews focused on reliability, validity and diagnostic accuracy; two examined predictive ability for adverse health outcomes; and one investigated validity, diagnostic accuracy and predictive ability. In total, 26 questionnaires and brief assessments and eight frailty indicators were analyzed, most of which were applied to community-dwelling older people. The Frailty Index was examined in almost all these dimensions, with the exception of reliability, and its diagnostic and predictive characteristics were shown to be satisfactory. Gait speed showed high sensitivity, but only moderate specificity, and excellent predictive ability for future disability in activities of daily living. The Tilburg Frailty Indicator was shown to be a reliable and valid measure for frailty screening, but its diagnostic accuracy was not evaluated. Screening Letter, Timed-up-and-go test and PRISMA 7 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) demonstrated high sensitivity and moderate specificity for identifying frailty. In general, low physical activity, variously measured, was one of the most powerful predictors of future decline in activities of daily living. Conclusion Only a few frailty measures seem to be demonstrably valid, reliable and diagnostically accurate, and have good predictive ability. Among them, the Frailty Index and gait speed emerged as the most useful in routine care and community settings. However, none of the included systematic reviews provided responses that met all of our research questions on their own and there is a need for studies that could fill this gap, covering all these issues within the same study. Nevertheless, it was clear that no suitable tool for assessing frailty appropriately in emergency departments was identified. © 2017 THE JOANNA BRIGGS INSTITUTE.},
author_keywords={Diagnostic test accuracy;  Frail elderly;  Frailty;  Pre-frailty;  Screening},
keywords={clinical outcome;  cognition;  comorbidity;  diagnostic accuracy;  fatigue;  frailty;  gait;  hospitalization;  human;  mental health;  mortality;  muscle strength;  physical activity;  physical performance;  psychometry;  quality control;  questionnaire;  Review;  risk;  screening;  sensitivity and specificity;  systematic review;  weight reduction;  aged;  exercise;  frail elderly;  geriatric assessment;  health status indicator;  independent living;  predictive value;  procedures;  questionnaire;  risk factor, Aged;  Exercise;  Frail Elderly;  Geriatric Assessment;  Health Status Indicators;  Humans;  Independent Living;  Predictive Value of Tests;  Risk Factors;  Surveys and Questionnaires},
references={Rodriguez-Manas, L., Feart, C., Mann, G., Viña, J., Chatterji, S., Chodzko-Zajko, W., Searching for an operational definition of frailty: A Delphi method based consensus statement: The frailty operative definition-consensus conference project (2013) J Gerontol A Biol Sci Med Sci, 68 (1), pp. 62-67; Lang, P.O., Michel, J.P., Zekry, D., Frailty syndrome: A transitional state in a dynamic process (2009) Gerontology, 55 (5), pp. 539-549; Fried, L.P., Ferrucci, L., Darer, J., Williamson, J.D., Anderson, G., Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care (2004) J Gerontol A Biol Sci Med Sci, 59 (3), pp. 255-263; Rockwood, K., What would make a definition of frailty successful? Commentaries (2005) Age and Ageing, 34 (5), pp. 432-434; Sternberg, S.A., Schwartz, A.W., Karunananthan, S., Bergman, H., Mark Clarfield, A., The identification of frailty: A systematic literature review (2011) Prog Geriatr, 59 (11), pp. 2129-2139; Le Maguet, P., Roquilly, A., Lasocki, S., Asehnoune, K., Carise, E., Saint Martin, M., Prevalence and impact of frailty on mortality in elderly ICU patients: A prospective, multicenter, observational study (2014) Intensive Care Med, 40 (5), pp. 674-682; Arya, S., Kim, S.I., Duwayri, Y., Brewster, L.P., Veeraswamy, R., Salam, A., Frailty increases the risk of 30-day mortality, morbidity, and failure to rescue after elective abdominal aortic aneurysm repair independent of age and comorbidities (2015) J Vasc Surg, 61 (2), pp. 324-331; Lahousse, L., Maes, B., Ziere, G., Loth, D.W., Verlinden, V.J., Zillikens, M.C., Adverse outcomes of frailty in the elderly: The Rotterdam Study (2014) Eur J Epidemiol, 29 (6), pp. 419-427; Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., Frailty in older adults: Evidence for a phenotype (2001) J Gerontol A Biol Med Sci, 5 (6), pp. M146-M156; Langlois, F., Vu, T.T.M., Kergoat, M.J., Chassé, K., Dupuis, G., Bherer, L., The multiple dimensions of frailty: Physical capacity, cognition, and quality of life (2012) Int Psychogeriatr, 24 (9), pp. 1429-1436; Ávila-Funes, J.A., Amieva, H., Barberger-Gateau, P., Le Goff, M., Raoux, N., Ritchie, K., Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: The three-city study (2009) J Am Geriatr Soc, 57 (3), pp. 453-461; Collard, R.M., Comijs, H.C., Naarding, P., Penninx, B.W., Milaneschi, Y., Ferrucci, L., Frailty as a predictor of the incidence and course of depressed mood (2015) J Am Med Direct Ass, 16 (6), pp. 509-514; Rockwood, K., Mitnitski, A., Frailty defined by deficit accumulation and geriatric medicine defined by frailty (2011) Clin Geriatr Med, 27 (1), pp. 17-26; Collard, R.M., Boter, H., Schoevers, R.A., Oude Voshaar, R.C., Prevalence of frailty in community-dwelling older persons: A systematic review (2012) J Am Geriatr Soc, 60 (8), pp. 1487-1492; Ferrucci, L., Windham, B.G., Fried, L.P., Frailty in older persons (2005) Genus, 61 (1), pp. 39-53; Varadhan, R., Seplaki, C.S., Xue, Q.L., Bandeen-Roche, K., Fried, L.P., Stimulus-response paradigm for characterizing the loss of resilience in homeostatic regulation associated with frailty (2008) Mech Ageing Dev, 129 (11), pp. 666-670; Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., Rockwood, K., Frailty in elderly people (2013) Lancet, 381, pp. 752-762; D’Avanzo, B., Shaw, R., Riva, S., Apostolo, J., Bobrowicz-Campos, E., Kurpas, D., Stakeholders’ views and experiences of care and interventions for addressing frailty and pre-frailty: a meta-synthesis of qualitative evidence. Submitted; Bergman, H., Ferrucci, L., Guralnik, J., Hogan, D.B., Hummel, S., Karunananthan, S., Frailty: An emerging research and clinical paradigm - issues and controversies (2007) J Gerontol A: Biol Sci Med Sci, 62 (7), pp. 731-737; Topinková, E., Aging, disability and frailty (2008) Ann Nutr Metab, 52, pp. 6-11; Gobbens, R., van Assen, M., Luijkx, K., Wijnen-Sponselee, M.T., Schols, J.M., Determinants of frailty (2010) J Am Med Dir Assoc, 11 (5), pp. 356-364; Cameron, I.D., Fairhall, N., Langron, C., Lockwood, K., Monaghan, N., Ch, A., A multifactorial interdisciplinary intervention reduces frailty in older people: Randomized trial (2013) BC Med, 11, p. 65. , http://www.biomedcentral.com/1741-7015/11/65, Cited June 19, available from; Cesari, M., Vellas, B., Hsu, F.-C., Newman, A.B., Doss, H., King, A.C., A physical activity intervention to treat the frailty syndrome in older persons - results from the LIFE-P study (2015) J Gerontol A Biol Sci Med Sci, 70 (2), pp. 216-222; Pulignano, G., Del Sindaco, D., Di Lenarda, A., Tarantini, L., Cioffi, G., Gregori, D., Usefulness of frailty profile for targeting older heart failure patients in disease management programs: A cost-effectiveness, pilot study (2010) J Cardiovasc Med, 11 (10), pp. 739-747; Eklund, K., Wilhelmson, K., Gustafsson, H., Landahl, S., Dahlin-Ivanoff, S., One-year outcome of frailty indicators and activities of daily living following the randomized controlled trial (2015) Continuum of care for frail older people, 13, p. 76. , http://www.biomedcentral.com/1471-2318/13/76, BMC Geriatr 2013, Cited June 22, available from; Rockwood, K., Andrew, M., Mitnitski, A., A comparison of two approaches to measuring frailty in elderly people (2007) J Gerontol A Biol Sci Med Sci, 62 (7), pp. 738-743; Basic, D., Ch, S., Frailty in older inpatients population: Using the clinical frailty scale to predict patient outcomes (2015) J Aging Health, 27 (4), pp. 670-685; Pijpers, E., Ferreira, I., Stehouwer, C., Nieuwenhuijzen Kruseman, A.C., The frailty dilemma (2012) Review of the predictive accuracy of major frailty scores. Eur J Intern Med, 23 (2), pp. 118-123; (2014) Joanna Briggs Institute reviewers’ manual, , Adelaide: The Joanna Briggs Institute; Apóstolo, J., Cooke, R., Bobrowicz-Campos, E., Santana, S., Marcucci, M., Cano, A., Predicting risk and outcomes for frail older adults: A protocol for an umbrella review of available frailty screening tools (2015) JBI Database System Rev Implement Rep, 13 (12), pp. 14-24; Rockwood, K., Song, X., MacKnight, C., Bergman, H., Hogan, D.B., McDowell, I., A global clinical measure of fitness and frailty in elderly people (2005) CMAJ, 173 (5), pp. 489-495; Jones, D.M., Song, X., Rockwood, K., Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians (2005) Aging Clin Exp Res, 17 (6), pp. 465-471; Rubenstein, L.Z., Stuck, A.E., Siu, A.L., Wieland, D., Impacts of geriatric evaluation and management programs on defined outcomes: Overview of the evidence (1991) J Am Geriatr Soc, 39 (9), pp. 8-16. , discussion 17S-18S; (2014) Joanna Briggs Institute reviewers’ manual: Methodology for JBI umbrella reviews Adelaide, , The Joanna Briggs Institute; Clegg, A., Rogers, L., Young, J., Diagnostic test accuracy of simple instruments for identifying frailty in communitydwelling older people: A systematic review (2015) Age Ageing, 44 (1), pp. 148-152; Drubbel, I., Numans, M.E., Kranenburg, G., Bleijenberg, N., de Wit, N.J., Schuurmans, M.J., Screening for frailty in primary care: A systematic review of the psychometric properties of the frailty index in community-dwelling older people (2014) BMC Geriatr, 14 (1), p. 27; Pialoux, T., Goyard, J., Lesourd, B., Screening tools for frailty in primary health care: A systematic review (2012) Geriatr Gerontol Int, 12 (2), pp. 189-197; Carpenter, C.R., Shelton, E., Fowler, S., Suffoletto, B., Platts-Mills, T.F., Rothman, R.E., Risk factors and screening instruments to predict adverse outcomes for undifferentiated older emergency department patients: A systematic review and meta-analysis (2015) Acad Emerg Med, 22 (1), pp. 1-21; Vermeulen, J., Neyens, J.C.L., van Rossum, E., Spreeuwenberg, M.D., de Witte, L.P., Predicting ADL disability in communitydwelling elderly people using physical frailty indicators: A systematic review (2011) BMC Geriatr, 11 (1), p. 33; Hofer, S.M., Sliwinski, M.J., Design and analysis of longitudinal studies in aging (2006) Handbook of the psychology of aging, pp. 15-37. , Birren JE, Schaie KW, editors, 6th ed. San Diego: Academic Press; D’Amico, G., Maliza, G., D’Amico, M., Prognosis research and risk of bias (2016) Intern Emerg Med, 11 (2), pp. 251-260; de Vries, N.M., Staal, J.B., van Ravensberg, C.D., Hobbelen, J.S., Olde Rikkert, M.G., Nijhuis-van der Sanden, M.W., Outcome instruments to measure frailty: A systematic review (2011) Ageing Res Rev, 10 (1), pp. 104-114; Pijpers, E., Ferreira, I., Stehouwer, C.D., Nieuwenhuijzen Kruseman, A.C., The frailty dilemma (2012) Review of the predictive accuracy of major frailty scores. Eur J Intern Med, 23 (2), pp. 118-123; van Kan, G.A., Rolland, Y., Andrieu, S., Bauer, J., Beauchet, O., Bonnefoy, M., Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an international academy on nutrition and aging (IANA) task force (2009) J Nutr Health Aging, 13 (10), pp. 881-889; Hamaker, M.E., Jonker, J.M., de Rooij, S.E., Vos, A.G., Smorenburg, C.H., van Munster, B.C., Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: A systematic review (2012) Lancet Oncol, 13 (10), pp. E437-E444; Feng, M.A., McMillan, D.T., Crowell, K., Muss, H., Nielsen, M.E., Smith, A.B., geriatric assessment in surgical oncology: A systematic review (2015) J Surg Res, 193 (1), pp. 265-272; Langlois, F., Vu, T.T., Kergoat, M.J., Chassé, K., Dupuis, G., Bherer, L., The multiple dimensions of frailty: Physical capacity, cognition, and quality of life (2012) Int Psychogeriatr, 24 (9), pp. 1429-1436; Guralnik, J.M., Ferrucci, L., Pieper, C.F., Leveille, S.G., Markides, K.S., Ostir, G.V., Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery (2000) J Gerontol A Biol Sci Med Sci, 55 (4), pp. M221-M231; Holtzer, R., Verghese, J., Xue, X., Lipton, R.B., Cognitive processes related to gait velocity: Results from the Einstein aging study (2006) Neuropsychology, 20 (2), pp. 215-223; Watson, N.L., Rosano, C., Boudreau, R.M., Simonsick, E.M., Ferrucci, L., Sutton-Tyrrell, K., Executive function, memory, and gait speed decline in well-functioning older adults (2010) J Gerontol A Biol Sci Med Sci, 65 A (10), pp. 1093-1100; Studenski, S., Perera, S., Patel, K., Rosano, C., Faulkner, K., Inzitari, M., Gait speed and survival in older adults (2011) JAMA, 305 (1), pp. 50-58; Rosano, C., Studenski, S.A., Aizenstein, H.J., Boudreau, R.M., Longstreth, W.T., Newman, A.B., Slower gait, slower information processing and smaller prefrontal area in older adults (2012) Age Ageing, 41 (1), pp. 58-64; Aichele, S., Rabbitt, P., Ghisletta, P., Life span decrements in fluid intelligence and processing speed predict mortality risk (2015) Psychol Aging, 30 (3), pp. 598-612; Lima-Costa, F.M., Steptoe, A., Cesar, C.C., de Oliveira, C., Proietti, F.A., Marmot, M., The influence of socioeconomic status on the predictive power of self-rated health for 6-year mortality in English and Brazilian older adults: The ELSA and Bambui cohort studies (2012) Ann Epidemiol, 22 (9), pp. 644-648; Aichele, S., Rabbitt, P., Ghisletta, P., Think fast, feel fine, live long: A 29 year study of cognition, health and survival in middleaged and older adults (2016) Psychol Sci, 27 (4), pp. 518-529; Psychology (2015) Estimating the reproducibility of psychological science. Science, 349 (6251), p. 4716; Gilbert, D.T., King, G., Pettigrew, S., Wison, T.D., Comment on “Estimating the reproducibility of psychological science” (2016) Science, 351 (6277), p. 1037; Anderson, C.J., Bahník, Š., Barnett-Cowan, M., Bosco, F.A., Chandler, J., Chartier, C.R., Response to comment on “Estimating the reproducibility of psychological science” (2016) Science, 351 (6277), p. 1037; Cesari, M., Gambassi, G., van Kan, G., Vellas, B., Commentary (2014) The frailty phenotype and the frailty index: Different instruments for different purposes. Age Ageing, 43 (1), pp. 10-12; Rockwood, K., Mitnitski, A., Frailty in relation to the accumulation of deficits (2007) J Gerontol A Biol Sci Med Sci, 62 (7), pp. 722-727},
correspondence_address1={Apóstolo, J.; Health Sciences Research Unit, Australia; email: apostolo@esenfc.pt},
publisher={Joanna Briggs Institute},
issn={22024433},
pubmed_id={28398987},
language={English},
abbrev_source_title={JBI Database Syst. Rev. Implement. Rep.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Yu20201201,
author={Yu, J.-T. and Xu, W. and Tan, C.-C. and Andrieu, S. and Suckling, J. and Evangelou, E. and Pan, A. and Zhang, C. and Jia, J. and Feng, L. and Kua, E.-H. and Wang, Y.-J. and Wang, H.-F. and Tan, M.-S. and Li, J.-Q. and Hou, X.-H. and Wan, Y. and Tan, L. and Mok, V. and Tan, L. and Dong, Q. and Touchon, J. and Gauthier, S. and Aisen, P.S. and Vellas, B.},
title={Evidence-based prevention of Alzheimer's disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials},
journal={Journal of Neurology, Neurosurgery and Psychiatry},
year={2020},
volume={91},
number={11},
pages={1201-1209},
doi={10.1136/jnnp-2019-321913},
note={cited By 117},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088694580&doi=10.1136%2fjnnp-2019-321913&partnerID=40&md5=d92e7367400fe92bd0b05afb25afd2cb},
affiliation={Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China; Department of Epidemiology and Public Health, University of Toulouse III, Toulouse, France; Department of Psychiatry, Medical Research Council and Wellcome Trust Behavioural, Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina, Medical School, Ioannina, Greece; Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States; Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China; Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong; Department of Neurology, University Hospital of Montpellier, Montpellier, France; McGill Center for Studies in Aging, McGill University, Montreal, QC, Canada; Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, CA, United States; Department of Geriatrics, Purpan University Hospital, Toulouse, France},
abstract={Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret due to varying study designs with heterogeneous endpoints and credibility. We completed a systematic review and meta-analysis of current evidence with prospective designs to propose evidence-based suggestions on AD prevention. Methods Electronic databases and relevant websites were searched from inception to 1 March 2019. Both observational prospective studies (OPSs) and randomised controlled trials (RCTs) were included. The multivariable-adjusted effect estimates were pooled by random-effects models, with credibility assessment according to its risk of bias, inconsistency and imprecision. Levels of evidence and classes of suggestions were summarised. Results A total of 44 676 reports were identified, and 243 OPSs and 153 RCTs were eligible for analysis after exclusion based on pre-decided criteria, from which 104 modifiable factors and 11 interventions were included in the meta-analyses. Twenty-one suggestions are proposed based on the consolidated evidence, with Class I suggestions targeting 19 factors: 10 with Level A strong evidence (education, cognitive activity, high body mass index in latelife, hyperhomocysteinaemia, depression, stress, diabetes, head trauma, hypertension in midlife and orthostatic hypotension) and 9 with Level B weaker evidence (obesity in midlife, weight loss in late life, physical exercise, smoking, sleep, cerebrovascular disease, frailty, atrial fibrillation and vitamin C). In contrast, two interventions are not recommended: oestrogen replacement therapy (Level A2) and acetylcholinesterase inhibitors (Level B). Interpretation Evidence-based suggestions are proposed, offering clinicians and stakeholders current guidance for the prevention of AD. ©},
author_keywords={alzheimer's disease;  epidemiology;  meta-analysis;  systematic reviews},
keywords={ascorbic acid;  antihypertensive agent, Alzheimer disease;  atrial fibrillation;  body mass;  body weight loss;  cerebrovascular disease;  clinical practice;  cognition;  depression;  diabetes mellitus;  educational status;  evidence based medicine;  exercise;  frailty;  head injury;  human;  hyperhomocysteinemia;  hypertension;  meta analysis;  obesity;  orthostatic hypotension;  practice guideline;  preventive medicine;  priority journal;  Review;  sleep quality;  smoking habit;  stress;  systematic review;  Alzheimer disease;  depression;  diabetes mellitus;  education;  head injury;  hyperhomocysteinemia;  hypertension;  lifestyle;  mental stress;  obesity;  observational study;  orthostatic hypotension;  randomized controlled trial (topic);  risk reduction, Alzheimer Disease;  Antihypertensive Agents;  Cognition;  Craniocerebral Trauma;  Depression;  Diabetes Mellitus;  Education;  Evidence-Based Medicine;  Exercise;  Humans;  Hyperhomocysteinemia;  Hypertension;  Hypotension, Orthostatic;  Life Style;  Obesity;  Observational Studies as Topic;  Randomized Controlled Trials as Topic;  Risk Reduction Behavior;  Stress, Psychological},
chemicals_cas={ascorbic acid, 134-03-2, 15421-15-5, 50-81-7; Antihypertensive Agents},
funding_details={Abbott LaboratoriesAbbott Laboratories},
funding_details={Eli Lilly and CompanyEli Lilly and Company},
funding_details={RocheRoche},
funding_details={SanofiSanofi},
funding_details={Janssen BiotechJanssen Biotech},
funding_details={BiogenBiogen},
funding_details={AbbVieAbbVie},
funding_details={Science and Technology Commission of Shanghai MunicipalityScience and Technology Commission of Shanghai Municipality, STCSM, 2018SHZDZX03},
funding_details={Otsuka PharmaceuticalOtsuka Pharmaceutical, OPC},
funding_details={National Key Research and Development Program of ChinaNational Key Research and Development Program of China, NKRDPC, 2018YFC1314702},
funding_text 1={Funding This study was supported by grants from the National Key R&D Program of China (2018YFC1314702), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX03) and ZHANGJiANG LAB.},
funding_text 2={This study was supported by grants from the National Key R&D Program of China (2018YFC1314702), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX03) and ZHANGJIANG LAB.},
funding_text 3={Competing interests JTY serves as an associate editor-in-chief for Annals of Translational Medicineand is senior editor for Journal of Alzheimer’s Disease. SA has received grants from europe, ipsen, and France Alzheimer, served as a consultant for ipsen, Pierre Fabre, Lilly, Nestlé, Sanofi and Servier, and received non-financial support from Biogen, Nutrition Santé, Pfzer and icon, and other support from the AMPA Association. GS has received clinical trial support from Lilly and Roche in DiAN-TU, TauRx Therapeutics (TauRx) and Lundbeck; has been a data safety monitoring board (DSMB) member of ADCS, ATRi, APi and eisai; and has been a scientific adviser to Affiris, Boehringer ingelheim, Lilly, Roche, Servier, Sanofi, Schwabe, Takeda and TauRx. PSA has received grants from the US Alzheimer’s Association, Janssen, Lilly, the US National institute on Aging and Toyama; and consulting fees from Abbott, Abbvie, Amgen, Anavex, AstraZeneca, Biogen idec, Biotie, Bristol-Myers Squibb, Cardeus, Cohbar, eisai, elan, eli Lilly, Genentech, ichor, iPerian, Janssen, Lundbeck, Medivation, Merck, NeuroPhage, Novartis, Pfizer, Probiodrug, Roche, Somaxon and Toyama, outside the submitted work. Bv reports grants from Pierre Fabre, Avid, exonhit, Abbvie, Lilly, Lundbeck, MSD, Otsuka, Regenron, Sanofi, Roche, AstraZeneca, LPG Systems, Nestlé and Alzheon, and personal fees from Lilly, Lundbeck, MSD, Otsuka, Roche, Sanofi, Biogen, Nestlé, Transition Therapeutics and Takeda.},
references={Qiu, C., Von Strauss, E., Bäckman, L., Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden (2013) Neurology, 80, pp. 1888-1894; Matthews, F.E., Arthur, A., Barnes, L.E., A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II (2013) Lancet, 382, pp. 1405-1412; Satizabal, C.L., Beiser, A.S., Chouraki, V., Incidence of dementia over three decades in the Framingham Heart Study (2016) N Engl J Med, 374, pp. 523-532; Wu, Y.-T., Fratiglioni, L., Matthews, F.E., Dementia in Western Europe: Epidemiological evidence and implications for policy making (2016) Lancet Neurol, 15, pp. 116-124; Andrieu, S., Coley, N., Lovestone, S., Prevention of sporadic Alzheimer's disease: Lessons learned from clinical trials and future directions (2015) Lancet Neurol, 14, pp. 926-944; Livingston, G., Sommerlad, A., Orgeta, V., Dementia prevention, intervention, and care (2017) Lancet, 390, pp. 2673-2734; Winblad, B., Amouyel, P., Andrieu, S., Defeating Alzheimer's disease and other dementias: A priority for European science and society (2016) Lancet Neurol, 15, pp. 455-532; Mazure, C.M., Swendsen, J., Sex differences in Alzheimer's disease and other dementias (2016) Lancet Neurol, 15, pp. 451-452; Coley, N., Andrieu, S., Gardette, V., Dementia prevention: Methodological explanations for inconsistent results (2008) Epidemiol Rev, 30, pp. 35-66; Moher, D., Liberati, A., Tetzlaff, J., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2010) Int J Surg, 8, pp. 336-341; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology: A proposal for reporting (2000) Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Jama, 283, pp. 2008-2012; W Euve, J.M.M., Blacker, D., The AlzRisk Database. Alzheimer Research Forum, , http://www.alzforum.org, Accessed [date of access; McKhann, G., Drachman, D., Folstein, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, pp. 939-944; http://community.cochrane.org/editorial-and-publishing-policy-resource/cochrane-review-development/cochrane-handbooks/cochrane-handbook-systematicreviews-interventions; Deeks, J.J., Dinnes, J., D'Amico, R., Evaluating non-randomised intervention studies (2003) Health Technol Assess, 7, p. 27; Guyatt, G.H., Oxman, A.D., Vist, G., GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias) (2011) J Clin Epidemiol, 64, pp. 407-415; Guyatt, G.H., Oxman, A.D., Kunz, R., GRADE guidelines: 7 Rating the quality of evidence-inconsistency (2011) J Clin Epidemiol, 64, pp. 1294-1302; Guyatt, G.H., Oxman, A.D., Kunz, R., GRADE guidelines 6 Rating the quality of evidence-imprecision (2011) J Clin Epidemiol, 64, pp. 1283-1293; Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Measuring inconsistency in meta-analyses (2003) Bmj, 327, pp. 557-560; Riley, R.D., Higgins, J.P.T., Deeks, J.J., Interpretation of random effects meta-analyses (2011) Bmj, 342, p. d549; Higgins, J.P.T., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; E Gger, M., Davey Smith, G., Schneider, M., Bias in meta-analysis detected by a simple, graphical test (1997) Bmj, 315, pp. 629-634; Peters, J.L., Sutton, A.J., Jones, D.R., Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry (2008) J Clin Epidemiol, 61, pp. 991-996; Moffat, S.D., Zonderman, A.B., Metter, E.J., Free testosterone and risk for Alzheimer disease in older men (2004) Neurology, 62, pp. 188-193; Dal Forno, G., Palermo, M.T., Donohue, J.E., Depressive symptoms, sex, and risk for Alzheimer's disease (2005) Ann Neurol, 57, pp. 381-387; Koepsell, T.D., Monsell, S.E., Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis (2012) Neurology, 79, pp. 1591-1598; Fratiglioni, L., Wang, H.X., Ericsson, K., Influence of social network on occurrence of dementia: A community-based longitudinal study (2000) Lancet, 355, pp. 1315-1319; Stower, H., Linking Alzheimer's disease and frailty (2019) Nat Med, 25, p. 358; Kane, R.L., Butler, M., Fink, H.A., (2017) Interventions to Prevent Age-related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-type Dementia, , Rockville MD; Ngandu, T., Lehtisalo, J., Solomon, A., A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial (2015) Lancet, 385, pp. 2255-2263; Donohue, M.C., Sperling, R.A., Petersen, R., Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons (2017) Jama, 317, pp. 2305-2316; Kivimäki, M., Luukkonen, R., Batty, G.D., Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals (2018) Alzheimers Dement, 14, pp. 601-609; Zissimopoulos, J.M., Barthold, D., Brinton, R.D., Sex and race differences in the association between statin use and the incidence of Alzheimer disease (2017) Jama Neurol, 74, pp. 225-232; Rajan, K.B., Barnes, L.L., Wilson, R.S., BP and risk of incident AD dementia by antihypertensive and APOE epsilon4 allele (2018) Ann Neurol, 83, pp. 935-944; Kryscio, R.J., Secondary prevention trials in Alzheimer disease: The challenge of identifying a meaningful end point (2014) Jama Neurol, 71, pp. 947-949; Lamb, S.E., Sheehan, B., Atherton, N., Dementia and physical activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: Randomised controlled trial (2018) Bmj, 361, p. k1675},
correspondence_address1={Yu, J.-T.; Department of Neurology and Institute of Neurology, China; email: jintai_yu@fudan.edu.cn},
publisher={BMJ Publishing Group},
issn={00223050},
coden={JNNPA},
pubmed_id={32690803},
language={English},
abbrev_source_title={J. Neurol. Neurosurg. Psychiatry},
document_type={Review},
source={Scopus},
}

@ARTICLE{Stanton2013,
author={Stanton, A. and Grimshaw, G.},
title={Tobacco cessation interventions for young people},
journal={Cochrane Database of Systematic Reviews},
year={2013},
volume={2013},
number={8},
doi={10.1002/14651858.CD003289.pub5},
art_number={CD003289},
note={cited By 116},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892418113&doi=10.1002%2f14651858.CD003289.pub5&partnerID=40&md5=e61518308d029f9c7ac53205be742c46},
affiliation={Heart of England Foundation Trust, 3, The Green, Shirley, B90 4LA, United Kingdom; Warwick Medical School, Medical Teaching Centre, University of Warwick, Coventry, CV4 7AL, United Kingdom},
abstract={Background: Most tobacco control programmes for adolescents are based around prevention of uptake, but teenage smoking is still common. It is unclear if interventions that are effective for adults can also help adolescents to quit. This is the second update of a Cochrane review first published in 2006. Objectives: To evaluate the effectiveness of strategies that help young people to stop smoking tobacco. Search methods: We searched the Cochrane Tobacco Addiction Group's Specialized Register in February 2013. This includes reports for trials identified in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and PsyclNFO. Selection criteria: We included randomized controlled trials, cluster-randomized controlled trials and other controlled trials recruiting young people, aged less than 20, who were regular tobacco smokers. We included any interventions; these could include pharmacotherapy, psycho-social interventions and complex programmes targeting families, schools or communities. We excluded programmes primarily aimed at prevention of uptake. The primary outcome was smoking status after at least six months follow-up among those who smoked at baseline. Data collection and analysis: Both authors independently assessed the eligibility of candidate trials and extracted data. Included studies were evaluated for risk of bias using standard Cochrane methodology. Where meta-analysis was appropriate, we estimated pooled risk ratios using a Mantel-Haenszelfixed-effect method, based on the quit rates at longest follow-up. Main results: Twenty-eight trials involving approximately 6000 young people met our inclusion criteria (12 cluster-randomized controlled trials, 14 randomized controlled trials and 2 controlled trials). The majority of studies were judged to be at high or unclear risk of bias in at least one domain. Many studies combined components from various theoretical backgrounds to form complex interventions. The majority used some form of motivational enhancement combined with psychological support such as cognitive behavioural therapy (CBT) and some were tailored to stage of change using the transtheoretical model (TTM). Three trials based mainly on TTM interventions achieved moderate long-term success, with a pooled risk ratio (RR) of 1.56 at one year (95% confidence interval (CI) 1.21 to 2.01). The 12 trials that included some form of motivational enhancement gave an estimated RR of 1.60 (95% CI 1.28 to 2.01). None of the 13 individual trials of complex interventions that included cognitive behavioural therapy achieved statistically significant results, and results were not pooled due to clinical heterogeneity. There was a marginally significant effect of pooling six studies of the Not on Tobacco programme (RR of 1.31, 95% CI 1.01 to 1.71), although three of the trials used abstinence for as little as 24 hours at six months as the cessation outcome. A small trial testing nicotine replacement therapy did not detect a statistically significant effect. Two trials of bupropion, one testing two doses and one testing it as an adjunct to NRT, did not detect significant effects. Studies of pharmacotherapies reported some adverse events considered related to study treatment, though most were mild, whereas no adverse events were reported in studies of behavioural interventions. Authors' conclusions: Complex approaches show promise, with some persistence of abstinence (30 days point prevalence abstinence or continuous abstinence at six months), especially those incorporating elements sensitive to stage of change and using motivational enhancement and CBT. Given the episodic nature of adolescent smoking, more data is needed on sustained quitting. There were few trials with evidence about pharmacological interventions (nicotine replacement and bupropion), and none demonstrated effectiveness for adolescent smokers. There is not yet sufficient evidence to recommend widespread implementation of any one model. There continues to be a need for well-designed adequately powered randomized controlled trials of interventions for this population of smokers. © 2013 The Cochrane Collaboration.},
keywords={amfebutamone, adolescent smoking;  age distribution;  clinical effectiveness;  cognitive behavioral therapy;  follow up;  health care delivery;  health care policy;  human;  intention to treat analysis;  motivational interviewing;  nicotine replacement therapy;  priority journal;  Review;  smoking cessation program;  smoking habit;  Social Cognitive Theory;  social psychology;  systematic review;  tobacco dependence;  adolescent;  cognitive therapy;  controlled clinical trial (topic);  meta analysis;  procedures;  psychology;  randomized controlled trial (topic);  smoking cessation;  young adult;  methodology;  psychological aspect;  review;  smoking cessation, Adolescent;  Cognitive Therapy;  Controlled Clinical Trials as Topic;  Humans;  Randomized Controlled Trials as Topic;  Tobacco Use Cessation;  Young Adult, Adolescent;  Cognitive Therapy;  Controlled Clinical Trials as Topic;  Humans;  Randomized Controlled Trials as Topic;  Tobacco Use Cessation;  Young Adult},
chemicals_cas={amfebutamone, 31677-93-7, 34911-55-2},
funding_text 1={Eriksen M, Mackay J, Ross H. The Tobacco Atlas. 4th Edition. Atlanta GA: World Lung Foundation and American Cancer Society, 2012.},
references={Aveyard, P., Cheng, K.K., Almond, J., Sherratt, E., Lancashire, R., Lawrence, T., Cluster randomised controlled trial of expert system based on the transtheoretical (''stages of change'') model for smoking prevention and cessation in schools (1999) BMJ, 319, pp. 948-953; Aveyard, P., Sherratt, E., Almond, J., Lawrence, T., Lancashire, R., Griffin, C., The change-in-stage and updated smoking status results from a cluster-randomized trial of smoking prevention and cessation using the transtheoretical model among British adolescents (2001) Preventive Medicine, 33, pp. 313-324; Brown, R.A., Ramsey, S.E., Strong, D.R., Myers, M.G., Kahler, C.W., Lejuez, C.W., Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders (2003) Tobacco Control, 12, pp. iv3-iv10; Brown, R.A., Strong, D.R., Abrantes, A.M., Myers, M.G., Ramsey, S.E., Kahler, C.W., Effects on substance use outcomes in adolescents receiving motivational interviewing for smoking cessation during psychiatric hospitalization (2009) Addictive Behaviours, 34, pp. 887-891; MacPherson, L., Strong, D.R., Kahler, C.W., Abrantes, A.M., Ramsey, S.E., Brown, R.A., Association of post-treatment smoking change with future smoking and cessation efforts among adolescents with psychiatric comorbidity (2007) Nicotine Tobacco Research, 9 (12), pp. 1297-1307; Macpherson, L., Strong, D.R., Palm, K.M., Abrantes, A.M., Brown, R.A., Post-intervention lapse and relapse in adolescent smokers with psychiatric comorbidity (POS1-84) (2007), Society for Research on Nicotine and Tobacco 13th Annual Meeting, February 21-24, Austin, Texas; Chan, C.W., Witherspoon, J.M., Health risk appraisal modifies cigarette smoking behavior among college students (1988) Journal of General Internal Medicine, 3 (6), pp. 555-559; Colby, S.M., Monti, P.M., O'Leary Tevyaw, T., Barnett, N.P., Spirito, A., Rohsenow, D.J., Brief motivational intervention for adolescent smokers in medical settings (2005) Addictive Behaviors, 30 (5), pp. 865-874; Monti, P., Colby, S.M., O'Leary, T.A., Spirito, A., Woolard, R.H., Lewander, W.J., Motivational interviewing for adolescent smokers: preliminary results from a randomized clinical trial (2002), Society for Research on Nicotine and Tobacco 8th Annual Meeting Rapid Communications Posters (RP-27) Savannah, Georgia; February 20-23 2002; Greenberg, J.S., Deputat, Z., Smoking intervention: comparing three methods in a high school setting (1978) Journal of School Health, 48, pp. 489-502; Hoffman, J., Nemes, S., Weil, J., Zack, S., Adolescent smoking cessation escaping nicotine and tobacco (ASCENT): outcomes (2005), Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March; Prague, Czech Republic; Hoffman, J., Nemes, S., Weil, J., Zack, S., Munly, K., Hess, L., Evaluation of the ASCENT smoking cessation program for adolescents (2008) Journal of Smoking Cessation, 3 (1), pp. 2-8; Hoffman, J., Nemes, S., Weil, J., Zack, S., Munly, K., Levin, H., Adolescent smoking cessation escaping nicotine and tobacco (ASCENT): Outcome evaluation preliminary findings (2003), Society for Research on Nicotine and Tobacco 9th Annual Meeting, February 19-22 New Orleans, Louisiana; Zack, S.L., Hoffman, J., Nemes, S., Weil, J., Hess, J., Participation in a successful and multifaceted teen cessation program (2005), National Conference on Tobacco or Health. Chicago; Hollis, J.F., Polen, M.R., Whitlock, E.P., Lichtenstein, E., Mullooly, J.P., Velicer, W.F., Teen Reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care (2005) Pediatrics, 115 (4), pp. 981-989; Horn, K., Dino, G., Hamilton, C., Noerachmanto, N., Efficacy of an emergency department-based motivational teenage smoking intervention (2007) Preventing Chronic Disease, 4 (1), p. A08; Joffe, A., McNeely, C., Colantuoni, E., An, M., Wang, W., Scharfstein, D., Evaluation of school-based smoking-cessation interventions for self-described adolescent smokers (2009) Pediatrics, 124, pp. e187-e194; Kelly, A.B., Lapworth, K., The HYP program-targeted motivational interviewing for adolescent violations of school tobacco policy (2006) Preventive Medicine, 43 (6), pp. 466-471; Killen, J.D., Robinson, T.N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers (2004) Journal of Consulting and Clinical Psychology, 72 (4), pp. 729-735; Lipkus, I.M., McBride, C.M., Pollak, K.I., Schwartz-Bloom, R.D., Bloom, P.N., Tilson, E., A randomized trial comparing the effects of self-help materials and proactive telephone counseling on teen smoking cessation (2004) Health Psychology, 23 (4), pp. 397-406; Collins, C.C., Epstein, D.H., Parzynski, C.S., Zimmerman, D., Moolchan, E.T., Heishman, S.J., Puffing behavior during the smoking of a single cigarette in tobacco-dependent adolescents (2010) Nicotine and bTobacco Research, 12 (2), pp. 164-167; Franken, F.H., Pickworth, W.B., Epstein, D.H., Moolchan, E.T., Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy (2006) Cancer Epidemiology, Biomarkers & Prevention, 15 (1), pp. 154-157; Mancha, B., Cranford, D., Snidow, N., Radzius, A., Conrad, S., Cadet, J.L., Patterns of compliance of teenage smokers in cessation treatment: are the first two weeks determining? (PO3 75) (2001), Society for Research on Nicotine and Tobacco 7th Annual Meeting March 23-23 2001 Seattle Washington; Moolchan, E.T., Robinson, M.L., Ernst, M., Cadet, J.L., Pickworth, W.B., Heishman, S.J., Safety and efficacy of the nicotine patch and gum for treatment of adolescent tobacco addiction (2005) Pediatrics, 115 (4), pp. 407-414; Moolchan, E.T., Robinson, M.L., Schroeder, J.R., Huestis, M.A., Ernst, M., A randomized trial of the efficacy of the nicotine gum and patch for adolescent smokers (PA2-8) (2004), Society for Research on Nicotine and Tobacco 10th Annual Meeting February 18-21 2004, Phoenix, Arizona; Robinson, M.L., Schroeder, J.R., Moolchan, E.T., Adolescent smokers screened for a nicotine replacement treatment trial: Correlates of eligibility and enrollment (2006) Nicotine and Tobacco Research, 8, pp. 447-454; Thorner-Bantug, E., Jaszyna-Gasior, M., Schroeder, J.R., Collins, C.C., Moolchan, E.T., Weight gain, related concerns, and treatment outcomes among adolescent smokers enrolled in cessation treatment (2009) Journal of National Mediacl Association, 101 (10), pp. 1009-1014; Muramoto, M., Leischow, S., Sherrill, D.L., A randomized trial of the efficacy of bupropion for adolescent smoking cessation [RP-064] (2005), Society for Research on Nicotine and Tobacco 11th annual meeting, March 2005; Prague, Czech Republic. Rapid Communications posters; Muramoto, M.L., Leischow, S.J., Enright, P., Strayer, L., Hadjioannou, M., Matthews, E., So you want to do a smoking cessation study with teens. interim process evaluation of 'Lessons Learned' from a dose response study of safety and efficacy of sustained release bupropion for smoking cessation in adolescents (PO3-67) (2001), Society for Research on Nicotine and Tobacco 7th Annual Meeting, Seattle WA; Muramoto, M.L., Leischow, S.J., Sherrill, D., Matthews, E., Strayer, L.J., Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation (2007) Archives of Pediatrics & Adolescent Medicine, 161, pp. 1068-1074; Myers, M.G., Brown, S.A., A controlled study of a cigarette smoking cessation intervention for adolescents in substance abuse treatment (2005) Psychology of Addictive Behaviors, 19 (2), pp. 230-233; Myers, M.G., Gwaltney, C.J., Strong, D.R., Ramsey, S.E., Brown, R.A., Monti, P.M., Adolescent first lapse following smoking cessation: Situation characteristics, precipitants and proximal influences (2011) Addictive Behaviors, 36 (12), pp. 1253-1260; Myers, M.G., Prochaska, J.J., Does smoking intervention influence adolescent substance use disorder treatment outcomes? (2008) Substance Abuse, 29 (2), pp. 81-88; Kohler, C., Schoenberger, Y.M., Phillips, M., Effectiveness evaluation of a school-based smoking cessation program for adolescents (2005), Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic; Kohler, C.L., Schoenberger, Y.M., Beasley, T.M., Phillips, M.M., Effectiveness evaluation of the N-O-T smoking cessation program for adolescents (2008) American Journal of Health Behavior, 32 (4), pp. 368-379; Vaid, I.G., Self-efficacy to resist smoking as a mediator between nicotine dependence and quit attempt in adolescent smokers in Alabama (2008) Dissertation Abstracts International: Section B: The Sciences and Engineering, 69 (5); Dino, G., Goldcamp, J., Fernandes, A., Kalsekar, I., Massey, C., A 2-year efficacy study of Not On Tobacco in Florida: An overview of program successes in changing teen smoking behavior (2001) Preventive Medicine, 33 (6), pp. 600-605; Joffe, A., McNeely, C., Colantuoni, E., An, M., Wang, W., Scharfstein, D., Evaluation of school-based smoking-cessation interventions for self-described adolescent smokers (2009) Pediatrics, 124, pp. e187-e194; Horn, K., Dino, G., Kalsekar, I., Mody, R., The impact of NoT On Tobacco on teen smoking cessation (2005) Journal of Adolescent Research, 20 (6), pp. 640-661; Horn, K., Fernandes, A., Dino, G., Massey, C.J., Kalsekar, I., Adolescent nicotine dependence and smoking cessation outcomes (2003) Addictive Behaviors, 28, pp. 769-776; Horn, K.A., Dino, G.A., Kalsekar, I.D., Fernandes, A.W., Appalachian teen smokers: Not On Tobacco 15 months later (2004) American Journal of Public Health, 94 (2), pp. 181-184; Horn, K., Dino, G., Branstetter, S., Noerachanto, N., Zhang, J., Jarrett, T., Taylor, M., Effects of physical activity on teen smoking cessation (2011) Pediatrics, 128 (4), pp. e801-e811; Croghan, I.T., Campbell, H.M., Patten, C.A., Croghan, G.A., Schroeder, D.R., Novotny, P.J., A contest to create media messages aimed at recruiting adolescents for stop smoking programs (2004) Journal of School Health, 74 (8), pp. 325-328; Patten, C.A., Croghan, I.T., Meis, T.M., Decker, P.A., Pingree, S., Colligan, R.C., Randomized clinical trial of an Internet-based versus brief office intervention for adolescent smoking cessation (2006) Patient Education & Counseling, 64 (1-3), pp. 249-258; Bricker, J.B., Liu, J., Comstock, B.A., Peterson, A.V., Kealey, K.A., Marek, P.M., Social cognitive mediators of adolescent smoking cessation: results from a large randomized intervention trial (2010) Psychology of Addictive Behaviors, 24 (3), pp. 436-445; Kealey, K.A., Ludman, E.J., Mann, S.L., Marek, P.M., Phares, M.M., Riggs, K.R., Peterson, A.V., Jr., Overcoming barriers to recruitment and retention in adolescent smoking cessation (2007) Nicotine & Tobacco Research, 9 (2), pp. 257-270; Kealey, K.A., Ludman, E.J., Marek, P.M., Mann, S.L., Bricker, J.B., Peterson, A., Design and implementation of an effective telephone counseling intervention for adolescent smoking cessation. (2009) Journal of the National Cancer Institute, 101 (19), pp. 1393-1405; Liu, J., Peterson, A.V., Jr., Kealey, K.A., Mann, S.L., Bricker, J.B., Marek, P.M., Addressing challenges in adolescent smoking cessation: design and baseline characteristics of the HS Group-Randomized trial (2007) Preventive Medicine, 45 (2-3), pp. 215-225; Peterson, A.V., Jr., Kealey, K.A., Mann, S.L., Marek, P.M., Ludman, E.J., Liu, J., Bricker, J.B., Group-randomized trial of a proactive, personalized telephone counseling intervention for adolescent smoking cessation (2009) Journal of the National Cancer Institute, 101, pp. 1378-1392; Dent, C.W., Pfingston, Y.M., Schmuker, K., Granstra, J., Nicotine replacement in school-based cessation (RP-33) (2002), Society for Research on Nicotine and Tobacco 8th Annual Meeting Rapid Communications Posters February 20-23 2002 Savannah, Georgia; McCuller, W.J., Sussman, S., Wapner, M., Dent, C., Weiss, D.J., Motivation to quit as a mediator of tobacco cessation among at-risk youth (2006) Addictive Behaviors, 31, pp. 880-888; Sussman, S., Dent, C.W., Litchman, K.L., Project EX: Outcomes of teen smoking cessation program (2001) Addictive Behaviors, 26, pp. 425-438; Sussman, S., McCuller, W.J., Zheng, H., Pfingston, Y.M., Miyano, J., Dent, C.W., Project EX: A program of empirical research on adolescent tobacco use cessation (2004) Tobacco Induced Diseases, 2 (3), pp. 119-132; Idrisov, B., Sun, P., Akhmadeev, L., Arpawong, T.E., Kukhareva, P., Sussman, S., Immediate and six-month effects of Project EX Russia: A smoking cessation intervention pilot program (2013) Addictive Behaviors, 38 (8), pp. 2402-2408; Robinson, L.A., Vander Weg, M.W., Riedel, B.W., Klesges, R.C., McLain-Allen, B., "Start to stop": results of a randomised controlled trial of a smoking cessation programme for teens (2003) Tobacco Control, 12, pp. iv26-iv33; Sherbot, N.A., The use of motivational enhancement therapy and the quit 4 life program as a means to facilitate adolescent smoking cessation (2005) Dissertation Abstracts International: Section B: The Sciences and Engineering, 66 (1), p. 574; Woodruff, S.I., Conway, T.L., Edwards, C.C., Sociodemographic and smoking-related psychosocial predictors of smoking behavior change among high school smokers (2008) Addictive Behaviors, 33, pp. 354-358; Woodruff, S.I., Conway, T.L., Edwards, C.C., Elliott, S.P., Crittenden, J., Evaluation of an Internet virtual world chat room for adolescent smoking cessation (2007) Addictive Behaviors, 32, pp. 1769-1786; Abelin, T., Ehrsam, R., Buhler Reichert, A., Imhof, P.R., Muller, P., Thommen, A., Effectiveness of a transdermal nicotine system in smoking cessation studies (1989) Methods and Findings in Experimental and Clinical Pharmacology, 11, pp. 205-214; Abroms, L.C., Windsor, R., Simons-Morton, B., Getting young adults to quit smoking: A formative evaluation of the X-Pack Program (2008) Nicotine & Tobacco Research, 10, pp. 27-33; Abroms, L.C., Windsor, R., Simons-Morton, B.A., A formative evaluation of an email-based program for smoking cessation in young adults (POS1-115) (2007), Society for Research on Nicotine & Tobacco 13th Annual Meeting Febuary 21-22 Austin, Texas; Adelman, W.P., Duggan, A., Hauptman, P., Joffe, A., Effectiveness of a high school smoking cessation program (2000) Journal of Adolescent Health, 26 (2), p. 83; Adelman, W.P., Duggan, A.K., Hauptman, P., Joffe, A., Effectiveness of a high school smoking cessation program (2001) Pediatrics, 107 (4), pp. e50-e59; Adelman, W.P., Nicotine nasal spray neither effective nor well-tolerated by adolescent smokers (2009) Journal of Pediatrics, 154 (3), pp. 462-463; Ames, S., Patten, C., Werch, C., Covil, E., Craggs, J., Olmos, J., Expressive writing as a smoking cessation treatment adjunct for young adult smokers (POS2-28) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Ames, S.C., Patten, C.A., Offord, K.P., Pennebaker, J.W., Croghan, I.T., Tri, D.M., Expressive writing intervention for young adult cigarette smokers (2005) Journal of Clinical Psychology, 61, pp. 1555-1570; Ames, S.C., Patten, C.A., Werch, C.E., Schroeder, D.R., Stevens, S.R., Fredrickson, P.A., Expressive writing as a smoking cessation treatment adjunct for young adult smokers (2007) Nicotine & Tobacco Research, 9 (2), pp. 185-194; An, L.C., Hennrikus, D.J., Perry, C.L., Lein, E.B., Klatt, C., Farley, D.M., Feasibility of Internet health screening to recruit college students to an online smoking cessation intervention (2007) Nicotine and Tobacco Research, 9, pp. s11-s18; Audrain-McGovern, J., Stevens, S., Murray, P.J., Kinsman, S., Zuckoff, A., Pletcher, J., The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change (2011) Pediatrics, 128 (1); Audrey, S., Holliday, J., Campbell, R., Commitment and compatibility: Teachers' perspectives on the implementation of an effective school-based, peer-led smoking intervention (2008) Health Education Journal, 67 (2), pp. 74-90; Bauman, K.E., Ennett, S.T., Foshee, V.A., Pemberton, M., King, T.S., Koch, G.G., Influence of a family-directed program on adolescent cigarette and alcohol cessation (2000) Prevention Science, 1, pp. 227-237; Bloor, M., Frankland, J., Langdon, N.P., Robinson, M., Allerston, S., Catherine, A., A controlled evaluation of an intensive, peer-led, schools-based, anti-smoking programme (1999) Health Education Journal, 58 (1), pp. 17-25; Bond, L., Patton, G., Glover, S., Carlin, J.B., Butler, H., Thomas, L., The Gatehouse Project: Can a multilevel school intervention affect emotional wellbeing and health risk behaviours? (2004) Journal of Epidemiology and Community Health, 58 (12), pp. 997-1003; Bramley, D., Riddell, T., Whittaker, R., Corbett, T., Lin, R.B., Wills, M., Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori (2005) New Zealand Medical Journal, 118 (1216), p. U1494; Rodgers, A., Corbett, T., Bramley, D., Riddell, T., Wills, M., Lin, R.B., Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging (2005) Tobacco Control, 14 (4), pp. 255-261; Braverman, M.T., Moskowitz, J.M., D'Onofrio, C.N., Foster, V., Project 4-health develops program to curb youth tobacco use (1994) California Agriculture, 48, pp. 39-43; Brendryen, H., Drozd, F., Kraft, P., A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): randomized controlled trial (2008) Journal of Medical Internet Research, 10 (5); Burton, D., Tobacco cessation programs for adolescents (1994) Interventions for smokers: an international perspective, pp. 95-136. , In: Richmond R editor(s). Baltimore: Williams and Wilkins; Burton, D., Chakravorty, B., Weekes, K., Flay, B.R., Outcome of TNT tobacco-cessation randomised trial with high school students (1994) Unpublished material; Burton, D., Chakravorty, B., Weeks, K., Flay, B.R., Dent, C., Stacy, A., Outcome of a tobacco use cessation randomized trial with high-school students (2009) Substance Use & Misuse, 44 (7), pp. 965-980; Cai, Y.M., Zhao, C.X., Wong, S.U., Zhang, L., Lim, S.K., Laser acupuncture for adolescent smokers - A randomized double-blind controlled trial (2000) American Journal of Chinese Medicine, 28 (3-4), pp. 443-449; Yiming, C., Laser acupuncture for adolescent smokers - a randomised double blind controlled study. (1999), 2, p. 105. , XI World Congress of Psychiatry, Hamburg, August 6-11, 1999; Campbell, R., Starkey, F., Holliday, J., Audrey, S., Bloor, M., Parry-Langdon, N., An informal school-based peer-led intervention for smoking prevention in adolescence (ASSIST): a cluster randomised trial (2008) Lancet, 371 (10), pp. 1595-1602; Starkey, F., Moore, L., Campbell, R., Sidaway, M., Bloor, M., Correction: rationale, design and conduct of a comprehensive evaluation of a school-based peer-led anti-smoking intervention in the UK: the ASSIST cluster randomised trial (2007) BMC. Public Health, 7, p. 301; Cavallo, D.A., Smith, A.E., Liss, T.B., McFetridge, A.K., Babuscio, T., Contingency management and cognitive behavioral therapy for smoking cessation in adolescent smokers: comparison of two different CBT formats (2007), p. 54. , Society for Research on Nicotine and Tobacco 13th Annual Meeting February 21-24, Austin, Texas; Chen, H.H., Yeh, M.L., Developing and evaluating a smoking cessation program combined with an internet-assisted instruction program for adolescents with smoking (2006) Patient Education and Counseling, 61 (3), pp. 411-418; Chen, H.H., Yeh, M.L., Chao, Y.H., Comparing effects of auricular acupressure with and without an internet-assisted program on smoking cessation and self-efficacy of adolescents (2006) Journal of Alternative & Complementary Medicine, 12 (2), pp. 147-152; Colby, S.M., Monti, P.M., Barnett, N.P., Rohsenow, D.J., Weissman, K., Spirito, A., Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study (1998) Journal of Consulting and Clinical Psychology, 66 (3), pp. 574-578; Monti, P., Colby, S.M., O'Leary, T.A., Spirito, A., Woolard, R., Rohsenow, D., Motivational interviewing plus parental intervention for adolescent smokers: results from a randomized clinical trial (POS4-31) (2003), Society for Research on Nicotine and Tobacco 9th Annual Meeting February 19-22 2003 New Orleans, Louisiana; Digiusto, W.E., Pros and cons of cessation interventions for adolescent smokers at school (1994) Interventions for smoking - an international perspective, pp. 107-136. , In: Richmond R editor(s). Baltimore: Williams and Wilkins; Dino, G., Horn, K., Meit, H., A pilot study of Not On Tobacco: a stop smoking programme for adolescents (1998) Health Education, 6, pp. 230-241; Egger, G., Fitzgerald, W., Frape, G., Monaem, A., Rubinstein, P., Tyler, C., Results of large scale media antismoking campaign in Australia: North Coast 'Quit for Life' programme (1983) British Medical Journal, 287, pp. 1125-1128; Ehrsam, R.E., Buhler, A., Muller, P., Mauli, D., Schumacher, P.M., Howald, H., [Weaning of young smokers using a transdermal nicotine patch] (1991) Schweizerische Rundschau für Medizin Praxis, 80 (7), pp. 145-150; Elsasser, G.N., Guck, T.P., Destache, C.J., Daher, P.M., Frey, D.R., Jones, J., Sustained release bupropion in the treatment of nicotine addiction among teenage smokers (RP-32) (2002), Society for Research on Nicotine and Tobacco 8th Annual Meeting Rapid Communications Posters February 20-23 2002 Savannah, Georgia; Emmons, K.M., Butterfield, R.M., Puleo, E., Park, E.R., Mertens, A., Gritz, E.R., Smoking among participants in the childhood cancer survivors cohort: the Partnership for Health Study (2003) Journal of Clinical Oncology, 21 (2), pp. 189-196; Erol, S., Erdogan, S., Application of a stage based motivational interviewing approach to adolescent smoking cessation: The Transtheoretical Model-based study (2008) Patient Education and Counseling, 72 (1), pp. 42-48; Escoffery, C., McCormick, L., Bateman, K., Development and process evaluation of a web-based smoking cessation program for college smokers: innovative tool for education (2004) Patient Education and Counseling, 53 (2), pp. 217-225; Faessel, H., Ravva, P., Williams, K., Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study (2009) Clinical Therapeutics, 31 (1), pp. 177-189; Fagan, P., Stoddard, A.M., Hunt, M.K., Frazier, L., Girod, K., Sorensen, G., The feasibility of evaluating a tobacco control intervention for working youth (2003) Tobacco Control, 12, pp. 34-39; Figa-Talamanca, I., Modolo, M., Evaluation of an anti-smoking educational programme among adolescents in Italy (1989) Hygie, 8, pp. 24-28; Flay, B.R., Miller, T.Q., Hedeker, D., Siddiqui, O., Britton, C.F., Brannon, B.R., The television, school, and family smoking prevention and cessation project. VIII student outcomes and mediating variables (1995) Preventive Medicine, 24, pp. 29-40; Carpenter, M.J., Baker, N.L., Gray, K.M., Upadhyaya, H.P., Assessment of nicotine dependence among adolescent and young adult smokers: A comparison of measures (2010) Addictive Behaviours, 35 (11), pp. 977-982; Gray, K.M., Carpenter, M.J., Baker, N.L., Hartwell, K.J., Lewis, A.L., Hiott, D.W., Bupropion SR and contingency management for adolescent smoking cessation (2011) Journal of Substance Abuse Treatment, 40 (1), pp. 77-86; Hamilton, G., Cross, D., Resnicow, K., Hall, M., A school-based harm minimization smoking intervention trial: outcome results (2005) Addiction, 100 (5), pp. 689-700; Hancock, L., Sanson-Fisher, R., Perkins, J., Girgis, A., Howley, P., Schofield, M., The effect of a community action intervention on adolescent smoking rates in rural Australian towns: the CART project. Cancer Action in Rural Towns (2001) Preventive Medicine, 32 (4), pp. 332-340; Dickmann, P.J., Mooney, M.E., Allen, S.S., Hanson, K., Hatsukami, D.K., Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive use (2009) Addictive Behaviors, 34 (6-7), pp. 620-623; Hanson, K., Allen, S., Jensen, S., Hatsukami, D., Treatment of adolescent smokers with the nicotine patch (2003) Nicotine & Tobacco Research, 5 (4), pp. 515-526; Hanson, K., Zylla, E., Allen, S., Avery, G., Harm reduction: an intervention for adolescent smokers (SYM3B) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Hanson, K., Zylla, E., Allen, S., Li, Z., Hatsukami, D.K., Cigarette reduction: An intervention for adolescent smokers (2008) Drug and Alcohol Dependance, 95, pp. 164-168; Harris, K.J., Catley, D., Good, G.E., Cronk, N.J., Harrar, S., Williams, K.B., Motivational interviewing for smoking cessation in college students: a group randomized controlled trial (2010) Preventive Medicine, 51 (5), pp. 387-393; Haug, S., Meyer, C., Schorr, G., Bauer, S., John, U., Continuous individual support of smoking cessation using text messaging: A pilot experimental study (2009) Nicotine & Tobacco Research, 11 (8), pp. 915-923; Heikkinen, A.M., Broms, U., Pitkäniemi, J., Koskenvuo, M., Meurman, J., Key factors in smoking cessation intervention among 15-16-year-olds (2009) Behavioral Medicine, 35, pp. 93-99; Hellmann, R., O'Shea, R.M., Kunz, M.L., Schimpfhauser, F.T., University health service physician intervention with cigarette smokers (1988) Journal of American College Health, 37, pp. 91-93; Helstrom, A., Hutchison, K., Bryan, A., Motivational enhancement therapy for high-risk adolescent smokers (2007) Addictive Behaviors, 32, pp. 2404-2410; Helstrom, A.W., A smoking intervention for high-risk adolescents (2004) Dissertation Abstracts International: Section B: The Sciences and Engineering, 64 (7), p. 3525; Higgs, P.E., Edwards, D., Harbin, R.E., Higgs, P.C., Evaluation of a self-directed smoking prevention and cessation program (2000) Pediatric Nursing, 26 (2), pp. 150-155; Hollis, J.F., Vogt, T.M., Stevens, V., Biglan, A., Severson, H., Lichtenstein, E., The tobacco reduction and cancer control (TRACC) program: team approaches to counseling in medical and dental settings (1994) Tobacco and the clinician: interventions for medical and dental practice:, 1, p. 143. , In: U.S. Dept of Healh and Human Services, editor(s). Washington DC: U.S. Govt printing office; Horn, K., Dino, G., Kalsekar, I., Massey, C.J., Manzo-Tennant, K., McGloin, T., Exploring the relationship between mental health and smoking cessation: a study of rural teens (2004) Prevention Science, 5 (2), pp. 113-126; Hort, W., Hort, H., Willers, R., [An interventional study against cigarette smoking among Dusseldorf high school students 1992-94] (1995) Zeitschrift Fur Kardiologie, 84 (9), pp. 700-711; Jason, L.A., Mollica, M., Ferrone, L., Evaluating an early secondary smoking prevention intervention (1982) Preventive Medicine, 11 (1), pp. 96-102; Josendal, O., Aaro, L.E., Evaluation of an intervention programme for smokefree schools (2002) Tidsskrift for den Norske Laegeforening, 122 (4), pp. 403-407; Josendal, O., Aaro, L.E., Bergh, I.H., Effects of a school-based smoking prevention program among subgroups of adolescents (1998) Health Education Research, 13 (2), pp. 215-224; Kang, H.-C., Shin, K.-K., Kim, K.-K., Youn, B.-B., The effects of the acupuncture treatment for smoking cessation in high school student smokers (2005) Yonsei Medical Journal, 46 (2), pp. 206-212; Kealey, K.A., Ludman, E.J., Marek, P.M., Mann, S.L., Bricker, J.B., Peterson, A.V., Design and implementation of an effective telephone counseling intervention for adolescent smoking cessation (2009) Journal of the National Cancer Institute, 101 (20), pp. 1393-1405; Kelleher, C.C., Fallon, U.B., McCarthy, E., Dineen, B.D., O'Donnell, M., Killian, M., Feasibility of a lifestyle cardiovascular health promotion programme for 8-15-year olds in Irish general practice: results of the Galway Health Project (1999) Health Promotion International, 14, pp. 221-229; Kentala, J., Utriainen, P., Pahkala, K., Mattila, K., Can brief intervention through community dental care have an effect on adolescent smoking? (1999) Preventive Medicine, 29, pp. 107-111; Killen, J.D., Robinson, T.N., Telch, M.J., Saylor, K.E., Maron, D.J., Rich, T., Bryson, S., The Stanford Adolescent Heart Health Program (1989) Health Education Quarterly, 16 (2), pp. 263-283; Killen, J.D., Telch, M.J., Robinson, T.N., Maccoby, N., Taylor, C.B., Farquhar, J.W., Cardiovascular disease risk reduction for tenth graders. A multiple-factor school-based approach (1988) Journal of the American Medical Association, 260, pp. 1728-1733; Kim, S., Nam, K.A., Seo, M., Lee, H.H., Effectiveness of a smoking cessation program for adolescents (2004) Taehan Kanho Hakhoe Chi, 34 (4), pp. 646-654; Knishkowy, B., Verbov-Lei, G., Amitai, Y., Zamir-Stein, C., Rosen, L., Results from a religion-based tobacco control trial among Haredi (Jewish ultra-orthodox) male adolescents in Jerusalem (2008) Unpublished Work; Lando, H.A., Hennrikus, D., Boyle, R., Lazovich, D., Stafne, E., Rindal, B., Promoting tobacco abstinence among older adolescents in dental clinics (2007) Journal of Smoking Cessation, 2 (1), pp. 23-30; Lotecka, L., MacWhinney, M., Enhancing decision behavior in high school 'smokers' (1983) International Journal of the Addictions, 18, pp. 479-490; McCambridge, J., Strang, J., The efficacy of single session motivational interviewing in reducing drug consumption and perceptions of drug related risk and harm among young people: results from a multi-site cluster randomized trial (2004) Addiction, 99 (1), pp. 39-52; McCuller, W.J., Sussman, S., Wapner, M., Dent, C., Weiss, D.J., Motivation to quit as a mediator of tobacco cessation among at-risk youth (2006) Addictive Behaviors, 31 (5), pp. 880-888; Mermelstein, R., Turner, L., Web-based support as an adjunct to group-based smoking cessation for adolescents (2006) Nicotine & Tobacco Research, 8, pp. S69-S76; Turner, L., Mermelstein, R., Web-based support as an adjunct to group-based smoking cessation for adolescents (POS2-50) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Myers, M.G., Gwaltney, C.J., Strong, D.R., Ramsey, S.E., Brown, R.A., Monti, P.M., Adolescent first lapse following smoking cessation: Situation characteristics, precipitants and proximal influences (2011) Addictive Behaviors, 36 (12), pp. 1253-1260; Myers, M.G., Prochaska, J.J., Does smoking intervention influence adolescent substance use disorder treatment outcomes? (2008) Substance Abuse, 29 (2), pp. 81-88; Niederhofer, H., Huber, M., Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results (2004) Pharmacotherapy, 24 (11), pp. 1524-1528; Norman, C.D., Maley, O., Li, X., Skinner, H.A., Using the internet to assist smoking prevention and cessation in schools: A randomized, controlled trial (2008) Health Psychology, 27 (6), pp. 799-810; Skinner, H., Maley, O., Norman, C., Website intervention for youth smoking prevention: findings from school-based randomized controlled trial (2005), Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic; Skinner, H., Norman, C., Maley, O., Web-based intervention for youth smoking prevention and cessation (2002), 130th Annual Meeting of APHA,12th November; O'Neill, H.K., Gillispie, M.A., Slobin, K., Stages of change and smoking cessation: a computer-administered intervention program for young adults (2000) American Journal of Health Promotion, 15 (2), pp. 93-96 and iii; Pallonen, U.E., Velicer, W.F., Prochaska, J.O., Rossi, J.S., Bellis, J.M., Tsoh, J.Y., Computer-based smoking cessation interventions in adolescents: Description, feasibility, and six-month follow-up findings (1998) Substance Use and Misuse, 33 (4), pp. 935-965; Pbert, L., Osganian, S.K., Gorak, D., Druker, S., Reed, G., O'Neill, K.M., A school nurse-delivered adolescent smoking cessation intervention: A randomized controlled trial (2006) Preventive Medicine, 43, pp. 312-320; Pbert, L., Flint, A.J., Fletcher, K.E., Young, M.H., Druker, S., DiFranza, J.R., Effect of a pediatric practice-based smoking prevention and cessation intervention for adolescents: a randomized, controlled trial (2008) Pediatrics, 121 (4), pp. e738-e747; Perry, C., Killen, J., Telch, M., Slinkard, L.A., Danaher, B.G., Modifying smoking behavior of teenagers: a school-based intervention (1980) American Journal of Public Health, 70 (7), pp. 722-725; Quinlan, K.B., McCaul, K.D., Matched and mismatched interventions with young adult smokers: testing a stage theory (2000) Health Psychology, 19 (2), pp. 165-171; Rabius, V., McAlister, A.L., Geiger, A., Huang, P., Todd, R., Telephone counseling increases cessation rates among young adult smokers (2004) Health Psychology, 23 (5), pp. 539-541; Rice, V.H., Weglicki, L.S., Templin, T., Jamil, H., Hammad, A., Intervention effects on tobacco use in Arab and non-Arab American adolescents (2010) Addictive Behaviors, 35 (1), pp. 46-48; Roddy, E., Romilly, N., Challenger, A., Lewis, S., Britton, J., Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial (2006) Tobacco Control, 15 (5), pp. 373-376; Rubinstein, M.L., Benowitz, N.L., Auerback, G.M., Moscicki, A.B., A randomized trial of nicotine nasal spray in adolescent smokers (2008) Pediatrics, 122 (3), pp. e595-e600; Leeman, R.F., Schepis, T.S., Cavallo, D.A., McFetridge, A.K., Liss, T.B., Krishnan-Sarin, S., Nicotine dependence severity as a cross-sectional predictor of alcohol-related problems in a sample of adolescent smokers (2010) Nicotine and Tobacco Research, 12 (5), pp. 521-524; Schepis, T.S., Warren, K.A., Rao, U., Evaluation of a cognitive-behavioral smoking cessation treatment for adolescents and young adults (POS2-53) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Severson, H., Glasgow, R.E., Wirt, R., Brozovsky, P., Zoref, L., Black, C., Preventing the use of smokeless tobacco and cigarettes by teens: results of a classroom intervention (1991) Health Education Research, 6, pp. 109-120; Simmons, V.N., Heckman, B., Fink, A.C., Patel, R., Bello, L., Brandon, T.H., Efficacy of an experiential, web-based smoking intervention for college smokers [PA2-2] (2011), p. 17. , SRNT 17th Annual Meeting. Toronto, Ontario; Sims, T., Smith, S.S., McAfee, T., Baker, T.B., Fiore, M., Sheffer, M., Randomized clinical trial to evaluate quitline cessation counseling for 18 to 24 year-old smokers [PA2-1] (2011) Society for Research on Nicotine & Tobacco 17th Annual Meeting, February 16-19, Toronto; Sims, T.H., McAfee, T., Fraser, D.L., Baker, T.B., Fiore, M.C., Smith, S.S., Quitline cessation counseling for young adult smokers: A randomized clinical trial (2013) Nicotine & Tobacco Research, 15 (5), pp. 932-941; Solomon, L.J., Bunn, J.Y., Flynn, B.S., Pirie, P.L., Worden, J.K., Ashikaga, T., Mass media for smoking cessation in adolescents (2009) Health Education & Behavior, 36 (4), pp. 642-659; Stein-Seroussi, A., Stockton, L., Brodish, P., Meyer, M., Randomized controlled trial of the ACTION smoking cessation curriculum in tobacco-growing communities (2009) Addictive Behaviors, 34 (9), pp. 737-743; Stephens, S.A., The effectiveness of Motivational Enhancement Therapy in adolescent smoking cessation (2001) Dissertation Abstracts International, 62 (2), p. 1101; Stoddard, A.M., Fagan, P., Sorensen, G., Hunt, M.K., Frazier, L., Girod, K., Reducing cigarette smoking among working adolescents: Results from the SMART study (2005) Cancer Causes & Control, 16 (10), pp. 1159-1164; Sussman, S., Dent, C.W., Burton, D., Stacey, A.W., Flay, B.R., Cessation Clinic Evaluation (1995) Developing school-based tobacco use prevention and cessation programmes, pp. 204-210. , California: Sage; Sun, P., Miyano, J., Rohrbach, L.A., Dent, C.W., Sussman, S., Short term effects of Project EX4: a classroom based smoking prevention and cessation intervention program (SYM3A) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Sussman, S., Miyano, J., Rohrbach, L.A., Dent, C., Sun, P., Six-month and one-year effects of project EX-4: a classroom-based smoking prevention and cessation intervention program (2007) Addictive Behaviors, 32 (12), pp. 3005-3014; Travis, H.E., Lawrance, K.A., Randomized controlled trial examining the effectiveness of a tailored self-help smoking-cessation intervention for postsecondary smokers (2009) Journal of American College Health, 57 (4), pp. 437-444; Turner, L., Mermelstein, R., Web-based support as an adjunct to group-based smoking cessation for adolescents (POS2-50) (2006), Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida; Wang, K., Lee, A.H., Hamilton, G., Yau, K.K.W., Multilevel logistic regression modelling with correlated random effects: Application to the Smoking Cessation for Youth study (2006) Statistics in Medicine, 25 (22), pp. 3864-3876; Werch, C.E., Bian, H., Carlson, J.M., Moore, M.J., Diclemente, C.C., Huang, I.C., Brief integrative multiple behavior intervention effects and mediators for adolescents (2011) Journal of Behavioral Medicine, 34 (1), pp. 3-12; Werch, C.E., Bian, H., Diclemente, C.C., Moore, M.J., Thombs, D., Ames, S.C., A brief image-based prevention intervention for adolescents (2010) Psychology of Addictive Behaviors, 24 (1), pp. 170-175; Werch, C.E., Moore, M.J., Bian, H., DiClemente, C.C., Ames, S.C., Weiler, R.M., Efficacy of a brief image-based multiple-behavior intervention for college students (2008) Annals of Behavioral Medicine, 36 (2), pp. 149-157; Whittaker, R., Dorey, E., Bramley, D., Bullen, C., Denny, S., Elley, C.R., A theory-based video messaging mobile phone intervention for smoking cessation: randomized controlled trial (2011) Journal of Medical Internet Research, 13 (1); Winkleby, M.A., Feighery, E., Dunn, M., Kole, S., Ahn, D., Killen, J.D., Effects of an advocacy intervention to reduce smoking among teenagers (2004) Archives Of Pediatrics & Adolescent Medicine, 158, pp. 269-275; Wongwiwatthananukit, S., Dumrongpiwat, S., Krittiyanunt, S., Dhummaupakorn, R., Suwanmajo, S., Development and evaluation of pharmacist-based smoking cessation program for youth offenders (2010) Journal of the American Pharmacists Association, 50 (2), pp. 267-268; Minary, L., Cambon, L., Martini, H., Wirth, N., Acouetey, D.S., Thouvenot, F., Efficacy of a smoking cessation program in a population of adolescent smokers in vocational schools: a public health evaluative controlled study (2013) BMC Public Health, 13, p. 149; Minary, L., Martini, H., Wirth, N., Thouvenot, F., Acouetey, D.S., Martinet, Y., TABADO: "Evaluation of a smoking cessation program among adolescents in vocational training centers": Study protocol (2009) BMC Public Health, 9, p. 411; Arora, M., Stigler, M., Gupta, V., Bassi, S., Dhavan, P., Mathur, N., Tobacco control among disadvantaged youth living in low-income communities in India: Introducing Project ACTIVITY (2010) Asian Pacific Journal of Cancer Prevention, 11 (1), pp. 45-52; Smoking Cessation in Healthy Adolescent Smokers Ongoing study, , TBC; Amos, A., Wiltshire, S., Haw, S., NcNeill, A., Ambivalence and uncertainty: experiences of and attitudes towards addiction and smoking cessation in the mid-to-late teens (2006) Health Education Research, 21 (2), pp. 181-191; Boden, J.M., Fergusson, D.M., Horwood, J., Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. (2010) British Journal of Psychiatry, 196, pp. 440-446; Brinn, M.P., Carson, K.V., Esterman, A.J., Chang, A.B., Smith, B.J., Mass media interventions for preventing smoking in young people (2010) Cochrane Database of Systematic Reviews, (11); Burt, R., Peterson, A.V., Smoking cessation among high school seniors (1998) Preventive Medicine, 27, pp. 319-327; Campbell, M.K., Elbourne, D.R., CONSORT statement: extension to cluster randomised trials (2004) BMJ, 328, pp. 702-708. , Altman DG [for the CONSORT Group]; Campbell, M.J., Extending CONSORT to include cluster trials: welcome extension will help to understand trials better and reduce bias (2004) BMJ, 328, pp. 654-655; Carson, K.V., Brinn, M.P., Labiszewski, N.A., Esterman, A.J., Chang, A.B., Smith, B.J., Community interventions for preventing smoking in young people (2011) Cochrane Database of Systematic Reviews, (7); Carson, K.V., Brinn, M.P., Labiszewski, N.A., Peters, M., Chang, A.B., Veale, A., Interventions for tobacco use prevention in Indigenous youth (2012) Cochrane Database of Systematic Reviews, (8); Coleman, T., Chamberlain, C., Davey, M.A., Cooper, S.E., Leonardi-Bee, J., Pharmacological interventions for promoting smoking cessation during pregnancy (2012) Cochrane Database of Systematic Reviews, (9); Coppo, A., Galanti, M.R., Buscemi, D., Giordano, L., Faggiano, F., School policies for preventing smoking among young people (2012) Cochrane Database of Systematic Reviews, (7); Corby, E.A., Roll, J.M., Ledgerwood, D.M., Schuster, C.R., Contingency management interventions for treating the substance abuse of adolescents: A feasibility study (2000) Experimental & Clinical Psychopharmacology, 8, pp. 371-376; Cause and Effect: Tobacco Marketing Increases Tobacco Use: Findings of 2012 Surgeon General's report (2012), Center for Public Health and Tobacco Policy. Boston, MA; DiFranza, J.R., Richmond, J.B., Let the children be heard (2008) Paediatrics, 121 (3), pp. 623-624; Eriksen, M., Mackay, J., Ross, H., The Tobacco Atlas, , 4th Edition. Atlanta GA: World Lung Foundation and American Cancer Society, 2012; Thakur, G.A., Sengupta, S.M., Grizenko, N., Choudhry, Z., Joober, R., Family-based association study of ADHD and genes increasing the risk for smoking behaviours (2012) Arch Dis Child, 97, pp. 1027-1033; Gervais, A., O'Loughlin, J., Dugas, E., Eisenberg, M.J., Wellman, R.J., DiFranza, J.R., A systematic review of randomized controlled trials of youth smoking cessation interventions (2007) Drogués Santé et société, 6 (1), pp. ii1-ii26; Green, H., McGinnity, A., Meltzer, H., Ford, T., Goodman, R., Mental health of children and young people in Great Britain, 2004 (2004) Office for National Statistics, , http://wwwesdsacuk/doc/5269/mrdoc/pdf/5269technicalreportpdf, Accessed 31/1/13; Grimshaw, G., Stanton, A., Blackburn, C., Andrews, K., Grimshaw, C., Podinovskaya, Y., Patterns of smoking, quit attempts and services for a cohort of 15 to 19 year olds (2003) Child: Care, Health and Development, 29, pp. 457-464; Hahn, S., Puffer, S., Torgerson, D.J., Watson, J., Methodological bias in cluster randomised trials (2005) BMC Medical Research Methodology, 5 (10), pp. 1-8; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327 (7414), pp. 557-560; Hu, S.C., Lanese, R.R., The applicability of the theory of planned behavior to the intention to quit smoking across workplaces in southern Taiwan (1998) Addictive Behaviors, 23, pp. 225-237; Hughes, J.R., Keeley, J.P., Niaura, R.S., Ossip-Klein, D.J., Richmond, R.L., Swan, G.E., Measures of abstinence in clinical trials: issues and recommendations (2003) Nicotine & Tobacco Research, 5 (1), pp. 13-25; Kealey, K.A., Ludman, E.J., Marek, P.M., Mann, S.L., Bricker, J.B., Peterson, A., Design and Implementation of an Effective Telephone Counseling Intervention for Adolescent Smoking Cessation (2009) Journal of the National Cancer Institute, 101, pp. 1393-1405; Kishchuk, N., Tremblay, M., Lapierre, J., Heneman, B., O'Loughlin, J., Qualitative investigation of young smokers and ex-smokers views on smoking cessation methods (2004) Nicotine & Tobacco Research, 6 (3), pp. 491-500; Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., Watson, L., Interventions for promoting smoking cessation during pregnancy (2009) Cochrane Database of Systematic Reviews, (3); McDonald, P., Colwell, B., Backinger, C., Huston, C., Maule, C., Better practices for youth tobacco cessation. evidence of review panel (2003) American Journal of Health Behavior, 27, pp. S144-S158; Mermelstein, R., Colby, S.M., Patten, C., Prokhorov, A., Brown, R., Myers, M., Methodological issues in measuring treatment outcomes in adolescent smoking cessation studies (2002) Nicotine & Tobacco Research, 4 (4), pp. 395-403; High School Students Who Tried to Quit Smoking Cigarettes - United States, 2007 (2009) MMWR, Morbidity and Mortality Weekly Report, 58 (16), pp. 428-431. , Centers for Disease Control and Prevention; Current Tobacco Use Among Middle and High School Students-United States, 2011 (2012) Morbidity and Mortality Weekly Report, 61 (30), pp. 581-585. , Centers for Disease Control and Prevention; Fuller, E., Gill, V., Hawkins, V., Mandalia, D., Whalley, R., Smoking, drinking and drug use among young people in England in 2011 (2012) NatCen Social Research on behalf of the Health and Social Care Information Centre, , https://catalogueicnhsuk/publications/public-health/surveys/smok-drin-drug-youn-peop-eng-2011/smok-drin-drug-youn-peop-eng-2011-rep2.pdf, Accessed 14/3/13; Statistics on smoking, England, 2012 (2012), https://catalogueicnhsuk/publications/public-health/smoking/smok-eng-2012/smok-eng-2012-rep.pdf, Acessed 14/2/13; O'Loughlin, J., DiFranza, J., Tyndale, R.F., Meshefedjian, G., McMillan-Davey, E., Clarke, P.B.S., Nicotine-dependence symptoms are associated with smoking frequency in adolescents (2003) American Journal of Preventive Medicine, 25, pp. 219-225; Drug use, smoking and drinking among young teenagers in 1999 (2000), 189. , www.statistics.gov.uk/pdfdir/drugs0500.pdf, Office for National Statistics. (accessed 4th March 2005); Patnode, C.D., O'Connor, E., Whitlock, E.P., Perdue, L.A., Soh, C., Hollis, J., Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force (2013) Annals of Internal Medicine, 158 (4), pp. 253-260; Prochaska, J.O., Stages of change model for smoking prevention and cessation in schools (2000) BMJ, 320, p. 447; Prokhorov, A.V., de Moor, C., Pallonen, U.E., Suchanek Hudmon, K., Kole, S., Hu, S., Validation of the modified Fagerström tolerance questionnaire with salivary cotinine among adolescents (2000) Addictive Behaviors, 25 (3), pp. 429-433; Raw, M., McNeill, A., West, R., Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority (1998) Thorax, 53 (1), pp. S1-19; Riemsma, R.P., Pattenden, J., Bridle, C., Sowden, A.J., Mather, L., Watt, I.S., Systematic review of the effectiveness of stage-based interventions to promote smoking cessation (2003) BMJ, 326 (7400), pp. 1175-1177; Shepperd, S., Lewin, S., Straus, S., Clarke, M., Eccles, M.P., Fitzpatrick, R., Can we systematically review studies that evaluate complex interventions? (2009) PLoS Med, 6 (8); Stanton, A., Grimshaw, G.M., Andrews, K., Grimshaw, C.M., Robertson, W., Blackburn, C., (2001) Maybe not tomorrow but soon, , Warwick: University of Warwick; Stead, L.F., Lancaster, T., Interventions for preventing tobacco sales to minors (2005) Cochrane Database of Systematic Reviews, (1); Sussman, S., Dent, C.W., Nezami, E., Stacy, A.W., Burton, D., Flay, B.R., Reasons for quitting and smoking temptation among adolescent smokers: gender differences (1998) Substance Use & Misuse, 33, pp. 2703-2720; Sussman, S., Lichtman, K., Ritt, A., Pallonen, U.E., Effects of thirty-four adolescent tobacco use cessation and prevention trials on regular users of tobacco products (1999) Substance Use and Misuse, 34, pp. 1469-1503; Sussman, S., Effects of sixty-six adolescent tobacco use cessation trials and seventeen prospective studies of self-initiated quitting (2002) Tobacco Induced Diseases, 1 (1), pp. 35-81; Sussman, S., Sun, P., Dent, C.W., A meta-analysis of teen cigarette smoking cessation (2006) Health Psychology, 25 (2), pp. 549-557; (2000) Nicotine addiction in Britain, , Tobacco Advisory Group. London: Royal College of Physicians; Thomas, R.E., McLellan, J., Perera, R., School-based programmes for preventing smoking (2013) Cochrane Database of Systematic Reviews, (4); Villanti, A.C., McKay, H.S., Abrams, D.B., Holtgrave, D.R., Bowie, J.V., Smoking-cessation interventions for U.S. young adults: a systematic review (2010) American Journal of Preventive Medicine, 39 (6), pp. 564-574; West, R., Hajek, P., Stead, L., Stapleton, J., Outcome criteria in smoking cessation trials: proposal for a common standard (2005) Addiction, 100 (3), pp. 299-303; Grimshaw, G., Stanton, A., Tobacco cessation interventions for young people (2006) Cochrane Database of Systematic Reviews, (4)},
correspondence_address1={Grimshaw, G.; Warwick Medical School, University of Warwick, United Kingdom; email: gill@gillgrimshaw.com},
publisher={John Wiley and Sons Ltd},
issn={1469493X},
pubmed_id={23975659},
language={English},
abbrev_source_title={Cochrane Database Syst. Rev.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Angelino2019652,
author={Angelino, D. and Godos, J. and Ghelfi, F. and Tieri, M. and Titta, L. and Lafranconi, A. and Marventano, S. and Alonzo, E. and Gambera, A. and Sciacca, S. and Buscemi, S. and Ray, S. and Galvano, F. and Del Rio, D. and Grosso, G.},
title={Fruit and vegetable consumption and health outcomes: an umbrella review of observational studies},
journal={International Journal of Food Sciences and Nutrition},
year={2019},
volume={70},
number={6},
pages={652-667},
doi={10.1080/09637486.2019.1571021},
note={cited By 115},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062233464&doi=10.1080%2f09637486.2019.1571021&partnerID=40&md5=102ec71590d6b36d78ab5b28c1d83257},
affiliation={The Laboratory of Phytochemicals in Physiology, Department of Food and Drug, University of Parma, Parma, Italy; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy; NNEdPro Global Centre for Nutrition and Health, St John's Innovation Centre, Cambridge, United Kingdom; Wolfson College at the University of Cambridge, United Kingdom; Nutrition Innovation Centre for Food and Health at Ulster University, United Kingdom; SmartFood Program, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Biccoca, University of Milano, Milan, Italy; Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands; Rimini Women’s Health, Childhood and Adolescent Department, AUSL Romagna, Rimini, Italy; Food and Nutrition Security and Public Health Service, ASP Catania, Catania, Italy; Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy; Medical Research Council (MRC) Human Nutrition Research Unit, Cambridge, United Kingdom; The Laboratory of Phytochemicals in Physiology, Department of Veterinary Science, University of Parma, Parma, Italy},
abstract={The aim of this study was to provide a comprehensive evaluation of current evidence on fruit and vegetable consumption and health outcomes. A systematic search for quantitative syntheses was performed. Several criteria, including study design, dose–response relationship, heterogeneity and agreement of results over time, and identification of potential confounding factors, were used to assess the level of evidence. The strongest (probable) evidence was found for cardiovascular disease protection; possible evidence for decreased risk of colon cancer, depression and pancreatic diseases was found for fruit intake; and colon and rectal cancer, hip fracture, stroke, depression and pancreatic diseases was found for vegetable intake. Suggestive and rather limited associations with other outcomes have been found. Evidence of potential confounding by sex and geographical localisation has been reported. Despite findings are consistent enough for hypothesising causation (at least for cardiovascular-related outcomes), further studies are needed to clarify the role of potential confounding factors. © 2019, © 2019 Taylor & Francis Group, LLC.},
author_keywords={cohort study;  evidence;  Fruit;  meta-analysis;  umbrella review;  vegetable},
keywords={cardiovascular disease;  colon tumor;  depression;  factual database;  fruit;  health behavior;  human;  meta analysis;  observational study;  pancreas disease;  randomized controlled trial (topic);  risk factor;  vegetable, Cardiovascular Diseases;  Colonic Neoplasms;  Databases, Factual;  Depression;  Diet, Healthy;  Fruit;  Health Behavior;  Humans;  Observational Studies as Topic;  Pancreatic Diseases;  Randomized Controlled Trials as Topic;  Risk Factors;  Vegetables},
funding_details={Biotechnology and Biological Sciences Research CouncilBiotechnology and Biological Sciences Research Council, BBSRC, BB/P028225/1},
references={Adrogue, H.J., Madias, N.E., Sodium and potassium in the pathogenesis of hypertension (2007) N Engl J Med, 356, pp. 1966-1978; Alissa, E.M., Ferns, G.A., Dietary fruits and vegetables and cardiovascular diseases risk (2017) Critic Rev Food Sci Nutr, 57, pp. 1950-1962; Alsamarrai, A., Das, S.L., Windsor, J.A., Petrov, M.S., Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies (2014) Clin Gastroenterol Hepatol, 12, pp. 1635-1644; Prevention or delay of type 2 diabetes: standards of medical care in diabetes-2018 (2018) Diabetes Care, 41, pp. S51-S54. , 5; Ananthakrishnan, A.N., Khalili, H., Konijeti, G.G., Higuchi, L.M., de Silva, P., Korzenik, J.R., Fuchs, C.S., A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis (2013) Gastroenterology, 145, pp. 970-977. , Willett WC, Richter JM, Chan AT; Anderson, J.W., Hanna, T.J., Peng, X., Kryscio, R.J., Whole grain foods and heart disease risk (2000) J Am Coll Nutr, 19, pp. 291S-299S; Angelino, D., Jeffery, E., Glucosinolate hydrolysis and bioavailability of resulting isothiocyanates: focus on glucoraphanin (2014) J Funct Foods, 7, pp. 67-76; Araújo, J.R., Martel, F., Borges, N., Araújo, J.M., Keating, E., Folates and aging: role in mild cognitive impairment, dementia and depression (2015) Ageing Res Rev, 22, pp. 9-19; Aune, D., Chan, D.S., Vieira, A.R., Rosenblatt, D.A., Vieira, R., Greenwood, D.C., Norat, T., Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies (2012) Breast Cancer Res Treat, 134, pp. 479-493; Aune, D., Lau, R., Chan, D.S., Vieira, R., Greenwood, D.C., Kampman, E., Norat, T., Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies (2011) Gastroenterology, 141, pp. 106-118; Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., Cooney, M.T., 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) (2016) Eur J Prev Cardiol, 23, pp. NP1-NP96. , Corrà U, Cosyns B, Deaton C; Bandera, E.V., Kushi, L.H., Moore, D.F., Gifkins, D.M., McCullough, M.L., Fruits and vegetables and endometrial cancer risk: a systematic literature review and meta-analysis (2007) Nutr Cancer, 58, pp. 6-21; Ben, Q., Zhong, J., Liu, J., Wang, L., Sun, Y., Yv, L., Yuan, Y., Association between consumption of fruits and vegetables and risk of colorectal adenoma: A PRISMA-compliant meta-analysis of observational studies (2015) Medicine, 94, p. e1599; Blaine, J., Chonchol, M., Levi, M., Renal control of calcium, phosphate, and magnesium homeostasis (2015) Clin J Am Soc Nephrol, 10, pp. 1257-1272; Bosetti, C., Negri, E., Kolonel, L., Ron, E., Franceschi, S., Preston-Martin, S., McTiernan, A., A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International) (2002) Cancer Cause Control, 13, pp. 765-775. , Dal Maso L, Mark SD, Mabuchi K, et al; Brighenti, F., Valtuena, S., Pellegrini, N., Ardigo, D., Del Rio, D., Salvatore, S., Piatti, P., Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects (2005) Br J Nutr, 93, pp. 619-625. , Serafini M, Zavaroni I; Bultman, S.J., Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer (2017) Mol Nutr Food Res, 61. , 1500902; Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity (2015) Nat Rev Endocrinol, 11, pp. 577-591; Cao, W., Zeng, F., Li, B., Lin, J., Liang, Y., Chen, Y., Higher dietary carotenoid intake associated with lower risk of hip fracture in middle-aged and elderly Chinese: a matched case-control study (2018) Bone, 111, pp. 116-122; Chen, G.C., Lv, D.B., Pang, Z., Liu, Q.F., Fruits and vegetables consumption and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies (2013) Int J Cancer, 133, pp. 190-200; Cooper, A.J., Forouhi, N.G., Ye, Z., Buijsse, B., Arriola, L., Balkau, B., Barricarte, A., Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis (2012) Eur J Clin Nutr, 66, pp. 1082-1092; Dauchet, L., Amouyel, P., Dallongeville, J., Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies (2005) Neurology, 65, pp. 1193-1197; Dauchet, L., Amouyel, P., Hercberg, S., Dallongeville, J., Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies (2006) J Nutr, 136, pp. 2588-2593; De Kok, T.M., Van Breda, S.G., Manson, M.M., Mechanisms of combined action of different chemopreventive dietary compounds: a review (2008) Eur J Nutr, 47, pp. 51-59; Devereux, G., Seaton, A., Diet as a risk factor for atopy and asthma (2005) J Allergy Clin Immunol, 115, pp. 1109-1118; Dinkova-Kostova, A.T., Abramov, A.Y., The emerging role of Nrf2 in mitochondrial function (2015) Free Radic Biol Med, 88, pp. 179-188; Dinkova-Kostova, A.T., Fahey, J.W., Kostov, R.V., Kensler, T.W., KEAP1 and done? Targeting the NRF2 pathway with sulforaphane (2017) Trends Food Sci Technol, 69, pp. 257-269; Du, H., Li, L., Bennett, D., Guo, Y., Turnbull, I., Yang, L., Bragg, F., Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults (2017) PLOS Med, 14, p. e1002279; Eckel, R.H., Jakicic, J.M., Ard, J.D., de Jesus, J.M., Houston Miller, N., Hubbard, V.S., Lee, I.M., 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) J Am Coll Cardiol, 63, pp. 2960-2984; Engelbrecht, A.M., Mattheyse, M., Ellis, B., Loos, B., Thomas, M., Smith, R., Peters, S., Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line (2007) Cancer Lett, 258, pp. 144-153; Fang, X., Wei, J., He, X., An, P., Wang, H., Jiang, L., Shao, D., Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies (2015) Eur J Cancer, 51, pp. 2820-2832; Farzaei, M.H., Rahimi, R., Abdollahi, M., The role of dietary polyphenols in the management of inflammatory bowel disease (2015) Curr Pharm Biotechnol, 16, pp. 196-210; Flammer, A.J., Martin, E.A., Gössl, M., Widmer, R.J., Lennon, R.J., Sexton, J.A., Loeffler, D., Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells (2013) Eur J Nutr, 52, pp. 289-296; Forbes-Hernandez, T.Y., Giampieri, F., Gasparrini, M., Mazzoni, L., Quiles, J.L., Alvarez-Suarez, J.M., Battino, M., The effects of bioactive compounds from plant foods on mitochondrial function: a focus on apoptotic mechanisms (2014) Food Chem Toxicol, 68, pp. 154-182; Gan, Y., Tong, X., Li, L., Cao, S., Yin, X., Gao, C., Herath, C., Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies (2015) Int J Cardiol, 183, pp. 129-137. , Li W, Jin Z, Chen Y; Gandini, S., Merzenich, H., Robertson, C., Boyle, P., Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients (2000) Eur J Cancer, 36, pp. 636-646; Grosso, G., Bella, F., Godos, J., Sciacca, S., Del Rio, D., Ray, S., Galvano, F., Giovannucci, E.L., Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk (2017) Nutr Rev, 175, pp. 405-419; Grosso, G., Godos, J., Lamuela-Raventos, R., Ray, S., Micek, A., Pajak, A., Sciacca, S., A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations (2017) Mol Nutr Food Res, 61. , DOrazio N, Del Rio D, Galvano F; Grosso, G., Micek, A., Godos, J., Pajak, A., Sciacca, S., Galvano, F., Boffetta, P., Health risk factors associated with meat, fruit and vegetable consumption in cohort studies: a comprehensive meta-analysis (2017) PLoS One, 12; Grosso, G., Micek, A., Godos, J., Pajak, A., Sciacca, S., Galvano, F., Giovannucci, E.L., Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis (2017) Am J Epidemiol, 185, pp. 1304-1316; Hamer, M., Chida, Y., Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-analysis (2007) J Hypertens, 5, pp. 2361-2369; Hanhineva, K., Törrönen, R., Bondia-Pons, I., Pekkinen, J., Kolehmainen, M., Mykkänen, H., Poutanen, K., Impact of dietary polyphenols on carbohydrate metabolism (2010) Int J Mol Sci, 11, pp. 1365-1402; He, F.J., Nowson, C.A., Lucas, M., MacGregor, G.A., Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies (2007) J Hum Hypertens, 21, pp. 717-728; Hu, D., Huang, J., Wang, Y., Zhang, D., Qu, Y., Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies (2014) Stroke, 45, pp. 1613-1619; Huang, G., Wu, L., Qiu, L., Lai, J., Huang, Z., Liao, L., Association between vegetables consumption and the risk of age-related cataract: a meta-analysis (2015) Int J Clin Exp Med, 8, pp. 18455-18461; Huxley, R.R., Ansary-Moghaddam, A., Clifton, P., Czernichow, S., Parr, C.L., Woodward, M., The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence (2009) Int J Cancer, 125, pp. 171-180; (2012), Global Guideline for Type 2 Diabetes; Jin, J., Ouyang, Z., Wang, Z., Association of fruit and vegetables with the risk of nasopharyngeal cancer: evidence from a meta-analysis (2014) Sci Rep, 104, p. 5229; Johnson, I.T., Phytochemicals and cancer (2007) Proc Nutr Soc, 66, pp. 207-215; Johnson, C.M., Wei, C., Ensor, J.E., Smolenski, D.J., Amos, C.I., Levin, B., Berry, D.A., Meta-analyses of colorectal cancer risk factors (2013) Cancer Cause Control, 24, pp. 1207-1222; Kahleova, H., Levin, S., Barnard, N., Cardio-metabolic benefits of plant-based diets (2017) Nutrients, 99. , 848; Key, T.J., Schatzkin, A., Willett, W.C., Allen, N.E., Spencer, E.A., Travis, R.C., Diet, nutrition and the prevention of cancer (2004) Public Health Nutr, 7, pp. 187-200; Lang, U.E., Borgwardt, S., Molecular mechanisms of depression: perspectives on new treatment strategies (2013) Cell Physiol Biochem, 31, pp. 761-777; Law, M.R., Morris, J.K., By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? (1998) Eur J Clin Nutr, 52, pp. 549-556; Li, Y., Association between fruit and vegetable intake and risk for glioma: a meta-analysis (2014) Nutrition, 30, pp. 1272-1278; Li, M., Fan, Y., Zhang, X., Hou, W., Tang, Z., Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies (2014) BMJ Open, 54, p. e005497; Li, B., Jiang, G., Zhang, G., Xue, Q., Zhang, H., Wang, C., Zhao, T., Intake of vegetables and fruit and risk of esophageal adenocarcinoma: a meta-analysis of observational studies (2014) Eur J Nutr, 53, pp. 1511-1521; Li, B., Li, F., Wang, L., Zhang, D., Fruit and vegetables consumption and risk of hypertension: a meta-analysis (2016) J Clin Hypertens, 18, pp. 468-476; Li, F., Liu, X., Wang, W., Zhang, D., Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis (2015) Eur J Gastroenterol Hepatol, 27, pp. 623-630; Li, S., Miao, S., Huang, Y., Liu, Z., Tian, H., Yin, X., Tang, W., Fruit intake decreases risk of incident type 2 diabetes: an updated meta-analysis (2015) Endocrine, 48, pp. 454-460. , Steffen LM, Xi B; Liu, R.H., Health-promoting components of fruits and vegetables in the diet (2013) Adv Nutr, 14, pp. 384S-392S; Liu, Z.T., Lin, A.H., Dietary factors and thyroid cancer risk: a meta-analysis of observational studies (2014) Nutr Cancer, 66, pp. 1165-1178; Liu, H., Wang, X.C., Hu, G.H., Guo, Z.F., Lai, P., Xu, L., Huang, T.B., Xu, Y.F., Fruit and vegetable consumption and risk of bladder cancer: an updated meta-analysis of observational studies (2015) Eur J Cancer Prev, 24, pp. 508-516; Liu, J., Wang, J., Leng, Y., Lv, C., Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies (2013) Int J Cancer, 133, pp. 473-485; Liu, X., Yan, Y., Li, F., Zhang, D., Fruit and vegetable consumption and the risk of depression: a meta-analysis (2016) Nutrition, 32, pp. 296-302; Lunet, N., Lacerda-Vieira, A., Barros, H., Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies (2005) Nutr Cancer, 53, pp. 1-10; Lunet, N., Valbuena, C., Vieira, A.L., Lopes, C., Lopes, C., David, L., Carneiro, F., Barros, H., Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis (2007) Eur J Cancer Prev, 16, pp. 312-327; Lunn, J., Buttriss, J.L., Carbohydrates and dietary fibre (2007) Nutr Bull, 32, pp. 21-64; Luo, S., Li, Y., Luo, H., Yin, X., Lin Du, R., Zhao, K., Huang, G., Song, J., Increased intake of vegetables, but not fruits, may be associated with reduced risk of hip fracture: a meta-analysis (2016) Sci Rep, 6, p. 19783; Luo, A.J., Wang, F.Z., Luo, D., Hu, D.H., Mao, P., Xie, W.Z., He, X.F., Consumption of vegetables may reduce the risk of liver cancer: results from a meta-analysis of case-control and cohort studies (2015) Clin Res Hepatol Gastroenterol, 39, pp. 45-51. , Kan W, Wang Y; Meng, H., Hu, W., Chen, Z., Shen, Y., Fruit and vegetable intake and prostate cancer risk: a meta-analysis (2014) Asia Pac J Clin Oncol, 10, pp. 133-140; Meschia, J.F., Bushnell, C., Boden-Albala, B., Braun, L.T., Bravata, D.M., Chaturvedi, S., Creager, M.A., Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association (2014) Stroke, 45, pp. 3754-3832; Milaneschi, Y., Bandinelli, S., Penninx, B.W., Corsi, A.M., Lauretani, F., Vazzana, R., Semba, R.D., The relationship between plasma carotenoids and depressive symptoms in older persons (2012) World J Biol Psychiatry, 13, pp. 588-598. , Guralnik JM, Ferrucci L; Nagendraprabhu, P., Sudhandiran, G., Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2 (2011) Invest New Drugs, 29, pp. 207-224; Norat, T., Aune, D., Chan, D., Romaguera, D., Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention (2014) Cancer Treat Res, 159, pp. 35-50; Norat, T., Riboli, E., Fruit and vegetable consumption and risk of cancer of the digestive tract: meta-analysis of published case-control and cohort studies (2002) IARC Sci Publ, 156, pp. 123-125; Oskarsson, V., Sadr-Azodi, O., Orsini, N., Andrén-Sandberg, Å., Wolk, A., Vegetables, fruit and risk of non-gallstone-related acute pancreatitis: a population-based prospective cohort study (2013) Gut, 62, pp. 1187-1192; Palozza, P., Serini, S., Torsello, A., Di Nicuolo, F., Maggiano, N., Ranelletti, F.O., Wolf, F.I., Calviello, G., Mechanism of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells (2003) Nutr Cancer, 47, pp. 76-87; Paluszkiewicz, P., Smolińska, K., Dębińska, I., Turski, W.A., Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies (2012) Cancer Epidemiol, 36, pp. 60-67; Pan, M.H., Lai, C.S., Wu, J.C., Ho, C.T., Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds (2011) Mol Nutr Food Res, 55, pp. 32-45; Papakostas, G.I., Petersen, T., Lebowitz, B.D., Mischoulon, D., Ryan, J.L., Nierenberg, A.A., Bottiglieri, T., The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine (2005) Int J Neuropsychopharmacol, 8, pp. 523-528. , Alpert JE, Rosenbaum JF, Fava M; Park, S., Choi, J., Inhibition of beta-catenin/Tcf signaling by flavonoids (2010) J Cell Biochem, 110, pp. 1376-1385; Pavia, M., Pileggi, C., Nobile, C.G., Angelillo, I.F., Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies (2006) Am J Clin Nutr, 83, pp. 1126-1134; Payne, M.E., Steck, S.E., George, R.R., Steffens, D.C., Fruit, vegetable, and antioxidant intakes are lower in older adults with depression (2012) J Acad Nutr Diet, 112, pp. 2022-2027; Pignatelli, P., di Santo, S., Buchetti, B., Sanguigni, V., Brunelli, A., Violi, F., Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment (2006) FASEB J, 20, pp. 1082-1089; Qiu, R., Cao, W.T., Tian, H.Y., He, J., Chen, G.D., Chen, Y.M., Greater intake of fruit and vegetables is associated with greater bone mineral density and lower osteoporosis risk in middle-aged and elderly adults (2017) PLoS One, 12; Rajilic-Stojanovic, M., Jonkers, D.M., Salonen, A., Hanevik, K., Raes, J., Jalanka, J., de Vos, W.M., Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? (2015) Am J Gastroenterol, 110, pp. 278-287. , Manichanh C, Golic N, Enck P; Ramos, S., Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways (2008) Mol Nutr Food Res, 52, pp. 507-526; Rao, L.G., Mackinnon, E.S., Josse, R.G., Murray, T.M., Strauss, A., Rao, A.V., Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women (2007) Osteoporos Int, 18, pp. 109-115; Riboli, E., Norat, T., Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk (2003) Am J Clin Nutr, 78, pp. 559S-569S; Satija, A., Hu, F.B., Plant-based diets and cardiovascular health (2018) Trends Cardiovasc Med, 28, pp. 437-441; Scalbert, A., Manach, C., Morand, C., Rémésy, C., Jiménez, L., Dietary polyphenols and the prevention of diseases (2005) Critic Rev Food Sci Nutr, 45, pp. 287-306; Schwingshackl, L., Schwedhelm, C., Galbete, C., Hoffmann, G., Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis (2017) Nutrients, 69, p. 1063; Scorrano, L., Korsmeyer, S.J., Mechanisms of cytochrome c release by proapoptotic BCL-2 family members (2003) Biochem Biophys Res Commun, 304, pp. 437-444; Seyedrezazadeh, E., Moghaddam, M.P., Ansarin, K., Vafa, M.R., Sharma, S., Kolahdooz, F., Fruit and vegetable intake and risk of wheezing and asthma: a systematic review and meta-analysis (2014) Nutr Rev, 72, pp. 411-428; Siriwardena, A.K., Mason, J.M., Balachandra, S., Bagul, A., Galloway, S., Formela, L., Hardman, J.G., Jamdar, S., Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis (2007) Gut, 6, pp. 1439-1444; Slavin, J.L., Lloyd, B., Health benefits of fruits and vegetables (2012) Adv Nutr, 13, pp. 506-516; Smith-Warner, S.A., Spiegelman, D., Yaun, S.S., Adami, H.O., Beeson, W.L., van den Brandt, P.A., Folsom, A.R., Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies (2001) JAMA, 285, pp. 769-776. , Fraser GE, Freudenheim JL, Goldbohm RA; Steinmaus, C.M., Nunez, S., Smith, A.H., Diet and bladder cancer: a meta-analysis of six dietary variables (2000) Am J Epidemiol, 151, pp. 693-702; Surh, Y.J., Cancer chemoprevention with dietary phytochemicals (2003) Nat Rev Cancer, 3, pp. 768-780; Talalay, P., Fahey, J.W., Holtzclaw, W.D., Prestera, T., Zhang, Y., Chemoprotection against cancer by phase 2 enzyme induction (1995) Toxicol Lett, 82-83, pp. 173-179; Trock, B., Lanza, E., Greenwald, P., Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence (1990) J Natl Cancer Inst, 82, pp. 650-661; Trzeciakiewicz, A., Habauzit, V., Horcajada, M.N., When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols (2009) Nutr Res Rev, 22, pp. 68-81; Tucker, K.L., Osteoporosis prevention and nutrition (2009) Curr Osteoporos Rep, 7, pp. 111-117; Vanamala, J., Food systems approach to cancer prevention (2017) Crit Rev Food Sci Nutr, 57, pp. 2573-2588; Vieira, A.R., Abar, L., Vingeliene, S., Chan, D.S., Aune, D., Navarro-Rosenblatt, D., Stevens, C., Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis (2016) Ann Oncol, 27, pp. 81-96. , Greenwood D, Norat T; Vieira, A.R., Vingeliene, S., Chan, D.S., Aune, D., Abar, L., Navarro Rosenblatt, D., Greenwood, D.C., Norat, T., Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis (2015) Cancer Med, 4, pp. 136-146; Waldthaler, A., Schutte, K., Malfertheiner, P., Causes and mechanisms in acute pancreatitis (2010) Dig Dis, 28, pp. 364-372; Wang, Q., Chen, Y., Wang, X., Gong, G., Li, G., Li, C., Consumption of fruit, but not vegetables, may reduce risk of gastric cancer: results from a meta-analysis of cohort studies (2014) Eur J Cancer, 50, pp. 1498-1509; Wang, P.Y., Fang, J.C., Gao, Z.H., Zhang, C., Xie, S.Y., Higher intake of fruits, vegetables or their fiber reduces the risk of type 2 diabetes: a meta-analysis (2016) J Diabetes Invest, 7, pp. 56-69; Wang, Y., Li, F., Wang, Z., Qiu, T., Shen, Y., Wang, M., Fruit and vegetable consumption and risk of lung cancer: a dose-response meta-analysis of prospective cohort studies (2015) Lung Cancer, 88, pp. 124-130; Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., Hu, F.B., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies (2014) BMJ, 349, p. g4490; Wang, M., Qin, S., Zhang, T., Song, X., Zhang, S., The effect of fruit and vegetable intake on the development of lung cancer: a meta-analysis of 32 publications and 20,414 cases (2015) Eur J Clin Nutr, 69, pp. 1184-1192; (2018), http://dietandcancerreport.org, Diet, nutrition, physical activity and breast cancer. Diet, nutrition, physical activity and lung cancer. Available from; Weaver, C., Daly, R.M., Bischoff-Ferrari, H.A., (2016), Nutritional Influences on Bone Health. 9th International Symposium: Springer Nature; Weickert, M.O., Pfeiffer, A.F.H., Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes (2018) J. Nutr, 148, pp. 7-12; Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Jr., Collins, K.J., Dennison Himmelfarb, C., DePalma, S.M., 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2018) Hypertension, 71, pp. 1269-1324. , Gidding S, Jamerson KA, Jones DW; Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., Jenkins, D.J., Colonic health: fermentation and short chain fatty acids (2006) J Clin Gastroenterol, 40, pp. 235-243; Woodside, J.V., Young, I.S., McKinley, M.C., Fruit and vegetable intake and risk of cardiovascular disease (2013) Proc Nutr Soc, 72, pp. 399-406; Wu, L., Sun, D., He, Y., Fruit and vegetables consumption and incident hypertension: dose-response meta-analysis of prospective cohort studies (2016) J Hum Hypertens, 30, pp. 573-580; Wu, Q.J., Wu, L., Zheng, L.Q., Xu, X., Ji, C., Gong, T.T., Consumption of fruit and vegetables reduces risk of pancreatic cancer: evidence from epidemiological studies (2016) Eur J Cancer Prev, 25, pp. 196-205; Wu, Y., Zhang, D., Jiang, X., Jiang, W., Fruit and vegetable consumption and risk of type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies (2015) Nutr Metab Cardiovasc Dis, 25, pp. 140-147; Xu, C., Zeng, X.T., Liu, T.Z., Zhang, C., Yang, Z.H., Li, S., Chen, X.Y., Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies (2015) Medicine, 94, p. e759; Yang, Y., Zhang, D., Feng, N., Chen, G., Liu, J., Chen, G., Zhu, Y., Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis (2014) Gastroenterology, 147, pp. 1031-1042; Yao, B., Yan, Y., Ye, X., Fang, H., Xu, H., Liu, Y., Li, S., Zhao, Y., Intake of fruit and vegetables and risk of bladder cancer: a dose-response meta-analysis of observational studies (2014) Cancer Cause Control, 25, pp. 1645-1658; Zeng, H., Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention (2014) World J Gastrointestinal Oncol, 6, p. 41; Zhan, J., Liu, Y.J., Cai, L.B., Xu, F.R., Xie, T., He, Q.Q., Fruit and vegetable consumption and risk of cardiovascular disease: a meta-analysis of prospective cohort studies (2017) Crit Rev Food Sci Nutr, 57, pp. 1650-1663; Zhao, Z., Pu, Z., Yin, Z., Yu, P., Hao, Y., Wang, Q., Guo, M., Zhao, Q., Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis (2016) Sci Rep, 36, p. 27334},
correspondence_address1={Grosso, G.; Department of Biomedical and Biotechnological Sciences, Via Santa Sofia 97, Italy; email: giuseppe.grosso@studium.unict.it},
publisher={Taylor and Francis Ltd},
issn={09637486},
coden={IJFNE},
pubmed_id={30764679},
language={English},
abbrev_source_title={Int. J. Food Sci. Nutr.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Ehsan2019,
author={Ehsan, A. and Klaas, H.S. and Bastianen, A. and Spini, D.},
title={Social capital and health: A systematic review of systematic reviews},
journal={SSM - Population Health},
year={2019},
volume={8},
doi={10.1016/j.ssmph.2019.100425},
art_number={100425},
note={cited By 114},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067202618&doi=10.1016%2fj.ssmph.2019.100425&partnerID=40&md5=44e031735e95a8fbd5cfb004ba36dd3e},
affiliation={Life Course and Inequality Research Centre, Institute for Social Sciences, University of Lausanne. Quartier UNIL-Mouline, Batiment Géopolis, Lausanne, CH-1015, Switzerland; Swiss National Centre of Competence in Research LIVES, University of Lausanne. Quartier UNIL-Mouline, Batiment Géopolis, Lausanne, CH-1015, Switzerland},
abstract={There are many systematic reviews on social capital (SC) and various health outcomes, but each of these reviews shows one piece of the larger SC and health puzzle. The aim of this research was to systematically review systematic reviews on SC and health, in order to provide an overview of existing evidence and to identify strategies for future research. Nine databases were searched for key words that could fall under the broad umbrella of SC and health outcomes. We screened 4941 titles and abstracts and read 187 reviews before retaining 20 of them. A critical appraisal of each review was conducted. The reviews show there is good evidence to suggest that SC predicts better mental and physical health, and indicators of SC are protective against mortality. At the same time, many reviews also found numerous non-significant and negative relationships that are important to consider. It was unclear whether SC interventions for health were really improving SC, or other aspects of the social environment. Overall, this research shows that evidence on how various aspects of SC affect different health outcomes for different actors remains unclear. Intergroup and lifecourse perspectives could help clarify this link. Future research could benefit from conceptualizing the link between SC and health in a what, who, where, when, why and how framework. © 2019 The Authors},
author_keywords={Health;  Lifecourse;  Social capital;  Social cohesion;  Social identity;  Social networks;  Systematic review},
keywords={article;  health;  human;  human experiment;  mortality;  social capital;  social network;  social status;  systematic review},
funding_details={Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF},
funding_details={Université de LausanneUniversité de Lausanne, UNIL},
funding_details={National Centre of Competence in Research RoboticsNational Centre of Competence in Research Robotics},
funding_text 1={This publication benefited from the support of the Swiss National Centre of Competence in Research LIVES —Overcoming vulnerability: Life course perspectives (NCCR LIVES) , financed by the Swiss National Science Foundation . We thank Dr. Felicity Turner-Zwinkels for her guidance and Dr. Nicolas Sommet for his comments on the manuscript. We would also like to thank the two anonymous reviewers for their helpful comments.},
funding_text 2={This publication benefited from the support of the Swiss National Centre of Competence in Research LIVES—Overcoming vulnerability: Life course perspectives (NCCR LIVES), financed by the Swiss National Science Foundation. We thank Dr. Felicity Turner-Zwinkels for her guidance and Dr. Nicolas Sommet for his comments on the manuscript. We would also like to thank the two anonymous reviewers for their helpful comments.The authors are funded by the Institute of Social Sciences at the University of Lausanne and the Swiss National Centre of Competence in Research LIVES—Overcoming vulnerability: Life course perspectives (NCCR LIVES), which is financed by the Swiss National Science Foundation.},
funding_text 3={The authors are funded by the Institute of Social Sciences at the University of Lausanne and the Swiss National Centre of Competence in Research LIVES —Overcoming vulnerability: Life course perspectives (NCCR LIVES), which is financed by the Swiss National Science Foundation .},
references={Agampodi, T.C., Agampodi, S.B., Glozier, N., Siribaddana, S., Measurement of social capital in relation to health in low and middle income countries (LMIC): A systematic review (2015) Social Science & Medicine, 128, pp. 95-104; Almedom, A.M., Social capital and mental health: An interdisciplinary review of primary evidence (2005) Social Science & Medicine, 61 (5), pp. 943-964; Alvarez, E.C., Kawachi, I., Romani, J.R., Family social capital and health–a systematic review and redirection (2017) Sociology of Health & Illness, 39 (1), pp. 5-29; American Psychiatric Association, Diagnostic and statistical manual of mental disorders (DSM-5®) (2013), American Psychiatric Pub; Best, S.J., Krueger, B.S., Online interactions and social capital: Distinguishing between new and existing ties (2006) Social Science Computer Review, 24 (4), pp. 395-410; Blane, D., Social determinants of health&socioeconomic status, social class, and ethnicity (1995) American Journal of Public Health, 85 (7), pp. 903-905; Bourdieu, P., The forms of capital. Handbook of theory and research for the sociology of education (1986) JG Richardson. New York, Greenwood, 241 (258), p. 19; Cameron, J.E., A three-factor model of social identity (2004) Self and Identity, 3 (3), pp. 239-262; Carlson, E.D., Chamberlain, R.M., Social capital, health, and health disparities (2003) Journal of Nursing Scholarship, 35 (4), pp. 325-331; Carpiano, R.M., Toward a neighborhood resource-based theory of social capital for health: Can Bourdieu and sociology help? (2006) Social Science & Medicine, 62 (1), pp. 165-175; Carpiano, R.M., Hystad, P.W., “Sense of community belonging” in health surveys: What social capital is it measuring? (2011) Health & Place, 17 (2), pp. 606-617; Choi, M., Mesa-Frias, M., Nüesch, E., Hargreaves, J., Prieto-Merino, D., Bowling, A., Social capital, mortality, cardiovascular events and cancer: A systematic review of prospective studies (2014) International Journal of Epidemiology, 43 (6), pp. 1895-1920; Coleman, J., Social capital (1990) Foundations of social theory. Coleman, James (comp), , The Belknap Press of Harvard University Press. Links Cambridge, Massachusetts; Coll-Planas, L., Nyqvist, F., Puig, T., Urrutia, G., Sola, I., Monteserin, R., Social capital interventions targeting older people and their impact on health: A systematic review (2017) Journal of Epidemiology & Community Health, 71 (7), pp. 663-672; Cruwys, T., Dingle, G.A., Haslam, C., Haslam, S.A., Jetten, J., Morton, T.A., Social group memberships protect against future depression, alleviate depression symptoms and prevent depression relapse (2013) Social Science & Medicine, 98, pp. 179-186; Cullati, S., Kliegel, M., Widmer, E., Development of reserves over the life course and onset of vulnerability in later life (2018) Nature Human Behaviour, 1; De Silva, M.J., McKenzie, K., Harpham, T., Huttly, S.R.A., Social capital and mental illness: A systematic review (2005) Journal of Epidemiology & Community Health, 59 (8), pp. 619-627; Deaux, K., Social identification (1996) Social psychology: Handbook of basic principles, pp. 777-798. , E.T. Higgins A.W. Kruglanski Guilford Press New York, NY, US; Dodge, R., Daly, A.P., Huyton, J., Sanders, L.D., The challenge of defining wellbeing (2012) International Journal of Wellbeing, 2 (3), pp. 222-235; Drukker, M., Kaplan, C., Feron, F., Van Os, J., Children's health-related quality of life, neighborhood socio-economic deprivation and social capital. A contextual analysis (2003) Social Science & Medicine, 57 (5), pp. 825-841; Ehsan, A.M., De Silva, M.J., Social capital and common mental disorder: A systematic review (2015) Journal of Epidemiology & Community Health, 69 (10), pp. 1021-1028; Elo, S., Kyngäs, H., The qualitative content analysis process (2008) Journal of Advanced Nursing, 62 (1), pp. 107-115; Firouzbakht, M., Tirgar, A., Workplace social capital and employee health: A systematic review study (2017) Journal of Ergonomics, 5 (1), pp. 18-25; Flores, E.C., Fuhr, D.C., Bayer, A.M., Lescano, A.G., Thorogood, N., Simms, V., Mental health impact of social capital interventions: A systematic review (2018) Social Psychiatry and Psychiatric Epidemiology, 53 (2), pp. 107-119; Fong, P., Cruwys, T., Haslam, C., Haslam, S.A., Neighbourhood identification and mental health: How social identification moderates the relationship between socioeconomic disadvantage and health (2019) Journal of Environmental Psychology, 61 (2019), pp. 101-114; French, D.P., Cameron, E., Benton, J.S., Deaton, C., Harvie, M., Can communicating personalised disease risk promote healthy behaviour change? A systematic review of systematic reviews (2017) Annals of Behavioral Medicine, 51 (5), pp. 718-729; Gallagher, H.C., Block, K., Gibbs, L., Forbes, D., Lusher, D., Molyneaux, R., The effect of group involvement on post-disaster mental health: A longitudinal multilevel analysis (2018) Social Science & Medicine, 220 (2018), pp. 161-175; Gilbert, K.L., Quinn, S.C., Goodman, R.M., Butler, J., Wallace, J., A meta-analysis of social capital and health: A case for needed research (2013) Journal of Health Psychology, 18 (11), pp. 1385-1399; Harpham, T., The measurement of community social capital through surveys (2008) Social capital and health, pp. 51-62. , Springer New York, NY; Haslam, C., Holme, A., Haslam, S.A., Iyer, A., Jetten, J., Williams, W.H., Maintaining group memberships: Social identity continuity predicts well-being after stroke (2008) Neuropsychological Rehabilitation, 18 (5-6), pp. 671-691; Heinrich, L.M., Gullone, E., The clinical significance of loneliness: A literature review (2006) Clinical Psychology Review, 26 (6), pp. 695-718; Holt-Lunstad, J., Smith, T.B., Layton, J.B., Social relationships and mortality risk: A meta-analytic review (2010) PLoS Medicine, 7 (7); Hu, F., Hu, B., Chen, R., Ma, Y., Niu, L., Qin, X., A systematic review of social capital and chronic non-communicable diseases (2014) Bioscience trends, 8 (6), pp. 290-296; Islam, M.K., Merlo, J., Kawachi, I., Lindström, M., Gerdtham, U.-G., Social capital and health: Does egalitarianism matter? A literature review (2006) International Journal for Equity in Health, 5 (1), p. 3; Iyer, A., Jetten, J., Tsivrikos, D., Postmes, T., Haslam, S.A., The more (and the more compatible) the merrier: Multiple group memberships and identity compatibility as predictors of adjustment after life transitions (2009) British Journal of Social Psychology, 48 (4), pp. 707-733; Jetten, J., Haslam, S.A., Cruwys, T., Greenaway, K.H., Haslam, C., Steffens, N.K., Advancing the social identity approach to health and well-being: Progressing the social cure research agenda (2017) European Journal of Social Psychology, 47 (7), pp. 789-802; Jones, J.M., Jetten, J., Recovering from strain and enduring pain: Multiple group memberships promote resilience in the face of physical challenges (2011) Social Psychological and Personality Science, 2 (3), pp. 239-244; Kawachi, I., Berkman, L.F., Social capital, social cohesion, and health (2014) Social epidemiology, 2, pp. 290-319; Kawachi, I., Kennedy, B.P., Lochner, K., Prothrow-Stith, D., Social capital, income inequality, and mortality (1997) American journal of public health, 87 (9), pp. 1491-1498; Khazaeian, S., Kariman, N., Ebadi, A., Nasiri, M., The impact of social capital and social support on the health of female-headed households: A systematic review (2017) Electronic Physician, 9 (12), pp. 6027-6034; Kripper, C.E., Sapag, J.C., Social capital and health in Latin America and the caribbean: A systematic review (2009) Revista panamericana de salud publica= Pan American journal of public health, 25 (2), pp. 162-170; Langlois, E.V., Tunçalp, Ö., Norris, S.L., Askew, I., Ghaffar, A., Qualitative evidence to improve guidelines and health decision-making (2018) Bulletin of the World Health Organization, 96 (2), p. 79; Lin, N., (2002) Social capital: A theory of social structure and action, 19. , Cambridge university press; Lin, N., Building a network theory of social capital (2017) Social capital, pp. 3-28. , Routledge; Macinko, J., Starfield, B., The utility of social capital in research on health determinants (2001) The Milbank Quarterly, 79 (3), pp. 387-427; McKenzie, K., Harpham, T., Social capital and mental health (2006), Jessica Kingsley Publishers; McPherson, K., Kerr, S., Cheater, F., Morgan, A., The role and impact of social capital on the health and wellbeing of children and adolescents: A systematic review (2013) Glasgow Centre for population health, , Glasgow Caledonian University Glasgow; McPherson, K., Kerr, S., McGee, E., Morgan, A., Cheater, F.M., McLean, J., The association between social capital and mental health and behavioural problems in children and adolescents: An integrative systematic review (2014) BMC Psychology, 2 (1), p. 7; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2009) PLoS Medicine, 6 (7); Moore, S., Kawachi, I., Twenty years of social capital and health research: A glossary (2017) Journal of Epidemiology & Community Health, 71 (5), pp. 513-517; Murayama, H., Fujiwara, Y., Kawachi, I., Social capital and health: A review of prospective multilevel studies (2012) Journal of Epidemiology, 22 (3), pp. 179-187; Nahapiet, J., Ghoshal, S., Social capital, intellectual capital, and the organizational advantage (1998) Academy of Management Review, 23 (2), pp. 242-266; Naseri, S., Online social network sites and SC: A case of facebook (2017) International Journal of Applied Sociology, 7 (1); Nieminen, T., Prättälä, R., Martelin, T., Härkänen, T., Hyyppä, M.T., Alanen, E., Social capital, health behaviours and health: A population-based associational study (2013) BMC Public Health, 13 (1), p. 613; Nyqvist, F., Forsman, A.K., Giuntoli, G., Cattan, M., Social capital as a resource for mental well-being in older people: A systematic review (2013) Aging & Mental Health, 17 (4), pp. 394-410; Nyqvist, F., Pape, B., Pellfolk, T., Forsman, A.K., Wahlbeck, K., Structural and cognitive aspects of social capital and all-cause mortality: A meta-analysis of cohort studies (2014) Social Indicators Research, 116 (2), pp. 545-566; Obst, P., White, K., Three-dimensional strength of identification across group memberships: A confirmatory factor analysis (2005) Self and Identity, 4 (1), pp. 69-80; Poortinga, W., Do health behaviors mediate the association between social capital and health? (2006) Preventive Medicine, 43 (6), pp. 488-493; Porta, M., Greenland, S., Hernán, M., Dos Santos Silva, I., Last, J.M., A dictionary of epidemiology (2015), 6th ed. Oxford University Press New York; Portes, A., Social capital: Its origins and applications in modern sociology (1998) Annual Review of Sociology, 24 (1), pp. 1-24; Putnam, R.D., Bowling alone: America's declining social capital (2000) Culture and politics, pp. 223-234. , Palgrave Macmillan; Putnam, R.D., Leonardi, R., Nanetti, R.Y., Making democracy work: Civic traditions in modern Italy (1994), Princeton university press; Ransome, Y., Thurber, K.A., Swen, M., Crawford, N.D., German, D., Dean, L.T., Social capital and HIV/AIDS in the United States: Knowledge, gaps, & future directions (2018) SSM-Population Health, 5, pp. 73-85; Rosenheck, R., Morrissey, J., Lam, J., Calloway, M., Stolar, M., Johnsen, M., Service delivery and community: SC, service systems integration, and outcomes among homeless persons with severe mental illness (2001) Health Services Research, 36 (4), p. 691; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Medical Research Methodology, 7 (1), p. 10; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) Journal of Clinical Epidemiology, 62 (10), pp. 1013-1020; Shiell, A., Hawe, P., Kavanagh, S., Evidence suggests a need to rethink social capital and social capital interventions (2018) Social Science & Medicine; Smith, V., Devane, D., Begley, C.M., Clarke, M., Methodology in conducting a systematic review of systematic reviews of healthcare interventions (2011) BMC Medical Research Methodology, 11 (1), p. 15; Spini, D., Bernardi, L., Oris, M., Toward a life course framework for studying vulnerability (2017) Research in Human Development, 14 (1), pp. 5-25; Spini, D., Jopp, D.S., Pin, S., Stringhini, S., The multiplicity of aging: Lessons for theory and conceptual development from longitudinal studies. Handbook of theories of aging (2016), pp. 669-690; Steptoe, A., Feldman, P.J., Neighborhood problems as sources of chronic stress: Development of a measure of neighborhood problems, and associations with socioeconomic status and health (2001) Annals of Behavioral Medicine, 23 (3), pp. 177-185; Uphoff, E.P., Pickett, K.E., Cabieses, B., Small, N., Wright, J., A systematic review of the relationships between social capital and socioeconomic inequalities in health: A contribution to understanding the psychosocial pathway of health inequalities (2013) International Journal for Equity in Health, 12, p. 54; Villalonga-Olives, E., Kawachi, I., The measurement of social capital (2015) Gaceta Sanitaria, 29 (1), pp. 62-64; Villalonga-Olives, E., Kawachi, I., The dark side of social capital: A systematic review of the negative health effects of social capital (2017) Social Science & Medicine, 194, pp. 105-127; Villalonga-Olives, E., Wind, T.R., Kawachi, I., Social capital interventions in public health: A systematic review (2018) Social Science & Medicine, 212, pp. 203-218; Widmer, E.D., Social capital in wide family contexts: An empirical assessment using social network methods (2007) International Review of Sociology—Revue Internationale de Sociologie, 17 (2), pp. 225-238; Wilkinson, R.G., Pickett, K.E., The problems of relative deprivation: Why some societies do better than others (2007) Social Science & Medicine, 65 (9), pp. 1965-1978},
correspondence_address1={Ehsan, A.; Quartier UNIL-Mouline, Switzerland; email: annahita.ehsan@unil.ch},
publisher={Elsevier Ltd},
issn={23528273},
language={English},
abbrev_source_title={SSM Popul. Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Patel20151046,
author={Patel, C.J. and Burford, B. and Ioannidis, J.P.A.},
title={Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations},
journal={Journal of Clinical Epidemiology},
year={2015},
volume={68},
number={9},
pages={1046-1058},
doi={10.1016/j.jclinepi.2015.05.029},
note={cited By 114},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939433385&doi=10.1016%2fj.jclinepi.2015.05.029&partnerID=40&md5=b69e6703f4f406033317904d01f84c28},
affiliation={Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck St., Boston, MA  02115, United States; Melbourne School of Population and Global Health, University of Melbourne, Level 4, 207 Bouverie St.VIC  3010, Australia; Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, 1265 Welch Rd, Stanford, CA  94305, United States; Department of Statistics, Stanford University, School of Humanities and Sciences, Stanford, CA  94305, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA  94305, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA  94305, United States},
abstract={Objectives Model specification - what adjusting variables are analytically modeled - may influence results of observational associations. We present a standardized approach to quantify the variability of results obtained with choices of adjustments called the "vibration of effects" (VoE). Study Design and Setting We estimated the VoE for 417 clinical, environmental, and physiological variables in association with all-cause mortality using National Health and Nutrition Examination Survey data. We selected 13 variables as adjustment covariates and computed 8,192 Cox models for each of 417 variables' associations with all-cause mortality. Results We present the VoE by assessing the variance of the effect size and in the -log10(P-value) obtained by different combinations of adjustments. We present whether there are multimodality patterns in effect sizes and P-values and the trajectory of results with increasing adjustments. For 31% of the 417 variables, we observed a Janus effect, with the effect being in opposite direction in the 99th versus the 1st percentile of analyses. For example, the vitamin E variant α-tocopherol had a VoE that indicated higher and lower risk for mortality. Conclusion Estimating VoE offers empirical estimates of associations are under different model specifications. When VoE is large, claims for observational associations should be very cautious. © 2015 Elsevier Inc.},
author_keywords={Biostatistics;  Confounding;  Environment-wide association study;  Model specification;  Observational association;  Vibration of effects},
keywords={alpha tocopherol;  vitamin D;  alpha tocopherol, Article;  association constant;  effect size;  health survey;  human;  model;  mortality;  nutrient;  observational study;  priority journal;  statistical significance;  variance;  vitamin blood level;  environmental exposure;  epidemiology;  nutrition;  observational study;  phenotype;  risk assessment;  statistical model;  statistics and numerical data;  trends;  United States, Confounding Factors (Epidemiology);  Environmental Exposure;  Epidemiologic Methods;  Humans;  Models, Statistical;  Mortality;  Nutrition Surveys;  Observational Studies as Topic;  Phenotype;  Risk Assessment;  United States;  Vitamin E},
chemicals_cas={alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; Vitamin E},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99ES023504, R21 ES0250252, R21ES025052},
funding_details={Pharmaceutical Research and Manufacturers of America FoundationPharmaceutical Research and Manufacturers of America Foundation},
funding_text 1={Funding : This work was supported by a National Institute of Environmental Health Sciences grant K99 ES023504 and R21 ES0250252 and a PhRMA foundation award to C.J.P.},
references={Smith, G.D., Lawlor, D.A., Harbord, R., Timpson, N., Day, I., Ebrahim, S., Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology (2007) PLos Med, 4, p. e352; Ioannidis, J.P.A., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Sala-I-Martin, X., I just ran two million regressions (1997) Am Econ Rev, 87, pp. 178-183; Leamer, E., Sensitivity analyses would help (1985) Am Econ Rev, 57, pp. 308-313; Leamer, E., Leonard, H., Reporting the fragility of regression estimates (1983) Rev Econ Stat, 65, pp. 306-317; Akil, H., Martone, M.E., Van Essen, D.C., Challenges and opportunities in mining neuroscience data (2011) Science, 331, pp. 708-712; Boffetta, P., McLaughlin, J.K., La Vecchia, C., Tarone, R.E., Lipworth, L., Blot, W.J., False-positive results in cancer epidemiology: A plea for epistemological modesty (2008) J Natl Cancer Inst, 100, pp. 988-995; Fiedler, K., Voodoo correlations are everywhere - Not only in neuroscience (2011) Perspect Psychol Sci, 6, pp. 163-171; Young, S.S., Karr, A., Deming, data and observational studies (2011) Significance, 8, pp. 116-120; Pearl, J., (2009) Causality: Models, Reasoning and Inference, , Cambridge University Press Cambridge; Young, S.S., Yu, M., Association of bisphenol A with diabetes and other abnormalities (2009) J Am Med Assoc, 301, pp. 720-721. , author reply 1-2; Gaziano, J.M., Vitamin e and cardiovascular disease: Observational studies (2004) Ann N y Acad Sci, 1031, pp. 280-291; Sung, L., Greenberg, M.L., Koren, G., Tomlinson, G.A., Tong, A., Malkin, D., Vitamin E: The evidence for multiple roles in cancer (2003) Nutr Cancer, 46, pp. 1-14; Song, Y., Cook, N.R., Albert, C.M., Van Denburgh, M., Manson, J.E., Effects of vitamins C and e and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: A randomized controlled trial (2009) Am J Clin Nutr, 90, pp. 429-437; MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial (2002) Lancet, 360, pp. 23-33; Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., Sleight, P., Vitamin e supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators (2000) N Engl J Med, 342, pp. 154-160; Virtamo, J., Pietinen, P., Huttunen, J.K., Korhonen, P., Malila, N., Virtanen, M.J., Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up (2003) JAMA, 290, pp. 476-485; Vivekananthan, D.P., Penn, M.S., Sapp, S.K., Hsu, A., Topol, E.J., Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials (2003) Lancet, 361, pp. 2017-2023; Miller, E.R., III, Pastor-Barriuso, R., Dalal, D., Riemersma, R.A., Appel, L.J., Guallar, E., Meta-analysis: High-dosage vitamin e supplementation may increase all-cause mortality (2005) Ann Intern Med, 142, pp. 37-46; Wright, M.E., Lawson, K.A., Weinstein, S.J., Pietinen, P., Taylor, P.R., Virtamo, J., Higher baseline serum concentrations of vitamin e are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (2006) Am J Clin Nutr, 84, pp. 1200-1207; Fillenbaum, G.G., Burchett, B.M., Blazer, D.G., Identifying a national death index match (2009) Am J Epidemiol, 170, pp. 515-518; Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., Compendium of physical activities: An update of activity codes and MET intensities (2000) Med Sci Sports Exerc, 32, pp. S498-S504; Patel, C.J., Cullen, M.R., Ioannidis, J.P., Butte, A.J., Systematic evaluation of environmental factors: Persistent pollutants and nutrients correlated with serum lipid levels (2012) Int J Epidemiol, 41, pp. 828-843; (2008) 2008 Physical Activity Guidelines for Americans, , US Department of Health and Human Services Washington DC; Blanton, C.A., Moshfegh, A.J., Baer, D.J., Kretsch, M.J., The USDA Automated Multiple-Pass Method accurately estimates group total energy and nutrient intake (2006) J Nutr, 136, pp. 2594-2599; (2003) What We Eat in America, NHANES 2003-2004, , U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, et al; (2001) What We Eat in America, NHANES 2001-2002., , U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Group FSR, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, et al; (1999) What We Eat in America, NHANES 1999-2000, , U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, et al; Samitz, G., Egger, M., Zwahlen, M., Domains of physical activity and all-cause mortality: Systematic review and dose-response meta-analysis of cohort studies (2011) Int J Epidemiol, 40, pp. 1382-1400; Arrieta, A., Russell, L.B., Effects of leisure and non-leisure physical activity on mortality in U.S. Adults over two decades (2008) Ann Epidemiol, 18, pp. 889-895; Tellez-Plaza, M., Navas-Acien, A., Menke, A., Crainiceanu, C.M., Pastor-Barriuso, R., Guallar, E., Cadmium exposure and all-cause and cardiovascular mortality in the U.S. General population (2012) Environ Health Perspect, 120, pp. 1017-1022; Flegal, K.M., Graubard, B.I., Williamson, D.F., Gail, M.H., Cause-specific excess deaths associated with underweight, overweight, and obesity (2007) J Am Med Assoc, 298, pp. 2028-2037; Ford, E.S., Zhao, G., Tsai, J., Li, C., Vitamin D and all-cause mortality among adults in USA: Findings from the National Health and Nutrition Examination Survey Linked Mortality Study (2011) Int J Epidemiol, 40, pp. 998-1005; Patel, C.J., Rehkopf, D.H., Leppert, J.T., Bortz, W.M., Cullen, M.R., Chertow, G., Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey (2013) Int J Epidemiol, 42, pp. 1795-1810; Patel, C.J., Bhattacharya, J., Butte, A.J., An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus (2010) PLoS One, 5, p. e10746; Therneau, T., Grambsch, P., (2010) Modeling Survival Data: Extending the Cox Model, , Springer New York; Lumley, T., (2010) Complex Surveys: A Guide to Analysis Using R. Hoboken, , Wiley New Jersey; Patsopoulos, N.A., Tatsioni, A., Ioannidis, J.P., Claims of sex differences: An empirical assessment in genetic associations (2007) JAMA, 298, pp. 880-893; Gotzsche, P.C., Believability of relative risks and odds ratios in abstracts: Cross sectional study (2006) BMJ, 333, pp. 231-234; Von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies (2007) Lancet, 370, pp. 1453-1457; Ioannidis, J.P.A., Why most published research findings are false (2005) PLos Med, 2, p. e124; Altham, P., Improving the precision of estimation by fitting a model (1984) J R Stat Soc Series B Stat Methodol, 46, pp. 118-119; Babyak, M.A., What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models (2004) Psychosom Med, 66, pp. 411-421; Altman, D.G., Andersen, P.K., Bootstrap investigation of the stability of a Cox regression model (1989) Stat Med, 8, pp. 771-783; Copas, J.B., Regression, prediction and shrinkage (1983) J R Stat Soc Series B Stat Methodol, 45, pp. 311-354; Hoeting, J., Madigan, D., Raftery, A.E., Chris, T., Bayesian model averaging: A tutorial (1999) Stat Sci, 14, pp. 382-417; Claeskins, G., Hjort, N., (2008) Model Selection and Model Averaging, , Cambridge University Press Cambridge; Grömping, U., Estimators of relative importance in linear regression based on variance decomposition (2007) Am Stat, 61, pp. 139-147; Clyde, M., Model uncertainty and health effect studies for particulate matter (2000) Environmetrics, 11, pp. 745-763; Berry, D., Multiplicities in cancer research: Ubiquitous and necessary evils (2012) J Natl Cancer Inst, 104, pp. 1124-1132; Berry, D., The difficult and ubiquitous problems of multiplicities (2007) Pharm Stat, 6, pp. 155-160; Dwan, K., Altman, D.G., Arnaiz, J.A., Bloom, J., Chan, A.W., Cronin, E., Systematic review of the empirical evidence of study publication bias and outcome reporting bias (2008) PLoS One, 3, p. e3081; Chan, A.W., Altman, D.G., Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors (2005) BMJ, 330, p. 753; Furnival, G.M., Wilson, Jr.R.W., Regressions by leaps and bounds (1974) Technometrics, 16, pp. 499-511; Ryan, P.B., Madigan, D., Stang, P.E., Overhage, J.M., Racoosin, J.A., Hartzema, A.G., Empirical assessment of methods for risk identification in healthcare data: Results from the experiments of the Observational Medical Outcomes Partnership (2012) Stat Med, 31, pp. 4401-4415; Madigan, D., Ryan, P.B., Schuemie, M., Stang, P.E., Overhage, J.M., Hartzema, A.G., Evaluating the impact of database heterogeneity on observational study results (2013) Am J Epidemiol, 178, pp. 645-651; Pittas, A.G., Chung, M., Trikalinos, T., Mitri, J., Brendel, M., Patel, K., Systematic review: Vitamin D and cardiometabolic outcomes (2010) Ann Intern Med, 152, pp. 307-314; Glaeser, E.L., (2006) Researcher Incentives and Empirical Methods},
correspondence_address1={Ioannidis, J.P.A.; Department of Biomedical Informatics, 10 Shattuck St., United States; email: jioannid@stanford.edu},
publisher={Elsevier Inc.},
issn={08954356},
coden={JCEPE},
pubmed_id={26279400},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Becker2011,
author={Becker, L.A. and Oxman, A.D.},
title={Chapter 22: Overviews of reviews},
journal={Cochrane Handbook for Systematic Reviews of Interventions},
year={2011},
note={cited By 114},
source={Scopus},
}

@ARTICLE{Engelender20174,
author={Engelender, S. and Isacson, O.},
title={The Threshold Theory for Parkinson's Disease},
journal={Trends in Neurosciences},
year={2017},
volume={40},
number={1},
pages={4-14},
doi={10.1016/j.tins.2016.10.008},
note={cited By 113},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007341714&doi=10.1016%2fj.tins.2016.10.008&partnerID=40&md5=3237bebbdabc231720fd322401aa7fca},
affiliation={Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, 31096, Israel; Neuroregeneration Research Institute, McLean Hospital, Belmont, MA  02478, United States; Harvard Medical School, Boston, MA  02115, United States},
abstract={Parkinson's disease (PD) is recognized by the accumulation of α-synuclein within neurons. In contrast to the current ascending theory where α-synuclein would propagate from neuron to neuron, we now propose the threshold theory for PD based on evidence of parallel degeneration of both central nervous system (CNS) and peripheral nervous system (PNS) in PD. The functional threshold is lower for the emergence of early symptoms before the classical motor symptoms of PD. This is due to the larger functional reserve of the midbrain dopamine and integrated basal ganglia motor systems to control movement. This threshold theory better accounts for the current neurobiology of PD symptom progression compared to the hypothesis that the disease ascends from the PNS to the CNS as proposed by Braak's hypothesis. © 2016 Elsevier Ltd},
author_keywords={dopaminergic neurons;  functional threshold;  Parkinson's disease;  spreading theory;  α-synuclein},
keywords={alpha synuclein, brain;  brain graft;  human;  Lewy body;  mesencephalon;  nerve cell;  neurologic disease;  neuropathology;  nonhuman;  Parkinson disease;  priority journal;  protein aggregation;  Review;  symptom;  synapse;  theory;  threshold theory;  animal;  biological model;  dopaminergic nerve cell;  Parkinson disease;  pathophysiology;  physiology, Animals;  Brain;  Dopaminergic Neurons;  Humans;  Models, Neurological;  Parkinson Disease},
chemicals_cas={alpha synuclein, 154040-18-3},
references={Kalia, L.V., Lang, A.E., Parkinson's disease (2015) Lancet, 386, pp. 896-912; Brownell, A.L., Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease (1998) Nat. Med., 4, pp. 1308-1312; Wullner, U., Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT (1994) Exp. Neurol., 126, pp. 305-309; Marras, C., Chaudhuri, K.R., Nonmotor features of Parkinson's disease subtypes (2016) Mov. Disord., 31, pp. 1095-1102; Maetzler, W., Progression of Parkinson's disease in the clinical phase: potential markers (2009) Lancet Neurol., 8, pp. 1158-1171; Singleton, A., Hardy, J., The evolution of genetics: Alzheimer and Parkinson's diseases (2016) Neuron, 90, pp. 1154-1163; Spillantini, M.G., α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies (1998) Proc. Natl. Acad. Sci. U.S.A., 95, pp. 6469-6473; Kalia, L.V., α-Synuclein oligomers and clinical implications for Parkinson disease (2013) Ann. Neurol., 73, pp. 155-169; Bendor, J.T., The function of α-synuclein (2013) Neuron, 79, pp. 1044-1066; Hunn, B.H., Impaired intracellular trafficking defines early Parkinson's disease (2015) Trends Neurosci., 38, pp. 178-188; Davidson, W.S., Stabilization of α-synuclein secondary structure upon binding to synthetic membranes (1998) J. Biol. Chem., 273, pp. 9443-9449; Beilina, A., Cookson, M.R., Genes associated with Parkinson's disease: regulation of autophagy and beyond (2015) J. Neurochem., 139, pp. 91-107; Martin, I., Recent advances in the genetics of Parkinson's disease (2011) Annu. Rev. Genomics Human Genet., 12, pp. 301-325; Chu, Y., Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease (2012) Brain, 135, pp. 2058-2073; Chung, C.Y., Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α-synucleinopathy (2009) J. Neurosci., 29, pp. 3365-3373; Luk, K.C., Lee, V.M., Modeling Lewy pathology propagation in Parkinson's disease (2014) Parkinsonism. Relat. Disord., 20, pp. S85-S87; Watts, J.C., Prusiner, S.B., Mouse models for studying the formation and propagation of prions (2014) J. Biol. Chem., 289, pp. 19841-19849; Braak, H., Staging of brain pathology related to sporadic Parkinson's disease (2003) Neurobiol. Aging, 24, pp. 197-211; Visanji, N.P., The prion hypothesis in Parkinson's disease: Braak to the future (2013) Acta Neuropathol. Commun., 1, p. 2; Sung, J.Y., Proteolytic cleavage of extracellular secreted α−synuclein via matrix metalloproteinases (2005) J. Biol. Chem., 280, pp. 25216-25224; Li, J.Y., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation (2008) Nat. Med., 14, pp. 501-503; Li, W., Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain (2016) Proc. Natl. Acad. Sci. U.S.A., 113, pp. 6544-6549; Kordower, J.H., Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease (2008) Nat. Med., 14, pp. 504-506; Hallett, P.J., Long-term health of dopaminergic neuron transplants in Parkinson's disease patients (2014) Cell Rep., 7, pp. 1755-1761; Mendez, I., Dopamine neurons implanted into people with Parkinson disease survive without pathology for 14 years (2008) Nat. Med., 14, pp. 507-509; Walsh, D.M., Selkoe, D.J., A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration (2016) Nat. Rev. Neurosci., 17, pp. 251-260; Kalaitzakis, M.E., The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α-synuclein staging (2008) Neuropathol. Appl. Neurobiol., 34, pp. 284-295; Jellinger, K.A., A critical reappraisal of current staging of Lewy-related pathology in human brain (2008) Acta Neuropathol., 116, pp. 1-16; Beach, T.G., Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (2010) Acta Neuropathol., 119, pp. 689-702; Annerino, D.M., Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss (2012) Acta Neuropathol., 124, pp. 665-680; Sung, H.Y., The frequency and severity of gastrointestinal symptoms in patients with early Parkinson's disease (2014) J. Mov. Disord., 7, pp. 7-12; Wakabayashi, K., Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses (1988) Acta Neuropathol., 76, pp. 217-221; Wakabayashi, K., Restricted occurrence of Lewy bodies in the dorsal vagal nucleus in a patient with late-onset parkinsonism (1999) J. Neurol. Sci., 165, pp. 188-191; Brooks, D.J., Examining Braak's hypothesis by imaging Parkinson's disease (2010) Mov. Disord., 25, pp. S83-S88; Chung, C.Y., Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 22474-22479; Chung, C.Y., Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection (2005) Hum. Mol. Genet., 14, pp. 1709-1725; Deleidi, M., The toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration (2010) J. Neurosci., 30, pp. 16091-16101; Floor, E., Wetzel, M.G., Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay (1998) J. Neurochem., 70, pp. 268-275; Guzman, J.N., Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 (2010) Nature, 468, pp. 696-700; Kraytsberg, Y., Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons (2006) Nat. Genet., 38, pp. 518-520; Liang, C.L., Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons (2004) J. Comp. Neurol., 473, pp. 97-106; Surmeier, D.J., The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease (2011) Neuroscience, 198, pp. 221-231; Cersosimo, M.G., Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms (2013) J. Neurol., 260, pp. 1332-1338; Edwards, L.L., Gastrointestinal symptoms in Parkinson's disease (1991) Mov. Disord., 6, pp. 151-156; Rao, M., Gershon, M.D., The bowel and beyond: the enteric nervous system in neurological disorders (2016) Nat. Rev. Gastroenterol. Hepatol., 13, pp. 517-528; Gross, M., Orthostatic hypotension in Parkinson's disease (1972) Lancet, 1, pp. 174-176; Hallett, P.J., α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits (2012) Neurobiol. Dis., 47, pp. 258-267; Kuo, Y.M., Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes (2010) Hum. Mol. Genet., 19, pp. 1633-1650; Howell, M.J., Schenck, C.H., Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease (2015) JAMA Neurol., 72, pp. 707-712; Seidel, K., The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies (2015) Brain Pathol., 25, pp. 121-135; Roselli, F., Caroni, P., From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases (2015) Neuron, 85, pp. 901-910; Lams, B.E., Loss of transmitter-associated enzyme staining following axotomy does not indicate death of brainstem cholinergic neurons (1988) Brain Res., 475, pp. 401-406; Sofroniew, M.V., Isacson, O., Distribution of degeneration of cholinergic neurons in the septum following axotomy in different portions of the fimbria-fornix: a correlation between degree of cell loss and proximity of neuronal somata to the lesion (1988) J. Chem. Neuroanat., 1, pp. 327-337; Kristensson, K., Co-induction of neuronal interferon-γand nitric oxide synthase in rat motor neurons after axotomy: a role in nerve repair or death? (1994) J. Neurocytol., 23, pp. 453-459; Laiwand, R., Time course and distribution of motoneuronal loss in the dorsal motor vagal nucleus of guinea pig after cervical vagotomy (1987) J. Comp. Neurol., 256, pp. 527-537; Engel, A.K., Kreutzberg, G.W., Neuronal surface changes in the dorsal vagal motor nucleus of the guinea pig in response to axotomy (1988) J. Comp. Neurol., 275, pp. 181-200; Fernandez, E., Levocarnitine acetyl prevents cell death following long-term section of the vagus nerve in rats (1992) Int. J. Clin. Pharmacol. Res., 12, pp. 289-297; Saffrey, M.J., Cellular changes in the enteric nervous system during ageing (2013) Dev. Biol., 382, pp. 344-355; Tanaka, Y., Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test (2011) J. Neurol., 258, pp. 421-426; Wakabayashi, K., Lewy bodies in the enteric nervous system in Parkinson's disease (1989) Arch. Histol. Cytol., 52, pp. 191-194; Alexander, G.E., Parallel organization of functionally segregated circuits linking basal ganglia and cortex (1986) Annu. Rev. Neurosci., 9, pp. 357-381; DeLong, M.R., Wichmann, T., Basal ganglia circuits as targets for neuromodulation in parkinson disease (2015) JAMA Neurol., 72, pp. 1354-1360; Cooper, O., Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients (2009) J. Neurol., 256, pp. 310-316; Hantraye, P., Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism (1992) Neuroreport, 3, pp. 265-268; Marsden, C.D., Basal ganglia disease (1982) Lancet, 2, pp. 1141-1147; McCann, H., Neuropathology of α-synuclein propagation and braak hypothesis (2016) Mov. Disord., 31, pp. 152-160; Burkhardt, C.R., Diffuse Lewy body disease and progressive dementia (1988) Neurology, 38, pp. 1520-1528; Baba, M., Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies (1998) Am. J. Pathol., 152, pp. 879-884; Irizarry, M.C., Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity (1998) J. Neuropathol. Exp. Neurol., 57, pp. 334-337; Sonnenberg, A., The ‘institutional colon’: a frequent colonic dysmotility in psychiatric and neurologic disease (1994) Am. J. Gastroenterol., 89, pp. 62-66; Pan-Montojo, F., Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice (2010) PloS ONE, 5, p. e8762; Ulusoy, A., Caudo-rostral brain spreading of α-synuclein through vagal connections (2013) EMBO Mol. Med., 5, pp. 1051-1059; Maroteaux, L., Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal (1988) J. Neurosci., 8, pp. 2804-2815; Mori, F., Immunohistochemical comparison of α- and β-synuclein in adult rat central nervous system (2002) Brain Res., 941, pp. 118-126; Helwig, M., Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice (2016) Brain, 139, pp. 856-870; Drolet, R.E., Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology (2009) Neurobiol. Dis., 36, pp. 96-102; Eaker, E.Y., Chronic alterations in jejunal myoelectric activity in rats due to MPTP (1987) Am J. Physiol., 253, pp. G809-G815; Wang, L., Mice overexpressing wild-type human α-synuclein display alterations in colonic myenteric ganglia and defecation (2012) Neurogastroenterol. Motil., 24, pp. e425-e436; Jang, H., Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 14063-14068; Pan-Montojo, F., Environmental toxins trigger PD-like progression via increased α-synuclein release from enteric neurons in mice (2012) Sci. Rep., 2, p. 898; Svensson, E., Vagotomy and subsequent risk of Parkinson's disease (2015) Ann. Neurol., 78, pp. 522-529; Tysnes, O.B., Does vagotomy reduce the risk of Parkinson's disease? (2015) Ann. Neurol., 78, pp. 1011-1012; Emmanouilidou, E., Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival (2010) J. Neurosci., 30, pp. 6838-6851; Lee, H.J., Intravesicular localization and exocytosis of α-synuclein and its aggregates (2005) J. Neurosci., 25, pp. 6016-6024; Desplats, P., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 13010-13015; Konno, M., Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy (2012) Mol. Neurodegener., 7, p. 38; Lee, H.J., Direct transfer of α-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies (2010) J. Biol. Chem., 285, pp. 9262-9272; Braak, H., Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease (2007) Acta Neuropathol., 114, pp. 231-241; Picard, F., Postencephalitic stereotyped involuntary movements responsive to L-Dopa (1996) Mov. Disord., 11, pp. 567-570; Deleidi, M., Isacson, O., Viral and inflammatory triggers of neurodegenerative diseases (2012) Sci. Transl. Med., 4, p. 121ps123; Kumar, D.K., Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease (2016) Sci. Transl. Med., 8, p. 340ra372; Luk, K.C., Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice (2012) Science, 338, pp. 949-953; Luk, K.C., Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice (2012) J. Exp. Med., 209, pp. 975-986; Masuda-Suzukake, M., Prion-like spreading of pathological α-synuclein in brain (2013) Brain, 136, pp. 1128-1138; Osterberg, V.R., Progressive aggregation of α-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism (2015) Cell Rep., 10, pp. 1252-1260; Paumier, K.L., Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration (2015) Neurobiol. Dis., 82, pp. 185-199; Sacino, A.N., Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein (2013) Acta Neuropathol. Commun., 1, p. 38; Bernis, M.E., Prion-like propagation of human brain-derived α-synuclein in transgenic mice expressing αwild-type α-synuclein (2015) Acta Neuropathol. Commun., 3, p. 75; Recasens, A., Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys (2014) Ann. Neurol., 75, pp. 351-362; Watts, J.C., Transmission of multiple system atrophy prions to transgenic mice (2013) Proc. Natl. Acad. Sci. U.S.A., 110, pp. 19555-19560; Masuda-Suzukake, M., Pathological α-synuclein propagates through neural networks (2014) Acta Neuropathol. Commun., 2, p. 88; Fagerqvist, T., Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo (2013) Amyloid, 20, pp. 233-244; Sacino, A.N., Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice (2014) Acta Neuropathol., 127, pp. 645-665; Sastry, N., No apparent transmission of transgenic α-synuclein into nigrostriatal dopaminergic neurons in multiple mouse models (2015) Transl. Neurodegener., 4, p. 23; Luk, K.C., Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 20051-20056; Rey, N.L., Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease (2016) J. Exp. Med., 213, pp. 1759-1778; Volpicelli-Daley, L.A., Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death (2011) Neuron, 72, pp. 57-71; Reyes, J.F., α-Synuclein transfers from neurons to oligodendrocytes (2014) Glia, 62, pp. 387-398; Sacino, A.N., Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker (2014) J. Neurosci., 34, pp. 12368-12378; Rutherford, N.J., Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice (2015) Mol. Neurodegener., 10, p. 32; Gao, H.M., Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration (2008) J. Neurosci., 28, pp. 7687-7698; Newell, K.L., α-Synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury (1999) J. Neuropathol. Exp. Neurol., 58, pp. 1263-1268; Smith, D.H., Protein accumulation in traumatic brain injury (2003) Neuromolecular Med., 4, pp. 59-72; Uryu, K., Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans (2007) Exp. Neurol., 208, pp. 185-192; Freed, C.R., Transplantation of embryonic dopamine neurons for severe Parkinson's disease (2001) N. Engl. J. Med., 344, pp. 710-719; Kurowska, Z., Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease (2011) J. Parkinsons Dis., 1, pp. 83-92; Olanow, C.W., A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease (2003) Ann. Neurol., 54, pp. 403-414; Redmond, D.E., Jr., Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease (2008) Neurobiol. Dis., 29, pp. 103-116; Masliah, E., Effects of α-synuclein immunization in a mouse model of Parkinson's disease (2005) Neuron, 46, pp. 857-868; Selkoe, D.J., Hardy, J., The amyloid hypothesis of Alzheimer's disease at 25 years (2016) EMBO Mol. Med., 8, pp. 595-608; Nicoll, J.A., Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report (2003) Nat. Med., 9, pp. 448-452; Orgogozo, J.M., Subacute meningoencephalitis in a subset of patients with AD after Aβ2 immunization (2003) Neurology, 61, pp. 46-54; Rinne, J.O., 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (2010) Lancet Neurol., 9, pp. 363-372; Maraganore, D.M., Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease (2006) Jama, 296, pp. 661-670; Rott, R., α-Synuclein ubiquitination and novel therapeutic targets for Parkinson disease (2014) CNS Neurol. Disord. Drug Targets, 13, pp. 630-637; Koprich, J.B., Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease (2008) J. Neuroinflammation, 5, p. 8; Pott Godoy, M.C., Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease (2008) Brain, 131, pp. 1880-1894; Theodore, S., Targeted overexpression of human α-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease (2008) J. Neuropathol. Exp. Neurol., 67, pp. 1149-1158; Brownell, A.L., Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease (1999) Biomed. Pharmacother., 53, pp. 131-140; Fearnley, J.M., Lees, A.J., Ageing and Parkinson's disease: substantia nigra regional selectivity (1991) Brain, 114, pp. 2283-2301; Malek, N., α-Synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease – a systematic review (2014) Acta Neurol. Scand., 130, pp. 59-72; Wakabayashi, K., Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain (2010) Acta Neuropathol., 120, pp. 1-12; Hawkes, C.H., The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it? (2008) Mov. Disord., 23, pp. 1799-1807; Pont-Sunyer, C., The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study) (2015) Mov. Disord., 30, pp. 229-237; Angelone, T., Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic control (2011) Curr. Med. Chem., 18, pp. 4976-4986; Kebabian, J.W., Saavedra, J.M., Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites (1976) Science, 193, pp. 683-685},
correspondence_address1={Engelender, S.Israel; email: simone@tx.technion.ac.il},
publisher={Elsevier Ltd},
issn={01662236},
coden={TNSCD},
pubmed_id={27894611},
language={English},
abbrev_source_title={Trends Neurosci.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Koukouli2017347,
author={Koukouli, F. and Rooy, M. and Tziotis, D. and Sailor, K.A. and O'Neill, H.C. and Levenga, J. and Witte, M. and Nilges, M. and Changeux, J.-P. and Hoeffer, C.A. and Stitzel, J.A. and Gutkin, B.S. and Digregorio, D.A. and Maskos, U.},
title={Nicotine reverses hypofrontality in animal models of addiction and schizophrenia},
journal={Nature Medicine},
year={2017},
volume={23},
number={3},
pages={347-354},
doi={10.1038/nm.4274},
note={cited By 111},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010894766&doi=10.1038%2fnm.4274&partnerID=40&md5=b48ee4a1c8a7f4a008ab7f795528f278},
affiliation={Institut Pasteur, Neurobiologie Intégrative des Systèmes Cholinergiques, Paris, France; CNRS UMR 3571, Paris, France; Group for Neural Theory, Laboratoire de Neurosciences Cognitives, INSERM Unité 969, Département d'Études Cognitive, École Normale Supérieure, Paris, France; Institut Pasteur, Structural Bioinformatics Unit, CNRS UMR 3528, Paris, France; Institut Pasteur, Perception and Memory Unit, Paris, France; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, United States; Institute for Neuroanatomy, Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen, Germany; Centre for Cognition and Decision Making, National Research University Higher School of Economics, Moscow, Russian Federation; Institut Pasteur, Dynamic Neuronal Imaging Unit, Paris, France},
abstract={The prefrontal cortex (PFC) underlies higher cognitive processes that are modulated by nicotinic acetylcholine receptor (nAChR) activation by cholinergic inputs. PFC spontaneous default activity is altered in neuropsychiatric disorders, including schizophrenia - a disorder that can be accompanied by heavy smoking. Recently, genome-wide association studies (GWAS) identified single-nucleotide polymorphisms (SNPs) in the human CHRNA5 gene, encoding the α5 nAChR subunit, that increase the risks for both smoking and schizophrenia. Mice with altered nAChR gene function exhibit PFC-dependent behavioral deficits, but it is unknown how the corresponding human polymorphisms alter the cellular and circuit mechanisms underlying behavior. Here we show that mice expressing a human α5 SNP exhibit neurocognitive behavioral deficits in social interaction and sensorimotor gating tasks. Two-photon calcium imaging in awake mouse models showed that nicotine can differentially influence PFC pyramidal cell activity by nAChR modulation of layer II/III hierarchical inhibitory circuits. In α5-SNP-expressing and α5-knockout mice, lower activity of vasoactive intestinal polypeptide (VIP) interneurons resulted in an increased somatostatin (SOM) interneuron inhibitory drive over layer II/III pyramidal neurons. The decreased activity observed in α5-SNP-expressing mice resembles the hypofrontality observed in patients with psychiatric disorders, including schizophrenia and addiction. Chronic nicotine administration reversed this hypofrontality, suggesting that administration of nicotine may represent a therapeutic strategy for the treatment of schizophrenia, and a physiological basis for the tendency of patients with schizophrenia to self-medicate by smoking. © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.},
keywords={calcium;  nicotine;  somatostatin;  vasoactive intestinal polypeptide;  beta 2 adrenergic receptor;  bungarotoxin receptor;  CHRNA5 protein, mouse;  Chrna7 protein, mouse;  nicotine;  nicotinic agent;  nicotinic receptor, addiction;  animal experiment;  animal model;  Article;  cell activity;  chronic drug administration;  controlled study;  interneuron;  male;  mouse;  nonhuman;  priority journal;  pyramidal nerve cell;  schizophrenia;  sensory gating;  single nucleotide polymorphism;  social interaction;  wakefulness;  animal;  animal behavior;  CRISPR Cas system;  disease model;  drug effects;  fluorescent antibody technique;  genetics;  knockout mouse;  nerve cell inhibition;  pathophysiology;  prefrontal cortex;  prepulse inhibition;  schizophrenia;  social behavior;  startle reflex;  tobacco dependence;  transgenic mouse, alpha7 Nicotinic Acetylcholine Receptor;  Animals;  Behavior, Animal;  CRISPR-Cas Systems;  Disease Models, Animal;  Fluorescent Antibody Technique;  Male;  Mice;  Mice, Knockout;  Mice, Transgenic;  Neural Inhibition;  Nicotine;  Nicotinic Agonists;  Polymorphism, Single Nucleotide;  Prefrontal Cortex;  Prepulse Inhibition;  Pyramidal Cells;  Receptors, Adrenergic, beta-2;  Receptors, Nicotinic;  Reflex, Startle;  Schizophrenia;  Social Behavior;  Tobacco Use Disorder},
chemicals_cas={calcium, 7440-70-2, 14092-94-5; nicotine, 54-11-5; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; alpha7 Nicotinic Acetylcholine Receptor; CHRNA5 protein, mouse; Chrna7 protein, mouse; Nicotine; Nicotinic Agonists; Receptors, Adrenergic, beta-2; Receptors, Nicotinic},
funding_details={242167},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute on Drug AbuseNational Institute on Drug Abuse, NIDA, P30DA015663},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, P01CA089392},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, R01NS086933},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, 202088},
funding_details={Agence Nationale de la RechercheAgence Nationale de la Recherche, ANR},
funding_details={Fondation pour la Recherche MédicaleFondation pour la Recherche Médicale, FRM, DPA20140629803},
funding_details={Stavros Niarchos FoundationStavros Niarchos Foundation, SNF},
funding_details={Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique, CNRS, UMR 3571},
funding_details={Institut National Du CancerInstitut National Du Cancer, INCa, CANCEROPOLE IDF 2016-1-TABAC-01-IP-1},
funding_details={École des Neurosciences Paris Île de FranceÉcole des Neurosciences Paris Île de France, ENP},
funding_text 1={We would like to thank S. Pons for valuable support and discussions on lentiviral constructs, and M. Soudant for production of lentiviral vectors. We also acknowledge the Pasteur Institute Shared Neuroscience Department imaging facility funded by Ile-de-France Domaine d'Intérêt Majeur (DIM/NeRF). We acknowledge the GENIE Program and the Janelia Research Campus and specifically V. Jayaraman, D.S. Kim, L.L. Looger and K. Svoboda from the GENIE Project, Janelia Research Campus, Howard Hughes Medical Institute for making AAV.Syn.GCaMP6f and AAV.Syn.Flex.GCaMP6f available. Finally, we thank G. Fond and M. Groszer for comments on the manuscript. F.K. is a scholar of the Pasteur Paris University Doctoral Program (PPU) and received a stipend from the Stavros Niarchos Foundation. This work was supported by the CNRS UMR 3571, the Fondation de la Recherche Médicale (FRM grant DPA20140629803), the Agence Nationale de la Recherche (ANR), the Laboratoire d'Excellence BIO-PSY (including salary support to F.K., AAP Fin de Thèse 2015), the program PasteurInnov 2012, the FP7 ERANET program NICO-GENE, Grant Agreement n009 BLANC 20092009BLANC 20, the European Commission FP7 RTD Project HEALTH-2009-Neurocyp.08-202088 Grant 242167, French National Cancer Institute Grant CANCEROPOLE IDF 2016-1-TABAC-01-IP-1 MASKOS (all to U.M.), and NIH grants CA089392 and DA015663 (to J.S.). The laboratories of U.M., B.S.G. and D.A.D. are part of the École des Neurosciences de Paris Ile-de-France RTRA network. U.M. and D.A.D. are members of the Laboratory of Excellence, LabEx BIO-PSY. As such, this work was supported by French state funds managed by the ANR within the Investissements d'Avenir program under reference ANR-11-IDEX-0004-02. B.S.G. is a member of the Laboratory of Excellence, LabEx IEC. B.S.G. acknowledges support from the Russian Academic Excellence Project '5-100'.},
references={Dehaene, S., Changeux, J.-P., Experimental and theoretical approaches to conscious processing (2011) Neuron, 70, pp. 200-227; Bloem, B., Poorthuis, R.B., Mansvelder, H.D., Cholinergic modulation of the medial prefrontal cortex: The role of nicotinic receptors in attention and regulation of neuronal activity (2014) Front. Neural Circuits, 8, p. 17; Raichle, M.E., The brain's default mode network (2015) Annu. Rev. Neurosci, 38, pp. 433-447; Buckner, R.L., Andrews-Hanna, J.R., Schacter, D.L., The brain's default network: Anatomy, function, and relevance to disease (2008) Ann. NY Acad. Sci, 1124, pp. 1-38; Barch, D.M., Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia (2001) Arch. Gen. Psychiatry, 58, pp. 280-288; De Leon, J., Diaz, F.J., A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors (2005) Schizophr. Res, 76, pp. 135-157; Genome-wide meta-analyses identify multiple loci associated with smoking behavior (2010) Nat. Genet, 42, pp. 441-447; Biological insights from 108 schizophrenia-associated genetic loci (2014) Nature, 511, pp. 421-427; Young, J.W., Impaired attention is central to the cognitive deficits observed in α7 deficient mice (2007) Eur. Neuropsychopharmacol, 17, pp. 145-155; Guillem, K., Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention (2011) Science, 333, pp. 888-891; Bailey, C.D.C., De Biasi, M., Fletcher, P.J., Lambe, E.K., The nicotinic acetylcholine receptor α5 subunit plays a key role in attention circuitry and accuracy (2010) J. Neurosci, 30, pp. 9241-9252; Hong, L.E., A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction (2010) Proc. Natl. Acad. Sci. USA, 107, pp. 13509-13514; Adler, L.E., Schizophrenia, sensory gating, and nicotinic receptors (1998) Schizophr. Bull, 24, pp. 189-202; Robbins, T.W., Roberts, A.C., Differential regulation of fronto-executive function by the monoamines and acetylcholine (2007) Cereb. Cortex, 17, pp. i151-i160; Poorthuis, R.B., Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors (2013) Cereb. Cortex, 23, pp. 148-161; Sarter, M., Parikh, V., Howe, W.M., Phasic acetylcholine release and the volume transmission hypothesis: Time to move on (2009) Nat. Rev. Neurosci, 10, pp. 383-390; Sinkus, M.L., The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function (2015) Neuropharmacology, 96, pp. 274-288; Bierut, L.J., Variants in nicotinic receptors and risk for nicotine dependence (2008) Am. J. Psychiatry, 165, pp. 1163-1171; Sciaccaluga, M., Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons (2015) FASEB J, 29, pp. 3389-3398; Proulx, E., Piva, M., Tian, M.K., Bailey, C.D.C., Lambe, E.K., Nicotinic acetylcholine receptors in attention circuitry: The role of layer VI neurons of prefrontal cortex (2014) Cell. Mol. Life Sci, 71, pp. 1225-1244; Derntl, B., Habel, U., Deficits in social cognition: A marker for psychiatric disorders? Eur (2011) Arch. Psychiatry Clin. Neurosci, 261, pp. S145-S149; Nadler, J.J., Automated apparatus for quantitation of social approach behaviors in mice (2004) Genes Brain Behav, 3, pp. 303-314; Braff, D.L., Geyer, M.A., Swerdlow, N.R., Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies (2001) Psychopharmacology (Berl.), 156, pp. 234-258; Porter, J.T., Selective excitation of subtypes of neocortical interneurons by nicotinic receptors (1999) J. Neurosci, 19, pp. 5228-5235; Pi, H.-J., Cortical interneurons that specialize in disinhibitory control (2013) Nature, 503, pp. 521-524; Poorthuis, R.B., Bloem, B., Verhoog, M.B., Mansvelder, H.D., Layer-specific interference with cholinergic signaling in the prefrontal cortex by smoking concentrations of nicotine (2013) J. Neurosci, 33, pp. 4843-4853; Kawaguchi, Y., Kubota, Y., GABAergic cell subtypes and their synaptic connections in rat frontal cortex (1997) Cereb. Cortex, 7, pp. 476-486; McGehee, D.S., Role, L.W., Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons (1995) Annu. Rev. Physiol, 57, pp. 521-546; Sander, J.D., Joung, J.K., CRISPR-Cas systems for editing, regulating and targeting genomes (2014) Nat. Biotechnol, 32, pp. 347-355; Pfeffer, C.K., Xue, M., He, M., Huang, Z.J., Scanziani, M., Inhibition of inhibition in visual cortex: The logic of connections between molecularly distinct interneurons (2013) Nat. Neurosci, 16, pp. 1068-1076; Levin, E.D., McClernon, F.J., Rezvani, A.H., Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization (2006) Psychopharmacology (Berl.), 184, pp. 523-539; Hambsch, B., Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia (2014) Br. J. Pharmacol, 171, pp. 1758-1771; Matta, S.G., Guidelines on nicotine dose selection for in vivo research (2007) Psychopharmacology (Berl.), 190, pp. 269-319; Morel, C., Nicotine consumption is regulated by a human polymorphism in dopamine neurons (2014) Mol. Psychiatry, 19, pp. 930-936; Orr-Urtreger, A., Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents (1997) J. Neurosci, 17, pp. 9165-9171; Picciotto, M.R., Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain (1995) Nature, 374, pp. 65-67; Salas, R., The nicotinic acetylcholine receptor subunit α5 mediates short-term effects of nicotine in vivo (2003) Mol. Pharmacol, 63, pp. 1059-1066; Fuchs, E.C., Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 3571-3576; Tolu, S., A versatile system for the neuronal subtype specific expression of lentiviral vectors (2010) FASEB J, 24, pp. 723-730; Arroyo, S., Bennett, C., Aziz, D., Brown, S.P., Hestrin, S., Prolonged disynaptic inhibition in the cortex mediated by slow, non-α7 nicotinic excitation of a specific subset of cortical interneurons (2012) J. Neurosci, 32, pp. 3859-3864; Prönneke, A., Characterizing VIP neurons in the barrel cortex of VIPcre/tdTomato mice reveals layer-specific differences (2015) Cereb. Cortex, 25, pp. 4854-4868; Choi, G.B., The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring (2016) Science, 351, pp. 933-939; Holtmaat, A., Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window (2009) Nat. Protoc, 4, pp. 1128-1144; Naldini, L., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector (1996) Science, 272, pp. 263-267; Maskos, U., Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors (2005) Nature, 436, pp. 103-107; Lepousez, G., Lledo, P.-M., Odor discrimination requires proper olfactory fast oscillations in awake mice (2013) Neuron, 80, pp. 1010-1024; Guo, Z.V., Procedures for behavioral experiments in head-fixed mice (2014) PLoS One, 9, p. e88678; Besson, M., Long-term effects of chronic nicotine exposure on brain nicotinic receptors (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 8155-8160},
correspondence_address1={Maskos, U.; Institut Pasteur, France; email: umaskos@pasteur.fr},
publisher={Nature Publishing Group},
issn={10788956},
coden={NAMEF},
pubmed_id={28112735},
language={English},
abbrev_source_title={Nat. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Patel2012828,
author={Patel, C.J. and Cullen, M.R. and Ioannidis, J.P. and Butte, A.J.},
title={Systematic evaluation of environmental factors: Persistent pollutants and nutrients correlated with serum lipid levels},
journal={International Journal of Epidemiology},
year={2012},
volume={41},
number={3},
pages={828-843},
doi={10.1093/ije/dys003},
art_number={dys003},
note={cited By 108},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863511620&doi=10.1093%2fije%2fdys003&partnerID=40&md5=aceb13860ecb982cd13abefdd12b1f75},
affiliation={Department of Pediatrics, Division of Systems Medicine, Stanford University School of Medicine, Stanford, CA, United States; Lucile Packard Children's Hospital, Palo Alto, CA, United States; Department of Medicine, Division of General Medical Disciplines, Stanford University School of Medicine, Stanford, CA, United States; Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={Background Both genetic and environmental factors contribute to triglyceride, low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C) levels. Although genome-wide association studies are currently testing the genetic factors systematically, testing and reporting one or a few factors at a time can lead to fragmented literature for environmental chemical factors. We screened for correlation between environmental factors and lipid levels, utilizing four independent surveys with information on 188 environmental factors from the Centers of Disease Control, National Health and Nutrition Examination Survey, collected between 1999 and 2006.Methods We used linear regression to correlate each environmental chemical factor to triglycerides, LDL-C and HDL-C adjusting for age, age2, sex, ethnicity, socio-economic status and body mass index. Final estimates were adjusted for waist circumference, diabetes status, blood pressure and survey. Multiple comparisons were controlled for by estimating the false discovery rate and significant findings were tentatively validated in an independent survey. Results We identified and validated 29, 9 and 17 environmental factors correlated with triglycerides, LDL-C and HDL-C levels, respectively. Findings include hydrocarbons and nicotine associated with lower HDL-C and vitamin E (γ-tocopherol) associated with unfavourable lipid levels. Higher triglycerides and lower HDL-C were correlated with higher levels of fat-soluble contaminants (e.g. polychlorinated biphenyls and dibenzofurans). Nutrients and vitamin markers (e.g. vitamins B, D and carotenes), were associated with favourable triglyceride and HDL-C levels. Conclusions Our systematic association study has enabled us to postulate about broad environmental correlation to lipid levels. Although subject to confounding and reverse causality bias, these findings merit evaluation in additional cohorts. Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2012.},
author_keywords={Cholesterol;  Environment;  EWAS;  GWAS;  Lipids;  Nutrients;  Pollutants},
keywords={alpha tocopherol;  carotene;  dibenzofuran;  environmental chemical;  high density lipoprotein cholesterol;  hydrocarbon;  lipid;  low density lipoprotein cholesterol;  nicotine;  polychlorinated biphenyl;  triacylglycerol;  vitamin B group;  vitamin D, age class;  body mass;  cohort analysis;  diabetes;  environmental factor;  ethnicity;  genotype-environment interaction;  hypertension;  lipid;  nutrient;  persistence;  serum;  socioeconomic status;  steroid;  temporal analysis;  vitamin, article;  blood pressure;  body mass;  correlation analysis;  diabetes mellitus;  environmental factor;  genetic association;  health survey;  heredity;  human;  linear regression analysis;  lipid blood level;  nutrient;  pollutant;  priority journal;  social status;  socioeconomics;  systematic review;  validation study;  waist circumference, Adult;  Age Factors;  Aged;  Body Mass Index;  Centers for Disease Control and Prevention (U.S.);  Cholesterol, HDL;  Cholesterol, LDL;  Environmental Exposure;  Environmental Pollutants;  Female;  Humans;  Lipids;  Male;  Micronutrients;  Middle Aged;  Nutrition Surveys;  Sex Factors;  Socioeconomic Factors;  Triglycerides;  United States},
chemicals_cas={alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; dibenzofuran, 132-64-9; lipid, 66455-18-3; nicotine, 54-11-5; vitamin B group, 12001-76-2; Cholesterol, HDL; Cholesterol, LDL; Environmental Pollutants; Lipids; Micronutrients; Triglycerides},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={Howard Hughes Medical InstituteHoward Hughes Medical Institute, HHMI},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, T32HL007034},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, R01GM079719},
funding_details={U.S. National Library of MedicineU.S. National Library of Medicine, NLM, R01LM009719, T15LM007033},
funding_details={National Center for Research ResourcesNational Center for Research Resources, NCRR, UL1RR025744},
funding_text 1={The National Library of Medicine (grant numbers T15 LM 007033 and R01 LM009719); National Institute of General Medical Sciences (grant number R01 GM079719); National Institutes of Health Clinical and Translational Science Award (UL1 RR025744); Lucile Packard Foundation for Children’s Health, Howard Hughes Medical Institute.},
references={Heller, D.A., de Faire, U., Pedersen, N.L., Dahlen, G., McClearn, G.E., Genetic and environmental influences on serum lipid levels in twins (1993) N Engl J Med, 328, pp. 1150-1156; Costanza, M.C., Cayanis, E., Ross, B.M., Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population (2005) Am J Epidemiol, 161, pp. 714-724; Kris-Etherton, P.M., Krummel, D., Russell, M.E., The effect of diet on plasma lipids, lipoproteins, and coronary heart disease (1988) J Am Diet Assoc, 88, pp. 1373-1400; Schaefer, E.J., Lipoproteins, nutrition, and heart disease (2002) Am J Clin Nutr, 75, pp. 191-212; Varady, K.A., Jones, P.J., Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? (2005) J Nutr, 135, pp. 1829-1835; Craig, W.Y., Palomaki, G.E., Haddow, J.E., Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data BMJ, 298, pp. 784-788; Kraus, W.E., Houmard, J.A., Duscha, B.D., Effects of the amount and intensity of exercise on plasma lipoproteins (2002) N Engl J Med, 347, pp. 1483-1492; Goncharov, A., Haase, R.F., Santiago-Rivera, A., High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population (2008) Environ Res, 106, pp. 226-239; Sergeev, A.V., Carpenter, D.O., Hospitalization rates for coronary heart disease in relation to residence near areas contaminated with persistent organic pollutants and other pollutants (2005) Environ Health Perspect, 113, pp. 756-761; Lee, D.H., Steffes, M.W., Sjodin, A., Jones, R.S., Needham, L.L., Jacobs Jr, D.R., Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes (2011) PLoS One, 6, pp. e15977; Lee, D.H., Lee, I.K., Porta, M., Steffes, M., Jacobs Jr, D.R., Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002 (2007) Diabetologia, 50, pp. 1841-1851; Lee, D.H., Steffes, M.W., Sjodin, A., Jones, R.S., Needham, L.L., Jacobs Jr, D.R., Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study (2010) Environ Health Perspect, 118, pp. 1235-1242; Lee, D.H., Lee, I.K., Song, K., A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002 (2006) Diabetes Care, 29, pp. 1638-1644; Park, S.K., Son, H.K., Lee, S.K., Relationship between serum concentrations of organochlorine pesticides and metabolic syndrome among non-diabetic adults (2010) J Prev Med Public Health, 43, pp. 1-8; Brook, R.D., Rajagopalan, S., Pope III, C.A., Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association (2010) Circulation, 121, pp. 2331-2378; Teslovich, T.M., Musunuru, K., Smith, A.V., Biological, clinical and population relevance of 95 loci for blood lipids (2010) Nature, 466, pp. 707-713; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P., Selection in reported epidemiological risks: an empirical assessment (2007) PLoS Med, 4, pp. e79; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Ioannidis, J., Loy, E.Y., Poulton, R., Chia, K.S., Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification (2009) Sci Transl Med, 1, pp. 7-8; Boffetta, P., McLaughlin, J.K., La Vecchia, C., Tarone, R.E., Lipworth, L., Blot, W.J., False-positive results in cancer epidemiology: a plea for epistemological modesty (2008) J Natl Cancer Inst, 100, pp. 988-995; Dwan, K., Altman, D.G., Arnaiz, J.A., Systematic review of the empirical evidence of study publication bias and outcome reporting bias (2008) PLoS One, 3, pp. e3081; Young, S.S., Acknowledge and fix the multiple testing problem (2010) Int J Epidemiol, 39, p. 934. , Author reply 934-35; (2006) Human Biomonitoring for Environmental Chemicals, , Committee on Human Biomonitoring for Environmental Toxicants. Washington, DC: National Academies Press; Porta, M., Puigdomenech, E., Ballester, F., Monitoring concentrations of persistent organic pollutants in the general population: the international experience (2008) Environ Int, 34, pp. 546-561; Patel, C., Bhattacharya, J., Butte, A., A Environment-wide Association Study (EWAS) to type 2 diabetes (2010) PLoS One, 5, pp. e10746; (2011) National Health and Nutrition Examination Survey, 2009, , http://www.cdc.gov/nchs/nhanes/, Centers for Disease Control and Prevention (CDC). (9 January, date last accessed); Wang, L., Gaziano, J.M., Norkus, E.P., Buring, J.E., Sesso, H.D., Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women (2008) Am J Clin Nutr, 88, pp. 747-754; Ioannidis, J.P.A., Why most published research findings are false (2005) PLoS Med, 2, pp. e124; Ezzati, T.M., Massey, J.T., Waksberg, J., Chu, A., Maurer, K.R., Sample design: Third National Health and Nutrition Examination Survey (1992) Vital Health Stat, 2, pp. 1-35; Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge (1972) Clin Chem, 18, pp. 499-502; Lumley, T., (2009) Survey: analysis of complex survey samples, , 3. 14 ed; Storey, J.D., A direct approach to False Discovery Rates (2002) J R Statist Soc B, 64, pp. 479-498; Cohen, J., (1988) Statistical Power Analysis for the Behavioral Sciences, , 2nd edn. Hillsdale, NJ: Erlbaum; Fryar, C.D., Hirsch, R., Eberhardt, M.S., Yoon, S.S., Wright, J.D., Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006 (2010) NCHS Data Brief, pp. 1-8; Ford, E.S., Li, C., Zhao, G., Pearson, W.S., Mokdad, A.H., Hypertriglyceridemia and Its pharmacologic treatment among US Adults (2009) Arch Intern Med, 169, pp. 572-578; Morgan, T.M., Krumholz, H.M., Lifton, R.P., Spertus, J.A., Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study (2007) J Am Med Assoc, 297, pp. 1551-1561; Sexton, K., Hattis, D., Assessing cumulative health risks from exposure to environmental mixtures - three fundamental questions (2007) Environ Health Perspect, 115, pp. 825-832; Blair, A., Saracci, R., Vineis, P., Epidemiology, public health, and the rhetoric of false positives (2009) Environ Health Perspect, 117, pp. 1809-1813; Fallin, M.D., Kao, W.H.L., Is 'X'-WAS the future for all of epidemiology? (2011) Epidemiology, 22, pp. 457-459; Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., Sleight, P., Vitamin E supplementation and cardiovascular events in high-risk patients (2000) The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 342, pp. 154-160; Omenn, G.S., Goodman, G.E., Thornquist, M., Brunzell, J.D., Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the beta-carotene and retinol efficacy trial (1994) Cancer Epidemiol Biomarkers Prev, 3, pp. 711-713; Redlich, C.A., Chung, J.S., Cullen, M.R., Blaner, W.S., Van Bennekum, A.M., Berglund, L., Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET) (1999) Atherosclerosis, 145, pp. 425-432; Vivekananthan, D.P., Penn, M.S., Sapp, S.K., Hsu, A., Topol, E.J., Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials (2003) Lancet, 361, pp. 2017-2023; Miller III, E.R., Pastor-Barriuso, R., Dalal, D., Riemersma, R.A., Appel, L.J., Guallar, E., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality (2005) Ann Intern Med, 142, pp. 37-46; Mente, A., de Koning, L., Shannon, H.S., Anand, S.S., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease (2009) Arch Intern Med, 169, pp. 659-669; Willcox, B.J., Curb, J.D., Rodriguez, B.L., Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies (2008) Am J Cardiol, 101, pp. 75D-86D; White, E., Kristal, A.R., Shikany, J.M., Correlates of serum alpha and gamma-tocopherol in the women's health initiative (2001) Ann Epidemiol, 11, pp. 136-144; Semmler, A., Moskau, S., Grigull, A., Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis (2010) Nutr J, 9, p. 31; Jorde, R., Figenschau, Y., Hutchinson, M., Emaus, N., Grimnes, G., High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile (2010) Eur J Clin Nutr, 64, pp. 1457-1464; Smith, K.M., Barraj, L.M., Kantor, M., Sahyoun, N.R., Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999-2002) (2009) Public Health Nutr, 12, pp. 1261-1269; Hu, F.B., Willett, W.C., Optimal diets for prevention of coronary heart disease (2002) J Am Med Assoc, 288, pp. 2569-2578; Joshipura, K.J., Hu, F.B., Manson, J.E., The effect of fruit and vegetable intake on risk for coronary heart disease (2001) Ann Intern Med, 134, pp. 1106-1114; Bassett, C.M., Rodriguez-Leyva, D., Pierce, G.N., Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed (2009) Appl Physiol Nutr Metab, 34, pp. 965-974; Pan, A., Yu, D., Demark-Wahnefried, W., Franco, O.H., Lin, X., Meta-analysis of the effects of flaxseed interventions on blood lipids (2009) Am J Clin Nutr, 90, pp. 288-297; Park, D., Huang, T., Frishman, W.H., Phytoestrogens as cardioprotective agents (2005) Cardiol Rev, 13, pp. 13-17; Xu, X., Cook, R.L., Ilacqua, V.A., Kan, H., Talbott, E.O., Kearney, G., Studying associations between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases in the United States (2010) Sci Total Environ, 408, pp. 4943-4948; Pope III, C.A., Burnett, R.T., Thurston, G.D., Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease (2004) Circulation, 109, pp. 71-77; Miller, K.A., Siscovick, D.S., Sheppard, L., Long-term exposure to air pollution and incidence of cardiovascular events in women (2007) N Engl J Med, 356, pp. 447-458; Wilson, P.W., Garrison, R.J., Abbott, R.D., Castelli, W.P., Factors associated with lipoprotein cholesterol levels (1983) The Framingham study. Arteriosclerosis, 3, pp. 273-281; Njolstad, I., Arnesen, E., Lund-Larsen, P.G., Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study (1996) Circulation, 93, pp. 450-456; Moffatt, R.J., Chelland, S.A., Pecott, D.L., Stamford, B.A., Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C (2004) Prev Med, 38, pp. 637-641; Everett, C.J., Mainous III, A.G., Frithsen, I.L., Player, M.S., Matheson, E.M., Association of polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition Examination Survey (2008) Environ Res, 108, pp. 94-97; Uemura, H., Arisawa, K., Hiyoshi, M., Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population (2009) Environ Health Perspect, 117, pp. 568-573; Longnecker, M.P., Daniels, J.L., Environmental contaminants as etiologic factors for diabetes (2001) Environmental Health Perspectives, 109 (SUPPL 6), pp. 871-876; Porta, M., Persistent organic pollutants and the burden of diabetes (2006) Lancet, 368, pp. 558-559; Remillard, R.B., Bunce, N.J., Linking dioxins to diabetes: epidemiology and biologic plausibility (2002) Environ Health Perspect, 110, pp. 853-858; Lee, D.-H., Jacobs, D.R., Miquel, P., Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation (2009) Environ Health Perspect, 117, pp. 1799-1802; Rusiecki, J.A., Baccarelli, A., Bollati, V., Tarantini, L., Moore, L.E., Bonefeld-Jorgensen, E.C., Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit (2008) Environ Health Perspect, 116, pp. 1547-1552; Lind, P.M., van Bavel, B., Salihovic, S., Lind, L., Circulating levels of Persistent Organic Pollutants (POPs) and carotid atherosclerosis in the elderly (2011) Environ Health Perspect, 120, pp. 38-43; Schisterman, E.F., Whitcomb, B.W., Louis, G.M., Louis, T.A., Lipid adjustment in the analysis of environmental contaminants and human health risks (2005) Environ Health Perspect, 113, pp. 853-857; Porta, M., Jariod, M., Lopez, T., Correcting serum concentrations of organochlorine compounds by lipids: alternatives to the organochlorine/total lipids ratio (2009) Environ Int, 35, pp. 1080-1085; Covaci, A., Voorspoels, S., Thomsen, C., van Bavel, B., Neels, H., Evaluation of total lipids using enzymatic methods for the normalization of persistent organic pollutant levels in serum (2006) Sci Total Environ, 366, pp. 361-366; Bernert, J.T., Turner, W.E., Patterson Jr, D.G., Needham, L.L., Calculation of serum "total lipid" concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples (2007) Chemosphere, 68, pp. 824-831; Dirinck, E., Jorens, P.G., Covaci, A., Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls (2011) Obesity, 19, pp. 709-714; James, R.A., Hertz-Picciotto, I., Willman, E., Keller, J.A., Charles, M.J., Determinants of serum polychlorinated biphenyls and organochlorine pesticides measured in women from the child health and development study cohort, 1963-1967 (2002) Environ Health Perspect, 110, pp. 617-624; Porta, M., Gasull, M., Puigdomenech, E., Distribution of blood concentrations of persistent organic pollutants in a representative sample of the population of Catalonia (2010) Environ Int, 36, pp. 655-664; Hue, O., Marcotte, J., Berrigan, F., Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery (2006) Obes Surg, 16, pp. 1145-1154; Wolff, M.S., Britton, J.A., Teitelbaum, S.L., Improving organochlorine biomarker models for cancer research (2005) Cancer Epidemiol Biomarkers Prev, 14, pp. 2224-2236; Wolff, M.S., Anderson, H.A., Britton, J.A., Rothman, N., Pharmacokinetic variability and modern epidemiology-the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort (2007) Cancer Epidemiol Biomarkers Prev, 16, pp. 1925-1930; Mendez, M.A., Garcia-Esteban, R., Guxens, M., Prenatal organochlorine compound exposure, rapid weight gain and overweight in infancy (2011) Environ Health Perspect, 119, pp. 272-278; Willett, W.C., (1998) Nutritional Epidemiology, , New York: Oxford University Press; Bender, D., (2003) Nutritional Biochemistry of the Vitamins, , Cambridge: University of Cambridge Press; Ogihara, T., Miki, M., Kitagawa, M., Mino, M., Distribution of tocopherol among human plasma lipoproteins (1988) Clin Chim Acta, 174, pp. 299-305; Winbauer, A.N., Pingree, S.S., Nuttall, K.L., Evaluating serum alpha-tocopherol (vitamin E) in terms of a lipid ratio (1999) Ann Clin Lab Sci, 29, pp. 185-191; Noren, K., Weistrand, C., Karpe, F., Distribution of PCB congeners, DDE, hexachlorobenzene, and methylsulfonyl metabolites of PCB and DDE among various fractions of human blood plasma (1999) Arch Environ Contam Toxicol, 37, pp. 408-414; Petreas, M., Smith, D., Hurley, S., Jeffrey, S.S., Gilliss, D., Reynolds, P., Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues: lessons learned from a breast cancer study (2004) Cancer Epidemiol Biomarkers Prev, 13, pp. 416-424; Lopez-Carrillo, L., Torres-Sanchez, L., Lopez-Cervantes, M., Blair, A., Cebrian, M.E., Uribe, M., The adipose tissue to serum dichlorodiphenyldichloroethane (DDE) ratio: some methodological considerations (1999) Environ Res, 81, pp. 142-145; Hamilton, C.M., Strader, L.C., Pratt, J.G., The PhenX toolkit: get the most from your measures (2011) Am J Epidemiol, 174, pp. 253-260},
correspondence_address1={Butte, A.J.; Department of Pediatrics, 1265 Welch Road, Stanford, CA 94305, United States; email: abutte@stanford.edu},
issn={03005771},
coden={IJEPB},
pubmed_id={22421054},
language={English},
abbrev_source_title={Int. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Heslehurst2018,
author={Heslehurst, N. and Brown, H. and Pemu, A. and Coleman, H. and Rankin, J.},
title={Perinatal health outcomes and care among asylum seekers and refugees: A systematic review of systematic reviews},
journal={BMC Medicine},
year={2018},
volume={16},
number={1},
doi={10.1186/s12916-018-1064-0},
art_number={89},
note={cited By 105},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048330294&doi=10.1186%2fs12916-018-1064-0&partnerID=40&md5=aae80b0bad90d13ea381c4ba3c1b76f3},
affiliation={Newcastle University, Institute of Health and Society, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX, United Kingdom},
abstract={Background: Global migration is at an all-time high with implications for perinatal health. Migrant women, especially asylum seekers and refugees, represent a particularly vulnerable group. Understanding the impact on the perinatal health of women and offspring is an important prerequisite to improving care and outcomes. The aim of this systematic review was to summarise the current evidence base on perinatal health outcomes and care among women with asylum seeker or refugee status. Methods: Twelve electronic database, reference list and citation searches (1 January 2007-July 2017) were carried out between June and July 2017. Quantitative and qualitative systematic reviews, published in the English language, were included if they reported perinatal health outcomes or care and clearly stated that they included asylum seekers or refugees. Screening for eligibility, data extraction, quality appraisal and evidence synthesis were carried out in duplicate. The results were summarised narratively. Results: Among 3415 records screened, 29 systematic reviews met the inclusion criteria. Only one exclusively focussed on asylum seekers; the remaining reviews grouped asylum seekers and refugees with wider migrant populations. Perinatal outcomes were predominantly worse among migrant women, particularly mental health, maternal mortality, preterm birth and congenital anomalies. Access and use of care was obstructed by structural, organisational, social, personal and cultural barriers. Migrant women's experiences of care included negative communication, discrimination, poor relationships with health professionals, cultural clashes and negative experiences of clinical intervention. Additional data for asylum seekers and refugees demonstrated complex obstetric issues, sexual assault, offspring mortality, unwanted pregnancy, poverty, social isolation and experiences of racism, prejudice and stereotyping within perinatal healthcare. Conclusions: This review identified adverse pregnancy outcomes among asylum seeker and refugee women, representing a double burden of inequality for one of the most globally vulnerable groups of women. Improvements in the provision of perinatal healthcare could reduce inequalities in adverse outcomes and improve women's experiences of care. Strategies to overcome barriers to accessing care require immediate attention. The systematic review evidence base is limited by combining heterogeneous migrant, asylum seeker and refugee populations, inconsistent use of definitions and limited data on some perinatal outcomes and risk factors. Future research needs to overcome these limitations to improve data quality and address inequalities. Systematic registration: Systematic review registration number: PROSPERO CRD42017073315. © 2018 The Author(s).},
author_keywords={Access to care;  Asylum seeker;  Migrant health;  Perinatal health;  Pregnancy;  Refugee;  Systematic review},
keywords={Article;  asylum seeker;  birth weight;  congenital malformation;  health care access;  human;  maternal mortality;  mental health;  perinatal care;  perinatal period;  poverty;  pregnancy outcome;  premature labor;  racism;  sexual assault;  social isolation;  stereotyping;  systematic review;  unwanted pregnancy;  women's health;  female;  health care delivery;  male;  psychology;  refugee, Female;  Health Services Accessibility;  Humans;  Male;  Refugees},
funding_details={Economic and Social Research CouncilEconomic and Social Research Council, ESRC, 160149300},
funding_text 1={AP is funded by a UK Economic and Social Research Council North East Doctoral Training Centre Award (Ref: 160149300).},
references={Global trends: forced displacement in 2016 (2017), Geneva: United Nations High Commissioner for Refugees; Cheng, I.H., Drillich, A., Schattner, P., Refugee experiences of general practice in countries of resettlement: a literature review (2015) Br J Gen Pract, 65 (632), pp. e171-e176; Khanlou, N., Haque, N., Skinner, A., Mantini, A., Kurtz Landy, C., Scoping review on maternal health among immigrant and refugee women in Canada: prenatal, intrapartum, and postnatal care. (2017) J Pregnancy, , https://doi.org/10.1155/2017/8783294; Chauvin, P., Simonnot, N., Douay, C., Vanbiervliet, F., Access to healthcare for the most vulnerable in a Europe in social crisis (2015), Doctors of the World/Médecins du Monde International Network Position Paper; Anderson, F.M., Hatch, S.L., Comacchio, C., Howard, L.M., Prevalence and risk of mental disorders in the perinatal period among migrant women: a systematic review and meta-analysis (2017) Archives Women's Mental Health, 20 (3), pp. 449-462; Fellmeth, G., Fazel, M., Plugge, E., Migration and perinatal mental health in women from low-and middle-income countries: a systematic review and meta-analysis (2017) BJOG Int J Obstet Gynaecol, 124 (5), pp. 742-752; Merry, L., Vangen, S., Small, R., Caesarean births among migrant women in high-income countries (2016) Best Practice Res Clin Obstet Gynaecol, 32, pp. 88-99; Schmied, V., Black, E., Naidoo, N., Dahlen, H.G., Liamputtong, P., Migrant women's experiences, meanings and ways of dealing with postnatal depression: a meta-ethnographic study (2017) PLoS One, 12 (3); Aubrey, C., Chari, R., Mitchell, B.F.P., Mumtaz, Z., Gender of provider-barrier to immigrant women's obstetrical care: a narrative review (2017) J Obstet Gynaecol Can, 39 (7), pp. 567-577; Mengesha, Z.B., Dune, T., Perz, J., Culturally and linguistically diverse women's views and experiences of accessing sexual and reproductive health care in Australia: a systematic review (2016) Sex Health, 13 (4), pp. 299-310; Winn, A., Hetherington, E., Tough, S., Systematic review of immigrant women's experiences with perinatal care in North America (2017) JOGNN., 46 (5), pp. 764-775; The Joanna Briggs Institute reviewers' manual 2014: methodology for JBI umbrella reviews (2014), Adelaide: The Joanna Briggs Institute; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) PLoS Med, 6 (7); Hadgkiss, E.J., Renzaho, A.M.N., The physical health status, service utilisation and barriers to accessing care for asylum seekers residing in the community: a systematic review of the literature (2014) Aust Health Rev, 38 (2), pp. 142-159; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Thacker, S.B., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group (2000) JAMA, 283 (15), pp. 2008-2012; Alhasanat, D., Fry-McComish, J., Postpartum depression among immigrant and Arabic women: literature review (2015) J Immigr Minor Health, 17 (6), pp. 1882-1894; Falah-Hassani, K., Shiri, R., Vigod, S., Dennis, C.-L., Prevalence of postpartum depression among immigrant women: a systematic review and meta-analysis (2015) J Psychiatr Res, 70, pp. 67-82; Collins, C.H., Zimmerman, C., Howard, L.M., Refugee, asylum seeker, immigrant women and postnatal depression: rates and risk factors (2011) Archives Women's Mental Health, 14 (1), pp. 3-11; De Maio, F.G., Immigration as pathogenic: a systematic review of the health of immigrants to Canada (2010) Int J Equity Health, 9 (1), p. 27; Tobin, C.L., Di Napoli, P., Beck, C.T., Refugee and immigrant women's experience of postpartum depression: a meta-synthesis (2018) J Transcult Nurs., 1, pp. 84-100; Wittkowski, A., Patel, S., Fox, J.R., The experience of postnatal depression in immigrant mothers living in Western countries: a meta-synthesis (2017) Clin Psychology Psychotherapy, 24 (2), pp. 411-427; Nilaweera, I., Doran, F., Fisher, J., Prevalence, nature and determinants of postpartum mental health problems among women who have migrated from South Asian to high-income countries: a systematic review of the evidence (2014) J Affect Disord, 166, pp. 213-226; Higginbottom, G., Bell, A.S., Arsenault, J., Pillay, J., An integrative review of experiences of maternity services for immigrant women in Canada (2012) Diversity Equality Health Care., 9, pp. 253-266; Pedersen, G.S., Grøntved, A., Mortensen, L.H., Andersen, A.-M., Rich-Edwards, J., Maternal mortality among migrants in Western Europe: a meta-analysis (2014) Matern Child Health J, 18 (7), pp. 1628-1638; Gagnon, A.J., Zimbeck, M., Zeitlin, J., Migration to western industrialised countries and perinatal health: a systematic review (2009) Soc Sci Med, 69 (6), pp. 934-946; Bollini, P., Pampallona, S., Wanner, P., Kupelnick, B., Pregnancy outcome of migrant women and integration policy: a systematic review of the international literature (2009) Soc Sci Med, 68 (3), pp. 452-461; Gissler, M., Alexander, S., Macfarlane, A., Small, R., Stray-Pedersen, B., Zeitlin, J., Zimbeck, M., Gagnon, A., Stillbirths and infant deaths among migrants in industrialized countries (2009) Acta Obstet Gynecol Scand, 88 (2), pp. 134-148; Merry, L., Small, R., Blondel, B., Gagnon, A.J., International migration and caesarean birth: a systematic review and meta-analysis (2013) BMC Pregnancy Childbirth, 13, p. 27; Villalonga-Olives, E., Kawachi, I., von Steinbüchel, N., Pregnancy and birth outcomes among immigrant women in the US and Europe: a systematic review (2017) J Immigr Minor Health., 6, pp. 1469-1487; Balaam, M.C., Akerjordet, K., Lyberg, A., Kaiser, B., Schoening, E., Fredriksen, A.M., Ensel, A., Severinsson, E., A qualitative review of migrant women's perceptions of their needs and experiences related to pregnancy and childbirth (2013) J Adv Nurs, 69 (9), pp. 1919-1930; Downe, S., Finlayson, K., Walsh, D., Lavender, T., 'Weighing up and balancing out': a meta-synthesis of barriers to antenatal care for marginalised women in high-income countries (2009) BJOG Int J Obstet Gynaecol, 116 (4), pp. 518-529; Higginbottom, G.M.A., Hadziabdic, E., Yohani, S., Paton, P., Immigrant women's experience of maternity services in Canada: a meta-ethnography (2014) Midwifery, 30 (5), pp. 544-559; Small, R., Roth, C., Raval, M., Shafiei, T., Korfker, D., Heaman, M., McCourt, C., Gagnon, A., Immigrant and non-immigrant women's experiences of maternity care: a systematic and comparative review of studies in five countries (2014) BMC Pregnancy Childbirth, 14, p. 152; Wikberg, A., Bondas, T., A patient perspective in research on intercultural caring in maternity care: a meta-ethnography (2010) Int J Qual Stud Health Well-being, 5 (1), p. 4648; Heaman, M., Bayrampour, H., Kingston, D., Blondel, B., Gissler, M., Roth, C., Alexander, S., Gagnon, A., Migrant women's utilization of prenatal care: a systematic review (2013) Matern Child Health J, 17 (5), pp. 816-836; Higginbottom, G.M.A., Morgan, M., Alexandre, M., Chiu, Y., Forgeron, J., Kocay, D., Barolia, R., Immigrant women's experiences of maternity-care services in Canada: a systematic review using a narrative synthesis (2015) Systematic Reviews, 4 (1), p. 13; Stewart, D.E., Gagnon, A., Saucier, J.-F., Wahoush, O., Dougherty, G., Postpartum depression symptoms in newcomers (2008) Can J Psychiatry, 53 (2), pp. 121-124; Gagnon, A.J., Merry, L., Haase, K., Predictors of emergency cesarean delivery among international migrant women in Canada (2013) Int J Gynecol Obstet, 121 (3), pp. 270-274; Merry, L.A., Gagnon, A.J., Kalim, N., Bouris, S.S., Refugee claimant women and barriers to health and social services post-birth (2011) Can J Public Health., 4, pp. 286-290; Kurth, E., Jaeger, F.N., Zemp, E., Tschudin, S., Bischoff, A., Reproductive health care for asylum-seeking women-a challenge for health professionals (2010) BMC Public Health, 10 (1), p. 659; Kennedy, P., Murphy-Lawless, J., The maternity care needs of refugee and asylum seeking women in Ireland (2003) Fem Rev, 73 (1), pp. 39-53; McLeish, J., Maternity experiences of asylum seekers in England (2005) Br J Midwifery, 13 (12), pp. 782-785; Briscoe, L., Lavender, T., Exploring maternity care for asylum seekers and refugees (2009) Br J Midwifery, 17 (1), pp. 17-23; Iliadi, P., Refugee women in Greece: a qualitative study of their attitudes and experience in antenatal care (2008) Health Sci J., 2 (3), pp. 173-180; Matthey, S., Silove, D., Barnett, B., Fitzgerald, M.H., Mitchell, P., Correlates of depression and PTSD in Cambodian women with young children: a pilot study (1999) Stress Health, 15 (2), pp. 103-107; Edge, D., Perinatal depression: its absence among Black Caribbean women (2006) Br JMidwifery, 14 (11), pp. 646-652; Reynolds, B., White, J., Seeking asylum and motherhood: health and wellbeing needs (2010) Community Practitioner, 830 (20), p. 3; Gagnon, A.J., Dougherty, G., Wahoush, O., Saucier, J.-F., Dennis, C.-L., Stanger, E., Palmer, B., Stewart, D.E., International migration to Canada: the post-birth health of mothers and infants by immigration class (2013) Soc Sci Med, 76, pp. 197-207; Lalchandani, S., MacQuillan, K., Sheil, O., Obstetric profiles and pregnancy outcomes of immigrant women with refugee status (2001) Ir Med J, 94 (3), pp. 79-80; Essén, B., Hanson, B.S., ÖStergren, P.O., Lindquist, P.G., Gudmundsson, S., Increased perinatal mortality among sub-Saharan immigrants in a city-population in Sweden (2000) Acta Obstet Gynecol Scand, 79 (9), pp. 737-743; Schulpen, T.W.J., Van Steenbergen, J.E., Van Driel, H.F., Influences of ethnicity on perinatal and child mortality in the Netherlands (2001) Arch Dis Child, 84 (3), pp. 222-226; Vangen, S., Stoltenberg, C., Johansen, R.E.B., Sundby, J., Stray-Pedersen, B., Perinatal complications among ethnic Somalis in Norway (2002) Acta Obstet Gynecol Scand, 81 (4), pp. 317-322; Kuvacic, I., Skrablin, S., Hodzic, D., Milkovic, G., Possible influence of expatriation on perinatal outcome (1996) Acta Obstet Gynecol Scand, 75 (4), pp. 367-371; Nedić, B., Loncar, S., Ravić, J., Komazec, J., Deliveries in the outpatient birthing facility in Ruma during 1989 and between 1992 and 1995 (1999) Med Pregl, 52 (1-2), pp. 53-56; Goosen, S., Uitenbroek, D., Wijsen, C., Stronks, K., Induced abortions and teenage births among asylum seekers in The Netherlands: analysis of national surveillance data (2009) J Epidemiology Community Health., 7, pp. 528-533; Rogstad, K.E., Dale, H., What are the needs of asylum seekers attending an STI clinic and are they significantly different from those of British patients? (2004) Int J STD AIDS, 15 (8), pp. 515-518; Gagnon, A.J., Stanger, E., Dougherty, G., Oxman-Martinez, J., Platt, R.W., Saucier, J.-F., Wahoush, O., Stewart, D.E., Refugee and refugee-claimant women and infants post-birth: migration histories as a predictor of Canadian health system response to needs (2007) Can J Public Health., 4, pp. 287-291; Kandasamy, T., Cherniak, R., Shah, R., Yudin, M.H., Spitzer, R., Obstetric risks and outcomes of refugee women at a single centre in Toronto (2014) J Obstet Gynaecol Can, 36 (4), pp. 296-302; Small, R., Gagnon, A., Gissler, M., Zeitlin, J., Bennis, M., Glazier, R.H., Haelterman, E., Urquia, M., Somali women and their pregnancy outcomes postmigration: data from six receiving countries (2008) BJOG Int J Obstet Gynaecol, 115 (13), pp. 1630-1640; Reed, M.M., Westfall, J.M., Bublitz, C., Battaglia, C., Fickenscher, A., Birth outcomes in Colorado's undocumented immigrant population (2005) BMC Public Health, 5 (1), p. 100; Kelaher, M., Jessop, D.J., Differences in low-birthweight among documented and undocumented foreign-born and US-born Latinas (2002) Soc Sci Med, 55 (12), pp. 2171-2175; Van Hanegem, N., Miltenburg, A.S., Zwart, J.J., Bloemenkamp, K.W.M., Van Roosmalen, J.O.S., Severe acute maternal morbidity in asylum seekers: a two-year nationwide cohort study in the Netherlands (2011) Acta Obstet Gynecol Scand, 90 (9), pp. 1010-1016; Harper Bulman, K., McCourt, C., Somali refugee women's experiences of maternity care in west London: a case study (2002) Critical Public Health, 12 (4), pp. 365-380; Herrel, N., Olevitch, L., DuBois, D.K., Terry, P., Thorp, D., Kind, E., Said, A., Somali refugee women speak out about their needs for care during pregnancy and delivery (2004) J Midwifery Women's Health, 49 (4), pp. 345-349; Dartnall, L., Ganguly, N., Batterham, J., Access to Maternity Services Research Report (2005), London: COI and Department of Health; Riggs, E., Davis, E., Gibbs, L., Block, K., Szwarc, J., Casey, S., Duell-Piening, P., Waters, E., Accessing maternal and child health services in Melbourne, Australia: reflections from refugee families and service providers (2012) BMC Health Serv Res., 12, p. 117; Redwood-Campbell, L., Thind, H., Howard, M., Koteles, J., Fowler, N., Kaczorowski, J., Understanding the health of refugee women in host countries: lessons from the Kosovar re-settlement in Canada (2008) Prehospital and Disaster Medicine, 23 (4), pp. 322-327; Carolan, M., Cassar, L., Pregnancy care for African refugee women in Australia: attendance at antenatal appointments (2007) Evidence-Based Midwifery, 5 (2), pp. 54-59; Carolan, M., Cassar, L., Antenatal care perceptions of pregnant African women attending maternity services in Melbourne, Australia (2010) Midwifery, 26 (2), pp. 189-201; Hill, N., Hunt, E., Hyrkäs, K., Somali immigrant women's health care experiences and beliefs regarding pregnancy and birth in the United States (2012) J Transcult Nurs, 23 (1), pp. 72-81; Kulig, J.C., Childbearing beliefs among Cambodian refugee women (1990) West J Nurs Res, 12 (1), pp. 108-118; O'Mahony, J.M., Donnelly, T.T., Bouchal, S.R., Este, D., Cultural background and socioeconomic influence of immigrant and refugee women coping with postpartum depression (2013) J Immigr Minor Health, 15 (2), pp. 300-314; Allotey, P., Manderson, L., Baho, S., Demian, L., Reproductive health for resettling refugee and migrant women (2004) Health issues, 78, pp. 12-17; Carroll, J., Epstein, R., Fiscella, K., Gipson, T., Volpe, E., Jean-Pierre, P., Caring for Somali women: implications for clinician-patient communication (2007) Patient Educ Couns, 66 (3), pp. 337-345; Murray, L., Windsor, C., Parker, E., Tewfik, O., The experiences of African women giving birth in Brisbane, Australia (2010) Health Care Women Int, 31 (5), pp. 458-472; Beine, K., Fullerton, J., Palinkas, L., Anders, B., Conceptions of prenatal care among Somali women in San Diego (1995) J Nurse Midwifery, 40 (4), pp. 376-381; Huster, K.M.J., Patterson, N., Schilperoord, M., Spiegel, P., Cesarean sections among Syrian refugees in Lebanon from December 2012/January 2013 to June 2013: probable causes and recommendations (2014) Yale J Biology Medicine, 87 (3), p. 269; O'Mahony, J.M., Donnelly, T.T., Bouchal, S.R., Este, D., Barriers and facilitators of social supports for immigrant and refugee women coping with postpartum depression (2012) Adv Nurs Sci, 35 (3), pp. E42-E56; CG110 Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors 2010. https://www.nice.org.uk/guidance/cg110, Accessed 25 Jan 2018; Clinical Practice Guidelines: Pregnancy Care (2018), Canberra: Australian Government Department of Health},
correspondence_address1={Heslehurst, N.; Newcastle University, Baddiley-Clark Building, Richardson Road, United Kingdom; email: Nicola.heslehurst@ncl.ac.uk},
publisher={BioMed Central Ltd.},
issn={17417015},
pubmed_id={29890984},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Lahiri2010291,
author={Lahiri, D.K. and Maloney, B.},
title={The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps},
journal={Experimental Gerontology},
year={2010},
volume={45},
number={4},
pages={291-296},
doi={10.1016/j.exger.2010.01.001},
note={cited By 105},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-77649339701&doi=10.1016%2fj.exger.2010.01.001&partnerID=40&md5=0448467ea8195be9bd376452b0cc49d5},
affiliation={Laboratory of Molecular Neurogenetics, Department of Psychiatry, Institute of Psychiatric Research, 791 Union Drive, Indianapolis, IN, United States; Deapartment of Medical and Molecular Genetics, Indiana University School of Medicine, 791 Union Drive, Indianapolis, IN, United States; Stark Neurosciences Research Insititue, Indiana University School of Medicine, 791 Union Drive, Indianapolis, IN, United States},
abstract={The neurodegenerative disorder Alzheimer's disease (AD) is the 6th leading cause of death in the USA. In addition to neurological and psychiatric symptoms, AD is characterized by deficiencies in S-adenylmethionine (SAM), vitamin B12, and folate. Deficiency in these nutrients has been shown to result in gene promoter methylation with upregulation of AD-associated genes. While some cases of AD are due to specific mutations in genes such as presenilin 1 (PSEN) and the amyloid-β peptide precursor protein (APP), these familial AD (FAD) cases account for a minority of cases. The majority of genetic contribution consists of risk factors with incomplete penetrance. Several environmental risk factors, such as cholesterol and diet, head trauma, and reduced levels of exercise, have also been determined for AD. Nevertheless, the majority of risk for AD appears to be established early in life. We propose to explain this via the LEARn (Latent Early-life Associated Regulation) model. LEARn-AD (LAD) would be a "two-hit" disorder, wherein the first hit would occur due to environmental stress within the regulatory sequences of AD-associated genes, maintained by epigenetic changes such as in DNA methylation. This hit would most likely come in early childhood. The second hit could consist of further stress, such as head trauma, poor mid-life diet, or even general changes in expression of genes that occur later in life independent of any pathogenesis. Given that the primary risk for LAD would be maintained by DNA (hypo)methylation, we propose that long-term nutritional remediation based on the LEARn model, or LEARn-based nutritional gain (LEARnING), beginning early in life, would significantly reduce risk for AD late in life. © 2010 Elsevier Inc. All rights reserved.},
author_keywords={Aging;  Chemicals;  Dementia;  Diet;  Environment;  Epigenetics;  Gene promoter;  Late-life disorder;  Latent;  Metals},
keywords={cyanocobalamin;  folic acid;  homocysteine;  pyridoxine;  s adenosylmethionine, aging;  Alzheimer disease;  article;  disease classification;  DNA methylation;  environmental factor;  environmental stress;  epigenetics;  genetic association;  genetic risk;  genotype;  human;  nonhuman;  nutrition;  oxidative stress;  priority journal;  risk assessment;  risk factor;  risk reduction;  vitamin supplementation, Alzheimer Disease;  DNA Methylation;  Environment;  Humans;  Life Style;  Models, Biological;  Nutritional Status;  Oxidative Stress;  Risk Factors},
chemicals_cas={cyanocobalamin, 53570-76-6, 68-19-9, 8064-09-3; folic acid, 59-30-3, 6484-89-5; homocysteine, 454-28-4, 6027-13-0; pyridoxine, 12001-77-3, 58-56-0, 65-23-6, 8059-24-3; s adenosylmethionine, 29908-03-0, 485-80-3},
funding_details={National Institute on AgingNational Institute on Aging, NIA, R01AG018379, R01AG018884},
references={Aisen, P.S., Egelko, S., Andrews, H., Diaz-Arrastia, R., Weiner, M., DeCarli, C., Jagust, W., Sano, M., A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease (2003) Am. J. Geriatr. Psychiatry, 11, pp. 246-249; Aisen, P.S., Schneider, L.S., Sano, M., Diaz-Arrastia, R., van Dyck, C.H., Weiner, M.F., Bottiglieri, T., Thal, L.J., High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial (2008) JAMA, 300, pp. 1774-1783; 2009 Alzheimer's disease facts and figures (2009) Alzheimers Dement., 5, pp. 234-270. , Alzheimer's Association; Ashford, J.W., Mortimer, J.A., Non-familial Alzheimer's disease is mainly due to genetic factors (2002) J. Alzheimers Dis., 4, pp. 169-177; Bales, K.R., Du, Y., Holtzman, D., Cordell, B., Paul, S.M., Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E (2000) Neurobiol. Aging, 21, pp. 427-432; Barker, D.J., Winter, P.D., Osmond, C., Margetts, B., Simmonds, S.J., Weight in infancy and death from ischaemic heart disease (1989) Lancet, 2, pp. 577-580; Basha, M.R., Wei, W., Bakheet, S.A., Benitez, N., Siddiqi, H.K., Ge, Y.W., Lahiri, D.K., Zawia, N.H., The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain (2005) J. Neurosci., 25, pp. 823-829; Bergem, A.L., Engedal, K., Kringlen, E., The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study (1997) Arch. Gen. Psychiatry, 54, pp. 264-270; Bestor, T.H., The DNA methyltransferases of mammals (2000) Hum. Mol. Genet., 9, pp. 2395-2402; Bjornsson, H.T., Sigurdsson, M.I., Fallin, M.D., Irizarry, R.A., Aspelund, T., Cui, H., Yu, W., Feinberg, A.P., Intra-individual change over time in DNA methylation with familial clustering (2008) JAMA, 299, pp. 2877-2883; Bolin, C.M., Basha, R., Cox, D., Zawia, N.H., Maloney, B., Lahiri, D.K., Cardozo-Pelaez, F., Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain (2006) FASEB J., 20, pp. 788-790; Borenstein, A.R., Copenhaver, C.I., Mortimer, J.A., Early-life risk factors for Alzheimer disease (2006) Alzheimer Dis. Assoc. Disord., 20, pp. 63-72; Buehlmeyer, K., Doering, F., Daniel, H., Kindermann, B., Schulz, T., Michna, H., Alteration of gene expression in rat colon mucosa after exercise (2008) Ann. Anat., 190, pp. 71-80; Campos, A.C., Molognoni, F., Melo, F.H., Galdieri, L.C., Carneiro, C.R., D'Almeida, V., Correa, M., Jasiulionis, M.G., Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation (2007) Neoplasia, 9, pp. 1111-1121; Chan, A., Shea, T.B., Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress (2006) J. Alzheimers Dis., 10, pp. 353-358; Christensen, M.A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., Song, W., Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1 (2004) Mol. Cell. Biol., 24, pp. 865-874; Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families (1993) Science, 261, pp. 921-923; Dennis, N.A., Browndyke, J.N., Stokes, J., Need, A., Burke, J.R., Welsh-Bohmer, K.A., Cabeza, R., Temporal lobe functional activity and connectivity in young adult APOE epsilon4 carriers (2009) Alzheimers Dement., , 10.1016/j.jalz.2009.07.003 [Epub ahead of print]; Fowler, B.A., Whittaker, M.H., Lipsky, M., Wang, G., Chen, X.Q., Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: an overview (2004) Biometals, 17, pp. 567-568; Friedland, R.P., Fritsch, T., Smyth, K.A., Koss, E., Lerner, A.J., Chen, C.H., Petot, G.J., Debanne, S.M., Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 3440-3445; Fuso, A., Nicolia, V., Cavallaro, R.A., Ricceri, L., D'Anselmi, F., Coluccia, P., Calamandrei, G., Scarpa, S., B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice (2008) Mol. Cell. Neurosci., 37, pp. 731-746; Fuso, A., Nicolia, V., Pasqualato, A., Fiorenza, M.T., Cavallaro, R.A., Scarpa, S., Changes in presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency (2009) Neurobiol. Aging; Fuso, A., Seminara, L., Cavallaro, R.A., D'Anselmi, F., Scarpa, S., S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production (2005) Mol. Cell. Neurosci., 28, pp. 195-204; Galic, M.A., Riazi, K., Heida, J.G., Mouihate, A., Fournier, N.M., Spencer, S.J., Kalynchuk, L.E., Pittman, Q.J., Postnatal inflammation increases seizure susceptibility in adult rats (2008) J. Neurosci., 28, pp. 6904-6913; Gluckman, P.D., Hanson, M.A., Beedle, A.S., Early life events and their consequences for later disease: a life history and evolutionary perspective (2007) Am. J. Hum. Biol., 19, pp. 1-19; Hall, D.B., Holmlin, R.E., Barton, J.K., Oxidative DNA damage through long-range electron transfer (1996) Nature, 382, pp. 731-735; Hardy, J., A hundred years of Alzheimer's disease research (2006) Neuron, 52, pp. 3-13; Kivipelto, M., Solomon, A., Alzheimer's disease - the ways of prevention (2008) J. Nutr. Health Aging, 12, pp. 89S-94S; Knudson Jr., A.G., Mutation and cancer: statistical study of retinoblastoma (1971) Proc. Natl. Acad. Sci. USA, 68, pp. 820-823; Lahiri, D.K., Maloney, B., Genes are not our destiny: the somatic epitype bridges between the genotype and the phenotype (2006) Nat. Rev. Neurosci., 7. , 10.1038/nrn2022-c1; Lahiri, D.K., Maloney, B., Ge, Y.-W., BACE1 gene promoter is differentially regulated: detection of a novel promoter region for its cell type-specific regulation (2006) J. Mol. Neurosci., 28 (2), pp. 193-210; Lahiri, D.K., Maloney, B., Basha, M.R., Ge, Y.W., Zawia, N.H., How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (Latent Early Associated Regulation) may explain the triggering of AD (2007) Curr. Alzheimer Res., 4, pp. 219-228; Lahiri, D.K., Maloney, B., Zawia, N.H., The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases (2009) Molecular Psychiatry, 14, pp. 992-1003; Lahiri, D.K., Zawia, N.H., Greig, N.H., Sambamurti, K., Maloney, B., Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model (2008) Biogerontology, 9, pp. 375-379; Latha, K.S., Anitha, S., Rao, K.S., Viswamitra, M.A., Molecular understanding of aluminum-induced topological changes in (CCG)12 triplet repeats: relevance to neurological disorders (2002) Biochim. Biophys. Acta, 1588, pp. 56-64; Lu, T., Pan, Y., Kao, S.Y., Li, C., Kohane, I., Chan, J., Yankner, B.A., Gene regulation and DNA damage in the ageing human brain (2004) Nature, 429, pp. 883-891; Luchsinger, J.A., Tang, M.X., Miller, J., Green, R., Mayeux, R., Higher folate intake is related to lower risk of Alzheimer's disease in the elderly (2008) J. Nutr. Health Aging, 12, pp. 648-650; Maloney, B., Ge, Y.-W., Peterson, R.C., Hardy, J., Rogers, J.T., Pérez-Tur, J., Lahiri, D.K., Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence (2010) Am. J. Med. Genet. B Neuropsychiatr. Genet., 153 B, pp. 185-201; Maslow, K., 2008 Alzheimer's disease facts and figures (2008) Alzheimers Dement., 4, pp. 110-133; Mastroeni, D., Coleman, P.D., Grover, A., Sue, L., McKee, A., Rogers, J., Differential DNA methylation in neurons of identical twins discordant for Alzheimer's disease (2009) Alzheimer's Dement., 5, pp. P145; Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P.D., Rogers, J., Epigenetic changes in Alzheimer's disease: decrements in DNA methylation (2008) Neurobiol. Aging; Mortimer, J.A., van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., Rocca, W.A., Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group (1991) Int. J. Epidemiol., 20 (SUPPL. 2), pp. S28-S35; Myers, R.H., Schaefer, E.J., Wilson, P.W., D'Agostino, R., Ordovas, J.M., Espino, A., Au, R., Wolf, P.A., Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham Study (1996) Neurology, 46, pp. 673-677; Pacheco-Quinto, J., Rodriguez de Turco, E.B., DeRosa, S., Howard, A., Cruz-Sanchez, F., Sambamurti, K., Refolo, L., Pappolla, M.A., Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels (2006) Neurobiol. Dis., 22, pp. 651-656; Plagemann, A., Harder, T., Brunn, M., Harder, A., Roepke, K., Wittrock-Staar, M., Ziska, T., Dudenhausen, J.W., Hypothalamic POMC promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome (2009) J. Physiol.; Riley, K.P., Snowdon, D.A., Desrosiers, M.F., Markesbery, W.R., Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study (2005) Neurobiol. Aging, 26, pp. 341-347; Sambamurti, K., Granholm, A.C., Kindy, M.S., Bhat, N.R., Greig, N.H., Lahiri, D.K., Mintzer, J.E., Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors (2004) Curr. Drug Targets, 5, pp. 517-528; Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., Sapienza, C., A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 7480-7484; Seshadri, S., Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? (2006) J. Alzheimers Dis., 9, pp. 393-398; Snowdon, D.A., Greiner, L.H., Markesbery, W.R., Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study (2000) Ann. NY Acad. Sci., 903, pp. 34-38; Suzuki, H., Toyota, M., Kondo, Y., Shinomura, Y., Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome (2009) Methods Mol. Biol., 512, pp. 55-69; Szyf, M., The dynamic epigenome and its implications in toxicology (2007) Toxicol. Sci., 100, pp. 7-23; Takiguchi, M., Achanzar, W.E., Qu, W., Li, G., Waalkes, M.P., Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation (2003) Exp. Cell Res., 286, pp. 355-365; Valinluck, V., Tsai, H.H., Rogstad, D.K., Burdzy, A., Bird, A., Sowers, L.C., Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2) (2004) Nucleic Acids Res., 32, pp. 4100-4108; Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Meaney, M.J., Epigenetic programming by maternal behavior (2004) Nat. Neurosci., 7, pp. 847-854; Whalley, L.J., Dick, F.D., McNeill, G., A life-course approach to the aetiology of late-onset dementias (2006) Lancet Neurol., 5, pp. 87-96; Winerman, L., A second look at twin studies (2004) Monit. Psychol., 35, p. 46; Wu, J., Basha, M.R., Brock, B., Cox, D.P., Cardozo-Pelaez, F., McPherson, C.A., Harry, J., Zawia, N.H., Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD (2008) J. Neurosci., 28, pp. 3-9; Zhang, C.E., Wei, W., Liu, Y.H., Peng, J.H., Tian, Q., Liu, G.P., Zhang, Y., Wang, J.Z., Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain (2009) Am. J. Pathol., 174, pp. 1481-1491; Zhu, X., Lee, H.G., Perry, G., Smith, M.A., Alzheimer disease, the two-hit hypothesis: an update (2007) Biochim. Biophys. Acta, 1772, pp. 494-502},
correspondence_address1={Lahiri, D.K.; Laboratory of Molecular Neurogenetics, 791 Union Drive, Indianapolis, IN, United States; email: dlahiri@iupui.edu},
issn={05315565},
coden={EXGEA},
pubmed_id={20064601},
language={English},
abbrev_source_title={Exp. Gerontol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Köhler2018189,
author={Köhler, C.A. and Evangelou, E. and Stubbs, B. and Solmi, M. and Veronese, N. and Belbasis, L. and Bortolato, B. and Melo, M.C.A. and Coelho, C.A. and Fernandes, B.S. and Olfson, M. and Ioannidis, J.P.A. and Carvalho, A.F.},
title={Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies},
journal={Journal of Psychiatric Research},
year={2018},
volume={103},
pages={189-207},
doi={10.1016/j.jpsychires.2018.05.020},
note={cited By 103},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048199710&doi=10.1016%2fj.jpsychires.2018.05.020&partnerID=40&md5=0890467b7d20192410e94bb890b3a898},
affiliation={Translational Psychiatry Research Group and Department of Clinical Medicine, Federal University of Ceará, Fortaleza, CE, Brazil; Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, United Kingdom; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, United Kingdom; Faculty of Health, Social Care and Education, Anglia Ruskin University, Bishop Hall Lane, Chelmsford, CM1 1SQ, United Kingdom; Institute for Clinical Research and Education in Medicine (IREM), Padova, Italy; Department of Neuroscience, University of Padova, Padova, Italy; National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; IMPACT Strategic Research Centre, Deakin University School of Medicine, and Barwon Health, Geelong, VIC, Australia; Laboratory of Calcium Binding Proteins in the Central Nervous System, Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Psychiatry, New York State Psychiatric Institute and Columbia University, New York, NY, United States; Departments of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Palo Alto, California, CA  94305, United States; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Center for Addiction and Mental Health (CAMH), Toronto, ON, Canada},
abstract={The development of depression may involve a complex interplay of environmental and genetic risk factors. PubMed and PsycInfo databases were searched from inception through August 3, 2017, to identify meta-analyses and Mendelian randomization (MR) studies of environmental risk factors associated with depression. For each eligible meta-analysis, we estimated the summary effect size and its 95% confidence interval (CI) by random-effects modeling, the 95% prediction interval, heterogeneity with I 2 , and evidence of small-study effects and excess significance bias. Seventy meta-analytic reviews met the eligibility criteria and provided 134 meta-analyses for associations from 1283 primary studies. While 109 associations were nominally significant (P &lt; 0.05), only 8 met the criteria for convincing evidence and, when limited to prospective studies, convincing evidence was found in 6 (widowhood, physical abuse during childhood, obesity, having 4–5 metabolic risk factors, sexual dysfunction, job strain). In studies in which depression was assessed through a structured diagnostic interview, only associations with widowhood, job strain, and being a Gulf War veteran were supported by convincing evidence. Additionally, 8 MR studies were included and provided no consistent evidence for the causal effects of obesity, smoking, and alcohol consumption. The proportion of variance explained by genetic risk factors was extremely small (0.1–0.4%), which limited the evidence provided by the MR studies. Our findings suggest that despite the large number of putative risk factors investigated in the literature, few associations were supported by robust evidence. The current findings may have clinical and research implications for the early identification of individuals at risk for depression. © 2018 Elsevier Ltd},
author_keywords={Depression;  Meta-analyses;  Prevention;  Psychiatry;  Risk factors;  Umbrella review},
keywords={alcohol consumption;  childhood obesity;  depression;  disease association;  environmental factor;  genetic risk;  human;  job stress;  lifespan;  Mendelian randomization analysis;  meta analysis;  physical abuse;  priority journal;  Review;  risk factor;  sexual dysfunction;  smoking;  veteran;  war;  widow;  depression;  genetics;  longevity;  Mendelian randomization analysis;  risk assessment;  risk factor, Depression;  Humans;  Longevity;  Mendelian Randomization Analysis;  Risk Assessment;  Risk Factors},
funding_details={Petroleum InstitutePetroleum Institute, PI},
funding_details={Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorCoordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES},
funding_details={Conselho Nacional de Desenvolvimento Científico e TecnológicoConselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq},
funding_details={Fundação Cearense de Apoio ao Desenvolvimento Científico e TecnológicoFundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico, FUNCAP},
funding_text 1={Of 89 associations of environmental risk factors for depression in adults (age ≥ 18 years), 68 (77.3%) were nominally significant (P < 0.05). These associations pertained to dietary factors (number of associations, k = 18), drugs/substances (k = 3), family factors (k = 2), habits/lifestyle factors (k = 6), infections (k = 6); medical history and comorbid diseases (k = 14), obesity and metabolic abnormalities (k = 17), pregnancy and birth-related factors (k = 3), socio-demographic factors (k = 10), and exposure to trauma/disasters (k = 10) (Table 1). Only 8 associations were supported by type I evidence: obesity, exposure to physical abuse in childhood, the presence of 4–5 metabolic risk factors, tea intake, sexual dysfunction, job strain, widowhood, and dietary zinc (Fig. 2). However, in a sensitivity analysis in which only prospective studies were considered, obesity, exposure to physical abuse in childhood, the presence of 4–5 metabolic risk factors, sexual dysfunction, job strain, and widowhood remained supported by type I evidence, while the association with tea intake was no longer statistically significant, and only 2 studies found an association with zinc intake (Table S4, available online). In a sensitivity analysis where only studies in which a case definition of depression was established using a structured diagnostic interview as opposed to studies that used screening instruments were considered, only job strain and widowhood remained supported by type I evidence (Table S5, available online), while sexual dysfunction dropped to type II evidence (after the PI crossed the null and evidence of small-study effects emerged). Exposure to physical abuse was now supported by weak evidence after the number of cases dropped to less than 1000 (Table S5, available online). Fewer than 3 independent studies in which a structured diagnostic interview was used to assess depression were available for obesity (k = 2 studies), the presence of 4–5 metabolic risk factors (k = 2), tea intake (k = 1), and dietary zinc (k = 1). Thus, sensitivity analyses were not performed.},
funding_text 2={CAK was the recipient of a postdoctoral fellowship award from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES; Brazil). AFC was the recipient of a research fellowship award from the Conselho de Desenvolvimento Científico e Tecnológico (CNPq; Brazil).},
references={Almeida, O.P., Hankey, G.J., Yeap, B.B., Golledge, J., Flicker, L., The triangular association of ADH1B genetic polymorphism, alcohol consumption and the risk of depression in older men (2014) Mol. Psychiatr., 19 (9), pp. 995-1000; American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-5 ® ) (2013), American Psychiatric Pub; Anglin, R.E., Samaan, Z., Walter, S.D., McDonald, S.D., Vitamin D deficiency and depression in adults: systematic review and meta-analysis (2013) Br. J. Psychiatry, 202, pp. 100-107; Ashrafioun, L., Pigeon, W.R., Conner, K.R., Leong, S.H., Oslin, D.W., Prevalence and correlates of suicidal ideation and suicide attempts among veterans in primary care referred for a mental health evaluation (2016) J. Affect. Disord., 189, pp. 344-350; Atlantis, E., Fahey, P., Cochrane, B., Smith, S., Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis (2013) Chest, 144 (3), pp. 766-777; Atlantis, E., Sullivan, T., Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis (2012) J. Sex. Med., 9 (6), pp. 1497-1507; Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., Riemann, D., Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies (2011) J. Affect. Disord., 135 (1-3), pp. 10-19; Bao, Y.-P., Han, Y., Ma, J., Wang, R.-J., Shi, L., Wang, T.-Y., He, J., Lu, L., Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review (2017) Neurosci. Biobehav. Rev., 75, pp. 257-273; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol., 14 (3), pp. 263-273; Bellou, V., Belbasis, L., Tzoulaki, I., Middleton, L.T., Ioannidis, J.P., Evangelou, E., Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses (2017) Alzheimer's Dementia J. Alzheimer's Assoc., 13 (4), pp. 406-418. , [Epub 2016 Sep 4]; Beydoun, H.A., Beydoun, M.A., Kaufman, J.S., Lo, B., Zonderman, A.B., Intimate partner violence against adult women and its association with major depressive disorder, depressive symptoms and postpartum depression: a systematic review and meta-analysis (2012) Soc. Sci. Med., 75 (6), pp. 959-975; Bifulco, A.T., Brown, G.W., Harris, T.O., Childhood loss of parent, lack of adequate parental care and adult depression: a replication (1987) J. Affect. Disord., 12 (2), pp. 115-128; Birnbaum, H.G., Kessler, R.C., Kelley, D., Ben-Hamadi, R., Joish, V.N., Greenberg, P.E., Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance (2010) Depress. Anxiety, 27 (1), pp. 78-89; Blore, J., Sim, M., Forbes, A., Creamer, M., Kelsall, H., Depression in Gulf War veterans: a systematic review and meta-analysis (2015) Psychol. Med., 45 (8), pp. 1565-1580; Bonde, J.P., Utzon-Frank, N., Bertelsen, M., Borritz, M., Eller, N., Nordentoft, M., Olesen, K., Rugulies, R., Risk of depressive disorder following disasters and military deployment: systematic review with meta-analysis (2016) Br. J. Psychiatry, 208 (4), pp. 330-336; Booij, L., Wang, D., Levesque, M.L., Tremblay, R.E., Szyf, M., Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression (2013) Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 368 (1615), p. 20120251; Bortolato, B., Kohler, C.A., Evangelou, E., Leon-Caballero, J., Solmi, M., Stubbs, B., Belbasis, L., Kessing, L.V., Systematic Assessment of Environmental Risk Factors for Bipolar Disorder: an Umbrella Review of Systematic Reviews and Meta-analyses (2017), pp. 84-96. , 19(2); Broadhead, W.E., Blazer, D.G., George, L.K., Tse, C.K., Depression, disability days, and days lost from work in a prospective epidemiologic survey (1990) J. Am. Med. Assoc., 264 (19), pp. 2524-2528; Bromet, E., Andrade, L.H., Hwang, I., Sampson, N.A., Alonso, J., de Girolamo, G., de Graaf, R., Kessler, R.C., Cross-national epidemiology of DSM-IV major depressive episode (2011) BMC Med., 9, p. 90; Bruce, M.L., Psychosocial risk factors for depressive disorders in late life (2002) Biol. Psychiatr., 52 (3), pp. 175-184; Carvalho, A.F., Kohler, C.A., Brunoni, A.R., Miskowiak, K.W., Herrmann, N., Lanctot, K.L., Hyphantis, T.N., Berk, M., Bias in peripheral depression biomarkers (2016) Psychother. Psychosom., 85 (2), pp. 81-90; Carvalho, A.F., Kohler, C.A., Fernandes, B.S., Quevedo, J., Miskowiak, K.W., Brunoni, A.R., Machado-Vieira, R., Berk, M., Bias in emerging biomarkers for bipolar disorder (2016) Psychol. Med., 46 (11), pp. 2287-2297; Carvalho, A.F., Sharma, M.S., Brunoni, A.R., Vieta, E., Fava, G.A., The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature (2016) Psychother. Psychosom., 85 (5), pp. 270-288; Chang-Quan, H., Xue-Mei, Z., Bi-Rong, D., Zhen-Chan, L., Ji-Rong, Y., Qing-Xiu, L., Health status and risk for depression among the elderly: a meta-analysis of published literature (2010) Age Ageing, 39 (1), pp. 23-30; Chang-Quan, H., Zheng-Rong, W., Yong-Hong, L., Yi-Zhou, X., Qing-Xiu, L., Education and risk for late life depression: a meta-analysis of published literature (2010) Int. J. Psychiatr. Med., 40 (1), pp. 109-124; Chen, L.P., Murad, M.H., Paras, M.L., Colbenson, K.M., Sattler, A.L., Goranson, E.N., Elamin, M.B., Zirakzadeh, A., Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis (2010) Mayo Clin. Proc., 85 (7), pp. 618-629; Chen, S., Zhang, Q., Dai, G., Hu, J., Zhu, C., Su, L., Wu, X., Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis (2016) Endocrine, 53 (1), pp. 35-46; Cheungpasitporn, W., Thongprayoon, C., Mao, M.A., Srivali, N., Ungprasert, P., Varothai, N., Sanguankeo, A., Erickson, S.B., Hypomagnesaemia linked to depression: a systematic review and meta-analysis (2015) Intern. Med. J., 45 (4), pp. 436-440; Cohen, J., Statistical Power Analysis for the Behavioral Sciences (1977), Lawrence Erlbaum Associates, Inc Hillsdale, NJ, US; Cole, M.G., Dendukuri, N., Risk factors for depression among elderly community subjects: a systematic review and meta-analysis (2003) Am. J. Psychiatr., 160 (6), pp. 1147-1156; Cuijpers, P., Smit, F., Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies (2004) Acta Psychiatr. Scand., 109 (5), pp. 325-331; Cuijpers, P., Smit, F., Patel, V., Dias, A., Li, J., Reynolds, C.F., 3rd, Prevention of depressive disorders in older adults: an overview (2015) Psychiatry J., 4 (1), pp. 3-10; Dal-Re, R., Ioannidis, J.P., Bracken, M.B., Buffler, P.A., Chan, A.W., Franco, E.L., La Vecchia, C., Weiderpass, E., Making prospective registration of observational research a reality (2014) Sci. Transl. Med., 6 (224). , 224cm221; de Abreu Barata, B.C., Affective disorders and sexual function: from neuroscience to clinic (2017) Curr. Opin. Psychiatr., 30 (6), pp. 396-401; de Melo, L.G.P., Nunes, S.O.V., Anderson, G., Vargas, H.O., Barbosa, D.S., Galecki, P., Carvalho, A.F., Maes, M., Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders (2017) Prog. Neuro Psychopharmacol. Biol. Psychiatr., 78, pp. 34-50; de Wit, L., Luppino, F., van Straten, A., Penninx, B., Zitman, F., Cuijpers, P., Depression and obesity: a meta-analysis of community-based studies (2010) Psychiatr. Res., 178 (2), pp. 230-235; Diprose, W., Sundram, F., Menkes, D.B., Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy (2016) Epilepsy Behav. E&B, 56, pp. 123-130; Direk, N., Williams, S., Smith, J.A., Ripke, S., Air, T., Amare, A.T., Amin, N., Sullivan, P.F., An analysis of two genome-wide association meta-analyses identifies a new locus for broad depression phenotype (2017) Biol. Psychiatr., 82 (5), pp. 322-329. , [Epub 2016 Dec 8]; Dokras, A., Clifton, S., Futterweit, W., Wild, R., Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis (2011) Obstet. Gynecol., 117 (1), pp. 145-152; Dong, X., Yang, C., Cao, S., Gan, Y., Sun, H., Gong, Y., Yang, H., Lu, Z., Tea consumption and the risk of depression: a meta-analysis of observational studies (2015) Aust. N. Z. J. Psychiatr., 49 (4), pp. 334-345; Dowlatshahi, E.A., Wakkee, M., Arends, L.R., Nijsten, T., The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis (2014) J. Invest. Dermatol., 134 (6), pp. 1542-1551; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ (Clin. Res. ed.), 315 (7109), pp. 629-634; Eke, A.C., Saccone, G., Berghella, V., Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis (2016) BJOG An Int. J. Obstet. Gynaecol., 123 (12), pp. 1900-1907; Endicott, J., Spitzer, R.L., Use of the research diagnostic criteria and the schedule for affective disorders and schizophrenia to study affective disorders (1979) Am. J. Psychiatr., 136 (1), pp. 52-56; Fava, G.A., Guidi, J., Semprini, F., Tomba, E., Sonino, N., Clinical assessment of allostatic load and clinimetric criteria (2010) Psychother. Psychosom., 79 (5), pp. 280-284; Fiest, K.M., Dykeman, J., Patten, S.B., Wiebe, S., Kaplan, G.G., Maxwell, C.J., Bulloch, A.G., Jette, N., Depression in epilepsy: a systematic review and meta-analysis (2013) Neurology, 80 (6), pp. 590-599; Fiske, A., Wetherell, J.L., Gatz, M., Depression in older adults (2009) Annu. Rev. Clin. Psychol., 5, pp. 363-389; Flint, J., Kendler, K.S., The genetics of major depression (2014) Neuron, 81 (3), pp. 484-503; Gage, S.H., Smith, G.D., Zammit, S., Hickman, M., Munafo, M.R., Using Mendelian randomisation to infer causality in depression and anxiety research (2013) Depress. Anxiety, 30 (12), pp. 1185-1193; Garcia-Blanco, T., Davalos, A., Visioli, F., Tea, cocoa, coffee, and affective disorders: vicious or virtuous cycle? (2017) J. Affect. Disord., 224, pp. 61-68. , [Epub 2016 Nov 25]; Gilbody, S., Lightfoot, T., Sheldon, T., Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity (2007) J. Epidemiol. Community Health, 61 (7), pp. 631-637; Grosso, G., Micek, A., Marventano, S., Castellano, S., Mistretta, A., Pajak, A., Galvano, F., Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies (2016) J. Affect. Disord., 205, pp. 269-281; Han, J., Wang, M., Jing, X., Shi, H., Ren, M., Lou, H., (-)-Epigallocatechin gallate protects against cerebral ischemia-induced oxidative stress via Nrf2/ARE signaling (2014) Neurochem. Res., 39 (7), pp. 1292-1299; Harris, T., Brown, G.W., Bifulco, A., Loss of parent in childhood and adult psychiatric disorder: the role of lack of adequate parental care (1986) Psychol. Med., 16 (3), pp. 641-659; Hartwig, F.P., Bowden, J., Loret de Mola, C., Tovo-Rodrigues, L., Davey Smith, G., Horta, B.L., Body mass index and psychiatric disorders: a Mendelian randomization study (2016) Sci. Rep., 6, p. 32730; Hasan, S.S., Mamun, A.A., Clavarino, A.M., Kairuz, T., Incidence and risk of depression associated with diabetes in adults: evidence from longitudinal studies (2015) Community Ment. Health J., 51 (2), pp. 204-210; Hasler, G., Drevets, W.C., Manji, H.K., Charney, D.S., Discovering endophenotypes for major depression (2004) Neuropsychopharmacology Official Pub. Am. Col. Neuropsychopharmacol., 29 (10), pp. 1765-1781; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat. Med., 21 (11), pp. 1539-1558; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J. Roy. Stat. Soc. Ser. A Stat. Soc., 172 (1), pp. 137-159; Ho, R.C., Zhang, M.W., Tsang, T.Y., Toh, A.H., Pan, F., Lu, Y., Cheng, C., Mak, K.K., The association between internet addiction and psychiatric co-morbidity: a meta-analysis (2014) BMC Psychiatr., 14, p. 183; Hu, M.X., Lamers, F., de Geus, E.J., Penninx, B.W., Differential autonomic nervous system reactivity in depression and anxiety during stress depending on type of stressor (2016) Psychosom. Med., 78 (5), pp. 562-572; Huang, C.Q., Dong, B.R., Lu, Z.C., Yue, J.R., Liu, Q.X., Chronic diseases and risk for depression in old age: a meta-analysis of published literature (2010) Ageing Res. Rev., 9 (2), pp. 131-141; Hung, C.F., Rivera, M., Craddock, N., Owen, M.J., Gill, M., Korszun, A., Maier, W., McGuffin, P., Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study (2014) Br. J. Psychiatry, 205 (1), pp. 24-28; Ignacio, Z.M., Reus, G.Z., Abelaira, H.M., Maciel, A.L., de Moura, A.B., Matos, D., Demo, J.P., Quevedo, J., Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation (2016) Behav. Brain Res., 320, pp. 225-232; IntHout, J., Ioannidis, J.P., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) BMJ Open, 6 (7); Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ Can. Med. Assoc. J. Journal de l'Association Medicale Canadienne, 181 (8), pp. 488-493; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J. Math. Psychol., 57 (5), pp. 184-187; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin. Trials, 4 (3), pp. 245-253; Ioannidis, J.P.A., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ Br. Med. J. (Clin. Res. Ed.), 335 (7626), pp. 914-916; Ioannidis, J.P.A., Trikalinos, T.A., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey (2007) CMAJ Can. Med. Assoc. J, 176 (8), pp. 1091-1096; Januar, V., Saffery, R., Ryan, J., Epigenetics and depressive disorders: a review of current progress and future directions (2015) Int. J. Epidemiol., 44 (4), pp. 1364-1387; Jokela, M., Hamer, M., Singh-Manoux, A., Batty, G., Kivimaki, M., Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies (2014) Mol. Psychiatr., 19 (8), pp. 910-914; Karasek, R.A., Theorell, T., Schwartz, J.E., Schnall, P.L., Pieper, C.F., Michela, J.L., Job characteristics in relation to the prevalence of myocardial infarction in the US health examination survey (HES) and the health and nutrition examination survey (HANES) (1988) Am. J. Publ. Health, 78 (8), pp. 910-918; Katon, W.J., Lin, E.H., Von Korff, M., Ciechanowski, P., Ludman, E.J., Young, B., Peterson, D., McCulloch, D., Collaborative care for patients with depression and chronic illnesses (2010) N. Engl. J. Med., 363 (27), pp. 2611-2620; Keller, M.C., Neale, M.C., Kendler, K.S., Association of different adverse life events with distinct patterns of depressive symptoms (2007) Am. J. Psychiatr., 164 (10), pp. 1521-1529. , quiz 1622; Kessler, R.C., Bromet, E.J., The epidemiology of depression across cultures (2013) Annu. Rev. Publ. Health, 34, pp. 119-138; Kim, T.J., von dem Knesebeck, O., Perceived job insecurity, unemployment and depressive symptoms: a systematic review and meta-analysis of prospective observational studies (2016) Int. Arch. Occup. Environ. Health, 89 (4), pp. 561-573; Kisely, S., Alichniewicz, K.K., Black, E.B., Siskind, D., Spurling, G., Toombs, M., The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis (2017) J. Psychiatr. Res., 84, pp. 137-152; Kohler, C.A., Freitas, T.H., Maes, M., de Andrade, N.Q., Liu, C.S., Fernandes, B.S., Stubbs, B., Carvalho, A.F., Peripheral Cytokine and Chemokine Alterations in Depression: a Meta-analysis of 82 Studies (2017), pp. 373-387. , 135(5); Kuehner, C., Why is depression more common among women than among men? (2017) Lancet Psychiatr., 4 (2), pp. 146-158. , [Epub 2016 Nov 15]; Kwok, M.K., Leung, G.M., Schooling, C.M., Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study (2016) Sci. Rep., 6, p. 36500; Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M.J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., Tsilidis, K.K., Adiposity and cancer at major anatomical sites: umbrella review of the literature (2017) BMJ (Clin. Res. ed.), 356, p. j477; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann. Intern. Med., 127 (9), pp. 820-826; Lev-Ran, S., Roerecke, M., Le Foll, B., George, T.P., McKenzie, K., Rehm, J., The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies (2014) Psychol. Med., 44 (4), pp. 797-810; Levis, B., Benedetti, A., Levis, A.W., Ioannidis, J.P.A., Shrier, I., Cuijpers, P., Gilbody, S., Thombs, B.D., Selective cutoff reporting in studies of diagnostic test accuracy: a comparison of conventional and individual-patient-data meta-analyses of the Patient Health Questionnaire-9 Depression Screening Tool (2017) Am. J. Epidemiol., 185 (10), pp. 954-964; Li, B., Lv, J., Wang, W., Zhang, D., Dietary magnesium and calcium intake and risk of depression in the general population: a meta-analysis (2017) Aust. N. Z. J. Psychiatr., 51 (3), pp. 219-229; Li, F., Liu, X., Zhang, D., Fish consumption and risk of depression: a meta-analysis (2016) J. Epidemiol. Community Health, 70 (3), pp. 299-304; Li, M., D'Arcy, C., Meng, X., Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions (2016) Psychol. Med., 46 (4), pp. 717-730; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., Campbell, H., Theodoratou, E., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ (Clin. Res. ed.), 357, p. j2376; Li, Z., Li, B., Song, X., Zhang, D., Dietary zinc and iron intake and risk of depression: a meta-analysis (2017) Psychiatr. Res., 251, pp. 41-47; Lichtenberg, P., Belmaker, R.H., Subtyping major depressive disorder (2010) Psychother. Psychosom., 79 (3), pp. 131-135; Liu, C.S., Carvalho, A.F., McIntyre, R.S., Towards a “metabolic” subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction (2014) CNS Neurol. Disord. - Drug Targets, 13 (10), pp. 1693-1707; Lopizzo, N., Bocchio Chiavetto, L., Cattane, N., Plazzotta, G., Tarazi, F.I., Pariante, C.M., Riva, M.A., Cattaneo, A., Gene-environment interaction in major depression: focus on experience-dependent biological systems (2015) Front. Psychiatr., 6, p. 68; Lorant, V., Deliege, D., Eaton, W., Robert, A., Philippot, P., Ansseau, M., Socioeconomic inequalities in depression: a meta-analysis (2003) Am. J. Epidemiol., 157 (2), pp. 98-112; Loret de Mola, C., de Franca, G.V., Quevedo Lde, A., Horta, B.L., Low birth weight, preterm birth and small for gestational age association with adult depression: systematic review and meta-analysis (2014) Br. J. Psychiatry, 205 (5), pp. 340-347; Lu, Y., Mak, K.K., van Bever, H.P., Ng, T.P., Mak, A., Ho, R.C., Prevalence of anxiety and depressive symptoms in adolescents with asthma: a meta-analysis and meta-regression (2012) Pediatr. Allergy Immunol. Official Pub. European Soc. Pediatric Allergy and Immunol., 23 (8), pp. 707-715; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am. J. Epidemiol., 131 (3), pp. 552-566; Luger, T.M., Suls, J., Vander Weg, M.W., How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models (2014) Addict. Behav., 39 (10), pp. 1418-1429; Luppino, F.S., de Wit, L.M., Bouvy, P.F., Stijnen, T., Cuijpers, P., Penninx, B.W., Zitman, F.G., Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies (2010) Arch. Gen. Psychiatr., 67 (3), pp. 220-229; Madsen, I., Nyberg, S., Magnusson Hanson, L., Ferrie, J., Ahola, K., Alfredsson, L., Batty, G., Kivimaki, M., Job strain as a risk factor for clinical depression: systematic review and meta-analysis with additional individual participant data (2017) Psychol. Med., 47 (8), pp. 1342-1356; Mandelli, L., Petrelli, C., Serretti, A., The role of specific early trauma in adult depression: a meta-analysis of published literature. Childhood trauma and adult depression (2015) Eur. Psychiatr., 30 (6), pp. 665-680; Mansur, R.B., Brietzke, E., McIntyre, R.S., Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders (2015) Neurosci. Biobehav. Rev., 52, pp. 89-104; Maughan, B., Collishaw, S., Stringaris, A., Depression in childhood and adolescence (2013) J. Can. Acad. Child Adoles. Psychiatr., 22 (1), pp. 35-40; McEwen, B.S., Mood disorders and allostatic load (2003) Biol. Psychiatr., 54 (3), pp. 200-207; McIntyre, R.S., Soczynska, J.Z., Woldeyohannes, H.O., Alsuwaidan, M.T., Cha, D.S., Carvalho, A.F., Jerrell, J.M., Kennedy, S.H., The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project (2015) Compr. Psychiatr., 56, pp. 279-282; Merry, S.N., Hetrick, S.E., Cox, G.R., Brudevold-Iversen, T., Bir, J.J., McDowell, H., Psychological and educational interventions for preventing depression in children and adolescents (2011) Cochrane Database Syst. Rev., 12. , Cd003380; Mitchell, A.J., Ferguson, D.W., Gill, J., Paul, J., Symonds, P., Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis (2013) Lancet Oncol., 14 (8), pp. 721-732; Munoz, R.F., Cuijpers, P., Smit, F., Barrera, A.Z., Leykin, Y., Prevention of major depression (2010) Annu. Rev. Clin. Psychol., 6, pp. 181-212; Nemeroff, C.B., Paradise lost: the neurobiological and clinical consequences of child abuse and neglect (2016) Neuron, 89 (5), pp. 892-909; Nordgaard, J., Sass, L.A., Parnas, J., The psychiatric interview: validity, structure, and subjectivity (2013) Eur. Arch. Psychiatr. Clin. Neurosci., 263 (4), pp. 353-364; Nouwen, A., Nefs, G., Caramlau, I., Connock, M., Winkley, K., Lloyd, C.E., Peyrot, M., Pouwer, F., Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium (2011) Diabetes Care, 34 (3), pp. 752-762; Nouwen, A., Winkley, K., Twisk, J., Lloyd, C.E., Peyrot, M., Ismail, K., Pouwer, F., Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis (2010) Diabetologia, 53 (12), pp. 2480-2486; Onrust, S., Cuijpers, P., Mood and anxiety disorders in widowhood: a systematic review (2006) Aging Ment. Health, 10 (4), pp. 327-334; Osborn, A., Mathias, J., Fairweather-Schmidt, A., Depression following adult, non-penetrating traumatic brain injury: a meta-analysis examining methodological variables and sample characteristics (2014) Neurosci. Biobehav. Rev., 47, pp. 1-15; Otte, C., Gold, S.M., Penninx, B.W., Pariante, C.M., Etkin, A., Fava, M., Mohr, D.C., Schatzberg, A.F., Major depressive disorder (2016) Nat. Rev. Disease primers, 2, p. 16065; Pan, A., Keum, N., Okereke, O.I., Sun, Q., Kivimaki, M., Rubin, R.R., Hu, F.B., Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies (2012) Diabetes Care, 35 (5), pp. 1171-1180; Panagioti, M., Bower, P., Kontopantelis, E., Lovell, K., Gilbody, S., Waheed, W., Dickens, C., Coventry, P.A., Association between chronic physical conditions and the effectiveness of collaborative care for depression: an individual participant data meta-analysis (2016) JAMA Psychiatry, 73 (9), pp. 978-989; Parker, G., Gladstone, G., Wilhelm, K., Mitchell, P., Hadzi-Pavlovic, D., Austin, M.P., Dysfunctional parenting: over-representation in non-melancholic depression and capacity of such specificity to refine sub-typing depression measures (1997) Psychiatr. Res., 73 (1-2), pp. 57-71; Parsaik, A.K., Singh, B., Murad, M.H., Singh, K., Mascarenhas, S.S., Williams, M.D., Lapid, M.I., Rummans, T.A., Statins use and risk of depression: a systematic review and meta-analysis (2014) J. Affect. Disord., 160, pp. 62-67; Patsopoulos, N.A., Evangelou, E., Ioannidis, J.P., Heterogeneous views on heterogeneity (2009) Int. J. Epidemiol., 38 (6), pp. 1740-1742; Petridou, E.T., Kousoulis, A.A., Michelakos, T., Papathoma, P., Dessypris, N., Papadopoulos, F.C., Stefanadis, C., Folate and B12 serum levels in association with depression in the aged: a systematic review and meta-analysis (2016) Aging Ment. Health, 20 (9), pp. 965-973; Petrilli, M.A., Kranz, T.M., Kleinhaus, K., Joe, P., Getz, M., Johnson, P., Chao, M.V., Malaspina, D., The emerging role for zinc in depression and psychosis (2017) Front. Pharmacol., 8, p. 414; Peyrot, W.J., Lee, S.H., Milaneschi, Y., Abdellaoui, A., Byrne, E.M., Esko, T., de Geus, E.J., Penninx, B.W., The association between lower educational attainment and depression owing to shared genetic effects? Results in ∼25,000 subjects (2015) Mol. Psychiatr., 20 (6), pp. 735-743; Pieper, D., Buechter, R.B., Li, L., Prediger, B., Eikermann, M., Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties (2015) J. Clin. Epidemiol., 68 (5), pp. 574-583; Post, R.M., Weiss, S.R., Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression (1998) Biol. Psychiatr., 44 (3), pp. 193-206; Prisciandaro, J.J., Roberts, J.E., A comparison of the predictive abilities of dimensional and categorical models of unipolar depression in the National Comorbidity Survey (2009) Psychol. Med., 39 (7), pp. 1087-1096; Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scarmeas, N., Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis (2013) Ann. Neurol., 74 (4), pp. 580-591; Puthran, R., Zhang, M.W., Tam, W.W., Ho, R.C., Prevalence of depression amongst medical students: a meta-analysis (2016) Med. Educ., 50 (4), pp. 456-468; Rahe, C., Unrath, M., Berger, K., Dietary patterns and the risk of depression in adults: a systematic review of observational studies (2014) Eur. J. Nutr., 53 (4), pp. 997-1013; Richardson, R., Westley, T., Gariepy, G., Austin, N., Nandi, A., Neighborhood socioeconomic conditions and depression: a systematic review and meta-analysis (2015) Soc. Psychiatr. Psychiatr. Epidemiol., 50 (11), pp. 1641-1656; Salanti, G., Ioannidis, J.P., Synthesis of observational studies should consider credibility ceilings (2009) J. Clin. Epidemiol., 62 (2), pp. 115-122; Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G.I., Fava, M., Berk, M., Ng, C.H., Adjunctive nutraceuticals for depression: a systematic review and meta-analyses (2016) Am. J. Psychiatr., 173 (6), pp. 575-587; Schoenfeld, J.D., Ioannidis, J.P., Is everything we eat associated with cancer? A systematic cookbook review (2013) Am. J. Clin. Nutr., 97 (1), pp. 127-134; Schuch, F., Vancampfort, D., Firth, J., Rosenbaum, S., Ward, P., Reichert, T., Bagatini, N.C., Stubbs, B., Physical activity and sedentary behavior in people with major depressive disorder: a systematic review and meta-analysis (2016) J. Affect. Disord., 210, pp. 139-150; Schuch, F.B., Vancampfort, D., Firth, J., Rosenbaum, S., Ward, P.B., Silva, E.S., Hallgren, M., Stubbs, B., Physical activity and incident depression: a meta-analysis of prospective cohort studies (2018) Am. J. Psychiatr., , [Epub ahead of print]; Sequeira, M.-E., Lewis, S.J., Bonilla, C., Smith, G.D., Joinson, C., Association of timing of menarche with depressive symptoms and depression in adolescence: Mendelian randomisation study (2017) Br. J. Psychiatr., 210 (1), pp. 39-46; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med. Res. Meth., 7, p. 10; Slyepchenko, A., Maes, M., Jacka, F.N., Kohler, C.A., Barichello, T., McIntyre, R.S., Berk, M., Carvalho, A.F., Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities (2017) Psychother. Psychosom., 86 (1), pp. 31-46; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Lau, J., Carpenter, J., Higgins, J.P., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ (Clin. Res. ed.), 343, p. d4002; Stewart, W.F., Ricci, J.A., Chee, E., Hahn, S.R., Morganstein, D., Cost of lost productive work time among US workers with depression (2003) J. Am. Med. Assoc., 289 (23), pp. 3135-3144; Stringer, T.P., Guerrieri, D., Vivar, C., van Praag, H., (2015) Plant-derived Flavanol (-)epicatechin Mitigates Anxiety in Association with Elevated Hippocampal Monoamine and BDNF Levels, but Does Not Influence Pattern Separation in Mice, 5, p. e493; Swardfager, W., Herrmann, N., Mazereeuw, G., Goldberger, K., Harimoto, T., Lanctot, K.L., Zinc in depression: a meta-analysis (2013) Biol. Psychiatr., 74 (12), pp. 872-878; Tarricone, I., Stivanello, E., Poggi, F., Castorini, V., Marseglia, M.V., Fantini, M.P., Berardi, D., Ethnic variation in the prevalence of depression and anxiety in primary care: a systematic review and meta-analysis (2012) Psychiatr. Res., 195 (3), pp. 91-106; Taylor, A.E., Fluharty, M.E., Bjorngaard, J.H., Gabrielsen, M.E., Skorpen, F., Marioni, R.E., Campbell, A., Munafo, M.R., Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium (2014) BMJ Open, 4 (10). , e006141; Tong, A., Wang, X., Li, F., Xu, F., Li, Q., Zhang, F., Risk of depressive symptoms associated with impaired glucose metabolism, newly diagnosed diabetes, and previously diagnosed diabetes: a meta-analysis of prospective cohort studies (2016) Acta Diabetol., 53 (4), pp. 589-598; Ttofi, M.M., Farrington, D.P., Losel, F., Loeber, R., Do the victims of school bullies tend to become depressed later in life? A systematic review and meta-analysis of longitudinal studies (2011) J. Aggress. Confl. Peace Res., 3 (2), pp. 63-73; van Agtmaal, M.J.M., Houben, A., Pouwer, F., Stehouwer, C.D.A., Schram, M.T., Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis (2017) JAMA Psychiatr., 74 (7), pp. 729-739; van Zoonen, K., Buntrock, C., Ebert, D.D., Smit, F., Reynolds, C.F., 3rd, Beekman, A.T., Cuijpers, P., Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions (2014) Int. J. Epidemiol., 43 (2), pp. 318-329; Vandenbroucke, J.P., von Elm, E., Altman, D.G., Gotzsche, P.C., Mulrow, C.D., Pocock, S.J., Poole, C., Egger, M., Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration (2007) PLoS Med., 4 (10), p. e297; Walker, E.R., McGee, R.E., Druss, B.G., Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis (2015) JAMA Psychiatr., 72 (4), pp. 334-341; Wan, K.H., Chen, L.J., Young, A.L., Depression and anxiety in dry eye disease: a systematic review and meta-analysis (2016) Eye, 30 (12), pp. 1558-1567; Wang, L., Shen, X., Wu, Y., Zhang, D., Coffee and caffeine consumption and depression: a meta-analysis of observational studies (2016) Aust. N. Z. J. Psychiatr., 50 (3), pp. 228-242; Wang, X., Zhang, L., Lei, Y., Liu, X., Zhou, X., Liu, Y., Wang, M., Xie, P., Meta-analysis of infectious agents and depression (2014) Sci. Rep., 4, p. 4530; Watanabe, K., Imamura, K., Kawakami, N., Working hours and the onset of depressive disorder: a systematic review and meta-analysis (2016) Occup. Environ. Med., 73 (12), pp. 877-884; Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression (2015) Int. J. Epidemiol., 44 (2), pp. 566-577; Wium-Andersen, M.K., Orsted, D.D., Tolstrup, J.S., Nordestgaard, B.G., Increased alcohol consumption as a cause of alcoholism, without similar evidence for depression: a Mendelian randomization study (2015) Int. J. Epidemiol., 44 (2), pp. 526-539; World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research (1993); Xiu-Ying, H., Qian, C., Xiao-Dong, P., Xue-Mei, Z., Chang-Quan, H., Living arrangements and risk for late life depression: a meta-analysis of published literature (2012) Int. J. Psychiatr. Med., 43 (1), pp. 19-34; Yan, X.Y., Huang, S.M., Huang, C.Q., Wu, W.H., Qin, Y., Marital status and risk for late life depression: a meta-analysis of the published literature (2011) J. Int. Med. Res., 39 (4), pp. 1142-1154; Zeng, Y.N., Li, Y.M., Secondhand smoke exposure and mental health in adults: a meta-analysis of cross-sectional studies (2016) Soc. Psychiatr. Psychiatr. Epidemiol., 51 (9), pp. 1339-1348; Zhai, L., Zhang, H., Zhang, D., Sleep duration and depression among adults: a meta-analysis of prospective studies (2015) Depress. Anxiety, 32 (9), pp. 664-670; Zhai, L., Zhang, Y., Zhang, D., Sedentary behaviour and the risk of depression: a meta-analysis (2015) Br. J. Sports Med., 49 (11), pp. 705-709; Zhao, K.X., Huang, C.Q., Xiao, Q., Gao, Y., Liu, Q.X., Wang, Z.R., Li, Y.H., Xie, Y.Z., Age and risk for depression among the elderly: a meta-analysis of the published literature (2012) CNS Spectr., 17 (3), pp. 142-154},
correspondence_address1={Carvalho, A.F.; Centre for Addiction and Mental Health (CAMH), 33 Russel Street, room RS1050S, Canada; email: andre.carvalho@camh.ca},
publisher={Elsevier Ltd},
issn={00223956},
coden={JPYRA},
pubmed_id={29886003},
language={English},
abbrev_source_title={J. Psychiatr. Res.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Wang2017101,
author={Wang, M.-D. and Little, J. and Gomes, J. and Cashman, N.R. and Krewski, D.},
title={Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis},
journal={NeuroToxicology},
year={2017},
volume={61},
pages={101-130},
doi={10.1016/j.neuro.2016.06.015},
note={cited By 102},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84998775169&doi=10.1016%2fj.neuro.2016.06.015&partnerID=40&md5=d36840351087f215ea5b07b26bd71b58},
affiliation={School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of OttawaON  K1 H 8M5, Canada; School of Life Science, Changchun Normal University, Changchun, Jilin  130032, China; McLaughlin Center for Population Risk Assessment, University of Ottawa, Ottawa, ON, Canada; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of OttawaON, Canada; Environmental Health Research Unit, Interdisciplinary School of Health Sciences University of Ottawa, 25 University Pvt., Ottawa, ON  K1 N 6N5, Canada; Brain Research Centre, Department of Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada; Risk Sciences International, Ottawa, ON, Canada},
abstract={Although amyotrophic lateral sclerosis (ALS) was identified as a neurological condition 150 years ago, risk factors related to the onset and progression of ALS remain largely unknown. Monogenic mutations in over 30 genes are associated with about 10% of ALS cases. The age at onset of ALS and disease types has been found to influence ALS progression. The present study was designed to identify additional putative risk factors associated with the onset and progression of ALS using systematic review and meta-analysis of observational studies. Risk factors that may be associated with ALS include: 1) genetic mutations, including the intermediate CAG repeat expansion in ATXN2; 2) previous exposure to heavy metals such as lead and mercury; 3) previous exposure to organic chemicals, such as pesticides and solvents; 4) history of electric shock; 5) history of physical trauma/injury (including head trauma/injury); 6) smoking (a weak risk factor for ALS in women); and 6) other risk factors, such as participating in professional sports, lower body mass index, lower educational attainment, or occupations requiring repetitive/strenuous work, military service, exposure to Beta-N-methylamino-L-alanin and viral infections. Risk factors that may be associated with ALS progression rate include: 1) nutritional status, including vitamin D deficiency; 2) comorbidities; 3) ethnicity and genetic factors; 4) lack of supportive care; and 4) smoking. The extent to which these associations may be causal is discussed, with further research recommended to strengthen the evidence on which determinations of causality may be based. © 2016},
author_keywords={Amyotrophic lateral sclerosis;  Etiology;  Meta-analysis;  Onset;  Progression;  Risk factor;  Systematic review},
keywords={2 amino 3 methylaminopropionic acid;  angiogenin;  apolipoprotein E;  aryldialkylphosphatase 1;  aryldialkylphosphatase 2;  ataxin 2;  heavy metal;  uric acid;  vasculotropin;  ATXN2L protein, human;  nerve protein;  pesticide, amyotrophic lateral sclerosis;  ANG gene;  APEX1 gene;  APOE gene;  Article;  ATXN2 gene;  body mass;  CAG repeat;  comorbidity;  disease course;  electric shock;  gene;  gene mutation;  genetic association;  genetic polymorphism;  genetic risk;  GRIA2 gene;  GWA9p21 gene;  head injury;  HFE gene;  human;  military service;  nutritional status;  observational study;  PON1 gene;  PON2 gene;  PON3 gene;  priority journal;  repetitive work;  smoking;  strenuous work;  UNC13A gene;  uric acid blood level;  VEGFA gene;  virus infection;  vitamin D deficiency;  work;  amyotrophic lateral sclerosis;  bibliographic database;  disease exacerbation;  environmental exposure;  genetics;  meta analysis;  mutation;  onset age;  risk factor;  statistics and numerical data;  vitamin D deficiency, Age of Onset;  Amyotrophic Lateral Sclerosis;  Databases, Bibliographic;  Disease Progression;  Environmental Exposure;  Humans;  Mutation;  Nerve Tissue Proteins;  Nutritional Status;  Pesticides;  Risk Factors;  Vitamin D Deficiency},
chemicals_cas={2 amino 3 methylaminopropionic acid, 16676-91-8; angiogenin, 97950-81-7; uric acid, 69-93-2; vasculotropin, 127464-60-2; ATXN2L protein, human; Nerve Tissue Proteins; Pesticides},
funding_details={University of OttawaUniversity of Ottawa, U of O},
funding_details={Public Health Agency of CanadaPublic Health Agency of Canada, PHAC},
funding_details={University of British ColumbiaUniversity of British Columbia, UBC},
funding_text 1={Financial Support for this project was provided by the Public Health Agency of Canada in association with Neurological Health Charities Canada through a contribution agreement administered through the University of Ottawa. N. Cashman holds a Canada Research Chair in Neurodegeneration and Protein Misfolding Diseases at the University of British Columbia; J. Little holds a Canada Research Chair in Human Genome Epidemiology at the University of Ottawa; D. Krewski holds the McLaughlin Chair in Risk Science at the University of Ottawa. The authors acknowledge the expert opinions expressed by Dr. Hannah Briemberg on an earlier draft of this manuscript.},
references={ALSGEN Consortium, Ahmeti, K.B., Ajroud-Driss, S., Al-Chalabi, A., Andersen, P.M., Armstrong, J., Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 (2013) Neurobiol. Aging, 34, p. 357. , (e7,357.19); Abel, O., Powell, J.F., Andersen, P.M., Al-Chalabi, A., ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics (2012) Hum. Mutat., 33, pp. 1345-1351; Abel, E.L., Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis (2007) Percept. Mot. Skills, 104, pp. 1251-1254; Abhinav, K., Al-Chalabi, A., Hortobagyi, T., Leigh, P.N., Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature (2007) J. Neurol. Neurosurg. Psychiatry, 78, pp. 450-453; Abraham, A., Drory, V.E., Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis (2014) J. Neurol., 261, pp. 1133-1138; Aggarwal, A., Nicholson, G., Age dependent penetrance of three different superoxide dismutase 1 (sod 1) mutations (2005) Int. J. Neurosci., 115, pp. 1119-1130; Ahdab, R., Ayache, S.S., Maltonti, F., Brugieres, P., Lefaucheur, J.P., Motor neuron disorder with tongue spasms due to pyrethroid insecticide toxicity (2011) Neurology, 76, pp. 196-197; Ahmed, A., Wicklund, M.P., Amyotrophic lateral sclerosis: what role does environment play (2011) Neurol. Clin., 29, pp. 689-711; Al-Ajmi, A., Rousseff, R.T., Khuraibet, A.J., Clinically definite ALS presenting weeks after mild electric injury: causality or coincidence? (2012) Neurol. Sci.; Al-Chalabi, A., Fang, F., Hanby, M.F., Leigh, P.N., Shaw, C.E., Ye, W., An estimate of amyotrophic lateral sclerosis heritability using twin data (2010) J. Neuro. Neurosurg. Psychiatry, pp. 1324-1326. , PMC2988617 (December 01); Alonso, A., Logroscino, G., Jick, S.S., Hernan, M.A., Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study (2009) Eur. J. Neurol., 16, pp. 745-751; Alonso, A., Logroscino, G., Hernan, M.A., Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis (2010) J. Neurol. Neurosurg. Psychiatry, 81, pp. 1249-1252; Alonso, A., Logroscino, G., Jick, S., Hernan, M., Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study (2010) BMC Neurol., 10; Alonso, V., Villaverde-Hueso, A., Hens, M.J., Morales-Piga, A., Abaitua, I., de la Paz, M.P., Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990–2005) (2011) Amyotroph. Lateral Scler., 12, pp. 192-198; Alpers, B.J., Farmer, R.A., Role of repeated trauma by pneumatic drill in production of amyotrophic lateral sclerosis (1949) Arch. Neurol. Psychiatry, 62, pp. 178-182; Alsod, U., ALS, O.G.D., (2014), World Federation of Neurology and European Network to Cure ALS. Jan. 2014;; The Amyotrophic Lateral Sclerosis Functional Rating Scale, Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I–II study group (1996) Arch. Neurol., 53, pp. 141-147; Aridegbe, T., Kandler, R., Walters, S.J., Walsh, T., Shaw, P.J., McDermott, C.J., The natural history of motor neuron disease: assessing the impact of specialist care (2013) Amyotroph. Lateral Scler. Frontotemporal. Degener., 14, pp. 13-19; Armon, C., Smoking may be considered an established risk factor for sporadic ALS (2009) Neurology, 73, pp. 1693-1698; Banack, S.A., Caller, T.A., Stommel, E.W., The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis (2010) Toxins (Basel), 2, pp. 2837-2850; Barbeito, A.G., Martinez-Palma, L., Vargas, M.R., Pehar, M., Manay, N., Beckman, J.S., Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS (2010) Neurobiol. Dis., 37, pp. 574-580; Barth, S., Kang, H., Bullman, T., Wallin, M., Neurological mortality among US veterans of the persian gulf war: 13-year follow-up (2009) Am. J. Ind. Med., 52, pp. 663-670; Beard, J.D., Kamel, F., Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival (2015) Epidemiol. Rev., 37, pp. 55-70; Beghi, E., Logroscino, G., Chio, A., Hardiman, O., Millul, A., Mitchell, D., Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study (2010) Amyotroph. Lateral Scler., 11, pp. 289-292; Beghi, E., Pupillo, E., Messina, P., Giussani, G., Chio, A., Zoccolella, S., Coffee and amyotrophic lateral sclerosis: a possible preventive role (2011) Am. J. Epidemiol., 174, pp. 1002-1008; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies (2016) Neuroepidemiology, 46, pp. 96-105; Belli, S., Vanacore, N., Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease (2005) Eur. J. Epidemiol., 20, pp. 237-242; Berg, L., de Jong, S., Huisman, M., Van der Kooi, A., De Visser, M., Schelhaas, H., Smoking, alcohol consumption and the risk of amyotrophic lateral sclerosis: a population-based study (2011) Neurology, 76, p. A115; Berger, M.M., Kopp, N., Vital, C., Redl, B., Aymard, M., Lina, B., Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS (2000) Neurology, 54, pp. 20-25; Bergman, B.P., Mackay, D.F., Pell, J.P., Motor neurone disease and military service: evidence from the Scottish Veterans Health Study (2015) Occup. Environ. Med., 72, pp. 877-879; Binazzi, A., Belli, S., Uccelli, R., Desiato, M.T., Talamanca, I.F., Antonini, G., An exploratory case-control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome (2009) Amyotroph. Lateral Scler., 10, pp. 361-369; Bonnefont-Rousselot, D., Lacomblez, L., Jaudon, M., Lepage, S., Salachas, F., Bensimon, G., Blood oxidative stress in amyotrophic lateral sclerosis (2000) J. Neurol. Sci., 178, pp. 57-62; Bowman, A.B., Kwakye, G.F., Hernandez, E.H., Aschner, M., Role of manganese in neurodegenerative diseases (2011) J. Trace Elem. Med. Biol., 25, pp. 191-203; Braconi, D., Bernardini, G., Santucci, A., Linking protein oxidation to environmental pollutants: redox proteomic approaches (2011) J. Proteomics, 74, pp. 2324-2337; Brody, J.A., Grant, M.D., Age-associated diseases and conditions: implications for decreasing late life morbidity (2001) Aging (Milano), 13, pp. 64-67; Bryan, L., Kaye, W., Antao, V., Mehta, P., Muravov, O., Horton, D.K., Preliminary results of national amyotrophic lateral sclerosis (ALS) registry risk factor survey data (2016) PLoS One, 11, p. e0153683; Buckley, J., Warlow, C., Smith, P., Hilton-Jones, D., Irvine, S., Tew, J.R., Motor neuron disease in England and Wales, 1959–1979 (1983) J. Neurol. Neurosurg. Psychiatry, 46, pp. 197-205; Burns, C.J., Beard, K.K., Cartmill, J.B., Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945–94: an update (2001) Occup. Environ. Med., 58, pp. 24-30; Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study (2012) Lancet Neurol., 11, pp. 232-240; Caban-Holt, A., Mattingly, M., Cooper, G., Schmitt, F.A., Neurodegenerative memory disorders: a potential role of environmental toxins (2005) Neurol. Clin., 23, pp. 485-521; Callaghan, B., Feldman, D., Gruis, K., Feldman, E., The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications (2011) Neurodegenerative Dis., 8, pp. 1-8; Caller, T.A., Doolin, J.W., Haney, J.F., Murby, A.J., West, K.G., Farrar, H.E., A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms (2009) Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Motor Neuron Dis., 10, pp. 101-108; Caller, T.A., Field, N.C., Chipman, J.W., Shi, X., Harris, B.T., Stommel, E.W., Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA (2012) Amyotroph. Lateral Scler., 13, pp. 25-32; Campbell, A.M., Williams, E.R., Barltrop, D., Motor neurone disease and exposure to lead (1970) J. Neurol. Neurosurg. Psychiatry, 33, pp. 877-885; Camu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis (2013) Neurobiol. Aging; Cannon, J.R., Timothy Greenamyre, J., The role of environmental exposures in neurodegeneration and neurodegenerative diseases (2011) Toxicol. Sci.; Catala-Lopez, F., Suarez-Pinilla, M., Suarez-Pinilla, P., Valderas, J.M., Gomez-Beneyto, M., Martinez, S., Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies (2014) Psychother. Psychosom., 83, pp. 89-105; Cermelli, C., Vinceti, M., Beretti, F., Pietrini, V., Nacci, G., Pietrosemoli, P., Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7 (2003) Eur. J. Epidemiol., 18, pp. 123-127; Ceroni, M., Malaspina, A., Poloni, T.E., Alimonti, D., Rognoni, F., Habgood, J., Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation (1999) Neurology, 53, pp. 1064-1071; Chancellor, A.M., Slattery, J.M., Fraser, H., Warlow, C.P., Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register (1993) J. Neurol. Neurosurg. Psychiatry, 56, pp. 1200-1206; Chen, Y., Huang, R., Chen, K., Song, W., Yang, Y., Zhao, B., Association analysis of PON polymorphisms in sporadic ALS in a Chinese population (2012) Neurobiol. Aging, 33, p. 2949. , (e1,2949. e3); Chen, Y., Li, S., Su, L., Sheng, J., Lv, W., Chen, G., Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis (2015) J. Neurol., 262, pp. 814-822; Chen, Y., Lin, Z., Chen, X., Cao, B., Wei, Q., Ou, R., Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis (2016) Neurobiol. Aging, 38, p. 217. , (e15,217. e22); Chio, A., Calvo, A., Dossena, M., Ghiglione, P., Mutani, R., Mora, G., ALS in Italian professional soccer players: the risk is still present and could be soccer-specific (2009) Amyotroph. Lateral Scler., 10, pp. 205-209; Chio, A., Calvo, A., Ilardi, A., Cavallo, E., Moglia, C., Mutani, R., Lower serum lipid levels are related to respiratory impairment in patients with ALS (2009) Neurology, 73, pp. 1681-1685; Chio, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Prognostic factors in ALS: a critical review (2009) Amyotroph. Lateral Scler., 10, pp. 310-323; Chio, A., Calvo, A., Moglia, C., Mazzini, L., Mora, G., PARALS study group: phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 740-746; Chio, A., Calvo, A., Mazzini, L., Cantello, R., Mora, G., Moglia, C., Extensive genetics of ALS: a population-based study in Italy (2012) Neurology, 79, pp. 1983-1989; Chio, A., Hammond, E.R., Mora, G., Bonito, V., Filippini, G., Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis (2013) J. Neurol. Neurosurg. Psychiatry; Chio, A., Mora, G., Restagno, G., Brunetti, M., Ossola, I., Barberis, M., UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study (2013) Neurobiol. Aging, 34, p. 357. , (e1,357. e5); Chio, A., Brunetti, M., Barberis, M., Iazzolino, B., Montuschi, A., Ilardi, A., The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis (2016) JAMA Neurol., 73, pp. 425-430; Consales, C., Merla, C., Marino, C., Benassi, B., Electromagnetic fields, oxidative stress, and neurodegeneration (2012) Int. J. Cell Biol., 2012, p. 683897; Cooper-Knock, J., Hewitt, C., Highley, J.R., Brockington, A., Milano, A., Man, S., Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72 (2012) Brain, 135, pp. 751-764; Cox, P., Richer, R., Metcalf, J., Banack, S., Codd, G., Bradley, W., Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans (2009) Amyotroph. Lateral Scler., 10, pp. 109-117; Cronin, S., Hardiman, O., Traynor, B.J., Ethnic variation in the incidence of ALS: a systematic review (2007) Neurology, 68, pp. 1002-1007; Cruz-Aguado, R., Winkler, D., Shaw, C.A., Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice (2006) Pharmacol. Biochem. Behav., 84, pp. 294-299; Czaplinski, A., Yen, A.A., Simpson, E.P., Appel, S.H., Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing (2006) Arch. Neurol., 63, pp. 1139-1143; Daviglus, M.L., Plassman, B.L., Pirzada, A., Bell, C.C., Bowen, P.E., Burke, J.R., Risk factors and preventive interventions for Alzheimer disease: state of the science (2011) Arch. Neurol., 68, pp. 1185-1190; Dedic, S.I., Stevic, Z., Dedic, V., Stojanovic, V.R., Milicev, M., Lavrnic, D., Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis (2012) Neurol. Res., 34, pp. 576-580; de Jong, S.W., Huisman, M.H., Sutedja, N.A., van der Kooi, A.J., de Visser, M., Schelhaas, H.J., Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study (2012) Am. J. Epidemiol.; de Munck, E., Munoz-Saez, E., Miguel, B.G., Solas, M.T., Ojeda, I., Martinez, A., beta-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS (2013) Environ. Toxicol. Pharmacol., 36, pp. 243-255; Desnuelle, C., Dib, M., Garrel, C., Favier, A., A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group (2001) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 2, pp. 9-18; Diekstra, F.P., Van Deerlin, V.M., van Swieten, J.C., Al-Chalabi, A., Ludolph, A.C., Weishaupt, J.H., C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis (2014) Ann. Neurol., 76, pp. 120-133; Doi, H., Kikuchi, H., Murai, H., Kawano, Y., Shigeto, H., Ohyagi, Y., Motor neuron disorder simulating ALS induced by chronic inhalation of pyrethroid insecticides (2006) Neurology, 67, pp. 1894-1895; Doi, Y., Yokoyama, T., Tango, T., Takahashi, K., Fujimoto, K., Nakano, I., Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004 (2010) J. Neurol. Sci., 298, pp. 78-84; Dorst, J., Kuhnlein, P., Hendrich, C., Kassubek, J., Sperfeld, A.D., Ludolph, A.C., Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis (2011) J. Neurol., 258, pp. 613-617; Drory, V.E., Artmonov, I., Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin. A clue to modifying genetic factors? (2007) J. Neurol. Sci., 258, pp. 39-43; Drory, V.E., Birnbaum, M., Korczyn, A.D., Chapman, J., Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis (2001) J. Neurol. Sci., 190, pp. 17-20; Duncan, M.W., Steele, J.C., Kopin, I.J., Markey, S.P., 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam (1990) Neurology, 40, pp. 767-772; Dupuis, L., Corcia, P., Fergani, A., Gonzalez De Aguilar, J.L., Bonnefont-Rousselot, D., Bittar, R., Dyslipidemia is a protective factor in amyotrophic lateral sclerosis (2008) Neurology, 70, pp. 1004-1009; Edrissi, B., Taghizadeh, K., Dedon, P.C., Quantitative analysis of histone modifications: formaldehyde is a source of pathological n(6)-formyllysine that is refractory to histone deacetylases (2013) PLoS Genet., 9, p. e1003328; Ermilova, I.P., Ermilov, V.B., Levy, M., Ho, E., Pereira, C., Beckman, J.S., Protection by dietary zinc in ALS mutant G93A SOD transgenic mice (2005) Neurosci. Lett., 379, pp. 42-46; Esik, O., Vönöczky, K., Lengyel, Z., Sáfrány, G., Trón, L., Characteristics of radiogenic lower motor neurone disease, a possible link with a preceding viral infection (2004) Spinal Cord Off. J. Int. Med. Soc. Paraplegia, 42 (February 01), pp. 99-105; Fang, F., Ye, W., Smoking may be considered an established risk factor for sporadic als (2010) Neurology, 74, p. 1927; Fang, F., Bellocco, R., Heman, M., Ye, W., Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis – a prospective cohort study (2006) Neuroepidemiology, 27, pp. 217-221; Fang, F., Quinlan, P., Ye, W., Barber, M.K., Umbach, D.M., Sandler, D.P., Workplace exposures and the risk of amyotrophic lateral sclerosis (2009) Environ. Health Perspect., 117, pp. 1387-1392; Fang, F., Kwee, L.C., Allen, K.D., Umbach, D.M., Ye, W., Watson, M., Association between blood lead and the risk of amyotrophic lateral sclerosis (2010) Am. J. Epidemiol., 171, pp. 1126-1133; Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G.N., Radi, E., Mitochondria, oxidative stress and neurodegeneration (2012) J. Neurol. Sci., 322, pp. 254-262; Ferrari, R., Hernandez, D.G., Nalls, M.A., Rohrer, J.D., Ramasamy, A., Kwok, J.B., Frontotemporal dementia and its subtypes: a genome-wide association study (2014) Lancet Neurol., 13, pp. 686-699; Field, N.C., Metcalf, J.S., Caller, T.A., Banack, S.A., Cox, P.A., Stommel, E.W., Linking beta-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD (2013) Toxicon, 70, pp. 179-183; Figueroa-Romero, C., Hur, J., Bender, D.E., Delaney, C.E., Cataldo, M.D., Smith, A.L., Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis (2012) PLoS One, 7, p. e52672; Fitzgerald, K.C., O'Reilly, E.J., Fondell, E., Falcone, G.J., McCullough, M.L., Park, Y., Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies (2013) Ann. Neurol., 73, pp. 236-245; Fitzgerald, K.C., O'Reilly, E.J., Falcone, G.J., McCullough, M.L., Park, Y., Kolonel, L.N., Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis (2014) JAMA Neurol.; Fogh, I., Ratti, A., Gellera, C., Lin, K., Tiloca, C., Moskvina, V., A genome-wide association meta-analysis identifies a novel locus at 17q11: 2 associated with sporadic amyotrophic lateral sclerosis (2014) Hum. Mol. Genet., 23, pp. 2220-2231; Fondell, E., Fitzgerald, K.C., Falcone, G.J., O'Reilly, E.J., Ascherio, A., Early-onset alopecia and amyotrophic lateral sclerosis: a cohort study (2013) Am. J. Epidemiol., 178, pp. 1146-1149; Fondell, E., O'Reilly, E.I., Fitzgerald, K.C., Falcone, G.J., Kolonel, L.N., Park, Y., Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: results from five cohort studies (2015) Amyotroph. Lateral Scler. Frontotemporal Degener., 16, pp. 366-371; Fonseca, R.G., Resende, L.A., Silva, M.D., Camargo, A., Chronic motor neuron disease possibly related to intoxication with organochlorine insecticides (1993) Acta Neurol. Scand., 88, pp. 56-58; Forbes, R.B., Colville, S., Cran, G.W., Swingler, R.J., Scottish Motor Neurone Disease Register: unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease (2004) J. Neurol. Neurosurg. Psychiatry, 75, pp. 1753-1755; Freedman, D.M., Wu, J., Daugherty, S.E., Kuncl, R.W., Enewold, L.R., Pfeiffer, R.M., The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study (2014) Int. J. Cancer, 135, pp. 1745-1750; Galbussera, A., Tremolizzo, L., Brighina, L., Testa, D., Lovati, R., Ferrarese, C., Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study (2006) Neurol. Sci., 27, pp. 190-193; Gallagher, J.P., Sanders, M., Trauma and amyotrophic lateral sclerosis: a report of 78 patients (1987) Acta Neurol. Scand., 75, pp. 145-150; Gallo, V., Bueno-De-Mesquita, H., Vermeulen, R., Andersen, P.M., Kyrozis, A., Linseisen, J., Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort (2009) Ann. Neurol., 65, pp. 378-385; Gargiulo-Monachelli, G.M., Janota, F., Bettini, M., Shoesmith, C.L., Strong, M.J., Sica, R.E., Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis (2012) Eur. J. Neurol., 19, pp. 834-841; Georgoulopoulou, E., Vinceti, M., Bonvicini, F., Sola, P., Goldoni, C.A., De Girolamo, G., Changing incidence and subtypes of ALS in Modena, Italy: a 10-years prospective study (2011) Amyotroph. Lateral Scler., 12, pp. 451-457; Gibson, S.B., Abbott, D., Farnham, J.M., Thai, K.K., McLean, H., Figueroa, K.P., Population-based risks for cancer in patients with ALS (2016) Neurology, 87, pp. 289-294; Gil, J., Vazquez, M.C., Ketzoian, C., Perna, A., Marin, B., Preux, P.M., Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population (2009) Amyotroph. Lateral Scler., 10, pp. 355-360; Glover, W.B., Mash, D.C., Murch, S.J., The natural non-protein amino acid N-beta-methylamino-L-alanine (BMAA) is incorporated into protein during synthesis (2014) Amino Acids, 46, pp. 2553-2559; Goh, K.J., Tian, S., Shahrizaila, N., Ng, C.W., Tan, C.T., Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population (2011) Amyotroph. Lateral Scler., 12, pp. 124-129; Gordon, P.H., Artaud, F., Aouba, A., Laurent, F., Meininger, V., Elbaz, A., Changing mortality for motor neuron disease in France (1968–2007): an age-period-cohort analysis (2011) Eur. J. Epidemiol., 26, pp. 729-737; Gordon, P.H., Delgadillo, D., Piquard, A., Bruneteau, G., Pradat, P.F., Salachas, F., The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance (2011) Amyotroph. Lateral Scler., 12, pp. 372-378; Gordon, P.H., Salachas, F., Bruneteau, G., Pradat, P.F., Lacomblez, L., Gonzalez-Bermejo, J., Improving survival in a large French ALS center cohort (2012) J. Neurol., 259, pp. 1788-1792; Goris, A., van Setten, J., Diekstra, F., Ripke, S., Patsopoulos, N.A., Sawcer, S.J., No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis (2014) Hum. Mol. Genet., 23, pp. 1916-1922; Govone, F., Vacca, A., Rubino, E., Gai, A., Boschi, S., Gentile, S., Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: a comprehensive meta-analysis (2014) Amyotroph. Lateral Scler. Frontotemporal Degener., 15, pp. 551-556; Grad, L.I., Guest, W.C., Yanai, A., Pokrishevsky, E., O'Neill, M.A., Gibbs, E., Intermolecular transmission of superoxide dismutase 1 misfolding in living cells (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 16398-16403; Graf, M., Ecker, D., Horowski, R., Kramer, B., Riederer, P., Gerlach, M., High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study (2005) J. Neural Transm., 112, pp. 649-660; Gresham, L.S., Molgaard, C.A., Golbeck, A.L., Smith, R., Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study (1986) Neuroepidemiology, 5, pp. 29-38; Gresham, L.S., Molgaard, C.A., Golbeck, A.L., Smith, R., Lead exposure and ALS (1992) Neurology, 42, pp. 2228-2229; Groeneveld, G.J., de Leeuw van Weenen, J., van Muiswinkel, F.L., Veldman, H., Veldink, J.H., Wokke, J.H., Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis (2003) Neurosci. Lett., 352, pp. 175-178; Guest, W.C., Plotkin, S.S., Cashman, N.R., Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions (2011) J. Toxicol. Environ. Health A, 74, pp. 154-160; Gunnarsson, L.G., Lindberg, G., Soderfeldt, B., Axelson, O., Amyotrophic lateral sclerosis in Sweden in relation to occupation (1991) Acta Neurol. Scand., 83, pp. 394-398; Gunnarsson, L.G., Lygner, P.E., Veiga-Cabo, J., de Pedro-Cuesta, J., An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973–1984 (1996) Neuroepidemiology, 15, pp. 142-152; Haley, R.W., Excess incidence of ALS in young Gulf War veterans (2003) Neurology, 61, pp. 750-756; Hall, E.D., Andrus, P.K., Oostveen, J.A., Fleck, T.J., Gurney, M.E., Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS (1998) J. Neurosci. Res., 53, pp. 66-77; Hamidou, B., Couratier, P., Besancon, C., Nicol, M., Preux, P.M., Marin, B., Epidemiological evidence that physical activity is not a risk factor for ALS (2014) Eur. J. Epidemiol., 29, pp. 459-475; Harwood, C.A., McDermott, C.J., Shaw, P.J., Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence (2009) Amyotroph. Lateral Scler., 10, pp. 191-204; He, J., Mangelsdorf, M., Fan, D., Bartlett, P., Brown, M.A., Amyotrophic lateral sclerosis genetic studies: from genome-wide association mapping to genome sequencing (2015) Neuroscientist, 21, pp. 599-615; Hersi, M., Quach, P., Wang, M.D., Gomes, J., Gaskin, J., Krewski, D., Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview (2016) Neurotoxicology, (July 1). , pii: S0161-813X(16)30118-8; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat. Med., 21, pp. 1539-1558; Horner, R.D., Kamins, K.G., Feussner, J.R., Grambow, S.C., Hoff-Lindquist, J., Harati, Y., Occurrence of amyotrophic lateral sclerosis among Gulf War veterans (2003) Neurology, 61, pp. 742-749; Horner, R.D., Grambow, S.C., Coffman, C.J., Lindquist, J.H., Oddone, E.Z., Allen, K.D., Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak (2008) Neuroepidemiology, 31, pp. 28-32; Huang, R., Guo, X., Chen, X., Zheng, Z., Wei, Q., Cao, B., The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south-west China and a meta-analysis (2015) Amyotroph. Lateral Scler. Frontotemporal Degener., 16, pp. 359-365; Huss, A., Spoerri, A., Egger, M., Roosli, M., Swiss National Cohort Study: residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population (2009) Am. J. Epidemiol., 169, pp. 167-175; Ingram, C.J., Weale, M.E., Plaster, C.A., Morrison, K.E., Goodall, E.F., Pall, H.S., Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis (2012) Amyotroph. Lateral Scler., 13, pp. 341-346; Iwami, O., Watanabe, T., Moon, C., Nakatsuka, H., Ikeda, M., Motor neuron disease on the kii peninsula of Japan: excess manganese intake from food coupled with low magnesium in drinking water as a risk factor (1994) Sci. Total Environ., 149, p. 121; Jawaid, A., Poon, M., Strutt, A.M., Rice, L.K., McDowell, E.J., Salamone, A.R., Does apolipoprotein E genotype modify the clinical expression of ALS (2011) Eur. J. Neurol., 18, pp. 618-624; Johnson, F., Atchison, W., The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis (2009) Neurotoxicology, 30, pp. 761-765; Jokanovic, M., Kosanovic, M., Neurotoxic effects in patients poisoned with organophosphorus pesticides (2010) Environ. Toxicol. Pharmacol., 29, pp. 195-201; Jubelt, B., Lipton, H.L., ALS: persistent scientists do not find persisting enteroviruses (2004) Neurology, 62, pp. 1250-1251; Jubelt, B., Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas (1992) Curr. Opin. Neurol. Neurosurg., 5, pp. 655-658; Kaal, E.C., Veldman, H., Sodaar, P., Joosten, E.A., Dop Bar, P.R., Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons (1998) J. Neurosci. Res., 54, pp. 778-786; Kamel, F., Umbach, D.M., Munsat, T.L., Shefner, J.M., Sandler, D.P., Association of cigarette smoking with amyotrophic lateral sclerosis (1999) Neuroepidemiology, 18, pp. 194-202; Kamel, F., Umbach, D., Munsat, T., Shefner, J., Hu, H., Sandler, D., Lead exposure and amyotrophic lateral sclerosis (2002) Epidemiology, 13, pp. 311-319; Kamel, F., Umbach, D.M., Hu, H., Munsat, T.L., Shefner, J.M., Taylor, J.A., Lead exposure as a risk factor for amyotrophic lateral sclerosis (2005) Neurodegener. Dis., 2, pp. 195-201; Kamel, F., Umbach, D.M., Stallone, L., Richards, M., Hu, H., Sandler, D.P., Association of lead exposure with survival in amyotrophic lateral sclerosis (2008) Environ. Health Perspect., 116, pp. 943-947; Kamel, F., Umbach, D.M., Bedlack, R.S., Richards, M., Watson, M., Alavanja, M.C., Pesticide exposure and amyotrophic lateral sclerosis (2012) Neurotoxicology, 33, pp. 457-462; Kaneb, H.M., Dion, P.A., Rouleau, G.A., The FUS about arginine methylation in ALS and FTLD (2012) EMBO J., 31, pp. 4249-4251; Kang, H., Cha, E.S., Choi, G.J., Lee, W.J., Amyotrophic lateral sclerosis and agricultural environments: a systematic review (2014) J. Korean Med. Sci., 29, pp. 1610-1617; Keller, M.F., Ferrucci, L., Singleton, A.B., Tienari, P.J., Laaksovirta, H., Restagno, G., Genome-wide analysis of the heritability of amyotrophic lateral sclerosis (2014) JAMA Neurol., 71, pp. 1123-1134; Kihira, T., Kanno, S., Miwa, H., Okamoto, K., Kondo, T., The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan (2007) Amyotroph. Lateral Scler., 8, pp. 150-156; Kihira, T., Yoshida, S., Okamoto, K., Kazimoto, Y., Ookawa, M., Hama, K., Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966–2005 (2008) J. Neurol. Sci., 268, pp. 95-101; Kim, W.K., Liu, X., Sandner, J., Pasmantier, M., Andrews, J., Rowland, L.P., Study of 962 patients indicates progressive muscular atrophy is a form of ALS (2009) Neurology, 73, pp. 1686-1692; Kim, S.M., Kim, H., Kim, J.E., Park, K.S., Sung, J.J., Kim, S.H., Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice (2011) PLoS One, 6, p. e17985; Korczyn, A.D., Drory, V.E., Smoking and amyotrophic lateral sclerosis (2010) Ann. Neurol., 67, p. 694; Korner, S., Kollewe, K., Ilsemann, J., Muller-Heine, A., Dengler, R., Krampfl, K., Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis (2013) Eur. J. Neurol., 20, pp. 647-654; Kurlander, H.M., Patten, B.M., Metals in spinal cord tissue of patients dying of motor neuron disease (1979) Ann. Neurol., 6, pp. 21-24; Lacomblez, L., Doppler, V., Beucler, I., Costes, G., Salachas, F., Raisonnier, A., APOE: a potential marker of disease progression in ALS (2002) Neurology, 58, pp. 1112-1114; Laffita-Mesa, J.M., Rodriguez Pupo, J.M., Moreno Sera, R., Vazquez Mojena, Y., Kouri, V., Laguna-Salvia, L., De novo mutations in ataxin-2 gene and ALS risk (2013) PLoS One, 8, p. e70560; Lambrechts, D., Poesen, K., Fernandez-Santiago, R., Al-Chalabi, A., Del Bo, R., Van Vught, P., Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the-2578AA genotype (2009) J. Med. Genet., 46, pp. 840-846; Lee, Y.H., Kim, J.H., Seo, Y.H., Choi, S.J., Ji, J.D., Song GG. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis (2015) Neurol. Sci., 36, pp. 11-20; Li, C.Y., Sung, F.C., Association between occupational exposure to power frequency electromagnetic fields and amyotrophic lateral sclerosis: a review (2003) Am. J. Ind. Med., 43, pp. 212-220; Li, M., Wang, L., Wang, W., Qi, X.L., Tang, Z.Y., Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies (2014) Braz. J. Med. Biol. Res., 47, pp. 215-222; Lill, C.M., Abel, O., Bertram, L., Al-Chalabi, A., Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases (2011) Amyotroph. Lateral Scler., 12, pp. 238-249; Lill, C.M., Rengmark, A., Pihlstrom, L., Fogh, I., Shatunov, A., Sleiman, P.M., The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease (2015) Alzheimers Dement., 11, pp. 1407-1416; Livesley, B., Sissons, C.E., Chronic lead intoxication mimicking motor neurone disease (1968) Br. Med. J., 4, pp. 387-388; Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Couratier, P., Mitchell, J.D., Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues (2008) J. Neurol. Neurosurg. Psychiatry, 79, pp. 6-11; Longstreth, W.T., McGuire, V., Koepsell, T.D., Wang, Y., van Belle, G., Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study (1998) Arch. Neurol., 55, pp. 201-206; Ludolph, A.C., Brettschneider, J., Weishaupt, J.H., Amyotrophic lateral sclerosis (2012) Curr. Opin. Neurol., 25, pp. 530-535; Mackenzie, I.R., Ansorge, O., Strong, M., Bilbao, J., Zinman, L., Ang, L.C., Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation (2011) Acta Neuropathol., 122, pp. 87-98; Maiti, T.K., Konar, S., Bir, S., Kalakoti, P., Bollam, P., Nanda, A., Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review (2015) Neurosurg. Focus, 39, p. E3; Malaspina, A., Alimonti, D., Poloni, T., Ceroni, M., Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy (2002) Funct. Neurol., 17, pp. 177-182; Malek, A.M., Barchowsky, A., Bowser, R., Youk, A., Talbott, E.O., Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS (2012) Environ. Res.; Malek, A.M., Barchowsky, A., Bowser, R., Heiman-Patterson, T., Lacomis, D., Rana, S., Exposure to hazardous air pollutants and the risk of amyotrophic lateral sclerosis (2015) Environ. Pollut., 197, pp. 181-186; Marin, B., Couratier, P., Preux, P.M., Logroscino, G., Can mortality data be used to estimate amyotrophic lateral sclerosis incidence (2011) Neuroepidemiology, 36, pp. 29-38; Marin, B., Desport, J.C., Kajeu, P., Jesus, P., Nicolaud, B., Nicol, M., Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 628-634; Masseret, E., Banack, S., Boumediene, F., Abadie, E., Brient, L., Pernet, F., Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France (2013) PLoS One, 8, p. e83406; McCombe, P.A., Henderson, R.D., Effects of gender in amyotrophic lateral sclerosis (2010) Gend Med., 7, pp. 557-570; McGuire, V., Longstreth, W.T., Jr., Nelson, L.M., Koepsell, T.D., Checkoway, H., Morgan, M.S., Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study (1997) Am. J. Epidemiol., 145, pp. 1076-1088; McKee, A.C., Cantu, R.C., Nowinski, C.J., Hedley-Whyte, E.T., Gavett, B.E., Budson, A.E., Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury (2009) J. Neuropathol. Exp. Neurol., 68, pp. 709-735; McKee, A.C., Stein, T.D., Nowinski, C.J., Stern, R.A., Daneshvar, D.H., Alvarez, V.E., The spectrum of disease in chronic traumatic encephalopathy (2013) Brain, 136, pp. 43-64; Michal Freedman, D., Kuncl, R.W., Weinstein, S.J., Malila, N., Virtamo, J., Albanes, D., Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis (2013) Amyotroph. Lateral Scler. Frontotemporal Degener.; Miranda, M.L., Alicia Overstreet Galeano, M., Tassone, E., Allen, K.D., Horner, R.D., Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans (2008) Neurotoxicology, 29, pp. 964-970; Mitchell, J.D., East, B.W., Harris, I.A., Pentland, B., Manganese, selenium and other trace elements in spinal cord, liver and bone in motor neurone disease (1991) Eur. Neurol., 31, pp. 7-11; Mitchell, J.D., Callagher, P., Gardham, J., Mitchell, C., Dixon, M., Addison-Jones, R., Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)–a 20-year review: can we do better? (2010) Amyotroph. Lateral Scler., 11, pp. 537-541; Mitchell, J.D., Heavy metals and trace elements in amyotrophic lateral sclerosis (1987) Neurol. Clin., 5, pp. 43-60; Morahan, J.M., Pamphlett, R., Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study (2006) Neuroepidemiology, 27, pp. 130-135; Morahan, J.M., Yu, B., Trent, R.J., Pamphlett, R., A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis (2007) Neurotoxicology, 28, pp. 532-540; Morozova, N., Weisskopf, M., McCullough, M., Munger, K., Calle, E., Thun, M., Diet and amyotrophic lateral sclerosis (2008) Epidemiology, 19, pp. 324-337; Moulard, B., Sefiani, A., Laamri, A., Malafosse, A., Camu, W., Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis (1996) J. Neurol. Sci., 139, pp. 34-37; Murch, S.J., Cox, P.A., Banack, S.A., Steele, J.C., Sacks, O.W., Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam (2004) Acta Neurol. Scand., 110, pp. 267-269; Murray, M.E., DeJesus-Hernandez, M., Rutherford, N.J., Baker, M., Duara, R., Graff-Radford, N.R., Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 (2011) Acta Neuropathol., 122, pp. 673-690; Nalini, A., Thennarasu, K., Gourie-Devi, M., Shenoy, S., Kulshreshtha, D., Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India (2008) J. Neurol. Sci., 272, pp. 60-70; Nelson, L., Matkin, C., Longstreth, W., McGuire, V., Population-based case-control study of amyotrophic lateral sclerosis in western Washington Sate. II. Diet (2000) Am. J. Epidemiol., 151, pp. 164-173; Neuenschwander, A.G., Thai, K.K., Figueroa, K.P., Pulst, S.M., Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis (2014) JAMA Neurol., 71, pp. 1529-1534; Nix, W.A., Berger, M.M., Oberste, M.S., Brooks, B.R., McKenna-Yasek, D.M., Brown, R.H., Jr., Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method (2004) Neurology, 62, pp. 1372-1377; Nonaka, T., Masuda-Suzukake, M., Arai, T., Hasegawa, Y., Akatsu, H., Obi, T., Prion-like properties of pathological TDP-43 aggregates from diseased brains (2013) Cell Rep., 4, pp. 124-134; Noonan, C.W., White, M.C., Thurman, D., Wong, L.Y., Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998 (2005) Neurology, 64, pp. 1215-1221; O'Reilly, E.J., Wang, H., Weisskopf, M.G., Fitzgerald, K.C., Falcone, G., McCullough, M.L., Premorbid body mass index and risk of amyotrophic lateral sclerosis (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 14, pp. 205-211; Oh, S.S., Kim, E.A., Lee, S.W., Kim, M.K., Kang, S.K., A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead (2007) Neurotoxicology, 28, pp. 324-327; Oh, S.I., Baek, S., Park, J.S., Piao, L., Oh, K.W., Kim, S.H., Prognostic role of serum levels of uric acid in amyotrophic lateral sclerosis (2015) J. Clin. Neurol., 11, pp. 376-382; Okamoto, K., Kihira, T., Kobashi, G., Washio, M., Sasaki, S., Yokoyama, T., Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan (2009) Neuroepidemiology, 32, pp. 251-256; Okamoto, K., Kihira, T., Kondo, T., Kobashi, G., Washio, M., Sasaki, S., Lifestyle factors and risk of amyotrophic lateral sclerosis: a case-Control study in Japan (2009) Ann. Epidemiol., 19, pp. 359-364; Oteiza, P.I., Uchitel, O.D., Carrasquedo, F., Dubrovski, A.L., Roma, J.C., Fraga, C.G., Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients (1997) Neurochem. Res., 22, pp. 535-539; Paganoni, S., Deng, J., Jaffa, M., Cudkowicz, M.E., Wills, A.M., Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis (2011) Muscle Nerve, 44, pp. 20-24; Paganoni, S., Deng, J., Jaffa, M., Cudkowicz, M.E., Wills, A.M., What does body mass index measure in amyotrophic lateral sclerosis and why should we care? (2012) Muscle Nerve, 45, p. 612; Pall, H.S., Williams, A.C., Waring, R., Elias, E., Motoneurone disease as manifestation of pesticide toxicity (1987) Lancet, 2, p. 685; Pamphlett, R., Png, F.Y., Shrinkage of motor axons following systemic exposure to inorganic mercury (1998) J. Neuropathol. Exp. Neurol., 57, pp. 360-366; Pan, L., Deng, X., Ding, D., Leng, H., Zhu, X., Wang, Z., Association between the Angiogenin (ANG) K17I variant and amyotrophic lateral sclerosis risk in Caucasian: a meta-analysis (2015) Neurol. Sci., 36, pp. 2163-2168; Pan, L.S., Deng, X.B., Wang, Z., Leng, H.L., Zhu, X.P., Ding, D., Lack of association between the Angiogenin (ANG) rs11701 polymorphism and amyotrophic lateral sclerosis risk: a meta-analysis (2016) Neurol. Sci., 37, pp. 655-662; Park, R., Schulte, P., Bowman, J., Walker, J., Bondy, S., Yost, M., Potential occupational risks for neurodegenerative diseases (2005) Am. J. Ind. Med., 48, pp. 63-77; Parker, L., McGuckin, T.A., Leicht, A.S., Influence of exercise intensity on systemic oxidative stress and antioxidant capacity (2014) Clin. Physiol. Funct. Imaging, 34, pp. 377-383; Pastula, D.M., Coffman, C.J., Allen, K.D., Oddone, E.Z., Kasarskis, E.J., Lindquist, J.H., Factors associated with survival in the National Registry of Veterans with ALS (2009) Amyotroph. Lateral Scler., 10, pp. 332-338; Perry, T.L., Bergeron, C., Biro, A.J., Hansen, S., Beta-N-methylamino-L-alanine: chronic oral administration is not neurotoxic to mice (1989) J. Neurol. Sci., 94, pp. 173-180; Pfister, T., Sekhon, R., White, M., Scott, P., Munro, S., Johnston, M., Familial amyotrophic lateral sclerosis in Alberta, Canada (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 14, pp. 273-277; Phukan, J., Pender, N.P., Hardiman, O., Cognitive impairment in amyotrophic lateral sclerosis (2007) Lancet Neurol., 6, pp. 994-1003; Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study (2011) J. Neurol. Neurosurg. Psychiatry; Piaceri, I., Del Mastio, M., Tedde, A., Bagnoli, S., Latorraca, S., Massaro, F., Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis (2011) Clin. Genet.; Pierce-Ruhland, R., Patten, B.M., Repeat study of antecedent events in motor neuron disease (1981) Ann. Clin. Res., 13, pp. 102-107; Pinkerton, L.E., Hein, M.J., Meyers, A., Kamel, F., Assessment of ALS mortality in a cohort of formaldehyde-exposed garment workers (2013) Amyotroph. Lateral Scler. Frontotemporal Degener., 14, pp. 353-355; Plato, C.C., Garruto, R.M., Galasko, D., Craig, U., Plato, M., Gamst, A., Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years (2003) Am. J. Epidemiol., 157, pp. 149-157; Poloni, M., Micheli, A., Facchetti, D., Mai, R., Ceriani, F., Cattalini, C., Conjugal amyotrophic lateral sclerosis: toxic clustering or change (1997) Ital. J. Neurol. Sci., 18, pp. 109-112; Poulletier de Gannes, F., Ruffie, G., Taxile, M., Ladeveze, E., Hurtier, A., Haro, E., Amyotrophic lateral sclerosis (ALS) and extremely-low frequency (ELF) magnetic fields: a study in the SOD-1 transgenic mouse model (2009) Amyotroph. Lateral Scler., 10, pp. 370-373; Praline, J., Guennoc, A.M., Limousin, N., Hallak, H., de Toffol, B., Corcia, P., ALS and mercury intoxication: a relationship (2007) Clin. Neurol. Neurosurg., 109, pp. 880-883; Praline, J., Blasco, H., Vourc'h, P., Garrigue, M.A., Gordon, P.H., Camu, W., APOE epsilon4 allele is associated with an increased risk of bulbar-onset amyotrophic lateral sclerosis in men (2011) Eur. J. Neurol., 18, pp. 1046-1052; Provinciali, L., Giovagnoli, A.R., Antecedent events in amyotrophic lateral sclerosis: do they influence clinical onset and progression (1990) Neuroepidemiology, 9, pp. 255-262; Pupillo, E., Messina, P., Logroscino, G., Zoccolella, S., Chio, A., Calvo, A., Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry (2012) Eur. J. Neurol., 19, pp. 1509-1517; Qureshi, M.M., Hayden, D., Urbinelli, L., Ferrante, K., Newhall, K., Myers, D., Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) (2006) Amyotroph. Lateral Scler., 7, pp. 173-182; Ratti, A., Corrado, L., Castellotti, B., Del Bo, R., Fogh, I., Cereda, C., C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect (2012) Neurobiol. Aging, 33 (2528), pp. e7-14; Reisner, H.M., Lundblad, R.L., Identifying residues in antigenic determinants by chemical modification (2009) Methods Mol. Biol., 524, pp. 103-117; Rentzos, M., Evangelopoulos, E., Sereti, E., Zouvelou, V., Marmara, S., Alexakis, T., Alterations of T cell subsets in ALS: a systemic immune activation? (2011) Acta Neurol. Scand.; Ricci, C., Battistini, S., Cozzi, L., Benigni, M., Origone, P., Verriello, L., Lack of association of PON polymorphisms with sporadic ALS in an Italian population (2011) Neurobiol. Aging, 32, p. 552. , (e7,552.13); Robberecht, W., Genetics of amyotrophic lateral sclerosis (2000) J. Neurol., 247, pp. VI/2-VI/6; Roberts, A.L., Johnson, N.J., Cudkowicz, M.E., Eum, K.D., Weisskopf, M.G., Job-related formaldehyde exposure and ALS mortality in the USA (2015) J. Neurol. Neurosurg. Psychiatry; Rose, M.R., Brix, K.A., Neurological disorders in gulf war veterans (2006) Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 361 (April), p. 29; Rose, K.A., Electrical shock injury (1994) J. Manipulative Physiol. Ther., 17, pp. 174-176; Sabatelli, M., Madia, F., Conte, A., Luigetti, M., Zollino, M., Mancuso, I., Natural history of young-adult amyotrophic lateral sclerosis (2008) Neurology, 71, pp. 876-881; Sabatelli, M., Conte, A., Zollino, M., Clinical and genetic heterogeneity of amyotrophic lateral sclerosis (2013) Clin. Genet., 83, pp. 408-416; Saeed, M., Siddique, N., Hung, W.Y., Usacheva, E., Liu, E., Sufit, R.L., Paraoxonase cluster polymorphisms are associated with sporadic ALS (2006) Neurology, 67, pp. 771-776; Sathasivam, S., Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers (2010) Singapore Med. J., 51 (367), p. 72. , (quiz 373); Scarmeas, N., Shih, T., Stern, Y., Ottman, R., Rowland, L.P., Premorbid weight, body mass, and varsity athletics in ALS (2002) Neurology, 59, pp. 773-775; Scarpa, M., Colombo, A., Panzetti, P., Sorgato, P., Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead (1988) Acta Neurol. Scand., 77, pp. 456-460; Schmidt, S., Kwee, L.C., Allen, K.D., Oddone, E.Z., Association of ALS with head injury, cigarette smoking and APOE genotypes (2010) J. Neurol. Sci., 291, pp. 22-29; Seals, R.M., Hansen, J., Gredal, O., Weisskopf, M.G., Physical trauma and amyotrophic lateral sclerosis: a population-based study using danish national registries (2016) Am. J. Epidemiol., 183, pp. 294-301; Seltman, R.E., Matthews, B.R., Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management (2012) CNS Drugs, 26, pp. 841-870; Shea, B.J., Bouter, L.M., Peterson, J., Boers, M., Andersson, N., Ortiz, Z., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS One, 2, p. e1350; Shimizu, T., Nagaoka, U., Nakayama, Y., Kawata, A., Kugimoto, C., Kuroiwa, Y., Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan (2012) Amyotroph. Lateral Scler., 13, pp. 363-366; Silani, V., Messina, S., Poletti, B., Morelli, C., Doretti, A., Ticozzi, N., The diagnosis of Amyotrophic lateral sclerosis in 2010 (2011) Arch. Ital. Biol., 149, pp. 5-27; Sirdofsky, M.D., Hawley, R.J., Manz, H., Progressive motor neuron disease associated with electrical injury (1991) Muscle Nerve, 14, pp. 977-980; Sleegers, K., Brouwers, N., Maurer-Stroh, S., van Es, M.A., Van Damme, P., van Vught, P.W., Progranulin genetic variability contributes to amyotrophic lateral sclerosis (2008) Neurology, 71, pp. 253-259; Smethurst, P., Sidle, K.C., Hardy, J., Prion-like mechanisms of TDP-43 in ALS (2014) Neuropathol. Appl. Neurobiol.; Smith, B.N., Newhouse, S., Shatunov, A., Vance, C., Topp, S., Johnson, L., The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder (2012) Eur. J. Hum. Genet.; Smith, B.N., Vance, C., Scotter, E.L., Troakes, C., Wong, C.H., Topp, S., Novel mutations support a role for Profilin 1 in the pathogenesis of ALS (2015) Neurobiol. Aging, 36, p. 1602. , (e17,1602. e27); Spencer, P.S., Hugon, J., Ludolph, A., Nunn, P.B., Ross, S.M., Roy, D.N., Discovery and partial characterization of primate motor-system toxins (1987) Ciba Found. Symp., 126, pp. 221-238; Spencer, P.S., Nunn, P.B., Hugon, J., Ludolph, A.C., Ross, S.M., Roy, D.N., Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin (1987) Science, 237, pp. 517-522; Spencer, P.S., Palmer, V.S., Ludolph, A.C., On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea) (2005) Mov. Disord. Off. J. Mov. Disord. Soc., 20, pp. S119-S126. , (August 01, 2005); Spencer, P.S., Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by slow toxin(s) in food (1987) Can. J. Neurol. Sci., 14, pp. 347-357; Steele, J.C., Parkinsonism-dementia complex of Guam (2005) Mov. Disorders: Off. J. Mov. Disord. Soc., 20, pp. S99-S107. , (August 01, 2005); Stewart, H., Rutherford, N.J., Briemberg, H., Krieger, C., Cashman, N., Fabros, M., Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p (2012) Acta Neuropathol.; Stohs, S.J., Bagchi, D., Oxidative mechanisms in the toxicity of metal ions (1995) Free Radic. Biol. Med., 18, pp. 321-336; Stone, R., Guam: deadly disease dying out (1993) Science, 261, pp. 424-426; Strickland, D., Smith, S.A., Dolliff, G., Goldman, L., Roelofs, R.I., Physical activity, trauma, and ALS: a case-control study (1996) Acta Neurol. Scand., 94, pp. 45-50; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Meta-analysis of observational studies in epidemiology: a proposal for reporting: meta-analysis of observational studies in epidemiology (MOOSE) group (2000) JAMA, 283, pp. 2008-2012; Su, F.C., Goutman, S.A., Chernyak, S., Mukherjee, B., Callaghan, B.C., Batterman, S., Association of environmental toxins with amyotrophic lateral sclerosis (2016) JAMA Neurol., 73, pp. 803-811; Sutedja, N.A., Veldink, J.H., Fischer, K., Kromhout, H., Wokke, J.H., Huisman, M.H., Lifetime occupation, education, smoking, and risk of ALS (2007) Neurology, 69, pp. 1508-1514; Sutedja, N.A., Veldink, J.H., Fischer, K., Kromhout, H., Heederik, D., Huisman, M.H., Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review (2009) Amyotroph. Lateral Scler., 10, pp. 302-309; Sutedja, N.A., Fischer, K., Veldink, J.H., van der Heijden, G.J.M.G., Kromhout, H., Heederik, D., What we truly know about occupation as a risk factor for ALS: a critical and systematic review (2009) Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Motor Neuron Dis., 10, pp. 295-301; Sutedja, N.A., van der Schouw, Y.T., Fischer, K., Sizoo, E.M., Huisman, M.H., Veldink, J.H., Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 638-642; Talman, P., Forbes, A., Mathers, S., Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database (2009) Amyotroph. Lateral Scler., 10, pp. 79-84; Terry, P.D., Kamel, F., Umbach, D.M., Lehman, T.A., Hu, H., Sandler, D.P., VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS) (2004) J. Neurogenet., 18, pp. 429-434; Testa, D., Lovati, R., Ferrarini, M., Salmoiraghi, F., Filippini, G., Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period (2004) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 5, pp. 208-212; Tetsuka, S., Morita, M., Iida, A., Uehara, R., Ikegawa, S., Nakano, I., ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis (2013) J. Neurol. Sci., 324, pp. 163-166; Ticozzi, N., LeClerc, A.L., Keagle, P.J., Glass, J.D., Wills, A.M., van Blitterswijk, M., Paraoxonase gene mutations in amyotrophic lateral sclerosis (2010) Ann. Neurol., 68, pp. 102-107; Tosi, L., Righetti, C., Adami, L., Zanette, G., October 1942: a strange epidemic paralysis in Saval, Verona, Italy. Revision and diagnosis 50 years later of tri-ortho-cresyl phosphate poisoning (1994) J. Neurol. Neurosurg. Psychiatry, 57, pp. 810-813; Trumbull, K.A., Beckman, J.S., A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis (2009) Antioxid. Redox Signal., 11, pp. 1627-1639; Tsong, T.Y., Su, Z.D., Biological effects of electric shock and heat denaturation and oxidation of molecules, membranes, and cellular functions (1999) Ann. N. Y. Acad. Sci., 888, pp. 211-232; Turabelidze, G., Zhu, B.P., Schootman, M., Malone, J.L., Horowitz, S., Weidinger, J., An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998–2002 (2008) Neurotoxicology, 29, pp. 81-86; Turner, M.R., Abisgold, J., Yeates, D.G., Talbot, K., Goldacre, M.J., Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS (2010) J. Neurol. Sci., 288, pp. 45-48; Turner, M.C., Wigle, D.T., Krewski, D., Residential pesticides and childhood leukemia: a systematic review and meta-analysis (2011) Cien. Saude Colet., 16, pp. 1915-1931; Turner, M.R., Wotton, C., Talbot, K., Goldacre, M.J., Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study (2012) J. Neurol. Neurosurg. Psychiatry, 83, pp. 395-398; Turner, M.R., Hardiman, O., Benatar, M., Brooks, B.R., Chio, A., de Carvalho, M., Controversies and priorities in amyotrophic lateral sclerosis (2013) Lancet Neurol., 12, pp. 310-322; Turner, M.R., Goldacre, R., Talbot, K., Goldacre, M.J., Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis (2015) J. Neurol. Neurosurg. Psychiatry; Uccelli, R., Binazzi, A., Altavista, P., Belli, S., Comba, P., Mastrantonio, M., Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data (2007) Eur. J. Epidemiol., 22, pp. 781-790; Valenti, M., Pontieri, F.E., Conti, F., Altobelli, E., Manzoni, T., Frati, L., Amyotrophic lateral sclerosis and sports: a case-control study (2005) Eur. J. Neurol., 12, pp. 223-225; Valentine, J.S., Doucette, P.A., Zittin Potter, S., Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis (2005) Annu. Rev. Biochem., 74 (Jan 01), pp. 563-593; Vanacore, N., Binazzi, A., Bottazzi, M., Belli, S., Amyotrophic lateral sclerosis in an Italian professional soccer player (2006) Parkinsonism Relat. Disord., 12, pp. 327-329; Vanacore, N., Cocco, P., Fadda, D., Dosemeci, M., Job strain, hypoxia and risk of amyotrophic lateral sclerosis: results from a death certificate study (2010) Amyotroph. Lateral Scler., 11, pp. 430-434; Vandenberghe, N., Leveque, N., Corcia, P., Brunaud-Danel, V., Salort-Campana, E., Besson, G., Cerebrospinal fluid detection of enterovirus genome in ALS: a study of 242 patients and 354 controls (2010) Amyotroph. Lateral Scler., 11, pp. 277-282; van Blitterswijk, M., Blokhuis, A., van Es, M.A., van Vught, P.W., Rowicka, P.A., Schelhaas, H.J., Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients (2012) Neurobiol. Aging; van Blitterswijk, M., DeJesus-Hernandez, M., Rademakers, R., How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders (2012) Curr. Opin. Neurol., 25, pp. 689-700; van der Zee, J., Van Langenhove, T., Kovacs, G.G., Dillen, L., Deschamps, W., Engelborghs, S., Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration (2014) Acta Neuropathol., 128, pp. 397-410; van Es, M.A., Veldink, J.H., Saris, C.G., Blauw, H.M., van Vught, P.W., Birve, A., Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis (2009) Nat. Genet., 41, pp. 1083-1087; van Rheenen, W., Diekstra, F.P., van Doormaal, P.T., Seelen, M., Kenna, K., McLaughlin, R., H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis (2013) Neurobiol. Aging, 34, p. 1517. , (e5,1517. e7); Veldink, J.H., Kalmijn, S., Van der Hout, A.H., Lemmink, H.H., Groeneveld, G.J., Lummen, C., SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS (2005) Neurology, 65, pp. 820-825; Veldink, J., Kalmijn, S., Groeneveld, G., Titulaer, M., Wokke, J., van den Berg, L., Physical activity and the association with sporadic ALS (2005) Neurology, 64, pp. 241-245; Veldink, J.H., Kalmijn, S., Groeneveld, G., Wunderink, W., Koster, A., de Vries, J., Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis (2007) J. Neurol. Neurosurg. Psychiatry, 78, pp. 367-371; Vergara, X., Kheifets, L., Greenland, S., Oksuzyan, S., Cho, Y.S., Mezei, G., Occupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: a meta-analysis (2013) J. Occup. Environ. Med., 55, pp. 135-146; Vinceti, M., Bonvicini, F., Bergomi, M., Malagoli, C., Possible involvement of overexposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review (2010) Ann. Ist. Super. Sanita, 46, pp. 279-283; Vinceti, M., Bottecchi, I., Fan, A., Finkelstein, Y., Mandrioli, J., Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis (2012) Rev. Environ. Health, 27, pp. 19-41; Wang, M.D., Little, J., How credible are meta-Analyses of risk factors based on observational studies for amyotrophic lateral sclerosis a new insight from an umbrella review (2016) Neuroepidemiology, 46, pp. 271-272; Wang, Y., Mao, X.O., Xie, L., Banwait, S., Marti, H.H., Greenberg, D.A., Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice (2007) J. Neurosci., 27, pp. 304-307; Wang, H., Weisskopf, M., O'Reilly, E., Logroscino, G., McCullough, M., Schatzkin, A., Prospective studies on smoking and risk off amyotrophic lateral sclerosis (2008) Neurology, 70, p. A190; Wang, H., O'Reilly, E.J., Weisskopf, M.G., Logroscino, G., McCullough, M.L., Schatzkin, A., Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies (2011) Am. J. Epidemiol., 173, pp. 595-602; Wang, H., O'Reilly, É.J., Weisskopf, M.G., Logroscino, G., McCullough, M.L., Thun, M.J., Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts (2011) Arch. Neurol., 68, pp. 207-213; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS–a systematic review and meta-analysis of observational studies (2014) PLoS One, 9, p. e105534; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis (2014) J. Occup. Environ. Med., 56, pp. 1235-1242; Wang, X.B., Cui, N.H., Gao, J.J., Qiu, X.P., Zheng, F., SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: evidence from a meta-analysis (2014) J. Neurol. Sci., 340, pp. 63-68; Waring, S.C., Esteban-Santillan, C., Reed, D.M., Craig, U., Labarthe, D.R., Petersen, R.C., Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950–1989 (2004) Neuroepidemiology, 23, pp. 192-200; Weisskopf, M.G., McCullough, M.L., Calle, E.E., Thun, M.J., Cudkowicz, M., Ascherio, A., Prospective study of cigarette smoking and amyotrophic lateral sclerosis (2004) Am. J. Epidemiol., 160, pp. 26-33; Weisskopf, M.G., McCullough, M.L., Morozova, N., Calle, E.E., Thun, M.J., Ascherio, A., Prospective study of occupation and amyotrophic lateral sclerosis mortality (2005) Am. J. Epidemiol., 162, pp. 1146-1152; Weisskopf, M.G., O'Reilly, E.J., McCullough, M.L., Calle, E.E., Thun, M.J., Cudkowicz, M., Prospective study of military service and mortality from ALS (2005) Neurology, 64, pp. 32-37; Weisskopf, M.G., Morozova, N., O'Reilly, E., McCullough, M.L., Calle, E.E., Thun, M.J., Prospective study of chemical exposures and amyotrophic lateral sclerosis (2009) J. Neurol. Neurosurg. Psychiatry, 80, pp. 558-561; Weisskopf, M.G., Gallo, V., O'Reilly, E.J., Vineis, P., Ascherio, A., Smoking may be considered an established risk factor for sporadic ALS (2010) Neurology, 74 (June 8), p. 8. , author reply 1928–1929; Weisskopf, M.G., Cudkowicz, M.E., Johnson, N., Military service and amyotrophic lateral sclerosis in a population-based cohort (2015) Epidemiology, 26, pp. 831-838; Wicks, P., Ganesalingham, J., Collin, C., Prevett, M., Leigh, N.P., Al-Chalabi, A., Three soccer playing friends with simultaneous amyotrophic lateral sclerosis (2007) Amyotroph. Lateral Scler., 8, pp. 177-179; Wijesekera, L.C., Leigh, P.N., Amyotrophic lateral sclerosis (2009) Orphanet J. Rare Dis., 4, p. 3; Wills, A.M., Cronin, S., Slowik, A., Kasperaviciute, D., Van Es, M.A., Morahan, J.M., A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS (2009) Neurology, 73, pp. 16-24; Wingo, T.S., Cutler, D.J., Yarab, N., Kelly, C.M., Glass, J.D., The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry (2011) PLoS One, 6, p. e27985; Yang, X., Xi, J., An, R., Yu, L., Lin, Z., Zhou, H., Lack of evidence for an association between the V393A variant of COQ2 and amyotrophic lateral sclerosis in a Han Chinese population (2015) Neurol. Sci., 36, pp. 1211-1215; Yang, X., Xi, J., Zhao, Q., Jia, H., An, R., Liu, Z., Association of the COQ2 V393A variant with parkinson's disease: a case-Control study and meta-Analysis (2015) PLoS One, 10, p. e0130970; Yoshida, S., Uebayashi, Y., Kihira, T., Kohmoto, J., Wakayama, I., Taguchi, S., Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: active or disappearing focus? (1998) J. Neurol. Sci., 155, pp. 146-155; Zetterberg, H., Jacobsson, J., Rosengren, L., Blennow, K., Andersen, P.M., Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis (2008) J. Neurol. Sci., 273, pp. 67-69; Zhang, C., The report of organophosphorus pesticides cause delayed nervous system diseases (143 cases) (1991) Zhonghua Shen Jing Shen Ke Za Zhi, 24. , (336,8, 383); Zhao, Q., Yang, X., Tian, S., An, R., Zheng, J., Xu, Y., Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature (2016) Neurol. Sci., 37, pp. 423-430; Zhou, H., Chen, G., Chen, C., Yu, Y., Xu, Z., Association between extremely low-frequency electromagnetic fields occupations and amyotrophic lateral sclerosis: a meta-analysis (2012) PLoS One, 7, p. e48354; Zhou, Z., Zhang, X., Cui, F., Liu, R., Dong, Z., Wang, X., Subacute motor neuron hyperexcitability with mercury poisoning: a case series and literature review (2014) Eur. Neurol., 72, pp. 218-222},
correspondence_address1={Wang, M.-D.; School of Epidemiology, Canada; email: myang015@uottawa.ca},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={27377857},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Ioannidis20171456,
author={Ioannidis, J.},
title={Next-generation systematic reviews: Prospective meta-analysis, individual-level data, networks and umbrella reviews},
journal={British Journal of Sports Medicine},
year={2017},
volume={51},
number={20},
pages={1456-1458},
doi={10.1136/bjsports-2017-097621},
note={cited By 100},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030556136&doi=10.1136%2fbjsports-2017-097621&partnerID=40&md5=27e31a10dbc2daf42d513780c150f3ad},
affiliation={Stanford Prevention Research Center, Department of Medicine, Stanford, CA, United States; Department of Health Research and Policy, Stanford University, School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University, School of Humanities and Sciences, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford, CA, United States},
author_keywords={Injuries;  Injury;  Injury prevention},
keywords={human;  literature;  meta analysis (topic);  methodology;  prospective study;  sports medicine;  standards, Humans;  Meta-Analysis as Topic;  Prospective Studies;  Research Design;  Review Literature as Topic;  Sports Medicine},
references={Ioannidis, J.P., The mass production of redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses (2016) Milbank Q, 94, pp. 485-514; Altman, D.G., The scandal of poor medical research (1994) BMJ, 308, pp. 283-284; Province, M.A., Hadley, E.C., Hornbrook, M.C., The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and injuries: Cooperative studies of intervention techniques (1995) JAMA, 273, pp. 1341-1347; Ioannidis, J.P., Karassa, F.B., The need to consider the wider agenda in systematic reviews and metaanalyses: Breadth, timing, and depth of the evidence (2010) BMJ, 341, p. c4875; Alves, C., Marques, F.B., Macedo, A.F., Drug-safety alerts issued by regulatory authorities: Usefulness of metaanalysis in predicting risks earlier (2014) Eur J Clin Pharmacol, 70, pp. 745-756; Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy.133 randomised trials involving 31, 000 recurrences and 24, 000 deaths among 75, 000 women (1992) Lancet, 339, pp. 1-15. , Early Breast Cancer Trialists' Collaborative Group; Huang, Y., Tang, J., Tam, W.W., Comparing the overall result and interaction in aggregate data Meta-Analysis and individual patient data Meta-Analysis (2016) Medicine, 95, p. e3312; Simmonds, M., Stewart, G., Stewart, L., A decade of individual participant data meta-analyses: A review of current practice (2015) Contemp Clin Trials, 45, pp. 76-83; Haasova, M., Warren, F.C., Ussher, M., The acute effects of physical activity on cigarette cravings: Exploration of potential moderators, mediators and physical activity attributes using individual participant data (IPD) meta-analyses (2014) Psychopharmacology, 231, pp. 1267-1275; Haasova, M., Warren, F.C., Ussher, M., The acute effects of physical activity on cigarette cravings: Systematic review and meta-analysis with individual participant data (2013) Addiction, 108, pp. 26-37; Smart, N.A., Meyer, T., Butterfield, J.A., Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure (2012) Eur J Prev Cardiol, 19, pp. 428-435; Biau, D.J., Katsahian, S., Kartus, J., Patellar tendon versus hamstring tendon autografts for reconstructing the anterior cruciate ligament: A meta-analysis based on individual patient data (2009) Am J Sports Med, 37, pp. 2470-2478; Kelley, G.A., Kelley, K.S., Exercise and bone mineral density at the femoral neck in postmenopausal women: A meta-analysis of controlled clinical trials with individual patient data (2006) Am J Obstet Gynecol, 194, pp. 760-767; Kelley, G.A., Kelley, K.S., Efficacy of resistance exercise on lumbar spine and femoral neck bone mineral density in premenopausal women: A meta-analysis of individual patient data (2004) J Womens Health, 13, pp. 293-300; De Morton, N.A., Jones, C.T., Keating, J.L., The effect of exercise on outcomes for hospitalised older acute medical patients: An individual patient data metaanalysis (2007) Age Ageing, 36, pp. 219-222; Ekelund, U., Steene-Johannessen, J., Brown, W.J., Lancet physical activity series 2 executive Committe. Lancet sedentary behaviour working group. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality. A harmonised meta-analysis of data from more than 1 million men and women (2016) Lancet, 388, pp. 1302-1310; Moore, S.C., Lee, I.M., Weiderpass, E., Association of Leisure-Time physical activity with risk of 26 types of Cancer in 1. 44 million adults (2016) JAMA Intern Med, 176, pp. 816-825; Perreault, K., Bauman, A., Johnson, N., Does physical activity moderate the association between alcohol drinking and all-cause, cancer and cardiovascular diseases mortality A pooled analysis of eight British population cohorts (2017) Br J Sports Med, 51, pp. 651-657; Taichman, D.B., Backus, J., Baethge, C., Sharing clinical trial data: A proposal from the international committee of medical journal editors (2016) PLoS Med, 13, p. e1001950; Ross, J.S., Clinical research data sharing: What an open science world means for researchers involved in evidence synthesis (2016) Syst Rev, 5, p. 159; Salanti, G., Higgins, J.P., Ades, A.E., Evaluation of networks of randomized trials (2008) Stat Methods Med Res, 17, pp. 279-301; Naci, H., Ioannidis, J.P., Comparative effectiveness of exercise and drug interventions on mortality outcomes: Metaepidemiological study (2013) BMJ, 347, p. f5577; Corbett, M.S., Rice, S.J., Madurasinghe, V., Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: Network meta-analysis (2013) Osteoarthritis Cartilage, 21, pp. 1290-1298; Uthman, O.A., Van Der Windt, D.A., Jordan, J.L., Exercise for lower limb osteoarthritis: Systematic review incorporating trial sequential analysis and network meta-analysis (2013) BMJ, 347, p. f5555; Arirachakaran, A., Sangkaew, C., Kongtharvonskul, J., Patellofemoral resurfacing and patellar denervation in primary total knee arthroplasty (2015) Knee Surg Sports Traumatol Arthrosc, 23, pp. 1770-1781; Krogh, T.P., Bartels, E.M., Ellingsen, T., Comparative effectiveness of injection therapies in lateral epicondylitis: A systematic review and network metaanalysis of randomized controlled trials (2013) Am J Sports Med, 41, pp. 1435-1446; Dong, W., Goost, H., Lin, X.B., Injection therapies for lateral epicondylalgia: A systematic review and Bayesian network meta-analysis (2016) Br J Sports Med, 50, pp. 900-908; Tsikopoulos, K., Vasiliadis, H.S., Mavridis, D., Injection therapies for plantar fasciopathy ('plantar fasciitis'): A systematic review and network meta-analysis of 22 randomised controlled trials (2016) Br J Sports Med, 50, pp. 1367-1375; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments metaanalyses (2009) CMAJ, 181, pp. 488-493; Markozannes, G., Tzoulaki, I., Karli, D., Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence (2016) Eur J Cancer, 69, pp. 61-69; Schuit, E., Ioannidis, J.P., Network meta-analyses performed by contracting companies and commissioned by industry (2016) Syst Rev, 5, p. 198; Ebrahim, S., Bance, S., Athale, A., Meta-analyses with industry involvement are massively published and report no caveats for antidepressants (2016) J Clin Epidemiol, 70, pp. 155-163},
correspondence_address1={Ioannidis, J.; Stanford Prevention Research Center, United States; email: jioannid@stanford.edu},
publisher={BMJ Publishing Group},
issn={03063674},
coden={BJSMD},
pubmed_id={28223307},
language={English},
abbrev_source_title={Br. J. Sports Med.},
document_type={Editorial},
source={Scopus},
}

@ARTICLE{Kleinberg20111102,
author={Kleinberg, S. and Hripcsak, G.},
title={A review of causal inference for biomedical informatics},
journal={Journal of Biomedical Informatics},
year={2011},
volume={44},
number={6},
pages={1102-1112},
doi={10.1016/j.jbi.2011.07.001},
note={cited By 96},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855951317&doi=10.1016%2fj.jbi.2011.07.001&partnerID=40&md5=070941142eba267a634c2f01c3a35ff4},
affiliation={Department of Biomedical Informatics, Columbia University, New York, NY, United States},
abstract={Causality is an important concept throughout the health sciences and is particularly vital for informatics work such as finding adverse drug events or risk factors for disease using electronic health records. While philosophers and scientists working for centuries on formalizing what makes something a cause have not reached a consensus, new methods for inference show that we can make progress in this area in many practical cases. This article reviews core concepts in understanding and identifying causality and then reviews current computational methods for inference and explanation, focusing on inference from large-scale observational data. While the problem is not fully solved, we show that graphical models and Granger causality provide useful frameworks for inference and that a more recent approach based on temporal logic addresses some of the limitations of these methods. © 2011 Elsevier Inc.},
author_keywords={Causal explanation;  Causal inference;  Electronic health records},
keywords={Biomedical informatics;  Causal explanation;  Causal inference;  Electronic health record;  Granger Causality;  GraphicaL model;  Health science;  Informatics;  Observational data;  Risk factors, Health;  Information science;  Philosophical aspects;  Records management;  Temporal logic, Health risks, algorithm;  Bayes theorem;  bioinformatics;  biomedical informatics;  causal attribution;  causal modeling;  computer analysis;  computer system;  human;  logic;  lung cancer;  medical informatics;  personalized medicine;  priority journal;  review;  smoking;  structural equation modeling;  system analysis, Bayes Theorem;  Causality;  Drug Toxicity;  Electronic Health Records;  Epidemiology;  Humans;  Individualized Medicine;  Medical Informatics;  Risk Factors},
funding_details={R01 LM006910},
funding_details={National Science FoundationNational Science Foundation, NSF, 1019343},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={U.S. Department of Health and Human ServicesU.S. Department of Health and Human Services, HHS, HHSN276201000024C},
funding_details={U.S. National Library of MedicineU.S. National Library of Medicine, NLM, R01LM006910},
funding_text 1={This material is based upon work supported by the National Science Foundation under Grant #1019343 to the Computing Research Association for the CIFellows project. This work was partially funded by a grant from the National Library of Medicine , “Discovering and applying knowledge in clinical databases” (R01 LM006910), and with Federal funds from the National Library of Medicine, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN276201000024C, “Causal inference on narrative and structured temporal data to augment discovery and care.”},
references={Agbabiaka, T., Savovic, J., Ernst, E., Methods for causality assessment of adverse drug reactions: a systematic review (2008) Drug Saf, 31 (1), pp. 21-37; Rizzi, D., Causal reasoning and the diagnostic process (1994) Theor Med Bioeth, 15 (3), pp. 315-333; Johnson, M., Crown, W., Martin, B., Dormuth, C., Siebert, U., Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ispor good research practices for retrospective database analysis task force report part iii (2009) Value Health, 12 (8), pp. 1062-1073; Karhausen, L., Causation: the elusive grail of epidemiology (2000) Med Health Care Philos, 3 (1), pp. 59-67; Parascandola, M., Weed, D., Causation in epidemiology (2001) J Epidemiol Community Health, 55 (12), p. 905; Russo, F., Variational causal claims in epidemiology (2009) Perspect Biol Med, 52 (4), pp. 540-554; Joffe, M., Mindell, J., Complex causal process diagrams for analyzing the health impacts of policy interventions (2006) Am J Public Health, 96 (3), p. 473; Cochrane, A., (1972) Effectiveness and efficiency: random reflections on health services, , Nuffield Provincial Hospitals Trust; Cartwright, N., Evidence-based policy: whats to be done about relevance? (2009) Philos Stud, 143 (1), pp. 127-136; Schulz, K., Chalmers, I., Hayes, R., Altman, D., Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273 (5), p. 408; Dekkers, O., Elm, E., Algra, A., Romijn, J., Vandenbroucke, J., How to assess the external validity of therapeutic trials: a conceptual approach (2010) Int J Epidemiol, 39 (1), p. 89; Rothwell, P., Factors that can affect the external validity of randomised controlled trials (2006) PLoS Clin Trials, 1 (1), pp. e9; Rothwell, P., Treating individuals 1 external validity of randomised controlled trials: to whom do the results of this trial apply? (2005) Lancet, 365, pp. 82-93; Victora, C., Habicht, J., Bryce, J., Evidence-based public health: moving beyond randomized trials (2004) Am J Public Health, 94 (3), p. 400; Cartwright, N., Are RCTs the gold standard? (2007) Biosocieties, 2 (1), pp. 11-20; Cartwright, N., Munro, E., The limitations of randomized controlled trials in predicting effectiveness (2010) J Eval Clin Pract, 16 (2), pp. 260-266; Mackenzie, F., Grossman, J., The randomized controlled trial: gold standard, or merely standard? (2005) Perspect Biol Med, 48 (4), pp. 516-534; Ward, A., Johnson, P., Addressing confounding errors when using non-experimental, observational data to make causal claims (2008) Synthese, 163 (3), pp. 419-432; Granger, C.W., Investigating causal relations by econometric models and cross-spectral methods (1969) Econometrica, 37 (3), pp. 424-438; Pearl, J., (2000) Causality: models, reasoning, and inference, , Cambridge University Press; Rubin, D., Estimating causal effects of treatments in randomized and nonrandomized studies (1974) J Educ Psychol, 66 (5), pp. 688-701; Spirtes, P., Glymour, C., Scheines, R., (2000) Causation, prediction, and search, , MIT Press; Pearl, J., Graphs, causality, and structural equation models (1998) Sociol Methods Res, 27 (2), p. 226; Pearl, J., Statistics and causal inference: a review (2003) Test, 12 (2), pp. 281-345; Bellazzi, R., Zupan, B., Predictive data mining in clinical medicine: current issues and guidelines (2008) Int J Med Inform, 77 (2), pp. 81-97; Wu, J., Roy, J., Stewart, W., Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches (2010) Med Care, 48 (6), pp. S106; Suermondt, H., Cooper, G., An evaluation of explanations of probabilistic inference (1992) Proceedings of the annual symposium on computer application in medical care, p. 579. , American Medical Informatics Association; Reichenbach, H., (1956) The direction of time, , University of California Press, Berkeley, CA; Lewis, D., Causal explanation (1986) Philos Pap, 2, pp. 214-240; (1994), 2. , Aristotle. Physics, The Internet Classics Archive; Hume, D., (1748), An enquiry concerning human understanding; Mill, J.S., (1986) A system of logic, , Lincoln-Rembrandt Pub; Koch, R., Die aetiologie der tuberkulose (1932) J Mol Med, 11, pp. 490-492. , 10.1007/BF01765224; Hill, A.B., The environment and disease: association or causation? (1965) Proc R Soc Med, 58, pp. 295-300; Rothman, K., Causes (1995) Am J Epidemiol, 141 (2), p. 90; Naranjo, C., Busto, U., Sellers, E., Sandor, P., Ruiz, I., Roberts, E., A method for estimating the probability of adverse drug reactions (1981) Clin Pharmacol Ther, 30 (2), pp. 239-245; Gatto, N., Campbell, U., Redundant causation from a sufficient cause perspective (2010) Epidemiol Perspect Innovat, 7 (1), p. 5; Eells, E., (1991) Probabilistic causality, , Cambridge University Press; Good, I.J., A causal calculus (I) (1961) Br J Philos Sci, 11 (44), pp. 305-318; Suppes, P., (1970) A probabilistic theory of causality, , North-Holland; Kleinberg, S., An Algorithmic Enquiry Concerning Causality. PhD thesis, New York University (2010); Gaziano, J.M., The evolution of population science (2010) JAMA: J Am Med Assoc, 304 (20), pp. 2288-2289; Susser, M., (1973) Causal thinking in the health sciences concepts and strategies of epidemiology, , Oxford University Press; Susser, M., What is a cause and how do we know one? A grammar for pragmatic epidemiology (1991) Am J Epidemiol, 133 (7), p. 635; Lewis, D., Causation (1973) J Philos, 70, pp. 556-567; Woodward, J., Probabilistic causality, direct causes and counterfactual dependence (2001) Stochas Causal, pp. 39-63; Russo, F., Williamson, J., Interpreting causality in the health sciences (2007) Int Stud Philos Sci, 21 (2), pp. 157-170; Morabia, A., On the origin of Hill's causal criteria (1991) Epidemiology, 2 (5), p. 367; Thygesen, L., Andersen, G., Andersen, H., A philosophical analysis of the Hill criteria (2005) Br Med J, 59 (6), p. 512; Höfler, M., The Bradford Hill considerations on causality: a counterfactual perspective (2005) Emerg Themes Epidemiol, 2 (1), p. 11; Ward, A., The role of causal criteria in causal inferences: Bradford Hill's aspects of association (2009) Epidemiol Perspect Innovat, 6 (1), p. 2; Ward, A., Causal criteria and the problem of complex causation (2009) Med Health Care Philos, 12 (3), pp. 333-343; Rothman, K., Greenland, S., Causation and causal inference in epidemiology (2005) Am J Public Health, 95 (S1), pp. S144; Phillips, C., Goodman, K., The missed lessons of Sir Austin Bradford Hill (2004) Epidemiol Perspect Innovat, 1 (1), p. 3; Hausman, D.M., Causal relata: tokens, types, or variables? (2005) Erkenntnis, 63 (1), pp. 33-54; Sober, E., Papineau, D., Causal factors, causal inference, causal explanation (1986) Proc Aristotelian Soc Suppl Vol, 60, pp. 97-136; Woodward, J., (2005) Making things happen: a theory of causal explanation, , Oxford University Press, USA; Reiter, R., A theory of diagnosis from first principles (1987) Artif Intell, 32 (1), pp. 57-95; Bouzid, M., Ligeza, A., Temporal causal networks for simulation and diagnosis (1996), 96, pp. 458-65. , In: Proceedings of the second IEEE international conference on engineering of complex computer systems, ICECCS; Chao, C., Yang, D., Liu, A., An automated fault diagnosis system using hierarchical reasoning and alarm correlation (2001) J Netw Syst Manag, 9 (2), pp. 183-202; Lunze, J., Schiller, F., An example of fault diagnosis by means of probabilistic logic reasoning (1999) Control Eng Pract, 7 (2), pp. 271-278; Rizzi, D., Pedersen, S., Causality in medicine: towards a theory and terminology (1992) Theor Med Bioeth, 13 (3), pp. 233-254; Szolovits, P., Pauker, S., Categorical and probabilistic reasoning in medical diagnosis (1978) Artif Intell, 11 (1-2), pp. 115-144; Kuipers, B., Qualitative simulation as causal explanation (2007) IEEE Trans Syst Man Cybernet, 17 (3), pp. 432-444; Shibahara, T., Tsotsos, J., Mylopoulos, J., Covvey, H., CAA: a knowledge based system using causal knowledge to diagnose cardiac rhythm disorders (1983), In: Proceedings international joint conference on artificial intelligence; Cooper, G., NESTOR: a computer-based medical diagnostic aid that integrates causal and probabilistic knowledge (1984), PhD thesis, Stanford University; Long, W., Temporal reasoning for diagnosis in a causal probabilistic knowledge base (1996) Artif Intell Med, 8 (3), pp. 193-215; Oniésko, A., Lucas, P., Druzdzel, M., Comparison of rule-based and Bayesian network approaches in medical diagnostic systems (2001) Artif Intell Med, pp. 283-292; Lerner, U., Parr, R., Inference in hybrid networks: theoretical limits and practical algorithms (2001), pp. 310-8. , In: Proceedings of the 17th conference on uncertainty in artificial intelligence; Kleinberg, S., A logic for causal inference in time series with discrete and continuous variables (2011), In: Proceedings of the twenty-second international joint conference on artificial intelligence; Twardy, C., Nicholson, A., Korb, K., McNeil, J., Epidemiological data mining of cardiovascular Bayesian networks (2006) Electron J Health Inform, 1 (1), pp. e3; Mani, S., Cooper, G., Causal discovery using a Bayesian local causal discovery algorithm (2004) Proc MedInfo, pp. 731-735; Aliferis, C., Tsamardinos, I., Statnikov, A., Brown, L., Causal explorer: a causal probabilistic network learning toolkit for biomedical discovery (2003), pp. 371-6. , In: International conference on mathematics and engineering techniques in medicine and biological sciences (METMBS03), Citeseer; Murphy, K., The bayes net toolbox for matlab (2001) Comput Sci Stat, 33 (2), pp. 1024-1034; Glymour, C., Scheines, R., Spirtes, P., Ramsey, J., (2004), TETRAD IV software; Simpson, E.H., The interpretation of interaction in contingency tables (1951) J R Stat Soc: Ser B (Methodol), 13 (2), pp. 238-241; Spirtes, P., Meek, C., Richardson, T., Causal inference in the presence of latent variables and selection bias (1995), pp. 499-506. , In: Proceedings of the eleventh conference on uncertainty in artificial intelligence; Cooper, G., An overview of the representation and discovery of causal relationships using Bayesian networks (1999) Computation, causation, and discovery, , AAAI Press and MIT Press, C. Glymour, G. Cooper (Eds.); Cooper, G., Herskovits, E., A Bayesian method for the induction of probabilistic networks from data (1992) Mach Learn, 9 (4), pp. 309-347; Cartwright, N., What is wrong with Bayes nets? (2003) Monist, 84 (2); Silva, R., Scheine, R., Glymour, C., Spirtes, P., Learning the structure of linear latent variable models (2006) J Mach Learn Res, 7, pp. 191-246; Entner, D., Hoyer, P., On causal discovery from time series data using FCI (2010), In: Probabilistic graphical models; Zhang, J., Spirtes, P., Detection of unfaithfulness and robust causal inference (2008) Minds Mach, 18 (2), pp. 239-271; Halpern, J.Y., Pearl, J., Causes and explanations: a structural-model approach. Part I: causes (2005) Br J Philos Sci, 56 (4), pp. 843-887; Murphy, K., Dynamic Bayesian networks: representation, inference and learning (2002), PhD thesis, University of California, Berkley; Zou, M., Conzen, S., A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data (2005) Bioinformatics, 21 (1), p. 71; Eldawlatly, S., Zhou, Y., Jin, R., Oweiss, K., On the use of dynamic bayesian networks in reconstructing functional neuronal networks from spike train ensembles (2010) Neural Comput, 22 (1), pp. 158-189; Charitos, T., van der Gaag, L., Visscher, S., Schurink, K., Lucas, P., A dynamic Bayesian network for diagnosing ventilator-associated pneumonia in ICU patients (2009) Expert Syst Appl, 36 (2), pp. 1249-1258; van Gerven, M., Taal, B., Lucas, P., Dynamic Bayesian networks as prognostic models for clinical patient management (2008) J Biomed Inform, 41 (4), pp. 515-529; Hartemink, A.J., Banjo: Bayesian network inference with Java objects (2008), http://www.cs.duke.edu/amink/software/banjo/; Xiang, Z., Minter, R., Bi, X., Woolf, P., He, Y., MiniTUBA: medical inference by network integration of temporal data using Bayesian analysis (2007) Bioinformatics, 23 (18), p. 2423; Robinson, J., Hartemink, A., Learning non-stationary dynamic bayesian networks (2010) J Mach Learn Res, 9999, pp. 3647-3680; Grzegorczyk, M., Husmeier, D., Non-stationary continuous dynamic bayesian networks (2009) Adv Neural Inform Process Syst, 22, pp. 682-690; Granger, C.W., Testing for causality: a personal viewpoint (1980) J Econ Dyn Control, 2, pp. 329-352; Mukhopadhyay, N.D.D., Chatterjee, S., Causality and pathway search in microarray time series experiment (2007) Bioinformatics, 23 (4), p. 442; Ding, M., Chen, Y., Bressler, S.L., Granger causality: basic theory and application to neuroscience (2006), Arxiv preprint q-bio/0608035; Kamiński, M., Ding, M., Truccolo, W.A., Bressler, S.L., Evaluating causal relations in neural systems: Granger causality, directed transfer function and statistical assessment of significance (2001) Biol Cybernet, 85 (2), pp. 145-157; Brandt, P., (2009), MSBVAR R package version 0.4; Zou, C., Feng, J., Granger causality vs. dynamic Bayesian network inference: a comparative study (2009) BMC Bioinform, 10 (1), p. 122; Chen, Y., Rangarajan, G., Feng, J., Ding, M., Analyzing multiple nonlinear time series with extended Granger causality (2004) Phys Lett A, 324, pp. 26-35; Eichler, M., Didelez, V., Causal reasoning in graphical time series models (2007), In: Proceedings of the 23rd conference on uncertainty in artificial intelligence; Eichler, M., Causal inference from multivariate time series: what can be learned from granger causality (2009) Methodology and philosophy of science, , King's College Publications, London, D.W.C. Glymour, W. Wang (Eds.) Proceedings from the 13th international congress of logic; Agrawal, R., Srikant, R., Mining sequential patterns (1995), pp. 3-14. , In: Proceedings of the eleventh international conference on data engineering; Kleinberg, S., Mishra, B., The temporal logic of causal structures (2009), pp. 303-12. , In: Proceedings of the 25th conference on uncertainty in artificial intelligence (UAI-09), Corvallis, Oregon; Hansson, H., Jonsson, B., A logic for reasoning about time and reliability (1994) Formal Aspects Comput, 6 (5), pp. 512-535; Chan, K., Poernomo, I., Schmidt, H., Jayaputera, J., A model-oriented framework for runtime monitoring of nonfunctional properties (2005) Lecture notes in computer science, 3712, p. 38; Benjamini, Y., Yekutieli, D., The control of the false discovery rate in multiple testing under dependency (2001) Ann Stat, 29 (4), pp. 1165-1188; Efron, B., Large-scale simultaneous hypothesis testing: the choice of a null hypothesis (2004) J Am Stat Assoc, 99 (465), pp. 96-105; Kleinberg, S., Mishra, B., Multiple testing of causal hypotheses (2011) Causality in the sciences, , Oxford University Press, P.M. Illari, F. Russo, J. Williamson (Eds.); Kleinberg, S., Kolm, P., Mishra, B., Investigating causal relationships in stock returns with temporal logic based methods (2010), ArXiv e-prints; Kleinberg, S., Mishra, B., The Temporal logic of token causes In: Proceedings of the 12th international conference on the principles of knowledge representation and reasoning (KR2010), Toronto, Canada; May 2010; Guyon, I., Aliferis, C., Cooper, G., Elisseeff, A., Pellet, J., Spirtes, P., Design and analysis of the causation and prediction challenge (2008) JMLR W&CP, 3, pp. 1-33; Wright, S., The method of path coefficients (1934) Ann Math Stat, 5 (3), pp. 161-215; Eberhardt, F., Scheines, R., Interventions and causal inference (2006), In: Proceedings of the 20th biennial meeting of the philosophy of science association},
correspondence_address1={Kleinberg, S.; Department of Biomedical Informatics, 622 W 168th st., VC-5, New York, NY 10032, United States; email: samantha@dbmi.columbia.edu},
issn={15320464},
coden={JBIOB},
pubmed_id={21782035},
language={English},
abbrev_source_title={J. Biomed. Informatics},
document_type={Review},
source={Scopus},
}

@ARTICLE{Tzoulaki2013664,
author={Tzoulaki, I. and Siontis, K.C. and Evangelou, E. and Ioannidis, J.P.A.},
title={Bias in associations of emerging biomarkers with cardiovascular disease},
journal={JAMA Internal Medicine},
year={2013},
volume={173},
number={8},
pages={664-671},
doi={10.1001/jamainternmed.2013.3018},
note={cited By 93},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876785828&doi=10.1001%2fjamainternmed.2013.3018&partnerID=40&md5=d0ce8d311a46d0e6c6dbc58c08bf1a16},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom; Mayo School of Graduate Medical Education, College of Medicine, Mayo Clinic, Rochester, MI, United States; Stanford Prevention Research Center, Stanford University, School of Medicine, 1265 Welch Rd, Stanford, CA 94350, United States},
abstract={Importance: Numerous cardiovascular biomarkers are proposed as potential predictors of cardiovascular risk. Objective: To evaluate whether there is evidence for biases favoring statistically significant results and inflating associations in this literature. Design and Setting: PubMed search for metaanalyses of cardiovascular biomarkers that are not part of the Framingham Risk Score. Main Outcome Measures: We estimated summary effects and between-study heterogeneity (considered 'very large' for I2&gt;75%). We evaluated whether large studies had significantly more conservative results than smaller studies (small-study effects) and whether there were too many studies with statistically significant results compared with what would be expected on the basis of the findings of the largest study in each meta-analysis. Results: Of 56 eligible meta-analyses, 49 had statistically significant results. Very large heterogeneity and small-study effects were seen in 9 and 13 meta-analyses, respectively. In 29 meta-analyses (52%), there was a significant excess of studies with statistically significant results. Only 13 of the statistically significant metaanalyses had more than 1000 cases and no hints of large heterogeneity, small-study effects, or excess significance. These included the associations of glomerular filtration rate and albumin to creatinine ratio in general and high-risk populations with cardiovascular disease mortality and of non-high-density lipoprotein cholesterol, serum albumin, Chlamydia pneumoniae IgG, glycosylated hemoglobin, nonfasting insulin, apolipoprotein B/AI ratio, erythrocyte sedimentation rate, and lipoproteinassociated phospholipase mass or activity with coronary heart disease. Conclusions and Relevance: Selective reporting biases may be common in the evidence on emerging cardiovascular biomarkers. Most of the proposed associations of these biomarkers may be inflated. © 2013 American Medical Association.},
keywords={adiponectin;  apolipoprotein A1;  apolipoprotein B;  biological marker;  C reactive protein;  cystatin C;  fibrinogen;  glucose;  glycosylated hemoglobin;  hemoglobin A1c;  high density lipoprotein cholesterol;  homocysteine;  immunoglobulin G;  insulin;  lipoprotein A;  lipoprotein associated phospholipase;  phospholipase;  selenium;  serum albumin;  triacylglycerol;  troponin T;  unclassified drug;  uric acid, abdominal obesity;  article;  blood pressure;  body mass;  cardiovascular disease;  cardiovascular mortality;  Chlamydophila pneumoniae;  erythrocyte sedimentation rate;  glomerulus filtration rate;  high risk population;  human;  ischemic heart disease;  leukocyte count;  microalbuminuria;  priority journal;  uric acid blood level;  waist hip ratio, Biological Markers;  Cardiovascular Diseases;  Humans;  Publication Bias;  Risk Factors},
chemicals_cas={C reactive protein, 9007-41-4; adiponectin, 283182-39-8; fibrinogen, 9001-32-5; glucose, 50-99-7, 84778-64-3; glycosylated hemoglobin, 9062-63-9; hemoglobin A1c, 62572-11-6; homocysteine, 454-28-4, 6027-13-0; immunoglobulin G, 97794-27-9; insulin, 9004-10-8; phospholipase, 9013-93-8; selenium, 7782-49-2; serum albumin, 9048-46-8; troponin T, 60304-72-5; uric acid, 69-93-2; Biological Markers},
references={Hlatky, M.A., Greenland, P., Arnett, D.K., Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the american heart association (2009) Circulation., 119 (17), pp. 2408-2416. , American Heart Association Expert Panel On Subclinical Atherosclerotic Diseases And Emerging Risk Factors And The Stroke Council, [published correction appears in circulation. 2009; 119(25) :e606]; Wang, T.J., Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction (2011) Circulation., 123 (5), pp. 551-565; Gilstrap, L.G., Wang, T.J., Biomarkers and cardiovascular risk assessment for primary prevention: An update (2012) Clin Chem., 58 (1), pp. 72-82; Ioannidis, J.P., Tzoulaki, I., Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease (2012) Circ Res., 110 (5), pp. 658-662; Wilson, P.W., Challenges to improve coronary heart disease risk assessment (2009) JAMA, 302 (21), pp. 2369-2370; Lloyd-Jones, D.M., Cardiovascular risk prediction: Basic concepts, current status, and future directions (2010) Circulation., 121 (15), pp. 1768-1777; Tzoulaki, I., Liberopoulos, G., Ioannidis, J.P., Use of reclassification for assessment of improved prediction: An empirical evaluation (2011) Int J Epidemiol., 40 (4), pp. 1094-1105; Tzoulaki, I., Liberopoulos, G., Ioannidis, J.P., Assessment of claims of improved prediction beyond the framingham risk score (2009) JAMA, 302 (21), pp. 2345-2352; Ioannidis, J.P., Tzoulaki, I., What makes a good predictor? the evidence applied to coronary artery calcium score (2010) JAMA, 303 (16), pp. 1646-1647; Tzoulaki, I., Siontis, K.C., Ioannidis, J.P., Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: Metaepidemiology study (2011) BMJ, 343, pp. d6829. , doi:10.1136/bmj.d6829; Vasan, R.S., Biomarkers of cardiovascular disease: Molecular basis and practical considerations (2006) Circulation., 113 (19), pp. 2335-2362; Wilson, P.W., D'Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H., Kannel, W.B., Prediction of coronary heart disease using risk factor categories (1998) Circulation., 97 (18), pp. 1837-1847; Greenland, P., Alpert, J.S., Beller, G.A., (2010) Circulation., 122 (25), pp. e584-e636. , American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; Apple, F.S., Wu, A.H., Mair, J., Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome (2005) Clin Chem., 51 (5), pp. 810-824; Naghavi, M., Libby, P., Falk, E., From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I (2003) Circulation., 108 (14), pp. 1664-1672; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med., 127 (9), pp. 820-826; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335 (7626), pp. 914-916; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, pp. d4002. , doi:10.1136/bmj.d4002; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials., 4 (3), pp. 245-253; Kavvoura, F.K., McQueen, M.B., Khoury, M.J., Tanzi, R.E., Bertram, L., Ioannidis, J.P., Evaluation of the potential excess of statistically significant findings in published genetic association studies: Application to Alzheimer's disease (2008) Am J Epidemiol., 168 (8), pp. 855-865; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry., 68 (8), pp. 773-780; Freedman, L.S., Tables of the number of patients required in clinical trials using the logrank test (1982) Stat Med., 1 (2), pp. 121-129; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med., 19 (22), pp. 3127-3131; Wormser, D., Kaptoge, S., Di Angelantonio, E., Separate and combined associations of body mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies (2011) Lancet., 377 (9771), pp. 1085-1095. , Emerging Risk Factors Collaboration; Santos-Oliveira, R., Purdy, C., Da Silva, M.P., Dos Anjos Carneiro-Leao, A.M., Machado, M., Einarson, T.R., Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: A meta-analysis of prospective cohorts (2011) Diabetologia., 54 (6), pp. 1327-1334; Van Der Velde, M., Matsushita, K., Coresh, J., Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality: A collaborative metaanalysis of high-risk population cohorts (2011) Kidney Int., 79 (12), pp. 1341-1352. , Chronic Kidney Disease Prognosis Consortium; Hansen, T.W., Li, Y., Boggia, J., Thijs, L., Richart, T., Staessen, J.A., Predictive role of the nighttime blood pressure (2011) Hypertension., 57 (1), pp. 3-10; Lee, M., Saver, J.L., Huang, W.H., Chow, J., Chang, K.H., Ovbiagele, B., Impact of elevated cystatin C level on cardiovascular disease risk in predominantly highcardiovascular-risk populations: A meta-analysis (2010) Circ Cardiovasc Qual Outcomes., 3 (6), pp. 675-683; Pierdomenico, S.D., Cuccurullo, F., Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: An updated meta analysis (2011) Am J Hypertens., 24 (1), pp. 52-58; Sarwar, N., Aspelund, T., Eiriksdottir, G., Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review (2010) PLoS Med., 7 (5), pp. e1000278. , doi:10.1371/journal .pmed.1000278; Matsushita, K., Van Der Velde, M., Astor, B.C., (2010) Lancet., 375 (9731), pp. 2073-2081. , Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis; Erqou, S., Thompson, A., Di Angelantonio, E., Apolipoprotein(a) isoforms and the risk of vascular disease: Systematic review of 40 studies involving 58,000 participants (2010) J Am Coll Cardiol., 55 (19), pp. 2160-2167; Thompson, A., Gao, P., Orfei, L., Lp-PLA (2) Studies Collaboration. Lipoproteinassociated phospholipase A2 and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies (2010) Lancet., 375 (9725), pp. 1536-1544; Kaptoge, S., Di Angelantonio, E., Lowe, G., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis (2010) Lancet., 375 (9709), pp. 132-140. , Emerging Risk Factors Collaboration; Vlachopoulos, C., Aznaouridis, K., Stefanadis, C., Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis (2010) J Am Coll Cardiol., 55 (13), pp. 1318-1327; Di Angelantonio, E., Chowdhury, R., Sarwar, N., B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies (2009) Circulation., 120 (22), pp. 2177-2187; Di Angelantonio, E., Sarwar, N., Perry, P., Major lipids apolipoproteins and risk of vascular disease (2009) JAMA, 302 (18), pp. 1993-2000. , Emerging Risk Factors Collaboration; Erqou, S., Kaptoge, S., Perry, P.L., Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality (2009) JAMA, 302 (4), pp. 412-423. , Emerging Risk Factors Collaboration; McGeechan, K., Liew, G., Macaskill, P., Meta-analysis: Retinal vessel caliber and risk for coronary heart disease (2009) Ann Intern Med., 151 (6), pp. 404-413; Inaba, Y., Bergmann, S.R., Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systematic review (2010) J Nucl Cardiol., 17 (1), pp. 61-70; Ryding, A.D., Kumar, S., Worthington, A.M., Burgess, D., Prognostic value of brain natriuretic peptide in noncardiac surgery: A meta-analysis (2009) Anesthesiology., 111 (2), pp. 311-319; Sarwar, A., Shaw, L.J., Shapiro, M.D., Diagnostic and prognostic value of absence of coronary artery calcification [published correction appears in JACC Cardiovasc Imaging. 2010;3(10):1089] (2009) JACC Cardiovasc Imaging., 2 (6), pp. 675-688; Kodama, S., Saito, K., Tanaka, S., Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis (2009) JAMA, 301 (19), pp. 2024-2035; Sarwar, N., Sattar, N., Gudnason, V., Danesh, J., Circulating concentrations of insulin markers and coronary heart disease: A quantitative review of 19 Western prospective studies (2007) Eur Heart J., 28 (20), pp. 2491-2497; Lorenz, M.W., Markus, H.S., Bots, M.L., Rosvall, M., Sitzer, M., Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis (2007) Circulation., 115 (4), pp. 459-467; Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R., Guallar, E., Selenium and coronary heart disease: A meta-analysis (2006) Am J Clin Nutr., 84 (4), pp. 762-773; Sattar, N., Wannamethee, G., Sarwar, N., Adiponectin and coronary heart disease: A prospective study and meta-analysis (2006) Circulation., 114 (7), pp. 623-629; Thompson, A., Danesh, J., Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio, and coronary heart disease: A literature-based meta-analysis of prospective studies (2006) J Intern Med., 259 (5), pp. 481-492; Khan, N.A., Hemmelgarn, B.R., Tonelli, M., Thompson, C.R., Levin, A., Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis (2005) Circulation., 112 (20), pp. 3088-3096; Danesh, J., Lewington, S., Thompson, S.G., Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis (2005) JAMA, 294 (14), pp. 1799-1809. , Fibrinogen Studies Collaboration; Wheeler, J.G., Juzwishin, K.D., Eiriksdottir, G., Gudnason, V., Danesh, J., Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis (2005) PLoS Med., 2 (3), pp. e76. , doi:10.1371/journal.pmed.0020076; Whincup, P.H., Danesh, J., Walker, M., Von willebrand factor and coronary heart disease: Prospective study and meta-analysis (2002) Eur Heart J., 23 (22), pp. 1764-1770; Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis (2002) JAMA, 288 (16), pp. 2015-2022. , Homocysteine Studies Collaboration; Ottani, F., Galvani, M., Nicolini, F.A., Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes (2000) Am Heart J., 140 (6), pp. 917-927; Danesh, J., Whincup, P., Walker, M., Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis (2000) BMJ, 321 (7255), pp. 208-213; Danesh, J., Whincup, P., Walker, M., Low-grade inflammation and coronary heart disease: Prospective study and updated meta-analyses (2000) BMJ, 321 (7255), pp. 199-204; Danesh, J., Collins, R., Peto, R., Lowe, G.D., Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease (2000) Eur Heart J., 21 (7), pp. 515-520; Padayachee, L., Rodseth, R.N., Biccard, B.M., A meta-analysis of the utility of Creactive protein in predicting early, intermediate-term, and long-term mortality and major adverse cardiac events in vascular surgical patients (2009) Anaesthesia., 64 (4), pp. 416-424; Ioannidis, J.P., Panagiotou, O.A., Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses (2011) JAMA, 305 (21), pp. 2200-2210; Dwan, K., Altman, D.G., Arnaiz, J.A., Systematic review of the empirical evidence of study publication bias and outcome reporting bias (2008) PLoS One, 3 (8), pp. e3081. , doi:10.1371/journal.pone.0003081; Andre, F., McShane, L.M., Michiels, S., Biomarker studies: A call for a comprehensive biomarker study registry (2011) Nat Rev Clin Oncol., 8 (3), pp. 171-176; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology., 22 (4), pp. 450-456; Ioannidis, J.P., Why most published research findings are false (2005) PLoS Med, 2 (8), pp. e124. , doi:10.1371/journal.pmed.0020124; Chan, A.W., Altman, D.G., Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors (2005) BMJ, 330 (7494), p. 753. , doi:10.1136/bmj.38356.424606.8F; Chan, A.W., Hróbjartsson, A., Haahr, M.T., Gøtzsche, P.C., Altman, D.G., Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles (2004) JAMA, 291 (20), pp. 2457-2465},
correspondence_address1={Ioannidis, J.P.A.; Stanford Prevention Research Center, 1265 Welch Rd, Stanford, CA 94350, United States; email: jioannid@stanford.edu},
issn={21686106},
pubmed_id={23529078},
language={English},
abbrev_source_title={JAMA Intern. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Yang2015269,
author={Yang, F. and Lagerros, Y.T. and Bellocco, R. and Adami, H.-O. and Fang, F. and Pedersen, N.L. and Wirdefeldt, K.},
title={Physical activity and risk of Parkinson's disease in the Swedish National March Cohort},
journal={Brain},
year={2015},
volume={138},
number={2},
pages={269-275},
doi={10.1093/brain/awu323},
note={cited By 92},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922385846&doi=10.1093%2fbrain%2fawu323&partnerID=40&md5=55104d8d6146aa963a1f72b68519558f},
affiliation={Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 17177, Sweden; Department of Medicine, Unit of Clinical Epidemiology, Karolinska Institutet, Stockholm, 17176, Sweden; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy; Department of Epidemiology, Harvard School of Public Health, Boston, MA  02115, United States; Department of Psychology, University of Southern California, Los Angeles, CA  90089-1061, United States; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden},
abstract={Physical exercise has been associated with neuroprotective effects in the nigrostriatal dopaminergic system. To examine the impact of physical activity on Parkinson's disease risk prospectively, we followed 43 368 individuals who provided extensive information on physical activity at baseline. We estimated hazard ratios with 95% confidence intervals using Cox proportional hazards regression. During an average of 12.6 years of follow-up, 286 incident Parkinson's disease cases were identified. In males, there was an inverse association with Parkinson's disease for total physical activity (hazard ratio 0.55, 95% confidence interval 0.35-0.87 for medium versus low level), for sum of household, commuting and leisure time exercise (hazard ratio 0.53, 95% confidence interval 0.33-0.85 for high versus low level), and for household and commuting physical activity specifically (hazard ratio 0.50, 95% confidence interval 0.31-0.81 for >6 versus <2 h per week). No association was observed for leisure time exercise or occupational physical activity with Parkinson's disease, among either males or females. Meta-analysis of the present study and five previous prospective studies showed a pooled hazard ratio of 0.66 (95% confidence interval 0.57-0.78) for highest versus lowest physical activity level. Our results indicate that a medium level of physical activity lowers Parkinson's disease risk. © 2014 The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.},
author_keywords={Cohort studies;  Epidemiology;  Exercise;  Meta-analysis;  Parkinson's disease},
keywords={adult;  Article;  cohort analysis;  exercise;  female;  follow up;  household;  human;  incidence;  leisure;  major clinical study;  male;  middle aged;  occupation;  Parkinson disease;  physical activity;  priority journal;  risk assessment;  risk factor;  Sweden;  travel;  age;  aged;  motor activity;  Parkinson disease;  prospective study;  questionnaire;  risk;  risk factor, Age Factors;  Aged;  Cohort Studies;  Female;  Humans;  Leisure Activities;  Male;  Middle Aged;  Motor Activity;  Parkinson Disease;  Prospective Studies;  Questionnaires;  Risk;  Risk Factors;  Sweden},
funding_details={International Communication AssociationInternational Communication Association, ICA},
funding_details={CancerfondenCancerfonden, CAN 2012/591},
funding_details={Karolinska InstitutetKarolinska Institutet, KI, 2368/10-221},
funding_details={Stockholms Läns LandstingStockholms Läns Landsting},
funding_details={VetenskapsrådetVetenskapsrådet, VR, 521-2010-2479, 521-2013-2488},
funding_text 1={This work was supported by the Swedish Research Council (grants 521-2010-2479 and 521-2013-2488); the companies ICA Sweden and Ericsson; the Swedish Cancer Society (grant CAN 2012/591); Karolinska Institutet Distinguished Professor Award (HOA grant 2368/10-221); and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (Y.T.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Y.T.L. has received consulting fees from Novo Nordisk. Other authors have no conflict of interest to declare.},
references={Ahlskog, J.E., Does vigorous exercise have a neuroprotective effect in parkinson disease (2011) Neurology., 77, pp. 288-294; Ainsworth, B.E., Haskell, W.L., Leon, A.S., Jacobs, D.R., Jr., Montoye, H.J., Sallis, J.F., Compendium of physical activities: Classification of energy costs of human physical activities (1993) Med Sci Sports Exerc., 25, pp. 71-80; Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., Compendium of physical activities: An update of activity codes and met intensities (2000) Med Sci Sports Exerc., 32, pp. S498-504; Chen, H., Zhang, S.M., Schwarzschild, M.A., Hernan, M.A., Ascherio, A., Physical activity and the risk of parkinson disease (2005) Neurology., 64, pp. 664-669; Cohen, A.D., Tillerson, J.L., Smith, A.D., Schallert, T., Zigmond, M.J., Neuroprotective effects of prior limb use in 6-hydroxydopaminetreated rats: Possible role of gdnf (2003) J Neurochem., 85, pp. 299-305; Costa, J., Lunet, N., Santos, C., Santos, J., Vaz-Carneiro, A., Caffeine exposure and the risk of parkinson's disease: A systematic review and meta-analysis of observational studies (2010) J Alzheimers Dis., 20, pp. S221-S238; Feldman, A.L., Johansson, A.L., Gatz, M., Flensburg, M., Petzinger, G.M., Widner, H., Accuracy and sensitivity of parkinsonian disorder diagnoses in two swedish national health registers (2012) Neuroepidemiology., 38, pp. 186-193; Green, H.J., Fraser, I.G., Differential-effects of exercise intensity on serum uric-acid concentration (1988) Med Sci Sports Exerc., 20, pp. 55-59; Hawkes, C.H., The prodromal phase of sporadic parkinson's disease: Does it exist and if so how long is it (2008) Mov Disord., 23, pp. 1799-1807; Hu, G., Jousilahti, P., Nissinen, A., Antikainen, R., Kivipelto, M., Tuomilehto, J., Body mass index and the risk of parkinson disease (2006) Neurology., 67, pp. 1955-1959; Lagerros, Y.T., Bellocco, R., Adami, H.O., Nyren, O., Measures of physical activity and their correlates: The swedish national march cohort (2009) Eur J Epidemiol., 24, pp. 161-169; Lagerros, Y.T., Mucci, L.A., Bellocco, R., Nyren, O., Balter, O., Balter, K.A., Validity and reliability of self-reported total energy expenditure using a novel instrument (2006) Eur J Epidemiol., 21, pp. 227-236; Logroscino, G., Sesso, H.D., Paffenbarger, R.S., Jr., Lee, I.M., Physical activity and risk of parkinson's disease: A prospective cohort study (2006) J Neurol Neurosurg Psychiatry., 77, pp. 1318-1322; Pate, R.R., Pratt, M., Blair, S.N., Haskell, W.L., Macera, C.A., Bouchard, C., Physical activity and public health a recommendation from the centers for disease control and prevention and the american college of sports medicine (1995) JAMA., 273, pp. 402-407; Petzinger, G.M., Fisher, B.E., McEwen, S., Beeler, J.A., Walsh, J.P., Jakowec, M.W., Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in parkinson's disease (2013) Lancet Neurol., 12, pp. 716-726; Petzinger, G.M., Walsh, J.P., Akopian, G., Hogg, E., Abernathy, A., Arevalo, P., Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury (2007) J Neurosci., 27, pp. 5291-5300; Saaksjarvi, K., Knekt, P., Mannisto, S., Lyytinen, J., Jaaskelainen, T., Kanerva, N., Reduced risk of parkinson's disease associated with lower body mass index and heavy leisure-time physical activity (2014) Eur J Epidemiol., 29, pp. 285-292; Sasco, A.J., Paffenbarger, R.S., Jr., Gendre, I., Wing, A.L., The role of physical exercise in the occurrence of parkinson's disease (1992) Arch Neurol-Chicago., 49, pp. 360-365; Schwarzschild, M.A., Schwid, S.R., Marek, K., Watts, A., Lang, A.E., Oakes, D., Serum urate as a predictor of clinical and radiographic progression in parkinson disease (2008) Arch Neurol., 65, pp. 716-723; Thacker, E.L., Ascherio, A., Familial aggregation of parkinson's disease: A meta-analysis (2008) Mov Disord., 23, pp. 1174-1183; Thacker, E.L., Chen, H., Patel, A.V., McCullough, M.L., Calle, E.E., Thun, M.J., Recreational physical activity and risk of parkinson's disease (2008) Mov Disord., 23, pp. 69-74; Tillerson, J.L., Caudle, W.M., Reveron, M.E., Miller, G.W., Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of parkinson's disease (2003) Neuroscience., 119, pp. 899-911; Tillerson, J.L., Cohen, A.D., Philhower, J., Miller, G.W., Zigmond, M.J., Schallert, T., Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine (2001) J Neurosci., 21, pp. 4427-4435; Wang, G.J., Volkow, N.D., Logan, J., Pappas, N.R., Wong, C.T., Zhu, W., Brain dopamine and obesity (2001) Lancet., 357, pp. 354-357; Weisskopf, M.G., O'Reilly, E., Chen, H., Schwarzschild, M.A., Ascherio, A., Plasma urate and risk of parkinson's disease (2007) Am J Epidemiol., 166, pp. 561-567; Wirdefeldt, K., Adami, H.O., Cole, P., Trichopoulos, D., Mandel, J., Epidemiology and etiology of parkinson's disease: A review of the evidence (2011) Eur J Epidemiol., 26, pp. S1-58; Wirdefeldt, K., Gatz, M., Pawitan, Y., Pedersen, N.L., Risk and protective factors for parkinson's disease: A study in swedish twins (2005) Ann Neurol., 57, pp. 27-33; Vuckovic, M.G., Li, Q., Fisher, B., Nacca, A., Leahy, R.M., Walsh, J.P., Exercise elevates dopamine d2 receptor in a mouse model of parkinson's disease: In vivo imaging with [(1)(8)f]fallypride (2010) Mov Disord., 25, pp. 2777-2784; Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., Physical activities and future risk of parkinson disease (2010) Neurology., 75, pp. 341-348},
correspondence_address1={Yang, F.; Department of Medical Epidemiology and Biostatistics, Sweden; email: fei.yang@ki.se},
publisher={Oxford University Press},
issn={00068950},
coden={BRAIA},
pubmed_id={25410713},
language={English},
abbrev_source_title={Brain},
document_type={Article},
source={Scopus},
}

@ARTICLE{Machado2018,
author={Machado, M.O. and Veronese, N. and Sanches, M. and Stubbs, B. and Koyanagi, A. and Thompson, T. and Tzoulaki, I. and Solmi, M. and Vancampfort, D. and Schuch, F.B. and Maes, M. and Fava, G.A. and Ioannidis, J.P.A. and Carvalho, A.F.},
title={The association of depression and all-cause and cause-specific mortality: An umbrella review of systematic reviews and meta-analyses},
journal={BMC Medicine},
year={2018},
volume={16},
number={1},
doi={10.1186/s12916-018-1101-z},
art_number={112},
note={cited By 91},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050298079&doi=10.1186%2fs12916-018-1101-z&partnerID=40&md5=5d2ee0a8bbfe5b195671c087149729b8},
affiliation={Federal University of Ceará, Department of Clinical Medicine and Translational Psychiatry Research Group, Faculty of Medicine, Fortaleza, CE, 60430-140, Brazil; Institute for Clinical Research and Education in Medicine (IREM), Padova, 35128, Italy; National Research Council, Neuroscience Institute, Aging Branch, Padova, 35128, Italy; Biostatistical Consulting Unit, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, United Kingdom; King's College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), De Crespigny Park, London, AF, SE5 8, United Kingdom; Anglia Ruskin University, Faculty of Health, Social Care and Education, Chelmsford, CM1 1SQ, United Kingdom; Universitat de Barcelona, Fundació Sant Joan de Déu/CIBERSAM, Parc Sanitari Sant Joan de Déu, Barcelona, 08950, Spain; University of Greenwich, Faculty of Education and Health, London, SE10 9LS, United Kingdom; School of Public Health, Imperial College London, Department of Epidemiology and Biostatistics, W2 1PG, London, United Kingdom; School of Public Health, Imperial College London, MRC-PHE Centre for Environment, London, W2 1PG, United Kingdom; University of Ioannina Medical School, Department of Hygiene and Epidemiology, Ioannina, Greece; University of Padova, Department of Neuroscience, Padova, 35100, Italy; KU Leuven - University of Leuven, Department of Rehabilitation Sciences, Leuven, 3001, Belgium; KU Leuven - University of Leuven, University Psychiatric Center KU Leuven, Leuven, Kortenberg, 3070, Belgium; Centro Universitário La Salle, Canoas, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Chulalongkorn University, Department of Psychiatry, Faculty of Medicine, Bangkok, 10330, Thailand; Deakin University, IMPACT Strategic Research Center, Barwon Health, Geelong, VIC, Australia; University of Bologna, Department of Psychology, viale Berti Pichat 5, Bologna, 40127, Italy; Erie County Medical Center, Department of Psychiatry, 462 Grider Street, Buffalo, NY  14215, United States; Stanford University, Department of Medicine, Palo Alto, CA  94305, United States; Stanford University, Department of Health Research and Policy, Palo Alto, CA  94305, United States; Stanford University, Department of Statistics, Palo Alto, CA  94305, United States; Stanford University, Department of Meta-Research Innovation Center, Stanford (METRICS), Palo Alto, CA  94305, United States; University of Toronto, Department of Psychiatry, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), 33 Russel Street, Toronto, ON  M5S 2S1, Canada},
abstract={Background: Depression is a prevalent and disabling mental disorder that frequently co-occurs with a wide range of chronic conditions. Evidence has suggested that depression could be associated with excess all-cause mortality across different settings and populations, although the causality of these associations remains unclear. Methods: We conducted an umbrella review of systematic reviews and meta-analyses of observational studies. PubMed, PsycINFO, and Embase electronic databases were searched through January 20, 2018. Systematic reviews and meta-analyses that investigated associations of depression and all-cause and cause-specific mortality were selected for the review. The evidence was graded as convincing, highly suggestive, suggestive, or weak based on quantitative criteria that included an assessment of heterogeneity, 95% prediction intervals, small-study effects, and excess significance bias. Results: A total of 26 references providing 2 systematic reviews and data for 17 meta-analytic estimates met inclusion criteria (19 of them on all-cause mortality); data from 246 unique studies (N = 3,825,380) were synthesized. All 17 associations had P < 0.05 per random effects summary effects, but none of them met criteria for convincing evidence. Associations of depression and all-cause mortality in patients after acute myocardial infarction, in individuals with heart failure, in cancer patients as well as in samples from mixed settings met criteria for highly suggestive evidence. However, none of the associations remained supported by highly suggestive evidence in sensitivity analyses that considered studies employing structured diagnostic interviews. In addition, associations of depression and all-cause mortality in cancer and post-acute myocardial infarction samples were supported only by suggestive evidence when studies that tried to adjust for potential confounders were considered. Conclusions: Even though associations between depression and mortality have nominally significant results in all assessed settings and populations, the evidence becomes weaker when focusing on studies that used structured interviews and those that tried to adjust for potential confounders. A causal effect of depression on all-cause and cause-specific mortality remains unproven, and thus interventions targeting depression are not expected to result in lower mortality rates at least based on current evidence from observational studies. © 2018 The Author(s).},
author_keywords={All-cause;  Cause-specific;  Depression;  Meta-analyses;  Mortality;  Psychiatry;  Survival;  Systematic reviews;  Umbrella review},
keywords={acute heart infarction;  all cause mortality;  Article;  Beck Depression Inventory;  cause specific mortality;  chronic obstructive lung disease;  comorbidity;  effect size;  follow up;  human;  major depression;  mortality;  Patient Health Questionnaire 9;  population research;  prospective study;  quantitative study;  self report;  structured interview;  systematic review;  cause of death;  depression;  meta analysis;  pathology;  survival rate;  trends, Cause of Death;  Depression;  Humans;  Survival Rate},
funding_details={Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorCoordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES, CP13/00150, PI15/00862},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={European Regional Development FundEuropean Regional Development Fund, FEDER},
funding_text 1={CAK is supported by a postdoctoral research fellowship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil). AK’s work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Research - and the European Regional Development Fund (ERDF-FEDER).},
references={Bromet, E., Andrade, L.H., Hwang, I., Sampson, N.A., Alonso, J., de Girolamo, G., de Graaf, R., Iwata, N., Cross-national epidemiology of DSM-IV major depressive episode (2011) BMC Med, 9, p. 90; Kessler, R.C., Bromet, E.J., The epidemiology of depression across cultures (2013) Annu Rev Public Health, 34, pp. 119-138; Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) Lancet, 386 (9995), pp. 743-800; Ferrari, A.J., Charlson, F.J., Norman, R.E., Patten, S.B., Freedman, G., Murray, C.J., Vos, T., Whiteford, H.A., Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010 (2013) PLoS Med, 10 (11); Rackley, S., Bostwick, J.M., Depression in medically ill patients (2012) Psychiatr Clin North Am, 35 (1), pp. 231-247; Rotella, F., Mannucci, E., Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies (2013) J Clin Psychiatry, 74 (1), pp. 31-37; Luppino, F.S., de Wit, L.M., Bouvy, P.F., Stijnen, T., Cuijpers, P., Penninx, B.W., Zitman, F.G., Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies (2010) Arch Gen Psychiatry, 67 (3), pp. 220-229; Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Ntzani, E.E., Ioannidis, J.P., Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies (2015) BMJ, 350; Wu, Q., Kling, J.M., Depression and the risk of myocardial infarction and coronary death: a meta-analysis of prospective cohort studies (2016) Medicine (Baltimore), 95 (6); Cherbuin, N., Kim, S., Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis (2015) BMJ Open, 5 (12); Read, J.R., Sharpe, L., Modini, M., Dear, B.F., Multimorbidity and depression: a systematic review and meta-analysis (2017) J Affect Disord, 221, pp. 36-46; Rotella, F., Mannucci, E., Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies (2013) Diabetes Res Clin Pract, 99 (2), pp. 98-104; Hackett, M.L., Pickles, K., Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies (2014) Int J Stroke, 9 (8), pp. 1017-1025; Lichtman, J.H., Froelicher, E.S., Blumenthal, J.A., Carney, R.M., Doering, L.V., Frasure-Smith, N., Freedland, K.E., Sheps, D.S., Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association (2014) Circulation, 129 (12), pp. 1350-1369; Bennett, S., Thomas, A.J., Depression and dementia: cause, consequence or coincidence? (2014) Maturitas, 79 (2), pp. 184-190; Walker, E.R., McGee, R.E., Druss, B.G., Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis (2015) JAMA Psychiatry, 72 (4), pp. 334-341; Pratt, L.A., Druss, B.G., Manderscheid, R.W., Walker, E.R., Excess mortality due to depression and anxiety in the United States: results from a nationally representative survey (2016) Gen Hosp Psychiatry, 39, pp. 39-45; Bolton, J.M., Gunnell, D., Turecki, G., Suicide risk assessment and intervention in people with mental illness (2015) BMJ, 351; Cuijpers, P., Smit, F., Excess mortality in depression: a meta-analysis of community studies (2002) J Affect Disord, 72 (3), pp. 227-236; Bartoli, F., Lillia, N., Lax, A., Crocamo, C., Mantero, V., Carra, G., Agostoni, E., Clerici, M., Depression after stroke and risk of mortality: a systematic review and meta-analysis (2013) Stroke Res Treat, 2013, p. 862978; Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., Penninx, B.W., Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison (2014) J Affect Disord, 161, pp. 47-54; Rethorst, C.D., Leonard, D., Barlow, C.E., Willis, B.L., Trivedi, M.H., DeFina, L.F., Effects of depression, metabolic syndrome, and cardiorespiratory fitness on mortality: results from the Cooper Center longitudinal study (2017) Psychol Med., 47 (14), pp. 1-7; Schuch, F., Vancampfort, D., Firth, J., Rosenbaum, S., Ward, P., Reichert, T., Bagatini, N.C., Stubbs, B., Physical activity and sedentary behavior in people with major depressive disorder: a systematic review and meta-analysis (2017) J Affect Disord, 210, pp. 139-150; Prochaska, J.J., Das, S., Young-Wolff, K.C., Smoking, mental illness, and public health (2017) Annu Rev Public Health, 38, pp. 165-185; Liu, N.H., Daumit, G.L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., Druss, B., Fujii, C., Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas (2017) World Psychiatry, 16 (1), pp. 30-40; Barth, J., Schumacher, M., Herrmann-Lingen, C., Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis (2004) Psychosom Med, 66 (6), pp. 802-813; Palmer, S.C., Vecchio, M., Craig, J.C., Tonelli, M., Johnson, D.W., Nicolucci, A., Pellegrini, F., Hedayati, S.S., Association between depression and death in people with CKD: a meta-analysis of cohort studies (2013) Am J Kidney Dis, 62 (3), pp. 493-505; Fan, H., Yu, W., Zhang, Q., Cao, H., Li, J., Wang, J., Shao, Y., Hu, X., Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis (2014) Prev Med, 63, pp. 36-42; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M.J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., Tsilidis, K.K., Adiposity and cancer at major anatomical sites: umbrella review of the literature (2017) BMJ, 356; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14 (3), pp. 263-273; (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research, , Geneva: World Health Organization; (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), , Arlington: American Psychiatric Pub; Spitzer, R.L., Endicott, J., Robins, E., Research diagnostic criteria: rationale and reliability (1978) Arch Gen Psychiatry, 35 (6), pp. 773-782; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127 (9), pp. 820-826; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172 (1), pp. 137-159; IntHout, J., Ioannidis, J.P., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) BMJ Open, 6 (7); Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21 (11), pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335 (7626), pp. 914-916; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Carvalho, A.F., Kohler, C.A., Brunoni, A.R., Miskowiak, K.W., Herrmann, N., Lanctot, K.L., Hyphantis, T.N., Berk, M., Bias in peripheral depression biomarkers (2016) Psychother Psychosom, 85 (2), pp. 81-90; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57 (5), pp. 184-187; Bortolato, B., Kohler, C.A., Evangelou, E., Leon-Caballero, J., Solmi, M., Stubbs, B., Belbasis, L., Kessing, L.V., Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses (2017) Bipolar Disord, 19 (2), pp. 84-96; Salanti, G., Ioannidis, J.P., Synthesis of observational studies should consider credibility ceilings (2009) J Clin Epidemiol, 62 (2), pp. 115-122; Papatheodorou, S.I., Tsilidis, K.K., Evangelou, E., Ioannidis, J.P., Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk (2015) J Clin Epidemiol, 68 (2), pp. 163-174; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J Clin Epidemiol, 62 (10), pp. 1013-1020; Pieper, D., Buechter, R.B., Li, L., Prediger, B., Eikermann, M., Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties (2015) J Clin Epidemiol, 68 (5), pp. 574-583; Factors influencing risk of premature mortality in community cases of depression: a meta-analytic review (2011) Epidemiol Res Int 2011, p. 832945; Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., Penninx, B.W., Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses (2014) Am J Psychiatry, 171 (4), pp. 453-462; Dew, M.A., Rosenberger, E.M., Myaskovsky, L., DiMartini, A.F., DeVito Dabbs, A.J., Posluszny, D.M., Steel, J., Greenhouse, J.B., Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis (2015) Transplantation, 100 (5), pp. 988-1003; van Dooren, F.E., Nefs, G., Schram, M.T., Verhey, F.R., Denollet, J., Pouwer, F., Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis (2013) PLoS One, 8 (3); Gathright, E.C., Goldstein, C.M., Josephson, R.A., Hughes, J.W., Depression increases the risk of mortality in patients with heart failure: a meta-analysis (2017) J Psychosom Res, 94, pp. 82-89; Hofmann, M., Kohler, B., Leichsenring, F., Kruse, J., Depression as a risk factor for mortality in individuals with diabetes: a meta-analysis of prospective studies (2013) PLoS One, 8 (11); Leung, Y.W., Flora, D.B., Gravely, S., Irvine, J., Carney, R.M., Grace, S.L., The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis (2012) Psychosom Med, 74 (8), pp. 786-801; Meijer, A., Conradi, H.J., Bos, E.H., Thombs, B.D., van Melle, J.P., de Jonge, P., Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research (2011) Gen Hosp Psychiatry, 33 (3), pp. 203-216; Van Melle, J.P., De Jonge, P., Spijkerman, T.A., Tijssen, J.G.P., Ormel, J., Van Veldhuisen, D.J., Van Den Brink, R.H.S., Van Den Berg, M.P., Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis (2004) Psychosom Med, 66 (6), pp. 814-822; Pan, A., Depression and risk of stroke morbidity and mortality: A meta-analysis and systematic review (2011) JAMA, 306 (11), pp. 1241-1249; Park, M., Katon, W.J., Wolf, F.M., Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review (2013) Gen Hosp Psychiatry, 35 (3), pp. 217-225; Pederson, J.L., Warkentin, L.M., Majumdar, S.R., McAlister, F.A., Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: a systematic review and meta-analysis (2016) J Hosp Med, 11 (5), pp. 373-380; Satin, J.R., Linden, W., Phillips, M.J., Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis (2009) Cancer, 115 (22), pp. 5349-5361; Sokoreli, I., de Vries, J.J.G., Pauws, S.C., Steyerberg, E.W., Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis (2016) Heart Fail Rev, 21 (1), pp. 49-63; Sorensen, C., Friis-Hasche, E., Haghfelt, T., Bech, P., Postmyocardial infarction mortality in relation to depression: a systematic critical review (2005) Psychother Psychosom, 74 (2), pp. 69-80; Stenman, M., Holzmann, M.J., Sartipy, U., Association between preoperative depression and long-term survival following coronary artery bypass surgery - a systematic review and meta-analysis (2016) Int J Cardiol, 222, pp. 462-466; Correll, C.U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa-Chhetri, N., Collantoni, E., Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls (2017) World Psychiatry, 16 (2), pp. 163-180; Meijer, A., Conradi, H.J., Bos, E.H., Anselmino, M., Carney, R.M., Denollet, J., Doyle, F., Hosseini, S.H., Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis (2013) Br J Psychiatry, 203 (2), pp. 90-102; Barber, B., Dergousoff, J., Slater, L., Harris, J., O'Connell, D., El-Hakim, H., Biron, V.L., Seikaly, H., Depression and survival in patients with head and neck Cancer: a systematic review (2016) JAMA Otolaryngol Head Neck Surg, 142 (3), pp. 284-288; Salte, K., Titlestad, I., Halling, A., Depression is associated with poor prognosis in patients with chronic obstructive pulmonary disease - a systematic review (2015) Dan Med J, 62 (10), p. A5137; Ødegård, O., The excess mortality of the insane (1952) Acta Psychiatr Scand, 27 (3-4), pp. 353-367; Jarvis, E., On the comparative liability of males and females to insanity, and their comparative curability and mortality when insane (1850) Am J Psychiatr, 7 (2), pp. 142-171; Chesney, E., Goodwin, G.M., Fazel, S., Risks of all-cause and suicide mortality in mental disorders: a meta-review (2014) World Psychiatry, 13 (2), pp. 153-160; Slyepchenko, A., Maes, M., Jacka, F.N., Kohler, C.A., Barichello, T., McIntyre, R.S., Berk, M., Vieta, E., Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities (2017) Psychother Psychosom, 86 (1), pp. 31-46; Black, C.N., Bot, M., Scheffer, P.G., Cuijpers, P., Penninx, B.W., Is depression associated with increased oxidative stress? A systematic review and meta-analysis (2015) Psychoneuroendocrinology, 51, pp. 164-175; de Melo, L.G.P., Nunes, S.O.V., Anderson, G., Vargas, H.O., Barbosa, D.S., Galecki, P., Carvalho, A.F., Maes, M., Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders (2017) Prog Neuro-Psychopharmacol Biol Psychiatry, 78, pp. 34-50; Penninx, B.W., Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms (2017) Neurosci Biobehav Rev, 74, pp. 277-286; Vancampfort, D., Stubbs, B., Mitchell, A.J., De Hert, M., Wampers, M., Ward, P.B., Rosenbaum, S., Correll, C.U., Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis (2015) World Psychiatry, 14 (3), pp. 339-347; Fava, G.A., Cosci, F., Sonino, N., Current psychosomatic practice (2017) Psychother Psychosom, 86 (1), pp. 13-30; Crawshaw, J., Auyeung, V., Norton, S., Weinman, J., Identifying psychosocial predictors of medication non-adherence following acute coronary syndrome: a systematic review and meta-analysis (2016) J Psychosom Res, 90, pp. 10-32; Smith, S.G., Sestak, I., Forster, A., Partridge, A., Side, L., Wolf, M.S., Horne, R., Cuzick, J., Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis (2016) Ann Oncol, 27 (4), pp. 575-590; Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M.R., Rahman, A., No health without mental health (2007) Lancet, 370 (9590), pp. 859-877; Jacka, F.N., Pasco, J.A., Mykletun, A., Williams, L.J., Hodge, A.M., O'Reilly, S.L., Nicholson, G.C., Berk, M., Association of Western and traditional diets with depression and anxiety in women (2010) Am J Psychiatry, 167 (3), pp. 305-311; Levis, B., Benedetti, A., Levis, A.W., Ioannidis, J.P.A., Shrier, I., Cuijpers, P., Gilbody, S., Patten, S.B., Selective cutoff reporting in studies of diagnostic test accuracy: a comparison of conventional and individual-patient-data meta-analyses of the patient health Questionnaire-9 depression screening tool (2017) Am J Epidemiol, 185 (10), pp. 954-964; Miloyan, B., Fried, E., A reassessment of the relationship between depression and all-cause mortality in 3,604,005 participants from 293 studies (2017) World Psychiatry, 16 (2), pp. 219-220; Lichtenberg, P., Belmaker, R.H., Subtyping major depressive disorder (2010) Psychother Psychosom, 79 (3), pp. 131-135; Ormel, J., de Jonge, P., Unipolar depression and the progression of coronary artery disease: toward an integrative model (2011) Psychother Psychosom, 80 (5), pp. 264-274; de Miranda Azevedo, R., Roest, A.M., Hoen, P.W., de Jonge, P., Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis (2014) Psychol Med, 44 (13), pp. 2689-2703; Caruso, R., GiuliaNanni, M., Riba, M.B., Sabato, S., Grassi, L., Depressive spectrum disorders in cancer: diagnostic issues and intervention. A Critical Review (2017) Curr Psychiatry Rep, 19 (6), p. 33; Lambert, S.D., Clover, K., Pallant, J.F., Britton, B., King, M.T., Mitchell, A.J., Carter, G., Making sense of variations in prevalence estimates of depression in Cancer: a co-calibration of commonly used depression scales using Rasch analysis (2015) J Natl Compr Cancer Netw, 13 (10), pp. 1203-1211; Cosci, F., Fava, G.A., Sonino, N., Mood and anxiety disorders as early manifestations of medical illness: a systematic review (2015) Psychother Psychosom, 84 (1), pp. 22-29; Harris, E.C., Barraclough, B., Excess mortality of mental disorder (1998) Br J Psychiatry, 173, pp. 11-53; Laursen, T.M., Munk-Olsen, T., Nordentoft, M., Mortensen, P.B., Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia (2007) J Clin Psychiatry, 68 (6), pp. 899-907; Laursen, T.M., Musliner, K.L., Benros, M.E., Vestergaard, M., Munk-Olsen, T., Mortality and life expectancy in persons with severe unipolar depression (2016) J Affect Disord, 193, pp. 203-207; Fekadu, A., Medhin, G., Kebede, D., Alem, A., Cleare, A.J., Prince, M., Hanlon, C., Shibre, T., Excess mortality in severe mental illness: 10-year population-based cohort study in rural Ethiopia (2015) Br J Psychiatry, 206 (4), pp. 289-296; Markkula, N., Harkanen, T., Perala, J., Partti, K., Pena, S., Koskinen, S., Lonnqvist, J., Saarni, S.I., Mortality in people with depressive, anxiety and alcohol use disorders in Finland (2012) Br J Psychiatry, 200 (2), pp. 143-149; Pizzi, C., Rutjes, A.W., Costa, G.M., Fontana, F., Mezzetti, A., Manzoli, L., Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease (2011) Am J Cardiol, 107 (7), pp. 972-979; Whalley, B., Thompson, D.R., Taylor, R.S., Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis (2014) Int J Behav Med, 21 (1), pp. 109-121},
correspondence_address1={Carvalho, A.F.; University of Toronto, Canada; email: andre.carvalho@camh.ca},
publisher={BioMed Central Ltd.},
issn={17417015},
pubmed_id={30025524},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Galbete2018909,
author={Galbete, C. and Schwingshackl, L. and Schwedhelm, C. and Boeing, H. and Schulze, M.B.},
title={Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses},
journal={European Journal of Epidemiology},
year={2018},
volume={33},
number={10},
pages={909-931},
doi={10.1007/s10654-018-0427-3},
note={cited By 90},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050333747&doi=10.1007%2fs10654-018-0427-3&partnerID=40&md5=7454c5115554161173bf4c9a844ca202},
affiliation={Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; NutriAct – Competence Cluster Nutrition Research Berlin-Potsdam, Nuthetal, Germany; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany},
abstract={Several meta-analyses have been published summarizing the associations of the Mediterranean diet (MedDiet) with chronic diseases. We evaluated the quality and credibility of evidence from these meta-analyses as well as characterized the different indices used to define MedDiet and re-calculated the associations with the different indices identified. We conducted an umbrella review of meta-analyses on cohort studies evaluating the association of the MedDiet with type 2 diabetes, cardiovascular disease, cancer and cognitive-related diseases. We used the AMSTAR (A MeaSurement Tool to Assess systematic Reviews) checklist to evaluate the methodological quality of the meta-analyses, and the NutriGrade scoring system to evaluate the credibility of evidence. We also identified different indices used to define MedDiet; tests for subgroup differences were performed to compare the associations with the different indices when at least 2 studies were available for different definitions. Fourteen publications were identified and within them 27 meta-analyses which were based on 70 primary studies. Almost all meta-analyses reported inverse associations between MedDiet and risk of chronic disease, but the credibility of evidence was rated low to moderate. Moreover, substantial heterogeneity was observed on the use of the indices assessing adherence to the MedDiet, but two indices were the most used ones [Trichopoulou MedDiet (tMedDiet) and alternative MedDiet (aMedDiet)]. Overall, we observed little difference in risk associations comparing different MedDiet indices in the subgroup meta-analyses. Future prospective cohort studies are advised to use more homogenous definitions of the MedDiet to improve the comparability across meta-analyses. © 2018, The Author(s).},
author_keywords={Chronic diseases;  Cohort studies;  Heterogeneity;  Mediterranean diet;  Meta-analyses;  Umbrella review},
keywords={cardiometabolic risk;  cardiovascular disease;  chronic disease;  cognitive defect;  cohort analysis;  human;  information retrieval;  Mediterranean diet;  meta analysis (topic);  non insulin dependent diabetes mellitus;  Review;  risk assessment;  scoring system;  cardiovascular disease;  chronic disease;  cognitive defect;  meta analysis (topic);  metabolic syndrome X;  non insulin dependent diabetes mellitus;  obesity, Cardiovascular Diseases;  Chronic Disease;  Cognitive Dysfunction;  Diabetes Mellitus, Type 2;  Diet, Mediterranean;  Humans;  Meta-Analysis as Topic;  Metabolic Syndrome;  Obesity},
references={Menotti, A., Kromhout, D., Blackburn, H., Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study (1999) Eur J Epidemiol, 15 (6), pp. 507-515; Trichopoulou, A., Kouris-Blazos, A., Wahlqvist, M.L., Diet and overall survival in elderly people (1995) BMJ (Clin Res Ed), 311 (7018), pp. 1457-1460. , COI: 1:STN:280:DyaK28%2Fps1erug%3D%3D; Toledo, E., Salas-Salvado, J., Donat-Vargas, C., Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial (2015) JAMA Intern Med, 175 (11), pp. 1752-1760; Stojanovic, J., Giraldi, L., Arzani, D., Adherence to Mediterranean diet and risk of gastric cancer: results of a case-control study in Italy (2017) Eur J Cancer Prev Off J Eur Cancer Prev Org, 26 (6), pp. 491-496; Rosato, V., Guercio, V., Bosetti, C., Mediterranean diet and colorectal cancer risk: a pooled analysis of three Italian case-control studies (2016) Br J Cancer, 115 (7), pp. 862-865; Salas-Salvado, J., Bullo, M., Babio, N., Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial (2011) Diabetes Care, 34 (1), pp. 14-19; Dominguez, L.J., Bes-Rastrollo, M., de la Fuente-Arrillaga, C., Similar prediction of total mortality, diabetes incidence and cardiovascular events using relative- and absolute-component Mediterranean diet score: the SUN cohort (2013) Nutr Metab Cardiovasc Dis NMCD, 23 (5), pp. 451-458; Filippatos, T.D., Panagiotakos, D.B., Georgousopoulou, E.N., Mediterranean diet and 10-year (2002–2012) incidence of diabetes and cardiovascular disease in participants with prediabetes: the ATTICA study (2016) Rev Diabet Stud RDS, 13 (4), pp. 226-235; Martinez-Lapiscina, E.H., Clavero, P., Toledo, E., Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial (2013) J Neurol Neurosurg Psychiatry, 84 (12), pp. 1318-1325; Galbete, C., Toledo, E., Toledo, J.B., Mediterranean diet and cognitive function: the SUN project (2015) J Nutr Health Aging, 19 (3), pp. 305-312; Mayor, S., Sixty seconds on… the Mediterranean diet (2018) BMJ (Clin Res Ed), 361, p. k2667; Estruch, R., Ros, E., Salas-Salvado, J., Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (2018) New Engl J Med, 378 (25); Hodge, A.M., English, D.R., Itsiopoulos, C., O’Dea, K., Giles, G.G., Does a Mediterranean diet reduce the mortality risk associated with diabetes: evidence from the Melbourne Collaborative Cohort Study (2011) Nutr Metab Cardiovasc Dis NMCD, 21 (9), pp. 733-739; Davis, C., Hodgson, J., Bryan, J., Garg, M., Woodman, R., Murphy, K., Older Australians can achieve high adherence to the Mediterranean diet during a 6 month randomised intervention; results from the Medley study (2017) Nutrients, 9 (6), p. 534; Kanauchi, M., Kanauchi, K., Development of a Mediterranean diet score adapted to Japan and its relation to obesity risk (2016) Food Nutr Res, 60, p. 32172; Jannasch, F., Kroger, J., Schulze, M.B., Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies (2017) J Nutr, 147 (6), pp. 1174-1182; Schwingshackl, L., Schwedhelm, C., Galbete, C., Hoffmann, G., Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis (2017) Nutrients, 9 (10), p. 1063; Davis, C., Bryan, J., Hodgson, J., Murphy, K., Definition of the Mediterranean diet: a literature review (2015) Nutrients, 7 (11), pp. 9139-9153; Sofi, F., Macchi, C., Abbate, R., Gensini, G.F., Casini, A., Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score (2014) Public Health Nutr, 17 (12), pp. 2769-2782; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) PLoS Med, 6 (7); Schwingshackl, L., Hoffmann, G., Missbach, B., Stelmach-Mardas, M., Boeing, H., An umbrella review of nuts intake and risk of cardiovascular disease (2017) Curr Pharm Des, 23 (7), pp. 1016-1027; Schwingshackl, L., Missbach, B., Hoffmann, G., An umbrella review of garlic intake and risk of cardiovascular disease (2016) Phytomed Int J Phytother Phytopharmacol, 23 (11), pp. 1127-1133; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7 (1), p. 10; Huedo-Medina, T.B., Garcia, M., Bihuniak, J.D., Kenny, A., Kerstetter, J., Methodologic quality of meta-analyses and systematic reviews on the Mediterranean diet and cardiovascular disease outcomes: a review (2016) Am J Clin Nutr, 103 (3), pp. 841-850; (2015) U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans, , https://health.gov/dietaryguidelines/2015/guidelines/, 8th ed, Accessed 11 Nov 2017; Schwingshackl, L., Knuppel, S., Schwedhelm, C., Perspective: NutriGrade: a scoring system to assess and judge the meta-evidence of randomized controlled trials and cohort studies in nutrition research (2016) Adv Nutr, 7 (6), pp. 994-1004; Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population (2003) New Engl J Med, 348 (26), pp. 2599-2608; Dersimonian, R., Laird, N., Metaanalysis in clinical-trials (1986) Control Clin Trials, 7 (3), pp. 177-188; Riley, R.D., Higgins, J.P., Deeks, J.J., Interpretation of random effects meta-analyses (2011) BMJ, 342, p. d549; Koloverou, E., Esposito, K., Giugliano, D., Panagiotakos, D., The effect of Mediterranean diet on the development of type 2 diabetes mellitus: a meta-analysis of 10 prospective studies and 136,846 participants (2014) Metabolism, 63 (7), pp. 903-911; Esposito, K., Chiodini, P., Maiorino, M.I., Bellastella, G., Panagiotakos, D., Giugliano, D., Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies (2014) Endocrine, 47 (1), pp. 107-116; Rosato, V., Temple, N.J., La Vecchia, C., Castellan, G., Tavani, A., Guercio, V., Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies (2017) Eur J Nutr; Grosso, G., Marventano, S., Yang, J., A comprehensive meta-analysis on evidence of mediterranean diet and cardiovascular disease: Are individual components equal? (2017) Crit Rev Food Sci Nutr, 57 (15), pp. 3218-3232; Martinez-Gonzalez, M.A., Bes-Rastrollo, M., Dietary patterns, Mediterranean diet, and cardiovascular disease (2014) Curr Opin Lipidol, 25 (1), pp. 20-26; Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scarmeas, N., Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis (2013) Ann Neurol, 74 (4), pp. 580-591; Bloomfield, H.E., Koeller, E., Greer, N., MacDonald, R., Kane, R., Wilt, T.J., Effects on health outcomes of a mediterranean diet with no restriction on fat intake: a systematic review and meta-analysis (2016) Ann Intern Med, 165 (7), pp. 491-500; Wu, L., Sun, D., Adherence to Mediterranean diet and risk of developing cognitive disorders: an updated systematic review and meta-analysis of prospective cohort studies (2017) Sci Rep, 7, p. 41317; Cao, L., Tan, L., Wang, H.F., Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies (2016) Mol Neurobiol, 53 (9), pp. 6144-6154; Singh, B., Parsaik, A.K., Mielke, M.M., Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis (2014) J Alzheimer’s Dis JAD, 39 (2), pp. 271-282; Schwingshackl, L., Missbach, B., Konig, J., Hoffmann, G., Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis (2015) Public Health Nutr, 18 (7), pp. 1292-1299; Agnoli, C., Krogh, V., Grioni, S., A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort (2011) J Nutr, 141 (8), pp. 1552-1558; Benetou, V., Trichopoulou, A., Orfanos, P., Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort (2008) Br J Cancer, 99 (1), pp. 191-195; de Leon, A.C., Coello, S.D., Gonzalez, D.A., Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands (2012) Diabet Med, 29 (3), pp. 399-403; Dilis, V., Katsoulis, M., Lagiou, P., Trichopoulos, D., Naska, A., Trichopoulou, A., Mediterranean diet and CHD: the Greek european prospective investigation into cancer and nutrition cohort (2012) Br J Nutr, 108 (4), pp. 699-709; Lagiou, P., Trichopoulos, D., Sandin, S., Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden (2006) Br J Nutr, 96 (2), pp. 384-392. , COI: 1:CAS:528:DC%2BD28XovFOjs7Y%3D; Martinez-Gonzalez, M.A., de la Fuente-Arrillaga, C., Nunez-Cordoba, J.M., Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study (2008) BMJ (Clinical research ed.), 336 (7657), pp. 1348-1351; Martinez-Gonzalez, M.A., Garcia-Lopez, M., Bes-Rastrollo, M., Mediterranean diet and the incidence of cardiovascular disease: a Spanish cohort (2011) Nutr Metab Cardiovasc Dis NMCD, 21 (4), pp. 237-244; Martinez-Gonzalez, M.A., Guillen-Grima, F., De Irala, J., The Mediterranean diet is associated with a reduction in premature mortality among middle-aged adults (2012) J Nutr, 142 (9), pp. 1672-1678; Misirli, G., Benetou, V., Lagiou, P., Bamia, C., Trichopoulos, D., Trichopoulou, A., Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population (2012) Am J Epidemiol, 176 (12), pp. 1185-1192; Rossi, M., Turati, F., Lagiou, P., Mediterranean diet and glycaemic load in relation to incidence of type 2 diabetes: results from the Greek cohort of the population-based European prospective investigation into cancer and nutrition (EPIC) (2013) Diabetologia, 56 (11), pp. 2405-2413; Chan, R., Chan, D., Woo, J., The association of a priori and a posterior dietary patterns with the risk of incident stroke in Chinese older people in Hong Kong (2013) J Nutr Health Aging, 17 (10), pp. 866-874; Tong, T.Y., Wareham, N.J., Khaw, K.T., Imamura, F., Forouhi, N.G., Prospective association of the Mediterranean diet with cardiovascular disease incidence and mortality and its population impact in a non-Mediterranean population: the EPIC-Norfolk study (2016) BMC Med, 14 (1), p. 135; Couto, E., Boffetta, P., Lagiou, P., Mediterranean dietary pattern and cancer risk in the EPIC cohort (2011) Br J Cancer, 104 (9), pp. 1493-1499; Couto, E., Sandin, S., Lof, M., Ursin, G., Adami, H.O., Weiderpass, E., Mediterranean dietary pattern and risk of breast cancer (2013) PLoS One, 8 (2); Bamia, C., Lagiou, P., Buckland, G., Mediterranean diet and colorectal cancer risk: results from a European cohort (2013) Eur J Epidemiol, 28 (4), pp. 317-328; Gardener, H., Wright, C.B., Gu, Y., Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study (2011) Am J Clin Nutr, 94 (6), pp. 1458-1464; Cuenca-Garcia, M., Artero, E.G., Sui, X., Lee, D.C., Hebert, J.R., Blair, S.N., Dietary indices, cardiovascular risk factors and mortality in middle-aged adults: findings from the Aerobics Center Longitudinal Study (2014) Ann Epidemiol, 24 (4), pp. 297-303.e2; Buckland, G., Agudo, A., Lujan, L., Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study (2010) Am J Clin Nutr, 91 (2), pp. 381-390; Buckland, G., Agudo, A., Travier, N., Adherence to the Mediterranean diet reduces mortality in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain) (2011) Br J Nutr, 106 (10), pp. 1581-1591; Buckland, G., Gonzalez, C.A., Agudo, A., Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study (2009) Am J Epidemiol, 170 (12), pp. 1518-1529; InterAct, C., Romaguera, D., Guevara, M., Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project (2011) Diabetes Care, 34 (9), pp. 1913-1918; Buckland, G., Travier, N., Cottet, V., Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study (2013) Int J Cancer, 132 (12), pp. 2918-2927; Roberts, R.O., Geda, Y.E., Cerhan, J.R., Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment (2010) Dement Geriatr Cogn Disord, 29 (5), pp. 413-423; Scarmeas, N., Stern, Y., Mayeux, R., Manly, J.J., Schupf, N., Luchsinger, J.A., Mediterranean diet and mild cognitive impairment (2009) Arch Neurol, 66 (2), pp. 216-225; Scarmeas, N., Stern, Y., Tang, M.X., Mayeux, R., Luchsinger, J.A., Mediterranean diet and risk for Alzheimer’s disease (2006) Ann Neurol, 59 (6), pp. 912-921; Feart, C., Samieri, C., Rondeau, V., Adherence to a Mediterranean diet, cognitive decline, and risk of dementia (2009) JAMA, 302 (6), pp. 638-648; Tsivgoulis, G., Psaltopoulou, T., Wadley, V.G., Adherence to a Mediterranean diet and prediction of incident stroke (2015) Stroke, 46 (3), pp. 780-785; Lassale, C., Gunter, M.J., Romaguera, D., Diet quality scores and prediction of all-cause, cardiovascular and cancer mortality in a Pan-European cohort study (2016) PLoS One, 11 (7); Bosire, C., Stampfer, M.J., Subar, A.F., Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study (2013) Am J Epidemiol, 177 (6), pp. 504-513; Fung, T.T., Hu, F.B., McCullough, M.L., Newby, P.K., Willett, W.C., Holmes, M.D., Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women (2006) J Nutr, 136 (2), pp. 466-472. , COI: 1:CAS:528:DC%2BD28Xht1Wisbo%3D; Fung, T.T., Rexrode, K.M., Mantzoros, C.S., Manson, J.E., Willett, W.C., Hu, F.B., Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women (2009) Circulation, 119 (8), pp. 1093-1100; George, S.M., Ballard-Barbash, R., Manson, J.E., Comparing indices of diet quality with chronic disease mortality risk in postmenopausal women in the Women’s Health Initiative Observational Study: evidence to inform national dietary guidance (2014) Am J Epidemiol, 180 (6), pp. 616-625; Harmon, B.E., Boushey, C.J., Shvetsov, Y.B., Associations of key diet-quality indexes with mortality in the Multiethnic Cohort: the Dietary Patterns Methods Project (2015) Am J Clin Nutr, 101 (3), pp. 587-597; Jacobs, S., Harmon, B.E., Boushey, C.J., A priori-defined diet quality indexes and risk of type 2 diabetes: the Multiethnic Cohort (2015) Diabetologia, 58 (1), pp. 98-112; Reedy, J., Krebs-Smith, S.M., Miller, P.E., Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults (2014) J Nutr, 144 (6), pp. 881-889; Tobias, D.K., Hu, F.B., Chavarro, J., Rosner, B., Mozaffarian, D., Zhang, C., Healthful dietary patterns and type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus (2012) Arch Intern Med, 172 (20), pp. 1566-1572; Sotos-Prieto, M., Bhupathiraju, S.N., Mattei, J., Changes in diet quality scores and risk of cardiovascular disease among US men and women (2015) Circulation, 132 (23), pp. 2212-2219; Mitrou, P.N., Kipnis, V., Thiebaut, A.C., Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study (2007) Arch Intern Med, 167 (22), pp. 2461-2468; de Koning, L., Chiuve, S.E., Fung, T.T., Willett, W.C., Rimm, E.B., Hu, F.B., Diet-quality scores and the risk of type 2 diabetes in men (2011) Diabetes Care, 34 (5), pp. 1150-1156; Lopez-Garcia, E., Rodriguez-Artalejo, F., Li, T.Y., The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease (2014) Am J Clin Nutr, 99 (1), pp. 172-180; Haring, B., Wu, C., Mossavar-Rahmani, Y., No association between dietary patterns and risk for cognitive decline in older women with 9-year follow-up: data from the Women’s Health Initiative Memory Study (2016) J Acad Nutr Diet., 116 (6), pp. 921-930.e1; Abiemo, E.E., Alonso, A., Nettleton, J.A., Relationships of the Mediterranean dietary pattern with insulin resistance and diabetes incidence in the Multi-Ethnic Study of Atherosclerosis (MESA) (2013) Br J Nutr, 109 (8), pp. 1490-1497; Mozaffarian, D., Marfisi, R., Levantesi, G., Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors (2007) Lancet, 370 (9588), pp. 667-675; Vormund, K., Braun, J., Rohrmann, S., Bopp, M., Ballmer, P., Faeh, D., Mediterranean diet and mortality in Switzerland: An alpine paradox? (2015) Eur J Nutr, 54 (1), pp. 139-148; Hoevenaar-Blom, M.P., Nooyens, A.C., Kromhout, D., Mediterranean style diet and 12-year incidence of cardiovascular diseases: the EPIC-NL cohort study (2012) PLoS One, 7 (9); Hoevenaar-Blom, M.P., Spijkerman, A.M., Boshuizen, H.C., Boer, J.M., Kromhout, D., Verschuren, W.M., Effect of using repeated measurements of a Mediterranean style diet on the strength of the association with cardiovascular disease during 12 years: the Doetinchem Cohort Study (2014) Eur J Nutr, 53 (5), pp. 1209-1215; Sjogren, P., Becker, W., Warensjo, E., Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden (2010) Am J Clin Nutr, 92 (4), pp. 967-974; Olsson, E., Karlstrom, B., Kilander, L., Byberg, L., Cederholm, T., Sjogren, P., Dietary patterns and cognitive dysfunction in a 12-year follow-up study of 70 year old men (2015) J Alzheimer’ Dis JAD, 43 (1), pp. 109-119; Tognon, G., Lissner, L., Saebye, D., Walker, K.Z., Heitmann, B.L., The Mediterranean diet in relation to mortality and CVD: a Danish cohort study (2014) Br J Nutr, 111 (1), pp. 151-159; Bertoia, M.L., Triche, E.W., Michaud, D.S., Mediterranean and dietary approaches to stop hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women (2014) Am J Clin Nutr, 99 (2), pp. 344-351; Tektonidis, T.G., Akesson, A., Gigante, B., Wolk, A., Larsson, S.C., A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: a population-based cohort study (2015) Atherosclerosis, 243 (1), pp. 93-98; Bellavia, A., Tektonidis, T.G., Orsini, N., Wolk, A., Larsson, S.C., Quantifying the benefits of Mediterranean diet in terms of survival (2016) Eur J Epidemiol, 31 (5), pp. 527-530; Yau, W.Y., Hankey, G.J., Which dietary and lifestyle behaviours may be important in the aetiology (and prevention) of stroke? (2011) J Clin Neurosci Off J Neurosurg Soc Australas, 18 (1), pp. 76-80; Whalen, K.A., Judd, S., McCullough, M.L., Flanders, W.D., Hartman, T.J., Bostick, R.M., Paleolithic and Mediterranean diet pattern scores are inversely associated with all-cause and cause-specific mortality in adults (2017) J Nutr, 147 (4), pp. 612-620; Morris, M.C., Tangney, C.C., Wang, Y., Sacks, F.M., Bennett, D.A., Aggarwal, N.T., MIND diet associated with reduced incidence of Alzheimer’s disease (2015) Alzheimer’s Dement J Alzheimer’s Assoc, 11 (9), pp. 1007-1014; Knoops, K.T., de Groot, L.C., Kromhout, D., Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project (2004) JAMA, 292 (12), pp. 1433-1439; Agnoli, C., Grioni, S., Sieri, S., Italian Mediterranean Index and risk of colorectal cancer in the Italian section of the EPIC cohort (2013) Int J Cancer, 132 (6), pp. 1404-1411; Brunner, E.J., Mosdol, A., Witte, D.R., Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality (2008) Am J Clin Nutr, 87 (5), pp. 1414-1421. , COI: 1:CAS:528:DC%2BD1cXmtFWjsLs%3D; Menotti, A., Alberti-Fidanza, A., Fidanza, F., Lanti, M., Fruttini, D., Factor analysis in the identification of dietary patterns and their predictive role in morbid and fatal events (2012) Public Health Nutr, 15 (7), pp. 1232-1239; Tognon, G., Nilsson, L.M., Lissner, L., The Mediterranean diet score and mortality are inversely associated in adults living in the subarctic region (2012) J Nutr, 142 (8), pp. 1547-1553; Chiuve, S.E., Fung, T.T., Rimm, E.B., Alternative dietary indices both strongly predict risk of chronic disease (2012) J Nutr, 142 (6), pp. 1009-1018; Mursu, J., Steffen, L.M., Meyer, K.A., Duprez, D., Jacobs, D.R., Jr., Diet quality indexes and mortality in postmenopausal women: the Iowa Women’s Health Study (2013) Am J Clin Nutr, 98 (2), pp. 444-453; Chrysohoou, C., Panagiotakos, D.B., Aggelopoulos, P., The Mediterranean diet contributes to the preservation of left ventricular systolic function and to the long-term favorable prognosis of patients who have had an acute coronary event (2010) Am J Clin Nutr, 92 (1), pp. 47-54; Panagiotakos, D.B., Pitsavos, C., Chrysohoou, C., Skoumas, I., Stefanadis, C., Study, A., Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study (2008) Vasc Med, 13 (2), pp. 113-121; Menotti, A., Alberti-Fidanza, A., Fidanza, F., The association of the Mediterranean Adequacy Index with fatal coronary events in an Italian middle-aged male population followed for 40 years (2012) Nutr Metab Cardiovasc, 22 (4), pp. 369-375; Tsivgoulis, G., Judd, S., Letter, A.J., Adherence to a Mediterranean diet and risk of incident cognitive impairment (2013) Neurology, 80 (18), pp. 1684-1692; Benisi-Kohansal, S., Saneei, P., Salehi-Marzijarani, M., Larijani, B., Esmaillzadeh, A., Whole-grain intake and mortality from all causes, cardiovascular disease, and cancer: a systematic review and dose-response meta-analysis of prospective cohort studies (2016) Adv Nutr, 7 (6), pp. 1052-1065; Zhang, B., Zhao, Q., Guo, W., Bao, W., Wang, X., Association of whole grain intake with all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis from prospective cohort studies (2017) Eur J Clin Nutr; Lu, W., Chen, H., Niu, Y., Wu, H., Xia, D., Wu, Y., Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies (2016) Nutr J, 15 (1), p. 91; (2017) Cancer Facts Figures, , World Cancer Research Fund International London; Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Food groups and risk of colorectal cancer (2018) Int J Cancer, 142 (9), pp. 1748-1758; Seal, C.J., Brownlee, I.A., Whole-grain foods and chronic disease: evidence from epidemiological and intervention studies (2015) Proc Nutr Soc, 74 (3), pp. 313-319; Aune, D., Keum, N., Giovannucci, E., Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies (2016) BMJ, 353, p. i2716; Ekmekcioglu, C., Wallner, P., Kundi, M., Weisz, U., Haas, W., Hutter, H.P., Red meat, diseases, and healthy alternatives: a critical review (2018) Crit Rev Food Sci Nutr, 58 (2), pp. 247-261; Bechthold, A., Boeing, H., Schwedhelm, C., Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies (2017) Critical Rev Food Sci Nutr; Schwingshackl, L., Hoffmann, G., Lampousi, A.-M., Knüppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Boeing, H., Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies (2017) Eur J Epidemiol, 32 (5), pp. 363-375; Bach-Faig, A., Berry, E.M., Lairon, D., Reguant, J., Trichopoulou, A., Dernini, S., Medina, F.X., Serra-Majem, L., Mediterranean diet pyramid today. Science and cultural updates (2011) Public Health Nutr, 14 (12A), pp. 2274-2284},
correspondence_address1={Schwingshackl, L.; NutriAct – Competence Cluster Nutrition Research Berlin-PotsdamGermany; email: lukas.schwingshackl@dife.de},
publisher={Springer Netherlands},
issn={03932990},
coden={EJEPE},
pubmed_id={30030684},
language={English},
abbrev_source_title={Eur. J. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Frieden20151748,
author={Frieden, T.R.},
title={The future of public health},
journal={New England Journal of Medicine},
year={2015},
volume={373},
number={18},
pages={1748-1754},
doi={10.1056/NEJMsa1511248},
note={cited By 90},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946091437&doi=10.1056%2fNEJMsa1511248&partnerID=40&md5=575890f3e570d4fdd433d0dfb6e1796d},
affiliation={Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA  30333, United States},
keywords={sodium, acquired immune deficiency syndrome;  Africa;  alcohol consumption;  Article;  blood pressure regulation;  cerebrovascular accident;  chronic disease;  diabetes mellitus;  Ebola hemorrhagic fever;  futurology;  government;  heart infarction;  human;  Human immunodeficiency virus infection;  hypertension;  influenza;  malaria;  Middle East respiratory syndrome coronavirus;  mortality;  obesity;  pneumonia;  priority journal;  public health;  risk assessment;  risk reduction;  severe acute respiratory syndrome;  smoking cessation;  socioeconomics;  sodium intake;  total quality management;  traffic accident;  tuberculosis;  United States;  world health organization;  chronic disease;  Communicable Diseases;  Disease Outbreaks;  forecasting;  health;  health care delivery;  health promotion;  infection control;  organization and management;  prevention and control;  procedures;  public health;  public health service;  smoking;  trends, Chronic Disease;  Communicable Disease Control;  Communicable Diseases;  Delivery of Health Care;  Disease Outbreaks;  Forecasting;  Global Health;  Health Promotion;  Humans;  Public Health;  Public Health Administration;  Smoking;  United States},
chemicals_cas={sodium, 7440-23-5},
references={Ten great public health achievements - United States, 1900-1999 (1999) MMWR Morb Mortal Wkly Rep, 48, pp. 241-243; Bunker, J.P., Frazier, H.S., Mosteller, F., Improving health: Measuring effects of medical care (1994) Milbank Q, 72, pp. 225-258; Riley, J.C., Estimates of regional and global life expectancy, 1800-2001 (2005) Popul Dev Rev, 31, pp. 537-543; Riley, J.C., (2001) Rising Life Expectancy: A Global History, , Cambridge, United Kingdom: Cambridge University Press; Fee, E., Brown, T.M., The unfulfilled promise of public health: D?j? Vu all over again (2002) Health Aff (Millwood), 21, pp. 31-43; Frieden, T.R., A framework for public health action: The health impact pyramid (2010) Am J Public Health, 100, pp. 590-595; Farley, T.A., Dalal, M.A., Mostashari, F., Frieden, T.R., Deaths preventable in the U.S. by improvements in use of clinical preventive services (2010) Am J Prev Med, 38, pp. 600-609; Vital signs: Awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010 (2012) MMWR Morb Mortal Wkly Rep, 61, pp. 703-709; CDC National Health Report: Leading causes of morbidity and mortality and associated behavioral risk and protective factors - United States, 2005-2013 (2014) MMWR Surveill Summ, 63, pp. 3-27; Murphy, S.L., Kochanek, K.D., Xu, J., Heron, M., (2015) Deaths: Final Data for 2012, 63, p. 9. , National Vital Statistics Reports, Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; (2013) Antibiotic Resistance Threats in the United States, 2013, , Atlanta: Centers for Disease Control and Prevention; (2015) Core Elements of Hospital Antibiotic Stewardship Programs, , www.cdc.gov/getsmart/healthcare/implementation/core-elements.html, Atlanta: Centers for Disease Control and Prevention; Vital signs: HIV diagnosis, care, and treatment among persons living with HIV - United States, 2011 (2014) MMWR Morb Mortal Wkly Rep, 63, pp. 1113-1117; Vital signs: Estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities - United States (2015) MMWR Morb Mortal Wkly Rep, 64, pp. 826-831; (2014) Global Update on the Health Sector Response to HIV, 2014, , Geneva: World Health Organization; (2014) Global Tuberculosis Report 2014, , Geneva: World Health Organization; (2015) Achieving the Malaria MDG Target: Reversing the Incidence of Malaria 2000 2015, , Geneva: World Health Organization and United Nations Children's Fund; Neglected tropical diseases: Becoming less neglected (2014) Lancet, 383, p. 1269; Progress towards polio eradication worldwide, 2014-2015 (2015) Wkly Epidemiol Rec, 90, pp. 253-259; Progress toward global eradication of dracunculiasis - January 2013-June 2014 (2014) MMWR Morb Mortal Wkly Rep, 63, pp. 1050-1054; (2013) Global Vaccine Action Plan 2011-2020, , Geneva: World Health Organization; (2015) Global Health - Global Health Security Agenda, , www.cdc.gov/globalhealth/security, Atlanta: Centers for Disease Control and Prevention;; Frieden, T.R., Tappero, J.W., Dowell, S.F., Hien, N.T., Guillaume, F.D., Aceng, J.R., Safer countries through global health security (2014) Lancet, 383, pp. 764-766; Frieden, T.R., Woodley, C.L., Crawford, J.T., Lew, D., Dooley, S.M., The molecular epidemiology of tuberculosis in New York City: The importance of nosocomial transmission and laboratory error (1996) Tuber Lung Dis, 77, pp. 407-413; Frieden, T.R., Brudney, K.F., Harries, A.D., Global tuberculosis: Perspectives, prospects, and priorities (2014) JAMA, 312, pp. 1393-1394; Laxminarayan, R., Duse, A., Wattal, C., Antibiotic resistance-the need for global solutions (2013) Lancet Infect Dis, 13, pp. 1057-1098; Banaei, N., Anikst, V., Schroeder, L.F., Burden of Clostridium difficile infection in the United States (2015) N Engl J Med, 372, pp. 2368-2369; Maltezou, H.C., Wicker, S., Measles in health-care settings (2013) Am J Infect Control, 41, pp. 661-663; Xu, X., Alexander, R.L., Jr., Simpson, S.A., A cost-effectiveness analysis of the first federally funded antismoking campaign (2015) Am J Prev Med, 48, pp. 318-325; Guo, F., He, D., Zhang, W., Walton, R.G., Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010 (2012) J Am Coll Cardiol, 60, pp. 599-606; Nwankwo, T., Yoon, S.S., Burt, V., Gu, Q., (2013) Hypertension among Adults in the US: National Health and Nutrition Examination Survey, 2011-2012, , NCHS Data Brief. No. 133. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; Jaffe, M.G., Lee, G.A., Young, J.D., Sidney, S., Go, A.S., Improved blood pressure control associated with a large-scale hypertension program (2013) JAMA, 310, pp. 699-705; Luepker, R.V., Steffen, L.M., Jacobs, D.R., Jr., Zhou, X., Blackburn, H., Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: The Minnesota Heart Survey (2012) Circulation, 126, pp. 1852-1857; Shah, N.R., Identifying hypertension in electronic health records: A comparison of various approaches (2009) AHRQ Comparative Effectiveness Research Methods Symposium, , Rockville, MD, June 1-2; Rakotz, M.K., Ewigman, B.G., Sarav, M., A technology-based quality innovation to identify undiagnosed hypertension among active primary care patients (2014) Ann Fam Med, 12, pp. 352-358; Wall, H.K., Hannan, J.A., Wright, J.S., Patients with undiagnosed hypertension: Hiding in plain sight (2014) JAMA, 312, pp. 1973-1974; Coxson, P.G., Cook, N.R., Joffres, M., Mortality benefits from US populationwide reduction in sodium consumption: Projections from 3 modeling approaches (2013) Hypertension, 61, pp. 564-570; Bibbins-Domingo, K., Chertow, G.M., Coxson, P.G., Projected effect of dietary salt reductions on future cardiovascular disease (2010) N Engl J Med, 362, pp. 590-599; Adler, A.J., Taylor, F., Martin, N., Gottlieb, S., Taylor, R.S., Ebrahim, S., Reduced dietary salt for the prevention of cardiovascular disease (2014) Cochrane Database Syst Rev, 12, p. CD009217; He, F.J., Brinsden, H.C., MacGregor, G.A., Salt reduction in the United Kingdom: A successful experiment in public health (2014) J Hum Hypertens, 28, pp. 345-352; He, F.J., Pombo-Rodrigues, S., Macgregor, G.A., Salt reduction in England from 2003 to 2011: Its relationship to blood pressure, stroke and ischaemic heart disease mortality (2014) BMJ Open, 4 (4), p. e004549; Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011-2012 (2014) JAMA, 311, pp. 806-814; Frieden, T.R., Dietz, W., Collins, J., Reducing childhood obesity through policy change: Acting now to prevent obesity (2010) Health Aff (Millwood), 29, pp. 357-363; (2015) WHO Report on the Global Tobacco Epidemic, 2015: Raising Taxes on Tobacco, , Geneva: World Health Organization; Levy, D.T., Ellis, J.A., Mays, D., Huang, A.T., Smoking-related deaths averted due to three years of policy progress (2013) Bull World Health Organ, 91, pp. 509-518; Angell, S.Y., De Cock, K.M., Frieden, T.R., A public health approach to global management of hypertension (2015) Lancet, 385, pp. 825-827; Intersalt: An international study of electrolyte excretion and blood pressure: Results for 24 hour urinary sodium and potassium excretion (1988) BMJ, 297, pp. 319-328. , Intersalt Cooperative Research Group; Frieden, T.R., Government's role in protecting health and safety (2013) N Engl J Med, 368, pp. 1857-1859; Ten great public health achievements - United States, 2001-2010 (2011) MMWR Morb Mortal Wkly Rep, 60, pp. 619-623; Bayer, R., Galea, S., Public health in the precision-medicine era (2015) N Engl J Med, 373, pp. 499-501},
correspondence_address1={Frieden, T.R.; Centers for Disease Control and Prevention, 1600 Clifton Rd., United States; email: tfrieden@cdc.gov},
publisher={Massachussetts Medical Society},
issn={00284793},
coden={NEJMA},
pubmed_id={26510022},
language={English},
abbrev_source_title={New Engl. J. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Richardson2019,
author={Richardson, T.G. and Harrison, S. and Hemani, G. and Smith, G.D.},
title={An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome},
journal={eLife},
year={2019},
volume={8},
doi={10.7554/eLife.43657},
art_number={e43657},
note={cited By 86},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062403821&doi=10.7554%2feLife.43657&partnerID=40&md5=ea29a72e706a6ec93f24d4197846054f},
affiliation={MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom},
abstract={The age of large-scale genome-wide association studies (GWAS) has provided us with an unprecedented opportunity to evaluate the genetic liability of complex disease using polygenic risk scores (PRS). In this study, we have analysed 162 PRS (p&lt;5x10-05) derived from GWAS and 551 heritable traits from the UK Biobank study (N = 334,398). Findings can be investigated using a web application (http://mrcieu.mrsoftware.org/PRS_atlas/), which we envisage will help uncover both known and novel mechanisms which contribute towards disease susceptibility. To demonstrate this, we have investigated the results from a phenome-wide evaluation of schizophrenia genetic liability. Amongst findings were inverse associations with measures of cognitive function which extensive follow-up analyses using Mendelian randomization (MR) provided evidence of a causal relationship. We have also investigated the effect of multiple risk factors on disease using mediation and multivariable MR frameworks. Our atlas provides a resource for future endeavours seeking to unravel the causal determinants of complex disease. © Richardson et al.},
keywords={ac 1202;  lipid;  low density lipoprotein;  triacylglycerol, Alzheimer disease;  anxiety;  area under the curve;  Article;  body mass;  cognition;  depression;  disease association;  disease predisposition;  follow up;  gene;  gene expression;  gene locus;  genetic predisposition;  genome;  genome-wide association study;  genotype;  gout;  human;  Mendelian randomization analysis;  multifactorial inheritance;  neurosis;  outcome assessment;  phenotype;  pleiotropy;  receiver operating characteristic;  risk assessment;  risk factor;  schizophrenia;  sensitivity analysis;  sensitivity and specificity;  simulation;  single nucleotide polymorphism;  sleep time;  tension;  ulcerative colitis;  genetic database;  genetic predisposition;  genetics;  genome-wide association study;  risk assessment;  United Kingdom, Databases, Genetic;  Genetic Predisposition to Disease;  Genome-Wide Association Study;  Humans;  Multifactorial Inheritance;  Risk Assessment;  Schizophrenia;  United Kingdom},
chemicals_cas={lipid, 66455-18-3},
funding_details={Wellcome TrustWellcome Trust},
funding_details={Wellcome TrustWellcome Trust, WT, 208806/Z/17/Z},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_UU_00011/1, MR/S003886/1},
funding_details={University of BristolUniversity of Bristol},
funding_text 1={We are extremely grateful to all the authors of the genome-wide association studies who have made their summary statistics publicly available for the benefit of this study. We would also like to thank the efforts of the Neale Lab who conducted extensive heritability analyses in the UK Biobank which guided our selection of traits to analyse. This work was supported by the Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1). SH is part of a project entitled ‘social and economic consequences of health: causal inference methods and longitudinal, intergenerational data’, which is part of the Health Foundation’s Efficiency Research Programme. The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK. GH is supported by the Wellcome Trust [208806/Z/17/Z]. TGR is a UKRI Innovation Research Fellow (MR/S003886/1).},
funding_text 2={This work was supported by the Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1). SH is part of a project entitled ‘social and economic consequences of health: causal inference methods and longitudinal, intergenerational data’, which is part of the Health Foundation’s Efficiency Research Programme. The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK. GH is supported by the Wellcome Trust [208806/Z/17/Z]. TGR is a UKRI Innovation Research Fellow (MR/S003886/1).},
references={Abdellaoui, A., Hugh-Jones, D., Kemper, K.E., Holtz, Y., Nivard, M.G., Veul, L., Yengo, L., Visscher, P.M., Genetic consequences of social stratification in great britain (2018) Biorxiv, , https://doi.org/10.1101/457515; Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Project, G., An integrated map of genetic variation from 1,092 human genomes (2012) Nature, 491, pp. 56-65; Abraham, G., Havulinna, A.S., Bhalala, O.G., Byars, S.G., De Livera, A.M., Yetukuri, L., Tikkanen, E., Inouye, M., Genomic prediction of coronary heart disease (2016) European Heart Journal, 37, pp. 3267-3278. , https://doi.org/10.1093/eurheartj/ehw450, PMID: 27655226; Bowden, J., Davey Smith, G., Burgess, S., Mendelian randomization with invalid instruments: Effect estimation and bias detection through egger regression (2015) International Journal of Epidemiology, 44, pp. 512-525. , https://doi.org/10.1093/ije/dyv080, PMID: 26050253; Bowden, J., Davey Smith, G., Haycock, P.C., Burgess, S., Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator (2016) Genetic Epidemiology, 40, pp. 304-314. , https://doi.org/10.1002/gepi.21965, PMID: 27061298; Burgess, S., Butterworth, A., Thompson, S.G., Mendelian randomization analysis with multiple genetic variants using summarized data (2013) Genetic Epidemiology, 37, pp. 658-665. , https://doi.org/10.1002/gepi.21758; Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L.T., Sharp, K., Motyer, A., Marchini, J., The UK biobank resource with deep phenotyping and genomic data (2018) Nature, 562, pp. 203-209. , https://doi.org/10.1038/s41586-018-0579-z, PMID: 30305743; Cai, T., Zhang, Y., Ho, Y.L., Link, N., Sun, J., Huang, J., Cai, T.A., Tsao, P., Association of interleukin 6 receptor variant with cardiovascular disease effects of interleukin 6 receptor blocking therapy: A Phenome-Wide association study (2018) JAMA Cardiology, 3, p. 849. , https://doi.org/10.1001/jamacardio.2018.2287, PMID: 30090940; Davey Smith, D., Ebrahim, S., ‘Mendelian randomization’: Can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) International Journal of Epidemiology, 32, pp. 1-22. , https://doi.org/10.1093/ije/dyg070, PMID: 12689998; Davey Smith, G., Hemani, G., Mendelian randomization: Genetic anchors for causal inference in epidemiological studies (2014) Human Molecular Genetics, 23, pp. R89-R98. , https://doi.org/10.1093/hmg/ddu328, PMID: 25064373; Davies, N.M., Von Hinke Kessler Scholder, S., Farbmacher, H., Windmeijer, F., Smith, G.D., Smith, G.D., The many weak instruments problem and mendelian randomization (2015) Statistics in Medicine, 34, pp. 454-468. , https://doi.org/10.1002/sim.6358, PMID: 25382280; Davies, N.M., Holmes, M.V., Davey Smith, G., Reading mendelian randomisation studies: A guide, glossary, and checklist for clinicians (2018) Bmj, 362, p. k601. , https://doi.org/10.1136/bmj.k601, PMID: 30002074; Denny, J.C., Bastarache, L., Ritchie, M.D., Carroll, R.J., Zink, R., Mosley, J.D., Field, J.R., Bielinski, S.J., Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data (2013) Nature Biotechnology, 31, pp. 1102-1111. , https://doi.org/10.1038/nbt.2749, PMID: 24270849; Felsky, D., Patrick, E., Schneider, J.A., Mostafavi, S., Gaiteri, C., Patsopoulos, N., Bennett, D.A., De Jager, P.L., Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain (2018) Molecular Neurodegeneration, 13, p. 38. , https://doi.org/10.1186/s13024-018-0272-6, PMID: 30041668; Fritsche, L.G., Gruber, S.B., Wu, Z., Schmidt, E.M., Zawistowski, M., Moser, S.E., Blanc, V.M., Mukherjee, B., Association of polygenic risk scores for multiple cancers in a Phenome-wide study: Results from the michigan genomics initiative (2018) The American Journal of Human Genetics, 102, pp. 1048-1061. , https://doi.org/10.1016/j.ajhg.2018.04.001, PMID: 29779563; Gough, S.C., Simmonds, M.J., The HLA region and autoimmune disease: Associations and mechanisms of action (2007) Current Genomics, 8, pp. 453-465. , https://doi.org/10.2174/138920207783591690, PMID: 19412418; Green, M.F., What are the functional consequences of neurocognitive deficits in schizophrenia? (1996) The American Journal of Psychiatry, 153, pp. 321-330. , https://doi.org/10.1176/ajp.153.3.321, PMID: 8610818; Hartwig, F.P., Davey Smith, G., Bowden, J., Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption (2017) International Journal of Epidemiology, 46, pp. 1985-1998. , https://doi.org/10.1093/ije/dyx102, PMID: 29040600; Hemani, G., Tilling, K., Davey Smith, G., Orienting the causal relationship between imprecisely measured traits using GWAS summary data (2017) PLOS Genetics, 13, p. e1007081. , https://doi.org/10.1371/journal.pgen.1007081, PMID: 29149188; Hemani, G., Zheng, J., Elsworth, B., Wade, K.H., Haberland, V., Baird, D., Laurin, C., Haycock, P.C., The MR-Base platform supports systematic causal inference across the human phenome (2018) eLife, 7, p. e34408. , https://doi.org/10.7554/eLife.34408, PMID: 29846171; Holmes, M.V., Asselbergs, F.W., Palmer, T.M., Drenos, F., Lanktree, M.B., Nelson, C.P., Dale, C.E., Zabaneh, D., Mendelian randomization of blood lipids for coronary heart disease (2015) European Heart Journal, 36, pp. 539-550. , https://doi.org/10.1093/eurheartj/eht571; Hu, B., Shao, J., Palta, M., Pseudo-R2 in logistic regression model (2006) Statistica Sinica, 16, pp. 847-860; Jones, S.E., Tyrrell, J., Wood, A.R., Beaumont, R.N., Ruth, K.S., Tuke, M.A., Yaghootkar, H., Gehrman, P.R., Genome-Wide association analyses in 128,266 individuals identifies new morningness and sleep duration loci (2016) PLOS Genetics, 12, p. e1006125. , https://doi.org/10.1371/journal.pgen.1006125; Khera, A.V., Chaffin, M., Aragam, K.G., Haas, M.E., Roselli, C., Choi, S.H., Natarajan, P., Kathiresan, S., Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations (2018) Nature Genetics, 50, pp. 1219-1224. , https://doi.org/10.1038/s41588-018-0183-z, PMID: 30104762; Krapohl, E., Euesden, J., Zabaneh, D., Pingault, J.B., Rimfeld, K., von Stumm, S., Dale, P.S., Plomin, R., Phenome-wide analysis of genome-wide polygenic scores (2016) Molecular Psychiatry, 21, pp. 1188-1193. , https://doi.org/10.1038/mp.2015.126, PMID: 26303664; Lee, J.J., Wedow, R., Okbay, A., Kong, E., Maghzian, O., Zacher, M., Nguyen-Viet, T.A., Yengo, L., Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) Nature Genetics, 50, pp. 1112-1121. , https://doi.org/10.1038/s41588-018-0147-3, PMID: 30038396; Lewis, C.M., Vassos, E., Prospects for using risk scores in polygenic medicine (2017) Genome Medicine, 9, p. 96. , https://doi.org/10.1186/s13073-017-0489-y, PMID: 29132412; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., Campbell, H., Theodoratou, E., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and mendelian randomisation studies (2017) Bmj, 357, p. j2376. , https://doi.org/10.1136/bmj.j2376, PMID: 28592419; Major, T.J., Topless, R.K., Dalbeth, N., Merriman, T.R., Evaluation of the diet wide contribution to serum urate levels: Meta-analysis of population based cohorts (2018) Bmj, 363, p. k3951. , https://doi.org/10.1136/bmj.k3951, PMID: 30305269; Matsubara, K., Matsuzawa, Y., Jiao, S., Takama, T., Kubo, M., Tarui, S., Relationship between hypertriglyceridemia and uric acid production in primary gout (1989) Metabolism, 38, pp. 698-701. , https://doi.org/10.1016/0026-0495(89)90110-8, PMID: 2739579; Millard, L.A., Davies, N.M., Timpson, N.J., Tilling, K., Flach, P.A., Davey Smith, G., MR-PheWAS: Hypothesis prioritization among potential causal effects of body mass index on many outcomes, using mendelian randomization (2015) Scientific Reports, 5, p. 16645. , https://doi.org/10.1038/srep16645, PMID: 26568383; Mohamed, S., Paulsen, J.S., O’Leary, D., Arndt, S., Andreasen, N., Generalized cognitive deficits in schizophrenia: A study of first-episode patients (1999) Archives of General Psychiatry, 56, pp. 749-754. , https://doi.org/10.1001/archpsyc.56.8.749, PMID: 10435610; Munafò, M.R., Davey Smith, G., Robust research needs many lines of evidence (2018) Nature, 553, pp. 399-401. , https://doi.org/10.1038/d41586-018-01023-3, PMID: 29368721; (2017) Rapid GWAS of thousands of phenotypes for 337,000 samples in the UK Biobank, , http://www.nealelab.is/blog/2017/7/19/rapid-gwas-of-thousands-of-phenotypes-for-337000-samples-in-the-uk-biobank, [Accessed September 27, 2018]; O’Connor, L.J., Price, A.L., Distinguishing genetic correlation from causation across 52 diseases and complex traits (2018) Nature Genetics, 50, pp. 1728-1734. , https://doi.org/10.1038/s41588-018-0255-0, PMID: 30374074; Palmer, T.M., Lawlor, D.A., Harbord, R.M., Sheehan, N.A., Tobias, J.H., Timpson, N.J., Davey Smith, G., Sterne, J.A., Using multiple genetic variants as instrumental variables for modifiable risk factors (2012) Statistical Methods in Medical Research, 21, pp. 223-242. , https://doi.org/10.1177/0962280210394459, PMID: 21216802; Ripatti, S., Tikkanen, E., Orho-Melander, M., Havulinna, A.S., Silander, K., Sharma, A., Guiducci, C., Kathiresan, S., A multilocus genetic risk score for coronary heart disease: Case-control and prospective cohort analyses (2010) The Lancet, 376, pp. 1393-1400. , https://doi.org/10.1016/S0140-6736(10)61267-6; Sacco, K.A., Termine, A., Seyal, A., Dudas, M.M., Vessicchio, J.C., Krishnan-Sarin, S., Jatlow, P.I., George, T.P., Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms (2005) Archives of General Psychiatry, 62, pp. 649-659. , https://doi.org/10.1001/archpsyc.62.6.649, PMID: 15939842; Sanderson, E., Davey Smith, G., Windmeijer, F., Bowden, J., An examination of multivariable mendelian randomization in the single-sample and two-sample summary data settings (2018) International Journal of Epidemiology, p. 44. , https://doi.org/10.1093/ije/dyy262; Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Collins, R., UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age (2015) PLOS Medicine, 12, p. e1001779. , https://doi.org/10.1371/journal.pmed.1001779, PMID: 25826379; Timpson, N.J., Nordestgaard, B.G., Harbord, R.M., Zacho, J., Frayling, T.M., Tybjærg-Hansen, A., Davey Smith, G., C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal mendelian randomization (2011) International Journal of Obesity, 35, pp. 300-308. , https://doi.org/10.1038/ijo.2010.137; Torkamani, A., Wineinger, N.E., Topol, E.J., The personal and clinical utility of polygenic risk scores (2018) Nature Reviews Genetics, 19, pp. 581-590. , https://doi.org/10.1038/s41576-018-0018-x, PMID: 29789686; Visscher, P.M., Wray, N.R., Zhang, Q., Sklar, P., McCarthy, M.I., Brown, M.A., Yang, J., 10 years of GWAS discovery: Biology, function, and translation (2017) The American Journal of Human Genetics, 101, pp. 5-22. , https://doi.org/10.1016/j.ajhg.2017.06.005, PMID: 28686856; Warren, M., The approach to predictive medicine that is taking genomics research by storm (2018) Nature, 562, pp. 181-183. , https://doi.org/10.1038/d41586-018-06956-3, PMID: 30305759; Wootton, R.E., Causal effects of lifetime smoking on risk for depression and schizophrenia: Evidence from a mendelian randomisation study (2018) Biorxiv, , https://doi.org/10.1101/381301},
correspondence_address1={Richardson, T.G.; MRC Integrative Epidemiology Unit (IEU), United Kingdom; email: Tom.G.Richardson@bristol.ac.uk},
publisher={eLife Sciences Publications Ltd},
issn={2050084X},
pubmed_id={30835202},
language={English},
abbrev_source_title={eLife},
document_type={Article},
source={Scopus},
}

@ARTICLE{Reich2008865,
author={Reich, M.R. and Takemi, K. and Roberts, M.J. and Hsiao, W.C.},
title={Global action on health systems: a proposal for the Toyako G8 summit},
journal={The Lancet},
year={2008},
volume={371},
number={9615},
pages={865-869},
doi={10.1016/S0140-6736(08)60384-0},
note={cited By 86},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-40049105024&doi=10.1016%2fS0140-6736%2808%2960384-0&partnerID=40&md5=3d4413b06646a612180960db5b299d85},
affiliation={Department of Population and International Health, Harvard School of Public Health, Boston, MA, United States; Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, United States; Research Institute of Science and Technology, Tokai University, Tokyo, Japan},
keywords={acquired immune deficiency syndrome;  article;  childhood mortality;  health care;  health care delivery;  health care facility;  health care organization;  health care policy;  health care system;  health insurance;  health program;  health status;  human;  Human immunodeficiency virus;  immunization;  malaria;  maternal mortality;  patient satisfaction;  poliomyelitis;  poverty;  priority journal;  tuberculosis;  world health organization;  X ray},
correspondence_address1={Reich, M.R.; Department of Population and International Health, , Boston, MA, United States; email: michael_reich@harvard.edu},
publisher={Elsevier B.V.},
issn={01406736},
coden={LANCA},
pubmed_id={18328932},
language={English},
abbrev_source_title={Lancet},
document_type={Note},
source={Scopus},
}

@ARTICLE{Khan2019190,
author={Khan, S.U. and Khan, M.U. and Riaz, H. and Valavoor, S. and Zhao, D. and Vaughan, L. and Okunrintemi, V. and Riaz, I.B. and Khan, M.S. and Kaluski, E. and Murad, M.H. and Blaha, M.J. and Guallar, E. and Michos, E.D.},
title={Effects of nutritional supplements and dietary interventions on cardiovascular outcomes},
journal={Annals of Internal Medicine},
year={2019},
volume={171},
number={3},
pages={190-198},
doi={10.7326/M19-0341},
note={cited By 83},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070865265&doi=10.7326%2fM19-0341&partnerID=40&md5=40fd4d8cb7a54f4fb233c67d0b302a73},
affiliation={West Virginia University, One Medical Center Drive, Morgantown, WV  26508, United States; Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH  44195, United States; Johns Hopkins Bloomberg School of Public Health, Welch Center, 2024 East Monument Street, Baltimore, MD  21205, United States; East Carolina University, 2100 Stantonsburg Road, Greenville, NC  27834, United States; Mayo Clinic, 200 1st Street Southwest, Rochester, MN  55901, United States; 903 South Ashland Avenue, Chicago, IL  60607, United States; Guthrie Robert Packer Hospital, One Guthrie Square, Sayre, PA  18840, United States; Johns Hopkins School of Medicine, 600 North Wolfe Street, Baltimore, MD  21287, United States},
abstract={Background: The role of nutritional supplements and dietary interventions in preventing mortality and cardiovascular disease (CVD) outcomes is unclear. Purpose: To examine evidence about the effects of nutritional supplements and dietary interventions on mortality and cardiovascular outcomes in adults. Data Sources: PubMed, CINAHL, and the Cochrane Library from inception until March 2019; ClinicalTrials.gov (10 March 2019); journal Web sites; and reference lists. Study Selection: English-language, randomized controlled trials (RCTs) and meta-analyses of RCTs that assessed the effects of nutritional supplements or dietary interventions on all-cause mortality or cardiovascular outcomes, such as death, myocardial infarction, stroke, and coronary heart disease. Data Extraction: Two independent investigators abstracted data, assessed the quality of evidence, and rated the certainty of evidence. Data Synthesis: Nine systematic reviews and 4 new RCTs were selected that encompassed a total of 277 trials, 24 interventions, and 992 129 participants. A total of 105 meta-analyses were generated. There was moderate-certainty evidence that reduced salt intake decreased the risk for all-cause mortality in normotensive participants (risk ratio [RR], 0.90 [95% CI, 0.85 to 0.95]) and cardiovascular mortality in hypertensive participants (RR, 0.67 [CI, 0.46 to 0.99]). Low-certainty evidence showed that omega-3 long-chain polyunsaturated fatty acid (LC-PUFA) was associated with reduced risk for myocardial infarction (RR, 0.92 [CI, 0.85 to 0.99]) and coronary heart disease (RR, 0.93 [CI, 0.89 to 0.98]). Folic acid was associated with lower risk for stroke (RR, 0.80 [CI, 0.67 to 0.96]; low certainty), whereas calcium plus Vitamin D increased the risk for stroke (RR, 1.17 [CI, 1.05 to 1.30]; moderate certainty). Other nutritional supplements, such as vitamin B6, Vitamin A, multivitamins, antioxidants, and iron and dietary interventions, such as reduced fat intake, had no significant effect on mortality or cardiovascular disease outcomes (very low- to moderate-certainty evidence). Limitations: Suboptimal quality and certainty of evidence. Conclusion: Reduced salt intake, omega-3 LC-PUFA use, and folate supplementation could reduce risk for some cardiovascular outcomes in adults. Combined calcium plus Vitamin D might increase risk for stroke. © 2019 American College of Physicians.},
keywords={antioxidant;  folic acid;  multivitamin;  nutrition supplement;  polyunsaturated fatty acid;  retinol;  vitamin D, all cause mortality;  cardiovascular disease;  cardiovascular mortality;  cerebrovascular accident;  diet therapy;  fat intake;  heart infarction;  human;  ischemic heart disease;  outcome assessment;  priority journal;  quality control;  Review;  systematic review;  cardiovascular disease;  cause of death;  cerebrovascular accident;  coronary artery disease;  dietary supplement;  epidemiology;  heart infarction;  meta analysis;  mortality;  randomized controlled trial (topic);  United States, Cardiovascular Diseases;  Cause of Death;  Coronary Disease;  Diet, Healthy;  Dietary Supplements;  Humans;  Myocardial Infarction;  Randomized Controlled Trials as Topic;  Stroke;  United States},
chemicals_cas={folic acid, 59-30-3, 6484-89-5; retinol, 68-26-8, 82445-97-4},
funding_details={U.S. Food and Drug AdministrationU.S. Food and Drug Administration, FDA},
funding_details={Aetna FoundationAetna Foundation},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI},
funding_details={National Institute of General Medical SciencesNational Institute of General Medical Sciences, NIGMS, U54GM104942},
funding_details={American Heart AssociationAmerican Heart Association, AHA},
funding_details={AmgenAmgen},
funding_details={NovartisNovartis},
funding_details={SanofiSanofi},
funding_details={Johns Hopkins UniversityJohns Hopkins University, JHU},
funding_details={Bayer FundBayer Fund, BF},
funding_details={Novo NordiskNovo Nordisk},
funding_text 1={Disclosures: Dr. Blaha reports grants from the National Heart, Lung, and Blood Institute, the Food and Drug Administration, the American Heart Association, Amgen, and the Aetna Foundation and personal fees from the Food and Drug Administration, Amgen, Sanofi, Novartis, Novo Nordisk, and Bayer outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterest Forms.do?msNum=M19-0341.},
funding_text 2={Financial Support: Drs. Zhao, Guallar, and Michos are funded by the Blumenthal Scholars Fund in Preventive Cardiology at Johns Hopkins University.},
references={DeSalvo, K.B., Olson, R., Casavale, K.O., Dietary guidelines for Americans (2016) JAMA, 315, pp. 457-458. , [PMID: 26746707]; Chen, F., Du, M., Blumberg, J.B., Association among dietary supplement use, nutrient intake, and mortality among U.S adults. A cohort study (2019) Ann Intern Med, , [PMID: 30959527]; Kim, J., Choi, J., Kwon, S.Y., Association of multivitamin and mineral supplementation and risk of cardiovascular disease: A systematic review and meta-analysis (2018) Circ Cardiovasc Qual Outcomes, 11, p. e004224. , [PMID: 29991644]; Kantor, E.D., Rehm, C.D., Du, M., Trends in dietary supplement use among US adults from 1999-2012 (2016) JAMA, 316, pp. 1464-1474. , [PMID: 27727382]; Gahche, J.J., Bailey, R.L., Potischman, N., Dietary supplement use was very high among older adults in the United States in 2011-2014 (2017) J Nutr, 147, pp. 1968-1976. , [PMID: 28855421]; Fortmann, S.P., Burda, B.U., Senger, C.A., Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer. An updated systematic evidence review for the U.S. Preventive Services Task Force (2013) Ann Intern Med, 159, pp. 824-834. , [PMID: 24217421]; Jenkins, D.J.A., Spence, J.D., Giovannucci, E.L., Supplemental vitamins and minerals for CVD prevention and treatment (2018) J Am Coll Cardiol, 71, pp. 2570-2584. , [PMID: 29852980]; Manson, J.E., Cook, N.R., Lee, I.M., Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (2019) N Engl J Med, 380, pp. 23-32. , [PMID: 30415637] VITAL Research Group; Bhatt, D.L., Steg, P.G., Miller, M., Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (2019) N Engl J Med, 380, pp. 11-22. , [PMID: 30415628] REDUCE-IT Investigators; Bowman, L., Mafham, M., Wallendszus, K., Effects of n-3 fatty acid supplements in diabetes mellitus (2018) N Engl J Med, 379, pp. 1540-1550. , [PMID: 30146932] ASCEND Study Collaborative Group; Manson, J.E., Cook, N.R., Lee, I.M., Vitamin D supplements and prevention of cancer and cardiovascular disease (2019) N Engl J Med, 380, pp. 33-44. , [PMID: 30415629] VITAL Research Group; Scragg, R., Stewart, A.W., Waayer, D., Effect of monthly highdose Vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: A randomized clinical trial (2017) JAMA Cardiol, 2, pp. 608-616. , [PMID: 28384800]; Dodge, T., Litt, D., Kaufman, A., Influence of the Dietary Supplement Health and Education Act on consumer beliefs about the safety and effectiveness of dietary supplements (2011) J Health Commun, 16, pp. 230-244. , [PMID: 21120738]; Farah, W.H., Alsawas, M., Mainou, M., Non-pharmacological treatment of depression: A systematic review and evidence map (2016) Evid Based Med, 21, pp. 214-221. , [PMID: 27836921]; Veroniki, A.A., Jackson, D., Viechtbauer, W., Methods to estimate the between-study variance and its uncertainty in metaanalysis (2016) Res Synth Methods, 7, pp. 55-79. , [PMID: 26332144]; Egger, M., Smith, G.D., Schneider, M., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634. , [PMID: 9310563]; Martin, N., Germanò, R., Hartley, L., Nut consumption for the primary prevention of cardiovascular disease (2015) Cochrane Database Syst Rev, p. CD011583. , [PMID: 26411417]; Hartley, L., Igbinedion, E., Holmes, J., Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases (2013) Cochrane Database Syst Rev, p. CD009874. , [PMID: 23736950]; Hartley, L., May, M.D., Loveman, E., Dietary fibre for the primary prevention of cardiovascular disease (2016) Cochrane Database Syst Rev, p. CD011472. , [PMID: 26758499]; Hartley, L., Flowers, N., Holmes, J., Green and black tea for the primary prevention of cardiovascular disease (2013) Cochrane Database Syst Rev, p. CD009934. , [PMID: 23780706]; Mansoor, N., Vinknes, K.J., Veierød, M.B., Effects of lowcarbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: A meta-analysis of randomised controlled trials (2016) Br J Nutr, 115, pp. 466-479. , [PMID: 26768850]; Adler, A.J., Taylor, F., Martin, N., Reduced dietary salt for the prevention of cardiovascular disease (2014) Cochrane Database Syst Rev, p. CD009217. , [PMID: 25519688]; Liyanage, T., Ninomiya, T., Wang, A., Effects of the Mediterranean diet on cardiovascular outcomes: A systematic review and meta-analysis (2016) PLoS One, 11, p. e0159252. , [PMID: 27509006]; Abdelhamid, A.S., Brown, T.J., Brainard, J.S., Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (2018) Cochrane Database Syst Rev, 11, p. CD003177. , [PMID: 30521670]; Hooper, L., Al-Khudairy, L., Abdelhamid, A.S., Omega-6 fats for the primary and secondary prevention of cardiovascular disease (2018) Cochrane Database Syst Rev, 7, p. CD011094. , [PMID: 30019765]; Hooper, L., Summerbell, C.D., Thompson, R., Reduced or modified dietary fat for preventing cardiovascular disease (2011) Cochrane Database Syst Rev, p. CD002137. , [PMID: 21735388]; Hooper, L., Martin, N., Abdelhamid, A., Reduction in saturated fat intake for cardiovascular disease (2015) Cochrane Data-base Syst Rev, p. CD011737. , [PMID: 26068959]; Riaz, H., Khan, S.U., Rahman, H., Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis (2019) Eur J Prev Cardiol, 26, pp. 533-543. , [PMID: 30861690]; Mente, A., O'Donnell, M., Rangarajan, S., Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: A pooled analysis of data from four studies (2016) Lancet, 388, pp. 465-475. , [PMID: 27216139] PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators; Higgins, J.P., Altman, D.G., Gøtzsche, P.C., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011) BMJ, 343, p. d5928. , [PMID: 22008217] Cochrane Bias Methods Group; Cook, N.R., Appel, L.J., Whelton, P.K., Lower levels of sodium intake and reduced cardiovascular risk (2014) Circulation, 129, pp. 981-989. , [PMID: 24415713]; Cook, N.R., Appel, L.J., Whelton, P.K., Sodium intake and all-cause mortality over 20 years in the Trials of Hypertension Prevention (2016) J Am Coll Cardiol, 68, pp. 1609-1617. , [PMID: 27712772]; O'Donnell, M., Mente, A., Rangarajan, S., Urinary sodium and potassium excretion, mortality, and cardiovascular events (2014) N Engl J Med, 371, pp. 612-623. , [PMID: 25119607] PURE Investigators; Kalogeropoulos, A.P., Georgiopoulou, V.V., Murphy, R.A., Dietary sodium content, mortality, and risk for cardiovascular events in older adults: The Health, Aging, and Body Composition (Health ABC) Study (2015) JAMA Intern Med, 175, pp. 410-419. , [PMID: 25599120]; Graudal, N., Jürgens, G., Baslund, B., Compared with usual sodium intake, low- And excessive-sodium diets are associated with increased mortality: A meta-analysis (2014) Am J Hypertens, 27, pp. 1129-1137. , [PMID: 24651634]; He, F.J., Li, J., Macgregor, G.A., Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials (2013) BMJ, 346, p. f1325. , [PMID: 23558162]; Bray, G.A., Vollmer, W.M., Sacks, F.M., A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: Results of the DASH-Sodium Trial (2004) Am J Cardiol, 94, pp. 222-227. , [PMID: 15246908] DASH Collaborative Research Group; He, F.J., Markandu, N.D., Sagnella, G.A., Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives (1998) Hypertension, 32, pp. 820-824. , [PMID: 9822438]; He, F.J., MacGregor, G.A., How far should salt intake be reduced? (2003) Hypertension, 42, pp. 1093-1099. , [PMID: 14610100]; Huo, Y., Li, J., Qin, X., Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial (2015) JAMA, 313, pp. 1325-1335. , [PMID: 25771069] CSPPT Investigators; Bolland, M.J., Grey, A., Avenell, A., Calcium supplements with or without Vitamin D and risk of cardiovascular events: Reanalysis of the Women's Health Initiative limited access dataset and metaanalysis (2011) BMJ, 342, p. d2040. , [PMID: 21505219]; Chin, K., Appel, L.J., Michos, E.D., Vitamin D, calcium, and cardiovascular disease: A"D"vantageous or "D"etrimental? An era of uncertainty (2017) Curr Atheroscler Rep, 19, p. 5. , [PMID: 28127710]; Anderson, J.J., Kruszka, B., Delaney, J.A., Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA) (2016) J Am Heart Assoc, 5. , [PMID: 27729333]; Bolland, M.J., Avenell, A., Baron, J.A., Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis (2010) BMJ, 341, p. c3691. , [PMID: 20671013]; Moyer, V.A., Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer. U.S. Preventive Services Task Force recommendation statement (2014) Ann Intern Med, 160, pp. 558-564. , [PMID: 24566474] U.S. Preventive Services Task Force; Lichtenstein, A.H., Appel, L.J., Brands, M., Diet and Lifestyle Recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee (2006) Circulation, 114, pp. 82-96. , [PMID: 16785338] American Heart Association Nutrition Committee; Singh, R.B., Dubnov, G., Niaz, M.A., Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): A randomised single-blind trial (2002) Lancet, 360, pp. 1455-1461. , [PMID: 12433513]; Estruch, R., Ros, E., Salas-Salvadó, J., Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (2018) N Engl J Med, 378, p. e34. , [PMID: 29897866] PREDIMED Study Investigators; Aung, T., Halsey, J., Kromhout, D., Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: Meta-analysis of 10 trials involving 77 917 individuals (2018) JAMA Cardiol, 3, pp. 225-234. , [PMID: 29387889] Omega-3 Treatment Trialists' Collaboration; Nissen, S.E., U.S dietary guidelines. An evidence-free zone (2016) Ann Intern Med, 164, pp. 558-559. , [PMID: 26783992]; Schwarzer, G., Carpenter, J.R., Rücker, G., Small-study effects in meta-analysis (2015) Meta-Analysis with R. Cham, pp. 107-141. , In: Schwarzer G, Carpenter JR, Rücker G, eds., Switzerland: Springer Publishing;},
correspondence_address1={Khan, S.U.; West Virginia University, One Medical Center Drive, United States; email: safinmc@gmail.com},
publisher={American College of Physicians},
issn={00034819},
coden={AIMEA},
pubmed_id={31284304},
language={English},
abbrev_source_title={Ann. Intern. Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Patel20131795,
author={Patel, C.J. and Rehkopf, D.H. and Leppert, J.T. and Bortz, W.M. and Cullen, M.R. and Chertow, G.M. and Ioannidis, J.P.A.},
title={Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the united states national health and nutrition examination survey},
journal={International Journal of Epidemiology},
year={2013},
volume={42},
number={6},
pages={1795-1810},
doi={10.1093/ije/dyt208},
art_number={dyt208},
note={cited By 83},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892451351&doi=10.1093%2fije%2fdyt208&partnerID=40&md5=a83258b5dc5c054efb5d237b80258001},
affiliation={Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, United States; Division of General Medical Disciplines, Stanford University School of Medicine, Stanford, CA, United States; Department of Urology, Stanford University School of Medicine, Stanford, CA, United States; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States},
abstract={Background: Environmental and behavioural factors are thought to contribute to all-cause mortality. Here, we develop a method to systematically screen and validate the potential independent contributions to all-cause mortality of 249 environmental and behavioural factors in the National Health and Nutrition Examination Survey (NHANES).Methods: We used Cox proportional hazards regression to associate 249 factors with all-cause mortality while adjusting for sociodemographic factors on data in the 1999-2000 and 2001-02 surveys (median 5.5 follow-up years). We controlled for multiple comparisons with the false discovery rate (FDR) and validated significant findings in the 2003-04 survey (median 2.8 follow-up years). We selected 249 factors from a set of all possible factors based on their presence in both the 1999-2002 and 2003-04 surveys and linkage with at least 20 deceased participants. We evaluated the correlation pattern of validated factors and built a multivariable model to identify their independent contribution to mortality.Results: We identified seven environmental and behavioural factors associated with all-cause mortality, including serum and urinary cadmium, serum lycopene levels, smoking (3-level factor) and physical activity. In a multivariable model, only physical activity, past smoking, smoking in participant's home and lycopene were independently associated with mortality. These three factors explained 2.1% of the variance of all-cause mortality after adjusting for demographic and socio-economic factors.Conclusions: Our association study suggests that, of the set of 249 factors in NHANES, physical activity, smoking, serum lycopene and serum/urinary cadmium are associated with all-cause mortality as identified in previous studies and after controlling for multiple hypotheses and validation in an independent survey. Whereas other NHANES factors may be associated with mortality, they may require larger cohorts with longer time of follow-up to detect. It is possible to use a systematic association study to prioritize risk factors for further investigation. Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2013; all rights reserved.},
author_keywords={All-cause mortality;  Behaviour;  Environment-wide association study;  Exposure},
keywords={cadmium;  lycopene, cadmium;  cohort analysis;  demographic trend;  environmental factor;  health survey;  human behavior;  mortality;  mortality risk;  multivariate analysis;  nutrition;  pigment;  prioritization;  regression analysis;  risk factor;  serum;  smoking;  urine, adult;  aged;  article;  behavior;  environmental factor;  female;  follow up;  health survey;  human;  major clinical study;  male;  mortality;  Negro;  nutrition;  physical activity;  priority journal;  public health;  serum;  smoking;  United States, United States, All-cause mortality;  behaviour;  environment-wide association study;  exposure, Adult;  Aged;  Cadmium;  Carotenoids;  Environmental Exposure;  Female;  Humans;  Male;  Middle Aged;  Mortality;  Motor Activity;  Multivariate Analysis;  Nutrition Surveys;  Proportional Hazards Models;  Risk Factors;  Smoking;  United States},
chemicals_cas={cadmium, 22537-48-0, 7440-43-9; lycopene, 502-65-8},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, T32HL007034},
funding_details={National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, K23DK089086, K24DK085446},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99ES023504},
funding_text 1={This work was supported by the National Heart, Lung, and Blood Institute [T32 HL007034] to C.J.P., and the National Institute of Diabetes and Digestive Diseases [K24 DK085446] to G.M.C. and [K23 DK089086] to J.T.L.},
references={McGinnis, J.M., Foege, W.H., Actual causes of death in the United States (1993) JAMA, 270, pp. 2207-2212; Mokdad, A.H., Marks, J.S., Stroup, D.F., Gerberding, J.L., Actual causes of death in the United States, 2000 (2004) JAMA, 291, pp. 1238-1245; Danaei, G., Ding, E.L., Mozaffarian, D., The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors (2009) PLoS Med, 6, pp. e1000058; Wild, C.P., The exposome: from concept to utility (2012) Int J Epidemiol, 41, pp. 24-32; Schwartz, D., Collins, F., Medicine. Environmental biology and human disease (2007) Science, 316, pp. 695-696; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Ioannidis, J.P.A., Why Most Published Research Findings Are False (2005) PLoS Med, 2, pp. e124; Ioannidis, J., Loy, E.Y., Poulton, R., Chia, K.S., Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification (2009) Sci Transl Med, 1, p. 8; Patel, C.J., Bhattacharya, J., Butte, A.J., An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus (2010) PLoS One, 5, pp. e10746; Patel, C.J., Cullen, M.R., Ioannidis, J.P., Butte, A.J., Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels (2012) Int J Epidemiol, 41, pp. 828-843; Tzoulaki, I., Patel, C.J., Okamura, T., A nutrient-wide association study on blood pressure (2012) Circulation, 126, pp. 2456-2464; Fillenbaum, G.G., Burchett, B.M., Blazer, D.G., Identifying a national death index match (2009) Am J Epidemiol, 170, pp. 515-518; Adler, N.E., Rehkopf, D.H., U.S.disparities in health: descriptions, causes, and mechanisms (2008) Annu Rev Public Health, 29, pp. 235-252; Rehkopf, D.H., Berkman, L.F., Coull, B., Krieger, N., The nonlinear risk of mortality by income level in a healthy population: US National Health and Nutrition Examination Survey mortality follow-up cohort, 1988-2001 (2008) BMC Public Health, 8, p. 383; Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Compendium of physical activities: an update of activity codes and MET intensities (2000) Med Sci Sports Exerc, 32 (SUPPL. 9), pp. S498-504; (2008) Physical Activity Guidelines for Americans, , http://www.health.gov/paguidelines/pdf/paguide.pdf, US Department of Health and Human Services. (15 January 2013, date last accessed); Blanton, C.A., Moshfegh, A.J., Baer, D.J., Kretsch, M.J., The USDA Automated Multiple-Pass Method accurately estimates group total energy and nutrient intake (2006) J Nutr, 136, pp. 2594-2599; (2003) What We Eat in America, NHANES, , ftp://ftp.cdc.gov/pub/Health_Statistics/nchs/nhanes/2003-2004/DR1TOT_C.XPT, U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center et al. Beltsville, MD: Beltsville Human Nutrition Research Center (15 January 2013, date last accessed); (2001) What We Eat in America, NHANES, , ftp://ftp.cdc.gov/pub/Health_Statistics/nchs/nhanes/2001-2002/DRXTOT_B.XPT, U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center et al. Beltsville, MD: Beltsville Human Nutrition Research Center (15 January 2013, date last accessed); (1999) What We Eat in America, NHANES, , ftp://ftp.cdc.gov/pub/Health_Statistics/nchs/nhanes/1999-2000/DRXTOT.XPT, U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center et al. Beltsville, MD: Beltsville Human Nutrition Research Center (15 January 2013, date last accessed); Flegal, K.M., Graubard, B.I., Williamson, D.F., Gail, M.H., Cause-specific excess deaths associated with underweight, overweight, and obesity (2007) JAMA, 298, pp. 2028-2037; Therneau, T., (2012) A Package for Survival Analysis in S, , R package version 2.36-14; Lumley, T., (2009) Survey: Analysis of Complex Survey Samples, , R package version 3.14; (2007), StataCorp. Stata Statistical Software: Release 10. 10th edn. College Station, TX: StataCorp LP; Patel, C.J., Chen, R., Kodama, K., Ioannidis, J.P., Butte, A.J., Systematic identification of interaction effects between genome-and environment-wide associations in type 2 diabetes mellitus (2013) Hum Genet, 132, pp. 495-509; Efron, B., (2010) Large-Scale Inference, , Cambridge, UK: Cambridge University Press; Gordon, A., (1999) Classification, , 2nd edn. Boca Raton, FL: Chapman and Hall/CRC; Qiu, W., Chavarro, J., Lazarus, R., Rosner, B., Ma, J., Power SurvEpi: Power and sample size calculation for survival analysis of epidemiological studies (2012), R package version 0.0.6; Hsieh, F.Y., Lavori, P.W., Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates (2000) Control Clin Trials, 21, pp. 552-560; Schoenfeld, D.A., Sample-size formula for the proportionalhazards regression model (1983) Biometrics, 39, pp. 499-503; Davison, A., Hinkley, D., (1997) Bootstrap Methods and Their Application, , Cambridge, UK: Cambridge University Press; Gellert, C., Schottker, B., Brenner, H., Smoking and all-cause mortality in older people: systematic review and metaanalysis (2012) Arch Intern Med, 172, pp. 837-844; Samitz, G., Egger, M., Zwahlen, M., Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies (2011) Int J Epidemiol, 40, pp. 1382-1400; Moore, S.C., Patel, A.V., Matthews, C.E., Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis (2012) PLoS Med, 9, pp. e1001335; Jha, P., Ramasundarahettige, C., Landsman, V., 21stcentury hazards of smoking and benefits of cessation in the United States (2013) N Engl J Med, 368, pp. 341-350; Pirie, K., Peto, R., Reeves, G.K., Green, J., Beral, V., The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK (2013) Lancet, 381, pp. 133-141; Loef, M., Walach, H., The combined effects of healthy lifestyle behaviours on all cause mortality: a systematic review and meta-analysis (2012) Prev Med, 5, pp. 163-170; Nicklett, E.J., Semba, R.D., Xue, Q.L., Fruit and vegetable intake, physical activity, and mortality in older community-dwelling women (2012) J Am Geriatr Soc, 60, pp. 862-868; Lauretani, F., Semba, R.D., Dayhoff-Brannigan, M., Low total plasma carotenoids are independent predictors of mortality among older persons: the InCHIANTI study (2008) Eur J Nutr, 47, pp. 335-340; Shardell, M.D., Alley, D.E., Hicks, G.E., Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey (2011) Nutr Res, 31, pp. 178-189; MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet, 360, pp. 23-33; Thies, F., Masson, L.F., Rudd, A., Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial (2012) Am J Clin Nutr, 95, pp. 1013-1022; Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C., Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases (2012) Cochrane Database Syst Rev, 3. , CD007176; Hu, F.B., Willett, W.C., Optimal Diets for Prevention of Coronary Heart Disease (2002) JAMA, 288, pp. 2569-2578; Tellez-Plaza, M., Navas-Acien, A., Menke, A., Crainiceanu, C.M., Pastor-Barriuso, R., Guallar, E., Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population (2012) Environ Health Perspect, 120, pp. 1017-1022; ATDSR-Toxicological Profile: Cadmium, , http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=48&tid=15, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry. (15 January 2013, date last accessed); Altekruse, S.F., McGlynn, K.A., Reichman, M.E., Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 (2009) J Clin Oncol, 27, pp. 1485-1491; Rappaport, S.M., Smith, M.T., Environment and Disease Risks (2010) Science, 330, pp. 460-461; Athersuch, T.J., The role of metabolomics in characterizing the human exposome (2012) Bioanalysis, 4, pp. 2207-2212; Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A., Needham, L.L., Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004 (2008) Environ Health Perspect, 116, pp. 39-44; Briefel, R.R., Flegal, K.M., Winn, D.M., Loria, C.M., Johnson, C.L., Sempos, C.T., Assessing the nation's diet: limitations of the food frequency questionnaire (1992) J Am Diet Assoc, 92, pp. 959-962; Byers, T., Food frequency dietary assessment: how bad is good enough? (2001) Am J Epidemiol, 154, pp. 1087-1088; Brown, D., Do food frequency questionnaires have too many limitations? (2006) J Am Diet Assoc, 106, pp. 1541-1542; Schatzkin, A., Kipnis, V., Carroll, R.J., A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study (2003) Int J Epidemiol, 32, pp. 1054-1062},
correspondence_address1={Ioannidis, J.P.A.; Stanford Prevention Research Center, 1265 Welch Rd, Stanford 94305, CA, United States; email: jioannid@stanford.edu},
issn={03005771},
coden={IJEPB},
pubmed_id={24345851},
language={English},
abbrev_source_title={Int. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Dragioti20191241,
author={Dragioti, E. and Solmi, M. and Favaro, A. and Fusar-Poli, P. and Dazzan, P. and Thompson, T. and Stubbs, B. and Firth, J. and Fornaro, M. and Tsartsalis, D. and Carvalho, A.F. and Vieta, E. and McGuire, P. and Young, A.H. and Shin, J.I. and Correll, C.U. and Evangelou, E.},
title={Association of Antidepressant Use with Adverse Health Outcomes: A Systematic Umbrella Review},
journal={JAMA Psychiatry},
year={2019},
volume={76},
number={12},
pages={1241-1255},
doi={10.1001/jamapsychiatry.2019.2859},
note={cited By 75},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073050563&doi=10.1001%2fjamapsychiatry.2019.2859&partnerID=40&md5=73169864d83c17161c89f3255f6d455c},
affiliation={Pain and Rehabilitation Centre, Department of Medicine and Health Sciences, Linköping University, Linköping, SE-581 85, Sweden; Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, University Campus, Ioannina, Greece; Department of Neuroscience, University of Padua, Padua, Italy; Padova Neuroscience Center (PNC), University of Padua, Padua, Italy; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; OASIS Service, South London and Maudsley NHS (National Health Service) Foundation Trust, London, United Kingdom; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Section of Imaging, Neurobiology, and Psychosis, Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research (NIHR), Mental Health Biomedical Research Centre at South London and Maudsley, NHS Foundation Trust, London, United Kingdom; Department of Psychology, Social Work and Counselling, University of Greenwich, Greenwich, United Kingdom; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London, United Kingdom; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; NICM Health Research Institute, School of Science and Health, University of Western Sydney, Sydney, Australia; Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia; Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, Naples, Italy; Department of Clinical Physiology, Linköping University, Linköping, Sweden; Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychiatry and Psychology, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Spanish Ministry of Science and Innovation (CIBERSAM), Barcelona, Catalonia, Spain; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, Kent, United Kingdom; Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea; Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, United States; Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY, United States; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, United States; Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin Institute of Health, Berlin, Germany; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom},
abstract={Importance: Antidepressant use is increasing worldwide. Yet, contrasting evidence on the safety of antidepressants is available from meta-analyses, and the credibility of these findings has not been quantified. Objective: To grade the evidence from published meta-analyses of observational studies that assessed the association between antidepressant use or exposure and adverse health outcomes. Data Sources: PubMed, Scopus, and PsycINFO were searched from database inception to April 5, 2019. Evidence Review: Only meta-analyses of observational studies with a cohort or case-control study design were eligible. Two independent reviewers recorded the data and assessed the methodological quality of the included meta-analyses. Evidence of association was ranked according to established criteria as follows: convincing, highly suggestive, suggestive, weak, or not significant. Results: Forty-five meta-analyses (17.9%) from 4471 studies identified and 252 full-text articles scrutinized were selected that described 120 associations, including data from 1012 individual effect size estimates. Seventy-four (61.7%) of the 120 associations were nominally statistically significant at P ≤.05 using random-effects models. Fifty-two associations (43.4%) had large heterogeneity (I2 &gt; 50%), whereas small-study effects were found for 17 associations (14.2%) and excess significance bias was found for 9 associations (7.5%). Convincing evidence emerged from both main and sensitivity analyses for the association between antidepressant use and risk of suicide attempt or completion among children and adolescents, autism spectrum disorders with antidepressant exposure before and during pregnancy, preterm birth, and low Apgar scores. None of these associations remained supported by convincing evidence after sensitivity analysis, which adjusted for confounding by indication. Conclusions and Relevance: This study's findings suggest that most putative adverse health outcomes associated with antidepressant use may not be supported by convincing evidence, and confounding by indication may alter the few associations with convincing evidence. Antidepressant use appears to be safe for the treatment of psychiatric disorders, but more studies matching for underlying disease are needed to clarify the degree of confounding by indication and other biases. No absolute contraindication to antidepressants emerged from this umbrella review. © 2019 American Medical Association. All rights reserved.},
keywords={antidepressant agent;  antidepressant agent, adverse outcome;  Apgar score;  autism;  case control study;  cohort analysis;  depression;  drug exposure;  human;  meta analysis;  observational study;  pregnancy;  premature labor;  Review;  risk factor;  sensitivity analysis;  suicide attempt;  systematic review;  adolescent;  Apgar score;  child;  female;  mental disease;  meta analysis (topic);  prematurity;  prenatal exposure;  suicide attempt, Adolescent;  Antidepressive Agents;  Apgar Score;  Autism Spectrum Disorder;  Child;  Female;  Humans;  Mental Disorders;  Meta-Analysis as Topic;  Observational Studies as Topic;  Pregnancy;  Premature Birth;  Prenatal Exposure Delayed Effects;  Suicide, Attempted;  Suicide, Completed},
chemicals_cas={Antidepressive Agents},
funding_details={National Institute of Mental HealthNational Institute of Mental Health, NIMH},
funding_details={Abbott FundAbbott Fund},
funding_details={Bristol-Myers SquibbBristol-Myers Squibb, BMS},
funding_details={AstraZenecaAstraZeneca},
funding_details={Johnson and JohnsonJohnson and Johnson, J&J},
funding_details={RocheRoche},
funding_details={SanofiSanofi},
funding_details={Janssen BiotechJanssen Biotech},
funding_details={Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries},
funding_details={Stanley Medical Research InstituteStanley Medical Research Institute, SMRI},
funding_details={ShireShire},
funding_details={AllerganAllergan},
funding_details={King’s College LondonKing’s College London},
funding_details={South London and Maudsley NHS Foundation TrustSouth London and Maudsley NHS Foundation Trust},
funding_details={SunovionSunovion},
funding_details={Wellcome TrustWellcome Trust, WT},
funding_details={Maudsley CharityMaudsley Charity},
funding_details={LivaNovaLivaNova},
funding_details={Takeda CanadaTakeda Canada},
funding_details={Forest Research InstituteForest Research Institute},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR},
funding_details={Western Economic Diversification CanadaWestern Economic Diversification Canada, WD},
funding_details={Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research, MSFHR},
funding_details={Medical Research CouncilMedical Research Council, MRC},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR, ICA-CL-2017-03-001},
funding_details={British Medical AssociationBritish Medical Association, BMA},
funding_details={Royal College of PhysiciansRoyal College of Physicians, RCP},
funding_details={King's College LondonKing's College London},
funding_details={Dainippon Sumitomo PharmaDainippon Sumitomo Pharma},
funding_details={Gedeon RichterGedeon Richter},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7},
funding_details={Angelini PharmaAngelini Pharma},
funding_details={Centro de Investigación Biomédica en Red de Salud MentalCentro de Investigación Biomédica en Red de Salud Mental, CIBERSAM},
funding_details={Horizon 2020Horizon 2020},
funding_details={ServierServier},
funding_details={Faculty of Science, Agriculture and Engineering, Newcastle UniversityFaculty of Science, Agriculture and Engineering, Newcastle University, SAgE},
funding_details={NIHR Collaboration for Leadership in Applied Health Research and Care South LondonNIHR Collaboration for Leadership in Applied Health Research and Care South London},
funding_details={Grupo Ferrer Internacional, S.AGrupo Ferrer Internacional, S.A},
funding_text 1={reported receiving grants and personal fees from Lundbeck outside the submitted work. Dr Vieta reported receiving grants and serving as a consultant, advisor, or continuing medical education speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, AstraZeneca, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Galenica, Gedeon Richter, GlaxoSmithKline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, SAGE, Sanofi, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, CIBERSAM, the Seventh European Framework Programme and Horizon 2020, and the Stanley Medical Research Institute. Dr Young reported receiving grants and personal fees from Janssen; receiving personal fees from Lundbeck, Allegan, Sunovion, Livanova, Johnson & Johnson, and Bionomics outside the submitted work; being employed by King's College London and an honorary consultant for SLaM (NHS United Kingdom); receiving fees for lectures and service on advisory boards for the following companies with drugs for affective and related disorders: AstraZeneca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, and Bionomics; being a consultant to Johnson & Johnson and Livanova; not having share holdings in pharmaceutical companies; being lead investigator for the Embolden Study (AstraZeneca), BCI Neuroplasticity Study, and Aripiprazole Mania Study and participating in investigator-initiated studies from AstraZeneca, Eli Lilly, Lundbeck, Wyeth, and Janssen; and receiving past and present grant funding from the National Institute of Mental Health, Canadian Institutes of Health Research, National Alliance for Research on Schizophrenia and Depression, Stanley Medical Research Institute, Medical Research Council, Wellcome Trust, Royal College of Physicians, British Medical Association, Vancouver General Hospital and University of Bristish Columbia Hospital Foundation, Western Economic Diversification Canada, Canadian Cancer},
funding_text 2={Society Depression Research Fund, Michael Smith Foundation for Health Research, National Institute for Health Research (NIHR), and Janssen. Dr Correll reported receiving personal fees from Alkermes, Allergan, Angelini, Boehringer-Ingelheim, Gedeon Richter, Indivior, LB Pharma, Lundbeck, MedAvante-ProPhase, Merck, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, and Supernus; receiving grants and personal fees from Janssen/Johnson & Johnson and Teva outside the submitted work; serving on a data safety monitoring board for Boehringer-Ingelheim, Lundbeck, Rovi, Supernus, and Teva; providing expert testimony for Bristol-Myers Squibb, Janssen, and Otsuka; receiving royalties from UpToDate and grant support from Janssen and Takeda; and being shareholder of LB Pharma. No other disclosures were reported.},
funding_text 3={funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. Dr Firth was supported by a Blackmores Institute Fellowship. Dr Stubbs holds a clinical lectureship supported by Health Education England and the NIHR Integrated Clinical Academic (ICA) Programme (ICA-CL-2017-03-001) and was supported in part by the Maudsley Charity and the NIHR Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust.},
references={Pratt, L.A., Brody, D.J., Gu, Q., Antidepressant use in persons aged 12 and over: United States, 2005-2008 (2011) NCHS Data Brief, (76), pp. 1-8. , 22617183; Davey, C.G., Chanen, A.M., The unfulfilled promise of the antidepressant medications (2016) Med J Aust, 204 (9), pp. 348-350. , http://dx.doi.org/10.5694/mja16.00194, doi: 27169968; Skapinakis, P., Caldwell, D.M., Hollingworth, W., Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: A systematic review and network meta-analysis (2016) Lancet Psychiatry, 3 (8), pp. 730-739. , http://dx.doi.org/10.1016/S2215-0366(16)30069-4, doi: 27318812; Locher, C., Koechlin, H., Zion, S.R., Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: A systematic review and meta-analysis (2017) JAMA Psychiatry, 74 (10), pp. 1011-1020. , http://jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2017.2432, doi: 28854296; Bighelli, I., Castellazzi, M., Cipriani, A., Antidepressants versus placebo for panic disorder in adults (2018) Cochrane Database Syst Rev, 4, p. CD010676. , http://dx.doi.org/10.1002/14651858.CD010676.pub2, doi: 29620793; Leon, A.C., The revised warning for antidepressants and suicidality: Unveiling the black box of statistical analyses (2007) Am J Psychiatry, 164 (12), pp. 1786-1789. , http://dx.doi.org/10.1176/appi.ajp.2007.07050775, doi: 18056231; Hammad, T.A., Laughren, T., Racoosin, J., Suicidality in pediatric patients treated with antidepressant drugs (2006) Arch Gen Psychiatry, 63 (3), pp. 332-339. , http://jamanetwork.com/article.aspx?doi=10.1001/archpsyc.63.3.332, doi: 16520440; Gibbons, R.D., Brown, C.H., Hur, K., Davis, J., Mann, J.J., Suicidal thoughts and behavior with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine (2012) Arch Gen Psychiatry, 69 (6), pp. 580-587. , http://jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2011.2048, doi: 22309973; Carvalho, A.F., Sharma, M.S., Brunoni, A.R., Vieta, E., Fava, G.A., The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature (2016) Psychother Psychosom, 85 (5), pp. 270-288. , http://dx.doi.org/10.1159/000447034, doi: 27508501; Cipriani, A., Furukawa, T.A., Salanti, G., Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis (2018) Lancet, 391, pp. 1357-1366. , http://dx.doi.org/10.1016/S0140-6736(17)32802-7, doi: 29477251; Gartlehner, G., Gaynes, B.N., Amick, H.R., Comparative benefits and harms of antidepressant, psychological, complementary, and exercise treatments for major depression: An evidence report for a clinical practice guideline from the American College of Physicians (2016) Ann Intern Med, 164 (5), pp. 331-341. , http://dx.doi.org/10.7326/M15-1813, doi: 26857743; Bridge, J.A., Iyengar, S., Salary, C.B., Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials (2007) JAMA, 297 (15), pp. 1683-1696. , http://jamanetwork.com/article.aspx?doi=10.1001/jama.297.15.1683, doi: 17440145; Cipriani, A., Zhou, X., Del Giovane, C., Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis (2016) Lancet, 388, pp. 881-890. , http://dx.doi.org/10.1016/S0140-6736(16)30385-3, doi: 27289172; Moret, C., Isaac, M., Briley, M., Problems associated with long-term treatment with selective serotonin reuptake inhibitors (2009) J Psychopharmacol, 23 (8), pp. 967-974. , http://dx.doi.org/10.1177/0269881108093582, doi: 18635702; Corrigan-Curay, J., Sacks, L., Woodcock, J., Real-world evidence and real-world data for evaluating drug safety and effectiveness (2018) JAMA, 320 (9), pp. 867-868. , http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.10136, doi: 30105359; Solmi, M., Correll, C.U., Carvalho, A.F., Ioannidis, J.P.A., The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: Beyond qualitative synthesis (2018) Epidemiol Psychiatr Sci, 27 (6), pp. 537-542. , http://dx.doi.org/10.1017/S204579601800032X, doi: 30008278; Benson, K., Hartz, A.J., A comparison of observational studies and randomized, controlled trials (2000) N Engl J Med, 342 (25), pp. 1878-1886. , http://dx.doi.org/10.1056/NEJM200006223422506, doi: 10861324; Kyriacou, D.N., Lewis, R.J., Confounding by indication in clinical research (2016) JAMA, 316 (17), pp. 1818-1819. , http://jamanetwork.com/article.aspx?doi=10.1001/jama.2016.16435, doi: 27802529; Cipriani, A., Barbui, C., Geddes, J.R., Suicide, depression, and antidepressants (2005) BMJ, 330 (7488), pp. 373-374. , http://dx.doi.org/10.1136/bmj.330.7488.373, doi: 15718515; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493. , http://dx.doi.org/10.1503/cmaj.081086, doi: 19654195; Ioannidis, J., Next-generation systematic reviews: Prospective meta-analysis, individual-level data, networks and umbrella reviews (2017) Br J Sports Med, 51 (20), pp. 1456-1458. , http://dx.doi.org/10.1136/bjsports-2017-097621, doi: 28223307; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035. , http://dx.doi.org/10.1136/bmj.g2035, doi: 24690624; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376. , http://dx.doi.org/10.1136/bmj.j2376, doi: 28592419; Radua, J., Ramella-Cravaro, V., Ioannidis, J.P.A., What causes psychosis? An umbrella review of risk and protective factors (2018) World Psychiatry, 17 (1), pp. 49-66. , http://dx.doi.org/10.1002/wps.20490, doi: 29352556; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA statement (2009) PLoS Med, 6 (7), p. e1000097. , http://dx.doi.org/10.1371/journal.pmed.1000097, doi: 19621072; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of Observational Studies in Epidemiology: A proposal for reporting (2000) JAMA, 283 (15), pp. 2008-2012. , http://jamanetwork.com/article.aspx?doi=10.1001/jama.283.15.2008, doi: 10789670; Raglan, O., Kalliala, I., Markozannes, G., Risk factors for endometrial cancer: An umbrella review of the literature (2019) Int J Cancer, 145 (7), pp. 1719-1730. , http://dx.doi.org/10.1002/ijc.31961, doi: 30387875; Shea, B.J., Reeves, B.C., Wells, G., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008. , http://dx.doi.org/10.1136/bmj.j4008, doi: 28935701; Dersimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7 (3), pp. 177-188. , http://dx.doi.org/10.1016/0197-2456(86)90046-2, doi: 3802833; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327 (7414), pp. 557-560. , http://dx.doi.org/10.1136/bmj.327.7414.557, doi: 12958120; Riley, R.D., Higgins, J.P., Deeks, J.J., Interpretation of random effects meta-analyses (2011) BMJ, 342, p. d549. , http://dx.doi.org/10.1136/bmj.d549, doi: 21310794; Bortolato, B., Köhler, C.A., Evangelou, E., Systematic assessment of environmental risk factors for bipolar disorder: An umbrella review of systematic reviews and meta-analyses (2017) Bipolar Disord, 19 (2), pp. 84-96. , http://dx.doi.org/10.1111/bdi.12490, doi: 28470927; Dragioti, E., Evangelou, E., Larsson, B., Gerdle, B., Effectiveness of multidisciplinary programmes for clinical pain conditions: An umbrella review (2018) J Rehabil Med, 50 (9), pp. 779-791. , http://dx.doi.org/10.2340/16501977-2377, doi: 30132012; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253. , http://dx.doi.org/10.1177/1740774507079441, doi: 17715249; Ioannidis, J.P.A., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57 (5), pp. 184-187. , http://dx.doi.org/10.1016/j.jmp.2013.03.002; Dragioti, E., Karathanos, V., Gerdle, B., Evangelou, E., Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials (2017) Acta Psychiatr Scand, 136 (3), pp. 236-246. , http://dx.doi.org/10.1111/acps.12713, doi: 28240781; Veronese, N., Solmi, M., Caruso, M.G., Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses (2018) Am J Clin Nutr, 107 (3), pp. 436-444. , http://dx.doi.org/10.1093/ajcn/nqx082, doi: 29566200; Masarwa, R., Bar-Oz, B., Gorelik, E., Reif, S., Perlman, A., Matok, I., Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: A systematic review, meta-analysis, and network meta-analysis (2019) Am J Obstet Gynecol, 220 (1), pp. 57e1-57e13. , http://dx.doi.org/10.1016/j.ajog.2018.08.030, doi: 30170040; Halvorsen, A., Hesel, B., Ostergaard, S.D., Danielsen, A.A., In utero exposure to SSRIs and development of mental disorders: A systematic review and meta-analysis (2019) Acta Psychiatr Scand, 139 (6), pp. 493-507. , http://dx.doi.org/10.1111/acps.13030, doi: 30937904; Wang, Y.C., Tai, P.A., Poly, T.N., Increased risk of dementia in patients with antidepressants: A meta-analysis of observational studies (2018) Behav Neurol, 2018. , http://dx.doi.org/10.1155/2018/5315098, doi: 30123386; Schweiger, J.U., Schweiger, U., Hüppe, M., The use of antidepressive agents and bone mineral density in women: A meta-analysis (2018) Int J Environ Res Public Health, 15 (7), p. E1373. , http://dx.doi.org/10.3390/ijerph15071373, doi: 29966324; Khanassov, V., Hu, J., Reeves, D., Van Marwijk, H., Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis (2018) Int J Geriatr Psychiatry, 33 (12), pp. 1688-1708. , http://dx.doi.org/10.1002/gps.4974, doi: 30247774; Jiang, H.Y., Peng, C.T., Zhang, X., Ruan, B., Antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in the children: A meta-analysis of cohort studies (2018) BJOG, 125 (9), pp. 1077-1084. , http://dx.doi.org/10.1111/1471-0528.15059, doi: 29243299; Gao, S.Y., Wu, Q.J., Sun, C., Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: A systematic review and meta-analysis of cohort studies of more than 9 million births (2018) BMC Med, 16 (1), p. 205. , http://dx.doi.org/10.1186/s12916-018-1193-5, doi: 30415641; Guan, H.B., Wei, Y., Wang, L.L., Qiao, C., Liu, C.X., Prenatal selective serotonin reuptake inhibitor use and associated risk for gestational hypertension and preeclampsia: A meta-analysis of cohort studies (2018) J Womens Health (Larchmt), 27 (6), pp. 791-800. , http://dx.doi.org/10.1089/jwh.2017.6642, doi: 29489446; Chappuis, V., Avila-Ortiz, G., Araújo, M.G., Monje, A., Medication-related dental implant failure: Systematic review and meta-analysis (2018) Clin Oral Implants Res, 29, pp. 55-68. , http://dx.doi.org/10.1111/clr.13137, doi: 30328197; Na, K.S., Jung, H.Y., Cho, S.J., Cho, S.E., Can we recommend mirtazapine and bupropion for patients at risk for bleeding?: A systematic review and meta-analysis (2018) J Affect Disord, 225, pp. 221-226. , http://dx.doi.org/10.1016/j.jad.2017.08.002, doi: 28841484; Man, K.K.C., Chan, E.W., Ip, P., Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis (2018) Neurosci Biobehav Rev, 86, pp. 1-11. , http://dx.doi.org/10.1016/j.neubiorev.2017.12.007, doi: 29247762; Fu, Y., Dai, Q., Zhu, L., Wu, S., Antidepressants use and risk of cataract development: A systematic review and meta-analysis (2018) BMC Ophthalmol, 18 (1), p. 31. , http://dx.doi.org/10.1186/s12886-018-0699-0, doi: 29409486; Zhou, X.H., Li, Y.J., Ou, J.J., Li, Y.M., Association between maternal antidepressant use during pregnancy and autism spectrum disorder: An updated meta-analysis (2018) Mol Autism, 9, p. 21. , http://dx.doi.org/10.1186/s13229-018-0207-7, doi: 29599960; Morales, D.R., Slattery, J., Evans, S., Kurz, X., Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: Systematic review of observational studies and methodological considerations (2018) BMC Med, 16 (1), p. 6. , http://dx.doi.org/10.1186/s12916-017-0993-3, doi: 29332605; Andalib, S., Emamhadi, M.R., Yousefzadeh-Chabok, S., Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review (2017) Eur Psychiatry, 45, pp. 161-166. , http://dx.doi.org/10.1016/j.eurpsy.2017.06.001, doi: 28917161; Zhang, T.N., Gao, S.Y., Shen, Z.Q., Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: A meta-analysis of cohort studies (2017) Sci Rep, 7, p. 43085. , http://dx.doi.org/10.1038/srep43085, doi: 28220881; Shen, Z.Q., Gao, S.Y., Li, S.X., Sertraline use in the first trimester and risk of congenital anomalies: A systemic review and meta-analysis of cohort studies (2017) Br J Clin Pharmacol, 83 (4), pp. 909-922. , http://dx.doi.org/10.1111/bcp.13161, doi: 27770542; Laporte, S., Chapelle, C., Caillet, P., Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies (2017) Pharmacol Res, 118, pp. 19-32. , http://dx.doi.org/10.1016/j.phrs.2016.08.017, doi: 27521835; Gao, S.Y., Wu, Q.J., Zhang, T.N., Fluoxetine and congenital malformations: A systematic review and meta-analysis of cohort studies (2017) Br J Clin Pharmacol, 83 (10), pp. 2134-2147. , http://dx.doi.org/10.1111/bcp.13321, doi: 28513059; Biffi, A., Scotti, L., Corrao, G., Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: A meta-analysis of observational studies (2017) Eur J Clin Pharmacol, 73 (4), pp. 487-497. , http://dx.doi.org/10.1007/s00228-016-2187-x, doi: 28070601; Jiang, H.Y., Xu, L.L., Li, Y.C., Deng, M., Peng, C.T., Ruan, B., Antidepressant use during pregnancy and risk of postpartum hemorrhage: A systematic review and meta-analysis (2016) J Psychiatr Res, 83, pp. 160-167. , http://dx.doi.org/10.1016/j.jpsychires.2016.09.001, doi: 27637098; Healy, D., Le Noury, J., Mangin, D., Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence (2016) Int J Risk Saf Med, 28 (3), pp. 125-141. , http://dx.doi.org/10.3233/JRS-160726, doi: 27662278; Eke, A.C., Saccone, G., Berghella, V., Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: A systematic review and meta-analysis (2016) BJOG, 123 (12), pp. 1900-1907. , http://dx.doi.org/10.1111/1471-0528.14144, doi: 27239775; Bérard, A., Iessa, N., Chaabane, S., Muanda, F.T., Boukhris, T., Zhao, J.P., The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: A systematic review and meta-analysis (2016) Br J Clin Pharmacol, 81 (4), pp. 589-604. , http://dx.doi.org/10.1111/bcp.12849, doi: 26613360; Undela, K., Parthasarathi, G., John, S.S., Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis (2015) Indian J Pharmacol, 47 (3), pp. 256-262. , http://dx.doi.org/10.4103/0253-7613.157112, doi: 26069361; Singh, I., Achuthan, S., Chakrabarti, A., Rajagopalan, S., Srinivasan, A., Hota, D., Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: A meta-analysis (2015) Pharmacoepidemiol Drug Saf, 24 (3), pp. 237-245. , http://dx.doi.org/10.1002/pds.3632, doi: 24789076; Jiang, H.Y., Chen, H.Z., Hu, X.J., Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: A systematic review and meta-analysis (2015) Clin Gastroenterol Hepatol, 13 (1), pp. 42-50e3. , http://dx.doi.org/10.1016/j.cgh.2014.06.021, doi: 24993365; Shin, D., Oh, Y.H., Eom, C.S., Park, S.M., Use of selective serotonin reuptake inhibitors and risk of stroke: A systematic review and meta-analysis (2014) J Neurol, 261 (4), pp. 686-695. , http://dx.doi.org/10.1007/s00415-014-7251-9, doi: 24477492; Huang, H., Coleman, S., Bridge, J.A., Yonkers, K., Katon, W., A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight (2014) Gen Hosp Psychiatry, 36 (1), pp. 13-18. , http://dx.doi.org/10.1016/j.genhosppsych.2013.08.002, doi: 24094568; Huybrechts, K.F., Sanghani, R.S., Avorn, J., Urato, A.C., Preterm birth and antidepressant medication use during pregnancy: A systematic review and meta-analysis (2014) PLoS One, 9 (3), p. e92778. , http://dx.doi.org/10.1371/journal.pone.0092778, doi: 24671232; Grigoriadis, S., Vonderporten, E.H., Mamisashvili, L., Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: Systematic review and meta-analysis (2014) BMJ, 348, p. f6932. , http://dx.doi.org/10.1136/bmj.f6932, doi: 24429387; Oh, S.W., Kim, J., Myung, S.K., Hwang, S.S., Yoon, D.H., Antidepressant use and risk of coronary heart disease: Meta-analysis of observational studies (2014) Br J Clin Pharmacol, 78 (4), pp. 727-737. , http://dx.doi.org/10.1111/bcp.12383, doi: 24646010; Wu, Q., Qu, W., Crowell, M.D., Hentz, J.G., Frey, K.A., Tricyclic antidepressant use and risk of fractures: A meta-analysis of cohort and case-control studies (2013) J Bone Miner Res, 28 (4), pp. 753-763. , http://dx.doi.org/10.1002/jbmr.1813, doi: 23165455; Ross, L.E., Grigoriadis, S., Mamisashvili, L., Selected pregnancy and delivery outcomes after exposure to antidepressant medication: A systematic review and meta-analysis (2013) JAMA Psychiatry, 70 (4), pp. 436-443. , http://jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2013.684, doi: 23446732; Riggin, L., Frankel, Z., Moretti, M., Pupco, A., Koren, G., The fetal safety of fluoxetine: A systematic review and meta-analysis (2013) J Obstet Gynaecol Can, 35 (4), pp. 362-369. , http://dx.doi.org/10.1016/S1701-2163(15)30965-8, doi: 23660045; Grigoriadis, S., Vonderporten, E.H., Mamisashvili, L., The effect of prenatal antidepressant exposure on neonatal adaptation: A systematic review and meta-analysis (2013) J Clin Psychiatry, 74 (4), pp. e309-e320. , http://dx.doi.org/10.4088/JCP.12r07967, doi: 23656856; Myles, N., Newall, H., Ward, H., Large, M., Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations (2013) Aust N Z J Psychiatry, 47 (11), pp. 1002-1012. , http://dx.doi.org/10.1177/0004867413492219, doi: 23761574; Nikfar, S., Rahimi, R., Hendoiee, N., Abdollahi, M., Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis (2012) Daru, 20 (1), p. 75. , http://dx.doi.org/10.1186/2008-2231-20-75, doi: 23351929; Oderda, L.H., Young, J.R., Asche, C.V., Pepper, G.A., Psychotropic-related hip fractures: Meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs (2012) Ann Pharmacother, 46 (7-8), pp. 917-928. , http://dx.doi.org/10.1345/aph.1Q589, doi: 22811347; Eom, C.S., Park, S.M., Cho, K.H., Use of antidepressants and the risk of breast cancer: A meta-analysis (2012) Breast Cancer Res Treat, 136 (3), pp. 635-645. , http://dx.doi.org/10.1007/s10549-012-2307-y, doi: 23139055; Lee, H.K., Eom, C.S., Kwon, Y.M., Ahn, J.S., Kim, S., Park, S.M., Meta-analysis: Selective serotonin reuptake inhibitors and colon cancer (2012) Eur J Gastroenterol Hepatol, 24 (10), pp. 1153-1157. , http://dx.doi.org/10.1097/MEG.0b013e328355e289, doi: 22735609; Cosgrove, L., Shi, L., Creasey, D.E., Anaya-Mckivergan, M., Myers, J.A., Huybrechts, K.F., Antidepressants and breast and ovarian cancer risk: A review of the literature and researchers' financial associations with industry (2011) PLoS One, 6 (4), p. e18210. , http://dx.doi.org/10.1371/journal.pone.0018210, doi: 21494667; Barbui, C., Esposito, E., Cipriani, A., Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies (2009) CMAJ, 180 (3), pp. 291-297. , http://dx.doi.org/10.1503/cmaj.081514, doi: 19188627; Hemels, M.E., Einarson, A., Koren, G., Lanctôt, K.L., Einarson, T.R., Antidepressant use during pregnancy and the rates of spontaneous abortions: A meta-analysis (2005) Ann Pharmacother, 39 (5), pp. 803-809. , http://dx.doi.org/10.1345/aph.1E547, doi: 15784808; (2009) Depression in Adults. Clinical Guideline (CG 90)., , http://www.nice.org.uk/, Published October. Accessed November 2018; Eckersley, M.J., Sepehripour, A.H., Casula, R., Punjabi, P., Athanasiou, T., Do selective serotonin reuptake inhibitors increase the risk of bleeding or mortality following coronary artery bypass graft surgery? a meta-analysis of observational studies (2018) Perfusion, 33 (6), pp. 415-422. , http://dx.doi.org/10.1177/0267659118765933, doi: 29569518; Brännström, J., Lövheim, H., Gustafson, Y., Nordström, P., Association between antidepressant drug use and hip fracture in older people before and after treatment initiation (2019) JAMA Psychiatry, 76 (2), pp. 172-179. , http://jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.3679, doi: 30601883; (2009) British National Formulary 57, , Royal Pharmaceutical Society. London, UK: BMJ Group & RPS Publishing; Kim, J.Y., Son, M.J., Son, C.Y., Environmental risk factors and biomarkers for autism spectrum disorder: An umbrella review of the evidence (2019) Lancet Psychiatry, 6 (7), pp. 590-600. , http://dx.doi.org/10.1016/S2215-0366(19)30181-6, doi: 31230684; Howland, R.H., Antidepressant medication and pregnancy: Time for randomized controlled trials (2013) J Psychosoc Nurs Ment Health Serv, 51 (2), pp. 11-14. , http://dx.doi.org/10.3928/02793695-20130109-01, doi: 23330797; Firth, J., Siddiqi, N., Koyanagi, A., The Lancet Psychiatry Commission: A blueprint for protecting physical health in people with mental illness (2019) Lancet Psychiatry, 6 (8), pp. 675-712. , http://dx.doi.org/10.1016/S2215-0366(19)30132-4, doi: 31324560},
correspondence_address1={Dragioti, E.; Pain and Rehabilitation Centre, Sweden; email: elena.dragioti@liu.se},
publisher={American Medical Association},
issn={2168622X},
pubmed_id={31577342},
language={English},
abbrev_source_title={JAMA Psychiatry},
document_type={Review},
source={Scopus},
}

@ARTICLE{Willett2020644,
author={Willett, W.C. and Ludwig, D.S.},
title={Milk and health},
journal={New England Journal of Medicine},
year={2020},
volume={382},
number={7},
pages={644-654},
doi={10.1056/NEJMra1903547},
note={cited By 71},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079337109&doi=10.1056%2fNEJMra1903547&partnerID=40&md5=f69bba0e4acf15eced684a47c1ab26c4},
affiliation={Departments of Nutrition, Harvard T.H. Chan School of Public Health, Boston, United States; Departments of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States; Department of Pediatrics, Harvard Medical School, Boston, United States; New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, United States},
keywords={age distribution;  blood pressure;  body weight;  bone development;  bone growth;  calcium intake;  cardiovascular disease;  clinical outcome;  dairy product;  diabetes mellitus;  environmental factor;  grass;  hip fracture;  human;  lipid analysis;  malignant neoplasm;  milk allergy;  milk intolerance;  mortality rate;  musculoskeletal system;  nonhuman;  nutritional assessment;  nutritional requirement;  nutritional status;  obesity;  organic food;  priority journal;  prophylaxis;  Review;  risk reduction;  adult;  adverse event;  animal;  body height;  child;  female;  food allergy;  fracture;  hypertension;  immunology;  lactose intolerance;  male;  milk;  nutritional requirement, calcium, Adult;  Animals;  Body Height;  Calcium;  Child;  Female;  Food Hypersensitivity;  Fractures, Bone;  Humans;  Hypertension;  Lactose Intolerance;  Male;  Milk;  Nutritional Requirements},
chemicals_cas={calcium, 7440-70-2, 14092-94-5; Calcium},
references={(2015) Scientific Report of the Dietary Guidelines Advisory Committee, , Department of Agriculture, Department of Health and Human Services. Washington, DC: Government Printing Office; FoodData Central, , https://fdc.nal.usda.gov/index.html, Department of Agriculture, Agricultural Research Service; Adebamowo, C.A., Spiegelman, D., Danby, F.W., Frazier, A.L., Willett, W.C., Holmes, M.D., High school dietary dairy intake and teenage acne (2005) J Am Acad Dermatol, 52, pp. 207-214; Maruyama, K., Oshima, T., Ohyama, K., Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows (2010) Pediatr Int, 52, pp. 33-38; Hartman, S., Lacorn, H., Steinhart, H., Natural occurrence of steroid hormones in food (1998) Food Chem, 62, pp. 7-20; Darling, J.A., Laing, A.H., Harkness, R.A., A survey of the steroids in cows' milk (1974) J Endocrinol, 62, pp. 291-297; Echternkamp, S.E., Aad, P.Y., Eborn, D.R., Spicer, L.J., Increased abundance of aromatase and follicle stimulating hormone receptor mRNA and decreased insulin-like growth factor-2 receptor mRNA in small ovarian follicles of cattle selected for twin births (2012) J Anim Sci, 90, pp. 2193-2200; Managing cow lactation cycles (2015) The Cattle Site, , http://www.thecattlesite.com/articles/4248/managing-cow-lactation-cycles/, May 18; Ganmaa, D., Sato, A., The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers (2005) Med Hypotheses, 65, pp. 1028-1037; Fernandez, M., Hudson, J.A., Korpela, R., De Los Reyes-Gavilan, C.G., Impact on human health of microorganisms present in fermented dairy products: An overview (2015) Biomed Res Int, 2015, p. 412714; Messina, V., Mangels, A.R., Considerations in planning vegan diets: Children (2001) J Am Diet Assoc, 101, pp. 661-669; De Beer, H., Dairy products and physical stature: A systematic review and metaanalysis of controlled trials (2012) Econ Hum Biol, 10, pp. 299-309; Berkey, C.S., Colditz, G.A., Rockett, H.R., Frazier, A.L., Willett, W.C., Dairy consumption and female height growth: Prospective cohort study (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 1881-1887; Olsen, S.F., Halldorsson, T.I., Willett, W.C., Milk consumption during pregnancy is associated with increased infant size at birth: Prospective cohort study (2007) Am J Clin Nutr, 86, pp. 1104-1110; Barr, S.I., McCarron, D.A., Heaney, R.P., Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults (2000) J Am Diet Assoc, 100, pp. 810-817; Cadogan, J., Eastell, R., Jones, N., Barker, M.E., Milk intake and bone mineral acquisition in adolescent girls: Randomised, controlled intervention trial (1997) BMJ, 315, pp. 1255-1260; Zhu, K., Du, X., Cowell, C.T., Effects of school milk intervention on cortical bone accretion and indicators relevant to bone metabolism in Chinese girls aged 10-12 y in Beijing (2005) Am J Clin Nutr, 81, pp. 1168-1175; Rich-Edwards, J.W., Ganmaa, D., Pollak, M.N., Milk consumption and the prepubertal somatotropic axis (2007) Nutr J, 6, p. 28; (1985) Energy and Protein Requirements: Report of a Joint FAO/WHO/UNU Expert Consultation, , FAO/WHO/UNU ad hoc Expert Consultation on Energy and Protein Requirements, WHO technical report no. 724. Geneva: World Health Organization; Harrison, S., Lennon, R., Holly, J., Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis (2017) Cancer Causes Control, 28, pp. 497-528; Melnik, B.C., Milk - A nutrient system of mammalian evolution promoting mTORC1-dependent translation (2015) Int J Mol Sci, 16, pp. 17048-17087; Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: Individual participant meta-analysis (2012) Int J Epidemiol, 41, pp. 1419-1433; (2007) Second Expert Report: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, , World Cancer Research Fund, American Institute for Cancer Research. Washington, DC: AICR; Hemenway, D., Azrael, D.R., Rimm, E.B., Feskanich, D., Willett, W.C., Risk factors for hip fracture in US men aged 40 through 75 years (1994) Am J Public Health, 84, pp. 1843-1845; (2010) Dietary Reference Intakes for Calcium and Vitamin D, , Institute of Medicine. Washington, DC: National Academy of Sciences; (1998) Nutrition and Bone Health with Particular Reference to Calcium and Vitamin D: Report of the Subgroup on Bone Health, , Working Group on the Nutritional Status of the Population of the Committee on Medical Aspects of Food and Nutrition Policy. London: The Stationery Office, U.K. Department of Health; (2003) Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation (Report 916), , Geneva: World Health Organization; New Food Balances (Preliminary Data), , http://www.fao.org/faostat/en/#data/FBS, New York: Food and Agriculture Organization of the United Nations; Kanis, J.A., Oden, A., McCloskey, E.V., A systematic review of hip fracture incidence and probability of fracture worldwide (2012) Osteoporos Int, 23, pp. 2239-2256; Hegsted, D.M., Calcium and osteoporosis (1986) J Nutr, 116, pp. 2316-2319; Hegsted, D.M., Fractures, calcium, and the modern diet (2001) Am J Clin Nutr, 74, pp. 571-573; Hunt, C.D., Johnson, L.K., Calcium requirements: New estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies (2007) Am J Clin Nutr, 86, pp. 1054-1063; Hegsted, D.M., Moscoso, I., Collazos, C., A study of the minimum calcium requirements of adult men (1952) J Nutr, 46, pp. 181-201; Elders, P.J., Lips, P., Netelenbos, J.C., Long-term effect of calcium supplementation on bone loss in perimenopausal women (1994) J Bone Miner Res, 9, pp. 963-970; Dawson-Hughes, B., Harris, S.S., Krall, E.A., Dallal, G.E., Effect of withdrawal of calcium and Vitamin D supplements on bone mass in elderly men and women (2000) Am J Clin Nutr, 72, pp. 745-750; Bischoff-Ferrari, H.A., Kiel, D.P., Dawson-Hughes, B., Dietary calcium and serum 25-hydroxyVitamin D status in relation to BMD among U.S. adults (2009) J Bone Miner Res, 24, pp. 935-942; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Baron, J.A., Calcium intake and hip fracture risk in men and women: A metaanalysis of prospective cohort studies and randomized controlled trials (2007) Am J Clin Nutr, 86, pp. 1780-1790; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Baron, J.A., Milk intake and risk of hip fracture in men and women: A metaanalysis of prospective cohort studies (2011) J Bone Miner Res, 26, pp. 833-839; Bian, S., Hu, J., Zhang, K., Wang, Y., Yu, M., Ma, J., Dairy product consumption and risk of hip fracture: A systematic review and meta-analysis (2018) BMC Public Health, 18, p. 165; Matia-Martin, P., Torrego-Ellacuria, M., Larrad-Sainz, A., Fernandez-Perez, C., Cuesta-Triana, F., Rubio-Herrera, M.A., Effects of milk and dairy products on the prevention of osteoporosis and osteoporotic fractures in Europeans and Non-Hispanic whites from North America: A systematic review and updated meta-analysis (2019) Adv Nutr, 10, pp. S120-S143; Feskanich, D., Meyer, H.E., Fung, T.T., Bischoff-Ferrari, H.A., Willett, W.C., Milk and other dairy foods and risk of hip fracture in men and women (2018) Osteoporos Int, 29, pp. 385-396; Holvik, K., Meyer, H.E., Laake, I., Feskanich, D., Omsland, T.K., Sogaard, A.J., Milk drinking and risk of hip fracture: The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) (2018) Br J Nutr, , December 27 (Epub ahead of print); Abrams, S.A., Griffin, I.J., Hicks, P.D., Gunn, S.K., Pubertal girls only partially adapt to low dietary calcium intakes (2004) J Bone Miner Res, 19, pp. 759-763; Abrams, S.A., Chen, Z., Hawthorne, K.M., Magnesium metabolism in 4-year-old to 8-year-old children (2014) J Bone Miner Res, 29, pp. 118-122; Winzenberg, T.M., Shaw, K., Fryer, J., Jones, G., Calcium supplementation for improving bone mineral density in children (2006) Cochrane Database Syst Rev, 2, p. CD005119; Merrilees, M.J., Smart, E.J., Gilchrist, N.L., Effects of diary food supplements on bone mineral density in teenage girls (2000) Eur J Nutr, 39, pp. 256-262; Lee, W.T., Leung, S.S., Leung, D.M., Cheng, J.C., A follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of children (1996) Am J Clin Nutr, 64, pp. 71-77; Lee, W.T., Leung, S.S., Leung, D.M., Bone mineral acquisition in low calcium intake children following the withdrawal of calcium supplement (1997) Acta Paediatr, 86, pp. 570-576; Slemenda, C.W., Peacock, M., Hui, S., Zhou, L., Johnston, C.C., Reduced rates of skeletal remodeling are associated with increased bone mineral density during the development of peak skeletal mass (1997) J Bone Miner Res, 12, pp. 676-682; Vogel, K.A., Martin, B.R., McCabe, L.D., The effect of dairy intake on bone mass and body composition in early pubertal girls and boys: A randomized controlled trial (2017) Am J Clin Nutr, 105, pp. 1214-1229; Lee, A.W., Cho, S.S., Association between phosphorus intake and bone health in the NHANES population (2015) Nutr J, 14, p. 28; Feskanich, D., Bischoff-Ferrari, H.A., Frazier, A.L., Willett, W.C., Milk consumption during teenage years and risk of hip fractures in older adults (2014) JAMA Pediatr, 168, pp. 54-60; Chen, M., Pan, A., Malik, V.S., Hu, F.B., Effects of dairy intake on body weight and fat: A meta-analysis of randomized controlled trials (2012) Am J Clin Nutr, 96, pp. 735-747; Mozaffarian, D., Hao, T., Rimm, E.B., Willett, W.C., Hu, F.B., Changes in diet and lifestyle and long-term weight gain in women and men (2011) N Engl J Med, 364, pp. 2392-2404; Le Chatelier, E., Nielsen, T., Qin, J., Richness of human gut microbiome correlates with metabolic markers (2013) Nature, 500, pp. 541-546; Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: Human gut microbes associated with obesity (2006) Nature, 444, pp. 1022-1023; Ridaura, V.K., Faith, J.J., Rey, F.E., Gut microbiota from twins discordant for obesity modulate metabolism in mice (2013) Science, 341, p. 1241214; Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest (2006) Nature, 444, pp. 1027-1031; Berkey, C.S., Rockett, H.R.H., Willett, W.C., Colditz, G.A., Milk, dairy fat, dietary calcium, and weight gain: A longitudinal study of adolescents (2005) Arch Pediatr Adolesc Med, 159, pp. 543-550; Scharf, R.J., Demmer, R.T., DeBoer, M.D., Longitudinal evaluation of milk type consumed and weight status in preschoolers (2013) Arch Dis Child, 98, pp. 335-340; Huh, S.Y., Rifas-Shiman, S.L., Rich-Edwards, J.W., Taveras, E.M., Gillman, M.W., Prospective association between milk intake and adiposity in preschool-aged children (2010) J Am Diet Assoc, 110, pp. 563-570; Barba, G., Troiano, E., Russo, P., Venezia, A., Siani, A., Inverse association between body mass and frequency of milk consumption in children (2005) Br J Nutr, 93, pp. 15-19; Noel, S.E., Ness, A.R., Northstone, K., Emmett, P., Newby, P.K., Milk intakes are not associated with percent body fat in children from ages 10 to 13 years (2011) J Nutr, 141, pp. 2035-2041; Baker, I.A., Elwood, P.C., Hughes, J., Jones, M., Moore, F., Sweetnam, P.M., A randomised controlled trial of the effect of the provision of free school milk on the growth of children (1980) J Epidemiol Community Health, 34, pp. 31-34; St-Onge, M.P., Goree, L.L., Gower, B., High-milk supplementation with healthy diet counseling does not affect weight loss but ameliorates insulin action compared with low-milk supplementation in overweight children (2009) J Nutr, 139, pp. 933-938; Albala, C., Ebbeling, C.B., Cifuentes, M., Lera, L., Bustos, N., Ludwig, D.S., Effects of replacing the habitual consumption of sugar-sweetened beverages with milk in Chilean children (2008) Am J Clin Nutr, 88, pp. 605-611; Lambourne, K., Washburn, R.A., Lee, J., A 6-month trial of resistance training with milk supplementation in adolescents: Effects on body composition (2013) Int J Sport Nutr Exerc Metab, 23, pp. 344-356; Arnberg, K., Molgaard, C., Michaelsen, K.F., Jensen, S.M., Trolle, E., Larnkjar, A., Skim milk, whey, and casein increase body weight and whey and casein increase the plasma C-peptide concentration in overweight adolescents (2012) J Nutr, 142, pp. 2083-2090; Lappe, J.M., McMahon, D.J., Laughlin, A., The effect of increasing dairy calcium intake of adolescent girls on changes in body fat and weight (2017) Am J Clin Nutr, 105, pp. 1046-1053; Maki, K.C., Rains, T.M., Schild, A.L., Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension (2013) Vasc Health Risk Manag, 9, pp. 369-379; Van Meijl, L.E., Mensink, R.P., Low-fat dairy consumption reduces systolic blood pressure, but does not improve other metabolic risk parameters in overweight and obese subjects (2011) Nutr Metab Cardiovasc Dis, 21, pp. 355-361; Cohen, L., Curhan, G., Forman, J., Association of sweetened beverage intake with incident hypertension (2012) J Gen Intern Med, 27, pp. 1127-1134; Appel, L.J., Sacks, F.M., Carey, V.J., Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial (2005) JAMA, 294, pp. 2455-2464; Willett, W.C., Stampfer, M., Diet and coronary heart disease (2013) Nutritional Epidemiology. 3rd Ed, pp. 426-427. , In: Willett WC, ed. New York: Oxford University Press; Mensink, R.P., Zock, P.L., Kester, A.D., Katan, M.B., Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials (2003) Am J Clin Nutr, 77, pp. 1146-1155; Astrup, A., Dyerberg, J., Elwood, P., The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? (2011) Am J Clin Nutr, 93, pp. 684-688; Brassard, D., Tessier-Grenier, M., Allaire, J., Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: A randomized controlled trial (2017) Am J Clin Nutr, 105, pp. 800-809; Guo, J., Astrup, A., Lovegrove, J.A., Gijsbers, L., Givens, D.I., Soedamah-Muthu, S.S., Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies (2017) Eur J Epidemiol, 32, pp. 269-287; Bernstein, A.M., Sun, Q., Hu, F.B., Stampfer, M.J., Manson, J.E., Willett, W.C., Major dietary protein sources and risk of coronary heart disease in women (2010) Circulation, 122, pp. 876-883; Bernstein, A.M., Pan, A., Rexrode, K.M., Dietary protein sources and the risk of stroke in men and women (2012) Stroke, 43, pp. 637-644; Chen, M., Li, Y., Sun, Q., Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults (2016) Am J Clin Nutr, 104, pp. 1209-1217; Dehghan, M., Mente, A., Rangarajan, S., Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): A prospective cohort study (2018) Lancet, 392, pp. 2288-2297; Knip, M., Simell, O., Environmental triggers of type 1 diabetes (2012) Cold Spring Harb Perspect Med, 2 (7), p. a007690; Knip, M., Akerblom, H.K., Becker, D., Hydrolyzed infant formula and early β-cell autoimmunity: A randomized clinical trial (2014) JAMA, 311, pp. 2279-2287; Aune, D., Norat, T., Romundstad, P., Vatten, L.J., Dairy products and the risk of type 2 diabetes: A systematic review and doseresponse meta-analysis of cohort studies (2013) Am J Clin Nutr, 98, pp. 1066-1083; Chen, M., Sun, Q., Giovannucci, E., Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis (2014) BMC Med, 12, p. 215; Gijsbers, L., Ding, E.L., Malik, V.S., De Goede, J., Geleijnse, J.M., Soedamah-Muthu, S.S., Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies (2016) Am J Clin Nutr, 103, pp. 1111-1124; Bergholdt, H.K., Nordestgaard, B.G., Ellervik, C., Milk intake is not associated with low risk of diabetes or overweightobesity: A Mendelian randomization study in 97, 811 Danish individuals (2015) Am J Clin Nutr, 102, pp. 487-496; Pan, A., Malik, V.S., Schulze, M.B., Manson, J.E., Willett, W.C., Hu, F.B., Plain-water intake and risk of type 2 diabetes in young and middle-aged women (2012) Am J Clin Nutr, 95, pp. 1454-1460; Ganmaa, D., Li, X.M., Wang, J., Qin, L.Q., Wang, P.Y., Sato, A., Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices (2002) Int J Cancer, 98, pp. 262-267; Qin, L.Q., He, K., Xu, J.Y., Milk consumption and circulating insulin-like growth factor-I level: A systematic literature review (2009) Int J Food Sci Nutr, 60, pp. 330-340; Shi, R., Yu, H., McLarty, J., Glass, J., IGF-I and breast cancer: A meta-analysis (2004) Int J Cancer, 111, pp. 418-423; Aune, D., Navarro Rosenblatt, D.A., Chan, D.S., Dairy products, calcium, and prostate cancer risk: A systematic review and meta-analysis of cohort studies (2015) Am J Clin Nutr, 101, pp. 87-117; Ganmaa, D., Cui, X., Feskanich, D., Hankinson, S.E., Willett, W.C., Milk, dairy intake and risk of endometrial cancer: A 26-year follow-up (2012) Int J Cancer, 130, pp. 2664-2671; Genkinger, J.M., Hunter, D.J., Spiegelman, D., Dairy products and ovarian cancer: A pooled analysis of 12 cohort studies (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 364-372; Aune, D., Lau, R., Chan, D.S., Dairy products and colorectal cancer risk: A systematic review and meta-analysis of cohort studies (2012) Ann Oncol, 23, pp. 37-45; Cho, E., Smith-Warner, S.A., Spiegelman, D., Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies (2004) J Natl Cancer Inst, 96, pp. 1015-1022; Mahabir, S., Aagaard, K., Anderson, L.M., Challenges and opportunities in research on early-life events/exposures and cancer development later in life (2012) Cancer Causes Control, 23, pp. 983-990; Linos, E., Willett, W.C., Cho, E., Frazier, L., Adolescent diet in relation to breast cancer risk among premenopausal women (2010) Cancer Epidemiol Biomarkers Prev, 19, pp. 689-696; Sackesen, C., Assa'Ad, A., Baena-Cagnani, C., Cow's milk allergy as a global challenge (2011) Curr Opin Allergy Clin Immunol, 11, pp. 243-248; Murray, M.G., Kanuga, J., Yee, E., Bahna, S.L., Milk-induced wheezing in children with asthma (2013) Allergol Immunopathol (Madr), 41, pp. 310-314; Von Berg, A., Filipiak-Pittroff, B., Kramer, U., Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study (2013) J Allergy Clin Immunol, 131, pp. 1565-1573; Iacono, G., Cavataio, F., Montalto, G., Intolerance of cow's milk and chronic constipation in children (1998) N Engl J Med, 339, pp. 1100-1104; Pelikan, Z., Asthmatic response to milk ingestion challenge in adults: A comparison of the open and double-blind challenges (2013) Int Arch Allergy Immunol, 161, pp. 163-173; Olivier, C.E., Lorena, S.L., Pavan, C.R., Is it just lactose intolerance? (2012) Allergy Asthma Proc, 33, pp. 432-436; Ding, M., Li, J., Qi, L., Associations of dairy intake with risk of mortality in women and men: Three prospective cohort studies (2019) BMJ, 367, p. l6204; Song, M., Fung, T.T., Hu, F.B., Association of animal and plant protein intake with all-cause and cause-specific mortality (2016) JAMA Intern Med, 176, pp. 1453-1463; Report on animal welfare aspects of the use of bovine somatotrophin (1999), https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scah_out21_en.pdf, Scientific Committee on Animal Health and Animal Welfare. March 10; (1999) Canada Rejects Bovine Growth Hormone, , http://www.ipsnews.net/1999/01/environment-canada-rejects-bovine-growth-hormone/, January 19; Benbrook, C.M., Butler, G., Latif, M.A., Leifert, C., Davis, D.R., Organic production enhances milk nutritional quality by shifting fatty acid composition: A United Stateswide, 18-month study (2013) PLoS One, 8 (12), p. e82429; Smith-Spangler, C., Brandeau, M.L., Hunter, G.E., Are organic foods safer or healthier than conventional alternatives? A systematic review (2012) Ann Intern Med, 157, pp. 348-366; Willett, W., Rockstrom, J., Loken, B., Food in the Anthropocene: The EATLancet Commission on healthy diets from sustainable food systems (2019) Lancet, 393, pp. 447-492; The dairy sector, agriculture, trade and the environment (2004), Organisation for Economic Co-Operation and Development. Paris: OECD Publishing; Pimental, D., Pimental, M.H., Livestock production and energy use (2011) Food, Energy, and Society. 3rd Ed, pp. 67-76. , In: Pimental D, Pimental MH, eds. Boca Raton, FL: CRC Press; Garnett, T., Where are the best opportunities for reducing greenhouse gas emissions in the food system (including the food chain)? (2011) Food Policy, 36, pp. S23-S32; Springmann, M., Clark, M., Mason-D'Croz, D., Options for keeping the food system within environmental limits (2018) Nature, 562, pp. 519-525; Gonzales, A.D., Frostell, B., Carlsson-Kanyama, A., Protein efficiency per unit energy and per unit greenhouse gas emissions: Potential contribution of diet choices to climate change mitigation (2011) Food Policy, 36, pp. 562-570; Gerosa, S., Skoet, J., (2012) Milk Availability: Trend in Production and Demand and Future Outlook, , Rome: Food and Agriculture Organization of the United Nations; Goodland, R., A fresh look at livestock greenhouse gas emissions and mitigation potential in Europe (2014) Glob Chang Biol, 20, pp. 2042-2044; (2016) Vitamin D and Health, , https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf, Scientific Advisory Committee on Nutrition. July; Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets (2003) Can J Diet Pract Res, 64, pp. 62-81. , American Dietetic Association, Dietitians of Canada},
publisher={Massachussetts Medical Society},
issn={00284793},
coden={NEJMA},
pubmed_id={32053300},
language={English},
abbrev_source_title={New Engl. J. Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Patel20141096,
author={Patel, C.J. and Ioannidis, J.P.A.},
title={Placing epidemiological results in the context of multiplicity and typical correlations of exposures},
journal={Journal of Epidemiology and Community Health},
year={2014},
volume={68},
number={11},
pages={1096-1100},
doi={10.1136/jech-2014-204195},
note={cited By 71},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911368398&doi=10.1136%2fjech-2014-204195&partnerID=40&md5=089b678a2c6e2b7f613e8b3e15d63511},
affiliation={Center for Biomedical Informatics, Harvard Medical School, Boston, MA, United States; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford, CA, United States},
abstract={Epidemiological studies evaluate multiple exposures, but the extent of multiplicity often remains non-transparent when results are reported. There is extensive debate in the literature on whether multiplicity should be adjusted for in the design, analysis, and reporting of most epidemiological studies, and, if so, how this should be done. The challenges become more acute in an era where the number of exposures that can be studied (the exposome) can be very large. Here, we argue that it can be very insightful to visualize and describe the extent of multiplicity by reporting the number of effective exposures for each category of exposures being assessed, and to describe the distribution of correlation between exposures and/or between exposures and outcomes in epidemiological datasets. The results of new proposed associations can be placed in the context of this background information. An association can be assigned to a percentile of magnitude of effect based on the distribution of effects seen in the field. We offer an example of how such information can be routinely presented in an epidemiological study/dataset using data on 530 exposure and demographic variables classified in 32 categories in the National Health and Nutrition Examination Survey (NHANES). Effects that survive multiplicity considerations and that are large may be prioritized for further scrutiny.},
keywords={correlation;  data set;  demographic survey;  epidemiology;  health survey, environmental exposure;  epidemiology;  human;  nutrition;  outcome assessment;  procedures;  statistical analysis;  statistics and numerical data, Data Interpretation, Statistical;  Environmental Exposure;  Epidemiologic Research Design;  Epidemiologic Studies;  Humans;  Nutrition Surveys;  Outcome Assessment (Health Care)},
funding_details={K99 ES023504},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, T32HL007034},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99ES023504},
references={Wang, Z., Klipfell, E., Bennett, B.J., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease (2011) Nature, 472, pp. 57-63; Rappaport, S.M., Barupal, D.K., Wishart, D., The blood exposome and its role in discovering causes of disease. (2014) Environ Health Perspect, , http://dx.doi.org/10.1289/ehp.1308015; Idaghdour, Y., Czika, W., Shianna, K.V., Geographical genomics of human leukocyte gene expression variation in southern Morocco (2010) Nat Genet, 42, pp. 62-67; Athersuch, T.J., The role of metabolomics in characterizing the human exposome (2012) Bioanalysis, 4, pp. 2207-2212; Wang, T.J., Larson, M.G., Vasan, R.S., Metabolite profiles and the risk of developing diabetes (2011) Nat Med, 17, pp. 448-453; Spira, A., Beane, J., Shah, V., Effects of cigarette smoke on the human airway epithelial cell transcriptome (2004) Proc Natl Acad Sci USA, 101, pp. 10143-10148; Willett, W.C., Sampson, L., Stampfer, M.J., Reproducibility and validity of a semiquantitative food frequency questionnaire (1985) Am J Epidemiol, 122, pp. 51-65; Sun, M., Fernstrom, J.D., Jia, W., A wearable electronic system for objective dietary assessment (2010) J Am Diet Assoc, 110, pp. 45-47; Kerr, J., Duncan, S., Schipperijn, J., Using global positioning systems in health research: a practical approach to data collection and processing (2011) Am J Prev Med, 41, pp. 532-540; Madan, A., Cebrian, M.E., Lazer, D., Social Sensing to Model Epidemiological Behavior Change. (2010) Proceedings of ACM Ubicomp; Rappaport, S.M., Smith, M.T., Environment and disease risks (2010) Science, 330, pp. 460-461; Patel, C.J., Bhattacharya, J., Butte, A.J., An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus (2010) PLoS ONE, 5; Patel, C.J., Cullen, M.R., Ioannidis, J.P., Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels (2012) Int J Epidemiol, 41, pp. 828-843; Patel, C.J., Ioannidis, J.P.A., Studying the elusive environment in large-scale. (2014) J Am Med Assoc, , In press; Patel, C.J., Rehkopf, D.H., Leppert, J.T., Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey (2013) Int J Epidemiol, 42, pp. 1795-1810; Patel, C.J., Yang, T., Hu, Z., Investigation of maternal environmental exposures in association with self-reported preterm birth. (2013) Reprod Toxicol, 45 (C), pp. 1-7; Tzoulaki, I., Patel, C.J., Okamura, T., A nutrient-wide association study on blood pressure (2012) Circulation, 126, pp. 2456-2464; Hall, M.A., Dudek, S.M., Goodloe, R., Environment-wide association study (EWAS) for type 2 diabetes in the Marshfield Personalized Medicine Research Project Biobank. (2014) Pac Symp Biocomput, pp. 200-211; Lind, P.M., Riserus, U., Salihovic, S., An environmental wide association study (EWAS) approach to the metabolic syndrome (2013) Environ Int, 55, pp. 1-8; Rappaport, S.M., Biomarkers intersect with the exposome (2012) Biomarkers, 17, pp. 483-489; Rhee, E.P., Cheng, S., Larson, M.G., Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans (2011) J Clin Invest, 121, pp. 1402-1411; Townsend, M.K., Clish, C.B., Kraft, P., Reproducibility of metabolomic profiles among men and women in 2 large cohort studies (2013) Clin Chem, 59, pp. 1657-1667; Ioannidis, J.P.A., Why most published research findings are false (2005) PLoS Med, 2; Rothman, K.J., No adjustments are needed for multiple comparisons (1990) Epidemiology, 1, pp. 43-46; Dal-Re, R., Ioannidis, J.P., Bracken, M.B., Making prospective registration of observational research a reality (2014) Sci Transl Med, 6. , 224cm1; Sterne, J.A., Davey Smith, G., Sifting the evidence-what's wrong with significance tests? (2001) BMJ, 322, pp. 226-231; Pearson, T.A., Manolio, T.A., How to interpret a genome-wide association study (2008) J Am Med Assoc, 299, pp. 1335-1344; Ioannidis, J., Loy, E.Y., Poulton, R., Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification (2009) Sci Transl Med, 1, p. 8; Smith, G.D., Lawlor, D.A., Harbord, R., Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology (2007) PLoS Med, 4; National health and nutrition examination survey data, 2003- 2004. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; Nyholt, D.R., A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other (2004) Am J Hum Genet, 74, pp. 765-769; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing (1995) J R Stat Soc B, 57, pp. 289-300; Storey, J.D., Tibshirani, R., Statistical significance for genomewide studies (2003) Proc Natl Acad Sci USA, 100, pp. 9440-9445; (2014) Diabetes Care, 37, pp. S81-90; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Greenland, S., Pearl, J., Robins, J.M., Causal diagrams for epidemiologic research (1999) Epidemiology, 10, pp. 37-48; Hernan, M.A., Hernandez-Diaz, S., Werler, M.M., Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology (2002) Am J Epidemiol, 155, pp. 176-184; Guyatt, G.H., Oxman, A.D., Vist, G.E., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336, pp. 924-926; Ioannidis, J.P.A., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Siontis, G.C., Ioannidis, J.P., Risk factors and interventions with statistically significant tiny effects (2011) Int J Epidemiol, 40, pp. 1292-1307},
correspondence_address1={Ioannidis, J.P.A.1265 Welch Rd, MSOB X306, United States},
publisher={BMJ Publishing Group},
issn={0143005X},
coden={JECHD},
pubmed_id={24923805},
language={English},
abbrev_source_title={J. Epidemiol. Community Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{McRae201710,
author={McRae, M.P.},
title={Health Benefits of Dietary Whole Grains: An Umbrella Review of Meta-analyses},
journal={Journal of Chiropractic Medicine},
year={2017},
volume={16},
number={1},
pages={10-18},
doi={10.1016/j.jcm.2016.08.008},
note={cited By 70},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006854956&doi=10.1016%2fj.jcm.2016.08.008&partnerID=40&md5=77d1f328f94a7eb02d28f55533b75dd0},
affiliation={Department of Basic Sciences, National University of Health Sciences, LombardIL, United States},
abstract={Objective The purpose of this study is to review the effectiveness of the role of whole grain as a therapeutic agent in type 2 diabetes, cardiovascular disease, cancer, and obesity. Methods An umbrella review of all published meta-analyses was performed. A PubMed search from January 1, 1980, to May 31, 2016, was conducted using the following search strategy: (whole grain OR whole grains) AND (meta-analysis OR systematic review). Only English language publications that provided quantitative statistical analysis on type 2 diabetes, cardiovascular disease, cancer, and weight loss were retrieved. Results Twenty-one meta-analyses were retrieved for inclusion in this umbrella review, and all the meta-analyses reported statistically significant positive benefits for reducing the incidence of type 2 diabetes (relative risk [RR] = 0.68-0.80), cardiovascular disease (RR = 0.63-0.79), and colorectal, pancreatic, and gastric cancers (RR = 0.57-0.94) and a modest effect on body weight, waist circumference, and body fat mass. Significant reductions in cardiovascular and cancer mortality were also observed (RR = 0.82 and 0.89, respectively). Some problems of heterogeneity, publication bias, and quality assessment were found among the studies. Conclusion This review suggests that there is some evidence for dietary whole grain intake to be beneficial in the prevention of type 2 diabetes, cardiovascular disease, and colorectal, pancreatic, and gastric cancers. The potential benefits of these findings suggest that the consumption of 2 to 3 servings per day (~45 g) of whole grains may be a justifiable public health goal. © 2016},
author_keywords={Whole Grains, Meta-analysis, Diabetes Mellitus, Cardiovascular Diseases, Neoplasms, Obesity},
references={Seal, C.J., Brownlee, I.A., Whole-grain foods and chronic disease: evidence from epidemiological and intervention studies (2015) Proc Nutr Soc, 74 (3), pp. 313-319; Steffen, L.M., Jacobs, D.R., Stevens, J., Shahar, E., Carithers, T., Folsom, A.R., Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study (2003) Am J Clin Nutr, 78 (3), pp. 383-390; Huang, T., Xu, M., Lee, A., Cho, S., Qi, L., Consumption of whole grains and cereal fiber and total and cause-specific mortality: prospective analysis of 367,442 individuals (2015) BMC Med, 13, p. 59; Aune, D., Norat, T., Romundstad, P., Vatten, L.J., Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies (2013) Eur J Epidemiol, 28 (11), pp. 845-858; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Based Healthc, 13 (3), pp. 132-140; Nettleton, J.A., McKeown, N.M., Kanoni, S., Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies (2010) Diabetes Care, 33 (12), pp. 2684-2691; de Munter, J.S., Hu, F.B., Spiegelman, D., Franz, M., van Dam, R.M., Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review (2007) PLoS Med, 4 (8), p. e261; Chanson-Rolle, A., Meynier, A., Aubin, F., Systematic review and meta-analysis of human studies to support a quantitative recommendation for whole grain intake in relation to type 2 diabetes (2015) PLoS One, 10 (6), p. e0131377; Ye, E.Q., Chacko, S.A., Chou, E.L., Kugizaki, M., Liu, S., Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain (2012) J Nutr, 142 (7), pp. 1304-1313; Kelly, S.A., Summerbell, C.D., Brynes, A., Whittaker, V., Frost, G., Wholegrain cereals for coronary heart disease (2007) Cochrane Database Syst Rev, 2, p. CD005051; Hollænder, P.L., Ross, A.B., Kristensen, M., Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies (2015) Am J Clin Nutr, 102 (3), pp. 556-572; Anderson, J.W., Hanna, T.J., Peng, X., Kryscio, R.J., Whole grain foods and heart disease risk (2000) J Am Coll Nutr, 19, pp. 291S-299S; Mellen, P.B., Walsh, T.F., Herrington, D.M., Whole grain intake and cardiovascular disease: a meta-analysis (2008) Nutr Metab Cardiovasc Dis, 18 (4), pp. 283-290; Tang, G., Wang, D., Long, J., Yang, F., Si, L., Meta-analysis of the association between whole grain intake and coronary heart disease risk (2015) Am J Cardiol, 115 (5), pp. 625-629; Fang, L., Li, W., Zhang, W., Wang, Y., Fu, S., Association between whole grain intake and stroke risk: evidence from a meta-analysis (2015) Int J Clin Exp Med, 8 (9), pp. 16978-16983; Chen, J., Huang, Q., Shi, W., Yang, L., Chen, J., Lan, Q., (2016), Meta-analysis of the association between whole and refined grain consumption and stroke risk based on prospective cohort studies [epub ahead of print]. Asia Pac J Public Health. pii: 539516650722. Accessed May 1, 2016; Wei, H., Gao, Z., Liang, R., Li, Z., Hao, H., Liu, X., Whole-grain consumption and the risk of all-cause, CVD and cancer mortality: a meta-analysis of prospective cohort studies (2016) Br J Nutr, 116 (3), pp. 514-525; Chen, G.C., Tong, X., Xu, J.Y., Whole-grain intake and total, cardiovascular, and cancer mortality: a systematic review and meta-analysis of prospective studies (2016) Am J Clin Nutr, 104 (1), pp. 164-172; Jacobs, D.R., Jr., Marquart, L., Slavin, J., Kushi, L.H., Whole-grain intake and cancer: an expanded review and meta-analysis (1998) Nutr Cancer, 30 (2), pp. 85-96; Haas, P., Machado, M.J., Anton, A.A., Silva, A.S., de Francisco, A., Effectiveness of whole grain consumption in the prevention of colorectal cancer: meta-analysis of cohort studies (2009) Int J Food Sci Nutr, 60, pp. 1-13; Aune, D., Chan, D.S., Lau, R., Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies (2011) BMJ, 343, p. d6617; Lei, Q., Zheng, H., Bi, J., Whole grain intake reduces pancreatic cancer risk: a meta-analysis of observational studies (2016) Medicine, 95 (9), p. e2747; Wang, R.J., Tang, J.E., Chen, Y., Gao, J.G., Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer (2015) Onco Targets Ther, 8, pp. 2415-2426; Harland, J.I., Garton, L.E., Whole-grain intake as a marker of healthy body weight and adiposity (2008) Public Health Nutr, 11 (6), pp. 554-563; Pol, K., Christensen, R., Bartels, E.M., Raben, A., Tetens, I., Kristensen, M., Whole grain and body weight changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies (2013) Am J Clin Nutr, 98 (4), pp. 872-884; Zhu, J., Ma, S., Xiao, P., Li, L., Yang, Y., Meta-analysis on the relationship among fiber of grain and intestinal motility and symptoms (2015) Wei Sheng Yan Jiu, 44 (1), pp. 1-7; Ferruzzi, M.G., Jonnalagadda, S.S., Liu, S., Developing a standard definition of whole-grain foods for dietary recommendations: summary report of a multidisciplinary expert roundtable discussion (2014) Adv Nutr, 5 (2), pp. 164-176; Kaline, K., Bornstein, S.R., Bergmann, A., Hauner, H., Schwarz, P.E., The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products (2007) Horm Metab Res, 39 (9), pp. 687-693; Dong, J.Y., Xun, P., He, K., Qin, L.Q., Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies (2011) Diabetes Care, 34 (9), pp. 2116-2122; Yin, R.V., Phung, O.J., Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus (2015) Nutr J, 14, p. 14; Brufau, G., Canela, M.A., Rafecas, M., Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties (2008) Nutr Res, 28 (4), pp. 217-225; Bazzano, L.A., Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk (2008) Curr Atheroscler Rep, 10 (6), pp. 473-477; Biesinger, S., Michaels, H.A., Quadros, A.S., A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects (2016) Eur J Clin Nutr, 70 (1), pp. 10-16; Slavin, J., Why whole grains are protective: biological mechanisms (2003) Proc Nutr Soc, 62 (1), pp. 129-134; Delgado, M.E., Haza, A.I., Arranz, N., García, A., Morales, P., Dietary polyphenols protect against N-nitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells (2008) Eur J Nutr, 47 (8), pp. 479-490; Song, P., Wu, L., Guan, W., Dietary nitrates, nitrites, and nitrosamines intake and the risk of gastric cancer: a meta-analysis (2015) Nutrients, 7 (12), pp. 9872-9895; Thielecke, F., Jonnalagadda, S.S., Can whole grain help in weight management? (2014) J Clin Gastroenterol, 48, pp. S70-S77},
correspondence_address1={McRae, M.P.; National University of Health Sciences, 200 E. Roosevelt Rd., United States; email: mmcrae@nuhs.edu},
publisher={Elsevier USA},
issn={15563707},
language={English},
abbrev_source_title={J. Chiropr. Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Pollock201748,
author={Pollock, M. and Fernandes, R.M. and Hartling, L.},
title={Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions},
journal={BMC medical research methodology},
year={2017},
volume={17},
number={1},
pages={48},
doi={10.1186/s12874-017-0325-5},
art_number={48},
note={cited By 68},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024370378&doi=10.1186%2fs12874-017-0325-5&partnerID=40&md5=760da69a348e16989607a82050830631},
affiliation={4-472 Edmonton Clinic Health Academy, 11405 87 Avenue NW, Edmonton, AB  T6G-1C9, Canada; 4-472 Edmonton Clinic Health Academy, 11405 87 Avenue NW, Edmonton, AB  T6G-1C9, Canada; 4-472 Edmonton Clinic Health Academy, 11405 87 Avenue NW, Edmonton, AB  T6G-1C9, Canada; 4-472 Edmonton Clinic Health Academy, 11405 87 Avenue NW, Edmonton, AB  T6G-1C9, Canada},
abstract={METHODS: We selected seven overviews of healthcare interventions and included all SRs meeting each overview's inclusion criteria. For each SR, two reviewers independently conducted AMSTAR assessments with consensus and discussed challenges encountered. We also examined the correlation between AMSTAR assessments and SR results/conclusions.
BACKGROUND: Overviews of reviews (overviews) compile information from multiple systematic reviews (SRs) to provide a single synthesis of relevant evidence for decision-making. It is recommended that authors assess and report the methodological quality of SRs in overviews-for example, using A MeaSurement Tool to Assess systematic Reviews (AMSTAR). Currently, there is variation in whether and how overview authors assess and report SR quality, and limited guidance is available. Our objectives were to: examine methodological considerations involved in using AMSTAR to assess the quality of Cochrane and non-Cochrane SRs in overviews of healthcare interventions; identify challenges (and develop potential decision rules) when using AMSTAR in overviews; and examine the potential impact of considering methodological quality when making inclusion decisions in overviews.
RESULTS: Ninety-five SRs were included (30 Cochrane, 65 non-Cochrane). Mean AMSTAR assessments (9.6/11 vs. 5.5/11; p < 0.001) and inter-rater reliability (AC1 statistic: 0.84 vs. 0.69; "almost perfect" vs. "substantial" using the Landis & Koch criteria) were higher for Cochrane compared to non-Cochrane SRs. Four challenges were identified when applying AMSTAR in overviews: the scope of the SRs and overviews often differed; SRs examining similar topics sometimes made different methodological decisions; reporting of non-Cochrane SRs was sometimes poor; and some non-Cochrane SRs included other SRs as well as primary studies. Decision rules were developed to address each challenge. We found no evidence that AMSTAR assessments were correlated with SR results/conclusions.
CONCLUSIONS: Results indicate that the AMSTAR tool can be used successfully in overviews that include Cochrane and non-Cochrane SRs, though decision rules may be useful to circumvent common challenges. Findings support existing recommendations that quality assessments of SRs in overviews be conducted independently, in duplicate, with a process for consensus. Results also suggest that using methodological quality to guide inclusion decisions (e.g., to exclude poorly conducted and reported SRs) may not introduce bias into the overview process.},
author_keywords={Bias;  Knowledge synthesis;  Methodological quality;  Observer agreement;  Overview of reviews;  Systematic review},
keywords={decision making;  evidence based medicine;  health care quality;  human;  reproducibility;  treatment outcome, Decision Making;  Evidence-Based Medicine;  Humans;  Quality of Health Care;  Reproducibility of Results;  Treatment Outcome},
funding_details={National Science FoundationNational Science Foundation, NSF, 1002028},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR, 119373},
funding_details={Alberta Innovates - Health SolutionsAlberta Innovates - Health Solutions, AIHS},
funding_text 1={This project was funded in part by a Canadian Institutes of Health Research (CIHR) Operating Grant (Grant Number 119373). MP is supported by an Alberta Innovates Health Solutions Graduate Studentship and a Knowledge Translation Canada Graduate Student Fellowship. LH is supported by a CIHR New Investigator Salary Award.},
issn={14712288},
pubmed_id={28335734},
language={English},
abbrev_source_title={BMC Med Res Methodol},
document_type={Article},
source={Scopus},
}

@ARTICLE{Gassen2017356,
author={Gassen, N.C. and Chrousos, G.P. and Binder, E.B. and Zannas, A.S.},
title={Life stress, glucocorticoid signaling, and the aging epigenome: Implications for aging-related diseases},
journal={Neuroscience and Biobehavioral Reviews},
year={2017},
volume={74},
pages={356-365},
doi={10.1016/j.neubiorev.2016.06.003},
note={cited By 68},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85004140679&doi=10.1016%2fj.neubiorev.2016.06.003&partnerID=40&md5=44c99868891841205352f4c7bbfa2b14},
affiliation={Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany; First Department of Pediatrics, University of Athens Medical School, Athens, Greece; Department of Psychiatry and Behavioral Sciences, Emory University Medical School, Atlanta, GA, United States; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States},
abstract={Life stress has been associated with accelerated cellular aging and increased risk for developing aging-related diseases; however, the underlying molecular mechanisms remain elusive. A highly relevant process that may underlie this association is epigenetic regulation. In this review, we build upon existing evidence to propose a model whereby exposure to life stress, in part via its effects on the hypothalamic-pituitary axis and the glucocorticoid signaling system, may alter the epigenetic landscape across the lifespan and, consequently, influence genomic regulation and function in ways that are conducive to the development of aging-related diseases. This model is supported by recent studies showing that life stressors and stress-related phenotypes can accelerate epigenetic aging, a measure that is based on DNA methylation prediction of chronological age and has been associated with several aging-related disease phenotypes. We discuss the implications of this model for the prevention and treatment of aging-related diseases, as well as the challenges and limitations of this line of research. © 2016 Elsevier Ltd},
author_keywords={Aging;  Cancer;  Cardiovascular disease;  Dementia;  DNA methylation;  Epigenetics;  Glucocorticoid signaling;  Stress},
keywords={glucocorticoid;  histone;  glucocorticoid, age;  aging;  aging related disease;  cell aging;  chromatin assembly and disassembly;  disease course;  DNA methylation;  down regulation;  epigenetics;  gene expression regulation;  genetic association;  genetic regulation;  histone modification;  human;  hypothalamus hypophysis system;  life stress;  lifespan;  phenotype;  physical disease;  Review;  signal transduction;  stress;  upregulation;  aging;  genetic epigenesis;  mental stress, Aging;  DNA Methylation;  Epigenesis, Genetic;  Glucocorticoids;  Humans;  Stress, Psychological},
chemicals_cas={histone, 9062-68-4; Glucocorticoids},
references={Ahola, K., Siren, I., Kivimaki, M., Ripatti, S., Aromaa, A., Lonnqvist, J., Hovatta, I., Work-related exhaustion and telomere length: a population-based study (2012) PLoS One, 7, p. e40186; Bamberger, C.M., Schulte, H.M., Chrousos, G.P., Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids (1996) Endocr. Rev., 17, pp. 245-261; Barha, C.K., Brummelte, S., Lieblich, S.E., Galea, L.A., Chronic restraint stress in adolescence differentially influences hypothalamic-pituitary-adrenal axis function and adult hippocampal neurogenesis in male and female rats (2011) Hippocampus, 21, pp. 1216-1227; Bell, J.T., Tsai, P.C., Yang, T.P., Pidsley, R., Nisbet, J., Glass, D., Mangino, M., Deloukas, P., Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population (2012) PLoS Genet., 8, p. e1002629; Benayoun, B.A., Pollina, E.A., Brunet, A., Epigenetic regulation of ageing: linking environmental inputs to genomic stability (2015) Nat. Rev. Mol. Cell Biol., 16, pp. 593-610; Biddie, S.C., Conway-Campbell, B.L., Lightman, S.L., Dynamic regulation of glucocorticoid signalling in health and disease (2012) Rheumatology (Oxford), 51, pp. 403-412; Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Putz, B., Papiol, S., Muller-Myhsok, B., Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment (2004) Nat. Genet., 36, pp. 1319-1325; Binder, E.B., Bradley, R.G., Liu, W., Epstein, M.P., Deveau, T.C., Mercer, K.B., Tang, Y., Ressler, K.J., Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults (2008) JAMA, 299, pp. 1291-1305; Bjornsson, H.T., Sigurdsson, M.I., Fallin, M.D., Irizarry, R.A., Aspelund, T., Cui, H., Yu, W., Feinberg, A.P., Intra-individual change over time in DNA methylation with familial clustering (2008) JAMA, 299, pp. 2877-2883; Blair, L.J., Nordhues, B.A., Hill, S.E., Scaglione, K.M., O'Leary, J.C., 3rd, Fontaine, S.N., Breydo, L., Dickey, C.A., Accelerated neurodegeneration through chaperone-mediated oligomerization of tau (2013) J. Clin. Invest., 123, pp. 4158-4169; Bocklandt, S., Lin, W., Sehl, M.E., Sanchez, F.J., Sinsheimer, J.S., Horvath, S., Vilain, E., Epigenetic predictor of age (2011) PLoS One, 6, p. e14821; Boks, M.P., Mierlo, H.C., Rutten, B.P., Radstake, T.R., De Witte, L., Geuze, E., Horvath, S., Vermetten, E., Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder (2015) Psychoneuroendocrinology, 51, pp. 506-512; Bose, R., Moors, M., Tofighi, R., Cascante, A., Hermanson, O., Ceccatelli, S., Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations (2010) Cell. Death. Dis., 1, p. e92; Bose, R., Spulber, S., Kilian, P., Heldring, N., Lonnerberg, P., Johnsson, A., Conti, M., Ceccatelli, S., Tet3 mediates stable glucocorticoid-induced alterations in DNA methylation and Dnmt3a/Dkk1 expression in neural progenitors (2015) Cell. Death. Dis., 6, p. e1793; Bourke, C.H., Neigh, G.N., Behavioral effects of chronic adolescent stress are sustained and sexually dimorphic (2011) Horm. Behav., 60, pp. 112-120; Breitling, L.P., Saum, K.U., Perna, L., Schottker, B., Holleczek, B., Brenner, H., Frailty is associated with the epigenetic clock but not with telomere length in a German cohort (2016) Clin. Epigenet., 8, p. 21; Brody, G.H., Miller, G.E., Yu, T., Beach, S.R., Chen, E., Supportive family environments ameliorate the link between racial discrimination and epigenetic aging: a replication across two longitudinal cohorts (2016) Psychol. Sci., 27, pp. 530-541; Brody, G.H., Yu, T., Chen, E., Beach, S.R., Miller, G.E., Family-centered prevention ameliorates the longitudinal association between risky family processes and epigenetic aging (2016) J. Child Psychol. Psychiatry, 57, pp. 566-574; Brunet, A., Berger, S.L., Epigenetics of aging and aging-related disease (2014) J. Gerontol. A Biol. Sci. Med. Sci., 69, pp. S17-S20; Capra, J.A., Extrapolating histone marks across developmental stages, tissues, and species: an enhancer prediction case study (2015) BMC Genomics, 16, p. 104; Castillo-Diaz, S.A., Garay-Sevilla, M.E., Hernandez-Gonzalez, M.A., Solis-Martinez, M.O., Zaina, S., Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries (2010) Int. J. Mol. Med., 26, pp. 691-700; Chandola, T., Brunner, E., Marmot, M., Chronic stress at work and the metabolic syndrome: prospective study (2006) BMJ, 332, pp. 521-525; Christensen, B.C., Houseman, E.A., Marsit, C.J., Zheng, S., Wrensch, M.R., Wiemels, J.L., Nelson, H.H., Kelsey, K.T., Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context (2009) PLoS Genet., 5, p. e1000602; Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis (1992) JAMA, 267, pp. 1244-1252; de Kloet, C.S., Vermetten, E., Geuze, E., Kavelaars, A., Heijnen, C.J., Westenberg, H.G., Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review (2006) J. Psychiatr. Res., 40, pp. 550-567; Denham, J., O'Brien, B.J., Marques, F.Z., Charchar, F.J., Changes in the leukocyte methylome and its effect on cardiovascular-related genes after exercise (2015) J. Appl. Physiol., 118, pp. 475-488; Denny, W.B., Valentine, D.L., Reynolds, P.D., Smith, D.F., Scammell, J.G., Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding (2000) Endocrinology, 141, pp. 4107-4113; Di Stefano, V., Wang, B., Parobchak, N., Roche, N., Rosen, T., RelB/p52-associated CBP/HDAC1 mediate acetylation/de-acetylation of H3K9 to upregulate CRH in term human placenta (2015) Sci. Signal., 8 (391), p. ra85; Elliott, H.R., Tillin, T., McArdle, W.L., Ho, K., Duggirala, A., Frayling, T.M., Davey Smith, G., Relton, C.L., Differences in smoking associated DNA methylation patterns in South Asians and Europeans (2014) Clin. Epigenet., 6, p. 4; Entringer, S., Epel, E.S., Kumsta, R., Lin, J., Hellhammer, D.H., Blackburn, E.H., Wust, S., Wadhwa, P.D., Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. E513-E518; Entringer, S., Epel, E.S., Lin, J., Buss, C., Shahbaba, B., Blackburn, E.H., Simhan, H.N., Wadhwa, P.D., Maternal psychosocial stress during pregnancy is associated with newborn leukocyte telomere length (2013) Am. J. Obstet. Gynecol., 208 (134), pp. e131-e137; Epel, E.S., Blackburn, E.H., Lin, J., Dhabhar, F.S., Adler, N.E., Morrow, J.D., Cawthon, R.M., Accelerated telomere shortening in response to life stress (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17312-17315; Eriksson, M., Raikkonen, K., Eriksson, J.G., Early life stress and later health outcomes–findings from the Helsinki Birth Cohort Study (2014) Am. J. Hum. Biol., 26, pp. 111-116; Eskelinen, M., Ollonen, P., Life stress and losses and deficit in adulthood as breast cancer risk factor: a prospective case-control study in Kuopio, Finland (2010) In Vivo, 24, pp. 899-904; Everson-Rose, S.A., Roetker, N.S., Lutsey, P.L., Kershaw, K.N., Longstreth, W.T., Jr., Sacco, R.L., Diez Roux, A.V., Alonso, A., Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis (2014) Stroke, 45, pp. 2318-2323; Farre, P., Jones, M.J., Meaney, M.J., Emberly, E., Turecki, G., Kobor, M.S., Concordant and discordant DNA methylation signatures of aging in human blood and brain (2015) Epigenet. Chromatin, 8, p. 19; Florath, I., Butterbach, K., Muller, H., Bewerunge-Hudler, M., Brenner, H., Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites (2014) Hum. Mol. Genet., 23, pp. 1186-1201; Fraga, M.F., Ballestar, E., Paz, M.F., Ropero, S., Setien, F., Ballestar, M.L., Heine-Suner, D., Esteller, M., Epigenetic differences arise during the lifetime of monozygotic twins (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 10604-10609; Fraga, M.F., Genetic and epigenetic regulation of aging (2009) Curr. Opin. Immunol., 21, pp. 446-453; Gassen, N.C., Fries, G.R., Zannas, A.S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Rein, T., Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine (2015) Sci. Signal., 8, p. ra119; Gronniger, E., Weber, B., Heil, O., Peters, N., Stab, F., Wenck, H., Korn, B., Lyko, F., Aging and chronic sun exposure cause distinct epigenetic changes in human skin (2010) PLoS Genet., 6, p. e1000971; Hamer, M., Kivimaki, M., Stamatakis, E., Batty, G.D., Psychological distress as a risk factor for death from cerebrovascular disease (2012) CMAJ, 184, pp. 1461-1466; Hannon, E., Lunnon, K., Schalkwyk, L., Mill, J., Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes (2015) Epigenetics, 10, pp. 1024-1032; Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Zhang, K., Genome-wide methylation profiles reveal quantitative views of human aging rates (2013) Mol. Cell, 49, pp. 359-367; Hanzelmann, S., Beier, F., Gusmao, E.G., Koch, C.M., Hummel, S., Charapitsa, I., Joussen, S., Wagner, W., Replicative senescence is associated with nuclear reorganization and with DNA methylation at specific transcription factor binding sites (2015) Clin. Epigenet., 7, p. 19; Heim, C., Mletzko, T., Purselle, D., Musselman, D.L., Nemeroff, C.B., The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma (2008) Biol. Psychiatry, 63, pp. 398-405; Heim, C., Newport, D.J., Mletzko, T., Miller, A.H., Nemeroff, C.B., The link between childhood trauma and depression: insights from HPA axis studies in humans (2008) Psychoneuroendocrinology, 33, pp. 693-710; Herbstman, J.B., Wang, S., Perera, F.P., Lederman, S.A., Vishnevetsky, J., Rundle, A.G., Hoepner, L.A., Tang, D., Predictors and consequences of global DNA methylation in cord blood and at three years (2013) PLoS One, 8, p. e72824; Hernandez, D.G., Nalls, M.A., Gibbs, J.R., Arepalli, S., van der Brug, M., Chong, S., Moore, M., Singleton, A.B., Distinct DNA methylation changes highly correlated with chronological age in the human brain (2011) Hum. Mol. Genet., 20, pp. 1164-1172; Heyn, H., Li, N., Ferreira, H.J., Moran, S., Pisano, D.G., Gomez, A., Diez, J., Esteller, M., Distinct DNA methylomes of newborns and centenarians (2012) Proc. Natl. Acad. Sci. U. S. A., 109, pp. 10522-10527; Hirabayashi, Y., Gotoh, Y., Epigenetic control of neural precursor cell fate during development (2010) Nat. Rev. Neurosci., 11, pp. 377-388; Horvath, S., DNA methylation age of human tissues and cell types (2013) Genome Biol., 14, p. R115; Horvath, S., Ritz, B.R., Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients (2015) Aging (Milano), 7 (12), pp. 1130-1142; Horvath, S., Zhang, Y., Langfelder, P., Kahn, R.S., Boks, M.P., van Eijk, K., van den Berg, L.H., Ophoff, R.A., Aging effects on DNA methylation modules in human brain and blood tissue (2012) Genome Biol., 13, p. R97; Horvath, S., Erhart, W., Brosch, M., Ammerpohl, O., von Schonfels, W., Ahrens, M., Heits, N., Hampe, J., Obesity accelerates epigenetic aging of human liver (2014) Proc. Natl. Acad. Sci. U. S. A., 111, pp. 15538-15543; Horvath, S., Garagnani, P., Bacalini, M.G., Pirazzini, C., Salvioli, S., Gentilini, D., Di Blasio, A.M., Franceschi, C., Accelerated epigenetic aging in Down syndrome (2015) Aging Cell, 14, pp. 491-495; Issa, J.P., Aging and epigenetic drift: a vicious cycle (2014) J. Clin. Invest., 124, pp. 24-29; Issler, O., Haramati, S., Paul, E.D., Maeno, H., Navon, I., Zwang, R., Gil, S., Chen, A., MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity (2014) Neuron, 83, pp. 344-360; Jankord, R., Solomon, M.B., Albertz, J., Flak, J.N., Zhang, R., Herman, J.P., Stress vulnerability during adolescent development in rats (2011) Endocrinology, 152, pp. 629-638; Jodczyk, S., Fergusson, D.M., Horwood, L.J., Pearson, J.F., Kennedy, M.A., No association between mean telomere length and life stress observed in a 30 year birth cohort (2014) PLoS One, 9, p. e97102; Jones, P.A., Baylin, S.B., The epigenomics of cancer (2007) Cell, 128, pp. 683-692; Jones, M.J., Goodman, S.J., Kobor, M.S., DNA methylation and healthy human aging (2015) Aging Cell, 14 (16), pp. 924-932; Kaltsas, G., Zannas, A.S., Chrousos, G.P., Hypothalamic-pituitary-adrenal axis and cardiovascular disease (2012) Stress and Cardiovascular Disease, , P. Hjemdahl A. Rosengren A. Steptoe Springer London, UK; Kananen, L., Surakka, I., Pirkola, S., Suvisaari, J., Lonnqvist, J., Peltonen, L., Ripatti, S., Hovatta, I., Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls (2010) PLoS One, 5, p. e10826; Karatsoreos, I.N., McEwen, B.S., Psychobiological allostasis: resistance, resilience and vulnerability (2011) Trends Cogn. Sci., 15, pp. 576-584; Klengel, T., Binder, E.B., FKBP5 allele-specific epigenetic modification in gene by environment interaction (2015) Neuropsychopharmacology, 40, pp. 244-246; Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J.C., Pariante, C.M., Pace, T.W., Binder, E.B., Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions (2013) Nat. Neurosci., 16, pp. 33-41; Koch, C.M., Wagner, W., Epigenetic-aging-signature to determine age in different tissues (2011) Aging (Milano), 3, pp. 1018-1027; Kroenke, C.H., Hankinson, S.E., Schernhammer, E.S., Colditz, G.A., Kawachi, I., Holmes, M.D., Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence (2004) Am. J. Epidemiol., 159, pp. 1019-1027; Langevin, S.M., Pinney, S.M., Leung, Y.K., Ho, S.M., Does epigenetic drift contribute to age-related increases in breast cancer risk? (2014) Epigenomics, 6, pp. 367-369; Lee, R.S., Tamashiro, K.L., Yang, X., Purcell, R.H., Harvey, A., Willour, V.L., Huo, Y., Potash, J.B., Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice (2010) Endocrinology, 151, pp. 4332-4343; Lee, R.S., Tamashiro, K.L., Yang, X., Purcell, R.H., Huo, Y., Rongione, M., Potash, J.B., Wand, G.S., A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice (2011) Psychopharmacology (Berl), 218, pp. 303-312; Lessard, J., Holman, E.A., FKBP5 and CRHR1 polymorphisms moderate the stress-physical health association in a national sample (2014) Health Psychol., 33, pp. 1046-1056; Levine, A., Worrell, T.R., Zimnisky, R., Schmauss, C., Early life stress triggers sustained changes in histone deacetylase expression and histone H4 modifications that alter responsiveness to adolescent antidepressant treatment (2012) Neurobiol. Dis., 45, pp. 488-498; Levine, M.E., Hosgood, H.D., Chen, B., Absher, D., Assimes, T., Horvath, S., DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative (2015) Aging (Milano), 7, pp. 690-700; Levine, M.E., Lu, A.T., Bennett, D.A., Horvath, S., Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning (2015) Aging (Milano), 7 (12), pp. 1198-1211; Li, Y., Liu, Y., Strickland, F.M., Richardson, B., Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes (2010) Exp. Gerontol., 45, pp. 312-322; Li, S., Papale, L.A., Zhang, Q., Madrid, A., Chen, L., Chopra, P., Keles, S., Alisch, R.S., Genome-wide alterations in hippocampal 5-hydroxymethylcytosine links plasticity genes to acute stress (2015) Neurobiol. Dis., 86, pp. 99-108; Litzelman, K., Witt, W.P., Gangnon, R.E., Nieto, F.J., Engelman, C.D., Mailick, M.R., Skinner, H.G., Association between informal caregiving and cellular aging in the survey of the health of wisconsin: the role of caregiving characteristics, stress, and strain (2014) Am. J. Epidemiol., 179, pp. 1340-1352; Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The hallmarks of aging (2013) Cell, 153, pp. 1194-1217; Maglioni, S., Schiavi, A., Runci, A., Shaik, A., Ventura, N., Mitochondrial stress extends lifespan in C elegans through neuronal hormesis (2014) Exp. Gerontol., 56, pp. 89-98; Marioni, R.E., Shah, S., McRae, A.F., Chen, B.H., Colicino, E., Harris, S.E., Gibson, J., Deary, I.J., DNA methylation age of blood predicts all-cause mortality in later life (2015) Genome Biol., 16, p. 25; Marioni, R.E., Shah, S., McRae, A.F., Ritchie, S.J., Muniz-Terrera, G., Harris, S.E., Gibson, J., Deary, I.J., The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936 (2015) Int. J. Epidemiol., 44 (4), pp. 1388-1396; Marioni, R.E., Harris, S.E., Shah, S., McRae, A.F., von Zglinicki, T., Martin-Ruiz, C., Wray, N.R., Deary, I.J., The epigenetic clock and telomere length are independently associated with chronological age and mortality (2016) Int. J. Epidemiol., , pii: dyw041; McCabe, L., Marash, D., Li, A., Matthews, S.G., Repeated antenatal glucocorticoid treatment decreases hypothalamic corticotropin releasing hormone mRNA but not corticosteroid receptor mRNA expression in the fetal guinea-pig brain (2001) J. Neuroendocrinol., 13, pp. 425-431; McGowan, P.O., Sasaki, A., D'Alessio, A.C., Dymov, S., Labonte, B., Szyf, M., Turecki, G., Meaney, M.J., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse (2009) Nat. Neurosci., 12, pp. 342-348; Michael, Y.L., Carlson, N.E., Chlebowski, R.T., Aickin, M., Weihs, K.L., Ockene, J.K., Bowen, D.J., Ritenbaugh, C., Influence of stressors on breast cancer incidence in the Women's Health Initiative (2009) Health Psychol., 28, pp. 137-146; Murgatroyd, C., Patchev, A.V., Wu, Y., Micale, V., Bockmuhl, Y., Fischer, D., Holsboer, F., Spengler, D., Dynamic DNA methylation programs persistent adverse effects of early-life stress (2009) Nat. Neurosci., 12, pp. 1559-1566; Niccoli, T., Partridge, L., Ageing as a risk factor for disease (2012) Curr. Biol., CB 22, pp. R741-R752; Nielsen, N.R., Zhang, Z.F., Kristensen, T.S., Netterstrom, B., Schnohr, P., Gronbaek, M., Self reported stress and risk of breast cancer: prospective cohort study (2005) BMJ, 331, p. 548; Nielsen, N.R., Strandberg-Larsen, K., Gronbaek, M., Kristensen, T.S., Schnohr, P., Zhang, Z.F., Self-reported stress and risk of endometrial cancer: a prospective cohort study (2007) Psychosom. Med., 69, pp. 383-389; Non, A.L., Binder, A.M., Kubzansky, L.D., Michels, K.B., Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy (2014) Epigenetics, 9, pp. 964-972; O'Leary, J.C., 3rd, Dharia, S., Blair, L.J., Brady, S., Johnson, A.G., Peters, M., Cheung-Flynn, J., Dickey, C.A., A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51 (2011) PLoS One, 6, p. e24840; Osorio, F.G., Varela, I., Lara, E., Puente, X.S., Espada, J., Santoro, R., Freije, J.M., Lopez-Otin, C., Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease (2010) Aging Cell, 9, pp. 947-957; Parks, C.G., Miller, D.B., McCanlies, E.C., Cawthon, R.M., Andrew, M.E., DeRoo, L.A., Sandler, D.P., Telomere length, current perceived stress, and urinary stress hormones in women (2009) Cancer Epidemiol. Biomarkers Prev., 18, pp. 551-560; Peavy, G.M., Salmon, D.P., Jacobson, M.W., Hervey, A., Gamst, A.C., Wolfson, T., Patterson, T.L., Galasko, D., Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults (2009) Am. J. Psychiatry, 166, pp. 1384-1391; Pereira, D.B., Antoni, M.H., Danielson, A., Simon, T., Efantis-Potter, J., Carver, C.S., Duran, R.E., O'Sullivan, M.J., Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus (2003) Psychosom. Med., 65, pp. 427-434; Perroud, N., Paoloni-Giacobino, A., Prada, P., Olie, E., Salzmann, A., Nicastro, R., Guillaume, S., Malafosse, A., Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma (2011) Transl. Psychiatry, 1, p. e59; Poulsen, P., Esteller, M., Vaag, A., Fraga, M.F., The epigenetic basis of twin discordance in age-related diseases (2007) Pediatr. Res., 61, pp. 38r-42r; (2013), The State of Aging and Health in America 2013, Atlanta, GA; Puterman, E., Lin, J., Blackburn, E., O'Donovan, A., Adler, N., Epel, E., The power of exercise: buffering the effect of chronic stress on telomere length (2010) PLoS One, 5, p. e10837; Rakyan, V.K., Down, T.A., Maslau, S., Andrew, T., Yang, T.P., Beyan, H., Whittaker, P., Spector, T.D., Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains (2010) Genome Res., 20, pp. 434-439; Rodgers, A.B., Morgan, C.P., Bronson, S.L., Revello, S., Bale, T.L., Paternal stress exposure alters sperm microRNA content and reprograms offspring HPA stress axis regulation (2013) J. Neurosci., 33, pp. 9003-9012; Rozanski, A., Blumenthal, J.A., Kaplan, J., Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy (1999) Circulation, 99, pp. 2192-2217; Sabbagh, J.J., O'Leary, J.C., 3rd, Blair, L.J., Klengel, T., Nordhues, B.A., Fontaine, S.N., Binder, E.B., Dickey, C.A., Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency (2014) PLoS One, 9, p. e107241; Sapolsky, R.M., Stress and the brain: individual variability and the inverted-U (2015) Nat. Neurosci., 18, pp. 1344-1346; Savolainen, K., Eriksson, J.G., Kananen, L., Kajantie, E., Pesonen, A.K., Heinonen, K., Raikkonen, K., Associations between early life stress, self-reported traumatic experiences across the lifespan and leukocyte telomere length in elderly adults (2014) Biol. Psychol., 97, pp. 35-42; Sawamura, T., Klengel, T., Armario, A., Jovanovic, T., Norrholm, S.D., Ressler, K.J., Andero, R., Dexamethasone treatment leads to enhanced fear extinction and dynamic fkbp5 regulation in amygdala (2015) Neuropsychopharmacology, 41 (3), pp. 832-846; Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., Baldwin, A.S., Jr., Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors (1995) Mol. Cell. Biol., 15, pp. 943-953; Schmauss, C., Lee-McDermott, Z., Medina, L.R., Trans-generational effects of early life stress: the role of maternal behavior (2014) Sci. Rep., 4, p. 4873; Schraut, K.G., Jakob, S.B., Weidner, M.T., Schmitt, A.G., Scholz, C.J., Strekalova, T., El Hajj, N., Van den Hove, D.L., Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice (2014) Transl. Psychiatry, 4, p. e473; Shalev, I., Moffitt, T.E., Braithwaite, A.W., Danese, A., Fleming, N.I., Goldman-Mellor, S., Harrington, H.L., Caspi, A., Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder (2014) Mol. Psychiatry, 19, pp. 1163-1170; Shumaker, D.K., Dechat, T., Kohlmaier, A., Adam, S.A., Bozovsky, M.R., Erdos, M.R., Eriksson, M., Goldman, R.D., Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 8703-8708; Simons, R.L., Lei, M.K., Beach, S.R., Philibert, R.A., Cutrona, C.E., Gibbons, F.X., Barr, A., Economic hardship and biological weathering: the epigenetics of aging in a U.S. sample of black women (2016) Soc. Sci. Med., 150, pp. 192-200; (2012), National Population Projections, 2012-based Statistical Bulletin, Newport, UK; Suadicani, P., Andersen, L.L., Holtermann, A., Mortensen, O.S., Gyntelberg, F., Perceived psychological pressure at work, social class, and risk of stroke: a 30-year follow-up in Copenhagen male study (2011) J. Occup. Environ. Med., 53, pp. 1388-1395; Talens, R.P., Christensen, K., Putter, H., Willemsen, G., Christiansen, L., Kremer, D., Suchiman, H.E., Heijmans, B.T., Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs (2012) Aging Cell, 11, pp. 694-703; Telese, F., Gamliel, A., Skowronska-Krawczyk, D., Garcia-Bassets, I., Rosenfeld, M.G., Seq-ing insights into the epigenetics of neuronal gene regulation (2013) Neuron, 77, pp. 606-623; Teschendorff, A.E., Menon, U., Gentry-Maharaj, A., Ramus, S.J., Weisenberger, D.J., Shen, H., Campan, M., Widschwendter, M., Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer (2010) Genome Res., 20, pp. 440-446; Teschendorff, A.E., West, J., Beck, S., Age-associated epigenetic drift: implications, and a case of epigenetic thrift? (2013) Hum. Mol. Genet., 22, pp. R7-r15; Thomassin, H., Flavin, M., Espinas, M.L., Grange, T., Glucocorticoid-induced DNA demethylation and gene memory during development (2001) EMBO J., 20, pp. 1974-1983; Tran, L., Schulkin, J., Ligon, C.O., Greenwood-Van Meerveld, B., Epigenetic modulation of chronic anxiety and pain by histone deacetylation (2015) Mol. Psychiatry, 20, pp. 1219-1231; Tsigos, C., Chrousos, G.P., Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress (2002) J. Psychosom. Res., 53, pp. 865-871; Tsolaki, M., Kounti, F., Karamavrou, S., Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications (2009) Am. J. Alzheimers Dis. Other Demen., 24, pp. 85-94; Unternaehrer, E., Luers, P., Mill, J., Dempster, E., Meyer, A.H., Staehli, S., Lieb, R., Meinlschmidt, G., Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF) after acute psychosocial stress (2012) Transl. Psychiatry, 2, p. e150; Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Meaney, M.J., Epigenetic programming by maternal behavior (2004) Nat. Neurosci., 7, pp. 847-854; Weaver, I.C., Champagne, F.A., Brown, S.E., Dymov, S., Sharma, S., Meaney, M.J., Szyf, M., Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life (2005) J. Neurosci., 25, pp. 11045-11054; Weaver, I.C., Meaney, M.J., Szyf, M., Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 3480-3485; Weidner, C.I., Lin, Q., Koch, C.M., Eisele, L., Beier, F., Ziegler, P., Bauerschlag, D.O., Wagner, W., Aging of blood can be tracked by DNA methylation changes at just three CpG sites (2014) Genome Biol., 15, p. R24; Wiench, M., John, S., Baek, S., Johnson, T.A., Sung, M.H., Escobar, T., Simmons, C.A., Hager, G.L., DNA methylation status predicts cell type-specific enhancer activity (2011) EMBO J., 30, pp. 3028-3039; Wiench, M., Miranda, T.B., Hager, G.L., Control of nuclear receptor function by local chromatin structure (2011) FEBS J., 278, pp. 2211-2230; Willour, V.L., Chen, H., Toolan, J., Belmonte, P., Cutler, D.J., Goes, F.S., Zandi, P.P., Potash, J.B., Family-based association of FKBP5 in bipolar disorder (2009) Mol. Psychiatry, 14, pp. 261-268; Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F., Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells (2005) J. Biol. Chem., 280, pp. 4609-4616; Wolf, E.J., Logue, M.W., Hayes, J.P., Sadeh, N., Schichman, S.A., Stone, A., Salat, D.H., Miller, M.W., Accelerated DNA methylation age: associations with PTSD and neural integrity (2015) Psychoneuroendocrinology, 63, pp. 155-162; Wong, H.P., Li, Z.J., Shin, V.Y., Tai, E.K., Wu, W.K., Yu, L., Cho, C.H., Effects of cigarette smoking and restraint stress on human colon tumor growth in mice (2009) Digestion, 80, pp. 209-214; Xydous, M., Prombona, A., Sourlingas, T.G., The role of H3K4me3 and H3K9/14ac in the induction by dexamethasone of Per1 and Sgk1, two glucococorticoid early response genes that mediate the effects of acute stress in mammals (2014) Biochim. Biophys. Acta, 1839, pp. 866-872; Yang, X., Ewald, E.R., Huo, Y., Tamashiro, K.L., Salvatori, R., Sawa, A., Wand, G.S., Lee, R.S., Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5 (2012) Biochem. Biophys. Res. Commun., 420, pp. 570-575; Yehuda, R., Daskalakis, N.P., Bierer, L.M., Bader, H.N., Klengel, T., Holsboer, F., Binder, E.B., Holocaust exposure induced intergenerational effects on FKBP5 methylation (2015) Biol. Psychiatry, , pii: S0006-3223(15)00652-6; Zannas, A.S., Binder, E.B., Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism (2014) Genes Brain Behav., 13 (1), pp. 25-37; Zannas, A.S., Chrousos, G.P., Glucocorticoid signaling drives epigenetic and transcription factors to induce key regulators of human parturition (2015) Sci. Signal., 8, p. fs19; Zannas, A.S., West, A.E., Epigenetics and the regulation of stress vulnerability and resilience (2014) Neuroscience, 264, pp. 157-170; Zannas, A.S., McQuoid, D.R., Steffens, D.C., Chrousos, G.P., Taylor, W.D., Stressful life events, perceived stress, and 12-month course of geriatric depression: direct effects and moderation by the 5-HTTLPR and COMT Val158Met polymorphisms (2012) Stress, 15, pp. 425-434; Zannas, A.S., Arloth, J., Carrillo-Roa, T., Iurato, S., Roh, S., Ressler, K.J., Nemeroff, C.B., Mehta, D., Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (2015) Genome Biol., 16, p. 266; Zannas, A.S., Wiechmann, T., Gassen, N.C., Binder, E.B., Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications (2016) Neuropsychopharmacology, 41 (1), pp. 261-274; Zannas, A.S., Editorial perspective: psychological stress and epigenetic aging – what can we learn and how can we prevent? (2016) J. Child Psychol. Psychiatry, 57 (6), pp. 674-675; Zhao, R., Zhang, R., Li, W., Liao, Y., Tang, J., Miao, Q., Hao, W., Genome-wide DNA methylation patterns in discordant sib pairs with alcohol dependence (2013) Asia-Pac. Psychiatry, 5, pp. 39-50; Zheng, Y., Joyce, B.T., Colicino, E., Liu, L., Zhang, W., Dai, Q., Shrubsole, M.J., Hou, L., Blood epigenetic age may predict cancer incidence and mortality (2016) EBioMedicine, 5, pp. 68-73},
correspondence_address1={Zannas, A.S.; Department of Translational Research in Psychiatry, Germany; email: anthony_zannas@psych.mpg.de},
publisher={Elsevier Ltd},
issn={01497634},
coden={NBRED},
pubmed_id={27343999},
language={English},
abbrev_source_title={Neurosci. Biobehav. Rev.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Lill2011238,
author={Lill, C.M. and Abel, O. and Bertram, L. and Al-Chalabi, A.},
title={Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases},
journal={Amyotrophic Lateral Sclerosis},
year={2011},
volume={12},
number={4},
pages={238-249},
doi={10.3109/17482968.2011.584629},
note={cited By 67},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959763071&doi=10.3109%2f17482968.2011.584629&partnerID=40&md5=d4c584d2fd258efb50971cef71d18356},
affiliation={Neuropsychiatric Genetics Group, Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Department of Neurology, Johannes Gutenberg University, Mainz, Germany; MRC Centre for Neurodegeneration Research, King's College London Institute of Psychiatry P 041, London SE5 8AF, United Kingdom; Max Planck Institute for Molecular Genetics, Ihnestr. 63, Berlin, Germany},
abstract={Amyotrophic lateral sclerosis (ALS) is a genetically heterogeneous disorder that shows a characteristic dichotomy of familial forms typically displaying Mendelian inheritance patterns, and sporadic ALS showing no or less obvious familial aggregation. While the former is caused by rare, highly penetrant, and pathogenic mutations, risk for sporadic ALS is probably the result of the combined effects of common polymorphisms with minor to moderate effect sizes. Owing to recent advances in high-throughput genotyping and sequencing technologies, genetic research in both fields is evolving at a rapidly increasing pace making it more and more difficult to follow and evaluate the most significant progress in the field. To alleviate this problem, our groups have created dedicated and freely available online databases, ALSoD (http://alsod.iop.kcl.ac.uk/) and ALSGene (http://www.alsgene.org), which provide systematic and in-depth qualitative and quantitative overviews of genetic research in both familial and sporadic ALS. This review briefly introduces the background and main features of both databases and provides an overview of the currently most compelling genetic findings in ALS derived from analyses using these resources. © 2011 Informa Healthcare.},
author_keywords={ALS;  ALSGene;  ALSoD;  amyotrophic lateral sclerosis;  database;  genetic;  UNC13A},
keywords={amyotrophic lateral sclerosis;  article;  gene identification;  gene mutation;  gene sequence;  genetic polymorphism;  genotype;  genotype phenotype correlation;  human;  inheritance;  medical research;  priority journal, Amyotrophic Lateral Sclerosis;  Databases, Factual;  Genetic Predisposition to Disease;  Genotype;  Humans;  Mutation;  Phenotype;  Software;  User-Computer Interface},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, 259867},
funding_text 1={ALSoD is a joint project of the World Federation of Neurology (WFN) and European Network for the Cure ALS (ENCALS).We are especially grateful for the long-standing and continued funding of this project from the ALS Association and the MND Association of Great Britain and Northern Ireland. We also thank ALS Canada, MNDA Iceland and the ALS Therapy Alliance. The research leading to these results has received funding from the European Community ' s Health Seventh Framework Programme FP7/2007-2013) under grant agreement n° 259867. We also thank the NIHR Biomedical Research Centre for Mental Health. We thank Aleks Radunovic, Nigel Leigh, and Ian Gowrie, who originally conceived ALSoD, and the ALSoD team, especially Peter Andersen and John Powell.},
references={Schottkzy, J., Ueber praesenile verbloedungen (1932) Z. Ges. Neurol. Psychiat., 140, pp. 333-397; Gowers, W.R., A Manual of Diseases of the nervous system I (1900) Diseases of the Nerves and Spinal Cord, , 3rd edn Philadelphia: P. Blakistons Son & Co; Aran, F.A., Recherches sur une maladie non encore decrite dy systeme musculaire atrophie musculaire progressive (1850) Archs. Gen. Med., 3, pp. 5-35; Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Herzfeldt, B., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis (1993) Nature, 362 (6415), pp. 59-62. , DOI 10.1038/362059a0; Hamosh, A., Scott, A.F., Amberger, J., Valle, D., McKusick, V.A., (2000) Online Mendelian Inheritance in Man OMIM Hum. Mutat., 15, pp. 57-61; Cotton, R.G., McKusick, V., Scriver, C.R., The HUGO mutation database initiative (1998) Science, 279, pp. 10-11; Scriver, C.R., Nowacki, P.M., Lehvaslaiho, H., Antonarakis, S., Beroud, C., Brown, A., Cooper, D.N., Wjst, M., Guidelines and recommendations for content, structure, and deployment of mutation databases: II. Journey in progress (2000) Human Mutation, 15 (1), pp. 13-15. , DOI 10.1002/(SICI)1098-1004(200001)15:1<13::AID-HUMU5>3.0.CO;2-Y; Claustres, M., Horaitis, O., Vanevski, M., Cotton, R.G.H., Time for a unified system of mutation description and reporting: A review of locus-specific mutation databases (2002) Genome Research, 12 (5), pp. 680-688. , DOI 10.1101/gr.217702; George, R.A., Smith, T.D., Callaghan, S., Hardman, L., Pierides, C., Horaitis, O., Wouters, M.A., Cotton, R.G.H., General mutation databases: Analysis and review (2008) Journal of Medical Genetics, 45 (2), pp. 65-70. , DOI 10.1136/jmg.2007.052639; Soussi, T., Ishioka, C., Claustres, M., Beroud, C., Locus-specific mutation databases: Pitfalls and good practice based on the p53 experience (2006) Nature Reviews Cancer, 6 (1), pp. 83-90. , DOI 10.1038/nrc1783; Radunovic, A., Leigh, P.N., (1999) ALSO Database: Database of SOD1 and Other Gene Mutations in ALS on the Internet European Fals Group and Alsod Consortium Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp. 45-49; Wroe, R., Wai-Ling Butler, A., Andersen, P.M., Powell, J.F., Al-Chalabi, A., ALSOD: The amyotrophic lateral sclero sis online database (2008) Amyotroph Lateral Scler, 9, pp. 249-250; Yoshida, M., Takahashi, Y., Koike, A., Fukuda, Y., Goto, J., Tsuji, S., A mutation database for amyotrophic lateral sclerosis (2010) Hum. Mutat., 31, pp. 1003-1010; Warde-Farley, D., Donaldson, S.L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., The gene mania prediction server: Biological network integration for gene prioritization and predicting gene function (2010) Nucleic Acids Res., 38, pp. 214-220; Dunckley, T., Huentelman, M.J., Craig, D.W., Pearson, J.V., Szelinger, S., Joshipura, K., Halperin, R.F., Stephan, D.A., Whole-genome analysis of sporadic amyotrophic lateral sclerosis (2007) New England Journal of Medicine, 357 (8), pp. 775-788. , http://content.nejm.org/cgi/reprint/357/8/775.pdf; Schymick, J.C., Scholz, S.W., Fung, H.-C., Britton, A., Arepalli, S., Gibbs, J.R., Lombardo, F., Traynor, B.J., Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: First stage analysis and public release of data (2007) Lancet Neurology, 6 (4), pp. 322-328. , DOI 10.1016/S1474-4422(07)70037-6, PII S1474442207700376; Van Es, M.A., Van Vught, P.W., Blauw, H.M., Franke, L., Saris, C.G., Andersen, P.M., Van Den Bosch, L., Van Den Berg, L.H., ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: A genome-wide association study (2007) Lancet Neurology, 6 (10), pp. 869-877. , DOI 10.1016/S1474-4422(07)70222-3, PII S1474442207702223; Cronin, S., Berger, S., Ding, J., Schymick, J.C., Washecka, N., Hernandez, D.G., Greenway, M.J., Hardiman, O., A genome-wide association study of sporadic ALS in a homogenous Irish population (2008) Human Molecular Genetics, 17 (5), pp. 768-774. , DOI 10.1093/hmg/ddm361; Van Es, M.A., Van Vught, P.W., Blauw, H.M., Franke, L., Saris, C.G., Van Den Bosch, L., Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis (2008) Nat. Genet., 40, pp. 29-31; Van Es, M.A., Veldink, J.H., Saris, C.G., Blauw, H.M., Van Vught, P.W., Birve, A., Genome-wide association study identifi es 19p13.3 UNC13A and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis (2009) Nat. Genet., 41, pp. 1083-1087; Landers, J.E., Melki, J., Meininger, V., Glass, J.D., Van Den Berg, L.H., Van Es, M.A., Reduced expression of the kinesin- Associated Protein 3 KIFAP3 gene increases survival in sporadic amyotrophic lateral sclerosis (2009) Proc. Natl. Acad. Sci., 106, pp. 9004-9009. , U S A; Chio, A., Schymick, J.C., Restagno, G., Scholz, S.W., Lombardo, F., Lai, S.L., A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis (2009) Hum. Mol. Genet., 18, pp. 1524-1532; Laaksovirta, H., Peuralinna, T., Schymick, J.C., Scholz, S.W., Lai, S.L., Myllykangas, L., Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: A genome-wide association study (2010) Lancet Neurol., 9, pp. 978-985; Shatunov, A., Mok, K., Newhouse, S., Weale, M.E., Smith, B., Vance, C., Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: A genome-wide association study (2010) Lancet Neurol., 9, pp. 986-994; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database (2007) Nature Genetics, 39 (1), pp. 17-23. , DOI 10.1038/ng1934, PII NG1934; Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.M., PD Gene Database Alzheimer Research Forum., , http://www.pdgene.org/, Available at:; Ioannidis, J.P.A., Boffetta, P., Little, J., O'Brien, T.R., Uitterlinden, A.G., Vineis, P., Balding, D.J., Khoury, M.J., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) International Journal of Epidemiology, 37 (1), pp. 120-132. , DOI 10.1093/ije/dym159; Khoury, M.J., Bertram, L., Boffetta, P., Butterworth, A.S., Chanock, S.J., Dolan, S.M., Genome-wide association studies field synopses and the development of the knowledge base on genetic variation and human diseases (2009) Am. J. Epidemiol., 170, pp. 269-279; Ioannidis, J.P., Effect of formal statistical signifi cance on the credibility of observational associations (2008) Am. J. Epidemiol., 168, pp. 374-383. , discussion 384-90; Daoud, H., Belzil, V., Desjarlais, A., Camu, W., Dion, P.A., Rouleau, G.A., Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis (2010) Arch. Neurol., 67, pp. 516-517; Iida, A., Takahashi, A., Deng, M., Zhang, Y., Wang, J., Atsuta, N., Replication analysis of SNPs on 9p21.2 and 19p13.3 with amyotrophic lateral sclerosis in East Asians (2011) Neurobiol. Aging., 32 (757), pp. e13-e14},
correspondence_address1={Bertram, L.; Max Planck Institute for Molecular Genetics, Ihnestr. 63, Berlin, Germany; email: lbertram@molgen.mpg.de},
issn={17482968},
pubmed_id={21702733},
language={English},
abbrev_source_title={Amyotrophic Lateral Scler.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Belbasis201696,
author={Belbasis, L. and Bellou, V. and Evangelou, E.},
title={Environmental risk factors and amyotrophic lateral sclerosis: An umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies},
journal={Neuroepidemiology},
year={2016},
volume={46},
number={2},
pages={96-105},
doi={10.1159/000443146},
note={cited By 65},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953791991&doi=10.1159%2f000443146&partnerID=40&md5=457fdba63325447a0babe5c1f6e662ab},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, GR-45110, Greece; Department of Biostatistics and Epidemiology, Imperial College London, London, United Kingdom},
abstract={Background: The pathogenesis of amyotrophic lateral sclerosis (ALS) involves both environmental and genetic factors. Our study aimed at summarising the environmental risk factors for ALS, assessing the evidence for diverse biases, and pinpointing risk factors with high epidemiological credibility. Methods: We searched PubMed from inception to August 20, 2015, to identify systematic reviews and meta-analyses of observational studies examining associations between environmental factors and ALS. For each meta-analysis, we estimated the summary effect size by the use of random-effects and fixed-effects models, the 95% CI, the 95% prediction interval (PI), and the between-study heterogeneity. We assessed the evidence of small-study effects and excess significance bias. Results: Sixteen unique meta-analyses of different risk factors and ALS were considered. Of them, 5 were statistically significant at p < 0.001 under the random-effects model. Only one factor presented robust evidence for a convincing association. This association pertained to chronic occupational exposure to lead (random-effects OR 1.81, 95% CI 1.39-2.35). Conclusions: A small number of published meta-analyses on environmental factors and risk of ALS was identified, a phenomenon that could be attributed to the challenges in studying a rare neurological disease. More observational studies with adequate sample size and study design are needed to clarify the environmental component of ALS pathogenesis. © 2016 S. Karger AG, Basel.},
author_keywords={Amyotrophic lateral sclerosis;  Epidemiology;  Meta-analysis;  Risk factors;  Umbrella review},
keywords={amyotrophic lateral sclerosis;  Article;  environmental factor;  human;  meta analysis;  observational study;  occupational exposure;  prediction interval;  risk factor;  statistical parameters;  systematic review;  amyotrophic lateral sclerosis;  environmental exposure;  female;  male;  risk factor, Amyotrophic Lateral Sclerosis;  Environmental Exposure;  Female;  Humans;  Male;  Observational Studies as Topic;  Risk Factors},
references={Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S., Goutman, S., Feldman, E.L., Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era (2015) Nat Rev Neurol, 11, pp. 266-279; Renton, A.E., Chiò, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics (2014) Nat Neurosci, 17, pp. 17-23; Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Amyotrophic lateral sclerosis (2011) Lancet, 377, pp. 942-955; Chiò, A., Logroscino, G., Traynor, B.J., Collins, J., Simeone, J.C., Goldstein, L.A., Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature (2013) Neuroepidemiology, 41, pp. 118-130; Al-Chalabi, A., Hardiman, O., The epidemiology of ALS: A conspiracy of genes, environment and time (2013) Nat Rev Neurol, 9, pp. 617-628; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-Analyses (2015) Lancet Neurol, 14, pp. 263-273; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson?s disease: An umbrella review of meta-Analyses (2015) Parkinsonism Relat Disord, , Inpress; Ioannidis, J.P., Integration of evidence from multiple meta-Analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-Analyses (2009) CMAJ, 181, pp. 488-493; Lill, C.M., Abel, O., Bertram, L., Al-Chalabi, A., Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases (2011) Amyotroph Lateral Scler, 12, pp. 238-249; DerSimonian, R., Laird, N., Meta-Analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-Analysis (2009) J R Stat Soc ser A Stat Soc, 172, pp. 137-159; Higgins, J.P., Commentary: Heterogeneity in meta-Analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-Analysis (2000) Stat Med, 19, pp. 3127-3131; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-Analysis (2002) Stat Med, 21, pp. 1539-1558; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-Analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am J Epidemiol, 131, pp. 552-566; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22, pp. 450-456; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci U S A., 110, pp. 19313-19317; Lekoubou, A., Matsha, T.E., Sobngwi, E., Kengne, A.P., Effects of diabetes mellitus on amyotrophic lateral sclerosis: A systematic review (2014) BMC Res Notes, 7, p. 171; Hamidou, B., Couratier, P., Besançon, C., Nicol, M., Preux, P.M., Marin, B., Epidemiological evidence that physical activity is not a risk factor for ALS (2014) Eur J Epidemiol, 29, pp. 459-475; Alonso, A., Logroscino, G., Hernán, M.A., Smoking and the risk of amyotrophic lateral sclerosis: A systematic review and meta-Analysis (2010) J Neurol Neurosurg Psychiatry, 81, pp. 1249-1252; Vergara, X., Kheifets, L., Greenland, S., Oksuzyan, S., Cho, Y.S., Mezei, G., Occupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: A meta-Analysis (2013) J Occup Environ Med, 55, pp. 135-146; Wang, H., O'Reilly, É.J., Weisskopf, M.G., Logroscino, G., McCullough, M.L., Thun, M.J., Smoking and risk of amyotrophic lateral sclerosis: A pooled analysis of 5 prospective cohorts (2011) Arch Neurol, 68, pp. 207-213; Malek, A.M., Barchowsky, A., Bowser, R., Youk, A., Talbott, E.O., Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-Analysis of epidemiological studies: Pesticide exposure as a risk factor for ALS (2012) Environ Res, 117, pp. 112-119; Capozzella, A., Sacco, C., Chighine, A., Loreti, B., Scala, B., Casale, T., Work related etiology of amyotrophic lateral sclerosis (ALS): A meta-Analysis (2014) Ann Ig., 26, pp. 456-472; Kamel, F., Umbach, D.M., Bedlack, R.S., Richards, M., Watson, M., Alavanja, M.C., Pesticide exposure and amyotrophic lateral sclerosis (2012) Neurotoxicology, 33, pp. 457-462; Sutedja, N.A., Veldink, J.H., Fischer, K., Kromhout, H., Heederik, D., Huisman, M.H., Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review (2009) Amyotroph Lateral Scler, 10, pp. 302-309; Kang, H., Cha, E.S., Choi, G.J., Lee, W.J., Amyotrophic lateral sclerosis and agricultural environments: A systematic review (2014) J Korean Med Sci, 29, pp. 1610-1617; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., A meta-Analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis (2014) J Occup Environ Med, 56, pp. 1235-1242; Fitzgerald, K.C., O'Reilly, E.J., Falcone, G.J., Mc-Cullough, M.L., Park, Y., Kolonel, L.N., Dietary ?-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis (2014) JAMA Neurol, 71, pp. 1102-1110; Abraham, A., Drory, V.E., Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: A meta-Analysis (2014) J Neurol, 261, pp. 1133-1138; Huang, R., Guo, X., Chen, X., Zheng, Z., Wei, Q., Cao, B., The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-Analysis (2015) Amyotroph Lateral Scler Frontotemporal Degener, 16, pp. 359-365; Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Ntzani, E.E., Ioannidis, J.P., Type 2 diabetes and cancer: Umbrella review of meta-Analyses of observational studies (2015) BMJ, 350, p. g7607; Belbasis, L., Panagiotou, O.A., Dosis, V., Evangelou, E., A systematic appraisal of field synopses in genetic epidemiology: A HuGE review (2015) Am J Epidemiol, 181, pp. 1-16; Fang, F., Kwee, L.C., Allen, K.D., Umbach, D.M., Ye, W., Watson, M., Association between blood lead and the risk of amyotrophic lateral sclerosis (2010) Am J Epidemiol, 171, pp. 1126-1133; Kamel, F., Umbach, D.M., Munsat, T.L., Shefner, J.M., Hu, H., Sandler, D.P., Lead exposure and amyotrophic lateral sclerosis (2002) Epidemiology, 13, pp. 311-319; Callaghan, B., Feldman, D., Gruis, K., Feldman, E., The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications (2011) Neurodegener Dis, 8, pp. 1-8; Chen, H., Richard, M., Sandler, D.P., Umbach, D.M., Kamel, F., Head injury and amyotrophic lateral sclerosis (2007) Am J Epidemiol, 166, pp. 810-816; Jafari, S., Etminan, M., Aminzadeh, F., Samii, A., Head injury and risk of Parkinson disease: A systematic review and meta-Analysis (2013) Mov Disord, 28, pp. 1222-1229; Wirdefeldt, K., Adami, H.O., Cole, P., Trichopoulos, D., Mandel, J., Epidemiology and etiology of Parkinson?s disease: A review of the evidence (2011) Eur J Epidemiol, 26, pp. S1-S58; Armon, C., Nelson, L.M., Is head trauma a risk factor for amyotrophic lateral sclerosis?. An evidence based review (2012) Amyotroph Lateral Scler, 13, pp. 351-356; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-Analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Tzoulaki, I., Siontis, K.C., Evangelou, E., Ioannidis, J.P., Bias in associations of emerging biomarkers with cardiovascular disease (2013) JAMA Intern Med, 173, pp. 664-671; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J Clin Epidemiol, 62, pp. 1013-1020; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gøtzsche, P.C., Vandenbroucke, J.P., The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies (2008) J Clin Epidemiol, 61, pp. 344-349; Ioannidis, J.P., The importance of potential studies that have not existed and registration of observational data sets (2012) JAMA, 308, pp. 575-576; Dal-Ré, R., Ioannidis, J.P., Bracken, M.B., Buffler, P.A., Chan, A.W., Franco, E.L., Making prospective registration of observational research a reality (2014) Sci Transl Med, 6. , 224cm1; Fitzgerald, K.C., O'Reilly, É.J., Fondell, E., Falcone, G.J., McCullough, M.L., Park, Y., Intakes of Vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies (2013) Ann Neurol, 73, pp. 236-245; Zheng, Z., Sheng, L., Shang, H., Statins and amyotrophic lateral sclerosis: A systematic review and meta-Analysis (2013) Amyotroph Lateral Scler Frontotemporal Degener, 14, pp. 241-245; Zhou, H., Chen, G., Chen, C., Yu, Y., Xu, Z., Association between extremely low-frequency electromagnetic fields occupations and amyotrophic lateral sclerosis: A meta-Analysis (2012) PLoS One, 7, p. e48354},
correspondence_address1={Evangelou, E.; Department of Hygiene and Epidemiology, Greece; email: vangelis@cc.uoi.gr},
publisher={S. Karger AG},
issn={02515350},
coden={NEEPD},
pubmed_id={26731747},
language={English},
abbrev_source_title={Neuroepidemiology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Patel20142173,
author={Patel, C.J. and Ioannidis, J.P.A.},
title={Studying the elusive environment in large scale},
journal={JAMA},
year={2014},
volume={311},
number={21},
pages={2173-2174},
doi={10.1001/jama.2014.4129},
note={cited By 64},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901759936&doi=10.1001%2fjama.2014.4129&partnerID=40&md5=1b536d9c34972456449cd66cf3145fbc},
affiliation={Center for Biomedical Informatics, Harvard Medical School, Boston, MA, United States; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford, CA, United States},
keywords={air pollution;  biosensor;  cardiovascular disease;  correlation analysis;  diet;  environmental exposure;  environmental factor;  genetic association;  genotype environment interaction;  lifestyle;  metabolomics;  molecular evolution;  priority journal;  proteomics;  reproducibility;  risk assessment;  short survey;  smoking;  validity, Data Collection;  Environmental Exposure;  Environmental Health;  Epidemiologic Studies;  Humans;  Models, Theoretical;  Risk Assessment;  Terminology as Topic},
funding_details={National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute, NHLBI, T32HL007034},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99ES023504},
references={Rappaport, S.M., Smith, M.T., Epidemiology: Environment and disease risks (2010) Science, 330 (6003), pp. 460-461; Tzoulaki, I., Patel, C.J., Okamura, T., A nutrient-wide association study on blood pressure (2012) Circulation, 126 (21), pp. 2456-2464; Patel, C.J., Bhattacharya, J., Butte, A.J., An environment-wide association study (EWAS) on type 2 diabetes mellitus (2010) PLoS One, 5 (5), pp. e10746; Wang, Z., Klipfell, E., Bennett, B.J., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease (2011) Nature, 472 (7341), pp. 57-63; Buck Louis, G.M., Sundaram, R., Exposome: Time for transformative research (2012) Stat Med, 31 (22), pp. 2569-2575; Thomas, D.C., Lewinger, J.P., Murcray, C.E., Gauderman, W.J., Invited commentary: GE-Whiz! Ratcheting gene-environment studies up to the whole genome and the whole exposome (2012) Am J Epidemiol, 175 (3), pp. 203-209; Rappaport, S.M., Biomarkers intersect with the exposome (2012) Biomarkers, 17 (6), pp. 483-489; Hamilton, C.M., Strader, L.C., Pratt, J.G., The PhenX Toolkit: Get the most from your measures (2011) Am J Epidemiol, 174 (3), pp. 253-260},
correspondence_address1={Ioannidis, J.P.A.; Stanford Prevention Research Center, , Stanford, CA, United States; email: jioannid@stanford.edu},
publisher={American Medical Association},
issn={00987484},
coden={JAMAA},
pubmed_id={24893084},
language={English},
abbrev_source_title={JAMA},
document_type={Short Survey},
source={Scopus},
}

@ARTICLE{Liu2016628,
author={Liu, Q.-P. and Wu, Y.-F. and Cheng, H.-Y. and Xia, T. and Ding, H. and Wang, H. and Wang, Z.-M. and Xu, Y.},
title={Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies},
journal={Nutrition},
year={2016},
volume={32},
number={6},
pages={628-636},
doi={10.1016/j.nut.2015.11.015},
note={cited By 62},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961221655&doi=10.1016%2fj.nut.2015.11.015&partnerID=40&md5=e64ba36f68a10e0813ba18f0e2267481},
affiliation={Department of Neurology, Drum Tower Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China},
abstract={Objective: Findings from epidemiologic studies of coffee consumption and risk for cognitive decline or dementia are inconclusive. The aim of this study was to conduct a meta-analysis of prospective studies to assess the association between coffee consumption and the risk for cognitive decline and dementia. Methods: Relevant studies were identified by searching PubMed and Embase databases between 1966 and December 2014. Prospective cohorts that reported relative risk (RRs) and 95% confidence intervals (CIs) for the association of coffee consumption with dementia incidence or cognitive changing were eligible. Study-specific RRs were combined by using a random-effects model. Results: Eleven prospective studies, including 29,155 participants, were included in the meta-analysis. The combined RR indicated that high coffee consumption was not associated with the different measures of cognitive decline or dementia (summary RR, 0.97; 95% CI, 0.84-1.11). Subgroup analyses suggested a significant inverse association between highest coffee consumption and the risk for Alzheimer disease (summary RR, 0.73; 95% CI, 0.55-0.97). The dose-response analysis, including eight studies, did not show an association between the increment of coffee intake and cognitive decline or dementia risk (an increment of 1 cup/d of coffee consumed; summary RR, 1.00; 95% CI, 0.98-1.02). Conclusions: The present study suggests that higher coffee consumption is associated with reduced risk for Alzheimer disease. Further randomized controlled trials or well-designed cohort studies are needed to determine the association between coffee consumption and cognitive decline or dementia. © 2016 Elsevier Inc.},
author_keywords={Alzheimer disease;  Coffee consumption;  Cognitive decline;  Dementia;  Meta-analysis},
keywords={Alzheimer disease;  Article;  coffee;  cognitive defect;  dementia;  disease association;  food intake;  human;  priority journal;  risk factor;  risk reduction;  systematic review;  Cognitive Dysfunction;  dementia;  dose response;  meta analysis;  prospective study, coffee, Coffee;  Cognitive Dysfunction;  Dementia;  Dose-Response Relationship, Drug;  Humans;  Prospective Studies;  Risk Factors},
chemicals_cas={Coffee},
funding_details={LJ201101},
funding_details={Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province, BL2012013},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 81230026, 81171085, 81300988},
funding_text 1={This study was supported by the National Natural Science Foundation of China (No. 81171085 , 81230026 , and 81300988 ), the Natural Science Foundation of Jiangsu Province of China ( BL2012013 ), and the Medical Leading Talent and Innovation Team Project of Jiangsu Province (LJ201101). Q-PL and Y-FW contributed equally to this study and reviewed articles and extracted information. YX, Q-PL, and Y-FW conceived the idea and designed the study. Y-FW and Z-MW undertook the statistical analysis. Y-FW, H-YC, and TX wrote the first draft of the manuscript. HD and HW edited the English. All of the authors helped interpret the results and write and revise the manuscript. The authors acknowledge Brad Peterson for editing the English. The authors have no conflicts of interest to declare.},
references={Barranco, Q.J., Allam, M.F., Serrano, D.C., Fernandez-Crehuet, N.R., Alzheimer disease and coffee: a quantitative review (2007) Neurol Res, 29, pp. 91-95; Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., Lunet, N., Caffeine intake and dementia: systematic review and meta-analysis (2010) J Alzheimers Dis, 20, pp. S187-S204; Beydoun, M.A., Beydoun, H.A., Gamaldo, A.A., Teel, A., Zonderman, A.B., Wang, Y., Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) BMC Public Health, 14, p. 643; Mirza, S.S., Tiemeier, H., de Bruijn, R.F., Hofman, A., Franco, O.H., Kiefte-de, J.J., Coffee consumption and incident dementia (2014) Eur J Epidemiol, 29, pp. 735-741; Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions (1998) J Epidemiol Community Health, 52, pp. 377-384; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Wang, Z.M., Zhao, D., Nie, Z.L., Zhao, H., Zhou, B., Gao, W., Flavonol intake and stroke risk: a meta-analysis of cohort studies (2014) Nutrition, 30, pp. 518-523; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135, pp. 1301-1309; Orsini, N., Bellocco, R., Greenland, S., Generalized least squares for trend estimation of summarized dose-response data (2006) Stata J, 1, pp. 40-57; Nie, Z.L., Wang, Z.M., Zhou, B., Tang, Z.P., Wang, S.K., Magnesium intake and incidence of stroke: meta-analysis of cohort studies (2013) Nutr Metab Cardiovasc Dis, 23, pp. 169-176; Egger, M., Davey, S.G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) BMJ, 339, p. b2535; Tyas, S.L., Manfreda, J., Strain, L.A., Montgomery, P.R., Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada (2001) Int J Epidemiol, 30, pp. 590-597; Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G.B., Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging (2002) Am J Epidemiol, 156, pp. 445-453; Ritchie, K., Carriere, I., de Mendonca, A., Portet, F., Dartigues, J.F., Rouaud, O., The neuroprotective effects of caffeine: a prospective population study (the Three City Study) (2007) Neurology, 69, pp. 536-545; Ng, T.P., Feng, L., Niti, M., Kua, E.H., Yap, K.B., Tea consumption and cognitive impairment and decline in older Chinese adults (2008) Am J Clin Nutr, 88, pp. 224-231; Eskelinen, M.H., Ngandu, T., Tuomilehto, J., Soininen, H., Kivipelto, M., Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study (2009) J Alzheimers Dis, 16, pp. 85-91; Laitala, V.S., Kaprio, J., Koskenvuo, M., Raiha, I., Rinne, J.O., Silventoinen, K., Coffee drinking in middle age is not associated with cognitive performance in old age (2009) Am J Clin Nutr, 90, pp. 640-646; Santos, C., Lunet, N., Azevedo, A., de Mendonca, A., Ritchie, K., Barros, H., Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal (2010) J Alzheimers Dis, 20, pp. S175-S185; Gelber, R.P., Petrovitch, H., Masaki, K.H., Ross, G.W., White, L.R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates (2011) J Alzheimers Dis, 23, pp. 607-615; Vercambre, M.N., Berr, C., Ritchie, K., Kang, J.H., Caffeine and cognitive decline in elderly women at high vascular risk (2013) J Alzheimers Dis, 35, pp. 413-421; Noguchi-Shinohara, M., Yuki, S., Dohmoto, C., Ikeda, Y., Samuraki, M., Iwasa, K., Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline (2014) PLoS One, 9, p. e96013; Cropley, V., Croft, R., Silber, B., Neale, C., Scholey, A., Stough, C., Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study (2012) Psychopharmacology (Berl), 219, pp. 737-749; Dall'Igna, O.P., Fett, P., Gomes, M.W., Souza, D.O., Cunha, R.A., Lara, D.R., Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice (2007) Exp Neurol, 203, pp. 241-245; Arendash, G.W., Cao, C., Caffeine and coffee as therapeutics against Alzheimer's disease (2010) J Alzheimers Dis, 20, pp. S117-S126},
correspondence_address1={Xu, Y.; Department of Neurology, China; email: Xuyun20042001@aliyun.com},
publisher={Elsevier Inc.},
issn={08999007},
coden={NUTRE},
pubmed_id={26944757},
language={English},
abbrev_source_title={Nutrition},
document_type={Article},
source={Scopus},
}

@ARTICLE{KrnicMartinic2019,
author={Krnic Martinic, M. and Pieper, D. and Glatt, A. and Puljak, L.},
title={Definition of a systematic review used in overviews of systematic reviews, meta-epidemiological studies and textbooks},
journal={BMC Medical Research Methodology},
year={2019},
volume={19},
number={1},
doi={10.1186/s12874-019-0855-0},
art_number={203},
note={cited By 61},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074549242&doi=10.1186%2fs12874-019-0855-0&partnerID=40&md5=5fe35804cdf0ec6a904951dd809c821b},
affiliation={Department of Otorhinolaryngology, University Hospital Split, Split, Croatia; Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Cologne, Germany; Center for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Ilica 242, Zagreb, 10000, Croatia},
abstract={Background: A standard or consensus definition of a systematic review does not exist. Therefore, if there is no definition about a systematic review in secondary studies that analyse them or the definition is too broad, inappropriate studies might be included in such evidence synthesis. The aim of this study was to analyse the definition of a systematic review (SR) in health care literature, elements of the definitions that are used and to propose a starting point for an explicit and non-ambiguous SR definition. Methods: We included overviews of systematic reviews (OSRs), meta-epidemiological studies and epidemiology textbooks. We extracted the definitions of SRs, as well as the inclusion and exclusion criteria that could indicate which definition of a SR the authors used. We extracted individual elements of SR definitions, categorised and quantified them. Results: Among the 535 analysed sources of information, 188 (35%) provided a definition of a SR. The most commonly used reference points for the definitions of SRs were Cochrane and the PRISMA statement. We found 188 different elements of SR definitions and divided them into 14 categories. The highest number of SR definition elements was found in categories related to searching (N = 51), analysis/synthesis (N = 23), overall methods (N = 22), quality/bias/appraisal/validity (N = 22) and aim/question (N = 13). The same five categories were also the most commonly used combination of categories in the SR definitions. Conclusion: Currently used definitions of SRs are vague and ambiguous, often using terms such as clear, explicit and systematic, without further elaboration. In this manuscript we propose a more specific definition of a systematic review, with the ultimate aim of motivating the research community to establish a clear and unambiguous definition of this type of research. © 2019 The Author(s).},
author_keywords={Definition;  Research methodology;  Systematic review},
keywords={book;  classification;  epidemiology;  evidence based medicine;  human;  literature;  medical research;  meta analysis (topic);  procedures;  reproducibility, Biomedical Research;  Epidemiologic Studies;  Evidence-Based Medicine;  Humans;  Meta-Analysis as Topic;  Reproducibility of Results;  Review Literature as Topic;  Systematic Reviews as Topic;  Textbooks as Topic},
funding_details={Agency for Healthcare Research and QualityAgency for Healthcare Research and Quality, AHRQ},
funding_details={Delaney AIDS Research EnterpriseDelaney AIDS Research Enterprise, DARE},
funding_details={National Institute for Health and Care ExcellenceNational Institute for Health and Care Excellence, NICE},
funding_details={National Health and Medical Research CouncilNational Health and Medical Research Council, NHMRC, 1002028},
funding_text 1={Explicit mentions of the names of the organisations, checklists, databases associated with a definition of SRs or criteria for the inclusion of SRs were found in 43 out of 535 (8%) analysed sources of information. Those were Cochrane (N = 24), the PRISMA statement (N = 13), criteria of Database of Reviews of Effect (DARE) (N = 5), National Institute for Health and Care Excellence (NICE) (N = 3), NHS Centre for Reviews and Dissemination (N = 3), Campbell collaboration (N = 2) National Health and Medical Research Council (N = 1), QUOROM (QUality Of Reporting of Meta-analyses) recommendations (N = 1), Guidelines from Agency for Healthcare Research and Quality (AHRQ) (N = 1), Institute of Medicine (IOM) (N = 1) and author Andy Oxman (N = 1), referred to as the “Oxman criteria“. Cochrane was mentioned most commonly, either as a reference to a whole organisation, the Cochrane Handbook for Systematic Reviews of Interventions or a specific Cochrane entity: the Dutch Cochrane Centre in one source of information. Details about the definitions and references provided in those 43 studies are shown in Additional file 1: Table S1. The most commonly used supporting references in those studies were the manuscripts by Moher et al. and Liberati et al. describing the PRISMA statement, the PRISMA-P checklist, and the Cochrane Handbook (Additional file 1: Table S1).},
references={Sur, R.L., Dahm, P., History of evidence-based medicine (2011) Indian Journal of Urology: IJU: Journal of the Urological Society of India, 27 (4), pp. 487-489; Evidence-based medicine. A new approach to teaching the practice of medicine (1992) JAMA, 268 (17), pp. 2420-2425. , Group EW; Sackett, D.L., Rosenberg, W.M., Gray, J.A., Haynes, R.B., Richardson, W.S., Evidence based medicine: What it is and what it isn't (1996) BMJ, 312 (7023), pp. 71-72. , 1:STN:280:DyaK287ktF2itw%3D%3D; Greenhalgh, T., Howick, J., Maskrey, N., Evidence based medicine: A movement in crisis? (2014) BMJ, 348, p. g3725; Page, M.J., Shamseer, L., Altman, D.G., Tetzlaff, J., Sampson, M., Tricco, A.C., Catala-Lopez, F., Sarkis-Onofre, R., Epidemiology and reporting characteristics of systematic reviews of biomedical research: A cross-sectional study (2016) PLoS Med, 13 (5). , e1002028; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Riva, N., Puljak, L., Moja, L., Ageno, W., Schunemann, H., Magrini, N., Squizzato, A., Multiple overlapping systematic reviews facilitate the origin of disputes: The case of thrombolytic therapy for pulmonary embolism (2017) J Clin Epidemiol; Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L.A., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015) Systematic Reviews, 4, p. 1; Pieper, D., Pollock, M., Fernandes, R.M., Buchter, R.B., Hartling, L., Epidemiology and reporting characteristics of overviews of reviews of healthcare interventions published 2012-2016: Protocol for a systematic review (2017) Systematic Reviews, 6 (1), p. 73; Pieper, D., Koensgen, N., Breuing, J., Ge, L., Wegewitz, U., (2017) How Is AMSTAR Applied by Authors-a Call for Better Reporting, , Unpublished data; Lunny, C., McKenzie, J.E., McDonald, S., Retrieval of overviews of systematic reviews in MEDLINE was improved by the development of an objectively derived and validated search strategy (2016) J Clin Epidemiol, 74, pp. 107-118; Schwartz, S., Campbell, U.B., Gatto, N.M., Gordon, K., Toward a clarification of the taxonomy of "bias" in epidemiology textbooks (2015) Epidemiology, 26 (2), pp. 216-222; Aziz, T., Compton, S., Nassar, U., Matthews, D., Ansari, K., Flores-Mir, C., Methodological quality and descriptive characteristics of prosthodontic-related systematic reviews (2013) J Oral Rehabil, 40 (4), pp. 263-278. , 1:STN:280:DC%2BC3szgs1Sjuw%3D%3D; Clarke, M., Chalmers, I., Discussion sections in reports of controlled trials published in general medical journals: Islands in search of continents? (1998) Jama, 280 (3), pp. 280-282. , 1:STN:280:DyaK1czjvFejtg%3D%3D; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2009) PLoS Med, 6 (7), p. e1000097; Puljak, L., If there is only one author or only one database was searched, a study should not be called a systematic review (2017) J Clin Epidemiol; Antman, E.M., Lau, J., Kupelnick, B., Mosteller, F., Chalmers, T.C., A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction (1992) JAMA, 268 (2), pp. 240-248. , 1:STN:280:DyaK38zgtVyqtA%3D%3D; Oxman, A.D., Guyatt, G.H., The science of reviewing research (1993) Ann N y Acad Sci, 703, pp. 125-133. , 1:STN:280:DyaK2c3kvFyhtQ%3D%3D discussion 133-124; Cobey, K.D., Lalu, M.M., Skidmore, B., Ahmadzai, N., Grudniewicz, A., Moher, D., What is a predatory journal? A scoping review (2018) F1000Research, 7, p. 1001},
correspondence_address1={Puljak, L.; Center for Evidence-Based Medicine and Health Care, Ilica 242, Croatia; email: livia.puljak@gmail.com},
publisher={BioMed Central Ltd.},
issn={14712288},
pubmed_id={31684874},
language={English},
abbrev_source_title={BMC Med. Res. Methodol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Patel2015231,
author={Patel, C.J. and Manrai, A.K.},
title={Development of exposome correlation globes to map out environment-wide associations},
journal={Pacific Symposium on Biocomputing},
year={2015},
pages={231-242},
note={cited By 56; Conference of 20th Pacific Symposium on Biocomputing, PSB 2015 ; Conference Date: 4 January 2015 Through 8 January 2015;  Conference Code:112847},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971326365&partnerID=40&md5=9a66b0b3d91dadcaba727e699f16785a},
affiliation={Center for Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA  02215, United States; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA  02138, United States},
abstract={The environment plays a major role in influencing diseases and health. The phenomenon of environmental exposure is complex and humans are not exposed to one or a handful factors but potentially hundreds factors throughout their lives. The exposome, the totality of exposures encountered from birth, is hypothesized to consist of multiple inter-dependencies, or correlations, between individual exposures. These correlations may reflect how individuals are exposed. Currently, we lack methods to comprehensively identify robust and replicated correlations between environmental exposures of the exposome. Further, we have not mapped how exposures associated with disease identified by environment-wide association studies (EWAS) are correlated with other exposures. To this end, we implement methods to describe a first "exposome globe", a comprehensive display of replicated correlations between individual exposures of the exposome. First, we describe overall characteristics of the dense correlations between exposures, showing that we are able to replicate 2,656 correlations between individual exposures of 81,937 total considered (3%). We document the correlation within and between broad a priori defined categories of exposures (e.g., pollutants and nutrient exposures). We also demonstrate utility of the exposome globe to contextualize exposures found through two EWASs in type 2 diabetes and all-cause mortality, such as exposure clusters putatively related to smoking behaviors and persistent pollutant exposure. The exposome globe construct is a useful tool for the display and communication of the complex relationships between exposure factors and between exposure factors related to disease status.},
keywords={Pollution, Complex relationships;  Dense correlations;  Environmental exposure;  Exposure factors;  Individual exposures;  Inter-dependencies;  Overall characteristics;  Pollutant exposures, Software packages, adverse effects;  biology;  Disease;  environmental exposure;  environmental health;  human;  nutrition;  risk factor;  unsupervised machine learning, Computational Biology;  Disease;  Environmental Exposure;  Environmental Health;  Humans;  Nutrition Surveys;  Risk Factors;  Unsupervised Machine Learning},
funding_details={National Human Genome Research InstituteNational Human Genome Research Institute, NHGRI, T32HG002295},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99ES023504},
references={Wild, C.P., Complementing the genome with an "exposome" the outstanding challenge of environmental exposure measurement in molecular epidemiology (2005) Cancer Epidemiol Biomarkers Prev, 14 (8), pp. 1847-1850; Rappaport, S.M., Smith, M.T., Environment and disease risks (2010) Science, 330 (6003), pp. 460-461; Patel, C.J., Ioannidis, J.P., Studying the elusive environment in large scale (2014) J Am Med Assoc, 311 (21), pp. 2173-2174; Patel, C.J., Bhattacharya, J., Butte, A.J., An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus (2010) PLoS One, 5 (5), p. e10746; Patel, C.J., Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey (2013) Int J Epidemiol, 42 (6), pp. 1795-1810; Hall, M.A., Environment-wide association study (EWAS) for type 2 diabetes in the marshfield personalized medicine research project biobank (2014) Pac Symp Biocomput, pp. 200-211; Ioannidis, J.P.A., Researching genetic versus nongenetic determinants of disease: A comparison and proposed unification (2009) Sci Transl Med, 1 (7), p. 8; Smith, G.D., Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology (2007) PLoS Med, 4 (12), p. e352; Patel, C.J., Ioannidis, J.P., Placing epidemiological results in the context of multiplicity and typical correlations of exposures (2014) J Epidemiol Community Health; Carlin, D., Unraveling the health effects of environmental mixtures: An niehs priority (2012) Environ Health Perspect, 121 (1), pp. a6-a8; Horvath, S., Weighted Network Analysis: Applications in Genomics and Systems Biology2011, , New York Springer; Eisen, M.B., Cluster analysis and display of genome-wide expression patterns (1998) Proc Natl Acad Sci U S A, 95 (25), pp. 14863-14868; Butte, A.J., Kohane, I.S., Mutual information relevance networks: Functional genomic clustering using pairwise entropy measurements (2000) Pac Symp Biocomput, pp. 418-429; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing (1995) J R Stat Soc B, 57 (1), pp. 289-300; Borenstein, M., Introduction to Meta-Analysis2009, , Chichester, UK: John Wiley and Sons; Krzywinski, M., Circos: An information aesthetic for comparative genomics (2009) Genome Res, 19 (9), pp. 1639-1645; Porta, M., Persistent organic pollutants and the burden of diabetes (2006) Lancet, 368 (9535), pp. 558-559; Pearson, T.A., Manolio, T.A., How to interpret a genome-wide association study (2008) J Am Med Assoc, 299 (11), pp. 1335-1344; Patel, C.J., Chen, R., Butte, A.J., Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with disease (2012) Bioinformatics, 28 (12), pp. i121-i126; Patel, C.J., Systematic identification of interaction effects between genome-and environment-wide associations in type 2 diabetes mellitus (2013) Hum Genet, 132 (5), pp. 495-508; Park, S.K., Environmental risk score as a new tool to examine multi-pollutants in epidemiologic research: An example from the NHANES study using serum lipid levels (2014) PLoS One, 9 (6), p. e98632; Yang, J., Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits (2012) Nat Genet, 44 (4); Magwene, P.M., Kim, J., Estimating genomic coexpression networks using first-order conditional independence (2004) Genome Biol, 5 (12), p. R100; Friedman, J., Hastie, T., Tibshirani, R., Sparse inverse covariance estimation with the graphical lasso (2008) Biostatistics, 9 (3), pp. 432-441},
correspondence_address1={Patel, C.J.; Center for Biomedical Informatics, 10 Shattuck Street, United States; email: chirag_patel@hms.harvard.edu},
sponsors={Computational Genetics Laboratory at Dartmouth College; DNAnexus; Institute for Computational Biology; National Library of Medicine (NLM)/National Institutes of Health},
issn={23356928},
pubmed_id={25592584},
language={English},
abbrev_source_title={Pac Symp Biocomput},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Godos2020138,
author={Godos, J. and Tieri, M. and Ghelfi, F. and Titta, L. and Marventano, S. and Lafranconi, A. and Gambera, A. and Alonzo, E. and Sciacca, S. and Buscemi, S. and Ray, S. and Del Rio, D. and Galvano, F. and Grosso, G.},
title={Dairy foods and health: an umbrella review of observational studies},
journal={International Journal of Food Sciences and Nutrition},
year={2020},
volume={71},
number={2},
pages={138-151},
doi={10.1080/09637486.2019.1625035},
note={cited By 52},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067561670&doi=10.1080%2f09637486.2019.1625035&partnerID=40&md5=84b7e20d289e1817322ee6c3c826796a},
affiliation={Oasi Research Institute–IRCCS, Troina, Italy; SmartFood Program, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy; NNEdPro Global Centre for Nutrition and Health, St John’s Innovation Centre, Cambridge, United Kingdom; Wolfson College at the University of Cambridge, Cambridge, United Kingdom; Nutrition Innovation Centre for Food and Health, Ulster University, Ulster, United Kingdom; Rimini Women’s Health, Childhood and Adolescent Department, AUSL Romagna, Rimini, Italy; University of Milano–Biccoca, Milan, Italy; Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands; Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Food and Nutrition Security and Public Health Service, ASP Catania, Catania, Italy; Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy; Medical Research Council (MRC) Human Nutrition Research Unit, Cambridge, United Kingdom; Laboratory of Phytochemicals in Physiology, Department of Food and Drug, University of Parma, Parma, Italy; Laboratory of Phytochemicals in Physiology, Department of Veterinary Science, University of Parma, Parma, Italy; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy},
abstract={Evidence on consumption of dairy foods and human health is contradictory. This study aimed to summarize the level of evidence of dairy consumption on various health outcomes. A systematic search for meta-analyses was performed: study design, dose–response relationship, heterogeneity and agreement of results over time, and identification of potential confounding factors were considered to assess the level of evidence. Convincing and probable evidence of decreased risk of colorectal cancer, hypertension and cardiovascular disease, elevated blood pressure and fatal stroke, respectively, was found for total dairy consumption; possible decreased risk of breast cancer, metabolic syndrome, stroke and type-2 diabetes, and increased risk of prostate cancer and Parkinson’s disease was also found. Similar, yet not entirely consistent evidence for individual dairy products was reported. Among potential confounding factors, geographical localisation and fat content of dairy have been detected. In conclusions, dairy may be part of a healthy diet; however, additional studies exploring confounding factors are needed to ascertain the potential detrimental effects. © 2019, © 2019 Taylor & Francis Group, LLC.},
author_keywords={butter;  cheese;  cohort;  Dairy products;  evidence;  meta-analysis;  milk;  prospective;  umbrella review;  yogurt},
keywords={adverse event;  dairy product;  health status;  human;  meta analysis (topic);  observational study, Dairy Products;  Health Status;  Humans;  Meta-Analysis as Topic;  Observational Studies as Topic},
references={Abbas, M.A., Physiological functions of Vitamin D in adipose tissue (2017) J Steroid Biochem Mol Biol, 165, pp. 369-381; Abedini, M., Falahi, E., Roosta, S., Dairy product consumption and the metabolic syndrome (2015) Diabetes Metab Syndr, 9 (1), pp. 34-37; Abid, Z., Cross, A.J., Sinha, R., Meat, dairy, and cancer (2014) Am J Clin Nutr, 100 Suppl 1, pp. 386S-393S; Alexander, D.D., Bylsma, L.C., Vargas, A.J., Cohen, S.S., Doucette, A., Mohamed, M., Irvin, S.R., Fryzek, J.P., Dairy consumption and CVD: a systematic review and meta-analysis–corrigendum (2016) Br J Nutr, 115 (12), p. 2268; Aune, D., Lau, R., Chan, D.S., Vieira, R., Greenwood, D.C., Kampman, E., Norat, T., Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies (2012) Ann Oncol, 23 (1), pp. 37-45; Aune, D., Navarro Rosenblatt, D.A., Chan, D.S., Vieira, A.R., Vieira, R., Greenwood, D.C., Vatten, L.J., Norat, T., Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies (2015) Am J Clin Nutr, 101 (1), pp. 87-117; Aune, D., Norat, T., Romundstad, P., Vatten, L.J., Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies (2013) Am J Clin Nutr, 98 (4), pp. 1066-1083; Bandera, E.V., Kushi, L.H., Moore, D.F., Gifkins, D.M., McCullough, M.L., Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis (2007) Cancer Causes Control, 18 (9), pp. 967-988; Bernstein, H., Bernstein, C., Payne, C.M., Dvorakova, K., Garewal, H., Bile acids as carcinogens in human gastrointestinal cancers (2005) Mutat Res, 589 (1), pp. 47-65; Bischoff-Ferrari, H.A., Dawson-Hughes, B., Baron, J.A., Kanis, J.A., Orav, E.J., Staehelin, H.B., Kiel, D.P., Spiegelman, D., Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies (2011) J Bone Miner Res, 26 (4), pp. 833-839; Bjornshave, A., Hermansen, K., Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes (2014) Rev Diabet Stud, 11 (2), pp. 153-166; Boyd, N.F., Martin, L.J., Noffel, M., Lockwood, G.A., Trichler, D.L., A meta-analysis of studies of dietary fat and breast cancer risk (1993) Br J Cancer, 68 (3), pp. 627-636; Boyd, N.F., Stone, J., Vogt, K.N., Connelly, B.S., Martin, L.J., Minkin, S., Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature (2003) Br J Cancer, 89 (9), pp. 1672-1685; Caini, S., Masala, G., Gnagnarella, P., Ermini, I., Russell-Edu, W., Palli, D., Gandini, S., Food of animal origin and risk of non-Hodgkin lymphoma and multiple myeloma: a review of the literature and meta-analysis (2016) Crit Rev Oncol Hematol, 100, pp. 16-24; Chen, H., O’Reilly, E., McCullough, M.L., Rodriguez, C., Schwarzschild, M.A., Calle, E.E., Thun, M.J., Ascherio, A., Consumption of dairy products and risk of Parkinson’s disease (2007) Am J Epidemiol, 165 (9), pp. 998-1006; Chen, M., Sun, Q., Giovannucci, E., Mozaffarian, D., Manson, J.E., Willett, W.C., Hu, F.B., Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis (2014) BMC Med, 12, p. 215; Chen, G.C., Szeto, I.M., Chen, L.H., Han, S.F., Li, Y.J., van Hekezen, R., Qin, L.Q., Dairy products consumption and metabolic syndrome in adults: systematic review and meta-analysis of observational studies (2015) Sci Rep, 5, p. 14606; Chen, G.C., Wang, Y., Tong, X., Szeto, I.M.Y., Smit, G., Li, Z.N., Qin, L.Q., Cheese consumption and risk of cardiovascular disease: a meta-analysis of prospective studies (2017) Eur J Nutr, 56 (8), pp. 2565-2575; Cho, E., Smith-Warner, S.A., Spiegelman, D., Beeson, W.L., van den Brandt, P.A., Colditz, G.A., Folsom, A.R., Giovannucci, E., Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies (2004) J Natl Cancer Inst, 96 (13), pp. 1015-1022; Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H.A., Johnson, L., Franco, O.H., Thompson, S.G., Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis (2014) Ann Intern Med, 160 (6), pp. 398-406; Comerford, K.B., Pasin, G., Gene-dairy food interactions and health outcomes: a review of nutrigenetic studies (2017) Nutrients, 9, p. pii: E710; Crotty, G.F., Ascherio, A., Schwarzschild, M.A., Targeting urate to reduce oxidative stress in Parkinson disease (2017) Exp Neurol, 298, pp. 210-224; Dardiotis, E., Xiromerisiou, G., Hadjichristodoulou, C., Tsatsakis, A.M., Wilks, M.F., Hadjigeorgiou, G.M., The interplay between environmental and genetic factors in Parkinson’s disease susceptibility: the evidence for pesticides (2013) Toxicology, 307, pp. 17-23; Davoodi, H., Esmaeili, S., Mortazavian, A.M., Effects of milk and milk products consumption on cancer: a review (2013) Compr Rev Food Sci Food Saf, 12 (3), pp. 249-264; de Goede, J., Geleijnse, J.M., Ding, E.L., Soedamah-Muthu, S.S., Effect of cheese consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials (2015) Nutr Rev, 73 (5), pp. 259-275; de Goede, J., Soedamah-Muthu, S.S., Pan, A., Gijsbers, L., Geleijnse, J.M., Dairy consumption and risk of stroke: a systematic review and updated dose-response meta-analysis of prospective cohort studies (2016) J Am Heart Assoc, 5. , pii: e002787; de Souza, R.J., Mente, A., Maroleanu, A., Cozma, A.I., Ha, V., Kishibe, T., Uleryk, E., Beyene, J., Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies (2015) BMJ, 351, p. h3978; Dong, J.Y., Zhang, L., He, K., Qin, L.Q., Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies (2011) Breast Cancer Res Treat, 127 (1), pp. 23-31; Elwood, P.C., Pickering, J.E., Hughes, J., Fehily, A.M., Ness, A.R., Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies (2004) Eur J Clin Nutr, 58 (5), pp. 718-724; Feldman, D., Krishnan, A.V., Swami, S., Giovannucci, E., Feldman, B.J., The role of vitamin D in reducing cancer risk and progression (2014) Nat Rev Cancer, 14 (5), pp. 342-357; Gao, X., LaValley, M.P., Tucker, K.L., Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis (2005) J Natl Cancer Inst, 97 (23), pp. 1768-1777; Gao, D., Ning, N., Wang, C., Wang, Y., Li, Q., Meng, Z., Liu, Y., Li, Q., Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis (2013) PLoS One, 8 (9); Giganti, M.G., Tresoldi, I., Masuelli, L., Modesti, A., Grosso, G., Liuni, F.M., Celi, M., Bei, R., Fracture healing: from basic science to role of nutrition (2014) Front Biosci, 19 (7), pp. 1162-1175; Gijsbers, L., Ding, E.L., Malik, V.S., de Goede, J., Geleijnse, J.M., Soedamah-Muthu, S.S., Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies (2016) Am J Clin Nutr, 103 (4), pp. 1111-1124; Gillingham, L.G., Harris-Janz, S., Jones, P.J., Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors (2011) Lipids, 46 (3), pp. 209-228; Guo, Y., Shan, Z., Ren, H., Chen, W., Dairy consumption and gastric cancer risk: a meta-analysis of epidemiological studies (2015) Nutr Cancer, 67 (4), pp. 555-568; Harrison, S., Lennon, R., Holly, J., Higgins, J.P.T., Gardner, M., Perks, C., Gaunt, T., Emmet, P., Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis (2017) Cancer Causes Control, 28 (6), pp. 497-528; Hu, D., Huang, J., Wang, Y., Zhang, D., Qu, Y., Dairy foods and risk of stroke: a meta-analysis of prospective cohort studies (2014) Nutr Metab Cardiovasc Dis, 24 (5), pp. 460-469; Huncharek, M., Muscat, J., Kupelnick, B., Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies (2008) Nutr Cancer, 60 (4), pp. 421-441; Huncharek, M., Muscat, J., Kupelnick, B., Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies (2009) Nutr Cancer, 61 (1), pp. 47-69; Huth, P.J., Park, K.M., Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence (2012) Adv Nutr, 3 (3), pp. 266-285; Jiang, W., Ju, C., Jiang, H., Zhang, D., Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies (2014) Eur J Epidemiol, 29 (9), pp. 613-619; Kim, Y., Je, Y., Dairy consumption and risk of metabolic syndrome: a meta-analysis (2016) Diabet Med, 33 (4), pp. 428-440; Kris-Etherton, P.M., Griel, A.E., Psota, T.L., Gebauer, S.K., Zhang, J., Etherton, T.D., Dietary stearic acid and risk of cardiovascular disease: intake, sources, digestion, and absorption (2005) Lipids, 40 (12), pp. 1193-1200; Larsson, S.C., Orsini, N., Wolk, A., Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies (2006) Int J Cancer, 118 (2), pp. 431-441; Li, F., An, S.L., Zhou, Y., Liang, Z.K., Jiao, Z.J., Jing, Y.M., Wan, P., Tan, W.L., Milk and dairy consumption and risk of bladder cancer: a meta-analysis (2011) Urology, 78 (6), pp. 1298-1305; Li, B.L., Jiang, G.X., Xue, Q., Zhang, H., Wang, C., Zhang, G.X., Xu, Z.Y., Dairy consumption and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies (2016) Asia Pac J Clin Oncol, 12 (2), pp. e269-e279; Lin, X., Liu, L., Fu, Y., Gao, J., He, Y., Wu, Y., Lian, X., Dietary cholesterol intake and risk of lung cancer: a meta-analysis (2018) Nutrients, 10, p. pii: E185; Liu, J., Tang, W., Sang, L., Dai, X., Wei, D., Luo, Y., Zhang, J., Milk, yogurt, and lactose intake and ovarian cancer risk: a meta-analysis (2015) Nutr Cancer, 67 (1), pp. 68-72; Lorenzen, P.C., Clawin-Rädecker, I., Einhoff, K., Hammer, P., Hartmann, R., Hoffmann, W., Martin, D., Devrese, M., A survey of the quality of extended shelf life (ESL) milk in relation to HTST and UHT milk (2011) Int J Dairy Tech, 64 (2), pp. 166-178; Lu, W., Chen, H., Niu, Y., Wu, H., Xia, D., Wu, Y., Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies (2016) Nutr J, 15, p. 91; Mao, Q.Q., Dai, Y., Lin, Y.W., Qin, J., Xie, L.P., Zheng, X.Y., Milk consumption and bladder cancer risk: a meta-analysis of published epidemiological studies (2011) Nutr Cancer, 63 (8), pp. 1263-1271; Min, B., Effects of vitamin d on blood pressure and endothelial function (2013) Korean J Physiol Pharmacol, 17 (5), pp. 385-392. , Oct; Mirmiran, P., Golzarand, M., Bahadoran, Z., Ataee, M., Azizi, F., Paradoxical association of dairy intake between men and women with the incidence of hypertension: a three‐year follow up in Tehran Lipid and Glucose Study (2016) Nutr Diet, 73, pp. 153-161; Mozaffarian, D., Cao, H., King, I.B., Lemaitre, R.N., Song, X., Siscovick, D.S., Hotamisligil, G.S., Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study (2010) Ann Intern Med, 153 (12), pp. 790-799; Mozaffarian, D., de Oliveira Otto, M.C., Lemaitre, R.N., Fretts, A.M., Hotamisligil, G., Tsai, M.Y., Siscovick, D.S., Nettleton, J.A., trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA) (2013) Am J Clin Nutr, 97 (4), pp. 854-861; Muldowney, S., Kiely, M., Vitamin D and cardiometabolic health: a review of the evidence (2011) Nutr Res Rev, 24 (1), pp. 1-20; Mullie, P., Pizot, C., Autier, P., Daily milk consumption and all-cause mortality, coronary heart disease and stroke: a systematic review and meta-analysis of observational cohort studies (2016) BMC Public Health, 16, p. 1236; Okajima, K., Harada, N., Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications (2006) Curr Med Chem, 13 (19), pp. 2241-2251; O’Sullivan, T.A., Hafekost, K., Mitrou, F., Lawrence, D., Food sources of saturated fat and the association with mortality: a meta-analysis (2013) Am J Public Health, 103 (9), pp. e31-e42; Paganoni, S., Schwarzschild, M.A., Urate as a marker of risk and progression of neurodegenerative disease (2017) Neurotherapeutics, 14 (1), pp. 148-153; Pal, S., Woodford, K., Kukuljan, S., Ho, S., Milk intolerance, beta-casein and lactose (2015) Nutrients, 7 (9), pp. 7285-7297; Palomer, X., Gonzalez-Clemente, J.M., Blanco-Vaca, F., Mauricio, D., Role of vitamin D in the pathogenesis of type 2 diabetes mellitus (2008) Diabetes Obes Metab, 10 (3), pp. 185-197; Pannu, P.K., Calton, E.K., Soares, M.J., Calcium and vitamin D in obesity and related chronic disease (2016) Adv Food Nutr Res, 77, pp. 57-100; Pereira, P.C., Milk nutritional composition and its role in human health (2014) Nutrition, 30 (6), pp. 619-627; Pimpin, L., Wu, J.H., Haskelberg, H., Del Gobbo, L., Mozaffarian, D., Is butter back? A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, and total mortality (2016) PLoS One, 11 (6); Qin, L.Q., Xu, J.Y., Han, S.F., Zhang, Z.L., Zhao, Y.Y., Szeto, I.M., Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies (2015) Asia Pac J Clin Nutr, 24, pp. 90-100; Qin, L.Q., Xu, J.Y., Wang, P.Y., Hashi, A., Hoshi, K., Sato, A., Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies (2005) Eur J Cancer Prev, 14 (1), pp. 13-19; Qin, L.Q., Xu, J.Y., Wang, P.Y., Kaneko, T., Hoshi, K., Sato, A., Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies (2004) Nutr Cancer, 48 (1), pp. 22-27; Qin, L.Q., Xu, J.Y., Wang, P.Y., Tong, J., Hoshi, K., Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies (2007) Asia Pac J Clin Nutr, 16, pp. 467-476; Ralston, R.A., Lee, J.H., Truby, H., Palermo, C.E., Walker, K.Z., A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods (2012) J Hum Hypertens, 26 (1), pp. 3-13; Ralston, R.A., Truby, H., Palermo, C.E., Walker, K.Z., Colorectal cancer and nonfermented milk, solid cheese, and fermented milk consumption: a systematic review and meta-analysis of prospective studies (2014) Crit Rev Food Sci Nutr, 54 (9), pp. 1167-1179; Riaz Rajoka, M.S., Shi, J., Mehwish, H.M., Zhu, J., Li, Q., Shao, D., Huang, Q., Yang, H., Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health (2017) Food Sci Human Wellness, 6 (3), pp. 121-130; Rice Bradley, B.H., Dietary fat and risk for type 2 diabetes: a review of recent research (2018) Curr Nutr Rep, 7 (4), pp. 214-226; Roddam, A.W., Allen, N.E., Appleby, P., Key, T.J., Ferrucci, L., Carter, H.B., Metter, E.J., Fitzpatrick, A., Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies (2008) Ann Intern Med, 149, pp. 461-471; Serrano, S.E., Braun, J., Trasande, L., Dills, R., Sathyanarayana, S., Phthalates and diet: a review of the food monitoring and epidemiology data (2014) Environ Health, 13 (1), p. 43; Siri-Tarino, P.W., Sun, Q., Hu, F.B., Krauss, R.M., Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease (2010) Am J Clin Nutr, 91 (3), pp. 535-546; Sluijs, I., Forouhi, N.G., Beulens, J.W., van der Schouw, Y.T., Agnoli, C., Arriola, L., Balkau, B., Bueno-de-Mesquita, H.B., The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study (2012) Am J Clin Nutr, 96 (2), pp. 382-390; Soedamah-Muthu, S.S., Ding, E.L., Al-Delaimy, W.K., Hu, F.B., Engberink, M.F., Willett, W.C., Geleijnse, J.M., Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies (2011) Am J Clin Nutr, 93 (1), pp. 158-171; Soedamah-Muthu, S.S., Verberne, L.D., Ding, E.L., Engberink, M.F., Geleijnse, J.M., Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies (2012) Hypertension, 60 (5), pp. 1131-1137; Sun, Y., Lin, L.J., Sang, L.X., Dai, C., Jiang, M., Zheng, C.Q., Dairy product consumption and gastric cancer risk: a meta-analysis (2014) WJG, 20 (42), pp. 15879-15898; Sun, X., Zemel, M.B., Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk (2008) J Nutr Biochem, 19 (6), pp. 392-399; Tian, S.B., Yu, J.C., Kang, W.M., Ma, Z.Q., Ye, X., Cao, Z.J., Association between dairy intake and gastric cancer: a meta-analysis of observational studies (2014) PLoS One, 9 (7); Tong, X., Dong, J.Y., Wu, Z.W., Li, W., Qin, L.Q., Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies (2011) Eur J Clin Nutr, 65 (9), pp. 1027-1031; Touvier, M., Fassier, P., His, M., Norat, T., Chan, D.S., Blacher, J., Hercberg, S., Latino-Martel, P., Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies (2015) Br J Nutr, 114 (3), pp. 347-357; Tunick, M.H., Ren, D.X., Van Hekken, D.L., Bonnaillie, L., Paul, M., Kwoczak, R., Tomasula, P.M., Effect of heat and homogenization on in vitro digestion of milk (2016) J Dairy Sci, 99 (6), pp. 4124-4139; Wang, J., Li, X., Zhang, D., Dairy product consumption and risk of non-hodgkin lymphoma: a meta-analysis (2016) Nutrients, 8 (3), p. 120; Whitfield, J.F., Calcium, calcium-sensing receptor and colon cancer (2009) Cancer Lett, 275 (1), pp. 9-16; Wu, L., Sun, D., Meta-analysis of milk consumption and the risk of cognitive disorders (2016) Nutrients, 8, p. pii: E824; Wu, J., Zeng, R., Huang, J., Li, X., Zhang, J., Ho, J.C., Zheng, Y., Dietary protein sources and incidence of breast cancer: a dose-response meta-analysis of prospective studies (2016) Nutrients, 8, p. pii: E730; Xu, C., Han, F.F., Zeng, X.T., Liu, T.Z., Li, S., Gao, Z.Y., Fat intake is not linked to prostate cancer: a systematic review and dose-response meta-analysis (2015) PLoS One, 10 (7); Xu, C., Zhang, C., Wang, X.L., Liu, T.Z., Zeng, X.T., Li, S., Duan, X.W., Self-fluid management in prevention of kidney stones: a PRISMA-compliant systematic review and dose-response meta-analysis of observational studies (2015) Medicine (Baltimore), 94 (27), p. e1042; Yang, Y., Wang, X., Yao, Q., Qin, L., Xu, C., Dairy product, calcium intake and lung cancer risk: a systematic review with meta-analysis (2016) Sci Rep, 6, p. 20624; Yang, J., Yu, J., The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get (2018) Protein Cell, 9 (5), pp. 474-487; Yu, Y., Li, H., Xu, K., Li, X., Hu, C., Wei, H., Zeng, X., Jing, X., Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies (2016) Onco Targets Ther, 9, pp. 111-116; YuPeng, L., YuXue, Z., PengFei, L., Cheng, C., YaShuang, Z., DaPeng, L., Chen, D., Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies (2015) Cancer Epidemiol Biomarkers Prev, 24 (7), pp. 1086-1093; Zang, J., Shen, M., Du, S., Chen, T., Zou, S., The association between dairy intake and breast cancer in Western and Asian populations: a systematic review and meta-analysis (2015) J Breast Cancer, 18 (4), pp. 313-322},
correspondence_address1={Grosso, G.; Department of Biomedical and Biotechnological Sciences, Via Santa Sofia 97, Italy; email: giuseppe.grosso@unict.it},
publisher={Taylor and Francis Ltd},
issn={09637486},
coden={IJFNE},
pubmed_id={31199182},
language={English},
abbrev_source_title={Int. J. Food Sci. Nutr.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Yi2019,
author={Yi, M. and Wu, X. and Zhuang, W. and Xia, L. and Chen, Y. and Zhao, R. and Wan, Q. and Du, L. and Zhou, Y.},
title={Tea Consumption and Health Outcomes: Umbrella Review of Meta-Analyses of Observational Studies in Humans},
journal={Molecular Nutrition and Food Research},
year={2019},
volume={63},
number={16},
doi={10.1002/mnfr.201900389},
art_number={1900389},
note={cited By 50},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068498227&doi=10.1002%2fmnfr.201900389&partnerID=40&md5=e239554336a400459993eb10c8c69887},
affiliation={Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China; Chinese Evidence-Based Medicine/Cochrane Center, Chengdu, 610041, China},
abstract={Scope: The aim of this article is to conduct an umbrella review to study the strength and validity of associations between tea consumption and diverse health outcomes. Methods and results: Meta-analyses of observational studies examining associations between tea consumption and health outcomes in all human populations and settings are screened. The umbrella review identifies 96 meta-analyses with 40 unique health outcomes. Tea consumption shows greater benefits than harm to health in this review. Dose–response analyses of tea consumption indicates reduced risks of total mortality, cardiac death, coronary artery disease, stroke, and type 2 diabetes mellitus with increment of two to three cups per day. Beneficial associations are also found for several cancers, skeletal, cognitive, and maternal outcomes. Harmful associations are found for esophageal and gastric cancer when the temperature of intake is more than 55–60 °C. Conclusion: Tea consumption, except for very hot tea, seems generally safe at usual levels of intake, with summary estimates indicating the largest reduction for diverse health outcomes at two to three cups per day. Generally, tea consumption seems more beneficial than harmful in this umbrella review. Randomized controlled trials are further needed to understand whether the observed associations are causal. © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim},
author_keywords={health;  meta-analysis;  tea consumption;  umbrella review},
keywords={cardiovascular disease;  cognition;  human;  meta analysis (topic);  mortality;  neoplasm;  observational study;  publishing;  tea, Cardiovascular Diseases;  Cognition;  Humans;  Meta-Analysis as Topic;  Neoplasms;  Observational Studies as Topic;  Publication Bias;  Tea},
chemicals_cas={Tea},
funding_details={98–680},
funding_details={2016SZ0047},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 30901427},
funding_text 1={Y.Z. and M.Y. together conceived the study. M.Y., X.W., Q.W., R.Z., W. Z., L.X., Y.C., and L.D. performed data extraction, analysis, and interpretation. M.Y. wrote the manuscript under the guidance of Y.Z. All authors have read the manuscript and approved the manuscript. This work was supported by Chinese Medical Board Grant on Evidence-Based Medicine, New York, USA (No. 98–680), National Natural Science Foundation of China (No. 30901427) and Sichuan Provincial Science and Technology Support Project (2016SZ0047).},
references={Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y., Tsuji, I., (2006) JAMA, J. Am. Med. Assoc., 296, p. 1255; Brody, H., (2019) Nature, 566, p. S1; Caderni, G., De Filippo, C., Luceri, C., Salvadori, M., Giannini, A., Biggeri, A., Remy, S., Dolara, P., (2000) Carcinogenesis, 21, p. 1965; Yamane, T., Nakatani, H., Kikuoka, N., Matsumoto, H., Iwata, Y., Kitao, Y., Oya, K., Takahashi, T., (1996) Cancer, 77, p. 1662; Xu, Y., Ho, C.T., Amin, S.G., Han, C., Chung, F.L., (1992) Cancer Res, 52, p. 3875; Zhu, M., Gong, Y., Yang, Z., Ge, G., Han, C., Chen, J., (1999) Nutr. Cancer, 35, p. 64; Raederstorff, D.G., Schlachter, M.F., Elste, V., Weber, P., (2003) J. Nutr. Biochem., 14, p. 326; Miura, Y., Chiba, T., Tomita, I., Koizumi, H., Miura, S., Umegaki, K., Hara, Y., Tomita, T., (2001) J. Nutr., 131, p. 27; Wu, L.Y., Juan, C.C., Ho, L.T., Hsu, Y.P., Hwang, L.S., (2004) J. Agric. Food Chem., 52, p. 643; Crespy, V., Williamson, G., (2004) J. Nutr., 134, p. 3431S; Ioannidis, J.P., (2008) Epidemiology, 19, p. 640; Ioannidis, J.P., (2007) PLoS Med., 4; Dwan, K., Gamble, C., Williamson, P.R., Kirkham, J.J., Reporting Bias, G., (2013) PLoS One, 8; Zhou, Y., Li, N., Zhuang, W., Liu, G.J., Wu, T.X., Yao, X., Du, L., Wu, X.T., (2008) Asia Pac. J. Clin. Nutr., 17, p. 159; Ioannidis, J.P., (2009) Can. Med. Assoc. J., 181, p. 488; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., (2015) Int. J. Evidence-Based Healthcare, 13, p. 132; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., (2007) BMC Med. Res. Methodol., 7, p. 10; Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., Norris, S., Schunemann, H.J., (2011) J. Clin. Epidemiol, 64, p. 383; Zhang, C., Qin, Y.Y., Wei, X., Yu, F.F., Zhou, Y.H., He, J., (2015) Eur. J. Epidemiol., 30, p. 103; Tang, J., Zheng, J.S., Fang, L., Jin, Y., Cai, W., Li, D., (2015) Br. J. Nutr, 114, p. 673; Xiong, J.P., Lin, J.Z., Wang, A.Q., Wang, Y.Q., Zheng, Y., Sang, X.T., Xu, Y.Y., Zhao, H.T., (2017) Oncotarget, 8, p. 39649; Zhang, W.D., Geng, T., Han, W.F., Dou, H.Q., (2014) Med. Sci. Monit., 20, p. 2142; Zhong, S.L., Chen, Z.Y., Yu, X.N., Chen, W.X., Lv, M.M., Ma, T.F., Zhao, J.H., (2014) Tumor Biol, 35, p. 5205; Ma, S.G., Wang, C.Y., Bai, J.D., Wang, X.P., Li, C.D., (2015) Int. J. Clin. Exp. Med., 8, p. 14345; Wang, L.F., Zhang, X.W., Liu, J., Shen, L., Li, Z.Q., (2014) Nutrition, 30, p. 1122; Malerba, S., Galeone, C., Pelucchi, C., Turati, F., Hashibe, M., La Vecchia, C., Tavani, A., (2013) Cancer Causes Control, 24, p. 267; Ni, C.X., Gong, H., Liu, Y., Qi, Y., Jiang, C.L., Zhang, J.P., (2017) Nutr. Cancer, 69, p. 211; Zhang, D.Y., Kaushiva, A., Xi, Y.Z., Wang, T.T., Li, N., (2018) Carcinogenesis, 39, p. 808; Zhou, Q., Li, H., Zhou, J.G., Ma, Y., Wu, T., Ma, H., (2016) Arch. Gynecol. Obstet., 293, p. 143; Zheng, J.S., Yang, J., Fu, Y.Q., Huang, T., Huang, Y.J., Li, D., (2013) Nutr. Cancer, 65, p. 1; Zhu, G., Hua, J., Wang, Z., She, F., Chen, Y., (2015) Mol. Clin. Oncol., 3, p. 613; Chen, Y., Wu, Y., Du, M., Chu, H., Zhu, L., Tong, N., Zhang, Z., Chen, J., (2017) Oncotarget, 8, p. 37367; Huang, Y.H., Chen, H.R., Zhou, L., Li, G.M., Yi, D.L., Zhang, Y.Q., Wu, Y.Z., Yi, D., (2017) Public Health Nutr, 20, p. 3183; Zhang, Y.F., Xu, Q., Lu, J., Wang, P., Zhang, H.W., Zhou, L., Ma, X.Q., Zhou, Y.H., (2015) Eur. J. Cancer Prev., 24, p. 353; Najafi, M.N., Salehi, M., Ghazanfarpour, M., Hoseini, Z.S., Khadem-Rezaiyan, M., (2018) Phytother. Res., 32, p. 1855; Nie, X.C., Dong, D.S., Bai, Y., Xia, P., (2014) Nutr. Cancer, 66, p. 1009; Caini, S., Cattaruzza, M.S., Bendinelli, B., Tosti, G., Masala, G., Gnagnarella, P., Assedi, M., Gandini, S., (2017) Eur. J. Nutr., 56, p. 2005; Weng, H., Zeng, X.T., Li, S., Kwong, J.S.W., Liu, T.Z., Wang, X.H., (2017) Front. Physiol, 7, p. 693; Guo, Y.M., Zhi, F., Chen, P., Zhao, K.K., Xiang, H., Mao, Q., Wang, X.H., Zhang, X.H., (2017) Medicine, 96; Lin, Y.-W., Hu, Z.-H., Wang, X., Mao, Q.-Q., Qin, J., Zheng, X.-Y., Xie, L.-P., (2014) World J. Surg. Oncol, 12. , 38; Chen, K., Zhang, Q., Peng, M., Shen, Y.P., Wan, P., Xie, G.M., (2014) Eur. J. Cancer Prev., 23, p. 353; Wang, Z.H., Gao, Q.Y., Fang, J.Y., (2012) Nutr. Cancer, 64, p. 1143; Sun, C.L., Yuan, J.M., Koh, W.P., Yu, M.C., (2006) Carcinogenesis, 27, p. 1301; Hu, Z.H., Lin, Y.W., Xu, X., Chen, H., Mao, Y.Q., Wu, J., Xu, X.L., Xie, L.P., (2013) Asian Pac. J. Cancer Prev., 14, p. 1691; Pang, J., Zhang, Z., Zheng, T.Z., Bassig, B.A., Mao, C., Liu, X.B., Zhu, Y., Peng, Y., (2016) Int. J. Cardiol., 202, p. 967; Wang, Z.M., Zhou, B., Wang, Y.S., Gong, Q.Y., Wang, Q.M., Yan, J.J., Gao, W., Wang, L.S., (2011) Am. J. Clin. Nutr., 93, p. 506; Yang, W.S., Wang, W.Y., Fan, W.Y., Deng, Q., Wang, X., (2014) Br. J. Nutr., 111, p. 1329; Sheng, J., Qu, X., Zhang, X., Zhai, Z., Li, H., Liu, X., Li, H., Dai, K., (2014) Osteoporosis Int., 25, p. 141; Yan, A., Zhang, H.H., Wang, S.Q., Zhao, Y., (2015) Int. J. Clin. Exp. Med., 8, p. 8347; Zhang, Z.F., Yang, J.L., Jiang, H.C., Lai, Z., Wu, F., Liu, Z.X., (2017) Medicine, 96; Sun, K., Wang, L., Ma, Q.P., Cui, Q.Y., Lv, Q.R., Zhang, W.Z., Li, X.H., (2017) Medicine, 96; Liu, X.Y., Du, X.Y., Han, G.Y., Gao, W.Y., (2017) Oncotarget, 8, p. 43306; Qi, H., Li, S.X., (2014) Geriatr. Gerontol. Int, 14, p. 430; Grosso, G., Micek, A., Castellano, S., Pajak, A., Galvano, F., (2016) Mol. Nutr. Food Res., 60, p. 223; Thomopoulos, T.P., Ntouvelis, E., Diamantaras, A.A., Tzanoudaki, M., Baka, M., Hatzipantelis, E., Kourti, M., Petridou, E.T., (2015) Cancer Epidemiol., 39, p. 1047; Lee, Y.H., Bae, S.C., Song, G.G., (2015) Clin. Rheumatol., 34, p. 403; Arts, I.C., Hollman, P.C., Feskens, E.J., Bueno de Mesquita, H.B., Kromhout, D., (2001) Am. J. Clin. Nutr, 74, p. 227; Halder, B., Pramanick, S., Mukhopadhyay, S., Giri, A.K., (2006) Toxicol. In Vitro, 20, p. 608; Sang, L.X., Chang, B., Li, X.H., Jiang, M., (2013) Nutr. Cancer, 65, p. 802; Bae, S.E., Hur, C., Choi, S.E., Tramontano, A., (2012) Gastroenterology, 142, pp. S-765; Tsubono, Y., Nishino, Y., Komatsu, S., Hsieh, C.C., Kanemura, S., Tsuji, I., Nakatsuka, H., Hisamichi, S., (2001) N. Engl. J. Med., 344, p. 632; Kono, S., (2001) N. Engl. J. Med., 344, p. 1867; Sano, T., Sasako, M., (2001) N. Engl. J. Med., 344, p. 675; McCann, S.E., Yeh, M., Rodabaugh, K., Moysich, K.B., (2009) Int. J. Cancer, 124, p. 1650; Zhang, M., Lee, A.H., Binns, C.W., Xie, X., (2004) Int. J. Cancer, 112, p. 465; Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., Corti, A., (2006) Cancer Res., 66, p. 1234; Yang, C.S., Wang, X., Lu, G., Picinich, S.C., (2009) Nat. Rev. Cancer, 9, p. 429; Valcic, S., Burr, J.A., Timmermann, B.N., Liebler, D.C., (2000) Chem. Res. Toxicol., 13, p. 801; Johnson, I.T., (2010) Lancet Oncol., 11, p. 519; Ju, J., Lu, G., Lambert, J.D., Yang, C.S., (2007) Semin. Cancer Biol., 17, p. 395; Mitsiades, C.S., Mitsiades, N.S., McMullan, C.J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Kung, A.L., (2004) Cancer Cell, 5, p. 221; Miller, P.E., Zhao, D., Frazier-Wood, A.C., Michos, E.D., Averill, M., Sandfort, V., Burke, G.L., Martin, S.S., (2017) Am. J. Med., 130, p. 188; Young, W., Hotovec, R.L., Romero, A.G., (1967) Nature, 216, p. 1015; Samavat, H., Newman, A.R., Wang, R., Yuan, J.M., Wu, A.H., Kurzer, M.S., (2016) Am. J. Clin. Nutr, 104, p. 1671; Cuccioloni, M., Mozzicafreddo, M., Spina, M., Tran, C.N., Falconi, M., Eleuteri, A.M., Angeletti, M., (2011) J. Lipid Res., 52, p. 897; Bose, M., Lambert, J.D., Ju, J., Reuhl, K.R., Shapses, S.A., Yang, C.S., (2008) J. Nutr., 138, p. 1677; Chen, Y.K., Cheung, C., Reuhl, K.R., Liu, A.B., Lee, M.J., Lu, Y.P., Yang, C.S., (2011) J. Agric. Food Chem., 59, p. 11862; de Whalley, C.V., Rankin, S.M., Hoult, J.R., Jessup, W., Leake, D.S., (1990) Biochem. Pharmacol., 39, p. 1743; Salonen, J.T., Yla-Herttuala, S., Yamamoto, R., Butler, S., Korpela, H., Salonen, R., Nyyssonen, K., Witztum, J.L., (1992) Lancet, 339, p. 883; Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, C.L., Hollenberg, N.K., Sies, H., Kelm, M., (2006) Proc. Natl. Acad. Sci. U. S. A, 103, p. 1024; Almeida Rezende, B., Pereira, A.C., Cortes, S.F., Lemos, V.S., (2016) Curr. Med. Chem., 23, p. 87; Cos, P., Ying, L., Calomme, M., Hu, J.P., Cimanga, K., Van Poel, B., Pieters, L., Vanden Berghe, D., (1998) J. Nat. Prod., 61, p. 71; Lorenz, M., Jochmann, N., von Krosigk, A., Martus, P., Baumann, G., Stangl, K., Stangl, V., (2007) Eur. Heart J., 28, p. 219; de la Torre, R., de Sola, S., Hernandez, G., Farre, M., Pujol, J., Rodriguez, J., Espadaler, J.M., Dierssen, M., (2016) Lancet Neurol., 15, p. 801; de la Torre, R., Dierssen, M., (2012) Prog. Brain Res, 197, p. 1; Ramakrishna, N., Meeker, H.C., Brown, W.T., (2016) Mol. Neurobiol., 53, p. 155; Vacca, R.A., Valenti, D., (2015) Clin. Nutr., 34, p. 783; Lee, S.J., Jia, Y., (2015) Curr. Opin. Lipidol., 26, p. 3; Brunning, D.A., (1974) Lancet, 303, p. 272; Islami, F., Pourshams, A., Nasrollahzadeh, D., Kamangar, F., Fahimi, S., Shakeri, R., Abedi-Ardekani, B., Boffetta, P., (2009) BMJ, 338, p. b929; Sheikh, M., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., Khoshnia, M., Gharavi, A., Malekzadeh, R., (2019) Gastroenterology, , 156, 1416; Yioris, N., Ivankovic, S., Lehnert, T., (1984) Oncology, 41, p. 36; Li, Z.G., Shimada, Y., Sato, F., Maeda, M., Itami, A., Kaganoi, J., Komoto, I., Imamura, M., (2003) Oncol. Rep, 10, p. 421; Mirvish, S.S., (1995) Cancer Lett, 93, p. 17; Putz, A., Hartmann, A.A., Fontes, P.R., Alexandre, C.O., Silveira, D.A., Klug, S.J., Rabes, H.M., (2002) Int. J. Cancer, 98, p. 99; Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Harris, C.C., (1999) JNCI, J. Natl. Cancer Inst., 91, p. 86},
correspondence_address1={Zhou, Y.; Department of Gastrointestinal Surgery, China; email: nutritioner@hotmail.com},
publisher={Wiley-VCH Verlag},
issn={16134125},
pubmed_id={31216091},
language={English},
abbrev_source_title={Mol. Nutr. Food Res.},
document_type={Review},
source={Scopus},
}

@ARTICLE{He2018543,
author={He, Y. and Li, X. and Gasevic, D. and Brunt, E. and McLachlan, F. and Millenson, M. and Timofeeva, M. and Ioannidis, J.P.A. and Campbell, H. and Theodoratou, E.},
title={Statins and multiple noncardiovascular outcomes: Umbrella review of meta-Analyses of observational studies and randomized controlled trials},
journal={Annals of Internal Medicine},
year={2018},
volume={169},
number={8},
pages={543-553},
doi={10.7326/M18-0808},
note={cited By 50},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055079791&doi=10.7326%2fM18-0808&partnerID=40&md5=38110e9e0861c4812013258990498e1a},
affiliation={Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, EH8 9AG, United Kingdom; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne Victoria, VIC  3004, Australia; University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG, United Kingdom; Children's Hospital of Philadelphia, Center for Pediatric Clinical Effectiveness, 2716 South Street, Philadelphia, PA  19146, United States; Colon Cancer Genetics Group, 4th Floor MRCHGU, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, United Kingdom; Stanford Prevention Research Center, Stanford University School of Medicine, Medical School Office Building, 1265 Welch Road, Stanford, CA  94305, United States},
abstract={Background: Many effects of statins on non-cardiovascular disease (non-CVD) outcomes have been reported. Purpose: To evaluate the quantity, validity, and credibility of evidence regarding associations between statins and non-CVD outcomes and the effects of statins on these outcomes. Data Sources: MEDLINE and EMBASE (English terms only, inception to 28 May 2018). Study Selection: Meta-Analyses (published in English) of observational studies and of randomized controlled trials (RCTs) that examined non-CVD outcomes of statin intake. Data Extraction: Two investigators extracted data from metaanalyses and individual studies. Credibility assessments based on summary effect sizes from a random-effects model, betweenstudy heterogeneity, 95% prediction interval, small-study effect, excess significance, and credibility ceilings were devised to classify evidence. Data Synthesis: This review explored 278 unique non-CVD outcomes from 112 meta-Analyses of observational studies and 144 meta-Analyses of RCTs. For observational studies, no convincing (class I) evidence, 2 highly suggestive (class II) associations (decreased cancer mortality in patients with cancer and decreased exacerbation in patients with chronic obstructive pulmonary disease), 21 suggestive (class III) associations, and 42 weak (class IV) associations were identified. One outcome from the RCTs (decreased all-cause mortality in patients with chronic kidney disease) attained a sufficient amount of evidence with no hints of bias. For adverse events, observational studies showed suggestive evidence that statins increase the risk for diabetes and myopathy. Among the RCTs, no statistically significant effects were found on myopathy, myalgia, or rhabdomyolysis. Limitations: Studies with relevant data and outcomes not included in the meta-Analyses may have been missed. Credibility assessments relied on several assumptions and arbitrary thresholds. Conclusion: The absence of convincing evidence of an association between statins and non-CVD outcomes supports leaving the current recommendations unchanged. Primary Funding Source: None. © 2018 American College of Physicians. All rights reserved.},
keywords={hydroxymethylglutaryl coenzyme A reductase inhibitor;  hydroxymethylglutaryl coenzyme A reductase inhibitor, adverse outcome;  all cause mortality;  cancer mortality;  chronic kidney failure;  chronic obstructive lung disease;  clinical evaluation;  clinical outcome;  comparative study;  credibility;  data analysis;  data extraction;  data synthesis;  diabetes mellitus;  disease association;  disease exacerbation;  drug safety;  Embase;  evidence based practice;  human;  malignant neoplasm;  Medline;  myalgia;  myopathy;  observational study;  outcome assessment;  priority journal;  quality control;  randomized controlled trial (topic);  Review;  rhabdomyolysis;  systematic review;  validity;  chronic kidney failure;  chronic obstructive lung disease;  diabetes mellitus;  meta analysis;  muscle disease;  neoplasm;  treatment outcome, Diabetes Mellitus;  Humans;  Hydroxymethylglutaryl-CoA Reductase Inhibitors;  Muscular Diseases;  Neoplasms;  Observational Studies as Topic;  Pulmonary Disease, Chronic Obstructive;  Randomized Controlled Trials as Topic;  Renal Insufficiency, Chronic;  Treatment Outcome},
chemicals_cas={Hydroxymethylglutaryl-CoA Reductase Inhibitors},
funding_details={Cancer Research UKCancer Research UK, CRUK, C31250/A22804},
funding_details={China Scholarship CouncilChina Scholarship Council, CSC},
funding_text 1={Grant Support: Dr. He and Ms. Li are supported by the China Scholarship Council. Dr. Theodoratou is supported by a Cancer Research UK (CRUK) Career Development Fellowship (C31250/A22804).},
references={Endo, A., A historical perspective on the discovery of statins (2010) Proc Jpn Acad ser B Phys Biol Sci, 86, pp. 484-493; Ross, S.D., Allen, I.E., Connelly, J.E., Korenblat, B.M., Smith, M.E., Bishop, D., Clinical outcomes in statin treatment trials: A meta-Analysis (1999) Arch Intern Med, 159, pp. 1793-1802; Brugts, J.J., Yetgin, T., Hoeks, S.E., Gotto, A.M., Shepherd, J., Westendorp, R.G., The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Metaanalysis of randomised controlled trials (2009) BMJ, 338, p. b2376; Adedinsewo, D., Taka, N., Agasthi, P., Sachdeva, R., Rust, G., Onwuanyi, A., Prevalence and factors associated with statin use among a nationally representative sample of US adults: National Health and Nutrition Examination Survey 2011-2012 (2016) Clin Cardiol, 39, pp. 491-496; Ioannidis, J.P., More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines (2014) JAMA, 311, pp. 463-464; Walley, T., Folino-Gallo, P., Schwabe, U., Van Ganse, E., Variations and increase in use of statins across Europe: Data from administrative databases (2004) BMJ, 328, pp. 385-386. , EuroMedStat group; Stone, N.J., Robinson, J.G., Lichtenstein, A.H., Bairey Merz, C.N., Blum, C.B., Eckel, R.H., (2014) J Am Coll Cardiol, 63, pp. 2889-2934. , American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines; DerSimonian, R., Laird, N., Meta-Analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Cornell, J.E., Mulrow, C.D., Localio, R., Stack, C.B., Meibohm, A.R., Guallar, E., Random-effects meta-Analysis of inconsistent effects: A time for change (2014) Ann Intern Med, 160, pp. 267-270; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a metaanalysis (2002) Stat Med, 21, pp. 1539-1558; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-Analysis (2009) J R Stat Soc ser A Stat Soc, 172, pp. 137-159; Higgins, J.P., Commentary: Heterogeneity in meta-Analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in metaanalysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry, 68, pp. 773-780; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Salanti, G., Ioannidis, J.P., Synthesis of observational studies should consider credibility ceilings (2009) J Clin Epidemiol, 62, pp. 115-122; Papatheodorou, S.I., Tsilidis, K.K., Evangelou, E., Ioannidis, J.P., Application of credibility ceilings probes the robustness of meta-Analyses of biomarkers and cancer risk (2015) J Clin Epidemiol, 68, pp. 163-174; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-Analysis (2000) Stat Med, 19, pp. 3127-3131; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-Analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008; Kavanagh, B.P., The GRADE system for rating clinical guidelines (2009) PLoS Med, 6, p. e1000094; Jpt, H., Green, S., (2011) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. London: The Cochrane Collaboration, , https://handbook-5-1.cochrane.org, on 31 August 2018; Pursnani, A., Massaro, J.M., DAgostino, R.B., Jr., O'Donnell, C.J., Hoffmann, U., Guideline-based statin eligibility, cancer events, and noncardiovascular mortality in the framingham heart study (2017) J Clin Oncol, 35, pp. 2927-2933; Sassano, A., Platanias, L.C., Statins in tumor suppression (2008) Cancer Lett, 260, pp. 11-19; Ukomadu, C., Dutta A. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases (2003) J Biol Chem, 278, pp. 43586-43594; Campbell, M.J., Esserman, L.J., Zhou, Y., Shoemaker, M., Lobo, M., Borman, E., Breast cancer growth prevention by statins (2006) Cancer Res, 66, pp. 8707-8714; Fedson, D.S., Treating influenza with statins and other immunomodulatory agents (2013) Antiviral Res, 99, pp. 417-435; Gilbert, C., Bergeron, M., Méthot, S., Giguère, J.F., Tremblay, M.J., Statins could be used to control replication of some viruses, including HIV-1 (2005) Viral Immunol, 18, pp. 474-489; Ou, X.M., Wang, B.D., Wen, F.Q., Feng, Y.L., Huang, X.Y., Xiao, J., Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats (2008) Chin Med J (Engl), 121, pp. 1680-1687; Arnaud, C., Burger, F., Steffens, S., Veillard, N.R., Nguyen, T.H., Trono, D., Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: New evidence for direct antiinflammatory effects of statins (2005) Arterioscler Thromb Vasc Biol, 25, pp. 1231-1236; Ito, T., Ikeda, U., Yamamoto, K., Shimada, K., Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells (2002) Atherosclerosis, 165, pp. 51-55; Murphy, D.M., Forrest, I.A., Corris, P.A., Johnson, G.E., Small, T., Jones, D., Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients (2008) Am J Physiol Lung Cell Mol Physiol, 294, pp. L592-L599; Criner, G.J., Bourbeau, J., Diekemper, R.L., Ouellette, D.R., Goodridge, D., Hernandez, P., Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline (2015) Chest, 147, pp. 894-942; (2015) Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, , www.goldcopd.org, on 27 August 2015; Gansevoort, R.T., Correa-Rotter, R., Hemmelgarn, B.R., Jafar, T.H., Heerspink, H.J., Mann, J.F., Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention (2013) Lancet, 382, pp. 339-352; Agarwal, R., Effects of statins on renal function Mayo Clin Proc, 2007 (82), pp. 1381-1390; Gröne, H.J., Walli, A., Gröne, E., Niedmann, P., Thiery, J., Seidel, D., Induction of glomerulosclerosis by dietary lipids A functional and morphologic study in the rat (1989) Lab Invest, 60, pp. 433-446; Vázquez-Pérez, S., Aragoncillo, P., De Las Heras, N., Navarro-Cid, J., Cediel, E., Sanz-Rosa, D., Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits (2001) Nephrol Dial Transplant, 16, pp. 40-44; Koren, M.J., Davidson, M.H., Wilson, D.J., Fayyad, R.S., Zuckerman, A., Reed, D.P., Investigators, A., Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD (2009) Am J Kidney Dis, 53, pp. 741-750; Lemos, P.A., Serruys, P.W., De Feyter, P., Mercado, N.F., Goedhart, D., Saia, F., Long-Term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy (2005) Am J Cardiol, 95, pp. 445-451; Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Canadian Society of Nephrology Guidelines for the management of chronic kidney disease (2008) CMAJ, 179, pp. 1154-1162; (2012) Am J Kidney Dis, 60, pp. 850-886. , National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD 2012 update; Guideline development group Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (EGFR &45 mL/min) (2015) Nephrol Dial Transplant, 30, pp. ii1-ii142; Kidney Disease Improving Global Outcomes.KDIGO clinical practice guideline for lipid management in chronic kidney Disease (2011) Kidney Int Suppl, 2013 (3), pp. 1-305. , atwww.kdigo.org/clinical_practice_guidelines/Lipids/KDIGO%20Lipid%20Management.%20Guideline%202013.pdf, Accessed on 12 November 2017; (2017) National Institute for Health and Care Excellence. Chronic Kidney Disease in Adults. Updated, , www.nice.org.uk/guidance/qs5/chapter/Quality-statement-3-Statins-for-people-with-CKD, July on 12 November 2017; Zhang, Z., Wu, P., Zhang, J., Wang, S., Zhang, G., The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-Analysis (2016) Pharmacol Res, 105, pp. 74-83; Palmer, S.C., Navaneethan, S.D., Craig, J.C., Johnson, D.W., Perkovic, V., Hegbrant, J., HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis (2014) Cochrane Database Syst Rev, p. CD007784; Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., Transcatheter versus surgical aortic-valve replacement in high-risk patients (2011) N Engl J Med, 364, pp. 2187-2198. , PARTNER Trial Investigators; Cohen, J.D., Brinton, E.A., Ito, M.K., Jacobson, T.A., Understanding Statin Use in America and Gaps in Patient Education (USAGE): An Internet-based survey of 10, 138 current and former statin users (2012) J Clin Lipidol, 6 (208), pp. 03.003. , 15; Joy, T.R., Hegele, R.A., Narrative review: Statin-related myopathy (2009) Ann Intern Med, 150, pp. 858-868; McClure, D.L., Valuck, R.J., Glanz, M., Hokanson, J.E., Systematic review and meta-Analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present Pharmacoepidemiol Drug Saf, 2007 (16), pp. 132-143; Ganga, H.V., Slim, H.B., Thompson, P.D., A systematic review of statininduced muscle problems in clinical trials (2014) Am Heart J, 168, pp. 6-15; Alberton, M., Wu, P., Druyts, E., Briel, M., Mills, E.J., Adverse events associated with individual statin treatments for cardiovascular disease: An indirect comparison meta-Analysis (2012) QJM, 105, pp. 145-157; Kashani, A., Phillips, C.O., Foody, J.M., Wang, Y., Mangalmurti, S., Ko, D.T., Risks associated with statin therapy: A systematic overview of randomized clinical trials (2006) Circulation, 114, pp. 2788-2797; Hou, W., Lv, J., Perkovic, V., Yang, L., Zhao, N., Jardine, M.J., Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and metaanalysis (2013) Eur Heart J., 34, pp. 1807-1817; Naci, H., Brugts, J., Ades, T., Comparative tolerability and harms of individual statins: A study-level network meta-Analysis of 246 955 participants from 135 randomized, controlled trials (2013) Circ Cardiovasc Qual Outcomes, 6, pp. 390-399; Palmer, S.C., Craig, J.C., Navaneethan, S.D., Tonelli, M., Pellegrini, F., Strippoli, G.F., Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-Analysis (2012) Ann Intern Med, 157 (263); Vuorio, A., Kuoppala, J., Kovanen, P.T., Humphries, S.E., Tonstad, S., Wiegman, A., Statins for children with familial hypercholesterolemia (2017) Cochrane Database Syst Rev, 7, p. CD006401; Goldacre, B., Meta-Analysis of side effects of statins shows need for trial transparency [Letter] (2014) BMJ, 348, p. g2940; Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Interpretation of the evidence for the efficacy and safety of statin therapy (2016) Lancet, 388, pp. 2532-2561; Maki, K.C., Ridker, P.M., Brown, W.V., Grundy, S.M., Sattar, N., The diabetes subpanel of the national lipid association expert panel an assessment by the statin diabetes safety task force 2014 update (2014) J Clin Lipidol, 8, pp. S17-S29; Maki, K.C., Diwadkar-Navsariwala, V., Kramer, M.W., Statin use and risk for type 2 diabetes: What clinicians should know (2018) Postgrad Med, 130, pp. 166-172; Rojas-Fernandez, C.H., Goldstein, L.B., Levey, A.I., Taylor, B.A., Bittner, V., The national lipid association's safety task force an assessment by the statin cognitive safety task force 2014 update (2014) J Clin Lipidol, 8, pp. S5-S16; Rojas-Fernandez, C., Hudani, Z., Bittner, V., Statins and cognitive side effects: What cardiologists need to know (2015) Cardiol Clin, 33, pp. 245-256; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-Analyses (2016) Milbank Q, 94, pp. 485-514; Greco, T., Zangrillo, A., Biondi-Zoccai, G., Landoni, G., Metaanalysis: Pitfalls and hints (2013) Heart Lung Vessel, 5, pp. 219-225; Siontis, K.C., Hernandez-Boussard, T., Ioannidis, J.P., Overlapping meta-Analyses on the same topic: Survey of published studies (2013) BMJ, 347, p. f4501; Krauth, D., Anglemyer, A., Philipps, R., Bero, L., Nonindustrysponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: A meta-Analysis (2014) PLoS Biol, 12, p. e1001770; Naci, H., Dias, S., Ades, A.E., Industry sponsorship bias in research findings: A network meta-Analysis of LDL cholesterol reduction in randomised trials of statins (2014) BMJ, 349, p. g5741; Naci, H., Dias, S., Ades, T., No evidence of industry sponsorship bias in statin trials [Letter] (2014) BMJ, 349, p. g6579; Anglemyer, A.T., Krauth, D., Bero, L., Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: A meta-Analysis (2015) BMC Med Res Methodol, 15, p. 12; Sellke, T., Bayarri, J.M., Berger, O.J., Calibration of P values for testing precise null hypotheses (2001) Am Stat, 55, pp. 62-71; Goodman, S.N., Toward Evidence-based Medical Statistics (1999) The Bayes factor. Ann Intern Med, 2 (130), pp. 1005-1013; Held, L., Ott, M., How the maximal evidence of P-values against point null hypotheses depends on sample size (2016) Am Stat, 70, pp. 335-341; Prasad, V., Jena, A.B., (2013) Prespecified Falsification End Points: Can They Validate True Observational Associations? JAMA, 309, pp. 241-242; Schuemie, M.J., Ryan, P.B., Suchard, M.A., Shahn, Z., Madigan, D., Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature (2014) Biostatistics, 15, pp. 36-39; Ioannidis, J.P., Why most published research findings are false (2005) PLoS Med, 2, p. e124; Ioannidis, J.P., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Harbord, R.M., Egger, M., Sterne, J.A., A modified test for small-study effects in meta-Analyses of controlled trials with binary endpoints (2006) Stat Med, 25, pp. 3443-3457; Macaskill, P., Walter, S.D., Irwig, L., A comparison of methods to detect publication bias in meta-Analysis (2001) Stat Med, 20, pp. 641-654; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Lau, J., Recommendations for examining and interpreting funnel plot asymmetry in meta-Analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Freedman, L.S., Tables of the number of patients required in clinical trials using the logrank test (1982) Stat Med, 1, pp. 121-129; Ling, Y., Yang, L., Huang, H., Hu, X., Zhao, C., Huang, H., Prognostic significance of statin use in colorectal cancer: A systematic review and meta-Analysis (2015) Medicine (Baltimore, 94, p. e908; Nielsen, S.F., Nordestgaard, B.G., Bojesen, S.E., Statin use and reduced cancer-related mortality (2012) N Engl J Med, 367, pp. 1792-1802; Shi, M., Zheng, H., Nie, B., Gong, W., Cui, X., Statin use and risk of liver cancer: An update meta-Analysis (2014) BMJ Open, 4, p. e005399; Tsan, Y.T., Lee, C.H., Ho, W.C., Lin, M.H., Wang, J.D., Chen, P.C., Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection (2013) J Clin Oncol, 31, pp. 1514-1521; Tsan, Y.T., Lee, C.H., Wang, J.D., Chen, P.C., Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection (2012) J Clin Oncol, 30, pp. 623-630; Zheng, Y.X., Zhou, P.C., Zhou, R.R., Fan, X.G., The benefit of statins in chronic hepatitis C patients: A systematic review and meta-Analysis (2017) Eur J Gastroenterol Hepatol, 29, pp. 759-766; Kamal, S., Khan, M.A., Seth, A., Cholankeril, G., Gupta, D., Singh, U., Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: A systematic review and meta-Analysis (2017) Am J Gastroenterol, 112, pp. 1495-1505; Fassett, R.G., Robertson, I.K., Ball, M.J., Geraghty, D.P., Coombes, J.S., Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial (2010) Atherosclerosis, 213, pp. 218-224; Asselbergs, F.W., Diercks, G.F., Hillege, H.L., Van Boven, A.J., Janssen, W.M., Voors, V., Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria (2004) Circulation, 110, pp. 2809-2816; Rayner, B.L., Byrne, M.J., Van Zyl Smit, R., A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone (1996) Clin Nephrol, 46, pp. 219-224; Verma, A., Ranganna, K.M., Reddy, R.S., Verma, M., Gordon, N.F., Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease (2005) Am J Cardiol, 96, pp. 1290-1292},
correspondence_address1={Theodoratou, E.; Centre for Global Health Research, United Kingdom; email: E.Theodoratou@ed.ac.uk},
publisher={American College of Physicians},
issn={00034819},
coden={AIMEA},
pubmed_id={30304368},
language={English},
abbrev_source_title={Ann. Intern. Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Wang20141235,
author={Wang, M.-D. and Gomes, J. and Cashman, N.R. and Little, J. and Krewski, D.},
title={A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis},
journal={Journal of Occupational and Environmental Medicine},
year={2014},
volume={56},
number={12},
pages={1235-1242},
doi={10.1097/JOM.0000000000000323},
note={cited By 50},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918540846&doi=10.1097%2fJOM.0000000000000323&partnerID=40&md5=1d5eca774d84a84f7583b07be12b4728},
affiliation={Department of Epidemiology and Community Medicine, Faculty of Medicine, University of OttawaON  K1H 8M5, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada},
abstract={Objective: The association between occupational exposure to lead and amyotrophic lateral sclerosis (ALS) was examined through systematic review and meta-analyses of relevant epidemiological studies and reported according to PRISMA guidelines.
Methods: Relevant studies were searched in multiple bibliographic databases through September 2013; additional articles were tracked through PubMed until submission. All records were screened in DistillerSR, and the data extracted from included articles were synthesized with meta-analysis.
Results: The risk of developing ALS among individuals with a history of exposure to lead was almost doubled (odds ratio, 1.81; 95% confidence interval, 1.39 to 2.36) on the basis of nine included case-control studies with specific lead exposure information, with no apparent heterogeneity across included studies (I2 = 14%). The attributable risk of ALS because of exposure to lead was estimated to be 5%.
Conclusions: Previous exposure to lead may be a risk factor for ALS. © 2014 Lippincott Williams and Wilkins. Unauthorized reproduction of this article is prohibited.},
keywords={copper zinc superoxide dismutase;  lead;  lead, amyotrophic lateral sclerosis;  Article;  attributable risk;  cerebrospinal fluid;  heavy metal poisoning;  human;  long term exposure;  meta analysis;  motor neuron disease;  muscle tissue;  nonhuman;  observational study;  occupational exposure;  systematic review;  work environment;  adverse effects;  amyotrophic lateral sclerosis;  chemically induced;  occupational exposure;  odds ratio;  risk factor, Amyotrophic Lateral Sclerosis;  Humans;  Lead;  Observational Studies as Topic;  Occupational Exposure;  Odds Ratio;  Risk Factors},
chemicals_cas={copper zinc superoxide dismutase, 149394-67-2; lead, 7439-92-1, 13966-28-4; Lead},
references={Byrne, S., Walsh, C., Lynch, C., Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis (2011) J Neurol Neurosurg Psychiatry, 82, pp. 623-627; Sato, K., Morimoto, N., Deguchi, K., Ikeda, Y., Matsuura, T., Abe, K., Seven amyotrophic lateral sclerosis patients diagnosed only after development of respiratory failure (2014) J Clin Neurosci, 21, pp. 1341-1343; Wijesekera, L.C., Leigh, P.N., Amyotrophic lateral sclerosis (2009) Orphanet J Rare Dis, 4, p. 3; Chio, A., Calvo, A., Mazzini, L., Extensive genetics of ALS: A populationbased study in Italy (2012) Neurology, 79, pp. 1983-1989; Chen, S., Sayana, P., Zhang, X., Le, W., Genetics of amyotrophic lateral sclerosis: An update (2013) Molecular Neurodegeneration, 8, p. 28; Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., Van Den Berg, L.H., The genetics and neuropathology of amyotrophic lateral sclerosis (2012) Acta Neuropathol, 124, pp. 339-352; Abel, O., Powell, J.F., Andersen, P.M., Al-Chalabi, A., ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics (2012) Hum Mutat, 33, pp. 1345-1351; (2014) World Federation of Neurology and European Network to Cure ALS, , ALS Online Genetics Database; Pfister, T., Sekhon, R., White, M., Familial amyotrophic lateral sclerosis in Alberta Canada (2013) Amyotroph Lateral Scler Frontotemporal Degener, 14, pp. 273-277; Robberecht, W., Genetics of amyotrophic lateral sclerosis (2000) J Neurol, 247, pp. 2-6. , VI; Van Blitterswijk, M., De Jesus-Hernandez, M., Rademakers, R., Howdo C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: Can we learn from other noncoding repeat expansion disorders? (2012) Curr Opin Neurol, 25, pp. 689-700; Smith, B.N., Shatunova, N.S., The C9ORF72 expansionmutation is a common cause of ALS+/-FTD in Europe and has a single founder (2013) Eur J Hum Genet, 21, pp. 102-108; Ratti, A., Corrado, L., Castellotti, B., C9ORF72 repeat expansion in a large Italian ALS cohort: Evidence of a founder effect (2012) Neurobiol Aging, 33, pp. 2528e7-2528e14; Soong, B.W., Lin, K.P., Guo, Y.C., Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis (2014) Neurobiol Aging, 35, pp. e1-6. , 2423; Vinceti, M., Fiore, M., Signorelli, C., Environmental risk factors for amyotrophic lateral sclerosis: Methodological issues in epidemiologic studies (2012) Ann Ig, 24, pp. 407-415; Al-Chalabi, A., Fang, F., Hanby, M.F., An estimate of amyotrophic lateral sclerosis heritability using twin data (2010) J Neurol Neurosurg Psychiatry, pp. 1324-1326. , PMC2988617; Wingo, T.S., Cutler, D.J., Yarab, N., Kelly, C.M., Glass, J.D., The heritability of amyotrophic lateral sclerosis in a clinically ascertained united states research registry (2011) PLoS One, 6, p. e27985; Meireles, A., Al-Chalabi, A., Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives (2009) Amyotrophic Lat Scler., 10, pp. 1-14; Johnson, F., Atchison, W., The role of environmentalmercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis (2009) Neurotoxicology., 30, pp. 761-765; Sutedja, N.A., Veldink, J.H., Fischer, K., Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review (2009) Amyotroph Lateral Scler, 10, pp. 302-309; Sutedja, N.A., Fischer, K., Veldink, J.H., Whatwe truly knowabout occupation as a risk factor for ALS: A critical and systematic review (2009) Amyotroph Lateral Scler, 10, pp. 295-301; Ahmed, A., Wicklund, M.P., Amyotrophic lateral sclerosis: What role does environment play? (2011) Neurol Clin., 29, pp. 689-711; Migliore, L., Coppede, F., Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases (2009) Mutat Res, 667, pp. 82-97; Oh, S.S., Kim, E.A., Lee, S.W., Kim, M.K., Kang, S.K., A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead (2007) Neurotoxicology, 28, pp. 324-327; Livesley, B., Sissons, C.E., Chronic lead intoxication mimicking motor neurone disease (1968) Br Med J., 4, pp. 387-388; Campbell, A.M., Williams, E.R., Barltrop, D., Motor neurone disease and exposure to lead (1970) J Neurol Neurosurg Psychiatry., 33, pp. 877-885; Chancellor, A.M., Slattery, J.M., Fraser, H., Warlow, C.P., Risk factors for motor neuron disease: A case-control study based on patients from the Scottish motor neuron disease register (1993) J Neurol Neurosurg Psychiatry., 56, pp. 1200-1206; Deapen, D.M., Henderson, B.E., A case-control study of amyotrophic lateral sclerosis (1986) Am J Epidemiol, 123, pp. 790-799; Deapen, D.M., A case-control study of amyotrophic lateral sclerosis (1982) ProQuest Dissertations and Theses; Gresham, L.S., Molgaard, C.A., Golbeck, A.L., Smith, R., Amyotrophic lateral sclerosis and occupational heavy metal exposure: A case-control study (1986) Neuroepidemiology, 5, pp. 29-38; Gresham, L.S., Molgaard, C.A., Golbeck, A.L., Smith, R., Amyotrophic lateral sclerosis and history of skeletal fracture: A case-control study (1987) Neurology, 37, pp. 717-719; Gresham, L.S., Molgaard, C.A., Golbeck, A.L., Smith, R., Lead exposure and ALS (1992) Neurology, 42, pp. 2228-2229; Kamel, F., Umbach, D., Munsat, T., Shefner, J., Hu, H., Sandler, D., Lead exposure and amyotrophic lateral sclerosis (2002) Epidemiology, 13, pp. 311-319; Kamel, F., Umbach, D.M., Hu, H., Lead exposure as a risk factor for amyotrophic lateral sclerosis (2005) Neurodegener Dis, 2, pp. 195-201; McGuire, V., Longstreth, W.T., Jr., Nelson, L.M., Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study (1997) Am J Epidemiol, 145, pp. 1076-1088; Pierce-Ruhland, R., Patten, B.M., Repeat study of antecedent events in motor neuron disease (1981) Ann Clin Res, 13, pp. 102-107; Binazzi, A., Belli, S., Uccelli, R., An exploratory case-control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome (2009) Amyotroph Lateral Scler, 10, pp. 361-369; Gunnarsson, L.G., Bodin, L., Soderfeldt, B., Axelson, O., A case-control study of motor neurone disease: Its relation to heritability, and occupational exposures, particularly to solvents (1992) Br J Ind Med, 49, pp. 791-798; Malek, A.M., Barchowsky, A., Bowser, R., Environmental and occupational risk factors for amyotrophic lateral sclerosis: A case-control study (2014) Neurodegener Dis, 14, pp. 31-38; Morahan, J.M., Pamphlett, R., Amyotrophic lateral sclerosis and exposure to environmental toxins: An Australian case-control study (2006) Neuroepidemiology, 27, pp. 130-135; Provinciali, L., Giovagnoli, A.R., Antecedent events in amyotrophic lateral sclerosis: Do they influence clinical onset and progression? (1990) Neuroepidemiology, 9, pp. 255-262; Qureshi, M.M., Hayden, D., Urbinelli, L., Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) (2006) Amyotroph Lateral Scler, 7, pp. 173-182; Feychting, M., Jonsson, F., Pedersen, N.L., Ahlbom, A., Occupational magnetic field exposure and neurodegenerative disease (2003) Epidemiology, 14, pp. 413-419. , discussion 427-428; Park, R., Schulte, P., Bowman, J., Potential occupational risks for neurodegenerative diseases (2005) Am J Ind Med, 48, pp. 63-77; Fang, F., Quinlan, P., Ye, W., Workplace exposures and the risk of amyotrophic lateral sclerosis (2009) Environ Health Perspect, 117, pp. 1387-1392; Fang, F., Kwee, L.C., Allen, K.D., Association between blood lead and the risk of amyotrophic lateral sclerosis (2010) Am J Epidemiol, 171, pp. 1126-1133; Scarpa, M., Colombo, A., Panzetti, P., Sorgato, P., Epidemiology of amyotrophic lateral sclerosis in the province of Modena Italy. Influence of environmental exposure to lead (1988) Acta Neurol Scand, 77, pp. 456-460; Turabelidze, G., Zhu, B.P., Schootman, M., An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson county Missouri 1998- 2002 (2008) Neurotoxicology, 29, pp. 81-86; Turner, M.C., Wigle, D.T., Krewski, D., Residential pesticides and childhood leukemia: A systematic review and meta-analysis (2011) Cien Saude Colet, 16, pp. 1915-1931; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group (2000) JAMA, 283, pp. 2008-2012; Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of themethodological quality both of randomised and non-randomised studies of health care interventions (1998) J Epidemiol Community Health, 52, pp. 377-384; Lu, L., Fu, D.L., Li, H.Q., Liu, A.J., Li, J.H., Zheng, G.Q., Diabetes and risk of Parkinsons disease: An updated meta-analysis of case-control studies (2014) PLoS One, 9, p. e85781; Breslow, N., Day, N., Satatistical methods in cancer research (1980) IARC Sci Publ, 32, pp. 5-338; Wartenberg, D., Residential EMF exposure and childhood leukemia: Meta-analysis and population attributable risk (2001) Bioelectromagnetics, 5, pp. S86-104; Sahai, H., Khurshid, A., (1996) Statistics in Epidemiology-Methods Techniques and Applications Boca Raton FL, , CRC Press; Liberati, A., Altman, D.G., Tetzlaff, J., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration (2009) J Clin Epidemiol, 62, pp. e1-34; Yu, Y., Su, F.C., Callaghan, B.C., Goutman, S.A., Batterman, S.A., Feldman, E.L., Environmental risk factors and amyotrophic lateral sclerosis (ALS): A casecontrol study of ALS in Michigan (2014) PLoS One, 9, p. e101186; Thomson, R.M., Parry, G.J., Neuropathies associated with excessive exposure to lead (2006) Muscle Nerve, 33, pp. 732-741; Bachmeyer, C., Bagur, E., Lenglet, T., Maier-Redelsperger, M., Lecomte, I., Lead poisoning mimicking amyotrophic lateral sclerosis: An adverse effect of rituals (2012) Am J Med, 125, pp. e5-e6; Fluri, F., Lyrer, P., Gratwohl, A., Raetz-Bravo, A.E., Steck, A.J., Lead poisoning from the beauty case: Neurologic manifestations in an elderly woman (2007) Neurology, 69, pp. 929-930; Boothby, J.A., Dejesus, P.V., Rowland, L.P., Reversible forms of motor neuron disease lead "neuritis." (1974) Arch Neurol, 31, pp. 18-23; Felmus, M.T., Patten, B.M., Swanke, L., Antecedent events in amyotrophic lateral sclerosis (1976) Neurology, 26, pp. 167-172; Mandybur, T.I., Cooper, G.P., Increased spinal cord lead content in amyotrophic lateral sclerosis-possibly a secondary phenomenon (1979) Med Hypotheses, 5, pp. 1313-1315; Petkau, A., Sawatzky, A., Hillier, C.R., Hoogstraten, J., Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: Case report and other considerations (1974) Br J Ind Med, 31, pp. 275-287; Conradi, S., Ronnevi, L.O., Vesterberg, O., Abnormal tissue distribution of lead in amyotrophic lateral sclerosis (1976) J Neurol Sci, 29, pp. 259-265; Conradi, S., Ronnevi, L.O., Vesterberg, O., Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry (1978) J Neurol Neurosurg Psychiatry, 41, pp. 389-393; Kurlander, H.M., Patten, B.M., Metals in spinal cord tissue of patients dying of motor neuron disease (1979) Ann Neurol, 6, pp. 21-24; Roos, P.M., Vesterbergo Syversen, T., Flaten, T.P., Nordberg, M., Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis (2013) Biol Trace Elem Res, 151, pp. 159-170; Conradi, S., Ronnevi, L.O., Vesterberg, O., Lead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects (1978) J Neurol Neurosurg Psychiatry, 41, pp. 1001-1004; Vinceti, M., Guidetti, D., Bergomi, M., Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis (1997) Ital J Neurol Sci., 18, pp. 87-92; Kapaki, E., Segditsa, J., Zournas, C., Xenos, D., Papageorgiou, C., Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases (1989) Experientia, 45, pp. 1108-1110; Cavalleri, A., Minoia, C., Ceroni, M., Poloni, M., Lead in cerebrospinal fluid and its relationship to plasma lead in humans (1984) J Appl Toxicol, 4, pp. 63-65; Stober, T., Stelte, W., Kunze, K., Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis (1983) J Neurol Sci, 61, pp. 21-26; Conradi, S., Ronnevi, L.O., Nise, G., Vesterberg, O., Abnormal distribution of lead in amyotrophic lateral sclerosis-reestimation of lead in the cerebrospinal fluid (1980) J Neurol Sci, 48, pp. 413-418; Damstra, T., Toxicological properties of lead (1977) Environ Health Perspect, 19, pp. 297-307; Mazliah, J., Barron, S., Bental, E., Rogowski, Z., Coleman, R., Silbermann, M., The effects of long-term lead intoxication on the nervous system of the chicken (1989) Neurosci Lett, 101, pp. 253-257; Mulligan, V.K., Chakrabartty, A., Protein misfolding in the late-onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis (2013) Proteins, 81, pp. 1285-1303; Kim, S., Hyun, J., Kim, H., Effects of lead exposure on nitric oxideassociated gene expression in the olfactory bulb of mice (2011) Biol Trace Elem Res, 142, pp. 683-692; Baranowska-Bosiacka, I., Gutowska, I., Marchlewicz, M., Disrupted proand antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to lead (2012) Brain Res, 1435, pp. 56-71; Rotunno, M.S., Bosco, D.A., An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis (2013) Front Cell Neurosci, 7, p. 253; Goering, P.L., Lead-protein interactions as a basis for lead toxicity (1993) Neurotoxicology, 14, pp. 45-60; Grad, L.I., Cashman, N.R., Prion-like activity of Cu/Zn superoxide dismutase: Implications for amyotrophic lateral sclerosis (2014) Prion, 8, pp. 33-41; Grad, L.I., Guest, W.C., Yanai, A., Intermolecular transmission of superoxide dismutase 1 misfolding in living cells (2011) Proc Natl Acad Sci USA, 108, pp. 16398-16403},
correspondence_address1={Wang, M.-D.; Department of Epidemiology and Community Medicine, Canada},
publisher={Lippincott Williams and Wilkins},
issn={10762752},
coden={JOEMF},
pubmed_id={25479292},
language={English},
abbrev_source_title={J. Occup. Environ. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Kim2019731,
author={Kim, Y. and Je, Y. and Giovannucci, E.},
title={Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers},
journal={European Journal of Epidemiology},
year={2019},
volume={34},
number={8},
pages={731-752},
doi={10.1007/s10654-019-00524-3},
note={cited By 47},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065287881&doi=10.1007%2fs10654-019-00524-3&partnerID=40&md5=e55bc9611a9b8813427df4f5722f6a49},
affiliation={Department of Food and Nutrition, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul, 02447, South Korea; Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, United States},
abstract={Coffee consumption has been associated with decreased mortality in previous studies. As aging, obesity, and lifestyle factors affect the risk of mortality, the association between coffee and mortality needs to be examined in various subpopulations by characteristics of subjects. To quantitatively assess this association, we conducted an updated meta-analysis including stratified analyses by potential modifiers. We searched in the PubMed and Web of Science databases through March 8, 2019, and conducted meta-analysis including linear and non-linear dose–response analyses. We identified 40 studies including 3,852,651 subjects and 450,256 all-cause and cause-specific deaths. Non-linear inverse associations between coffee consumption and mortality from all-causes, cardiovascular disease (CVD), and cancers were found. The lowest relative risk (RR) was at intakes of 3.5 cups/day for all-cause mortality (RR = 0.85, 95% CI 0.82–0.89), 2.5 cups/day for CVD mortality (RR = 0.83, 95% CI 0.80–0.87), and 2 cups/day for cancer mortality (RR = 0.96, 95% CI 0.94–0.99), while additional intakes were not associated with further lower mortality. An inverse association between coffee consumption and all-cause mortality was maintained irrespective of age, overweight status, alcohol drinking, smoking status, and caffeine content of coffee. By region, Europe and Asia showed stronger inverse associations than US. A non-linear inverse association was found for mortality from respiratory disease and diabetes, while linear inverse association was found for mortality from non-CVD, non-cancer causes. Moderate coffee consumption (e.g. 2–4 cups/day) was associated with reduced all-cause and cause-specific mortality, compared to no coffee consumption. The inverse association between coffee and all-cause mortality was consistent by potential modifiers except region. © 2019, Springer Nature B.V.},
author_keywords={Age;  Alcohol consumption;  BMI;  Coffee;  Meta-analysis;  Mortality},
keywords={caffeine;  caffeine, all cause mortality;  Article;  Asia;  cancer mortality;  cardiovascular disease;  cardiovascular mortality;  coffee;  diabetes mellitus;  disease association;  drinking behavior;  Europe;  human;  malignant neoplasm;  meta analysis;  obesity;  respiratory tract disease;  risk factor;  smoking;  systematic review;  adverse event;  causality;  cause of death;  coffee;  drinking behavior;  female;  male;  mortality;  neoplasm, Alcohol Drinking;  Caffeine;  Cardiovascular Diseases;  Causality;  Cause of Death;  Coffee;  Europe;  Female;  Humans;  Male;  Mortality;  Neoplasms;  Risk Factors},
chemicals_cas={caffeine, 58-08-2; Caffeine; Coffee},
funding_details={Ministry of EducationMinistry of Education, MOE, NRF-2017R1A6A3A01075728},
funding_details={Ministry of Science, ICT and Future PlanningMinistry of Science, ICT and Future Planning, MSIP, NRF-2018R1D1A1B07045353},
funding_details={National Research Foundation of KoreaNational Research Foundation of Korea, NRF},
funding_text 1={This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education (NRF-2017R1A6A3A01075728) and by the Ministry of Science, ICT and Future Planning (NRF-2018R1D1A1B07045353). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.},
references={Jeszka-Skowron, M., Zgola-Grzeskowiak, A., Grzeskowiak, T., Analytical methods applied for the characterization and the determination of bioactive compounds in coffee (2015) Eur Food Res Technol, 240 (1), pp. 19-31; Noordzij, M., Uiterwaal, C.S., Arends, L.R., Kok, F.J., Grobbee, D.E., Geleijnse, J.M., Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials (2005) J Hypertens, 23 (5), pp. 921-928; Hong, X., Xu, Q., Lan, K., Huang, H., Zhang, Y., Chen, S., The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational study (2018) Nutr Cancer, 1, pp. 1-11; Wu, W., Tong, Y., Zhao, Q., Yu, G., Wei, X., Lu, Q., Coffee consumption and bladder cancer: a meta-analysis of observational studies (2015) Sci Rep, 5, p. 9051; Loomis, D., Guyton, K.Z., Grosse, Y., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Carcinogenicity of drinking coffee, mate, and very hot beverages (2016) Lancet Oncol, 17 (7), pp. 877-878; Grosso, G., Godos, J., Galvano, F., Giovannucci, E.L., Coffee, caffeine, and health outcomes: an umbrella review (2017) Annu Rev Nutr, 37, pp. 131-156; Andersen, L.F., Jacobs, D.R., Jr., Carlsen, M.H., Blomhoff, R., Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study (2006) Am J Clin Nutr, 83 (5), pp. 1039-1046; Ding, M., Satija, A., Bhupathiraju, S.N., Hu, Y., Sun, Q., Han, J., Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts (2015) Circulation, 132 (24), pp. 2305-2315; Freedman, N.D., Park, Y., Abnet, C.C., Hollenbeck, A.R., Sinha, R., Association of coffee drinking with total and cause-specific mortality (2012) N Engl J Med, 366 (20), pp. 1891-1904; Gapstur, S.M., Anderson, R.L., Campbell, P.T., Jacobs, E.J., Hartman, T.J., Hildebrand, J.S., Associations of coffee drinking and cancer mortality in the cancer prevention study-II (2017) Cancer Epidemiol Biomark Prev, 26 (10), pp. 1477-1486; Gardener, H., Rundek, T., Wright, C.B., Elkind, M.S., Sacco, R.L., Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population (2013) J Nutr, 143 (8), pp. 1299-1308; Grosso, G., Stepaniak, U., Micek, A., Stefler, D., Bobak, M., Pajak, A., Coffee consumption and mortality in three Eastern European countries: results from the HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe) study (2017) Public Health Nutr, 20 (1), pp. 82-91; Gunter, M.J., Murphy, N., Cross, A.J., Dossus, L., Dartois, L., Fagherazzi, G., Coffee drinking and mortality in 10 European Countries: a multinational cohort study (2017) Ann Intern Med, 167 (4), pp. 236-247; Happonen, P., Laara, E., Hiltunen, L., Luukinen, H., Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population (2008) Br J Nutr, 99 (6), pp. 1354-1361; Hart, C., Smith, G.D., Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study (1997) J Epidemiol Community Health, 51 (4), pp. 461-462; Iwai, N., Ohshiro, H., Kurozawa, Y., Hosoda, T., Morita, H., Funakawa, K., Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population (2002) J Epidemiol, 12 (3), pp. 191-198; Jacobsen, B.K., Bjelke, E., Kvale, G., Heuch, I., Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study (1986) J Natl Cancer Inst, 76 (5), pp. 823-831; Jazbec, A., Simic, D., Corovic, N., Durakovic, Z., Pavlovic, M., Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia (2003) J Health Popul Nutr, 21 (4), pp. 332-340; Kahn, H.A., Phillips, R.L., Snowdon, D.A., Choi, W., Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists (1984) Am J Epidemiol, 119 (5), pp. 775-787; Klatsky, A.L., Armstrong, M.A., Friedman, G.D., Coffee, tea, and mortality (1993) Ann Epidemiol, 3 (4), pp. 375-381; Kleemola, P., Jousilahti, P., Pietinen, P., Vartiainen, E., Tuomilehto, J., Coffee consumption and the risk of coronary heart disease and death (2000) Arch Intern Med, 160 (22), pp. 3393-3400; LeGrady, D., Dyer, A.R., Shekelle, R.B., Stamler, J., Liu, K., Paul, O., Coffee consumption and mortality in the Chicago Western Electric Company Study (1987) Am J Epidemiol, 126 (5), pp. 803-812; Lim, W.H., Wong, G., Lewis, J.R., Lok, C.E., Polkinghorne, K.R., Hodgson, J., Total volume and composition of fluid intake and mortality in older women: a cohort study (2017) BMJ Open, 7 (3); Lindsted, K.D., Kuzma, J.W., Anderson, J.L., Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality (1992) J Clin Epidemiol, 45 (7), pp. 733-742; Liu, J., Sui, X., Lavie, C.J., Hebert, J.R., Earnest, C.P., Zhang, J., Association of coffee consumption with all-cause and cardiovascular disease mortality (2013) Mayo Clin Proc, 88 (10), pp. 1066-1074; Lof, M., Sandin, S., Yin, L., Adami, H.O., Weiderpass, E., Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women (2015) Eur J Epidemiol, 30 (9), pp. 1027-1034; Loftfield, E., Freedman, N.D., Graubard, B.I., Guertin, K.A., Black, A., Huang, W.Y., Association of coffee consumption with overall and cause-specific mortality in a large us prospective cohort study (2015) Am J Epidemiol, 182 (12), pp. 1010-1022; Loomba, R.S., Aggarwal, S., Arora, R.R., The effect of coffee and quantity of consumption on specific cardiovascular and all-cause mortality: coffee consumption does not affect mortality (2016) Am J Ther, 23 (1), pp. e232-e237; Mineharu, Y., Koizumi, A., Wada, Y., Iso, H., Watanabe, Y., Date, C., Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women (2011) J Epidemiol Community Health, 65 (3), pp. 230-240; Nordestgaard, A.T., Nordestgaard, B.G., Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000-223 000 individuals (2016) Int J Epidemiol, 45 (6), pp. 1938-1952; Odegaard, A.O., Koh, W.P., Yuan, J.M., Pereira, M.A., Beverage habits and mortality in Chinese adults (2015) J Nutr, 145 (3), pp. 595-604; Paganini-Hill, A., Kawas, C.H., Corrada, M.M., Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study (2007) Prev Med, 44 (4), pp. 305-310; Park, S.Y., Freedman, N.D., Haiman, C.A., Le Marchand, L., Wilkens, L.R., Setiawan, V.W., Association of coffee consumption with total and cause-specific mortality among nonwhite populations (2017) Ann Intern Med, 167 (4), pp. 228-235; Rosengren, A., Wilhelmsen, L., Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study (1991) J Intern Med, 230 (1), pp. 67-71; Saito, E., Inoue, M., Sawada, N., Shimazu, T., Yamaji, T., Iwasaki, M., Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center-based Prospective Study (2015) Am J Clin Nutr, 101 (5), pp. 1029-1037; Sugiyama, K., Kuriyama, S., Akhter, M., Kakizaki, M., Nakaya, N., Ohmori-Matsuda, K., Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women (2010) J Nutr, 140 (5), pp. 1007-1013; Tamakoshi, A., Lin, Y., Kawado, M., Yagyu, K., Kikuchi, S., Iso, H., Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study (2011) Eur J Epidemiol, 26 (4), pp. 285-293; van den Brandt, P.A., Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women (2018) Eur J Epidemiol; Vandenbroucke, J.P., Kok, F.J., van ‘t Bosch, G., van den Dungen, P.J., van der Heide-Wessel, C., van der Heide, R.M., Coffee drinking and mortality in a 25-year follow up (1986) Am J Epidemiol, 123 (2), pp. 359-361; Woodward, M., Tunstall-Pedoe, H., Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality (1999) J Epidemiol Community Health, 53 (8), pp. 481-487; Sado, J., Kitamura, T., Kitamura, Y., Sobue, T., Nishino, Y., Tanaka, H., Association between coffee consumption and all-sites cancer incidence and mortality (2017) Cancer Sci, 108 (10), pp. 2079-2087; Torres-Collado, L., Garcia-de-la-Hera, M., Navarrete-Munoz, E.M., Notario-Barandiaran, L., Gonzalez-Palacios, S., Zurriaga, O., Coffee consumption and mortality from all causes of death, cardiovascular disease and cancer in an elderly Spanish population (2018) Eur J Nutr; Loftfield, E., Cornelis, M.C., Caporaso, N., Yu, K., Sinha, R., Freedman, N., Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank (2018) JAMA Intern Med, 178 (8), pp. 1086-1097; Sado, J., Kitamura, T., Kitamura, Y., Liu, R., Ando, E., Sobue, T., Coffee consumption and all-cause and cardiovascular mortality-Three-Prefecture Cohort in Japan (2019) Circ J; Navarro, A.M., Martinez-Gonzalez, M.A., Gea, A., Grosso, G., Martin-Moreno, J.M., Lopez-Garcia, E., Coffee consumption and total mortality in a Mediterranean prospective cohort (2018) Am J Clin Nutr, 108 (5), pp. 1113-1120; Kohlmeier, L., Mensink, G., Kohlmeier, M., The relationship between coffee consumption and lipid levels in young and older people in the Heidelberg-Michelstadt-Berlin study (1991) Eur Heart J, 12 (8), pp. 869-874; Arciero, P.J., Ormsbee, M.J., Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women (2009) Appl Physiol Nutr Metab, 34 (4), pp. 754-762; Bracco, D., Ferrarra, J.M., Arnaud, M.J., Jequier, E., Schutz, Y., Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women (1995) Am J Physiol, 269 (4), pp. E671-E678; Acheson, K.J., Zahorska-Markiewicz, B., Pittet, P., Anantharaman, K., Jequier, E., Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals (1980) Am J Clin Nutr, 33 (5), pp. 989-997; Grosso, G., Micek, A., Godos, J., Sciacca, S., Pajak, A., Martinez-Gonzalez, M.A., Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis (2016) Eur J Epidemiol, 31 (12), pp. 1191-1205; Je, Y., Giovannucci, E., Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies (2014) Br J Nutr, 111 (7), pp. 1162-1173; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group (2000) JAMA, 283 (15), pp. 2008-2012; Wells, G.A.S.B., O’Connell, D., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis., , http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, Accessed 2 May 2019; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7 (3), pp. 177-188; Berlin, J.A., Longnecker, M.P., Greenland, S., Meta-analysis of epidemiologic dose-response data (1993) Epidemiology, 4 (3), pp. 218-228; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135 (11), pp. 1301-1309; Orsini, N., Bellocco, R., Greenland, S., Generalized least squares for trend estimation of summarized dose-response data (2006) Stata J, 6 (1), pp. 40-57; Orsini, N., Li, R., Wolk, A., Khudyakov, P., Spiegelman, D., Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software (2012) Am J Epidemiol, 175 (1), pp. 66-73; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50 (4), pp. 1088-1101; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Crippa, A., Discacciati, A., Larsson, S.C., Wolk, A., Orsini, N., Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis (2014) Am J Epidemiol, 180 (8), pp. 763-775; Jiang, X., Zhang, D., Jiang, W., Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies (2014) Eur J Nutr, 53 (1), pp. 25-38; Ding, M., Bhupathiraju, S.N., Satija, A., van Dam, R.M., Hu, F.B., Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies (2014) Circulation, 129 (6), pp. 643-659; van Dam, R.M., Hu, F.B., Coffee consumption and risk of type 2 diabetes: a systematic review (2005) JAMA, 294 (1), pp. 97-104; Cornelis, M.C., Kacprowski, T., Menni, C., Gustafsson, S., Pivin, E., Adamski, J., Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior (2016) Hum Mol Genet, 25 (24), pp. 5472-5482; Nightingale, C.M., Rudnicka, A.R., Owen, C.G., Wells, J.C., Sattar, N., Cook, D.G., Influence of adiposity on insulin resistance and glycemia markers among U.K. Children of South Asian, black African-Caribbean, and white European origin: child heart and health study in England (2013) Diabetes Care., 36 (6), pp. 1712-1719; Elsamadony, A., Yates, K.F., Sweat, V., Yau, P.L., Mangone, A., Joseph, A., Asian adolescents with excess weight are at higher risk for insulin resistance than Non-Asian Peers (2017) Obesity (Silver Spring), 25 (11), pp. 1974-1979; Alfaro, T.M., Monteiro, R.A., Cunha, R.A., Cordeiro, C.R., Chronic coffee consumption and respiratory disease: a systematic review (2018) Clin Respir J, 12 (3), pp. 1283-1294; Carlstrom, M., Larsson, S.C., Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis (2018) Nutr Rev, 76 (6), pp. 395-417; Kang, D., Kim, Y., Je, Y., Non-alcoholic beverage consumption and risk of depression: epidemiological evidence from observational studies (2018) Eur J Clin Nutr, 72 (11), pp. 1506-1516; Lucas, M., O’Reilly, E.J., Pan, A., Mirzaei, F., Willett, W.C., Okereke, O.I., Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults (2014) World J Biol Psychiatry, 15 (5), pp. 377-386; Schottker, B., Saum, K.U., Jansen, E.H., Boffetta, P., Trichopoulou, A., Holleczek, B., Oxidative stress markers and all-cause mortality at older age: a population-based cohort study (2015) J Gerontol A Biol Sci Med Sci, 70 (4), pp. 518-524; Franceschi, C., Campisi, J., Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases (2014) J Gerontol A Biol Sci Med Sci, 69, pp. S4-S9; Liang, N., Kitts, D.D., Antioxidant property of coffee components: assessment of methods that define mechanisms of action (2014) Molecules, 19 (11), pp. 19180-19208; Hoelzl, C., Knasmuller, S., Wagner, K.H., Elbling, L., Huber, W., Kager, N., Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules (2010) Mol Nutr Food Res, 54 (12), pp. 1722-1733; Natella, F., Nardini, M., Giannetti, I., Dattilo, C., Scaccini, C., Coffee drinking influences plasma antioxidant capacity in humans (2002) J Agric Food Chem, 50 (21), pp. 6211-6216; Misik, M., Hoelzl, C., Wagner, K.H., Cavin, C., Moser, B., Kundi, M., Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial (2010) Mutat Res, 692 (1-2), pp. 42-48; Hori, A., Kasai, H., Kawai, K., Nanri, A., Sato, M., Ohta, M., Coffee intake is associated with lower levels of oxidative DNA damage and decreasing body iron storage in healthy women (2014) Nutr Cancer, 66 (6), pp. 964-969; Williams, C.J., Fargnoli, J.L., Hwang, J.J., van Dam, R.M., Blackburn, G.L., Hu, F.B., Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study (2008) Diabetes Care, 31 (3), pp. 504-507; Zhang, Y., Zhang, D.Z., Is coffee consumption associated with a lower level of serum C-reactive protein? A meta-analysis of observational studies (2018) Int J Food Sci Nutr; Hang, D., Kvaerner, A.S., Ma, W., Hu, Y., Tabung, F.K., Nan, H., Coffee consumption and plasma biomarkers of metabolic and inflammatory pathways in US health professionals (2019) Am J Clin Nutr, 109 (3), pp. 635-647; Kempf, K., Herder, C., Erlund, I., Kolb, H., Martin, S., Carstensen, M., Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial (2010) Am J Clin Nutr, 91 (4), pp. 950-957; Zhang, Y., Zhang, D.Z., Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies (2018) Int J Food Sci Nutr; Li, Q., Liu, Y., Sun, X., Yin, Z., Li, H., Cheng, C., Caffeinated and decaffeinated coffee consumption and risk of all-cause mortality: a dose-response meta-analysis of cohort studies (2019) J Hum Nutr Diet},
correspondence_address1={Je, Y.; Department of Food and Nutrition, 26 Kyunghee-daero, Dongdaemun-gu, South Korea; email: youjinje@khu.ac.kr},
publisher={Springer Netherlands},
issn={03932990},
coden={EJEPE},
pubmed_id={31055709},
language={English},
abbrev_source_title={Eur. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Lodi20191569,
author={Lodi, S. and Phillips, A. and Lundgren, J. and Logan, R. and Sharma, S. and Cole, S.R. and Babiker, A. and Law, M. and Chu, H. and Byrne, D. and Horban, A. and Sterne, J.A.C. and Porter, K. and Sabin, C. and Costagliola, D. and Abgrall, S. and Gill, J. and Touloumi, G. and Pacheco, A.G. and Van Sighem, A. and Reiss, P. and Bucher, H.C. and Montoliu Giménez, A. and Jarrin, I. and Wittkop, L. and Meyer, L. and Perez-Hoyos, S. and Justice, A. and Neaton, J.D. and Hernán, M.A.},
title={Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples},
journal={American Journal of Epidemiology},
year={2019},
volume={188},
number={8},
pages={1569-1577},
doi={10.1093/aje/kwz100},
note={cited By 47},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072687046&doi=10.1093%2faje%2fkwz100&partnerID=40&md5=4ad221146d6c25fbd2efb65a06738f23},
affiliation={Department of Biostatistics, Boston University, School of Public Health, 801 Massachusetts Avenue, Boston, MA  02118, United States; Institute for Global Health, University College, London, United Kingdom; Department of Infectious Diseases Rigshospitalet, University of Copenhagen, Denmark; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States; Medical Research Council, Clinical Trials Unit, University College London, London, United Kingdom; Kirby Institute, Sydney, Australia; Division of Infectious Diseases, Department of Medicine, Cooper University Hospital, Cooper Medical School, Rowan UniversityNJ, United States; Medical University of Warsaw, Department for Adult's Infectious Diseases, Warsaw, Poland; Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom; INSERM, Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France; AP-HP, Hôpital Antoine Béclère, Service de Médecine Interne, Clamart, France; Southern Alberta Clinic, Calgary, Canada; Department of Medicine, University of Calgary, Canada; National and Kapodistrian University of Athens, Faculty of Medicine, Dept. of Hygiene, Epidemiology and Medical Statistics, Greece; Programa de Computação Científica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil; Stichting HIV Monitoring, Amsterdam, Netherlands; Amsterdam University Medical Centres, University of Amsterdam, Department of Global Health and Division of Infectious Diseases, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam Public Health Research Institute, Amsterdam, Netherlands; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Switzerland; Centre for Epidemiological Studies on HIV/STI in Catalonia (CEEISCAT), Agència de Salut Pública de Catalunya (ASPC), Badalona, Spain; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain; Univ. Bordeaux, ISPED Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219 CIC-EC 1401, Bordeaux, France; CHU de Bordeaux, Pôle de Santé Publique, Service d'Information Médicale, Bordeaux, France; Université Paris Sud, UMR 1018 le Kremlin Bicêtre, France; Vall d'Hebrón Research Institute, Barcelona, Spain; Yale University School of Medicine, New Haven, CT, United States; Department of Biostatistics, Harvard T.H. Chan, School of Public Health, United States; Harvard-MIT Division of Health Sciences and Technology, Boston, MA, United States},
abstract={Effect estimates from randomized trials and observational studies might not be directly comparable because of differences in study design, other than randomization, and in data analysis. We propose a 3-step procedure to facilitate meaningful comparisons of effect estimates from randomized trials and observational studies: 1) harmonization of the study protocols (eligibility criteria, treatment strategies, outcome, start and end of follow-up, causal contrast) so that the studies target the same causal effect, 2) harmonization of the data analysis to estimate the causal effect, and 3) sensitivity analyses to investigate the impact of discrepancies that could not be accounted for in the harmonization process. To illustrate our approach, we compared estimates of the effect of immediate with deferred initiation of antiretroviral therapy in individuals positive for the human immunodeficiency virus from the Strategic Timing of Antiretroviral Therapy (START) randomized trial and the observational HIV-CAUSAL Collaboration. © 2019 The Author(s). Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved.},
author_keywords={antiretroviral initiation;  causal inference;  per-protocol effect;  target trial},
keywords={estimation method;  human immunodeficiency virus;  observational method;  sensitivity analysis, adult;  antiretroviral therapy;  apple;  article;  controlled study;  female;  human;  human experiment;  Human immunodeficiency virus;  male;  nonhuman;  observational study;  randomized controlled trial;  comparative study;  epidemiology;  Human immunodeficiency virus infection;  methodology;  middle aged;  randomized controlled trial (topic), Human immunodeficiency virus, antiretrovirus agent, Adult;  Anti-Retroviral Agents;  Epidemiologic Methods;  Female;  HIV Infections;  Humans;  Male;  Middle Aged;  Observational Studies as Topic;  Randomized Controlled Trials as Topic;  Research Design},
chemicals_cas={Anti-Retroviral Agents},
funding_details={National Institutes of HealthNational Institutes of Health, NIH, AI102634, UL1TR001079},
funding_details={National Institute of Allergy and Infectious DiseasesNational Institute of Allergy and Infectious Diseases, NIAID, P30AI050410, U01AI136780, UM1AI068641, UM1AI120197},
funding_details={Bill and Melinda Gates FoundationBill and Melinda Gates Foundation, BMGF},
funding_details={Bristol-Myers SquibbBristol-Myers Squibb, BMS},
funding_details={Gilead SciencesGilead Sciences},
funding_details={National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences, NCATS, UL1TR001863},
funding_details={Meso Scale DiagnosticsMeso Scale Diagnostics, MSD},
funding_details={Harvard University Center for AIDS ResearchHarvard University Center for AIDS Research, HU CFAR, 5P30AI060354-13},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/M004236/1},
funding_details={University College LondonUniversity College London, UCL},
funding_details={European Centre for Disease Prevention and ControlEuropean Centre for Disease Prevention and Control, ECDC},
funding_details={Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport, VWS},
funding_text 1={Sport, during the conduct of the study, and grants from European Centre for Disease Prevention and Control, outside the submitted work. G.T. has received grants unrelated to this study from Gilead Sciences Europe, UCL, ECDC, and EU and National funds; D.C. reports grants from Janssen-Cilag, Merck-Sharp & Dohme-Chibret, and ViiV, as well as personal fees from Janssen-Cilagand Merck-Sharp & Dohme-Chibret for lectures, personal fees from ViiV for travel/accommodations/meeting expenses, personal fees from Gilead France for French HIV board, and personal fees from Innavirvax and Merck Switzerland for consultancy, outside the submitted work. P.R. has received independent scientific grant support through his institution from Gilead Sciences, Janssen Pharmaceuticals Inc., Merck & Co., and ViiV Healthcare; he has served on scientific advisory boards for Gilead Sciences, ViiV Healthcare, Merck & Co., Teva Pharmaceutical Industries, and on a data-safety monitoring committee for Janssen Pharmaceuticals Inc., for which his institution has received remuneration. The other authors report no conflicts.},
funding_text 2={Author affiliations: Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts (Sara Lodi); Institute for Global Health, University College London, United Kingdom (Andrew Phillips, Kholoud Porter, Caroline Sabin); Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark (Jens Lundgren); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Roger Logan, Miguel A. Hernán); Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota (Shweta Sharma, Haitao Chu, James D. Neaton); Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Stephen R. Cole); Medical Research Council Clinical Trials Unit in University College London, London, United Kingdom (Abdel Babiker); The Kirby Institute, Sidney, Australia (Matthew Law); Division of Infectious Diseases, Department of Medicine, Cooper University Hospital, Cooper Medical School at Rowan University, Camden, New Jersey (Dana Byrne); Department for Adult’s Infectious Diseases, Medical University of Warsaw, Warsaw, Poland (Andrzej Horban); Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom (Jonathan A. C. Sterne); Institut Pierre Louis d’Épidémiologie et de Santé Publique, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Paris, France (Dominique Costagliola, Sophie Abgrall); Service de Médecine Interne, Hôpital Antoine Béclère, AP-HP, Clamart, France (Sophie Abgrall); Southern Alberta Clinic, Calgary, Canada (John Gill); Department of Medicine, Faculty of Medicine, University of Calgary, Canada (John Gill); Department of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Greece (Giota Touloumi); Programa de Computação Científica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil (Antonio G. Pacheco); Stichting HIV Monitoring, Amsterdam, the Netherlands (Ard van Sighem, Peter Reiss); Department of Global Health, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands (Peter Reiss); Division of Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands (Peter Reiss); Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands (Peter Reiss); Amsterdam Public Health Research Institute, Amsterdam, the Netherlands (Peter Reiss); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Switzerland (Heiner C. Bucher); Centre for Epidemiological Studies on HIV/STI in Catalonia, Agència de Salut Pública de Catalunya, Badalona, Spain (Alexandra Montoliu Giménez); Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain (Inmaculada Jarrin); Bordeaux Population Health Research Center, Team MORPH3EUS, Unité Mixte de Recherche 1219, CIC-EC 1401, Institut de Santé Publique, d’Epidémiologie et de Développement, Institut National de la Santé et de la Recherche Médicale, University of Bordeaux, Bordeaux, France (Linda Wittkop); Service D’information Médicale, Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (Laurence Meyer); Unité Mixte de Recherche 1018, le Kremlin Bicêtre, Université Paris Sud, Paris, France (Laurence Meyer); Vall d’Hebrón Research Institute, Barcelona, Spain (Santiago Perez-Hoyos); Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut (Amy Justice); Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Miguel A. Hernán); and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts (Miguel A. Hernán). This work received funding from Harvard University Center for AIDS Research (grant 5P30AI060354-13) and the National Institutes of Health (grants AI102634, UL1TR001079, UM1-AI068641 and UM1-AI120197). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed are those of the author(s) and do not necessarily reflect the official views of the Uniformed Services University of the Health Sciences, the National Institutes of Health, the Department of Defense, or the Departments of the Army, Navy or Air Force. A complete list of contributors to the HIV-CAUSAL Collaboration and of the INSIGHT START group can be found in Web Appendices 1 and 2.},
funding_text 3={A.R. has received funding from the Bill & Melinda Gates Foundation; H.R. and his institution have received honoraria, support to attend conferences, or unrestricted research grants from Gilead Sciences, BMS, ViiV Healthcare, Janssen, Abbvie, and MSD in the 3 years preceding the submission date of this manuscript; C.S. received funding from Gilead Sciences, ViiV Healthcare, and Janssen-Cilag for membership in Data Safety and Monitoring Boards, Advisory Boards, and Speaker Panels and for the preparation of educational materials; A.v.S. reports grants from Dutch Ministry of Health, Welfare and},
references={Hernán, M.A., Alonso, A., Logan, R., Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease (2008) Epidemiology., 19 (6), pp. 766-779; Hernán, M.A., Sauer, B.C., Hernández-Díaz, S., Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses (2016) J Clin Epidemiol., 79, pp. 70-75; Hernán, M.A., Robins, J.M., Per-protocol analyses of pragmatic trials (2017) N Engl J Med., 377 (14), pp. 1391-1398; Anglemyer, A., Horvath, H.T., Bero, L., Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials (2014) Cochrane Database Syst Rev., 4, p. MR000034; Benson, K., Hartz, A.J., A comparison of observational studies and randomized, controlled trials (2000) N Engl J Med., 342 (25), pp. 1878-1886; Edwards, J.P., Kelly, E.J., Lin, Y., Meta-analytic comparison of randomized and nonrandomized studies of breast cancer surgery (2012) Can J Surg., 55 (3), pp. 155-162; Concato, J., Shah, N., Horwitz, R.I., Randomized, controlled trials, observational studies, and the hierarchy of research designs (2000) N Engl J Med., 342 (25), pp. 1887-1892; Hemkens, L.G., Contopoulos-Ioannidis, D.G., Ioannidis, J.P., Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: Metaepidemiological survey (2016) BMJ., 352, p. i493; Initiation of Antiretroviral Therapy in early asymptomatic HIV infection (2015) N Engl J Med., 373 (9), pp. 795-807. , INSIGHT START Study Group; Lodi, S., Phillips, A., Logan, R., Comparative effectiveness of strategies for antiretroviral treatment initiation in HIVpositive individuals in high-income countries: An observational cohort study of immediate universal treatment versus CD4-based initiation (2015) Lancet HIV., 2 (8), pp. e335-e343; (2018) Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, , https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf, DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Office of AIDS Research Advisory Council. Accessed January 19, 2019; European AIDS clinical society (2018) European Guidelines for Treatment of HIV Infected Adults in Europe, , http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html, Accessed January 19, 2019; A trial of early antiretrovirals and isoniazid preventive therapy in Africa (2015) N Engl J Med., 373 (9), pp. 808-822. , TEMPRANO ANRS Study Group; Severe, P., Juste, M.A., Ambroise, A., Early versus standard antiretroviral therapy for HIV-infected adults in Haiti (2010) N Engl J Med., 363 (3), pp. 257-265; Cohen, M.S., Chen, Y.Q., McCauley, M., Prevention of HIV-1 infection with early antiretroviral therapy (2011) N Engl J Med., 365 (6), pp. 493-505; Anglemyer, A., Rutherford, G.W., Easterbrook, P.J., Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: A systematic review (2014) AIDS., 28, pp. S105-S118; Cain, L.E., Logan, R., When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: An observational study (2011) Ann Intern Med., 154 (8), pp. 509-515. , HIV-CAUSAL Collaboration; Kitahata, M.M., Gange, S.J., Abraham, A.G., Effect of early versus deferred antiretroviral therapy for HIV on survival (2009) N Engl J Med., 360 (18), pp. 1815-1826; Sterne, J.A., May, M., Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies (2009) Lancet., 373 (9672), pp. 1352-1363. , When To Start Consortium; Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters (2011) Arch Intern Med., 171 (17), pp. 1560-1569. , Writing Committee for the CASCADE Collaboration; Young, J.G., Cain, L.E., Robins, J.M., Comparative effectiveness of dynamic treatment regimes: An application of the parametric g-formula (2011) Stat Biosci., 3 (1), pp. 119-143; Lodi, S., Sharma, S., Lundgren, J.D., The per-protocol effect of immediate versus deferred antiretroviral therapy initiation (2016) AIDS., 30 (17), pp. 2659-2663; Caniglia, E.C., Cain, L.E., Justice, A., Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions (2014) Neurology., 83 (2), pp. 134-141; Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries (2014) AIDS., 28 (16), pp. 2461-2473. , HIV-CAUSAL Collaboration; Ray, M., Logan, R., The effect of combined antiretroviral therapy on the overallmortality of HIV-infected individuals (2010) AIDS., 24 (1), pp. 123-137. , HIV-CAUSAL Collaboration; Hernán, M.A., Robins, J.M., Using big data to emulate a target trial when a randomized trial is not available (2016) Am J Epidemiol., 183 (8), pp. 758-764; Hernán, M.A., Robins, J.M., Causal Inference, , https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/, Forthcoming ed. Boca Raton, FL: Chapman & Hall/CRC. Accessed May 23, 2019; Ancelle-Park, R., Expanded European AIDS case definition (1993) Lancet., 341 (8842), p. 441; Hernán, M.A., Hernandez-Diaz, S., Beyond the intention-to-treat in comparative effectiveness research (2012) Clin Trials., 9 (1), pp. 48-55; Robins, J.M., A new approach to causal inference in mortality studies with a sustained exposure period: Application to the healthy worker survivor effect (1986) Math Model., 7 (9-12), pp. 1393-1512; Taubman, S.L., Robins, J.M., Mittleman, M.A., Intervening on risk factors for coronary heart disease: An application of the parametric g-formula (2009) Int J Epidemiol., 38 (6), pp. 1599-1611; Harrell, F.E., (2001) Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, , New York, NY: Springer; (2015) World Bank Country and LendingGroups, , https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups, TheWorld Bank. AccessedMay 6, 2019; Harvard Program on Causal Inference: Software, , http://www.hsph.harvard.edu/causal/software/, Accessed April 12, 2019; Harvard Program on Causal Inference: Sascode-Lodi-AJE19, , https://www.hsph.harvard.edu/causal/sascode_lodi_aje19/, Accessed April 12, 2019; Hong, J.L., Jonsson Funk, M., LoCasale, R., Generalizing randomized clinical trial results: Implementation and challenges related to missing data in the target population (2018) Am J Epidemiol., 187 (4), pp. 817-827; Cole, S.R., Stuart, E.A., Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial (2010) Am J Epidemiol., 172 (1), pp. 107-115; Wang, Q., Young, J., Bernasconi, E., Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone (2014) HIV Clin Trials., 15 (3), pp. 92-103; Daar, E.S., Tierney, C., Fischl, M.A., Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1 (2011) Ann Intern Med., 154 (7), pp. 445-456; Lodi, S., Del Amo, J., D'Arminio Monforte, A., Risk of tuberculosis following HIV seroconversion in high-income countries (2013) Thorax., 68 (3), pp. 207-213; Sonnenberg, P., Glynn, J.R., Fielding, K., How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners (2005) J Infect Dis., 191 (2), pp. 150-158; Guyatt, G.H., Briel, M., Glasziou, P., Problems of stopping trials early (2012) BMJ., 344, p. e3863; Bassler, D., Briel, M., Montori, V.M., Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis (2010) JAMA., 303 (12), pp. 1180-1187; Hernán, M.A., Robins, J.M., Early versus deferred antiretroviral therapy for HIV (2009) N Engl J Med., 361 (8), pp. 822-824. , author reply 3-4; Wong, V.C., Steiner, P.M., Designs of empirical evaluations of nonexperimental methods in field settings (2018) Eval Rev., 42 (2), pp. 176-213; VanderWeele, T.J., Ding, P., Sensitivity analysis in observational research: Introducing the E-value (2017) Ann Intern Med., 167 (4), pp. 268-274; MacLehose, R.F., Kaufman, S., Kaufman, J.S., Bounding causal effects under uncontrolled confounding using counterfactuals (2005) Epidemiology., 16 (4), pp. 548-555},
correspondence_address1={Lodi, S.; Department of Biostatistics, 801 Massachusetts Avenue, United States; email: slodi@bu.edu},
publisher={Oxford University Press},
issn={00029262},
coden={AJEPA},
pubmed_id={31063192},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{VanDerMei2016461,
author={Van Der Mei, I.A.F. and Lucas, R.M. and Taylor, B.V. and Valery, P.C. and Dwyer, T. and Kilpatrick, T.J. and Pender, M.P. and Williams, D. and Chapman, C. and Otahal, P. and Ponsonby, A.-L.},
title={Population attributable fractions and joint effects of key risk factors for multiple sclerosis},
journal={Multiple Sclerosis},
year={2016},
volume={22},
number={4},
pages={461-469},
doi={10.1177/1352458515594040},
note={cited By 47},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962623277&doi=10.1177%2f1352458515594040&partnerID=40&md5=bbf355c65967be18f16497c8a0f42b13},
affiliation={Menzies Research Institute, Private Bag 23, 17 Liverpool St, Hobart, TAS  7000, Australia; National Centre for Epidemiology and Population Health, Australian National University, Australia; Queensland Institute of Medical Research, Australia; International Agency for Research on Cancer, France; Centre for Neuroscience, University of Melbourne, Australia; Department of Neurophysiology, John Hunter Hospital, Australia; Department of Neurology, Barwon Health, Australia; Murdoch Childrens Research Institute, Australia},
abstract={Aim: We examined the combined effect of having multiple key risk factors and the interactions between the key risk factors of multiple sclerosis (MS). Methods: We performed an incident case-control study including cases with a first clinical diagnosis of central nervous system demyelination (FCD) and population-based controls. Results: Compared to those without any risk factors, those with one, two, three, and four or five risk factors had increased odds of being an FCD case of 2.12 (95% confidence interval (CI), 1.11-4.03), 4.31 (95% CI, 2.24-8.31), 7.96 (95% CI, 3.84-16.49), and 21.24 (95% CI, 5.48-82.40), respectively. Only HLA-DR15 and history of infectious mononucleosis interacted significantly on the additive scale (Synergy index, 3.78; p = 0.03). The five key risk factors jointly accounted for 63.8% (95% CI, 43.9-91.4) of FCD onset. High anti-EBNA IgG was another important contributor. Conclusions: A high proportion of FCD onset can be explained by the currently known risk factors, with HLA-DR15, ever smoking and low cumulative sun exposure explaining most. We identified a significant interaction between HLA-DR15 and history of IM in predicting an FCD of CNS demyelination, which together with previous observations suggests that this is a true interaction. © SAGE Publications.},
author_keywords={First demyelinating event;  gene-environment interaction;  multiple sclerosis;  population attributable fraction;  risk factors},
keywords={Epstein Barr virus antigen;  HLA DR15 antigen;  immunoglobulin G;  25 hydroxyvitamin D;  Epstein Barr virus antigen;  HLA DR antigen;  HLA-DR15 antigen;  immunoglobulin G;  virus antibody, adult;  Article;  attributable risk;  case control study;  controlled study;  demyelinating disease;  female;  history;  human;  incidence;  major clinical study;  male;  mononucleosis;  multiple sclerosis;  population research;  risk assessment;  smoking;  sun exposure;  actinic keratosis;  age;  aged;  demyelination;  gender;  liquid chromatography;  multiple sclerosis;  population based case control study;  risk factor;  single nucleotide polymorphism;  tandem mass spectrometry;  adolescent;  adverse effects;  Australia;  blood;  clinical trial;  genetics;  genotype environment interaction;  immunology;  Infectious Mononucleosis;  middle aged;  multicenter study;  multiple sclerosis;  multivariate analysis;  odds ratio;  prevalence;  risk factor;  season;  statistical model;  sunlight;  time factor;  young adult, Adolescent;  Adult;  Antibodies, Viral;  Australia;  Case-Control Studies;  Epstein-Barr Virus Nuclear Antigens;  Female;  Gene-Environment Interaction;  HLA-DR Serological Subtypes;  Humans;  Immunoglobulin G;  Incidence;  Infectious Mononucleosis;  Logistic Models;  Male;  Middle Aged;  Multiple Sclerosis;  Multivariate Analysis;  Odds Ratio;  Polymorphism, Single Nucleotide;  Prevalence;  Risk Assessment;  Risk Factors;  Seasons;  Smoking;  Sunlight;  Time Factors;  Young Adult},
chemicals_cas={immunoglobulin G, 97794-27-9; 25 hydroxyvitamin D, 64719-49-9; Antibodies, Viral; Epstein-Barr Virus Nuclear Antigens; HLA-DR Serological Subtypes; HLA-DR15 antigen; Immunoglobulin G},
references={Haines, J.L., Terwedow, H.A., Burgess, K., Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. the Multiple Sclerosis Genetics Group (1998) Hum Mol Genet, 7, pp. 1229-1234; Rubio, J.P., Bahlo, M., Butzkueven, H., Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis (2002) Am J Hum Genet, 70, pp. 1125-1137; Levin, L.I., Munger, K.L., Rubertone, M.V., Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis (2005) JAMA, 293, pp. 2496-2500; DeLorenze, G.N., Munger, K.L., Lennette, E.T., Epstein-Barr virus and multiple sclerosis: Evidence of association from a prospective study with long-term follow-up (2006) Arch Neurol, 63, pp. 839-844; Thacker, E.L., Mirzaei, F., Ascherio, A., Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis (2006) Ann Neurol, 59, pp. 499-503; Van Der Mei, I.A., Simpson, S., Jr., Stankovich, J., Individual and joint action of environmental factors and risk of MS (2011) Neurol Clin, 29, pp. 233-255; Lucas, R.M., Ponsonby, A.L., Dear, K., Sun exposure and Vitamin D are independent risk factors for CNS demyelination (2011) Neurology, 76, pp. 540-548; Hernán, M.A., Oleky, M.J., Ascherio, A., Cigarette smoking and incidence of multiple sclerosis (2001) Am J Epidemiol, 154, pp. 69-74; Hernán, M.A., Jick, S.S., Logroscino, G., Cigarette smoking and the progression of multiple sclerosis (2005) Brain, 128, pp. 1461-1465; Thorogood, M., Hannaford, P.C., The influence of oral contraceptives on the risk of multiple sclerosis (1998) Br J Obstet Gynaecol, 105, pp. 1296-1299; Villard-Mackintosh, L., Vessey, M.P., Oral contraceptives and reproductive factors in multiple sclerosis incidence (1993) Contraception, 47, pp. 161-168; Hawkes, C.H., Smoking is a risk factor for multiple sclerosis: A metanalysis (2007) Mult Scler, 13, pp. 610-615; De Jager, P.L., Simon, K.C., Munger, K.L., Integrating risk factors: HLA-DRB1∗1501 and Epstein-Barr virus in multiple sclerosis (2008) Neurology, 70, pp. 1113-1118; Simon, K.C., Van Der Mei, I.A., Munger, K.L., Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1∗1501 on multiple sclerosis risk (2010) Neurology, 74, pp. 1365-1371; Lucas, R.M., Ponsonby, A.L., McMichael, A.J., Observational analytic studies in multiple sclerosis: Controlling bias through study design and conduct. the Australian Multicentre Study of Environment and Immune Function (2007) Mult Scler, 13, pp. 827-839; McDonald, W.I., Relapse, remission, and progression in multiple sclerosis (2000) N Engl J Med, 343, pp. 1486-1487; Lucas, R.M., Ponsonby, A.L., Dear, K., Associations between silicone skin cast score, cumulative sun exposure, and other factors in the Ausimmune Study: A multicenter Australian study (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 2887-2894; Levin, L.I., Munger, K.L., Rubertone, M.V., Multiple sclerosis and Epstein-Barr virus (2003) JAMA, 289, pp. 1533-1536; Hosmer, D., Lemeshow, S., (2000) Applied Logistic Regression, , New York: John Wiley & Sons Inc; Halberg, F., Chronobiology (1969) Annu Rev Physiol, 31, pp. 675-725; Skrondal, A., Interaction as departure from additivity in case-control studies: A cautionary note (2003) Am J Epidemiol, 158, pp. 251-258; Hosmer, D.W., Lemeshow, S., Confidence interval estimation of interaction (1992) Epidemiology, 3, pp. 452-456; Rockhill, B., Newman, B., Weinberg, C., Use and misuse of population attributable fractions (1998) Am J Public Health, 88, pp. 15-19; Lehnert-Batar, A., Pfahlberg, A., Gefeller, O., Comparison of confidence intervals for adjusted attributable risk estimates under multinomial sampling (2006) Biom J, 48, pp. 805-819; Valery, P.C., Lucas, R.M., Williams, D.B., Occupational exposure and risk of central nervous system demyelination (2013) Am J Epidemiol, 177, pp. 954-961; Nielsen, T.R., Rostgaard, K., Askling, J., Effects of infectious mononucleosis and HLA-DRB1∗15 in multiple sclerosis (2009) Mult Scler, 15, pp. 431-436; Sundqvist, E., Sundström, P., Lindén, M., Epstein-Barr virus and multiple sclerosis: Interaction with HLA (2012) Genes Immun, 13, pp. 14-20; Disanto, G., Hall, C., Lucas, R., Assessing interactions between HLA-DRB1∗15 and infectious mononucleosis on the risk of multiple sclerosis (2013) Mult Scler, 19, pp. 1355-1358; Ramagopalan, S.V., Sadovnick, A.D., Ebers, G.C., Effects of infectious mononucleosis and HLA-DRB1∗15 in multiple sclerosis (2010) Mult Scler, 16, pp. 127-128; Boffetta, P., Winn, D.M., Ioannidis, J.P., Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans (2012) Int J Epidemiol, 41, pp. 686-704; Sundström, P., Nyström, L., Jidell, E., EBNA-1 reactivity and HLA DRB1∗1501 as statistically independent risk factors for multiple sclerosis: A case-control study (2008) Mult Scler, 14, pp. 1120-1122; Sundqvist, E., Sundström, P., Lindén, M., Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis (2012) Neurology, 79, pp. 1363-1368; Sundström, P., Nyström, M., Ruuth, K., Antibodies to specific EBNA-1 domains and HLA DRB1∗1501 interact as risk factors for multiple sclerosis (2009) J Neuroimmunol, 215, pp. 102-107; Rubicz, R., Yolken, R., Drigalenko, E., A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1) (2013) PLoS Genet, 9, p. e1003147; Berrick, A.J., The tobacco-free generation proposal (2013) Tob Control, 22, pp. i22-i26; Lucas, R.M., Valery, P., Van Der Mei, I., Sun exposure over a lifetime in Australian adults from latitudinally diverse regions (2013) Photochem Photobiol, 89, pp. 737-744; Pender, M.P., Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection (2009) Autoimmun Rev, 8, pp. 563-568},
correspondence_address1={Van Der Mei, I.A.F.; Menzies Research Institute, Private Bag 23, 17 Liverpool St, Australia; email: Ingrid.vanderMei@utas.edu.au},
publisher={SAGE Publications Ltd},
issn={13524585},
coden={MUSCF},
pubmed_id={26199349},
language={English},
abbrev_source_title={Mult. Scler.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Pieper201926,
author={Pieper, D. and Puljak, L. and González-Lorenzo, M. and Minozzi, S.},
title={Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies},
journal={Journal of Clinical Epidemiology},
year={2019},
volume={108},
pages={26-33},
doi={10.1016/j.jclinepi.2018.12.004},
note={cited By 45},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059483209&doi=10.1016%2fj.jclinepi.2018.12.004&partnerID=40&md5=d645a48ada61c521208ed2620f66c051},
affiliation={Institute for Research in Operative Medicine, Evidence-based Health Services Research, Faculty of Health, School of Medicine, Witten/Herdecke University, Ostmerheimer Str, Cologne, 200 51109, Germany; Catholic University of Croatia, Ilica 242, Zagreb, 10000, Croatia; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, Milan, Italy; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy},
abstract={Objective: To compare A Measurement Tool to Assess Systematic Reviews (AMSTAR 2) with a tool to assess risk of bias in systematic reviews (ROBIS) in terms of validity, reliability, and applicability. Study Design and Setting: We analyzed 30 systematic reviews (SRs) that included randomized and nonrandomized studies, with Cochrane and non-Cochrane SRs sampled in 1:1 ratio. Four reviewers assessed independently all 30 SRs with AMSTAR 2, followed by ROBIS. We calculated Fleiss’ Kappa as a measure of inter-rater reliability (IRR) across 4 raters. Results: The IRR for scoring the overall confidence in the SRs with AMSTAR 2 and the overall domain in ROBIS was fair (AMSTAR 2: κ = 0.30, 95% [confidence interval] CI: 0.17 to 0.43; ROBIS: κ = 0.28, 95% CI: 0.13 to 0.42). AMSTAR 2 confidence in review ratings strongly correlated with the overall domain rating in ROBIS (Spearman r s = 0.84). Mean time for scoring AMSTAR 2 was slightly higher than for ROBIS (18 vs. 16 min), with huge differences between the reviewers. Conclusion: Both AMSTAR 2 and ROBIS can be applied to SRs including both randomized controlled trials (RCTs) and non-RCTs. Measurement properties of ROBIS seemed not to be much different when comparing with other studies that include only SRs of RCTs. © 2018 Elsevier Inc.},
author_keywords={AMSTAR;  AMSTAR 2;  Methodological quality;  Risk of bias;  ROBIS;  Systematic reviews},
keywords={article;  controlled study;  human;  interrater reliability;  randomized controlled trial (topic);  risk assessment;  systematic review;  validity;  clinical trial (topic);  evidence based medicine;  observer variation;  randomized controlled trial (topic);  reproducibility;  statistical analysis;  statistical bias, Bias;  Clinical Trials as Topic;  Data Interpretation, Statistical;  Evidence-Based Medicine;  Humans;  Observer Variation;  Randomized Controlled Trials as Topic;  Reproducibility of Results;  Systematic Reviews as Topic},
references={Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Hartling, L., Chisholm, A., Thomson, D., Dryden, D.M., A descriptive analysis of overviews of reviews published between 2000 and 2011 (2012) PLoS One, 7, p. e49667; Pieper, D., Buechter, R., Jerinic, P., Eikermann, M., Overviews of reviews often have limited rigor: a systematic review (2012) J Clin Epidemiol, 65, pp. 1267-1273; Pieper, D., Buechter, R.B., Li, L., Prediger, B., Eikermann, M., Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties (2015) J Clin Epidemiol, 68, pp. 574-583; Burda, B.U., Holmer, H.K., Norris, S.L., Limitations of A Measurement tool to assess systematic reviews (AMSTAR) and suggestions for improvement (2016) Syst Rev, 5, p. 58; Faggion, C.M., Jr., Critical appraisal of AMSTAR: challenges, limitations, and potential solutions from the perspective of an assessor (2015) BMC Med Res Methodol, 15, p. 63; Wegewitz, U., Weikert, B., Fishta, A., Jacobs, A., Pieper, D., Resuming the discussion of AMSTAR: what can (should) be made better? (2016) BMC Med Res Methodol, 16, p. 111; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008; Norris, S.L., Atkins, D., Challenges in using nonrandomized studies in systematic reviews of treatment interventions (2005) Ann Intern Med, 142, pp. 1112-1119; Whiting, P., Savović, J., Higgins, J.P., Caldwell, D.M., Reeves, B.C., Shea, B., ROBIS: a new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 69, pp. 225-234; Higgins, J.P.T., Green, S., Cochrane Handbook for Systematic Reviews of Version 5.1.0 (2011), www.handbook.cochrane.org, The Cochrane Collaboration Available from http://handbook-5-1.cochrane.org; Buhn, S., Mathes, T., Prengel, P., Wegewitz, U., Ostermann, T., Robens, S., The risk of bias in systematic reviews tool showed fair reliability and good construct validity (2017) J Clin Epidemiol, 91, pp. 121-128; Banzi, R., Cinquini, M., Gonzalez-Lorenzo, M., Pecoraro, V., Capobussi, M., Minozzi, S., Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability (2018) J Clin Epidemiol, 99, pp. 24-32; Petticrew, M., Wilson, P., Wright, K., Song, F., Quality of cochrane reviews. Quality of cochrane reviews is better than that of non-cochrane reviews (2002) BMJ, 324, p. 545; Windsor, B., Popovich, I., Jordan, V., Showell, M., Shea, B., Farquhar, C., Methodological quality of systematic reviews in subfertility: a comparison of Cochrane and non-cochrane systematic reviews in assisted reproductive technologies (2012) Hum Reprod, 27, pp. 3460-3466; Fleming, P.S., Seehra, J., Polychronopoulou, A., Fedorowicz, Z., Pandis, N., A PRISMA assessment of the reporting quality of systematic reviews in orthodontics (2013) Angle Orthod, 83 (1), pp. 158-163; Biocic, M., Fidahic, M., Cikes, K., Puljak, L., Information sources used in systematic reviews of randomized controlled trials in the field of anesthesiology and pain (2018), [unpublished]; Polus, S., Pieper, D., Burns, J., Fretheim, A., Ramsay, C., Higgins, J.P.T., Heterogeneity in application, design, and analysis characteristics was found for controlled before-after and interrupted time series studies included in cochrane reviews (2017) J Clin Epidemiol, 91, pp. 56-69; Fleiss, J.L., Measuring nominal scale agreement among many raters (1971) Psychol Bull, 76 (5), p. 378; Gwet, K.L., Handbook of inter-rater reliability: The definitive guide to measuring the extent of agreement among raters (2014), www.handbook.cochrane.org, Advanced Analytics, LLC Available from http://handbook-5-1.cochrane.org; Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174; Pieper, D., Jacobs, A., Weikert, B., Fishta, A., Wegewitz, U., Inter-rater reliability of AMSTAR is dependent on the pair of reviewers (2017) BMC Med Res Methodol, 17, p. 98; da Costa, B.R., Beckett, B., Diaz, A., Resta, N.M., Johnston, B.C., Egger, M., Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study (2017) Syst Rev, 6 (1), p. 44; Gomez-Garcia, F., Ruano, J., Gay-Mimbrera, J., Aguilar-Luque, M., Sanz-Cabanillas, J.L., Alcalde-Mellado, P., Most systematic reviews of high methodological quality on psoriasis interventions are classified as high risk of bias using ROBIS tool (2017) J Clin Epidemiol, 92, pp. 79-88; Tao, H., Zhang, Y., Li, Q., Chen, J., Methodological quality evaluation of systematic reviews or meta-analyses on ERCC1 in non-small cell lung cancer: a systematic review (2017) J Cancer Res Clin Oncol, 143 (11), pp. 2245-2256; Perry, R., Leach, V., Davies, P., Penfold, C., Ness, A., Churchill, R., An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools (2017) Syst Rev, 6 (1), p. 97},
correspondence_address1={Pieper, D.; Institute for Research in Operative Medicine, Ostmerheimer Str, Germany; email: Dawid.pieper@uni-wh.de},
publisher={Elsevier USA},
issn={08954356},
coden={JCEPE},
pubmed_id={30543911},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Allen2020e50,
author={Allen, L.N. and Nicholson, B.D. and Yeung, B.Y.T. and Goiana-da-Silva, F.},
title={Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries},
journal={The Lancet Global Health},
year={2020},
volume={8},
number={1},
pages={e50-e58},
doi={10.1016/S2214-109X(19)30446-2},
note={cited By 44},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076171160&doi=10.1016%2fS2214-109X%2819%2930446-2&partnerID=40&md5=2bea397a9fa64d28b1d6c0783df688cf},
affiliation={Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; Centre of Health Policy, Institute of Global Health Innovation, Imperial College London, London, United Kingdom},
abstract={Background: Most countries have endorsed WHO non-communicable disease (NCD) best buy policies, but we know very little about global implementation patterns and about the geopolitical factors affecting implementation. We aimed to assess global implementation based on analysis of multiple geopolitical datasets. Methods: We used the 2015 and 2017 WHO NCD progress monitor reports to calculate aggregate implementation scores for 151 countries, based on their implementation of 18 WHO-recommended NCD policies. We ranked all countries and used descriptive statistics to analyse global trends. We used linear regression to assess the associations between policy implementation and World Bank geographic region, risk of premature NCD mortality, percentage of all deaths caused by NCDs, World Bank income group, human capital index, democracy index, and tax burden. Findings: In 2017, the mean NCD policy implementation score was 49·3% (SD 18·4%). Costa Rica and Iran had the joint-highest implementation scores (86·1% of all WHO-recommended policies). Scores were lowest in Haiti and South Sudan (5·5%). Between 2015 and 2017, aggregate implementation scores rose in 109 countries and regressed in 32 countries. Mean implementation rose for all of the 18 policies except for those targeting alcohol and physical activity. The most commonly implemented policies were clinical guidelines, graphic warnings on tobacco packaging, and NCD risk factor surveys. Our multiple linear regression model explained 61·1% of the variance in 2017 aggregate scores (p<0·0001), but we found evidence of a high degree of collinearity between the explanatory variables. Interpretation: Implementation of WHO-recommended NCD policies is increasing over time. On average, countries implemented just under half of the NCD policies recommended by WHO in 2017. Nutrition-related policies saw gains, while those related to alcohol and physical activity were the most likely to have been dropped. Aggregate implementation scores tended to be highest in high-income countries that invest in health care and education. Funding: National Institute for Health Research, Imperial College London, University of Oxford. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license},
keywords={alcohol consumption;  Angola;  Article;  Brazil;  Bulgaria;  Burundi;  capital;  cause of death;  Comoros;  Congo;  Costa Rica;  Cote d'Ivoire;  democracy;  Estonia;  Finland;  funding;  Gabon;  Gambia;  geographic distribution;  Guinea;  Haiti;  health care policy;  health survey;  human;  income group;  Iran;  Italy;  Latvia;  Lesotho;  Liberia;  Lithuania;  Malta;  Mauritania;  Moldova;  mortality;  Nicaragua;  Nigeria;  non communicable disease;  Norway;  nutrition;  packaging;  Papua New Guinea;  physical activity;  politics;  Portugal;  practice guideline;  priority journal;  risk factor;  Russian Federation;  Rwanda;  Saudi Arabia;  Sierra Leone;  Slovenia;  South Sudan;  Spain;  tax;  Thailand;  tobacco;  trend study;  Turkey (republic);  United Kingdom;  World Bank;  World Health Organization;  Zambia;  Zimbabwe;  global health;  management;  non communicable disease;  practice guideline, Global Health;  Guidelines as Topic;  Health Policy;  Humans;  Noncommunicable Diseases;  Policy Making;  World Health Organization},
funding_details={National Institute for Health and Care ResearchNational Institute for Health and Care Research, NIHR},
funding_details={Imperial College LondonImperial College London},
funding_text 1={LNA and BDN hold National Institute for Health Research (NIHR) fellowships. BYTY holds a Rhodes scholarship and held a NIHR School for Primary Care Research summer research internship award at the time this research was being done. FG-d-S holds an Imperial College London scholarship. After submission, Imperial College London kindly agreed to fund the open access fees for this paper. Our thanks to Imperial College London for funding the open access fees and Richard Stevens and José M Ordóñez-Mena, statisticians from Oxford Nuffield Department of Primary Care Health Sciences, for their advice on statistical analysis.},
references={GBD 2017: a fragile world (2018) Lancet, 392; Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases (2017), https://apps.who.int/iris/bitstream/handle/10665/259232/WHO-NMH-NVI-17.9-eng.pdf?sequence=1&isAllowed=y, World Health Organization Geneva (Accessed 3 January 2019); Noncommunicable diseases progress monitor 2015 (2015), https://apps.who.int/iris/bitstream/handle/10665/184688/9789241509459_eng.pdf?sequence=1, World Health Organization Geneva (Accessed 3 January 2019); Noncommunicable diseases progress monitor 2017 (2017), https://apps.who.int/iris/bitstream/handle/10665/258940/9789241513029-eng.pdf?sequence=1, World Health Organization Geneva (Accessed 3 January 2019); Roth, G.A., Abate, D., Abate, K.H., Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) Lancet, 392, pp. 1736-1788; Allen, L., Williams, J., Townsend, N., Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review (2017) Lancet Glob Health, 5, pp. e277-e289; 2017 POS NCD summit grid report, updated Sept 2017 http://onecaribbeanhealth.org/wp-content/uploads/2018/03/POS-Declaration-country-grid-2017.pdf, (Accessed 3 January 2019); Kessler, M., Draft political declaration for UN High-Level Meeting on NCDs lacks strength and ambition required to avoid a preventable global health crisis. ENOUGH NCDs (2018), https://enoughncds.com/draft-political-declaration/, (Accessed 3 January 2019); Juma, P.A., Mohamed, S.F., Matanje Mwagomba, B.L., Non-communicable disease prevention policy process in five African countries (2018) BMC Public Health, 18, p. 961; Dalal, S., Beunza, J.J., Volmink, J., Non-communicable diseases in sub-Saharan Africa: what we know now (2011) Int J Epidemiol, 40, pp. 885-901; WHO. Implementation guide on health-related food and drink taxation. Copenhagen: WHO Europe (in press); Sacco, R.L., Smith, S.C., Holmes, D., Accelerating progress on non-communicable diseases (2013) Lancet, 382, pp. e4-e5; Jamison, D.T., Summers, L.H., Alleyne, G., Global health 2035: a world converging within a generation (2013) Lancet, 382, pp. 1898-1955; Hunter, D.J., Reddy, K.S., Noncommunicable diseases (2013) N Engl J Med, 369, pp. 1336-1343; Lupafya, P.C., Mwagomba, B.L., Hosig, K., Maseko, L.M., Chimbali, H., Implementation of policies and strategies for control of noncommunicable diseases in Malawi: challenges and opportunities (2016) Health Educ Behav, 43, pp. 64-69S; Bennett, J.E., Stevens, G.A., Mathers, C.D., NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 (2018) Lancet, 392, pp. 1072-1088; Back the idea of human capital with solid research (2018) Nature, 562, pp. 459-460; Allais, S., ‘Economics imperialism’, education policy and educational theory (2012) J Educ Policy, 27, pp. 253-274; Gravely, S., Giovino, G.A., Craig, L., Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study (2017) Lancet Public Health, 2, pp. e166-e174; Hiilamo, H., Glantz, S., Limited implementation of the framework convention on tobacco control's tobacco tax provision: global comparison (2018) BMJ Open, 8; Marshall, M.G., Cole, B.R., Global Report 2014: conflict, governance and state fragility. Center for Systemic Peace https://www.systemicpeace.org/vlibrary/GlobalReport2014.pdf, (Accessed 13 January 2019); Tuangratananon, T., Wangmo, S., Widanapathirana, N., Implementation of national action plans on noncommunicable diseases, Bhutan, Cambodia, Indonesia, Philippines, Sri Lanka, Thailand and Viet Nam (2019) Bull World Health Organ, 97, pp. 129-141; McGuire, J.W., Political regime and social performance (2013) Contemp Polit, 19, pp. 55-75; Feigl, A.B., Ding, E.L., Evidenced Formal Coverage Index and universal healthcare enactment: a prospective longitudinal study of economic, social, and political predictors of 194 countries (2013) Health Policy, 113, pp. 50-60; Bollyky, T.J., Templin, T., Cohen, M., Schoder, D., Dieleman, J.L., Wigley, S., The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis (2019) Lancet, 393, pp. 1628-1640},
correspondence_address1={Allen, L.N.; Nuffield Department of Primary Care Health Sciences, United Kingdom; email: drlukeallen@gmail.com},
publisher={Elsevier Ltd},
issn={2214109X},
pubmed_id={31813787},
language={English},
abbrev_source_title={Lancet Global Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Seitz2019,
author={Seitz, M.W. and Listl, S. and Bartols, A. and Schubert, I. and Blaschke, K. and Haux, C. and Van Der Zande, M.M.},
title={Current knowledge on correlations between highly prevalent dental conditions and chronic diseases: An umbrella review},
journal={Preventing Chronic Disease},
year={2019},
volume={16},
number={9},
doi={10.5888/pcd16.180641},
art_number={180641},
note={cited By 44},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068547729&doi=10.5888%2fpcd16.180641&partnerID=40&md5=50fccecbef28b1ce7c03cff69ed3b231},
affiliation={University of Heidelberg, Institute of Medical Biometry and Informatics, Heidelberg, Germany; Section for Translational Health Economics, Department of Conservative Dentistry, Heidelberg University, Heidelberg, Germany; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Dentistry - Quality and Safety of Oral Healthcare, Nijmegen, Netherlands; Dental Academy for Continuing Professional Development, Karlsruhe, Germany; Christian-Albrechts-University Kiel, Clinic for Conservative Dentistry and Periodontology, Kiel, Germany; PMV Research Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany},
abstract={Introduction Studies have investigated the relationships between chronic systemic and dental conditions, but it remains unclear how such knowledge can be used in clinical practice. In this article, we provide an overview of existing systematic reviews, identifying and evaluating the most frequently reported dental-chronic disease correlations and common risk factors. Methods We conducted a systematic review of existing systematic reviews (umbrella review) published between 1995 and 2017 and indexed in 4 databases. We focused on the 3 most prevalent dental conditions and 10 chronic systemic diseases with the highest burden of disease in Germany. Two independent reviewers assessed all articles for eligibility and methodologic quality using the AMSTAR criteria and extracted data from the included studies. Results Of the initially identified 1,249 systematic reviews, 32 were included for qualitative synthesis. The dental condition with most frequently observed correlations to chronic systemic diseases was periodontitis. The chronic systemic disease with the most frequently observed correlations with a dental condition was type 2 diabetes mellitus (T2DM). Most dental-chronic disease correlations were found between periodontitis and T2DM and periodontitis and cardiovascular disease. Frequently reported common risk factors were smoking, age, sex, and overweight. Using the AMSTAR criteria, 2 studies were assessed as low quality, 26 studies as moderate quality, and 4 studies as high quality. Conclusion The quality of included systematic reviews was heterogeneous. The most frequently reported correlations were found for periodontitis with T2DM and for periodontitis with cardiovascular disease. However, the strength of evidence for these and other disease correlations is limited, and the evidence to assess the causality of these disease correlations remains unclear. Future research should focus on the causality of disease links in order to provide more decisive evidence with respect to the design of intersectoral care processes. © 2019 Centers for Disease Control and Prevention (CDC).},
keywords={cerebrovascular accident;  complication;  coronary artery disease;  dental caries;  human;  non insulin dependent diabetes mellitus;  periodontal disease, Coronary Disease;  Dental Caries;  Diabetes Mellitus, Type 2;  Humans;  Periodontal Diseases;  Stroke},
funding_details={01VSF16052},
funding_text 1={Grant support for this project was provided by the Federal Joint Committee (G-BA) Innovation Fund, grant agreement no. 01VSF16052. This review was conducted as part of the Dent@Prevent project. Consortium members of the Dent@Prevent project have included Andreas Bartols, Joachim Bentz, Katja Blaschke, Joachim Fessler, Petra Knaup-Gregori, Christian Haux, Martin Hellmich, Olivier Kalmus, Stefan Listl, Bernt-Peter Robra, Christina Samel, Tanja Schamma, Ingrid Schubert, Max W. Seitz, Kirsten Smits, Jochen Walker, Winfried Walther, Marieke M. van der Zande. We thank all contributors to the Dent@Prevent project. No copyrighted materials/surveys/instruments/tools were used in our study. M. W. Seitz and M. van der Zande contributed to conception, design, data acquisition, analysis, and interpretation, and drafted and critically revised the manuscript. A. Bartols, I. Schubert, K. Blaschke, and C. Haux contributed to design and interpretation and critically revised the manuscript. S. Listl contributed to conception, design, and interpretation and critically revised the manuscript. The authors declare that there are no conflicts of interest.},
funding_text 2={Grant support for this project was provided by the Federal Joint Committee (G-BA) Innovation Fund, grant agreement no. 01VSF16052. This review was conducted as part of the Dent@Prevent project. Consortium members of the Dent@Prevent project have included Andreas Bartols, Joachim Bentz, Katja Blaschke, Joachim Fessler, Petra Knaup-Gregori, Christian Haux, Martin Hellmich, Olivier Kalmus, Stefan Listl, Bernt-Peter Robra, Christina Samel, Tanja Schamma, Ingrid Schubert, Max W. Seitz, Kirsten Smits, Jochen Walker, Winfried Walther, Marieke M. van der Zande. We thank all contributors to the Dent@Prevent project. No copyrighted materials/surveys/instruments/tools were used in our study.},
references={Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A., GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) Lancet, 388, pp. 1459-1544; Salomon, J.A., Wang, H., Freeman, M.K., Vos, T., Flaxman, A.D., Lopez, A.D., Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010 (2012) Lancet, 380 (9859), pp. 2144-2162; Wagner, E.H., Austin, B.T., Von Korff, M., Organizing care for patients with chronic illness (1996) Milbank Q, 74 (4), pp. 511-544; van den Akker, M., Buntinx, F., Metsemakers, J.F., Roos, S., Knottnerus, J.A., Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases (1998) J Clin Epidemiol, 51 (5), pp. 367-375; DuGoff, E.H., Canudas-Romo, V., Buttorff, C., Leff, B., Anderson, G.F., Multiple chronic conditions and life expectancy: a life table analysis (2014) Med Care, 52 (8), pp. 688-694; Linden, G.J., Lyons, A., Scannapieco, F.A., Periodontal systemic associations: review of the evidence (2013) J Clin Periodontol, 40, pp. S8-S19; Petersen, P.E., The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of the WHO Global Oral Health Programme (2003) Community Dent Oral Epidemiol, 31, pp. 3-23; Haux, C., Listl, S., Ganzinger, M., Schubert, I., Knaup, P., (2017) Towards an evidence-informed and patient centered decision support system for intersectoral care; (2016) Global burden of disease, , http://www.healthdata.org/germany, Accessed February 10, 2018; Plass, D., Vos, T., Hornberg, C., Scheidt-Nave, C., Zeeb, H., Krämer, A., Trends in disease burden in Germany: results, implications and limitations of the Global Burden of Disease study (2014) Dtsch Arztebl Int, 111 (38), pp. 629-638; Schardt, C., Adams, M.B., Owens, T., Keitz, S., Fontelo, P., Utilization of the PICO framework to improve searching PubMed for clinical questions (2007) BMC Med Inform Decis Mak, 7 (1), p. 16; Marcenes, W., Kassebaum, N.J., Bernabé, E., Flaxman, A., Naghavi, M., Lopez, A., Global burden of oral conditions in 1990-2010: a systematic analysis (2013) J Dent Res, 92 (7), pp. 592-597; Petersen, P.E., Ogawa, H., The global burden of periodontal disease: towards integration with chronic disease prevention and control (2012) Periodontol 2000, 60 (1), pp. 15-39; Haag, D.G., Peres, K.G., Balasubramanian, M., Brennan, D.S., Oral conditions and health-related quality of life: a systematic review (2017) J Dent Res, 96 (8), pp. 864-874; Bernell, S., Howard, S.W., Use your words carefully: what is a chronic disease? (2016) Front Public Health, 4, p. 159; (2016) Noncommunicable diseases, , http://www.who.int/topics/noncommunicable_diseases/en/, Accessed January20, 2018; McHugh, M.L., Interrater reliability: the kappa statistic (2012) Biochem Med (Zagreb), 22 (3), pp. 276-282; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7 (1), p. 10; Abduljabbar, T., Javed, F., Shah, A., Samer, M.S., Vohra, F., Akram, Z., Role of lasers as an adjunct to scaling and root planing in patients with type 2 diabetes mellitus: a systematic review (2017) Lasers Med Sci, 32 (2), pp. 449-459; Abduljabbar, T., Vohra, F., Javed, F., Akram, Z., Antimicrobial photodynamic therapy adjuvant to non-surgical periodontal therapy in patients with diabetes mellitus: a meta-analysis (2017) Photodiagn Photodyn Ther, 17, pp. 138-146; Al-Hamoudi, N., Is antimicrobial photodynamic therapy an effective treatment for chronic periodontitis in diabetes mellitus and cigarette smokers: a systematic review and metaanalysis (2017) Photodiagn Photodyn Ther, 19, pp. 375-382; Azarpazhooh, A., Leake, J.L., Systematic review of the association between respiratory diseases and oral health (2006) J Periodontol, 77 (9), pp. 1465-1482; Batista, R.M., Zandonade, E., Roelke, L.H., Emmerich, A.O., Rosetti, E.P., Molina, M.C., Association between periodontal disease and subclinic atherosclerosis: a systematic review [Associacao entre doenca periodontal e aterosclerose subclinica: Uma revisao sistematica.] (2011) J Vasc Bras, 10 (3), pp. 229-238; Botero, J.E., Rodríguez, C., Agudelo-Suarez, A.A., Periodontal treatment and glycemic control in patients with diabetes and periodontitis: an umbrella review (2016) Aust Dent J, 61 (2), pp. 134-148; Dai, R., Lam, O.L., Lo, E.C., Li, L.S., Wen, Y., McGrath, C., A systematic review and meta-analysis of clinical, microbiological, and behavioural aspects of oral health among patients with stroke (2015) J Dent, 43 (2), pp. 171-180; D'Aiuto, F., Gable, D., Syed, Z., Allen, Y., Wanyonyi, K.L., White, S., Evidence summary: the relationship between oral diseases and diabetes (2017) Br Dent J, 222 (12), pp. 944-948; D'Aiuto, F., Orlandi, M., Gunsolley, J.C., Evidence that periodontal treatment improves biomarkers and CVD outcomes (2013) J Periodontol, 84 (4), pp. S85-S105; Dietrich, T., Webb, I., Stenhouse, L., Pattni, A., Ready, D., Wanyonyi, K.L., Evidence summary: the relationship between oral and cardiovascular disease (2017) Br Dent J, 222 (5), pp. 381-385; Faggion, C.M., Jr., Cullinan, M.P., Atieh, M., An overview of systematic reviews on the effectiveness of periodontal treatment to improve glycemic control (2016) J Periodontal Res, 51 (6), pp. 716-725; Hasuike, A., Iguchi, S., Suzuki, D., Kawano, E., Sato, S., Systematic review and assessment of systematic reviews examining the effect of periodontal treatment on glycemic control in patients with diabetes (2017) Med Oral Patol Oral Cir Bucal, 22 (2), pp. e167-e176; Kelly, J.T., Avila-Ortiz, G., Allareddy, V., Johnson, G.K., Elangovan, S., The association between periodontitis and coronary heart disease: a quality assessment of systematic reviews (2013) J Am Dent Assoc, 144 (4), pp. 371-379; Kothari, M., Pillai, R.S., Kothari, S.F., Spin-Neto, R., Kumar, A., Nielsen, J.F., Oral health status in patients with acquired brain injury: a systematic review (2017) Oral Surg Oral Med Oral Pathol Oral Radiol, 123 (2), pp. 205-219; Lafon, A., Pereira, B., Dufour, T., Rigouby, V., Giroud, M., Béjot, Y., Periodontal disease and stroke: a meta-analysis of cohort studies (2014) Eur J Neurol, 21 (9), pp. 1155-1161; Lam, O.L.T., Zhang, W., Samaranayake, L.P., Li, L.S.W., McGrath, C., A systematic review of the effectiveness of oral health promotion activities among patients with cardiovascular disease (2011) Int J Cardiol, 151 (3), pp. 261-267; Leira, Y., Seoane, J., Blanco, M., Rodríguez-Yáñez, M., Takkouche, B., Blanco, J., Association between periodontitis and ischemic stroke: a systematic review and meta-analysis (2017) Eur J Epidemiol, 32 (1), pp. 43-53; Leng, W.D., Zeng, X.T., Kwong, J.S.W., Hua, X.P., Periodontal disease and risk of coronary heart disease: an updated metaanalysis of prospective cohort studies (2015) Int J Cardiol, 201, pp. 469-472; Li, C., Lv, Z., Shi, Z., Zhu, Y., Wu, Y., Li, L., Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis (2014) Cochrane Database Syst Rev, (8); Lira, R., Santos, C.M., Oliveira, B.H., Fischer, R.G., Santos, A., Effects on HbA1c in diabetic patients of adjunctive use of systemic antibiotics in nonsurgical periodontal treatment: a systematic review (2017) J Dent, 66, pp. 1-7; Martin-Cabezas, R., Seelam, N., Petit, C., Agossa, K., Gaertner, S., Tenenbaum, H., Association between periodontitis and arterial hypertension: a systematic review and meta-analysis (2016) Am Heart J, 180, pp. 98-112; Mauri-Obradors, E., Estrugo-Devesa, A., Jané-Salas, E., Viñas, M., López-López, J., Oral manifestations of Diabetes Mellitus. A systematic review (2017) Med Oral Patol Oral Cir Bucal, 22 (5), pp. e586-e594; Orlandi, M., Suvan, J., Petrie, A., Donos, N., Masi, S., Hingorani, A., Association between periodontal disease and its treatment, flow-mediated dilatation and carotid intima-media thickness: a systematic review and meta-analysis (2014) Atherosclerosis, 236 (1), pp. 39-46; Sanchez, P., Everett, B., Salamonson, Y., Ajwani, S., George, A., Oral healthcare and cardiovascular disease: a scoping review of current strategies and implications for nurses (2017) J Cardiovasc Nurs, 32 (3), pp. E10-E20; Schmitt, A., Carra, M.C., Boutouyrie, P., Bouchard, P., Periodontitis and arterial stiffness: a systematic review and meta-analysis (2015) J Clin Periodontol, 42 (11), pp. 977-987; Teeuw, W.J., Slot, D.E., Susanto, H., Gerdes, V.E., Abbas, F., D'Aiuto, F., Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis (2014) J Clin Periodontol, 41 (1), pp. 70-79; Tonsekar, P.P., Jiang, S.S., Yue, G., Periodontal disease, tooth loss and dementia: Is there a link?. A systematic review (2017) Gerodontology, 34 (2), pp. 151-163; Ungprasert, P., Wijarnpreecha, K., Wetter, D.A., Periodontitis and risk of psoriasis: a systematic review and meta-analysis (2017) J Eur Acad Dermatol Venereol, 31 (5), pp. 857-862; Xu, S., Song, M., Xiong, Y., Liu, X., He, Y., Qin, Z., The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies (2017) BMC Cardiovasc Disord, 17 (1), p. 50; Zeng, X.T., Leng, W.D., Lam, Y.Y., Yan, B.P., Wei, X.M., Weng, H., Periodontal disease and carotid atherosclerosis: a metaanalysis of 17,330 participants (2016) Int J Cardiol, 203, pp. 1044-1051; Zeng, X.T., Tu, M.L., Liu, D.Y., Zheng, D., Zhang, J., Leng, W., Periodontal disease and risk of chronic obstructive pulmonary disease: a meta-analysis of observational studies (2012) PLoS One, 7 (10); Zeng, X.T., Xia, L.Y., Zhang, Y.G., Li, S., Leng, W.D., Kwong, J.S., Periodontal disease and incident lung cancer risk: a metaanalysis of cohort studies (2016) J Periodontol, 87 (10), pp. 1158-1164; Glenny, A.M., Esposito, M., Coulthard, P., Worthington, H.V., The assessment of systematic reviews in dentistry (2003) Eur J Oral Sci, 111 (2), pp. 85-92; (2009) IDF Guideline on oral health for people with diabetes, , Brussels: International Diabetes Federation;; Sanz, M., Ceriello, A., Buysschaert, M., Chapple, I., Demmer, R.T., Graziani, F., Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology (2018) Diabetes Res Clin Pract, 137, pp. 231-241; Sheiham, A., Watt, R.G., The common risk factor approach: a rational basis for promoting oral health (2000) Community Dent Oral Epidemiol, 28 (6), pp. 399-406; Savage, A., Eaton, K.A., Moles, D.R., Needleman, I., A systematic review of definitions of periodontitis and methods that have been used to identify this disease (2009) J Clin Periodontol, 36 (6), pp. 458-467; Sippli, K., Rieger, M.A., Huettig, F., GPs' and dentists' experiences and expectations of interprofessional collaboration: findings from a qualitative study in Germany (2017) BMC Health Serv Res, 17 (1), p. 179; (2018) Advancing excellence in health care, , https://cds.ahrq.gov/, Accessed May 14, 2018. Global burden of disease},
correspondence_address1={Seitz, M.W.; Institute of Medical Biometry and Informatics, Marsilius-Arkaden Turm West, Im Neuenheimer Feld 130.3, Germany; email: max.seitz@med.uni-heidelberg.de},
publisher={Centers for Disease Control and Prevention (CDC)},
issn={15451151},
pubmed_id={31560644},
language={English},
abbrev_source_title={Prev. Chronic Dis.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Papatheodorou2019543,
author={Papatheodorou, S.},
title={Umbrella reviews: what they are and why we need them},
journal={European Journal of Epidemiology},
year={2019},
volume={34},
number={6},
pages={543-546},
doi={10.1007/s10654-019-00505-6},
note={cited By 44},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062703629&doi=10.1007%2fs10654-019-00505-6&partnerID=40&md5=d65fd20be92614578dc12f0573e0a273},
affiliation={Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Cyprus University of Technology, Limassol, Cyprus},
keywords={epidemiology;  human;  Medline, Epidemiologic Studies;  Humans;  PubMed;  Systematic Reviews as Topic},
references={Sackett, D.L., Rosenberg, W.M., Gray, J.A., Haynes, R.B., Richardson, W.S., Evidence based medicine: What it is and what it isn’t (1996) BMJ, 312 (7023), pp. 71-72; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Silagy, C.A., Middleton, P., Hopewell, S., Publishing protocols of systematic reviews: Comparing what was done to what was planned (2002) JAMA, 287 (21), pp. 2831-2834; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2009) BMJ, 339, p. b2535; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358; Salanti, G., Ioannidis, J.P., Synthesis of observational studies should consider credibility ceilings (2009) J Clin Epidemiol, 62 (2), pp. 115-122; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Poole, R., Kennedy, O.J., Roderick, P., Fallowfield, J.A., Hayes, P.C., Parkes, J., Coffee consumption and health: Umbrella review of meta-analyses of multiple health outcomes (2017) BMJ, 359; Machado, M.O., Veronese, N., Sanches, M., Stubbs, B., Koyanagi, A., Thompson, T., The association of depression and all-cause and cause-specific mortality: An umbrella review of systematic reviews and meta-analyses (2018) BMC Med, 16 (1); Bellou, V., Belbasis, L., Tzoulaki, I., Middleton, L.T., Ioannidis, J.P.A., Evangelou, E., Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses (2017) Alzheimer’s Dement J Alzheimer’s Assoc, 13 (4), pp. 406-418; Houze, B., El-Khatib, H., Arbour, C., Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches (2017) Prog Neuropsychopharmacol Biol Psychiatry, 79, pp. 192-205; Corso, E., Hind, D., Beever, D., Fuller, G., Wilson, M.J., Wrench, I.J., Enhanced recovery after elective caesarean: A rapid review of clinical protocols, and an umbrella review of systematic reviews (2017) BMC Pregnancy Childbirth, 17 (1); Giannakou, K., Evangelou, E., Papatheodorou, S.I., Genetic and nongenetic risk factors for pre-eclampsia: Umbrella review of systematic reviews and meta-analyses of observational studies (2018) Ultrasound Obstet Gynecol: Off J Int Soc Ultrasound Obstet Gynecol, 51 (6), pp. 720-730; Solmi, M., Correll, C.U., Carvalho, A.F., Ioannidis, J.P.A., The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: Beyond qualitative synthesis (2018) Epidemiol Psychiatric Sci, 27 (6), pp. 537-542; Kohler, C.A., Evangelou, E., Stubbs, B., Solmi, M., Veronese, N., Belbasis, L., Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies (2018) J Psychiatry Res, 103, pp. 189-207; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19 (22), pp. 3127-3131; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104 (24), pp. 1867-1878; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253},
correspondence_address1={Papatheodorou, S.; Department of Epidemiology, United States; email: spapathe@hsph.harvard.edu},
publisher={Springer Science and Business Media B.V.},
issn={03932990},
coden={EJEPE},
pubmed_id={30852716},
language={English},
abbrev_source_title={Eur. J. Epidemiol.},
document_type={Note},
source={Scopus},
}

@ARTICLE{Vercambre2013413,
author={Vercambre, M.-N. and Berr, C. and Ritchie, K. and Kang, J.H.},
title={Caffeine and cognitive decline in elderly women at high vascular risk},
journal={Journal of Alzheimer's Disease},
year={2013},
volume={35},
number={2},
pages={413-421},
doi={10.3233/JAD-122371},
note={cited By 42},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877154857&doi=10.3233%2fJAD-122371&partnerID=40&md5=3a56138332df653c1f2bfe43e91de06d},
affiliation={MGEN Foundation for Public Health, 3 square Max Hymans, 75748 Paris Cedex 15, France; Inserm, U1061, Montpellier, France; University of Montpellier 1, Montpellier, France; Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States},
abstract={Background: Persons with vascular disorders are at higher risk of cognitive decline. Objective: To determine whether caffeine may be associated with cognitive decline reduction in elderly at high vascular risk. Methods: We included 2,475 women aged 65+ years in the Women's Antioxidant Cardiovascular Study, a randomized trial of antioxidants and B vitamins for cardiovascular disease secondary prevention. We ascertained regular caffeine intake at baseline (1995-1996) using a validated 116 item-food frequency questionnaire. From 1998-2000 to 2005-2006, we administered four telephone cognitive assessments at two-year intervals evaluating global cognition, verbal memory, and category fluency. The primary outcome was the change in global cognitive score, which was the average of the z-scores of all tests. We used generalized linear models for repeated measures that were adjusted for various sociodemographic, health, and lifestyle factors to evaluate the difference in cognitive decline rates across quintiles of caffeine intake. Results: We observed significantly slower rates of cognitive decline with increasing caffeine intake (p-trend = 0.02). The rate difference between the highest and lowest quintiles of usual caffeine intake (>371 versus <30 mg/day) was equivalent to that observed between those who were 7 years apart in age (p = 0.006). Consumption of caffeinated coffee was significantly related to slower cognitive decline (p-trend = 0.05), but not other caffeinated products (e.g., decaf, tea, cola, chocolate). We conducted interaction analyses and observed stronger associations in women assigned to vitamin B supplementation (p-interaction = 0.02). Conclusions: Caffeine intake was related to moderately better cognitive maintenance over 5 years in older women with vascular disorders. © 2013 - IOS Press and the authors. All rights reserved.},
author_keywords={Aging;  caffeine;  cognition;  cohort studies;  epidemiology;  risk factors},
keywords={antioxidant;  caffeine;  vitamin B group, aged;  article;  cardiovascular disease;  cardiovascular risk;  cognition;  cohort analysis;  dietary intake;  female;  food frequency questionnaire;  human;  lifestyle;  major clinical study;  mental deterioration;  outcome assessment;  priority journal;  randomized controlled trial (topic);  secondary prevention;  speech;  teleconsultation;  verbal memory;  visual memory;  vitamin supplementation},
chemicals_cas={caffeine, 58-08-2; vitamin B group, 12001-76-2},
references={Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E.E., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use (1999) Pharmacol Rev, 51, pp. 83-133; Freedman, N.D., Park, Y., Abnet, C.C., Hollenbeck, A.R., Sinha, R., Association of coffee drinking with total and causespecific mortality (2012) N Engl J Med, 366, pp. 1891-1904; Ritchie, K., Carriere, I., De Mendonca, A., Portet, F., Dartigues, J.F., Rouaud, O., Barberger-Gateau, P., Ancelin, M.L., The neuroprotective effects of caffeine: A prospective population study (the three city study (2007) Neurology, 69, pp. 536-545; Van Gelder, B.M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., Kromhout, D., Coffee consumption is inversely associated with cognitive decline in elderly european men: The fine study (2007) Eur J Clin Nutr, 61, pp. 226-232; Santos, C., Lunet, N., Azevedo, A., De Mendonça, A., Ritchie, K., Barros, H., Caffeine intake is associated with a lower risk of cognitive decline: A cohort study from portugal (2010) J Alzheimers Dis, 20, pp. 175-185; Arab, L., Biggs, M.L., O'Meara, E.S., Longstreth, W.T., Crane, P.K., Fitzpatrick, A.L., Gender differences in tea, coffee, and cognitive decline in the elderly: The cardiovascular health study (2011) J Alzheimers Dis, 27, pp. 553-566; A united approach to vascular disease and neurodegeneration (2012) Lancet Neurol, 11, p. 293; Frary, C.D., Johnson, R.K., Wang, M.Q., Food sources and intakes of caffeine in the diets of persons in the United States (2005) J Am Diet Assoc, 105, pp. 110-113; Garriguet, D., Beverage consumption of canadian adults (2008) Health Rep, 19, pp. 23-29; Pase, M.P., Grima, N.A., Stough, C.K., Scholey, A., Pipingas, A., Cardiovascular disease risk and cerebral blood flow velocity (2012) Stroke, 43, pp. 2803-2805; Van Dam, R.M., Hu, F.B., Coffee consumption and risk of type 2 diabetes: A systematic review (2005) JAMA, 294, pp. 97-104; Wu, J.N., Ho, S.C., Zhou, C., Ling, W.H., Chen, W.Q., Wang, C.L., Chen, Y.M., Coffee consumption and risk of coronary heart diseases: A meta-Analysis of 21 prospective cohort studies (2009) Int J Cardiol, 137, pp. 216-225; Mostofsky, E., Rice, M.S., Levitan, E.B., Mittleman, M.A., Habitual coffee consumption and risk of heart failure:Adoseresponse meta-Analysis (2012) Circ Heart Fail, 5, pp. 401-405; Lopez-Garcia, E., Rodriguez-Artalejo, F., Li, T.Y., Mukamal, K.J., Hu, F.B., Van Dam, R.M., Coffee consumption and mortality in women with cardiovasculardisease (2011) Am J Clin Nutr, 94, pp. 218-224; Cook, N.R., Albert, C.M., Gaziano, J.M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J.E., Manson, J.E., A randomized factorial trial of vitamins c and e and beta carotene in the secondary prevention of cardiovascular events in women: Results from thewomen's antioxidant cardiovascular study (2007) Arch Intern Med, 167, pp. 1610-1618; Albert, C.M., Cook, N.R., Gaziano, J.M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J.E., Manson, J.E., Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial (2008) JAMA, 299, pp. 2027-2036; Kang, J.H., Cook, N., Manson, J., Buring, J.E., Albert, C.M., Grodstein, F., A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease (2008) Am J Clin Nutr, 88, pp. 1602-1610; Kang, J.H., Cook, N.R., Manson, J.E., Buring, J.E., Albert, C.M., Grodstein, F., Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study (2009) Circulation, 119, pp. 2772-2780; Vercambre, M.N., Grodstein, F., Berr, C., Kang, J.H., Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors (2012) J Acad Nutr Diet, 112, pp. 816-823; Vercambre, M.N., Grodstein, F., Manson, J.E., Stampfer, M.J., Kang, J.H., Physical activity and cognition in women with vascular conditions (2011) Arch Intern Med, 171, pp. 1244-1250; Brandt, J., Spencer, M., Folstein, M., The telephone Interview for Cognitive Status (1988) Neuropsych Neuropsychol Behav Neurol, 1, pp. 111-117; Scherr, P.A., Albert, M.S., Funkenstein, H.H., Cook, N.R., Hennekens, C.H., Branch, L.G., White, L.R., Evans, D.A., Correlates of cognitive function in an elderly community population (1988) Am J Epidemiol, 128, pp. 1084-1101; Morris, J.C., Heyman, A., Mohs, R.C., Hughes, J.P., Van Belle, G., Fillenbaum, G., Mellits, E.D., Clark, C., The consortium to establish a registry for alzheimer's disease (cerad part i clinical and neuropsychological assessment of alzheimer's disease (1989) Neurology, 39, pp. 1159-1165; Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B., Backman, L., The course of cognitive impairment in preclinical alzheimer disease: Three-And 6-year follow-up of a population-based sample (2000) Arch Neurol, 57, pp. 839-844; Robinson, G., Shallice, T., Bozzali, M., Cipolotti, L., The differing roles of the frontal cortex in fluency tests (2012) Brain, 135, pp. 2202-2214; Peters, N., Opherk, C., Danek, A., Ballard, C., Herzog, J., Dichgans, M., The pattern of cognitive performance in CADASIL: A monogenic condition leading to subcortical ischemic vascular dementia (2005) Am J Psychiatry, 162, pp. 2078-2085; Willett, W.C., Sampson, L., Stampfer, M.J., Rosner, B., Bain, C., Witschi, J., Hennekens, C.H., Speizer, F.E., Reproducibility and validity of a semiquantitative food frequency questionnaire (1985) Am J Epidemiol, 122, pp. 51-65; Salvini, S., Hunter, D.J., Sampson, L., Stampfer, M.J., Colditz, G.A., Rosner, B., Willett, W.C., Food-based validation of a dietary questionnaire: The effects of week-To-week variation in food consumption (1989) Int J Epidemiol, 18, pp. 858-867; Willett, W., Stampfer, M.J., Total energy intake: Implications for epidemiologic analyses (1986) AmJ Epidemiol, 124, pp. 17-27; Santos, C., Costa, J.O., Santos, J.O., Vaz-Carneiro, A.N., Lunet, N., Caffeine intake and dementia: Systematic review and meta-Analysis (2010) J Alzheimers Dis, 20, pp. 187-204; Ritchie, K., Artero, S., Portet, F., Brickman, A., Muraskin, J., Beanino, E., Ancelin, M.-L., Carriere, I., Caffeine, cognitive functioning, and white matter lesions in the elderly: Establishing causality from epidemiological evidence (2010) J Alzheimers Dis, 20, pp. 161-166; Gelber, R.P., Petrovitch, H., Masaki, K.H., Ross, G.W., White, L.R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates (2011) J Alzheimers Dis, 23, pp. 607-615; Dall'Igna, O.P., Fett, P., Gomes, M.W., Souza, D.O., Cunha, R.A., Lara, D.R., Caffeine and adenosine A (2a) receptor antagonists prevent beta-Amyloid (25-35)-induced cognitive deficits in mice (2007) Exp Neurol, 203, pp. 241-245; Arendash, G.W., Schleif, W., Rezai-Zadeh, K., Jackson, E.K., Zacharia, L.C., Cracchiolo, J.R., Shippy, D., Tan, J., Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-Amyloid production (2006) Neuroscience, 142, pp. 941-952; Cao, C., Cirrito, J.R., Lin, X., Wang, L., Verges, D.K., Dickson, A., Mamcarz, M., Potter, H., Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice (2009) J Alzheimers Dis, 17, pp. 681-697; Arendash, G.W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Potter, H., Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged alzheimer's disease mice (2009) J Alzheimers Dis, 17, pp. 661-680; Duarte, J.M.N., Agostinho, P.M., Carvalho, R.A., Cunha, R.A., Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/ LTJ mice (2012) PLoS ONE, 7, pp. e21899; Lucas, M., Mirzaei, F., Pan, A., Okereke, O.I., Willett, W.C., O'Reilly, E.J., Koenen, K., Ascherio, A., Coffee, caffeine, and risk of depression among women (2011) Arch Intern Med, 171, pp. 1571-1578; Beaudreau, S.A., O'Hara, R., The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults (2009) Psychol Aging, 24, pp. 507-512; Verhoef, P., Pasman, W.J., Van Vliet, T., Urgert, R., Katan, M.B., Contribution of caffeine to the homocysteine-raising effect of coffee: A randomized controlled trial in humans (2002) Am J Clin Nutr, 76, pp. 1244-1248; Obeid, R., Herrmann, W., Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia (2006) FEBS Lett, 580, pp. 2994-3005; MacGregor, J.T., Schlegel, R., Wehr, C.M., Alperin, P., Ames, B.N., Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine (1990) Proc Natl Acad Sci, 87, pp. 9962-9965; Shukitt-Hale, B., Miller, M.G., Chu, Y.F., Lyle, B.J., Joseph, J.A., Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging (2013) Age (Dordr, pp. 9509-9514. , in press, doi: 10.1007/s11357-012-},
correspondence_address1={Vercambre, M.-N.; MGEN Foundation for Public Health, 3 square Max Hymans, 75748 Paris Cedex 15, France; email: mvercambre@mgen.fr},
publisher={IOS Press},
issn={13872877},
coden={JADIF},
language={English},
abbrev_source_title={J. Alzheimer's Dis.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Yu2020e430,
author={Yu, K. and Lv, J. and Qiu, G. and Yu, C. and Guo, Y. and Bian, Z. and Yang, L. and Chen, Y. and Wang, C. and Pan, A. and Liang, L. and Hu, F.B. and Chen, Z. and Li, L. and Wu, T. and Chen, J. and Clarke, R. and Collins, R. and Peto, R. and Walters, R. and Avery, D. and Boxall, R. and Chang, Y. and Du, H. and Gilbert, S. and Hacker, A. and Hill, M. and Holmes, M. and Iona, A. and Kartsonaki, C. and Kerosi, R. and Kong, L. and Kurmi, O. and Lancaster, G. and Lewington, S. and Lin, K. and McDonnell, J. and Millwood, I. and Nie, Q. and Radhakrishnan, J. and Ryder, P. and Sansome, S. and Schmidt, D. and Sherliker, P. and Sohoni, R. and Stevens, B. and Turnbull, I. and Wang, J. and Wang, L. and Wright, N. and Yang, X. and Han, X. and Hou, C. and Pei, P. and Liu, C. and Tan, Y. and Pang, Z. and Gao, R. and Li, S. and Wang, S. and Liu, Y. and Du, R. and Zang, Y. and Cheng, L. and Tian, X. and Zhang, H. and Zhai, Y. and Ning, F. and Sun, X. and Li, F. and Lv, S. and Wang, J. and Hou, W. and Zeng, M. and Jiang, G. and Zhou, X. and Yang, L. and He, H. and Yu, B. and Li, Y. and Xu, Q. and Kang, Q. and Guo, Z. and Wang, D. and Hu, X. and Wang, H. and Chen, J. and Fu, Y. and Fu, Z. and Wang, X. and Weng, M. and Guo, Z. and Wu, S. and Li, Y. and Li, H. and Fu, Z. and Wu, M. and Zhou, Y. and Zhou, J. and Tao, R. and Yang, J. and Su, J. and Liu, F. and Zhang, J. and Hu, Y. and Lu, Y. and Ma, L. and Tang, A. and Zhang, S. and Jin, J. and Liu, J. and Tang, Z. and Chen, N. and Huang, Y. and Li, M. and Meng, J. and Pan, R. and Jiang, Q. and Lan, J. and Liu, Y. and Wei, L. and Zhou, L. and Chen, N. and Wang, P. and Meng, F. and Qin, Y. and Wang, S. and Wu, X. and Zhang, N. and Chen, X. and Zhou, W. and Luo, G. and Li, J. and Zhong, X. and Liu, J. and Sun, Q. and Ge, P. and Ren, X. and Dong, C. and Zhang, H. and Mao, E. and Wang, X. and Wang, T. and Zhang, X. and Zhang, D. and Zhou, G. and Feng, S. and Chang, L. and Fan, L. and Gao, Y. and He, T. and Sun, H. and He, P. and Hu, C. and Zhang, X. and Wu, H. and Yu, M. and Hu, R. and Wang, H. and Qian, Y. and Wang, C. and Xie, K. and Chen, L. and Zhang, Y. and Pan, D. and Gu, Q. and Huang, Y. and Chen, B. and Yin, L. and Liu, H. and Fu, Z. and Xu, Q. and Xu, X. and Zhang, H. and Long, H. and Li, X. and Zhang, L. and Qiu, Z.},
title={Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study},
journal={The Lancet Global Health},
year={2020},
volume={8},
number={3},
pages={e430-e439},
doi={10.1016/S2214-109X(19)30525-X},
note={cited By 41},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077999952&doi=10.1016%2fS2214-109X%2819%2930525-X&partnerID=40&md5=992e513a582479ce75a2cbdc7e3314ac},
affiliation={Department of Occupational and Environmental Health and Department of Epidemiology and Biostatistics, Key Laboratory of Environment and Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China; Chinese Academy of Medical Sciences, Beijing, China; Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Department of Epidemiology and Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, United States; Department of Nutrition and Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, United States},
abstract={Background: Cooking practice has transitioned from use of solid fuels to use of clean fuels, with addition of better ventilation facilities. However, the change in mortality risk associated with such a transition remains unclear. Methods: The China Kadoorie Biobank (CKB) Study enrolled participants (aged 30–79 years) from ten areas across China; we chose to study participants from five urban areas where transition from use of solid fuels to clean fuels for cooking was prevalent. Participants who reported regular cooking (weekly or more frequently) at baseline were categorised as persistent clean fuel users, previous solid fuel users, or persistent solid fuel users, according to self-reported fuel use histories. All-cause and cardiopulmonary mortality were identified through linkage to China's Disease Surveillance Point system and local mortality records. Findings: Between June 24, 2004, and July 15, 2008, 226 186 participants living in five urban areas of China were enrolled in the CKB Study. Among 171 677 participants who reported cooking regularly (weekly or more frequently), 75 785 (44%) were persistent clean fuel users, 80 511 (47%) were previous solid fuel users, and 15 381 (9%) were persistent solid fuel users. During a mean of 9·8 (SD 1·7) years of follow-up, 10 831 deaths were documented, including 3819 cardiovascular deaths and 761 respiratory deaths. Compared with persistent clean fuel users, persistent solid fuel users had significantly higher risks of all-cause mortality (hazard ratio [HR] 1·19, 95% CI 1·10–1·28), cardiovascular mortality (1·24, 1·10–1·39), and respiratory mortality (1·43, 1·10–1·85). The excess risk of all-cause and cardiopulmonary mortality fell by more than 60% in 5 years after cessation of solid fuel use and continued to decrease afterwards. Use of ventilation was associated with lower all-cause mortality risk, even among persistent clean fuel users (HR 0·78, 0·69–0·89). Interpretation: Solid fuel use for cooking is associated with a higher risk of mortality, and cessation of solid fuel use cuts excess mortality risks swiftly and substantially within 5 years. Ventilation use also lowers the risk of mortality, even among people who persistently use clean fuels. It is of prime importance for both policy makers and the public to accelerate the transition from solid fuels to clean fuels and promote efficient ventilation to minimise further adverse health effects. Funding: National Natural Science Foundation of China, Wellcome Trust, and Kadoorie Charitable Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license},
keywords={clean fuel;  fuel;  solid fuel;  unclassified drug;  fossil fuel, adult;  aged;  all cause mortality;  Article;  brain hemorrhage;  brain ischemia;  cardiopulmonary insufficiency;  cardiovascular disease;  cardiovascular mortality;  cerebrovascular accident;  China;  chronic obstructive lung disease;  cohort analysis;  cooking;  disease surveillance;  female;  follow up;  health care policy;  human;  ICD-10;  ischemic heart disease;  lung ventilation;  male;  mortality;  mortality risk;  outcome assessment;  pneumonia;  priority journal;  prospective study;  respiratory mortality;  respiratory tract disease;  risk factor;  urban population;  cause of death;  cooking;  electricity;  epidemiology;  lung disease;  middle aged;  mortality;  procedures;  risk;  wood, Adult;  Aged;  Cardiovascular Diseases;  Cause of Death;  China;  Cooking;  Electricity;  Female;  Fossil Fuels;  Humans;  Lung Diseases;  Male;  Middle Aged;  Prospective Studies;  Risk;  Urban Population;  Wood},
chemicals_cas={Fossil Fuels},
funding_details={Center for Outcomes Research and Evaluation, Yale School of MedicineCenter for Outcomes Research and Evaluation, Yale School of Medicine, CORE},
funding_details={Wellcome TrustWellcome Trust, WT, 088158/Z/09/Z, 104085/Z/14/Z},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_UU_12026/2, MR/P025080/1},
funding_details={British Heart FoundationBritish Heart Foundation, BHF},
funding_details={Research Councils UKResearch Councils UK, RCUK},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 81390540, 91643202, 91843302},
funding_details={Ministry of Science and Technology of the People's Republic of ChinaMinistry of Science and Technology of the People's Republic of China, MOST, 2011BAI09B01},
funding_details={National Basic Research Program of China (973 Program)National Basic Research Program of China (973 Program), 2016YFC0900500, 2016YFC0900501, 2016YFC0900504},
funding_details={Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities, 2019kfyXMBZ015},
funding_details={National Key Research and Development Program of China Stem Cell and Translational ResearchNational Key Research and Development Program of China Stem Cell and Translational Research, 2016YFC0900800},
funding_details={Higher Education Discipline Innovation ProjectHigher Education Discipline Innovation Project},
funding_text 1={Requests for data should be submitted to the China Kadoorie Biobank (CKB) Data Access Committee. As stated in the CKB data policy, the CKB Study Group (as data custodian) must maintain the integrity of the database for future use and regulate data access to comply with previous conditions agreed with the Chinese Government. Data security is an integral part of CKB Study protocols. Data can be released outside the CKB research group only with appropriate security safeguards. Acknowledgments This work was supported by grants from the National Natural Science Foundation of China ( 91843302 , 91643202 , and 81390540 ), the Foundation of National Key Program of Research and Development of China ( 2016YFC0900800 ), the 111 Project and the Program for Changjiang Scholars, Innovative Research Team in University, and the Fundamental Research Funds for the Central Universities ( 2019kfyXMBZ015 ). The China Kadoorie Biobank baseline survey and the first resurvey were supported by the Kadoorie Charitable Foundation in Hong Kong. Long-term follow-up is supported by the UK Wellcome Trust ( 088158/Z/09/Z and 104085/Z/14/Z ), the National Key Research and Development Program of China ( 2016YFC0900500 , 2016YFC0900501 , and 2016YFC0900504 ), and the Chinese Ministry of Science and Technology ( 2011BAI09B01 ). The British Heart Foundation, UK Medical Research Council, and Cancer Research provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University for the project.},
funding_text 2={This work was supported by grants from the National Natural Science Foundation of China (91843302, 91643202, and 81390540), the Foundation of National Key Program of Research and Development of China (2016YFC0900800), the 111 Project and the Program for Changjiang Scholars, Innovative Research Team in University, and the Fundamental Research Funds for the Central Universities (2019kfyXMBZ015). The China Kadoorie Biobank baseline survey and the first resurvey were supported by the Kadoorie Charitable Foundation in Hong Kong. Long-term follow-up is supported by the UK Wellcome Trust (088158/Z/09/Z and 104085/Z/14/Z), the National Key Research and Development Program of China (2016YFC0900500, 2016YFC0900501, and 2016YFC0900504), and the Chinese Ministry of Science and Technology (2011BAI09B01). The British Heart Foundation, UK Medical Research Council, and Cancer Research provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University for the project.},
references={Bonjour, S., Adair-Rohani, H., Wolf, J., Solid fuel use for household cooking: country and regional estimates for 1980–2010 (2013) Environ Health Perspect, 121, pp. 784-790; Edwards, R.D., Smith, K.R., Zhang, J., Ma, Y., Implications of changes in household stoves and fuel use in China (2004) Energy Policy, 32, pp. 395-411; World energy outlook 2017 (2017), International Energy Agency Paris; Global Health Observatory (GHO) data: public health and environment http://www.who.int/gho/phe/en/, (Accessed 9 December 2019); Rehfuess, E., Mehta, S., Prüss-Ustün, A., Assessing household solid fuel use: multiple implications for the millennium development goals (2006) Environ Health Perspect, 114, pp. 373-378; Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) Lancet, 392, pp. 1923-1994; Zhao, B., Zheng, H., Wang, S., Change in household fuels dominates the decrease in PM2·5 exposure and premature mortality in China in 2005–2015 (2018) Proc Natl Acad Sci USA, 115, pp. 12401-12406; Chafe, Z.A., Brauer, M., Klimont, Z., Household cooking with solid fuels contributes to ambient PM2·5 air pollution and the burden of disease (2014) Environ Health Perspect, 122, pp. 1314-1320; Smith, K.R., Bruce, N., Balakrishnan, K., Millions dead: how do we know and what does it mean? Methods used in the comparative risk assessment of household air pollution (2014) Annu Rev Public Health, 35, pp. 185-206; Yu, K., Qiu, G., Chan, K.H., Association of solid fuel use with risk of cardiovascular and all-cause mortality in rural China (2018) JAMA, 319, pp. 1351-1361; Lewis, J.J., Pattanayak, S.K., Who adopts improved fuels and cookstoves? A systematic review (2012) Environ Health Perspect, 120, pp. 637-645; Duan, X., Jiang, Y., Wang, B., Household fuel use for cooking and heating in China: results from the first Chinese Environmental Exposure-Related Human Activity Patterns Survey (CEERHAPS) (2014) Appl Energ, 136, pp. 692-703; Chen, Y., Shen, H., Zhong, Q., Transition of household cookfuels in China from 2010 to 2012 (2016) Appl Energ, 184, pp. 800-809; Chan, K.H., Lam, K.B.H., Kurmi, O.P., Trans-generational changes and rural-urban inequality in household fuel use and cookstove ventilation in China: a multi-region study of 0·5 million adults (2017) Int J Hyg Environ Health, 220, pp. 1370-1381; Chan, K.H., Kurmi, O.P., Bennett, D.A., Solid fuel use and risks of respiratory diseases: a cohort study of 280 000 Chinese never-smokers (2019) Am J Respir Crit Care Med, 199, pp. 352-361; Kim, C., Seow, W.J., Shu, X.O., Cooking coal use and all-cause and cause-specific mortality in a prospective cohort study of women in Shanghai, China (2016) Environ Health Perspect, 124, pp. 1384-1389; Lan, Q., Chapman, R.S., Schreinemachers, D.M., Tian, L., He, X., Household stove improvement and risk of lung cancer in Xuanwei, China (2002) J Natl Cancer Inst, 94, pp. 826-835; Dennekamp, M., Howarth, S., Dick, C.A., Cherrie, J.W., Donaldson, K., Seaton, A., Ultrafine particles and nitrogen oxides generated by gas and electric cooking (2001) Occup Environ Med, 58, pp. 511-516; Chen, Z., Chen, J., Collins, R., China Kadoorie Biobank of 0·5 million people: survey methods, baseline characteristics and long-term follow-up (2011) Int J Epidemiol, 40, pp. 1652-1666; Chen, Z., Lee, L., Chen, J., Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC) (2005) Int J Epidemiol, 34, pp. 1243-1249; Yang, G.H., Wang, Y., Zeng, Y., Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 (2013) Lancet, 381, pp. 1987-2015; The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research (1993), http://www.who.int/classifications/icd/en/GRNBOOK.pdf, (Accessed 17 June 2019); Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174; Grambsch, P.M., Therneau, T.M., Proportional hazards tests and diagnostics based on weighted residuals (1994) Biometrika, 81, pp. 515-526; Durrleman, S., Simon, R., Flexible regression models with cubic splines (1989) Stat Med, 8, pp. 551-561; Arku, R.E., Ezzati, M., Baumgartner, J., Elevated blood pressure and household solid fuel use in premenopausal women: analysis of 12 Demographic and Health Surveys (DHS) from 10 countries (2018) Environ Res, 160, pp. 499-505; Lee, M.S., Hang, J.Q., Zhang, F.Y., Dai, H.L., Su, L., Christiani, D.C., In-home solid fuel use and cardiovascular disease: a cross-sectional analysis of the Shanghai Putuo study (2012) Environ Health, 11, p. 18; Li, J., Qin, C., Lv, J., Solid fuel use and incident COPD in Chinese adults: findings from the China Kadoorie Biobank (2019) Environ Health Perspect, 127; Hystad, P., Duong, M., Brauer, M., Health effects of household solid fuel use: findings from 11 countries within the prospective urban and rural epidemiology study (2019) Environ Health Perspect, 127; Sadorsky, P., The effect of urbanization and industrialization on energy use in emerging economies: implications for sustainable development (2014) Am J Econ Sociol, 73, pp. 392-409; Hutcheon, J.A., Chiolero, A., Hanley, J.A., Random measurement error and regression dilution bias (2010) BMJ, 340},
correspondence_address1={Wu, T.; School of Public Health, China; email: wut@mails.tjmu.edu.cn},
publisher={Elsevier Ltd},
issn={2214109X},
pubmed_id={31972151},
language={English},
abbrev_source_title={Lancet Global Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Prüss-Ustün2019,
author={Prüss-Ustün, A. and Van Deventer, E. and Mudu, P. and Campbell-Lendrum, D. and Vickers, C. and Ivanov, I. and Forastiere, F. and Gumy, S. and Dora, C. and Adair-Rohani, H. and Neira, M.},
title={Environmental risks and non-communicable diseases},
journal={BMJ (Online)},
year={2019},
volume={364},
doi={10.1136/bmj.l265},
art_number={l265},
note={cited By 41},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060637274&doi=10.1136%2fbmj.l265&partnerID=40&md5=5fe668e861db95620a8bcb878193159d},
affiliation={Department of Public Health, Environmental and Social Determinants of Health, World Health Organization, Geneva, Switzerland; European Centre for Environment and Health, World Health Organization, Bonn, Germany; Global Environmental Health Justice and Governance, Mailman School of Public Health, Columbia University, New York, NY, United States},
keywords={air pollution;  Article;  cardiovascular disease;  cerebrovascular accident;  chronic obstructive lung disease;  climate change;  disease exacerbation;  environmental exposure;  environmental health;  global health;  health hazard;  human;  ischemic heart disease;  kidney disease;  lung cancer;  mortality;  non communicable disease;  priority journal;  risk factor;  risk reduction;  smoking;  environment;  non communicable disease;  risk factor, Environment;  Humans;  Noncommunicable Diseases;  Risk Factors},
funding_details={World Health OrganizationWorld Health Organization, WHO},
funding_text 1={For other articles in the series see www.bmj.com/NCD-solutions Contributors and sources: Information sources include a review of the effects on NCDs of environmental risk factors and the draft WHO strategy on health, environment, and climate change. APU conceived the outline of the paper and drafted the first version. MN is the director of the department and provided overall guidance. All authors contributed intellectual content, provided specific inputs on their area of expertise, edited the manuscript, and approved the final version for submission. Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. The authors alone are responsible for the views expressed in this article, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated. Provenance and peer review: Commissioned; externally peer reviewed. This article is part of a series proposed by the WHO Global Coordination Mechanism on NCDs and commissioned by The BMJ, which peer reviewed, edited, and made the decision to publish. Open access fees are funded by WHO.},
references={Landrigan, P.J., Fuller, R., Acosta, N.J.R., The Lancet Commission on pollution and health (2018) Lancet, 391, pp. 462-512; Neira, M., Prüss-Ustün, A., Mudu, P., Reduce air pollution to beat NCDs: From recognition to action (2018) Lancet, 392, pp. 1178-1179; World Health Organization. Preventing noncommunicable diseases (NCDs) by reducing environmental risk factors . WHO, 2017; (2018), https://ncdalliance.org/sites/default/files/Political_Declaration_final_text_0.pdf, United Nations. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. Time to deliver: accelerating our response to address non-communicable diseases for the health and well-being of present and future generations; World Health Organization. Noncommunicable diseases country profiles 2018. WHO, 2018; http://ghdx.healthdata.org/gbd-results-tool, Institute for Health Metrics and Evaluation. Global Health Data Exchange. 2018 [accessed1. Oct 2018; (2018), http://www.who.int/gho/database/en/, World Health Organization. Global Health Observatory-Data repository; (2019), https://gbd2016.healthdata.org/gbd-search/, Institute for Health Metrics and Evaluation. Global Health Data Exchange Seattle: IHME; World Health Organization. Ambient (outdoor) air quality and health. Fact sheet. WHO, 2018; Prüss-Ustün, A., Wolf, J., Corvalán, C., Bos, R., Neira, M., (2016) Preventing Disease Through Healthy Environments: A Global Assessment of the Burden of Disease from Environmental Risks, , WHO; Wolf, J., Prüss-Ustün, A., Ivanov, I., (2018) Preventing Disease Through A Healthier and Safer Workplace, , WHO; Broadfoot, M., (2019) Pollution Is A Global but Solvable Threat to Health, Say Scientists: National Institute of Environmental Health Science, , https://factor.niehs.nih.gov/2019/1/sciencehighlights/pollution/index.htm; Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 (2018) Lancet, 392, pp. 1923-1994. , GBD 2017 Risk Factor Collaborators; Wolch, J.R., Byrne, J., Newell, J.P., Urban green space, public health, and environmental justice: The challenge of making cities 'just green enough' (2014) Landsc Urban Plan, 125, pp. 234-4410; World Health Organization. Urban green spaces and health-A review of the evidence. WHO Regional Office for Europe, 2016; Kondo, M.C., Fluehr, J.M., McKeon, T., Branas, C.C., Urban green space and its impact on human health (2018) J Environ Res Public Health, 15, p. E445; United Nations. Policy brief #2: Achieving universal access to clean and modern cooking fules, technologies and services; Policy brief #10: Health and environment linkages-maximizing health benefits from the sustainable energy transition. Accelerating SDG7 achievement Policy briefs in support of the first SDG7 review at the UN high-level political forum 2018. United Nations, 2018; Campbell-Lendrum, D., Prüss-Ustün, A., (2018) Climate Change, Air Pollution and Noncommunicable Diseases, , https://www.who.int/bulletin/online_first/18-224295.pdf?ua=1; Haaland, C., Van Den Bosch, C.K., Challenges and strategies for urban green-space planning in cities undergoing densification: A review (2015) Urban for Urban Green, 14, pp. 760-7110; Organisation for Economic Cooperation and Development. Public spending on health and long-term care: a new set of projections. OECD, 2013; Coady, D., Parry, I., Sears, L., Shang, B.P., How large are global fossil fuel subsidies? (2017) World Dev, 91, pp. 11-2710; World Health Organization. Health, environment and climate change. Report by the Director-General. EB142/12. WHO, 2017; World Health Organization. Health in all policies: training manual. WHO, 2015; (2018), https://www.apsc.gov.au/1-whole-government-challenge, Australian Public Service Commission. The whole of government challenge; (2018), https://www.who.int/phe/publications/global-strategy/en/, World Health Organization. Draft WHO global strategy on health, environment and climate change},
correspondence_address1={Prüss-Ustün, A.; Department of Public Health, Switzerland; email: pruessa@who.int},
publisher={BMJ Publishing Group},
issn={09598146},
coden={BMJOA},
pubmed_id={30692085},
language={English},
abbrev_source_title={BMJ (Online)},
document_type={Article},
source={Scopus},
}

@ARTICLE{Posadzki2018,
author={Posadzki, P.P. and Bajpai, R. and Kyaw, B.M. and Roberts, N.J. and Brzezinski, A. and Christopoulos, G.I. and Divakar, U. and Bajpai, S. and Soljak, M. and Dunleavy, G. and Jarbrink, K. and Nang, E.E.K. and Soh, C.K. and Car, J.},
title={Melatonin and health: An umbrella review of health outcomes and biological mechanisms of action},
journal={BMC Medicine},
year={2018},
volume={16},
number={1},
doi={10.1186/s12916-017-1000-8},
art_number={18},
note={cited By 40},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041469246&doi=10.1186%2fs12916-017-1000-8&partnerID=40&md5=16e1c497cf1fe18519977be55fb042fa},
affiliation={Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Novena Campus, Nanyang Technological University, 11 Mandalay Road, Level 18 Clinical Sciences Building, Singapore, 308232, Singapore; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, G4 0BA, United Kingdom; The Hebrew University Medical School, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel; Nanyang Business School, Division of Strategy Management and Organisation, Nanyang Technological University, Singapore, 639798, Singapore; School of Civil and Environmental Engineering, College of Engineering, Nanyang Technological University, Singapore, 639798, Singapore; Global eHealth Unit, School of Public Health, Imperial College London, London, W6 8RP, United Kingdom},
abstract={Background: Our aims were to evaluate critically the evidence from systematic reviews as well as narrative reviews of the effects of melatonin (MLT) on health and to identify the potential mechanisms of action involved. Methods: An umbrella review of the evidence across systematic reviews and narrative reviews of endogenous and exogenous (supplementation) MLT was undertaken. The Oxman checklist for assessing the methodological quality of the included systematic reviews was utilised. The following databases were searched: MEDLINE, EMBASE, Web of Science, CENTRAL, PsycINFO and CINAHL. In addition, reference lists were screened. We included reviews of the effects of MLT on any type of health-related outcome measure. Results: Altogether, 195 reviews met the inclusion criteria. Most were of low methodological quality (mean -4.5, standard deviation 6.7). Of those, 164 did not pool the data and were synthesised narratively (qualitatively) whereas the remaining 31 used meta-analytic techniques and were synthesised quantitatively. Seven meta-analyses were significant with P values less than 0.001 under the random-effects model. These pertained to sleep latency, pre-operative anxiety, prevention of agitation and risk of breast cancer. Conclusions: There is an abundance of reviews evaluating the effects of exogenous and endogenous MLT on health. In general, MLT has been shown to be associated with a wide variety of health outcomes in clinically and methodologically heterogeneous populations. Many reviews stressed the need for more high-quality randomised clinical trials to reduce the existing uncertainties. © 2018 The Author(s).},
author_keywords={Effectiveness;  Health;  Melatonin;  Meta-analyses;  Systematic reviews;  Umbrella review},
keywords={agomelatine;  melatonin;  melatonin receptor;  ramelteon;  tasimelteon;  melatonin, agitation;  anxiety;  Article;  biological activity;  breast cancer;  drug efficacy;  drug mechanism;  drug receptor binding;  health;  human;  hypertension;  randomized controlled trial (topic);  sleep disorder;  sleep latency;  systematic review;  unspecified side effect;  circadian rhythm;  drug therapy;  meta analysis;  physiology;  psychology;  quality of life, Anxiety;  Circadian Rhythm;  Humans;  Melatonin;  Quality of Life},
chemicals_cas={agomelatine, 138112-76-2; melatonin, 73-31-4; ramelteon, 196597-26-9; tasimelteon, 609799-22-6; Melatonin},
tradenames={circadin},
funding_text 1={This material is based on research and work supported by award L2NICCFP1-2013-2 to principal investigator CKS from the Land and Liveability National Innovation Challenge (L2 NIC)). Any opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of L2 NIC.},
references={Edgar, R.S., Green, E.W., Zhao, Y., Ooijen, G., Olmedo, M., Qin, X., Peroxiredoxins are conserved markers of circadian rhythms (2012) Nature, 485 (7399), pp. 459-464; Wu, A.H., Sleep duration, melatonin and breast cancer among Chinese women in Singapore (2008) Carcinogenesis, 29 (6), pp. 1244-1248; Arendt, J., Melatonin, circadian rhythms, and sleep (2000) N Engl J Med, 343 (15), pp. 1114-1116; Mirick, D.K., Davis, S., Melatonin as a biomarker of circadian dysregulation (2008) Cancer Epidemiol, 17 (12), pp. 3306-3313; Brzezinski, A., Melatonin in humans (1997) N Engl J Med, 336 (3), pp. 186-195; Eisenstein, M., Chronobiology: stepping out of time (2013) Nature, 497 (7450), pp. S10-12; Bass, J., Takahashi, J.S., Circadian integration of metabolism and energetics (2010) Science, 330 (6009), pp. 1349-1354; Boyce, P., Barriball, E., Circadian rhythms and depression (2010) Aust Family Physician, 39 (5), pp. 307-310; Mea, F., Vitamin D, status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism (2010) Clin Endocrinol, 73 (5), pp. 573-580; Haus, E., Smolensky, M., Biological clocks and shift work: circadian dysregulation and potential long-term effects (2006) Cancer Causes Control, 17 (4), pp. 489-500; Kvaskoff, M., Weinstein, P., Are some melanomas caused by artificial light? (2010) Med Hypothesises, 75 (3), pp. 305-311; Mahoney, M.M., Shift work, jet lag, and female reproduction (2010) Int J Endocrinol, 2010 (9). , https://doi.org/10.1155/2010/813764; Rana, S., Mahmood, S., Circadian rhythm and its role in malignancy (2010) J Circadian Rhythms., 8 (3), pp. 1-13; Bass, J., Lazar, M.A., Circadian time signatures of fitness and disease (2016) Science, 354 (6315), pp. 994-999; Bonmati-Carrion, M.A., Arguelles-Prieto, R., Martinez-Madrid, M.J., Reiter, R., Hardeland, R., Rol, M.A., Protecting the melatonin rhythm through circadian healthy light exposure (2014) Int J Mol Sci, 15 (12), pp. 23448-23500; Schlafer, O., Wenzel, V., Hogl, B., Sleep disorders among physicians on shift work (2014) Anaesthetist, 63 (11), pp. 844-851; Scholtens, R.M., Munster, B.C., Kempen, M.F., Rooij, S.E.J.A., Physiological melatonin levels in healthy older people: a systematic review (2016) J Psychosom Res, 86, pp. 20-27; Higgins, J., Green, S., (2011) Cochrane handbook for systematic reviews of interventions, , http://handbook-5-1.cochrane.org/, editors., version 5.1.0 (updated March 2011). The Cochrane Collaboration; Posadzki, P., Ernst, E., Systematic reviews of spinal manipulations for headaches: an attempt to clear up the confusion (2011) Headache, 51 (9), pp. 1419-1425; Pae, C.-U., Why systematic review rather than narrative review? (2015) Psychiatry Invest, 12 (3), pp. 417-419; Oxman, A.D., Guyatt, G.H., Validation of an index of the quality of review articles (1991) J Clin Epidemiol, 44 (11), pp. 1271-1278; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Pieper, D., Antoine, S.L., Mathes, T., Neugebauer, E.A., Eikermann, M., Systematic review finds overlapping reviews were not mentioned in every other overview (2014) J Clin Epidemiol, 67 (4), pp. 368-375; Seko, L.M., Moroni, R.M., Leitao, V.M., Teixeira, D.M., Nastri, C.O., Martins, W.P., Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials (2014) Fertil Steril, 101 (1), pp. 154-161; Winkler, A., Auer, C., Doering, B.K., Rief, W., Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials (2014) CNS Drugs, 28 (9), pp. 799-816; Macleod, M.R., O'Collins, T., Horky, L.L., Howells, D.W., Donnan, G.A., Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke (2005) J Pineal Res, 38 (1), pp. 35-41; Brzezinski, A., Vangel, M.G., Wurtman, R.J., Norrie, G., Zhdanova, I., Ben-Shushan, A., Effects of exogenous melatonin on sleep: a meta-analysis (2005) Sleep Med Rev, 9 (1), pp. 41-50; Ferracioli-Oda, E., Qawasmi, A., Bloch, M.H., Meta-analysis: melatonin for the treatment of primary sleep disorders (2013) PLoS One, 8 (5); Jansen, S.L., Forbes, D.A., Duncan, V., Morgan, D.G., Melatonin for cognitive impairment (2006) Cochrane Database Syst Rev, (1); Wang, Y.M., Jin, B.Z., Ai, F., Duan, C.H., Lu, Y.Z., Dong, T.F., The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials (2012) Cancer Chemother Pharmacol, 69 (5), pp. 1213-1220; Yang, L., Yao, M., Lan, Y., Mo, W., Sun, Y.L., Wang, J., Melatonin for spinal cord injury in animal models: a systematic review and network meta-analysis (2016) J Neurotrauma, 33 (3), pp. 290-300; Andersen, L.P., Werner, M.U., Rosenberg, J., Gogenur, I., A systematic review of peri-operative melatonin (2014) Anaesthesia, 69 (10), pp. 1163-1171; Guaiana, G., Gupta, S., Chiodo, D., Davies, S.J., Haederle, K., Koesters, M., Agomelatine versus other antidepressive agents for major depression (2013) Cochrane Database Syst Rev., (12); Chen, S., Shi, L., Liang, F., Xu, L., Desislava, D., Wu, Q., Exogenous melatonin for delirium prevention: a meta-analysis of randomized controlled trials (2016) Mol Neurobiol., 53 (6), pp. 4046-4053; Wright, A., Diebold, J., Otal, J., Stoneman, C., Wong, J., Wallace, C., The effect of melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: a systematic review and meta-analysis (2015) Drugs Aging, 32 (12), pp. 1009-1018; Seely, D., Wu, P., Fritz, H., Kennedy, D.A., Tsui, T., Seely, A.J., Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials (2012) Integr Cancer Ther, 11 (4), pp. 293-303; Liira, J., Verbeek, J.H., Costa, G., Driscoll, T.R., Sallinen, M., Isotalo, L.K., Pharmacological interventions for sleepiness and sleep disturbances caused by shift work (2014) Cochrane Database Syst Rev., (8); Kuriyama, A., Honda, M., Hayashino, Y., Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis (2014) Sleep Med, 15 (4), pp. 385-392; Liu, J., Wang, L.N., Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis (2012) Int J Clin Pract, 66 (9), pp. 867-873; Mihara, T., Nakamura, N., Ka, K., Oba, M.S., Goto, T., Effects of melatonin premedication to prevent emergence agitation after general anaesthesia in children: a systematic review and meta-analysis with trial sequential analysis (2015) Eur J Anaesthesiol, 32 (12), pp. 862-871; Leger, D., Quera-Salva, M.A., Vecchierini, M.F., Ogrizek, P., Perry, C.A., Dressman, M.A., Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies (2015) Expert Opin Drug Saf, 14 (11), pp. 1673-1685; Pandi-Perumal, S.R., Trakht, I., Srinivasan, V., Spence, D.W., Maestroni, G.J., Zisapel, N., Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways (2008) Prog Neurobiol, 85 (3), pp. 335-353; Carrillo-Vico, A., Guerrero, J.M., Lardone, P.J., Reiter, R.J., A review of the multiple actions of melatonin on the immune system (2005) Endocrine, 27 (2), pp. 189-200; Reiter, R.J., Tan, D.X., Osuna, C., Gitto, E., Actions of melatonin in the reduction of oxidative stress. A review (2000) J Biomed Sci, 7 (6), pp. 444-458; Reiter, R.J., Tan, D.X., Qi, W., Manchester, L.C., Karbownik, M., Calvo, J.R., Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo (2000) Biol Signals Recept, 9 (3-4), pp. 160-171; Maldonado, M.D., Murillo-Cabezas, F., Calvo, J.R., Lardone, P.J., Tan, D.X., Guerrero, J.M., Reiter, R.J., Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage (2007) Crit Care Med, 35 (4), pp. 1177-1185; Vielma, J.R., Bonilla, E., Chacin-Bonilla, L., Mora, M., Medina-Leendertz, S., Bravo, Y., Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review (2014) Acta Trop, 137, pp. 31-38; Reiter, R.J., Tan, D.X., Pappolla, M.A., Melatonin relieves the neural oxidative burden that contributes to dementias (2004) Ann NY Acad Sci., 1035 (1), pp. 179-196; Terry, P.D., Villinger, F., Bubenik, G.A., Sitaraman, S.V., Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research (2009) Inflamm Bowel Dis, 15 (1), pp. 134-140; Hardeland, R., Cardinali, D.P., Brown, G.M., Pandi-Perumal, S.R., Melatonin and brain inflammaging (2015) Prog Neurobiol., 127-128, pp. 46-63; Jena, G., Trivedi, P.P., A review of the Uue of melatonin in ulcerative colitis: experimental evidence and new approaches (2014) Inflamm Bowel Dis, 20 (3), pp. 553-563; Hosseinzadeh, A., Kamrava, S.K., Joghataei, M.T., Darabi, R., Shakeri-Zadeh, A., Shahriari, M., Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin (2016) J Pineal Res, 61 (4), pp. 411-425; Wang, X., The antiapoptotic activity of melatonin in neurodegenerative diseases (2009) CNS Neurosci Ther, 15 (4), pp. 345-357; Srinivasan, V., Lauterbach, E.C., Ho, K.Y., Acuña-Castroviejo, D., Zakaria, R., Brzezinski, A., Melatonin in antinociception: its therapeutic applications (2012) Curr Neuropharmacol, 10 (2), pp. 167-178; Beyer, C.E., Steketee, J.D., Saphier, D., Antioxidant properties of melatonin - an emerging mystery (1998) Biochem Pharmacol, 56 (10), pp. 1265-1272; Grossman, E., Laudon, M., Zisapel, N., Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials (2011) Vasc Health Risk Manag, 7, pp. 577-584; Tain, Y.L., Huang, L.T., Hsu, C.N., Developmental programming of adult disease: reprogramming by melatonin? (2017) Int J Mol Sci, 18 (2), p. 16; Mayo, J.C., Sainz, R.M., González Menéndez, P., Cepas, V., Tan, D.X., Reiter, R.J., Melatonin and sirtuins: a 'not-so unexpected' relationship (2017) J Pineal Res, 62 (2), pp. 1-17; Biran, V., Phan Duy, A., Decobert, F., Bednarek, N., Alberti, C., Baud, O., Is melatonin ready to be used in preterm infants as a neuroprotectant? (2014) Dev Med Child Neurol, 56 (8), pp. 717-723; Cheung, R.T., The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion (2003) J Pineal Res, 34 (3), pp. 153-160; Wilkinson, D., Shepherd, E., Wallace, E.M., Melatonin for women in pregnancy for neuroprotection of the fetus (2016) Cochrane Database Syst Rev., 3; Govender, J., Loos, B., Marais, E., Engelbrecht, A.M., Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin (2014) J Pineal Res, 57 (4), pp. 367-380; Yang, Y., Sun, Y., Yi, W., Li, Y., Fan, C., Xin, Z., A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases (2014) J Pineal Res, 57 (4), pp. 357-366; Ramos, E., Patino, P., Reiter, R.J., Gil-Martin, E., Marco-Contelles, J., Parada, E., Ischemic brain injury: new insights on the protective role of melatonin (2017) Free Radic Biol Med, 104, pp. 32-53; Huang, K.L., Lu, W.C., Wang, Y.Y., Hu, G.C., Lu, C.H., Lee, W.Y., Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials (2014) Aust NZ J Psychiatry, 48 (7), pp. 663-671; Farez, M.F., Mascanfroni, I.D., Méndez-Huergo, S.P., Yeste, A., Murugaiyan, G., Garo, L.P., Melatonin contributes to the seasonality of multiple sclerosis relapses (2015) Cell, 162 (6), pp. 1338-1352; Mills, E., Wu, P., Seely, D., Guyatt, G., Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis (2005) J Pineal Res, 39 (4), pp. 360-366; Basler, M., Jetter, A., Fink, D., Seifert, B., Kullak-Ublick, G.A., Trojan, A., Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature (2014) Breast Care, 9 (3), pp. 182-187; Yang, W.S., Deng, Q., Fan, W.Y., Wang, W.Y., Wang, X., Light exposure at night, sleep duration, melatonin, and breast cancer: a dose-response analysis of observational studies (2014) Eur J Cancer Prev, 23 (4), pp. 269-276; Jonghe, A., Korevaar, J.C., Munster, B.C., Rooij, S.E., Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review (2010) Int J Geriatric Psychiatry, 25 (12), pp. 1201-1208; Rondanelli, M., Faliva, M.A., Perna, S., Antoniello, N., Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks (2013) Aging Clin Exp Res, 25 (5), pp. 499-510; Shiu, S.Y.W., Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment (2007) J Pineal Res, 43 (1), pp. 1-9; Xin, Z., Jiang, S., Jiang, P., Yan, X., Fan, C., Di, S., Melatonin as a treatment for gastrointestinal cancer: a review (2015) J Pineal Res, 58 (4), pp. 375-387; Mehta, A., Kaur, G., Potential role of melatonin in prevention and treatment of oral carcinoma (2014) Indian J Dent, 5 (2), pp. 86-91; Bartsch, C., Bartsch, H., The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies (2006) Cancer Causes Control, 17 (4), pp. 559-571; Benitez-King, G., Soto-Vega, E., Ramirez-Rodriguez, G., Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration (2009) Histol Histopathol, 24 (6), pp. 789-799; Bizzarri, M., Proietti, S., Cucina, A., Reiter, R.J., Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review (2013) Expert Opin Ther Targets, 17 (12), pp. 1483-1496; Bonnefont-Rousselot, D., Collin, F., Melatonin: action as antioxidant and potential applications in human disease and aging (2010) Toxicology, 278 (1), pp. 55-67; Bubenik, G.A., Blask, D.E., Brown, G.M., Maestroni, G.J., Pang, S.F., Reiter, R.J., Prospects of the clinical utilization of melatonin (1998) Biol Signals Recept, 7 (4), pp. 195-219; Carpentieri, A., Diaz de Barboza, G., Areco, V., Peralta Lopez, M., Tolosa de Talamoni, N., New perspectives in melatonin uses (2012) Pharmacol Res, 65 (4), pp. 437-444; Cos, S., Sanchez-Barcelo, E.J., Melatonin, experimental basis for a possible application in breast cancer prevention and treatment (2000) Histol Histopathol, 15 (2), pp. 637-647; Cutando, A., Aneiros-Fernandez, J., Aneiros-Cachaza, J., Arias-Santiago, S., Melatonin and cancer: current knowledge and its application to oral cavity tumours (2011) J Oral Pathol Med, 40 (8), pp. 593-597; Bella, L., Gualano, L., Key aspects of melatonin physiology: thirty years of research (2006) Neuro Endocrinol Lett, 27 (4), pp. 425-432; Dopfel, R.P., Schulmeister, K., Schernhammer, E.S., Nutritional and lifestyle correlates of the cancer-protective hormone melatonin (2007) Cancer Detect Prev, 31 (2), pp. 140-148; Dziegiel, P., Podhorska-Okolow, M., Zabel, M., Melatonin: adjuvant therapy of malignant tumors (2008) Med Sci Monit, 14 (5), pp. 64-70; Giannoulia-Karantana, A., Vlachou, A., Polychronopoulou, S., Papassotiriou, I., Chrousos, G.P., Melatonin and immunomodulation: connections and potential clinical applications (2006) Neuroimmunomodulation, 13 (3), pp. 133-144; Hill, S.M., Belancio, V.P., Dauchy, R.T., Xiang, S., Brimer, S., Mao, L., Melatonin: an inhibitor of breast cancer (2015) Endocr Relat Cancer, 22 (3), pp. R183-204; Jung, B., Ahmad, N., Melatonin in cancer management: progress and promise (2006) Cancer Res, 66 (20), pp. 9789-9793; Karaaslan, C., Suzen, S., Antioxidant properties of melatonin and its potential action in diseases (2015) Curr Top Med Chem, 15 (9), pp. 894-903; Ma, Z., Yang, Y., Fan, C., Han, J., Wang, D., Di, S., Melatonin as a potential anticarcinogen for non-small-cell lung cancer (2016) Oncotarget., 7 (29), pp. 46768-46784; Malhotra, S., Sawhney, G., Pandhi, P., The therapeutic potential of melatonin: a review of the science (2004) MedGenMed, 6 (2), p. 46; Panzer, A., Viljoen, M., The validity of melatonin as an oncostatic agent (1997) J Pineal Res, 22 (4), pp. 184-202; Reiter, R.J., Melatonin: clinical relevance (2003) Best Pract Res Clin Endocrinol Metab, 17 (2), pp. 273-285; Sanchez-Barcelo, E.J., Cos, S., Mediavilla, D., Martinez-Campa, C., Gonzalez, A., Alonso-Gonzalez, C., Melatonin-estrogen interactions in breast cancer (2005) J Pineal Res, 38 (4), pp. 217-222; Sanchez-Barcelo, E.J., Mediavilla, M.D., Alonso-Gonzalez, C., Reiter, R.J., Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation (2012) Expert Opin Investig Drugs, 21 (6), pp. 819-831; Shirazi, A., Ghobadi, G., Ghazi-Khansari, M., A radiobiological review on melatonin: a novel radioprotector (2007) J Radiat Res, 48 (4), pp. 263-272; Vijayalaxmi Reiter, R.J., Tan, D.X., Herman, T.S., Thomas, C.R., Melatonin as a radioprotective agent: a review (2004) Int J Radiat Oncol Biol Phys, 59 (3), pp. 639-653; Cutando, A., Lopez-Valverde, A., Vicente, J., Gimenez, J.L., Carcia, I.A., Diego, R.G., Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (2014) Oncol Lett, 7 (4), pp. 923-926; Reiter, R.J., Tan, D.X., Manchester, L.C., Qi, W., Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence (2001) Cell Biochem Biophys, 34 (2), pp. 237-256; Chen, C.Q., Fichna, J., Bashashati, M., Li, Y.Y., Storr, M., Distribution, function and physiological role of melatonin in the lower gut (2011) World J Gastroenterol, 17 (34), pp. 3888-3898; Jung-Hynes, B., Reiter, R.J., Ahmad, N., Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer (2010) J Pineal Res, 48 (1), pp. 9-19; Brzezinski, A., 'Melatonin replacement therapy' for postmenopausal women: is it justified? (1998) Menopause, 5 (1), pp. 60-64; Blask, D.E., Hill, S.M., Dauchy, R.T., Xiang, S., Yuan, L., Duplessis, T., Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night (2011) J Pineal Res, 51 (3), pp. 259-269; Nowak, J.Z., Zawilska, J.B., Melatonin and its physiological and therapeutic properties (1998) Pharm World Sci, 20 (1), pp. 18-27; Paul, R., Borah, A., The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine (2015) Life Sci, 139, pp. 97-107; Pandi-Perumal, S.R., Trakht, I., Spence, D.W., Srinivasan, V., Dagan, Y., Cardinali, D.P., The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders (2008) Nat Clin Pract Neurol, 4 (8), pp. 436-447; Su, S.C., Hsieh, M.J., Yang, W.E., Chung, W.H., Reiter, R.J., Yang, S.F., Cancer metastasis: mechanisms of inhibition by melatonin (2017) J Pineal Res, 62 (1), pp. 1-11; Rodríguez, A.D., Melatonin in the acute coronary syndromes (2007) Salud(i)Ciencia, 15 (6), pp. 983-985; Chang, Y.S., Lin, M.H., Lee, J.H., Lee, P.L., Dai, Y.S., Chu, K.H., Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial (2016) JAMA Pediatr, 170 (1), pp. 35-42; Favero, G., Rodella, L.F., Reiter, R.J., Rezzani, R., Melatonin and its atheroprotective effects: a review (2014) Mol Cell Endocrinol, 382 (2), pp. 926-937; Hrenak, J., Paulis, L., Repova, K., Aziriova, S., Nagtegaal, E.J., Reiter, R.J., Melatonin and renal protection: novel perspectives from animal experiments and human studies (review) (2015) Curr Pharm Des, 21 (7), pp. 936-949; Nduhirabandi, F., Toit, E.F., Lochner, A., Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? (2012) Acta Physiol, 205 (2), pp. 209-223; Reiter, R.J., Rosales-Corral, S.A., Manchester, L.C., Liu, X., Tan, D.X., Melatonin in the biliary tract and liver: health implications (2014) Curr Pharm Des, 20 (30), pp. 4788-4801; Reiter, R.J., Tan, D.X., Tamura, H., Cruz, M.H., Fuentes-Broto, L., Clinical relevance of melatonin in ovarian and placental physiology: a review (2014) Gynecol Endocrinol, 30 (2), pp. 83-89; Chen, Y.C., Tain, Y.L., Sheen, J.M., Huang, L.T., Melatonin utility in neonates and children (2012) J Formos Med Assoc, 111 (2), pp. 57-66; Srinivasan, V., Mohamed, M., Kato, H., Melatonin in bacterial and viral infections with focus on sepsis: a review (2012) Recent Pat Endocr Metab Immune Drug Discov, 6 (1), pp. 30-39; Aversa, S., Pellegrino, S., Barberi, I., Reiter, R.J., Gitto, E., Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period (2012) J Matern Fetal Neonatal Med, 25 (3), pp. 207-221; Marseglia, L., D'Angelo, G., Manti, S., Reiter, R.J., Gitto, E., Potential utility of melatonin in preeclampsia, intrauterine fetal growth retardation, and perinatal asphyxia (2016) Reprod Sci, 23 (8), pp. 970-977; Ramis, M.R., Esteban, S., Miralles, A., Tan, D.X., Reiter, R.J., Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review (2015) Curr Med Chem, 22 (22), pp. 2690-2711; Romero, A., Ramos, E., Los Rios, C., Egea, J., Pino, J., Reiter, R.J., A review of metal-catalyzed molecular damage: protection by melatonin (2014) J Pineal Res, 56 (4), pp. 343-370; Jemima, J., Bhattacharjee, P., Singhal, R.S., Melatonin - a review on the lesser known potential nutraceutical (2011) Int J Pharm Sci Res, 2 (8), pp. 1975-1987; Reiter, R.J., Benitez-King, G., Melatonin reduces neuronal loss and cytoskeletal deterioration: implications for psychiatry (2009) Salud Mental, 32 (1), pp. 3-11; Xu, J., Wang, L.L., Dammer, E.B., Li, C.B., Xu, G., Chen, S.D., Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials (2015) Am J Alzheimers Dis Other Demen, 30 (5), pp. 439-447; Pacchierotti, C., Iapichino, S., Bossini, L., Pieraccini, F., Castrogiovanni, P., Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry (2001) Front Neuroendocrinol, 22 (1), pp. 18-32; Maldonado, M.D., Reiter, R.J., Perez-San-Gregorio, M.A., Melatonin as a potential therapeutic agent in psychiatric illness (2009) Hum Psychopharmacol, 24 (5), pp. 391-400; Agorastos, A., Linthorst, A.C.E., Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder (2016) J Pineal Res, 61 (1), pp. 3-26; De Crescenzo, F., Lennox, A., Gibson, J.C., Cordey, J.H., Stockton, S., Cowen, P.J., Melatonin as a treatment for mood disorders: a systematic review (2017) Acta Psychiatrica Scandinavica., 136 (6), pp. 549-558; Pytka, K., Mlyniec, K., Podkowa, K., Podkowa, A., Jakubczyk, M., Zmudzka, E., The role of melatonin, neurokinin, neurotrophic tyrosine kinase and glucocorticoid receptors in antidepressant-like effect (2017) Pharmacol Rep, 69 (3), pp. 546-554; Wang, H.R., Woo, Y.S., Bahk, W.M., The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review (2016) Int Clin Psychopharmacol, 31 (6), pp. 301-306; Wilhelmsen, M., Amirian, I., Reiter, R.J., Rosenberg, J., Gogenur, I., Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies (2011) J Pineal Res, 51 (3), pp. 270-277; Leone, M., Bussone, G., Melatonin in cluster headache: rationale for use and possible therapeutic potential (1998) CNS Drugs, 9 (1), pp. 7-16; Srinivasan, V., Spence, W.D., Pandi-Perumal, S.R., Zakharia, R., Bhatnagar, K.P., Brzezinski, A., Melatonin and human reproduction: shedding light on the darkness hormone (2009) Gynecol Endocrinol, 25 (12), pp. 779-785; Tamura, H., Nakamura, Y., Korkmaz, A., Manchester, L.C., Tan, D.X., Sugino, N., Melatonin and the ovary: physiological and pathophysiological implications (2009) Fertil Steril, 92 (1), pp. 328-343; Tamura, H., Nakamura, Y., Terron, M.P., Flores, L.J., Manchester, L.C., Tan, D.X., Melatonin and pregnancy in the human (2008) Reprod Toxicol, 25 (3), pp. 291-303; Tamura, H., Takasaki, A., Taketani, T., Tanabe, M., Lee, L., Tamura, I., Melatonin and female reproduction (2014) J Obstet Gynaecol Res, 40 (1), pp. 1-11; Valenzuela, F.J., Vera, J., Venegas, C., Pino, F., Lagunas, C., Circadian system and melatonin hormone: risk factors for complications during pregnancy (2015) Obstet Gynecol Int, 2015, p. 825802; Dragojevic Dikic, S., Jovanovic, A.M., Dikic, S., Jovanovic, T., Jurisic, A., Dobrosavljevic, A., Melatonin: a 'Higgs boson' in human reproduction (2015) Gynecol Endocrinol, 31 (2), pp. 92-101; Fernando, S., Rombauts, L., Melatonin: shedding light on infertility? - A review of the recent literature (2014) J Ovarian Res, 7, p. 98; Turk, J., Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary (2003) J Med Genet, 40 (11), pp. 793-796; Vural, E.M.S., Munster, B.C., Rooij, S.E., Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature (2014) Drugs Aging, 31 (6), pp. 441-451; Wade, A., Downie, S., Prolonged-release melatonin for the treatment of insomnia in patients over 55 years (2008) Expert Opin Investigat Drugs, 17 (10), pp. 1567-1572; Rossignol, D.A., Frye, R.E., Melatonin in autism spectrum disorders: a systematic review and meta-analysis (2011) Dev Med Child Neurol, 53 (9), pp. 783-792; Guenole, F., Godbout, R., Nicolas, A., Franco, P., Claustrat, B., Baleyte, J.M., Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion (2011) Sleep Med Rev, 15 (6), pp. 379-387; McGrane, I.R., Leung, J.G., St Louis, E.K., Boeve, B.F., Melatonin therapy for REM sleep behavior disorder: a critical review of evidence (2015) Sleep Med, 16 (1), pp. 19-26; Olde Rikkert, M.G., Rigaud, A.S., Melatonin in elderly patients with insomnia. A systematic review (2001) Z Gerontol Geriatr, 34 (6), pp. 491-497; Sajith, S.G., Clarke, D., Melatonin and sleep disorders associated with intellectual disability: a clinical review (2007) J Intellect Disabil Res, 51, pp. 2-13; Heiligenstein, E., Guenther, G., Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava (1998) J Am Coll Health, 46 (6), pp. 271-276; Lanfumey, L., Mongeau, R., Hamon, M., Biological rhythms and melatonin in mood disorders and their treatments (2013) Pharmacol Ther, 138 (2), pp. 176-184; Lemoine, P., Zisapel, N., Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia (2012) Expert Opin Pharmacother, 13 (6), pp. 895-905; Jan, J.E., Wasdell, M.B., Reiter, R.J., Weiss, M.D., Johnson, K.P., Ivanenko, A., Melatonin therapy of pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treat (2007) Curr Pediatric Rev, 3 (3), pp. 214-224; Armour, D., Paton, C., Melatonin in the treatment of insomnia in children and adolescents (2004) Psychiatr Bull, 28 (6), pp. 222-224; Bellon, A.M., Searching for new options for treating insomnia: are melatonin and ramelteon beneficial? (2006) J Psychiatr Pract, 12 (4), pp. 229-243; Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., The efficacy and safety of exogenous melatonin for primary sleep disorders: a meta-analysis (2005) J Gen Intern Med, 20 (12), pp. 1151-1158; Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis (2006) BMJ, 332 (7538), pp. 385-393; Cardinali, D.P., Golombek, D.A., Rosenstein, R.E., Brusco, L.I., Vigo, D.E., Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse (2016) Pharmacol Res., 109, pp. 12-23; Herxheimer, A., Petrie, K.J., Melatonin for the prevention and treatment of jet lag (2002) Cochrane Database Syst Rev, 2; Zhang, W., Chen, X.Y., Su, S.W., Jia, Q.Z., Ding, T., Zhu, Z.N., Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials (2016) Neurol Sci, 37 (1), pp. 57-65; Wang-Weigand, S., McCue, M., Ogrinc, F., Mini, L., Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis (2009) Curr Med Res Opin, 25 (5), pp. 1209-1213; Phillips, L., Appleton, R.E., Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment (2004) Dev Med Child Neurol, 46 (11), pp. 771-775; Geijlswijk, I.M., Korzilius, H.P., Smits, M.G., The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis (2010) Sleep, 33 (12), pp. 1605-1614; Reiter, R.J., Tan, D.X., Leon, J., Kilic, U., Kilic, E., When melatonin gets on your nerves: its beneficial actions in experimental models of stroke (2005) Exp Biol Med, 230 (2), pp. 104-117; Samantaray, S., Das, A., Thakore, N.P., Matzelle, D.D., Reiter, R.J., Ray, S.K., Therapeutic potential of melatonin in traumatic central nervous system injury (2009) J Pineal Res, 47 (2), pp. 134-142; Reiter, R.J., Acuna-Castroviejo, D., Tan, D.X., Burkhardt, S., Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system (2001) Ann NY Acad Sci, 939, pp. 200-215; Keegan, L.J., Reed-Berendt, R., Neilly, E., Morrall, M.C., Murdoch-Eaton, D., Effectiveness of melatonin for sleep impairment post paediatric acquired brain injury: evidence from a systematic review (2014) Dev Neurorehabil, 17 (5), pp. 355-362; Hong, Y., Palaksha, K.J., Park, K., Park, S., Kim, H.-D., Reiter, R.J., Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury (2010) J Pineal Res, 49 (3), pp. 201-209; Reiter, R.J., Sainz, R.M., Lopez-Burillo, S., Mayo, J.C., Manchester, L.C., Tan, D.X., Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke (2003) Ann NY Acad Sci, 993, pp. 35-47; Cervantes, M., Morali, G., Letechipia-Vallejo, G., Melatonin and ischemia-reperfusion injury of the brain (2008) J Pineal Res, 45 (1), pp. 1-7; Braam, W., Smits, M.G., Didden, R., Korzilius, H., Geijlswijk, I.M., Curfs, L.M., Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis (2009) Dev Med Child Neurol, 51 (5), pp. 340-349; Marrin, K., Drust, B., Gregson, W., Atkinson, G., A meta-analytic approach to quantify the dose-response relationship between melatonin and core temperature (2013) Eur J Appl Physiol, 113 (9), pp. 2323-2329},
correspondence_address1={Posadzki, P.P.; Centre for Population Health Sciences, 11 Mandalay Road, Level 18 Clinical Sciences Building, Singapore; email: paul.posadzki@ntu.edu.sg},
publisher={BioMed Central Ltd.},
issn={17417015},
pubmed_id={29397794},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Bonaccio20171478,
author={Bonaccio, M. and Di Castelnuovo, A. and Pounis, G. and Costanzo, S. and Persichillo, M. and Cerletti, C. and Donati, M.B. and de Gaetano, G. and Iacoviello, L. and On behalf of the Moli-sani Study Investigators},
title={High adherence to the Mediterranean diet is associated with cardiovascular protection in higher but not in lower socioeconomic groups: Prospective findings from the Moli-sani study},
journal={International Journal of Epidemiology},
year={2017},
volume={46},
number={5},
pages={1478-1487},
doi={10.1093/IJE/DYX145},
note={cited By 40},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041303297&doi=10.1093%2fIJE%2fDYX145&partnerID=40&md5=5fd2e351ea1ab747ecc98c5182c227e6},
affiliation={Department of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy},
abstract={Background: It is uncertain whether the cardiovascular benefits associated with Mediterranean diet (MD) may differ across socioeconomic groups. Methods: Prospective analysis on 18991 men and women aged ≥35 years from the general population of the Moli-sani cohort (Italy). Adherence to MD was appraised by the Mediterranean diet score (MDS). Household income (euros/year) and educational level were used as indicators of socioeconomic status. Hazard ratios (HR) were calculated by multivariable Cox proportional hazard models. Results: Over 4.3 years of follow-up, 252 cardiovascular disease (CVD) events occurred. Overall, a two-point increase in MDS was associated with 15% reduced CVD risk (95% confidence interval: 1% to 27%). Such association was evident in highly (HR=0.43; 0.25-0.72) but not in less (HR=0.94; 0.78-1.14) educated subjects (P for interaction=0.042). Similarly, CVD advantages associated with the MD were confined to the high household income group (HR=0.39; 0.23-0.66, and HR=1.01; 0.79-1.29 for high- and low-income groups, respectively; P for interaction=0.0098). In a subgroup of individuals of different socioeconomic status but sharing similar MDS, diet-related disparities were found as different intakes of antioxidants and polyphenols, fatty acids, micronutrients, dietary antioxidant capacity, dietary diversity, organic vegetables and whole grain bread consumption. Conclusions: MD is associated with lower CVD risk but this relationship is confined to higher socioeconomic groups. In groups sharing similar scores of adherence to MD, dietrelated disparities across socioeconomic groups persisted. These nutritional gaps may reasonably explain at least in part the socioeconomic pattern of CVD protection from the MD. © The Author 2017.},
author_keywords={Cardiovascular disease;  Coronary heart disease;  Interaction;  Mediterranean diet;  Socioeconomic status;  Stroke},
keywords={antioxidant;  fatty acid derivative;  polyphenol derivative;  trace element, cardiovascular disease;  cohort analysis;  diet;  disease control;  household income;  Mediterranean environment;  public health;  socioeconomic status, adult;  Article;  bread;  calcium intake;  caloric intake;  cardiovascular disease;  cardiovascular risk;  cohort analysis;  dietary compliance;  dietary fiber;  educational status;  feeding behavior;  female;  fish;  follow up;  food frequency questionnaire;  food intake;  fruit;  health disparity;  highest income group;  household income;  human;  Italy;  lowest income group;  major clinical study;  male;  meat;  Mediterranean diet;  middle aged;  nut;  nutritional assessment;  priority journal;  prospective study;  risk reduction;  social status;  socioeconomics;  vegetable;  vitamin intake;  whole grain;  aged;  cardiovascular disease;  multivariate analysis;  patient compliance;  questionnaire;  regression analysis;  risk factor;  social class, Italy, Adult;  Aged;  Cardiovascular Diseases;  Diet, Mediterranean;  Female;  Humans;  Italy;  Male;  Middle Aged;  Multivariate Analysis;  Patient Compliance;  Prospective Studies;  Regression Analysis;  Risk Factors;  Social Class;  Surveys and Questionnaires},
funding_details={GR-2013-02356060},
funding_details={Pfizer FoundationPfizer Foundation},
funding_details={Ministero dell’Istruzione, dell’Università e della RicercaMinistero dell’Istruzione, dell’Università e della Ricerca, MIUR, 1588},
funding_details={Fondazione Umberto VeronesiFondazione Umberto Veronesi},
funding_text 1={The enrolment phase of the Moli-sani Study was supported by research grants from the Pfizer Foundation (Rome, Italy), the Italian Ministry of University and Research (MIUR, Rome, Italy)– Programma Triennale di Ricerca, Decreto no.1588 and Instrumentation Laboratory, Milan, Italy. M.B. was supported by a Fondazione Umberto Veronesi Fellowship. The present analyses were partially supported by the Italian Ministry of Health [Grant number GR-2013-02356060]. Funders had no role in study design; collection, analysis or interpretation of data; the writing of the manuscript; or the decision to submit the article for publication.},
references={Bonaccio, M., Iacoviello, L., de Gaetano, G., The Mediterranean diet: The reasons for a success (2012) Thromb Res, 129, pp. 401-404; Tektonidis, T.G., Åkesson, A., Gigante, B., Wolk, A., Larsson, S.C., A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study (2015) Atherosclerosis, 243, pp. 93-98; Stefler, D., Malyutina, S., Kubinova, R., Mediterranean diet score and total and cardiovascular mortality in Eastern Europe: the HAPIEE study (2017) Eur J Nutr, 56, pp. 421-429; Bonaccio, M., Di Castelnuovo, A., Costanzo, S., Adherence to the traditional Mediterranean diet and mortality in subjects with diabetes. Prospective results from the MOLI-SANI study (2016) Eur J Prev Cardiol, 23, pp. 400-407; Schwingshackl, L., Hoffmann, G., Does a Mediterranean-type diet reduce cancer risk? (2016) Curr Nutr Rep, 5, pp. 9-17; Sofi, F., Abbate, R., Gensini, G.F., Casini, A., Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis (2010) Am J Clin Nutr, 92, pp. 1189-1196; Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population (2003) N Engl J Med, 348, pp. 2599-2608; Estruch, R., Ros, E., Salas-Salvado, J., Primary prevention of cardiovascular disease with a Mediterranean diet (2013) N Engl J Med, 368, pp. 1279-1290; de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Boucher, P., Mamelle, N., Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate (1998) Arch Intern Med, 158, pp. 1181-1187; Bonaccio, M., Bonanni, A.E., Di Castelnuovo, A., Low income is associated with poor adherence to a Mediterranean diet and a higher prevalence of obesity: cross-sectional results from the Moli-sani study (2012) BMJ Open, 2; Pampel, F.C., Krueger, P.M., Denney, J.T., Socioeconomic disparities in health behaviors (2010) Annu Rev Sociol, 36, pp. 349-370; Turrell, G., Kavanagh, A.M., Socio-economic pathways to diet: modelling the association between socio-economic position and food purchasing behaviour (2006) Public Health Nutr, 9, pp. 375-383; Bonaccio, M., Bes-Rastrollo, M., de Gaetano, G., Iacoviello, L., Challenges to the Mediterranean diet at a time of economic crisis (2016) Nutr Metab Cardiovas Dis, 26, pp. 1057-1063; Hoffman, R., Gerber, M., Food processing and the Mediterranean diet (2015) Nutrients, 7, pp. 7925-7964; Di Castelnuovo, A., Costanzo, S., Persichillo, M., Distribution of short and lifetime risks for cardiovascular disease in Italians (2012) Eur J Prev Cardiol, 19, pp. 723-730; Luepker, R.V., Apple, F.S., Christenson, R.H., Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention (2003) Circulation, 108, pp. 2543-2549; Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA, 285, pp. 2486-2497; Pisani, P., Faggiano, F., Krogh, V., Palli, D., Vineis, P., Berrino, F., Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres (1997) Int J Epidemiol, 26, pp. S152-S160; Pounis, G., Costanzo, S., di Giuseppe, R., Consumption of healthy foods at different content of antioxidant vitamins and phytochemicals and metabolic risk factors for cardiovascular disease in men and women of the Moli-sani study (2013) Eur J Clin Nutr, 67, pp. 207-213; Pounis, G., Bonaccio, M., Di Castelnuovo, A., Polyphenol intake is associated with low-grade inflammation, using a novel data analysis from the Moli-sani study (2016) Thromb Haemost, 115, pp. 344-352; di Giuseppe, R., Arcari, A., Serafini, M., Total dietary antioxidant capacity and lung function in an Italian population: a favorable role in premenopausal/never smoker women (2012) Eur J Clin Nutr, 66, pp. 61-68; Jeurnink, S.M., Buchner, F.L., Bueno-de-Mesquita, H.B., Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition (2012) Int J Cancer, 131, pp. E963-E973; Uribarri, J., Woodruff, S., Goodman, S., Advanced glycation end products in foods and a practical guide to their reduction in the diet (2010) J Am Diet Assoc, 110, pp. 911.e12-916.e12; de Lorgeril, M., Mediterranean diet and cardiovascular disease: historical perspective and latest evidence (2013) Curr Atheroscler Rep, 15, p. 370; Chowdhury, R., Stevens, S., Gorman, D., Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis (2012) BMJ, 345; Barbaresko, J., Koch, M., Schulze, M.B., Nothlings, U., Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review (2013) Nutr Rev, 71, pp. 511-527; Pechey, R., Jebb, S.A., Kelly, M.P., Socioeconomic differences in purchases of more less healthy foods and beverages: analysis of over 25, 000 British households in 2010 (2013) Soc Sci Med, 92, pp. 22-26; Curl, C.L., Beresford, S.A., Hajat, A., Associations of organic produce consumption with socioeconomic status and the local food environment: Multi-Ethnic Study of Atherosclerosis (MESA) (2013) PLoS One, 8; Baranski, M., Srednicka-Tober, D., Volakakis, N., Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses (2014) Br J Nutr, 112, pp. 794-811; Semba, R.D., Bandinelli, S., Sun, K., Guralnik, J.M., Ferrucci, L., Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults (2009) J Am Geriatr Soc, 57, pp. 1874-1880},
correspondence_address1={Bonaccio, M.; Department of Epidemiology and Prevention, Italy; email: marialaura.bonaccio@neuromed.it},
publisher={Oxford University Press},
issn={03005771},
coden={IJEPB},
pubmed_id={29040542},
language={English},
abbrev_source_title={Int. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Papola2019227,
author={Papola, D. and Ostuzzi, G. and Gastaldon, C. and Morgano, G.P. and Dragioti, E. and Carvalho, A.F. and Fusar-Poli, P. and Correll, C.U. and Solmi, M. and Barbui, C.},
title={Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies},
journal={Acta Psychiatrica Scandinavica},
year={2019},
volume={140},
number={3},
pages={227-243},
doi={10.1111/acps.13066},
note={cited By 39},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070332268&doi=10.1111%2facps.13066&partnerID=40&md5=5882682a40c0cb6d0adfd243838e2898},
affiliation={WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Science, Section of Psychiatry, University of Verona, Verona, Italy; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Pain and Rehabilitation centre and Department of Medicine and Health Sciences (IMH), Faculty of Health Sciences, University of Linköping, Linköping, SE, Sweden; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; OASIS Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom; Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, United States; Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States; Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Manhasset, NY, United States; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany; Neuroscience Centre, University of Padua, Padua, Italy; Department of Neuroscience, University of Padua, Padua, Italy},
abstract={Objective: To quantify the risk of hip fracture, thromboembolism, stroke, myocardial infarction, pneumonia and sudden cardiac death associated with exposure to antipsychotics. Methods: Systematic searches were conducted in Medline, Embase and PsycINFO from inception until 30/07/2018 for systematic reviews of observational studies. AMSTAR-2 was used for the quality assessment of systematic reviews, while the strength of associations was measured using GRADE and quantitative umbrella review criteria (URC). Results: Sixty-eight observational studies from six systematic reviews were included. The association between antipsychotic exposure and pneumonia was the strongest [URC = class I; GRADE = low quality; odds ratio (OR) = 1.84, 95% confidence interval (CI) = 1.62–2.09; participants = 28 726; age = 76.2 ± 12.3 years], followed by the association with hip fracture (URC = class II; GRADE = low quality; OR = 1.57, 95% CI = 1.42–1.74; participants = 5 288 118; age = 55.4 ± 12.5 years), and thromboembolism (URC = class II; GRADE = very low quality; OR = 1.55, 95% CI = 1.31–1.83; participants = 31 417 175; age = 55.5 ± 3.2 years). The association was weak for stroke (URC = class III; GRADE = very low quality; OR = 1.45, 95% CI = 1.24–1.70; participants = 65 700; age = 68.7 ± 13.8 years), sudden cardiac death (URC = class III; GRADE = very low quality; OR = 2.24, 95% CI = 1.45–3.46; participants = 77 488; age = 52.2 ± 6.2 years) and myocardial infarction (URC = class III; GRADE = very low quality; OR = 2.21, 95% CI = 1.41–3.46; participants = 399 868; age = 74.1 ± 9.3 years). Conclusion: The most robust results were found for the risk of pneumonia, followed by the risk of hip fracture and thromboembolism. For stroke, sudden cardiac death and myocardial infarction, the strength of association was weak. The observational nature of the primary studies may represent a source of bias. © 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd},
author_keywords={antipsychotics;  methodology;  pharmacoepidemiology;  side effects},
keywords={neuroleptic agent;  neuroleptic agent, age;  cerebrovascular accident;  disease association;  drug use;  heart infarction;  hip fracture;  human;  meta analysis;  observational study;  pneumonia;  priority journal;  Review;  risk assessment;  sensitivity analysis;  sudden cardiac death;  systematic review;  venous thromboembolism;  cerebrovascular accident;  heart infarction;  hip fracture;  observational study;  pneumonia;  sudden cardiac death;  thromboembolism, Antipsychotic Agents;  Death, Sudden, Cardiac;  Hip Fractures;  Humans;  Myocardial Infarction;  Observational Studies as Topic;  Pneumonia;  Stroke;  Thromboembolism},
chemicals_cas={Antipsychotic Agents},
funding_text 1={Dr. Correll has been a consultant and/or advisor to or has received honoraria from: Alkermes, Allergan, Angelini, Boehringer-Ingelheim, Gerson Lehrman Group, Indivior, IntraCellular Therapies, Janssen/J&J, LB Pharma, Lundbeck, MedA-vante-ProPhase, Medscape, Merck, Neurocrine, Noven, Otsuka, Pfizer, Rovi, Servier, Sunovion, Supernus, Takeda and Teva. He has provided expert testimony for Bristol-Myers Squibb, Jans-sen and Otsuka. He served on a Data Safety Monitoring Board for Boehringer-Ingelheim, Lundbeck, Rovi, Supernus and Teva. He received royalties from UpToDate and grant support from Janssen and Takeda. He is also a shareholder of LB Pharma. Dr. Fusar-Poli received grant funds or advisory board fees from Lundbeck.},
references={Ilyas, S., Moncrieff, J., Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010 (2012) Br J Psychiatry, 200, pp. 393-398; Carton, L., Cottencin, O., Lapeyre-Mestre, M., Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends (2015) Curr Pharm Des, 21, pp. 3280-3297; Maglione, M., Maher, A.R., Hu, J., (2011) Off-label use of atypical antipsychotics: an update, , Rockville (MD), Agency for Healthcare Research and Quality (US); Solmi, M., Murru, A., Pacchiarotti, I., Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review (2017) Ther Clin Risk Manag, 13, pp. 757-777; Jackson, J.W., Schneeweiss, S., Vanderweele, T.J., Blacker, D., Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis (2014) PLoS ONE, 9; Frieden, T.R., Evidence for health decision making – beyond randomized, controlled trials (2017) N Engl J Med, 377, pp. 465-475; Solmi, M., Correll, C.U., Carvalho, A.F., Ioannidis, J.P.A., The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis (2018) Epidemiol Psychiatr Sci, 27, pp. 537-542; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Based Healthc, 13, pp. 132-140; Fusar-Poli, P., Radua, J., Ten simple rules for conducting umbrella reviews (2018) Evid Based Mental Health, 21, pp. 95-100; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181, pp. 488-493; Grant, M.J., Booth, A., A typology of reviews: an analysis of 14 review types and associated methodologies (2009) Health Inform Libraries J, 26, pp. 91-108; Fusar-Poli, P., Hijazi, Z., Stahl, D., Steyerberg, E.W., The science of prognosis in psychiatry: a review (2018) JAMA Psychiatry, 75, pp. 1289-1297; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement (2009) BMJ, 339, p. b2535; Solmi, M., Kohler, C.A., Stubbs, B., Environmental risk factors and nonpharmacological and nonsurgical interventions for obesity: An umbrella review of meta-analyses of cohort studies and randomized controlled trials (2018) Eur J Clin Invest, 48; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; (2019), https://www.whocc.no/atc_ddd_index/, Oslo, Norway., Accessed January 17, 2019; Shea, B.J., Reeves, B.C., Wells, G., AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008; Dersimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Higgins, J.P.T., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172, pp. 137-159; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Egger, M., Davey, S.G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Lubin, J.H., Gail, M.H., On power and sample size for studying features of the relative odds of disease (1990) Am J Epidemiol, 131, pp. 552-566; Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Ntzani, E.E., Ioannidis, J.P.A., Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies (2015) BMJ, 350, p. g7607; Dragioti, E., Karathanos, V., Gerdle, B., Evangelou, E., Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials (2017) Acta Psychiatr Scand, 136, pp. 236-246; Machado, M.O., Veronese, N., Sanches, M., The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses (2018) BMC Med, 16, p. 112; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Guyatt, G.H., Oxman, A.D., Vist, G.E., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336, pp. 924-926; Guyatt, G.H., Thorlund, K., Oxman, A.D., GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes (2013) J Clin Epidemiol, 66, pp. 173-183; Iorio, A., Spencer, F.A., Falavigna, M., Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients (2015) BMJ, 350, p. h870; Balshem, H., Helfand, M., Schunemann, H.J., GRADE guidelines: 3. Rating the quality of evidence (2011) J Clin Epidemiol, 64, pp. 401-406; Papola, D., Ostuzzi, G., Thabane, L., Guyatt, G., Barbui, C., Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies (2018) Int Clin Psychopharmacol, 33, pp. 181-196; Barbui, C., Conti, V., Cipriani, A., Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies (2014) Drug Saf, 37, pp. 79-90; Hsu, W.T., Esmaily-Fard, A., Lai, C.C., Antipsychotics and the risk of cerebrovascular accident: a systematic review and meta-analysis of observational studies (2017) J Am Med Dir Assoc, 18, pp. 692-699; Huang, K.L., Fang, C.J., Hsu, C.C., Wu, S.I., Juang, J.J.M., Stewart, R., Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies (2017) J Psychopharmacol, 31, pp. 1544-1555; Nose, M., Recla, E., Trifiro, G., Barbui, C., Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies (2015) Pharmacoepidemiol Drug Saf, 24, pp. 812-820; Salvo, F., Pariente, A., Shakir, S., Sudden cardiac and sudden unexpected death related to antipsychotics: a meta-analysis of observational studies (2016) Clin Pharmacol Ther, 99, pp. 306-314; Zhang, Y., Chapman, A.-M., Plested, M., Jackson, D., Purroy, F., The Incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review (2012) Stroke Res Treat, 2012, p. 436125; Heit, J.A., Epidemiology of venous thromboembolism (2015) Nat Rev Cardiol, 12, pp. 464-474; Torres, A., Peetermans, W.E., Viegi, G., Blasi, F., Risk factors for community-acquired pneumonia in adults in Europe: a literature review (2013) Thorax, 68, pp. 1057-1065; Roger, V.L., Epidemiology of myocardial infarction (2007) Med Clin North Am, 91, pp. 537-552; Corbett, A., Burns, A., Ballard, C., Don't use antipsychotics routinely to treat agitation and aggression in people with dementia (2014) BMJ, 349, p. g6420; Hermes, E.D.A., Sernyak, M., Rosenheck, R., Use of second-generation antipsychotic agents for sleep and sedation: a provider survey (2013) Sleep, 36, pp. 597-600; Kamble, P., Chen, H., Sherer, J.T., Aparasu, R.R., Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data (2009) Drugs Aging, 26, pp. 483-492; Anderson, F.A., Jr., Spencer, F.A., Risk factors for venous thromboembolism (2003) Circulation, 107, pp. I9-I16; Leucht, S., Cipriani, A., Spineli, L., Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis (2013) Lancet, 382, pp. 951-962; Barbui, C., Sharing all types of clinical data and harmonizing journal standards (2016) BMC Med, 14, p. 63; Rockhold, F., Nisen, P., Freeman, A., Data sharing at a crossroads (2016) N Engl J Med, 375, pp. 1115-1117; Mcdonald, L., Schultze, A., Simpson, A., Graham, S., Wasiak, R., Ramagopalan, S.V., Lack of data sharing in observational studies (2017) BMJ, 359, p. j4866},
correspondence_address1={Papola, D.; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Italy; email: davide.papola@univr.it},
publisher={Blackwell Publishing Ltd},
issn={0001690X},
coden={APYSA},
pubmed_id={31264708},
language={English},
abbrev_source_title={Acta Psychiatr. Scand.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Finlay2020250,
author={Finlay, B.B. and CIFAR Humans and the Microbiome},
title={Are noncommunicable diseases communicable?},
journal={Science},
year={2020},
volume={367},
number={6475},
pages={250-251},
doi={10.1126/science.aaz3834},
note={cited By 38},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077942239&doi=10.1126%2fscience.aaz3834&partnerID=40&md5=d7700ed42dc7ac94e7261ff6006fc6e9},
affiliation={Michael Smith Laboratories, Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada; Canadian Institute for Advanced Research (CIFAR), Toronto, ON  M5G 1M1, Canada},
keywords={infectious disease;  infectivity;  noncommunicable disease;  physiology, bacterial flora;  body mass;  cardiovascular disease;  communicable disease;  disease transmission;  environmental factor;  genetic predisposition;  heredity;  human;  inflammatory bowel disease;  lifestyle;  malignant neoplasm;  microflora;  mortality rate;  mouse;  non communicable disease;  nonhuman;  obesity;  phenotype;  prevalence;  priority journal;  respiratory tract disease;  risk factor;  Short Survey;  social network;  ulcerative colitis;  communicable disease;  dysbiosis;  intestine flora;  microbiology, Communicable Diseases;  Dysbiosis;  Gastrointestinal Microbiome;  Humans;  Noncommunicable Diseases},
funding_details={Canadian Institute for Advanced ResearchCanadian Institute for Advanced Research, CIFAR},
funding_text 1={We acknowledge funding from the Canadian Institute for Advanced Research (CIFAR).},
references={https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases; Brito, I.L., (2019) Nat. Microbiol., 4, p. 964; Turnbaugh, P.J., (2006) Nature, 444, p. 1027; Thaiss, C.A., (2016) Nature, 540, p. 544; Christakis, N.A., Fowler, J.H., (2007) N. Engl.J. Med., 357, p. 370; Datar, A., Nicosia, N., (2018) JAMAPediatr, 172, p. 239; Thaiss, C.A., (2014) Cell159, p. 514; Elinav, E., (2011) Cell145, p. 745; Ananthakrishnan, A.N., (2015) Nat. Rev. Gastro. Hep., 12, p. 205; Vonaesch, P., Anderson, M., Sansonetti, P.J., (2018) FEMSMicrobiol. Rev., 42, p. 273; Zhu, W., (2016) Cell165, p. 111; Wang, Z., (2011) Nature, 472, p. 57; Kahleova, H., Levin, S., Barnard, N.D., (2018) Prog. Cardiovasc. Dis., 61, p. 54; Gregory, J.C., (2015) J. Biol. Chem., 290, p. 5647; Arrieta, M.C., (2015) Sci.Transl. Med., 7, p. 307ra152},
correspondence_address1={Finlay, B.B.; Michael Smith Laboratories, Canada; email: bfinlay@msl.ubc.ca},
publisher={American Association for the Advancement of Science},
issn={00368075},
coden={SCIEA},
pubmed_id={31949069},
language={English},
abbrev_source_title={Sci.},
document_type={Short Survey},
source={Scopus},
}

@ARTICLE{Viguiliouk2019S308,
author={Viguiliouk, E. and Glenn, A.J. and Nishi, S.K. and Chiavaroli, L. and Seider, M. and Khan, T. and Bonaccio, M. and Iacoviello, L. and Mejia, S.B. and Jenkins, D.J.A. and Kendall, C.W.C. and Kahleová, H. and Rahelić, D. and Salas-Salvadó, J. and Sievenpiper, J.L.},
title={Associations between Dietary Pulses Alone or with Other Legumes and Cardiometabolic Disease Outcomes: An Umbrella Review and Updated Systematic Review and Meta-analysis of Prospective Cohort Studies},
journal={Advances in Nutrition},
year={2019},
volume={10},
pages={S308-S319},
doi={10.1093/advances/nmz113},
note={cited By 38},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075062320&doi=10.1093%2fadvances%2fnmz113&partnerID=40&md5=eb6b42c14f72c3c4e7b12327aa013014},
affiliation={Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy; Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Endocrinology and Metabolism, St. Michael's Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada; Physicians Committee for Responsible Medicine, Washington, DC, United States; Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Endocrinology, Diabetes and Clinical Pharmacology, Dubrava University Hospital, School of Medicine, University of Zagreb, Zagreb, Croatia; CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, Madrid, Spain; Human Nutrition Department, IISPV, Universitat Rovira i Virgili, Reus, Spain},
abstract={To update the European Association for the Study of Diabetes clinical practice guidelines for nutrition therapy, we conducted an umbrella review and updated systematic review and meta-analysis (SRMA) of prospective cohort studies of the association between dietary pulses with or without other legumes and cardiometabolic disease outcomes. We searched the PubMed, MEDLINE, EMBASE, and Cochrane databases through March 2019. We included the most recent SRMAs of prospective cohort studies and new prospective cohort studies published after the census dates of the included SRMAs assessing the relation between dietary pulses with or without other legumes and incidence and mortality of cardiovascular diseases (CVDs) [including coronary heart disease (CHD), myocardial infarction (MI), and stroke], diabetes, hypertension, and/or obesity. Two independent reviewers extracted data and assessed risk of bias. Risk estimates were pooled using the generic inverse variance method and expressed as risk ratios (RRs) with 95% CIs. The overall certainty of the evidence was assessed using the GRADE approach. Six SRMAs were identified and updated to include 28 unique prospective cohort studies with the following number of cases for each outcome: CVD incidence, 10,261; CVD mortality, 16,168; CHD incidence, 7786; CHD mortality, 3331; MI incidence, 2585; stroke incidence, 8570; stroke mortality, 2384; diabetes incidence, 10,457; hypertension incidence, 83,284; obesity incidence, 8125. Comparing the highest with the lowest level of intake, dietary pulses with or without other legumes were associated with significant decreases in CVD (RR: 0.92; 95% CI: 0.85, 0.99), CHD (RR: 0.90; 95% CI: 0.83, 0.99), hypertension (RR: 0.91; 95% CI: 0.86, 0.97), and obesity (RR: 0.87; 95% CI: 0.81, 0.94) incidence. There was no association with MI, stroke, and diabetes incidence or CVD, CHD, and stroke mortality. The overall certainty of the evidence was graded as "low" for CVD incidence and "very low" for all other outcomes. Current evidence shows that dietary pulses with or without other legumes are associated with reduced CVD incidence with low certainty and reduced CHD, hypertension, and obesity incidence with very low certainty. More research is needed to improve our estimates. This trial was registered at clinicaltrials.gov as NCT03555734. © The Author(s) 2019.},
author_keywords={cardiovascular disease;  diabetes;  GRADE;  hypertension;  legumes;  meta-analysis;  obesity;  prospective cohort;  pulses;  systematic review},
keywords={cardiovascular disease;  cerebrovascular accident;  coronary artery disease;  diabetes mellitus;  diet;  Fabaceae;  feeding behavior;  heart infarction;  human;  hypertension;  meta analysis;  metabolic disorder;  obesity;  plant seed;  prospective study, Cardiovascular Diseases;  Coronary Disease;  Diabetes Mellitus;  Diet;  Fabaceae;  Feeding Behavior;  Humans;  Hypertension;  Metabolic Diseases;  Myocardial Infarction;  Obesity;  Prospective Studies;  Seeds;  Stroke},
funding_details={Abbott LaboratoriesAbbott Laboratories},
funding_details={Procter and GambleProcter and Gamble, P&G},
funding_details={PepsiCoPepsiCo},
funding_details={California Strawberry CommissionCalifornia Strawberry Commission},
funding_details={UnileverUnilever},
funding_details={Canadian Diabetes AssociationCanadian Diabetes Association, CDA},
funding_details={Arizona State UniversityArizona State University, ASU},
funding_details={Advanced Foods and Materials NetworkAdvanced Foods and Materials Network, AFMNet},
funding_details={Ontario Research FoundationOntario Research Foundation, ORF},
funding_details={St. Michael’s Hospital FoundationSt. Michael’s Hospital Foundation},
funding_details={Canadian Nutrition SocietyCanadian Nutrition Society, CNS},
funding_details={Flax Council of CanadaFlax Council of Canada},
funding_details={Peanut InstitutePeanut Institute, TPI},
funding_details={Soy Nutrition InstituteSoy Nutrition Institute, SNI},
funding_details={Government of CanadaGovernment of Canada},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, IRSC, 129920},
funding_details={Institute of Nutrition, Metabolism and DiabetesInstitute of Nutrition, Metabolism and Diabetes, INMD},
funding_details={Banting and Best Diabetes Centre, University of TorontoBanting and Best Diabetes Centre, University of Toronto, BBDC},
funding_details={Canada Foundation for InnovationCanada Foundation for Innovation, CFI},
funding_details={Physicians' Services Incorporated FoundationPhysicians' Services Incorporated Foundation, PSI},
funding_details={Ministero della SaluteMinistero della Salute, GR-2013-02356060},
funding_details={Ontario Ministry of Research, Innovation and ScienceOntario Ministry of Research, Innovation and Science, MRIS},
funding_details={Fondazione Umberto VeronesiFondazione Umberto Veronesi},
funding_details={Hospital for Sick ChildrenHospital for Sick Children, SickKids},
funding_details={Alpro FoundationAlpro Foundation},
funding_details={International Nut and Dried Fruit CouncilInternational Nut and Dried Fruit Council, INC},
funding_details={Canadian Agri-Food Policy InstituteCanadian Agri-Food Policy Institute, CAPI},
funding_details={Canadian Society of Endocrinology and MetabolismCanadian Society of Endocrinology and Metabolism, CSEM},
funding_text 1={Aspects of this work were presented at the 7th International Congress on Vegetarian Nutrition, Loma Linda, CA, USA, 26–28 February 2018, and the 36th International Symposium on Diabetes and Nutrition, Opatija, Croatia, 27–30 June 2018. Supported by Canadian Institutes of Health Research grant 129920 through the Canada-wide Human Nutrition Trialists’Network. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) commissioned this systematic review and meta-analysis and provided funding and logistical support for meetings as part of their development of clinical practice guidelines for nutrition therapy. The Diet, Digestive tract, and Disease (3D) Centre, funded through the Canada Foundation for Innovation and the Ministry of Research and Innovation’s Ontario Research Fund, provided the infrastructure for the conduct of this project. EV was supported by a Toronto 3D Knowledge Synthesis and Clinical Trials Foundation Internship Award. MB was supported by a Fondazione Umberto Veronesi Fellowship and by Italian Ministry of Health grant GR-2013-02356060. DJAJ was funded by the Government of Canada through the Canada Research Chair Endowment. JLS was funded by a PSI Graham Farquharson Knowledge Translation Fellowship, Diabetes Canada Clinician Scientist Award, Canadian Institutes of Health Research (CIHR) New Investigator Partnership Prize, and Banting & Best Diabetes Centre (BBDC) Sun Life Financial New Investigator Award for Diabetes Research. Author disclosures: EV and AJG serve as scientific advisors for New Era Nutrition. SKN worked as a clinical research dietitian at Glycaemic Index Laboratories, Toronto, Ontario, Canada, and is currently a registered dietitian and study sub-coordinator at Diabetes Heart Research Centre for clinical trials of AstraZeneca, Boehringer Ingelheim, Novo Nordisk, and Sanofi. LC worked as a clinical research coordinator at Glycaemic Index Laboratories, Toronto, Ontario, Canada. TK has received research support from the Canadian Institutes of Health Research (CIHR) and an unrestricted travel donation from Bee Maid Honey Ltd. He has been an invited speaker at the Calorie Control Council Annual meeting for which he has received an honorarium. DJAJ has received research grants from Saskatchewan & Alberta Pulse Growers Associations, the Agricultural Bioproducts Innovation Program through the Pulse Research Network, the Advanced Foods and Material Network, Loblaw Companies Ltd, Unilever Canada and Netherlands, Barilla, the Almond Board of California, Agriculture and Agri-food Canada, Pulse Canada, Kellogg’s Company, Canada, Quaker Oats, Canada, Procter & Gamble Technical Centre Ltd, Bayer Consumer Care, Springfield, NJ, Pepsi/Quaker, International Nut & Dried Fruit (INC), Soy Foods Association of North America, the Coca-Cola Company (investigator initiated, unrestricted grant), Solae, Haine Celestial, the Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Soy Nutrition Institute (SNI), the Canola and Flax Councils of Canada, the Calorie Control Council, the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI), and the Ontario Research Fund (ORF). He has received in-kind supplies for trials as a research support from the Almond Board of California, Walnut Council of California, American Peanut Council, Barilla, Unilever, Unico, Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Bunge Limited, Kellogg Canada, WhiteWave Foods. He has been on the speaker’s panel, served on the scientific advisory board and/or received travel support and/or honoraria from the Almond Board of California, Canadian Agriculture Policy Institute, Loblaw Companies Ltd, the Griffin Hospital (for the development of the NuVal scoring system), the Coca-Cola Company, EPICURE, Danone, Diet Quality Photo Navigation (DQPN), Better Therapeutics (FareWell), Verywell, True Health Initiative (THI), Institute of Food Technologists (IFT), Soy Nutrition Institute (SNI), Herbalife Nutrition Institute (HNI), Saskatchewan & Alberta Pulse Growers Associations, Sanitarium Company, Orafti, the American Peanut Council, the International Tree},
funding_text 2={Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Herbalife International, Pacific Health Laboratories, Nutritional Fundamentals for Health (NFH), Barilla, Metagenics, Bayer Consumer Care, Unilever Canada and Netherlands, Solae, Kellogg, Quaker Oats, Procter & Gamble, Abbott Laboratories, Dean Foods, the California Strawberry Commission, Haine Celestial, PepsiCo, the Alpro Foundation, Pioneer Hi-Bred International, DuPont Nutrition and Health, Spherix Consulting and WhiteWave Foods, the Advanced Foods and Material Network, the Canola and Flax Councils of Canada, Agri-Culture and Agri-Food Canada, the Canadian Agri-Food Policy Institute, Pulse Canada, the Soy Foods Association of North America, the Nutrition Foundation of Italy (NFI), Nutra-Source Diagnostics, the McDougall Program, the Toronto Knowledge Translation Group (St. Michael’s Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society (CNS), the American Society of Nutrition (ASN), Arizona State University, Paolo Sorbini Foundation, and the Institute of Nutrition, Metabolism and Diabetes. He received an honorarium from the United States Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture. He received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council. He received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association (CDA). He is a member of the International Carbohydrate Quality Consortium (ICQC). His wife, Alexandra L Jenkins, is a director and partner of Glycemic Index Laboratories, Inc., and his sister, Caroline Brydson, received funding through a grant from the St. Michael’s Hospital Foundation to develop a cookbook for one of his studies. CWCK has received grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada (AAFC), Almond Board of California, American Peanut Council, Barilla, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd, Pulse Canada, and Unilever. He has received in-kind research support from the Almond Board of California, American Peanut Council, Barilla, California Walnut Commission, Kellogg Canada, Loblaw Companies, Quaker (PepsiCo), Primo, Unico, Unilever, WhiteWave Foods/Danone. He has received travel support and/or honoraria from the American Peanut Council, Barilla, California Walnut Commission, Canola Council of Canada, General Mills, International Nut and Dried Fruit Council, International Pasta Organization, Loblaw Brands Ltd, Nutrition Foundation of Italy, Oldways Preservation Trust, Paramount Farms, Peanut Institute, Pulse Canada, Sun-Maid, Tate & Lyle, Unilever, and White Wave Foods/Danone. He has served on the scientific advisory board for the International Tree Nut Council, International Pasta Organization, McCormick Science Institute, and Oldways Preservation Trust. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the EASD and is a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. HK is the Director of Clinical Research of the Physicians Committee for Responsible Medicine, a non-profit organization conducting research and education. DR has served as principal investigator or co-investigator in clinical trials of AstraZeneca, Eli Lilly, Merck Sharp & Dohme (MSD), Novo Nordisk, Sanofi Aventis, Solvay, and Trophos. He has received honoraria for speaking or advisory board engagements and consulting fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Lifescan—Johnson & Johnson, MSD, Novartis, Novo Nordisk, Pfizer, Pliva, Roche, Salvus, Sanofi Aventis, and Takeda. JS-S reports serving on the board of and receiving grant support through his institution from the International Nut and Dried Fruit Council (INC) and the Eroski Foundation. He reports serving in the Executive Committee of the Instituto Danone Spain. He reports receiving research support from the Instituto de Salud Carlos III, Spain; Ministerio de Educación y Ciencia, Spain; Departament de Salut Pública de la Generalitat de Catalunya, Catalonia, Spain; European Commission; California Walnut Commission, Sacramento, CA, USA; Patrimonio Comunal Olivarero, Spain; La Morella Nuts, Spain; and Borges SA, Spain. He reports receiving consulting fees or travel expenses from Danone, California Walnut Commission, Eroski Foundation, Instituto Danone—Spain, Nuts for Life, Australian Nut Industry Council, Nestlé, Abbot Laboratories, and Font Vella Lanjarón. He is on the Clinical Practice Guidelines Expert Committee of the EASD, and served in the Scientific Committee of the Spanish Food and Safety Agency, and the Spanish Federation of the Scientific Societies of Food, Nutrition and Dietetics. He is a member of the International Carbohydrate Quality Consortium (ICQC) and an Executive Board Member of the DNSG of the EASD. JLS has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of Health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade},
references={Mitchell, D.C., Lawrence, F.R., Hartman, T.J., Curran, J.M., Consumption of dry beans, peas, and lentils could improve diet quality in the US population (2009) J Am Diet Assoc, 109 (5), pp. 909-913; Mudryj, A.N., Yu, N., Hartman, T.J., Mitchell, D.C., Lawrence, F.R., Aukema, H.M., Pulse consumption in Canadian adults influences nutrient intakes (2012) Br J Nutr, 108, pp. S27-36; Foster-Powell, K., Holt, S.H., Brand-Miller, J.C., International table of glycemic index and glycemic load values: 2002 (2002) Am J Clin Nutr, 76 (1), pp. 5-56; Eckel, R.H., Jakicic, J.M., Ard, J.D., De Jesus, J.M., HoustonMiller, N., Hubbard, V.S., Lee, I.M., Millen, B.E., 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) J Am Coll Cardiol, 63 (25), pp. 2960-2984; Anderson, T.J., Gregoire, J., Pearson, G.J., Barry, A.R., Couture, P., Dawes, M., Francis, G.A., Gupta, M., 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult (2016) Can J Cardiol, 32 (11), pp. 1263-1282; Catapano, A.L., Graham, I., De Backer, G., Wiklund, O., Chapman, M.J., Drexel, H., Hoes, A.W., Pedersen, T.R., 2016 ESC/EAS guidelines for the management of dyslipidaemias (2016) Eur Heart J, 37 (39), pp. 2999-3058; Sievenpiper, J.L., Chan, C.B., Dworatzek, P.D., Freeze, C., Williams, S.L., Nutrition therapy (2018) Can J Diabetes, 42, pp. S64-S79; 4. Lifestyle management: Standards of medical care in diabetes-2018 (2018) Diabetes Care, 41, pp. S38-S50. , American Diabetes Association; Mann, J.I., De Leeuw, I., Hermansen, K., Karamanos, B., Karlstrom, B., Katsilambros, N., Riccardi, G., Slama, G., Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus (2004) NutrMetab Cardiovasc Dis, 14 (6), pp. 373-394; Higgins, J.P.T., Green, S., Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 [Internet], , www.cochrane-handbook.org, The Cochrane Collaboration; 2011 [updatedMarch 2011 cited 2019Oct 14]; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Thacker, S.B., Meta-analysis of observational studies in epidemiology: A proposal for reporting (2000) JAMA, 283 (15), pp. 2008-2012; Viguiliouk, E., Blanco Mejia, S., Kendall, C.W., Sievenpiper, J.L., Can pulses play a role in improving cardiometabolic health? Evidence from systematic reviews and meta-analyses (2017) Ann N y Acad Sci, 1392 (1), pp. 43-57; Lassale, C., Beulens, J., Van Der Schouw, Y., Roswall, N., Weiderpass, E., Romaguera, D., Riboli, E., Tzoulaki, I., Abstract 16: A pro-vegetarian food pattern and cardiovascular mortality in the Epic study (2015) Circulation, 131, p. A16; Bonaccio, M., Di Castelnuovo, A., Costanzo, S., Persichillo, M., Donati, M.B., De Gaetano, G., Iacoviello, L., Higher adherence to the traditional Mediterranean diet is associated with lower cardiovascular risk and allcause mortality in the elderly: Prospective findings from the Moli-sani study (2017) Eur J Prev Cardiol, 24 (1), p. S8; Papandreou, C., Becerra-Tomás, N., Bulló, M., Martínez-González, M.A., Corella, D., Estruch, R., Ros, E., Fitó, M., Legume consumption and risk of all-cause, cardiovascular, and cancer mortality in the PREDIMED study (2019) Clin Nutr, 38 (1), pp. 348-356; Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses [Internet], , www.ohri.ca/programs/clinical_epidemiology/oxford.asp, Ottawa: Ottawa Hospital Research Institute; 2014[cited 2019 Oct 14]; Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., Vist, G.E., Norris, S., GRADE guidelines: 3 Rating the quality of evidence (2011) J Clin Epidemiol, 64 (4), pp. 401-406; Brunetti, M., Shemilt, I., Pregno, S., Vale, L., Oxman, A.D., Lord, J., Sisk, J., Guyatt, G.H., GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence (2013) J Clin Epidemiol, 66 (2), pp. 140-150; Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., Norris, S., DeBeer, H., GRADE guidelines: 1 Introduction-GRADE evidence profiles and summary of findings tables (2011) J Clin Epidemiol, 64 (4), pp. 383-394; Guyatt, G., Oxman, A.D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Jaeschke, R., GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes (2013) J Clin Epidemiol, 66 (2), pp. 151-157; Guyatt, G.H., Oxman, A.D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Schunemann, H.J., GRADE guidelines: 2. Framing the question and deciding on important outcomes (2011) J Clin Epidemiol, 64 (4), pp. 395-400; Guyatt, G.H., Oxman, A.D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P.J., Vist, G., GRADE guidelines 6. Rating the quality of evidence-imprecision (2011) J Clin Epidemiol, 64 (12), pp. 1283-1293; Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Vist, G., GRADE guidelines: 8. Rating the quality of evidence-indirectness (2011) J Clin Epidemiol, 64 (12), pp. 1303-1310; Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Akl, E.A., GRADE guidelines: 7. Rating the quality of evidence-inconsistency (2011) J Clin Epidemiol, 64 (12), pp. 1294-1302; Guyatt, G.H., Oxman, A.D., Montori, V., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Falck-Ytter, Y., GRADE guidelines: 5. Rating the quality of evidence-publication bias (2011) J Clin Epidemiol, 64 (12), pp. 1277-1282; Guyatt, G.H., Oxman, A.D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Djulbegovic, B., GRADE guidelines: 12 Preparing summary of findings tables-binary outcomes (2013) J Clin Epidemiol, 66 (2), pp. 158-172; Guyatt, G.H., Oxman, A.D., Sultan, S., Glasziou, P., Akl, E.A., Alonso-Coello, P., Atkins, D., Montori, V., GRADE guidelines: 9 Rating up the quality of evidence (2011) J Clin Epidemiol, 64 (12), pp. 1311-1316; Guyatt, G.H., Oxman, A.D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Montori, V., Falck-Ytter, Y., GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias) (2011) J Clin Epidemiol, 64 (4), pp. 407-415; Guyatt, G.H., Thorlund, K., Oxman, A.D., Walter, S.D., Patrick, D., Furukawa, T.A., Johnston, B.C., Vist, G., GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes (2013) J Clin Epidemiol, 66 (2), pp. 173-183; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7 (3), pp. 177-188; Greenland, S., Longnecker, M.P., Methods for trend estimation from summarized dose-response data, with applications to meta-analysis (1992) Am J Epidemiol, 135 (11), pp. 1301-1309; Orsini, N., Li, R., Wolk, A., Khudyakov, P., Spiegelman, D., Meta-analysis for linear and nonlinear dose-response relations: Examples, an evaluation of approximations, and software (2011) Am J Epidemiol, 175 (1), pp. 66-73; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics, 50 (4), pp. 1088-1101; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Bechthold, A., Boeing, H., Schwedhelm, C., Hoffmann, G., Knuppel, S., Iqbal, K., De Henauw, S., Schlesinger, S., Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies (2019) Crit Rev Food Sci Nutr, 59 (7), pp. 1071-1090; Grosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., Galvano, F., Kales, S.N., A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal? (2017) Crit Rev Food Sci Nutr, 57 (15), pp. 3218-3232; Marventano, S., Izquierdo Pulido, M., Sánchez-González, C., Godos, J., Speciani, A., Galvano, F., Grosso, G., Legume consumption and CVD risk: A systematic review and meta-analysis (2017) Public Health Nutr, 20 (2), pp. 245-254; Schwingshackl, L., Hoffmann, G., Lampousi, A.M., Knuppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Boeing, H., Food groups and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies (2017) Eur J Epidemiol, 32 (5), pp. 363-375; Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Knuppel, S., Iqbal, K., Andriolo, V., Bechthold, A., Boeing, H., Foodgroups and risk of hypertension: A systematic reviewand dose-response meta-analysis of prospective studies (2017) Adv Nutr, 8 (6), pp. 793-803; Schlesinger, S., Neuenschwander, M., Schwedhelm, C., Hoffmann, G., Bechthold, A., Boeing, H., Schwingshackl, L., Food groups and risk of overweight, obesity, and weight gain: A systematic review and dose-response meta-analysis of prospective studies (2019) Adv Nutr, 10 (2), pp. 205-218; Wang, J.B., Fan, J.H., Dawsey, S.M., Sinha, R., Freedman, N.D., Taylor, P.R., Qiao, Y.L., Abnet, C.C., Dietary components and risk of total, cancer and cardiovascular disease mortality in the Linxian Nutrition Intervention Trials cohort in China (2016) Sci Rep, 6, p. 22619; Buil-Cosiales, P., Martinez-Gonzalez, M.A., Ruiz-Canela, M., Díez-Espino, J., García-Arellano, A., Toledo, E., Consumption of fruit or fiber-fruit decreases the risk of cardiovascular disease in a Mediterranean young cohort (2017) Nutrients, 9 (3), p. 295; Farvid, M.S., Malekshah, A.F., Pourshams, A., Poustchi, H., Sepanlou, S.G., Sharafkhah, M., Khoshnia, M., Kamangar, F., Dietary protein sources and all-cause and cause-specific mortality: The Golestan Cohort Study in Iran (2017) Am J Prev Med, 52 (2), pp. 237-248; Miller, V., Mente, A., Dehghan, M., Rangarajan, S., Zhang, X., Swaminathan, S., Dagenais, G., Lear, S., Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): A prospective cohort study (2017) Lancet, 390, pp. 2037-2049. , 10107; Stefler, D., Malyutina, S., Kubinova, R., Pajak, A., Peasey, A., Pikhart, H., Brunner, E.J., Bobak, M., Mediterranean diet score and total and cardiovascular mortality in Eastern Europe: The HAPIEE study (2017) Eur J Nutr, 56 (1), pp. 421-429; Russell, J., Flood, V., Regular consumption of legumes reduces the risk of cardiovascular mortality (2014) J Nutr Intermed Metab, 1, pp. 18-19; Van Den Brandt, P.A., Red meat, processed meat, and other dietary protein sources and risk of overall and cause-specific mortality in the Netherlands Cohort Study (2019) Eur J Epidemiol, 34 (4), pp. 351-369; Becerra-Tomás, N., Díaz-López, A., Rosique-Esteban, N., Ros, E., Buil-Cosiales, P., Corella, D., Estruch, R., Arós, F., Legume consumption is inversely associated with type 2 diabetes incidence in adults: A prospective assessment from the PREDIMED study (2018) Clin Nutr, 37 (3), pp. 906-913; Khalili-Moghadam, S., Mirmiran, P., Bahadoran, Z., Azizi, F., The Mediterranean diet and risk of type 2 diabetes in Iranian population (2019) Eur J Clin Nutr, 73 (1), pp. 72-78; Lelong, H., Blacher, J., Baudry, J., Adriouch, S., Galan, P., Fezeu, L., Hercberg, S., Kesse-Guyot, E., Individual and combined effects of dietary factors on risk of incident hypertension: Prospective analysis from the NutriNet-Santé cohort (2017) Hypertension, 70 (4), pp. 712-720; Bazzano, L.A., He, J., Ogden, L.G., Loria, C., Vupputuri, S., Myers, L., Whelton, P.K., Legume consumption and risk of coronary heart disease in USmen and women: NHANES i Epidemiologic Follow-up Study (2001) Arch Intern Med, 161 (21), pp. 2573-2578; Kokubo, Y., Iso, H., Ishihara, J., Okada, K., Inoue, M., Tsugane, S., Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: The Japan Public Health Center-based (JPHC) study cohort i (2007) Circulation, 116 (22), pp. 2553-2562; Von Ruesten, A., Feller, S., Bergmann, M.M., Boeing, H., Diet and risk of chronic diseases: Results from the first 8 years of follow-up in the EPICPotsdam study (2013) Eur J Clin Nutr, 67 (4), pp. 412-419; Nouri, F., Sarrafzadegan, N., Mohammadifard, N., Sadeghi, M., Mansourian, M., Intake of legumes and the risk of cardiovascular disease: Frailty modeling of a prospective cohort study in the Iranian middle-aged and older population (2016) Eur J Clin Nutr, 70 (2), pp. 217-221; Nagura, J., Iso, H., Watanabe, Y., Maruyama, K., Date, C., Toyoshima, H., Yamamoto, A., Kondo, T., Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: The JACC Study (2009) Br J Nutr, 102 (2), pp. 285-292; Gardener, H., Wright, C.B., Gu, Y., Demmer, R.T., Boden-Albala, B., Elkind, M.S., Sacco, R.L., Scarmeas, N., Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: The Northern Manhattan Study (2011) Am J Clin Nutr, 94 (6), pp. 1458-1464; Buckland, G., González, C.A., Agudo, A., Vilardell, M., Berenguer, A., Amiano, P., Ardanaz, E., Basterretxea, M., Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study (2009) Am J Epidemiol, 170 (12), pp. 1518-1529; Bernstein, A.M., Sun, Q., Hu, F.B., Stampfer, M.J., Manson, J.E., Willett, W.C., Major dietary protein sources and risk of coronary heart disease in women (2010) Circulation, 122 (9), pp. 876-883; Martínez-González, M.A., García-López, M., Bes-Rastrollo, M., Toledo, E., Martínez-Lapiscina, E.H., Delgado-Rodriguez, M., Vazquez, Z., Beunza, J.J., Mediterranean diet and the incidence of cardiovascular disease: A Spanish cohort (2011) Nutr Metab Cardiovasc Dis, 21 (4), pp. 237-244; Dilis, V., Katsoulis, M., Lagiou, P., Trichopoulos, D., Naska, A., Trichopoulou, A., Mediterranean diet and CHD: The Greek European Prospective Investigation into Cancer and Nutrition cohort (2012) Br J Nutr, 108 (4), pp. 699-709; Haring, B., Gronroos, N., Nettleton, J.A., Von Ballmoos, M.C., Selvin, E., Alonso, A., Dietary protein intake and coronary heart disease in a large community based cohort: Results from the Atherosclerosis Risk in Communities (ARIC) study [corrected] (2014) PLoS One, 9 (10), p. e109552; Yu, D., Zhang, X., Gao, Y.T., Li, H., Yang, G., Huang, J., Zheng, W., Shu, X.O., Fruit and vegetable intake and risk of CHD: Results from prospective cohort studies of Chinese adults in Shanghai (2014) Br J Nutr, 111 (2), pp. 353-362; Fraser, G.E., Sabate, J., Beeson, W.L., Strahan, T.M., A possible protective effect of nut consumption on risk of coronary heart disease (1992) Arch Intern Med, 152 (7), pp. 1416-1424. , The Adventist Health Study; Kelemen, L.E., Kushi, L.H., Jacobs, D.R., Jr., Cerhan, J.R., Associations of dietary protein with disease and mortality in a prospective study of postmenopausal women (2005) Am J Epidemiol, 161 (3), pp. 239-249; Mizrahi, A., Knekt, P., Montonen, J., Laaksonen, M.A., Heliovaara, M., Jarvinen, R., Plant foods and the risk of cerebrovascular diseases: A potential protection of fruit consumption (2009) Br J Nutr, 102 (7), pp. 1075-1083; Bernstein, A.M., Pan, A., Rexrode, K.M., Stampfer, M., Hu, F.B., Mozaffarian, D., Willett, W.C., Dietary protein sources and the risk of stroke in men and women (2012) Stroke, 43 (3), pp. 637-644; Misirli, G., Benetou, V., Lagiou, P., Bamia, C., Trichopoulos, D., Trichopoulou, A., Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population (2012) Am J Epidemiol, 176 (12), pp. 1185-1192; Haring, B., Misialek, J.R., Rebholz, C.M., Petruski-Ivleva, N., Gottesman, R.F., Mosley, T.H., Alonso, A., Association of dietary protein consumption with incident silent cerebral infarcts and stroke: The Atherosclerosis Risk in Communities (ARIC) study (2015) Stroke, 46 (12), pp. 3443-3450; Meyer, K.A., Kushi, L.H., Jacobs, D.R., Jr., Slavin, J., Sellers, T.A., Folsom, A.R., Carbohydrates, dietary fiber, and incident type 2 diabetes in older women (2000) Am J Clin Nutr, 71 (4), pp. 921-930; Hodge, A.M., English, D.R., O'Dea, K., Giles, G.G., Glycemic index and dietary fiber and the risk of type 2 diabetes (2004) Diabetes Care, 27 (11), pp. 2701-2706; Bazzano, L.A., Li, T.Y., Joshipura, K.J., Hu, F.B., Intake of fruit, vegetables, and fruit juices and risk of diabetes in women (2008) Diabetes Care, 31 (7), pp. 1311-1317; Villegas, R., Gao, Y.T., Yang, G., Li, H.L., Elasy, T.A., Zheng, W., Shu, X.O., Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study (2008) Am J Clin Nutr, 87 (1), pp. 162-167; Ericson, U., Sonestedt, E., Gullberg, B., Hellstrand, S., Hindy, G., Wirfalt, E., Orho-Melander, M., High intakes of protein and processed meat associate with increased incidence of type 2 diabetes (2013) Br J Nutr, 109 (6), pp. 1143-1153; Núñez-Córdoba, J.M., Valencia-Serrano, F., Toledo, E., Alonso, A., Martínez-González, M.A., The Mediterranean diet and incidence of hypertension: The Seguimiento Universidad de Navarra (SUN) study (2009) Am J Epidemiol, 169 (3), pp. 339-346; Weng, L.C., Steffen, L.M., Szklo, M., Nettleton, J., Chambless, L., Folsom, A.R., A diet pattern with more dairy and nuts, but less meat is related to lower risk of developing hypertension in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) study (2013) Nutrients, 5 (5), pp. 1719-1733; Borgi, L., Muraki, I., Satija, A., Willett, W.C., Rimm, E.B., Forman, J.P., Fruit and vegetable consumption and the incidence of hypertension in three prospective cohort studies (2016) Hypertension, 67 (2), pp. 288-293; Golzarand, M., Bahadoran, Z., Mirmiran, P., Azizi, F., Protein foods group and 3-year incidence of hypertension: A prospective study from Tehran Lipid and Glucose Study (2016) J Ren Nutr, 26 (4), pp. 219-225; Rautiainen, S., Wang, L., Lee, I.M., Manson, J.E., Buring, J.E., Sesso, H.D., Higher intake of fruit, but not vegetables or fiber, at baseline is associated with lower risk of becoming overweight or obese in middle-aged and older women of normal BMI at baseline (2015) J Nutr, 145 (5), pp. 960-968; Ha, V., Sievenpiper, J.L., De Souza, R.J., Jayalath, V.H., Mirrahimi, A., Agarwal, A., Chiavaroli, L., Di Buono, M., Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic review and meta-analysis of randomized controlled trials (2014) CMAJ, 186 (8), pp. E252-E262; Sievenpiper, J.L., Kendall, C.W., Esfahani, A., Wong, J.M., Carleton, A.J., Jiang, H.Y., Bazinet, R.P., Jenkins, D.J., Effect of non-oil-seed pulses on glycaemic control: A systematic reviewandmeta-analysis of randomised controlled experimental trials in people with and without diabetes (2009) Diabetologia, 52 (8), pp. 1479-1495; Jayalath, V.H., De Souza, R.J., Sievenpiper, J.L., Ha, V., Chiavaroli, L., Mirrahimi, A., Di Buono, M., Kris-Etherton, P.M., Effect of dietary pulses on blood pressure: A systematic review and meta-analysis of controlled feeding trials (2014) Am J Hypertens, 27 (1), pp. 56-64; Kim, S.J., De Souza, R.J., Choo, V.L., Ha, V., Cozma, A.I., Chiavaroli, L., Mirrahimi, A., Bernstein, A.M., Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials (2016) Am J Clin Nutr, 103 (5), pp. 1213-1223; Dhurandhar, N.V., Schoeller, D., Brown, A.W., Heymsfield, S.B., Thomas, D., Sorensen, T.I., Speakman, J.R., Allison, D.B., Energy balance measurement: When something is not better than nothing (2015) Int J Obes (Lond), 39 (7), pp. 1109-1113; Mudryj, A.N., Aukema, H.M., Yu, N., Intake patterns and dietary associations of soya protein consumption in adults and children in the Canadian Community Health Survey, cycle 2. 2 (2015) Br J Nutr, 113 (2), pp. 299-309; Ding, M., Pan, A., Manson, J.E., Willett, W.C., Malik, V., Rosner, B., Giovannucci, E., Sun, Q., Consumption of soy foods and isoflavones and risk of type 2 diabetes: A pooled analysis of three US cohorts (2016) Eur J Clin Nutr, 70 (12), pp. 1381-1387; (2014) NordicNutrition Recommendations 2012: Integrating Nutrition and Physical Activity, , Nordic Council ofMinisters 5th ed. Copenhagen: Nordic Council of Ministers; Davis, C., Bryan, J., Hodgson, J., Murphy, K., Definition of the Mediterranean diet; A literature review (2015) Nutrients, 7 (11), pp. 9139-9153; Trichopoulou, A., Martínez-González, M.A., Tong, T.Y., Forouhi, N.G., Khandelwal, S., Prabhakaran, D., Mozaffarian, D., De Lorgeril, M., Definitions and potential health benefits of the Mediterranean diet: Views from experts around the world (2014) BMC Med, 12, p. 112; Halkjær, J., Olsen, A., Bjerregaard, L.J., Deharveng, G., Tjønneland, A., Welch, A.A., Crowe, F.L., Niravong, M., Intake of total, animal and plant proteins, and their food sources in 10 countries in the European Prospective Investigation into Cancer and Nutrition (2009) Eur J Clin Nutr, 63, pp. S16-36; Abdullah, M.M.H., Marinangeli, C.P.F., Jones, P.J.H., Carlberg, J.G., Canadian potential healthcare and societal cost savings from consumption of pulses: A cost-of-illness analysis (2017) Nutrients, 9 (7), p. E793; (2019) Pulse Benefits: Environmental Sustainability [Internet], , http://www.pulsecanada.com/environment/sustainability, Pulse Canada Winnipeg, MB: Pulse Canada [cited 9 Jun, 2019]},
correspondence_address1={Sievenpiper, J.L.; Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Canada; email: john.sievenpiper@utoronto.ca},
publisher={Oxford University Press},
issn={21618313},
pubmed_id={31728500},
language={English},
abbrev_source_title={Adv. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Peters2016119,
author={Peters, T.L. and Beard, J.D. and Umbach, D.M. and Allen, K. and Keller, J. and Mariosa, D. and Sandler, D.P. and Schmidt, S. and Fang, F. and Ye, W. and Kamel, F.},
title={Blood levels of trace metals and amyotrophic lateral sclerosis},
journal={NeuroToxicology},
year={2016},
volume={54},
pages={119-126},
doi={10.1016/j.neuro.2016.03.022},
note={cited By 38},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964377991&doi=10.1016%2fj.neuro.2016.03.022&partnerID=40&md5=bc5910aa7dd6eeb7edaa6d8d88e8bce7},
affiliation={Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC, United States; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC, United States; Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC, United States; Department of Medicine and Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, United States; Westat Inc., Durham, NC, United States; Department of Medicine, Duke University Medical Center, Durham, NC, United States},
abstract={Some trace metals may increase risk of amyotrophic lateral sclerosis (ALS), whereas others may be beneficial. Our goal was to examine associations of ALS with blood levels of selenium (Se), zinc (Zn), copper (Cu), and manganese (Mn). We conducted a case-control study of 163 neurologist confirmed patients from the National Registry of Veterans with ALS and 229 frequency-matched veteran controls. We measured metal levels in blood using inductively coupled plasma mass spectrometry and estimated odds ratios (ORs) and 95% confidence intervals (CIs) for associations between ALS and a doubling of metal levels using unconditional logistic regression, adjusting for age, gender, and race/ethnicity. ALS was inversely associated with both Se (OR = 0.4, 95% CI: 0.2-0.8) and Zn (OR = 0.4, 95% CI: 0.2-0.8). Inverse associations with Se were stronger in patients with bulbar compared to spinal onset, worse function, longer diagnostic delay, and longer collection delay; inverse associations with Zn were stronger for those with worse function and longer collection delay. In contrast, ALS was positively associated with Cu (OR = 3.4, 95% CI: 1.5-7.9). For Mn, no linear trend was evident (OR = 0.9, 95% CI: 0.6-1.3, Ptrend = 0.51). Associations of Se, Zn, Cu, and Mn with ALS were independent of one another. Adjustment for lead levels attenuated the positive association of ALS with Cu but did not change associations with Se, Zn, or Mn. In conclusion, Se and Zn were inversely associated with ALS, particularly among those with worse function, suggesting that supplementation with these metals may benefit such patients, while Cu was positively associated with ALS. Deficiencies of Se and Zn and excess Cu may have a role in ALS etiology. © 2016.},
author_keywords={Amyotrophic lateral sclerosis;  Case-Control study;  Motor neuron disease;  Risk factors;  Trace metals},
keywords={copper;  manganese;  selenium;  trace metal;  zinc;  copper;  lead;  manganese;  selenium;  trace element;  zinc, adult;  amyotrophic lateral sclerosis;  Article;  blood sampling;  bulbar paralysis;  case control study;  clinical feature;  controlled study;  copper blood level;  delayed diagnosis;  disease association;  female;  functional status;  human;  major clinical study;  male;  manganese blood level;  mass spectrometry;  middle aged;  neuropathology;  priority journal;  selenium blood level;  spinal paralysis;  trace metal blood level;  trend study;  veteran;  zinc blood level;  age;  aged;  amyotrophic lateral sclerosis;  blood;  very elderly, Adult;  Age Factors;  Aged;  Aged, 80 and over;  Amyotrophic Lateral Sclerosis;  Case-Control Studies;  Copper;  Female;  Humans;  Lead;  Male;  Manganese;  Middle Aged;  Selenium;  Trace Elements;  Zinc},
chemicals_cas={copper, 15158-11-9, 7440-50-8; manganese, 16397-91-4, 7439-96-5; selenium, 7782-49-2; zinc, 7440-66-6, 14378-32-6; lead, 7439-92-1, 13966-28-4; Copper; Lead; Manganese; Selenium; Trace Elements; Zinc},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={Centers for Disease Control and PreventionCenters for Disease Control and Prevention, CDC, T42OH00867302},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, R01ES013244, ZIAES049004, ZIAES049005, ZIAES049028},
funding_details={National Institute for Occupational Safety and HealthNational Institute for Occupational Safety and Health, NIOSH},
funding_details={U.S. Department of Veterans AffairsU.S. Department of Veterans Affairs, VA, CSP #500A},
funding_details={Amyotrophic Lateral Sclerosis AssociationAmyotrophic Lateral Sclerosis Association, ALSA, ALSA-1230},
funding_details={Office of Research and DevelopmentOffice of Research and Development, ORD},
funding_details={Karolinska InstitutetKarolinska Institutet, KI},
funding_details={VetenskapsrådetVetenskapsrådet, VR},
funding_text 1={We thank K Levine (Research Triangle Institute) and BJ Collins (National Toxicology Program) for measuring blood metal levels. This work was supported by the Intramural Research Program of the National Institutes of Health , National Institute of Environmental Health Sciences ( Z01-ES-049005 ), by grants from the National Institutes of Health, National Institute of Environmental Health Sciences ( R01-ES-013244 ), the ALS Association ( ALSA-1230 ), the Swedish Research Council, the Karolinska Institutet , and the Swedish Society of Medical Research , and by a training grant from the National Institute for Occupational Safety and Health/Centers for Disease Control and Prevention ( T42OH00867302 ). The National Registry of Veterans with ALS and its DNA bank were supported by the Office of Research and Development, Cooperative Studies Program, Department of Veterans Affairs (CSP #500A).},
references={Al-Chalabi, A., Hardiman, O., The epidemiology of ALS: a conspiracy of genes, environment and time (2013) Nat. Rev. Neurol., 9, pp. 617-628; Alimonti, A., Bocca, B., Mannella, E., Petrucci, F., Zennaro, F., Cotichini, R., Assessment of reference values for selected elements in a healthy urban population (2005) Ann. Ist. Super. Sanita, 41, pp. 181-187; Allen, K.D., Kasarskis, E.J., Bedlack, R.S., Rozear, M.P., Morgenlander, J.C., Sabet, A., The National Registry of Veterans with amyotrophic lateral sclerosis (2008) Neuroepidemiology, 30, pp. 180-190; Bergomi, M., Vinceti, M., Nacci, G., Pietrini, V., Bratter, P., Alber, D., Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case-control study (2002) Environ. Res., 89, pp. 116-123; Bocca, B., Madeddu, R., Asara, Y., Tolu, P., Marchal, J.A., Forte, G., Assessment of reference ranges for blood Cu, Mn Se and Zn in a selected Italian population (2011) J. Trace Elem. Med. Biol., 25, pp. 19-26; Bowman, A.B., Kwakye, G.F., Herrero Hernandez, E., Aschner, M., Role of manganese in neurodegenerative diseases (2011) J. Trace Elem. Med. Biol., 25, pp. 191-203; Brooks, B.R., Miller, R.G., Swash, M., Munsat, T.L., World Federation of Neurology Research Group on Motor Neuron Diseases,. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 1, pp. 293-299; Combs, G.F., Selenium in global food systems (2001) Br. J. Nutr., 85, pp. 517-547; DiMartino, L., Allen, K.D., Kasarskis, E., Lindquist, J.H., Coffman, C.J., Oddone, E.Z., Characteristics associated with participation in DNA banking: the national registry of veterans with ALS (2007) Contemp. Clin. Trials, 28, pp. 572-582; Dickson, D.W., Weller, R.O., (2011) Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, , Wiley-Blackwell Hoboken; Fang, F., Kwee, L.C., Allen, K.D., Umbach, D.M., Ye, W., Watson, M., Association between blood lead and the risk of amyotrophic lateral sclerosis (2010) Am. J. Epidemiol., 171, pp. 1126-1133; Garzillo, E.M., Lamberti, M., Genovese, G., Pedata, P., Feola, D., Sannolo, N., Blood lead, manganese, and aluminum levels in a regional Italian cohort of ALS patients: does aluminum have an influence? (2014) J. Occup. Env. Med., 56, pp. 1062-1066; Gordon, P.H., Miller, R.G., Moore, D.H., ALSFRS-R (2004) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 5, pp. 90-93; Hare, D.J., Gerlach, M., Riederer, P., Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients (2012) J. Neural Transm., 119, pp. 1515-1521; Heitland, P., Koster, H.D., Biomonitoring of 37 trace elements in blood samples from inhabitants of northern Germany by ICP-MS (2006) J. Trace Elem. Med. Biol., 20, pp. 253-262; Ingre, C., Roos, P.M., Piehl, F., Kamel, F., Fang, F., Risk factors for amyotrophic lateral sclerosis (2015) Clin. Epidemiol., 7, pp. 181-193; Jain, R.B., Choi, Y.S., Normal reference ranges for and variability in the levels of blood manganese and selenium by gender, age, and race/ethnicity for general U.S. population (2014) J. Trace Elements Med. Biol., 30, pp. 142-152; Jellinger, K.A., The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations (2013) Int. Rev. Neurobiol., 110, pp. 1-47; Kamel, F., Umbach, D.M., Hu, H., Munsat, T.L., Shefner, J.M., Taylor, J.A., Lead exposure as a risk factor for amyotrophic lateral sclerosis (2005) Neurodegen. Dis., 2, pp. 195-201; Kapaki, E., Zournas, C., Kanias, G., Zambelis, T., Kakami, A., Papageorgiou, C., Essential trace element alterations in amyotrophic lateral sclerosis (1997) J. Neurol. Sci., 147, pp. 171-175; Kihira, T., Mukoyama, M., Ando, K., Yase, Y., Yasui, M., Determination of manganese concentrations in the spinal cords from amyotrophic lateral sclerosis patients by inductively coupled plasma emission spectroscopy (1990) J. Neurol. Sci., 98, pp. 251-258; Kilness, A.W., Hichberg, F.H., Amyotrophic lateral sclerosis in a high selenium environment (1977) JAMA, 237, pp. 2843-2844; Kurlander, H.M., Patten, B.M., Metals in spinal cord tissue of patients dying of motor neuron disease (1979) Ann. Neurol., 6, pp. 21-24; Martinez-Finley, E.J., Gavin, C.E., Aschner, M., Gunter, T.E., Manganese neurotoxicity and the role of reactive oxygen species (2013) Free Radicals Biol. Med., 62, pp. 65-75; Mitchell, J.D., East, B.W., Harris, I.A., Pentland, B., Manganese, selenium and other trace elements in spinal cord: liver and bone in motor neurone disease (1991) Eur. Neurol., 31, pp. 7-11; Miyata, S., Nakamura, S., Nagata, H., Kameyama, M., Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis (1983) J. Neurol. Sci., 61, pp. 283-293; Nagata, H., Miyata, S., Nakamura, S., Kameyama, M., Katsui, Y., Heavy metal concentrations in blood cells in patients with amyotrophic lateral sclerosis (1985) J. Neurol. Sci., 67, pp. 173-178; Navarro-Alarcon, M., Cabrera-Vique, C., Selenium in food and the human body: a review (2008) Sci. Total Environ., 400, pp. 115-141; Pamphlett, R., McQuilty, R., Zarkos, K., Blood levels of toxic and essential metals in motor neuron disease (2001) Neurotoxicology, 22, pp. 401-410; Pierce-Ruhland, R., Patten, B.M., Muscle metals in motor neuron disease (1980) Ann. Neurol., 8, pp. 193-195; Prasad, A.S., Zinc is an antioxidant and anti-inflammatory agent: its role in human health (2014) Front. Nutr., 1, p. 14; Rivera-Mancia, S., Perez-Neri, I., Rios, C., Tristan-Lopez, L., Rivera-Espinosa, L., Montes, S., The transition metals copper and iron in neurodegenerative diseases (2010) Chem. Biol. Interact., 186, pp. 184-199; Roos, P.M., Vesterberg, O., Syversen, T., Flaten, T.P., Nordberg, M., Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis (2013) Biol. Trace Elem. Res., 151, pp. 159-170; Rosborg, I., Hyllen, E., Lidbeck, J., Nihlgard, B., Gerhardsson, L., Trace element pattern in patients with fibromyalgia (2007) Sci. Total Environ., 385, pp. 20-27; Rothman, K.J., Greenland, S., Lash, T.L., Case-control studies (2008) Modern Epidemiology, pp. 111-127. , Lippincott Williams and Wilkins, Pennsylvania, K.J. Rothman, S. Greenland, T.L. Lash (Eds.); Schmidt, S., Allen, K.D., Loiacono, V.T., Norman, B., Stanwyck, C.L., Nord, K.M., Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study Rationale, study design and demographic characteristics (2008) Neuroepidemiology, 30, pp. 191-204; Schrag, M., Mueller, C., Oyoyo, U., Smith, M.A., Kirsch, W.M., Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion (2011) Prog. Neurobiol., 94, pp. 296-306; Steinbrenner, H., Sies, H., Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system (2013) Arch. Biochem. Biophys., 536, pp. 152-157; Sutedja, N.A., Veldink, J.H., Fischer, K., Kromhout, H., Heederik, D., Huisman, M.H., Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review (2009) Amyotroph. Lateral Scler., 10, pp. 302-309; Trumbull, K.A., Beckman, J.S., A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis (2009) Antioxid. Redox Signal., 11, pp. 1627-1639; Vinceti, M., Bonvicini, F., Rothman, K.J., Vescovi, L., Wang, F., The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study (2010) Environ. Health, 9, p. 77; Vonk, W.I., Klomp, L.W., Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis (2008) Biochem. Soc. Trans., 36, pp. 1322-1328; Wijesekera, L.C., Leigh, P.N., Amyotrophic lateral sclerosis (2009) Orphanet J. Rare Dis., 4, p. 3},
correspondence_address1={Kamel, F.; Epidemiology Branch, PO Box 12233, MD A3-05, United States; email: kamel@niehs.nih.gov},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={27085208},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Leonenko2019456,
author={Leonenko, G. and Sims, R. and Shoai, M. and Frizzati, A. and Bossù, P. and Spalletta, G. and Fox, N.C. and Williams, J. and Hardy, J. and Escott-Price, V. and the GERAD consortium},
title={Polygenic risk and hazard scores for Alzheimer's disease prediction},
journal={Annals of Clinical and Translational Neurology},
year={2019},
volume={6},
number={3},
pages={456-465},
doi={10.1002/acn3.716},
note={cited By 36},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062875050&doi=10.1002%2facn3.716&partnerID=40&md5=104c13e08e1b84aa7239ef18aa2ed865},
affiliation={MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom; Institute of Neurology, University College London, London, United Kingdom; Department of Clinical and Behavioral Neurology, Experimental Neuropsychobiology Laboratory, IRCCS Santa Lucia Foundation, Rome, Italy; UK Dementia Research Institute, Cardiff University, Cardiff, United Kingdom},
abstract={Objective: Genome-wide association studies (GWAS) have identified over 30 susceptibility loci associated with Alzheimer's disease (AD). Using AD GWAS data from the International Genomics of Alzheimer's Project (IGAP), Polygenic Risk Score (PRS) was successfully applied to predict life time risk of AD development. A recently introduced Polygenic Hazard Score (PHS) is able to quantify individuals with age-specific genetic risk for AD. The aim of this study was to quantify the age-specific genetic risk for AD with PRS and compare the results generated by PRS with those from PHS. Methods: Quantification of individual differences in age-specific genetic risk for AD identified by the PRS, was performed with Cox Regression on 9903 (2626 cases and 7277 controls) individuals from the Genetic and Environmental Risk in Alzheimer's Disease consortium (GERAD). Polygenic Hazard Scores were generated for the same individuals. The age-specific genetic risk for AD identified by the PRS was compared with that generated by the PHS. This was repeated using varying SNPs P-value thresholds for disease association. Results: Polygenic Risk Score significantly predicted the risk associated with age at AD onset when SNPs were preselected for association to AD at P ≤ 0.001. The strongest effect (B = 0.28, SE = 0.04, P = 2.5 × 10−12) was observed for PRS based upon genome-wide significant SNPs (P ≤ 5 × 10−8). The strength of association was weaker with less stringent SNP selection thresholds. Interpretation: Both PRS and PHS can be used to predict an age-specific risk for developing AD. The PHS approach uses SNP effect sizes derived with the Cox Proportional Hazard Regression model. When SNPs were selected based upon AD GWAS case/control P ≤ 10−3, we found no advantage of using SNP effects sizes calculated with the Cox Proportional Hazard Regression model in our study. When SNPs are selected for association with AD risk at P &gt; 10−3, the age-specific risk prediction results are not significant for either PRS or PHS. However PHS could be more advantageous than PRS of age specific AD risk predictions when SNPs are prioritized for association with AD age at onset (i.e., powerful Cox Regression GWAS study). © 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.},
keywords={Alzheimer disease;  Article;  disease association;  genetic risk;  genetic variability;  genome-wide association study;  genotype;  human;  Polygenic Hazard Score;  prediction;  priority journal;  proportional hazards model;  sample size;  scoring system;  single nucleotide polymorphism;  survival analysis},
funding_details={EU Joint Programme – Neurodegenerative Disease ResearchEU Joint Programme – Neurodegenerative Disease Research, JPND},
funding_details={Medical Research CouncilMedical Research Council, G0300429, G0600237, G0801418, G9810900, MC_PC_17112, MR/K013041/1, MR/L010305/1, MR/L023784/1, MR/L023784/2, MR/M009076/1, UKDRIdata023},
funding_text 1={This work was supported by JPND 505472 Medical Research Council MR/L010305/1; MR/L023784/2; UKDRIdata023.},
references={Sloane, P.D., Zimmerman, S., Suchindran, C., The Public Health Impact of Alzheimer's Disease, 2000–2050: potential Implication of Treatment Advances [Internet] (2002) Annu Rev Public Health, 23, pp. 213-231; Prince, M., Wimo, A., Guerchet, M., World Alzheimer Report 2015: the Global Impact of Dementia - An analysis of prevalence, incidence, cost and trends (2015) Alzheimer's Dis Int, 84, p. 425; Gatz, M., Reynolds, C.A., Fratiglioni, L., Role of genes and environments for explaining Alzheimer disease (2006) Arch Gen Psychiatry, 63, pp. 168-174; Farrer, L.A., Cupples, L.A., Haines, J.L., Effects of age, sex, and ethnicity on the association between apolipoprotein E Genotype and Alzheimer Disease: a Meta-analysis (1997) JAMA J Am Med Assoc, 278, pp. 1349-1356; Corder, E.H., Saunders, A.M., Strittmatter, W.J., Gene Dose of Apolipoprotein-E Type-4 Allele and the Risk of Alzheimers-Disease in Late-Onset Families (1993) Science, 261, pp. 921-923; Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) Nat Genet, 45, pp. 1452-1458; Jones, L., Lambert, J.C., Wang, L.S., Convergent genetic and expression data implicate immunity in Alzheimer's disease (2015) Alzheimer's Dement, 11, pp. 658-671; Escott-Price, V., Sims, R., Bannister, C., Common polygenic variation enhances risk prediction for Alzheimer's disease (2015) Brain, 138, pp. 3673-3684; Escott-Price, V., Myers, A.J., Huentelman, M., Hardy, J., Polygenic risk score analysis of pathologically confirmed Alzheimer disease (2017) Ann Neurol, 82, pp. 311-314; Desikan, R.S., Fan, C.C., Wang, Y., Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score (2017) PLoS Med, 14; Cox, D.R., Regression models and life tables (1972) J R Stat Soc Ser B, 34, pp. 187-220; Ingram, D.D., Kleinman, J.C., Empirical comparisons of proportional hazards and logistic regression models (1989) Stat Med, 8, pp. 525-538; Staley, J.R., Jones, E., Kaptoge, S., A comparison of Cox and logistic regression for use in genome-wide association studies of cohort and case-cohort design (2017) Eur J Hum Genet, 25, pp. 854-862; Moriguchi, S., Hayashi, Y., Nose, Y., A comparison of the logistic regression and the Cox proportional hazard models in retrospective studies on the prognosis of patients with gastric cancer (1993) J Surg Oncol, 52, pp. 9-13; Hashemian, A.H., Garshasbi, M., Pourhoseingholi, M.A., Eskandari, S., A comparative study of cox regression vs. log-logistic regression (with and without its frailty) in estimating survival time of patients with colorectal cancer (2017) J Med Biomed Sci, 6, pp. 35-43; Annesi, I., Moreau, T., Lellouch, J., Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies (1989) Stat Med, 8, pp. 1515-1521; Moghimi-Dehkordi, B., Safaee, A., Tabei, S.Z., A comparison between Cox proportional hazard models and logistic regression on prognostic factors in gastric cancer (2009) East Afr J Public Health, 6, pp. 20-22; Tan, C.H., Desikan, R.S., Interpreting Alzheimer disease polygenic scores (2018) Ann Neurol, 83, pp. 443-445; Purcell, S.M., Wray, N.R., Stone, J.L., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder (2009) Nature, 10 (AuGuST), p. 8192; Harold, D., Abraham, R., Hollingworth, P., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) Nat Genet, 41, pp. 1088-1093; McCarthy, S., Das, S., Kretzschmar, W., (2015) A reference panel of 64,976 haplotypes for genotype imputation [Internet], , http://biorxiv.org/content/early/2015/12/23/035170.abstract, Available from; Tan, C.H., Fan, C.C., Mormino, E.C., Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition (2018) Acta Neuropathol, 135, pp. 85-93},
correspondence_address1={Escott-Price, V.; MRC Centre for Neuropsychiatric Genetics and Genomics, United Kingdom; email: escottpricev@cardiff.ac.uk},
publisher={Wiley-Blackwell},
issn={23289503},
language={English},
abbrev_source_title={Ann. Clin. Transl. Neurol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Mentis2017606,
author={Mentis, A.-F.A. and Dardiotis, E. and Grigoriadis, N. and Petinaki, E. and Hadjigeorgiou, G.M.},
title={Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation},
journal={Acta Neurologica Scandinavica},
year={2017},
volume={136},
number={6},
pages={606-616},
doi={10.1111/ane.12775},
note={cited By 36},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019631105&doi=10.1111%2fane.12775&partnerID=40&md5=7ae76021dedaa3cb9e1477cb51d710db},
affiliation={Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; The Johns Hopkins University, AAP, Baltimore, MD, United States; Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Laboratory of Experimental Neurology and Neuroimmunology, B’ Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece},
abstract={Multiple sclerosis is an immune-mediated disease with an environmental component. According to a long-standing but unproven hypothesis dating to initial descriptions of multiple sclerosis (MS) at the end of the 19th century, viruses are either directly or indirectly implicated in MS pathogenesis. Whether viruses in MS are principally causal or simply contributory remains to be proven, but many viruses or viral elements—predominantly Epstein-Barr virus, human endogenous retroviruses (HERVs) and human herpesvirus 6 (HHV-6) but also less common viruses such as Saffold and measles viruses—are associated with MS. Here, we present an up-to-date and comprehensive review of the main candidate viruses implicated in MS pathogenesis and summarize how these viruses might cause or lead to the hallmark demyelinating and inflammatory lesions of MS. We review data from epidemiological, animal and in vitro studies and in doing so offer a transdisciplinary approach to the topic. We argue that it is crucially important not to interpret “absence of evidence” as “evidence of absence” and that future studies need to focus on distinguishing correlative from causative associations. Progress in the MS-virus field is expected to arise from an increasing body of knowledge on the interplay between viruses and HERVs in MS. Such interactions suggest common HERV-mediated pathways downstream of viral infection that cause both neuroinflammation and neurodegeneration. We also comment on the limitations of existing studies and provide future research directions for the field. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd},
author_keywords={Epstein-Barr virus;  human endogenous retroviruses;  human herpesvirus 6;  multiple sclerosis;  viruses},
keywords={Coronaviridae;  Cytomegalovirus;  endogenous retrovirus;  Epstein Barr virus;  futurology;  human;  Human immunodeficiency virus;  Lymphocytic choriomeningitis virus;  Measles virus;  meta analysis (topic);  Morbillivirus;  multiple sclerosis;  nonhuman;  Review;  systematic review (topic);  Varicella zoster virus;  virus;  animal;  complication;  endogenous retrovirus;  multiple sclerosis;  virology;  virus infection, Animals;  Endogenous Retroviruses;  Humans;  Multiple Sclerosis;  Virus Diseases},
funding_details={Alexander S. Onassis Public Benefit FoundationAlexander S. Onassis Public Benefit Foundation},
funding_text 1={A.-F.A.M. has been supported through an educational scholarship from the Onassis Public Benefit Foundation. The latter played no role in the design of the study, collection and/or interpretation of data, or writing of the review article.},
references={Procaccini, C., de Rosa, V., Pucino, V., Formisano, L., Matarese, G., Animal models of multiple sclerosis (2015) Eur J Pharmacol, 759, pp. 182-191; Tselis, A., Evidence for viral etiology of multiple sclerosis (2011) Semin Neurol, 31, pp. 307-316; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P.A., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Dendrou, C.A., Fugger, L., Friese, M.A., Immunopathology of multiple sclerosis (2015) Nat Rev Immunol, 15, pp. 545-558; Grigoriadis, N., van Pesch, V., Paradig, M.S.G., A basic overview of multiple sclerosis immunopathology (2015) Eur J Neurol, 22, pp. 3-13; Brodin, P., Jojic, V., Gao, T., Variation in the human immune system is largely driven by non-heritable influences (2015) Cell, 160, pp. 37-47; Olsson, T., Barcellos, L.F., Alfredsson, L., Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis (2017) Nat Rev Neurol, 13, pp. 25-36; Baranzini, S.E., Mudge, J., van Velkinburgh, J.C., Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis (2010) Nature, 464, pp. 1351-1356; Sotelo, J., Corona, T., Varicella zoster virus and relapsing remitting multiple sclerosis (2011) Mult Scler Int, 2011, p. 214763; Hohlfeld, R., Dornmair, K., Meinl, E., Wekerle, H., The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research (2016) Lancet Neurol, 15, pp. 317-331; Behan, P.O., Chaudhuri, A., EAE is not a useful model for demyelinating disease (2014) Mult Scler Relat Disord, 3, pp. 565-574; Brandle, S.M., Obermeier, B., Senel, M., Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins (2016) Proc Natl Acad Sci U S A, 113, pp. 7864-7869; Venkatesan, A., Johnson, R.T., Infections and multiple sclerosis (2014) Handb Clin Neurol, 122, pp. 151-171; Brown, C., Aetiology: neighbourhood watch (2016) Nature, 540, pp. S4-S6; Brettschneider, J., Tumani, H., Kiechle, U., IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome (2009) PLoS One, 4; Grigoriadis, N., Hadjigeorgiou, G.M., Virus-mediated autoimmunity in multiple sclerosis (2006) J Autoimmune Dis, 3, p. 1; Galama, J.M., Zoll, J.G., Lanke, K.H., Saffold cardiovirus and multiple sclerosis: no evidence for an association (2014) Ann Clin Transl Neurol, 1, pp. 618-621; Lamberto, I., Gunst, K., Muller, H., Zur Hausen, H., De Villiers, E.M., Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients (2014) Genome Announc, 2, pp. e00814-e00848. , pii; Pakpoor, J., Ramagopalan, S.V., Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: yes (2013) Mult Scler, 19, pp. 1690-1691; Salzer, J., Myhr, K.M., Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no (2013) Mult Scler, 19, pp. 1692-1693; ‘t Hart, B.A., Gran, B., Weissert, R., EAE: imperfect but useful models of multiple sclerosis (2011) Trends Mol Med, 17, pp. 119-125; Fernandez-Menendez, S., Fernandez-Moran, M., Fernandez-Vega, I., Perez-Alvarez, A., Villafani-Echazu, J., Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies (2016) J Neurol Sci, 361, pp. 213-219; Lassmann, H., Niedobitek, G., Aloisi, F., Middeldorp, J.M., Neuropromise, E.B.V.W.G., Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria (2011) Brain, 134, pp. 2772-2786; Pakpoor, J., Giovannoni, G., Ramagopalan, S.V., Epstein-Barr virus and multiple sclerosis: association or causation? (2013) Expert Rev Neurother, 13, pp. 287-297; Mckay, K.A., Jahanfar, S., Duggan, T., Tkachuk, S., Tremlett, H., Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review (2016) Neurotoxicology, , [Epub ahead of print]; McKay, K.A., Kwan, V., Duggan, T., Tremlett, H., Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review (2015) Biomed Res Int, 2015, p. 817238; Almohmeed, Y.H., Avenell, A., Aucott, L., Vickers, M.A., Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis (2013) PLoS One, 8; Hwang, A.E., Hamilton, A.S., Cockburn, M.G., Evidence of genetic susceptibility to infectious mononucleosis: a twin study (2012) Epidemiol Infect, 140, pp. 2089-2095; Wergeland, S., Myhr, K.M., Loken-Amsrud, K.I., Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients (2016) Eur J Neurol, 23, pp. 1064-1070; Tschochner, M., Leary, S., Cooper, D., Identifying patient-specific Epstein-Barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis (2016) PLoS One, 11; Xiao, D., Ye, X., Zhang, N., A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis (2015) Sci Rep, 5, p. 18083; Salzer, J., Nystrom, M., Hallmans, G., Stenlund, H., Wadell, G., Sundstrom, P., Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples (2013) Mult Scler, 19, pp. 1587-1591; Tao, C., Simpson, S., Jr., Taylor, B.V., van der Mei, I., Association between human herpesvirus & human endogenous retrovirus and MS onset & progression (2017) J Neurol Sci, 372, pp. 239-249; Salzer, J., Stenlund, H., Sundstrom, P., The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age (2014) Mult Scler, 20, pp. 747-750; Bjornevik, K., Riise, T., Bostrom, I., Negative interaction between smoking and EBV in the risk of multiple sclerosis: the EnvIMS study (2016) Mult Scler, , [Epub ahead of print]; Munger, K.L., Levin, L.I., O'Reilly, E.J., Falk, K.I., Ascherio, A., Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel (2011) Mult Scler, 17, pp. 1185-1193; Nejati, A., Shoja, Z., Shahmahmoodi, S., EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature (2016) Med Microbiol Immunol, 205, pp. 143-154; Ricigliano, V.A., Handel, A.E., Sandve, G.K., EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy (2015) PLoS One, 10; Latham, L.B., Lee, M.J., Lincoln, J.A., Ji, N., Forsthuber, T.G., Lindsey, J.W., Antivirus immune activity in multiple sclerosis correlates with MRI activity (2016) Acta Neurol Scand, 133, pp. 17-24; Kvistad, S., Myhr, K.M., Holmoy, T., Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis (2014) Mult Scler, 20, pp. 1833-1840; Angelini, D.F., Serafini, B., Piras, E., Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis (2013) PLoS Pathog, 9; Lossius, A., Johansen, J.N., Vartdal, F., High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells (2014) Eur J Immunol, 44, pp. 3439-3452; Jagessar, S.A., Holtman, I.R., Hofman, S., Lymphocryptovirus infection of nonhuman primate B cells converts destructive into productive processing of the pathogenic CD8 T cell epitope in myelin oligodendrocyte glycoprotein (2016) J Immunol, 197, pp. 1074-1088; Pender, M.P., Burrows, S.R., Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy (2014) Clin Transl Immunology, 3; Kakalacheva, K., Regenass, S., Wiesmayr, S., Infectious mononucleosis triggers generation of IgG auto-antibodies against native myelin oligodendrocyte glycoprotein (2016) Viruses, 8, p. E51; Magliozzi, R., Serafini, B., Rosicarelli, B., B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis (2013) J Neuropathol Exp Neurol, 72, pp. 29-41; Thart, B.A., Kap, Y.S., Morandi, E., Laman, J.D., Gran, B., EBV infection and multiple sclerosis: lessons from a marmoset model (2016) Trends Mol Med, 22, pp. 1012-1024; Lodato, M.A., Woodworth, M.B., Lee, S., Somatic mutation in single human neurons tracks developmental and transcriptional history (2015) Science, 350, pp. 94-98; Santon, A., Cristóbal, E., Aparicio, M., Royuela, A., Villar, L.M., Alvarez-Cermeño, J.C., High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis (2011) Mult Scler, 17, pp. 1295-1300; Owens, G.P., Bennett, J.L., Trigger, pathogen, or bystander: the complex nexus linking Epstein-Barr virus and multiple sclerosis (2012) Mult Scler, 18, pp. 1204-1208; Casiraghi, C., Marquez, A.C., Shanina, I., Horwitz, M.S., Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis (2015) Sci Rep, 5, p. 13995; Hecker, M., Fitzner, B., Wendt, M., High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients (2016) Mol Cell Proteomics, 15, pp. 1360-1380; Sugden, B., Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen (2014) PLoS Biol, 12; Khankhanian, P., Cozen, W., Himmelstein, D.S., Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis (2016) Int J Epidemiol, 45, pp. 728-740; Jha, H.C., Mehta, D., Lu, J., Gammaherpesvirus infection of human neuronal cells (2015) MBio, 6, pp. e01815-e01844; Zhou, Y., Zhu, G., Charlesworth, J.C., Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis (2016) Mult Scler, 22, pp. 1655-1664; Leibovitch, E.C., Jacobson, S., Evidence linking HHV-6 with multiple sclerosis: an update (2014) Curr Opin Virol, 9, pp. 127-133; Álvarez-Lafuente, R., García-Montojo, M., Heras, V.D.L., Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients (2008) Mult Scler, 14, pp. 595-601; Simpson, S., Jr., Taylor, B., Burrows, J., EBV & HHV6 reactivation is infrequent and not associated with MS clinical course (2014) Acta Neurol Scand, 130, pp. 328-337; Garcia-Montojo, M., Martinez, A., De Las Heras, V., Herpesvirus active replication in multiple sclerosis: a genetic control? (2011) J Neurol Sci, 311, pp. 98-102; Tai, A.K., Luka, J., Ablashi, D., Huber, B.T., HHV-6A infection induces expression of HERV-K18-encoded superantigen (2009) J Clin Virol, 46, pp. 47-48; Curtin, F., Perron, H., Faucard, R., Porchet, H., Lang, A.B., Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis (2015) Mol Diagn Ther, 19, pp. 255-265; Leibovitch, E., Wohler, J.E., Cummings Macri, S.M., Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization (2013) PLoS Pathog, 9; Harberts, E., Yao, K., Wohler, J.E., Human herpesvirus-6 entry into the central nervous system through the olfactory pathway (2011) Proc Natl Acad Sci U S A, 108, pp. 13734-13739; Broccolo, F., Fusetti, L., Ceccherini-Nelli, L., Possible role of human herpesvirus 6 as a trigger of autoimmune disease (2013) ScientificWorldJournal, 2013, p. 867389; Shao, Q., Lin, Z., Wu, X., Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte (2016) Oncotarget, 7, pp. 48070-48080; Berth, S., Carbunar, O., Yang, N.S., Fredericks, B., Lipton, H.L., Valyi-Nagy, T., Varicella-zoster virus encephalomyelitis with a prominent demyelinating component (2015) Neuropathology, 35, pp. 587-591; Ahlgren, C., Toren, K., Oden, A., Andersen, O., A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk (2009) Eur J Epidemiol, 24, pp. 541-552; Rodriguez-Violante, M., Ordonez, G., Bermudez, J.R., Sotelo, J., Corona, T., Association of a history of varicella virus infection with multiple sclerosis (2009) Clin Neurol Neurosurg, 111, pp. 54-56; Kang, J.H., Sheu, J.J., Kao, S., Lin, H.C., Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study (2011) J Infect Dis, 204, pp. 188-192; Najafi, S., Ghane, M., Yousefzadeh-Chabok, S., Amiri, M., The high prevalence of the varicella zoster virus in patients with relapsing-remitting multiple sclerosis: a case-control study in the north of Iran (2016) Jundishapur J Microbiol, 9; Yoshimura, S., Isobe, N., Matsushita, T., Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients (2014) PLoS One, 9; Sotelo, J., Ordonez, G., Pineda, B., Varicella-zoster virus at relapses of multiple sclerosis (2007) J Neurol, 254, pp. 493-500; Mancuso, R., Delbue, S., Borghi, E., Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis (2007) J Med Virol, 79, pp. 192-199; Burgoon, M.P., Cohrs, R.J., Bennett, J.L., Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis (2009) Ann Neurol, 65, pp. 474-479; Hon, G.M., Erasmus, R.T., Matsha, T., Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression (2014) J Clin Neurosci, 21, pp. 1437-1440; Mancuso, R., Hernis, A., Cavarretta, R., Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis (2010) J Med Virol, 82, pp. 1051-1057; Sotelo, J., Martínez-Palomo, A., Ordoñez, G., Pineda, B., Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis (2008) Ann Neurol, 63, pp. 303-311; Sotelo, J., Ordonez, G., Pineda, B., Flores, J., The participation of varicella zoster virus in relapses of multiple sclerosis (2014) Clin Neurol Neurosurg, 119, pp. 44-48; Ordoñez, G., Martinez-Palomo, A., Corona, T., Varicella zoster virus in progressive forms of multiple sclerosis (2010) Clin Neurol Neurosurg, 112, pp. 653-657; Otto, C., Hofmann, J., Finke, C., Zimmermann, M., Ruprecht, K., The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis (2014) Fluids Barriers CNS, 11, p. 3; Sotelo, J., On the viral hypothesis of multiple sclerosis: participation of varicella-zoster virus (2007) J Neurol Sci, 262, pp. 113-116; Torkildsen, O., Power, O., Storstein, A., Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis (2016) BMJ Case Rep, 2016; Brudek, T., Luhdorf, P., Christensen, T., Hansen, H.J., Moller-Larsen, A., Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV (2007) J Neuroimmunol, 187, pp. 147-155; Nissen, K.K., Laska, M.J., Hansen, B., Endogenous retroviruses and multiple sclerosis-new pieces to the puzzle (2013) BMC Neurol, 13, p. 111; Varade, J., Garcia-Montojo, M., de la Hera, B., Multiple sclerosis retrovirus-like envelope gene: role of the chromosome 20 insertion (2015) BBA Clin, 3, pp. 162-167; Dolei, A., Perron, H., The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease (2009) J Neurovirol, 15, pp. 4-13; Suntsova, M., Garazha, A., Ivanova, A., Kaminsky, D., Zhavoronkov, A., Buzdin, A., Molecular functions of human endogenous retroviruses in health and disease (2015) Cell Mol Life Sci, 72, pp. 3653-3675; Brutting, C., Emmer, A., Kornhuber, M., Staege, M.S., A survey of endogenous retrovirus (ERV) sequences in the vicinity of multiple sclerosis (MS)-associated single nucleotide polymorphisms (SNPs) (2016) Mol Biol Rep, 43, pp. 827-836; Nexo, B.A., Christensen, T., Frederiksen, J., The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1 (2011) PLoS One, 6; de la Hera, B., Varade, J., Garcia-Montojo, M., Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis (2014) PLoS One, 9; Brodziak, A., Ziółko, E., Muc-Wierzgoń, M., Nowakowska-Zajdel, E., Kokot, T., Klakla, K., Endogenous retroviruses_Auto-immune disease (2012) Med Sci Monit, 18, pp. RA80-RA88; Chuong, E.B., Elde, N.C., Feschotte, C., Regulatory evolution of innate immunity through co-option of endogenous retroviruses (2016) Science, 351, pp. 1083-1087; Morandi, E., Tarlinton, R.E., Gran, B., Multiple sclerosis between genetics and infections: human endogenous retroviruses in monocytes and macrophages (2015) Front Immunol, 6, p. 647; van Horssen, J., van der Pol, S., Nijland, P., Amor, S., Perron, H., Human endogenous retrovirus W in brain lesions: rationale for targeted therapy in multiple sclerosis (2016) Mult Scler Relat Disord, 8, pp. 11-18; Perron, H., Germi, R., Bernard, C., Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease (2012) Mult Scler, 18, pp. 1721-1736; Antony, J.M., Izad, M., Bar-Or, A., Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases (2006) AIDS Res Hum Retroviruses, 22, pp. 1253-1259; Brudek, T., Christensen, T., Aagaard, L., Petersen, T., Hansen, H.J., Moller-Larsen, A., B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity (2009) Retrovirology, 6, p. 104; Duperray, A., Barbe, D., Raguenez, G., Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4 (2015) Int Immunol, 27, pp. 545-553; Madeira, A., Burgelin, I., Perron, H., Curtin, F., Lang, A.B., Faucard, R., MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: relevance of GNbAC1 in multiple sclerosis treatment (2016) J Neuroimmunol, 291, pp. 29-38; Antony, J., Ellestad, K.K., Hammond, R., The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis (2007) J Immunol, 179, pp. 1210-1224; Perron, H., Dougier-Reynaud, H.L., Lomparski, C., Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice (2013) PLoS One, 8; Li, F., Nellaker, C., Sabunciyan, S., Transcriptional derepression of the ERVWE1 locus following influenza A virus infection (2014) J Virol, 88, pp. 4328-4337; Mameli, G., Poddighe, L., Mei, A., Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis (2012) PLoS One, 7; Mavragani, C.P., Sagalovskiy, I., Guo, Q., Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease (2016) Arthritis Rheumatol, 68, pp. 2686-2696; Schmitt, K., Richter, C., Backes, C., Meese, E., Ruprecht, K., Mayer, J., Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing (2013) J Virol, 87, pp. 13837-13852; Laufer, G., Mayer, J., Mueller, B.F., Mueller-Lantzsch, N., Ruprecht, K., Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences (2009) Retrovirology, 6, p. 37; Moyes, D.L., Goris, A., Ban, M., HERV-K113 is not associated with multiple sclerosis in a large family-based study (2008) AIDS Res Hum Retroviruses, 24, pp. 363-365; Do Olival, G.S., Faria, T.S., Nali, L.H., Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen (2013) Front Microbiol, 4, p. 172; Uleri, E., Mei, A., Mameli, G., Poddighe, L., Serra, C., Dolei, A., HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS (2014) AIDS, 28, pp. 2659-2670; Christensen, T., Human endogenous retroviruses in neurologic disease (2016) APMIS, 124, pp. 116-126; Chin, J.H., Multiple sclerosis and HIV-1 infection: case report of a HIV controller (2015) J Neurovirol, 21, pp. 464-467; Delgado, S.R., Maldonado, J., Rammohan, K.W., CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review (2014) J Neurovirol, 20, pp. 531-537; Gold, J., Goldacre, R., Maruszak, H., Giovannoni, G., Yeates, D., Goldacre, M., HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study (2015) J Neurol Neurosurg Psychiatry, 86, pp. 9-12; Kop, M.L.V.D., Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis? (2015) Neurol Neurosurg Psychiatry, 86, p. 3; Vanheusden, M., Stinissen, P., Stinissen, P., ‘t Hart, B.A., Hellings, N., Cytomegalovirus: a culprit or protector in multiple sclerosis? (2015) Trends Mol Med, 21, pp. 16-23; Pakpoor, J., Pakpoor, J., Disanto, G., Giovannoni, G., Ramagopalan, S.V., Cytomegalovirus and multiple sclerosis risk (2013) J Neurol, 260, pp. 1658-1660; Sundqvist, E., Bergstrom, T., Daialhosein, H., Cytomegalovirus seropositivity is negatively associated with multiple sclerosis (2014) Mult Scler, 20, pp. 165-173; Wunsch, M., Hohmann, C., Milles, B., The correlation between the virus- and brain antigen-specific B cell response in the blood of patients with multiple sclerosis (2016) Viruses, 8, p. 105; Zivadinov, R., Nasuelli, D., Tommasi, M.A., Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients (2006) Neurol Res, 28, pp. 262-269; Martinez-Rodriguez, J.E., Cobo-Calvo, A., Villar, L.M., Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis (2016) Mult Scler, 22, pp. 741-752; Pirko, I., Cardin, R., Chen, Y., CMV infection attenuates the disease course in a murine model of multiple sclerosis (2012) PLoS One, 7; Ahlgren, C., Oden, A., Toren, K., Andersen, O., Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations (2009) Acta Neurol Scand, 119, pp. 313-320; Sips, G.J., Chesik, D., Glazenburg, L., Wilschut, J., de Keyser, J., Wilczak, N., Involvement of morbilliviruses in the pathogenesis of demyelinating disease (2007) Rev Med Virol, 17, pp. 223-244; Jarius, S., Eichhorn, P., Franciotta, D., The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature (2016) J Neurol, 264, pp. 453-466; Pohl, D., Rostasy, K., Jacobi, C., Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis (2010) J Neurol, 257, pp. 212-216; Rosche, B., Laurent, S., Conradi, S., Hofmann, J., Ruprecht, K., Harms, L., Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis (2012) PLoS One, 7; Ahlgren, C., Oden, A., Bergstrom, T., Lycke, J., Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome (2012) J Neuroimmunol, 247, pp. 70-74; Beineke, A., Puff, C., Seehusen, F., Baumgartner, W., Pathogenesis and immunopathology of systemic and nervous canine distemper (2009) Vet Immunol Immunopathol, 127, pp. 1-18; Lempp, C., Spitzbarth, I., Puff, C., New aspects of the pathogenesis of canine distemper leukoencephalitis (2014) Viruses, 6, pp. 2571-2601; Wilson, M.R., Peters, C.J., Diseases of the central nervous system caused by lymphocytic choriomeningitis virus and other arenaviruses (2014) Handb Clin Neurol, 123, pp. 671-681; Hogeboom, C., Peptide motif analysis predicts lymphocytic choriomeningitis virus as trigger for multiple sclerosis (2015) Mol Immunol, 67, pp. 625-635; Shenghua, Z., Halle, A., Kurt-Jones, E.A., Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses (2008) J Neuroimmunol, 194, pp. 70-82; Matullo, C.M., O'Regan, K.J., Curtis, M., Rall, G.F., CNS recruitment of CD8+ T lymphocytes specific for a peripheral virus infection triggers neuropathogenesis during polymicrobial challenge (2011) PLoS Pathog, 7; Bleau, C., Filliol, A., Samson, M., Lamontagne, L., Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells (2015) J Virol, 89, pp. 9896-9908; Desforges, M., le Coupanec, A., Brison, E., Meessen-Pinard, M., Talbot, P.J., Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans (2014) Adv Exp Med Biol, 807, pp. 75-96; Savarin, C., Bergmann, C.C., Gaignage, M., Stohlman, S.A., Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery (2015) J Neuroinflammation, 12, p. 207; Chiu, C.Y., Greninger, A.L., Kanada, K., Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections (2008) Proc Natl Acad Sci U S A, 105, pp. 14124-14129; Zoll, J., ErkensHulshof, S., Lanke, K., Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life (2009) PLoS Pathog, 5; Voumvourakis, K.I., Kitsos, D.K., Tsiodras, S., Petrikkos, G., Stamboulis, E., Human herpesvirus 6 infection as a trigger of multiple sclerosis (2010) Mayo Clin Proc, 85, pp. 1023-1030; Simmonds, P., Adams, M.J., Benko, M., Consensus statement: virus taxonomy in the age of metagenomics (2017) Nat Rev Micro, 15, pp. 161-168; Lieberman, P.M., Epigenetics and genetics of viral latency (2016) Cell Host Microbe, 19, pp. 619-628; Dooley, M.M., de Gannes, S.L., Fu, K.A., Lindsey, J.W., The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins (2016) J Neuroimmunol, 299, pp. 147-151; Ruprecht, K., Obojes, K., Wengel, V., Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis (2006) J Neurovirol, 12, pp. 65-71; Nexo, B.A., Jensen, S.B., Nissen, K.K., Hansen, B., Laska, M.J., Two endogenous retroviral loci appear to contribute to multiple sclerosis (2016) BMC Neurol, 16, p. 57; Perron, H., Lang, A., The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation (2010) Clin Rev Allergy Immunol, 39, pp. 51-61; Tai, A.K., O'Reilly, E.J., Alroy, K.A., Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis (2008) Mult Scler, 14, pp. 1175-1180},
correspondence_address1={Mentis, A.-F.A.; Department of Microbiology, Greece; email: amentis1@jhu.edu},
publisher={Blackwell Publishing Ltd},
issn={00016314},
coden={ANRSA},
pubmed_id={28542724},
language={English},
abbrev_source_title={Acta Neurol. Scand.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Dardiotis2017190,
author={Dardiotis, E. and Arseniou, S. and Sokratous, M. and Tsouris, Z. and Siokas, V. and Mentis, A.-F.A. and Michalopoulou, A. and Andravizou, A. and Dastamani, M. and Paterakis, K. and Bogdanos, D. and Brotis, A.},
title={Vitamin B12, folate, and homocysteine levels and multiple sclerosis: A meta-analysis},
journal={Multiple Sclerosis and Related Disorders},
year={2017},
volume={17},
pages={190-197},
doi={10.1016/j.msard.2017.08.004},
note={cited By 35},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027858391&doi=10.1016%2fj.msard.2017.08.004&partnerID=40&md5=1d1c2745b28279c36c701319adb68dfa},
affiliation={Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Johns Hopkins University, AAP, Baltimore, MD, United States; Department of Neurosurgery, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Department of Rheumatology and Clinical Immunology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Centre for Research and Technology-Hellas (CERTH), Institute for Research and Technology-Thessaly (IRETETH), Larissa, Greece},
abstract={Background Multiple sclerosis (MS) is a demyelinating and disabling inflammatory disease of the central nervous system. Several factors contribute to MS pathogenesis including genetic-environmental interactions. Case-control studies suggest that there might be associations between MS and homocysteine (Hcy), vitamin B12, and folate blood levels. Aim To meta-analyze all available data describing associations between MS and serum or plasma Hcy, vitamin B12, and folate levels. Methods The PubMed, MEDLINE, and EMBASE databases were searched for eligible case-control studies published until June 2017. After data extraction, separate analyses using mainly random-effects models were conducted to test for associations between MS and vitamin B12, Hcy, or folate blood levels. Results Twelve, 12, and 9 studies met the inclusion criteria for meta-analysis of MS and Hcy, vitamin B12, and folate levels, respectively. The standardized mean difference (SMD) between MS patients and controls was statistically significant for Hcy (SMD: 0.70, 95% CI: 0.06, 1.34). Stratification according to clinical pattern did not reveal significant differences between relapsing-remitting MS patients and controls (SMD: 0.30, 95% CI: −0.93, 1.54) or between secondary progressive MS patients and controls (SMD: 0.12, 95% CI: −1.65, 1.90). There were no significant differences in SMD between MS patients and healthy individuals for vitamin B12 (SMD: −0.09, 95% CI: −0.29, 0.10) or folate (SMD: −0.06, 95% CI: −0.17, 0.05). Conclusion MS patients tend to have elevated Hcy blood levels compared to healthy controls. Hcy may contribute to the pathogenesis of the disease. © 2017},
author_keywords={Folic acid;  Hyperhomocysteinemia;  Multiple sclerosis;  Relapsing-remitting;  Secondary progressive multiple sclerosis;  Vitamin B 12},
keywords={cyanocobalamin;  folic acid;  homocysteine;  cyanocobalamin;  folic acid;  homocysteine, case control study;  folic acid blood level;  human;  meta analysis (topic);  multiple sclerosis;  neuropathology;  Review;  risk assessment;  vitamin blood level;  blood;  meta analysis;  multiple sclerosis, Folic Acid;  Homocysteine;  Humans;  Multiple Sclerosis;  Vitamin B 12},
chemicals_cas={cyanocobalamin, 53570-76-6, 68-19-9, 8064-09-3; folic acid, 59-30-3, 6484-89-5; homocysteine, 454-28-4, 6027-13-0; Folic Acid; Homocysteine; Vitamin B 12},
references={Aksungar, F.B., Topkaya, A.E., Yildiz, Z., Sahin, S., Turk, U., Coagulation status and biochemical and inflammatory markers in multiple sclerosis (2008) J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas., 15 (4), pp. 393-397; Allen, L.H., How common is vitamin B-12 deficiency? (2009) Am. J. Clin. Nutr., 89 (2), pp. 693s-696s; Ansari, R., Mahta, A., Mallack, E., Luo, J.J., Hyperhomocysteinemia and neurologic disorders: a review (2014) J. Clin. Neurol., 10 (4), pp. 281-288; Besler, H.T., Comoglu, S., Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis (2003) Nutr. Neurosci., 6 (3), pp. 189-196; Bonetti, F., Brombo, G., Zuliani, G., The relationship between hyperhomocysteinemia and neurodegeneration (2016) Neurodegener. Dis. Manag., 6 (2), pp. 133-145; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control. Clin. Trials, 7 (3), pp. 177-188; Fu, Y.F., Zhu, Y.N., Ni, J., Zhong, X.G., Tang, W., Re, Y.D., Shi, L.P., Zuo, J.P., A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation (2006) J. Pharmacol. Exp. Ther., 319 (2), pp. 799-808; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) Br. Med. J. (Clin. Res. Ed.), 327 (7414), pp. 557-560; Hozo, S.P., Djulbegovic, B., Hozo, I., Estimating the mean and variance from the median, range, and the size of a sample (2005) BMC Med. Res. Methodol., 5, p. 13; Kararizou, E., Paraskevas, G., Triantafyllou, N., Koutsis, G., Evangelopoulos, M.E., Mandellos, D., Sfagos, C., Kapaki, E., Plasma homocysteine levels in patients with multiple sclerosis in the Greek population (2013) J. Chin. Med. Assoc., 76 (11), pp. 611-614; Karussis, D., The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review (2014) J. Autoimmun., 48-49, pp. 134-142; Kim, J.K., Mastronardi, F.G., Wood, D.D., Lubman, D.M., Zand, R., Moscarello, M.A., Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis (2003) Mol. Cell. Proteom., 2 (7), pp. 453-462; Kira, J., Tobimatsu, S., Goto, I., Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis (1994) Intern. Med., 33 (2), pp. 82-86; Kocer, B., Engur, S., Ak, F., Yilmaz, M., Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis (2009) J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas., 16 (3), pp. 399-403; Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009) Br. Med. J. (Clinical Res. Ed.), 339; MacFarlane, A.J., Greene-Finestone, L.S., Shi, Y., Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey (2011) Am. J. Clin. Nutr., 94 (4), pp. 1079-1087; Mantel, N., Haenszel, W., Statistical aspects of the analysis of data from retrospective studies of disease (1959) J. Natl. Cancer Inst., 22 (4), pp. 719-748; Mattson, M.P., Shea, T.B., Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders (2003) Trends Neurosci., 26 (3), pp. 137-146; Moghaddasi, M., Mamarabadi, M., Mohebi, N., Razjouyan, H., Aghaei, M., Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: a case control study (2013) Clin. Neurol. Neurosurg., 115 (9), pp. 1802-1805; Najafi, M.R., Shaygannajad, V., Mirpourian, M., Gholamrezaei, A., Vitamin B(12) deficiency and multiple sclerosis; is there any association? (2012) Int. J. Prev. Med., 3 (4), pp. 286-289; Nijst, T.Q., Wevers, R.A., Schoonderwaldt, H.C., Hommes, O.R., de Haan, A.F., Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia (1990) J. Neurol., Neurosurg., Psychiatry, 53 (11), pp. 951-954; Obeid, R., McCaddon, A., Herrmann, W., The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases (2007) Clin. Chem. Lab. Med., 45 (12), pp. 1590-1606; Ramsaransing, G.S.M., Fokkema, M.R., Teelken, A., Arutjunyan, A.V., Koch, M., De Keyser, J., Plasma homocysteine levels in multiple sclerosis (2006) J. Neurol., Neurosurg., Psychiatry, 77 (2), pp. 189-192; Reynolds, E.H., Multiple sclerosis and vitamin B12 metabolism (1992) J. Neuroimmunol., 40 (2-3), pp. 225-230; Russo, C., Morabito, F., Luise, F., Piromalli, A., Battaglia, L., Vinci, A., Trapani Lombardo, V., Aguglia, U., Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis (2008) J. Neurol., 255 (1), pp. 64-69; Salemi, G., Gueli, M.C., Vitale, F., Battaglieri, F., Guglielmini, E., Ragonese, P., Trentacosti, A., Bono, A., Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients (2010) Lipids Health Dis., 9. , (19-19); Schalinske, K.L., Smazal, A.L., Homocysteine imbalance: a pathological metabolic marker (2012) Adv. Nutr., 3 (6), pp. 755-762; Sibarov, D.A., Abushik, P.A., Giniatullin, R., Antonov, S.M., GluN2A subunit-containing NMDA receptors are the preferential neuronal targets of homocysteine (2016) Front. Cell. Neurosci., 10, p. 246; Siokas, V., Dardiotis, E., Tsironi, E.E., Tsivgoulis, G., Rikos, D., Sokratous, M., Koutsias, S., Hadjigeorgiou, G.M., The role of TOR1A polymorphisms in dystonia: a systematic review and meta-analysis (2017) PLoS ONE, 12 (1), p. e0169934; Teunissen, C.E., Killestein, J., Kragt, J.J., Polman, C.H., Dijkstra, C.D., Blom, H.J., Serum homocysteine levels in relation to clinical progression in multiple sclerosis (2008) J. Neurol., Neurosurg., Psychiatry, 79 (12), pp. 1349-1353; Triantafyllou, N., Evangelopoulos, M.E., Kimiskidis, V.K., Kararizou, E., Boufidou, F., Fountoulakis, K.N., Siamouli, M., Vassilopoulos, D., Increased plasma homocysteine levels in patients with multiple sclerosis and depression (2008) Ann. General. Psychiatry, 7, p. 17; Vrethem, M., Mattsson, E., Hebelka, H., Leerbeck, K., Osterberg, A., Landtblom, A.M., Balla, B., Kagedal, B., Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid (2003) Mult. Scler., 9 (3), pp. 239-245; Zhu, Y., He, Z.Y., Liu, H.N., Meta-analysis of the relationship between homocysteine, vitamin B(1)(2), folate, and multiple sclerosis (2011) J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas., 18 (7), pp. 933-938; Zoccolella, S., Tortorella, C., Iaffaldano, P., Direnzo, V., D'Onghia, M., Paolicelli, D., Livrea, P., Trojano, M., Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender (2012) J. Neurol., 259 (10), pp. 2105-2110},
correspondence_address1={Dardiotis, E.; Department of Neurology, Greece; email: edar@med.uth.gr},
publisher={Elsevier B.V.},
issn={22110348},
pubmed_id={29055456},
language={English},
abbrev_source_title={Mult. Scler. Relat. Disord.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Bellón2015S22,
author={Bellón, J.A. and Moreno-Peral, P. and Motrico, E. and Rodríguez-Morejón, A. and Fernández, A. and Serrano-Blanco, A. and Zabaleta-del-Olmo, E. and Conejo-Cerón, S.},
title={Effectiveness of psychological and/or educational interventions to prevent the onset of episodes of depression: A systematic review of systematic reviews and meta-analyses},
journal={Preventive Medicine},
year={2015},
volume={76},
number={S},
pages={S22-S32},
doi={10.1016/j.ypmed.2014.11.003},
note={cited By 35},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930871893&doi=10.1016%2fj.ypmed.2014.11.003&partnerID=40&md5=ca4d7ffb8826bfc60476b7dc7f6ff6da},
affiliation={Centro de Salud El Palo, Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Investigación del Distrito de Atención Primaria Málaga-Guadalhorce, Departamento de Medicina Preventiva y Salud Pública, Universidad de Málaga, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Investigación del Distrito de Atención Primaria Málaga-Guadalhorce, Málaga, Spain; Departamento de Psicología Psicología y Trabajo Social, Universidad de Loyola, Sevilla, Spain; Departamento de Personalidad, Evaluación Tratamiento Psicológico, Universidad de Málaga, Málaga, Spain; Centre for Disability Research Policy - Brain Mind Research Institute, Faculty of Health Sciences, University of Sydney, Sydney, Australia; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain; Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol, Barcelona, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Investigación del Distrito de Atención Primaria Málaga-Guadalhorce, Málaga, Spain},
abstract={Objective: To determine the effectiveness of psychological and/or educational interventions to prevent the onset of episodes of depression. Methods: Systematic review of systematic reviews and meta-analyses (SR/MA). We searched PubMed, PsycINFO, Cochrane Database of Systematic Reviews, OpenGrey, and PROSPERO from their inception until February 2014. Two reviewers independently evaluated the eligibility criteria of all SR/MA, abstracted data, and determined bias risk (AMSTAR). Results: Twelve SR/MA (156 non-repeated trials and 56,158 participants) were included. Of these, 142 (91%) were randomized-controlled, 13 (8.3%) controlled trials, and 1 (0.6%) had no control group. Five SR/MA focused on children and adolescents, four on specific populations (women after childbirth, of low socioeconomic status, or unfavorable circumstances; patients with severe traumatic physical injuries or stroke) and three addressed the general population. Nine (75%) SR/MA concluded that interventions to prevent depression were effective. Of the 156 trials, 137 (87.8%) reported some kind of effect size calculation. Effect sizes were small in 45 (32.8%), medium in 26 (19.1%), and large in 25 (18.2%) trials; 41 (29.9%) trials were not effective. Of the 141 trials for which follow-up periods were available, only 34 (24.1%) exceeded 12. months. Conclusion: Psychological and/or educational interventions to prevent onset of episodes of depression were effective, although most had small or medium effect sizes. © 2014 .},
author_keywords={Depression;  Primary prevention;  Systematic review},
keywords={Article;  child psychiatry;  clinical effectiveness;  clinical trial (topic);  cognitive therapy;  controlled clinical trial (topic);  depression;  health education;  human;  meta analysis (topic);  primary prevention;  priority journal;  psychotherapy;  puerperal depression;  randomized controlled trial (topic);  social status;  systematic review;  systematic review (topic);  therapy effect;  treatment outcome;  adolescent;  adult;  child;  depression;  Depressive Disorder;  education;  female;  literature;  male;  procedures;  psychotherapy, Adolescent;  Adult;  Child;  Depression;  Depressive Disorder;  Female;  Humans;  Male;  Meta-Analysis as Topic;  Primary Prevention;  Psychotherapy;  Review Literature as Topic},
references={Becker, L., Oxman, A.D., Overviews of reviews (2011) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011), , www.cochrane-handbook.org, The Cochrane Collaboration, Oxford, (Available from , J.P.T. Higgins, S. Green (Eds.); Bellón, J.A., Luna, J.D., King, M., Predicting the onset of major depression in primary care: international validation of a risk prediction algorithm from Spain (2011) Psychol. Med., 41 (10), pp. 2075-2088; Bellón, J.A., Conejo-Cerón, S., Moreno-Peral, P., Preventing the onset of major depression based on the level and profile of risk of primary care attendees: protocol of a cluster randomised trial (the predictD-CCRT study) (2013) BMC Psychiatry, 13, p. 171; Bromet, E., Andrade, L.H., Hwang, I., Cross-national epidemiology of DSM-IV major depressive episode (2011) BMC Med., 9, p. 90; Brownson, R.C., Remington, P.I., Davis, J.R., (1998) Chronic Disease Epidemiology and Control, , American Public Health Association, Washington DC, (Eds.); Buntrock, C., Ebert, D.D., Lehr, D., Evaluating the efficacy and cost-effectiveness of web-based indicated prevention of major depression: design of a randomised controlled trial (2014) BMC Psychiatry, 14, p. 25. , (Jan 31); Calear, L., Christensen, H., Systematic review of school-based prevention and early intervention programs for depression (2010) J. Adolesc., 33, pp. 429-438; Chisholm, D., Sanderson, K., Ayuso-Mateos, J.L., Saena, S., Reducing the global burden of depression: population-level analysis of intervention cost effectiveness in 14 world regions (2004) Br. J. Psychiatry, 184, pp. 393-403; Clark, C., Rodgers, B., Caldwell, T., Power, C., Stansfeld, S., Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort (2007) Arch. Gen. Psychiatry, 64 (6), pp. 668-678; Cohen, J., (1988) Statistical Power Analysis for the Behavioral Sciences, , Erlbaum, Hillsdale, NJ; Cooper, H., Koenka, A.C., The overview of reviews: unique challenges and opportunities when research syntheses are the principal elements of new integrative scholarship (2012) Am. Psychol., 67 (6), pp. 446-462; Cuijpers, P., Van Straten, A., Smit, F., Mihalopoulos, C., Beekman, A., Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions (2008) Am. J. Psychiatry, 165, pp. 1272-1280; Cuijpers, P., Muñoz, R.F., Clarke, G.N., Lewinsohn, P.M., Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later (2009) Clin. Psychol. Rev., 29, pp. 449-458; Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., Dobson, K.S., A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments (2013) Can. J. Psychiatry, 58 (7), pp. 376-385; De Silva, M., Maclachlan, M., Devane, D., Psychosocial interventions for the prevention of disability following traumatic physical injury (2009) Cochrane Database Syst. Rev., 7, p. 4; Dennis, C.L., Dowswell, T., Psychosocial and psychological interventions for preventing postpartum depression (2013) Cochrane Database Syst. Rev., 2, p. CD001134; Estruch, R., Ros, E., Salas-Salvadó, J., Primary prevention of cardiovascular disease with a Mediterranean diet (2013) N. Engl. J. Med., 368 (14), pp. 1279-1290; Fleiss, J.L., (1981) Statistical Methods for Rates and Proportions, , John Wiley, New York; Gustavsson, A., Svensson, M., Jacobi, F., Cost of disorders of the brain in Europe 2010 (2011) Eur. Neuropsychopharmacol., 21 (10), pp. 718-779; Hackett, M.L., Anderson, C.S., House, A., Halteh, C., Interventions for preventing depression after stroke (2008) Cochrane Database Syst. Rev., 3; Kavanagh, J., Oliver, S., Lorenc, T., School-based cognitive-behavioural interventions: a systematic review of effects and inequalities (2009) Health Sociol. Rev., 18, pp. 61-78; King, M., Nazareth, I., Levy, G., Development and validation of a risk prediction algorithm for episodes of major depression in European general practice attendees: the PREDICT study (2008) Arch. Gen. Psychiatry, 65 (12), pp. 1368-1376; Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030 (2006) PLoS Med., 3, p. 442; Merry, S.N., Hetrick, S.E., Cox, G.R., Brudevold-Iversen, T., Bir, J.J., McDowell, H., Psychological and educational interventions for preventing depression in children and adolescents (2011) Cochrane Database Syst. Rev., (12); Mihalopoulos, C., Vos, T., Pirkis, J., Carter, R., The economic analysis of prevention in mental health programs (2011) Annu. Rev. Clin. Psychol., 7, pp. 169-201; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement (2009) BMJ, 339, p. b2535; Muñoz, R.F., Cuijpers, S.F., Barrera, A.Z., Leykin, Y., Prevention of major depression (2010) Annu. Rev. Clin. Psychol., 6, pp. 181-212; Murray, C.J., Vos, T., Lozano, R., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) Lancet, 380, pp. 2197-2223; Neil, A.L., Christensen, H., Australian school-based prevention and early intervention programs for anxiety and depression: a systematic review (2007) Med. J. Aust., 186, pp. 305-308; Pieper, D., Buechter, R., Jerinic, P., Eikermann, M., Overviews of reviews often have limited rigor: a systematic review (2012) J. Clin. Epidemiol., 65, pp. 1267-1273; Pieper, D., Antoine, S.L., Mathes, T., Neugebauer, E.A.M., Eikermann, M., Systematic review finds overlapping reviews were not mentioned in every other overview (2014) J. Clin. Epidemiol., 67, pp. 368-375; Shaw, E., Levitt, C., Wong, S., Kaczorowski, J., Systematic review of the literature on postpartum care: effectiveness of postpartum support to improve maternal parenting, mental health, quality of life, and physical health (2006) Birth, 33, pp. 210-220; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med. Res. Methodol., 7, p. 10; Shea, B.J., Hamel, C., Wells, G.A., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J. Clin. Epidemiol., 62 (10), pp. 1013-1020. , (Oct); Siontis, K.C., Hernandez-Boussard, T., Ioannidis, J.P.A., Overlapping meta-analyses on the same topic: survey of published studies (2013) BMJ, 347, p. f4501; Smith, V., Devane, D., Begley, C.M., Clarke, M., Methodology in conducting a systematic review of systematic reviews of healthcare interventions (2011) BMC Med. Res. Methodol., 11 (1), p. 15; Stice, E., Shaw, H., Bohon, C., Marti, C.N., Rohde, P., A meta-analytic review of depression prevention programs for children and adolescents: factors that predict magnitude of intervention effects (2009) J. Consult. Clin. Psychol., 77, pp. 486-503; Tonelli, M., Lloyd, A., Clement, F., Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis (2011) CMAJ, 183, pp. E1189-E1202; van der Waerden, J.E., Hoefnagels, C., Hosman, C.M., Psychosocial preventive interventions to reduce depressive symptoms in low-SES women at risk: a meta-analysis (2011) J. Affect. Disord., 128, pp. 10-23; Vázquez, F., Blanco, V., Torres, A., Otero, P., Hermida, E., The effectiveness of indicated prevention of depression: a review (2014) An. Psicol., 30, pp. 9-24. , [article in Spanish]; Weich, S., Prevention of the common mental disorders: a public health perspective (1997) Psychol. Med., 27, pp. 757-764},
correspondence_address1={Bellón, J.A.; Departamento de Medicina Preventiva, Campus de Teatinos, Spain},
publisher={Academic Press Inc.},
issn={00917435},
coden={PVTMA},
pubmed_id={25445331},
language={English},
abbrev_source_title={Prev. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Stamp2017457,
author={Stamp, L. and Dalbeth, N.},
title={Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution},
journal={Seminars in Arthritis and Rheumatism},
year={2017},
volume={46},
number={4},
pages={457-464},
doi={10.1016/j.semarthrit.2016.07.015},
note={cited By 34},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014018460&doi=10.1016%2fj.semarthrit.2016.07.015&partnerID=40&md5=38814823e6230d68fc0419216999fd4e},
affiliation={Department of Medicine, University of Otago, Christchurch, 2 Riccarton Ave, P.O. Box 4345, Christchurch, New Zealand; Department of Medicine, University of Auckland, Auckland, New Zealand},
abstract={Objective The observed associations of hyperuricaemia with hypertension, cardiovascular disease and kidney disease are receiving increasing interest. The potential role of urate-lowering therapy in the management of these “non-gout diseases” has been raised, and in some countries it is already recommended. However, there is no consistent definition of hyperuricaemia or asymptomatic hyperuricaemia, much remains unknown about the causal role of urate in these “non-gout diseases” and there is currently a lack of evidence about the effects of urate lowering on disease progression. In addition, there is potential for serious adverse effects associated with urate-lowering therapies with recent evidence suggesting that asymptomatic hyperuricaemia may be an independent risk factor for the potentially fatal allopurinol hypersensitivity syndrome. Methods Pubmed was searched in January 2016 using the search term “asymptomatic hyperuricaemia”. Results and Conclusions Herein, we discuss the issues related to treating asymptomatic hyperuricaemia, which at present seems premature. © 2017 Elsevier Inc.},
author_keywords={Asymptomatic;  Hyperuricaemia;  Urate-lowering therapy},
keywords={allopurinol;  febuxostat;  probenecid;  allopurinol;  antigout agent;  febuxostat;  probenecid;  uricosuric agent, alcohol consumption;  blood dyscrasia;  body mass;  brain ischemia;  cardiovascular disease;  cerebrovascular accident;  chronic kidney failure;  comorbidity;  disease association;  disease course;  DRESS syndrome;  drug efficacy;  drug hypersensitivity;  drug safety;  dual energy computed tomography;  heart failure;  human;  hypertension;  hyperuricemia;  incidence;  measurement accuracy;  meta analysis;  observational study;  open study;  Parkinson disease;  prospective study;  randomized controlled trial (topic);  rash;  Review;  risk benefit analysis;  side effect;  systematic review;  urolithiasis;  asymptomatic disease;  chemically induced;  Drug Eruptions;  drug hypersensitivity;  hyperuricemia;  urolithiasis, Allopurinol;  Asymptomatic Diseases;  Drug Eruptions;  Drug Hypersensitivity;  Febuxostat;  Gout Suppressants;  Humans;  Hyperuricemia;  Probenecid;  Uricosuric Agents;  Urolithiasis},
chemicals_cas={allopurinol, 315-30-0; febuxostat, 144060-53-7; probenecid, 57-66-9; Allopurinol; Febuxostat; Gout Suppressants; Probenecid; Uricosuric Agents},
funding_details={Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company, TPC},
funding_details={ACEA BiosciencesACEA Biosciences},
funding_text 1={L.K.S. has received grant funds from Ardea Biosciences, outside the current work. N.D. has received consulting fees, speaker fees or grants from the following companies: Takeda, Menarini, Teijin, Pfizer, Crealta, Cymabay, Fonterra, Ardea Biosciences and AstraZeneca, outside the submitted work.},
references={Fessel, W., Siegelaub, A., Johnson, E., Correlates and consequences of asymptomatic hyperuricaemia (1973) Arch Int Med, 132, pp. 44-54; Liang, M., Fries, J., Asymptomatic hyperuricaemia: the case for conservative management (1978) Ann Intern Med, 88, pp. 666-670; Levy, G., Cheetham, T., Is it time to start treating asymptomatic hyperuricaemia? (2015) Am J Kidney Dis, 66, pp. 933-935; Yamanaka, H., Japanese guideline for the management of hyperuricaemia and gout: second edition (2011) Nucleosides Nucleotides Nucleic Acids, 30, pp. 1018-1029; Bardin, T., Richette, P., Defintion of hyperuricaemia and gouty conditions (2014) Curr Opin Rheumatol, 26, pp. 186-191; Campion, E., Glynn, R., DeLabry, L., Asymptomatic hyperuricaemia: risks and consequence in the normative aging study (1987) Am J Med, 82, pp. 421-426; Lin, K.-C., Lin, H.-Y., Chou, P., The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricaemic men in a prospective study (2000) J Rheumatol, 27, pp. 1501-1505; Dalbeth, N., House, M.E., Aati, O., Tan, P., Franklin, C., Horne, A., Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study (2015) Ann Rheum Dis, 74, pp. 908-911; Puig, J., de Miguel, E., Castillo, M., Rocha, A., Martínez, M., Torres, R., Asymptomatic hyperuricemia: impact of ultrasonography (2008) Nucleosides Nucleotides Nucleic Acids, 27, pp. 592-595; Pineda, C., Amezcua-Guerra, L., Solano, C., Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study (2011) Arthritis Res Ther, 13, p. R4; Sun, Y., Ma, L., Zhou, Y., Features of urate deposition in patients with gouty arthritis of the foot using dual-energy computed tomography (2013) Int J Rheum Dis; Wang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., Li, J., Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies (2014) PLoS One, 9, p. e114259; Kim, S., Guevara, J., Kim, K., Choi, H., Heitjan, D., Albert, D., Hyperuricaemia and coronary heart disease: a systematic review and meta-analysis (2010) Arthritis Care Res, 62, pp. 170-180; Kim, S., Guevara, J., Kim, K., Choi, H., Heitjan, D., Albert, D., Hyperuricaemia and risk of stroke: a systematic review and meta-analysis (2009) Arthritis Care Res, 61, pp. 885-892; Zhao, G., Huang, L., Song, M., Song, L., Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies (2013) Atherosclerosis, 231, pp. 61-68; Li, L., Yang, C., Zhao, Y., Zeng, X., Liu, F., Fu, P., Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies (2014) BMC Nephrol, 15; Keenan, T., Zhao, W., Rasheed, A., Causal assessment of serum uratelevels in cardiometabolic diseases through a mendelian randomization study (2016) J Am Coll Cardiol, 67, pp. 407-416; Palmer, T., Nordestgaard, B., Benn, M., Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts (2013) Br Med J, 347; Hughes, K., Flynn, T., de Zoysa, J., Dalbeth, N., Merriman, T., Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function (2013) Kidney Int, 85, pp. 344-351; Oikonen, M., Wendelin-Saarenhovi, M., Lyytikainen, L., Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study (2012) Atherosclerosis, 223, pp. 497-503; Perez-Ruiz, F., Calabozo, M., Pijoan, J., Herrero-Beites, A., Ruibal, A., Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout (2002) Arthritis Care Res., 47, pp. 356-360; Becker, M., Schumacher, H.R., Wortmann, R., Febuxostat compared with allopurinol in patients with hyperuricaemia and gout (2005) N Engl J Med, 353, pp. 2450-2461; Ko, T., Tsai, C., Chen, S., Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study (2015) Br Med J Case Rep, 351, p. h4848; Stamp, L., Taylor, W., Jones, P., Starting dose, but not maximum maintenance dose, is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol (2012) Arthritis Rheum, 64, pp. 2529-2536; Agarwal, V., Hans, N., Messerli, F., Effect of allopurinol on blood pressure: a systematic review and meta-analysis (2013) J Clin Hypertens, 15, pp. 435-442; Givertz, M., Anstrom, K., Redfield, M., Effects of xanthine oxidaseinhibition in hyperuricemic heart failure patients the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study (2015) Circulation, 131, pp. 1763-1771; Hare, J.M., Mangal, B., Brown, J., Impact of oxypurinol in patients with symptomatic heart failure (2008) J Am Coll Cardiol, 51, pp. 2301-2309; Norman, A., Ang, D., Ogston, S., Lang, C., Struthers, A., Effect of high dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial (2010) Lancet, 375, pp. 2161-2167; Kanji, T., Ganghi, M., Clase, C., Yang, R., Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis (2015) BMC Nephrol, 16, p. 58; Wang, H., Wei, Y., Kong, X., Xu, D., Effects of urate lowering therapy in hyperuricaemia on slowing the progression of renal function: a meta-analysis (2013) J Renal Nutr, 23, pp. 389-396; Carnovale, C., Venegoni, M., Clementi, E., Allopurinol overuse in asymptomatic hyperuricemia: a teachable moment (2014) JAMA Intern Med, 174, pp. 1031-1032; Gutierrez-Macias, A., Lizarralde-Palacios, E., Martinez-Odriozola, P., Miguel-De la Villa, F., Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia (2005) Br Med J, 331, pp. 623-624; Yang, C.-Y., Chen, C.-H., Deng, S.-T., Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan (2015) JAMA Intern Med, 175, pp. 1550-1557; Chamorro, A., Dirnagl, U., Urra, X., Planas, A., Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation (2016) Lancet Neurol, 15, pp. 869-881; Shen, C., Guo, Y., Luo, W., Lin, C., Ding, M., Serum urate and the risk of Parkinson's disease: results from a meta-analysis (2013) Can J Neurol Sci, 40, pp. 73-79; Fan, Y., Wei, F., Lang, Y., Wang, S.-Y., Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis (2015) J Hypertens, 33, pp. 681-688; Tai, V., Grey, A., Bolland, M., Results of observational studies: analysis of findings from the Nurses’ Health Study (2014) PLoS One, 9, p. e110403; Feig, D., Soletsky, B., Johnson, R., Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension (2008) J Am Med Assoc, 300, pp. 924-932; Tanaka, K., Nakayama, M., Kanno, M., Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial (2015) Clin Exp Nephrol, 9, pp. 1044-1053; Shibagaki, Y., Ohno, I., Hosoya, T., Kimura K. Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction (2014) Hypertens Res, 37, pp. 919-925; Kanbay, M., Ozkara, A., Selcoki, Y., Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal function (2007) Int Urol Nephrol, 39, pp. 1227-1233; Segal, M., Srinivas, T., Mohandas, R., The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic (2015) J Am Soc Hypertens, 9, pp. 610-619; Assadi, F., Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension (2014) J Nephrol., 27, pp. 51-56; Kostka-Jeziorny, K., Uruski, P., Tykarski, A., Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients (2011) Blood Press, 20, pp. 104-110; Goicoechea, M., de Vinuesa, S., Verdalles, U., Effect of allopurinol in chronic kidney disease progression and cardiovascular risk (2010) Clin J Am Soc Nephrol, 5, pp. 1388-1393; Siu, Y.-P., Leung, K.-T., Tong, M., Kwan, T.-H., Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level (2006) Am J Kidney Dis, 47, pp. 51-59; Goicoechea, M., de Vinuesa, S., Verdalles, U., Allopurinol and progression of CKD and cardiovascular events: long term followup of a randomised controlled trial (2015) Am J Kidney Dis; Terawaki, H., Nakayama, M., Miyazawa, E., Effect of allopurinol on cardiovascular incidence amoung hypertensive nephropathy patients: the Gonryo study (2013) Clin Exp Nephrol, 17, pp. 549-553; Kanbay, M., Huddam, B., Azak, A., A randomized study of allopruinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricaemic subjects with normal renal function (2011) Clin J Am Soc Nephrol, 6, pp. 1887-1894; Kao, M., Ang, D., Gandy, S., Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease (2011) J Am Soc Nephrol, 22, pp. 1382-1389; Shi, Y., Chen, W., Jalal, D., Clinical outcome of hyperuricaemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial (2012) Kidney Blood Press Res, 35, pp. 153-160; Liu, P., Chen, Y., Wang, B., Zhang, F., Wang, D., Wang, Y., Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricaemia: a three year randomized parallel-controlled trial (2015) Clin Endocrinol, 83, pp. 475-482; Sircar, D., Chatterjee, S., Waikhom, R., Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricaemia: a 6-month double-blind, randomized, placebo-controlled trial (2015) Am J Kidney Dis, 66, pp. 945-950; Sezai, A., Soma, M., Nakata, K., Comparison of febuxostat and allopurinol for hyperuricaemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD) (2015) J Cardiol, 66, pp. 298-303},
correspondence_address1={Stamp, L.; Department of Medicine, 2 Riccarton Ave, P.O. Box 4345, New Zealand; email: lisa.stamp@cdhb.health.nz},
publisher={W.B. Saunders},
issn={00490172},
coden={SAHRB},
pubmed_id={27591828},
language={English},
abbrev_source_title={Semin. Arthritis Rheum.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Hopfner2020247,
author={Hopfner, F. and Höglinger, G.U. and Kuhlenbäumer, G. and Pottegård, A. and Wod, M. and Christensen, K. and Tanner, C.M. and Deuschl, G.},
title={β-adrenoreceptors and the risk of Parkinson's disease},
journal={The Lancet Neurology},
year={2020},
volume={19},
number={3},
pages={247-254},
doi={10.1016/S1474-4422(19)30400-4},
note={cited By 33},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078446951&doi=10.1016%2fS1474-4422%2819%2930400-4&partnerID=40&md5=03f77125ee0c50f8a2b50415a4643e38},
affiliation={Department of Neurology, University Medical Center Schleswig Holstein, Christian-Albrechts-University, Kiel, Germany; Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany; Department of Neurology, Technical University of Munich, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark; The Unit of Epidemiology, Biostatistics and Biodemography, the Danish Twin Registry, the Danish Aging Research Center, Department of Public Health, University of Southern Denmark, Odense, Denmark; Department of Clinical Genetics, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California-San Francisco, San Francisco, CA, United States; San Francisco Veterans Affairs Health Care System, San Francisco, CA, United States},
abstract={Background: β-adrenoceptors are widely expressed in different human organs, mediate important body functions and are targeted by medications for various diseases (such as coronary heart disease and heart attack) and many β-adrenoceptor acting drugs are listed on the WHO Model List of Essential Medicines. β-adrenoceptor antagonists are used by billions of patients with neurological disorders, primarily for the treatment of migraine and action tremor (mainly essential tremor), worldwide. Recent developments: An observational study reported a link between the chronic use of the β-adrenoceptor antagonist propranolol and an increased risk of Parkinson's disease, while the chronic use of the β-adrenoceptor agonists was associated with a decreased risk. Further support of this association was provided by a dose-dependent decrease in the risk of Parkinson's disease with chronic β-adrenoceptor agonist (eg, salbutamol) use, and by functional data indicating a possible underlying molecular mechanism. Five additional epidemiological studies have examined the modulation of the risk of Parkinson's disease as a result of the use of β-adrenoceptor-acting drugs in different populations. Overall, similar estimates but different interpretations of the associations were provided. Several findings suggest that the increase in risk of Parkinson's disease associated with β-adrenoceptor antagonists use can be explained by reverse causation because prodromal Parkinson's disease is often associated with non-specific action tremor, which is usually treated with propranolol. The lower risk of Parkinson's disease seen in patients receiving β-adrenoceptor agonists is likely to be indirectly mediated by smoking because smoking has a strong inverse association with Parkinson's disease (people that smoke have a reduced risk of developing Parkinson's disease). Smoking also causes chronic obstructive pulmonary disease, which is treated with β-adrenoceptor-agonist medications. Even if causal, the effect of β-adrenoceptor antagonists on the risk of Parkinson's disease would be small compared with other Parkinson's disease risk factors and would be similar to the risk evoked by pesticide exposure. The estimated risk of Parkinson's disease because of β-adrenoceptor antagonists use corresponds to one case in 10 000 patients after 5 years of propranolol use, and would be considered a very rare adverse effect. Thus, not using β-adrenoceptor antagonists would severely harm patients with recommended indications, such as heart disease or migraine. Similarly, 50 000 people would have to be treated for 5 years with salbutamol to prevent Parkinson's disease in one patient, suggesting that primary preventive therapy studies on disease modification are not warranted. Where next?: Epidemiological evidence for a causal relationship between use of β2-adrenoceptor antagonists and the increased risk of Parkinson's disease is weak, with other explanations for the association being more probable. Future observational studies are warranted to clarify this association. However, given the very low risk associated with propranolol, most clinicians are unlikely to change their treatment approach. © 2020 Elsevier Ltd},
keywords={alpha synuclein;  beta adrenergic receptor;  beta adrenergic receptor blocking agent;  beta adrenergic receptor stimulating agent;  beta adrenergic receptor;  beta adrenergic receptor blocking agent;  beta adrenergic receptor stimulating agent;  propranolol, drug efficacy;  drug safety;  epidemiological data;  gene expression regulation;  human;  Parkinson disease;  priority journal;  protein function;  Review;  risk factor;  side effect;  metabolism;  Parkinson disease;  pathophysiology;  risk factor;  signal transduction, Adrenergic beta-Agonists;  Adrenergic beta-Antagonists;  Humans;  Parkinson Disease;  Propranolol;  Receptors, Adrenergic, beta;  Risk Factors;  Signal Transduction},
chemicals_cas={alpha synuclein, 154040-18-3; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Propranolol; Receptors, Adrenergic, beta},
funding_details={116060},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={U.S. Department of DefenseU.S. Department of Defense, DOD},
funding_details={Michael J. Fox Foundation for Parkinson's ResearchMichael J. Fox Foundation for Parkinson's Research, MJFF},
funding_details={Boehringer IngelheimBoehringer Ingelheim, BI},
funding_details={Astellas Pharma USAstellas Pharma US, APUS},
funding_details={AstraZenecaAstraZeneca},
funding_details={MedtronicMedtronic, SFB 1261},
funding_details={Biogen IdecBiogen Idec},
funding_details={Velux FondenVelux Fonden},
funding_details={CurePSPCurePSP},
funding_details={Parkinson's FoundationParkinson's Foundation, PF},
funding_details={European Federation of Pharmaceutical Industries and AssociationsEuropean Federation of Pharmaceutical Industries and Associations, EFPIA},
funding_details={Deutsche Gesellschaft für Parkinson und BewegungsstörungenDeutsche Gesellschaft für Parkinson und Bewegungsstörungen, DPG},
funding_details={European CommissionEuropean Commission, EC},
funding_details={Deutscher Akademischer AustauschdienstDeutscher Akademischer Austauschdienst, DAAD},
funding_details={Deutsche ForschungsgemeinschaftDeutsche Forschungsgemeinschaft, DFG, 390857198, HO2402/18-1 MSAomics},
funding_details={Bundesministerium für Bildung und ForschungBundesministerium für Bildung und Forschung, BMBF, 01KU1403A EpiPD},
funding_details={NOMIS StiftungNOMIS Stiftung},
funding_details={Thiemann StiftungThiemann Stiftung},
funding_text 1={FH reports grants from the German Research Council, Thiemann foundation, and Deutsche Parkinson Gesellschaft, outside the submitted work. GUH reports grants from the German Research Foundation under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy—ID 390857198); German Research Foundation (HO2402/6-2 Heisenberg Program, HO2402/18-1 MSAomics); the German Federal Ministry of Education and Research (BMBF, 01KU1403A EpiPD; 01EK1605A HitTau); the NOMIS foundation (FTLD project); the ParkinsonFonds Germany (Hypothesis-free compound screen, α-Synuclein spreading in Parkinson's disease, PROMESA); the German Academic Exchange Service within the Transformation Partnership Programme “Al Tawasul”; the EU, the European Federation of Pharmaceutical Industries and Associations, and Innovative Medicines Initiative Joint Undertaking (IMPRIND grant n° 116060); CurePSP (Epigenetics of PSP), outside the submitted work. GUH has ongoing research collaborations with Orion and Prothena; serves as a consultant for Abbvie, Alzprotect, Asceneuron, Biogen, Biohaven, Lundbeck, Novartis, Roche, Sanofi, and Union Chimique Belge; received honoraria for scientific presentations from Abbvie, Biogen, Roche, Teva, Union Chimique Belge, and Zambon, outside the submitted work. CMT reports grants from the Michael J Fox Foundation, the Parkinson's Foundation, the US Department of Defense, and the National Institutes of Health; grants from BioElectron, Roche, Genentech, and Biogen Idec; personal fees from Biotie Therapeutics, Voyager Therapeutics, Intec Pharma, Neurocrine Biosciences, Adamas Therapeutics, Biogen Idec, 23andMe, Alexza, Grey Matter, Acorda, and CNS Ratings, outside the submitted work; and CMT is an employee of the University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA. AP reports grants from Alcon, Almirall, Astellas, Asra Zeneca, Boehringer-Ingelheim, Novo Nordisk, Servier, and Leo Pharma, outside the submitted work. KC reports grants from the National Institutes of Health and the Velux Foundation, outside the submitted work. GK reports grants from German Research Council and Christian-Albrechts-University Kiel, outside the submitted work. GD reports personal fees from Boston Scientific, Cavion, Functional Neuromodulation, and Thieme publishers and reports grants from Medtronic and the German research council (SFB 1261, TP B5), outside the submitted work. MW declares no competing interests.},
references={Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) Lancet Neurol, 17, pp. 939-953; Dorsey, E.R., Sherer, T., Okun, M.S., Bloem, B.R., The emerging evidence of the Parkinson pandemic (2018) J Parkinsons Dis, 8, pp. S3-S8; Ascherio, A., Schwarzschild, M.A., The epidemiology of Parkinson's disease: risk factors and prevention (2016) Lancet Neurol, 15, pp. 1257-1272; Marras, C., Canning, C.G., Goldman, S.M., Environment, lifestyle, and Parkinson's disease: implications for prevention in the next decade (2019) Mov Disord, 34, pp. 801-811; Berg, D., Postuma, R.B., Adler, C.H., MDS research criteria for prodromal Parkinson's disease (2015) Mov Disord, 30, pp. 1600-1611; Postuma, R.B., Berg, D., Advances in markers of prodromal Parkinson disease (2016) Nat Rev Neurol, 12, pp. 622-634; Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., Meta-analysis of early nonmotor features and risk factors for Parkinson disease (2012) Ann Neurol, 72, pp. 893-901; Magistrelli, L., Comi, C., Beta2-adrenoceptor agonists in parkinson's disease and other synucleinopathies (2019) J Neuroimmune Pharmacol, , published online Jan 7; Savitt, D., Jankovic, J., targeting α-synuclein in Parkinson's disease: progress towards the development of disease-modifying therapeutics (2019) Drugs, 79, pp. 797-810; Mittal, S., Bjørnevik, K., Im, D.S., β2-adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease (2017) Science, 357, pp. 891-898; Gronich, N., Abernethy, D.R., Auriel, E., Lavi, I., Rennert, G., Saliba, W., β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease (2018) Mov Disord, 33, pp. 1465-1471; Hopfner, F., Wod, M., Höglinger, G.U., Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease (2019) Neurology, 93, pp. e135-e142; Koren, G., Norton, G., Radinsky, K., Shalev, V., Chronic use of β-blockers and the risk of parkinson's disease (2019) Clin Drug Investig, 39, pp. 463-468; Ton, T.G., Heckbert, S.R., Longstreth, W.T., Jr, Calcium channel blockers and beta-blockers in relation to Parkinson's disease (2007) Parkinsonism Relat Disord, 13, pp. 165-169; Searles Nielsen, S., Gross, A., Camacho-Soto, A., Willis, A.W., Racette, B.A., β2-adrenoreceptor medications and risk of Parkinson disease (2018) Ann Neurol, 84, pp. 683-693; Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., Alpha-synuclein in Lewy bodies (1997) Nature, 388, pp. 839-840; Lewy, F.H., Zur pathologischen Anatomie der Paralysis Agitans (1913) Dtsch Z Nervenheilkd, 50, pp. 50-55; Braak, H., Bohl, J.R., Müller, C.M., Rüb, U., de Vos, R.A., Del Tredici, K., Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered (2006) Mov Disord, 21, pp. 2042-2051; Mu, S., Shimosawa, T., Ogura, S., Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension (2011) Nat Med, 17, pp. 573-580; Konno, T., Ross, O.A., Puschmann, A., Dickson, D.W., Wszolek, Z.K., Autosomal dominant Parkinson's disease caused by SNCA duplications (2016) Parkinsonism Relat Disord, 22, pp. S1-S6; Hertz, L., Lovatt, D., Goldman, S.A., Nedergaard, M., Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i (2010) Neurochem Int, 57, pp. 411-420; Deuschl, G., Raethjen, J., Hellriegel, H., Elble, R., Treatment of patients with essential tremor (2011) Lancet Neurol, 10, pp. 148-161; Scarpace, P.J., Abrass, I.B., Alpha- and beta-adrenergic receptor function in the brain during senescence (1988) Neurobiol Aging, 9, pp. 53-58; Gorman, A.L., Dunn, A.J., Beta-adrenergic receptors are involved in stress-related behavioral changes (1993) Pharmacol Biochem Behav, 45, pp. 1-7; Kuritzky, A., Bennet, E., Hering, R., Ebstein, R., Reduced sensitivity of lymphocyte beta-adrenergic receptors in migraine (1993) Headache, 33, pp. 198-200; Rabe, K.F., Watz, H., Chronic obstructive pulmonary disease (2017) Lancet, 389, pp. 1931-1940; Walters, E.H., Gibson, P.G., Lasserson, T.J., Walters, J.A.E., Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid (2007) Cochrane Database Syst Rev, 1; Dodick, D.W., Migraine (2018) Lancet, 391, pp. 1315-1330; Ong, H.T., Beta blockers in hypertension and cardiovascular disease (2007) BMJ, 334, pp. 946-949; Naghavi, M., Abajobir, A.A., Abbafati, C., Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) Lancet, 390, pp. 1151-1210; Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) Lancet, 390, pp. 1211-1259; Roth, G.A., Johnson, C., Abajobir, A., Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015 (2017) J Am Coll Cardiol, 70, pp. 1-25; Metra, M., Teerlink, J.R., Heart failure (2017) Lancet, 390, pp. 1981-1995; Zheng, S.L., Chan, F.T., Nabeebaccus, A.A., Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis (2018) Heart, 104, pp. 407-415; Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (1999) Lancet, 353, pp. 2001-2007; Hjalmarson, A., Goldstein, S., Fagerberg, B., Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF) (2000) JAMA, 283, pp. 1295-1302; Klapholz, M., Beta-blocker use for the stages of heart failure (2009) Mayo Clin Proc, 84, pp. 718-729; Louis, E.D., Ferreira, J.J., How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor (2010) Mov Disord, 25, pp. 534-541; Essential medicines and health products (2018), https://www.who.int/medicines/publications/essentialmeds_committeereports/en/, (Accessed 31 July 2019); Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) Lancet Neurol, 17, pp. 954-976; Ritz, B., Manthripragada, A.D., Qian, L., Statin use and Parkinson's disease in Denmark (2010) Mov Disord, 25, pp. 1210-1216; Becker, C., Jick, S.S., Meier, C.R., Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK (2008) Drug Saf, 31, pp. 399-407; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Chang, D., Nalls, M.A., Hallgrímsdóttir, I.B., A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci (2017) Nat Genet, 49, pp. 1511-1516; Sidransky, E., Nalls, M.A., Aasly, J.O., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease (2009) N Engl J Med, 361, pp. 1651-1661; Searles Nielsen, S., Warden, M.N., Camacho-Soto, A., Willis, A.W., Wright, B.A., Racette, B.A., A predictive model to identify Parkinson disease from administrative claims data (2017) Neurology, 89, pp. 1448-1456; Ikram, M.A., Brusselle, G.G.O., Murad, S.D., The Rotterdam Study: 2018 update on objectives, design and main results (2017) Eur J Epidemiol, 32, pp. 807-850; Gelber, R.P., Launer, L.J., White, L.R., The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment (2012) Curr Alzheimer Res, 9, pp. 664-672; Zheng, W., Chow, W.H., Yang, G., The Shanghai Women's Health Study: rationale, study design, and baseline characteristics (2005) Am J Epidemiol, 162, pp. 1123-1131; Hernán, M.A., Takkouche, B., Caamaño-Isorna, F., Gestal-Otero, J.J., A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease (2002) Ann Neurol, 52, pp. 276-284; Schrag, A., Horsfall, L., Walters, K., Noyce, A., Petersen, I., Prediagnostic presentations of Parkinson's disease in primary care: a case-control study (2015) Lancet Neurol, 14, pp. 57-64; Lo, R.Y., Tanner, C.M., Albers, K.B., Clinical features in early Parkinson disease and survival (2009) Arch Neurol, 66, pp. 1353-1358; Hollenbach, J.A., Norman, P.J., Creary, L.E., A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease (2019) Proc Natl Acad Sci USA, 116, pp. 7419-7424; Geneva, Switzerland Available at: https://cioms.ch, (Accessed 11 May 2019); CTCAE Files (2010), https://evs.nci.nih.gov/ftp1/CTCAE/About.html, (Accessed 17 December 2019); Migraine prophylaxis: preventing you a headache (2014), https://broomedocs.com/2014/07/migraine-prophylaxis-preventing-headache/, (Accessed 12 August 2019); Freemantle, N., Cleland, J., Young, P., Mason, J., Harrison, J., beta Blockade after myocardial infarction: systematic review and meta regression analysis (1999) BMJ, 318, pp. 1730-1737; Holroyd, K.A., Penzien, D.B., Cordingley, G.E., Propranolol in the management of recurrent migraine: a meta-analytic review (1991) Headache, 31, pp. 333-340; Linde, K., Rossnagel, K., Propranolol for migraine prophylaxis (2004) Cochrane Database Syst Rev, 2; Koller, W.C., Dose-response relationship of propranolol in the treatment of essential tremor (1986) Arch Neurol, 43, pp. 42-43; Koller, W.C., Biary, N., Effect of alcohol on tremors: comparison with propranolol (1984) Neurology, 34, pp. 221-222; Louis, E.D., Benito-Leon, J., Faust, P.L., Essential tremor seems to be a risk factor for Parkinson's disease (2016) Parkinsonism Relat Disord, 26, pp. 82-83; Adler, C.H., Shill, H.A., Beach, T.G., Essential tremor and Parkinson's disease: lack of a link (2011) Mov Disord, 26, pp. 372-377; Deuschl, G., Petersen, I., Lorenz, D., Christensen, K., Tremor in the elderly: essential and aging-related tremor (2015) Mov Disord, 30, pp. 1327-1334; Atlas: country resources for neurological disorders (2017), World Health Organization Geneva},
correspondence_address1={Deuschl, G.; Department of Neurology, Germany; email: g.deuschl@neurologie.uni-kiel.de},
publisher={Lancet Publishing Group},
issn={14744422},
coden={LNAEA},
pubmed_id={31999942},
language={English},
abbrev_source_title={Lancet Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Veronese20191101,
author={Veronese, N. and Demurtas, J. and Celotto, S. and Caruso, M.G. and Maggi, S. and Bolzetta, F. and Firth, J. and Smith, L. and Schofield, P. and Koyanagi, A. and Yang, L. and Solmi, M. and Stubbs, B.},
title={Is chocolate consumption associated with health outcomes? An umbrella review of systematic reviews and meta-analyses},
journal={Clinical Nutrition},
year={2019},
volume={38},
number={3},
pages={1101-1108},
doi={10.1016/j.clnu.2018.05.019},
note={cited By 33},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048548093&doi=10.1016%2fj.clnu.2018.05.019&partnerID=40&md5=bb34c1f598bbc1555280727b848bb16d},
affiliation={National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; Ambulatory of Nutrition, IRCCS “S. de Bellis” National Institute of Gastroenterology-Research Hospital, Castellana GrotteBari, Italy; Primary Care Department, Azienda USL Toscana Sud Est, Grosseto, Italy; Primary Care Department, Aziendale AAS3 Alto Friuli – Collina – Medio Friuli, Udine, Italy; Medical Department, Geriatric Unit, Azienda ULSS (Unità Locale Socio Sanitaria) 3 “Serenissima”, Dolo-Mirano District, Italy; NICM, School of Science and Health, University of Western Sydney, Australia; Division of Psychology and Mental Health, University of Manchester, United Kingdom; The Cambridge Centre for Sport & Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom; Faculty of Health, Social Care and Education, Anglia Ruskin University, Bishop Hall Lane, Chelmsford, CM1 1SQ, United Kingdom; Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain; Department of Epidemiology, Center for Public Health, Medical University of Vienna, Austria; University of Padova, Department of Neuroscience, Padova, Italy; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, United Kingdom; Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom},
abstract={Background & aims: The literature regarding the potential health benefits of chocolate consumption are unclear and the epidemiological credibility has not been systematically scrutinized, while the strength of the evidence is undetermined. We therefore aimed to map and grade the diverse health outcomes associated with chocolate consumption using an umbrella review of systematic reviews. Methods: Umbrella review of systematic reviews of observational and intervention studies (randomized placebo-controlled trials, RCTs). For each association, random-effects summary effect size, 95% confidence interval, and 95% prediction interval were estimated. We also assessed heterogeneity, evidence for small-study effect and evidence for excess significance bias. For significant outcomes of the RCTs, the GRADE assessment was furtherly used. Results: From 240 articles returned, 10 systematic reviews were included (8 of which included a meta-analysis), including a total of 84 studies (36 prospective observational studies and 48 interventional). Nineteen different outcomes were included. Among observational studies, including a total of 1,061,637 participants, the best available evidence suggests that chocolate consumption is associated with reduced risk of cardiovascular disease (CVD) death (n = 4 studies), acute myocardial infarction (n = 6), stroke (n = 5) and diabetes (n = 6), although this was based on a weak evidence of credibility. Across meta-analyses of intervention studies, chocolate consumption was positively associated with flow-mediated dilatation at 90–150 min (n = 3) and at 2–18 weeks (n = 3), and insulin resistance markers (n = 2). However, using the GRADE assessment, the evidence for these outcomes was low or very low. Data from two systematic reviews, reported that chocolate consumption was not associated with better depressive mood or cognitive function. Conclusions: There is weak evidence to suggest that chocolate consumption may be associated with favorable health outcomes. © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism},
author_keywords={Cardiovascular disease;  Chocolate;  Meta-analysis;  Umbrella review},
keywords={acute heart infarction;  Article;  cerebrovascular accident;  chocolate;  cognition;  depression;  diabetes mellitus;  evidence based practice;  food intake;  health status;  human;  mortality rate;  population risk;  risk factor;  risk reduction;  systematic review;  cardiovascular disease;  diet;  meta analysis (topic);  mortality;  pathophysiology, Cardiovascular Diseases;  Chocolate;  Diet;  Humans;  Meta-Analysis as Topic;  Systematic Reviews as Topic},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={European Regional Development FundEuropean Regional Development Fund, FEDER},
funding_text 1={Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII – General Branch Evaluation and Promotion of Health Research – and the European Regional Development Fund ( ERDF-FEDER ).},
references={ICCO, Challenges and opportunities of the global cocoa and chocolate sector & position of the Russian market (2015), https://www.statista.com/statistics/238849/global-chocolate-consumption/; Latif, R., Chocolate/cocoa and human health: a review (2013) Neth J Med, 71 (2), pp. 63-68; De Araujo, Q.R., Gattward, J.N., Almoosawi, S., Silva, M., Dantas, P.A., De Araujo Junior, Q.R., Cocoa and human health: from head to foot–a review (1549–7852 (electronic)) (2016) Crit Rev Food Sci Nutr, 56 (1), pp. 1-12; Messerli, F.H., Chocolate consumption, cognitive function, and nobel laureates (2012) N Engl J Med, 367 (16), pp. 1562-1564; Larsson, S.C., Coffee, tea, and cocoa and risk of stroke (2014) Stroke, 45 (1), pp. 309-314; Corti, R., Flammer, A.J., Hollenberg, N.K., Luscher, T.F., Cocoa and cardiovascular health (2009) Circulation, 119 (10), pp. 1433-1441; Latham, L.S., Hensen, Z.K., Minor, D.S., Chocolate–guilty pleasure or healthy supplement? (2014) J Clin Hypertens, 16 (2), pp. 101-106; Silva, N.R., Chocolate consumption and effects on serotonin synthesis (2010) Arch Intern Med, 170 (17), p. 1608. , author reply 1608–1609; Rose, N., Koperski, S., Golomb, B.A., Mood food: chocolate and depressive symptoms in a cross-sectional analysis (2010) Arch Intern Med, 170 (8), pp. 699-703; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Park Relat Disord, 23, pp. 1-9; Dinu, M., Pagliai, G., Casini, A., Sofi, F., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomized trials (2017) Nutr Metabol Cardiovasc Dis, 27 (1); Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P.A., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ Br Med J, 348; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Base Healthc, 13 (3), pp. 132-140; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127 (9), pp. 820-826; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172 (1), pp. 137-159; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21 (11), pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) BMJ, 335 (7626), pp. 914-916; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Carvalho, A.F., Köhler, C.A., Brunoni, A.R., Miskowiak, K.W., Herrmann, N., Lanctôt, K.L., Bias in peripheral depression biomarkers (2016) Psychother Psychosom, 85 (2), pp. 81-90; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4 (3), pp. 245-253; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Meth, 7 (1), p. 10; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357; Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336 (7650), p. 924; Scholey, A., Owen, L., Effects of chocolate on cognitive function and mood: a systematic review (2013) Nutr Rev, 71 (10), pp. 665-681; Garcia-Blanco, T., Davalos, A., Visioli, F., Tea, cocoa, coffee, and affective disorders: vicious or virtuous cycle? (2017) J Affect Disord, 224, pp. 61-68; Tokede, O.A., Gaziano, J.M., Djousse, L., Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis (2011) Eur J Clin Nutr, 65 (8), pp. 879-886; Hooper, L., Kay, C., Abdelhamid, A., Kroon, P.A., Cohn, J.S., Rimm, E.B., Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials (2012) Am J Clin Nutr, 95 (3), pp. 740-751; Larsson, S.C., Akesson, A., Gigante, B., Wolk, A., Chocolate consumption and risk of myocardial infarction: a prospective study and meta-analysis (2016) Heart (British Cardiac Society), 102 (13), pp. 1017-1022; Gianfredi, V., Salvatori, T., Nucci, D., Villarini, M., Moretti, M., Can chocolate consumption reduce cardio-cerebrovascular risk? A systematic review and meta-analysis (2018) Nutrition, 46, pp. 103-114; Ried, K., Fakler, P., Stocks, N.P., Effect of cocoa on blood pressure (2017) Cochrane Database Syst Rev, (4); Gong, F., Yao, S., Wan, J., Gan, X., Chocolate consumption and risk of heart failure: a meta-analysis of prospective studies (2017) Nutrients, 9 (4); Larsson, S.C., Drca, N., Jensen-Urstad, M., Wolk, A., Chocolate consumption and risk of atrial fibrillation: two cohort studies and a meta-analysis (2018) Am Heart J, 195, pp. 86-90; Yuan, S., Li, X., Jin, Y., Lu, J., Chocolate consumption and risk of coronary heart disease, stroke, and diabetes: a meta-analysis of prospective studies (2017) Nutrients, 9 (7); Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14 (1), p. 147; Veronese, N., Solmi, M., Caruso, M.G., Giannelli, G., Osella, A.R., Evangelou, E., Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses (2018) Am J Clin Nutr, 107, pp. 436-444; Johnson, V.E., Revised standards for statistical evidence (2013) Proc Natl Acad Sci Unit States Am, 110 (48), pp. 19313-19317; Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., Crozier, A., Plasma antioxidants from chocolate (2003) Nature, 424 (6952). , 1013–1013; Yang, Q., Zhang, Z., Gregg, E.W., Flanders, W.D., Merritt, R., Hu, F.B., Added sugar intake and cardiovascular diseases mortality among US adults (2014) JAMA internal medicine., 174 (4), pp. 516-524; Buijsse, B., Weikert, C., Drogan, D., Bergmann, M., Boeing, H., Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults (2010) Eur Heart J, 31 (13), pp. 1616-1623; Dalton, J.E., Bolen, S.D., Mascha, E.J., Publication bias: the elephant in the review (2016) Anesth Analg, 123 (4); Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom-Ruiz, S., Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo (2011) Arterioscler Thromb Vasc Biol, 31 (6), pp. 1368-1376; Loffredo, L., Perri, L., Catasca, E., Pignatelli, P., Brancorsini, M., Nocella, C., Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease (2014) J Am Heart Assoc, 3 (4); Fraga, C.G., Cocoa, diabetes, and hypertension: should we eat more chocolate? (2005) Am J Clin Nutr, 81 (3), pp. 541-542; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P., Selection in reported epidemiological risks: an empirical assessment (2007) PLoS Med, 4 (3)},
correspondence_address1={Veronese, N.; National Research Council, Aging Branch, Via Giustiniani, 2, Italy; email: ilmannato@gmail.com},
publisher={Churchill Livingstone},
issn={02615614},
coden={CLNUD},
pubmed_id={29903472},
language={English},
abbrev_source_title={Clin. Nutr.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Sáiz-Vazquez20201,
author={Sáiz-Vazquez, O. and Puente-Martínez, A. and Ubillos-Landa, S. and Pacheco-Bonrostro, J. and Santabárbara, J.},
title={Cholesterol and Alzheimer’s disease risk: A meta-meta-analysis},
journal={Brain Sciences},
year={2020},
volume={10},
number={6},
pages={1-13},
doi={10.3390/brainsci10060386},
art_number={386},
note={cited By 32},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089341645&doi=10.3390%2fbrainsci10060386&partnerID=40&md5=ba66b333d9193677d67d5e817239a8b9},
affiliation={Department of Occupational Therapy, Faculty of Health Science, University of Burgos, C/Villadiego, 1, Burgos, 09001, Spain; Department of Social Psychology and Methodology of Behavioral Science, University of the Basque Country, Avenida Tolosa 70, San Sebastián, 20018, Spain; Department of Social Psychology, Faculty of Health Science, University of Burgos, C/Villadiego, 1, Burgos, 09001, Spain; Department of Applied Economy, Faculty of Economics and Business Sciences, University of Burgos, Pza. De la Infanta Dª Elena, s/n, Burgos, 09001, Spain; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, C/Domingo Miral s/n, Zaragoza, 50009, Spain; Aragonese Institute of Health Sciences (IIS Aragón), Zaragoza, 50009, Spain},
abstract={Background: Alzheimer’s disease (AD) is the most common subtype of dementia. In the last ten years, the relationship between cholesterol and AD has been investigated. Evidence suggests that cholesterol is associated with AD and represents promising targets for intervention. However, the causality of these associations is unclear. Therefore, we sought to conduct a meta-meta-analysis to determine the effect of cholesterol on the development AD. Then, we assessed the effect of serum levels of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides (TG), on AD risk. Methods: A systematic search of meta-analyses was conducted. Scopus, Web of Science, Science direct, PubMed and Google academic system databases were reviewed. Results: We found 100 primary studies and five meta-analyses to analyze the relationships between cholesterol and AD. The total effect of cholesterol on risk of AD was significant and heterogeneous. Subgroup analysis shows that LDL-C levels influence the development of AD. However, non-significant effects of HDL-C, TC and TG levels on AD were found. Conclusions: These results strengthen the evidence that LDL-C cholesterol levels increase risk for AD. More initiatives to investigate the relationship between cholesterol and AD are needed. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.},
author_keywords={Alzheimer’s disease;  Cholesterol;  Etiology;  Meta-analysis;  Risk factors},
keywords={cholesterol;  high density lipoprotein cholesterol;  low density lipoprotein;  low density lipoprotein cholesterol;  triacylglycerol, Alzheimer disease;  body mass;  dementia;  disease risk assessment;  dispersity;  dyslipidemia;  evidence based medicine;  follow up;  human;  knowledge;  meta analysis;  meta analysis (topic);  morbidity;  Review;  risk factor;  sensitivity analysis;  statistical analysis;  systematic review},
chemicals_cas={cholesterol, 57-88-5},
funding_details={01/0255, 03/0815, 06/0617, 19/01874, 94/1562, 97/1321E, 98/0103, G03/128},
funding_details={Federación Española de Enfermedades RarasFederación Española de Enfermedades Raras, FEDER},
funding_details={Ministerio de Economía y CompetitividadMinisterio de Economía y Competitividad, MINECO, ECO2013-47129-C4-3-R, ECO2016-76567-C4-2-R},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={Junta de Castilla y LeónJunta de Castilla y León, JCYL, 665501, BU062U16, BU071G19, BU329U14},
funding_text 1={Funding: This research was funded by a research grant from the Basque Country, Spain (awarded to A.P.), by the Junta of Castilla y León (Spain) to the Social Inclusion and Quality of Life (SIQoL) (No.665501), by FEDER funds and the Spanish Ministry of Economy and Competitiveness (Projects ECO2013-47129-C4-3-R and ECO2016-76567-C4-2-R), by the Regional Government of Castilla y León and FEDER funds (Projects BU329U14, BU071G19 and BU062U16), and by the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, Madrid, Spain (grants 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128, 19/01874).},
references={Liu, Y., Zhong, X., Shen, J., Jiao, L., Tong, J., Zhao, W., Du, K., Wei, M., Elevated serum TC and LDL-C levels in Alzheimer’s disease and mild cognitive impairment: A meta-analysis study (2020) Brain Res, 1727, p. 146554. , [CrossRef] [PubMed]; Martin, P., Anders, W., Maëlenn, G., Ali, G.C., Wu, Y.-T., Prina, M., (2015) World Alzheimer Report 2015: The Global Impact of Dementia, , Alzheimer’s Disease International (ADI): London, UK; Kapogiannis, D., Mustapic, M., Shardell, M.D., Berkowitz, S.T., Diehl, T.C., Spangler, R.D., Tran, J., Gulyani, S., Association of extracellular vesicle biomarkers with Alzheimer disease in the Baltimore longitudinal study of aging (2019) JAMA Neurol, 76, pp. 1340-1351. , [CrossRef] [PubMed]; Wang, C., Shou, Y., Pan, J., Du, Y., Liu, C., Wang, H., The relationship between cholesterol level and Alzheimer’s disease-associated APP proteolysis/Aβ metabolism (2019) Nutr. Neurosci, 22, pp. 453-463. , [CrossRef] [PubMed]; Khachaturian, Z.S., Khachaturian, A.S., Politics of science: Progress toward prevention of the dementia– Alzheimer’s syndrome (2015) Mol. Aspects Med, 43, pp. 3-15. , [CrossRef] [PubMed]; Niu, H., Álvarez-Álvarez, I., Guillén-Grima, F., Aguinaga-Ontoso, I., Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: Metaanálisis (2017) Neurología, 32, pp. 523-532. , [CrossRef]; Cao, Q., Tan, C.-C., Xu, W., Hu, H., Cao, X.-P., Dong, Q., Tan, L., Yu, J.T., The Prevalence of Dementia: A Systematic Review and Meta-Analysis (2020) J. Alzheimers Dis, 73, pp. 1157-1166. , [CrossRef]; Pedro-Cuesta, J., Virués-Ortega, J., Vega, S., Seijo-Martínez, M., Saz, P., Rodríguez, F., Rodríguez-Laso, A., Mateos, R., Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990–2008 (2009) BMC Neurol, 9, p. 55. , [CrossRef]; Dement, A., Alzheimer’s disease facts and figures (2016) Alzheimer’s Dement. J. Alzheimer’s Assoc, 12, pp. 459-509. , [CrossRef]; Lesser, G.T., Association of Alzheimer Disease Pathology with Abnormal Lipid Metabolism: The Hisayama Study (2012) Neurology, 78, p. 1280. , [CrossRef]; Agirbasli, M., Tanrikulu, A., Sevim, B.A., Azizy, M., Bekiroglu, N., Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children (2015) J. Clin. Lipidol, 9, pp. 195-200. , [CrossRef]; Wu, Y., Wang, Z., Jia, X., Zhang, H., Zhang, H., Li, J., Zhang, K., Prediction of Alzheimer’s disease with serum lipid levels in Asian individuals: A meta-analysis (2019) Biomarkers, 24, pp. 341-351. , [CrossRef] [PubMed]; Xu, W., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Zhao, Q.-F., Yu, J.-T., Meta-analysis of modifiable risk factors for Alzheimer’s disease (2015) J. Neurol. Neurosurg. Psychiatry, 86, pp. 1299-1306. , [CrossRef] [PubMed]; Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C., Yaffe, K., Midlife cardiovascular risk factors and risk of dementia in late life (2005) Neurology, 64, pp. 277-281. , [CrossRef] [PubMed]; Versmissen, J., Oosterveer, D.M., Hoekstra, M., Out, R., Berbée, J.F., Blommesteijn-Touw, A.C., van Vark-van der Zee, L., Defesche, J.C., Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations (2011) Circ. Cardiovasc. Genet, 4, pp. 655-660. , [CrossRef] [PubMed]; Nägga, K., Gustavsson, A.-M., Stomrud, E., Lindqvist, D., van Westen, D., Blennow, K., Zetterberg, H., Hansson, O., Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later (2018) Neurology, 90, pp. e73-e81. , [CrossRef] [PubMed]; Hardy, J., Alzheimer’s disease: The amyloid cascade hypothesis: An update and reappraisal (2006) J. Alzheimers Dis, 9, pp. 151-153. , [CrossRef]; Wang, H.-L., Wang, Y.-Y., Liu, X.-G., Kuo, S.-H., Liu, N., Song, Q.-Y., Wang, M.-W., Cholesterol, 24-Hydroxy cholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer’s Disease: A Meta-Analysis (2016) J. Alzheimers Dis, 51, pp. 45-55. , [CrossRef]; Shibata, N., Ohnuma, T., Higashi, S., Higashi, M., Usui, C., Ohkubo, T., Watanabe, T., Ueki, A., No genetic association between PCSK9 polymorphisms and Alzheimer’s disease and plasma cholesterol level in Japanese patients (2005) Psychiatr. Genet, 15, p. 239. , [CrossRef]; Tynkkynen, J., Hernesniemi, J.A., Laatikainen, T., Havulinna, A.S., Sundvall, J., Leiviskä, J., Salo, P., Salomaa, V., Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer’s disease: The National Finnish population study (FINRISK) (2016) AGE, 38, pp. 465-473. , [CrossRef]; Michikawa, M., Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer’s disease? (2003) J. Neurosci. Res, 72, pp. 141-146. , [CrossRef]; Wolf, H., Hensel, A., Arendt, T., Kivipelto, M., Winblad, B., Gertz, H.J., Association between serum HDL cholesterol and hippocampal volume: A link to Alzheimer’s disease? (2004) Neurobiol. Aging, 25, p. 52. , [CrossRef]; Moher, D., Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009) Ann. Intern. Med, 151, p. 264. , [CrossRef] [PubMed]; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med. Res. Methodol, 7, p. 10. , [CrossRef] [PubMed]; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J. Clin. Epidemiol, 62, pp. 1013-1020. , [CrossRef] [PubMed]; Cleophas, T.J., Zwinderman, A.H., Meta-Meta-analysis (2017) Modern Meta-Analysis. Review and Update of Methodologies, pp. 135-143. , Springer: Berlin/Heidelberg, Germany, [CrossRef]; Reis, H.T., Judd, C.M., (2000) Handbook of Research Methods in Social and Personality Psychology, , Cambridge University Press: Cambridge, UK; Shrier, I., Steele, R., Understanding the Relationship between Risks and Odds Ratios (2006) Clin. J. Sport Med, 16, pp. 107-110. , [CrossRef] [PubMed]; Singh, A., Hussain, S., Najmi, A.K., Number of studies, heterogeneity, generalisability, and the choice of method for meta-analysis (2017) J. Neurol. Sci, 381, p. 347. , [CrossRef]; Borenstein, M., Hedges, L.V., Higgins, J.P., Rothstein, H.R., (2011) Introduction to Meta-Analysis, , John Wiley & Sons: Hoboken, NJ, USA; Borenstein, M., Hedges, L., Higgins, J.P.T., Rothstein, H., (2013) Comprehensive meta-analysis version 3, , Biostat: Englewood, NJ, USA; Cohen, J., (2013) Statistical Power Analysis For The Behavioral Sciences, , Academic Press: Cambridge, MA, USA, [CrossRef]; Zhou, Z., Liang, Y., Zhang, X., Xu, J., Lin, J., Zhang, R., Kang, K., Zhao, M., Low-Density Lipoprotein Cholesterol and Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2020) Front. Aging Neurosci, 12, p. 5. , [CrossRef]; Hall, J.R., Wiechmann, A.R., Johnson, L.A., Edwards, M., Barber, R.C., Cunningham, R., Singh, M., O’bryant, S.E., Total cholesterol and neuropsychiatric symptoms in Alzheimer’s disease: The impact of total cholesterol level and gender (2014) Dement. Geriatr. Cogn. Disord, 38, pp. 300-309. , [CrossRef]; Tan, Z.S., Seshadri, S., Beiser, A., Wilson, P.W., Kiel, D.P., Tocco, M., D’Agostino, R.B., Wolf, P.A., Plasma total cholesterol level as a risk factor for Alzheimer disease: The Framingham Study (2003) Arch. Intern. Med, 163, pp. 1053-1057. , [CrossRef]; Launer, L.J., White, L.R., Petrovitch, H., Ross, G.W., Curb, J.D., Cholesterol and neuropathologic markers of AD: A population-based autopsy study (2001) Neurology, 57, pp. 1447-1452. , [CrossRef]; Reitz, C., Tang, M.-X., Luchsinger, J., Mayeux, R., Relation of plasma lipids to Alzheimer disease and vascular dementia (2004) Arch. Neurol, 61, pp. 705-714. , [CrossRef] [PubMed]; Lauretti, E., Praticò, D., Alzheimer’s disease: Phenotypic approaches using disease models and the targeting of tau protein (2020) Expert Opin. Ther. Targets, , [CrossRef] [PubMed]; Theofilas, P., Ehrenberg, A.J., Nguy, A., Thackrey, J.M., Dunlop, S., Mejia, M.B., Alho, A.T., Suemoto, C.K., Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer’s disease Braak stages: A quantitative study in humans (2018) Neurobiol. Aging, 61, pp. 1-12. , [CrossRef] [PubMed]; Carleton, R.A., Dwyer, J., Finberg, L., Flora, J., Goodman, D.S., Grundy, S.M., Havas, S., Lauer, R.M., Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health (1991) Circulation, 83, pp. 2154-2232. , [CrossRef]; Sharrett, A.R., Patsch, W., Sorlie, P.D., Heiss, G., Bond, M.G., Davis, C.E., Associations of lipoprotein cholesterols, apolipoproteins AI and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study (1994) Arterioscler. Thromb. J. Vasc. Biol, 14, pp. 1098-1104. , [CrossRef]; Breteler, M.M., Claus, J.J., Grobbee, D.E., Hofman, A., Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study (1994) BMJ, 308, pp. 1604-1608. , [CrossRef]; Tatemichi, T.K., Desmond, D.W., Prohovnik, I., Eidelberg, D., Dementia associated with bilateral carotid occlusions: Neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery (1995) J. Neurol. Neurosurg. Psychiatry, 58, pp. 633-636. , [CrossRef]; Moroney, J.T., Tang, M.-X., Berglund, L., Small, S., Merchant, C., Bell, K., Stern, Y., Mayeux, R., Low-density lipoprotein cholesterol and the risk of dementia with stroke (1999) JAMA, 282, pp. 254-260. , [CrossRef]; Dias, I.H., Polidori, M.C., Li, L., Weber, D., Stahl, W., Nelles, G., Grune, T., Griffiths, H.R., Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities (2014) J. Alzheimers Dis, 40, pp. 399-408. , [CrossRef]; Button, E.B., Robert, J., Caffrey, T.M., Fan, J., Zhao, W., Wellington, C.L., HDL from an Alzheimer’s disease perspective (2019) Curr. Opin. Lipidol, 30, p. 224. , [CrossRef]; Lepara, O., Valjevac, A., Alajbegović, A., Zaćiragić, A., Nakaš-Ićindić, E., Decreased serum lipids in patients with probable Alzheimer’s disease (2009) Bosn. J. Basic Med. Sci, 9, p. 215. , [CrossRef] [PubMed]; Reitz, C., Tang, M.-X., Schupf, N., Manly, J.J., Mayeux, R., Luchsinger, J.A., Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease (2010) Arch. Neurol, 67, pp. 1491-1497. , [CrossRef] [PubMed]; Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G., Siegel, G., Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors (2000) Arch. Neurol, 57, pp. 1439-1443. , [CrossRef] [PubMed]; Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S., Drachman, D.A., Statins and the risk of dementia (2000) Lancet, 356, pp. 1627-1631. , [CrossRef]; Reitz, C., Luchsinger, J., Tang, M.-X., Manly, J., Mayeux, R., Impact of plasma lipids and time on memory performance in healthy elderly without dementia (2005) Neurology, 64, pp. 1378-1383. , [CrossRef] [PubMed]; Kivipelto, M., Helkala, E.-L., Laakso, M.P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Nissinen, A., Midlife vascular risk factors and Alzheimer’s disease in later life: Longitudinal, population based study (2001) BMJ, 322, pp. 1447-1451. , [CrossRef]; Skoog, I., Kalaria, R.N., Breteler, M.M., Vascular factors and Alzheimer disease (1999) Alzheimer Dis. Assoc. Disord, 13, pp. S106-s114. , [CrossRef]; An, Y., Zhang, X., Wang, Y., Wang, Y., Liu, W., Wang, T., Qin, Z., Xiao, R., Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: Results from EMCOA study (2019) Mol. Neurodegener, 14, pp. 1-19. , [CrossRef]; Clark, L.R., Norton, D., Berman, S.E., Johnson, S.C., Bendlin, B.B., Wieben, O., Turski, P., Gleason, C.E., Association of Cardiovascular and Alzheimer’s Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans (2019) J. Alzheimers Dis, pp. 1-11. , [CrossRef]; Yanagisawa, K., Cholesterol and pathological processes in Alzheimer’s disease (2002) J. Neurosci. Res, 70, pp. 361-366. , [CrossRef]},
correspondence_address1={Ubillos-Landa, S.; Department of Social Psychology, C/Villadiego, 1, Spain; email: subillos@ubu.es},
publisher={MDPI AG},
issn={20763425},
language={English},
abbrev_source_title={Brain Sci.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Veronese2020263,
author={Veronese, N. and Demurtas, J. and Pesolillo, G. and Celotto, S. and Barnini, T. and Calusi, G. and Caruso, M.G. and Notarnicola, M. and Reddavide, R. and Stubbs, B. and Solmi, M. and Maggi, S. and Vaona, A. and Firth, J. and Smith, L. and Koyanagi, A. and Dominguez, L. and Barbagallo, M.},
title={Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies},
journal={European Journal of Nutrition},
year={2020},
volume={59},
number={1},
pages={263-272},
doi={10.1007/s00394-019-01905-w},
note={cited By 32},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060754103&doi=10.1007%2fs00394-019-01905-w&partnerID=40&md5=b61a5b68a6b61965ac4ae80f9f0fb9e4},
affiliation={National Research Council, Neuroscience Institute, Aging Branch, Via Giustiniani, 2, Padova, 35128, Italy; Research Hospital, National Institute of Gastroenterlogy, IRCCS De Bellis, Castellana Grotte, BA, Italy; Primary Care Department, Azienda USL Toscana Sud Est, Grosseto, Italy; Primary Care Service, ASL 02, Chieti, Italy; Primary Care Department, Azienda per l’Assistenza Sanitaria 3 Alto Friuli -Collinare -Medio Friuli, Udine, Italy; Primary Care Service, AUSL Toscana Centro, Firenze, Italy; Primary Care Department, Azienda USL Toscana Centro, Prato, Italy; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, United Kingdom; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, De Crespigny Park, Box SE5 8AF, London, United Kingdom; Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, United Kingdom; Neuroscience Department, University of Padova, Padova, Italy; Primary Care Department, Azienda ULSS20 Verona, Verona, Italy; NICM Health Research Institute, University of Western Sydney, Penrith, Australia; Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom; The Cambridge Centre for Sport and Exercise Sciences, Department of Life Sciences, Anglia Ruskin University, Cambridge, United Kingdom; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3-5 Pabellón 11, Madrid, 28029, Spain; Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona, 0883, Spain; Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy},
abstract={Purpose: To map and grade all health outcomes associated with magnesium (Mg) intake and supplementation using an umbrella review. Methods: Umbrella review of systematic reviews with meta-analyses of observational studies and randomized controlled trials (RCTs) using placebo/no intervention as control group. We assessed meta-analyses of observational studies based on random-effect summary effect sizes and their p values, 95% prediction intervals, heterogeneity, small-study effects and excess significance. For meta-analyses of RCTs, outcomes with a random-effect p value < 0.005 and a high-GRADE assessment were classified as strong evidence. Results: From 2048 abstracts, 16 meta-analyses and 55 independent outcomes were included (36 in RCTs and 19 in observational studies). In RCTs of Mg versus placebo/no active treatment, 12 over 36 outcomes reported significant results (p < 0.05). A strong evidence for decreased need for hospitalization in pregnancy and for decreased risk of frequency and intensity of migraine relapses in people with migraine was observed using the GRADE assessment. In observational studies, 9/19 outcomes were significant (p < 0.05). However, only one outcome presented highly suggestive evidence (lower incidence of type 2 diabetes in people with higher Mg intake at baseline) and one suggestive (lower incidence of stroke associated with higher Mg intake at baseline). Conclusion: Strong evidence according to the GRADE suggests that Mg supplementation can decrease the risk of hospitalization in pregnant women and reduce the intensity/frequency of migraine. Higher Mg intake is associated with a decreased risk of type 2 diabetes and stroke with highly suggestive and suggestive evidence, respectively, in observational studies. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.},
author_keywords={Diabetes;  Magnesium;  Meta-analysis;  Pregnancy;  Stroke;  Umbrella review},
keywords={magnesium;  magnesium, Article;  cerebrovascular accident;  diet supplementation;  GRADE approach;  hospitalization;  human;  magnesium intake;  meta analysis;  migraine;  non insulin dependent diabetes mellitus;  outcome assessment;  pregnancy;  randomized controlled trial (topic);  systematic review;  dietary supplement;  health status;  observational study, Dietary Supplements;  Health Status;  Humans;  Magnesium;  Observational Studies as Topic},
chemicals_cas={magnesium, 7439-95-4; Magnesium},
funding_details={BayerBayer},
funding_details={King's College Hospital NHS Foundation TrustKing's College Hospital NHS Foundation Trust},
funding_details={National Institute for Health and Care ResearchNational Institute for Health and Care Research, NIHR, ICA-CL-2017-03-001},
funding_details={Instituto de Salud Carlos IIIInstituto de Salud Carlos III, ISCIII},
funding_details={European Regional Development FundEuropean Regional Development Fund, ERDF},
funding_text 1={Dr Koyanagi’s work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII—General Branch Evaluation and Promotion of Health Research—and the European Regional Development Fund (ERDF-FEDER). Dr. Demurtas received a honorary consultation from Bayer. Dr Stubbs is supported by Health Education England and the National Institute for Health Research HEE/ NIHR ICA Programme Clinical Lectureship (ICA-CL-2017-03-001). BS is partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. Dr Firth is supported by a Blackmores Institute Fellowship.},
references={Arnaud, M.J., Update on the assessment of magnesium status (2008) Br J Nutr, 99, pp. S24-S36; Swaminathan, R., Magnesium metabolism and its disorders (2003) Clin Biochem Rev Aust Assoc Clin Biochem, 24 (2), pp. 47-66. , COI: 1:STN:280:DC%2BD1cvgtVCmtw%3D%3D; Veronese, N., Zanforlini, B.M., Manzato, E., Sergi, G., Magnesium and healthy aging (2015) Magnes Res, 28 (3), pp. 112-115; Volpe, S.L., Magnesium in disease prevention and overall health (2013) Adv Nutr (Bethesda Md), 4 (3), pp. 378S-383S; Whang, R., Magnesium deficiency: pathogenesis, prevalence, and clinical implications (1987) Am J Med, 82 (3A), pp. 24-29. , COI: 1:CAS:528:DyaL2sXitFarsLY%3D; Galan, P., Preziosi, P., Durlach, V., Valeix, P., Ribas, L., Bouzid, D., Favier, A., Hercberg, S., Dietary magnesium intake in a French adult population (1997) Magnes Res, 10 (4), pp. 321-328; Moshfegh, A.G., Ahuja, J., Rhodes, J., Lacombrandy, D., What we eat in America (2009) NHANES 2005–2006: Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium, , https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/0506/usual_nutrient_intake_vitD_ca_phos_mg_2005-06.pdf, Accessed 20 May 2018; Barbagallo, M., Dominguez, L.J., Magnesium and type 2 diabetes (2015) World J Diabetes, 6 (10), pp. 1152-1157; Guerrero-Romero, F., Rodríguez-Morán, M., The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial (2009) J Hum hypertens, 23 (4), pp. 245-251; Veronese, N., Stubbs, B., Solmi, M., Noale, M., Vaona, A., Demurtas, J., Maggi, S., Dietary magnesium intake and fracture risk: data from a large prospective study (2017) Br J Nutr, 117 (11), pp. 1570-1576; Dominguez, L.J., Barbagallo, M., Lauretani, F., Bandinelli, S., Bos, A., Corsi, A.M., Simonsick, E.M., Ferrucci, L., Magnesium and muscle performance in older persons: the InCHIANTI study (2006) Am J Clin Nutr, 84 (2), pp. 419-426. , COI: 1:CAS:528:DC%2BD28XosVehsLc%3D; Veronese, N., Stubbs, B., Maggi, S., Notarnicola, M., Barbagallo, M., Firth, J., Dominguez, L.J., Caruso, M.G., Dietary magnesium and incident frailty in older people at risk for knee osteoarthritis: an eight-year longitudinal study (2017) Nutrients; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7 (1), p. 10; Avelino-Silva, T.J., Jaluul, O., Malnutrition in hospitalized older patients: management strategies to improve patient care and clinical outcomes (2017) Int J Gerontol, 11 (2), pp. 56-61; IntHout, J., Ioannidis, J.P.A., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) BMJ Open, 6 (7); Stroud, M., Duncan, H., Nightingale, J., Guidelines for enteral feeding in adult hospital patients (2003) Gut, 52, p. vii1. , PID: 14612488; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21 (11), pp. 1539-1558; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634. , COI: 1:STN:280:DyaK2svls1KjtA%3D%3D; Carvalho, A.F., Kohler, C.A., Brunoni, A.R., Miskowiak, K.W., Herrmann, N., Lanctot, K.L., Hyphantis, T.N., Berk, M., Bias in peripheral depression biomarkers (2016) Psychother Psychosom, 85 (2), pp. 81-90; Organization, W.H., WHO guidelines approved by the guidelines review committee (2011) WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia, , World Health Organization, Geneva; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid-Based Healthc, 13 (3), pp. 132-140; Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14 (1), p. 147; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Dinu, M., Pagliai, G., Casini, A., Sofi, F., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomized trials (2017) Nutr Metab Cardiovasc Dis, 27 (1); Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M.J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., Tsilidis, K.K., Adiposity and cancer at major anatomical sites: umbrella review of the literature (2017) BMJ, 356, p. j477; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, P.A., Campbell, H., Theodoratou, E., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P.A., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Veronese, N., Solmi, M., Caruso, M.G., Giannelli, G., Osella, A.R., Evangelou, E., Maggi, S., Tzoulaki, I., Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses (2018) Am J Clin Nutr, 107 (3), pp. 436-444; Ioannidis, J.A., The proposal to lower p value thresholds to 0.005 (2018) Jama, 319 (14), pp. 1429-1430; Benjamin, D.J., Berger, J.O., Johannesson, M., Nosek, B.A., Wagenmakers, E.J., Berk, R., Bollen, K.A., Johnson, V.E., Redefine statistical significance (2018) Nat Hum Behav, 2 (1), pp. 6-10; Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., Schünemann, H.J., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336 (7650), p. 924; Chen, G.C., Pang, Z., Liu, Q.F., Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies (2012) Eur J Clin Nutr, 66 (11), pp. 1182-1186; Sarai, M., Tejani, A.M., Chan, A.H., Kuo, I.F., Li, J., Magnesium for alcohol withdrawal (2013) Cochrane Database Syst Rev, 6, p. CD008358; Han, S., Crowther, C.A., Moore, V., Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour (2013) Cochrane Database Syst Rev, 5, p. CD000940; Makrides, M., Crosby, D.D., Bain, E., Crowther, C.A., Magnesium supplementation in pregnancy (2014) Cochrane Database Syst Rev, 4, p. CD000937; Ko, H.J., Youn, C.H., Kim, H.M., Cho, Y.J., Lee, G.H., Lee, W.K., Dietary magnesium intake and risk of cancer: a meta-analysis of epidemiologic studies (2014) Nutr Cancer, 66 (6), pp. 915-923; Zhang, X., Li, Y., Del Gobbo, L.C., Rosanoff, A., Wang, J., Zhang, W., Song, Y., Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials (2016) Hypertension, 68 (2), pp. 324-333; Chiu, H.Y., Yeh, T.H., Huang, Y.C., Chen, P.Y., Effects of Intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials (2016) Pain Physician, 19, pp. E97-E112. , PID: 26752497; Cheungpasitporn, W., Thongprayoon, C., Harindhanavudhi, T., Edmonds, P.J., Erickson, S.B., Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis (2016) Endocr Res, 41 (2), pp. 142-147; Fang, X., Han, H., Li, M., Liang, C., Fan, Z., Aaseth, J., He, J., Cao, Y., Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus: a systematic review and meta-regression analysis of prospective cohort studies (2016) Nutrients; Fang, X., Wang, K., Han, D., He, X., Wei, J., Zhao, L., Imam, M.U., Wang, F., Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies (2016) BMC Med, 14 (1), p. 210; Jiang, L., He, P., Chen, J., Liu, Y., Liu, D., Qin, G., Tan, N., Magnesium levels in drinking water and coronary heart disease mortality risk: a meta-analysis (2016) Nutrients; Han, H., Fang, X., Wei, X., Liu, Y., Jin, Z., Chen, Q., Fan, Z., Cao, Y., Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies (2017) Nutr J, 16 (1), p. 26; Wu, J., Xun, P., Tang, Q., Cai, W., He, K., Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies (2017) Nutr J, 16 (1), p. 60; Veronese, N., Watutantrige, S.F., Luchini, C., Solmi, M., Sartore, G., Sergi, G., Manzato, E., Stubbs, B., Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials (2016) Eur J Clin Nutr, 70 (12), pp. 1354-1359; Farsinejad-Marj, M., Saneei, P., Esmaillzadeh, A., Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis (2016) Osteop Int, 27 (4), pp. 1389-1399; Simental-Mendía, L.E., Sahebkar, A., Rodríguez-Morán, M., Guerrero-Romero, F., A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control (2016) Pharmacol Res, 111, pp. 272-282; Dong, J.-Y., Xun, P., He, K., Qin, L.-Q., Magnesium intake and risk of type 2 diabetes (2011) Meta-analysis of prospective cohort studies, 34 (9), pp. 2116-2122; Suarez, A., Pulido, N., Casla, A., Casanova, B., Arrieta, F.J., Rovira, A., Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats (1995) Diabetologia, 38 (11), pp. 1262-1270. , COI: 1:CAS:528:DyaK28XitlOitA%3D%3D; Mauskop, A., Altura, B.M., Magnesium for migraine (1998) CNS drugs, 9 (3), pp. 185-190. , COI: 1:CAS:528:DyaK1cXisFGlsbg%3D; Weaver, K., Magnesium and migraine (1990) Headache, 30 (3), p. 168168; Swanson, D.R., Migraine and magnesium: eleven neglected connections (1988) Perspect Biol Med, 31 (4), pp. 526-557. , COI: 1:STN:280:DyaL1MzhsFWlsA%3D%3D; Younger, D.S., Epidemiology of migraine (2016) Neurol Clin, 34 (4), pp. 849-861; Finkbeiner, S., Stevens, C.F., Applications of quantitative measurements for assessing glutamate neurotoxicity (1988) Proc Natl Acad Sci, 85 (11), p. 40714074; Stys, P.K., Ransom, B.R., Waxman, S.G., Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia (1990) Neurosci Lett, 115 (2-3), pp. 293-299. , COI: 1:CAS:528:DyaK3MXktlal; Ioannidis, J.P., Trikalinos, T.A., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey (2007) CMAJ, 176 (8), pp. 1091-1096; Ioannidis, J.P., Patsopoulos, N.A., Rothstein, H.R., Reasons or excuses for avoiding meta-analysis in forest plots (2008) BMJ, 336 (7658), pp. 1413-1415; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P., Selection in reported epidemiological risks: an empirical assessment (2007) PLoS Med, 4 (3); Gröber, U., Schmidt, J., Kisters, K., Magnesium in prevention and therapy (2015) Nutrients, 7 (9), pp. 8199-8226},
correspondence_address1={Veronese, N.; National Research Council, Via Giustiniani, 2, Italy; email: ilmannato@gmail.com},
publisher={Springer},
issn={14366207},
coden={EJNUF},
pubmed_id={30684032},
language={English},
abbrev_source_title={Eur. J. Nutr.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Smith20191,
author={Smith, L. and Luchini, C. and Demurtas, J. and Soysal, P. and Stubbs, B. and Hamer, M. and Nottegar, A. and Lawlor, R.T. and Lopez-Sanchez, G.F. and Firth, J. and Koyanagi, A. and Roberts, J. and Willeit, P. and Waldhoer, T. and Loosemore, M. and Abbs, A.D. and Johnstone, J. and Yang, L. and Veronese, N.},
title={Telomere length and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies},
journal={Ageing Research Reviews},
year={2019},
volume={51},
pages={1-10},
doi={10.1016/j.arr.2019.02.003},
note={cited By 31},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061644117&doi=10.1016%2fj.arr.2019.02.003&partnerID=40&md5=6f4d1c9fc8e1f0042105a06cb73ea69c},
affiliation={The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom; Department of Diagnostics and Public Health, University of Verona, Italy; Primary Care Department Azienda USL Toscana Sud Est, Grosseto, Italy; Kayseri Education and Research Hospital, Geriatric Center, Kayseri, Turkey; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, United Kingdom; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, De Crespigny Park, London, United Kingdom; School Sport Exercise Health Sciences, Loughborough University, Loughborough, United Kingdom; Department of Surgery, Section of Pathology, San Bortolo Hospital, Vicenza, Italy; ARC-Net Research Center, University of Verona, Verona, Italy; Faculty of Sports Sciences, University of Murcia, Spain; NICM Health Research Institute, University of Western Sydney, Sydney, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia; Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain; Department of Neurology, Medical University of Innsbruck, Austria; Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom; Department of Epidemiology, Center for Public Health, Medical University of Vienna, Austria; University College London, Institute of Sport, Exercise and Health, United Kingdom; Pennine Acute Hospitals, NHS Trust, United Kingdom; National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy},
abstract={The aim of the present study was to map and grade evidence for the relationships between telomere length with a diverse range of health outcomes, using an umbrella review of systematic reviews with meta-analyses. We searched for meta-analyses of observational studies reporting on the association of telomere length with any health outcome (clinical disease outcomes and intermediate traits). For each association, random-effects summary effect size, 95% confidence interval (CI), and 95% prediction interval were calculated. To evaluate the credibility of the identified evidence, we assessed also heterogeneity, evidence for small-study effect and evidence for excess significance bias. Twenty-one relevant meta-analyses were identified reporting on 50 different outcomes. The level of evidence was high only for the association of short telomeres with higher risk of gastric cancer in the general population (relative risk, RR = 1.95, 95%CI: 1.68–2.26), and moderate for the association of shorter telomeres with diabetes or with Alzheimer's disease, even if limited to meta-analyses of case-control studies. There was weak evidence for twenty outcomes and not significant association for 27 health outcomes. The present umbrella review demonstrates that shorter telomere length may have an important role in incidence gastric cancer and, probably, diabetes and Alzheimer's disease. At the same time, conversely to general assumptions, it does not find strong evidence supporting the notion that shorter telomere length plays an important role in many health outcomes that have been studied thus far. © 2019 Elsevier B.V.},
author_keywords={Observational studies;  Telomere length;  Umbrella review},
keywords={Alzheimer disease;  confidence interval;  diabetes mellitus;  effect size;  health status;  human;  meta analysis;  observational study;  outcome assessment;  predictive value;  Review;  risk factor;  stomach cancer;  systematic review;  telomere length;  Alzheimer disease;  case control study;  diabetes mellitus;  genetics;  incidence;  observational study;  physiology;  procedures;  stomach tumor;  telomere;  treatment outcome, Alzheimer Disease;  Case-Control Studies;  Diabetes Mellitus;  Humans;  Incidence;  Observational Studies as Topic;  Stomach Neoplasms;  Telomere;  Treatment Outcome},
references={Adam, R., Diez-Gonzalez, L., Ocana, A., Seruga, B., Amir, E., Templeton, A.J., Prognostic role of telomere length in malignancies: a meta-analysis and meta-regression (2017) Exp. Mol. Pathol., 102 (3), pp. 455-474; Adamson, D.J., King, D.J., Haites, N.E., Significant telomere shortening in childhood leukemia (1992) Cancer Genet. Cytogenet., 61 (2), pp. 204-206; Allsopp, R.C., Chang, E., Kashefi-Aazam, M., Telomere shortening is associated with cell division in vitro and in vivo (1995) Exp. Cell Res., 220 (1), pp. 194-200; American Diabetes A, Diagnosis and classification of diabetes mellitus (2010) Diabetes Care, 33. , S62-S9; Aragona, M., Maisano, R., Panetta, S., Telomere length maintenance in aging and carcinogenesis (2000) Int. J. Oncol., 17 (5), pp. 981-990; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach (2015) Int. J. Evid. Healthc., 13 (3), pp. 132-140; Belbasis, L., Savvidou, M.D., Kanu, C., Evangelou, E., Tzoulaki, I., Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses (2016) BMC Med., 14 (1), p. 147; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P.A., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat. Disord., 23, pp. 1-9; Blackburn, E.H., Epel, E.S., Lin, J., Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection (2015) Science (New York, NY), 350 (6265), pp. 1193-1198; Brownlee, M., Biochemistry and molecular cell biology of diabetic complications (2001) Nature, 414 (6865), pp. 813-820; Collaboration, C., Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Collaboration (2008); D'Arcangelo, D., Tinaburri, L., Dellambra, E., The role of p16(INK4a) pathway in human epidermal stem cell self-renewal, aging and Cancer (2017) Int. J. Mol. Sci., 18 (7); D'Mello, M.J., Ross, S.A., Briel, M., Anand, S.S., Gerstein, H., Pare, G., Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis (2015) Circ. Cardiovasc. Genet., 8 (1), pp. 82-90; Darrow, S.M., Verhoeven, J.E., Revesz, D., The association between psychiatric disorders and telomere length: a meta-analysis involving 14,827 persons (2016) Psychosom. Med., 78 (7), pp. 776-787; De Vitis, M., Berardinelli, F., Sgura, A., Telomere length maintenance in Cancer: At the crossroad between telomerase and alternative lengthening of telomeres (ALT) (2018) Int. J. Mol. Sci., 19 (2); Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Eitan, E., Hutchison, E.R., Mattson, M.P., Telomere shortening in neurological disorders: an abundance of unanswered questions (2014) Trends Neurosci., 37 (5), pp. 256-263; Engelhardt, M., Martens, U.M., The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review) (1998) Oncol. Rep., 5 (5), pp. 1043-1052; Ennour-Idrissi, K., Maunsell, E., Diorio, C., Telomere length and breast Cancer prognosis: a systematic review (2017) Cancer Epidemiol. Biomarkers Prev., 26 (1), pp. 3-10; Epel, E.S., Blackburn, E.H., Lin, J., Accelerated telomere shortening in response to life stress (2004) Proc. Natl. Acad. Sci. U. S. A., 101 (49), pp. 17312-17315; Forero, D.A., Gonzalez-Giraldo, Y., Lopez-Quintero, C., Castro-Vega, L.J., Barreto, G.E., Perry, G., Telomere length in Parkinson's disease: a meta-analysis (2016) Exp. Gerontol., 75, pp. 53-55; Forero, D.A., Gonzalez-Giraldo, Y., Lopez-Quintero, C., Castro-Vega, L.J., Barreto, G.E., Perry, G., Meta-analysis of telomere length in alzheimer's disease (2016) J. Gerontol. A Biol. Sci. Med. Sci., 71 (8), pp. 1069-1073; Harley, C.B., Vaziri, H., Counter, C.M., Allsopp, R.C., The telomere hypothesis of cellular aging (1992) Exp. Gerontol., 27 (4), pp. 375-382; Haycock, P.C., Heydon, E.E., Kaptoge, S., Butterworth, A.S., Thompson, A., Willeit, P., Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis (2014) BMJ, 349, p. g4227; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat. Med., 21 (11), pp. 1539-1558; Higgins, J.P.T., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J. R. Stat. Soc. Ser. A Stat. Soc., 172 (1), pp. 137-159; Huang, P., Zhou, J., Chen, S., Zou, C., Zhao, X., Li, J., The association between obstructive sleep apnea and shortened telomere length: a systematic review and meta-analysis (2018) Sleep Med., 48, pp. 107-112; Hug, N., Lingner, J., Telomere length homeostasis (2006) Chromosoma, 115 (6), pp. 413-425; Hunt, S.C., Kimura, M., Hopkins, P.N., Leukocyte telomere length and coronary artery calcium (2015) Am. J. Cardiol., 116 (2), pp. 214-218; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Ioannidis, J.P.A., Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) Can. Med. Assoc. J., 181 (8), pp. 488-493; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J. Math. Psychol., 57 (5), pp. 184-187; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q., 94 (3), pp. 485-514; Ioannidis, J., Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews (2017) Br. J. Sports Med. Engl., pp. 1456-1458; Ioannidis, J., Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews (2017) Br. J. Sports Med.; Ioannidis, J.P.A., The proposal to lower P value thresholds to.005 (2018) JAMA, 319 (14), pp. 1429-1430; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin. Trials, 4 (3), pp. 245-253; Januszkiewicz, D., Wysoki, J., Lewandowski, K., Lack of correlation between telomere length and telomerase activity and expression in leukemic cells (2003) Int. J. Mol. Med., 12 (6), pp. 935-938; Johnson, V.E., Revised standards for statistical evidence (2013) Proc. Natl. Acad. Sci.; Kachuri, L., Latifovic, L., Liu, G., Hung, R.J., Systematic review of genetic variation in chromosome 5p15.33 and telomere length as predictive and prognostic biomarkers for lung Cancer (2016) Cancer Epidemiol. Biomark. Prev., 25 (12), pp. 1537-1549; Kark, J.D., Nassar, H., Shaham, D., Leukocyte telomere length and coronary artery calcification in Palestinians (2013) Atherosclerosis, 229 (2), pp. 363-368; Kroenke, C.H., Pletcher, M.J., Lin, J., Telomerase, telomere length, and coronary artery calcium in black and white men in the CARDIA study (2012) Atherosclerosis, 220 (2), pp. 506-512; Latifovic, L., Peacock, S.D., Massey, T.E., King, W.D., The influence of alcohol consumption, cigarette smoking, and physical activity on leukocyte telomere length (2016) Cancer Epidemiol. Biomark. Prev., 25 (2), pp. 374-380; Lee, Y.H., Bae, S.C., Association between shortened telomere length and rheumatoid arthritis (2016) Zeitschrift für Rheumatologie, 77 (2), pp. 160-167; Lee, Y., Jung, J., Seo, Y., Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis (2017) Lupus, 26 (3), pp. 282-288; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357; Lu, W., Zhang, Y., Liu, D., Songyang, Z., Wan, M., Telomeres-structure, function, and regulation (2013) Exp. Cell Res., 319 (2), pp. 133-141; Mainous, A.G., 3rd, Codd, V., Diaz, V.A., Leukocyte telomere length and coronary artery calcification (2010) Atherosclerosis, 210 (1), pp. 262-267; Malouff, J.M., Schutte, N.S., A meta-analysis of the relationship between anxiety and telomere length (2017) Anxiety Stress Coping, 30 (3), pp. 264-272; Mehle, C., Ljungberg, B., Roos, G., Telomere shortening in renal cell carcinoma (1994) Cancer Res., 54 (1), pp. 236-241; Montpetit, A.J., Alhareeri, A.A., Montpetit, M., Telomere length: a review of methods for measurement (2014) Nurs. Res., 63 (4), pp. 289-299; Mundstock, E., Zatti, H., Louzada, F.M., Effects of physical activity in telomere length: systematic review and meta-analysis (2015) Ageing Res. Rev., 22, pp. 72-80; Naing, C., Aung, K., Lai, P.K., Mak, J.W., Association between telomere length and the risk of colorectal cancer: a meta-analysis of observational studies (2017) BMC Cancer, 17 (1), p. 24; Needham, B.L., Mezuk, B., Bareis, N., Lin, J., Blackburn, E.H., Epel, E.S., Depression, anxiety and telomere length in young adults: evidence from the National Health and Nutrition Examination Survey (2015) Mol. Psychiatry, 20 (4), pp. 520-528; Nilsonne, G., Tamm, S., Mansson, K.N., Akerstedt, T., Lekander, M., Leukocyte telomere length and hippocampus volume: a meta-analysis (2015) F1000Research, 4, p. 1073; Njajou, O.T., Hsueh, W.C., Blackburn, E.H., Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study (2009) J. Gerontol. A Biol. Sci. Med. Sci., 64 (8), pp. 860-864; Ohyashiki, J.H., Ohyashiki, K., Fujimura, T., Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes (1994) Cancer Res., 54 (13), pp. 3557-3560; Panossian, L.A., Porter, V.R., Valenzuela, H.F., Telomere shortening in T cells correlates with Alzheimer's disease status (2003) Neurobiol. Aging, 24 (1), pp. 77-84; Pavanello, S., Angelici, L., Hoxha, M., Sterol 27-hydroxylase polymorphism significantly associates with shorter telomere, higher cardiovascular and Type-2 diabetes risk in obese subjects (2018) Front. Endocrinol., 9, p. 309; Polho, G.B., De-Paula, V.J., Cardillo, G., dos Santos, B., Kerr, D.S., Leukocyte telomere length in patients with schizophrenia: a meta-analysis (2015) Schizophr. Res., 165 (2-3), pp. 195-200; Rehkopf, D.H., Needham, B.L., Lin, J., Leukocyte telomere length in relation to 17 biomarkers of cardiovascular disease risk: a cross-sectional study of US adults (2016) PLoS Med., 13 (11); Ridout, K.K., Ridout, S.J., Price, L.H., Sen, S., Tyrka, A.R., Depression and telomere length: a meta-analysis (2016) J. Affect. Disord., 191, pp. 237-247; Robinson, M.O., Telomerase and cancer (2000) Genet. Eng., 22, pp. 209-222; Russo, P., Prinzi, G., Proietti, S., Shorter telomere length in schizophrenia: evidence from a real-world population and meta-analysis of most recent literature (2018) Schizophr. Res.; Sanchez-Espiridion, B., Chen, M., Chang, J.Y., Telomere length in peripheral blood leukocytes and lung cancer risk: a large case–control study in Caucasians (2014) Cancer Res.; Shammas, M.A., Telomeres, lifestyle, cancer, and aging (2011) Curr. Opin. Clin. Nutr. Metab. Care, 14 (1), pp. 28-34; Shay, J.W., Wright, W.E., Telomerase activity in human cancer (1996) Curr. Opin. Oncol., 8 (1), pp. 66-71; Shea, B.J., Grimshaw, J.M., Wells, G.A., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med. Res. Methodol., 7 (1), p. 10; SN, S., MJ, M., The relationship between perceived stress and telomere length: a meta-analysis (2016) Stress Health, 32 (4), pp. 313-319; Sun, B., Wang, Y., Kota, K., Telomere length variation: a potential new telomere biomarker for lung cancer risk (2015) Lung Cancer (Amsterdam, Netherlands), 88 (3), pp. 297-303; Tentolouris, N., Nzietchueng, R., Cattan, V., White blood cells telomere length is shorter in males with type 2 diabetes and Microalbuminuria (2007) Diabetes Care, 30 (11), pp. 2909-2915; Veronese, N., Solmi, M., Caruso, M.G., Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses (2018) Am. J. Clin. Nutr., 107 (3), pp. 436-444; Wang, J., Dong, X., Cao, L., Association between telomere length and diabetes mellitus: a meta-analysis (2016) J. Int. Med. Res., 44 (6), pp. 1156-1173; Wang, W., Zheng, L., Zhou, N., Meta-analysis of associations between telomere length and colorectal cancer survival from observational studies (2017) Oncotarget, 8 (37), p. 62500; Yaffe, K., Lindquist, K., Kluse, M., Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study (2011) Neurobiol. Aging, 32 (11), pp. 2055-2060; Zhang, C., Chen, X., Li, L., Zhou, Y., Wang, C., Hou, S., The association between telomere length and Cancer prognosis: evidence from a meta-analysis (2015) PLoS One, 10 (7); Zhang, N., Fan, C., Gong, M., Leucocyte telomere length and paroxysmal atrial fibrillation: a prospective cohort study and systematic review with meta-analysis (2018) J. Clin. Lab. Anal.; Zhou, J., Wang, J., Shen, Y., The association between telomere length and frailty: a systematic review and meta-analysis (2018) Exp. Gerontol., 106, pp. 16-20; Zhu, X., Han, W., Xue, W., The association between telomere length and cancer risk in population studies (2016) Sci. Rep., 6, p. 22243},
correspondence_address1={Smith, L.; The Cambridge Centre for Sport and Exercise Sciences, United Kingdom; email: lee.smith@anglia.ac.uk},
publisher={Elsevier Ireland Ltd},
issn={15681637},
coden={ARRGA},
pubmed_id={30776454},
language={English},
abbrev_source_title={Ageing Res. Rev.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Lilford2019,
author={Lilford, R. and Kyobutungi, C. and Ndugwa, R. and Sartori, J. and Watson, S.I. and Sliuzas, R. and Kuffer, M. and Hofer, T. and Porto De Albuquerque, J. and Ezeh, A.},
title={Because space matters: Conceptual framework to help distinguish slum from non-slum urban areas},
journal={BMJ Global Health},
year={2019},
volume={4},
number={2},
doi={10.1136/bmjgh-2018-001267},
art_number={e001267},
note={cited By 31},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064993336&doi=10.1136%2fbmjgh-2018-001267&partnerID=40&md5=654598230e719dc4c69ca4289300e765},
affiliation={Warwick Medical School, University of Warwick Warwick Medical School, Coventry, United Kingdom; African Population and Health Research Centre, Nairobi, Kenya; Global Urban Observatory Unit, United Nations Human Settlements Programme, Nairobi, Kenya; Faculty of Geo-Information Science and Earth Observation, Universiteit Twente, Enschede, Netherlands; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States; Institute for Global Sustainable Development, University of Warwick, Coventry, United Kingdom; Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States},
abstract={Despite an estimated one billion people around the world living in slums, most surveys of health and well-being do not distinguish between slum and non-slum urban residents. Identifying people who live in slums is important for research purposes and also to enable policymakers, programme managers, donors and non-governmental organisations to better target investments and services to areas of greatest deprivation. However, there is no consensus on what a slum is let alone how slums can be distinguished from non-slum urban precincts. Nor has attention been given to a more fine-grained classification of urban spaces that might go beyond a simple slum/non-slum dichotomy. The purpose of this paper is to provide a conceptual framework to help tackle the related issues of slum definition and classification of the urban landscape. We discuss: The concept of space as an epidemiological variable that results in 'neighbourhood effects'. The problems of slum area definition when there is no 'gold standard'. A long-list of variables from which a selection must be made in defining or classifying urban slum spaces. Methods to combine any set of identified variables in an operational slum area definition. Two basic approaches to spatial slum area definitions - top-down (starting with a predefined area which is then classified according to features present in that area) and bottom-up (defining the areal unit based on its features). Different requirements of a slum area definition according to its intended use. Implications for research and future development. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.},
author_keywords={definition;  identification;  mapping;  slums;  urban},
funding_text 1={Please send all correspondence to Prof. Karl Peltzer, Human Sciences Research Council, Private Bag X41, Pretoria 0001, South Africa or e-mail at . The study was funded by the Human Sciences Research Council. Contributions to the study implementation by Sharon Kleintjes and Hilton Donson are hereby acknowledged.},
references={(2016) Urbanization and Development: Emerging Futures. World Cities Report 2016, , UN-Habitat.. Nairobi, Kenya UN-Habitat; Oakes, J.M., The (mis)estimation of neighborhood effects: Causal inference for a practicable social epidemiology (2004) Soc Sci Med, 58, pp. 1929-1952; Ezeh, A., Oyebode, O., Satterthwaite, D., The history, geography, and sociology of slums and the health problems of people who live in slums (2017) The Lancet, 389, pp. 547-558; Mayne, A., (2017) Slums: The History of Global Injustice, , London, England: Reaktion Books; Lilford, R.J., Oyebode, O., Satterthwaite, D., Improving the health and welfare of people who live in slums (2017) Lancet, 389, pp. 559-570; (2017) Distinguishing Slum from Non-slum Areas to Identify Occupants' Issues, , https://unhabitat.org/distinguishing-slum-from-non-slum-areas-to-identify-occupantsissues/2017/, Accessed 30 Oct 2018; (2018), https://en.oxforddictionaries.com/definition/slum, English Oxford Livingliving Dictionaries. Slum. Oxford, England: Oxford Dictionaries [Accessed 30 Oct 2018]; Virchow, R., Pathology, C., (1858) Die Cellularpathologie in Ihrer Begründung Auf Physiologische und Pathologische Gewebelehre, , Berlin: Verlag von August Hirschwald; Bollen, K.A., Bauldry, S., Three Cs in measurement models: Causal indicators, composite indicators, and covariates (2011) Psychol Methods, 16, pp. 265-284; Hand, D.J., Statistics and the theory of measurement (1996) J R Stat Soc ser A Stat Soc, 159, pp. 445-492; Jansson, L.B., Parnas, J., Competing definitions of schizophrenia: What can be learned from polydiagnostic studies? (2007) Schizophr Bull, 33, pp. 1178-1200; Kohli, D., Sliuzas, R., Kerle, N., An ontology of slums for imagebased classification (2012) Comput Environ Urban Syst, 36, pp. 154-163; Kuffer, M., Pfeffer, K., Sliuzas, R., Slums from Space-15 years of slum mapping using remote sensing (2016) Remote Sens, p. 8; Kohli, D., Warwadekar, P., Kerle, N., Transferability of Object-Oriented image analysis methods for slum identification (2013) Remote Sens, 5, pp. 4209-4228; Liberatos, P., Link, B.G., Kelsey, J.L., The measurement of social class in epidemiology (1988) Epidemiol Rev, 10, pp. 87-121; Lee, N., Chamberlain, L., Pride and prejudice and causal indicators (2016) Measurement: Interdisciplinary Research and Perspectives, 14, pp. 105-109; Bird, J., Montebruno, P., Regan, T., Life in a slum: Understanding living conditions in Nairobi's slums across time and space (2017) Oxf Rev Econ Policy, 33, pp. 496-520; Manaseki-Holland, S., Lilford, R.J., Bishop, J.R.B., Reviewing deaths in British and US hospitals: A study of two scales for assessing preventability (2017) BMJ Qual Saf, 26, pp. 408-416; Grippa, T., Lennert, M., Beaumont, B., An open-source semiautomated processing chain for urban object-based classification (2017) Remote Sensing, p. 9; Lilford, R., Taiwo, O.J., De Albuquerque, J.P., Characterisation of urban spaces from space: Going beyond the urban versus rural dichotomy (2018) Lancet Public Health, 3, pp. e61-e62; Klotz, M., Wurm, M., Xiaoxiang, Z., (2017) Digital Deserts on the Ground and from Space. 2017 Joint Urban Remote Sensing Event (JURSE), , March 6-8, Dubai, United Arab Emirates; Kabaria, C.W., Molteni, F., Mandike, R., Mapping intra-urban malaria risk using high resolution satellite imagery: A case study of Dar es Salaam (2016) Int J Health Geogr, p. 15; UN-Habitat. The state of the world cities report 2008/2009-harmonious cities. Nairobi, Kenya UN-Habitat; 2008; UN-Habitat. Expert group meeting on urban indicators. Revised draft report. Nairobi, Kenya UN-Habitat; 2002; (2013), http://www.censusindia.gov.in/2011-Documents/Slum-26-09-13.pdf, Office of the Registrar General & Census Commissioner I. Primary census Abstract for slum: census of India [Accessed 30 Oct 2018]; (2015) Census of Slum Areas and Floating Population-2014, , Bangladesh Bureau of Statistics.. Dhaka, Bangladesh: Bangladesh Bureau of Statistics; Ferreira, P.C., Monge-Naranjo, A., (2017) Torres de Mello Pereira L. of Cities and Slums, , Rio de Janeiro, Brazil: Federal Reserve Bank of St Louis and Federal Reserve System; Kuffer, M., Pfeffer, K., Sliuzas, R., Capturing the urban divide in nighttime light images from the International Space Station (2018) IEEE J Sel Top Appl Earth Obs Remote Sens, 11, pp. 2578-2586},
correspondence_address1={Lilford, R.; Warwick Medical School, United Kingdom; email: r.j.lilford@warwick.ac.uk},
publisher={BMJ Publishing Group},
issn={20597908},
language={English},
abbrev_source_title={BMJ Glob. Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Li2020,
author={Li, N. and Wu, X. and Zhuang, W. and Xia, L. and Chen, Y. and Zhao, R. and Yi, M. and Wan, Q. and Du, L. and Zhou, Y.},
title={Soy and Isoflavone Consumption and Multiple Health Outcomes: Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies and Randomized Trials in Humans},
journal={Molecular Nutrition and Food Research},
year={2020},
volume={64},
number={4},
doi={10.1002/mnfr.201900751},
art_number={1900751},
note={cited By 30},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074040746&doi=10.1002%2fmnfr.201900751&partnerID=40&md5=4e58cf7339c4dc41ff65bf996f0fef9e},
affiliation={Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China; Chinese Evidence-based Medicine/Cochrane Center, Chengdu, 610041, China},
abstract={Scope: To assess the existing evidence of associations between consumption of soy and isoflavone and multiple health outcomes. Methods and results: This is an umbrella review of meta-analyses and systematic reviews of randomized trials and observational studies in humans. 114 Meta-analyses and systematic reviews are identified with 43 unique outcomes. Soy and isoflavone consumption seems more beneficial than harmful for a series of health outcomes. Beneficial associations are identified for cancers, cardiovascular disease, gynecological, metabolic, musculoskeletal, endocrine, neurological, and renal outcomes, particularly in perimenopausal women. Harmful association is only found for gastric cancer (RR: 1.17, 95% CI: 1.02–1.36) for high intake of miso soup (1–5 cups per day) in male. Conclusion: Generally, soy and isoflavone consumption is more beneficial than harmful. The results herein support promoting soy intake as part of a healthy diet. Randomized controlled trials are necessary to confirm this finding. © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim},
author_keywords={health;  isoflavones;  meta-analysis;  soy;  systematic review;  umbrella review},
keywords={isoflavone derivative, cardiovascular disease;  female;  human;  male;  meta analysis;  mortality;  neoplasm;  observational study;  randomized controlled trial (topic);  soybean, Cardiovascular Diseases;  Female;  Humans;  Isoflavones;  Male;  Neoplasms;  Observational Studies as Topic;  Randomized Controlled Trials as Topic;  Soybeans},
chemicals_cas={Isoflavones},
funding_details={98–680},
funding_details={2016SZ0047},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 30901427},
funding_text 1={Y.Z. and N.L. conceived the study. N.L., X.W., W.Z., L.X., Y.C., R.Z., M.Y., Q.W., and L.D. performed data extraction, analysis, and interpretation. N.L. wrote the manuscript under the guidance of Y.Z. All authors have read and approved the manuscript. This work was supported by Chinese Medical Board Grant on Evidence-Based Medicine, New York, USA (No. 98–680), National Natural Science Foundation of China (No. 30901427), and Sichuan Provincial Science and Technology Support Project (2016SZ0047).},
references={Hymowitz, T., Newell, C.A., (1981) Econ. Bot., 35, p. 272; Schmutz, J., Cannon, S.B., Schlueter, J., Ma, J., Mitros, T., Nelson, W., Hyten, D.L., Zhu, L., (2010) Nature, 463, p. 178; Kim, J., Choi, J.N., Choi, J.H., Cha, Y.S., Muthaiya, M.J., Lee, C.H., (2013) Mol. Nutr. Food Res., 57, p. 1886; Velazquez-Villegas, L.A., Tovar-Palacio, C., Palacios-Gonzalez, B., Torres, N., Tovar, A.R., Diaz-Villasenor, A., (2017) Mol. Nutr. Food Res., 61; Shizuka, F., Kido, Y., Nakazawa, T., Kitajima, H., Aizawa, C., Kayamura, H., Ichijo, N., (2004) BioFactors, 22, p. 165; Choi, M.S., Lee, M.K., Jung, U.J., Kim, H.J., Do, G.M., Park, Y.B., Jeon, S.M., (2009) Mol. Nutr. Food Res., 53, p. 751; Xie, Q., Gu, X., Chen, J., Liu, M., Xiong, F., Wu, X., Zhang, Y., Zha, L., (2018) Mol. Nutr. Food Res., 62; Lee, S.H., Lee, J., Jung, M.H., Lee, Y.M., (2013) Mol. Nutr. Food Res., 57, p. 225; Kushida, M., Okouchi, R., Iwagaki, Y., Asano, M., Du, M.X., Yamamoto, K., Tsuduki, T., (2018) Mol. Nutr. Food Res., 62; Lee, H.J., Hwang, Y.H., Kim, D.H., (2018) Mol. Nutr. Food Res., 62; Barnes, S., (2010) Lymphatic Res. Biol., 8, p. 89; Zaheer, K., Humayoun Akhtar, M., (2017) Crit. Rev. Food Sci. Nutr., 57, p. 1280; Anderson, J.W., Johnstone, B.M., Cook-Newell, M.E., (1995) N. Engl. J. Med., 333, p. 276; (1999) Fed. Regist., 64; Jayachandran, M., Xu, B., (2019) Food Chem., 271, p. 362; Messina, M., (2016) Nutrients, 8, p. 754; Ioannidis, J.P., (2008) Epidemiology, 19, p. 640; Shrier, I., Boivin, J.F., Steele, R.J., Platt, R.W., Furlan, A., Kakuma, R., Brophy, J., Rossignol, M., (2007) Am. J. Epidemiol., 166, p. 1203; Yi, M., Wu, X., Zhuang, W., Xia, L., Chen, Y., Zhao, R., Wan, Q., Zhou, Y., (2019) Mol. Nutr. Food Res., 63; Ioannidis, J.P., (2009) Can. Med. Assoc. J., 181, p. 488; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., (2015) Int. J. Evid.-Based Healthcare, 13, p. 132; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., (2007) BMC Med. Res. Methodol., 7, p. 10; Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., Norris, S., Schunemann, H.J., (2011) J. Chronic Dis., 64, p. 383; Namazi, N., Saneei, P., Larijani, B., Esmaillzadeh, A., (2018) Food Funct., 9, p. 2576; Myung, S.K., Ju, W., Choi, H.J., Kim, S.C., (2009) BJOG, 116, p. 1697; Applegate, C.C., Rowles, J.L., Ranard, K.M., Jeon, S., Erdman, J.W., (2018) Nutrients, 10, p. 40; Weng, K.G., Yuan, Y.L., (2017) Medicine, 96; Yu, Y., Jing, X., Li, H., Zhao, X., Wang, D., (2016) Sci. Rep., 6; Wu, S.H., Liu, Z., (2013) Nutr. Cancer, 65, p. 625; Zhao, T.T., Jin, F., Li, J.G., Xu, Y.Y., Dong, H.T., Liu, Q., Xing, P., Miao, Z.F., (2019) Clin. Nutr., 38, p. 136; Zhong, X.S., Ge, J., Chen, S.W., Xiong, Y.Q., Ma, S.J., Chen, Q., (2018) J. Acad. Nutr. Diet., 118, p. 637; You, J., Sun, Y., Bo, Y., Zhu, Y., Duan, D., Cui, H., Lu, Q., (2018) BMC Public Health, 18, p. 510; Yan, Z., Zhang, X., Li, C., Jiao, S., Dong, W., (2017) Eur. J. Prevent. Cardiol., 24, p. 735; Beavers, D.P., Beavers, K.M., Miller, M., Stamey, J., Messina, M.J., (2012) Nutr., Metab. Cardiovasc. Dis., 22, p. 182; Kou, T., Wang, Q., Cai, J., Song, J., Du, B., Zhao, K., Ma, Y., Zhang, C., (2017) Food Funct., 8, p. 2663; Tokede, O.A., Onabanjo, T.A., Yansane, A., Gaziano, J.M., Djousse, L., (2015) Br. J. Nutr., 114, p. 831; Simental-Mendia, L.E., Gotto, A.M., Jr., Atkin, S.L., Banach, M., Pirro, M., Sahebkar, A., (2018) J. Clin. Lipidol., 12, p. 16; Taku, K., Melby, M.K., Kronenberg, F., Kurzer, M.S., Messina, M., (2012) Menopause, 19, p. 776; Li, L., Lv, Y., Xu, L., Zheng, Q., (2015) Br. J. Clin. Pharmacol., 79, p. 593; Liu, J., Yuan, F., Gao, J., Shan, B., Ren, Y., Wang, H., Gao, Y., (2016) Oncotarget, 7; Ghazanfarpour, M., Sadeghi, R., Roudsari, R.L., (2016) J. Obstet. Gynaecol., 36, p. 160; Hooper, L., Madhavan, G., Tice, J.A., Leinster, S.J., Cassidy, A., (2010) Hum. Reprod. Update, 16, p. 745; Li, W., Ruan, W., Peng, Y., Wang, D., (2018) Diabetes Res. Clin. Pract., 137, p. 190; Akhlaghi, M., Zare, M., Nouripour, F., (2017) Adv. Nutr., 8, p. 705; Zhang, X.M., Zhang, Y.B., Chi, M.H., (2016) Yonsei Med. J., 57, p. 681; Fang, K., Dong, H., Wang, D., Gong, J., Huang, W., Lu, F., (2016) Mol. Nutr. Food Res., 60, p. 1602; Bolanos, R., Francia, J., (2010) Menopause, 17, p. 1201; Lambert, M.N.T., Hu, L.M., Jeppesen, P.B., (2017) Am. J. Clin. Nutr., 106, p. 801; Taku, K., Melby, M.K., Kurzer, M.S., Mizuno, S., Watanabe, S., Ishimi, Y., (2010) Bone, 47, p. 413; Hooper, L., Ryder, J.J., Kurzer, M.S., Lampe, J.W., Messina, M.J., Phipps, W.R., Cassidy, A., (2009) Hum. Reprod. Update, 15, p. 423; Hamilton-Reeves, J.M., Vazquez, G., Duval, S.J., Phipps, W.R., Kurzer, M.S., Messina, M.J., (2010) Fertil. Steril., 94, p. 997; Otun, J., Sahebkar, A., Ostlundh, L., Atkin, S.L., Sathyapalan, T., (2019) Sci. Rep., 9, p. 3964; Cheng, P.F., Chen, J.J., Zhou, X.Y., Ren, Y.F., Huang, W., Zhou, J.J., Xie, P., (2015) Menopause, 22, p. 198; Thaung Zaw, J.J., Howe, P.R.C., Wong, R.H.X., (2017) Ann. N. Y. Acad. Sci., 1403, p. 150; Fattah, A., (2017) J. Menopausal Med., 23, p. 160; Jing, Z., Wei-Jie, Y., (2016) Clin. Nutr., 35, p. 117; Ignatowski, A.I., (1908) Arch. Med. Exp. Anat. Pathol., 20, p. 1; Carroll, K.K., (1982) Fed. Proc., 41, p. 2792; Sacks, F.M., Lichtenstein, A., Van Horn, L., Harris, W., Kris-Etherton, P., Winston, M., (2006) Circulation, 113, p. 1034; Blanco Mejia, S., Messina, M., Li, S.S., Viguiliouk, E., Chiavaroli, L., Khan, T.A., Srichaikul, K., Jenkins, D.J.A., (2019) J. Nutr., 149, p. 968; Lovati, M.R., Manzoni, C., Gianazza, E., Arnoldi, A., Kurowska, E., Carroll, K.K., Sirtori, C.R., (2000) J. Nutr., 130, p. 2543; Lammi, C., Zanoni, C., Arnoldi, A., Vistoli, G., (2015) J. Agric. Food Chem., 63, p. 7945; Jenkins, D.J., Mirrahimi, A., Srichaikul, K., Berryman, C.E., Wang, L., Carleton, A., Abdulnour, S., Kris-Etherton, P.M., (2010) J. Nutr., 140; Zhang, X., Shu, X.O., Gao, Y.T., Yang, G., Li, Q., Li, H., Jin, F., Zheng, W., (2003) J. Nutr., 133, p. 2874; Kokubo, Y., Iso, H., Ishihara, J., Okada, K., Inoue, M., Tsugane, S., Group, J.S., (2007) Circulation, 116, p. 2553; Sekikawa, A., Ihara, M., Lopez, O., Kakuta, C., Lopresti, B., Higashiyama, A., Aizenstein, H., Cui, C., (2019) Curr. Cardiol. Rev., 15, p. 114; Setchell, K.D., Clerici, C., (2010) J. Nutr., 140; Zhang, X., Gao, Y.T., Yang, G., Li, H., Cai, Q., Xiang, Y.B., Ji, B.T., Shu, X.O., (2012) Int. J. Epidemiol., 41, p. 1367; Liu, Z.M., Ho, S.C., Chen, Y.M., Ho, S., To, K., Tomlinson, B., Woo, J., (2014) Mol. Nutr. Food Res., 58, p. 709; Sacks, F.M., Lichtenstein, A.H., Wu, J.H.Y., Appel, L.J., Creager, M.A., Kris-Etherton, P.M., Miller, M., Van Horn, L.V., (2017) Circulation, 136; Hu, X., Gao, J., Zhang, Q., Fu, Y., Li, K., Zhu, S., Li, D., (2013) Mol. Nutr. Food Res., 57, p. 2147; Messina, M.J., (1999) Am. J. Clin. Nutr., 70, p. 439s; Zhao, Y., Martin, B.R., Weaver, C.M., (2005) J. Nutr., 135, p. 2379; Slavin, M., Kenworthy, W., Yu, L.L., (2009) J. Agric. Food Chem., 57; Yang, G., Shu, X.O., Li, H.L., Chow, W.H., Wen, W., Xiang, Y.B., Zhang, X., Zheng, W., (2013) J. Clin. Oncol., 31, p. 1548; Yang, G., Shu, X.O., Chow, W.H., Zhang, X., Li, H.L., Ji, B.T., Cai, H., Zheng, W., (2012) Am. J. Epidemiol., 176, p. 846; Shu, X.O., Zheng, Y., Cai, H., Gu, K., Chen, Z., Zheng, W., Lu, W., (2009) J. Am. Med. Assoc., 302, p. 2437; Lee, S.A., Shu, X.O., Li, H., Yang, G., Cai, H., Wen, W., Ji, B.T., Zheng, W., (2009) Am. J. Clin. Nutr., 89, p. 1920; Hamilton-Reeves, J.M., Rebello, S.A., Thomas, W., Kurzer, M.S., Slaton, J.W., (2007) Nutr. Cancer, 60, p. 7; Miyanaga, N., Akaza, H., Hinotsu, S., Fujioka, T., Naito, S., Namiki, M., Takahashi, S., Tsuji, H., (2012) Cancer Sci., 103, p. 125; Fleshner, N.E., Kapusta, L., Donnelly, B., Tanguay, S., Chin, J., Hersey, K., Farley, A., Parulekar, W.R., (2011) J. Clin. Oncol., 29, p. 2386; Bosland, M.C., Kato, I., Zeleniuch-Jacquotte, A., Schmoll, J., Enk Rueter, E., Melamed, J., Kong, M.X., Davies, J.A., (2013) J. Am. Med. Assoc., 310, p. 170; Khan, S.A., Chatterton, R.T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Bergan, R.C., (2012) Cancer Prev. Res., 5, p. 309; Quaas, A.M., Kono, N., Mack, W.J., Hodis, H.N., Felix, J.C., Paulson, R.J., Shoupe, D., (2013) Menopause, 20, p. 840; Oba, S., Nagata, C., Shimizu, N., Shimizu, H., Kametani, M., Takeyama, N., Ohnuma, T., Matsushita, S., (2007) Nutr. Cancer, 57, p. 151; Adlercreutz, H., Markkanen, H., Watanabe, S., (1993) Lancet, 342, p. 1209; Iwasaki, M., Inoue, M., Otani, T., Sasazuki, S., Kurahashi, N., Miura, T., Yamamoto, S., Tsugane, S., (2008) J. Clin. Oncol., 26, p. 1677; Kurahashi, N., Iwasaki, M., Inoue, M., Sasazuki, S., Tsugane, S., (2008) J. Clin. Oncol., 26, p. 5923; Shike, M., Doane, A.S., Russo, L., Cabal, R., Reis-Filho, J.S., Gerald, W., Cody, H., Norton, L., (2014) J. Natl. Cancer Inst., 106; Wood, C.E., Register, T.C., Cline, J.M., (2007) Carcinogenesis, 28, p. 801; Barzi, A., Lenz, A.M., Labonte, M.J., Lenz, H.J., (2013) Clin. Cancer Res., 19, p. 5842; Marcela, G.M., Eva, R.G., Del Carmen, R.M., Rosalva, M.E., (2016) Plant Foods Hum. Nutr., 71, p. 368; Gadgeel, S.M., Ali, S., Philip, P.A., Wozniak, A., Sarkar, F.H., (2009) Cancer, 115, p. 2165; Dia, V.P., Berhow, M.A., Gonzalez De Mejia, E., (2008) J. Agric. Food Chem., 56; Hamalainen, M., Nieminen, R., Vuorela, P., Heinonen, M., Moilanen, E., (2007) Mediators Inflammation, 2007, p. 1; Tsugane, S., Sasazuki, S., Kobayashi, M., Sasaki, S., (2004) Br. J. Cancer, 90, p. 128; Wakasugi, M., James Kazama, J., Narita, I., (2015) Intern. Med., 54, p. 903; Tsugane, S., Tei, Y., Takahashi, T., Watanabe, S., Sugano, K., (1994) Jpn. J. Cancer Res., 85, p. 474; Tatematsu, M., Takahashi, M., Fukushima, S., Hananouchi, M., Shirai, T., (1975) J. Natl. Cancer Inst., 55, p. 101; Takahashi, M., Hasegawa, R., (1985) Princess Takamatsu Symp., 16, p. 169; Correa, P., (1988) Cancer Res., 48, p. 3554; Fitzpatrick, L.A., (1999) Mayo Clin. Proc., 74, p. 601; Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Ockene, J., (2002) J. Am. Med. Assoc., 288, p. 321; Beral, V., (2003) Lancet, 362, p. 1330; Oseni, T., Patel, R., Pyle, J., Jordan, V.C., (2008) Planta Med., 74, p. 1656; Lieberman, S., (1996) J. Clin. Endocrinol. Metab., 81, p. 850; Hwang, C.S., Kwak, H.S., Lim, H.J., Lee, S.H., Kang, Y.S., Choe, T.B., Hur, H.G., Han, K.O., (2006) J. Steroid Biochem. Mol. Biol., 101, p. 246; Cook, C.D., (1960) N. Engl. J. Med., 263, p. 1076; Nordlee, J.A., Taylor, S.L., Townsend, J.A., Thomas, L.A., Bush, R.K., (1996) N. Engl. J. Med., 334, p. 688; Aguilar, F., Crebelli, R., Di Domenico, A., Dusemund, B., Frutos, M.J., Galtier, P., Gott, D., Sou, E.P.F.A.N., (2015) EFSA J., 13, p. 4246; Papatheodorou, S., (2019) Eur. J. Epidemiol., 34, p. 543},
correspondence_address1={Zhou, Y.; Department of Gastrointestinal Surgery, China; email: nutritioner@hotmail.com},
publisher={Wiley-VCH Verlag},
issn={16134125},
pubmed_id={31584249},
language={English},
abbrev_source_title={Mol. Nutr. Food Res.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Yang20192315,
author={Yang, T. and Li, X. and Montazeri, Z. and Little, J. and Farrington, S.M. and Ioannidis, J.P.A. and Dunlop, M.G. and Campbell, H. and Timofeeva, M. and Theodoratou, E.},
title={Gene–environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies},
journal={International Journal of Cancer},
year={2019},
volume={145},
number={9},
pages={2315-2329},
doi={10.1002/ijc.32057},
note={cited By 28},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060179889&doi=10.1002%2fijc.32057&partnerID=40&md5=31b152230aee11424e556fdb0a1fe395},
affiliation={Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom; Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, United Kingdom; Stanford Prevention Research Center, Departments of Medicine, of Health Research and Policy, and of Biomedical Data Science, Stanford University School of Medicine, and Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, United States},
abstract={The cause of colorectal cancer (CRC) is multifactorial, involving both genetic variants and environmental risk factors. We systematically searched the MEDLINE, EMBASE, China National Knowledge Infrastructure (CNKI) and Wanfang databases from inception to December 2016, to identify systematic reviews and meta-analyses of observational studies that investigated gene–environment (G×E) interactions in CRC risk. Then, we critically evaluated the cumulative evidence for the G×E interactions using an extension of the Human Genome Epidemiology Network's Venice criteria. Overall, 15 articles reporting systematic reviews of observational studies on 89 G×E interactions, 20 articles reporting meta-analyses of candidate gene- or single-nucleotide polymorphism-based studies on 521 G×E interactions, and 8 articles reporting 33 genome-wide G×E interaction analyses were identified. On the basis of prior and observed scores, only the interaction between rs6983267 (8q24) and aspirin use was found to have a moderate overall credibility score as well as main genetic and environmental effects. Though 5 other interactions were also found to have moderate evidence, these interaction effects were tenuous due to the lack of main genetic effects and/or environmental effects. We did not find highly convincing evidence for any interactions, but several associations were found to have moderate strength of evidence. Our conclusions are based on application of the Venice criteria which were designed to provide a conservative assessment of G×E interactions and thus do not include an evaluation of biological plausibility of an observed joint effect. © 2018 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC},
author_keywords={colorectal cancer;  diet;  environment;  gene;  interaction;  risk factor},
keywords={acetylsalicylic acid;  estrogen;  acetylsalicylic acid, alcohol consumption;  cancer risk;  colorectal cancer;  dietary intake;  drug exposure;  environmental exposure;  gene identification;  genetic analysis;  genetic variability;  genome-wide association study;  genotype environment interaction;  hormonal therapy;  human;  meta analysis;  obesity;  priority journal;  Review;  risk assessment;  risk factor;  single nucleotide polymorphism;  systematic review;  chromosome 8;  colorectal tumor;  genetic predisposition;  genetics;  genotype environment interaction;  observational study;  single nucleotide polymorphism, Aspirin;  Chromosomes, Human, Pair 8;  Colorectal Neoplasms;  Gene-Environment Interaction;  Genetic Predisposition to Disease;  Humans;  Observational Studies as Topic;  Polymorphism, Single Nucleotide;  Risk Factors;  Systematic Reviews as Topic},
chemicals_cas={acetylsalicylic acid, 493-53-8, 50-78-2, 53663-74-4, 53664-49-6, 63781-77-1; Aspirin},
funding_details={HHSN26120100037C, N01-PC-35137, N01-PC-67001},
funding_details={National Institutes of HealthNational Institutes of Health, NIH, K05 CA154337, K07 CA190673, P01 CA033619, P01 CA055075, P01 CA087969, P50 CA127003, R01 CA042182, R01 CA063464, R01 CA137178, R01 CA151993, R01 CA48998, R01 CA60987, R10CA012283, R35 CA197735, R37 CA54281, U01 CA167552, U01 HG 004438, U01 HG004446, UM1 CA186107, Z01 CP 010200},
funding_details={National Cancer InstituteNational Cancer Institute, NCI, CA015704R01, CA074778U01, CA074783U01/U24, CA074794U01/U24, CA074799U01/U24, CA074800U01/U24, CA074806U01/U24, CA097735UM1, CA122839U01/U24, CA137088P30, CA143247R01201407U01, R01CA076366, U01CA167551},
funding_details={California Department of Public HealthCalifornia Department of Public Health, CDPH, HHSN261201000035C},
funding_details={Association Anne de Bretagne GenetiqueAssociation Anne de Bretagne Genetique},
funding_details={Ontario Institute for Cancer ResearchOntario Institute for Cancer Research, OICR},
funding_details={Ontario Research FoundationOntario Research Foundation, ORF},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR},
funding_details={Medical Research CouncilMedical Research Council, MRC, MC_PC_U127527198, MR/K018647/1},
funding_details={Cancer Research UKCancer Research UK, CRUK, C31250/A22804C348/A18927},
funding_details={National Heart and Lung InstituteNational Heart and Lung Institute, NHLI, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN268201100046C, HHSN271201100004C},
funding_details={Deutsche ForschungsgemeinschaftDeutsche Forschungsgemeinschaft, DFG, BR 1704/17-1, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HE 5998/2-1, HO 5117/2-1, KL 2354/3-1, RO 2270/8-1},
funding_details={Bundesministerium für Bildung und ForschungBundesministerium für Bildung und Forschung, BMBF, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01KH0404},
funding_details={Ontario Ministry of Research, Innovation and ScienceOntario Ministry of Research, Innovation and Science, MRIS},
funding_details={China Scholarship CouncilChina Scholarship Council, CSC},
funding_details={Conseil Régional des Pays de la LoireConseil Régional des Pays de la Loire, HHSN2612013000121, N01-CN-67009, N01-PC-35142},
funding_details={Groupement des Entreprises Françaises dans la lutte contre le CancerGroupement des Entreprises Françaises dans la lutte contre le Cancer, GEFLUC, PHRC-BRD09/C},
funding_text 1={The work was supported by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre. Acknowledgments for the Scottish Colorectal Cancer Study: We thank the participants in all of the studies that contributed to this piece of work and all the recruitment teams and collaborators who make such studies possible. We acknowledge the excellent technical support from Marion Walker. We are grateful to Ruth Wilson, Donna Markie and all those who continue to contribute to recruitment, data collection and data curation for the Study of Colorectal Cancer in Scotland studies. In addition to all consultant colorectal surgeons who provided data on their patients, we are also indebted to the chairs and offices of the managed clinical networks throughout Scotland who contributed substantially to clinicopathologic data and staging information. We acknowledge the expert support on sample preparation from the Genetics Core of the Edinburgh Wellcome Trust Clinical Research Facility. Acknowledgements for the GECCO consortium: ASTERISK: We are very grateful to Dr. Bruno Buecher without whom this project would not have existed. We also thank all those who agreed to participate in our study, including the patients and the healthy control persons, as well as all the physicians, technicians and students. DACHS: We thank all participants and cooperating clinicians, and Ute Handte-Daub, Utz Benscheid, Muhabbet Celik and Ursula Eilber for excellent technical assistance. Harvard cohorts (HPFS, NHS, PHS): We would like to thank the participants and staff of the HPFS, NHS and PHS for their valuable contributions as well as the after state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY. The authors assume full responsibility for analyses and interpretation of these data. PLCO: The authors thank the PLCO Cancer Screening Trial screening center investigators and the staff from Information Management Services Inc and Westat Inc. Most importantly, we thank the study participants for their contributions that made our study possible. PMH: The authors would like to thank the study participants and staff of the Hormones and Colon Cancer study. WHI: The authors thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at: http://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Short%20List.pdf.},
funding_text 2={The work was supported by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre. Acknowledgments for the Scottish Colorectal Cancer Study: We thank the participants in all},
funding_text 3={Key words: colorectal cancer, diet, environment, gene, interaction, risk factor Abbreviations: AICR: American Institute for Cancer Research; CI: confidence interval; CNKI: China National Knowledge Infrastructure; CRC: colorectal cancer; CTNNB1: cadherin-associated protein β1; CUP: continuous update project; CYP24A1: cytochrome P450 family 24 subfamily A member 1; G×E: gene–environment; GATA3: GATA binding protein 3; GECCO: Genetics and Epidemiology of Colorectal Cancer Consortium; GWAS: genome-wide association study; HIATL1: hippocampus abundant transcript-like 1; MINK1: misshapen like kinase 1; NAT2: N-acetyltransferase 2; NSAID: nonsteroidal anti-inflammatory drug; OR: odds ratio; PI3K: phosphatidylinositol-4,5-bisphosphonate 3-kinase; PIK3C2G: phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma; PTCHD3: patched domain containing 3; RR: relative risk; SHMT1: serine hydroxymethyltransferase 1; SNP: single-nucleotide polymorphism; SOCCS: Scottish Colorectal Cancer Study; TCF7L2: transcription factor 7 like 2; WCRF: World Cancer Research Fund International Additional Supporting Information may be found in the online version of this article. M.T. and E.T. are joint and corresponding authors in this position Grant sponsor: Cancer Research UK; Grant numbers: C31250/A22804C348/A18927; Grant sponsor: China Scholarship Council; Grant sponsor: Groupement des Entreprises Françaises dans la Lutte contre le Cancer; Grant numbers: PHRC-BRD09/C; Grant sponsor: National Cancer Institute; Grant numbers: CA137088P30, CA015704R01, CA143247R01201407U01, CA074778U01, CA122839U01/U24, CA074783U01/U24, CA074794U01/U24, CA074799U01/U24, CA074800U01/U24, CA074806U01/U24, CA097735UM1, CA167551; Grant sponsor: National Heart, Lung, and Blood Institute; Grant numbers: HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN268201100046C, HHSN271201100004C; Grant sponsor: National Institutes of Health; Grant numbers: K05 CA154337, K07 CA190673, U01 HG 004438, U01 HG004446, P01 CA033619, P01 CA055075, P01 CA087969, P50 CA127003, R01 CA042182, R01 CA063464, R01 CA076366, R01 CA137178, R01 CA151993, R01 CA48998, R01 CA60987, R35 CA197735, R35 CA197735, R37 CA54281, U01 CA074783, U01 CA167552, UM1 CA167552, UM1 CA186107, Z01 CP 010200; Grant sponsor: The Association Anne de Bretagne Génétique and the Ligue Régionale Contre le Cancer; Grant numbers: PHRC-BRD09/C; Grant sponsor: The California Department of Public Health; Grant numbers: HHSN261201000035C; Grant sponsor: The Canadian Institutes of Health Research; Grant sponsor: The German Research Council; Grant numbers: BR 1704/17-1, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HE 5998/2-1, HO 5117/2-1, KL 2354/3-1, RO 2270/8-1; Grant sponsor: The Groupement des Entreprises Françaises dans la Lutte contre le Cancer; Grant numbers: PHRC-BRD09/C; Grant sponsor: The Hawai‘i Department of Health; Grant numbers: HHSN26120100037C, N01-PC-67001, N01-PC-35137; Grant sponsor: The Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany, and the German Federal Ministry of Education and Research; Grant numbers: 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01KH0404; Grant sponsor: The Ontario Institute for Cancer Research; Grant sponsor: The Ontario Ministry of Research and Innovation; Grant sponsor: The Ontario Research Fund; Grant sponsor: The Regional Council of Pays de la Loire; Grant numbers: PHRC-BRD09/C; Grant sponsor: The Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute to Fred Hutchinson Cancer Research Center; Grant numbers: HHSN2612013000121, N01-CN-67009, N01-PC-35142; Grant sponsor: The Victoria Cancer Registry and Ontario Cancer Registry DOI: 10.1002/ijc.32057 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. History: Received 15 Jun 2018; Accepted 15 Nov 2018; Online 11 Dec 2018 Correspondence to: Evropi Theodoratou, Usher Institute, The University of Edinburgh, Room 3.735, Doorway 1, Old Medical School, Teviot Place, Edinburgh EH8 9AG, United Kingdom, Tel.: +44-131-650-3210, E-mail: e.theodoratou@ed.ac.uk; or Maria N Timofeeva, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom, Tel.: +44-131-651-8631, E-mail: maria.timofeeva@igmm.ed.ac.uk},
references={Ferlay, J., Soerjomataram, I., Dikshit, R., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 (2015) Int J Cancer, 136, pp. E359-E386; Bode, A.M., Dong, Z., Wang, H., Cancer prevention and control: alarming challenges in China (2016) Natl Sci Rev, 3, pp. 117-127; Tze, C.N., Fitzgerald, H., Qureshi, A., Pioneering annual colorectal cancer screening and treatment targeting Low income communities in Malaysia (20102015) (2016) Asian Pac J Cancer Prev, 17, pp. 3179-3183; Munoz, M., Pong-Wong, R., Canela-Xandri, O., Evaluating the contribution of genetics and familial shared environment to common disease using the UKbiobank (2016) Nat Genet, 48, pp. 980-983; Hutter, C.M., Mechanic, L.E., Chatterjee, N., Gene-environment interactions in cancer epidemiology: a National Cancer Institute think tank report (2013) Genet Epidemiol, 37, pp. 643-657; Gauderman, W.J., Zhang, P., Morrison, J.L., Finding novel genes by testing G x E interactions in a genome-wide association study (2013) Genet Epidemiol, 37, pp. 603-613; Theodoratou, E., Timofeeva, M., Li, X., Nature, nurture, and cancer risks: genetic and nutritional contributions to cancer (2017) Annu Rev Nutr, 37, pp. 293-320; Boffetta, P., Winn, D.M., Ioannidis, J.P., Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans (2012) Int J Epidemiol, 41, pp. 686-704; Ioannidis, J.P., Boffetta, P., Little, J., Assessment of cumulative evidence on genetic associations: interim guidelines (2008) Int J Epidemiol, 37, pp. 120-132; (2018) Diet, Nutrition, Physical Activity and Cancer: A Global Perspective, , https://www.wcrf.org/dietandcancer; (2017) Continuous Update Project Report: Diet, Nutrition, Physical Activity and Colorectal Cancer, , https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf; (2016), https://www.wcrf.org/sites/default/files/CUP_colorectal_cancer_SLR_2016lo.pdf, International Systematic Literature Review. The Associations between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer; Bellou, V., Belbasis, L., Tzoulaki, I., Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Welter, D., MacArthur, J., Morales, J., The NHGRI GWAS catalog, a curated resource of SNP-trait associations (2014) Nucleic Acids Res, 42, pp. D1001-D1006; Beck, T., Hastings, R.K., Gollapudi, S., GWAS central: a comprehensive resource for the comparison and interrogation of genome-wide association studies (2014) Eur J Hum Genet, 22, pp. 949-952; Khoury, M.J., Bertram, L., Boffetta, P., Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases (2009) Am J Epidemiol, 170, pp. 269-279; Vineis, P., Manuguerra, M., Kavvoura, F.K., A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility (2009) J Natl Cancer Inst, 101, pp. 24-36; Dimitrakopoulou, V.I., Travis, R.C., Shui, I.M., Interactions between genome-wide significant genetic variants and circulating concentrations of 25-Hydroxyvitamin D in relation to prostate cancer risk in the National Cancer Institute BPC3 (2017) Am J Epidemiol, 185, pp. 452-464; Theodoratou, E., Farrington, S.M., Tenesa, A., Dietary vitamin B6 intake and the risk of colorectal cancer (2008) Cancer Epidemiol Biomarkers Prev, 17, pp. 171-182; Peters, U., Jiao, S., Schumacher, F.R., Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis (2013) Gastroenterology, 144, pp. 799-807; Andersen, V., Holst, R., Vogel, U., Systematic review: diet-gene interactions and the risk of colorectal cancer (2013) Aliment Pharmacol Ther, 37, pp. 383-391; Andersen, V., Vogel, U., Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer (2014) Aliment Pharmacol Ther, 40, pp. 147-159; Andersen, V., Vogel, U., Interactions between meat intake and genetic variation in relation to colorectal cancer (2015) Genes Nutr, 10, p. 448; Corella, D., Ordovas, J.M., Interactions between dietary n-3 fatty acids and genetic variants and risk of disease (2012) Br J Nutr, 107, pp. S271-S83; Cornelis, M.C., Gene-coffee interactions and health (2014) Curr Nutr Rep, 3, pp. 178-195; Cross, J.T., Poole, E.M., Ulrich, C.M., A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia (2008) Pharmacogenomics J, 8, pp. 237-247; Eichholzer, M., Luthy, J., Moser, U., Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence (2001) Swiss Med Wkly, 131, pp. 539-549; Houlston, R.S., Tomlinson, I.P., Polymorphisms and colorectal tumor risk (2001) Gastroenterology, 121, pp. 282-301; Karahalil, B., Bohr, V.A., Wilson, D.M., 3rd., Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk (2012) Hum Exp Toxicol, 31, pp. 981-1005; Klarich, D.S., Brasser, S.M., Hong, M.Y., Moderate alcohol consumption and colorectal cancer risk (2015) Alcohol Clin Exp Res, 39, pp. 1280-1291; Kostner, K., Denzer, N., Muller, C.S., The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature (2009) Anticancer Res, 29, pp. 3511-3536; Lenihan-Geels, G., Bishop, K.S., Ferguson, L.R., Cancer risk and eicosanoid production: interaction between the protective effect of long chain Omega-3 polyunsaturated fatty acid intake and genotype (2016) J Clin Med, 5 (2). , E25; Sharp, L., Little, J., Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review (2004) Am J Epidemiol, 159, pp. 423-443; Shin, A., Kim, J., Effect modification of meat intake by genetic polymorphisms on colorectal neoplasia susceptibility (2010) Asian Pac J Cancer Prev, 11, pp. 281-287; Simonds, N.I., Ghazarian, A.A., Pimentel, C.B., Review of the gene-environment interaction literature in cancer: what do we know? (2016) Genet Epidemiol, 40, pp. 356-365; Ananthakrishnan, A.N., Du, M., Berndt, S.I., Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies (2015) Cancer Epidemiol Biomarkers Prev, 24, pp. 198-205; Ding, W., Zhou, D.L., Jiang, X., Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies (2013) PLoS One, 8; Hiraki, L.T., Joshi, A.D., Ng, K., Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer (2014) PLoS One, 9; Hutter, C.M., Chang-Claude, J., Slattery, M.L., Characterization of gene-environment interactions for colorectal cancer susceptibility loci (2012) Cancer Res, 72, pp. 2036-2044; Hutter, C.M., Slattery, M.L., Duggan, D.J., Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis (2010) BMC Cancer, 10, p. 670; Jiao, S., Hsu, L., Bezieau, S., SBERIA: set-based gene-environment interaction test for rare and common variants in complex diseases (2013) Genet Epidemiol, 37, pp. 452-464; Kantor, E.D., Hutter, C.M., Minnier, J., Gene-environment interaction involving recently identified colorectal cancer susceptibility loci (2014) Cancer Epidemiol Biomarkers Prev, 23, pp. 1824-1833; Liu, Y., Qin, H., Zhang, Y., P53 codon 72 polymorphism and colorectal cancer: a meta-analysis of epidemiological studies (2011) Hepatogastroenterology, 58, pp. 1926-1929; Nan, H., Morikawa, T., Suuriniemi, M., Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations (2013) J Natl Cancer Inst, 105, pp. 1852-1861; Pabalan, N., Bapat, B., Sung, L., Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis (2008) Cancer Epidemiol Biomarkers Prev, 17, pp. 2773-2781; Pabalan, N., Jarjanazi, H., Ozcelik, H., A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations (2013) Int J Colorectal Dis, 28, pp. 925-932; Raimondi, S., Botteri, E., Iodice, S., Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis (2009) Mutat Res, 670, pp. 6-14; Smits, K.M., Gaspari, L., Weijenberg, M.P., Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study (2003) Biomarkers, 8, pp. 299-310; Tse, G., Eslick, G.D., Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis (2014) Nutr Cancer, 66, pp. 128-139; Wan, H., Zhou, Y., Yang, P., Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a meta-analysis (2010) Cancer Epidemiol, 34, pp. 66-72; Wang, H., Iwasaki, M., Haiman, C.A., Interaction between red meat intake and NAT2 genotype in increasing the risk of colorectal cancer in Japanese and African Americans (2015) PLoS One, 10; Wang, X., Xing, G.H., Fan, C.C., Association between the FAS rs2234767G/a polymorphism and cancer risk: a systematic review and meta-analysis (2014) DNA Cell Biol, 33, pp. 320-327; Lq, Z., Jn, Z., Wang, J., Absence of association between N-Acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies (2012) PLoS One, 7 (3); Danfeng, S., Xia, W., Jingyuan, F., Meta-analysis of the relationship between methylenetetrahydrofolate reductase gene polymorphism and colon cancer (2006) Gastroenterology, 11, pp. 516-521; Figueiredo, J.C., Hsu, L., Hutter, C.M., Genome-wide diet-gene interaction analyses for risk of colorectal cancer (2014) PLoS Genet, 10; Figueiredo, J.C., Lewinger, J.P., Song, C., Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study (2011) Cancer Epidemiol Biomarkers Prev, 20, pp. 758-766; Nan, H., Hutter, C.M., Lin, Y., Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants (2015) JAMA, 313, pp. 1133-1142; Du, M., Zhang, X., Hoffmeister, M., No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk (2014) Cancer Epidemiol Biomarkers Prev, 23, pp. 2971-2976; Garcia-Albeniz, X., Rudolph, A., Hutter, C., CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk (2016) Br J Cancer, 114, pp. 221-229; Gong, J., Hutter, C.M., Newcomb, P.A., Genome-wide interaction analyses between genetic variants and alcohol consumption and smoking for risk of colorectal cancer (2016) PLoS Genet, 12; Jiao, S., Peters, U., Berndt, S., Powerful set-based gene-environment interaction testing framework for complex diseases (2015) Genet Epidemiol, 39, pp. 609-618; Siegert, S., Hampe, J., Schafmayer, C., Genome-wide investigation of gene-environment interactions in colorectal cancer (2013) Hum Genet, 132, pp. 219-231; Qiao, Y., Yang, T., Gan, Y., Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies (2018) BMC Cancer, 18, p. 288; Tanskanen, T., van den Berg, L., Valimaki, N., Genome-wide association study and meta-analysis in northern European populations replicate multiple colorectal cancer risk loci (2017) Int J Cancer, 142 (3). , 540–546; Orlando, G., Law, P.J., Palin, K., Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease (2016) Hum Mol Genet, 25, pp. 2349-2359; Lin, K.J., Cheung, W.Y., Lai, J.Y., The effect of estrogen vs combined estrogen-progestogen therapy on the risk of colorectal cancer (2012) Int J Cancer, 130, pp. 419-430; Schumacher, F.R., Schmit, S.L., Jiao, S., Genome-wide association study of colorectal cancer identifies six new susceptibility loci (2015) Nat Commun, 6, p. 7138; Pomerantz, M.M., Ahmadiyeh, N., Jia, L., The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer (2009) Nat Genet, 41, pp. 882-884; Tuupanen, S., Turunen, M., Lehtonen, R., The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling (2009) Nat Genet, 41, pp. 885-890; Sur, I.K., Hallikas, O., Vaharautio, A., Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors (2012) Science (New York, NY), 338, pp. 1360-1363; Bos, C.L., Kodach, L.L., van den Brink, G.R., Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A (2006) Oncogene, 25, pp. 6447-6456; Fresno Vara, J.A., Casado, E., de Castro, J., PI3K/Akt signalling pathway and cancer (2004) Cancer Treat Rev, 30, pp. 193-204; Kaur, J., Sanyal, S.N., PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac (2010) Tumour Biol, 31, pp. 623-631; Grivennikov, S.I., Karin, M., Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage (2011) Ann Rheum Dis, 70, pp. i104-i108; Klampfer, L., Cytokines, inflammation and colon cancer (2011) Curr Cancer Drug Targets, 11, pp. 451-464; Symmons, O., Uslu, V.V., Tsujimura, T., Functional and topological characteristics of mammalian regulatory domains (2014) Genome Res, 24, pp. 390-400; Bareis, P., Bises, G., Bischof, M.G., 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression (2001) Biochem Biophys Res Commun, 285, pp. 1012-1017; Dong, L.M., Ulrich, C.M., Hsu, L., Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 2540-2548; Hosoya, T., Maillard, I., Engel, J.D., From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation (2010) Immunol Rev, 238, pp. 110-125; Hedlund, M., Padler-Karavani, V., Varki, N.M., Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression (2008) Proc Natl Acad Sci U S A, 105, pp. 18936-18941; Zheng, R., Blobel, G.A., GATA transcription factors and cancer (2010) Genes Cancer, 1, pp. 1178-1188; Schlessinger, A., Matsson, P., Shima, J.E., Comparison of human solute carriers (2010) Protein Sci, 19, pp. 412-428; Hoglund, P.J., Nordstrom, K.J., Schioth, H.B., The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species (2011) Mol Biol Evol, 28, pp. 1531-1541; Smith, P.G., Day, N.E., The design of case-control studies: the influence of confounding and interaction effects (1984) Int J Epidemiol, 13, pp. 356-365; Thomas, D., Gene--environment-wide association studies: emerging approaches (2010) Nat Rev Genet, 11, pp. 259-272; Burton, P.R., Hansell, A.L., Fortier, I., Size matters: just how BIG is BIG?: quantifying realistic sample size requirements for human genome epidemiology (2009) Int J Epidemiol, 38, pp. 263-273; Cornelis, M.C., Hu, F.B., Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges (2012) Annu Rev Nutr, 32, pp. 245-259; Theodoratou, E., Tzoulaki, I., Zgaga, L., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ (Clin Res Ed), 348, p. g2035; Belbasis, L., Savvidou, M.D., Kanu, C., Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses (2016) BMC Med, 14, p. 147; Sohani, Z.N., Meyre, D., de Souza, R.J., Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-genie) tool (2015) BMC Genet, 16, p. 50; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ (Clin Res Ed), 357, p. j2376; Borenstein, M., Higgins, J.P., Hedges, L.V., Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity (2017) Res Synth Methods, 8, pp. 5-18; Geneletti, S., Gallo, V., Porta, M., Assessing causal relationships in genomics: from Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs (2011) Emerg Themes Epidemiol, 8, p. 5; Fedak, K.M., Bernal, A., Capshaw, Z.A., Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology (2015) Emerg Themes Epidemiol, 12, p. 14},
correspondence_address1={Timofeeva, M.; Colon Cancer Genetics Group, United Kingdom; email: maria.timofeeva@igmm.ed.ac.uk},
publisher={Wiley-Liss Inc.},
issn={00207136},
coden={IJCNA},
pubmed_id={30536881},
language={English},
abbrev_source_title={Int. J. Cancer},
document_type={Review},
source={Scopus},
}

@ARTICLE{Schooling2018,
author={Schooling, C.M. and Jones, H.E.},
title={Clarifying questions about "risk factors": Predictors versus explanation},
journal={Emerging Themes in Epidemiology},
year={2018},
volume={15},
number={1},
doi={10.1186/s12982-018-0080-z},
art_number={10},
note={cited By 28},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051231288&doi=10.1186%2fs12982-018-0080-z&partnerID=40&md5=89401b3fd293710a05d4f4e58964a51a},
affiliation={Graduate School of Public Health and Health Policy, City University of New York, 55 West 125th St, New York, NY  10027, United States; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, Hong Kong},
abstract={Background: In biomedical research much effort is thought to be wasted. Recommendations for improvement have largely focused on processes and procedures. Here, we additionally suggest less ambiguity concerning the questions addressed. Methods: We clarify the distinction between two conflated concepts, prediction and explanation, both encompassed by the term "risk factor", and give methods and presentation appropriate for each. Results: Risk prediction studies use statistical techniques to generate contextually specific data-driven models requiring a representative sample that identify people at risk of health conditions efficiently (target populations for interventions). Risk prediction studies do not necessarily include causes (targets of intervention), but may include cheap and easy to measure surrogates or biomarkers of causes. Explanatory studies, ideally embedded within an informative model of reality, assess the role of causal factors which if targeted for interventions, are likely to improve outcomes. Predictive models allow identification of people or populations at elevated disease risk enabling targeting of proven interventions acting on causal factors. Explanatory models allow identification of causal factors to target across populations to prevent disease. Conclusion: Ensuring a clear match of question to methods and interpretation will reduce research waste due to misinterpretation. © 2018 The Author(s).},
author_keywords={Cause;  Confounding;  Predictor;  Risk factor;  Scientific inference;  Selection bias;  Statistical inference},
keywords={Article;  causal attribution;  causal factor;  health hazard;  human;  measurement error;  prediction;  risk assessment;  risk factor;  risk stratification;  selection bias},
references={Moher, D., Increasing value and reducing waste in biomedical research: Who's listening? (2016) Lancet, 387 (1002), pp. 1573-1586. , 26423180; Anderson, K.M., Cardiovascular disease risk profiles (1991) Am Heart J, 121 (1), pp. 293-298. , 1985385; Nicholls, S.J., CETP-inhibition and HDL-cholesterol: A story of CV risk or CV benefit, or both (2018) Clin Pharmacol Ther, , 10.1002/cpt.1118 29901215; Keene, D., Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: Meta-analysis of randomised controlled trials including 117 411 patients (2014) BMJ, 349, p. g4379. , 25038074 4103514; Voight, B.F., Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study (2012) Lancet, 380 (9841), pp. 572-580. , 22607825 3419820; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology, 22 (4), pp. 450-456. , 21490505; Wilson, P.W., Prediction of coronary heart disease using risk factor categories (1998) Circulation, 97 (18), pp. 1837-1847. , 9603539; Turnbull, A.K., Accurate prediction and validation of response to endocrine therapy in breast cancer (2015) J Clin Oncol, 33 (20), pp. 2270-2278. , 26033813; Lazer, D., Big data. The parable of Google Flu: Traps in big data analysis (2014) Science, 343 (6176), pp. 1203-1205. , 24626916; Liu, J., Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study (2004) JAMA, 291 (21), pp. 2591-2599. , 15173150; Pearl, J., (2009) Causality: Models, Reasoning, and Inference, , 2 Cambridge University Press Cambridge; Musunuru, K., Kathiresan, S., Surprises from genetic analyses of lipid risk factors for atherosclerosis (2016) Circ Res, 118 (4), pp. 579-585. , 26892959 4762058; Machiela, M.J., Genetic variants related to longer telomere length are associated with increased risk of renal cell carcinoma (2017) Eur Urol., 72 (5), pp. 747-754. , 28797570; Haycock, P.C., Association between telomere length and risk of cancer and non-neoplastic diseases: A Mendelian randomization study (2017) JAMA Oncol, 3 (5), pp. 636-651. , 28241208; Hernan, M.A., Hernandez-Diaz, S., Robins, J.M., A structural approach to selection bias (2004) Epidemiology, 15 (5), pp. 615-625. , 15308962; Bareinboim, B.T., Pearl, J., Recovering from selection bias in causal and statistical inference (2014) Proceedings of the Twenty-eighth AAAI Conference on Artificial Intelligence, pp. R-425; Smith, G.D., Ebrahim, S., 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) Int J Epidemiol, 32 (1), pp. 1-22. , 12689998; Holmes, M.V., Ala-Korpela, M., Smith, G.D., Mendelian randomization in cardiometabolic disease: Challenges in evaluating causality (2017) Nat Rev Cardiol, 14 (10), pp. 577-590. , 28569269 5600813; Lipsitch, M., Tchetgen, E., Cohen, T., Negative controls: A tool for detecting confounding and bias in observational studies (2010) Epidemiology, 21 (3), pp. 383-388. , 20335814 3053408; Schooling, C.M., Concordance with known causal effects is a potential validity measure for observational studies (2016) J Clin Epidemiol, 74, pp. 4-6. , 26802283; Petitti, D.P., Sidney, S., Postmenopausal estrogen use and heart disease (1986) NEJM, 315 (131-132); Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group (1973) JAMA, 226 (6), pp. 652-657. , The Coronary Drug Project; Petitti, D., Commentary: Hormone replacement therapy and coronary heart disease: Four lessons (2004) Int J Epidemiol, 33 (3), pp. 461-463. , 15166191; Bareinboim, E., Pearl, J., Causal inference and the data-fusion problem (2016) Proc Natl Acad Sci USA, 113 (27), pp. 7345-7352. , 27382148; Westreich, D., Greenland, S., The table 2 fallacy: Presenting and interpreting confounder and modifier coefficients (2013) Am J Epidemiol, 177 (4), pp. 292-298. , 23371353 3626058; Hernan, M.A., Alonso, A., Logroscino, G., Cigarette smoking and dementia: Potential selection bias in the elderly (2008) Epidemiology, 19 (3), pp. 448-450. , 18414087; Tobias, D.K., Body-mass index and mortality among adults with incident type 2 diabetes (2014) N Engl J Med, 370 (3), pp. 233-244. , 24428469 3966911},
correspondence_address1={Schooling, C.M.; Graduate School of Public Health and Health Policy, 55 West 125th St, United States; email: mary.schooling@sph.cuny.edu},
publisher={BioMed Central Ltd.},
issn={17427622},
language={English},
abbrev_source_title={Emerg. Themes Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Liao2019,
author={Liao, C. and Laporte, A.D. and Spiegelman, D. and Akçimen, F. and Joober, R. and Dion, P.A. and Rouleau, G.A.},
title={Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes},
journal={Nature Communications},
year={2019},
volume={10},
number={1},
doi={10.1038/s41467-019-12450-9},
art_number={4450},
note={cited By 27},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072847778&doi=10.1038%2fs41467-019-12450-9&partnerID=40&md5=a7e2186a32fbe3c7101b255bd2987a83},
affiliation={Department of Human Genetics, McGill University, Montréal, QC, Canada; Montreal Neurological Institute, McGill University, Montréal, QC, Canada; Department of Psychiatry, McGill University, Montréal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada},
abstract={Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental psychiatric disorder. Genome-wide association studies (GWAS) have identified several loci associated with ADHD. However, understanding the biological relevance of these genetic loci has proven to be difficult. Here, we conduct an ADHD transcriptome-wide association study (TWAS) consisting of 19,099 cases and 34,194 controls and identify 9 transcriptome-wide significant hits, of which 6 genes were not implicated in the original GWAS. We demonstrate that two of the previous GWAS hits can be largely explained by expression regulation. Probabilistic causal fine-mapping of TWAS signals prioritizes KAT2B with a posterior probability of 0.467 in the dorsolateral prefrontal cortex and TMEM161B with a posterior probability of 0.838 in the amygdala. Furthermore, pathway enrichment identifies dopaminergic and norepinephrine pathways, which are highly relevant for ADHD. Overall, our findings highlight the power of TWAS to identify and prioritize putatively causal genes. © 2019, The Author(s).},
keywords={ARTN protein, human;  dopamine receptor stimulating agent;  ELOVL1 protein, human;  histone acetyltransferase PCAF;  KAT2B protein, human;  membrane protein;  nerve protein;  noradrenalin;  TMEM161B protein, human;  transcriptome, amygdala;  attention deficit disorder;  gene expression;  gene locus;  genetic predisposition;  genetics;  genome-wide association study;  genomics;  genotype;  human;  isolation and purification;  metabolism;  phenotype;  probability;  single nucleotide polymorphism, Amygdala;  Attention Deficit Disorder with Hyperactivity;  Dopamine Agents;  Fatty Acid Elongases;  Gene Expression;  Genetic Loci;  Genetic Predisposition to Disease;  Genome-Wide Association Study;  Genomics;  Genotype;  Humans;  Membrane Proteins;  Nerve Tissue Proteins;  Norepinephrine;  p300-CBP Transcription Factors;  Phenotype;  Polymorphism, Single Nucleotide;  Probability;  Transcriptome},
chemicals_cas={noradrenalin, 1407-84-7, 51-41-2; ARTN protein, human; Dopamine Agents; ELOVL1 protein, human; Fatty Acid Elongases; KAT2B protein, human; Membrane Proteins; Nerve Tissue Proteins; Norepinephrine; p300-CBP Transcription Factors; TMEM161B protein, human},
funding_details={Canadian Institutes of Health ResearchCanadian Institutes of Health Research, CIHR},
references={Faraone, S.V., Attention-deficit/hyperactivity disorder (2015) Nat. Rev. Dis. Prim., 1, p. 15020; Bakhshani, N.-M., Attention-deficit/hyperactivity disorder (ADHD) and high risk behaviors (2013) Int. J. High Risk Behav. Addict., 2, pp. 1-2; Wyciszkiewicz, A., Pawlak, M.A., Krawiec, K., Cerebellar volume in children with attention-deficit hyperactivity disorder (ADHD) (2017) J. Child Neurol., 32, pp. 215-221; Vaidya, C.J., Neurodevelopmental abnormalities in ADHD (2012) Curr. Top. Behav. Neurosci., 9, pp. 49-66; Faraone, S.V., Larsson, H., Genetics of attention deficit hyperactivity disorder (2019) Mol. Psychiatry, 24, pp. 562-575. , COI: 1:CAS:528:DC%2BC1cXht1CjsLvP; Demontis, D., Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder (2019) Nat. Genet., 51, pp. 63-75. , COI: 1:CAS:528:DC%2BC1cXitlWnu77E; Gusev, A., Integrative approaches for large-scale transcriptome-wide association studies (2016) Nat. Genet., 48, pp. 245-252. , COI: 1:CAS:528:DC%2BC28Xit1ajtbc%3D; Wainberg, M., Opportunities and challenges for transcriptome-wide association studies (2019) Nat. Genet., 51, pp. 592-599. , COI: 1:CAS:528:DC%2BC1MXoslGlt7w%3D; Prince, J., Catecholamine dysfunction in attention-deficit/hyperactivity disorder (2008) J. Clin. Psychopharmacol., 28, pp. S39-S45. , COI: 1:CAS:528:DC%2BD1cXntFWhu7g%3D; Engert, V., Pruessner, J.C., Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate (2008) Curr. Neuropharmacol., 6, pp. 322-328. , COI: 1:CAS:528:DC%2BD1MXisVSqurc%3D; Mancuso, N., Probabilistic fine-mapping of transcriptome-wide association studies (2019) Nat. Genet., 51, pp. 675-682. , COI: 1:CAS:528:DC%2BC1MXoslGlt7g%3D; Arnsten, A.F.T., The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex (2009) J. Pediatr., 154; Tapias, A., Wang, Z.-Q., Lysine acetylation and deacetylation in brain development and neuropathies (2017) Genom. Proteom. Bioinforma., 15, pp. 19-36; Tajima-Pozo, K., Amygdala abnormalities in adults with ADHD (2018) J. Atten. Disord., 22, pp. 671-678; Turgay, A., Ansari, R., Major depression with ADHD: in children and adolescents (2006) Psychiatry, 3, pp. 20-32. , PID: 21103168; Analysis of shared heritability in common disorders of the brain (2018) Science, 360. , https://doi.org/10.1126/science.aap8757; Kovess, V., Maternal smoking and offspring inattention and hyperactivity: results from a cross-national European survey (2015) Eur. Child Adolesc. Psychiatry, 24, pp. 919-929; Fahira, A., Li, Z., Liu, N., Shi, Y., Prediction of causal genes and gene expression analysis of attention-deficit hyperactivity disorder in the different brain region, a comprehensive integrative analysis of ADHD (2019) Behav. Brain Res., 364, pp. 183-192. , COI: 1:CAS:528:DC%2BC1MXjs1Siu78%3D; Gamazon, E.R., A gene-based association method for mapping traits using reference transcriptome data (2015) Nat. Genet., 47, pp. 1091-1098. , COI: 1:CAS:528:DC%2BC2MXhtlSnurbM; Gamazon, E.R., Zwinderman, A.H., Cox, N.J., Denys, D., Derks, E.M., Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits (2019) Nat. Genet., 51, pp. 933-940. , COI: 1:CAS:528:DC%2BC1MXhtVSqs7rN; Sklar, P., Psychiatric genomics consortium: past and present (2017) Eur. Neuropsychopharmacol., 27, p. S359; Genetic effects on gene expression across human tissues (2017) Nature, 550, pp. 204-213; Deelen, P., Improving the diagnostic yield of exome- sequencing by predicting gene–phenotype associations using large-scale gene expression analysis (2019) Nat. Commun., 10; Bulik-Sullivan, B.K., LD score regression distinguishes confounding from polygenicity in genome-wide association studies (2015) Nat. Genet., 47, pp. 291-295. , COI: 1:CAS:528:DC%2BC2MXhvFCntb8%3D},
correspondence_address1={Rouleau, G.A.; Department of Human Genetics, Canada; email: guy.rouleau@mcgill.ca},
publisher={Nature Publishing Group},
issn={20411723},
pubmed_id={31575856},
language={English},
abbrev_source_title={Nat. Commun.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Sauzéat2018264,
author={Sauzéat, L. and Bernard, E. and Perret-Liaudet, A. and Quadrio, I. and Vighetto, A. and Krolak-Salmon, P. and Broussolle, E. and Leblanc, P. and Balter, V.},
title={Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis},
journal={iScience},
year={2018},
volume={6},
pages={264-271},
doi={10.1016/j.isci.2018.07.023},
note={cited By 26},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064088176&doi=10.1016%2fj.isci.2018.07.023&partnerID=40&md5=794f0ab249f83cb954579483a3e60587},
affiliation={Université de Lyon, ENS de Lyon, CNRS, LGL-TPE, Lyon, 69007, France; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Centre de Ressources et de Compétence SLA de Lyon, Service de Neurologie C, Bron, France; Université de Lyon, CNRS UMR5292, INSERM U1028, BioRan, Lyon, France; Hospices Civils de Lyon, Neurobiology Laboratory, Biochemistry and Molecular Biology Department, Lyon, France; Service Neurocognition et Neuroophtalmologie, Hôpital Neurologique, 59 Boulevard Pinel, Bron Cedex, 69677, France; Centre Mémoire Ressources Recherche de Lyon, Hospices Civils de Lyon, Hôpital des Charpennes, Villeurbanne, France; Université de Lyon, Faculté de Médecine Lyon Sud Charles Mérieux, Institut des Sciences Cognitives Marc Jeannerod, CNRS, UMR 5229, Lyon, France; Institut NeuroMyoGène, CNRS UMR5310, INSERM U1217, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon I, 8 Avenue Rockefeller, Lyon Cedex 08, 69373, France; Université Lyon 1, Hospices Civils de Lyon, Centre de Recherche en Neurosciences de Lyon, équipe IMPACT, Lyon, France},
abstract={Redox-active metals are thought to be implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). To address this point, we measured the concentrations of 12 elements and, for the first time, the stable isotope compositions of copper (redox-active)and zinc (redox-inactive)in human cerebrospinal fluids of 31 patients with ALS, 11 age-matched controls (CTRL), and 14 patients with Alzheimer disease. We first show that metal concentrations weakly discriminate patients with ALS from the two other groups. We then report that zinc isotopic compositions are similar in the three groups, but that patients with ALS have significantly 65copper-enriched isotopic compositions relative to CTRL and patients with AD. This result unambiguously demonstrates that copper is implicated in ALS. We suggest that this copper isotopic signature may result from abnormal protein aggregation in the brain parenchyma, and propose that isotopic analysis is a potential tool that may help unraveling the molecular mechanisms at work in ALS. © 2018 The Author(s)
Nuclear Medicine; Isotope Chemistry; Neuroscience; Clinical Neuroscience © 2018 The Author(s)},
author_keywords={Clinical Neuroscience;  Isotope Chemistry;  Neuroscience;  Nuclear Medicine},
funding_details={Association pour la Recherche sur le CancerAssociation pour la Recherche sur le Cancer, ARC},
funding_details={Advanced Foods and Materials CanadaAdvanced Foods and Materials Canada, AFM},
funding_details={Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche Médicale, Inserm},
funding_details={École Polytechnique Fédérale de LausanneÉcole Polytechnique Fédérale de Lausanne, EPFL},
funding_details={Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique, CNRS},
funding_details={Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du MotoneuroneAssociation pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone, ARSLA},
funding_details={Fondation MérieuxFondation Mérieux},
funding_text 1={We thank three anonymous reviewers for their very helpful comments, Philippe Télouk for his assistance during isotopic measurements, and Mélanie Simon for her help regarding chemical procedures. Thanks are also due to the clinicians Dr. Anne Nove-Josserand and Dr. Dominique Minier, the chiefs of the Division of Neurology at Hospital North of Villefranche sur Saône and at William Morey Hospital in Châlon sur Saône, respectively. V.B. and L.S. are grateful to Fondation Bullukian and Fondation Mérieux as well as the Ecole Polytechnique Fédérale of Lausanne (EPFL)for their financial support. P.L. received support from the Association pour la Recherche sur la SLA (ARSLA), the NeuroDis Foundation, the AFM (AFM-MyoNeuralp), the CNRS, and INSERM. Conceptualization, E. Bernard, E. Broussolle, P.L. and V.B.; Methodology, L.S. and V.B.; Investigation, L.S. E. Bernard, A.P.-L. I.Q. A.V. P.K.-S. and E. Broussolle; Resources, E. Bernard, A.P.-L. I.Q. A.V. P.K.-S. E. Broussolle, and V.B.; Writing – Original Draft, L.S. E. Bernard, E. Broussolle, P.L. and V.B.; Writing – Reviews and Editing, L.S. E. Bernard, E. Broussolle, P.L. and V.B.; Funding Acquisition, V.B. The authors have no financial interests to declare.},
funding_text 2={We thank three anonymous reviewers for their very helpful comments, Philippe Télouk for his assistance during isotopic measurements, and Mélanie Simon for her help regarding chemical procedures. Thanks are also due to the clinicians Dr. Anne Nove-Josserand and Dr. Dominique Minier, the chiefs of the Division of Neurology at Hospital North of Villefranche sur Saône and at William Morey Hospital in Châlon sur Saône, respectively. V.B. and L.S. are grateful to Fondation Bullukian and Fondation Mérieux as well as the Ecole Polytechnique Fédérale of Lausanne (EPFL) for their financial support. P.L. received support from the Association pour la Recherche sur la SLA (ARSLA), the NeuroDis Foundation , the AFM (AFM-MyoNeuralp), the CNRS , and INSERM .},
references={Albarède, F., Télouk, P., Balter, V., Bondanese, V.P., Albalat, E., Oger, P., Bonaventura, P., Fujii, T., Medical applications of Cu, Zn, and S isotope effects (2016) Metallomics, 8, pp. 1056-1070; Bäckström, D.C., Eriksson Domellöf, M., Linder, J., Olsson, B., Öhrfelt, A., Trupp, M., Cerebrospinal Fluid patterns and the risk of future dementia in early, incident Parkinson disease (2015) JAMA Neurol., 72, pp. 1175-1182; Balter, V., Nogueira da Costa, A., Bondanese, V.P., Jaouen, K., Lamboux, A., Sangrajrang, S., Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients (2015) Proc. Natl. Acad. Sci. USA, 112, pp. 982-985; Barnham, K.J., Bush, A.I., Biological metals and metal-targeting compounds in major neurodegenerative diseases (2014) Chem. Soc. Rev., 43, pp. 6727-6749; Büchl, A., Hawkesworth, C.J., Ragnarsdottir, K.V., Brown, D.R., Re-partitioning of Cu and Zn isotopes by modified protein expression (2008) Geochem. Trans., 9, p. 11; Costa, J., Swash, M., de Carvalho, M., Awaji criteria for the diagnosis of amyotrophic lateral sclerosis (2012) Arch. Neurol., 69, p. 1410; Costas-Rodriguez, M., Delanghe, J., Vanhaecke, F., High-precision isotopic analysis of essential mineral elements in biomedicine: natural isotope ratio variations as potential diagnostic and/or prognostic markers (2016) Trends Anal. Chem., 76, pp. 182-193; del Campo, M., Mollenhauer, B., Bertolotto, A., Engelborghsn, S., Hampel, H., Simonsen, A.H., Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update (2012) Biomarkers Med., 6, pp. 419-430; Enge, T.G., Ecroyd, H., Jolley, D.F., Yerbury, J.J., Dosseto, A., Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis (2017) Metallomics, 9, pp. 161-174; Garçon, M., Sauzéat, L., Carlson, R.W., Shirey, S.B., Simon, M., Balter, V., Nitrile, latex, neoprene and vinyl gloves: a primary source of contamination for trace element and Zn isotopic analyses in geological and biological samples (2017) Geostand. Geoanal. Res., 41, pp. 367-380; Hozumi, I., Hasegawa, T., Honda, A., Ozawa, K., Hayashi, Y., Hashimoto, K., Patterns of levels of biological metals in CSF differ among neurodegenerative diseases (2011) J. Neurol. Sci., 303, pp. 95-99; Ihara, Y., Nobukuni, K., Takata, H., Hayabara, T., Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation (2013) Neurol. Res., 27, pp. 105-108; Iyengar, V., Wolttiez, J., Trace elements in Human clinical specimens: evaluation of literature data to identify reference values (1988) Clin. Chem., 34, pp. 474-481; Jaouen, K., Balter, V., Herrscher, E., Lamboux, A., Télouk, P., Albarède, F., Fe and Cu stable isotopes in archeological human bones and their relationship to sex (2012) Am. J. Phys. Anthropol., 148, pp. 334-340; Jaouen, K., Gibert, M., Lamboux, A., Télouk, P., Fourel, F., Albarède, F., Is aging recorded in blood Cu and Zn isotope compositions? (2013) Metallomics, 5, pp. 1016-1024; Jaouen, K., Beasley, M., Schoeninger, M., Hublin, J.-J., Richards, M.P., Zinc isotope ratios of bones and teeth as new dietary indicators: results from a modern food web (Koobi Fora, Kenya) (2016) Sci. Rep., 6, pp. 1-8; Kanias, G.D., Kapaki, E., Trace elements, age, and sex in amyotrophic lateral sclerosis disease (1997) Biol. Trace Elem. Res., 56, pp. 187-201; Kapaki, E., Segditsa, C., Papageorgiou, C., Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders (1989) Acat. Neurol. Scand., 79, pp. 373-378; Kapaki, E., Zournas, C., Kanias, G., Zambelis, T., Kakami, A., Papageorgiou, C., Essential trace element alterations in amyotrophic lateral sclerosis (1997) J. Neurol. Sci., 147, pp. 171-175; Lelie, H.L., Liba, A., Bourassa, M.W., Chattopadhyay, M., Chan, P.K., Gralla, E.B., Miller, L.M., Whitelegge, J.P., Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice (2011) J. Biol. Chem., 286, pp. 2795-2806; Lind, A.-L., Wu, D., Freyhult, E., Bodolea, C., Ekegren, T., Larssson, A., A multiplex protein panel applied to cerebrospinal fluid reveals three new biomarker candidates in ALS but none in neuropathic pain patients (2016) PLoS One, 11, p. e0149821; Lu, C.H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis (2015) Neurology, 84, pp. 2247-2257; Maréchal, C.N., Télouk, P., Albarède, F., Precise analysis of copper and zinc isotopic compositions by plasma-source mass spectrometry (1999) Chem. Geol., 156, pp. 251-273; McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Jr., Kawas, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement., 7, pp. 263-269; Miller, K.A., Keenan, C.M., Martin, G.R., Jirik, F.R., Sharkey, K.A., Wieser, M.E., The expression levels of cellular prion protein affect copper isotopic shifts in the organs of mice (2016) J. Anal. Spectrom., 31, pp. 2015-2022; Moynier, F., Foriel, J., Shaw, A.S., Le Borgne, M., Distribution of Zn isotopes during Alzheimer's disease (2017) Geochem. Persp. Lett., 3, pp. 142-150; Narasimhan, S.D., A brief history of ALS (2015) Cell, 161, pp. 181-183; Ostachowicz, B., Lankosz, M., Tomik, B., Adamek, D., Wobrauschek, P., Streli, C., Analysis of some chosen elements of cerebrospinal fluid and serum in amyotrophic lateral sclerosis patients by total reflection X-ray fluorescence (2006) Spectrochim. Acta Part B At. Spectrosc., 61, pp. 1210-1213; Pasinetti, G.M., Ungar, L.H., Lange, D.J., Yemul, S., Deng, H., Yuan, X., Brown, R.H., Peskind, E., Identification of potential CSF biomarkers in ALS (2006) Neurology, 66, pp. 1218-1222; Pithadia, A., Lim, M.H., Metal-associated amyloid-β in Alzheimer's disease (2012) Curr. Opin. Chem. Biol., 16, pp. 67-73; Pokrishevsky, E., Grad, L.I., Yousefi, M., Wang, J., Mackenzie, I.R., Cashman, N.R., Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis (2012) PLoS One, 7, pp. 1-9; Roos, P.M., Vesterberg, O., Syversen, T., Flaten, T.P., Nordberg, M., Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis (2013) Biol. Trace Elem. Res., 151, pp. 159-170; Savage, N., Calculating disease (2017) Nature, 550, p. S115; Scheiber, I.F., Mercer, J.F.B., Dringen, R., Metabolism and functions of copper in brain (2014) Prog. Neurobiol., 116, pp. 33-57; Scott, A., On the treatment trail for ALS (2017) Nature, 550, p. S120; Shaw, B.F., Lelie, H.L., Durazo, A., Nersissian, A.M., Xu, G., Chan, P.K., Gralla, E.B., Borchelt, D.R., Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1 (2008) J. Biol. Chem., 283, pp. 8340-8350; Taylor, J.P., Brown, R.H., Cleveland, D.W., Decoding ALS: from genes to mechanism (2016) Nature, 539, pp. 197-206; Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., Marklund, S.L., Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities (2013) Neurobiol. Dis., 54, pp. 308-319; Valentine, J.S., Doucette, P.A., Zittin Potter, S., Copper-Zinc superoxide dismutase and amyotrophic lateral sclerosis (2005) Annu. Rev. Biochem., 74, pp. 563-593; Zetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J.Q., Portelius, E., Shaw, L.M., Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression (2016) JAMA Neurol., 73, p. 60},
correspondence_address1={Balter, V.; Université de Lyon, France; email: vincent.balter@ens-lyon.fr},
publisher={Elsevier Inc.},
issn={25890042},
language={English},
abbrev_source_title={iScience},
document_type={Article},
source={Scopus},
}

@ARTICLE{Gates2018,
author={Gates, A. and Gates, M. and Duarte, G. and Cary, M. and Becker, M. and Prediger, B. and Vandermeer, B. and Fernandes, R.M. and Pieper, D. and Hartling, L.},
title={Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: Protocol for a descriptive analytic study},
journal={Systematic Reviews},
year={2018},
volume={7},
number={1},
doi={10.1186/s13643-018-0746-1},
art_number={85},
note={cited By 26},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048494028&doi=10.1186%2fs13643-018-0746-1&partnerID=40&md5=6551a50ba372a58f59a2e34f83d02f51},
affiliation={University of Alberta, Alberta Research Centre for Health Evidence, Department of Pediatrics, 11405-87 Avenue NW, Edmonton, AB  T6G 1C9, Canada; University of Lisbon, Clinical Pharmacology Unit, Instituto de Medicina Molecular, Av. Professor Egas Moniz, Lisbon, 1649-028, Portugal; National Association of Pharmacies, Centre for Health Evaluation and Research (CEFAR), Rua Marechal Saldanha, no 1, Lisbon, 1249-069, Portugal; Universität Witten/Herdecke, Department für Humanmedizin, Institut für Forschung in der Operativen Medizin, Witten, Germany; Santa Maria Hospital, Department of Pediatrics, Lisbon, Portugal},
abstract={Background: Systematic reviews (SRs) of randomised controlled trials (RCTs) can provide the best evidence to inform decision-making, but their methodological and reporting quality varies. Tools exist to guide the critical appraisal of quality and risk of bias in SRs, but evaluations of their measurement properties are limited. We will investigate the interrater reliability (IRR), usability, and applicability of A MeaSurement Tool to Assess systematic Reviews (AMSTAR), AMSTAR 2, and Risk Of Bias In Systematic reviews (ROBIS) for SRs in the fields of biomedicine and public health. Methods: An international team of researchers at three collaborating centres will undertake the study. We will use a random sample of 30 SRs of RCTs investigating therapeutic interventions indexed in MEDLINE in February 2014. Two reviewers at each centre will appraise the quality and risk of bias in each SR using AMSTAR, AMSTAR 2, and ROBIS. We will record the time to complete each assessment and for the two reviewers to reach consensus for each SR. We will extract the descriptive characteristics of each SR, the included studies, participants, interventions, and comparators. We will also extract the direction and strength of the results and conclusions for the primary outcome. We will summarise the descriptive characteristics of the SRs using means and standard deviations, or frequencies and proportions. To test for interrater reliability between reviewers and between the consensus agreements of reviewer pairs, we will use Gwet's AC1 statistic. For comparability to previous evaluations, we will also calculate weighted Cohen's kappa and Fleiss' kappa statistics. To estimate usability, we will calculate the mean time to complete the appraisal and to reach consensus for each tool. To inform applications of the tools, we will test for statistical associations between quality scores and risk of bias judgments, and the results and conclusions of the SRs. Discussion: Appraising the methodological and reporting quality of SRs is necessary to determine the trustworthiness of their conclusions. Which tool may be most reliably applied and how the appraisals should be used is uncertain; the usability of newly developed tools is unknown. This investigation of common (AMSTAR) and newly developed (AMSTAR 2, ROBIS) tools will provide empiric data to inform their application, interpretation, and refinement. © 2018 The Author(s).},
author_keywords={Overviews of reviews;  Quality assessment;  Reliability;  Risk of bias;  Systematic reviews;  Validity},
keywords={Article;  decision making;  descriptive research;  evaluation study;  interrater reliability;  outcome assessment;  priority journal;  quality control;  reliability;  sampling bias;  statistical bias;  systematic review (topic);  validation process;  validity;  evidence based medicine;  health care quality;  human;  methodology;  randomized controlled trial (topic);  reproducibility;  standards, Bias;  Evidence-Based Medicine;  Humans;  Quality Assurance, Health Care;  Randomized Controlled Trials as Topic;  Reproducibility of Results;  Research Design},
funding_details={National Science FoundationNational Science Foundation, NSF, 1002028},
funding_details={National Health and Medical Research CouncilNational Health and Medical Research Council, NHMRC},
references={Systematic reviews: CRD's guidance for undertaking reviews in health care: University of York (UK) (2009), York: York Publishing Services Ltd; J.P.T, H., Green, S., Cochrane handbook for systematic reviews of interventions, version 5.1.0: The Cochrane Collaboration; 2011 http://handbook.cochrane.org/, Accessed 25 Oct 2017; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) J Clin Epidemiol, 62 (10), pp. 1006-1012; Page, M.J., Shamseer, L., Altman, D.G., Tetzlaff, J., Sampson, M., Tricco, A.C., Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study (2016) PLoS Med, 13 (5); Créquit, P., Trinquart, L., Yavchitz, A., Ravaud, P., Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer (2014) BMC Med, 14, p. 8; Pollock, M., Fernandes, R.M., Hartling, L., Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions (2017) BMC Med Res Methodol, 17, p. 48; Ballard, M., Montgomery, P., Risk of bias in overviews of reviews: a scoping review of methodological guidance and four-item checklist (2017) Res Synth Methods, 8 (1), pp. 92-108; Pollock, M., Fernandes, R.M., Becker, L.A., Featherstone, R., Hartling, L., What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary (2016) Syst Rev, 5 (1), p. 190; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med Res Methodol, 7, p. 10; Sacks, H.S., Berrier, J., Reitman, D., Ancona-Berk, V.A., Chalmers, T.C., Meta-analyses of randomized controlled trials (1987) N Engl J Med, 316 (8), pp. 450-455; Shea, B., Dube, C., Moher, D., Assessing the quality of reports of systematic reviews: the quorum statement compared to other tools (2008) Systematic reviews in health care, pp. 122-139. , Egger M, Smith GD, Altman DG, editors, London: BMJ Books; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358; Guyatt, G., Busse, J., Methods commentary: risk of bias in randomized trials 1 (2018), https://www.evidencepartners.com/resources/methodological-resources/risk-of-bias-commentary/, Ottawa: Evidence Partners; Whiting, P., Savovic, J., Higgins, J.P., Caldwell, D.M., Reeves, B.C., Shea, B., ROBIS: a new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 69, pp. 225-234; Pieper, D., Buechter, R.B., Li, L., Prediger, B., Eikermann, M., Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties (2015) J Clin Epidemiol, 68, pp. 574-583; Bühn, S., Mathes, T., Prengel, P., Wegewitz, U., Ostermann, T., Robens, S., The risk of bias in systematic reviews tool showed fair reliability and good construct validity (2017) J Clin Epidemiol., , https://doi.org/10.1016/j.jclinepi.2017.06.019; Perry, R., Leach, V., Davies, P., Penfold, C., Ness, A., Churchill, R., An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools (2017) Syst Rev, 6, p. 97; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J Clin Epidemiol, 62, pp. 1013-1020; Banzi, R., Cinquini, M., Gonzalez-Loranzo, M., Pecoraro, V., Capobussi, M., Minozzi, S., Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability (2018) J Clin Epidemiol., , https://doi.org/10.1016/j.clinepi.2018.02.024; Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015) BMJ, 349; Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015) Syst Rev, 4, p. 1; Moher, D., Dulberg, C.S., Wells, G.A., Statistical power, sample size, and their reporting in randomized controlled trials (1994) JAMA, 272, pp. 122-124; Tricco, A.C., Tetzlaff, J., Pham, B., Brehaut, J., Moher, D., Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study (2009) J Clin Epidemiol, 62, pp. 380-386.e1; Lai, N.M., Teng, C.L., Lee, M.L., Interpreting systematic reviews: are we ready to make our own conclusions? A cross-sectional study (2011) BMC Med, 9, p. 30; Song, F., Eastwood, A.J., Gilbody, S., Duley, L., Sutton, A.J., Publication and related biases (2000) Health Technol Assess, 4, pp. 1-115; Gwet, K.L., Computing inter-rater reliability and its variance in the presence of high agreement (2008) Br J Math Stat Psychol, 61, pp. 29-48; Feinstein, A.R., Cicchetti, D.V., High agreement but low kappa: I. The problems of two paradoxes (1990) J Clin Epidemiol, 43 (6), pp. 543-549; Liebetrau, A.M., Measures of association (1983), Newbury Park: Sage Publications; Fleiss, J., Levin, B.A., Paik, M.C., Statistical methods for rates and proportions (2003), 3rd ed. Hoboken: Wiley; Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174; Hartling, L., Hamm, M.P., Milne, A., Vandermeer, B., Santaguida, P.L., Ansari, M., Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs (2013) J Clin Epidemiol, 66 (9), pp. 973-981; Kang, D., Wu, Y., Hu, D., Hong, Q., Wang, J., Zhang, X., Reliability and external validity of AMSTAR in assessing quality of TCM systematic reviews (2012) Evid Based Complement Alternat Med, 2012, p. 732195; Pieper, D., Jacobs, A., Weikert, B., Fishta, A., Wegewitz, U., Inter-rater reliability of AMSTAR is dependent on the pair of reviewers (2017) BMC Med Res Methodol, 17 (1), p. 98; Hartling, L., Chisholm, A., Thomson, D., Dryden, D.M., A descriptive analysis of overviews of reviews published between 2000 and 2011 (2012) PLoS One, 7; Li, L., Tian, J., Tian, H., Sun, R., Liu, Y., Yang, K., Quality and transparency of overviews of systematic reviews (2012) J Evid Based Med, 5, pp. 166-173; Pieper, D., Buechter, R., Jerinic, P., Eikermann, M., Overviews of reviews often have limited rigor: a systematic review (2012) J Clin Epidemiol, 65, pp. 1267-1273},
correspondence_address1={Hartling, L.; University of Alberta, 11405-87 Avenue NW, Canada; email: hartling@ualberta.ca},
publisher={BioMed Central Ltd.},
issn={20464053},
pubmed_id={29898777},
language={English},
abbrev_source_title={Syst. Rev.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Wells2018688,
author={Wells, J.C.K.},
title={The capacity-load model of non-communicable disease risk: Understanding the effects of child malnutrition, ethnicity and the social determinants of health},
journal={European Journal of Clinical Nutrition},
year={2018},
volume={72},
number={5},
pages={688-697},
doi={10.1038/s41430-018-0142-x},
note={cited By 26},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047087287&doi=10.1038%2fs41430-018-0142-x&partnerID=40&md5=a0f5a86a285e7f3584cad331a91ca480},
affiliation={Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, United Kingdom},
abstract={The capacity-load model is a conceptual model developed to improve understanding of the life-course aetiology of non-communicable diseases (NCDs) and their ecological and societal risk factors. The model addresses continuous associations of both (a) nutrition and growth patterns in early life and (b) lifestyle factors at older ages with NCD risk. Metabolic capacity refers to physiological traits strongly contingent on early nutrition and growth during the first 1000 days, which promote the long-term capacity for homeostasis in the context of fuel metabolism and cardiovascular health. Metabolic load refers to components of nutritional status and lifestyle that challenge homeostasis. The higher the load, and the lower the capacity, the greater the NCD risk. The model therefore helps understand dose-response associations of both early development and later phenotype with NCD risk. Infancy represents a critical developmental period, during which slow growth can constrain metabolic capacity, whereas rapid weight gain may elevate metabolic load. Severe acute malnutrition in early childhood (stunting, wasting) may continue to deplete metabolic capacity, and confer elevated susceptibility to NCDs in the long term. The model can be applied to associations of NCD risk with socio-economic position (SEP): lower SEP is generally associated with lower capacity but often also with elevated load. The model can also help explain ethnic differences in NCD risk, as both early growth patterns and later body composition differ systematically between ethnic groups. Recent work has begun to clarify the role of organ development in metabolic capacity, which may further contribute to ethnic differences in NCD risk. © 2018 Macmillan Publishers Limited, part of Springer Nature.},
keywords={body composition;  body weight gain;  child growth;  Conference Paper;  energy metabolism;  ethnic difference;  ethnicity;  human;  lifestyle;  malnutrition;  metabolic capacity;  non communicable disease;  nutritional status;  risk factor;  social determinants of health;  social status;  stunting;  wasting syndrome;  child;  child development;  ethnic group;  homeostasis;  infant;  malnutrition;  non communicable disease;  randomized controlled trial (topic);  socioeconomics, Body Composition;  Child;  Child Development;  Ethnic Groups;  Homeostasis;  Humans;  Infant;  Life Style;  Malnutrition;  Noncommunicable Diseases;  Nutritional Status;  Randomized Controlled Trials as Topic;  Risk Factors;  Social Determinants of Health;  Socioeconomic Factors},
references={Barker, D.J., The developmental origins of adult disease (2004) J Am Coll Nutr, 23 (6), pp. 588S-958S; Bianco-Miotto, T., Craig, J.M., Gasser, Y.P., Van Dijk, S.J., Ozanne, S.E., Epigenetics and DOHaD: From basics to birth and beyond (2017) J Dev Orig Health Dis, 8, pp. 513-519; Rook, G., Backhed, F., Levin, B.R., McFall-Ngai, M.J., McLean, A.R., Evolution, human-microbe interactions, and life history plasticity (2017) Lancet, 390, pp. 521-530; Hales, C.N., Barker, D.J., Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis (1992) Diabetologia, 35, pp. 595-601; Hales, C.N., Barker, D.J., Clark, P.M., Cox, L.J., Fall, C., Osmond, C., Fetal and infant growth and impaired glucose tolerance at age 64 (1991) BMJ, 303, pp. 1019-1022; Bhargava, S.K., Sachdev, H.S., Fall, C.H., Osmond, C., Lakshmy, R., Barker, D.J., Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood (2004) N Engl J Med, 350, pp. 865-875; Petry, C.J., Dorling, M.W., Pawlak, D.B., Ozanne, S.E., Hales, C.N., Diabetes in old Male offspring of rat dams fed a reduced protein diet (2001) Int J Exp Diabetes Res, 2, pp. 139-143; Rich-Edwards, J.W., Colditz, G.A., Stampfer, M.J., Willett, W.C., Gillman, M.W., Hennekens, C.H., Birthweight and the risk for type 2 diabetes mellitus in adult women (1999) Ann Intern Med, 130 (4), pp. 278-284; Li, Y., Ley, S.H., Tobias, D.K., Chiuve, S.E., VanderWeele, T.J., Rich-Edwards, J.W., Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: Prospective cohort study (2015) BMJ, 351, p. h3672; Wells, J.C., The thrifty phenotype: An adaptation in growth or metabolism? (2011) Am J Hum Biol, 23, pp. 65-75; Wells, J.C., (2016) The Metabolic Ghetto: An Evolutionary Perspective on Nutrition, Power Relations and Chronic Disease, , Cambridge University Press Cambridge; Dominguez-Salas, P., Moore, S.E., Baker, M.S., Bergen, A.W., Cox, S.E., Dyer, R.A., Maternal nutrition at conception modulates DNA methylation of human metastable epialleles (2014) Nat Commun, 5, p. 3746; Hemachandra, A.H., Klebanoff, M.A., Use of serial ultrasound to identify periods of fetal growth restriction in relation to neonatal anthropometry (2006) Am J Hum Biol, 18, pp. 791-797; Lucas, A., Fewtrell, M.S., Cole, T.J., Fetal origins of adult disease-The hypothesis revisited (1999) BMJ, 319, pp. 245-249; Singhal, A., Kennedy, K., Lanigan, J., Fewtrell, M., Cole, T.J., Stephenson, T., Nutrition in infancy and long-term risk of obesity: Evidence from 2 randomized controlled trials (2010) Am J Clin Nutr, 92, pp. 1133-1144; McEwen, B.S., Stellar, E., Stress and the individual. Mechanisms leading to disease (1993) Arch Intern Med, 153, pp. 2093-2101; Keys, A., Brozek, J., Henschel, A., Mickelsen, O., Taylor, H.L., (1950) The Biology of Human Starvation, , University of Minnesota Press Minneapolis; Enesco, M., LeBlond, C.P., Increase in cell number as a factor in the growth of the organs and tissues of the young Male rat (1962) J Embryol Exp Morphol, 10, pp. 530-562; Adair, L.S., Martorell, R., Stein, A.D., Hallal, P.C., Sachdev, H.S., Prabhakaran, D., Size at birth, weight gain in infancy and childhood, and adult blood pressure in 5 low- and middle-income-country cohorts: When does weight gain matter? (2009) Am J Clin Nutr, 89, pp. 1383-1392; Leon, D.A., Koupilova, I., Lithell, H.O., Berglund, L., Mohsen, R., Vagero, D., Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men (1996) BMJ, 312, pp. 401-406; Li, Y., Ley, S.H., VanderWeele, T.J., Curhan, G.C., Rich-Edwards, J.W., Willett, W.C., Joint association between birth weight at term and later life adherence to a healthy lifestyle with risk of hypertension: A prospective cohort study (2015) BMC Med, 13, p. 175; Whincup, P.H., Kaye, S.J., Owen, C.G., Huxley, R., Cook, D.G., Anazawa, S., Birth weight and risk of type 2 diabetes: A systematic review (2008) JAMA, 300, pp. 2886-2897; Wu, C.Y., Chou, Y.C., Huang, N., Chou, Y.J., Hu, H.Y., Li, C.P., Association of body mass index with all-cause and cardiovascular disease mortality in the elderly (2014) PLoS ONE, 9, p. e102589; Lelijveld, N., Seal, A., Wells, J.C., Kirkby, J., Opondo, C., Chimwezi, E., Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): A cohort study (2016) Lancet Glob Health, 4, pp. e654-662; Office for National Statistics. Inequality in healthy life expectancy at birth by national deciles of area deprivation: England, 2009-11. London: Crown; 2014; Marmot, M., Social determinants of health inequalities (2005) Lancet, 365, pp. 1099-1104; Victora, C.G., Barros, F.C., Vaughan, J.P., Martines, J.C., Beria, J.U., Birthweight, socio-economic status and growth of Brazilian infants (1987) Ann Hum Biol, 14, pp. 49-57; Barros, A.J., Victora, C.G., Horta, B.L., Goncalves, H.D., Lima, R.C., Lynch, J., Effects of socioeconomic change from birth to early adulthood on height and overweight (2006) Int J Epidemiol, 35, pp. 1233-1238; Subramanian, S.V., Özaltin, E., Finlay, J.E., Height of nations: A socioeconomic analysis of cohort differences and patterns among women in 54 low- to middle-income countries (2011) PLoS ONE, 6, p. e18962; De La Grandmaison, G.L., Clairand, I., Durigon, M., Organ weight in 684 adult autopsies: New tables for a Caucasoid population (2001) Forensic Sci Int, 119, pp. 149-154; Borghol, N., Suderman, M., McArdle, W., Racine, A., Hallett, M., Pembrey, M., Associations with early-life socio-economic position in adult DNA methylation (2012) Int J Epidemiol, 41, pp. 62-74; Wardle, J., Waller, J., Jarvis, M.J., Sex differences in the association of socioeconomic status with obesity (2002) Am J Public Health, 92, pp. 1299-1304; Martorell, R., Khan, L.K., Hughes, M.L., Grummer-Strawn, L.M., Obesity in women from developing countries (2000) Eur J Clin Nutr, 54, pp. 247-252; Hruschka, D.J., Brewis, A.A., Absolute wealth and world region strongly predict overweight among women (ages 18-49) in 360 populations across 36 developing countries (2012) Econ Hum Biol, 11, pp. 337-344; Monteiro, C.A., Conde, W.L., Lu, B., Popkin, B.M., Obesity and inequities in health in the developing world (2004) Int J Obes, 28, pp. 1181-1186; Misra, A., Sharma, R., Pandey, R.M., Khanna, N., Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India (2001) Eur J Clin Nutr, 55, pp. 727-734; Bentley, A., Das, S., Alcock, G., Shah More, N., Pantvaidya, S., Osrin, D., Malnutrition and infant and young child feeding in informal settlements in Mumbai, India: Findings from a census (2015) Food Sci Nutr, 3, pp. 257-271; Kelly, Y., Panico, L., Bartley, M., Marmot, M., Nazroo, J., Sacker, A., Why does birthweight vary among ethnic groups in the UK? Findings from the Millennium Cohort Study (2009) J Public Health (Oxf), 31, pp. 131-137; Yajnik, C.S., Fall, C.H., Coyaji, K.J., Hirve, S.S., Rao, S., Barker, D.J., Neonatal anthropometry: The thin-fat Indian baby. The pune maternal nutrition study (2003) Int J Obes, 27, pp. 173-180; Stanfield, K.M., Wells, J.C., Fewtrell, M.S., Frost, C., Leon, D.A., Differences in body composition between infants of South Asian and European ancestry: The London Mother and Baby Study (2012) Int J Epidemiol, 41, pp. 1409-1418; Wells, J.C., Ethnic variability in adiposity and cardiovascular risk: The variable disease selection hypothesis (2009) Int J Epidemiol, 38, pp. 63-71; Nightingale, C.M., Rudnicka, A.R., Owen, C.G., Wells, J.C., Sattar, N., Cook, D.G., Influence of adiposity on insulin resistance and glycemia markers among United Kingdom children of South Asian, Black African-Caribbean, and White European origin: Child Heart and Health Study in England (2013) Diabetes Care, 36, pp. 1712-1719; Wells, J.C., Chomtho, S., Fewtrell, M.S., Programming of body composition by early growth and nutrition (2007) Proc Nutr Soc, 66, pp. 423-434; Martorell, R., Improved nutrition in the first 1000 days and adult human capital and health (2017) Am J Hum Biol, p. 29. , https://doi.org/10.1002/ajhb.22952; Kinra, S., Rameshwar Sarma, K.V., Ghafoorunissa, Mendu, V.V., Ravikumar, R., Mohan, V., Effect of integration of supplemental nutrition with public health programmes in pregnancy and early childhood on cardiovascular risk in rural Indian adolescents: Long term follow-up of Hyderabad nutrition trial (2008) BMJ, 337, p. a605; Petry, C.J., Desai, M., Ozanne, S.E., Hales, C.N., Early and late nutritional windows for diabetes susceptibility (1997) Proc Nutr Soc, 56, pp. 233-242; Latini, G., De Mitri, B., Del Vecchio, A., Chitano, G., De Felice, C., Zetterstrom, R., Foetal growth of kidneys, liver and spleen in intrauterine growth restriction: "programming" causing "metabolic syndrome" in adult age (2004) Acta Paediatr, 93, pp. 1635-1639; Wells, J.C., Devakumar, D., Grijalva-Eternod, C.S., Manandhar, D.S., Costello, A., Osrin, D., Blood pressure and the capacity-load model in 8-year-old children from Nepal: Testing the contributions of kidney size and intergenerational effects (2016) Am J Hum Biol, 28, pp. 555-565; Coppoletta, J.M., Wolbach, S.B., Body length and organ weights of infants and children: A study of the body length and normal weights of the more important vital organs of the body between birth and twelve years of age (1933) Am J Pathol, 9, pp. 55-70; Wells, J.C., Pomeroy, E., Walimbe, S.R., Popkin, B.M., Yajnik, C.S., The elevated susceptibility to diabetes in India: An evolutionary perspective (2016) Front Public Health, 4, p. 145},
correspondence_address1={Wells, J.C.K.; Childhood Nutrition Research Centre, United Kingdom; email: Jonathan.Wells@ucl.ac.uk},
publisher={Nature Publishing Group},
issn={09543007},
coden={EJCNE},
pubmed_id={29748656},
language={English},
abbrev_source_title={Eur. J. Clin. Nutr.},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Naik2019,
author={Naik, Y. and Baker, P. and Ismail, S.A. and Tillmann, T. and Bash, K. and Quantz, D. and Hillier-Brown, F. and Jayatunga, W. and Kelly, G. and Black, M. and Gopfert, A. and Roderick, P. and Barr, B. and Bambra, C.},
title={Going upstream - An umbrella review of the macroeconomic determinants of health and health inequalities},
journal={BMC Public Health},
year={2019},
volume={19},
number={1},
doi={10.1186/s12889-019-7895-6},
art_number={1678},
note={cited By 25},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077202218&doi=10.1186%2fs12889-019-7895-6&partnerID=40&md5=5ebe46cb9323f508eb748be899ed9732},
affiliation={Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7TF, United Kingdom; University of Liverpool Department of Public Health and Policy, 3rd Floor, Whelan Building, Brownlow Hill, Liverpool, L69 3GB, United Kingdom; Global Health and Development Group, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, United Kingdom; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, United Kingdom; Department of Primary Care and Public Health, Imperial College London, Reynolds Building, St Dunstans Road, London, W6 8RP, United Kingdom; Centre for Global Non-Communicable Diseases, Institute for Global Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, United Kingdom; NW School of Public Health, Health Education England North West, First Floor Regatta Place, Brunswick Business Park, Summers Road, Liverpool, L3 4BL, United Kingdom; Department of Sport and Exercise Sciences, Durham University, 42 Old Elvet, Durham, DH1 3HN, United Kingdom; Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom; Junior Doctor and National Medical Director's Fellow, London, United Kingdom; Faculty of Medical Sciences, Newcastle University, Sir James Spence Building, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, United Kingdom},
abstract={Background: The social determinants of health have been widely recognised yet there remains a lack of clarity regarding what constitute the macro-economic determinants of health and what can be done to address them. An umbrella review of systematic reviews was conducted to identify the evidence for the health and health inequalities impact of population level macroeconomic factors, strategies, policies and interventions. Methods: Nine databases were searched for systematic reviews meeting the Database of Abstracts of Reviews of Effects (DARE) criteria using a novel conceptual framework. Studies were assessed for quality using a standardised instrument and a narrative overview of the findings is presented. Results: The review found a large (n = 62) but low quality systematic review-level evidence base. The results indicated that action to promote employment and improve working conditions can help improve health and reduce gender-based health inequalities. Evidence suggests that market regulation of tobacco, alcohol and food is likely to be effective at improving health and reducing inequalities in health including strong taxation, or restriction of advertising and availability. Privatisation of utilities and alcohol sectors, income inequality, and economic crises are likely to increase health inequalities. Left of centre governments and welfare state generosity may have a positive health impact, but evidence on specific welfare interventions is mixed. Trade and trade policies were found to have a mixed effect. There were no systematic reviews of the health impact of monetary policy or of large economic institutions such as central banks and regulatory organisations. Conclusions: The results of this study provide a simple yet comprehensive framework to support policy-makers and practitioners in addressing the macroeconomic determinants of health. Further research is needed in low and middle income countries and further reviews are needed to summarise evidence in key gaps identified by this review. Trial registration: Protocol for umbrella review prospectively registered with PROSPERO CRD42017068357. © 2019 The Author(s).},
author_keywords={Economic policy;  Economy;  Health inequalities;  Macroeconomy;  Population health;  Public health;  Regulation;  Social determinants of health},
keywords={economics;  health disparity;  human;  social determinants of health, Economics;  Health Status Disparities;  Humans;  Social Determinants of Health;  Systematic Reviews as Topic},
references={Weisbrot, M., Ray, R., (2011) The Scorecard on Development, 1960-2010: Closing the Gap?; Starfield, B., Effects of poverty on health status (1992) Bull N y Acad Med, 68, pp. 17-24. , 1:STN:280:DyaK383gvVKgsA%3D%3D 1555023 1809870; Wagstaff, A., Poverty and health sector inequalities (2002) Bull World Health Organ, 80, pp. 97-105. , 11953787 2567730; Marmot, M., (2010) Fair Society, Healthy Lives Fair Society, Healthy Lives; Stamm, A.L., The End of an Era Builds New Team Spirit: Team Playing at Its Best (2000) Cataloging & Classification Quarterly, 30 (2-3), pp. 357-372; Shrecker, T., Bambra, C., (2015) How Politics Makes Us Sick: Neoliberal Epidemics, , Palgrave Macmillan Basingstoke; Marmot, M., Allen, J., Bell, R., Bloomer, E., Goldblatt, P., WHO European review of social determinants of health and the health divide (2012) Lancet; (2008) Commission on Social Determinants of Health: Closing the Gap in a Generation, , Geneva; Khan, M.S., Guan, B.Y., Audimulam, J., Liceras, F.C., Coker, R.J., Yoong, J., Economic interventions to improve population health: A scoping study of systematic reviews (2016) BMC Public Health, pp. 1-9. , https://doi.org/10.1186/s12889-016-3119-5; Thomson, K., Hillier-Brown, F., Todd, A., McNamara, C., Huijts, T., Bambra, C., The effects of public health policies on health inequalities in high-income countries: An umbrella review (2018) BMC Public Health, 18 (1), p. 869. , 30005611 6044092; McCartney, G., Hearty, W., Arnot, J., Popham, F., Cumbers, A., McMaster, R., Impact of political economy on population health: A systematic review of reviews (2019) Am J Public Health, 109, pp. 1-12. , 10.2105/AJPH.2019.305001; Forster, M., Chen, W., Llenanozal, A., (2008) Divided We Stand: Why Inequality Keeps Rising; (2015) The Helsinki Statement on Health in All Policies, , WHO; Naik, Y., Baker, P., Walker, I., The macro-economic determinants of health and health inequalities-umbrella review protocol (2017) Syst Rev, 6 (222). , https://doi.org/10.1186/s13643-017-0616-2; James, P., Magee, L., Scerri, A., Steger, M.B., (2015) Urban Sustainability in Theory and Practice: Circles of Sustainability, , Routledge London; (2016) JEL Codes [WWW Document], , AEA URL https://www.aeaweb.org/econlit/jelCodes.php; Bambra, C., Gibson, M., Case study of public health (2016) Umbrella Reviews: Evidence Synthesis with Overviews of Reviews and Meta-epidemiologic Studies, , G. Biondi-Zoccai (eds) Springer International Publishing Basel; Becker, L.A., Oxman, A.D., Overviews of reviews (2008) Cochrane Handbook for Systematic Reviews of Interventions, pp. 221-2221. , J.P.T. Higgins S. Green (eds) Wiley-Blackwell Chichester; Hoboken https://training.cochrane.org/handbook/chapter-22; Bambra, C., Gibson, M., Sowden, A., Wright, K., Whitehead, M., Petticrew, M., Tackling the wider social determinants of health and health inequalities: Evidence from systematic reviews (2009) Journal of Epidemiology & Community Health, 64 (4), pp. 284-291; Cairns, J., Warren, J., Garthwaite, K., Greig, G., Bambra, C., Go slow: An umbrella review of the effects of 20 mph zones and limits on health and health inequalities (2014) J Public Health, 37, pp. 515-520. , 10.1093/pubmed/fdu067; Search Filters [WWW Document], , http://www.sign.ac.uk/search-filters.html, SIGN, n.d. Accessed 26 Oct 2017; (2016) Database of Abstracts of Reviews of Effects (DARE). [WWW Document], , https://www.ncbi.nlm.nih.gov/pubmedhealth/about/DARE/, U.S. National Library of Medicine; Thomson, K., Bambra, C., McNamara, C., Huijts, T., Todd, A., The effects of public health policies on population health and health inequalities in European welfare states: Protocol for an umbrella review (2016) Syst Rev, 5, p. 57. , 10.1186/s13643-016-0235-3 27059307 4826536; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Henry, D.A., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, pp. 1-9. , https://doi.org/10.1136/bmj.j4008; Lorenc, T., Petticrew, M., Welch, V., Tugwell, P., What types of interventions generate inequalities? Evidence from systematic reviews: Table 1 (2012) Journal of Epidemiology and Community Health, 67 (2), pp. 190-193. , 22875078 22875078; Brown, T., Platt, S., Amos, A., Equity impact of population-level interventions and policies to reduce smoking in adults: A systematic review (2014) Drug Alcohol Depend, 138, pp. 7-16. , 10.1016/j.drugalcdep.2014.03.001 24674707 24674707; Faber, T., Kumar, A., MacKenbach, J.P., Millett, C., Basu, S., Sheikh, A., Been, J.V., Effect of tobacco control policies on perinatal and child health: A systematic review and meta-analysis (2017) Lancet Public Health, 2, pp. e420-e437. , 10.1016/S2468-2667(17)30144-5 28944313 5592249; Alagiyawanna, A., Townsend, N., Mytton, O., Scarborough, P., Roberts, N., Rayner, M., Studying the consumption and health outcomes of fiscal interventions (taxes and subsidies) on food and beverages in countries of different income classifications; A systematic review (2015) BMC Public Health, , https://doi.org/10.1186/s12889-015-2201-8; Niebylski, M., Redburn, K., Duhaney, T., Campbell, N.R., Healthy food subsidies and unhealthy food taxation: A systematic review of the evidence (2015) Nutrition, 31, pp. 787-795. , 10.1016/j.nut.2014.12.010 25933484 25933484; Wright, A., Smith, K.E., Hellowell, M., Policy lessons from health taxes: A systematic review of empirical studies (2017) BMC Public Health, pp. 1-14. , https://doi.org/10.1186/s12889-017-4497-z; Thow, A.M., Jan, S., Leeder, S., Swinburn, B., The effect of fiscal policy on diet, obesity and chronic disease: A systematic review (2010) Bulletin of the World Health Organization, 88 (8), pp. 609-614. , 20680126 2908970; Eyles, H., Ni Mhurchu, C., Nghiem, N., Blakely, T., Food Pricing Strategies, Population Diets, and Non-Communicable Disease: A Systematic Review of Simulation Studies (2012) PLoS Medicine, 9 (12), p. e1001353. , 23239943 3519906; Galvão, L.A.C., Haby, M.M., Chapman, E., Clark, R., Câmara, V.M., Luiz, R.R., Becerra-Posada, F., The new United Nations approach to sustainable development post-2015: Findings from four overviews of systematic reviews on interventions for sustainable development and health (2016) Pan Am J Public Health, 39, pp. 157-165; Patra, J., Giesbrecht, N., Rehm, J., Bekmuradov, D., Popova, S., Are Alcohol Prices and Taxes an Evidence-Based Approach to Reducing Alcohol-Related Harm and Promoting Public Health and Safety? A Literature Review (2012) Contemporary Drug Problems, 39 (1), pp. 7-48; Elder, R.W., Lawrence, B., Ferguson, A., Timothy, S., Brewer, R.D., Chattopadhyay, S.K., Traci, L., The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms (2010) Am J Prev Med, 38, pp. 217-229. , 10.1016/j.amepre.2009.11.005.The 20117579 3735171; Wagenaar, A.C., Tobler, A.L., Komro, K.A., Effects of alcohol tax and price policies on morbidity and mortality: A systematic review (2010) Am J Public Health, 100, pp. 2270-2278. , 10.2105/AJPH.2009.186007 20864710 2951962; Boniface, S., Scannell, J.W., Marlow, S., Evidence for the effectiveness of minimum pricing of alcohol: A systematic review and assessment using the Bradford Hill criteria for causality (2017) BMJ Open, 7 (5), p. e013497. , 28588106 5777460; Martineau, F., Tyner, E., Lorenc, T., Petticrew, M., Lock, K., Population-level interventions to reduce alcohol-related harm: An overview of systematic reviews (2013) Prev Med (Baltim), 57, pp. 278-296. , 10.1016/j.ypmed.2013.06.019; Hahn, R.A., Middleton, J.C., Elder, R., Brewer, R., Fielding, J., Naimi, T.S., Toomey, T.L., Lawrence, B., Effects of alcohol retail privatization on excessive alcohol consumption and related harms (2012) AMEPRE, 42, pp. 418-427. , 10.1016/j.amepre.2012.01.002; Burns, D.K., Jones, A.P., Suhrcke, M., The relationship between international trade and non-nutritional health outcomes: A systematic review of quantitative studies (2016) Soc Sci Med, 152, pp. 9-17. , 10.1016/j.socscimed.2016.01.021 26820112 26820112; Barlow, P., McKee, M., Basu, S., Stuckler, D., The health impact of trade and investment agreements: A quantitative systematic review and network co-citation analysis (2017) Glob Health, pp. 1-9. , https://doi.org/10.1186/s12992-017-0240-x; Falagas, M.E., Vouloumanou, E.K., Mavros, M.N., Karageorgopoulos, D.E., Economic crises and mortality: A review of the literature (2009) International Journal of Clinical Practice, 63 (8), pp. 1128-1135. , 1:STN:280:DC%2BD1Mrgt1WgtQ%3D%3D 19624782 19624782; Parmar, D., Stavropoulou, C., Ioannidis, J.P.A., Health outcomes during the 2008 financial crisis in Europe: Systematic literature review (2016) BMJ, 354, p. i4588. , 10.1136/bmj.i4588 27601477 5013230; Mucci, N., Giorgi, G., Perez, J.F., Arcangeli, G., The correlation between stress and economic crisis: A systematic review (2016) Neuropsychiatr Dis Treat, 12, pp. 983-993. , 27143898 4844458; Suhrcke, M., Stuckler, D., Suk, J.E., Desai, M., Senek, M., McKee, M., Tsolova, S., Semenza, J.C., The Impact of Economic Crises on Communicable Disease Transmission and Control: A Systematic Review of the Evidence (2011) PLoS ONE, 6 (6), p. e20724. , 1:CAS:528:DC%2BC3MXnvVSju7w%3D 21695209 3112201; Rajmil, L., De Sanmamed, M.F., Choonara, I., Faresjö, T., Impact of the 2008 economic and financial crisis on child health: A systematic review (2014) Int J Environ Res Public Health, pp. 6528-6546. , https://doi.org/10.3390/ijerph110606528; Simou, E., Koutsogeorgou, E., Effects of the economic crisis on health and healthcare in Greece in the literature from 2009 to 2013: A systematic review (2014) Health Policy (New York), 115, pp. 111-119. , 10.1016/j.healthpol.2014.02.002; Glonti, K., Gordeev, V.S., Goryakin, Y., Reeves, A., Stuckler, D., McKee, M., Roberts, B., A systematic review on health resilience to economic crises (2015) PLoS One, 10, pp. 1-22. , 10.1371/journal.pone.0123117 1:CAS:528:DC%2BC28Xos1Oksrc%3D; Herbig, B., Dragano, N., Angerer, P., Health in the long-term unemployed (2013) Dtsch Arztebl Int, 110, pp. 413-420. , 10.3238/arztebl.2013.0413 23837086 3702026; De Goeij, M.C.M., Suhrcke, M., Toffolutti, V., Van De Mheen, D., Schoenmakers, T.M., Kunst, A.E., How economic crises affect alcohol consumption and alcohol-related health problems: A realist systematic review (2015) Soc Sci Med, 131, pp. 131-146. , 10.1016/j.socscimed.2015.02.025 25771482 25771482; Kentikelenis, A., Karanikolos, M., Williams, G., Mladovsky, P., King, L., Pharris, A., Suk, J.E., Stuckler, D., How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review (2015) Eur J Pub Health, 25, pp. 937-944. , 10.1093/eurpub/ckv151; Downing, J., The health effects of the foreclosure crisis and unaffordable housing: A systematic review and explanation of evidence (2016) Soc Sci Med, 162, pp. 88-96. , 10.1016/j.socscimed.2016.06.014 27343818 27343818; Tsai, A.C., Home Foreclosure, Health, and Mental Health: A Systematic Review of Individual, Aggregate, and Contextual Associations (2015) PLOS ONE, 10 (4), p. e0123182. , 25849962 4388711 1:CAS:528:DC%2BC28XmsFGktrs%3D; Egan, M., Petticrew, M., Ogilvie, D., Hamilton, V., Drever, F., Profits before people"? A systematic review of the health and safety impacts of privatising public utilities and industries in developed countries (2007) J Epidemiol Community Health, 61 (10), pp. 862-870. , 10.1136/jech.2006.053231 17873221 2652962; Thomson, H., Do urban regeneration programmes improve public health and reduce health inequalities? A synthesis of the evidence from UK policy and practice (1980-2004) (2006) Journal of Epidemiology & Community Health, 60 (2), pp. 108-115; Black, A.P., Brimblecombe, J., Eyles, H., Morris, P., Vally, H., Dea, K.O., Food subsidy programs and the health and nutritional status of disadvantaged families in high income countries: A systematic review (2012) BMC Public Health, 12, p. 1. , 10.1186/1471-2458-12-1099; Pega, F., Sy, L., Walter, S., Sk, L., Unconditional cash transfers for assistance in humanitarian disasters: Effect on use of health services and health outcomes in low-and middle-income countries (Review) (2015) Cochrane Database Syst Rev, , https://doi.org/10.1002/14651858.CD011247.pub2.www.cochranelibrary.com; Pega, F., Carter, K., Blakely, T., Pj, L., In-work tax credits for families and their impact on health status in adults (2013) Cochrane Database Syst Rev, , https://doi.org/10.1002/14651858.CD009963.pub2.www.cochranelibrary.com; Kim, I., Muntaner, C., Vahid, F., Vives, A., Vanroelen, C., Benach, J., Welfare states, flexible employment, and health: A critical review (2012) Health Policy (New York), 104, pp. 99-127. , 10.1016/j.healthpol.2011.11.002; O'Campo, P., Molnar, A., Ng, E., Renahy, E., Mitchell, C., Shankardass, K., St. John, A., Muntaner, C., Social welfare matters: A realist review of when, how, and why unemployment insurance impacts poverty and health (2015) Soc Sci Med, 132, pp. 88-94. , 10.1016/j.socscimed.2015.03.025 25795992 25795992; Beckfield, J., Krieger, N., Epi 1 demos 1 cracy: Linking political systems and priorities to the magnitude of health inequities - Evidence, gaps, and a research agenda (2009) Epidemiol Rev, 31, pp. 152-177. , 10.1093/epirev/mxp002 19474091 19474091; Roy, M.J., Donaldson, C., Baker, R., Kerr, S., The potential of social enterprise to enhance health and well-being: A model and systematic review (2014) Soc Sci Med, 123, pp. 182-193. , 10.1016/j.socscimed.2014.07.031 25037852 25037852; Milner, A., Page, A., Lamontagne, A.D., Long-term unemployment and Suicide: A systematic review and meta-analysis (2013) PLoS One, 8, pp. 1-6. , 10.1371/journal.pone.0051333 1:CAS:528:DC%2BC3sXhsFyhsLk%3D; Jin, R.L., Shah, C.P., Svoboda, T.J., The impact of unemployment on health: A review of the evidence (1997) J Public Health Policy, 18, pp. 275-301; Gibson, M., Thomson, H., Banas, K., Lutje, V., Mj, M., Sp, M., Fenton, C., Bond, L., Welfare-to-work interventions and their effects on the mental and physical health of lone parents and their children (Review) (2017) Cochrane Database Syst Rev, , https://doi.org/10.1002/14651858.CD009820.pub3.www.cochranelibrary.com; Aitken, Z., Garrett, C.C., Hewitt, B., Keogh, L., Hocking, J.S., Kavanagh, A.M., Social science & medicine the maternal health outcomes of paid maternity leave: A systematic review (2015) Soc Sci Med, 130, pp. 32-41. , 10.1016/j.socscimed.2015.02.001 25680101 25680101; Borrell, C., Palència, L., Muntaner, C., Urquía, M., Malmusi, D., Campo, P.O., Influence of macrosocial policies on women' s health and gender inequalities in health (2014) Epidemiol Rev, 36, pp. 31-48. , 10.1093/epirev/mxt002 24025349 24025349; Suri, S., Das, R., Occupational health profile of workers employed in the manufacturing sector of India (2016) Natl Med J India, 29 (5), pp. 277-281. , 28098082 28098082; Rivara, F.P., Thompson, D.C., Prevention of falls in the construction industry evidence for program effectiveness (2000) Am J Prev Med, 18, pp. 23-26. , 1:STN:280:DC%2BD3c3lsFWrsg%3D%3D 10793277 10793277; Iemmi, V., Bantjes, J., Coast, E., Channer, K., McDaid, D., Palfreyman, A., Stephens, B., Suicide, C., Suicide and poverty in low-income and middle-income countries: A systematic review (2016) Lancet Psychiatry, 3 (8), pp. 774-783; Preston, S., The changing relation between mortality and level of economic development (1975) Popul Stud, 29 (2), pp. 231-248. , 10.2307/2173509 1:STN:280:DC%2BD3MrpsFaluw%3D%3D; O'Hare, B., Makuta, I., Chiwaula, L., Bar-Zeev, N., Income and child mortality in developing countries: A systematic review and meta-analysis (2013) J R Soc Med, 106, pp. 408-414. , 10.1177/0141076813489680 23824332 3791093; Kim, K., The relationships between income inequality, welfare regimes and aggregate health: A systematic review (2017) Eur J Public Health, 27, pp. 397-404. , 10.1093/eurpub/ckx055 28549140 28549140; MacInko, J.A., Shi, L., Starfield, B., Income inequality and health: A critical review of the literature (2003) Med Care Res Rev, 60, pp. 407-452. , 10.1177/1077558703257169 14677219 14677219; Spencer, N., The effect of income inequality and macro-level social policy on infant mortality and low birthweight in developed countries - A preliminary systematic review (2004) Child: Care, Health and Development, 30 (6), pp. 699-709. , 1:STN:280:DC%2BD2crls1WksQ%3D%3D; Kondo, N., Sembajwe, G., Kawachi, I., Van Dam, R.M., Subramanian, S.V., Yamagata, Z., Income inequality, mortality, and self rated health: Meta-analysis of multilevel studies (2009) BMJ, 339 (NOV10 2), p. b4471. , 19903981 2776131; Ngamaba, K., Panagioti, M., Armitage, C., Income inequality and subjective well-being: A systematic review and meta-analysis (2018) Qual Life Res, 27, pp. 577-596. , 10.1007/s11136-017-1719-x 29067589 29067589; Adjaye-Gbewonyo, K., Kawachi, I., Use of the Yitzhaki index as a test of relative deprivation for health outcomes: A review of recent literature (2012) Soc Sci Med, 75, pp. 129-137. , 10.1016/j.socscimed.2012.03.004 22521678 22521678; Singh, A., Harford, J., Schuch, H.S., Watt, R.G., Peres, M.A., Population health theoretical basis and explanation for the relationship between area-level social inequalities and population oral health outcomes - A scoping review (2016) SSM - Popul Health, 2, pp. 451-462. , 10.1016/j.ssmph.2016.06.001 29349160 5757950; Costa, S.M., Martins, C.C., Bonfim, M.D.L.C., Zina, L.G., (2012) A Systematic Review of Socioeconomic Indicators and Dental Caries in Adults, pp. 3540-3574. , 10.3390/ijerph9103540; Julien, D., Richard, L., Gauvin, L., Kestens, Y., Neighborhood characteristics and depressive mood among older adults: An integrative review (2012) International Psychogeriatrics, 24 (8), pp. 1207-1225. , 22300529 22300529; Meijer, M., Röhl, J., Bloom, K., Grittner, U., Do neighborhoods affect individual mortality ? A systematic review and meta-analysis of multilevel studies (2012) Soc Sci Med, 74, pp. 1204-1212. , 10.1016/j.socscimed.2011.11.034 22365939 22365939 review/Yan and S. final go/Data/PDC/4699. pd; Baade, P.D., Yu, X.Q., Smith, D.P., Dunn, J., Suzanne, K., Geographic disparities in prostate cancer outcomes - Review of international patterns (2015) Asian Pac J Cancer Prev, 16, pp. 1259-1275. , 25735366 25735366; Brennenstuhl, S., Quesnel-Vallée, A., McDonough, P., Welfare regimes, population health and health inequalities: A research synthesis (2012) J Epidemiol Community Health, 66, pp. 397-409. , 10.1136/jech-2011-200277 22080814 22080814; Bergqvist, K., Yngwe, M.Å., Lundberg, O., Understanding the role of welfare state characteristics for health and inequalities-an analytical review (2013) BMC Public Health; Barnish, M., Tørnes, M., Nelson-Horne, B., How much evidence is there that political factors are related to population health outcomes? An internationally comparative systematic review (2018) BMJ Open, 8 (10), p. e020886. , 30341112 6196855; Flanders, S., (2016) Inclusive Growth for People and Places - Findings from Inclusive Growth Commission Deep Dive Research; (2015) All on Board - Making Inclusive Growth Happen, , OECD; Utting, P., (2015) Social and Solidarity Economy: Beyond the Fringe, , Zed Books; Jackson, M., McInroy, N., (2015) Creating a Good Local Economy: The Role of Anchor Institutions; (2018) Circular Economy and Health: Opportunities and Risks, , WHO; Ruckert, A., Reducing health inequities: Is universal basic income the way forward? (2017) J Public Health (Bangkok); Ambasta, A., Buonocore, J.J., Carbon pricing: A win-win environmental and public health policy (2018) Can J Public Health, 109, pp. 779-781. , 10.17269/s41997-018-0099-5 29981108 29981108; Living Well within Limits [WWW Document], , https://lili.leeds.ac.uk/about/, University of Leeds, n.d; Knai, Systems thinking as a framework for analyzing commercial determinants of health (2018) Milbank Q, 96, pp. 472-498. , 10.1111/1468-0009.12339 30277610 6131339; Campbell, F., (2019) Nobody Left Behind. Maximising the Health Benefits of An Inclusive Local Economy; Fond, M., Volmert, A., (2018) Seeing Upstream [WWW Document], , https://frameworksinstitute.org/social-determinants-of-health-uk.html, Fram. Inst. Accessed 20 Sept 2006; Foster, J., From simplistic to complex systems in economics (2005) Camb J Econ, 29 (6), pp. 873-892. , 10.1093/cje/bei083; Bentley, R.A., Maddison, E.J., Ranner, H., Bissell, J., Caiado, C.C.S., Bhatanacharoen, P., Clark, T., Hollow, M., Social tipping points and earth systems dynamics (2014) Front Environ Sci, 2, pp. 1-7. , 10.3389/fenvs.2014.00035; Schafran, A., McDonald, C., Lopez Morales, E., Akyelken, N., Acuto, M., Replacing the services sector and three-sector theory: Urbanization and control as economic sectors (2018) Reg Stud, 52, pp. 1708-1719. , 10.1080/00343404.2018.1464136; Hillier-Brown, F., Thomson, K., McGowan, V., Cairns, J., Eikemo, T., Gil-González, D., Bambra, C., The effects of social protection policies on health inequalities in European welfare states: A review of systematic reviews (2019) Scand J Public Health, 47, pp. 655-666. , 31068103 31068103},
correspondence_address1={Naik, Y.; Leeds Teaching Hospitals NHS Trust, Beckett St, United Kingdom; email: yannishnaik@nhs.net},
publisher={BioMed Central Ltd.},
issn={14712458},
pubmed_id={31842835},
language={English},
abbrev_source_title={BMC Public Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Lakhani2019327,
author={Lakhani, C.M. and Tierney, B.T. and Manrai, A.K. and Yang, J. and Visscher, P.M. and Patel, C.J.},
title={Repurposing large health insurance claims data to estimate genetic and environmental contributions in 560 phenotypes},
journal={Nature Genetics},
year={2019},
volume={51},
number={2},
pages={327-334},
doi={10.1038/s41588-018-0313-7},
note={cited By 25},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060078322&doi=10.1038%2fs41588-018-0313-7&partnerID=40&md5=56fba24e28737ddf5012d2891e460dab},
affiliation={Department of Biomedical Informatics, Harvard Medical School, Boston, MA, United States; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, United States; Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA, United States; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Queensland Brain Institute, The University of Queensland, Brisbane, Australia},
abstract={We analysed a large health insurance dataset to assess the genetic and environmental contributions of 560 disease-related phenotypes in 56,396 twin pairs and 724,513 sibling pairs out of 44,859,462 individuals that live in the United States. We estimated the contribution of environmental risk factors (socioeconomic status (SES), air pollution and climate) in each phenotype. Mean heritability (h2 = 0.311) and shared environmental variance (c2 = 0.088) were higher than variance attributed to specific environmental factors such as zip-code-level SES (varSES = 0.002), daily air quality (varAQI = 0.0004), and average temperature (vartemp = 0.001) overall, as well as for individual phenotypes. We found significant heritability and shared environment for a number of comorbidities (h2 = 0.433, c2 = 0.241) and average monthly cost (h2 = 0.290, c2 = 0.302). All results are available using our Claims Analysis of Twin Correlation and Heritability (CaTCH) web application. © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.},
keywords={adolescent;  air pollution;  air quality;  air temperature;  Article;  child;  climate;  comorbidity;  cost;  environmental factor;  genetic disorder;  genotype environment interaction;  geographic distribution;  health insurance;  heritability;  human;  human genetics;  phenotypic variation;  priority journal;  sibling;  social status;  twins;  United States;  diseases;  environment;  female;  genetic predisposition;  genetics;  health insurance;  male;  phenotype, Disease;  Environment;  Female;  Genetic Predisposition to Disease;  Humans;  Insurance, Health;  Male;  Phenotype;  Twins},
funding_details={1078037, 1113400},
funding_details={R00ES23504, R21ES205052},
funding_details={National Science FoundationNational Science Foundation, NSF, 1636870},
funding_details={National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, T32DK110919},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, 4R00ES023504-03, R21ES025052},
funding_details={Sylvia and Charles Viertel Charitable FoundationSylvia and Charles Viertel Charitable Foundation},
funding_text 1={We thank K. Fox of Aetna, Inc., N. Palmer of Harvard Medical School, and I. Kohane of Harvard Medical School for support and providing access to the Aetna Insurance Claims Data. We are grateful to L. O’Connor and A. Price for helpful discussion. This research was supported by the Australian National Health and Medical Research Council (1078037 and 1113400), National Institutes of Health NIEHS (R00ES23504 and R21ES205052), the National Science Foundation (1636870), and the Sylvia & Charles Viertel Charitable Foundation.},
references={Collins, F.S., Varmus, H., A new initiative on precision medicine (2015) N. Engl. J. Med., 372, pp. 793-795. , COI: 1:CAS:528:DC%2BC2MXjvFGnsLY%3D; Roberts, N.J., The predictive capacity of personal genome sequencing (2012) Sci. Transl. Med., 4, p. 133ra58; Wray, N.R., Yang, J., Goddard, M.E., Visscher, P.M., The genetic interpretation of area under the ROC curve in genomic profiling (2010) PLoS Genet., 6; Wang, K., Gaitsch, H., Poon, H., Cox, N.J., Rzhetsky, A., Classification of common human diseases derived from shared genetic and environmental determinants (2017) Nat. Genet., 49, pp. 1319-1325. , COI: 1:CAS:528:DC%2BC2sXht1yhs7%2FM; Polubriaginof, F.C.G., Disease heritability inferred from familial relationships reported in medical records (2018) Cell, 173, p. 1692. , COI: 1:CAS:528:DC%2BC1cXpvVemsrg%3D; Benyamin, B., Wilson, V., Whalley, L.J., Visscher, P.M., Deary, I.J., Large, consistent estimates of the heritability of cognitive ability in two entire populations of 11-year-old twins from Scottish mental surveys of 1932 and 1947 (2005) Behav. Genet., 35, pp. 525-534; Graham, G.N., Why your zip code matters more than your genetic code: promoting healthy outcomes from mother to child (2016) Breastfeed. Med., 11, pp. 396-397; Slade-Sawyer, P., Is health determined by genetic code or zip code? Measuring the health of groups and improving population health (2014) N. C. Med. J., 75, pp. 394-397. , PID: 25402691; Heckerman, D., Linear mixed model for heritability estimation that explicitly addresses environmental variation (2016) Proc. Natl Acad. Sci. USA, 113, pp. 7377-7382. , COI: 1:CAS:528:DC%2BC28XhtFCrsbnK; Denny, J.C., Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data (2013) Nat. Biotechnol., 31, pp. 1102-1110. , COI: 1:CAS:528:DC%2BC3sXhvVaiu7jE; Storey, J.D., A direct approach to false discovery rates (2002) J. R. Stat. Soc. Series B Stat. Methodol., 64, pp. 479-498; Polderman, T.J.C., Meta-analysis of the heritability of human traits based on fifty years of twin studies (2015) Nat. Genet., 47, pp. 702-709. , COI: 1:CAS:528:DC%2BC2MXhtFemt7jN; van Dongen, J., Eline Slagboom, P., Draisma, H.H.M., Martin, N.G., Boomsma, D.I., The continuing value of twin studies in the omics era (2012) Nat. Rev. Genet., 13, pp. 640-653; Docherty, A.R., Comparison of twin and extended pedigree designs for obtaining heritability estimates (2015) Behav. Genet., 45, pp. 461-466; Liu, C., Revisiting heritability accounting for shared environmental effects and maternal inheritance (2015) Hum. Genet., 134, pp. 169-179; Loh, P.R., Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis (2015) Nat. Genet., 47, pp. 1385-1392. , COI: 1:CAS:528:DC%2BC2MXhslKgt7jF; Finucane, H.K., Partitioning heritability by functional annotation using genome-wide association summary statistics (2015) Nat. Genet., 47, pp. 1228-1235. , COI: 1:CAS:528:DC%2BC2MXhsFKqu7rF; Lee, S.H., Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs (2012) Nat. Genet., 44, pp. 247-250. , COI: 1:CAS:528:DC%2BC38XisVKrsr8%3D; Dieleman, J.L., US Spending on personal health care and public health, 1996–2013 (2016) JAMA, 316, pp. 2627-2646; McWilliams, J.M., Schwartz, A.L., Focusing on high-cost patients - the key to addressing high costs? (2017) N. Engl. J. Med., 376, pp. 807-809; Richesson, R.L., A comparison of phenotype definitions for diabetes mellitus (2013) J. Am. Med. Inform. Assoc., 20, pp. e319-e326; Krieger, N., Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: the public health disparities geocoding project (US) (2003) J. Epidemiol. Community Health, 57, pp. 186-199. , COI: 1:STN:280:DC%2BD3s%2FotlWjug%3D%3D; Blair, D.R., A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk (2013) Cell, 155, pp. 70-80. , COI: 1:CAS:528:DC%2BC3sXhsFens7%2FN; Huff, S.M., Development of the logical observation identifier names and codes (LOINC) vocabulary (1998) J. Am. Med. Inform. Assoc., 5, pp. 276-292. , COI: 1:STN:280:DyaK1c3ntVKlsw%3D%3D; Visscher, P.M., Benyamin, B., White, I., The use of linear mixed models to estimate variance components from data on twin pairs by maximum likelihood (2004) Twin. Res., 7, pp. 670-674; Beasley, T.M., Erickson, S., Allison, D.B., Rank-based inverse normal transformations are increasingly used, but are they merited? (2009) Behav. Genet., 39, pp. 580-595; Reich, T., James, J.W., Morris, C.A., The use of multiple thresholds in determining the mode of transmission of semi-continuous traits (1972) Ann. Hum. Genet., 36, pp. 163-184. , COI: 1:STN:280:DyaE3s7ktlWltg%3D%3D; Falconer, D.S., Mackay, T.C., (1989) Introduction to Quantitative Genetics, , John Wiley & Sons. Inc., New York; Weinberg, W., Beiträge zur Physiologie und Pathologie der Mehrlingsgeburten beim Menschen (1901) Pflugers Arch. Gesamte Physiol. Menschen Tiere, 88, pp. 346-430; Neale, M.C., A finite mixture distribution model for data collected from twins (2003) Twin. Res., 6, pp. 235-239; Scarr-Salapatek, S., Race, social class, and IQ (1971) Science, 174, pp. 1285-1295. , COI: 1:STN:280:DyaE38%2Foslehug%3D%3D; Benjamini, Y., Yekutieli, D., The control of the false discovery rate in multiple testing under dependency (2001) Ann. Stat., 29, pp. 1165-1188; Bates, D., Mächler, M., Bolker, B., Walker, S., Fitting linear mixed-effects models using lme4 (2015) J. Stat. Softw., 67, pp. 1-48; (2014) A Language and Environment for Statistical Computing, , R Foundation for Statistical Computing; Viechtbauer, W., Conducting meta-analyses in R with the metafor package (2010) J. Stat. Softw., 36, pp. 1-48; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control. Clin. Trials, 7, pp. 177-188. , COI: 1:STN:280:DyaL2s7gsVamtA%3D%3D; Qi, T., Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood (2018) Nat. Commun., 9},
correspondence_address1={Patel, C.J.; Department of Biomedical Informatics, United States; email: chirag_patel@hms.harvard.edu},
publisher={Nature Publishing Group},
issn={10614036},
coden={NGENE},
pubmed_id={30643253},
language={English},
abbrev_source_title={Nat. Genet.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Turner2018,
author={Turner, M.C. and Vineis, P. and Seleiro, E. and Dijmarescu, M. and Balshaw, D. and Bertollini, R. and Chadeau-Hyam, M. and Gant, T. and Gulliver, J. and Jeong, A. and Kyrtopoulos, S. and Martuzzi, M. and Miller, G.W. and Nawrot, T. and Nieuwenhuijsen, M. and Phillips, D.H. and Probst-Hensch, N. and Samet, J. and Vermeulen, R. and Vlaanderen, J. and Vrijheid, M. and Wild, C. and Kogevinas, M.},
title={EXPOsOMICS: Final policy workshop and stakeholder consultation David Stieb, Cecile Boot, Michelle Turner, Osmar Zaiane},
journal={BMC Public Health},
year={2018},
volume={18},
number={1},
doi={10.1186/s12889-018-5160-z},
art_number={260},
note={cited By 25},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042138213&doi=10.1186%2fs12889-018-5160-z&partnerID=40&md5=8cf941d19fdaf54df270999112721148},
affiliation={Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place, W2 1PG, London, United Kingdom; International Agency for Research on Cancer, Lyon, France; National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, United States; Former WHO Chief Scientist and Representative to the European Union, Brussels, Belgium; Public Health England, London, United Kingdom; University of Basel, Swiss Tropical and Public Health Institute, Basel, Switzerland; National Hellenic Research Association, Athens, Greece; World Health Organisation, Bonn, Germany; Emory University, Atlanta, United States; University of Hasselt, Hasselt, Belgium; King's College London, London, United Kingdom; Colorado School of Public Health, Aurora, United States; Utrecht University, Utrecht, Netherlands; IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain},
abstract={The final meeting of the EXPOsOMICS project "Final Policy Workshop and Stakeholder Consultation" took place 28-29 March 2017 to present the main results of the project and discuss their implications both for future research and for regulatory and policy activities. This paper summarizes presentations and discussions at the meeting related with the main results and advances in exposome research achieved through the EXPOsOMICS project; on other parallel research initiatives on the study of the exposome in Europe and in the United States and their complementarity to EXPOsOMICS; lessons learned from these early studies on the exposome and how they may shape the future of research on environmental exposure assessment; and finally the broader implications of exposome research for risk assessment and policy development on environmental exposures. The main results of EXPOsOMICS in relation to studies of the external exposome and internal exposome in relation to both air pollution and water contaminants were presented as well as new technologies for environmental health research (adductomics) and advances in statistical methods. Although exposome research strengthens the scientific basis for policy development, there is a need in terms of showing added value for public health to: improve communication of research results to non-scientific audiences; target research to the broader landscape of societal challenges; and draw applicable conclusions. Priorities for future work include the development and standardization of methodologies and technologies for assessing the external and internal exposome, improved data sharing and integration, and the demonstration of the added value of exposome science over conventional approaches in answering priority policy questions. © 2018 The Author(s).},
author_keywords={Adductomics;  Air pollution;  Exposome;  External exposome;  Internal exposome;  Policy;  Statistics;  Water contamination;  Workshop report},
keywords={air pollution;  environmental exposure;  environmental health;  Europe;  health care policy;  human;  medical research;  organization;  risk assessment;  stakeholder engagement;  water pollution, Air Pollution;  Biomedical Research;  Congresses as Topic;  Environmental Exposure;  Environmental Health;  Europe;  Health Policy;  Humans;  Risk Assessment;  Stakeholder Participation;  Water Pollution},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, 308610},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/L01341X/1},
references={Wild, C.P., Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology (2005) Cancer Epidemiol Biomark Prev, 14, pp. 1847-1850. , 1:CAS:528:DC%2BD2MXnsl2lu7c%3D; Rappaport, S.M., Smith, M.T., Environment and disease risks (2010) Science, 330 (6003), pp. 460-461. , 1:CAS:528:DC%2BC3cXhsVaqs7zM 20966241 4841276; Lioy, P.J., Rappaport, S.M., Exposure science and the exposome: An opportunity for coherence in the environmental health sciences (2011) Environ Health Perspect, 119, pp. A466-A467. , 22171373 3226514; Vineis, P., Chadeau-Hyam, M., Gmuender, H., Gulliver, J., Herceg, Z., Kleinjans, J., The exposome in practice: Design of the EXPOsOMICS project (2017) Int J Hyg Environ Health, 220 (2), pp. 142-151. , 1:STN:280:DC%2BC2szlvFOkug%3D%3D 27576363; De Hoogh, K., Gulliver, J., Van Donkelaar, A., Martin, R.V., Marshall, J.D., Bechle, M.J., Development of west-European PM2.5 and NO2 land use regression models incorporating satellite-derived and chemical transport modelling data (2016) Environ Res, 151, pp. 1-10. , 1:CAS:528:DC%2BC28Xht1aitL7P 27447442; Van Nunen, E., Vermeulen, R., Tsai, M.Y., Probst-Hensch, N., Ineichen, A., Land use regression models for ultrafine particles in six European areas (2017) Environ Sci Technol, 51, pp. 3336-3345. , 1:CAS:528:DC%2BC2sXjsVOnurc%3D 28244744 5362744; Beelen, R., Raaschou-Nielsen, O., Stafoggia, M., Jovanovic Andersen, Z., Weinmayr, G., Hoffmann, B., Effects of long-term exposure to air pollution on natural-cause mortality: An analysis of 22 European cohorts within the multicenter ESCAPE project (2014) Lancet, 383, pp. 785-795. , 1:CAS:528:DC%2BC3sXhvFyru7jP 24332274; Jacquemin, B., Siroux, V., Sanchez, M., Carsin, A.E., Schikowski, T., Adam, M., Ambient air pollution and adult asthma incidence in six European cohorts (ESCAPE) (2015) Environ Health Perspect, 123, pp. 613-621. , 1:CAS:528:DC%2BC28XovFarsrw%3D 25712593 4455584; McCreanor, J., Cullinan, P., Nieuwenhuijsen, M.J., Stewart-Evans, J., Malliarou, E., Jarup, L., Respiratory effects of exposure to diesel traffic in persons with asthma (2007) N Engl J Med, 357, pp. 2348-2358. , 1:CAS:528:DC%2BD2sXhsVWhtrrO 18057337; Chi, G.C., Liu, Y., MacDonald, J.W., Barr, R.G., Donohue, K.M., Hensley, M.D., Long-term outdoor air pollution and DNA methylation in circulating monocytes: Results from the multi-ethnic study of atherosclerosis (MESA) (2016) Environ Health, 15, p. 119. , 27903268 5131503; Panni, T., Mehta, A.J., Schwartz, J.D., Baccarelli, A.A., Just, A.C., Wolf, K., Genome-wide analysis of DNA methylation and fine particulate matter air pollution in three study populations: KORA F3, KORA F4, and the normative aging study (2016) Environ Health Perspect, 124, pp. 983-990. , 26731791 4937859; Plusquin, M., Guida, F., Polidoro, S., Vermeulen, R., Raaschou-Nielsen, O., Campanella, G., DNA methylation and exposure to ambient air pollution in two prospective cohorts (2017) Environ Int, 108, pp. 127-136. , 1:CAS:528:DC%2BC2sXhsVansr3F 28843141; Spiegelman, D., Regression calibration in air pollution epidemiology with exposure estimated by spatio-temporal modeling (2013) Environmetrics, 24, pp. 521-524. , 29081677; Huan, T., Esko, T., Peters, M.J., Pilling, L.C., Schramm, K., Schurmann, C., A meta-analysis of gene expression signatures of blood pressure and hypertension (2015) PLoS Genet, 11, p. e1005035. , 25785607 4365001; Richardson, S.D., DeMarini, D.M., Kogevinas, M., Fernandez, P., Marco, E., Lourencetti, C., What's in the pool? A comprehensive identification of disinfection by-products and assessment of mutagenicity of chlorinated and brominated swimming pool water (2010) Environ Health Perspect, 118, pp. 1523-1530. , 1:CAS:528:DC%2BC3cXhsFyqu7%2FL 20833605 2974688; Villanueva, C.M., Cantor, K.P., Cordier, S., Jaakkola, J.J., King, W.D., Lynch, C.F., Disinfection byproducts and bladder cancer: A pooled analysis (2004) Epidemiology, 15, pp. 357-367. , 15097021; Villanueva, C.M., Gracia-Lavedan, E., Bosetti, C., Righi, E., Molina, A.J., Martín, V., Colorectal cancer and long-term exposure to trihalomethanes in drinking water: A multicenter case-control study in Spain and Italy (2017) Environ Health Perspect, 125, pp. 56-65. , 27383820; Nieuwenhuijsen, M.J., Smith, R., Golfinopoulos, S., Best, N., Bennett, J., Aggazzotti, G., Health impacts of long-term exposure to disinfection by-products in drinking water in Europe: HIWATE (2009) J Water Health, 7, pp. 185-207; Plewa, M.J., Wagner, E.D., Muellner, M.G., Hsu, K.M., Richardson, S.D., Ceomparative mammalian cell toxicity of N-DBPs and C-DBPs (2008) Occurrence, Formation, Health Effects and Control of Disinfection By-products in Drinking Water, pp. 36-50. , T. Karanfil S.W. Krasner Westerhoff Y. Xie (eds) 995 American Chemical Society Washington, DC; Richardson, S.D., Plewa, M.J., Wagner, E.D., Schoeny, R., Demarini, D.M., Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: A review and roadmap for research (2007) Mutat Res, 636, pp. 178-242. , 1:CAS:528:DC%2BD2sXhtlGgtLbP 17980649; Vlaanderen, J., Van Veldhoven, K., Font-Ribera, L., Villanueva, C.M., Chadeau-Hyam, M., Portengen, L., Acute changes in serum immune markers due to swimming in a chlorinated pool (2017) Environ Int, 105, pp. 1-11. , 1:CAS:528:DC%2BC2sXns1WqsLg%3D 28478232; Kogevinas, M., Villanueva, C.M., Font-Ribera, L., Liviac, D., Bustamante, M., Espinoza, F., Genotoxic effects in swimmers exposed to disinfection by-products in indoor swimming pools (2010) Environ Health Perspect, 118, pp. 1531-1537. , 1:CAS:528:DC%2BC3cXhsFyqu7%2FE 20833606 2974689; Li, H., Grigoryan, H., Funk, W.E., Lu, S.S., Rose, S., Williams, E.R., Rappaport, S.M., Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring (2011) Mol Cell Proteomics, 3, p. M110. , 004606; Preston, G.W., Plusquin, M., Sozeri, O., Van Veldhoven, K., Bastian, L., Nawrot, T.S., Refinement of a methodology for untargeted detection of serum albumin adducts in human populations (2017) Chem Res Toxicol., 30, pp. 2120-2129. , 1:CAS:528:DC%2BC2sXhslCitbbM 29092396 5736992; Chadeau-Hyam, M., Campanella, G., Jombart, T., Bollolo, L., Portengen, L., Vineis, P., Deciphering the complex: Methodological overview of statistical models to derive OMICS-based biomarkers (2013) Environ Mol Mutagen, 54, pp. 542-557. , 1:CAS:528:DC%2BC3sXht1Wrs7zE 23918146; Agier, L., Portengen, L., Chadeau-Hyam, M., Basagaña, X., Giorgis-Allemand, L., Siroux, V., A systematic comparison of linear regression-based statistical methods to assess exposome-health associations (2016) Environ Health Perspect, 124, pp. 1848-1856. , 27219331 5132632; Guida, F., Sandanger, T.M., Castagné, R., Campanella, G., Polidoro, S., Palli, D., Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation (2015) Hum Mol Genet, 24, pp. 2349-2359. , 1:CAS:528:DC%2BC2MXhsVOhsLfL 25556184 4380075; Loh, M., Sarigiannis, D., Gotti, A., Karakitsios, S., Pronk, A., Kuijpers, E., How sensors might help define the external exposome (2017) Int J Environ Res Public Health., 14 (4); Juarez, D., Matthews-Juarez, P., Hood, D.B., Im, W., Levine, R.S., Kilbourne, B.J., The public health exposome: A population-based, exposure science approach to health disparities research (2014) Int J Environ Res Public Health, 11, pp. 12866-12895. , 25514145 4276651; The international HapMap project (2003) Nature, 426, pp. 789-796. , International HapMap Consortium; Robinson, O., Basagana, X., Agier, L., De Castro, M., Hernandez-Ferrer, C., Gonzalez, J.R., The pregnancy exposome: Multiple environmental exposures in the INMA-Sabadell birth cohort (2015) Environ Sci Technol, 49, pp. 10632-10641. , 1:CAS:528:DC%2BC2MXhtFGmtbbL 26168307; Nieuwenhuijsen, M.J., Donaire-Gonzalez, D., Foraster, M., Martinez, D., Cisneros, A., Using personal sensors to assess the exposome and acute health effects (2014) Int J Environ Res Public Health, 11, pp. 7805-7819. , 1:CAS:528:DC%2BC2cXhvFahsL3M 25101766 4143834; Boushey, C.J., Spoden, M., Zhu, F.M., Delp, E.J., Kerr, D.A., New mobile methods for dietary assessment: Review of image-assisted and image-based dietary assessment methods (2016) Proc Nutr Soc, 12, pp. 1-12; (2017) Using 21st Century Science to Improve Risk-related Evaluations, , U.S. National Academy Of sciences, engineering, and medicine The National Academies Press, Washington, DC; Hill, A.B., The environment and disease: Association or causation? (1965) Proc R Soc Med, 58, pp. 295-300. , 1:STN:280:DyaF2M%2FovVCmsw%3D%3D 14283879 1898525; Shaffer, R.M., Smith, M.N., Faustman, E.M., Developing the regulatory utility of the exposome: Mapping exposures for risk assessment through lifestage exposome snapshots (LEnS) (2017) Environ Health Perspect, 125 (8), p. 085003. , 28796633; Vrijheid, M., Slama, R., Robinson, O., Chatzi, L., Coen, M., The human early-life exposome (HELIX): Project rationale and design (2014) Environ Health Perspect, 122, pp. 535-544. , 24610234 4048258; Maitre, L., Lau, C.E., Vizcaino, E., Robinson, O., Casas, M., Siskos, A.P., Assessment of metabolic phenotypic variability in children's urine using 1H NMR spectroscopy (2017) Sci Rep, 7, p. 46082. , 1:CAS:528:DC%2BC2sXmsVSrs78%3D 28422130 5395814; (2007) Toxicity Testing in the 21st Century: A Vision and A Strategy, , U.S. National Research Council The National Academies Press Washington, DC; (2012) Exposure Science in the 21st Century: A Vision and A Strategy, , U.S. National Research Council The National Academies Press Washington, DC; Nieuwenhuijsen, M.J., (2015) Exposure Assessment in Environmental Epidemiology, , Oxford University Press, New York, NY; Smith, M.T., Guyton, K.Z., Gibbons, C.F., Fritz, J.M., Portier, C.J., Rusyn, I., Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis (2016) Environ Health Perspect, 124, pp. 713-721. , 26600562; Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674. , 1:CAS:528:DC%2BC3MXjsFeqtrk%3D 21376230; Edmands, W.M., Ferrari, P., Rothwell, J.A., Rinaldi, S., Slimani, N., Barupal, D.K., Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countries (2015) Am J Clin Nutr, 102, pp. 905-913. , 1:CAS:528:DC%2BC28XisVKls7c%3D 26269369; Neveu, V., Moussy, A., Rouaix, H., Wedekind, R., Pon, A., Knox, C., Exposome-explorer: A manually-curated database on biomarkers of exposure to dietary and environmental factors (2017) Nucleic Acids Res, 45 (D1), pp. D979-D984. , 1:CAS:528:DC%2BC1cXhslWht7w%3D 27924041; Patel, C.J., Rehkopf, D.H., Leppert, J.T., Bortz, W.M., Cullen, M.R., Chertow, G.M., Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States national health and nutrition examination survey (2013) Int J Epidemiol, 42, pp. 1795-1810. , 24345851 3887569; Patel, C.J., Manrai, A.K., Development of exposome correlation globes to map out environment-wide associations (2015) Pac Symp Biocomput., pp. 231-242; Siroux, V., Agier, L., Slama, R., The exposome concept: A challenge and a potential driver for environmental health research (2016) Eur Respir Rev, 25, pp. 124-129. , 27246588; Dennis, K.K., Marder, M.E., Balshaw, D.M., Cui, Y., Lynes, M.A., Patti, G.J., Biomonitoring in the era of the exposome (2017) Environ Health Perspect, 125, pp. 502-510. , 27385067; Rose, G., Sick individuals and sick populations (2001) Int J Epidemiol, 30, pp. 427-432. , 1:STN:280:DC%2BD3Mzlt1SisQ%3D%3D 11416056; Vineis, P., Ahsan, H., Parker, M., Genetic screening and occupational and environmental exposures (2005) Occup Environ Med, 62, pp. 657-662. , 1:STN:280:DC%2BD2Mvktlalsw%3D%3D 16109824 1741080},
correspondence_address1={Vineis, P.; MRC-PHE Centre for Environment and Health, Norfolk Place, W2 1PG, United Kingdom; email: p.vineis@imperial.ac.uk},
publisher={BioMed Central Ltd.},
issn={14712458},
pubmed_id={29448939},
language={English},
abbrev_source_title={BMC Public Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Charmandari2012,
author={Charmandari, E. and Achermann, J.C. and Carel, J.-C. and Soder, O. and Chrousos, G.P.},
title={Stress response and child health},
journal={Science Signaling},
year={2012},
volume={5},
number={248},
doi={10.1126/scisignal.2003595},
note={cited By 25},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868271223&doi=10.1126%2fscisignal.2003595&partnerID=40&md5=c4fef3f57d30c71f8e37673ba84a5726},
affiliation={Division of Endocrinology, Metabolism, Diabetes, First Department of Pediatrics, Aghia Sophia Children's Hospita, Athens, Greece; Clinical Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Developmental Endocrinology Research Group, University College London Institute of Child Health, University College London, London, United Kingdom; Department of Pediatric Endocrinology and Diabetology, Robert Debre Hospital, Paris, France; Department of Women's and Children's Health, Pediatric Endocrinology Unit, Karolinska Institute at Karolinska University Hospital, Stockholm, Sweden},
abstract={Stress is defi ned as a state of real or perceived threat to homeostasis. The principal effectors of the stress system are corticotropin-releasing hormone (CRH), arginine vasopressin, the proopiomelanocortin-derived peptides -melanocyte-stimulating hormone and -endorphin, the glucocorticoids, and the catecholamines norepinephrine and epinephrine. Appropriate responsiveness of the stress system to stressors is a crucial prerequisite for a sense of well-being, adequate performance of tasks, and positive social interactions. By contrast, inappropriate responsiveness of the stress system may impair growth and development and may account for various endocrine, metabolic, autoimmune, and psychiatric disorders. The development and severity of these conditions primarily depend on the genetic vulnerability of the individual, the exposure to adverse environmental factors, and the timing of stressful event(s). Prenatal life, infancy, childhood, and adolescence are critical periods characterized by increased vulnerability to stressors. This review summarizes the topics presented at the fi fth New Inroads to Child Health (NICHe) Conference Stress Response and Child Health held at Heraklion, Crete.},
keywords={corticotropin;  corticotropin releasing factor;  glucocorticoid;  neurosteroid;  unspecific monooxygenase;  vasopressin, adrenal insufficiency;  alertness;  Alzheimer disease;  arousal;  brain stem;  cardiovascular disease;  child;  child health;  chronic fatigue syndrome;  chronic stress;  circadian rhythm;  conference paper;  congenital adrenal hyperplasia;  Cushing syndrome;  diabetes control;  fibromyalgia;  genetic variability;  homeostasis;  human;  hyperthyroidism;  hypothyroidism;  immunopathology;  insulin dependent diabetes mellitus;  menopause;  metabolic syndrome X;  neuroendocrinology;  obesity;  obsessive compulsive disorder;  P450 oxidoreductase deficiency;  panic;  paraventricular thalamic nucleus;  posttraumatic stress disorder;  priority journal;  puerperal depression;  rheumatoid arthritis;  sexual abuse;  short stature;  skeleton malformation;  stress, Adolescent;  Adolescent Development;  Child;  Child Development;  Child, Preschool;  Congresses as Topic;  Developmental Disabilities;  Female;  Greece;  Hormones;  Humans;  Infant;  Infant, Newborn;  Male;  Stress, Physiological},
chemicals_cas={corticotropin, 11136-52-0, 9002-60-2, 9061-27-2; corticotropin releasing factor, 178359-01-8, 79804-71-0, 86297-72-5, 86784-80-7, 9015-71-8; unspecific monooxygenase, 9012-80-0, 9037-52-9, 9038-14-6; vasopressin, 11000-17-2; Hormones},
references={Chrousos, G.P., Stress and disorders of the stress system (2009) Nat. Rev. Endocrinol, 5, pp. 374-381; Chrousos, G.P., Organization and integration of the endocrine system (2002) Pediatric Endocrinology, pp. 1-14. , M. Sperling, Ed. Saunders, Philadelphia; Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis (1992) JAMA, 267, pp. 1244-1252; Charmandari, E., Tsigos, C., Chrousos, G., Endocrinology of the stress response (2005) Annual Review of Physiology, 67, pp. 259-284. , DOI 10.1146/annurev.physiol.67.040403.120816; Charmandari, E., Kino, T., Souvatzoglou, E., Chrousos, G.P., Pediatric stress: Hormonal mediators and human development (2003) Hormone Research, 59 (4), pp. 161-179. , DOI 10.1159/000069325; Gold, P.W., Chrousos, G.P., Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states (2002) Molecular Psychiatry, 7 (3), pp. 254-275. , DOI 10.1038/sj/mp/4001032; Chrousos, G.P., The hypothalamic-pituitary-adrenal axis and immune-mediated infl ammation (1995) N. Engl. J. Med, 332, pp. 1351-1362; Vale, W., Spiess, J., Rivier, C., Rivier, J., Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin (1981) Science, 213 (4514), pp. 1394-1397; Grigoriadis, D.E., The corticotropin-releasing factor receptor: A novel target for the treatment of depression and anxiety-related disorders (2005) Expert Opinion on Therapeutic Targets, 9 (4), pp. 651-684. , DOI 10.1517/14728222.9.4.651; Robel, P., Baulieu, E.-E., Neurosteroids: Biosynthesis and function (1995) Critical Reviews in Neurobiology, 9 (4), pp. 383-394; Baulieu, E.E., Neurosteroids: A novel function of the brain (1998) Psychoneuroendocrinology, 23 (8), pp. 963-987. , DOI 10.1016/S0306-4530(98)00071-7, PII S0306453098000717; Charalampopoulos, I., Remboutsika, E., Margioris, A.N., Gravanis, A., Neurosteroids as modulators of neurogenesis and neuronal survival (2008) Trends Endocrinol. Metab, 19, pp. 300-307; Chrousos, G.P., Charmandari, E., Kino, T., Editorial: Glucocorticoid Action Networks - An Introduction to Systems Biology (2004) Journal of Clinical Endocrinology and Metabolism, 89 (2), pp. 563-564. , DOI 10.1210/jc.2003-032026; Chrousos, G.P., Kino, T., Intracellular glucocorticoid signaling: A formerly simple system turns stochastic (2005) Sci. STKE, 2005, pp. e48; Chrousos, G.P., Kino, T., Glucocorticoid signaling in the cell: Expanding clinical implications to complex human behavioral and somatic disorders (2009) Ann. N.Y. Acad. Sci, 1179, p. 153; Nicolaides, N.C., Galata, Z., Kino, T., Chrousos, G.P., Charmandari, E., The human glucocorticoid receptor: Molecular basis of biologic function (2010) Steroids, 75, pp. 1-12; Gross, K.L., Lu, N.Z., Cidlowski, J.A., Molecular mechanisms regulating glucocorticoid sensitivity and resistance (2009) Mol. Cell. Endocrinol, 300, pp. 7-16; Oakley, R.H., Cidlowski, J.A., Cellular processing of the glucocorticoid receptor gene and protein: New mechanisms for generating tissue-specifi c actions of glucocorticoids (2011) J. Biol. Chem, 286, pp. 3177-3184; Nader, N., Chrousos, G.P., Kino, T., Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: Potential physiological implications (2009) FASEB J, 23, pp. 1572-1583; Nader, N., Chrousos, G.P., Kino, T., Interactions of the circadian CLOCK system and the HPA axis (2010) Trends Endocrinol. Metab, 21, pp. 277-286; Kino, T., Chrousos, G.P., Circadian CLOCKmediated regulation of target-tissue sensitivity to glucocorticoids: Implications for cardiometabolic diseases (2011) Endocr. Dev, 20, pp. 116-126; Wyrwoll, C.S., Holmes, M.C., Seckl, J.R., 11®-hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress (2011) Front. Neuroendocrinol, 32, pp. 265-286; Cottrell, E.C., Holmes, M.C., Livingstone, D.E., Kenyon, C.J., Seckl, J.R., Reconciling the nutritional and glucocorticoid hypotheses of fetal programming (2012) FASEB J, 26, pp. 1866-1874; Holmes, M.C., Carter, R.N., Noble, J., Chitnis, S., Dutia, A., Paterson, J.M., Mullins, J.J., Yau, J.L., 11®-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments (2010) J. Neurosci, 30, pp. 6916-6920; Sooy, K., Webster, S.P., Noble, J., Binnie, M., Walker, B.R., Seckl, J.R., Yau, J.L.W., Partial defi ciency or short-term inhibition of 11®-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice (2010) J. Neurosci, 30, pp. 13867-13872; Miller, W.L., Minireview: Regulation of steroidogenesis by electron transfer (2005) Endocrinology, 146 (6), pp. 2544-2550. , DOI 10.1210/en.2005-0096; Miller, W.L., P450 oxidoreductase deficiency: A new disorder of steroidogenesis with multiple clinical manifestations (2004) Trends in Endocrinology and Metabolism, 15 (7), pp. 311-315. , DOI 10.1016/j.tem.2004.07.005, PII S1043276004001535; Miller, W.L., Huang, N., Agrawal, V., Giacomini, K.M., Genetic variation in human P450 oxidoreductase (2009) Mol. Cell. Endocrinol, 300, pp. 180-184; Fernandez-Vojvodich, P., Palmblad, K., Karimian, E., Andersson, U., Sävendahl, L., Pro-infl ammatory cytokines produced by growth plate chondrocytes may act locally to modulate longitudinal bone growth (2012) Horm. Res. Paediatr, 77, pp. 180-187; Ahmed, S.F., Sävendahl, L., Promoting growth in chronic infl ammatory disease: Lessons from studies of the growth plate (2009) Horm. Res, 72 SUPPL. 1, pp. 42-47; Vojvodich, P.F., Hansen, J.B., Andersson, U., Savendahl, L., Hagelberg, S., Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis (2007) Journal of Rheumatology, 34 (12), pp. 2481-2485; Surwit, R.S., Schneider, M.S., Role of stress in the etiology and treatment of diabetes mellitus (1993) Psychosomatic Medicine, 55 (4), pp. 380-393; Dungan, K.M., Braithwaite, S.S., Preiser, J.C., Stress hyperglycaemia (2009) Lancet, 373, pp. 1798-1807; Wierson, M., Long, P.J., Forehand, R.L., Toward a new understanding of early menarche: The role of environmental stress in pubertal timing (1993) Adolescence, 28, pp. 913-924; Charmandari, E., Kino, T., Ichijo, T., Chrousos, G.P., Generalized glucocorticoid resistance: Clinical aspects, molecular mechanisms, and implications of a rare genetic disorder (2008) Journal of Clinical Endocrinology and Metabolism, 93 (5), pp. 1563-1572. , http://jcem.endojournals.org/cgi/reprint/93/5/1563, DOI 10.1210/jc.2008-0040; Charmandari, E., Kino, T., Chrousos syndrome: A seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes (2010) Eur. J. Clin. Invest, 40, pp. 932-942; Charmandari, E., Primary generalized glucocorticoid resistance and hypersensitivity (2011) Horm. Res. Paediatr, 76, pp. 145-155; Charmandari, E., Kino, T., Novel causes of generalized glucocorticoid resistance (2007) Hormone and Metabolic Research, 39 (6), pp. 445-450. , DOI 10.1055/s-2007-980196; Charmandari, E., Kino, T., Ichijo, T., Jubiz, W., Mejia, L., Zachman, K., Chrousos, G.P., A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance (2007) Journal of Clinical Endocrinology and Metabolism, 92 (10), pp. 3986-3990. , http://jcem.endojournals.org/cgi/reprint/92/10/3986, DOI 10.1210/jc.2006-2830; Charmandari, E., Chrousos, G.P., Kino, T., Identifi cation of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction level (2009) Methods Mol. Biol, 590, pp. 33-60; Scheeringa, M.S., Developmental considerations for diagnosing PTSD and acute stress disorder in preschool and school-age children (2008) Am. J. Psychiatry, 165, pp. 1237-1239; Pervanidou, P., Chrousos, G.P., Neuroendocrinology of post-traumatic stress disorder (2010) Prog. Brain Res, 182, pp. 149-160; Pervanidou, P., Kolaitis, G., Charitaki, S., Lazaropoulou, C., Papassotiriou, I., Hindmarsh, P., Bakoula, C., Chrousos, G.P., The Natural History of Neuroendocrine Changes in Pediatric Posttraumatic Stress Disorder (PTSD) After Motor Vehicle Accidents: Progressive Divergence of Noradrenaline and Cortisol Concentrations Over Time (2007) Biological Psychiatry, 62 (10), pp. 1095-1102. , DOI 10.1016/j.biopsych.2007.02.008, PII S0006322307001412, Stress and Anxiety: Developmental and Therapeutic Perspectives; Pervanidou, P., Kolaitis, G., Charitaki, S., Margeli, A., Lazaropoulou, C., Papassotiriou, I., Ferentinos, S., Chrousos, G.P., Elevated morning serum IL-6 or evening salivary cortisol predict PTSD in children and adolescents 6 months after motor vehicle accidents (2007) Psychoneuroendocrinology, 32, pp. 991-992; Wadhwa, P.D., Buss, C., Entringer, S., Swanson, J.M., Developmental origins of health and disease: Brief history of the approach and current focus on epigenetic mechanisms (2009) Semin. Reprod. Med, 27, pp. 358-368; Entringer, S., Buss, C., Wadhwa, P.D., Prenatal stress and developmental programming of human health and disease risk: Concepts and integration of empirical fi ndings (2010) Curr. Opin. Endocrinol. Diabetes Obes, 17, pp. 507-516; Entringer, S., Buss, C., Swanson, J.M., Cooper, D.M., Wing, D.A., Waffarn, F., Wadhwa, P.D., Fetal programming of body composition, obesity, and metabolic function: The role of intrauterine stress and stress biology (2012) J. Nutr. Metab 2012, , 632548},
correspondence_address1={Charmandari, E.; Division of Endocrinology, Metabolism, , Athens, Greece; email: evangelia.charmandari@googlemail.com},
issn={19450877},
pubmed_id={23112343},
language={English},
abbrev_source_title={Sci. Signal.},
document_type={Conference Paper},
source={Scopus},
}

@ARTICLE{Vink2018,
author={Vink, A. and Hanser, S.},
title={Music-based therapeutic interventions for people with dementia: A mini-review},
journal={Medicines},
year={2018},
volume={5},
number={4},
note={cited By 24},
source={Scopus},
}

@ARTICLE{Ziff2020,
author={Ziff, O.J. and Samra, M. and Howard, J.P. and Bromage, D.I. and Ruschitzka, F. and Francis, D.P. and Kotecha, D.},
title={Beta-blocker efficacy across different cardiovascular indications: An umbrella review and meta-analytic assessment},
journal={BMC Medicine},
year={2020},
volume={18},
number={1},
doi={10.1186/s12916-020-01564-3},
art_number={103},
note={cited By 23},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084276541&doi=10.1186%2fs12916-020-01564-3&partnerID=40&md5=bbe75256c9edfe7805b17d0a3e640958},
affiliation={University of Birmingham Institute of Cardiovascular Sciences, Medical School, Birmingham, B15 2TT, United Kingdom; University College London, London, WC1E 6BT, United Kingdom; Imperial College London, London, SW7 2AZ, United Kingdom; Kings College London, London, WC2R 2LS, United Kingdom; University Hospital Zurich, Zürich, 8091, Switzerland; Monash Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, VIC  3004, Australia; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Institute of Translational Medicine, Birmingham, B15 2GW, United Kingdom},
abstract={Background: Beta-blockers are widely used for many cardiovascular conditions; however, their efficacy in contemporary clinical practice remains uncertain. Methods: We performed a prospectively designed, umbrella review of meta-analyses of randomised controlled trials (RCTs) investigating the evidence of beta-blockers in the contemporary management of coronary artery disease (CAD), heart failure (HF), patients undergoing surgery or hypertension (registration: PROSPERO CRD42016038375). We searched MEDLINE, EMBASE and the Cochrane Library from inception until December 2018. Outcomes were analysed as beta-blockers versus control for all-cause mortality, myocardial infarction (MI), incident HF or stroke. Two independent investigators abstracted the data, assessed the quality of the evidence and rated the certainty of evidence. Results: We identified 98 meta-analyses, including 284 unique RCTs and 1,617,523 patient-years of follow-up. In CAD, 12 meta-analyses (93 RCTs, 103,481 patients) showed that beta-blockers reduced mortality in analyses before routine reperfusion, but there was a lack of benefit in contemporary studies where ≥ 50% of patients received thrombolytics or intervention. Beta-blockers reduced incident MI at the expense of increased HF. In HF with reduced ejection fraction, 34 meta-analyses (66 RCTs, 35,383 patients) demonstrated a reduction in mortality and HF hospitalisation with beta-blockers in sinus rhythm, but not in atrial fibrillation. In patients undergoing surgery, 23 meta-analyses (89 RCTs, 19,211 patients) showed no effect of beta-blockers on mortality for cardiac surgery, but increased mortality in non-cardiac surgery. In non-cardiac surgery, beta-blockers reduced MI after surgery but increased the risk of stroke. In hypertension, 27 meta-analyses (36 RCTs, 260,549 patients) identified no benefit versus placebo, but beta-blockers were inferior to other agents for preventing mortality and stroke. Conclusions: Beta-blockers substantially reduce mortality in HF patients in sinus rhythm, but for other conditions, clinicians need to weigh up both benefit and potential risk. © 2020 The Author(s).},
author_keywords={Coronary artery disease;  Heart failure;  Hypertension;  Meta-analysis;  Mortality;  Myocardial infarction;  Perioperative;  Stroke;  Systematic review},
keywords={beta adrenergic receptor blocking agent;  beta adrenergic receptor blocking agent, all cause mortality;  atrioventricular block;  bradycardia;  cardiovascular disease;  cardiovascular mortality;  cerebrovascular accident;  coronary artery disease;  drug efficacy;  drug indication;  drug safety;  heart failure;  heart failure with reduced ejection fraction;  human;  hypertension;  hypotension;  meta analysis;  Review;  risk reduction;  sinus rhythm;  systematic review;  cardiovascular disease;  prospective study, Adrenergic beta-Antagonists;  Cardiovascular Diseases;  Humans;  Prospective Studies},
chemicals_cas={Adrenergic beta-Antagonists},
references={Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D.G., Collins, P.D., Coats, A.J., Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: Individual patient data meta-analysis (2016) BMJ, 353, p. i1855; Barron, A.J., Zaman, N., Cole, G.D., Wensel, R., Okonko, D.O., Francis, D.P., Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient information (2013) Int J Cardiol, 168 (4), pp. 3572-3579; Hjalmarson, A., Elmfeldt, D., Herlitz, J., Holmberg, S., Malek, I., Nyberg, G., Ryden, L., Waagstein, F., Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial (1981) Lancet, 2 (8251), pp. 823-827. , 1:STN:280:DyaL38%2FjsVynuw%3D%3D; Chen, J., Radford, M.J., Wang, Y., Marciniak, T.A., Krumholz, H.M., Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma (2001) J Am Coll Cardiol, 37 (7), pp. 1950-1956. , 1:CAS:528:DC%2BD3MXltVGhsb4%3D; O'Gara, P.T., Kushner, F.G., Ascheim, D.D., Casey, D.E., Jr., Chung, M.K., De Lemos, J.A., Ettinger, S.M., Franklin, B.A., 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) Circulation, 127 (4), pp. 529-555; Bangalore, S., Makani, H., Radford, M., Thakur, K., Toklu, B., Katz, S.D., DiNicolantonio, J.J., Wetterslev, J., Clinical outcomes with beta-blockers for myocardial infarction: A meta-analysis of randomized trials (2014) Am J Med, 127 (10), pp. 939-953. , 1:CAS:528:DC%2BC2cXhslGrs7bI; Kotecha, D., Holmes, J., Krum, H., Altman, D.G., Manzano, L., Cleland, J.G., Lip, G.Y., Kirchhof, P., Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis (2014) Lancet, 384 (9961), pp. 2235-2243. , 1:CAS:528:DC%2BC2cXhsVymtr3K; Bouri, S., Shun-Shin, M.J., Cole, G.D., Mayet, J., Francis, D.P., Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery (2014) Heart, 100 (6), pp. 456-464; (2011) The Clinical Management of Primary Hypertension in Adults: Clinical Guideline 127, , National Institute for Health and Care Excellence; Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D.L., Dominiczak, A., 2018 ESC/ESH Guidelines for the management of arterial hypertension (2018) Eur Heart J, 39 (33), pp. 3021-3104; Lee, D.S., Tu, J.V., Juurlink, D.N., Alter, D.A., Ko, D.T., Austin, P.C., Chong, A., Laupacis, A., Risk-treatment mismatch in the pharmacotherapy of heart failure (2005) JAMA, 294 (10), pp. 1240-1247. , 1:CAS:528:DC%2BD2MXpvFKhtbk%3D; Soumerai, S.B., McLaughlin, T.J., Spiegelman, D., Hertzmark, E., Thibault, G., Goldman, L., Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction (1997) JAMA, 277 (2), pp. 115-121. , 1:CAS:528:DyaK2sXnvFaqsg%3D%3D; Kotecha, D., Ziff, O., (2016) Efficacy of Beta-blockers across Cardiovascular Health: a Systematic Review of Meta-analyses. PROSPERO International Prospective Register of Systematic Reviews, p. 375; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2009) Open Med, 3 (3), pp. 123-130. , Group P 21603045 3090117; Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., Schunemann, H.J., GRADE: An emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336 (7650), pp. 924-926; Cleland, J.G.F., Bunting, K.V., Flather, M.D., Altman, D.G., Holmes, J., Coats, A.J.S., Manzano, L., Van Veldhuisen, D.J., Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: An individual patient-level analysis of double-blind randomized trials (2018) Eur Heart J, 39 (1), pp. 26-35. , 1:CAS:528:DC%2BC1MXjvFehsLg%3D; Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group (1986) Lancet, 2 (8498), pp. 57-66. , ISIS-1; Chen, Z.M., Pan, H.C., Chen, Y.P., Peto, R., Collins, R., Jiang, L.X., Xie, J.X., Liu, L.S., Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial (2005) Lancet, 366 (9497), pp. 1622-1632. , group Cc 1:STN:280:DC%2BD2MrptlKmug%3D%3D; Yusuf, S., Peto, R., Lewis, J., Collins, R., Sleight, P., Beta blockade during and after myocardial infarction: An overview of the randomized trials (1985) Prog Cardiovasc Dis, 27 (5), pp. 335-371. , 1:STN:280:DyaL2M7ktFSitw%3D%3D; Komajda, M., Follath, F., Swedberg, K., Cleland, J., Aguilar, J.C., Cohen-Solal, A., Dietz, R., Hobbs, R., The EuroHeart Failure Survey programme-A survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment (2003) Eur Heart J, 24 (5), pp. 464-474. , 1:STN:280:DC%2BD3s7itVWjuw%3D%3D; Komajda, M., Hanon, O., Hochadel, M., Lopez-Sendon, J.L., Follath, F., Ponikowski, P., Harjola, V.P., Tavazzi, L., Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II (2009) Eur Heart J, 30 (4), pp. 478-486; Kotecha, D., Flather, M.D., Altman, D.G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Bohm, M., Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure (2017) J Am Coll Cardiol, 69 (24), pp. 2885-2896. , 1:CAS:528:DC%2BC2sXhtVShs77F; Neilan, T.G., Shah, R.V., Abbasi, S.A., Farhad, H., Groarke, J.D., Dodson, J.A., Coelho-Filho, O., Michaud, G.F., The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation (2013) J Am Coll Cardiol, 62 (23), pp. 2205-2214. , 1:CAS:528:DC%2BC3sXitVWnurfO; Kotecha, D., Gill, S.K., Flather, M.D., Holmes, J., Packer, M., Rosano, G., Böhm, M., Anker, S.D., Impact of renal impairment on beta-blocker efficacy in patients with heart failure (2019) J Am Coll Cardiol, 74 (23), pp. 2893-2904; Koudastal, P.J., Lowenberg, B., Van Der Maas, P.J., Oosting, J.M., Peters, R.J.G., Rabelink, A.J., (2012) Report on the 2012 Follow-up Investigation of Possible Breaches of Academic Integrity, , Board of Erasmus MC Follow-up Investigation Committee; Devereaux, P.J., Yang, H., Yusuf, S., Guyatt, G., Leslie, K., Villar, J.C., Xavier, D., Pogue, J., Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial (2008) Lancet, 371 (9627), pp. 1839-1847. , 1:CAS:528:DC%2BD1cXmsFKnsbc%3D; Blessberger, H., Kammler, J., Domanovits, H., Schlager, O., Wildner, B., Azar, D., Schillinger, M., Steinwender, C., Perioperative beta-blockers for preventing surgery-relatedmortality and morbidity (2014) Cochrane Database of Systematic Reviews., (9), p. CD004476; Hwang, A.Y., Dave, C., Smith, S.M., Trends in antihypertensive medication use among US patients with resistant hypertension, 2008 to 2014 (2016) Hypertension, 68 (6), pp. 1349-1354; Kotecha, D., Manzano, L., Altman, D.G., Krum, H., Erdem, G., Williams, N., Flather, M.D., Individual patient data meta-analysis of beta-blockers in heart failure: Rationale and design (2013) Syst Rev, 2 (7), p. 7. , Beta-Blockers in Heart Failure Collaborative G; Tudur Smith, C., Marcucci, M., Nolan, S.J., Iorio, A., Sudell, M., Riley, R., Rovers, M.M., Williamson, P.R., Individual participant data meta-analyses compared with meta-analyses based on aggregate data (2016) Cochrane Database Syst Rev, 9, p. MR000007. , 27595791; Kotecha, D., Calvert, M., Deeks, J.J., Griffith, M., Kirchhof, P., Lip, G.Y., Mehta, S., Steeds, R.P., A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial (2017) BMJ Open, 7 (7), p. 015099; Opie, L.H., Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise (1985) Am J Cardiol, 55 (10), pp. 95D-100D. , 1:STN:280:DyaL2M7psF2qtw%3D%3D},
correspondence_address1={Kotecha, D.; University of Birmingham Institute of Cardiovascular Sciences, United Kingdom; email: d.kotecha@bham.ac.uk},
publisher={BioMed Central Ltd.},
issn={17417015},
pubmed_id={32366251},
language={English},
abbrev_source_title={BMC Med.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Beecroft2017607,
author={Beecroft, S.J. and McLean, C.A. and Delatycki, M.B. and Koshy, K. and Yiu, E. and Haliloglu, G. and Orhan, D. and Lamont, P.J. and Davis, M.R. and Laing, N.G. and Ravenscroft, G.},
title={Expanding the phenotypic spectrum associated with mutations of DYNC1H1},
journal={Neuromuscular Disorders},
year={2017},
volume={27},
number={7},
pages={607-615},
doi={10.1016/j.nmd.2017.04.011},
note={cited By 23},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019894849&doi=10.1016%2fj.nmd.2017.04.011&partnerID=40&md5=75a54abf2a064d7a1b3529a7b0b1c005},
affiliation={Neurogenetic Diseases Group Centre for Medical Research, QEII Medical Centre, University of Western Australia, Nedlands, WA  6009, Australia; QEII Medical Centre, Harry Perkins Institute of Medical Research, Nedlands, WA  6009, Australia; Victorian Neuromuscular Laboratory, Alfred Health, Commercial Rd, Prahran, Vic.  3181, Australia; Bruce Lefroy Centre, Murdoch Childrens Research Institute, Parkville, Vic.  3052, Australia; Victorian Clinical Genetics Services, Parkville, Vic.  3052, Australia; Launceston General Hospital, Launceston, Tas.  7250, Australia; Neurology Department, Royal Children's Hospital, Melbourne, Vic.  3052, Australia; Department of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, 06100, Turkey; Pediatric Pathology Unit, Hacettepe University Children's Hospital, Ankara, 06100, Turkey; Neurogenetic Unit, Department of Neurology, Royal Perth Hospital, Australia; Neurogenetic Unit, Department of Diagnostic Genomics, PathWest, QEII Medical Centre, Nedlands, WA  6009, Australia},
abstract={Autosomal dominant mutations of DYNC1H1 cause a range of neurogenetic diseases, including mental retardation with cortical malformations, hereditary spastic paraplegia and spinal muscular atrophy. Using SNP array, linkage analysis and next generation sequencing, we identified two families and one isolated proband sharing a known spinal muscular atrophy, lower extremity predominant (SMALED) causing mutation DYNC1H1 c.1792C>T, p.Arg598Cys, and another family harbouring a c.2327C>T, p.Pro776Leu mutation. Here, we present a detailed clinical and pathological examination of these patients, and show that patients with DYNC1H1 mutations may present with a phenotype mimicking a congenital myopathy. We also highlight features that increase the phenotypic overlap with BICD2, which causes SMALED2. Serial muscle biopsies were available for several patients, spanning from infancy and early childhood to middle age. These provide a unique insight into the developmental and pathological origins of SMALED, suggesting in utero denervation with reinnervation by surrounding intact motor neurons and segmental anterior horn cell deficits. We characterise biopsy features that may make diagnosis of this condition easier in the future. © 2017 Elsevier B.V.},
author_keywords={Diagnosis by sequencing;  DYNC1H1;  Exome sequencing;  Myopathy;  SMALED},
keywords={arginine;  cysteine;  cytosine;  leucine;  proline;  thymine;  adenosine triphosphatase;  cytoplasmic dynein;  DYNC1H1 protein, human;  myosin, adolescent;  adult;  aged;  Article;  child;  clinical article;  cohort analysis;  controlled study;  DYNC1H1 gene;  gene;  gene mutation;  human;  human tissue;  linkage analysis;  male;  muscle biopsy;  next generation sequencing;  phenotype;  priority journal;  single nucleotide polymorphism;  spinal muscular atrophy;  spinal muscular atrophy lower extremity predominant;  Australia;  family health;  female;  genetic association study;  genetics;  infant;  metabolism;  middle aged;  mutation;  neuromuscular disease;  pathology;  phenotype;  preschool child;  skeletal muscle;  young adult, Adenosine Triphosphatases;  Adolescent;  Adult;  Aged;  Australia;  Child;  Child, Preschool;  Cytoplasmic Dyneins;  Family Health;  Female;  Genetic Association Studies;  Humans;  Infant;  Male;  Middle Aged;  Muscle, Skeletal;  Mutation;  Myosins;  Neuromuscular Diseases;  Phenotype;  Turkey;  Young Adult},
chemicals_cas={arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; cysteine, 4371-52-2, 52-89-1, 52-90-4; cytosine, 71-30-7; leucine, 61-90-5, 7005-03-0; proline, 147-85-3, 7005-20-1; thymine, 65-71-4; adenosine triphosphatase, 37289-25-1, 9000-83-3; Adenosine Triphosphatases; Cytoplasmic Dyneins; DYNC1H1 protein, human; Myosins},
funding_details={APP1117510, APP1122952},
funding_details={Association Française contre les MyopathiesAssociation Française contre les Myopathies, AFM, 18724, APP1080587},
funding_details={National Health and Medical Research CouncilNational Health and Medical Research Council, NHMRC},
funding_text 1={We would like to thank the patients and families for their involvement in this study. SJB is supported by The Fred Liuzzi Foundation (Australia). NGL (APP1117510) and GR (APP1122952) are supported by the Australian NHMRC. GR is also supported by Department of Health Future Health WA Merit Awards. This work is funded by TFLF, AFM (18724), and NHMRC (APP1080587). The funding agencies had no involvement in the design, completion or writing of this study.},
references={Walton, J., Thomas, P.K., Classification of neuromuscular diseases (1988) J Neurol Sci, 86, pp. 333-360; Melki, J., Sheth, P., Abdelhak, S., Burlet, P., Bachelot, M.F., Frézal, J., Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14 (1990) Lancet, 336, pp. 271-273; Melki, J., Abdelhak, S., Sheth, P., Bachelot, M.F., Burlet, P., Marcadet, A., Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q (1990) Nature, 344, pp. 767-768; Oates, E.C., Reddel, S., Rodriguez, M.L., Gandolfo, L.C., Bahlo, M., Hawke, S.H., Autosomal dominant congenital spinal muscular atrophy: a true form of spinal muscular atrophy caused by early loss of anterior horn cells (2012) Brain, 135; Harms, M.B., Allred, P., Gardner, R., Fernandes Filho, J.A., Florence, J., Pestronk, A., Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32 (2010) Neurology, 75, pp. 539-546; Harms, M.B., Ori-McKenney, K.M., Scoto, M., Tuck, E.P., Bell, S., Ma, D., Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy (2012) Neurology, 78, pp. 1714-1720; Weedon, M.N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease (2011) Am J Hum Genet, 89, pp. 308-312; Tsurusaki, Y., Saitoh, S., Tomizawa, K., Sudo, A., Asahina, N., Shiraishi, H., A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance (2012) Neurogenetics, 13, pp. 327-332; Fiorillo, C., Moro, F., Yi, J., Weil, S., Brisca, G., Astrea, G., Novel dynein DYNC1H1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development (2014) Hum Mutat, 35, pp. 298-302; Oates, E.C., Rossor, A.M., Hafezparast, M., Gonzalez, M., Speziani, F., Macarthur, D.G., Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia (2013) Am J Hum Genet, 92, pp. 965-973; Peeters, K., Litvinenko, I., Asselbergh, B., Almeida-Souza, L., Chamova, T., Geuens, T., Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance (2013) Am J Hum Genet, 92, pp. 955-964; Neveling, K., Martinez-Carrera, L.A., Hölker, I., Heister, A., Verrips, A., Hosseini-Barkooie, S.M., Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy (2013) Am J Hum Genet, 92, pp. 946-954; Synofzik, M., Martinez-Carrera, L.A., Lindig, T., Schöls, L., Wirth, B., Dominant spinal muscular atrophy due to BICD2: a novel mutation refines the phenotype (2014) J Neurol Neurosurg Psychiatry, 85, pp. 590-592; Ravenscroft, G., Di Donato, N., Hahn, G., Davis, M.R., Craven, P.D., Poke, G., Recurrent de novo BICD2 mutation associated with arthrogryposis multiplex congenita and bilateral perisylvian polymicrogyria (2016) Neuromuscul Disord, 26, pp. 744-748; Lipka, J., Kuijpers, M., Jaworski, J., Hoogenraad, C.C., Mutations in cytoplasmic dynein and its regulators cause malformations of cortical development and neurodegenerative diseases (2013) Biochem Soc Trans, 41, pp. 1605-1612; Prokop, A., The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance (2013) Neural Dev, 8, p. 17; Peeters, K., Bervoets, S., Chamova, T., Litvinenko, I., De Vriendt, E., Bichev, S., Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies (2015) Hum Mutat; Schiavo, G., Greensmith, L., Hafezparast, M., Fisher, E.M.C., Cytoplasmic dynein heavy chain: the servant of many masters (2013) Trends Neurosci, 36, pp. 641-651; Kardon, J.R., Vale, R.D., Regulators of the cytoplasmic dynein motor (2009) Nat Rev Mol Cell Biol, 10, pp. 854-865; Scoto, M., Rossor, A.M., Harms, M.B., Cirak, S., Calissano, M., Robb, S., Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy (2015) Neurology; Hoogenraad, C.C., Akhmanova, A., Howell, S.A., Dortland, B.R., De Zeeuw, C.I., Willemsen, R., Mammalian golgi-associated Bicaudal-D2 functions in the dynein-dynactin pathway by interacting with these complexes (2001) EMBO J, 20, pp. 4041-4054; McKenney, R.J., Huynh, W., Tanenbaum, M.E., Bhabha, G., Vale, R.D., Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes (2014) Science, 345, pp. 337-341; Schlager, M.A., Hoang, H.T., Urnavicius, L., Bullock, S.L., Carter, A.P., In vitro reconstitution of a highly processive recombinant human dynein complex (2014) EMBO J, 33, pp. 1855-1868; Ravenscroft, G., Laing, N.G., Bönnemann, C.G., Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus (2014) Brain; Strickland, A.V., Schabhüttl, M., Offenbacher, H., Synofzik, M., Hauser, N.S., Brunner-Krainz, M., Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1 (2015) J Neurol, 262, pp. 2124-2134; Willemsen, M.H., Vissers, L.E., Willemsen, M.A., van Bon, B.W., Kroes, T., de Ligt, J., Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects (2012) J Med Genet, 49, pp. 179-183; Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y., Boscheron, C., Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly (2013) Nat Genet, 45, pp. 639-647; Gelineau-Morel, R., Lukacs, M., Weaver, K.N., Hufnagel, R.B., Gilbert, D.L., Stottmann, R.W., Congenital cataracts and gut dysmotility in a DYNC1H1 dyneinopathy patient (2016) Genes (Basel), 7; Unger, A., Dekomien, G., Güttsches, A., Dreps, T., Kley, R., Tegenthoff, M., Expanding the phenotype of BICD2 mutations toward skeletal muscle involvement (2016) Neurology, 87, pp. 2235-2243; Punetha, J., Monges, S., Franchi, M.E., Hoffman, E.P., Cirak, S., Tesi-Rocha, C., Exome sequencing identifies DYNC1H1 variant associated with vertebral abnormality and SMA-LED (2014) Pediatr Neurol; Ding, D., Chen, Z., Li, K., Long, Z., Ye, W., Tang, Z., Identification of a de novo DYNC1H1 mutation via WES according to published guidelines (2016) Sci Rep, 6, p. 20423; Leidenroth, A., Sorte, H.S., Gilfillan, G., Ehrlich, M., Lyle, R., Hewitt, J.E., Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis (2012) Eur J Hum Genet, 20, pp. 999-1003; Ravenscroft, G., Davis, M.R., Lamont, P., Forrest, A., Laing, N.G., New era in genetics of early onset muscle disease: breakthroughs and challenges (2016) Semin Cell Dev Biol; Davis, M., Allcock, R., Laing, N., Next generation sequencing for neuromuscular disease in a diagnostic setting – the Perth custom neuromuscular gene panel 3 years on (2016) Neuromuscul Disord, 26, p. S161; Lek, M., Karczewski, K.J., Samocha, K.E., Banks, E., Fennell, T., O'Donnell-Luria, A.H., Analysis of protein-coding genetic variation in 60,706 humans (2016) bioRxiv, 536, p. 30338; Auton, A., Abecasis, G.R., Altshuler, D.M., Durbin, R.M., Abecasis, G.R., Bentley, D.R., A global reference for human genetic variation (2015) Nature, 526, pp. 68-74; Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., dbSNP: the NCBI database of genetic variation (2001) Nucleic Acids Res, 29, pp. 308-311; Cabrera-Serrano, M., Ghaoui, R., Ravenscroft, G., Johnsen, R.D., Davis, M.R., Corbett, A., Expanding the phenotype of GMPPB mutations (2015) Brain, 138, pp. 836-844; Bahlo, M., Bromhead, C.J., Generating linkage mapping files from Affymetrix SNP chip data (2009) Bioinformatics, 25, pp. 1961-1962; Abecasis, G.R., Cherny, S.S., Cookson, W.O., Cardon, L.R., Merlin-rapid analysis of dense genetic maps using sparse gene flow trees (2002) Nat Genet, 30, pp. 97-101; Sanger, F., Nicklen, S., Coulson, A.R., DNA sequencing with chain-terminating inhibitors (1977) Proc Natl Acad Sci USA, 74, pp. 5463-5467; Dubowitz, V., Sewry, C.A., Muscle biopsy: a practical approach (2007); Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) Genet Med, 17, pp. 405-423; Robinson, R., Carpenter, D., Shaw, M.A., Halsall, J., Hopkins, P., Mutations in RYR1 in malignant hypertheraiia and central core disease (2006) Hum Mutat, 27, pp. 977-989; Fleury, P., Hageman, G., Hagemant, G., Hageman, G., A dominantly inherited lower motor neuron disorder presenting at birth with associated arthrogryposis (1985) J Neurol Neurosurg Psychiatry, 48, pp. 1037-1048; Brown, L.M., Robson, M.J., Sharrard, W.J.W., The pathophysiology of arthrogryposis multiplex congenita neurologica (1980) J Bone Joint Surg Br, 62, pp. 291-296; Kanning, K.C., Kaplan, A., Henderson, C.E., Motor neuron diversity in development and disease (2010) Annu Rev Neurosci, 33, pp. 409-440; Bansagi, B., Griffin, H., Ramesh, V., Duff, J., Pyle, A., Chinnery, P.F., The p.Ser107Leu in BICD2 is a mutation “hot spot” causing distal spinal muscular atrophy (2015) Brain, 138, p. e391; Rossor, A.M., Oates, E.C., Salter, H.K., Liu, Y., Murphy, S.M., Schule, R., Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2 (2015) Brain, 138, pp. 293-310},
correspondence_address1={Ravenscroft, G.; Harry Perkins Institute of Medical Research, 6 Verdun St, Australia; email: gina.ravenscroft@perkins.uwa.edu.au},
publisher={Elsevier Ltd},
issn={09608966},
coden={NEDIE},
pubmed_id={28554554},
language={English},
abbrev_source_title={Neuromuscular Disord.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Papatheodorou2015163,
author={Papatheodorou, S.I. and Tsilidis, K.K. and Evangelou, E. and Ioannidis, J.P.A.},
title={Application of credibility ceilings probes the robustness of meta-Analyses of biomarkers and cancer risk},
journal={Journal of Clinical Epidemiology},
year={2015},
volume={68},
number={2},
pages={163-174},
doi={10.1016/j.jclinepi.2014.09.004},
note={cited By 23},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920564560&doi=10.1016%2fj.jclinepi.2014.09.004&partnerID=40&md5=8c92dcf045af285a0bbd930b89608c17},
affiliation={Department of Health Sciences, Cyprus Institute for Environmental and Public Health, Cyprus University of Technology, Eirinis 95 Str, Limassol, 3041, Cyprus; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, University Campus, Ioannina, 45110, Greece; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA  94305, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA  94305, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA  94305, United States},
abstract={Objectives Meta-Analyses of biomarkers often present spurious significant results and large effects. We applied sensitivity analyses with the use of credibility ceilings to assess whether and how the results of meta-Analyses of biomarkers and cancer risk would change. Study Design and Setting We evaluated 98 meta-Analyses, 43 (44%) of which had nominally statistically significant results. We assumed that any single study cannot give more than a maximum certainty 100 - c% (c, credibility ceiling) that the effect estimate [odds ratio (OR)] exceeds 1 (null) or 1.2. Results Nominal statistical significance was maintained for 21 (21%) meta-Analyses, for c = 10% and OR >1, and these proportions changed to 7%, 3%, and 6% with ceilings of 20%, 30%, and 40%, respectively. For ceilings for OR >1.2, the respective proportions were 37%, 21%, 7%, and 3%. Seven meta-Analyses on infectious agents retained statistical significance even with a high ceiling of c = 20% for OR >1.00. Meta-Analyses without other hints of bias (large between-study heterogeneity, small-study effects, excess significance) were more likely to retain statistical significance than those that had such hints of bias. Conclusion Credibility ceilings may be helpful in meta-Analyses of biomarkers to understand the robustness of the results to different levels of uncertainty. © 2015 Elsevier Inc.},
author_keywords={Biomarkers;  Cancer;  Credibility ceiling;  Meta-Analyses;  Predictive intervals},
keywords={biological marker;  tumor marker, analytic method;  Article;  cancer risk;  clinical practice;  confidence interval;  credibility ceiling method;  effect size;  environmental factor;  human;  maximum likelihood method;  meta analysis (topic);  predictive value;  priority journal;  probability;  sample size;  sensitivity analysis;  statistical analysis;  statistical model;  statistical parameters;  statistical significance;  chemistry;  clinical trial (topic);  epidemiology;  methodology;  Neoplasms;  risk;  risk factor;  selection bias;  standards;  statistical bias, Bias (Epidemiology);  Clinical Trials as Topic;  Confounding Factors (Epidemiology);  Data Interpretation, Statistical;  Humans;  Meta-Analysis as Topic;  Neoplasms;  Odds Ratio;  Research Design;  Risk Factors;  Selection Bias;  Tumor Markers, Biological},
chemicals_cas={Tumor Markers, Biological},
funding_details={Cyprus University of TechnologyCyprus University of Technology, CUT, 200-099},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, PIEF-GA-2010-276017},
funding_text 1={Funding: S.I.P. was funded from a Cyprus University of Technology internal grant (starting grant No 200-099). K.K.T. was supported by the seventh framework program of the European Union for his work on this article (PIEF-GA-2010-276017).},
references={Deeks, J.J., Dinnes, J., D'Amico, R., Sowden, A.J., Sakarovitch, C., Song, F., Evaluating non-randomised intervention studies (2003) Health Technol Assess, 7. , iii-x, 1-173; Rifai, N., Altman, D.G., Bossuyt, P.M., Reporting bias in diagnostic and prognostic studies: Time for action (2008) Clin Chem, 54, pp. 1101-1103; Moons, K.G., Altman, D.G., Vergouwe, Y., Royston, P., Prognosis and prognostic research: Application and impact of prognostic models in clinical practice (2009) BMJ, 338, p. b606; Kyzas, P.A., Denaxa-Kyza, D., Ioannidis, J.P., Almost all articles on cancer prognostic markers report statistically significant results (2007) Eur J Cancer, 43, pp. 2559-2579; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-Analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Ioannidis, J.P., Panagiotou, O.A., Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-Analyses (2011) JAMA, 305, pp. 2200-2210; Ioannidis, J.P., Tzoulaki, I., Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease (2012) Circ Res, 110, pp. 658-662; Ioannidis, J.P., Biomarker failures (2013) Clin Chem, 59, pp. 202-204; Spiegelhalter, D.J., Myles, P.J., Evidence synthesis (2004) Bayesian Approaches to Clinical Trials and Health-care Evaluations, , D.J. Spiegelhalter, K. Abrams, P.J. Myles, Chichester John Wiley Sons Ltd Chichester, New Hampshire, USA; Lilford, R.J., Braunholtz, D., The statistical basis of public policy: A paradigm shift is overdue (1996) BMJ, 313, pp. 603-607; Eddy, D.M., Hasselblad, V., Shachter, R., A Bayesian method for synthesizing evidence. The confidence profile method (1990) Int J Technol Assess Health Care, 6, pp. 31-55; Wolpert, R.L., Mengersen, K.L., Adjusted likelihoods for synthesizing empirical evidence from studies that differ in quality and design: Effects of environmental tobacco smoke (2004) Stat Sci [Internet], 19, pp. 450-471; Greenland, S., Multiple-bias modelling for analysis of observational data - Discussion (2005) J R Stat Soc ser A Stat Soc [Internet], 168, pp. 267-306; Thompson, S., Ekelund, U., Jebb, S., Lindroos, A.K., Mander, A., Sharp, S., A proposed method of bias adjustment for meta-Analyses of published observational studies (2011) Int J Epidemiol, 40, pp. 765-777; Ioannidis, J.P., Commentary: Adjusting for bias: A user's guide to performing plastic surgery on meta-Analyses of observational studies (2011) Int J Epidemiol, 40, pp. 777-779; Salanti, G., Ioannidis, J.P., Synthesis of observational studies should consider credibility ceilings (2009) J Clin Epidemiol, 62, pp. 115-122; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Lau, J., Recommendations for examining and interpreting funnel plot asymmetry in meta-Analyses of randomised controlled trials (2011) BMJ, 343, p. d4002; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-Analyses (2003) BMJ, 327, pp. 557-560; Higgins, J.P., Thompson, S.G., Presenting random effects meta-Analyses: Where are we going wrong? (2001) 9th International Cochrane Colloquium, , Lyon, France; Dersimonian, R., Laird, N., Meta-Analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-Analysis (2002) Stat Med, 21, pp. 1539-1558; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-Analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; Veglia, F., Loft, S., Matullo, G., Peluso, M., Munnia, A., Perera, F., DNA adducts and cancer risk in prospective studies: A pooled analysis and a meta-Analysis (2008) Carcinogenesis, 29, pp. 932-936; Wang, C., Yuan, Y., Hunt, R.H., The association between Helicobacter pylori infection and early gastric cancer: A meta-Analysis (2007) The Am J Gastroenterol, 102, pp. 1789-1798; Zhuo, X.L., Wang, Y., Zhuo, W.L., Zhang, X.Y., Possible association of Helicobacter pylori infection with laryngeal cancer risk: An evidence-based meta-Analysis (2008) Arch Med Res, 39, pp. 625-628; Zhuo, W.L., Zhu, B., Xiang, Z.L., Zhuo, X.L., Cai, L., Chen, Z.T., Assessment of the relationship between Helicobacter pylori and lung cancer: A meta-Analysis (2009) Arch Med Res, 40, pp. 406-410; Donato, F., Boffetta, P., Puoti, M., A meta-Analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma (1998) Int J Cancer, 75, pp. 347-354; Hobbs, C.G., Sterne, J.A., Bailey, M., Heyderman, R.S., Birchall, M.A., Thomas, S.J., Human papillomavirus and head and neck cancer: A systematic review and meta-Analysis (2006) Clin Otolaryngol, 31, pp. 259-266; Taylor, M.L., Mainous, A.G., III, Wells, B.J., Prostate cancer and sexually transmitted diseases: A meta-Analysis (2005) Fam Med, 37, pp. 506-512; Rinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: Results from the EPIC cohort, plus a meta-Analysis of prospective studies (2010) Int J Cancer, 126, pp. 1702-1715; Morris, J.K., George, L.M., Wu, T., Wald, N.J., Insulin-like growth factors and cancer: No role in screening. Evidence from the BUPA study and meta-Analysis of prospective epidemiological studies (2006) Br J Cancer, 95, pp. 112-117; Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A.W., Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies (2010) The Lancet Oncol, 11, pp. 530-542; Chen, B., Liu, S., Xu, W., Wang, X., Zhao, W., Wu, J., IGF-I and IGFBP-3 and the risk of lung cancer: A meta-Analysis based on nested case-control studies (2009) J Exp Clin Cancer Res, 28, p. 89; Rowlands, M.A., Gunnell, D., Harris, R., Vatten, L.J., Holly, J.M., Martin, R.M., Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-Analysis (2009) Int J Cancer, 124, pp. 2416-2429; Pisani, P., Hyper-insulinaemia and cancer, meta-Analyses of epidemiological studies (2008) Arch Physiol Biochem, 114, pp. 63-70; Roddam, A.W., Allen, N.E., Appleby, P., Key, T.J., Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies (2008) J Natl Cancer Inst, 100, pp. 170-183. , Endogenous H, Prostate Cancer Collaborative G; Key, T., Appleby, P., Barnes, I., Reeves, G., Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies (2002) J Natl Cancer Inst, 94, pp. 606-616. , Breast Cancer Collaborative G; Barba, M., Yang, L., Schunemann, H.J., Sperati, F., Grioni, S., Stranges, S., Urinary estrogen metabolites and prostate cancer: A case-control study and meta-Analysis (2009) J Exp Clin Cancer Res, 28, p. 135; Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-Analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk (2009) Aliment Pharmacol Ther, 30 (2), pp. 113-125; Yin, L., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-Analysis of longitudinal studies: Serum vitamin D and prostate cancer risk (2009) Cancer Epidemiol, 33, pp. 435-445; Chen, P., Hu, P., Xie, D., Qin, Y., Wang, F., Wang, H., Meta-Analysis of vitamin D, calcium and the prevention of breast cancer (2010) Breast Cancer Res Treat, 121 (2), pp. 469-477; Gallicchio, L., Boyd, K., Matanoski, G., Tao, X.G., Chen, L., Lam, T.K., Carotenoids and the risk of developing lung cancer: A systematic review (2008) The Am J Clin Nutr, 88, pp. 372-383; Zhuo, H., Smith, A.H., Steinmaus, C., Selenium and lung cancer: A quantitative analysis of heterogeneity in the current epidemiological literature (2004) Cancer Epidemiol Biomarkers Prev, 13, pp. 771-778; Saadatian-Elahi, M., Norat, T., Goudable, J., Riboli, E., Biomarkers of dietary fatty acid intake and the risk of breast cancer: A meta-Analysis (2004) Int J Cancer, 111, pp. 584-591; Buck, K., Zaineddin, A.K., Vrieling, A., Linseisen, J., Chang-Claude, J., Meta-Analyses of lignans and enterolignans in relation to breast cancer risk (2010) The Am J Clin Nutr, 92, pp. 141-153; Simon, J.A., Chen, Y.H., Bent, S., The relation of alpha-linolenic acid to the risk of prostate cancer: A systematic review and meta-Analysis (2009) The Am J Clin Nutr, 89, pp. 1558S-1564S; Larsson, S.C., Giovannucci, E., Wolk, A., Folate and risk of breast cancer: A meta-Analysis (2007) J Natl Cancer Inst, 99, pp. 64-76; Collin, S.M., Metcalfe, C., Refsum, H., Lewis, S.J., Zuccolo, L., Smith, G.D., Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: A case-control study, systematic review, and meta-Analysis (2010) Cancer Epidemiol Biomarkers Prev, 19, pp. 1632-1642; Larsson, S.C., Orsini, N., Wolk, A., Vitamin B6 and risk of colorectal cancer: A meta-Analysis of prospective studies (2010) JAMA, 303, pp. 1077-1083; Tsilidis, K.K., Branchini, C., Guallar, E., Helzlsouer, K.J., Erlinger, T.P., Platz, E.A., C-reactive protein and colorectal cancer risk: A systematic review of prospective studies (2008) Int J Cancer, 123, pp. 1133-1140; Heikkila, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Associations of circulating C-reactive protein and interleukin-6 with cancer risk: Findings from two prospective cohorts and a meta-Analysis (2009) Cancer Causes Control, 20, pp. 15-26; Huang, J.Q., Zheng, G.F., Sumanac, K., Irvine, E.J., Hunt, R.H., Meta-Analysis of the relationship between cagA seropositivity and gastric cancer (2003) Gastroenterology, 125, pp. 1636-1644; Zhao, Y.S., Wang, F., Chang, D., Han, B., You, D.Y., Meta-Analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer (2008) Int J Colorectal Dis, 23, pp. 875-882; Islami, F., Kamangar, F., Helicobacter pylori and esophageal cancer risk: A meta-Analysis (2008) Cancer Prev Res, 1, pp. 329-338; Gutierrez, J., Jimenez, A., De Dios Luna, J., Soto, M.J., Sorlozano, A., Meta-Analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus (2006) The J Urol, 176 (6), pp. 2474-2481. , PART 1 discussion 81; Mandelblatt, J.S., Kanetsky, P., Eggert, L., Gold, K., Is HIV infection a cofactor for cervical squamous cell neoplasia? (1999) Cancer Epidemiol Biomarkers Prev, 8, pp. 97-106; Khanjani, N., Hoving, J.L., Forbes, A.B., Sim, M.R., Systematic review and meta-Analysis of cyclodiene insecticides and breast cancer (2007) J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 25 (1), pp. 23-52; Lopez-Cervantes, M., Torres-Sanchez, L., Tobias, A., Lopez-Carrillo, L., Dichlorodiphenyldichloroethane burden and breast cancer risk: A meta-Analysis of the epidemiologic evidence (2004) Environ Health Perspect, 112, pp. 207-214; Zhang, Z.F., Begg, C.B., Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies (1994) Int J Epidemiol, 23, pp. 682-690; Panagiotou, O.A., Ioannidis, J.P., Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-Analysis compared with methodologists (2012) J Clin Epidemiol, 65, pp. 740-747; Boyle, P., Boffetta, P., Autier, P., Diet, nutrition and cancer: Public, media and scientific confusion (2008) Ann Oncol, 19 (10), pp. 1665-1667; Ioannidis, J.P., Implausible results in human nutrition research (2013) BMJ, 347, p. f6698; Schoenfeld, J.D., Ioannidis, J.P., Is everything we eat associated with cancer? A systematic cookbook review (2013) The Am J Clin Nutr, 97, pp. 127-134; Hill, A.B., The environment and disease: Association or causation? (1965) Proc R Soc Med, 58, pp. 295-300; Guyatt, G.H., Oxman, A.D., Schunemann, H.J., Tugwell, P., Knottnerus, A., GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology (2011) J Clin Epidemiol, 64, pp. 380-382; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-Analyses (2007) BMJ, 335, pp. 914-916; Lundh, A., Gotzsche, P.C., Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies (2008) BMC Med Res Methodol, 8, p. 22},
correspondence_address1={Ioannidis, J.P.A.; Medical School Office Building, 1265 Welch Road, United States},
publisher={Elsevier Inc.},
issn={08954356},
coden={JCEPE},
pubmed_id={25433443},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Mentis20173911,
author={Mentis, A.-F.A. and Dardiotis, E. and Grigoriadis, N. and Petinaki, E. and Hadjigeorgiou, G.M.},
title={Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities},
journal={Molecular Neurobiology},
year={2017},
volume={54},
number={5},
pages={3911-3923},
doi={10.1007/s12035-017-0530-6},
note={cited By 21},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018284399&doi=10.1007%2fs12035-017-0530-6&partnerID=40&md5=1218f4009736c36c3c32c7049a5817c6},
affiliation={Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; The Johns Hopkins University, AAP, Baltimore, MD, United States; Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; B’ Department of Neurology, Laboratory of Experimental Neurology and Neuroimmunology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece},
abstract={Viruses are directly or indirectly implicated in multiple sclerosis (MS). Here, we review the evidence on the virus-related pathophysiology of MS, introduce common experimental models, and explore the ways in which viruses cause demyelination. By emphasizing knowledge gaps, we highlight future research directions for effective MS diagnostics and therapies: (i) identifying biomarkers for at-risk individuals, (ii) searching for direct evidence of specific causative viruses, (iii) establishing the contribution of host genetic factors and viruses, and (iv) investigating the contribution of immune regulation at extra-CNS sites. Research in these areas is likely to be facilitated by the application of high-throughput technologies, the development of systems-based bioinformatic approaches, careful selection of experimental models, and the acquisition of high-quality clinical material for tissue-based research. © 2017, Springer Science+Business Media New York.},
author_keywords={Bystander activation;  Epitope spreading;  Molecular mimicry;  Multiple sclerosis;  Sequencing;  Virus},
keywords={alemtuzumab;  beta1a interferon;  daclizumab;  epitope;  fingolimod;  fumaric acid dimethyl ester;  interferon beta serine;  monoclonal antibody;  natalizumab;  teriflunomide;  virus envelope protein, acute disseminated encephalomyelitis;  autoimmunity;  bioinformatics;  bystander effect;  demyelination;  endogenous retrovirus;  epitope spreading;  experimental autoimmune encephalomyelitis;  fertile field theory;  human;  Human T-lymphotropic virus 1;  immunomodulation;  induced pluripotent stem cell;  intestine flora;  JC virus;  molecular mimicry;  multiple sclerosis;  Murine hepatitis virus;  next generation sequencing;  nonhuman;  progressive multifocal leukoencephalopathy;  Review;  Semliki Forest virus;  subacute sclerosing panencephalitis;  Theiler's murine encephalomyelitis virus;  theory;  translational research;  virus;  virus cell interaction;  animal;  biological model;  disease exacerbation;  disease model;  metabolism;  multiple sclerosis;  pathology;  pathophysiology;  stem cell;  translational research;  virology, Animals;  Disease Models, Animal;  Disease Progression;  Humans;  Models, Biological;  Multiple Sclerosis;  Stem Cells;  Translational Medical Research},
chemicals_cas={alemtuzumab, 216503-57-0; beta1a interferon, 145258-61-3, 74899-71-1; daclizumab, 152923-56-3; fingolimod, 162359-56-0; fumaric acid dimethyl ester, 624-49-7; interferon beta serine, 90598-63-3, 145155-23-3; natalizumab, 189261-10-7; teriflunomide, 108605-62-5, 282716-73-8, 163451-81-8},
tradenames={avonex; betaferon},
funding_text 1={A.-F.A.M. has been supported through an educational scholarship from the Onassis Public Benefit Foundation. The latter played no role in the design of the study, collection or/and interpretation of data, or writing of the review article.},
references={Kingwell, E.M.J., Jetté, N., Pringsheim, T., Makhani, N., Morrow, S.A., Fisk, J.D., Evans, C., Marrie, R.A., Incidence and prevalence of multiple sclerosis in Europe (2013) BMC Neurol, 13, p. 128. , PID: 24070256; Grytten, N., Torkildsen, O., Myhr, K.M., Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades (2015) Acta Neurol Scand, 132 (199), pp. 29-36. , COI: 1:STN:280:DC%2BC2Mbht12htw%3D%3D, PID: 26046556; Salomon, J.A., Vos, T., Hogan, D.R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Murray, C.J.L., Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) Lancet, 380 (9859), pp. 2129-2143. , PID: 23245605; Eskandarieh, S., Heydarpour, P., Minagar, A., Pourmand, S., Sahraian, M.A., Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: A systematic review (2016) Neuroepidemiology, 46 (3), pp. 209-221. , PID: 26901651; Leray, E., Moreau, T., Fromont, A., Edan, G., Epidemiology of multiple sclerosis (2016) Rev Neurol, 172 (1), pp. 3-13. , COI: 1:STN:280:DC%2BC28rmtVKhtw%3D%3D, PID: 26718593; DeSalvo, K., Galvez, E., Connecting health and care for the nation: a shared nationwide interoperability roadmap—version 1.0 (2015) Health IT Buzz; (2013) Mapping multiple sclerosis around the world, , Multiple Sclerosis International Federation, London; Paul Browne, D.C., Angood, C., Tremlett, H., Baker, C., Taylor, B.V., Thompson, A.J., Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity (2014) Neurology, 83 (11), pp. 1022-1024. , PID: 25200713; Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., Weinshenker, B.G., Multiple sclerosis (2000) N Engl J Med, 343 (13), pp. 938-952. , COI: 1:STN:280:DC%2BD3cvlvF2quw%3D%3D, PID: 11006371; Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Rajewsky, K., Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction (2000) J Exp Med, 192 (3), pp. 393-404. , COI: 1:CAS:528:DC%2BD3cXlsFygt7g%3D, PID: 10934227; Saxena, A., Martin-Blondel, G., Mars, L.T., Liblau, R.S., Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis (2011) FEBS Lett, 585 (23), pp. 3758-3763. , COI: 1:CAS:528:DC%2BC3MXhsFSis7zJ, PID: 21910991; Lublin, F., History of modern multiple sclerosis therapy (2005) J Neurol, 254 (4), p. 493500. , 252 Suppl 3:iii3-iii9; Benson, T., Grieve, G., (2016) Principles of health interoperability: SNOMED CT, HL7 and FHIR, , Springer, London; Tselis, A., Evidence for viral etiology of multiple sclerosis (2011) Semin Neurol, 31 (3), pp. 307-316. , PID: 21964847; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P.A., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) The Lancet Neurology, 14 (3), pp. 263-273. , PID: 25662901; Dendrou, C.A., Fugger, L., Friese, M.A., Immunopathology of multiple sclerosis (2015) Nat Rev Immunol, 15 (9), pp. 545-558. , COI: 1:CAS:528:DC%2BC2MXht12gurvE, PID: 26250739; Bashinskaya, V.V., Kulakova, O.G., Boyko, A.N., Favorov, A.V., Favorova, O.O., A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches (2015) Hum Genet, 134 (11-12), pp. 1143-1162. , COI: 1:CAS:528:DC%2BC2MXhsF2qsr7F, PID: 26407970; Baranzini, S.E., Mudge, J., van Velkinburgh, J.C., Khankhanian, P., Khrebtukova, I., Miller, N.A., Zhang, L., Kingsmore, S.F., Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis (2010) Nature, 464 (7293), pp. 1351-1356. , COI: 1:CAS:528:DC%2BC3cXltl2ltLw%3D, PID: 20428171; Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C.J., Furman, D., Shen-Orr, S., Davis, M.M., Variation in the human immune system is largely driven by non-heritable influences (2015) Cell, 160 (1-2), pp. 37-47. , COI: 1:CAS:528:DC%2BC2MXhtF2lsbg%3D, PID: 25594173; Owens, G.P., Gilden, D., Burgoon, M.P., Yu, X., Bennett, J.L., Viruses and multiple sclerosis (2011) Neuroscientist, 17 (6), pp. 659-676. , COI: 1:CAS:528:DC%2BC3MXhs1OmtrnM, PID: 22130640; Mattes, F.M., Emery, V.C., Clark, D.A., GriYths, P.D., Histopathological detection of owl’s eye inclusions (2000) J Clin Pathol, 53, pp. 612-614. , COI: 1:STN:280:DC%2BD3cvkvF2gtA%3D%3D, PID: 11002765; Libbey, J.E., Cusick, M.F., Fujinami, R.S., Role of pathogens in multiple sclerosis (2014) Int Rev Immunol, 33 (4), pp. 266-283. , COI: 1:CAS:528:DC%2BC2cXhtFaks7nL, PID: 24266364; Baltimore, D., Expression of animal virus genomes (1971) Bacteriol Rev, 35 (3), pp. 235-241. , COI: 1:CAS:528:DyaE38Xjt1WisA%3D%3D, PID: 4329869; Andrews, J., Precision medicine: analytics, data science and EHRs in the new age (2016) Healthcare IT News; Virtanen, J.O., Jacobson, S., Viruses and multiple sclerosis (2012) CNS Neurol Disord Drug Targets, 11 (5), pp. 528-544. , COI: 1:CAS:528:DC%2BC38XhtF2jur3L, PID: 22583435; Roots, B.I., The phylogeny of invertebrates and the evolution of myelin (2008) Neuron Glia Biol, 4 (2), pp. 101-109. , PID: 19508741; Travis, J., Origins. On the origin of the immune system (2009) Science, 324 (5927), pp. 580-582. , COI: 1:CAS:528:DC%2BD1MXls1OntLY%3D, PID: 19407173; Fang, Y., Lei, X., Li, X., Chen, Y., Xu, F., Feng, X., Wei, S., Li, Y., A novel model of demyelination and remyelination in a GFP-transgenic zebrafish (2014) Biol Open, 4 (1), pp. 62-68. , PID: 25527642; Amor, S., Groome, N., Linington, C., Morris, M.M., Dornmair, K., Gardinier, M.V., Matthieu, J.M., Baker, D., Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice (1994) J Immunol, 153 (10), pp. 4349-4356. , COI: 1:CAS:528:DyaK2MXit1eqsro%3D, PID: 7525700; Fazakerley, J.K., Amor, S., Webb, H.E., Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS (1983) Clin Exp Immunol, 52 (1), pp. 115-120. , COI: 1:STN:280:DyaL3s3jtlartg%3D%3D, PID: 6305540; Mokhtarian, F., Huan, C.M., Roman, C., Raine, C.S., Semliki Forest virus-induced demyelination and remyelination—involvement of B cells and anti-myelin antibodies (2003) J Neuroimmunol, 137 (1-2), pp. 19-31. , COI: 1:CAS:528:DC%2BD3sXitlGhtb0%3D, PID: 12667644; Tsunoda, I., Fujinami, R.S., Neuropathogenesis of Theiler’s murine encephalomyelitis virus infection, an animal model for multiple sclerosis (2010) J NeuroImmune Pharmacol, 5 (3), pp. 355-369. , PID: 19894121; Das Sarma, J., Kenyon, L.C., Hingley, S.T., Shindler, K.S., Mechanisms of primary axonal damage in a viral model of multiple sclerosis (2009) J Neurosci, 29 (33), pp. 10272-10280. , COI: 1:CAS:528:DC%2BD1MXhtVKqt7bP, PID: 19692601; Shindler, K.S., Kenyon, L.C., Dutt, M., Hingley, S.T., Das Sarma, J., Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus (2008) J Virol, 82 (17), pp. 8882-8886. , COI: 1:CAS:528:DC%2BD1cXhtVClt73L, PID: 18579591; Blair, T.C., Manoharan, M., Rawlings-Rhea, S.D., Tagge, I., Kohama, S.G., Hollister-Smith, J., Ferguson, B., Wong, S.W., Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis (2016) J Neuroimmunol, 291, pp. 1-10. , COI: 1:CAS:528:DC%2BC2MXitVSrs7nP, PID: 26857488; Kipp, M., van der Star, B., Vogel, D.Y., Puentes, F., van der Valk, P., Baker, D., Amor, S., Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond (2012) Mult Scler Relat Disord, 1 (1), pp. 15-28. , PID: 25876447; Procaccini, C., De Rosa, V., Pucino, V., Formisano, L., Matarese, G., Animal models of multiple sclerosis (2015) Eur J Pharmacol, 759, pp. 182-191. , COI: 1:CAS:528:DC%2BC2MXls1ajs7o%3D, PID: 25823807; Krishnamoorthy, G., Lassmann, H., Wekerle, H., Holz, A., Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation (2006) J Clin Invest, 116 (9), pp. 2385-2392. , COI: 1:CAS:528:DC%2BD28Xps1SgsLo%3D, PID: 16955140; Ousman, S.S., Tomooka, B.H., van Noort, J.M., Wawrousek, E.F., O’Connor, K.C., Hafler, D.A., Sobel, R.A., Steinman, L., Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination (2007) Nature, 448 (7152), pp. 474-479. , COI: 1:CAS:528:DC%2BD2sXotFajtbY%3D, PID: 17568699; Mastronardi, F.G., Ackerley, C.A., Arsenault, L., Roots, B.I., Moscarello, M.A., Demyelination in a transgenic mouse: a model for multiple sclerosis (1993) J Neurosci Res, 36 (3), pp. 315-324. , COI: 1:CAS:528:DyaK2cXivVKmuw%3D%3D, PID: 7505836; Blakemore, W.F., Franklin, R.J., Remyelination in experimental models of toxin-induced demyelination (2008) Curr Top Microbiol Immunol, 318, pp. 193-212. , COI: 1:CAS:528:DC%2BD1cXhs12rsLc%3D, PID: 18219819; Franklin, R.J., Crang, A.J., Blakemore, W.F., The reconstruction of an astrocytic environment in glia-deficient areas of white matter (1993) J Neurocytol, 22 (5), pp. 382-396. , COI: 1:STN:280:DyaK3szgtFKnug%3D%3D, PID: 8315415; Kipp, M., Clarner, T., Dang, J., Copray, S., Beyer, C., The cuprizone animal model: new insights into an old story (2009) Acta Neuropathol, 118 (6), pp. 723-736. , PID: 19763593; Mothe, A.J., Tator, C.H., Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination (2008) Exp Neurol, 213 (1), pp. 176-190. , COI: 1:CAS:528:DC%2BD1cXhtVSgurbM, PID: 18586031; Baker, D., Amor, S., Mouse models of multiple sclerosis: lost in translation? (2015) Curr Pharm Des, 21 (18), pp. 2440-2452. , COI: 1:CAS:528:DC%2BC2MXosVGntr0%3D, PID: 25777759; Lassmann, H., Bradl, M., Multiple sclerosis: experimental models and reality (2016) Acta Neuropathol; Gilli, F., Li, L., Pachner, A.R., The immune response in the CNS in Theiler’s virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response (2016) J Neuro-Oncol, 22 (1), pp. 66-79. , COI: 1:CAS:528:DC%2BC2MXhtlelur3J; Benner, B., Martorell, A.J., Mahadevan, P., Najm, F.J., Tesar, P.J., Freundt, E.C., Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler’s murine encephalomyelitis virus (2016) J Neuro-Oncol, 22 (3), pp. 336-348. , COI: 1:CAS:528:DC%2BC2MXhvF2ks7vM; Kang, H.S., Myoung, J., So, E.Y., Bahk, Y.Y., Kim, B.S., Transgenic expression of non-structural genes of Theiler’s virus suppresses initial viral replication and pathogenesis of demyelination (2016) J Neuroinflammation, 13 (1), p. 133. , PID: 27250711; Stavrou, S., Feng, Z., Lemon, S.M., Roos, R.P., Different strains of Theiler’s murine encephalomyelitis virus antagonize different sites in the type I interferon pathway (2010) J Virol, 84 (18), pp. 9181-9189. , PID: 20610716; Estep, R.D., Hansen, S.G., Rogers, K.S., Axthelm, M.K., Wong, S.W., Genomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating disease (2013) J Virol, 87 (1), pp. 512-523. , COI: 1:CAS:528:DC%2BC3sXltV2jsbk%3D, PID: 23097433; Grigoriadis, N., Hadjigeorgiou, G.M., Virus-mediated autoimmunity in multiple sclerosis (2006) J Autoimmune Dis, 3, p. 1. , PID: 16504001; Wortman, M.J., Lundberg, P.S., Dagdanova, A.V., Venkataraman, P., Daniel, D.C., Johnson, E.M., Opportunistic DNA recombination with Epstein-Barr virus at sites of control region rearrangements mediating JC virus Neurovirulence (2016) J Infect Dis, 213 (9), pp. 1436-1443. , PID: 26690342; Kweder, H., Ainouze, M., Brunel, J., Gerlier, D., Manet, E., Buckland, R., Measles virus: identification in the M protein primary sequence of a potential molecular marker for subacute sclerosing panencephalitis (2015) Adv Virol, 2015, p. 769837. , PID: 26587021; Behan, P.O., Chaudhuri, A., EAE is not a useful model for demyelinating disease (2014) Mult Scler Relat Disord, 3 (5), pp. 565-574. , PID: 26265268; Smyk, D.S., Alexander, A.K., Walker, M., Walker, M., Acute disseminated encephalomyelitis progressing to multiple sclerosis: are infectious triggers involved? (2014) Immunol Res, 60 (1), pp. 16-22. , COI: 1:CAS:528:DC%2BC2cXhsFKqsbzK, PID: 24668297; Di Ruscio, A., Patti, F., Welner, R.S., Tenen, D.G., Amabile, G., Multiple sclerosis: getting personal with induced pluripotent stem cells (2015) Cell Death Dis, 6. , COI: 1:CAS:528:DC%2BC2MXht1Wrtb7M, PID: 26158512; Song, B., Sun, G., Herszfeld, D., Sylvain, A., Campanale, N.V., Hirst, C.E., Caine, S., Bernard, C.C., Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis (2012) Stem Cell Res, 8 (2), pp. 259-273. , COI: 1:CAS:528:DC%2BC38Xht1Ontro%3D, PID: 22265745; Pamies, D., Barreras, P., Block, K., Makri, G., Kumar, A., Wiersma, D., Smirnova, L., Hogberg, H.T., A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity (2016) ALTEX; Marro, B.S., Blanc, C.A., Loring, J.F., Cahalan, M.D., Lane, T.E., Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies (2014) Expert Rev Neurother, 14 (10), pp. 1169-1179. , COI: 1:CAS:528:DC%2BC2cXhsFylsr3O, PID: 25245576; Li, X., Zhang, Y., Yan, Y., Ciric, B., Ma, C.G., Chin, J., Curtis, M., Zhang, G.X., LINGO-1-fc-transduced neural stem cells are effective therapy for chronic stage experimental autoimmune encephalomyelitis (2016) Mol Neurobiol; Voulgari-Kokota, A., Fairless, R., Karamita, M., Kyrargyri, V., Tseveleki, V., Evangelidou, M., Delorme, B., Probert, L., Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function (2012) Exp Neurol, 236 (1), pp. 161-170. , COI: 1:CAS:528:DC%2BC38XntlSru74%3D, PID: 22561409; Hoftberger, R., Leisser, M., Bauer, J., Lassmann, H., Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ? (2015) Acta Neuropathol Commun, 3, p. 80. , PID: 26637427; Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P.A., Cantor, H., Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection (1998) Science, 279, pp. 1344-1347. , COI: 1:CAS:528:DyaK1cXhtlequr8%3D, PID: 9478893; Cusick, M.F., Libbey, J.E., Fujinami, R.S., Multiple sclerosis: autoimmunity and viruses (2013) Curr Opin Rheumatol, 25 (4), pp. 496-501. , COI: 1:CAS:528:DC%2BC3sXosFKis78%3D, PID: 23656710; Lindsey, J.W., deGannes, S.L., Pate, K.A., Zhao, X., Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L (2016) Mol Immunol, 69, pp. 7-12. , COI: 1:CAS:528:DC%2BC2MXhvFWkt7nO, PID: 26637929; Mameli, G., Cossu, D., Cocco, E., Masala, S., Frau, J., Marrosu, M.G., Sechi, L.A., Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients (2014) J Neuroimmunol, 270 (1-2), pp. 51-55. , COI: 1:CAS:528:DC%2BC2cXksVWgsbs%3D, PID: 24642384; Gabibov, A.G., Belogurov, A.A., Jr., Lomakin, Y.A., Zakharova, M.Y., Avakyan, M.E., Dubrovskaya, V.V., Smirnov, I.V., Tikunova, N.V., Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen (2011) FASEB J, 25 (12), pp. 4211-4221. , COI: 1:CAS:528:DC%2BC3MXhs1Wlt7rJ, PID: 21859892; Lomakin, Y.A., Zakharova, M.Y., Belogurov, A.A., Bykova, N.A., Dronina, M.A., Tupikin, A.E., Knorre, V.D., Ponomarenko, N.A., Polyreactive monoclonal autoantibodies (2013) Acta Nat, 5 (4), pp. 94-104. , COI: 1:STN:280:DC%2BC2czoslyqug%3D%3D; Moise, L., Beseme, S., Tassone, R., Liu, R., Kibria, F., Terry, F., Martin, W., De Groot, A.S., T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity (2016) Expert Rev Vaccines, 15 (5), pp. 607-617. , COI: 1:CAS:528:DC%2BC28XisFKgurY%3D, PID: 26588466; Zheng, M.M., Zhang, X.H., Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats (2014) Biochem Biophys Res Commun, 443 (3), pp. 1118-1123. , COI: 1:CAS:528:DC%2BC2cXktFOkug%3D%3D, PID: 24388990; Carter, C.J., Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage (2012) Immunopharmacol Immunotoxicol, 34 (1), pp. 21-35. , COI: 1:CAS:528:DC%2BC3MXhs1Cisr%2FM, PID: 21486137; Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing (2016) Nat Rev Microbiol, 14 (6), pp. 360-373. , COI: 1:CAS:528:DC%2BC28XnvVamsrc%3D, PID: 27174148; Broccolo, F., Fusetti, L., Ceccherini-Nelli, L., Possible role of human herpesvirus 6 as a trigger of autoimmune disease (2013) ScientificWorldJournal, 2013, p. 867389. , PID: 24282390; t Hart, B.A., Hintzen, R.Q., Laman, J.D., Multiple sclerosis—a response-to-damage model (2009) Trends Mol Med, 15 (6), pp. 235-244. , COI: 1:CAS:528:DC%2BD1MXnt1ektLo%3D; Kakalacheva, K., Munz, C., Lunemann, J.D., Viral triggers of multiple sclerosis (2011) Biochim Biophys Acta, 1812 (2), pp. 132-140. , COI: 1:CAS:528:DC%2BC3cXhsFyrsrnM, PID: 20600868; McCoy, L., Tsunoda, I., Multiple sclerosis and virus induced immune responses-autoimmunity can be primed by molecular mimicry and augmented by bystander activation (2006) Autoimmunity, 39 (1), pp. 9-19. , COI: 1:CAS:528:DC%2BD28XhtVGnsL4%3D, PID: 16455578; Sanderson, N.S., Zimmermann, M., Eilinger, L., Gubser, C., Schaeren-Wiemers, N., Lindberg, R.L., Dougan, S.K., Derfuss, T., Cocapture of cognate and bystander antigens can activate autoreactive B cells (2017) Proc Natl Acad Sci U S A; Fujinami, R.S., von Herrath, M.G., Christen, U., Whitton, J.L., Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease (2006) Clin Microbiol Rev, 19 (1), pp. 80-94. , COI: 1:CAS:528:DC%2BD28XhsFGjtb0%3D, PID: 16418524; McMahon, E.J.B.S., Castenada, C.V., Waldner, H., Miller, S.D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis (2005) Nat Med, 11 (3), pp. 335-339. , COI: 1:CAS:528:DC%2BD2MXhvVSqsrs%3D, PID: 15735651; Fujinami, R.S., Whitton, J.L., Microorganisms and autoimmunity: making the barren field fertile (2003) Nature ReviewsMicrobiology, 1, pp. 151-156; Merkler, D., Horvath, E., Bruck, W., Zinkernagel, R.M., Del la Torre, J.C., Pinschewer, D.D., Viral deja vu” elicits organ-specific immune disease independent of reactivity to self (2006) J Clin Invest, 116 (5), pp. 1254-1263. , COI: 1:CAS:528:DC%2BD28XksVWnsrs%3D, PID: 16604192; Louveau, A., Smirnov, I., Keyes, T.J., Eccles, J.D., Rouhani, S.J., Peske, J.D., Derecki, N.C., Kipnis, J., Structural and functional features of central nervous system lymphatic vessels (2015) Nature, 523 (7560), pp. 337-341. , COI: 1:CAS:528:DC%2BC2MXhtFaitrrE, PID: 26030524; Palanichamy, A., Apeltsin, L., Kuo, T.C., Sirota, M., Wang, S., Pitts, S.J., Sundar, P.D., von Budingen, H.C., Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis (2014) Sci Transl Med, 6 (248), p. 248ra106. , PID: 25100740; Aspelund, A., Antila, S., Proulx, S.T., Karlsen, T.V., Karaman, S., Detmar, M., Wiig, H., Alitalo, K., A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules (2015) J Exp Med, 212 (7), pp. 991-999. , COI: 1:CAS:528:DC%2BC2MXhtFygtLjL, PID: 26077718; Iijima, N., Iwasaki, A., Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help (2016) Nature, 533 (7604), pp. 552-556. , COI: 1:CAS:528:DC%2BC28XotFOktL8%3D, PID: 27225131; Stern, J.N., Yaari, G., Vander Heiden, J.A., Church, G., Donahue, W.F., Hintzen, R.Q., Huttner, A.J., O'Connor, K.C., B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes (2014) Sci Transl Med, 6 (248), p. 248ra107. , PID: 25100741; Engelhardt, B., Carare, R.O., Bechmann, I., Flugel, A., Laman, J.D., Weller, R.O., Vascular, glial, and lymphatic immune gateways of the central nervous system (2016) Acta Neuropathol, 132 (3), pp. 317-338. , COI: 1:CAS:528:DC%2BC28XhtlyjsrvI, PID: 27522506; Pfeiffer, J.K., Virgin, H.W., Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine (2016) Science, 351 (6270); Berer, K., Krishnamoorthy, G., Microbial view of central nervous system autoimmunity (2014) FEBS Lett, 588 (22), pp. 4207-4213. , COI: 1:CAS:528:DC%2BC2cXnt1Ggs7g%3D, PID: 24746689; Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Wekerle, H., Krishnamoorthy, G., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination (2011) Nature, 479 (7374), pp. 538-541. , COI: 1:CAS:528:DC%2BC3MXhtlOntbbP, PID: 22031325; Lee, Y.K., Menezes, J.S., Umesaki, Y., Mazmanian, S.K., Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis (2011) Proc Natl Acad Sci U S A, 108, pp. 4615-4622. , COI: 1:CAS:528:DC%2BC3MXjvVCku74%3D, PID: 20660719; Berer, K., Krishnamoorthy, G., Commensal gut flora and brain autoimmunity: a love or hate affair? (2012) Acta Neuropathol, 123 (5), pp. 639-651. , COI: 1:CAS:528:DC%2BC38XltVKjtb4%3D, PID: 22322994; Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Soldan, M.M., Luckey, D.H., Mangalam, A.K., Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls (2016) Sci Rep, 6, p. 28484. , COI: 1:CAS:528:DC%2BC28XhtFSis7fM, PID: 27346372; Jangi, S., Gandhi, R., Cox, L.M., Li, N., von Glehn, F., Yan, R., Patel, B., Weiner, H.L., Alterations of the human gut microbiome in multiple sclerosis (2016) Nat Commun, 7, p. 12015. , COI: 1:CAS:528:DC%2BC28XhtFSqtr3M, PID: 27352007; Mielcarz, D.W., Kasper, L.H., The gut microbiome in multiple sclerosis (2015) Curr Treat Options Neurol, 17 (4), p. 344. , PID: 25843302; Westall, F.C., Molecular mimicry revisited: gut bacteria and multiple sclerosis (2006) J Clin Microbiol, 44 (6), pp. 2099-2104. , COI: 1:CAS:528:DC%2BD28XmvFKgsLo%3D, PID: 16757604; Norman, J.M., Handley, S.A., Baldridge, M.T., Droit, L., Liu, C.Y., Keller, B.C., Kambal, A., Virgin, H.W., Disease-specific alterations in the enteric virome in inflammatory bowel disease (2015) Cell, 160 (3), pp. 447-460. , COI: 1:CAS:528:DC%2BC2MXhsVars70%3D, PID: 25619688; Reyes, A., Haynes, M., Hanson, N., Angly, F.E., Heath, A.C., Rohwer, F., Gordon, J.I., Viruses in the faecal microbiota of monozygotic twins and their mothers (2010) Nature, 466 (7304), pp. 334-338. , COI: 1:CAS:528:DC%2BC3cXosl2rs7c%3D, PID: 20631792; Modi, S.R., Lee, H.H., Spina, C.S., Collins, J.J., Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome (2013) Nature, 499 (7457), pp. 219-222. , COI: 1:CAS:528:DC%2BC3sXptVahs7g%3D, PID: 23748443; Young, G.R., Eksmond, U., Salcedo, R., Alexopoulou, L., Stoye, J.P., Kassiotis, G., Resurrection of endogenous retroviruses in antibody-deficient mice (2012) Nature, 491 (7426), pp. 774-778. , COI: 1:CAS:528:DC%2BC38XhsFOmtLnE, PID: 23103862; Emmer, A., Staege, M.S., Kornhuber, M.E., The retrovirus/superantigen hypothesis of multiple sclerosis (2014) Cell Mol Neurobiol, 34 (8), pp. 1087-1096. , COI: 1:CAS:528:DC%2BC2cXhsVSisLzP, PID: 25138639; Lill, C.M., Recent advances and future challenges in the genetics of multiple sclerosis (2014) Front Neurol, 5, p. 130. , PID: 25071715; Ramagopalan, S.V., Dyment, D.A., Cader, M.Z., Morrison, K.M., Disanto, G., Morahan, J.M., Berlanga-Taylor, A.J., Ebers, G.C., Rare variants in the CYP27B1 gene are associated with multiple sclerosis (2011) Ann Neurol, 70 (6), pp. 881-886. , COI: 1:CAS:528:DC%2BC3MXhs1CqurbF, PID: 22190362; Sanders, K.A., Benton, M.C., Lea, R.A., Maltby, V.E., Agland, S., Griffin, N., Scott, R.J., Lechner-Scott, J., Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells (2016) Clin Epigenetics, 8 (1), p. 87. , PID: 27570566; Perlejewski, K., Bukowska-Osko, I., Nakamura, S., Motooka, D., Stokowy, T., Ploski, R., Rydzanicz, M., Radkowski, M., Metagenomic analysis of cerebrospinal fluid from patients with multiple sclerosis (2016) Adv Exp Med Biol; Jovel, J., Okeefe, S., Patterson, J., Bording-Jorgensen, M., Wang, W., Mason, A.L., Warren, K.G., Wong, G.K.-S., Cerebrospinal fluid in a small cohort of patients with multiple sclerosis was generally free of microbial DNA (2016) Front Cell Infect Microbiol, 6, p. 198. , PID: 28111617; Rounds, W.H., Salinas, E.A., Wilks, T.B., 2nd, Levin, M.K., Ligocki, A.J., Ionete, C., Pardo, C.A., Monson, N.L., MSPrecise: a molecular diagnostic test for multiple sclerosis using next generation sequencing (2015) Gene, 572 (2), pp. 191-197. , COI: 1:CAS:528:DC%2BC2MXhtFOkt7bI, PID: 26172868; Branton, W.G., Lu, J.Q., Surette, M.G., Holt, R.A., Lind, J., Laman, J.D., Power, C., Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis (2016) Sci Rep, 6, p. 37344. , COI: 1:CAS:528:DC%2BC28XitFWgtb7I, PID: 27892518; Kriesel, J.D., Hobbs, M.R., Jones, B.B., Milash, B., Nagra, R.M., Fischer, K.F., Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain (2012) PLoS One, 7 (3). , COI: 1:CAS:528:DC%2BC38XktF2isr4%3D, PID: 22412845; Han, M.H., Hwang, S.I., Roy, D.B., Lundgren, D.H., Price, J.V., Ousman, S.S., Fernald, G.H., Steinman, L., Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets (2008) Nature, 451 (7182), pp. 1076-1081. , COI: 1:CAS:528:DC%2BD1cXisFWjtrg%3D, PID: 18278032; Koopman, F.A., Chavan, S.S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P.R., Mehta, A.D., Tak, P.P., Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis (2016) Proc Natl Acad Sci U S A, 113 (29), pp. 8284-8289. , COI: 1:CAS:528:DC%2BC28XhtFentrvO, PID: 27382171; Wiles, T.J., Jemielita, M., Baker, R.P., Schlomann, B.H., Logan, S.L., Ganz, J., Melancon, E., Parthasarathy, R., Host gut motility promotes competitive exclusion within a model intestinal microbiota (2016) PLoS Biol, 14 (7). , PID: 27458727; Ulusoy, A., Phillips, R.J., Helwig, M., Klinkenberg, M., Powley, T.L., Di Monte, D.A., Brain-to-stomach transfer of alpha-synuclein via vagal preganglionic projections (2016) Acta Neuropathol, , PID: 28012041; Zintzaras, E., Doxani, C., Mprotsis, T., Schmid, C.H., Hadjigeorgiou, G.M., Network analysis of randomized controlled trials in multiple sclerosis (2012) Clin Ther, 34 (4), pp. 857-869. , COI: 1:CAS:528:DC%2BC38XlvFGitLg%3D, PID: 22444787, e859; The effect of disease modifying therapies on disease progression in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis (2015) PLoS One, , Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K et al, Helani 10(12):e0144538; Thompson, A.J., Challenge of progressive multiple sclerosis therapy (2017) Curr Opin Neurol, , PID: 28338498; Curtin, F., Perron, H., Faucard, R., Porchet, H., Lang, A.B., Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis (2015) Mol Diagn Ther, 19 (5), pp. 255-265. , COI: 1:CAS:528:DC%2BC2MXhsFKgtbzP, PID: 26376649; Perron, H., Garson, J.A., Bedin, F., Beseme, F., Paranhos-Baccala, G., Komurian-Pradel, F., Mallet, F., Mandrand, B., Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis (1997) Proc Natl Acad Sci U S A, 94 (14), pp. 7583-7588. , COI: 1:CAS:528:DyaK2sXksFynsLc%3D, PID: 9207135},
correspondence_address1={Mentis, A.-F.A.; The Johns Hopkins University, United States; email: amentis1@jhu.edu},
publisher={Humana Press Inc.},
issn={08937648},
coden={MONBE},
pubmed_id={28455696},
language={English},
abbrev_source_title={Mol. Neurobiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Serghiou201658,
author={Serghiou, S. and Patel, C.J. and Tan, Y.Y. and Koay, P. and Ioannidis, J.P.A.},
title={Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications},
journal={Journal of Clinical Epidemiology},
year={2016},
volume={71},
pages={58-67},
doi={10.1016/j.jclinepi.2015.09.004},
note={cited By 21},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962953658&doi=10.1016%2fj.jclinepi.2015.09.004&partnerID=40&md5=1241084677d0139ebe6d5c3bfb0f6541},
affiliation={College of Medicine and Veterinary Medicine, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, Edinburgh, United Kingdom; Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street 4th Floor Boston MA 02115, United States; Ophthalmology Department, St John's Hospital, Howden South Road, Livingston West Lothian EH54 6PP, United Kingdom; The Princess Alexandra Eye Pavilion, Chalmers Street Edinburgh EH3 9HA, United Kingdom; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, 1265 Welch Rd MSOB X306 Stanford CA 94305, United States; Department of Health Research and Policy, Stanford University School of Medicine, 150 Governor's Lane Stanford CA 94305, United States; Department of Statistics, Stanford University School of Humanities and Sciences, 390 Serra Mall Stanford CA 94305, United States; Meta-Research Innovation Center at Stanford (METRICS), Stanford School of Medicine, 1070 Arastradero Road Palo Alto CA 94304, United States},
abstract={Objectives Instead of evaluating one risk factor at a time, we illustrate the utility of “field-wide meta-analyses” in considering all available data on all putative risk factors of a disease simultaneously. Study Design and Setting We identified studies on putative risk factors of pterygium (surfer's eye) in PubMed, EMBASE, and Web of Science. We mapped which factors were considered, reported, and adjusted for in each study. For each putative risk factor, four meta-analyses were done using univariate only, multivariate only, preferentially univariate, or preferentially multivariate estimates. Results A total of 2052 records were screened to identify 60 eligible studies reporting on 65 putative risk factors. Only 4 of 60 studies reported both multivariate and univariate regression analyses. None of the 32 studies using multivariate analysis adjusted for the same set of risk factors. Effect sizes from different types of regression analyses led to significantly different summary effect sizes (P-value &lt; 0.001). Observed heterogeneity was very high for both multivariate (median I2, 76.1%) and univariate (median I2, 85.8%) estimates. No single study investigated all 11 risk factors that were statistically significant in at least one of our meta-analyses. Conclusion Field-wide meta-analyses can map availability of risk factors and trends in modeling, adjustments and reporting, as well as the impact of differences in model specification. © 2016 Elsevier Inc.},
author_keywords={Big data;  Exposome-wide association study;  Meta-analysis;  Observational study;  Risk factor epidemiology;  Statistical modeling},
keywords={Article;  effect size;  Embase;  human;  Medline;  meta analysis;  multivariate analysis;  observational study;  priority journal;  pterygium;  risk factor;  statistical significance;  univariate analysis;  Web of Science;  methodology;  observational study;  risk factor;  statistics and numerical data;  theoretical model, Humans;  Models, Theoretical;  Observational Studies as Topic;  Research Design;  Risk Factors},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, K99/R00, K99ES023504, R21ES025052},
funding_details={Pharmaceutical Research and Manufacturers of America FoundationPharmaceutical Research and Manufacturers of America Foundation},
funding_text 1={Funding: This work was supported by a NIEHS K99/R00 (K99ES023504) and a PhRMA Foundation grant to C.J.P. The work of Dr. Ioannidis is also supported by an unrestricted gift from Sue and Bob O'Donnell.},
references={Jones, D.R., Meta-analysis of observational epidemiological studies: a review (1992) J R Soc Med, 85, pp. 165-168; Friedenreich, C.M., Methods for pooled analyses of epidemiologic studies (1993) Epidemiology, 4, pp. 295-302; Blettner, M., Sauerbrei, W., Schlehofer, B., Scheuchenpflug, T., Friedenreich, C., Traditional reviews, meta-analyses and pooled analyses in epidemiology (1999) Int J Epidemiol, 28, pp. 1-9; Egger, M., Schneider, M., Davey Smith, G., Spurious precision? Meta-analysis of observational studies (1998) BMJ, 316, pp. 140-144; Blettner, M., Schlehofer, B., Sauerbrei, W., Limitations of meta-analysis from published data in epidemiological research (1997) Soz Praventivmed, 42, pp. 95-104; Bennett, D.A., Review of analytical methods for prospective cohort studies using time to event data: single studies and implications for meta-analysis (2003) Stat Methods Med Res, 12, pp. 297-319; Madigan, D., Ryan, P.B., Schuemie, M., Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies (2013) Ther Adv Drug Saf, 4, pp. 53-62; Madigan, D., Stang, P.E., Berlin, J.A., Schuemie, M., Overhage, J.M., Suchard, M.A., A systematic statistical approach to evaluating evidence from observational studies (2014) Annu Rev Stat Appl, 1, pp. 11-39; Groenwold, R.H.H., Hoes, A.W., Hak, E., Confounding in publications of observational intervention studies (2007) Eur J Epidemiol, 22, pp. 413-415; Peters, J., Mengersen, K., Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses (2008) Eval Health Prof, 31, pp. 370-389; Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H., Brookhart, M.A., High-dimensional propensity score adjustment in studies of treatment effects using health care claims data (2009) Epidemiology, 20, pp. 512-522; Boffetta, P., McLaughlin, J.K., La Vecchia, C., Tarone, R.E., Lipworth, L., Blot, W.J., False-positive results in cancer epidemiology: a plea for epistemological modesty (2008) J Natl Cancer Inst, 100, pp. 988-995; Fiedler, K., Voodoo correlations are everywhere—not only in neuroscience (2011) Perspect Psychol Sci, 6, pp. 163-171; Ioannidis, J.P.A., Commentary: adjusting for bias: a user's guide to performing plastic surgery on meta-analyses of observational studies (2011) Int J Epidemiol, 40, pp. 777-779; Feinstein, A.R., Meta-analysis: statistical alchemy for the 21st century (1995) J Clin Epidemiol, 48, pp. 71-79; Ioannidis, J.P.A., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Ioannidis, J.P.A., Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) J Math Psychol, 57, pp. 184-187; http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-Home.php, Wilson D.B. Practical meta-analysis effect size calculator. Available at:. Accessed April 29, 2015; Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., Introduction to meta-analysis. 1st ed. Wiley: Chichester, UK, 2009; Mackenzie, F.D., Hirst, L.W., Battistutta, D., Green, A., Risk analysis in the development of pterygia (1992) Ophthalmology, 99, pp. 1056-1061; Zhang, J., Yu, K.F., What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes (1998) JAMA, 280, pp. 1690-1691; Maloof, A.J., Ho, A., Coroneo, M.T., Influence of corneal shape on limbal light focusing (1994) Invest Ophthalmol Vis Sci, 35, pp. 2592-2598; Detorakis, E.T., Spandidos, D.A., Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review) (2009) Int J Mol Med, 23, pp. 439-447; http://www.rstudio.com/, RStudio. RStudio: Integrated development environment for R. ​RStudio Team. RStudio, Inc.; Boston, MA, 2015, Available at:; Pohlert, T., The pairwise multiple comparison of mean ranks package (PMCMR). R. package, 2014; Viechtbauer, W., Conducting meta-analyses in R with the metafor package (2010) J Stat Softw, 36, pp. 1-48; Kerkenezov, N., A pterygium survey of the far north coast of New South Wales (1956) Trans Ophthalmol Soc Aust, 16, pp. 110-119; Ibechukwu, B.I., Astigmatism and visual impairment in pterygium: affected eyes in Jos, Nigeria (1990) East Afr Med J, 67, pp. 912-917; Detels, R., Dhir, S.P., Pterygium: a geographical study (1967) Arch Ophthalmol, 78, pp. 485-491; Xie, X.W., Xu, L., Wang, Y.X., Jonas, J.B., Body height and ocular diseases. The Beijing eye study (2009) Graefes Arch Clin Exp Ophthalmol, 247, pp. 1651-1657; Hernández-Díaz, S., Varas-Lorenzo, C., García Rodríguez, L.A., Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction (2006) Basic Clin Pharmacol Toxicol, 98, pp. 266-274; Loke, Y.K., Kwok, C.S., Singh, S., Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies (2011) BMJ, 342, p. d1309; Glaeser, E.L., http://www.nber.org/papers/t0329, Researcher incentives and empirical methods, ​National Bureau of Economic Research (NBER) Technical Working Paper Series 329, 2006. Available at: ​; Elm von, E., Altman, D.G., Egger, M., Pocock, S.J., Gøtzsche, P.C., Vandenbroucke, J.P., The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2014) Int J Surg, 12, pp. 1495-1499; Vandenbroucke, J.P., Elm von, E., Altman, D.G., Gøtzsche, P.C., Mulrow, C.D., Pocock, S.J., Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration (2014) Int J Surg, 12 (12), pp. 1500-1524; Ioannidis, J.P.A., Why most discovered true associations are inflated (2008) Epidemiology, 19, pp. 640-648; Patel, C.J., Burford, B., Ioannidis, J.P.A., Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations (2015) J Clin Epidemiol, 68, pp. 1046-1058; Lunt, M., Solomon, D., Rothman, K., Glynn, R., Hyrich, K., Symmons, D.P., Different methods of balancing covariates leading to different effect estimates in the presence of effect modification (2009) Am J Epidemiol, 169, pp. 909-917; Kavvoura, F.K., Liberopoulos, G., Ioannidis, J.P.A., Selection in reported epidemiological risks: an empirical assessment (2007) PLoS Med, 4, p. e79; de Vries, F., de Vries, C., Cooper, C., Leufkens, B., van Staa, T.-P., Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the general practice research database (2006) Int J Epidemiol, 35, pp. 1301-1308; Belbasis, L., Panagiotou, O.A., Dosis, V., Evangelou, E., A systematic appraisal of field synopses in genetic epidemiology: a HuGE review (2015) Am J Epidemiol, 181, pp. 1-16; Khoury, M.J., McBride, C.M., Schully, S.D., Ioannidis, J.P.A., Feero, W.G., Janssens, A.C.J.W., The scientific foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop (2009) Genet Med, 11, pp. 559-567; Allen, N.C., Bagade, S., McQueen, M.B., Ioannidis, J.P.A., Kavvoura, F.K., Khoury, M.J., Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database (2008) Nat Genet, 40, pp. 827-834; Patel, C.J., Bhattacharya, J., Butte, A.J., An environment-wide association study (EWAS) on type 2 diabetes mellitus (2010) PLoS One, 5, p. e10746; Patel, C.J., Cullen, M.R., Ioannidis, J.P.A., Butte, A.J., Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels (2012) Int J Epidemiol, 41, pp. 828-843; Patel, C.J., Rehkopf, D.H., Leppert, J.T., Bortz, W.M., Cullen, M.R., Chertow, G.M., Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United states national health and nutrition examination Survey (2013) Int J Epidemiol, 42, pp. 1795-1810; Patel, C.J., Ioannidis, J.P., Studying the elusive environment in large scale (2014) JAMA, 311, pp. 2173-2174; Patel, C.J., Ioannidis, J.P.A., Placing epidemiological results in the context of multiplicity and typical correlations of exposures (2014) J Epidemiol Community Health, 68, pp. 1096-1100; Patel, C.J., Manrai, A.K., Development of exposome correlation globes to map out environment-wide associations (2015) Pac Symp Biocomput, pp. 231-242; Ryan, P.B., Madigan, D., Stang, P.E., Overhage, J.M., Racoosin, J.A., Hartzema, A.G., Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership (2012) Stat Med, 31, pp. 4401-4415},
correspondence_address1={Ioannidis, J.P.A.; Stanford Prevention Research Center, United States; email: jioannid@stanford.edu},
publisher={Elsevier Inc.},
issn={08954356},
coden={JCEPE},
pubmed_id={26415577},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Hadjigeorgiou2019253,
author={Hadjigeorgiou, G.M. and Kountra, P.-M. and Koutsis, G. and Tsimourtou, V. and Siokas, V. and Dardioti, M. and Rikos, D. and Marogianni, C. and Aloizou, A.-M. and Karadima, G. and Ralli, S. and Grigoriadis, N. and Bogdanos, D. and Panas, M. and Dardiotis, E.},
title={Replication study of GWAS risk loci in Greek multiple sclerosis patients},
journal={Neurological Sciences},
year={2019},
volume={40},
number={2},
pages={253-260},
doi={10.1007/s10072-018-3617-6},
note={cited By 20},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055722256&doi=10.1007%2fs10072-018-3617-6&partnerID=40&md5=4750fb54acf95dac21c8b81cffabd88f},
affiliation={Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus; Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, University of Athens, Medical School, Athens, Greece; Laboratory of Experimental Neurology and Neuroimmunology, B’ Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Centre for Research and Technology-Hellas (CERTH), Institute for Research and Technology-Thessaly (IRETETH), Larissa, Greece},
abstract={Objectives: To validate in an ethnically homogeneous Greek multiple sclerosis (MS) cohort, genetic risk factors for the disease, identified through a number of previous multi-ethnic genome-wide association studies (GWAS). Methods: A total of 1228 MS cases and 1014 controls were recruited in the study, from 3 MS centers in Greece. We genotyped 35 susceptibility SNPs that emerged from previous GWAS or meta-analyses of GWAS. Allele and genotype single locus regression analysis, adjusted for gender and site, was performed. Permutation testing was applied to all analyses. Results: Six polymorphisms reached statistical significance (permutation p value < 0.05). In particular, rs2760524 of LOC105371664, near RGS1 (permutation p value 0.001), rs3129889 of HLA-DRA, near HLA-DRB1 (permutation p value < 1.00e-04), rs1738074 of TAGAP (permutation p value 0.007), rs703842 of METTL1/CYP27B1 (permutation p value 0.008), rs9596270 of DLEU1 (permutation p value < 1.00e-04), and rs17445836 of LincRNA, near IRF8 (permutation p value 0.001) were identified as susceptibility risk factors in our group. Conclusion: The current study replicated a number of GWAS susceptibility SNPs, which implies that some similarities between the examined Greek population and the MS genetic architecture of the GWAS populations do exist. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature.},
author_keywords={Genetic architecture;  Genetic variants;  Multiple sclerosis;  Risk factors;  SNPs;  Susceptibility},
keywords={cytochrome P450 family 27;  cytochrome p450 family 27b1;  deleted in lymphocytic leukemia 1 protein;  HLA DR antigen;  HLA DRB1 antigen;  interferon consensus sequence binding protein;  long untranslated RNA;  methyltransferase like protein 1;  protein;  unclassified drug, adult;  aged;  allele;  Article;  cohort analysis;  controlled study;  ethnic group;  female;  gender;  gene locus;  genetic risk;  genetic screening;  genetic susceptibility;  genome-wide association study;  genotype;  Greece;  human;  major clinical study;  male;  meta analysis;  multicenter study;  multiple sclerosis;  replication study;  retrospective study;  single nucleotide polymorphism;  Caucasian;  clinical trial;  ethnology;  genetic predisposition;  genetics;  genome-wide association study;  meta analysis (topic);  middle aged;  multiple sclerosis;  single nucleotide polymorphism;  young adult, Adult;  Aged;  Cohort Studies;  European Continental Ancestry Group;  Female;  Genetic Predisposition to Disease;  Genome-Wide Association Study;  Greece;  Humans;  Male;  Meta-Analysis as Topic;  Middle Aged;  Multiple Sclerosis;  Polymorphism, Single Nucleotide;  Young Adult},
chemicals_cas={protein, 67254-75-5},
funding_details={University of ThessalyUniversity of Thessaly},
funding_text 1={Funding The study was supported in part by a research grant of the Research Committee of the University of Thessaly, Greece (Code: 2845).},
references={Compston, A., Coles, A., Multiple sclerosis (2008) Lancet (London, England), 372 (9648), pp. 1502-1517; Compston, A., Sadovnick, A.D., Epidemiology and genetics of multiple sclerosis (1992) Curr Opin Neurol Neurosurg, 5 (2), pp. 175-181. , COI: 1:STN:280:DyaK38zitlWjuw%3D%3D, PID: 1623245; (2009) Nat Genet, 41 (7), pp. 824-828; Sokratous, M., Dardiotis, E., Bellou, E., Tsouris, Z., Michalopoulou, A., Dardioti, M., Siokas, V., Hadjigeorgiou, G.M., CpG Island methylation patterns in relapsing-remitting multiple sclerosis (2018) J Mol Neurosci: MN, 64 (3), pp. 478-484; Sokratous, M., Dardiotis, E., Tsouris, Z., Bellou, E., Michalopoulou, A., Siokas, V., Arseniou, S., Hadjigeorgiou, G.M., Deciphering the role of DNA methylation in multiple sclerosis: emerging issues (2016) Auto- immunity highlights, 7 (1), p. 12; Bomprezzi, R., Kovanen, P.E., Martin, R., New approaches to investigating heterogeneity in complex traits (2003) J Med Genet, 40 (8), pp. 553-559. , COI: 1:CAS:528:DC%2BD3sXnslGmtrs%3D; Mentis, A.A., Dardiotis, E., Grigoriadis, N., Petinaki, E., Hadjigeorgiou, G.M., Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities (2017) Mol Neurobiol, 54 (5), pp. 3911-3923; Trapp, B.D., Vignos, M., Dudman, J., Chang, A., Fisher, E., Staugaitis, S.M., Battapady, H., Rudick, R.A., Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study (2018) Lancet Neurol, , https://doi.org/10.1016/S1474-4422(18)30245-X; Zarei, M., Chandran, S., Compston, A., Hodges, J., Cognitive presentation of multiple sclerosis: evidence for a cortical variant (2003) J Neurol Neurosurg Psychiatry, 74 (7), pp. 872-877. , COI: 1:STN:280:DC%2BD3s3otlOjtQ%3D%3D; Bashinskaya, V.V., Kulakova, O.G., Boyko, A.N., Favorov, A.V., Favorova, O.O., A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches (2015) Hum Genet, 134 (11-12), pp. 1143-1162; Kowalec, K., Wright, G.E.B., Drogemoller, B.I., Aminkeng, F., Bhavsar, A.P., Kingwell, E., Yoshida, E.M., Carleton, B.C., Common variation near IRF6 is associated with IFN-beta-induced liver injury in multiple sclerosis (2018) Nat Genet, 50 (8), pp. 1081-1085; Dardiotis, E., Panayiotou, E., Provatas, A., Christodoulou, K., Hadjisavvas, A., Antoniades, A., Lourbopoulos, A., Kyriakides, T., Gene variants of adhesion molecules act as modifiers of disease severity in MS (2017) Neurology(R) Neuroimmunol Neuroinflammation, 4 (4); Sawcer, S., Franklin, R.J., Ban, M., Multiple sclerosis genetics (2014) Lancet Neurol, 13 (7), pp. 700-709; Axisa, P.P., Hafler, D.A., Multiple sclerosis: genetics, biomarkers, treatments (2016) Curr Opin Neurol, 29 (3), pp. 345-353; Lill, C.M., Recent advances and future challenges in the genetics of multiple sclerosis (2014) Front Neurol, 5; Torkamani, A., Pham, P., Libiger, O., Bansal, V., Zhang, G., Scott-Van Zeeland, A.A., Tewhey, R., Schork, N.J., Clinical implications of human population differences in genome-wide rates of functional genotypes (2012) Front Genet, 3; Patsopoulos, N.A., Bayer Pharma, M.S.G.W.G., Esposito, F., Reischl, J., Lehr, S., Bauer, D., Heubach, J., de Bakker, P.I., Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci (2011) Ann Neurol, 70 (6), pp. 897-912; Aggelakis, K., Zacharaki, F., Dardiotis, E., Xiromerisiou, G., Tsimourtou, V., Ralli, S., Gkaraveli, M., Hadjigeorgiou, G., Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS (2010) Neurol Sci, 31 (3), pp. 253-257; Bauchet, M., McEvoy, B., Pearson, L.N., Quillen, E.E., Sarkisian, T., Hovhannesyan, K., Deka, R., Shriver, M.D., Measuring European population stratification with microarray genotype data (2007) Am J Hum Genet, 80 (5), pp. 948-956; Shi, Y.Y., He, L., SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci (2005) Cell Res, 15 (2), pp. 97-98; Spencer, C.C., Su, Z., Donnelly, P., Marchini, J., Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip (2009) PLoS Genet, 5 (5); Soundararajan, M., Willard, F.S., Kimple, A.J., Turnbull, A.P., Ball, L.J., Schoch, G.A., Gileadi, C., Siderovski, D.P., Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits (2008) Proc Natl Acad Sci U S A, 105 (17), pp. 6457-6462; IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci (2010) Genes Immun, 11 (5), pp. 397-405; Tran, T., Paz, P., Velichko, S., Cifrese, J., Belur, P., Yamaguchi, K.D., Ku, K., Croze, E., Interferonbeta-1b induces the expression of RGS1 a negative regulator of G-protein signaling (2010) Int J Cell Biol, 2010, p. 529376; De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I., Ottoboni, L., Aggarwal, N.T., Piccio, L., Oksenberg, J.R., Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci (2009) Nat Genet, 41 (7), pp. 776-782; Jiang, T., Li, L., Wang, Y., Zhao, C., Yang, J., Ma, D., Guan, Y., Yang, J., The association between genetic polymorphism rs703842 in CYP27B1 and multiple sclerosis: a meta-analysis (2016) Medicine, 95 (19); Jones, G., Prosser, D.E., Kaufmann, M., Cytochrome P450-mediated metabolism of vitamin D (2014) J Lipid Res, 55 (1), pp. 13-31; Alharbi, F.M., Update in vitamin D and multiple sclerosis (2015) Neurosciences, 20 (4), pp. 329-335; Ramagopalan, S.V., Dyment, D.A., Cader, M.Z., Morrison, K.M., Disanto, G., Morahan, J.M., Berlanga-Taylor, A.J., Ebers, G.C., Rare variants in the CYP27B1 gene are associated with multiple sclerosis (2011) Ann Neurol, 70 (6), pp. 881-886; Runia, T.F., Hop, W.C., de Rijke, Y.B., Buljevac, D., Hintzen, R.Q., Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis (2012) Neurology, 79 (3), pp. 261-266; Berge, T., Leikfoss, I.S., Brorson, I.S., Bos, S.D., Page, C.M., Gustavsen, M.W., Bjolgerud, A., Spurkland, A., The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells (2016) Genes Immun, 17 (2), pp. 118-127; Huang, S.Q., Zhang, N., Zhou, Z.X., Huang, C.C., Zeng, C.L., Xiao, D., Guo, C.C., Jing, C.X., Association of LPP and TAGAP polymorphisms with celiac disease risk: a meta-analysis (2017) Int J Environ Res Public Health, 14 (2). , https://doi.org/10.3390/ijerph14020171; Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., McCauley, J.L., Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) Nat Genet, 45 (11), pp. 1353-1360; Mc Guire, C., Prinz, M., Beyaert, R., van Loo, G., Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology (2013) Trends Mol Med, 19 (10), pp. 604-613; Leibowitz, S.M., Yan, J., NF-κB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications (2016) Front Mol Neurosci, 9; Peng, H., Guerau-de-Arellano, M., Mehta, V.B., Yang, Y., Huss, D.J., Papenfuss, T.L., Lovett-Racke, A.E., Racke, M.K., Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling (2012) J Biol Chem, 287 (33), pp. 28017-28026; Dyment, D.A., Herrera, B.M., Cader, M.Z., Willer, C.J., Lincoln, M.R., Sadovnick, A.D., Risch, N., Ebers, G.C., Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance (2005) Hum Mol Genet, 14 (14), pp. 2019-2026; Kouri, I., Papakonstantinou, S., Bempes, V., Vasiliadis, H.S., Kyritsis, A.P., Pelidou, S.H., HLA associations with multiple sclerosis in Greece (2011) J Neurol Sci, 308 (1-2), pp. 28-31; Dardiotis, E., Arseniou, S., Sokratous, M., Tsouris, Z., Siokas, V., Mentis, A.A., Michalopoulou, A., Brotis, A., Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a meta-analysis (2017) Multiple sclerosis and related disorders, 17, pp. 190-197; Mentis, A.A., Dardiotis, E., Grigoriadis, N., Petinaki, E., Hadjigeorgiou, G.M., Viruses and endogenous retroviruses in multiple sclerosis: from correlation to causation (2017) Acta Neurol Scand, 136 (6), pp. 606-616},
correspondence_address1={Hadjigeorgiou, G.M.; Department of Neurology, Cyprus; email: hadjigeorgiou.georgios@ucy.ac.cy},
publisher={Springer-Verlag Italia s.r.l.},
issn={15901874},
coden={NESCC},
pubmed_id={30361804},
language={English},
abbrev_source_title={Neurol. Sci.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Wan20192451,
author={Wan, Q. and Li, N. and Du, L. and Zhao, R. and Yi, M. and Xu, Q. and Zhou, Y.},
title={Allium vegetable consumption and health: An umbrella review of meta-analyses of multiple health outcomes},
journal={Food Science and Nutrition},
year={2019},
volume={7},
number={8},
pages={2451-2470},
doi={10.1002/fsn3.1117},
note={cited By 20},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070693509&doi=10.1002%2ffsn3.1117&partnerID=40&md5=d37609507eb70518301f6ff55406aaaa},
affiliation={Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China; Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China; Chinese Evidence-Based Medicine/Cochrane Center, Chengdu, China; West China School of Medicine, Sichuan University, Chengdu, China},
abstract={Previously, our meta-analysis and other studies have suggested that allium vegetable consumption is beneficial for health, but no umbrella review has been conducted to assess the evidence of the various health benefits of allium vegetable consumption. Therefore, we conducted this umbrella review on this topic. This umbrella review included a total of 16 meta-analyses with 50 unique outcomes. The most beneficial cancer-related outcome was shown for gastric cancer (risk ratio 0.78; 95% confidence interval [CI] 0.67–0.91). In addition, only 8 weeks of garlic consumption significantly decreased serum total cholesterol (weighted mean differences −17.20 mg/dl; 95% CI −23.10 to −11.30), and patients with dyslipidemia who consumed garlic experienced more benefits than the whole population. Diabetic patients with longer durations of garlic intake experienced more benefits in terms of fasting blood glucose (FBG), HbA1c, and serum fructosamine than healthy participants, and garlic intake was associated with blood pressure reduction in hypertensive patients but not in normotensive participants. Limited side effects of garlic, such as garlic odor and gastrointestinal complaints, were reported among the included meta-analyses. Our results suggested that allium vegetables might be beneficial for cancer prevention. In particular, garlic was comparatively safe and is recommended as a long-term dietary component for patients with dyslipidemia, diabetes, and hypertension. © 2019 The Authors. Food Science & Nutrition published by Wiley Periodicals, Inc.},
author_keywords={allium vegetables;  garlic;  health-related outcomes;  onion;  umbrella review},
references={Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) International Journal of Evidence-Based Healthcare, 13 (3), pp. 132-140. , https://doi.org/10.1097/XEB.0000000000000055; Bagul, M., Kakumanu, S., Wilson, T.A., Crude garlic extract inhibits cell proliferation and induces cell cycle arrest and apoptosis of cancer cells in vitro (2015) Journal of Medicinal Food, 18 (7), pp. 731-737; Canizares, P., Gracia, I., Gomez, L.A., de Argila, C.M., Boixeda, D., Garcia, A., de Rafael, L., Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori (2004) Biotechnology Progress, 20 (1), pp. 397-401. , https://doi.org/10.1021/bp034143b; Chiavarini, M., Minelli, L., Fabiani, R., Garlic consumption and colorectal cancer risk in man: A systematic review and meta-analysis (2016) Public Health Nutrition, 19 (2), pp. 308-317. , https://doi.org/10.1017/S1368980015001263; de Giorgio, A., Stebbing, J., Garlic: A stake through the heart of cancer? (2016) The Lancet Oncology, 17 (7), pp. 879-880. , https://doi.org/10.1016/S1470-2045(16)30235-2; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315 (7109), pp. 629-634; Eilat-Adar, S., Sinai, T., Yosefy, C., Henkin, Y., Nutritional recommendations for cardiovascular disease prevention (2013) Nutrients, 5 (9), pp. 3646-3683. , https://doi.org/10.3390/nu5093646; Emami, S., Rouhani, M.H., Azadbakht, L., The effect of garlic intake on glycemic control in humans: A systematic review and meta-analysis (2017) Progress in Nutrition, 19, pp. 10-18. , https://doi.org/10.23751/pn.v19i1-S.5274; Fleischauer, A.T., Poole, C., Arab, L., Garlic consumption and cancer prevention: Meta-analyses of colorectal and stomach cancers (2000) American Journal of Clinical Nutrition, 72 (4), pp. 1047-1052. , https://doi.org/10.1093/ajcn/72.4.1047; Galeone, C., Pelucchi, C., Levi, F., Negri, E., Franceschi, S., Talamini, R., La Vecchia, C., Onion and garlic use and human cancer (2006) American Journal of Clinical Nutrition, 84 (5), pp. 1027-1032. , https://doi.org/10.1093/ajcn/84.5.1027; Guercio, V., Turati, F., La Vecchia, C., Galeone, C., Tavani, A., Allium vegetables and upper aerodigestive tract cancers: A meta-analysis of observational studies (2016) Molecular Nutrition & Food Research, 60 (1), pp. 212-222. , https://doi.org/10.1002/mnfr.201500587; Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., deBeer, H., GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables (2011) Journal of Clinical Epidemiology, 64 (4), pp. 383-394. , https://doi.org/10.1016/j.jclinepi.2010.04.026; Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses (2003) BMJ, 327 (7414), pp. 557-560. , https://doi.org/10.1136/bmj.327.7414.557; Hu, J.Y., Hu, Y.W., Zhou, J.J., Zhang, M.W., Li, D., Zheng, S., Consumption of garlic and risk of colorectal cancer: An updated meta-analysis of prospective studies (2014) World Journal of Gastroenterology, 20 (41), pp. 15413-15422. , https://doi.org/10.3748/wjg.v20.i41.15413; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493. , https://doi.org/10.1503/cmaj.081086; Jin, H.Y., He, Y.S., Gong, W., Zhang, C.X., Zhou, A.C., Effect of flavonoids in onions on colorectal cancer and hyperlipidemia: An in vivo study (2015) International Journal of Molecular Medicine, 36, p. S116; Jung, E.-S., Park, S.-H., Choi, E.-K., Ryu, B.-H., Park, B.-H., Kim, D.-S., Chae, S.-W., Reduction of blood lipid parameters by a 12-wk supplementation of aged black garlic: A randomized controlled trial (2014) Nutrition, 30 (9), pp. 1034-1039. , https://doi.org/10.1016/j.nut.2014.02.014; Khoo, Y.S.K., Aziz, Z., Garlic supplementation and serum cholesterol: A meta-analysis (2009) Journal of Clinical Pharmacy and Therapeutics, 34 (2), pp. 133-145. , https://doi.org/10.1111/j.1365-2710.2008.00998.x; Kodali, R.T., Eslick, G.D., Meta-analysis: Does garlic intake reduce risk of gastric cancer? (2015) Nutrition and Cancer, 67 (1), pp. 1-11. , https://doi.org/10.1080/01635581.2015.967873; Kwak, J.S., Kim, J.Y., Paek, J.E., Lee, Y.J., Kim, H.R., Park, D.S., Kwon, O., Garlic powder intake and cardiovascular risk factors: A meta-analysis of randomized controlled clinical trials (2014) Nutrition Research and Practice, 8 (6), pp. 644-654. , https://doi.org/10.4162/nrp.2014.8.6.644; Lee, Y.C., Chiang, T.H., Chou, C.K., Tu, Y.K., Liao, W.C., Wu, M.S., Graham, D.Y., Association between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and meta-analysis (2016) Gastroenterology, 150 (5), pp. 1113.e5-1124.e5. , https://doi.org/10.1053/j.gastro.2016.01.028; Li, Z.Y., Ying, X.J., Shan, F., Ji, J.F., The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis (2018) Helicobacter, 23 (5). , https://doi.org/10.1111/hel.12532; Liu, J., Zhang, G., Cong, X., Wen, C., Black garlic improves heart function in patients with coronary heart disease by improving circulating antioxidant levels (2018) Frontiers in Physiology, 9, p. 1435. , https://doi.org/10.3389/fphys.2018.01435; Lu, J., Cheng, B., Meng, Z., Fang, B., Li, T., Sun, M., Guan, S., Alliin attenuates 1, 3-dichloro-2-propanol-induced lipogenesis in HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway (2018) Life Sciences, 195, pp. 19-24. , https://doi.org/10.1016/j.lfs.2017.12.040; Miki, S., Inokuma, K.-I., Takashima, M., Nishida, M., Sasaki, Y., Ushijima, M., Morihara, N., Aged garlic extract suppresses the increase of plasma glycated albumin level and enhances the AMP-activated protein kinase in adipose tissue in TSOD mice (2017) Molecular Nutrition & Food Research, 61 (5). , https://doi.org/10.1002/mnfr.201600797; Morihara, N., Hino, A., Aged garlic extract suppresses platelet aggregation by changing the functional property of platelets (2017) Journal of Natural Medicines, 71 (1), pp. 249-256. , https://doi.org/10.1007/s11418-016-1055-4; Morris, C.A., Avorn, J., Internet marketing of herbal products (2003) JAMA, 290 (11), pp. 1505-1509. , https://doi.org/10.1001/jama.290.11.1505; Ohkubo, S., Dalla Via, L., Grancara, S., Kanamori, Y., Kanamori, Y., Garcia-Argaez, A.N., Canettieri, G., Agostinelli, E., The antioxidant, aged garlic extract, exerts cytotoxic effects on wild-type and multidrug-resistant human cancer cells by altering mitochondrial permeability (2018) International Journal of Oncology, 53 (3), pp. 1257-1268. , https://doi.org/10.3892/ijo.2018.4452; Petrovic, V., Nepal, A., Olaisen, C., Bachke, S., Hira, J., Søgaard, C., Otterlei, M., Anti-cancer potential of homemade fresh garlic extract is related to increased endoplasmic reticulum stress (2018) Nutrients, 10 (4), p. 450. , https://doi.org/10.3390/nu10040450; Pittler, M.H., Ernst, E., Clinical effectiveness of garlic (Allium sativum) (2007) Molecular Nutrition & Food Research, 51 (11), pp. 1382-1385. , https://doi.org/10.1002/mnfr.200700073; Rahman, K., Lowe, G.M., Smith, S., Aged garlic extract inhibits human platelet aggregation by altering intracellular signaling and platelet shape change (2016) Journal of Nutrition, 146 (2), pp. 410S-415S. , https://doi.org/10.3945/jn.114.202408; Reinhart, K.M., Coleman, C.I., Teevan, C., Vachhani, P., White, C.M., Effects of garlic on blood pressure in patients with and without systolic hypertension: A meta-analysis (2008) Annals of Pharmacotherapy, 42 (12), pp. 1766-1771. , https://doi.org/10.1345/aph.1L319; Reinhart, K.M., Talati, R., White, C.M., Coleman, C.I., The impact of garlic on lipid parameters: A systematic review and meta-analysis (2009) Nutrition Research Reviews, 22 (1), pp. 39-48. , https://doi.org/10.1017/S0954422409350003; Ried, K., Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: An updated meta-analysis and review (2016) Journal of Nutrition, 146 (2), pp. 389S-396S. , https://doi.org/10.3945/jn.114.202192; Ried, K., Frank, O.R., Stocks, N.P., Aged garlic extract reduces blood pressure in hypertensives: A dose-response trial (2013) European Journal of Clinical Nutrition, 67 (1), pp. 64-70. , https://doi.org/10.1038/ejcn.2012.178; Ried, K., Frank, O.R., Stocks, N.P., Fakler, P., Sullivan, T., Effect of garlic on blood pressure: A systematic review and meta-analysis (2008) BMC Cardiovascular Disorders, 8, p. 13. , https://doi.org/10.1186/1471-2261-8-13; Ried, K., Toben, C., Fakler, P., Effect of garlic on serum lipids: An updated meta-analysis (2013) Nutrition Reviews, 71 (5), pp. 282-299. , https://doi.org/10.1111/nure.12012; Rohner, A., Ried, K., Sobenin, I.A., Bucher, H.C., Nordmann, A.J., A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension (2015) American Journal of Hypertension, 28 (3), pp. 414-423. , https://doi.org/10.1093/ajh/hpu165; Sahebkar, A., Serban, C., Ursoniu, S., Banach, M., Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials (2016) Nutrition, 32 (1), pp. 33-40. , https://doi.org/10.1016/j.nut.2015.06.009; Scharbert, G., Kalb, M.L., Duris, M., Marschalek, C., Kozek-Langenecker, S.A., Garlic at dietary doses does not impair platelet function (2007) Anesthesia & Analgesia, 105 (5), pp. 1214-1218. , https://doi.org/10.1213/01.ane.0000287253.92211.06, table of contents; Schwingshackl, L., Missbach, B., Hoffmann, G., An umbrella review of garlic intake and risk of cardiovascular disease (2016) Phytomedicine, 23 (11), pp. 1127-1133. , https://doi.org/10.1016/j.phymed.2015.10.015; Shabani, E., Sayemiri, K., Mohammadpour, M., The effect of garlic on lipid profile and glucose parameters in diabetic patients: A systematic review and meta-analysis (2018) Primary Care Diabetes, 13 (1), pp. 28-42. , https://doi.org/10.1016/j.pcd.2018.07.007; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Bouter, L.M., Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews (2007) BMC Medical Research Methodology, 7, p. 10. , https://doi.org/10.1186/1471-2288-7-10; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) Journal of Clinical Epidemiology, 62 (10), pp. 1013-1020. , https://doi.org/10.1016/j.jclinepi.2008.10.009; Shi, L., Lin, Q., Li, X., Nie, Y., Sun, S., Deng, X., Luo, F., Alliin, a garlic organosulfur compound, ameliorates gut inflammation through MAPK-NF-kappaB/AP-1/STAT-1 inactivation and PPAR-gamma activation (2017) Molecular Nutrition & Food Research, 61 (9). , https://doi.org/10.1002/mnfr.201601013; Silagy, C.A., Neil, H.A., A meta-analysis of the effect of garlic on blood pressure (1994) Journal of Hypertension, 12 (4), pp. 463-468. , https://doi.org/10.1097/00004872-199404000-00017; Sivam, G.P., Lampe, J.W., Ulness, B., Swanzy, S.R., Potter, J.D., Helicobacter pylori–in vitro susceptibility to garlic (Allium sativum) extract (1997) Nutrition and Cancer, 27 (2), pp. 118-121. , https://doi.org/10.1080/01635589709514512; Stevinson, C., Pittler, M.H., Ernst, E., Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials (2000) Annals of Internal Medicine, 133 (6), pp. 420-429. , https://doi.org/10.7326/0003-4819-133-6-200009190-00009; Sun, Y.E., Wang, W.D., Qin, J., Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein: A meta-analysis (2018) Medicine, 97 (18). , https://doi.org/10.1097/Md.0000000000010255; Taghizadeh, M., Hamedifard, Z., Jafarnejad, S., Effect of garlic supplementation on serum C-reactive protein level: A systematic review and meta-analysis of randomized controlled trials (2018) Phytotherapy Research, 33 (2), pp. 243-252. , https://doi.org/10.1002/ptr.6225; Teshika, J.D., Zakariyyah, A.M., Zaynab, T., Zengin, G., Rengasamy, K.R., Pandian, S.K., Fawzi, M.M., Traditional and modern uses of onion bulb (Allium cepa L.): A systematic review (2018) Critical Reviews in Food Science and Nutrition, 59, pp. S39-S70. , https://doi.org/10.1080/10408398.2018.1499074; Turati, F., Guercio, V., Pelucchi, C., La Vecchia, C., Galeone, C., Colorectal cancer and adenomatous polyps in relation to allium vegetables intake: A meta-analysis of observational studies (2014) Molecular Nutrition & Food Research, 58 (9), pp. 1907-1914. , https://doi.org/10.1002/mnfr.201400169; Turati, F., Pelucchi, C., Guercio, V., La Vecchia, C., Galeone, C., Allium vegetable intake and gastric cancer: A case-control study and meta-analysis (2015) Molecular Nutrition & Food Research, 59 (1), pp. 171-179. , https://doi.org/10.1002/mnfr.201400496; Wang, H.P., Yang, J., Qin, L.Q., Yang, X.J., Effect of garlic on blood pressure: A meta-analysis (2015) The Journal of Clinical Hypertension, 17 (3), pp. 223-231. , https://doi.org/10.1111/jch.12473; Wang, J., Zhang, X.M., Lan, H.L., Wang, W.J., Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): A meta-analysis of randomized controlled trials (2017) Food & Nutrition Research, 61, p. 1377571. , https://doi.org/10.1080/16546628.2017.1377571; Warshafsky, S., Kamer, R.S., Sivak, S.L., Effect of garlic on total serum cholesterol. A meta-analysis (1993) Annals of Internal Medicine, 119 (7), pp. 599-605. , https://doi.org/10.7326/0003-4819-119-7_Part_1-199310010-00009; Xiong, X.J., Wang, P.Q., Li, S.J., Li, X.K., Zhang, Y.Q., Wang, J., Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials (2015) Phytomedicine, 22 (3), pp. 352-361. , https://doi.org/10.1016/j.phymed.2014.12.013; Yang, C., Li, L., Yang, L., Lu, H., Wang, S., Sun, G., Anti-obesity and Hypolipidemic effects of garlic oil and onion oil in rats fed a high-fat diet (2018) Nutrition & Metabolism, 15, p. 43. , https://doi.org/10.1186/s12986-018-0275-x; Zare, E., Alirezaei, A., Bakhtiyari, M., Mansouri, A., Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: A randomized double-blind clinical trial study (2019) BMC Nephrology, 20 (1), p. 26. , https://doi.org/10.1186/s12882-019-1204-6; Zeng, T., Guo, F.F., Zhang, C.L., Song, F.Y., Zhao, X.L., Xie, K.Q., A meta-analysis of randomized, double-blind, placebo-controlled trials for the effects of garlic on serum lipid profiles (2012) Journal of the Science of Food and Agriculture, 92 (9), pp. 1892-1902. , https://doi.org/10.1002/jsfa.5557; Zhao, Y.L., Fan, D.M., Zheng, Z.P., Li, E.T.S., Chen, F., Cheng, K.W., Wang, M.F., 8-C-(E-phenylethenyl)quercetin from onion/beef soup induces autophagic cell death in colon cancer cells through ERK activation (2017) Molecular Nutrition & Food Research, 61 (2); Zhou, X.F., Ding, Z.S., Liu, N.B., Allium vegetables and risk of prostate cancer: Evidence from 132,192 subjects (2013) Asian Pacific Journal of Cancer Prevention, 14 (7), pp. 4131-4134. , https://doi.org/10.7314/APJCP.2013.14.7.4131; Zhou, Y., Zhuang, W., Hu, W., Liu, G.J., Wu, T.X., Wu, X.T., Consumption of large amounts of Allium vegetables reduces risk for gastric cancer in a meta-analysis (2011) Gastroenterology, 141 (1), pp. 80-89. , https://doi.org/10.1053/j.gastro.2011.03.057; Zhu, B.B., Zou, L., Qi, L., Zhong, R., Miao, X.P., Allium vegetables and garlic supplements do not reduce risk of colorectal cancer, based on meta-analysis of prospective studies (2014) Clinical Gastroenterology and Hepatology, 12 (12), pp. 1991-2001. , https://doi.org/10.1016/j.cgh.2014.03.019, e1-4; Zhu, X., Jiang, X., Li, A., Sun, Y., Liu, Y., Sun, X., Zhao, Z., S-allylmercaptocysteine suppresses the growth of human gastric cancer xenografts through induction of apoptosis and regulation of MAPK and PI3K/Akt signaling pathways (2017) Biochemical and Biophysical Research Communications, 491 (3), pp. 821-826. , https://doi.org/10.1016/j.bbrc.2017.06.107; Zini, A., Mann, J., Mazor, S., Vered, Y., The efficacy of aged garlic extract on gingivitis – A randomized clinical trial (2018) The Journal of Clinical Dentistry, 29 (2), pp. 52-56},
correspondence_address1={Zhou, Y.; Department of Gastrointestinal Surgery, China; email: nutritioner@hotmail.com},
publisher={Wiley-Blackwell},
issn={20487177},
language={English},
abbrev_source_title={Food Sci. Nutr.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Karikari2018,
author={Karikari, T.K. and Charway-Felli, A. and Höglund, K. and Blennow, K. and Zetterberg, H.},
title={Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015},
journal={Frontiers in Neurology},
year={2018},
volume={9},
number={MAR},
doi={10.3389/fneur.2018.00201},
art_number={201},
note={cited By 20},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044636818&doi=10.3389%2ffneur.2018.00201&partnerID=40&md5=49e505c0ad1384c161faa39f26fd262a},
affiliation={School of Life Sciences, Midlands Integrative Biosciences Training Partnership, University of Warwick, Coventry, United Kingdom; Neurology Department, 37 Military Hospital, Accra, Ghana; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, The University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom},
author_keywords={Alzheimer's disease;  Biomarkers;  Dementia;  Low- and middle-income countries;  Neurodegenerative diseases},
funding_details={Biotechnology and Biological Sciences Research CouncilBiotechnology and Biological Sciences Research Council, BBSRC, BB/J014532/1},
references={(2015), http://www.who.int/ageing/events/world-report-2015-launch/en/, (accessed November 21 2017); Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 (2017) Lancet Neurol, 16, pp. 877-897; Olayinka, O.O., Mbuyi, N.N., Epidemiology of dementia among the elderly in Sub-Saharan Africa (2014) Int J Alzheimers Dis, 2014; Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis (2016) Lancet Neurol, 15, pp. 673-684; Gisslén, M., Krut, J., Andreasson, U., Blennow, K., Cinque, P., Brew, B.J., Amyloid and tau cerebrospinal fluid biomarkers in HIV infection (2009) BMC Neurol, 9, p. 63; Weston, P.S.J., Poole, T., Ryan, N.S., Nair, A., Liang, Y., Macpherson, K., Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration (2017) Neurology, 89 (21), pp. 2167-2175; Hellwig, K., Kvartsberg, H., Portelius, E., Andreasson, U., Oberstein, T.J., Lewczuk, P., Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease (2015) Alzheimers Res Ther, 7, p. 74},
correspondence_address1={Karikari, T.K.; School of Life Sciences, United Kingdom; email: t.k.karikari@warwick.ac.uk},
publisher={Frontiers Media S.A.},
issn={16642295},
language={English},
abbrev_source_title={Front. Neurol.},
document_type={Note},
source={Scopus},
}

@ARTICLE{Mentis2018,
author={Mentis, A.-F.A. and Pantelidi, K. and Dardiotis, E. and Hadjigeorgiou, G.M. and Petinaki, E.},
title={Precision medicine and global health: The good, the bad, and the ugly},
journal={Frontiers in Medicine},
year={2018},
volume={5},
number={MAR},
doi={10.3389/fmed.2018.00067},
art_number={67},
note={cited By 20},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050120441&doi=10.3389%2ffmed.2018.00067&partnerID=40&md5=d35cc7a4a85ec0c1d6ab1e9a2975c97e},
affiliation={The Johns Hopkins University, Baltimore, MD, United States; Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece; Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece},
abstract={Precision medicine holds significant promise for finding new ways to diagnose, prevent, and treat disease. In October 2017, Bill Gates and Francis Collins, thought-leaders in global health and genomics, respectively, jointly discussed shared perspectives in these arenas (1). A lot of the promise of precision medicine has yet to be realized (2), so, it is important that the global health community, itself facing challenges, enters this new era with its eyes wide open. © 2018 Mentis, Pantelidi, Dardiotis, Hadjigeorgiou and Petinaki.},
author_keywords={Big data;  Genomics;  Global health;  Health equity;  Health policy;  Precision medicine;  Sequencing;  Social determinants of health},
references={Karow, J., (2017) At ASHG, Bill Gates and Francis Collins Discuss Global Health and Genetics in the Computational Age, , https://www.genomeweb.com/business-policy-funding/ashg-bill-gates-and-francis-collins-discuss-global-health-and-genetics, (accessed December 12, 2017); Matuchansky, C., The promise of personalised medicine (2015) Lancet, 386 (9995), p. 742; Bayer, R., Galea, S., Public health in the precision-medicine era (2015) N Engl J Med, 373 (6), pp. 499-501; Patel, V., Rethinking personalised medicine (2015) Lancet, 385 (9980), pp. 1826-1827; Mentis, A.-F.A., Social determinants of tobacco use: towards an equity lens approach (2017) Tob Prev Cessation, 3, p. 7; Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A., Jr., Kinzler, K.W., Cancer genome landscapes (2013) Science, 339 (6127), pp. 1546-1558; Mentis, A.F., Epigenomic engineering for Down syndrome (2016) Neurosci Biobehav Rev, 71, pp. 323-327; Obermeyer, Z., Lee, T.H., Lost in thought-the limits of the human mind and the future of medicine (2017) N Engl J Med, 377 (13), pp. 1209-1211},
correspondence_address1={Mentis, A.-F.A.; The Johns Hopkins University, United States; email: amentis1@jhu.edu},
publisher={Frontiers Media S.A.},
issn={2296858X},
language={English},
abbrev_source_title={Front. Med.},
document_type={Note},
source={Scopus},
}

@ARTICLE{Krewski2017266,
author={Krewski, D. and Barakat-Haddad, C. and Donnan, J. and Martino, R. and Pringsheim, T. and Tremlett, H. and van Lieshout, P. and Walsh, S.J. and Birkett, N.J. and Gomes, J. and Little, J. and Bowen, S. and Candundo, H. and Chao, T.-K. and Collins, K. and Crispo, J.A.G. and Duggan, T. and El Sherif, R. and Farhat, N. and Fortin, Y. and Gaskin, J. and Gupta, P. and Hersi, M. and Hu, J. and Irvine, B. and Jahanfar, S. and MacDonald, D. and McKay, K. and Morrissey, A. and Quach, P. and Rashid, R. and Shin, S. and Sikora, L. and Tkachuk, S. and Taher, M.K. and Wang, M.-D. and Darshan, S. and Cashman, N.R.},
title={Determinants of neurological disease: Synthesis of systematic reviews},
journal={NeuroToxicology},
year={2017},
volume={61},
pages={266-289},
doi={10.1016/j.neuro.2017.04.002},
note={cited By 19},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020133246&doi=10.1016%2fj.neuro.2017.04.002&partnerID=40&md5=a5d2f0bef8cb712f7a0c8201aa2f691a},
affiliation={McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, OttawaOntario, Canada; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Risk Sciences International, Ottawa, Ontario, Canada; Faculty of Health Sciences, University of Ontario Institute of Technology, Canada; School of Pharmacy, Memorial University of Newfoundland, Health Science Centre, St. John'sNL, Canada; Department of Speech-Language Pathology, University of Toronto, Canada; Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Canada; Rehabilitation Sciences Institute, University of Toronto, Canada; Department of Community Health Sciences, University of Calgary, Canada; Faculty of Medicine (Neurology), Djavad Mowafaghian Centre for Brain Health, Vancouver Coastal Health Research Institute, University of British Columbia, Canada; Department of Psychology, University of Toronto, Canada; Toronto Rehabilitation Institute, University Health Network, Canada; Newfoundland and Labrador Centre for Health Information, 70 O'Leary Avenue, St. John's, NL, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada; Department of Medicine, University of Alberta, Canada; Department of Family Medicine, McGill University, Montreal, QC, Canada; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada; School of Health Sciences, Central Michigan University, Michigan, United States; Department of Pediatrics, McMaster University, Canada; Health Sciences Library, University of Ottawa, Ottawa, ON, Canada; School of Life Science, Changchun Normal University, Changchun, Jilin  130032, China; Brain Research Centre, Department of Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada},
abstract={Systematic reviews were conducted to identify risk factors associated with the onset and progression of 14 neurological conditions, prioritized as a component of the National Population Health Study of Neurological Conditions. These systematic reviews provided a basis for evaluating the weight of evidence of evidence for risk factors for the onset and progression of the 14 individual neurological conditions considered. A number of risk factors associated with an increased risk of onset for more than one condition, including exposure to pesticides (associated with an increased risk of AD, amyotrophic lateral sclerosis, brain tumours, and PD; smoking (AD, MS); and infection (MS, Tourette syndrome). Coffee and tea intake was associated with a decreased risk of onset of both dystonia and PD. Further understanding of the etiology of priority neurological conditions will be helpful in focusing future research initiatives and in the development of interventions to reduce the burden associated with neurological conditions in Canada and internationally. © 2017},
author_keywords={Burden of neurological disease;  Intervention;  Meta-analyses;  Mitigation;  Modifiable;  Neurological conditions;  Onset;  Progression;  Risk factors;  Systematic reviews},
keywords={5,10 methylenetetrahydrofolate reductase (FADH2);  dihydrofolate reductase, ADORA2A gene;  amyotrophic lateral sclerosis;  Apgar score;  Article;  Becker muscular dystrophy;  cerebral palsy;  DHFR gene;  diabetes mellitus;  disease course;  Duchenne muscular dystrophy;  dystonia;  Emery Dreifuss muscular dystrophy;  epilepsy;  facioscapulohumeral muscular dystrophy;  GCH1 gene;  gene;  gene interaction;  gene mutation;  genetic association;  genetic risk;  genetic susceptibility;  Gilles de la Tourette syndrome;  GRIN2A gene;  human;  Huntington chorea;  hydrocephalus;  infection;  Li-Fraumeni syndrome;  limb girdle muscular dystrophy;  MTHFR gene;  multiple sclerosis;  neurofibromatosis type 1;  neurofibromatosis type 2;  obesity;  Parkinson disease;  PDYN gene;  population research;  PPARGC1A gene;  priority journal;  REM sleep;  smoking;  spinal cord injury;  spinal dysraphism;  systematic review;  traumatic brain injury;  tuberous sclerosis;  disease exacerbation;  genetics;  meta analysis;  neurologic disease;  risk factor, Disease Progression;  Humans;  Nervous System Diseases;  Risk Factors},
chemicals_cas={5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7; dihydrofolate reductase, 9002-03-3},
references={Albanese, A., Bhatia, K., Bressman, S.B., Delong, M.R., Phenomenology and classification of dystonia: a consensus update (2013) Mov. Disord., 28, pp. 863-873; Ahrens, K., Yazdy, M.M., Mitchell, A.A., Werler, M.M., Folic acid intake and spina bifida in the era of dietary folic acid fortification (2011) Epidemiology, 22, pp. 731-737; Alfirevic, Z., Devane, D., Gyte, G.M., Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (2013) Cochrane Database Syst. Rev., p. 31. , CD006066; Alshaikh, B., Yusuf, K., Sauve, R., Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis (2013) J. Perinatol., 33, pp. 558-564; Artama, M., Ritvanen, A., Gissler, M., Isojarvi, J., Auvinen, A., Congenital structural anomalies in offspring of women with epilepsy—a population-based cohort study in Finland (2006) Int. J. Epidemiol., 35, pp. 280-287; Attewell, R.G., Glase, K., McFadden, M., Bicycle helmet efficacy: a metaanalysis (2001) Accid. Anal. Prev., 33, pp. 345-352; Barakat-Haddad, C., Shin, S., Candundo, H., Van Lieshout, P., Martino, R., A systematic review of risk factors associated with muscular dystrophies (2017) Neurotoxicology, 61, pp. 55-62; Barlow, K.M., Traumatic brain injury (2013) Pediatric Neurology Part II: Handbook of Clinical Neurology, 112, pp. 891-903. , O. Dulac M. Lassonde H.B. Samat Elsevier B.V. (Chapter 95); Berg, A.T., Berkovic, S.F., Brodie, M.J., Buchhalter, J., Cross, J.H., Van Emde Boas, W., Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009 (2010) Epilepsia, 51, pp. 676-685; Bertollini, R., Mastroiacovo, P., Segni, G., Maternal epilepsy and birth defects: a case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC) (1985) Eur. J. Epidemiol., 1, pp. 67-72; Blatter, B.M., Roeleveld, N., Spina bifida and parental occupation in a Swedish register-based study (1996) Scand. J. Work. Environ. Health, 22, pp. 433-437; Blatter, B.M., Roeleveld, N., Zielhuis, G.A., Gabreels, F.J., Verbeek, A.L., Maternal occupational exposure during pregnancy and the risk of spina bifida (1996) Occup. Environ. Med., 53, pp. 80-88; Blatter, B.M., Roeleveld, N., Zielhuis, G.A., Mullaart, R.A., Gabreels, F.J., Spina bifida and parental occupation (1996) Epidemiology, 7, pp. 188-193; Bloch, M.H., Leckman, J.F., Clinical course of Tourette syndrome (2009) J. Psychosom. Res., 67, pp. 497-501; Broussard, C.S., Rasmussen, S.A., Reefhuis, J., Friedman, J.M., Jann, M.W., Riehle-Colarusso, T., Honein, M.A., National Birth Defects Prevention Study, Maternal treatment with opioid analgesics and risk for birth defects (2011) Am. J. Obstet. Gynecol., 204, pp. 314.e1-314.e11; The Burden of Neurological Diseases, Disorders and Injuries in Canada (2007), Edited by Canadian Institute for Health Information: CIHI; The incidence of dementia in Canada (2000) Neurology, 55, pp. 66-73; Cappa, K.A., Conger, J.C., Conger, A.J., Injury severity and outcome: a meta-analysis of prospective studies on TBI outcome (2011) Health Psychol., 30, pp. 542-560; Cassidy, J.D., Carroll, L., Peloso, P., Borg, J., Von Holst, H., Holm, L., Kraus, J., Coronado, V., Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury (2004) J. Rehabil. Med., 36, pp. 28-60; Chao, T.K., Hu, J., Pringsheim, T., Prenatal risk factors for Tourette Syndrome: a systematic review (2014) BMC Pregnancy Childbirth, 14, p. 53; Chao, T.K., Hu, J., Pringsheim, T., Risk factors for the onset and progression of Huntington disease (2017) Neurotoxicology, 61, pp. 79-99; Cortes, F., Mellado, C., Pardo, R.A., Villarroel, L.A., Hertrampf, E., Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile (2012) Am. J. Med. Genet. A, 158A, pp. 1885-1890; Elwood, J.M., Little, J., Elwood, J.H., Epidemiology and control of neural tube defects (1992) Monographs in Epidemiology and Biostatistics 20, , Oxford University Press 926 & xv pp; Dawson, A., Tinker, S., Jamieson, D., Hobbs, C., Berry, R., Anderka, M., Keppler-Noreuil, K., Reefhuis, J., Twinning and birth defects. 45th Annual SER Meeting, Minneapolis, Minnesota, June 27, Abstract (2012) Am. J. Epidemiol., 175, p. S57; De Bonis, P., Pompucci, A., Mangiola, A., Rigante, L., Anile, C., Post-traumatic hydrocephalus after decompressive craniectomy: an underestimated risk factor (2010) J. Neurotrauma, 27, pp. 1965-1970; Donnan, J., Morrissey, A., Sikora, L., Walsh, S., Collins, K., MacDonald, D., A systematic review of the risk factors associated with the onset and natural progression of spina bifida (2017) Neurotoxicology, 61, pp. 20-31; Donnan, J., Walsh, S., Fortin, Y., Sikora, L., Eka, U., Morrissey, A., Bowen, S., MacDonald, D., Systematic review of the risk factors associated with the onset and natural progression of epilepsy (2017) Neurotoxicology, 61, pp. 64-77; Duong, H.T., Hoyt, A.T., Carmichael, S.L., Gilboa, S.M., Canfield, M.A., Case, A., McNeese, M.L., Waller, D.K., Is maternal parity an independent risk factor for birth defects? (2012) Birth Defects Res. A: Clin. Mol. Teratol., 94, pp. 230-236; Elmslie, K., Against the growing burden of disease (2015) Canadian Conference on Global Health, Montreal, Canada, November 5–7 2015; Emery, A.E., Population frequencies of inherited neuromuscular diseases: a world survey (1991) Neuromuscul. Disord., 1, pp. 19-29; Emery, A.E., The muscular dystrophies (2000) Lancet, 359, pp. 687-695; Evans, C., Beland, S.G., Kulaga, S., Wolfson, C., Kingwell, E., Marriott, J., Koch, M., Incidences and prevalence of multiple sclerosis in the Americas: a systematic review (2013) Neuroepidemiology, 40, pp. 195-210; Fisher, R.S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J.H., Elger, C.E., ILAE official report: a practical clinical definition of epilepsy (2014) Epilepsia, 55, pp. 475-482; Gaskin, J., Gomes, J., Darshan, S., Krewski, D., Burden of Neurological conditions in Canada (2017) Neurotoxicology, 61, pp. 2-10; Goh, Y.I., Bollano, E., Einarson, T.R., Koren, G., Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis (2006) J. Obstet. Gynaecol. Can., 28, pp. 680-689; Hernandez-Diaz, S., Werler, M.M., Walker, A.M., Mitchell, A.A., Neural tube defects in relation to use of folic acid antagonists during pregnancy (2001) Am. J. Epidemiol., 153, pp. 961-968; Hersi, M., Quach, P., Wand, M.-D., Gomes, J., Gaskin, J., Krewski, D., Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview (2017) Neurotoxicology, 61, pp. 12-18; Hersi, M., Irvine, B., Gupta, P., Gomes, J., Krewski, D., Risk factors associated with the onset and progression of Alzheimer's disease (2017) Neurotoxicology, pp. 143-187; Hirtz, D., Thurman, D., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A., Zalutsky, R., How common are the “common” neurologic disorders? (2007) Neurology, 68, pp. 326-337; Jacquemyn, Y., Zecic, A., Van Laere, D., Roelens, K., The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection (2015) Arch Gynecol Obstet., 291, pp. 969-975; Jafari, S., Etminan, M., Aminzadeh, F., Samii, A., Head injury and risk of Parkinson Disease: a systematic review and meta-analysis (2013) Mov. Disord., 28, pp. 1222-1229; Jentink, J., Bakker, M.K., Nijenhuis, C.M., Wilffert, B., de Jong-van den Berg, L.T., Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? (2010) Pharmacoepidemiol. Drug Saf., 19, pp. 803-807; Jentink, J., Dolk, H., Loane, M.A., Morris, J.K., Wellesley, D., Garne, E., de Jong-van den Berg, L., EUROCAT Antiepileptic Study Working Group, Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study (2010) Br. Med. J., 341, p. c6581; Jentink, J., Loane, M.A., Dolk, H., Barisic, I., Garne, E., Morris, J.K., de Jong-van den Berg, L.T., EUROCAT Antiepileptic Study Working Group, Valproic acid monotherapy in pregnancy and major congenital malformations (2010) N. Engl. J. Med., 362, pp. 2185-2193; Kazy, Z., Puho, E., Czeizel, A.E., Teratogenic potential of vaginal metronidazole treatment during pregnancy (2005) Eur. J. Obstet. Gynecol. Reprod. Biol., 123, pp. 174-178; Kubicsek, T., Kazy, Z., Czeizel, A.E., Teratogenic potential of tribenoside, a drug for the treatment of haemorrhoids and varicose veins – a population-based case-control study (2011) Reprod. Toxicol., 31, pp. 464-469; Knight, T., Steeves, T., Day, L., Lowerison, M., Jette, N., Pringsheim, T., Prevalence of tic disorders: a systematic review and meta-analysis (2012) Pediatr. Neurol., 47, pp. 77-90; Leary, S.M., Porter, B., Thompson, A.J., Multiple sclerosis: diagnosis and the management of acute relapses (2005) Postgrad. Med. J., 81, pp. 302-308; Leckman, J.F., Zhang, H., Vitale, A., Lahnin, F., Lynch, K., Bondi, C., Course of tic severity in Tourette syndrome: the first two decades (1998) Pediatrics, 102, pp. 14-19; Lee, R.S., Hagel, B.E., Karkhaneh, M., Rowe, B.H., A systematic review of correct bicycle helmet use: how varying definitions and study quality influence the results (2009) Inj. Prev., 15, pp. 125-131; Little, J., Barakat-Haddad, C., Martino, R., Pringsheim, T., Tremlett, H., McKay, K., van Lieshout, P., Krewski, D., Genetic variation associated with the occurrence and progression of neurological disorders (2017) Neurotoxicology, 61, pp. 243-264; Luthy, D.A., Wardinsky, T., Shurtleff, D.B., Hollenbach, K.A., Hickok, D.E., Nyberg, D.A., Benedetti, T.J., Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally (1991) N. Engl. J. Med., 324, pp. 662-666; Lynberg, M.C., Khoury, M.J., Lu, X., Cocian, T., Maternal flu, fever, the risk of neural tube defects: a population-based case-control study (1994) Am. J. Epidemiol., 140, pp. 244-255; Martino, R., Candundo, H., van Lieshout, P., Shin, S., Crispo, J.A.G., Barakat-Haddad, C., Onset and progression factors in Parkinson's Disease: a systematic review (2017) Neurotoxicology, 61, pp. 132-141; McIntyre, S., Taitz, D., Keogh, J., Goldsmith, S., Badawi, N., Blair, E., A systematic review of risk factors for cerebral palsy in children born at term in developed countries (2013) Dev Med Child Neurol., 55, pp. 499-508; McKay, K.A., Jahanfar, S., Duggan, T., Tkachuk, S., Tremlett, H., Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review (2017) Neurotoxicology, 61, pp. 189-212; Munch, T.N., Rasmussen, M., Wohlfahrt, J., Juhler, M., Melbye, M., Risk factors for primary congenital Hydrocephalus – a nationwide cohort study. 45th Annual SER Meeting, Minneapolis, Minnesota, June 27, Abstract (2012) Am. J. Epidemiol., 175, p. S57; Munch, T.N., Rostgaard, K., Rasmussen, M.L., Wohlfahrt, J., Juhler, M., Melbye, M., Familial aggregation of congenital hydrocephalus in a nationwide cohort (2012) Brain, 135, pp. 2409-2415; Ngo, A.D., Taylor, R., Roberts, C.L., Paternal exposure to agent orange and spina bifida: a meta-analysis (2010) Eur. J. Epidemiol., 25, pp. 37-44; O'Rourke, J.A., Scharf, J.M., Yu, D., Pauls, D.L., The genetics of Tourette syndrome: a review (2009) J. Psychosom. Res., 67, pp. 533-545; Oskoui, M., Coutinho, F., Dykeman, J., Jette, N., Pringsheim, T., An update on the prevalence of cerebral palsy: a systematic review and meta-analysis (2013) Dev. Med. Child Neurol., 55, pp. 509-519; Congenital Anomalies in Canada 2013. A perinatal health surveillance report (2013), http://publications.gc.ca/collections/collection_2014/aspc-phac/HP35-40-2013-eng.pdf, (accessed 07.02.17); Mapping connections: an understanding of neurological conditions in Canada, September 2014 (2014), www.phac-aspc.gc.ca/publicat/cd-mc/mc-ec/index-eng.php, 110 pages, (accessed 18.12.15); Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., Jette, N., The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis (2012) Mov. Disord., 27, pp. 1083-1091; Quach, P., Hersi, M., Reem, E.S., Gomes, J., Krewski, D., A systematic review of the risk factors associated with the onset and progression of primary brain tumours (2017) Neurotoxicology, 61, pp. 214-232; Rhomberg, L.R., Goodman, J.E., Bailey, L.A., Prueitt, R.L., Beck, N.B., Bevan, C., Honeycutt, M., Becker, R.A., A survey of frameworks for best practices in weight-of-evidence analyses (2013) Crit. Rev. Toxicol., 43, pp. 753-784; Shin, M., Besser, L.M., Siffel, C., Kucik, J.E., Shaw, G.M., Lu, C., Correa, A., Prevalence of spina bifida among children and adolescents in 10 regions in the United States (2010) Pediatrics, 126, pp. 274-279; Hydrocephalus fast facts (2013), http://www.folicacid.ca/sites/default/files/file/Media%20Resources/2011%2002%2028%20Medi a%20Resources%20-%20Hydrocephalus%20Fast%20Facts%20-%20EN.pdf, Available from (accessed 15.01.13); Unlocking the mystery of hydrocephalus (2007), http://www.sbhac.ca/sbhac_update_winter_2007.pdf, Available from (accessed 15.01.13); Statistics Canada, Canadian Community Health Survey, Share File, 2011 Cycle (2011); Stothard, K.J., Tennant, P.W., Bell, R., Rankin, J., Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis (2009) J. Am. Med. Assoc., 301, pp. 636-650; Tang, Y., Ma, C.X., Cui, W., Chang, V., Ariet, M., Morse, S.B., Resnick, M.B., Roth, J., The risk of birth defects in multiple births: a population-based study (2006) Matern. Child Health J., 10, pp. 75-81; Thompson, D.C., Rivara, F.P., Thompson, R., Helmets for preventing head and facial injuries in bicyclists (1999) Cochrane Database Syst. Rev., 4, p. CD001855; van Landingham, M., Nguyen, T.V., Roberts, A., Parent, A.D., Zhang, J., Risk factors of congenital hydrocephalus: a 10 year retrospective study (2009) J. Neurol. Neurosurg. Psychiatry, 80, pp. 213-217; van Lieshout, P., Candundo, H., Martino, R., Shin, S., Barakat-Haddad, C., Onset factors in cerebral palsy: a systematic review (2017) Neurotoxicology, 61, pp. 47-53; Walsh, S., Donnan, J., Morrissey, A., Fortrin, Y., Sikora, L., Bowen, S., Collins, K., MacDonald, D., A systematic review of the risks factors associated with the onset and natural progression of epilepsy (2017) Neurotoxicolgy, 61, pp. 64-77; Walsh, S., Donnan, J., Morrissey, A., Sikora, L., Bowen, S., Collins, K., MacDonald, D., A systematic review of the risks factors associated with the onset and natural progression of hydrocephalus (2017) Neurotoxicology, 61, pp. 33-45; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis approaches (2017) Neurotoxicology, 61, pp. 101-130; Wigle, D.T., Arbuckle, T.E., Turner, M.C., Bérubé, A., Yang, Q., Liu, S., Krewski, D., Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants (2008) J. Toxicol. Environ. Health B, 11, pp. 373-517; Zhang, J., Savitz, D.A., Schwingl, P.J., Cai, W.W., A case-control study of paternal smoking and birth defects (1992) Int. J. Epidemiol., 21, pp. 273-278},
correspondence_address1={Krewski, D.; McLaughlin Centre for Population Health Risk Assessment, Ottawa, Canada; email: dkrewski@uottawa.ca},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={28410962},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Marventano2020325,
author={Marventano, S. and Godos, J. and Tieri, M. and Ghelfi, F. and Titta, L. and Lafranconi, A. and Gambera, A. and Alonzo, E. and Sciacca, S. and Buscemi, S. and Ray, S. and Del Rio, D. and Galvano, F. and Grosso, G.},
title={Egg consumption and human health: an umbrella review of observational studies},
journal={International Journal of Food Sciences and Nutrition},
year={2020},
volume={71},
number={3},
pages={325-331},
doi={10.1080/09637486.2019.1648388},
note={cited By 17},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070482082&doi=10.1080%2f09637486.2019.1648388&partnerID=40&md5=2450aa32f73b3b340821f1b958628b5a},
affiliation={Department of Childhood and Adolescent, AUSL Romagna, Rimini Women’s Health, Rimini, Italy; Oasi Research Institute–IRCCS, Troina, Italy; SmartFood Program, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy; NNEdPro Global Centre for Nutrition and Health, St John’s Innovation Centre, Cambridge, United Kingdom; University of Milano–Bicocca, Milan, Italy; Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands; Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Food and Nutrition Security and Public Health Service, ASP Catania, Catania, Italy; Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy; Wolfson College at the University of Cambridge, Cambridge, United Kingdom; Nutrition Innovation Centre for Food and Health, Ulster University, Belfast, United Kingdom; Medical Research Council (MRC) Human Nutrition Research Unit, Cambridge, United Kingdom; The Laboratory of Phytochemicals in Physiology, Department of Veterinary Science, University of Parma, Parma, Italy; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy},
abstract={Egg consumption has been an area of controversy regarding its impact on human health largely due to the content in cholesterol and its potential role in cardio-metabolic outcomes. This study aimed to summarise the level of evidence of egg consumption on various health outcomes. A systematic search for meta-analyses was performed: study design, dose–response relationship, heterogeneity and agreement of results over time, and identification of potential confounding factors were considered to assess the level of evidence. Results from this umbrella review showed a substantial no association between egg consumption and a number of health outcomes, including cancer, cardiovascular and metabolic disorders. In contrast, evidence of possible beneficial effects toward stroke risk has been found. In conclusions, egg may be part of a healthy diet; however, additional studies exploring confounding factors are needed to ascertain the potential detrimental effects. © 2019, © 2019 Taylor & Francis Group, LLC.},
author_keywords={cohort;  Egg;  evidence;  meta-analysis;  prospective;  umbrella review},
keywords={cardiovascular disease;  diet;  egg;  human;  metabolic disorder;  risk factor, Cardiovascular Diseases;  Diet;  Diet, Healthy;  Eggs;  Humans;  Metabolic Diseases;  Risk Factors},
references={Alexander, D.D., Miller, P.E., Vargas, A.J., Weed, D.L., Cohen, S.S., Meta-analysis of egg consumption and risk of coronary heart disease and stroke (2016) J Am Coll Nutr, 35 (8), pp. 704-716; Angelino, D., Godos, J., Ghelfi, F., Tieri, M., Titta, L., Lafranconi, A., Marventano, S., Sciacca, S., Fruit and vegetable consumption and health outcomes: an umbrella review of observational studies (2019) Int J Food Sci Nutr, 70 (6), pp. 652-667; Bandera, E.V., Kushi, L.H., Moore, D.F., Gifkins, D.M., McCullough, M.L., Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis (2007) Cancer Causes Control, 18, pp. 967-988; Berger, S., Raman, G., Vishwanathan, R., Jacques, P.F., Johnson, E.J., Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis (2015) Am J Clin Nutr, 102 (2), pp. 276-294; Blesso, C.N., Egg phospholipids and cardiovascular health (2015) Nutrients, 7 (4), pp. 2731-2747; Caini, S., Masala, G., Gnagnarella, P., Ermini, I., Russell-Edu, W., Palli, D., Gandini, S., Food of animal origin and risk of non-Hodgkin lymphoma and multiple myeloma: a review of the literature and meta-analysis (2016) Crit Rev Oncol Hematol, 100, pp. 16-24; Clayton, Z.S., Fusco, E., Kern, M., Egg consumption and heart health: a review (2017) Nutrition, 37, pp. 79-85; (2015), http://www.who.int/nutrition/topics/5_population_nutrient/en/-diet5.1.2, Accessed November; (2015), https://health.gov/dietaryguidelines/2015/guidelines/, 2020. Available from; Djousse, L., Khawaja, O.A., Gaziano, J.M., Egg consumption and risk of type 2 diabetes: a meta-analysis of prospective studies (2016) Am J Clin Nutr, 103 (2), pp. 474-480; Dong, Y., Wu, G., Lack of association of poultry and eggs intake with risk of non-Hodgkin lymphoma: a meta-analysis of observational studies (2017) Eur J Cancer Care (Care), 26; Fang, D., Tan, F., Wang, C., Zhu, X., Xie, L., Egg intake and bladder cancer risk: a meta-analysis (2012) Exp Ther Med, 4 (5), pp. 906-912; Fuller, N.R., Sainsbury, A., Caterson, I.D., Markovic, T.P., Egg consumption and human cardio-metabolic health in people with and without diabetes (2015) Nutrients, pp. 7:7399-7420; Genkinger, J.M., Hunter, D.J., Spiegelman, D., Anderson, K.E., Beeson, W.L., Buring, J.E., Colditz, G.A., Goldbohm, R.A., A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer (2006) Cancer Causes Control, 17, pp. 273-285; Godos, J., Tieri, M., Ghelfi, F., Titta, L., Marventano, S., Lafranconi, A., Gambera, A., Buscemi, S., Dairy foods and health: an umbrella review of observational studies (2019) Int J Food Sci Nutr, 2019, pp. 1-14; Goldberg, I.J., Clinical review 124: diabetic dyslipidemia: causes and consequences (2001) J Clin Endocrinol Metab, 86 (3), pp. 965-971; Grosso, G., Godos, J., Galvano, F., Giovannucci, E.L., Coffee, caffeine, and health outcomes: an umbrella review (2017) Annu Rev Nutr, 37, pp. 131-156; Hu, F.B., Manson, J.E., Willett, W.C., Types of dietary fat and risk of coronary heart disease: a critical review (2001) J Am Coll Nutr, 20 (1), pp. 5-19; Ishihara, L., Brayne, C., A systematic review of nutritional risk factors of Parkinson's disease (2005) Nutr Res Rev, 18 (2), pp. 259-282; Johnson, L.A., Arbones-Mainar, J.M., Fox, R.G., Pendse, A.A., Altenburg, M.K., Kim, H.S., Maeda, N., Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor (2011) Diabetes, 60 (9), pp. 2285-2294; Katz, D.L., Evans, M.A., Nawaz, H., Njike, V.Y., Chan, W., Comerford, B.P., Hoxley, M.L., Egg consumption and endothelial function: a randomized controlled crossover trial (2005) Int J Cardiol, 99, pp. 65-70; Katz, D.L., Gnanaraj, J., Treu, J.A., Ma, Y., Kavak, Y., Njike, V.Y., Effects of egg ingestion on endothelial function in adults with coronary artery disease: a randomized, controlled, crossover trial (2015) Am Heart J, 169 (1), pp. 162-169; Keum, N., Lee, D.H., Marchand, N., Oh, H., Liu, H., Aune, D., Greenwood, D.C., Giovannucci, E.L., Egg intake and cancers of the breast, ovary and prostate: a dose–response meta-analysis of prospective observational studies (2015) Br J Nutr, 114, pp. 1099-1107; Kim, J.E., Campbell, W.W., Dietary cholesterol contained in whole eggs is not well absorbed and does not acutely affect plasma total cholesterol concentration in men and women: results from 2 randomized controlled crossover studies (2018) Nutrients, 10, p. pii: E1272; Kritchevsky, S.B., A review of scientific research and recommendations regarding eggs (2004) J Am Coll Nutr, 23 (6), pp. 596S-600S; Lecerf, J.M., de Lorgeril, M., Dietary cholesterol: from physiology to cardiovascular risk (2011) Br J Nutr, 106 (1), pp. 6-14; Li, F., Zhou, Y., Hu, R.T., Hou, L.N., Du, Y.J., Zhang, X.J., Olkkonen, V.M., Tan, W.L., Egg consumption and risk of bladder cancer: a meta-analysis (2013) Nutr Cancer, 65 (4), pp. 538-546; Li, Y., Zhou, C., Zhou, X., Li, L., Egg consumption and risk of cardiovascular diseases and diabetes: a meta-analysis (2013) Atherosclerosis, 229 (2), pp. 524-530; McDonald, J.D., Chitchumroonchokchai, C., Li, J., Mah, E., Labyk, A.N., Reverri, E.J., Ballard, K.D., Bruno, R.S., Replacing carbohydrate during a glucose challenge with the egg white portion or whole eggs protects against postprandial impairments in vascular endothelial function in prediabetic men by limiting increases in glycaemia and lipid peroxidation (2018) Br J Nutr, 119 (3), pp. 259-270; Mine, Y., Egg proteins and peptides in human health–chemistry, bioactivity and production (2007) Curr Pharm Des, 13 (9), pp. 875-884; Miranda, J.M., Anton, X., Redondo-Valbuena, C., Roca-Saavedra, P., Rodriguez, J.A., Lamas, A., Franco, C.M., Cepeda, A., Egg and egg-derived foods: effects on human health and use as functional foods (2015) Nutrients, 7, pp. 706-729; Missmer, S.A., Smith, W.S., Spiegelman, D., Yaun, S.S., Adami, H.O., Beeson, W.L., van den, B.P., Goldbohm, R.A., Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies (2002) Int J Epidemiol, 31, pp. 78-85; Njike, V., Faridi, Z., Dutta, S., Gonzalez-Simon, A.L., Katz, D.L., Daily egg consumption in hyperlipidemic adults–effects on endothelial function and cardiovascular risk (2010) Nutr J, 9, p. 28; Paluszkiewicz, P., Smolińska, K., Dębińska, I., Turski, W.A., Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case–control and cohort studies (2012) Cancer Epidemiol, 36 (1), pp. 60-67; Pearce, K.L., Clifton, P.M., Noakes, M., Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with type 2 diabetes (2011) Br J Nutr, 105 (4), pp. 584-592; Rong, Y., Chen, L., Zhu, T., Song, Y., Yu, M., Shan, Z., Sands, A., Liu, L., Egg consumption and risk of coronary heart disease and stroke: dose–response meta-analysis of prospective cohort studies (2013) BMJ, 346, p. e8539; Rouhani, M.H., Rashidi-Pourfard, N., Salehi-Abargouei, A., Karimi, M., Haghighatdoost, F., Effects of egg consumption on blood lipids: a systematic review and meta-analysis of randomized clinical trials (2018) J Am Coll Nutr, 37 (2), pp. 99-110; Sacks, F.M., The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia (2015) Curr Opin Lipidol, 26 (1), pp. 56-63; Shin, J.Y., Xun, P., Nakamura, Y., He, K., Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis (2013) Am J Clin Nutr, 98 (1), pp. 146-159; Si, R., Qu, K., Jiang, Z., Yang, X., Gao, P., Egg consumption and breast cancer risk: a meta-analysis (2014) Breast Cancer, 21 (3), pp. 251-261; Soliman, G.A., Dietary cholesterol and the lack of evidence in cardiovascular disease (2018) Nutrients, 10, p. pii: E780; Tamez, M., Virtanen, J.K., Lajous, M., Egg consumption and risk of incident type 2 diabetes: a dose-response meta-analysis of prospective cohort studies (2016) Br J Nutr, 115 (12), pp. 2212-2218; Tse, G., Eslick, G.D., Egg consumption and risk of GI neoplasms: dose-response meta-analysis and systematic review (2014) Eur J Nutr, 53 (7), pp. 1581-1590; Wallin, A., Forouhi, N.G., Wolk, A., Larsson, S.C., Egg consumption and risk of type 2 diabetes: a prospective study and dose-response meta-analysis (2016) Diabetologia, 59 (6), pp. 1204-1213; Wu, K., Spiegelman, D., Hou, T., Albanes, D., Allen, N.E., Berndt, S.I., van den Brandt, P.A., Alexandra Goldbohm, R., Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: a pooled analysis of 15 prospective cohort studies (2016) Int J Cancer, 138, pp. 2368-2382; Wu, J., Zeng, R., Huang, J., Li, X., Zhang, J., Ho, J.C., Zheng, Y., Dietary protein sources and incidence of breast cancer: a dose-response meta-analysis of prospective studies (2016) Nutrients, 8, p. pii: E730; Xie, B., He, H., No association between egg intake and prostate cancer risk: a meta-analysis (2012) Asian Pac J Cancer Prev, 13 (9), pp. 4677-4681; Yoon, H., Benamouzig, R., Little, J., Francois-Collange, M., Tome, D., Systematic review of epidemiological studies on meat, dairy products and egg consumption and risk of colorectal adenomas (2000) Eur J Cancer Prev, 9 (3), pp. 151-164; Zeng, S.T., Guo, L., Liu, S.K., Wang, D.H., Xi, J., Huang, P., Liu, D.T., Zhang, L., Egg consumption is associated with increased risk of ovarian cancer: evidence from a meta-analysis of observational studies (2015) Clin Nutr, 34 (4), pp. 635-641},
correspondence_address1={Grosso, G.; Department of Biomedical and Biotechnological Sciences, Via Santa Sofia 97, Italy; email: giuseppe.grosso@unict.it},
publisher={Taylor and Francis Ltd},
issn={09637486},
coden={IJFNE},
pubmed_id={31379223},
language={English},
abbrev_source_title={Int. J. Food Sci. Nutr.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Belbasis2020397,
author={Belbasis, L. and Bellou, V. and Evangelou, E. and Tzoulaki, I.},
title={Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies},
journal={Multiple Sclerosis Journal},
year={2020},
volume={26},
number={4},
pages={397-404},
doi={10.1177/1352458519872664},
note={cited By 17},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073798188&doi=10.1177%2f1352458519872664&partnerID=40&md5=05e881a7be2c568a05b296f964249ae8},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom},
abstract={Multiple sclerosis (MS) is a chronic demyelinating disease that is associated with permanent disability and low quality of life. Development of MS is attributed to a combination of genetic and environmental factors. Genome-wide association studies revealed more than 200 variants that are associated with risk of MS. An umbrella review showed that smoking, history of infectious mononucleosis, and anti-Epstein–Barr virus nuclear antigen (anti-EBNA) immunoglobulin G (IgG) seropositivity are credible risk factors of MS. In the present narrative review, we updated our published umbrella review, showing that body mass index in childhood and adolescence and anti-viral capsid antigen (anti-VCA) IgG seropositivity are additional credible risk factors of MS. In addition, we discuss the findings from Mendelian randomization studies, which present evidence for a potential causal role of serum vitamin D and adulthood body mass index on risk of MS. Finally, we discuss the potential limitations of meta-analyses, umbrella reviews, and Mendelian randomization studies in the search for risk factors of MS. © The Author(s), 2019.},
author_keywords={Biomarkers;  environmental factors;  Mendelian randomization;  meta-analysis;  multiple sclerosis;  risk factors;  umbrella review},
keywords={cell nucleus antigen;  Epstein Barr virus antigen;  immunoglobulin G;  virus capsid antigen;  vitamin D;  virus antigen, alcohol consumption;  amyotrophic lateral sclerosis;  body mass;  demyelinating disease;  environmental factor;  genetic association;  genetic risk;  genetic susceptibility;  genetic variability;  genetic variation;  genome-wide association study;  Helicobacter infection;  human;  Mendelian randomization analysis;  meta analysis (topic);  mononucleosis;  multiple sclerosis;  quality of life;  Review;  risk factor;  sclerosis;  sensitivity analysis;  single nucleotide polymorphism;  smoking;  systematic review;  systematic review (topic);  Toxoplasma gondii;  adolescent;  adult;  adverse event;  blood;  body mass;  child;  complication;  genetics;  Mendelian randomization analysis;  meta analysis (topic);  mononucleosis;  multiple sclerosis;  smoking, Adolescent;  Adult;  Antigens, Viral;  Body Mass Index;  Child;  Humans;  Infectious Mononucleosis;  Mendelian Randomization Analysis;  Meta-Analysis as Topic;  Multiple Sclerosis;  Smoking},
chemicals_cas={immunoglobulin G, 97794-27-9; Antigens, Viral},
funding_details={State Scholarships FoundationState Scholarships Foundation, IKY},
funding_text 1={The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: L.B. is supported by a PhD scholarship funded by Greek State Scholarships Foundation. V.B. is supported by a PhD scholarship funded by Greek State Scholarships Foundation.},
references={Thompson, A.J., Baranzini, S.E., Geurts, J., Multiple sclerosis (2018) Lancet, 391, pp. 1622-1636; Patsopoulos, N.A., Genetics of multiple sclerosis: An overview and new directions (2018) Cold Spring Harb Perspect Med, 8. , a028951; Low-frequency and rare-coding variation contributes to multiple sclerosis risk (2018) Cell, 175, pp. 1679-1687.e7; Ramagopalan, S.V., Dobson, R., Meier, U.C., Multiple sclerosis: Risk factors, prodromes, and potential causal pathways (2010) Lancet Neurol, 9 (7), pp. 727-739; Harroud, A., Richards, J.B., Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity (2018) Mult Scler, 24 (1), pp. 80-85; Ioannidis, J.P.A., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ, 181 (8), pp. 488-493; Bellou, V., Belbasis, L., Tzoulaki, I., Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Ioannidis, J.P.A., Boffetta, P., Little, J., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) Int J Epidemiol, 37 (1), pp. 120-132; Belbasis, L., Panagiotou, O.A., Dosis, V., A systematic appraisal of field synopses in genetic epidemiology: A HuGE review (2015) Am J Epidemiol, 181 (1), pp. 1-16; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14 (3), pp. 263-273; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and amyotrophic lateral sclerosis: An umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies (2016) Neuroepidemiology, 46 (2), pp. 96-105; Bellou, V., Belbasis, L., Tzoulaki, I., Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses (2017) Alzheimers Dement, 13 (4), pp. 406-418; Benjamin, D.J., Berger, J.O., Johannesson, M., Redefine statistical significance (2018) Nat Hum Behav, 2, pp. 6-10; Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Measuring inconsistency in meta-analyses (2003) BMJ, 327 (7414), pp. 557-560; Ioannidis, J.P.A., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Handel, A.E., Williamson, A.J., Disanto, G., Smoking and multiple sclerosis: An updated meta-analysis (2011) PLoS ONE, 6 (1). , (,): e16149; Handel, A.E., Williamson, A.J., Disanto, G., An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis (2010) PLoS ONE, 5 (9). , (,): e12496; Almohmeed, Y.H., Avenell, A., Aucott, L., Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis (2013) PLoS ONE, 8 (4). , (,): e61110; Saberi, R., Sharif, M., Sarvi, S., Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis (2018) J Neuroimmunol, 322, pp. 57-62; Mouchet, J., Salvo, F., Raschi, E., Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis (2018) Pharmacol Res, 132, pp. 108-118; Yao, G., Wang, P., Luo, X.-D., Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis (2016) Neurosci Lett, 620, pp. 1-7; Pormohammad, A., Azimi, T., Falah, F., Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis (2018) J Cell Physiol, 233 (4), pp. 2850-2862; Liu, Z., Zhang, T.-T., Yu, J., Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: A meta-analysis (2016) Neuroepidemiology, 47 (2), pp. 103-108; Zhu, T., Ye, X., Zhang, T., Association between alcohol consumption and multiple sclerosis: A meta-analysis of observational studies (2015) Neurol Sci, 36 (9), pp. 1543-1550; Davey, S.G., Ebrahim, S., Mendelian randomization: Prospects, potentials, and limitations (2004) Int J Epidemiol, 33 (1), pp. 30-42; Lawlor, D.A., Harbord, R.M., Sterne, J.A.C., Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology (2008) Stat Med, 27, pp. 1133-1163; Egger, M., Davey, S.G., Sterne, J.A.C., Uses and abuses of meta-analysis (2001) Clin Med (Lond), 1, pp. 478-484; Ramagopalan, S.V., Valdar, W., Criscuoli, M., Age of puberty and the risk of multiple sclerosis: A population based study (2009) Eur J Neurol, 16, pp. 342-347; Nielsen, N.M., Harpsoe, M., Simonsen, J., Age at menarche and risk of multiple sclerosis: A prospective cohort study based on the Danish national birth cohort (2017) Am J Epidemiol, 185 (8), pp. 712-719; Evans, D.M., Davey Smith, G., Mendelian randomization: New applications in the coming age of hypothesis-free causality (2015) Annu Rev Genomics Hum Genet, 16, pp. 327-350; Davies, N.M., Holmes, M.V., Davey Smith, G., Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians (2018) BMJ, 362. , k601; Gianfrancesco, M.A., Stridh, P., Rhead, B., Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS (2017) Neurology, 88 (17), pp. 1623-1629; Devorak, J., Mokry, L.E., Morris, J.A., Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study (2017) Mult Scler, 23 (11), pp. 1461-1468; Gianfrancesco, M.A., Glymour, M.M., Walter, S., Causal effect of genetic variants associated with body mass index on multiple sclerosis susceptibility (2017) Am J Epidemiol, 185 (3), pp. 162-171; Mokry, L.E., Ross, S., Ahmad, O.S., Vitamin D and risk of multiple sclerosis: A Mendelian randomization study (2015) PLoS Med, 12. , e1001866; Mokry, L.E., Ross, S., Timpson, N.J., Obesity and multiple sclerosis: A Mendelian randomization study (2016) PLoS Med, 13 (6). , (,): e1002053; Rhead, B., Baarnhielm, M., Gianfrancesco, M., Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk (2016) Neurol Genet, 2 (5). , (,): e97; Burgess, S., Bowden, J., Fall, T., Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants (2017) Epidemiology, 28 (1), pp. 30-42; Winkler, T.W., Justice, A.E., Graff, M., The influence of age and sex on genetic associations with adult body size and shape: A large-scale genome-wide interaction study (2015) PLoS Genet, 11. , e1005378; Elks, C.E., Loos, R.J.F., Hardy, R., Adult obesity susceptibility variants are associated with greater childhood weight gain and a faster tempo of growth: The 1946 British Birth Cohort Study (2012) Am J Clin Nutr, 95 (5), pp. 1150-1156; Bowden, J., Davey Smith, G., Burgess, S., Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression (2015) Int J Epidemiol, 44 (2), pp. 512-525; Verbanck, M., Chen, C.-Y., Neale, B., Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases (2018) Nat Genet, 50, pp. 693-698; Burgess, S., Thompson, S.G., Multivariable Mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects (2015) Am J Epidemiol, 181, pp. 251-260; The multiple sclerosis genomic map: Role of peripheral immune cells and resident microglia in susceptibility (2017) bioRxiv, , https://www.biorxiv.org/content/10.1101/143933v1; Evangelou, E., Ioannidis, J.P.A., Meta-analysis methods for genome-wide association studies and beyond (2013) Nat Rev Genet, 14 (6), pp. 379-389},
correspondence_address1={Tzoulaki, I.; Department of Hygiene and Epidemiology, Greece; email: i.tzoulaki@imperial.ac.uk},
publisher={SAGE Publications Ltd},
issn={13524585},
pubmed_id={32249718},
language={English},
abbrev_source_title={Mult. Scler. J.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Iwaki201775,
author={Iwaki, H. and Ando, R. and Miyaue, N. and Tada, S. and Tsujii, T. and Yabe, H. and Nishikawa, N. and Nagai, M. and Nomoto, M.},
title={One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan},
journal={Journal of the Neurological Sciences},
year={2017},
volume={383},
pages={75-78},
doi={10.1016/j.jns.2017.10.030},
note={cited By 17},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032296412&doi=10.1016%2fj.jns.2017.10.030&partnerID=40&md5=f525e5f15ceec96a6f369b0efe85959c},
affiliation={Department of Neurology, Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan},
abstract={Background Epidemiological studies have repeatedly reported that increased serum urate level is associated with a slower progress of Parkinson's disease (PD). The urate precursor, inosine, raises the serum urate level and is therefore a candidate for a disease modifying treatment. However, an elevated serum urate level is a risk factor for gout, urolithiasis, and cardiovascular diseases. Although there have been previous clinical studies, the use of inosine in a clinical setting is still limited, and its safety is unclear, especially in an Asian population. Methods We conducted a single-arm, single-center clinical trial to assess the safety of inosine for PD patients with relatively low urate levels. After informed consent, 10 subjects were orally administered inosine to maintain a target urate level between 6.0 mg/dl and 8.0 mg/dl for one year. All adverse effects were recorded and categorized by severity. Also, the efficacy of using inosine to raise the serum urate level was reported. Results We did not observe any adverse events requiring termination or reduction of the study drug, although uric acid crystalluria was transiently observed in a single subject. An inosine dosage of 1070 (SD = 501) mg/day significantly raises the urate level from 3.5 (0.84) mg/dl at baseline to 6.68 (1.11) mg/dl at the 52nd week. Conclusions Inosine was safely used for one year and effectively raised urate levels in a small group of subjects. Our study is the first report to use inosine for patients with PD in an Asian population. © 2017 Elsevier B.V.},
author_keywords={Antioxydant;  Asian;  Clinical trial;  Inosine;  Oxidative stress;  Parkinson's disease;  Urate;  Uric acid},
keywords={creatinine;  inosine;  urate;  uric acid;  antiparkinson agent;  inosine;  uric acid, adult;  Article;  asymptomatic disease;  body weight;  bone cyst;  clinical article;  controlled study;  creatinine urine level;  crystalluria;  disease severity;  dizziness;  drug efficacy;  drug safety;  echography;  electrocardiogram;  evening dosage;  female;  heart rate;  hemorrhoid;  human;  Japanese (people);  male;  morning dosage;  nausea;  overactive bladder;  Parkinson disease;  priority journal;  risk assessment;  tinea pedis;  Unified Parkinson Disease Rating Scale;  uric acid blood level;  urine pH;  aged;  blood;  clinical trial;  dose response;  Japan;  oral drug administration;  Parkinson disease;  treatment outcome, Administration, Oral;  Aged;  Antiparkinson Agents;  Dose-Response Relationship, Drug;  Female;  Humans;  Inosine;  Japan;  Male;  Parkinson Disease;  Treatment Outcome;  Uric Acid},
chemicals_cas={creatinine, 19230-81-0, 60-27-5; inosine, 58-63-9; urate, 1198-77-2, 3106-08-9, 59216-10-3; uric acid, 69-93-2; Antiparkinson Agents; Inosine; Uric Acid},
funding_details={Ehime UniversityEhime University},
funding_text 1={This work was financially supported by a hospital research grant from Ehime University Hospital .},
references={Pringsheim, T., Jette, N., Frolkis, A., Steeves, T.D.L., The prevalence of Parkinson's disease: a systematic review and meta-analysis (2014) Mov. Disord., 29 (13), pp. 1583-1590; Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., Jackson-Lewis, V.R., Oxidative stress and Parkinson's disease (2015) Front. Neuroanat., 9, pp. 1-9. , https://doi.org/10.3389/fnana.2015.00091, July; Kim, G.H., Kim, J.E., Rhie, S.J., Yoon, S., The role of oxidative stress in neurodegenerative diseases (2015) Exp. Neurobiol., 24 (4), pp. 325-340; Schapira, A.H., Mitochondria in the aetiology and pathogenesis of Parkinson's disease (2008) Lancet Neurol., 7 (1), pp. 97-109; Ames, B.N., Cathcart, R., Schwiers, E., Hochstein, P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis (1981) Proc. Natl. Acad. Sci. U. S. A., 78 (11), pp. 6858-6862. , http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=349151&tool=pmcentrez&rendertype=abstract; Kutzing, M., Altered uric acid levels and disease states (2008) J. Pharmacol. Exp., 324 (1), pp. 1-7; Davis, J.W., Grandinetti, A., Waslien, C.I., Ross, G.W., White, L.R., Morens, D.M., Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease (1996) Am. J. Epidemiol., 144 (5), pp. 480-484; de Lau, L.M.L., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., Serum uric acid levels and the risk of Parkinson disease (2005) Ann. Neurol., 58 (5), pp. 797-800; Weisskopf, M.G., O'Reilly, E., Chen, H., Schwarzschild, M.A., Ascherio, A., Plasma urate and risk of Parkinson's disease (2007) Am. J. Epidemiol., 166 (5), pp. 561-567; M a, S., Schwid, S.R., Marek, K., Serum urate as a predictor of clinical and radiographic progression in Parkinson disease (2008) Arch. Neurol., 65 (6), pp. 716-723; Ascherio, A., P a, L., Xu, K., Urate as a predictor of the rate of clinical decline in Parkinson disease (2009) Arch. Neurol., 66 (12), pp. 1460-1468; Facheris, M.F., A a, H., Minelli, C., Variation in the uric acid transporter gene SLC2A9 and its association with AAO of Parkinson's disease (2011) J. Mol. Neurosci., 43 (3), pp. 246-250; Simon, K.C., Eberly, S., Gao, X., Mendelian randomization of serum urate and parkinson disease progression (2014) Ann. Neurol., 76 (6), pp. 862-868; Matsuo, H., Tomiyama, H., Satake, W., ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout (2015) Ann. Clin. Transl. Neurol., 2 (3), pp. 302-306; Clyde, E., Markowitz, M.D., Sergei Spitsin, P.D., Vanessa Zimmerman, M.S.N., Dina Jacobs, M.D., Jayaram, K., Udupa, M.D.D., Hilary Koprowski, M., The treatment of multiple sclerosis with inosine (2009) J. Altern. Complement. Med., 15 (6), p. 609; Tončev, G., Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis (2006) Vojnosanit. Pregl., 63 (10), pp. 879-882; Zuo, T., Liu, X., Jiang, L., Mao, S., Yin, X., Guo, L., Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies (2016) BMC Cardiovasc. Disord., 16 (1), p. 207; Spitsin, S., Hooper, D.C., Leist, T., Streletz, L.J., Mikheeva, T., Koprowskil, H., Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease (2001) Mult. Scler., 7 (5), pp. 313-319. , http://www.ncbi.nlm.nih.gov/pubmed/11724447; Gonsette, R.E., Sindic, C., D'hooghe, M.B., Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon in relapsing- remitting Multiple Sclerosis (ASIIMS) trial (2010) Mult. Scler., 16 (4), pp. 455-462; M a, S., Ascherio, A., Beal, M.F., Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial (2014) JAMA Neurol., 71 (2), pp. 141-150; Muñoz García, D., Midaglia, L., Martinez Vilela, J., Associated inosine to interferon: results of a clinical trial in multiple sclerosis (2015) Acta Neurol. Scand., 131 (6), pp. 405-410; Kanabrocki, E.L., Third, J.L., Ryan, M.D., Circadian relationship of serum uric acid and nitric oxide (2000) JAMA, 283 (17), pp. 2240-2241. , http://www.ncbi.nlm.nih.gov/pubmed/10807381; Mikuls, T.R., Farrar, J.T., Bilker, W.B., Fernandes, S., Schumacher, H.R., Saag, K.G., Gout epidemiology: results from the UK general practice research database, 1990-1999 (2005) Ann. Rheum. Dis., 64 (2), pp. 267-272; Hakoda, M., Recent trends in hyperuricemia and gout in Japan (2012) Jpn. Med. Assoc. J. JMAJ., 55 (4), pp. 319-323. , http://www.ncbi.nlm.nih.gov/pubmed/25237240; Zhang, X., Yang, X., Wang, M., Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis (2016) Rheumatol. Int., 36 (8), pp. 1157-1165; Shekarriz, B., Stoller, M.L., Uric acid nephrolithiasis: current concepts and controversies (2002) J. Urol., 168 (4), pp. 1307-1314. , http://www.ncbi.nlm.nih.gov/pubmed/12352383},
correspondence_address1={Iwaki, H.; Department of Neurology, Shitsukawa, Japan; email: h-iwaki@m.ehime-u.ac.jp},
publisher={Elsevier B.V.},
issn={0022510X},
coden={JNSCA},
pubmed_id={29246629},
language={English},
abbrev_source_title={J. Neurol. Sci.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Hazar2016164,
author={Hazar, N. and Seddigh, L. and Rampisheh, Z. and Nojomi, M.},
title={Population attributable fraction of modifiable risk factors for Alzheimer disease: A systematic review of systematic reviews},
journal={Iran J Neurol},
year={2016},
volume={15},
number={3},
pages={164-172},
note={cited By 17},
source={Scopus},
}

@ARTICLE{Berman2019414,
author={Berman, M.G. and Kardan, O. and Kotabe, H.P. and Nusbaum, H.C. and London, S.E.},
title={The promise of environmental neuroscience},
journal={Nature Human Behaviour},
year={2019},
volume={3},
number={5},
pages={414-417},
doi={10.1038/s41562-019-0577-7},
note={cited By 16},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065813154&doi=10.1038%2fs41562-019-0577-7&partnerID=40&md5=7ece5ef9066059f1730711d6912d7839},
affiliation={The University of Chicago, Department of Psychology, Chicago, IL, United States; The Grossman Institute for Neuroscience, Quantitative Biology and Human Behavior, The University of Chicago, Chicago, IL, United States; The University of Chicago Center for Practical Wisdom, Chicago, IL, United States; Institute for Mind and Biology, The University of Chicago, Chicago, IL, United States},
abstract={The physical and social environment that surrounds us has a profound impact on our brains and behaviour. This impact is so fundamental that a complete understanding of neural mechanisms cannot be developed without taking into account the extensive interactions between neurobiology, psychology, behaviour and the environment. © 2019, Springer Nature Limited.},
keywords={animal;  environment;  human;  neuroscience;  psychology;  social environment, Animals;  Environment;  Humans;  Neurosciences;  Psychology;  Social Environment},
funding_details={National Science FoundationNational Science Foundation, NSF, BCS-1632445},
funding_details={John Templeton FoundationJohn Templeton Foundation, JTF},
funding_details={University of ChicagoUniversity of Chicago},
funding_text 1={Foundation to M.G.B., the John Templeton Foundation grant for the University of Chicago Center for Practical Wisdom to H.C.N., a grant from the National Science Foundation (BCS-1632445) to M.G.B., as well as an internal grant from the University of Chicago to M.G.B. We thank K. Schertz and E. Layden for their help in creating Fig. 1.},
funding_text 2={We dedicate this work in memory of one of M.G.B.’s mentors, Dr. Stephen Kaplan (1936–2018), who inspired a lot of this thinking. This work was supported in part by a grant from the TKF},
references={Markham, J.A., Greenough, W.T., (2004) Neuron Glia Biol., 1, pp. 351-363; Kelly, T.K., Ahmadiantehrani, S., Blattler, A., London, S.E., (2018) Proc. R. Soc. Lond. B, 285, p. 20180160; Berman, M.G., Jonides, J., Kaplan, S., (2008) Psychol. Sci., 19, pp. 1207-1212; Allen, J.G., (2016) Environ. Health Perspect., 124, pp. 805-812. , COI: 1:CAS:528:DC%2BC1cXmsFalu70%3D; Belsky, J., (2009) Mol. Psych., 14, pp. 746-754. , COI: 1:CAS:528:DC%2BD1MXptVCjtLc%3D; Lewin, K., (1936) Principles of Topological Psychology, 4-7. , McGraw-Hill, New York; Bonam, C.M., Bergsieker, H.B., Eberhardt, J.L., (2016) J. Exp. Psychol. Gen., 145, pp. 1561-1582; Kotabe, H.P., Kardan, O., Berman, M.G., (2016) J. Exp. Psychol. Gen., 145, pp. 1713-1727; Hagerhall, C.M., (2015) Nonlinear Dyn. Psychol. Life Sci., 19, pp. 1-12. , COI: 1:STN:280:DC%2BC2Mvls1Oltg%3D%3D; Calhoun, J.B., Population density and social pathology (1962) Sci. Am., 306, pp. 139-148; Zénon, A., Solopchuk, O., Pezzulo, G., (2019) Neuropsychologia, 123, pp. 5-18; Essex, M.J., (2013) Child Dev., 84, pp. 58-75},
correspondence_address1={Berman, M.G.; The University of Chicago, United States; email: bermanm@uchicago.edu},
publisher={Nature Publishing Group},
issn={23973374},
pubmed_id={31089299},
language={English},
abbrev_source_title={Nat. Hum. Behav.},
document_type={Note},
source={Scopus},
}

@ARTICLE{Lahiri2016373,
author={Lahiri, D.K. and Maloney, B. and Bayon, B.L. and Chopra, N. and White, F.A. and Greig, N.H. and Nurnberger, J.I.},
title={Transgenerational latent early-life associated regulation unites environment and genetics across generations},
journal={Epigenomics},
year={2016},
volume={8},
number={3},
pages={373-387},
doi={10.2217/epi.15.117},
note={cited By 16},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962505635&doi=10.2217%2fepi.15.117&partnerID=40&md5=b6afadc865373befbc53248cd88d85ea},
affiliation={Department of Psychiatry, Stark Neurosciences Research Institute, Indiana University, 320 West 15th Street, Indianapolis, IN  46202, United States; Department of Medical and Molecular Genetics, Indiana University, School of Medicine, 320 West 15th Street, Indianapolis, IN  46202, United States; Department of Anesthesia, Stark Neurosciences Research Institute, Indiana University, 320 West 15th Street, Indianapolis, IN  46202, United States; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD  21224, United States},
abstract={The origin of idiopathic diseases is still poorly understood. The latent early-life associated regulation (LEARn) model unites environmental exposures and gene expression while providing a mechanistic underpinning for later-occurring disorders. We propose that this process can occur across generations via transgenerational LEARn (tLEARn). In tLEARn, each person is a 'unit' accumulating preclinical or subclinical 'hits' as in the original LEARn model. These changes can then be epigenomically passed along to offspring. Transgenerational accumulation of 'hits' determines a sporadic disease state. Few significant transgenerational hits would accompany conception or gestation of most people, but these may suffice to 'prime' someone to respond to later-life hits. Hits need not produce symptoms or microphenotypes to have a transgenerational effect. Testing tLEARn requires longitudinal approaches. A recently proposed longitudinal epigenome/envirome-wide association study would unite genetic sequence, epigenomic markers, environmental exposures, patient personal history taken at multiple time points and family history. © 2016 Future Medicine Ltd.},
author_keywords={aging;  childhood;  development;  epigenetics;  experiences;  insult;  intergenerational;  late life;  neurodegenerative;  nutrition;  post traumatic},
keywords={Article;  environmental exposure;  epigenetics;  family history;  gene expression;  gene sequence;  genetic association;  genetic model;  genetic trait;  genetic variability;  human;  idiopathic disease;  latent early life associated regulation model;  molecular pathology;  priority journal;  Alzheimer disease;  animal;  biological model;  epigenetics;  female;  gene dosage;  gene expression regulation;  genetic epigenesis;  genetic variation;  genetics;  genotype environment interaction;  male;  maternal exposure;  Parkinson disease;  pregnancy;  schizophrenia, Alzheimer Disease;  Animals;  Epigenesis, Genetic;  Epigenomics;  Female;  Gene Dosage;  Gene Expression Regulation, Developmental;  Gene-Environment Interaction;  Genetic Variation;  Humans;  Male;  Maternal Exposure;  Models, Biological;  Parkinson Disease;  Pregnancy;  Schizophrenia},
funding_details={P30 AG010133},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={National Institute on AgingNational Institute on Aging, NIA, P30AG010133, R01AG051086, R21AG042804, ZIAAG000311},
funding_details={National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, R01DK100905},
funding_details={Purdue UniversityPurdue University},
funding_details={Indiana Clinical and Translational Sciences InstituteIndiana Clinical and Translational Sciences Institute, CTSI},
funding_details={Brain Injury Research CenterBrain Injury Research Center, BIRC},
funding_text 1={The work was supported by grants from the National Institute on Aging, NIH R01-AG051086 and R21-AG042804; and Indiana Clinical &amp; Translational Sciences Institute (ICTSI) and Indiana Spinal Cord and Brain Injury Research Fund (ISCBIRF); P30 AG010133 Indiana Alzheimer Disease Research Center, and R21 sub-award from Purdue University to DK Lahiri. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.},
references={Argmann, C.A., Edwards, J.Y., Sawyez, C.G., Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: A role for RhoA in ABCA1-mediated cholesterol efflux (2005) J. Biol. Chem, 280 (23), pp. 22212-22221; Nurnberger, J.I., Jr., Koller, D.L., Jung, J., Identification of pathways for bipolar disorder: A meta-analysis (2014) JAMA Psychiatry, 71 (6), pp. 657-664; Samocha, K.E., Robinson, E.B., Sanders, S.J., A framework for the interpretation of de novo mutation in human disease (2014) Nat. Genet, 46 (9), pp. 944-950; Rauch, A., Wieczorek, D., Graf, E., Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study (2012) Lancet, 380 (9854), pp. 1674-1682; Gershon, E.S., Alliey-Rodriguez, N., New ethical issues for genetic counseling in common mental disorders (2013) Am. J. Psychiatry, 170 (9), pp. 968-976; Song, C., Kanthasamy, A., Anantharam, V., Sun, F., Kanthasamy, A.G., Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: Relevance to epigenetic mechanisms of neurodegeneration (2010) Mol. Pharmacol, 77 (4), pp. 621-632; Bahari-Javan, S., Sananbenesi, F., Fischer, A., Histoneacetylation: A link between Alzheimer's disease and posttraumatic stress disorder? (2014) Front. Neurosci, 8, p. 160; Veitch, D.P., Friedl, K.E., Weiner, M.W., Military risk factors for cognitive decline, dementia and Alzheimer's disease (2013) Curr. Alzheimer Res, 10 (9), pp. 907-930; Turecki, G., Meaney, M.J., Effects of the social environment and stress on glucocorticoid receptor gene methylation: A systematic review (2016) Biol. Psychiatry, 79 (2), pp. 87-96; Schmitt, A., Malchow, B., Hasan, A., Falkai, P., The impact of environmental factors in severe psychiatric disorders (2014) Front. Neurosci, 8, p. 19; Abdolmaleky, H.M., Smith, C.L., Faraone, S.V., Methylomics in psychiatry: Modulation of geneenvironment interactions may be through DNA methylation (2004) Am J. Med. Genet. B Neuropsychiatr. Genet., 127 B (1), pp. 51-59; Biological insights from 108 schizophrenia-associated genetic loci (2014) Nature, 511 (7510), pp. 421-427; 2014 Alzheimer's disease facts and figures (2014) Alzheimers Dement, 10 (2), pp. e47-e92; Narayan, P.J., Lill, C., Faull, R., Ma, C., Dragunow, M., Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain (2015) Neurobiol. Dis, 74, pp. 281-294; Wang, B.Y., Zhong, Y., Zhao, Z., Miao, Y., Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils (2014) Pharmacol. Biochem. Behav, 126, pp. 83-89; Maloney, B., Lahiri, D.K., Epigenetics of dementias: Seeing dementia as a transformation rather than a condition (2016) Lancet Neurol, , In press; Feng, Y., Jankovic, J., Wu, Y.C., Epigenetic mechanisms in Parkinson's disease (2015) J. Neurol. Sci, 349 (1-2), pp. 3-9; Pihlstrom, L., Berge, V., Rengmark, A., Toft, M., Parkinson's disease correlates with promoter methylation in the alphasynuclein gene (2015) Mov. Disord, 30 (4), pp. 577-580; Haghighi, F., Xin, Y., Chanrion, B., Increased DNA methylation in the suicide brain (2014) Dialogues ClinNeurosci, 16 (3), pp. 430-438; Dempster, E.L., Wong, C.C., Lester, K.J., Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression (2014) Biol. Psychiatry, 76 (12), pp. 977-983; McGowan, P.O., Sasaki, A., Huang, T.C., Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain (2008) PLoS ONE, 3 (5), p. e2085; Zhu, L., Wang, X., Li, X.L., Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders (2014) Hum Mol. Genet, 23 (6), pp. 1563-1578; Ladd-Acosta, C., Hansen, K.D., Briem, E., Fallin, M.D., Kaufmann, W.E., Feinberg, A.P., Common DNA methylation alterations in multiple brain regions in autism (2013) Mol. Psychiatry, 19 (8), pp. 862-871; Wong, C.C., Meaburn, E.L., Ronald, A., Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits (2013) Mol. Psychiatry, 19 (4), pp. 495-503; Siniscalco, D., Cirillo, A., Bradstreet, J.J., Antonucci, N., Epigenetic findings in autism: New perspectives for therapy (2013) Int. J. Environ. Res. Public Health, 10 (9), pp. 4261-4273; Alanazi, A.S., The role of nutraceuticals in the management of autism (2013) Saudi Pharm. J., 21 (3), pp. 233-243; Yasuda, H., Tsutsui, T., Assessment of infantile mineral imbalances in autism spectrum disorders (ASDs) (2013) Int. J. Environ. Res. Public Health, 10 (11), pp. 6027-6043; Mastroeni, D., McKee, A., Grover, A., Rogers, J., Coleman, P.D., Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease (2009) PLoS ONE, 4 (8), p. e6617; Chouliaras, L., Mastroeni, D., Delvaux, E., Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients (2013) Neurobiol. Aging, 34 (9), pp. 2091-2099; Kaminsky, Z., Jones, I., Verma, R., DNA methylation and expression of KCNQ3 in bipolar disorder (2015) Bipolar Disord, 17 (2), pp. 150-159; Guidotti, A., Grayson, D.R., DNA methylation and demethylation as targets for antipsychotic therapy (2014) Dialogues Clin. Neurosci, 16 (3), pp. 419-429; Li, Y., Camarillo, C., Xu, J., Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder (2015) Bio. Med Res. Int, 2015, p. 201587; Kundakovic, M., Gudsnuk, K., Herbstman, J.B., Tang, D., Perera, F.P., Champagne, F.A., DNA methylation of BDNF as a biomarker of early-life adversity (2014) Proc. Natl Acad. Sci. USA, 112 (22), pp. 6807-6813; Dell'osso, B., D'Addario, C., Carlotta Palazzo, M., Epigenetic modulation of BDNF gene: Differences in DNA methylation between unipolar and bipolar patients (2014) J Affect. Disord, 166, pp. 330-333; Kouzarides, T., Chromatin modifications and their function (2007) Cell, 128 (4), pp. 693-705; Baltazar, M.T., Dinis-Oliveira, R.J., De Lourdes Bastos, M., Tsatsakis, A.M., Duarte, J.A., Carvalho, F., Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases: A mechanistic approach (2014) Toxicol. Lett, 230 (2), pp. 85-103; Song, C., Kanthasamy, A., Jin, H., Anantharam, V., Kanthasamy, A.G., Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration (2011) Neurotoxicology, 32 (5), pp. 586-595; Kanthasamy, A., Jin, H., Anantharam, V., Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration (2012) Neurotoxicology, 33 (4), pp. 833-837; Jin, H., Kanthasamy, A., Harischandra, D.S., Histone hyperacetylation up-regulates protein kinase C delta in dopaminergic neurons to induce cell death: Relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease (2014) J. Biol. Chem, 289 (50), pp. 34743-34767; Covington, H.E., III, Maze, I., Vialou, V., Nestler, E.J., Antidepressant action of HDAC inhibition in the prefrontal cortex (2015) Neuroscience, 298, pp. 329-335; Walker, D.M., Cates, H.M., Heller, E.A., Nestler, E.J., Regulation of chromatin states by drugs of abuse (2015) Curr. Opin. Neurobiol, 30, pp. 112-121; D'Onofrio, B.M., Rickert, M.E., Frans, E., Paternal age at childbearing and offspring psychiatric and academic morbidity (2014) JAMA Psychiatry, 71 (4), pp. 432-438; Jenkins, T.G., Aston, K.I., Pflueger, C., Cairns, B.R., Carrell, D.T., Age-associated sperm DNA methylation alterations: Possible implications in offspring disease susceptibility (2014) PLoS Genet, 10 (7), p. e1004458; Wang, S.H., Liu, C.M., Hwu, H.G., Hsiao, C.K., Chen, W.J., Association of older paternal age with earlier onset among coaffected schizophrenia sib-pairs (2015) Psychol. Med, , Epub ahead of print; Bell, C.G., Beck, S., The epigenomic interface between genome and environment in common complex diseases (2010) Brief. Funct. Genomics, 9, pp. 477-485; Migliore, L., Coppede, F., Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases (2009) Mutat. Res, 667 (1-2), pp. 82-97; Trollope, A.F., Gutierrez-Mecinas, M., Mifsud, K.R., Collins, A., Saunderson, E.A., Reul, J.M., Stress, epigenetic control of gene expression and memory formation (2012) Exp. Neurol, 233 (1), pp. 3-11; Long, J.M., Lahiri, D.K., Current drug targets for modulating Alzheimer's amyloid precursor protein: Role of specific micro-RNA species (2011) Curr. Med. Chem, 18 (22), pp. 3314-3321; Bao, N., Lye, K.W., Barton, M.K., MicroRNA binding sites in Arabidopsis class III HD-ZIP mRNAs are required for methylation of the template chromosome (2004) Dev. Cell, 7 (5), pp. 653-662; Tuddenham, L., Wheeler, G., Ntounia-Fousara, S., The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells (2006) FEBS Lett, 580 (17), pp. 4214-4217; Asada, K., Nakajima, T., Shimazu, T., Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study (2015) Gut, 64 (3), pp. 388-396; Szulwach, K.E., Li, X., Smrt, R.D., Cross talk between microRNA and epigenetic regulation in adult neurogenesis (2010) J. Cell Biol, 189 (1), pp. 127-141; Cimmino, L., Abdel-Wahab, O., Levine, R.L., Aifantis, I., TET family proteins and their role in stem cell differentiation and transformation (2011) Cell Stem Cell, 9 (3), pp. 193-204; Fabbri, M., Garzon, R., Cimmino, A., MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B (2007) Proc. Natl Acad. Sci. USA, 104 (40), pp. 15805-15810; Long, L.M., He, B.F., Huang, G.Q., Guo, Y.H., Liu, Y.S., Huo, J.R., MicroRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2 (2015) Oncol. Lett, 9 (2), pp. 645-650; Izzotti, A., Calin, G.A., Arrigo, P., Steele, V.E., Croce, C.M., De Flora, S., Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke (2009) FASEB J., 23 (3), pp. 806-812; Radom-Aizik, S., Zaldivar, F., Jr., Oliver, S., Galassetti, P., Cooper, D.M., Evidence for microRNA involvement in exerciseassociated neutrophil gene expression changes (2010) J. Appl. Physiol (1985), 109 (1), pp. 252-261; Bollati, V., Marinelli, B., Apostoli, P., Exposure to metalrich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes (2010) Environ. Health Perspect, 118 (6), pp. 763-768; Tang, X., Wen, S., Zheng, D., Acetylation of drosha on the N-Terminus inhibits its degradation by ubiquitination (2013) PLoS ONE, 8 (8), p. e72503; Liu, Y., Studzinski, C., Beckett, T., Murphy, M.P., Klein, R.L., Hersh, L.B., Circulating neprilysin clears brain amyloid (2010) Mol. Cell. Neurosci, 45 (2), pp. 101-107; Koumangoye, R.B., Andl, T., Taubenslag, K.J., SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells (2015) Mol. Cancer, 14, p. 24; Hwang, J.Y., Kaneko, N., Noh, K.M., Pontarelli, F., Zukin, R.S., The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die (2014) J. Mol. Biol, 426 (20), pp. 3454-3466; Lahiri, D.K., Maloney, B., Zawia, N.H., The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases (2009) Mol. Psychiatry, 14 (11), pp. 992-1003; Maloney, B., Sambamurti, K., Zawia, N., Lahiri, D.K., Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model (2012) Curr. Alzheimer Res, 9 (5), pp. 589-599; Vassiliev, O.N., Formulation of the multi-hit model with a non-Poisson distribution of hits (2012) Int. J. Radiat. Oncol. Biol. Phys, 83 (4), pp. 1311-1316; Teixeira, A.P., Dias, J.M., Carinhas, N., Cell functional enviromics: Unravelling the function of environmental factors (2011) BMC Syst. Biol, 5, p. 92; Lahiri, D.K., Maloney, B., Gene x environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS) (2012) Epigenomics, 4 (6), pp. 685-699; Wild, C.P., Complementing the genome with an "exposome" the outstanding challenge of environmental exposure measurement in molecular epidemiology (2005) Cancer Epidemiol. Biomarkers Prev, 14 (8), pp. 1847-1850; Coley, R.L., Carrano, J., Lewin-Bizan, S., Unpacking links between fathers' antisocial behaviors and children's behavior problems: Direct, indirect, and interactive effects (2011) J. Abnorm. Child Psychol., 39 (6), pp. 791-804; Saile, R., Ertl, V., Neuner, F., Catani, C., Does war contribute to family violence against children? Findings from a twogenerational multi-informant study in Northern Uganda (2014) Child Abuse Negl, 38 (1), pp. 135-146; Ma, B., Scaramella, L.V., Neppl, T.K., Ontai, L.L., Conger, R.D., Grandmother involvement as a protective factor for early childhood social adjustment (2010) J. Fam. Psychol, 24 (5), pp. 635-645; Jaffee, S.R., Bowes, L., Ouellet-Morin, I., Safe, stable, nurturing relationships break the intergenerational cycle of abuse: A prospective nationally representative cohort of children in the United Kingdom (2013) J. Adolesc. Health, 53, pp. S4-S10; Conger, R.D., Schofield, T.J., Neppl, T.K., Merrick, M.T., Disrupting intergenerational continuity in harsh and abusive parenting: The importance of a nurturing relationship with a romantic partner (2013) J. Adolesc. Health, 53, pp. S11-S17; Farrugia, D., Exploring stigma: Medical knowledge and the stigmatisation of parents of children diagnosed with autism spectrum disorder (2009) Sociol. Health Illn, 31 (7), pp. 1011-1027; Lidsky, T.I., Is the aluminum hypothesis dead? (2014) J. Occup. Environ. Med, 56, pp. S73-S79; Seeman, M.V., The changing role of mother of the mentally ill: From schizophrenogenic mother to multigenerational caregiver (2009) Psychiatry, 72 (3), pp. 284-294; Pentinat, T., Ramon-Krauel, M., Cebria, J., Diaz, R., Jimenez-Chillaron, J.C., Transgenerational inheritance of glucose intolerance in a mouse model of neonatal overnutrition (2010) Endocrinology, 151 (12), pp. 5617-5623; Ng, S.F., Lin, R.C., Maloney, C.A., Youngson, N.A., Owens, J.A., Morris, M.J., Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring (2014) FASEB J., 28 (4), pp. 1830-1841; Carone, B.R., Fauquier, L., Habib, N., Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals (2010) Cell, 143 (7), pp. 1084-1096; Crews, D., Gillette, R., Scarpino, S.V., Manikkam, M., Savenkova, M.I., Skinner, M.K., Epigenetic transgenerational inheritance of altered stress responses (2012) Proc. Natl Acad. Sci. USA, 109 (23), pp. 9143-9148; Matthews, S.G., Phillips, D.I., Transgenerational inheritance of stress pathology (2012) Exp. Neurol, 233 (1), pp. 95-101; Bohacek, J., Gapp, K., Saab, B.J., Mansuy, I.M., Transgenerational epigenetic effects on brain functions (2013) Biol. Psychiatry, 73 (4), pp. 313-320; Bohacek, J., Mansuy, I.M., Epigenetic inheritance of disease and disease risk (2013) Neuropsychopharmacology, 38 (1), pp. 220-236; Jiang, Y.H., Sahoo, T., Michaelis, R.C., A mixed epigenetic/ genetic model for oligogenic inheritance of autism with a limited role for UBE3A (2004) Am. J. Med. Genet, A131 (1), pp. 1-10; Saab, B.J., Mansuy, I.M., Neurobiological disease etiology and inheritance: An epigenetic perspective (2014) J. Exp. Biol, 217, pp. 94-101. , Pt1; Dias, B.G., Ressler, K.J., Parental olfactory experience influences behavior and neural structure in subsequent generations (2014) Nat. Neurosci, 17 (1), pp. 89-96; Lambrot, R., Xu, C., Saint-Phar, S., Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes (2013) Nat. Commun, 4, p. 2889; Mcgrath, J.J., Petersen, L., Agerbo, E., Mors, O., Mortensen, P.B., Pedersen, C.B., A comprehensive assessment of parental age and psychiatric disorders (2014) JAMA Psychiatry, 71 (3), pp. 301-309; Sampino, S., Juszczak, G.R., Zacchini, F., Grand-paternal age and the development of autism-like symptoms in mice progeny (2014) Transl. Psychiatry, 4, p. e386; Suren, P., Gunnes, N., Roth, C., Parental obesity and risk of autism spectrum disorder (2014) Pediatrics, 133 (5), pp. e1128-e1138; Bygren, L.O., Intergenerational health responses to adverse and enriched environments (2013) Annu. Rev. Public Health, 34, pp. 49-60; Lehrner, A., Bierer, L.M., Passarelli, V., Maternal PTSD associates with greater glucocorticoid sensitivity in offspring of Holocaust survivors (2014) Psychoneuroendocrinology, 40, pp. 213-220; Laffita-Mesa, J.M., Bauer, P.O., Kouri, V., Epigenetics DNA methylation in the core ataxin-2 gene promoter: Novel physiological and pathological implications (2012) Hum. Genet, 131 (4), pp. 625-638; Milosch, N., Tanriover, G., Kundu, A., Holo-APP and G-protein-mediated signaling are required for sAPPalphainduced activation of the Akt survival pathway (2014) Cell Death Dis, 5, p. e1391; Corrigan, F., Vink, R., Blumbergs, P.C., Masters, C.L., Cappai, R., Van Den Heuvel, C., Evaluation of the effects of treatment with sAPPalpha on functional and histological outcome following controlled cortical impact injury in mice (2012) Neurosci. Lett, 515 (1), pp. 50-54; Lahiri, D.K., Sokol, D.K., Erickson, C., Ray, B., Ho, C.Y., Maloney, B., Autism as early neurodevelopmental disorder: Evidence for an sAPPalpha-mediated anabolic pathway (2013) Front. Cell. Neurosci, 7, p. 94; Ray, B., Long, J.M., Sokol, D.K., Lahiri, D.K., Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: Proposal of a specific, anabolic pathway and putative biomarker (2011) PLoS ONE, 6 (6), p. e20405; Sokol, D.K., Chen, D., Farlow, M.R., High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression (2006) J. Child Neurol, 21 (6), pp. 444-449; Anway, M.D., Cupp, A.S., Uzumcu, M., Skinner, M.K., Epigenetic transgenerational actions of endocrine disruptors and male fertility (2005) Science, 308 (5727), pp. 1466-1469; Clement, T.M., Savenkova, M.I., Settles, M., Anway, M.D., Skinner, M.K., Alterations in the developing testis transcriptome following embryonic vinclozolin exposure (2010) Reprod. Toxicol, 30 (3), pp. 353-364; Schneider, S., Kaufmann, W., Buesen, R., Van Ravenzwaay, B., Vinclozolin - The lack of a transgenerational effect after oral maternal exposure during organogenesis (2008) Reprod. Toxicol, 25 (3), pp. 352-360; Vassoler, F.M., Sadri-Vakili, G., Mechanisms of transgenerational inheritance of addictive-like behaviors (2014) Neuroscience, 264, pp. 198-206; Vassoler, F.M., White, S.L., Schmidt, H.D., Sadri-Vakili, G., Pierce, R.C., Epigenetic inheritance of a cocaine-resistance phenotype (2013) Nat. Neurosci, 16 (1), pp. 42-47; Sadri-Vakili, G., Kumaresan, V., Schmidt, H.D., Cocaineinduced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine (2010) J. Neurosci, 30 (35), pp. 11735-11744; He, F., Lidow, I.A., Lidow, M.S., Consequences of paternal cocaine exposure in mice (2006) Neurotoxicol. Teratol, 28 (2), pp. 198-209; Stegemann, R., Buchner, D.A., Transgenerational inheritance of metabolic disease (2015) Semin. Cell Dev. Biol, 43, pp. 131-140; Drake, A.J., Liu, L., Intergenerational transmission of programmed effects: Public health consequences (2010) Trends Endocrinol. Metab, 21 (4), pp. 206-213; Raciti, G.A., Longo, M., Parrillo, L., Understanding Type 2 diabetes: From genetics to epigenetics (2015) Acta Diabetol, 52 (5), pp. 821-827; Plagemann, A., Harder, T., Brunn, M., Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: An epigenetic model of obesity and the metabolic syndrome (2009) J. Physiol, 587 (20), pp. 4963-4976; Franklin, T.B., Linder, N., Russig, H., Thony, B., Mansuy, I.M., Influence of early stress on social abilities and serotonergic functions across generations in mice (2011) PLoS ONE, 6 (7), p. e21842; Morgan, C.P., Bale, T.L., Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage (2011) J. Neurosci, 31 (33), pp. 11748-11755; Dietz, D.M., Laplant, Q., Watts, E.L., Paternal transmission of stress-induced pathologies (2011) Biol. Psychiatry, 70 (5), pp. 408-414; Champagne, F.A., Early environments, glucocorticoid receptors, and behavioral epigenetics (2013) Behav. Neurosci, 127 (5), pp. 628-636; Desai, M., Jellyman, J.K., Ross, M.G., Epigenomics, gestational programming and risk of metabolic syndrome (2015) Int. J. Obes. (Lond.), 39 (4), pp. 633-641; Heijmans, B.T., Tobi, E.W., Stein, A.D., Persistent epigenetic differences associated with prenatal exposure to famine in humans (2008) Proc. Natl Acad. Sci. USA, 105 (44), pp. 17046-17049; Tobi, E.W., Lumey, L.H., Talens, R.P., DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific (2009) Hum. Mol. Genet, 18 (21), pp. 4046-4053; Veenendaal, M.V., Painter, R.C., De Rooij, S.R., Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine (2013) BJOG, 120 (5), pp. 548-553; Dolinoy, D.C., Huang, D., Jirtle, R.L., Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development (2007) Proc. Natl Acad. Sci. USA, 104 (32), pp. 13056-13061; Branchi, I., Karpova, N.N., D'Andrea, I., Castren, E., Alleva, E., Epigenetic modifications induced by early enrichment are associated with changes in timing of induction of BDNF expression (2011) Neurosci. Lett, 495 (3), pp. 168-172; Vucetic, Z., Kimmel, J., Reyes, T.M., Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain (2011) Neuropsychopharmacology, 36 (6), pp. 1199-1206; Jirtle, R.L., Skinner, M.K., Environmental epigenomics and disease susceptibility (2007) Nat. Rev. Genet, 8 (4), pp. 253-262; Heindel, J.J., Mcallister, K.A., Worth, L., Jr., Tyson, F.L., Environmental epigenomics, imprinting and disease susceptibility (2006) Epigenetics, 1 (1), pp. 1-6; Sacco, A., Issa, G.C., Zhang, Y., Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology (2010) J. Hematol. Oncol, 3 (1), p. 38; (2008), 454 (7205), pp. 711-715. , Union, Network of Excellence, Scientific Advisory Board. Moving AHEAD with an international human epigenome project. Nature; Brena, R.M., Huang, T.H., Plass, C., Toward a human epigenome (2006) Nat. Genet, 38 (12), pp. 1359-1360; Yu, L., Chibnik, L.B., Srivastava, G.P., Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease (2015) JAMA Neurol, 72 (1), pp. 15-24; Marioni, R.E., Shah, S., Mcrae, A.F., The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936 (2015) Int. J. Epidemiol, 44 (4), pp. 1388-1396; Exalto, L.G., Van Der Flier, W.M., Van Boheemen, C.J., The metabolic syndrome in a memory clinic population: Relation with clinical profile and prognosis (2015) J. Neurol. Sci, 351 (1-2), pp. 18-23; Marioni, R.E., Shah, S., McRae, A.F., DNA methylation age of blood predicts all-cause mortality in later life (2015) Genome Biol, 16, p. 25; Reetz, K., Dogan, I., Costa, A.S., Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data (2015) Lancet Neurol, 14 (2), pp. 174-182; Abbruzzese, G., Barone, P., Ceravolo, R., Clinical variables associated with treatment changes in Parkinson's disease: Results from the longitudinal phase of the REASON study (2015) Neurol. Sci, 36 (6), pp. 935-943; Helles, A., Gillberg, C.I., Gillberg, C., Billstedt, E., Asperger syndrome in males over two decades: Stability and predictors of diagnosis (2015) J. Child Psychol. Psychiatry, 56 (6), pp. 711-718; Woodman, A.C., Smith, L.E., Greenberg, J.S., Mailick, M.R., Change in autism symptoms and maladaptive behaviors in adolescence and adulthood: The role of positive family processes (2015) J. Autism Dev. Disord, 45 (1), pp. 111-126; Hernandez, R.N., Feinberg, R.L., Vaurio, R., Passanante, N.M., Thompson, R.E., Kaufmann, W.E., Autism spectrum disorder in fragile X syndrome: A longitudinal evaluation (2009) Am. J. Med. Genet. A 149A, 6, pp. 1125-1137; Ma, S., Merranko, J.A., Goldstein, T.R., The longitudinal course of sleep timing and circadian preferences in adults with bipolar disorder (2015) Bipolar Disord, 17 (4), pp. 392-402; Nurnberger, J.I., Jr., Mcinnis, M., Reich, W., A high-risk study of bipolar disorder Childhood clinical phenotypes as precursors of major mood disorders (2011) Arch. Gen. Psychiatry, 68 (10), pp. 1012-1020; Savill, M., Banks, C., Khanom, H., Priebe, S., Do negative symptoms of schizophrenia change over time?. A meta-analysis of longitudinal data (2015) Psychol. Med, 45 (8), pp. 1613-1627; Ferguson, C.J., Is psychological research really as good as medical research? Effect size comparisons between psychology and medicine (2009) Rev. Gen. Psychol, 13 (2), pp. 130-136; Perry, C., Mackay-Sim, A., Feron, F., Mcgrath, J., Olfactory neural cells: An untapped diagnostic and therapeutic resource (2002) The 2000 Ogura Lecture. Laryngoscope, 112 (4), pp. 603-607; Chan, A., Shea, T.B., Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress (2006) J. Alzheimers Dis, 10 (4), pp. 353-358; Rogers, E.J., Milhalik, S., Orthiz, D., Shea, T.B., Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice (2004) J. Nutr. Health Aging, 8 (2), pp. 92-97; De Palma, G., Blennerhassett, P., Lu, J., Microbiota and host determinants of behaviouralphenotype in maternally separated mice (2015) Nat.Commun, 6, p. 7735},
correspondence_address1={Lahiri, D.K.; Department of Psychiatry, 320 West 15th Street, United States; email: dlahiri@iupui.edu},
publisher={Future Medicine Ltd.},
issn={17501911},
pubmed_id={26950428},
language={English},
abbrev_source_title={Epigenomics},
document_type={Article},
source={Scopus},
}

@ARTICLE{Romer20213839,
author={Romer, A.L. and Knodt, A.R. and Sison, M.L. and Ireland, D. and Houts, R. and Ramrakha, S. and Poulton, R. and Keenan, R. and Melzer, T.R. and Moffitt, T.E. and Caspi, A. and Hariri, A.R.},
title={Replicability of structural brain alterations associated with general psychopathology: evidence from a population-representative birth cohort},
journal={Molecular Psychiatry},
year={2021},
volume={26},
number={8},
pages={3839-3846},
doi={10.1038/s41380-019-0621-z},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075913866&doi=10.1038%2fs41380-019-0621-z&partnerID=40&md5=4973d37a12d3f034eaac9fee1ecf49c7},
affiliation={Laboratory of NeuroGenetics, Duke University, Durham, NC, United States; Department of Psychology & Neuroscience, Duke University, Durham, NC, United States; Dunedin Multidisciplinary Health and Development Research Unit, Department of Psychology, University of Otago, Dunedin, New Zealand; Christchurch Radiology Group, Christchurch, New Zealand; Department of Medicine, University of Otago, Christchurch, New Zealand; New Zealand Brain Research Institute, Christchurch, New Zealand; Department of Psychiatry & Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States; Center for Genomic and Computational Biology, Duke University, Durham, NC, United States; Social, Genetic, and Developmental Psychiatry Research Center, Institute of Psychiatry, Psychology & Neuroscience, King’s College, London, United Kingdom},
abstract={Transdiagnostic research has identified a general psychopathology factor—often called the ‘p’ factor—that accounts for shared variation across internalizing, externalizing, and thought disorders in diverse samples. It has been argued that the p factor may reflect dysfunctional thinking present in serious mental illness. In support of this, we previously used a theory-free, data-driven multimodal neuroimaging approach to find that higher p factor scores are associated with structural alterations within a cerebello-thalamo-cortical circuit (CTCC) and visual association cortex, both of which are important for monitoring and coordinating information processing in the service of executive control. Here we attempt to replicate these associations by conducting region-of-interest analyses using data from 875 members of the Dunedin Longitudinal Study, a five-decade study of a population-representative birth cohort, collected when they were 45 years old. We further sought to replicate a more recent report that p factor scores can be predicted by patterns of distributed cerebellar morphology as estimated through independent component analysis. We successfully replicated associations between higher p factor scores and both reduced gray matter volume of the visual association cortex and fractional anisotropy of pontine white matter pathways within the CTCC. In contrast, we failed to replicate prior associations between cerebellar structure and p factor scores. Collectively, our findings encourage further focus on the CTCC and visual association cortex as core neural substrates and potential biomarkers of general psychopathology. © 2019, The Author(s).},
keywords={adolescent;  adult;  Article;  brain;  brain atrophy;  brain disease;  brain size;  cerebello thalamo cortical circuit;  child;  cohort analysis;  disease association;  executive function;  female;  gray matter;  human;  major clinical study;  male;  mental disease;  middle aged;  multimodal imaging;  neuroimaging;  newborn;  preschool child;  school child;  visual cortex;  white matter;  diagnostic imaging;  longitudinal study;  white matter, Birth Cohort;  Brain;  Humans;  Longitudinal Studies;  Mental Disorders;  Middle Aged;  Psychopathology;  White Matter},
funding_details={National Science FoundationNational Science Foundation, NSF, 1106401},
funding_details={National Institutes of HealthNational Institutes of Health, NIH, F32CA005918},
funding_details={National Institute on AgingNational Institute on Aging, NIA, R01AG032282, R01AG049789},
funding_details={Humanities Research Center, Rice UniversityHumanities Research Center, Rice University, HRC},
funding_details={Alliance for Lupus ResearchAlliance for Lupus Research, ALR},
funding_details={Medical Research CouncilMedical Research Council, MRC, MR/P005918/1},
funding_details={Research Councils UKResearch Councils UK, RCUK},
funding_details={Health Research Council of New ZealandHealth Research Council of New Zealand, HRC},
funding_details={Ministry of Business, Innovation and EmploymentMinistry of Business, Innovation and Employment, MBIE},
funding_details={Jacobs FoundationJacobs Foundation},
funding_details={Ministry for Business Innovation and EmploymentMinistry for Business Innovation and Employment, MBIE},
funding_text 1={Acknowledgements The Dunedin Multidisciplinary Health and Development Study is supported by the NZ HRC and NZ MBIE. This research was supported by National Institute on Aging grant R01AG032282, R01AG049789, and UK Medical Research Council grant MR/P005918/1. Additional support was provided by the Jacobs Foundation. ALR received support from the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1106401. Thank you to members of the Advisory Board for the Dunedin Neu-roimaging Study. We thank the Dunedin Study members, unit research staff, Pacific Radiology staff, and Study founder Phil Silva.},
references={Lahey, B.B., Krueger, R.F., Rathouz, P.J., Waldman, I.D., Zald, D.H., A hierarchical causal taxonomy of psychopathology across the life span (2017) Psychol Bull, 143, pp. 142-186; Caspi, A., Houts, R.M., Belsky, D.W., Goldman-Mellor, S.J., Harrington, H., Israel, S., The p factor: One general psychopathology factor in the structure of psychiatric disorders? (2014) Clin Psychol Sci J Assoc Psychol Sci, 2, pp. 119-137; Caspi, A., Moffitt, T.E., All for one and one for all: mental disorders in one dimension (2018) Am J Psychiatry, 175, pp. 831-844; Romer, A.L., Knodt, A.R., Houts, R., Brigidi, B.D., Moffitt, T.E., Caspi, A., Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders (2018) Mol Psychiatry, 23, pp. 1084-1090. , COI: 1:STN:280:DC%2BC1cvms1KitA%3D%3D; Buckner, R.L., Krienen, F.M., Castellanos, A., Diaz, J.C., Yeo, B.T.T., The organization of the human cerebellum estimated by intrinsic functional connectivity (2011) J Neurophysiol, 106, pp. 2322-2345; Thomas Yeo, B.T., Krienen, F.M., Sepulcre, J., Sabuncu, M.R., Lashkari, D., Hollinshead, M., The organization of the human cerebral cortex estimated by intrinsic functional connectivity (2011) J Neurophysiol, 106, pp. 1125-1165; Middleton, F.A., Strick, P.L., Cerebellar projections to the prefrontal cortex of the primate (2001) J Neurosci, 21, pp. 700-712. , COI: 1:CAS:528:DC%2BD3MXnslCksg%3D%3D; Buckner, R.L., The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging (2013) Neuron, 80, pp. 807-815. , COI: 1:CAS:528:DC%2BC3sXhslSlsbbF; D’Angelo, E., Casali, S., Seeking a unified framework for cerebellar function and dysfunction: From circuit operations to cognition (2013) Front Neural Circuits, 6. , https://www.frontiersin.org/articles/10.3389/fncir.2012.00116/full#F3; Keren-Happuch, E., Chen, S.-H.A., Ho, M.-H.R., Desmond, J.E., A meta-analysis of cerebellar contributions to higher cognition from PET and fMRI studies (2014) Hum Brain Mapp, 35, pp. 593-615; Marek, S., Siegel, J.S., Gordon, E.M., Raut, R.V., Gratton, C., Newbold, D.J., Spatial and temporal organization of the individual human cerebellum (2018) Neuron, 100, pp. 977-993.e7. , COI: 1:CAS:528:DC%2BC1cXitVWju7bO; Ito, M., Movement and thought: identical control mechanisms by the cerebellum (1993) Trends Neurosci, 16, pp. 448-450. , COI: 1:STN:280:DyaK2c7is12htg%3D%3D; Ito, M., Control of mental activities by internal models in the cerebellum (2008) Nat Rev Neurosci, 9, pp. 304-313. , COI: 1:CAS:528:DC%2BD1cXjsFCks70%3D; Bernard, J.A., Mittal, V.A., Dysfunctional activation of the cerebellum in schizophrenia: a functional neuroimaging meta-analysis (2015) Clin Psychol Sci J Assoc Psychol Sci, 3, pp. 545-566; Moberget, T., Doan, N.T., Alnæs, D., Kaufmann, T., Córdova-Palomera, A., Lagerberg, T.V., Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls (2018) Mol Psychiatry, 23, pp. 1512-1520. , COI: 1:STN:280:DC%2BC1crnsFyqtQ%3D%3D; Andreasen, N.C., Paradiso, S., O’Leary, D.S., Cognitive Dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? (1998) Schizophr Bull, 24, pp. 203-218. , COI: 1:STN:280:DyaK1c3ntlKktQ%3D%3D; Schmahmann, J.D., Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome (2004) J Neuropsychiatry Clin Neurosci, 16, pp. 367-378; Schmahmann, J.D., Weilburg, J.B., Sherman, J.C., The neuropsychiatry of the cerebellum—insights from the clinic (2007) Cerebellum, 6, pp. 254-267; Moberget, T., Alnæs, D., Kaufmann, T., Doan, N.T., Córdova-Palomera, A., Norbom, L.B., Cerebellar gray matter volume is associated with cognitive function and psychopathology in adolescence (2019) Biol Psychiatry, 86, pp. 65-75; Elliott, M.L., Romer, A., Knodt, A.R., Hariri, A.R., A connectome-wide functional signature of transdiagnostic risk for mental illness (2018) Biol Psychiatry, 84, pp. 452-459; Poulton, R., Moffitt, T.E., Silva, P.A., The Dunedin Multidisciplinary Health and Development Study: Overview of the first 40 years, with an eye to the future (2015) Soc Psychiatry Psychiatr Epidemiol, 50, pp. 679-693; Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O., The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire (1991) Br J Addict, 86, pp. 1119-1127. , COI: 1:STN:280:DyaK38%2Fjtlejtg%3D%3D; Schaefer, J.D., Caspi, A., Belsky, D.W., Harrington, H., Houts, R., Horwood, L.J., Enduring mental health: prevalence and prediction (2017) J Abnorm Psychol, 126, pp. 212-224; Moffitt, T.E., Caspi, A., Taylor, A., Kokaua, J., Milne, B.J., Polanczyk, G., How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment (2010) Psychol Med, 40, pp. 899-909. , COI: 1:STN:280:DC%2BC3czgvFCrsQ%3D%3D; Steven, A.J., Zhuo, J., Melhem, E.R., Diffusion Kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain (2013) Am J Roentgenol, 202, pp. W26-W33; Ashburner, J., Friston, K.J., Unified segmentation (2005) NeuroImage., 26, pp. 839-851; Ashburner, J., A fast diffeomorphic image registration algorithm (2007) NeuroImage., 38, pp. 95-113; D’Agata, F., Caroppo, P., Boghi, A., Coriasco, M., Caglio, M., Baudino, B., Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients (2011) Brain Struct Funct, 216, pp. 275-288; Beckmann, C.F., Smith, S.M., Probabilistic independent component analysis for functional magnetic resonance imaging (2004) IEEE Trans Med Imaging, 23, pp. 137-152; Mišić, B., Sporns, O., From regions to connections and networks: new bridges between brain and behavior (2016) Curr Opin Neurobiol, 40, pp. 1-7; Bassett, D.S., Sporns, O., Network neuroscience (2017) Nat Neurosci, 20, pp. 353-364. , COI: 1:CAS:528:DC%2BC2sXjsVSmsrY%3D; Diamond, A., Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex (2000) Child Dev, 71, pp. 44-56. , COI: 1:STN:280:DC%2BD3cvlslequw%3D%3D; Schaie, K., Age changes and age differences (1967) Gerontologist., 7, pp. 128-132. , COI: 1:STN:280:DyaF2s3lt1SrtQ%3D%3D; Anderson, S.F., Maxwell, S.E., Addressing the “Replication Crisis”: using original studies to design replication studies with appropriate statistical power (2017) Multivar Behav Res, 52, pp. 305-324; Turner, B.O., Paul, E.J., Miller, M.B., Barbey, A.K., Small sample sizes reduce the replicability of task-based fMRI studies (2018) Commun Biol, 1, pp. 1-10; Diedrichsen, J., Zotow, E., Surface-based display of volume-averaged cerebellar imaging data (2015) PLoS One, 10},
correspondence_address1={Romer, A.L.; Laboratory of NeuroGenetics, United States; email: adrienne.romer@duke.edu},
publisher={Springer Nature},
issn={13594184},
coden={MOPSF},
pubmed_id={31796893},
language={English},
abbrev_source_title={Mol. Psychiatry},
document_type={Article},
source={Scopus},
}

@ARTICLE{Patel2020411,
author={Patel, B. and Legacy, J. and Hegland, K.W. and Okun, M.S. and Herndon, N.E.},
title={A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration},
journal={Expert Review of Gastroenterology and Hepatology},
year={2020},
volume={14},
number={6},
pages={411-424},
doi={10.1080/17474124.2020.1769475},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087928041&doi=10.1080%2f17474124.2020.1769475&partnerID=40&md5=1e20f0ab86f77b99dd95af8dddd34442},
affiliation={Department of Neurology, University of Florida College of Medicine, Gainesville, FL, United States; Norman Fixel Institute for Neurological Diseases, Gainesville, FL, United States; Department of Speech, Language, And Hearing Sciences, University of Florida, Gainesville, FL, United States},
abstract={Introduction: Bulbar dysfunction is common in Parkinson’s disease (PD) with more than 80% of affected individuals developing dysphagia during the course of the disease. Symptoms can begin in the preclinical stage and individuals may remain clinically asymptomatic for years. Furthermore, patients may be unaware of swallowing changes, which contributes to the difference between the prevalence of self-reported dysphagia and deficits identified during instrumental evaluations. Dysphagia is underrecognized and contributes to the development of aspiration pneumonia which is the leading cause of death in PD. Dysphagia in PD is complex and not completely understood. Both dopaminergic and nondopaminergic pathways likely underpin dysphagia. Areas covered: This comprehensive review will cover the epidemiology, pathophysiology, clinical evaluation, and expert management of dysphagia and aspiration in patients with PD. Expert Opinion: A multidisciplinary team approach is important to properly identify and manage PD dysphagia. Regular clinical screenings with objective instrumental assessments are necessary for early detection of dysphagia. Studies are needed to better understand the mechanism(s) involved in PD dysphagia, establish markers for early detection and progression, and develop evidence-based treatment options. © 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.},
author_keywords={Aspiration;  dysphagia;  evaluation;  management;  Parkinson’s disease;  pathophysiology;  swallowing;  treatment},
keywords={aspiration pneumonia;  behavior therapy;  brain depth stimulation;  diet therapy;  dysphagia;  esophagography;  esophagus;  fiberscope endoscopy;  fluoroscopy;  human;  manometry;  mouth;  neurorehabilitation;  Parkinson disease;  pathophysiology;  pharynx;  prevalence;  questionnaire;  Review;  acid aspiration;  aspiration pneumonia;  complication;  disease exacerbation;  dysphagia;  Parkinson disease;  physiology;  risk factor;  self report;  swallowing, Deglutition;  Deglutition Disorders;  Disease Progression;  Humans;  Parkinson Disease;  Pneumonia, Aspiration;  Respiratory Aspiration;  Risk Factors;  Self Report},
funding_details={National Institutes of HealthNational Institutes of Health, NIH, R01 HD091658},
funding_details={Michael J. Fox Foundation for Parkinson's ResearchMichael J. Fox Foundation for Parkinson's Research, MJFF},
funding_details={University of Florida FoundationUniversity of Florida Foundation, R01 NR014852, R01NS096008},
funding_details={Parkinson AllianceParkinson Alliance},
funding_details={Frances C. and William P. Smallwood FoundationFrances C. and William P. Smallwood Foundation},
funding_text 1={M S Okun serves as a consultant for the Parkinson’s Foundation and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann–Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. M S Okun’s DBS research is supported by NIH R01 NR014852 and R01NS096008. M Okun is PI of the NIH R25NS108939 Training Grant. M S Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford, and Cambridge (movement disorders books). M S Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology. M S Okun has participated in CME and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD/Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society, and by Vanderbilt University. The institution and not M S Okun receives grants from Medtronic, Abbvie, Boston Scientific, Abbott, and Allergan and the PI has no financial interest in these grants. M S Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry-sponsored trials over the years but has not received honoraria. Research projects at the University of Florida receive device and drug donations.},
funding_text 2={This paper was supported by an NIH grant on cough with overlap on aspiration, R01 HD091658 (Hegland). The Fixel Institute is supported by a Center of Excellence grant from the Parkinson’s Foundation.},
references={Mehanna, R., Jankovic, J., Respiratory problems in neurologic movement disorders (2010) Parkinsonism Related Disord, 16 (10), pp. 628-638; Kalf, J.G., de Swart, B.J.M., Bloem, B.R., Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis (2012) Parkinsonism Related Disord, 18 (4), pp. 311-315; Ding, X., Gao, J., Xie, C., Prevalence and clinical correlation of dysphagia in Parkinson disease: A study on Chinese patients (2018) Eur J Clin Nutr, 72 (1), pp. 82-86; Fall, P.A., Saleh, A., Fredrickson, M., Survival time, mortality, and cause of death in elderly patients with Parkinson’s disease: a 9-year follow-up (2003) Mov Disord, 18 (11), pp. 1312-1316. , Nov; Mogensen, P.H., Jakobsen, J., Causes of death in a community-based study of Parkinson’s disease (2001) Acta Neurol Scand; Marik, P.E., Aspiration pneumonitis and aspiration pneumonia (2001) N Engl J Med, 344 (9), pp. 665-671; Langmore, S.E., Terpenning, M.S., Schork, A., Predictors of aspiration pneumonia: how important is dysphagia? (1998) Dysphagia, 13 (2), pp. 69-81; Yoneyama, T., Yoshida, M., Ohrui, T., Oral care reduces pneumonia in older patients in nursing homes (2002) J Am Geriatr Soc, 50 (3), pp. 430-433; Ortega, O., Parra, C., Zarcero, S., Oral health in older patients with oropharyngeal dysphagia (2014) Age Ageing, 43 (1), pp. 132-137. , Jan; Manabe, T., Teramoto, S., Tamiya, N., Risk factors for aspiration pneumonia in older adults (2015) PLoS One, 10 (10). , http://www.ncbi.nlm.nih.gov/pubmed/26444916, Oct, 7, cited 2020 Feb12, Internet].,. Available from; Suttrup, I., Warnecke, T., Dysphagia in Parkinson’s disease (2016) Dysphagia, 31 (1), pp. 24-32; Troche, M.S., Schumann, B., Brandimore, A.E., Reflex Cough and disease duration as predictors of swallowing dysfunction in Parkinson’s disease (2016) Dysphagia, 31 (6), pp. 757-764. , Dec, 1; Fernandez, H.H., Lapane, K.L., Predictors of mortality among nursing home residents with a diagnosis of Parkinson’s disease (2002) Med Sci Monit, 8 (4), pp. CR624-CR628; Melo, A., Monteiro, L., Swallowing improvement after levodopa treatment in idiopathic Parkinson’s disease: lack of evidence (2013) Parkinsonism Related Disord, 19 (3), pp. 279-281; Plowman-Prine, E.K., Sapienza, C.M., Okun, M.S., The relationship between quality of life and swallowing in Parkinson’s disease (2009) Mov Disord, 24 (9), pp. 1352-1358. , Jul, 15; Sung, H.Y., Kim, J.S., Lee, K.S., The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson’s disease (2010) Mov Disord, 25 (14), pp. 2361-2368. , Oct, 30, cited 2020 Feb13. Available from. Internet]; Durcan, R., Wiblin, L., Lawson, R.A., Prevalence and duration of non-motor symptoms in prodromal Parkinson’s disease (2019) Eur J Neurol, 26 (7), pp. 979-985. , Jul, 1, cited 2020 Feb13. Available from. Internet]; Cereda, E., Cilia, R., Klersy, C., Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors (2014) Park Relat Disord, 20 (12), pp. 1382-1387. , Dec, 1; Simons, J.A., Fietzek, U.M., Waldmann, A., Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease (2014) Park Relat Disord, 20 (9), pp. 992-998; Lam, K., Lam, F.K.Y., Kwok, K.L., Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson’s disease (2007) Mov Disord, 22 (5), pp. 640-644. , Apr, 15; Umemoto, G., Furuya, H., Management of dysphagia in patients with Parkinson’s disease and related disorders (2019) Intern Med, , https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_2373-18/_article, cited 2019 Dec7,. Internet].,]; Available from; Curtis, J.A., Molfenter, S., Troche, M.S., Predictors of residue and airway invasion in parkinson’s disease (2019) Dysphagia, 1, p. 3. , cited 2019 Dec7,. Available from Internet]; Barbagelata, E., Nicolini, A., Tognetti, P., Swallowing dysfunctions in Parkinson’s disease patients: a novel challenge for the internist (2019) Ital J Med, 13 (2), pp. 91-94; Simons, J.A., Swallowing dysfunctions in Parkinson’s disease (2017) International Review of Neurobiology, pp. 1207-1238. , https://www.sciencedirect.com/science/article/pii/S0074774217300831?via%3Dihub, Academic Press, 2019 Dec6,. Internet]. Nonmotor Parkinson’s: The Hidden Face., [cited,]. p. Available from; Kwon, M., Lee, J.-H., Oro-pharyngeal dysphagia in Parkinson’s disease and related movement disorders (2019) Journal of Movement Disorders, 12 (3), pp. 152-160. , cited 2019 Dec8, Internet].,]. Available from; Finger, M.E., Madden, L.L., Haq, I.U., Analysis of the prevalence and onset of dysphonia and dysphagia symptoms in movement disorders at an academic medical center (2019) J Clin Neurosci, 64 (64), pp. 111-115. , Jun; Fabbri, M., Coelho, M., Abreu, D., Dysphagia predicts poor outcome in late-stage Parkinson’s disease (2019) Park Relat Disord, 64, pp. 73-81. , Jul, 1; Suttrup, I., Suttrup, J., Suntrup-Krueger, S., Esophageal dysfunction in different stages of Parkinson’s disease (2017) Neurogastroenterol Motil, 29 (1). , Jan, 1; Lang, I.M., Brain stem control of the phases of swallowing (2009) Dysphagia, 24 (3), pp. 333-348. , Springer; Pringsheim, T., Jette, N., Frolkis, A., The prevalence of Parkinson’s disease: a systematic review and meta-analysis (2014) Mov Disord, 29 (13), pp. 1583-1590. , cited 2020 Jan23,. Available from Internet].,;,): p; Dorsey, E.R., Sherer, T., Okun, M.S., The emerging evidence of the Parkinson pandemic (2018) J Parkinsons Dis, 8 (s1), pp. S3-S8. , IOS Press; Pflug, C., Bihler, M., Emich, K., Critical dysphagia is common in Parkinson disease and occurs even in early stages: a prospective cohort study (2018) Dysphagia, 33 (1), pp. 41-50. , Feb, 1, cited 2019 Dec8,. Available from Internet]; Miller, N., Allcock, L., Hildreth, A.J., Swallowing problems in Parkinson disease: frequency and clinical correlates (2009) J Neurol Neurosurg Psychiatry, 80 (9), pp. 1047-1049; Fujioka, S., Fukae, J., Ogura, H., Hospital-based study on emergency admission of patients with Parkinson’s disease (2016) eNeurologicalSci, 4, pp. 19-21. , Sep, 4; Tomita, S., Oeda, T., Umemura, A., Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson’s disease (2018) PLoS One, 13 (6); Jones, B., (2003) Normal and abnormal swallowing : imaging in diagnosis and therapy, p. 287. , Springer,. New York, NY:,. p; Mu, L., Sobotka, S., Chen, J., Parkinson disease affects peripheral sensory nerves in the pharynx (2013) J Neuropathol Exp Neurol, 72 (7), pp. 614-623. , Jul; Costa, M.M.B., Neural control of swallowing (2018) Arq Gastroenterol, 55, pp. 61-75. , IBEPEGE - Inst. Bras. Estudos Pesquisas Gastroent; Doty, R., (1968) Neural organization of deglutition, pp. 1861-1902. , Alimentary Canal. In: Handbook of physiology. American Physiological Society;,. p; Jean, A., Brain stem control of swallowing: neuronal network and cellular mechanisms (2001) Physiological Reviews, 81 (2), pp. 929-969. , http://physrev.physiology.org, cited 2020 Feb7, Internet]]. Available from; Jean, A., Brainstem control of swallowing: localization and organization of the central pattern generator for swallowing (1990) Neurophysiology of the Jaws and Teeth, , In:,. London: Macmillan Education UK;,. p. 294–321; Jean, A., Kessler J-P, T.F., Nucleus tractus solitarii and deglutition: monoamines, excitatory amino acids and cellular properties (1994) Nucleus of the Solitary Tract, pp. 361-375. , https://www.taylorfrancis.com/books/9781000005950, Barraco I.R.A., (ed), 1st, Boca Raton: CRC Press,. editor., [Internet]., editor,. p. Available from; Jean, A., brain stem control of swallowing (2001) Neuronal Network Cell Mech, , 81, Physiological Reviews. ,. p. 929–69; Jean, A., Dallaporta, M., Electrophysiologic characterization of the swallowing pattern generator in the brainstem (2006) GI Motil; Jankovic, J., Parkinson’s disease: clinical features and diagnosis (2008) J Neurol Neurosurg Psychiatry, 79 (4), pp. 368-376; van Hooren, M.R.A., Baijens, L.W.J., Voskuilen, S., Treatment effects for dysphagia in Parkinson’s disease: a systematic review (2014) Parkinsonism Related Disord, 20 (8), pp. 800-807. , Elsevier Ltd; Brabenec, L., Mekyska, J., Galaz, Z., Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation (2017) J Neural Transm, 124 (3), pp. 303-334. , Mar; Chaudhuri, K.R., Healy, D.G., Schapira, A.H.V., Non-motor symptoms of Parkinson’s disease: diagnosis and management (2006) Lancet Neurol, 5 (3), pp. 235-245; Mu, L., Sobotka, S., Chen, J., Altered pharyngeal muscles in parkinson disease (2012) J Neuropathol Exp Neurol, 71 (6), pp. 520-530. , http://www.ncbi.nlm.nih.gov/pubmed/22588389, Jun, cited 2020 Feb19,. Internet]. Available from; Jones, C.A., Hoffman, M.R., Lin, L., Identification of swallowing disorders in early and mid-stage Parkinson’s disease using pattern recognition of pharyngeal high-resolution manometry data (2018) Neurogastroenterol Motil, 30 (4); Mu, L., Sobotka, S., Chen, J., Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease (2013) J Neuropathol Exp Neurol, 72 (2), pp. 119-129; Hunker, C.J., Abbs, J.H., Barlow, S.M., The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: a quantitative analysis (1982) Neurology, 32 (7); Baradaran, N., Tan, S.N., Liu, A., Parkinson’s disease rigidity: relation to brain connectivity and motor performance (2013) Front Neurol, 4; Higo, R., Tayama, N., Watanabe, T., Abnormal elevation of resting pressure at the upper esophageal sphincter of Parkinson’s disease patients (2001) Eur Arch Oto-Rhino-Laryngology, 258 (10), pp. 552-556; Visanji, N.P., Marras, C., Hazrati, L.N., Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson’s disease biomarker (2014) Mov Disord, 29 (4), pp. 444-450. , http://www.ncbi.nlm.nih.gov/pubmed/24375496, cited 2020 Feb19,. Internet].,. John Wiley and Sons Inc.;,]. p. Available from; Fasano, A., Visanji, N.P., Liu, L.W.C., Gastrointestinal dysfunction in Parkinson’s disease (2015) Lancet Neurol, 14 (6), pp. 625-639. , Lancet Publishing Group; Umay, E., Ozturk, E., Gurcay, E., Swallowing in Parkinson’s disease: how is it affected? (2019) Clin Neurol Neurosurg, 177, pp. 37-41. , https://www.sciencedirect.com/science/article/pii/S0303846718304785, Feb, 1, cited 2019 Dec7, Internet]. Available from; Barrera, M.A., O’Connor Wells, B., Presbyphagia versus Dysphagia: normal versus abnormal swallowing symptoms in older Adults with Parkinson disease and multiple sclerosis (2019) Top Geriatr Rehabil, 35 (3), pp. 217-233; Muhle, P., Wirth, R., Glahn, J., Age-related changes in swallowing: physiology and pathophysiology (2015) Nervenarzt, , Apr;86(4):440-451; Daggett, A., Logemann, J., Rademaker, A., Laryngeal penetration during deglutition in normal subjects of various ages (2006) Dysphagia; Robbins, J., Bridges, A.D., Taylor, A., Oral, pharyngeal and esophageal motor function in aging (2006) GI Motil Online; Malandraki, G.A., Robbins, J.A., Effects of aging on the oral phase of deglutition (2013) Principles of deglutition: a multidisciplinary text for swallowing and its disorders, , In:,. New York, NY: Springer New York;,. p. 137-149; Argolo, N., Sampaio, M., Pinho, P., Swallowing disorders in Parkinson’s disease: impact of lingual pumping (2015) Int J Lang Commun Disord, 50 (5), pp. 659-664. , Sep, cited 2020 Jan23,. Available from Internet]; Umemoto, G., Tsuboi, Y., Kitashima, A., Impaired food transportation in parkinson’s disease related to lingual bradykinesia (2011) Dysphagia, 26 (3), pp. 250-255. , http://www.ncbi.nlm.nih.gov/pubmed/20803220, Sep, cited 2020 Feb13, Internet]. Available from; Wakasugi, Y., Yamamoto, T., Oda, C., Effect of an impaired oral stage on swallowing in patients with Parkinson’s disease (2017) J Oral Rehabil, 44 (10), pp. 756-762. , Oct, 1; Ali, G.N., Wallace, K.L., Schwartz, R., Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson’s disease (1996) Gastroenterology, 110 (2), pp. 383-392; Pitts, L.L., Morales, S., Stierwalt, J.A.G., Lingual pressure as a clinical indicator of swallowing function in Parkinson’s disease (2018) J Speech Lang Hear Res, 61 (2), pp. 257-265; Minagi, Y., Ono, T., Hori, K., Relationships between dysphagia and tongue pressure during swallowing in Parkinson’s disease patients (2018) J Oral Rehabil, 45 (6), pp. 459-466. , Jun, 1, cited 2020 Apr9. Internet]. [,]; Available from; Fukuoka, T., Ono, T., Hori, K., Tongue pressure measurement and videofluoroscopic study of swallowing in Patients with Parkinson’s disease (2019) Dysphagia, 34 (1), pp. 80-88. , Feb, 15, cited 2020 Apr9. Internet]. [,]; Available from; Curtis, J.A., Molfenter, S.M., Troche, M.S., Pharyngeal area changes in Parkinson’s disease and its effect on swallowing safety, efficiency, and kinematics (2020) Dysphagia, , 35(2):389–398; Gaeckle, M., Domahs, F., Kartmann, A., Predictors of penetration-aspiration in Parkinson’s disease patients with Dysphagia: a retrospective analysis (2019) Ann Otol Rhinol Laryngol, 128 (8), pp. 728-735; Hegland, K.W., Okun, M.S., Troche, M.S., Sequential voluntary cough and aspiration or aspiration risk in Parkinson’s disease (2014) Lung, 192 (4), pp. 601-608; Silverman, E.P., Carnaby, G., Singletary, F., Measurement of voluntary cough production and airway protection in parkinson disease (2016) Arch Phys Med Rehabil, 97 (3), pp. 413-420; Gross, R.D., Atwood, C.W., Ross, S.B., The coordination of breathing and swallowing in Parkinson’s disease (2008) Dysphagia, 23 (2), pp. 136-145. , http://www.ncbi.nlm.nih.gov/pubmed/18027027, Jun, cited 2020 Feb19, Internet]. Available from; Schröder, J.B., Marian, T., Claus, I., Substance P saliva reduction predicts pharyngeal dysphagia in Parkinson’s disease (2019) Front Neurol, 10. , https://www.frontiersin.org/article/10.3389/fneur.2019.00386/full, Apr, 16, cited 2020 Jan25, Internet].,. Available from; Renner, B., Ahne, G., Grosan, E., Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators (2013) Inflamm Res, 62 (12), pp. 1045-1051; Imoto, Y., Koji, M.A.A., Osawa, Y., Cough reflex induced by capsaicin inhalation in patients with dysphagia (2010) Acta Otolaryngol; Niel, J.P., Role of substance P in the nervous system control of digestive motility (1991) Arch Int Physiol Biochim Biophys, , Sep;99(5):A65-76. : 10.3109/13813459109145918; Kooi, A.H.J., Boo, J.P.L., Ng, S.Y.E., The modified Barium swallow impairment profile as a predictor of clinical outcomes of admission for pneumonia or choking in dysphagic patients with Parkinson’s disease (2019) Dysphagia, 34 (6), pp. 896-903. , Dec, 1; Bassotti, G., Germani, U., Pagliaricci, S., Esophageal manometric abnormalities in Parkinson’s disease (1998) Dysphagia, 13 (1), pp. 28-31; Langmore, S.E., Kenneth, S.M.A., Olsen, N., Fiberoptic endoscopic examination of swallowing safety: a new procedure (1988) Dysphagia, 2 (4), pp. 216-219. , Dec; McHorney, C.A., Bricker, D.E., Kramer, A.E., The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. conceptual foundation and item development (2000) Dysphagia, 15 (3), pp. 115-121; McHorney, C.A., Earl Bricker, D., Robbins, J., The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling (2000) Dysphagia, 15 (3), pp. 122-133; McHorney, C.A., Robbins, J.A., Lomax, K., The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity (2002) Dysphagia, 17 (2), pp. 97-114. , Mar; Belafsky, P.C., Mouadeb, D.A., Rees, C.J., Validity and reliability of the eating assessment tool (EAT-10) (2008) Ann Otol Rhinol Laryngol, 117 (12), pp. 919-924; Nativ-Zeltzer, N., Bayoumi, A., Mandin, V.P., Validation of the PILL-5: a 5-item patient reported outcome measure for pill dysphagia (2019) Front Surg, 6; Manor, Y., Giladi, N., Cohen, A., Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease (2007) Mov Disord, 22 (13), pp. 1917-1921. , Oct, 15; Buhmann, C., Bihler, M., Emich, K., Pill swallowing in Parkinson’s disease: a prospective study based on flexible endoscopic evaluation of swallowing (2019) Park Relat Disord, 62, pp. 51-56. , May, 1; Ott, D.J., Hodge, R.G., Pikna, L.A., Modified barium swallowclinical and radiographic correlation and relation to feeding recommendations (1996) Dysphagia, 11 (3), pp. 187-190; Langmore, S.E., Logemann, J.A., After the clinical bedside swallowing examination (1991) Am J Speech-Language Pathol, 1 (1), pp. 13-20; McCullough, G.H., Martino, R., Clinical evaluation of patients with dysphagia: importance of history taking and physical exam (2013) Manual of diagnostic and therapeutic techniques for disorders of Deglutition, , In:,. New York, NY: Springer New York;,. p.11-30; Kalf, H., De Swart, B., Bonnier-Baars, M., (2008) Guidelines for speech-language therapy in Parkinson’s disease, , http://www.ParkinsonNet.nl, cited 2020 Jan25,. Internet] Available from; Ertekin, C., Aydogdu, I., Yüceyar, N., Electrodiagnostic methods for neurogenic dysphagia (1998) Electroencephalogr Clin Neurophysiol - Electromyogr Mot Control, 109 (4), pp. 331-340; Potulska, A., Friedman, A., Królicki, L., Swallowing disorders in Parkinson’s disease (2003) Park Relat Disord, 9 (6), pp. 349-353; Nathadwarawala, K.M., McGroary, A., Wiles, C.M., Swallowing in neurological outpatients: use of a timed test (1994) Dysphagia, 9 (2), pp. 120-129; Brodsky, M.B., Suiter, D.M., González-Fernández, M., Screening accuracy for aspiration using bedside water swallow tests: a systematic review and meta-analysis (2016) Chest, 150 (1), pp. 148-163; Mulheren, R.W., Azola, A., González-Fernández, M., Do ratings of swallowing function differ by videofluoroscopic rate? An exploratory analysis in patients after acute stroke (2019) Arch Phys Med Rehabil, 100 (6), pp. 1085-1090. , http://www.ncbi.nlm.nih.gov/pubmed/30452891, Jun, 1, cited 2020 Feb7, Internet]. Available from; Bonilha, H.S., Blair, J., Carnes, B., Preliminary investigation of the effect of pulse rate on judgments of swallowing impairment and treatment recommendations (2013) Dysphagia, 28 (4), pp. 528-538. , http://www.ncbi.nlm.nih.gov/pubmed/23559454, Dec, cited 2020 Feb7,. Internet]. Available from; Martin-Harris, B., Jones, B., The videofluorographic swallowing study (2008) Phys Med Rehabil Clin N Am, 19 (4), pp. 769-785; Langmore, S.E., History of Fiberoptic Endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years (2017) Dysphagia, 32 (1), pp. 27-38. , Springer New York LLC; Rosenbek, J.C., Robbins, J.A., Roecker, E.B., A penetration-aspiration scale (1996) Dysphagia, 11 (2), pp. 93-98; Pearson, W.G., Molfenter, S.M., Smith, Z.M., Image-based measurement of post-swallow residue: the normalized residue ratio scale (2013) Dysphagia, 28 (2), pp. 167-177; Dyer, J.C., Leslie, P., Drinnan, M.J., Objective computer-based assessment of valleculae residue - Is it useful? (2008) Dysphagia, 23 (1), pp. 7-15; Rommel, N., Borgers, C., Van Beckevoort, D., Bolus Residue Scale: an easy-to-use and reliable videofluoroscopic analysis tool to score bolus residue in patients with dysphagia (2015) Int J Otolaryngol, 2015, pp. 1-7; Neubauer, P.D., Rademaker, A.W., Leder, S.B., The Yale Pharyngeal Residue Severity Rating Scale: an anatomically defined and image-based tool (2015) Dysphagia, 30 (5), pp. 521-528; Martin-Harris, B., Brodsky, M.B., Michel, Y., MBS measurement tool for swallow impairment-MBSimp: establishing a standard (2008) Dysphagia, 23 (4), pp. 392-405; Ertekin, C., Electrophysiological evaluation of oropharyngeal dysphagia in Parkinson’s disease (2014) J Mov Disord, 7 (2), pp. 31-56. , Oct, 30; Monteiro, L., Souza-Machado, A., Pinho, P., Swallowing impairment and pulmonary dysfunction in Parkinson’s disease: the silent threats (2014) J Neurol Sci, 339 (1-2), pp. 149-152. , Apr, 15; Oh, D.H., Park, J.S., Kim, W.J., Effect of neuromuscular electrical stimulation on lip strength and closure function in patients with dysphagia after stroke (2017) J Phys Ther Sci, 29 (11), pp. 1974-1975; Hsiao, M.-Y., Karunia Wahyuni, L., Wang, T.-G., Ultrasonography in assessing oropharyngeal dysphagia (2013) J Med Ultrasound, 21 (4), pp. 181-188. , Available from, cited 2020 Jan27; Tjaden, K., Speech and swallowing in Parkinson’s disease (2008) Top Geriatric Rehabil, 24 (2), pp. 115-126; Ra, J.Y., Hyun, J.K., Ko, K.R., Chin tuck for prevention of aspiration: effectiveness and appropriate posture (2014) Dysphagia, 29 (5), pp. 603-609. , Sep, 28; Rosenbek, J.C., Jones, H.N., Dysphagia in movement disorders (2009) Plural Pub, p. 265. , p; Ryu, J.S., Park, D., Oh, Y., The effects of bolus volume and texture on pharyngeal pressure events using high-resolution manometry and its comparison with videofluoroscopic swallowing study (2016) J Neurogastroenterol Motil, 22 (2), pp. 231-239; Park, J.W., Sim, G.J., Yang, D.C., Increased bolus volume effect on delayed pharyngeal swallowing response in post-stroke oropharyngeal dysphagia: a pilot study (2016) Ann Rehabil Med, 40 (6); Bisch, E.M., Logemann, J.A., Rademaker, A.W., Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects (1994) J Speech Hear Res, 37 (5), pp. 1041-1049; Butler, S.G., Stuart, A., Markley, L., Aspiration as a function of age, sex, liquid type, bolus volume, and bolus delivery across the healthy adult life span (2018) Ann Otol Rhinol Laryngol, 127 (1), pp. 21-32; Troche, M.S., Okun, M.S., Rosenbek, J.C., Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study (2014) Park Relat Disord, 20 (4), pp. 439-443; Logemann, J.A., The evaluation and treatment of swallowing disorders (1998) Curr Opin Otolaryngol Head Neck Surg, 6 (6), pp. 395-400. , Lippincott Williams and Wilkins; Clavé, P., De Kraa, M., Arreola, V., The effect of bolus viscosity on swallowing function in neurogenic dysphagia (2006) Aliment Pharmacol Ther, 24 (9), pp. 1385-1394; Cola, P.C., Gatto, A.R., Da Silva, R.G., The influence of sour taste and cold temperature in pharyngeal transit duration in patients with stroke (2010) Arq Gastroenterol, 47 (1), pp. 18-21; Gatto, A.R., Cola, P.C., Da Silva, R.G., Sour taste and cold temperature in the oral phase of swallowing in patients after stroke (2013) CODAS, 25 (2), pp. 163-167; Logemann, J.A., Pauloski, B.R., Colangelo, L., Effects of a sour bolus on oropharyngeal swallowing measures in patients with neurogenic dysphagia (1995) J Speech Hear Res, 38 (3), pp. 556-563; Logemann, J.A., Gensler, G., Robbins, J.A., A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease (2008) J Speech Lang Hear Res, 51 (1), pp. 173-183; Gillman, A., Winkler, R., Taylor, N.F., Implementing the Free Water Protocol does not result in aspiration pneumonia in carefully selected patients with dysphagia: a systematic review (2017) Dysphagia, 32 (3), pp. 345-361. , Jun, 1; Panther, K., The Frazier Free Water Protocol (2005) Perspect swallowing swallowing disorders, 14 (1), p. 4. , Mar, 1,. Dysphagia; Roche, V., Percutaneous endoscopic gastrostomy. Clinical care of PEG tubes in older adults (2003) Geriatrics, 58 (11), pp. 22-26. , http://www.ncbi.nlm.nih.gov/pubmed/14628393, Nov, cited 2020 Jan28. Internet] Available from; Loeb, M., McGeer, A., McArthur, M., Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities (1999) Arch Intern Med, 159 (17), pp. 2058-2064. , Sep, 27; Opilla, M., Aspiration risk and enteral feeding: a clinical approach (2003) Pract Gastroenterol, 1 (27), pp. 89-96. , Apr; Marik, P.E., Kaplan, D., Aspiration pneumonia and dysphagia in the elderly (2003) Chest, 124 (1), pp. 328-336. , American College of Chest Physicians; Ciocon, J.O., Silverstone, F.A., Graver, L.M., Tube feedings in elderly patients: indications, benefits, and complications (1988) Arch Intern Med, 148 (2), pp. 429-433; Koch, K.A., Patient Self-Determination Act (1992) J Fla Med Assoc, 79 (4), pp. 240-243. , http://www.ncbi.nlm.nih.gov/pubmed/1588296, Apr, cited 2020 Jan27. Internet] Available from; Pitts, T., Bolser, D., Rosenbek, J., Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease (2009) Chest, 135 (5), pp. 1301-1308. , May, 1; Sapienza, C., Wheeler, K., Respiratory muscle strength training: functional outcomes versus plasticity (2006) Semin Speech Lang, 27 (4), pp. 236-244. , http://www.thieme-connect.de/DOI/DOI?10.1055/s-2006-955114, Nov, cited 2020 Jan27, 27, Internet].]; Available from; Saleem, A.F., Sapienza, C.M., Okun, M.S., Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease (2005) NeuroRehabilitation, 20 (4), pp. 323-333; Troche, M.S., Okun, M.S., Rosenbek, J.C., Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial (2010) Neurology, 75 (21), pp. 1912-1919. , Nov, 23; Hegland, K.W., Davenport, P.W., Brandimore, A.E., Rehabilitation of swallowing and cough functions following stroke: an expiratory muscle strength training trial (2016) Arch Phys Med Rehabil, 97 (8), pp. 1345-1351; Miles, A., Jardine, M., Johnston, F., Effect of Lee Silverman voice treatment (LSVT LOUD®) on swallowing and cough in Parkinson’s disease: a pilot study (2017) J Neurol Sci, 383, pp. 180-187. , Dec, 15; Pitts, T., Bolser, D., Rosenbek, J., Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease (2009) Chest, 135 (5), pp. 1301-1308. , May; Wheeler-Hegland, K.M., Rosenbek, J.C., Sapienza, C.M., Submental sEMG and hyoid movement during Mendelsohn maneuver, effortful swallow, and expiratory muscle strength training (2008) J Speech Lang Hear Res, 51 (5), pp. 1072-1087. , Oct, 1; Ramig, L.O., Fox, C., Sapir, S., Speech treatment for Parkinson’s disease (2008) Expert Rev Neurother, 8 (2), pp. 297-309; Ramig, L.O., Sapir, S., Countryman, S., Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: A 2 year follow up (2001) J Neurol Neurosurg Psychiatry, 71 (4), pp. 493-498. , Oct; Sapir, S., Spielman, J.L., Ramig, L.O., Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings (2007) J Speech Lang Hear Res, 50 (4), pp. 899-912. , Aug, 1; El Sharkawi, A., Ramig, L., Logemann, J.A., Swallowing and voice effects of Lee Silverman voice treatment (LSVT®): a pilot study (2002) J Neurol Neurosurg Psychiatry, 72 (1), pp. 31-36; Miles, A., Jardine, M., Johnston, F., Effect of Lee Silverman voice treatment (LSVT LOUD®) on swallowing and cough in Parkinson’s disease: a pilot study (2017) J Neurol Sci, 383, pp. 180-187. , Dec; Crary, M.A., Carnaby, G.D., Groher, M.E., Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback (2004) Dysphagia, 19 (3); Park, J.S., Hwang, N.K., Kim, H.H., Effect of neuromuscular electrical stimulation combined with effortful swallowing using electromyographic biofeedback on oropharyngeal swallowing function in stroke patients with dysphagia: a pilot study (2019) Medicine (Baltimore); Hind, J.A., Nicosia, M.A., Roecker, E.B., Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults (2001) Arch Phys Med Rehabil, 82 (12), pp. 1661-1665; Wheeler-Hegland, K.M., Rosenbek, J.C., Sapienza, C.M., Submental sEMG and hyoid movement during Mendelsohn maneuver, effortful swallow, and expiratory muscle strength training (2008) J Speech Lang Hear Res, 51 (5), pp. 1072-1087. , Oct; Logemann, J.A., (1998) Head and, pp. 395-400. , Surgery N., (ed), Lippincott Williams and Wilkins, The evaluation and treatment of swallowing disorders. 6, Current Opinion Otolaryngology and,. p; McCullough, G.H., Kim, Y., Effects of the Mendelsohn maneuver on extent of hyoid movement and UES opening post-stroke (2013) Dysphagia, 28 (4), pp. 511-519. , Dec; McCullough, G.H., Kamarunas, E., Mann, G.C., Effects of Mendelsohn maneuver on measures of swallowing duration post stroke (2012) Top Stroke Rehabil, 19 (3), pp. 234-243. , Jan, 1; Miloro, K.V., Pearson, W.G., Langmore, S.E., Effortful pitch glide: a potential new exercise evaluated by dynamic MRI (2014) J Speech Lang Hear Res, 57 (4), pp. 1243-1250; Logemann, J.A., Pauloski, B.R., Rademaker, A.W., Speech and swallowing rehabilitation for head and neck cancer patients (1997) Oncology, 11 (5), pp. 651-659; Baijens, L.W.J., Speyer, R., Passos, V.L., The effect of surface electrical stimulation on swallowing in dysphagic parkinson patients (2012) Dysphagia, 27 (4), pp. 528-537; Chen, Y.W., Chang, K.H., Chen, H.C., The effects of surface neuromuscular electrical stimulation on post-stroke dysphagia: a systemic review and meta-analysis (2016) Clin Rehabil, 30 (1), pp. 24-35; Sun, Y., Chen, X., Qiao, J., Effects of transcutaneous neuromuscular electrical stimulation on swallowing disorders: a systematic review and meta-analysis (2020) Am J Phys Med Rehabil, , Publish Ah; Park, J.S., Oh, D.H., Hwang, N.K., Effects of neuromuscular electrical stimulation in patients with Parkinson’s disease and dysphagia: a randomized, single-blind, placebo-controlled trial (2018) NeuroRehabilitation, 42 (4), pp. 457-463; Kieser, J., Jones, G., Borlase, G., Dental treatment of patients with neurodegenerative disease (1999) N Z Dent J, 95 (422), pp. 130-134; Cersósimo, M.G., Perandones, C., Micheli, F.E., Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson’s disease Patients (2011) Mov Disord, 26 (1), pp. 188-190. , Jan, cited 2020 Jan27. Available from Internet]; Barbe, A.G., Bock, N., Derman, S.H.M., Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson’s disease Patients (2017) Gerodontology, 34 (1), pp. 135-143. , Mar, cited 2020 Jan27. Available from Internet]; Proulx, M., de Courval, F.P., Wiseman, M.A., Salivary production in Parkinson’s disease (2005) Mov Disord, 20 (2), pp. 204-207. , Feb; Srivanitchapoom, P., Pandey, S., Hallett, M., Drooling in Parkinson’s disease: a review (2014) Parkinsonism Related Disord, 20 (11), pp. 1109-1118; Dogu, O., Apaydin, D., Sevim, S., Ultrasound-guided versus “blind” intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease (2004) Clin Neurol Neurosurg, 106 (2), pp. 93-96. , Mar, 1; Lagalla, G., Millevolte, M., Capecci, M., Botulinum toxin type A for drooling in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (2006) Mov Disord, 21 (5), pp. 704-707. , May, 1, cited 2020 Feb13. Available from Internet]; Seppi, K., Weintraub, D., Coelho, M., The Movement Disorder Society Evidence-based Medicine Review Update: treatments for the non-motor symptoms of Parkinson’s disease (2011) Mov Disord, 26 (S3), pp. S42-S80. , Oct, 1, cited 2020 Feb13,. Available from. Internet]; Srivanitchapoom, P., Pandey, S., Hallett, M., Drooling in Parkinson’s disease: a review (2014) Parkinsonism Related Disord, 20 (11), pp. 1109-1118. , Elsevier Ltd; Jost, W.H., Friedman, A., Michel, O., SIAXI: placebo-controlled, randomized, double-blind study of incobotulinumtoxin A for sialorrhea (2019) Neurology, 92 (17), pp. E1982-E1991. , Apr, 23; (2000), https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf, updated, 2019 Aug, cited, 2020 Apr1, Available from; (2010), https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf.173, updated, 2019, July, cited, 2020 Apr1, Available from; Jolly, D.E., Paulson, R.B., Paulson, G.W., Parkinson’s disease: a review and recommendations for dental management (1989) Spec Care Dent, 9 (3), pp. 74-78. , May, cited 2020 Jan27. Available from Internet]; Johnston, B.T., Li, Q., Castell, J.A., Swallowing and esophageal function in Parkinson’s disease (1995) Am J Gastroenterol, 90 (10), pp. 1741-1746. , http://www.ncbi.nlm.nih.gov/pubmed/7572887, Oct, 2020 Jan27, Internet], [cited. Available from; Einarsdóttir, E.R., Gunnsteinsdóttir, H., Hallsdóttir, M.H., Dental health of patients with Parkinson’s disease in Iceland (2009) Spec Care Dent, 29 (3), pp. 123-127. , May, 2020 Jan27,. Internet], [cited. Available from; Fukayo, S., Nonaka, K., Shimizu, T., Oral health of patients with Parkinson’s disease: factors related to their better dental status (2003) Tohoku J Exp Med, 201 (3), pp. 171-179. , Nov; Friedlander, A.H., Mahler, M., Norman, K.M., Parkinson disease: Parkinson disease systemic and orofacial manifestations, medical and dental management (2009) J Am Dent Assoc, 140 (6), pp. 658-669; Baijens, L.W.J., Speyer, R., Effects of therapy for dysphagia in Parkinson’s disease: systematic review (2009) Dysphagia, 24 (1), pp. 91-102; Tada, A., Miura, H., Prevention of aspiration pneumonia (AP) with oral care (2012) Arch Gerontol Geriatr, 55 (1), pp. 16-21; Yoneyama, T., Yoshida, M., Matsui, T., Oral care and pneumonia (1999) Lancet, 354 (9177). , 8; Adachi, M., Ishihara, K., Abe, S., Professional oral health care by dental hygienists reduced respiratory infections in elderly persons requiring nursing care (2007) Int J Dent Hyg, 5 (2), pp. 69-74; Bassim, C.W., Gibson, G., Ward, T., Modification of the risk of mortality from pneumonia with oral hygiene care (2008) J Am Geriatr Soc, 56 (9), pp. 1601-1607; Sutton, J.P., Dysphagia in Parkinson’s disease is responsive to levodopa (2013) Park Relat Disord, 19 (3), pp. 282-284; Lim, A., Leow, L.P., Huckabee, M.L., A pilot study of respiration and swallowing integration in Parkinson’s disease: “On” and “Off” levodopa (2008) Dysphagia, 23 (1), pp. 76-81. , Mar; Warnecke, T., Suttrup, I., Schröder, J.B., Levodopa responsiveness of dysphagia in advanced Parkinson’s disease and reliability testing of the FEES-Levodopa-test (2016) Park Relat Disord, 28, pp. 100-106. , Jul, 1; Johnston, B.T., Li, Q., Castell, J.A., Swallowing and esophageal function in Parkinson’s disease (1995) Am J Gastroenterol, 90 (10), pp. 1741-1746. , Oct; Tison, F., Wiart, L., Guatterie, M., Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease (1996) Mov Disord, 11 (6), pp. 729-732; Monte, F.S., da Silva, F.P., Braga-Neto, P., Swallowing abnormalities and dyskinesia in Parkinson’s disease (2005) Mov Disord, 20 (4), pp. 457-462. , Apr; Troche, M.S., Brandimore, A.E., Foote, K.D., Swallowing and deep brain stimulation in Parkinson’s disease: A systematic review (2013) Parkinsonism Related Disord, 19 (9), pp. 783-788; Troche, M.S., Brandimore, A.E., Foote, K.D., Swallowing outcomes following unilateral STN vs. GPi surgery: A retrospective analysis (2014) Dysphagia, 29 (4), pp. 425-431; Xie, T., Vigil, J., MacCracken, E., Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD (2015) Neurology, 84 (4), pp. 415-420; Kim, M.K., Kantarcigil, C., Kim, B., Flexible submental sensor patch with remote monitoring controls for management of oropharyngeal swallowing disorders (2019) Sci Adv, 5 (12), p. eaay3210. , Dec, 13; Manabe, T., Teramoto, S., Tamiya, N., Risk factors for aspiration pneumonia in older adults (2015) PLoS One, 10 (10). , Oct},
correspondence_address1={Patel, B.; Department of Neurology, P.O. Box 100236, United States; email: Bhavana.patel@neurology.ufl.edu},
publisher={Taylor and Francis Ltd},
issn={17474124},
pubmed_id={32657208},
language={English},
abbrev_source_title={Expert Rev. Gastroenterol. Hepatol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Hong20198221,
author={Hong, X.-Y. and Lin, J. and Gu, W.-W.},
title={Risk factors and therapies in vascular diseases: An umbrella review of updated systematic reviews and meta-analyses},
journal={Journal of Cellular Physiology},
year={2019},
volume={234},
number={6},
pages={8221-8232},
doi={10.1002/jcp.27633},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054917106&doi=10.1002%2fjcp.27633&partnerID=40&md5=1728ccc9ee1b0cf2a328719bf64422f9},
affiliation={Department of Vascular Surgery, China-Japan Union Hospital of JiLin University, ChangChun, China; Department of Hepatopancreatobility Surgery, China-Japan Union Hospital of JiLin University, ChangChun, China},
abstract={Aberrant blood vessel functioning and systemic circulation are key causes for vascular disorders; cardiovascular, cerebrovascular, renal artery stenosis, and peripheral artery diseases. Epidemiological and basic science evidence supported genetic reasons, compounded by obesity, hypercholesterolemia, hypertension, diabetes, and smoking as risk factors. This is an umbrella review of risk factors and therapies in vascular disorders, exploring systematic reviews and meta-analyses studies in PubMed, Cochrane, Embase, and Central published in January 2000–May 2018. We made qualitative eligibility gradation of the articles based on inclusion criteria, and independently extracted descriptive and methodologic data to compile their outcomes. We considered 95% confidence interval and the between-study heterogeneity, designated by I 2. Overall, we extracted 217 studies of impressive quality and at low risk of bias, including 124, 30, 23, 32, and 8, respectively, for the search terms “cardiovascular,” “renal,” “cerebral,” and “limb ischemia” each in combination with “risk factors” and “therapeutics.” Our search on genome-wide analyses revealed genes associated with HDL-cholesterol, matrix metalloproteases, angiogenesis, notch3, renin-angiotensin, apolipoprotein E, insulin, and cytokine levels as critical participants in the pathogenesis of vascular diseases. Hypertension and endothelial growth factor-linked polymorphisms were found to contribute to vascular damage. The studies reinforced that lifestyle and dietary patterns influenced susceptibility of circulatory system diseases. Additionally, endovascular medicines, surgical vascularization, angioplasty, and renal artery stenting appeared as major therapeutic approaches in vascular patients. Altogether, our review offers up-to-date information on pathophysiology of vascular diseases and provides insight into existing research, clinical management and clinical gaps in the field. © 2018 Wiley Periodicals, Inc.},
author_keywords={cardiac;  cerebral;  ischemia;  peripheral;  renal},
keywords={5,10 methylenetetrahydrofolate reductase (FADH2);  adenosine monophosphate deaminase;  angiotensin receptor antagonist;  apolipoprotein E;  cytochrome P450 2C19;  cytokine;  dipeptidyl carboxypeptidase;  dipeptidyl carboxypeptidase inhibitor;  high density lipoprotein cholesterol;  metalloproteinase;  microRNA 146a;  Notch3 receptor;  phosphodiesterase;  vasculotropin;  endothelial cell growth factor, angioplasty;  blood vessel injury;  cardiovascular disease;  cardiovascular system;  cerebrovascular disease;  chronic kidney failure;  Cochrane Library;  coronary stenting;  dietary pattern;  disease association;  genetic association;  genetic polymorphism;  genetic risk;  genome analysis;  genome-wide association study;  heart muscle revascularization;  high risk patient;  human;  hypertension;  kidney artery;  limb ischemia;  low risk patient;  managed care;  Medline;  meta analysis;  metabolic disorder;  outcome assessment;  pathogenesis;  pathophysiology;  peripheral occlusive artery disease;  priority journal;  protein polymorphism;  qualitative analysis;  randomized controlled trial (topic);  renin angiotensin aldosterone system;  Review;  risk assessment;  risk factor;  systematic review;  vascular disease;  vascularization;  cardiovascular disease;  complication;  diabetic complication;  genetics;  hypercholesterolemia;  hypertension;  lifestyle;  obesity;  risk factor, Cardiovascular Diseases;  Diabetes Complications;  Endothelial Growth Factors;  Genome-Wide Association Study;  Humans;  Hypercholesterolemia;  Hypertension;  Life Style;  Obesity;  Risk Factors},
chemicals_cas={5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7; adenosine monophosphate deaminase, 9025-10-9; dipeptidyl carboxypeptidase, 9015-82-1; metalloproteinase, 81669-70-7; phosphodiesterase; vasculotropin, 127464-60-2; endothelial cell growth factor, 92880-73-4; Endothelial Growth Factors},
references={Agarwal, R., Tripathi, C.B., Association of apolipoprotein E genetic variation in Alzheimer’s disease in Indian population: A meta-analysis (2014) American Journal of Alzheimer’s Disease and Other Dementias, 29 (7), pp. 575-582; Ageno, W., Becattini, C., Brighton, T., Selby, R., Kamphuisen, P.W., Cardiovascular risk factors and venous thromboembolism: A meta-analysis (2008) Circulation, 117 (1), pp. 93-102; An, J., Shi, F., Liu, S., Ma, J., Ma, Q., Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery: A meta-analysis (2017) Interactive Cardiovascular and Thoracic Surgery, 25 (6), pp. 958-965; Ariyaratnam, R., Casas, J.P., Whittaker, J., Smeeth, L., Hingorani, A.D., Sharma, P., Genetics of ischaemic stroke among persons of non-European descent: A meta-analysis of eight genes involving approximately 32,500 individuals (2007) PLOS Medicine, 4 (4); Baghdadi, L.R., Woodman, R.J., Shanahan, E.M., Mangoni, A.A., The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis (2015) PLOS One, 10 (2); Bai, Y., Shi, X.B., Ma, C.S., Lip, G.Y.H., Meta-analysis of effectiveness and safety of oral anticoagulants in atrial fibrillation with focus on apixaban (2017) American Journal of Cardiology, 120 (9), pp. 1689-1695; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P.A., Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses (2016) Parkinsonism & Related Disorders, 23, pp. 1-9; Campbell, J.M., Bateman, E., Peters, M.D., Bowen, J.M., Keefe, D.M., Stephenson, M.D., Irinotecan-induced toxicity pharmacogenetics: An umbrella review of systematic reviews and meta-analyses (2016) Pharmacogenomics Journal, 17, pp. 435-451; Catalan-Matamoros, D., Gomez-Conesa, A., Stubbs, B., Vancampfort, D., Exercise improves depressive symptoms in older adults: An umbrella review of systematic reviews and meta-analyses (2016) Psychiatry Research, 244, pp. 202-209; Chen, C., Wei, J., AlBadri, A., Zarrini, P., Bairey Merz, C.N., Coronary Microvascular Dysfunction- Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy (2016) Circulation Journal, 81 (1), pp. 3-11; Cronin, O., Morris, D.R., Walker, P.J., Golledge, J., The association of obesity with cardiovascular events in patients with peripheral artery disease (2013) Atherosclerosis, 228 (2), pp. 316-323; Duron, E., Hanon, O., Hypertension, cognitive decline and dementia (2008) Archives of Cardiovascular Diseases, 101 (3), pp. 181-189; Fabiani, I., Calogero, E., Pugliese, N.R., Di Stefano, R., Nicastro, I., Buttitta, F., Di Bello, V., Critical limb ischemia: A practical up-to-date review (2017) Angiology, 69; Feng, A.F., Liu, Z.H., Zhou, S.L., Zhao, S.Y., Zhu, Y.X., Wang, H.X., Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: A meta-analysis (2017) BMC Cardiovascular Disorders, 17 (1), p. 174; Georgianos, P.I., Pikilidou, M.I., Liakopoulos, V., Balaskas, E.V., Zebekakis, P.E., Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials (2018) Hypertension Research, 41 (5), pp. 309-319; Giardino, I., D’apolito, M., Brownlee, M., Maffione, A.B., Colia, A.L., Sacco, M., Pettoello-Mantovani, M., Vascular toxicity of urea, a new "old player" in the pathogenesis of chronic renal failure induced cardiovascular diseases (2017) Turkish Archives of Pediatrics, 52 (4), pp. 187-193. , http://www.turkpediatriarsivi.com/eng/ozet/4024/309/Abstract; Gong, M., Dong, W., Shi, Z., Qiu, S., Yuan, R., Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies (2017) Oncotarget, 8 (5), pp. 8447-8458; Gouya, G., Arrich, J., Wolzt, M., Huber, K., Verheugt, F.W.A., Gurbel, P.A., Siller-Matula, J.M., Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: A systematic review and meta-analysis (2014) Stroke, 45 (2), pp. 492-503; Grams, M.E., Sang, Y., Ballew, S.H., Carrero, J.J., Djurdjev, O., Heerspink, H.J.L., Coresh, J., Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate (2018) Kidney International, 93 (6), pp. 1442-1451; Hallan, S.I., Matsushita, K., Sang, Y., Mahmoodi, B.K., Black, C., Ishani, A., Coresh, J., Age and association of kidney measures with mortality and end-stage renal disease (2012) Journal of the American Medical Association, 308 (22), pp. 2349-2360; He, Y., Yang, J., Kong, D., Lin, J., Xu, C., Ren, H., Wang, K., Association of miR-146a rs2910164 polymorphism with cardio-cerebrovascular diseases: A systematic review and meta-analysis (2015) Gene, 565 (2), pp. 171-179; Kayvanpour, E., Sedaghat-Hamedani, F., Amr, A., Lai, A., Haas, J., Holzer, D.B., Meder, B., Genotype-phenotype associations in dilated cardiomyopathy: Meta-analysis on more than 8000 individuals (2017) Clinical Research in Cardiology, 106 (2), pp. 127-139; Khandanpour, N., Willis, G., Meyer, F.J., Armon, M.P., Loke, Y.K., Wright, A.J.A., Jennings, B.A., Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis (2009) Journal of Vascular Surgery, 49 (3), pp. 711-718; Kim, R.J., Becker, R.C., Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies (2003) American Heart Journal, 146 (6), pp. 948-957; Laban, K.G., Vergouwen, M.D., Dijkhuizen, R.M., Sena, E.S., Macleod, M.R., Rinkel, G.J., van der Worp, H.B., Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: A systematic review and meta-analysis (2015) Journal of Cerebral Blood Flow and Metabolism, 35 (7), pp. 1085-1089; Lin, C., Yang, H.Y., Wu, C.C., Lee, H.S., Lin, Y.F., Lu, K.C., Su, S.L., Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies (2014) PLOS One, 9 (1); Liu, S., Wu, J.R., Zhang, D., Wang, K.H., Zhang, B., Zhang, X.M., Liu, X.K., Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: A network meta-analysis of randomized controlled trials (2018) BMC Complementary and Alternative Medicine, 18 (1), p. 120; Lu, L., Mackay, D.F., Pell, J.P., Meta-analysis of the association between cigarette smoking and peripheral arterial disease (2014) Heart, 100 (5), pp. 414-423; Lv, X., Zhang, Y., Niu, Y., Song, Q., Zhao, Q., Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis (2018) Medicine (Baltimore), 97 (15); Malik, J., Heart disease in chronic kidney disease - review of the mechanisms and the role of dialysis access (2018) The journal of vascular access, 19 (1), pp. 3-11; Meng, X.F., Yu, J.T., Wang, H.F., Tan, M.S., Wang, C., Tan, C.C., Tan, L., Midlife vascular risk factors and the risk of Alzheimer’s disease: A systematic review and meta-analysis (2014) Journal of Alzheimer’s Disease, 42 (4), pp. 1295-1310; Motlagh, B., O’Donnell, M., Yusuf, S., Prevalence of cardiovascular risk factors in the Middle East: A systematic review (2009) European journal of cardiovascular prevention and rehabilitation: official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 16 (3), pp. 268-280; Ne, J.Y.A., Cai, T.Y., Celermajer, D.S., Caterson, I.D., Gill, T., Lee, C.M.Y., Skilton, M.R., Obesity, arterial function and arterial structure - a systematic review and meta-analysis (2017) Obesity Science & Practice, 3 (2), pp. 171-184; Nicoll, R., Zhao, Y., Ibrahimi, P., Olivecrona, G., Henein, M., Diabetes and Hypertension Consistently Predict the Presence and Extent of Coronary Artery Calcification in Symptomatic Patients: A Systematic Review and Meta-Analysis (2016) International Journal of Molecular Sciences, 17 (9), p. 1481; Ozdemir, B.A., Brownrigg, J.R., Jones, K.G., Thompson, M.M., Hinchliffe, R.J., Systematic review of screening investigations for peripheral arterial disease in patients with diabetes mellitus (2013) Surgical Technology International, 23, pp. 51-58; Pan, Y., Chen, W., Xu, Y., Yi, X., Han, Y., Yang, Q., Wang, Y., Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis (2017) Circulation, 135 (1), pp. 21-33; Peck, G., Smeeth, L., Whittaker, J., Casas, J.P., Hingorani, A., Sharma, P., The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults (2008) PLOS One, 3 (11); Pei, H., Wang, W., Zhao, D., Wang, L., Su, G.H., Zhao, Z., The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: A systematic review and meta-analysis (2018) Medicine (Baltimore), 97 (16); Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Wittes, J., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators (1999) New England Journal of Medicine, 341 (10), pp. 709-717; Rabbani, N., Thornalley, P.J., Advanced glycation end products in the pathogenesis of chronic kidney disease (2018) Kidney International, 93 (4), pp. 803-813; Rafii, M.S., Hillis, A.E., Compendium of cerebrovascular diseases (2006) International Review of Psychiatry, 18 (5), pp. 395-407; Rigato, M., Monami, M., Fadini, G.P., Autologous cell therapy for peripheral arterial disease: Systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies (2017) Circulation Research, 120 (8), pp. 1326-1340; Roberts, I., Sydenham, E., Barbiturates for acute traumatic brain injury (2012) Cochrane Database of Systematic Reviews, , https://www.ncbi.nlm.nih.gov/pubmed/23235573, 12CD000033; El Sayed, I., Zaki, A., Fayed, A.M., Shehata, G.M., Abdelmonem, S., A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury (2018) Neurosurgical Review, 41 (2), pp. 427-438; Sedaghat, S., Mattace-Raso, F.U.S., Hoorn, E.J., Uitterlinden, A.G., Hofman, A., Ikram, M.A., Dehghan, A., Arterial Stiffness and Decline in Kidney Function (2015) Clinical Journal of the American Society of Nephrology, 10 (12), pp. 2190-2197; Song, Y., Stampfer, M.J., Liu, S., Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease (2004) Annals of Internal Medicine, 141 (2), pp. 137-147; Spanos, K., Karathanos, C., Athanasoulas, A., Saleptsis, V., Vasilopoulos, I., Xhepa, S., Giannoukas, A., Renal function impairment in patients undergoing elective EVAR vs. elective open repair during follow up period: A systematic review of the literature (2017) Current vascular pharmacology, 15 (2), pp. 103-111; Tang, J., Qin, Z., Li, X., Han, P., Wang, F., Yang, C., Zhang, W., Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis (2017) Oncotarget, 8 (30), pp. 50034-50050; Ueno, M., Elucidation of mechanism of blood-brain barrier damage for prevention and treatment of vascular dementia (2017) Rinsho Shinkeigaku (Clinical Neurology), 57 (3), pp. 95-109; Vagelatos, N.T., Eslick, G.D., Type 2 diabetes as a risk factor for Alzheimer’s disease: The confounders, interactions, and neuropathology associated with this relationship (2013) Epidemiologic Reviews, 35, pp. 152-160; Vazquez, F., Rodger, M., Carrier, M., Le Gal, G., Reny, J.L., Sofi, F., Gandara, E., Prothrombin G20210A mutation and lower extremity peripheral arterial disease: A systematic review and meta-analysis (2015) European Journal of Vascular and Endovascular Surgery, 50 (2), pp. 232-240; Violi, F., Soliman, E.Z., Pignatelli, P., Pastori, D., Atrial fibrillation and myocardial infarction: A systematic review and appraisal of pathophysiologic mechanisms (2016) Journal of the American Heart Association, 5 (5). , https://www.ncbi.nlm.nih.gov/pubmed/?term=PMC4889200; Vrsalovic, M., Vucur, K., Vrsalovic Presecki, A., Fabijanic, D., Milosevic, M., Impact of diabetes on mortality in peripheral artery disease: A meta-analysis (2017) Clinical Cardiology, 40 (5), pp. 287-291; Wang, J., Shen, C., Fu, Y., Yu, T., Song, J., The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: An updated meta-analysis (2017) OncoTargets and Therapy, 10, pp. 1725-1734; Wang, P., Yang, F., Liu, C.X., Wu, Y.M., Gu, C., Zhu, H.J., Association between PDE4D rs966221 polymorphism and risk of ischemic stroke: A systematic review and meta-analysis (2018) Metabolic Brain Disease, 33 (3), pp. 637-645; Wang, S.K., Murphy, M.P., Getting A leg up on cell therapy for critical limb ischemia (2017) Circulation Research, 120 (8), pp. 1227-1228; Webster, A., Nistor, I., Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease (2016) Nephrology, 21 (6), pp. 526-527; Whayne, T.F., Jr., Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review (2010) The International Journal of Angiology, 19 (3), pp. e96-e99; Xi, Z., Fang, F., Wang, J., AlHelal, J., Zhou, Y., Liu, W., CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis (2017) Platelets, pp. 1-12. , https://www.ncbi.nlm.nih.gov/pubmed/29257922; Yamagishi, S., Matsui, T., Role of ligands of receptor for advanced glycation end products (RAGE) in peripheral artery disease (2018) Rejuvenation Research., , https://www.ncbi.nlm.nih.gov/pubmed/29644926; Ye, Z., Liu, E.H., Higgins, J.P., Keavney, B.D., Lowe, G.D., Collins, R., Danesh, J., Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls (2006) Lancet, 367 (9511), pp. 651-658; Zhai, C.J., Yang, X.W., Sun, J., Wang, R., Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: A systematic review and meta-analysis (2015) International Urology and Nephrology, 47 (3), pp. 527-535; Zhu, Y., Ren, J., Ma, X., Chen, M.H., Zhou, Y., Jin, M., Liu, Z., Percutaneous revascularization for atherosclerotic renal artery stenosis: A meta-analysis of randomized controlled trials (2015) Annals of Vasular Surgery, 29 (7), pp. 1457-1467},
correspondence_address1={Gu, W.-W.; Department of Hepatopancreatobility Surgery, China; email: whywli@yahoo.com},
publisher={Wiley-Liss Inc.},
issn={00219541},
coden={JCLLA},
pubmed_id={30317627},
language={English},
abbrev_source_title={J. Cell. Physiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Solmi2018537,
author={Solmi, M. and Correll, C.U. and Carvalho, A.F. and Ioannidis, J.P.A.},
title={The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: Beyond qualitative synthesis},
journal={Epidemiology and Psychiatric Sciences},
year={2018},
volume={27},
number={6},
pages={537-542},
doi={10.1017/S204579601800032X},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050003201&doi=10.1017%2fS204579601800032X&partnerID=40&md5=1f43cc48d3d4ff47a7fcbe55ddf00ed8},
affiliation={Department of Neurosciences, University of Padua, Padua, Italy; University Hospital of Padua, Padua, Italy; Padova Neuroscience Center, University of Padua, Padua, Italy; Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, United States; Hofstra Northwell School of Medicine, Department of Psychiatry and Molecular Medicine, Hempstead, NY, United States; Charité Universitätsmedizin, Department of Child and Adolescent Psychiatry, Berlin, Germany; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, United States; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States; Meta-Research Innovation Center at Stanford, Stanford University, Stanford, CA, United States; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, United States},
abstract={(Primum non nocere)-Hιppocrates' principle should still guide daily medical prescribing. Therefore, assessing evidence of psychopharmacologic agents' safety and harms is essential. Randomised controlled trials (RCTs) and observational studies may provide complementary information about harms of psychopharmacologic medications from both experimental and real-world settings. It is considered that RCTs provide a better control of confounding variables, while observational studies provide evidence from larger samples, longer follow-ups, in more representative samples, which may be more reflective of real-life clinical scenarios. However, this may not always hold true. Moreover, in observational studies, safety data are poorly or inconsistently reported, precluding reliable quantitative synthesis in meta-analyses. Beyond individual studies, meta-analyses, which represent the highest level of 'evidence', can be misleading, redundant and of low methodological quality. Overlapping meta-analyses sometimes even reach different conclusions on the same topic. Meta-analyses should be assessed systematically. Descriptive reviews of reviews can be poorly informative. Conversely, 'umbrella reviews' can use a quantitative approach to grade evidence. In this editorial, we present the main factors involved in the assessment of psychopharmacologic agents' harms from individual studies, meta-analyses and umbrella reviews. Study design features, sample size, number of the events of interest, summary effect sizes, p-values, heterogeneity, 95% prediction intervals, confounding factor adjustment and tests of bias (e.g., small-study effects and excess significance) can be combined with other assessment tools, such as AMSTAR and GRADE to create a framework for assessing the credibility of evidence. © 2018 Cambridge University Press.},
author_keywords={Meta-analysis;  psychotropic medications;  safety;  umbrella review},
keywords={psychotropic agent;  psychotropic agent, Article;  clinical assessment tool;  drug safety;  drug screening;  evidence based practice;  experimental study;  follow up;  human;  meta analysis (topic);  observational study;  prediction;  quality control;  randomized controlled trial (topic);  reproducibility;  sample size;  methodology;  psychopharmacology, Humans;  Meta-Analysis as Topic;  Psychopharmacology;  Psychotropic Drugs;  Research Design},
chemicals_cas={Psychotropic Drugs},
references={(2013) Diagnostic and Statistical Manual of Mental Disorders, 5th Edn., , American Psychiatric Association Washington DC: Author; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and amyotrophic lateral sclerosis: An Umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies (2016) Neuroepidemiology, 46, pp. 96-105; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Related Disorders, 23, pp. 1-9; Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Leucht, S., Geddes, J.R., Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis (2018) Lancet, 391, pp. 1357-1366; Cohen, J., (1988) Statistical Power Analysis for the Behavioral Sciences, , (Ed Routledge); Correll, C.U., Rubio, J.M., Inczedy-Farkas, G., Birnbaum, M.L., Kane, J.M., Leucht, S., Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence (2017) Journal of American Medical Association Psychiatry, 74, pp. 675-684; Ebrahim, S., Sohani, Z.N., Montoya, L., Agarwal, A., Thorlund, K., Mills, E.J., Ioannidis, J.P., Reanalyses of randomized clinical trial data (2014) Journal of America Medical Association, 312, pp. 1024-1032; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) British Medical Journal, 315, pp. 629-634; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Statistics in Medicine, 21, pp. 1539-1558; Inthout, J., Ioannidis, J.P., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) British Medical Journal Open, 6, p. e010247; Ioannidis, J.P., Adverse events in randomized trials: Neglected, restricted, distorted, and silenced (2009) Archives of Internal Medicine, 169, pp. 1737-1739; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) Canadian Medical Association Journal, 181, pp. 488-493; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) The Milbank Quarterly, 94, pp. 485-514; Ioannidis, J., Next-generation systematic reviews: Prospective meta-analysis, individual-level data, networks and umbrella reviews (2017) British Journal of Sports Medicine, 51, pp. 1456-1458; Ioannidis, J.P.A., The proposal to lower p value thresholds to .005 (2018) Journal of American Medical Association, 319, pp. 1429-1430; Ioannidis, J.P., Lau, J., Can quality of clinical trials and meta-analyses be quantified (1998) Lancet, 352, pp. 590-591; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clinical Trials, 4, pp. 245-253; Ioannidis, J.P., Evans, S.J., Gotzsche, P.C., O'Neill, R.T., Altman, D.G., Schulz, K., Moher, D., Group, C., Better reporting of harms in randomized trials: An extension of the CONSORT statement (2004) Annals of Internal Medicine, 141, pp. 781-788; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) British Medical Journal, 335, pp. 914-916; Iqbal, S.A., Wallach, J.D., Khoury, M.J., Schully, S.D., Ioannidis, J.P., Reproducible research practices and transparency across the biomedical literature (2016) PLoS Biology, 14, p. e1002333; Lau, J., Ioannidis, J.P., Terrin, N., Schmid, C.H., Olkin, I., The case of the misleading funnel plot (2006) British Medical Journal, 333, pp. 597-600; Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F., Samara, M., Davis, J.M., Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis (2013) Lancet, 382, pp. 951-962; Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K.K., Ioannidis, J.P., Campbell, H., Theodoratou, E., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) British Medical Journal, 357, p. j2376; Munafò, M.R., Nosek, B.A., Bishop, D.V.M., Button, K.S., Chambers, C.D., Percie Du Sert, N., Simonsohn, U., Ioannidis, J.P.A., A manifesto for reproducible science (2017) Nature Human Behaviour, 1, p. 0021; Naudet, F., Sakarovitch, C., Janiaud, P., Cristea, I., Fanelli, D., Moher, D., Ioannidis, J.P.A., Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: Survey of studies published in the BMJ and PLOS medicine (2018) British Medical Journal, 360, p. k400; Papanikolaou, P.N., Ioannidis, J.P., Availability of large-scale evidence on specific harms from systematic reviews of randomized trials (2004) American Journal of Medicine, 117, pp. 582-589; Papanikolaou, P.N., Christidi, G.D., Ioannidis, J.P., Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies (2006) Canadian Medical Association Journal, 174, pp. 635-641; Pollock, M., Fernandes, R.M., Hartling, L., Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions (2017) BioMed Central Medical Research Methodology, 17, p. 48; Prasad, V., Jena, A.B., Prespecified falsification end points: Can they validate true observational associations (2013) Journal of American Medical Association, 309, pp. 241-242; Sawilowsky, S., New effect size rules of thumb (2009) Journal of Modern Applied Statistical Methods, 8, pp. 467-474; Schünemann, H., Broek, J., Guyatt, G.A., Oxman, A., (2013) Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach, , http://gdt.guidelinedevelopment.org/app/handbook/handbook.html, Accessed 31 May 2018; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) Journal of Clinical Epidemiol, 62, pp. 1013-1020; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Henry, D.A., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) British Medical Journal, 358, p. j4008; Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Carvalho, A.F., Safety, tolerability, and risks associated with firstand second-generation antipsychotics: A state-of-the-art clinical review (2017) Therapeutics and Clinical Risk Management, 13, pp. 757-777; Sterne, J.A., Sutton, A.J., Ioannidis, J.P., Terrin, N., Jones, D.R., Lau, J., Carpenter, J., Higgins, J.P., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) British Medical Journal, 343, p. d4002; Stodden, V., McNutt, M., Bailey, D.H., Deelman, E., Gil, Y., Hanson, B., Heroux, M.A., Taufer, M., Enhancing reproducibility for computational methods (2016) Science, 354, pp. 1240-1241; Szucs, D., Ioannidis, J.P.A., When null hypothesis significance testing is unsuitable for research: A reassessment (2017) Frontiers in Human Neuroscience, 11, p. 390; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) British Medical Journal, 348, p. g2035; Veronese, N., Solmi, M., Caruso, M.G., Giannelli, G., Osella, A.R., Evangelou, E., Maggi, S., Tzoulaki, I., Dietary fiber and health outcomes: An umbrella review of systematic reviews and metaanalyses (2018) American Journal of Clinical Nutrition, 107, pp. 436-444; Wasserstein, R.L., Lazar, N.A., The ASA' s statement on p-values: Context, process, and purpose (2016) The American Statistician, 70, pp. 129-133; Weihrauch, T.R., Gauler, T.C., Placebo-efficacy and adverse effects in controlled clinical trials (1999) Arzneimittel-Forschung, 49, pp. 385-393; Wells, G., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., (2013) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses, , http://www.ohri.ca/programs/clinicalepidemiology/oxford.asp, Accessed 31 May 2018; Zorzela, L., Loke, Y.K., Ioannidis, J.P., Golder, S., Santaguida, P., Altman, D.G., Moher, D., Vohra, S., PRISMA harms checklist: Improving harms reporting in systematic reviews (2016) British Medical Journal, 352, p. i157},
correspondence_address1={Solmi, M.; Department of Neurosciences, Italy; email: marco.solmi83@gmail.com},
publisher={Cambridge University Press},
issn={20457960},
pubmed_id={30008278},
language={English},
abbrev_source_title={Epidemiol. Psychiatr. Sci.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Little2017243,
author={Little, J. and Barakat-Haddad, C. and Martino, R. and Pringsheim, T. and Tremlett, H. and McKay, K.A. and van Lieshout, P. and Walsh, S.J. and Gomes, J. and Krewski, D.},
title={Genetic variation associated with the occurrence and progression of neurological disorders},
journal={NeuroToxicology},
year={2017},
volume={61},
pages={243-264},
doi={10.1016/j.neuro.2016.09.018},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995380130&doi=10.1016%2fj.neuro.2016.09.018&partnerID=40&md5=c482b4c2d9819decbb97d8a9f117443f},
affiliation={School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Faculty of Health Sciences, University of Ontario Institute of Technology, Canada; Department of Speech-Language Pathology, University of Toronto, Canada; Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Canada; Rehabilitation Sciences Institute, University of Toronto, Canada; University of Calgary and the Hotchkiss Brain Institute, Calgary, AB, Canada; Faculty of Medicine (Neurology), Djavad Mowafaghian Centre for Brain Health, Vancouver Coastal Health Research Institute, University of British Columbia, Canada; Department of Psychology, University of Toronto, Canada; Toronto Rehabilitation Institute, University Health Network, Canada; Newfoundland and Labrador Centre for Health Information, 70 O'Leary Avenue, St. John's, NL, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; Risk Sciences International, Ottawa, Ontario, Canada},
abstract={This paper presents an overview of genetic variation associated with the onset and progression of 14 neurological disorders, focusing primarily on association studies. The 14 disorders are heterogeneous in terms of their frequency, age of onset, etiology and progression. There is substantially less evidence on progression than onset. With regard to onset, the conditions are diverse in terms of their epidemiology and patterns of familial aggregation. While the muscular dystrophies and Huntington's disease are monogenic diseases, for the other 12 conditions only a small proportion of cases is associated with specific genetic syndromes or mutations. Excluding these, some familial aggregation remains for the majority of cases. There is considerable variation in the volume of evidence by condition, and by gene within condition. The volume of evidence is greatest for Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. As for common complex chronic diseases, genome wide association studies have found that validated genomic regions account for a low proportion of heritability. Apart from multiple sclerosis, which shares several susceptibility loci with other immune-related disorders, variation at HLA-DRB5 being associated both with Parkinson's disease and Alzheimer's disease, and the association of the C9orf72 repeat expansion with ALS and frontotemporal degeneration, there was little evidence of gene loci being consistently associated with more than one neurological condition or with other conditions. With the exception of spina bifida, for which maternal MTHFR genotype is associated with risk in the offspring, and corroborates other evidence of the importance of folate in etiology, there was little evidence that the pathways influenced by genetic variation are related to known lifestyle or environmental exposures. © 2016},
author_keywords={Familial association;  Genetic variation;  Genome wide association;  Neurological condition;  Onset;  Progression},
keywords={Alzheimer disease;  amyotrophic lateral sclerosis;  Article;  Becker muscular dystrophy;  cerebral palsy;  disease course;  disease severity;  dopamine responsive dystonia;  Duchenne muscular dystrophy;  dystonia;  Emery Dreifuss muscular dystrophy;  facioscapulohumeral muscular dystrophy;  gene frequency;  genetic risk;  genetic screening;  genetic susceptibility;  genetic variation;  genome-wide association study;  genotype;  Gilles de la Tourette syndrome;  glioblastoma;  homozygote;  human;  Huntington chorea;  hydrocephalus;  idiopathic torsion dystonia;  limb girdle muscular dystrophy;  missense mutation;  multiple sclerosis;  myoclonus dystonia;  nervous system injury;  nonhuman;  Parkinson disease;  pathogenicity;  priority journal;  promoter region;  single nucleotide polymorphism;  spinal dysraphism;  temporal lobe epilepsy;  torsion dystonia;  disease exacerbation;  genetic variation;  genetics;  genome-wide association study;  neurologic disease, guanine nucleotide exchange C9orf72;  HLA DRB5 antigen;  methylenetetrahydrofolate reductase (NADPH2);  MTHFR protein, human, C9orf72 Protein;  Disease Progression;  Genetic Variation;  Genome-Wide Association Study;  HLA-DRB5 Chains;  Humans;  Methylenetetrahydrofolate Reductase (NADPH2);  Nervous System Diseases},
chemicals_cas={methylenetetrahydrofolate reductase (NADPH2), 71822-25-8; C9orf72 Protein; HLA-DRB5 Chains; Methylenetetrahydrofolate Reductase (NADPH2); MTHFR protein, human},
references={ALSGEN Consortium, Ahmeti, K.B., Ajroud-Driss, S., Al-Chalabi, A., Andersen, P.M., Armstrong, J., Birve, A., Zheng, J.G., Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34. 1 (2013) Neurobiol. Aging, 34 (357), p. e7. , (357.19); http://xgene.molgen.mpg.de/alsgene/view?gene=APOE, ALSGene. APOE, chr19:45409011-45412650+/−50000 base pairs. (2016). Located at: (accessed 23.03.16.); Akimoto, C., Volk, A.E., van Blitterswijk, M., Van den Broeck, M., Leblond, C.S., Lumbroso, S., Camu, W., Kubisch, C., A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories (2014) J. Med. Genet., 51, pp. 419-424; Al-Chalabi, A., aLewis, C.M., Modelling the effects of penetrance and family size on rates of sporadic and familial disease (2011) Hum. Hered., 71, pp. 281-288; Al-Chalabi, A., Fang, F., Hanby, M.F., Leigh, P.N., Shaw, C.E., Ye, W., Rijsdijk, F., An estimate of amyotrophic lateral sclerosis heritability using twin data (2010) J. Neurol. Neurosur. Psychiatry, 81, pp. 1324-1326; Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., van den Berg, L.H., The genetics and neuropathology of amyotrophic lateral sclerosis (2012) Acta Neuropathol., 124, pp. 339-352; http://xgene.molgen.mpg.de/alsgene/top_results, ALSGene. Top results. (2016). Located at:, (accessed 21.03.16.); http://alsod.iop.kcl.ac.uk/Summary/summary.aspx, ALSoD. The Amyotrophic Lateral Sclerosis Online Genetic Database. (2013). Located at: (accessed 18.12.13.); http://www.alzgene.org/TopResults.asp, AlzGene. Top results. (2011). Located at: (accessed 24.03.16.); Antunez, C., Boada, M., Gonzalez-Perez, A., Gayan, J., Ramirez-Lorca, R., Marin, J., Hernandez, I., Ruiz, A., The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease (2011) Genome Med., 3, p. 33; Asadi-Pooya, A.A., Hojabri, K., Risk factors for childhood epilepsy: a case-control study (2005) Epilepsy Behav., 6, pp. 203-206; Au, K.S., Ashley-Koch, A., Northrup, H., Epidemiologic and genetic aspects of spina bifida and other neural tube defects (2010) Dev. Disabil. Res. Rev., 16, pp. 6-15; Barakat-Haddad, C., Shin, S., Candundo, H., Van Lieshout, P., Martino, R., A systematic review of risk factors associated with muscular dystrophies (2017) Neurotoxicology, 61, pp. 55-62; Beck, J., Poulter, M., Hensman, D., Rohrer, J.D., Mahoney, C.J., Adamson, G., Campbell, T., Mead, S., Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population (2013) Am. J. Hum. Genet., 92, pp. 345-353; Bello, L., Piva, L., Barp, A., Taglia, A., Picillo, E., Vasco, G., Pane, M., Pegoraro, E., Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy (2012) Neurology, 79, pp. 159-162; Benamer, H.T., de Silva, R., LRRK2 G2019S in the North African population: a review (2010) Eur. Neurol., 63, pp. 321-325; Benitez, B.A., Cruchaga, C., United States-Spain Parkinson's Disease Research Group, TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, pp. 1567-1568; Berg, D., Niwar, M., Maass, S., Zimprich, A., Moller, J.C., Wuellner, U., Schmitz-Hubsch, T., Riess, O., Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1900 patients (2005) Mov. Disord., 20, pp. 1191-1194; Berry, R.J., Bailey, L., Mulinare, J., Bower, C., Folic Acid Working Group, Fortification of flour with folic acid (2010) Food Nutr. Bull., 31, pp. S22-S35; Berry, R.J., Li, Z., Erickson, J.D., Li, S., Moore, C.A., Wang, H., Mulinare, J., Correa, A., Prevention of neural-tube defects with folic acid in China (1999) N. Engl. J. Med., 341, pp. 1485-1490; Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database (2007) Nat. Genet., 39, pp. 17-23; Bertram, L., Parrado, A.R., Tanzi, R.E., TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, p. 1565; Blair, D.R., Lyttle, C.S., Mortensen, J.M., Bearden, C.F., Jensen, A.B., Khiabanian, H., Melamed, R., Rzhetsky, A., A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk (2013) Cell, 155, pp. 70-80; Botto, L., Yang, Q., 5, 10-Methylenetetrahydrofolate Reductase gene variants and congenital anomalies: a HuGE review (2000) Am. J. Epidemiol., 151, pp. 862-877; Brancati, F., Valente, E.M., Castori, M., Vanacore, N., Sessa, M., Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia (2003) J. Neurol. Neurosurg. Psychiatry, 74, pp. 665-666; Bressman, S.B., Raymond, D., Fuchs, T., Heiman, G.A., Ozelius, L.J., Saunders-Pullman, R., Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study (2009) Lancet Neurol., 8, pp. 441-446; Burton, P.R., Hansell, A.L., Fortier, I., Manolio, T.A., Khoury, M.J., Little, J., Elliott, P., Size matters: just how big is BIG?: quantifying realistic sample size requirements for human genome epidemiology (2009) Int. J. Epidemiol., 38, pp. 263-273; Cady, J., Koval, E.D., Benitez, B.A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R.H., Harms, M.B., TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis (2014) JAMA Neurol., 71, pp. 449-453; Cardenas-Roldan, J., Rojas-Villarraga, A., Anaya, J.M., How do autoimmune diseases cluster in families? A systematic review and meta-analysis (2013) BMC Med., 11, p. 73. , (7015-11-73); Castellan Baldan, L., Williams, K.A., Gallezot, J.D., Pogorelov, V., Rapanelli, M., Crowley, M., Anderson, G.M., Pittenger, C., Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice (2014) Neuron, 81, pp. 77-90; http://www.cdc.gov/ncbddd/cp/data.html, Centers for Disease Control and Prevention. Cerebral palsy (CP). 2013. Located at: (accessed 15.01.14.); Centers for Disease Control and Prevention, 2009. Prevalence of diagnosed Tourette syndrome in persons aged 6–17 years—United States, 2007 (2009) MMWR Morb. Mortal. Wkly. Rep., 58, pp. 581-585; Chan, K.Y., Wang, W., Wu, J.J., Liu, L., Theodoratou, E., Car, J., Middleton, L., Global Health Epidemiology Reference Group (GHERG), Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis (2010) Lancet, 381, pp. 2016-2023; Che, H.V., Metzger, S., Portal, E., Deyle, C., Riess, O., Nguyen, H.P., Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease (2011) Mol. Neurodegener., 6, p. 1; Christensen, K., Thinggaard, M., Oksuzyan, A., Steenstrup, T., Andersen-Ranberg, K., Jeune, B., McGue, M., Vaupel, J.W., Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart (2013) Lancet, 382, pp. 1507-1513; Conti, A.M., Pullman, S., Frucht, S.J., The hand that has forgotten its cunning–lessons from musicians’ hand dystonia (2008) Mov. Disord., 23, pp. 1398-1406; Coon, K.D., Myers, A.J., Craig, D.W., Webster, J.A., Pearson, J.V., Lince, D.H., Zismann, V.L., Stephan, D.A., A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease (2007) J. Clin. Psychiatry, 68, pp. 613-618; Cooper-Knock, J., Shaw, P.J., Kirby, J., The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype (2014) Acta Neuropathol., 127, pp. 333-345; Copp, A.J., Stanier, P., Greene, N.D., Neural tube defects: recent advances, unsolved questions, and controversies (2013) Lancet Neurol., 12, pp. 799-810; Cordoba, M., Consalvo, D., Moron, D.G., Kochen, S., Kauffman, M.A., SLC6A4 gene variants and temporal lobe epilepsy susceptibility: a meta-analysis (2012) Mol. Biol. Rep., 39, pp. 10615-10619; Corti, O., Lesage, S., Brice, A., What genetics tells us about the causes and mechanisms of Parkinson's disease (2011) Physiol. Rev., 91, pp. 1161-1218; Cramer, S.C., Sampat, A., Haske-Palomino, M., Nguyen, S., Procaccio, V., Hermanowicz, N., Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia (2010) Neurosci. Lett., 468, pp. 42-45; Cummings, A.C., Jiang, L., Velez Edwards, D.R., McCauley, J.L., Laux, R., McFarland, L.L., Fuzzell, D., Haines, J.L., Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene (2012) Ann. Hum. Genet., 76, pp. 342-351; Cuyvers, E., Bettens, K., Philtjens, S., Van Langenhove, T., Gijselinck, I., van der Zee, J., Engelborghs, S., BELNEU consortium, Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia (2014) Neurobiol. Aging, 35 (726), pp. e11-e19; Czeizel, A.E., Dudas, I., Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation (1992) N. Engl. J. Med., 327, pp. 1832-1835; Daoud, A.S., Batieha, A., Bashtawi, M., El-Shanti, H., Risk factors for childhood epilepsy: a case-control study from Irbid, Jordan (2003) Seizure, 12, pp. 171-174; Davey Smith, G., Ebrahim, S., ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) Int. J. Epidemiol., 32, pp. 1-22; Dearlove, J.V., Fisher, P.G., Buffler, P.A., Family history of cancer among children with brain tumors: a critical review (2008) J. Pediatr. Hematol. Oncol., 30, pp. 8-14; Defazio, G., Abbruzzese, G., Girlanda, P., Buccafusca, M., Curra, A., Marchese, R., Martino, D., Berardelli, A., Primary cervical dystonia and scoliosis: a multicenter case-control study (2003) Neurology, 60, pp. 1012-1015; Defazio, G., Matarin, M., Peckham, E.L., Martino, D., Valente, E.M., Singleton, A., Crawley, A., Berardelli, A., The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm (2009) Mov. Disord., 24, pp. 613-616; DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Rademakers, R., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS (2011) Neuron, 72, pp. 245-256; Deng, H., Gao, K., Jankovic, J., The role of FUS gene variants in neurodegenerative diseases (2014) Nat. Rev. Neurol., 10, pp. 337-348; Dhaenens, C.M., Krystkowiak, P., Douay, X., Charpentier, P., Bele, S., Destee, A., Sablonniere, B., Clinical and genetic evaluation in a French population presenting with primary focal dystonia (2005) Mov. Disord., 20, pp. 822-825; Diekstra, F.P., Van Deerlin, V.M., van Swieten, J.C., Al-Chalabi, A., Ludolph, A.C., Weishaupt, J.H., Hardiman, O., Veldink, J.H., C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis (2014) Ann. Neurol., 76, pp. 120-133; Donnan, J., Morrissey, A., Sikora, L., Walsh, S., Collins, K., MacDonald, D., A systematic review of the risk factors associated with the onset and natural progression of spina bifida (2017) Neurotoxicology, 61, pp. 20-31; Donnan, J., Walsh, S., Fortin, Y., Sikora, L., Eka, U., Morrissey, A., Bowen, S., MacDonald, D., Systematic review of the risk factors associated with the onset and natural progression of epilepsy (2017) Neurotoxicology, 61, pp. 64-77; Ebbert, M.T., Ridge, P.G., Wilson, A.R., Sharp, A.R., Bailey, M., Norton, M.C., Tschanz, J.T., Kauwe, J.S., Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions (2014) Biol. Psychiatry, 75, pp. 732-737; Ebers, G.C., Sadovnick, A.D., Risch, N.J., A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group (1995) Nature, 377, pp. 150-151; Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y.I., Zenvirt, S., Jalas, C., Elpeleg, O., A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism (2012) PLoS, 7, p. e36458; Elwood, J.M., Elwood, J.H., Little, J., Classification, anatomy and embryology (1992) Epidemiology and Control of Neural Tube Defects, pp. 10-36. , J.M. Elwood J. Little J.H. Elwood Oxford University Press New York; Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen, A.S., Berkovic, S.F., Cossette, P., Delanty, N., Dlugos, D., Winawer, M.R., De novo mutations in epileptic encephalopathies (2013) Nature, 501, pp. 217-221; EPICURE Consortium, EMINet Consortium, Steffens, M., Leu, C., Ruppert, A.K., Zara, F., Striano, P., Sander, T., Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32 (2012) Hum. Mol. Genet., 21, pp. 5359-5372; Ercan-Sencicek, A.G., Stillman, A.A., Ghosh, A.K., Bilguvar, K., O'Roak, B.J., Mason, C.E., Abbott, T., State, M.W., L-histidine decarboxylase and Tourette's syndrome (2010) N. Engl. J. Med., 362, pp. 1901-1908; Eser, B., Cosar, M., Eser, O., Erdogan, M.O., Aslan, A., Yildiz, H., Boyaci, G., Solak, M., 677C > T and 1298A > C polymorphisms of methylenetetrahydropholate reductase gene and biochemical parameters in Turkish population with spina bifida occulta (2010) Turk Neurosurg., 20, pp. 9-15; http://www.eurocat-network.eu/accessprevalencedata/prevalencetables, EUROCAT. European surveillance of congenital anomalies. Prevalence tables. (2013). Located at: (accessed January 15.01.14.); EuroEPINOMICS-RES Consortium Electronic address: euroepinomics-RES@ua. ac. be, Epilepsy Phenome/Genome Project, Epi4K Consortium, EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium, De Novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies (2014) Am. J. Hum. Genet., 95, pp. 360-370; Evans, C., Beland, S.G., Kulaga, S., Wolfson, C., Kingwell, E., Marriott, J., Koch, M., Marrie, R.A., Incidence and prevalence of multiple sclerosis in the Americas: a systematic review (2013) Neuroepidemiology, 40, pp. 195-210; Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., van Duijn, C.M., Effects of age, sex, ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium (1997) JAMA, 278, pp. 1349-1356; Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Bray, F., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] (2013), http://globocan.iarc.fr, International Agency for Research on Cancer Lyon, France Located at:, (accessed 21.01.14.); Ferrari, R., Kapogiannis, D., Huey, E.D., Momeni, P., FTD and ALS: a tale of two diseases (2011) Curr. Alzheimer Res., 8, pp. 273-294; Feulner, T.M., Laws, S.M., Friedrich, P., Wagenpfeil, S., Wurst, S.H., Riehle, C., Kuhn, K.A., Riemenschneider, M., Examination of the current top candidate genes for AD in a genome-wide association study (2010) Mol. Psychiatry, 15, pp. 756-766; Figley, M.D., Thomas, A., Gitler, A.D., Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis (2014) Neurobiol. Aging, 35936, pp. e1-4; Finelli, D., Rollinson, S., Harris, J., Jones, M., Richardson, A., Gerhard, A., Snowden, J., Pickering-Brown, S., TREM2 analysis and increased risk of Alzheimer's disease (2014) Neurobiol. Aging, 36 (546), pp. e9-e13; Finsterer, J., Burgunder, J.M., Recent progress in the genetics of motor neuron disease (2014) Eur. J. Med. Genet., 57, pp. 103-112; Fogh, I., Ratti, A., Gellera, C., Lin, K., Tiloca, C., Moskvina, V., Corrado, L., the SLAGEN Consortium Collaborators, A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis (2014) Hum. Mol. Genet., 23, pp. 2220-2231; Fortier, I., Burton, P.R., Robson, P.J., Ferretti, V., Little, J., L'Heureux, F., Deschenes, M., Hudson, T.J., Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies (2010) Int. J. Epidemiol., 39, pp. 1383-1393; Fortier, I., Doiron, D., Little, J., Ferretti, V., L'Heureux, F., Stolk, R.P., Knoppers, B.M., International Harmonization Initiative, Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies (2011) Int. J. Epidemiol., 40, pp. 1314-1328; Frazer, K.A., Murray, S.S., Schork, N.J., Topol, E.J., Human genetic variation and its contribution to complex traits (2009) Nat. Rev. Genet., 10, pp. 241-251; Frederic, M.Y., Clot, F., Blanchard, A., Dhaenens, C.M., Lesca, G., Cif, L., The p.Asp216His TOR1A allele effect is not found in the French population (2009) Mov. Disord., 24, pp. 919-921; Gaj, P., Paziewska, A., Bik, W., Dabrowska, M., Baranowska-Bik, A., Styczynska, M., Chodakowska-Zebrowska, M., Ostrowski, J., Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients (2012) J. Alzheimers Dis., 32, pp. 157-168; Gallagher, M.D., Suh, E., Grossman, M., Elman, L., McCluskey, L., Van Swieten, J.C., Al-Sarraj, S., Chen-Plotkin, A.S., TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions (2014) Acta Neuropathol., 127, pp. 407-418; Gascon, E., Gao, F.B., The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders (2014) J. Neurogenet., 28, pp. 30-40; Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A., Pedersen, N.L., Role of genes and environments for explaining Alzheimer disease (2006) Arch. Gen. Psychiatry, 63, pp. 168-174; Gerrits, M.C., Foncke, E.M., de Haan, R., Hedrich, K., van de Leemput, Y.L., Baas, F., Ozelius, L.J., Tijssen, M.A., Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia (2006) Neurology, 66, pp. 759-761; Goldberg, Y.P., McMurray, C.T., Zeisler, J., Almqvist, E., Sillence, D., Richards, F., Gacy, A.M., Hayden, M.R., Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population (1995) Hum. Mol. Genet., 4, pp. 1911-1918; Goris, A., van Setten, J., Diekstra, F., Ripke, S., Patsopoulos, N.A., Sawcer, S.J., The International Multiple Sclerosis Genetics Consortium, de Bakker, P.I., No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis (2014) Hum. Mol. Genet., 23, pp. 1916-1922; Gorlov, I.P., Gorlova, O.Y., Sunyaev, S.R., Spitz, M.R., Amos, C.I., Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms (2008) Am. J. Hum. Genet., 82, pp. 100-112; Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., Meitinger, T., Strom, T.M., The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted (2003) Eur. J. Hum. Genet., 11, pp. 138-144; Graham, A.J., Macdonald, A.M., Hawkes, C.H., British motor neuron disease twin study (1997) J. Neurol. Neurosurg. Psychiatry, 62, pp. 562-569; Green, R.C., Roberts, J.S., Cupples, L.A., Relkin, N.R., Whitehouse, P.J., Brown, T., Eckert, S.L., REVEAL Study Group, Disclosure of APOE genotype for risk of Alzheimer's disease (2009) N. Engl. J. Med., 361, pp. 245-254; Guerreiro, R., Hardy, J., TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, pp. 1569-1570; Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Alzheimer Genetic Analysis Group, TREM2 variants in Alzheimer's disease (2013) N. Engl. J. Med., 368, pp. 117-127; Guo, Y., Baum, L.W., Sham, P.C., Wong, V., Ng, P.W., Lui, C.H., Sin, N.C., Kwan, P., Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese (2012) Hum. Mol. Genet., 21, pp. 1184-1189; Haerian, B.S., Lim, K.S., Tan, H.J., Wong, C.P., Wong, S.W., Tan, C.T., Raymond, A.A., Mohamed, Z., Lack of association between synapsin II (SYN2) gene polymorphism and susceptibility epilepsy: a case-control study and meta-analysis (2011) Synapse, 65, pp. 1073-1079; Hassin-Baer, S., Laitman, Y., Azizi, E., Molchadski, I., Galore-Haskel, G., Barak, F., Cohen, O.S., Friedman, E., The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel (2009) J. Neurol., 256, pp. 483-487; Hattersley, A.T., McCarthy, M.I., What makes a good genetic association study? (2005) Lancet, 366, pp. 1315-1323; Hawkes, C.H., Macgregor, A.J., Twin studies and the heritability of MS: a conclusion (2009) Mult. Scler., 15, pp. 661-667; Hećimović, S., Klepac, N., Vlasić, J., Vojta, A., Janko, D., Skarpa-Prpić, I., Canki-Klain, N., Pavelić, K., Genetic background of Huntington disease in Croatia: molecular analysis of CAG, CCG, Delta2642 (E2642del) polymorphisms (2002) Hum. Mutat., 20, p. 233; Hemminki, K., Li, X., Johansson, S.E., Sundquist, K., Sundquist, J., Familial risks for epilepsy among siblings based on hospitalizations in Sweden (2006) Neuroepidemiology, 27, pp. 67-73; Hemminki, K., Li, X., Sundquist, J., Hillert, J., Sundquist, K., Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions (2009) Neurogenetics, 10, pp. 5-11; Hemminki, K., Li, X., Sundquist, K., Sundquist, J., High familial risks for cerebral palsy implicate partial heritable aetiology (2007) Paediatr. Perinat. Epidemiol., 21, pp. 235-241; Hersi, M., Irvine, B., Krewski, D., Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence (2017) Neurotoxicology, 61, pp. 143-187; Hersi, M., Quach, P., Wand, M.-D., Gomes, J., Gaskin, J., Krewski, D., Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview (2017) Neurotoxicology, pp. 12-18; Hindorff, L.A., Junkins, H.A., Hall, P.N., Mehta, J.P., Manolio, T.A., A Catalog of Published Genome-Wide Association Studies (2013), http://www.genome.gov/26525384, Located at:, (accessed 19.12.13.); Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Carrasquillo, M.M., Abraham, R., Williams, J., Common variants at ABCA7, MS4A6A/MS4A4E EPHA1, CD33 and CD2AP are associated with Alzheimer's disease (2011) Nat. Genet., 43, pp. 429-435; Iguchi, Y., Katsuno, M., Ikenaka, K., Ishigaki, S., Sobue, G., Amyotrophic lateral sclerosis: an update on recent genetic insights (2013) J. Neurol., 260, pp. 2917-2927; International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., McCauley, J.L., Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) Nat. Genet., 45, pp. 1353-1360; Iyengar, S.K., Elston, R.C., The genetic basis of complex traits: rare variants or “common gene, common disease”? (2007) Methods Mol. Biol., 376, pp. 71-84; Johnson, W.G., Stenroos, E.S., Spychala, J.R., Chatkupt, S., Ming, S.X., Buyske, S., New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? (2004) Am. J. Med. Genet A., 124A, pp. 339-345; Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P.V., Snaedal, J., Bjornsson, S., Stefansson, K., Variant of TREM2 associated with the risk of Alzheimer's disease (2013) N. Engl. J. Med., 368, pp. 107-116; Jonsson, T., Stefansson, K., TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, pp. 1568-1569; Jouet, M., Rosenthal, A., MacFarlane, J., Kenwrick, S., Donnai, D., A missense mutation confirms the L1 defect in X-linked hydrocephalus (HSAS) (1993) Nat. Genet., 4, p. 331; Juriloff, D.M., Harris, M.J., A consideration of the evidence that genetic defects in planar cell polarity contribute to the etiology of human neural tube defects (2012) Birth Defects Res. A Clin. Mol. Teratol., 94, pp. 824-840; Kamboh, M.I., Demirci, F.Y., Wang, X., Minster, R.L., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Barmada, M.M., Genome-wide association study of Alzheimer's disease (2012) Transl. Psychiatry, 2, p. e117; Kamm, C., Uflacker, N., Asmus, F., Schrader, C., Wolters, A., Wittstock, M., Pahnke, J., Lohmann, K., No evidence for THAP1/DYT6 variants as disease modifiers in DYT1 dystonia (2011) Mov. Disord., 26, pp. 2136-2137; Kasperaviciute, D., Catarino, C.B., Heinzen, E.L., Depondt, C., Cavalleri, G.L., Caboclo, L.O., Tate, S.K., Sisodiya, S.M., Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study (2010) Brain, 133, pp. 2136-2147; Kasperaviciute, D., Catarino, C.B., Matarin, M., Leu, C., Novy, J., Tostevin, A., Leal, B., Sisodiya, S.M., Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A (2013) Brain, 136, pp. 3140-3150; Kauffman, M.A., Consalvo, D., Gonzalez, M.D., Kochen, S., Transcriptionally less active prodynorphin promoter alleles are associated with temporal lobe epilepsy: a case-control study and meta-analysis (2008) Dis. Markers, 24, pp. 135-140; Kauffman, M.A., Moron, D.G., Consalvo, D., Bello, R., Kochen, S., Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis (2008) Genet. Med., 10, pp. 83-88; Kauffman, M.A., Consalvo, D., Moron, D.G., Lereis, V.P., Kochen, S., ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis (2010) Epilepsy Res., 90, pp. 234-239; Keller, M.F., Ferrucci, L., Singleton, A.B., Tienari, P.J., Laaksovirta, H., Restagno, G., Chio, A., Nalls, M.A., Genome-wide analysis of the heritability of amyotrophic lateral sclerosis (2014) JAMA Neurol., 71, pp. 1123-1134; Keller, M.F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Wellcome Trust Case Control Consortium 2 (WTCCC2), Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson's disease (2012) Hum. Mol. Genet., 21, pp. 4996-5009; Kingwell, E., Marriott, J.J., Jette, N., Pringsheim, T., Makhani, N., Morrow, S.A., Fisk, J.D., Marrie, R.A., Incidence and prevalence of multiple sclerosis in Europe: a systematic review (2013) BMC Neurol., 13, p. 128; Kohli, M., Kunkle, B., Naj, A., Carney, R.M., Hamilton-Nelson, K., Rolati, S., Whitehead, P.L., The Alzheimer's Disease Genetics Consortium, The identification of rare variants in late-onset Alzheimer's disease using extended families (2013) Alzheimers Dement., 9, pp. P518-P519; Koroglu, C., Baysal, L., Cetinkaya, M., Karasoy, H., Tolun, A., DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability (2013) Parkinsonism Relat. Disord., 19, pp. 320-324; Krewski, D., Pringsheim, T., Tremlett, H., Barakat-Haddad, C., van Lieshout, P., Martino, R., Walsh, S.J., Little, J., Determinants of neurological disease: synthesis of systematic reviews (2017) Neurotoxicology, 61, pp. 266-289; Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Riess, O., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease (1998) Nat. Genet., 18, pp. 106-108; Lambert, J.C., Grenier-Boley, B., Harold, D., Zelenika, D., Chouraki, V., Kamatani, Y., Sleegers, K., Amouyel, P., Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (2013) Mol. Psychiatry, 18, pp. 461-470; Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., Jun, G., Amouyel, P., Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) Nat. Genet., 45, pp. 1452-1458; Lee, S.H., Harold, D., Nyholt, D.R., ANZGene Consortium, International Endogene Consortium, Genetic and Environmental Risk for Alzheimer's disease Consortium, Goddard, M.E., Visscher, P.M., Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis (2013) Hum. Mol. Genet., 22, pp. 832-841; Levy, G., Louis, E.D., Mejia-Santana, H., Cote, L., rews, H., Harris, J., Waters, C., Marder, K., Lack of familial aggregation of Parkinson disease and Alzheimer disease (2004) Arch. Neurol., 61, pp. 1033-1039; Lill, C.M., Abel, O., Bertram, L., Al-Chalabi, A., Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases (2011) Amyotroph Lateral Scler., 12, pp. 238-249; Lill, C.M., Roehr, J.T., McQueen, M.B., Bagade, S., Schjeide, B.M., Zipp, F., Bertram, L., The MSGene Database. Alzheimer Research Forum (2012), http://www.msgene.org/, a). Located at: (accessed 24.03.16.); Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.M., Schjeide, L.M., Bertram, L., Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database (2012) PLoS Genet., 8, p. e1002548; Little, J., Epidemiology of Childhood Cancer (1999), IARC Lyon; Little, J., Risks in siblings and other relatives (1992) Epidemiology and Control of Neural Tube Defects, pp. 604-676. , J.M. Elwood J. Little J.H. Elwood Oxford University Press New York; Little, J., Nevin, N.C., Genetic models (1992) Epidemiology and Control of Neural Tube Defects, pp. 677-710. , J.M. Elwood J. Little J.H. Elwood Oxford University Press New York; Logue, M.W., Schu, M., Vardarajan, B.N., Buros, J., Green, R.C., Go, R.C., Griffith, P., Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group, A comprehensive genetic association study of Alzheimer disease in African Americans (2011) Arch. Neurol., 68, pp. 1569-1579; Mackay, T.F., The genetic architecture of quantitative traits: lessons from Drosophila (2004) Curr. Opin. Genet. Dev., 14, pp. 253-257; Malek, N., Fletcher, N., Newman, E., Diagnosing dopamine-responsive dystonias (2015) Pract. Neurol., 5, pp. 340-345. , (Epub 04.06.15); Malmer, B., Henriksson, R., Gronberg, H., Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients (2003) Int. J. Cancer., 106, pp. 260-263; Martino, R., Candundo, H., van Lieshout, P., Shin, S., Crispo, J.A.G., Barakat-Haddad, C., Onset and progression factors in Parkinson's Disease: a systematic review (2017) Neurotoxicology, 61, pp. 132-141; Massimi, L., Paternoster, G., Fasano, T., Di Rocco, C., On the changing epidemiology of hydrocephalus (2009) Childs Nerv. Syst., 25, pp. 795-800; Matesanz, F., Gonzalez-Perez, A., Lucas, M., Sanna, S., Gayan, J., Urcelay, E., Zara, I., Izquierdo, G., Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1 (2012) PLoS One, 7, p. e36140; Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson, L., Brayne, C., Medical Research Council Cognitive Function and Ageing Collaboration, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study I and II (2013) Lancet, 382, pp. 1405-1412; Matuja, W.B., Kilonzo, G., Mbena, P., Mwango'mbola, R.L., Wong, P., Goodfellow, P., Jilek-Aall, L., Risk factors for epilepsy in a rural area in Tanzania. A community-based case-control study (2001) Neuroepidemiology, 20, pp. 242-247; Mayeux, R., Stern, Y., Epidemiology of Alzheimer disease (2012) Cold Spring Harb. Perspect. Med., 2; McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P., Hirschhorn, J.N., Genome-wide association studies for complex traits: consensus, uncertainty and challenges (2008) Nat. Rev. Genet., 9, pp. 356-369; McKay, K.A., Jahanfar, S., Duggan, T., Tkachuk, S., Tremlett, H., Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review (2017) Neurotoxicology, 61, pp. 189-212; McNeil, S.M., Novelletto, A., Srinidhi, J., Barnes, G., Kornbluth, I., Altherr, M.R., Wasmuth, J.J., Myers, R.H., Reduced penetrance of the Huntington's disease mutation (1997) Hum. Mol. Genet., 6, pp. 775-779; Miller, L.A., Romitti, P.A., Cunniff, C., Druschel, C., Mathews, K.D., Meaney, F.J., Matthews, D., Kenneson, A., The muscular dystrophy surveillance tracking and research network (MD STARnet): surveillance methodology (2006) Birth Defects Res. A Clin. Mol. Teratol., 76, pp. 793-797; Miyashita, A., Koike, A., Jun, G., Wang, L.S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Kuwano, R., SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians (2013) PLoS One, 8, p. e58618; Mollenhauer, B., Locascio, J.J., Schulz-Schaeffer, W., Sixel-Doring, F., Trenkwalder, C., Schlossmacher, M.G., alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (2011) Lancet Neurol., 10, pp. 230-240; Monetti, V.C., Granieri, E., Casetta, I., Tola, M.R., Paolino, E., Malagu, S., Govoni, V., Quatrale, R., Risk factors for idiopathic generalized seizures: a population-based case control study in Copparo, Italy (1995) Epilepsia, 36, pp. 224-229; Moore, J.H., The ubiquitous nature of epistasis in determining susceptibility to common human diseases (2003) Hum. Hered., 56, pp. 73-82; Morrissey, A., Donnan, J., Sikora, L., Walsh, S., Collins, K., MacDonald, D., A systematic review of the risk factors associated with the onset and natural progression of neurotrauma (2016) Neurotoxicology; MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council Vitamin Study (1991) Lancet, 338, pp. 131-137; Muangpaisan, W., Hori, H., Brayne, C., Systematic review of the prevalence and incidence of Parkinson's disease in Asia (2009) J. Epidemiol., 19, pp. 281-293; Munch, T.N., Rostgaard, K., Rasmussen, M.L., Wohlfahrt, J., Juhler, M., Melbye, M., Familial aggregation of congenital hydrocephalus in a nationwide cohort (2012) Brain, 135, pp. 2409-2415; Naj, A., Cruchaga, C., Kunkle, B., Mukherjee, S., Graham, R., Behrens, T., Mayeux, R., The Alzheimer's Disease Genetics Consortium, Exome array analysis identifies novel risk variants for non-familial early-onset Alzheimer's disease (2013) Alzheimers Dement., 9, p. P517; Naj, A.C., Jun, G., Beecham, G.W., Wang, L.S., Vardarajan, B.N., Buros, J., Gallins, P.J., Schellenberg, G.D., Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease (2011) Nat. Genet., 43, pp. 436-441; Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., DeStefano, A.L., Singleton, A.B., Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease (2014) Nat. Genet., 46, pp. 989-993; Németh, A.H., The genetics of primary dystonias and related disorders (2002) Brain, 125, pp. 695-721; Ngugi, A.K., Kariuki, S.M., Bottomley, C., Kleinschmidt, I., Sander, J.W., Newton, C.R., Incidence of epilepsy: a systematic review and meta-analysis (2011) Neurology, 77, pp. 1005-1012; Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., Hawkes, C.H., Giovannoni, G., Lees, A.J., Schrag, A., Meta-analysis of early nonmotor features and risk factors for Parkinson disease (2012) Ann. Neurol., 72, pp. 893-901; Nurmohamed, L., Garcia-Bournissen, F., Buono, R.J., Shannon, M.W., Finkelstein, Y., Predisposition to epilepsy-does the ABCB1 gene play a role? (2010) Epilepsia, 51, pp. 1882-1885; Nuytemans, K., Theuns, J., Cruts, M., Van Broeckhoven, C., Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, LRRK2 genes: a mutation update (2010) Hum. Mutat., 31, pp. 763-780; O'Callaghan, M.E., MacLennan, A.H., Gibson, C.S., McMichael, G.L., Haan, E.A., Broadbent, J., Priest, K., Australian Collaborative Cerebral Palsy Research Group, The Australian cerebral palsy research study-protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy (2011) J. Paediatr. Child Health, 47, pp. 99-110; Omuro, A., DeAngelis, L.M., Glioblastoma and other malignant gliomas: a clinical review (2013) JAMA, 310, pp. 1842-1850; O'Rourke, J.A., Scharf, J.M., Yu, D., Pauls, D.L., The genetics of Tourette syndrome: a review (2009) J. Psychosom. Res., 67, pp. 533-545; Orr-Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Giladi, N., The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? (2007) Neurology, 69, pp. 1595-1602; Oskoui, M., Coutinho, F., Dykeman, J., Jette, N., Pringsheim, T., An update on the prevalence of cerebral palsy: a systematic review and meta-analysis (2013) Dev. Med. Child Neurol., 55, pp. 509-519; Ozelius, L., Lubarr, N., (2014), http://www.ncbi.nlm.nih.gov/books/NBK1492/, DYT1 Early-Onset Primary Dystonia. GeneReviews® [Internet]. Available at: (accessed 18.09.16.); Ozelius, L.J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A.L., Bressman, S.B., 2006. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews (2006) N. Engl. J. Med., 354, pp. 424-425; Paisan-Ruiz, C., Lewis, P.A., Singleton, A.B., LRRK2: cause, risk, mechanism (2013) J. Parkinsons Dis., 3, pp. 85-103; http://www.pdgene.org/TopResults.asp, PDGene. PDGene top results. 19 August 2014. Located at: (accessed 23.03.16.); Pearson, C.E., Nichol Edamura, K., Cleary, J.D., Repeat instability: mechanisms of dynamic mutations (2005) Nat. Rev. Genet., 6, pp. 729-742; Pearson, T.A., Manolio, T.A., How to interpret a genome-wide association study (2008) JAMA, 299, pp. 1335-1344; Pegoraro, E., Hoffman, E.P., Piva, L., Gavassini, B.F., Cagnin, S., Ermani, M., Bello, L., Cooperative International Neuromuscular Research Group, SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy (2011) Neurology, 76, pp. 219-226; Peris-Bonet, R., Martinez-Garcia, C., Lacour, B., Petrovich, S., Giner-Ripoll, B., Navajas, A., Steliarova-Foucher, E., Childhood central nervous system tumours-incidence and survival in Europe (1978–1997): report from automated childhood cancer information system project (2006) Eur. J. Cancer, 42, pp. 2064-2080; Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Nussbaum, R.L., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease (1997) Science, 276, pp. 2045-2047; Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P., The global prevalence of dementia: a systematic review and metaanalysis (2013) Alzheimers Dement., 9 (63-75), p. e2; Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., Jette, N., The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis (2012) Mov. Disord., 27, pp. 1083-1091; Quach, P., Hersi, M., Reem, E.S., Gomes, J., Krewski, D., A systematic review of the risk factors associated with the onset and progression of primary brain tumours (2017) Neurotoxicology, 61, pp. 214-232; Qureshi, N., Wilson, B., Santaguida, P., Little, J., Carroll, J., Allanson, J., Raina, P., Family history and improving health (2009) Evid. Rep. Technol. Assess. (Full Rep), 186, pp. 1-135; Rajagopalan, P., Hibar, D.P., Thompson, P.M., TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, pp. 1565-1567; Rajaraman, P., Melin, B.S., Wang, Z., McKean-Cowdin, R., Michaud, D.S., Wang, S.S., Bondy, M., Chanock, S.J., Genome-wide association study of glioma and meta-analysis (2012) Hum. Genet., 131, pp. 1877-1888; Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W.W., Hatanpaa, K.J., Ross, O.A., TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease (2013) Mol. Neurodegener., 8, p. 19. , (1326-8-19); Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B.N., Wang, L.S., Valladares, O., Alzheimer Disease Genetics Consortium, Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4, and the risk of late-onset Alzheimer disease in African Americans (2013) JAMA, 309, pp. 1483-1492; Reitz, C., Mayeux, R., Alzheimer's Disease Genetics Consortium, TREM2 and neurodegenerative disease (2013) N. Engl. J. Med., 369, pp. 1564-1565; Relton, C.L., Wilding, C.S., Jonas, P.A., Lynch, S.A., Tawn, E.J., Burn, J., Genetic susceptibility to neural tube defect pregnancy varies with offspring phenotype (2003) Clin. Genet., 64, pp. 424-428; Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics (2014) Nat. Neurosci., 17, pp. 17-23; Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Traynor, B.J., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2011) Neuron, 72, pp. 257-268; Ridge, P.G., Mukherjee, S., Crane, P.K., Kauwe, J.S., Alzheimer's Disease Genetics Consortium, Alzheimer's disease: analyzing the missing heritability (2013) PLoS One, 8, p. e79771; Ritz, K., Groen, J.L., Kruisdijk, J.J., Baas, F., Koelman, J.H., Tijssen, M.A., Screening for dystonia genes DYT1, 11 and 16 in patients with writer's cramp (2009) Mov. Disord., 24, pp. 1390-1392; Rosen, A.R., Steenland, N.K., Hanfelt, J., Factor, S.A., Lah, J.J., Levey, A.I., Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history (2007) Neurogenetics, 8, pp. 263-270; Rosenblatt, A., Kumar, B.V., Mo, A., Welsh, C.S., Margolis, R.L., Ross, C.A., Age, CAG repeat length, clinical progression in Huntington's disease (2012) Mov. Disord., 27, pp. 272-276; Ross, O.A., Braithwaite, A.T., Skipper, L.M., Kachergus, J., Hulihan, M.M., Middleton, F.A., Nishioka, K., Farrer, M.J., Genomic investigation of alpha-synuclein multiplication and parkinsonism (2008) Ann. Neurol., 63, pp. 743-750; Ross, O.A., Soto-Ortolaza, A.I., Heckman, M.G., Aasly, J.O., Abahuni, N., Annesi, G., Bacon, J.A., Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium, Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study (2011) Lancet Neurol., 10, pp. 898-908; Sanson, M., Hosking, F.J., Shete, S., Zelenika, D., Dobbins, S.E., Ma, Y., Enciso-Mora, V., Simon, M., Chromosome 7p11.2 (EGFR) variation influences glioma risk (2011) Hum. Mol. Genet., 20, pp. 2897-2904; Scharf, J.M., Miller, L.L., Mathews, C.A., Ben-Shlomo, Y., Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort (2012) J. Am. Acad. Child Adolesc. Psychiatry, 51, p. e5. , (192,201); Scharf, J.M., Yu, D., Mathews, C.A., Neale, B.M., Stewart, S.E., Fagerness, J.A., Evans, P., Pauls, D.L., Genome-wide association study of Tourette's syndrome (2013) Mol. Psychiatry, 18, pp. 721-728; Scheurer, M.E., Etzel, C.J., Liu, M., Barnholtz-Sloan, J., Wiklund, F., Tavelin, B., Wrensch, M.R., GLIOGENE Consortium, Familial aggregation of glioma: a pooled analysis (2010) Am. J. Epidemiol., 172, pp. 1099-1107; Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, Genome-wide association study identifies five new schizophrenia loci (2011) Nat. Genet., 43, pp. 969-976; Schmidt, A., Altenmuller, E., Jabusch, H.C., Lee, A., Wiegers, K., Klein, C., Lohmann, K., The GAG deletion in Tor1A (DYT1) is a rare cause of complex musician's dystonia (2012) Parkinsonism Relat. Disord., 18, pp. 690-691; Schmidt, A., Jabusch, H.C., Altenmuller, E., Hagenah, J., Bruggemann, N., Hedrich, K., Saunders-Pullman, R., Klein, C., Dominantly transmitted focal dystonia in families of patients with musician's cramp (2006) Neurology, 67, pp. 691-693; Schmidt, A., Jabusch, H.C., Altenmuller, E., Hagenah, J., Bruggemann, N., Lohmann, K., Enders, L., Klein, C., Etiology of musician's dystonia: familial or environmental? (2009) Neurology, 72, pp. 1248-1254; Searles Nielsen, S., Mueller, B.A., Preston-Martin, S., Holly, E.A., Little, J., Bracci, P.M., McCredie, M., Lubin, F., Family cancer history and risk of brain tumors in children: results of the SEARCH International Brain Tumor Study (2008) Cancer Causes Control, 19, pp. 641-648; Service, S.K., Verweij, K.J., Lahti, J., Congdon, E., Ekelund, J., Hintsanen, M., Raikkonen, K., Freimer, N.B., A genome-wide meta-analysis of association studies of Cloninger's temperament scales (2012) Transl. Psychiatry, 2, p. e116; Shao, H., Burrage, L.C., Sinasac, D.S., Hill, A.E., Ernest, S.R., O'Brien, W., Courtland, H.W., Nadeau, J.H., Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 19910-19914; Sharma, M., Ioannidis, J.P., Aasly, J.O., Annesi, G., Brice, A., Bertram, L., Bozi, M., GEOPD Consortium, A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants (2012) J. Met. Genet., 49, pp. 721-726; Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., Simon, M., Houlston, R.S., Genome-wide association study identifies five susceptibility loci for glioma (2009) Nat. Genet., 41, pp. 899-904; Simpson, S., Jr., Blizzard, L., Otahal, P., Van der Mei, I., Taylor, B., Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 1132-1141; Singleton, A., Hardy, J., A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci (2011) Hum. Mol. Genet., 20, pp. R158-62; Sivakumaran, S., Agakov, F., Theodoratou, E., Prendergast, J.G., Zgaga, L., Manolio, T., Rudan, I., Campbell, H., Abundant pleiotropy in human complex diseases and traits (2011) Am. J. Hum. Genet., 89, pp. 607-618; Smith, M.A., Freidlin, B., Gloeckler Ries, L.A., Simon, R., Trends in reported incidence of primary malignant brain tumors in children in the United States (1998) J. Natl. Cancer Inst., 90, pp. 1269-1277; Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., Goedert, M., alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies (1998) Proc. Natl. Acad. Sci. U. S. A., 95, pp. 6469-6473; Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., Alpha-synuclein in Lewy bodies (1997) Nature, 388, pp. 839-840; Steeves, T.D., Day, L., Dykeman, J., Jette, N., Pringsheim, T., The prevalence of primary dystonia: a systematic review and meta-analysis (2012) Mov. Disord., 27, pp. 1789-1796; Stiller, C.A., Parkin, D.M., Geographic and ethnic variations in the incidence of childhood cancer (1996) Br. Med. Bull., 52, pp. 682-703; Su, X.W., Broach, J.R., Connor, J.R., Gerhard, G.S., Simmons, Z., Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research (2014) Muscle Nerve, 49, pp. 786-803; Suren, P., Bakken, I.J., Aase, H., Chin, R., Gunnes, N., Lie, K.K., Magnus, P., Stoltenberg, C., Autism spectrum disorder ADHD, epilepsy, cerebral palsy in Norwegian children (2012) Pediatrics, 130, pp. e152-8; Talbot, K., Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis? (2010) J. Neurol. Neurosurg. Psychiatry, 81, pp. 1299-1300; Tanzi, R.E., The genetics of Alzheimer disease (2012) Cold Spring Harb. Perspect. Med., 2; Tellez-Zenteno, J.F., Pondal-Sordo, M., Matijevic, S., Wiebe, S., National and regional prevalence of self-reported epilepsy in Canada (2004) Epilepsia, 45, pp. 1623-1629; Tezenas du Montcel, S., Clot, F., Vidailhet, M., Roze, E., Damier, P., Jedynak, C.P., Camuzat, A., French Dystonia Network, Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes (2006) J. Med. Genet., 43, pp. 394-400; Thelen, M., Razquin, C., Hernandez, I., Gorostidi, A., Sanchez-Valle, R., Ortega-Cubero, S., Wolfsgruber, S., Ramirez, A., Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes (2014) Neurobiol. Aging, 35 (2657), pp. e13-e19; Tremlett, H., Paty, D., Devonshire, V., Disability progression in multiple sclerosis is slower than previously reported (2006) Neurology, 66, pp. 172-177; Trinh, J., Farrer, M., Advances in the genetics of Parkinson disease (2013) Nat. Rev. Neurol., 9, pp. 445-454; Turner, M.R., Hardiman, O., Benatar, M., Brooks, B.R., Chio, A., de Carvalho, M., Ince, P.G., Kiernan, M.C., Controversies and priorities in amyotrophic lateral sclerosis (2013) Lancet Neurol., 12, pp. 310-322; van Blitterswijk, M., DeJesus-Hernandez, M., Niemantsverdriet, E., Murray, M.E., Heckman, M.G., Diehl, N.N., Brown, P.H., Rademakers, R., Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) Lancet Neurol., 12, pp. 978-988; van Blitterswijk, M., Mullen, B., Nicholson, A.M., Bieniek, K.F., Heckman, M.G., Baker, M.C., DeJesus-Hernandez, M., Rademakers, R., TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) Acta Neuropathol., 127, pp. 397-406; van Duijn, C.M., Stijnen, T., Hofman, A., Risk factors for Alzheimer's disease: overview of the EURODEM collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group (1991) Int. J. Epidemiol., 20, pp. S4-S12; van Lieshout, P., Candundo, H., Martino, R., Shin, S., Barakat-Haddad, C., Onset factors in cerebral palsy: a systematic review (2017) Neurotoxicology, 61, pp. 47-53; Vestergaard, M., Pedersen, C.B., Sidenius, P., Olsen, J., Christensen, J., The long-term risk of epilepsy after febrile seizures in susceptible subgroups (2007) Am. J. Epidemiol., 165, pp. 911-918; Vilarino-Guell, C., Rajput, A., Milnerwood, A.J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Farrer, M.J., DNAJC13 mutations in Parkinson disease (2014) Hum. Mol. Genet., 23, pp. 1794-1801; Vilarino-Guell, C., Wider, C., Ross, O.A., Dachsel, J.C., Kachergus, J.M., Lincoln, S.J., Soto-Ortolaza, A.I., Farrer, M.J., VPS35 mutations in Parkinson disease (2011) Am. J. Hum. Genet., 89, pp. 162-167; Volcik, K.A., Zhu, H., Shaw, G.M., Lammer, E.J., Finnell, R.H., Apolipoprotein E and apolipoprotein B genotypes and risk for spina bifida (2002) Teratology, 66, pp. 257-259; Wallingford, J.B., Niswander, L.A., Shaw, G.M., Finnell, R.H., The continuing challenge of understanding, preventing, treating neural tube defects (2013) Science, 339, p. 1222002; Walsh, S., Donnan, J., Morrissey, A., Sikora, L., Bowen, S., Collins, K., MacDonald, D., A systematic review of the risks factors associated with the onset and natural progression of hydrocephalus (2017) Neurotoxicology, 61, pp. 33-45; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS-a systematic review and meta-analysis of observational studies (2014) PLoS One, 9, p. e105534; Wang, M.D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Identification of risk factors associated with onset andprogression of amyotrophic lateral sclerosis using systematic review and meta-analysis (2017) Neurotoxicology, 61, pp. 101-130; Wang, X.W., Luo, Y.L., Wang, W., Zhang, Y., Chen, Q., Cheng, Y.L., Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis (2012) Am. J. Obstet. Gynecol., 206 (251), pp. e1-e7; Warby, S.C., Montpetit, A., Hayden, A.R., Carroll, J.B., Butland, S.L., Visscher, H., Collins, J.A., Hayden, M.R., CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup (2009) Am. J. Hum. Genet., 84, pp. 351-366; Warby, S.C., Visscher, H., Collins, J.A., Doty, C.N., Carter, C., Butland, S.L., Hayden, A.R., Hayden, M.R., HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia (2011) Eur. J. Hum. Genet., 19, pp. 561-566; Webster, J.A., Myers, A.J., Pearson, J.V., Craig, D.W., Hu-Lince, D., Coon, K.D., Zismann, V.L., Stephan, D.A., Sorl1 as an Alzheimer's disease predisposition gene? (2008) Neurodegener Dis., 5, pp. 60-64; Westerlind, H., Ramanujam, R., Uvehag, D., Kuja-Halkola, R., Boman, M., Bottai, M., Lichtenstein, P., Hillert, J., Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden (2014) Brain, 137, pp. 770-778; Willer, C.J., Dyment, D.A., Cherny, S., Ramagopalan, S.V., Herrera, B.M., Morrison, K.M., Sadovnick, A.D., Ebers, G.C., A genome-wide scan in forty large pedigrees with multiple sclerosis (2007) J. Hum. Genet., 52, pp. 955-962; Williams, L.C., Hegde, M.R., Nagappan, R., Faull, R.L., Giles, J., Winship, I., Snow, K., Love, D.R., Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability (2000) Genet. Test, 4, pp. 55-60; Winawer, M.R., Shinnar, S., Genetic epidemiology of epilepsy or what do we tell families? (2005) Epilepsia, 46, pp. 24-30; Wingo, T.S., Cutler, D.J., Yarab, N., Kelly, C.M., Glass, J.D., The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry (2011) PLoS One, 6, p. e27985; Worton, R.G., Duff, C., Sylvester, J.E., Schmickel, R.D., Willard, H.F., Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes (1984) Science, 224, pp. 1447-1449; Wrensch, M., Jenkins, R.B., Chang, J.S., Yeh, R.F., Xiao, Y., Decker, P.A., Ballman, K.V., Wiencke, J.K., Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility (2009) Nat. Genet., 41, pp. 905-908; Wu, L., Rosa-Neto, P., Hsiung, G.Y., Sadovnick, A.D., Masellis, M., Black, S.E., Jia, J., Gauthier, S., Early-onset familial Alzheimer's disease (EOFAD) (2012) Can. J. Neurol. Sci., 39, pp. 436-445; Xi, B., Chen, J., Yang, L., Wang, W., Fu, M., Wang, C., GABBR1 gene polymorphism(G1465A) is associated with temporal lobe epilepsy (2011) Epilepsy Res., 96, pp. 58-63; Xiao, Y., Decker, P.A., Rice, T., McCoy, L.S., Smirnov, I., Patoka, J.S., Hansen, H.M., Wrensch, M.R., SSBP2 variants are associated with survival in glioblastoma patients (2012) Clin. Cancer Res., 18, pp. 3154-3162; Xu, Z., Ma, W., Gao, L., Xing, B., Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis (2014) Tumour Biol., 35, pp. 3211-3221; Yan, L., Zhao, L., Long, Y., Zou, P., Ji, G., Gu, A., Zhao, P., Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies (2012) PLoS One, 7, p. e41689; Yang, T.H., Kon, M., Hung, J.H., Delisi, C., Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk (2011) BMC Med. Genomics, 4, p. 63; Zago, S., Poletti, B., Morelli, C., Doretti, A., Silani, V., Amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) (2011) Arch. Ital. Biol., 149, pp. 39-56; Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., de Yebenes, J.G., The new mutation E46K, of alpha-synuclein causes Parkinson and Lewy body dementia (2004) Ann. Neurol., 55, pp. 164-173; Zavodszky, E., Seaman, M.N., Moreau, K., Jimenez-Sanchez, M., Breusegem, S.Y., Harbour, M.E., Rubinsztein, D.C., Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy (2014) Nat. Commun., 5, p. 3828; Zhang, J., Williams, M.A., Rigamonti, D., Genetics of human hydrocephalus (2006) J. Neurol., 253, pp. 1255-1266; Zimprich, A., Benet-Pages, A., Struhal, W., Graf, E., Eck, S.H., Offman, M.N., Haubenberger, D., Strom, T.M., A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease (2011) Am. J. Hum. Genet., 89, pp. 168-175; Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Gasser, T., Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome (2001) Nat. Genet., 29, pp. 66-69},
correspondence_address1={Little, J.; School of Epidemiology, Canada; email: jlittle@uottawa.ca},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={27713094},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Hersi201712,
author={Hersi, M. and Quach, P. and Wang, M.-D. and Gomes, J. and Gaskin, J. and Krewski, D.},
title={Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: A methodological overview},
journal={NeuroToxicology},
year={2017},
volume={61},
pages={12-18},
doi={10.1016/j.neuro.2016.06.017},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979673776&doi=10.1016%2fj.neuro.2016.06.017&partnerID=40&md5=6ce5175d9ba1d2f39e88453b49064eed},
affiliation={McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; School of Life Science, Changchun Normal University, Changchun, Jilin  130032, China; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of OttawaON, Canada; Environmental Health Research Unit, University of OttawaON, Canada; Risk Sciences International, Ottawa, ON, Canada},
abstract={As a component of the National Population Health Study of Neurological conditions, systematic reviews were conducted to identify risk factors associated with the onset and progression of 14 priority neurological conditions. Between 2011 and 2013, electronic databases and grey literature sources were searched to identify systematic reviews and primary studies reporting on the onset and progression of each condition. Inclusion was restricted to studies of humans reported in English or French. Additional condition-specific eligibility criteria were also applied. Titles and abstracts were screened by one reviewer with excluded records verified by a second reviewer. Full-text reports were screened independently by two reviewers. Disagreements were resolved by consensus or third party adjudication. Systematic reviews were quality appraised using the AMSTAR criteria, with only moderate and high quality reviews considered for inclusion. Primary studies were also sought to ensure that evidence from existing systematic reviews was supplemented with recent primary study findings (i.e., those published after the most recent systematic review). Evidence from primary studies was also considered if a systematic review was unavailable or of poor quality. Data were extracted using standardized forms. Where feasible, data were extracted independently by two reviewers. Otherwise, data were extracted by a single reviewer and independent data extraction by a second reviewer was conducted for a randomly selected sample of studies. An updated search was conducted in 2016 to identify systematic reviews published since the initial search in 2011–2013. A summary of the methodology used to conduct the systematic reviews is described. Illustrative results are provided for the risk of amyotrophic lateral sclerosis in relation to occupational exposure to lead and other heavy metals © 2016},
author_keywords={AMSTAR;  Data extraction;  Meta-analyses;  Neurological disease;  Risk factors;  Systematic review},
keywords={ataxin 2, amyotrophic lateral sclerosis;  Article;  ATXN2 gene;  C9orf72 gene;  CAG repeat;  gene;  gene mutation;  human;  incidence;  neurologic disease;  occupational exposure;  prevalence;  priority journal;  quality control;  risk assessment;  risk factor;  scoring system;  SOD1 gene;  systematic review;  TARDBP gene;  bibliographic database;  disease exacerbation;  meta analysis (topic);  neurologic disease;  statistics and numerical data, Databases, Bibliographic;  Disease Progression;  Humans;  Meta-Analysis as Topic;  Nervous System Diseases;  Risk Factors},
references={Rx for Change: Methods for Development http://www.cadth.ca/resources/rx-for-change/methods-for-development, (accessed 23.06.11.); Couratier, P., Corcia, P., Lautrette, G., Nicol, M., Preux, P.M., Marin, B., Epidemiology of amyotrophic lateral sclerosis: a review of literature (2016) Rev. Neurol., 172 (1), pp. 37-45; Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions (1998) J. Epidemiol. Commun. Health, 52, pp. 377-384; Gaskin, J., Gomes, J., Darshan, S., Krewski, D., Burden of neurological conditions in Canada (2017) Neurotoxicology, 61, pp. 2-10; Hersi, M., Irvine, B., Gomes, J., Krewski, D., Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence (2017) Neurotoxicology, 61, pp. 143-187; International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Preamble (2016), http://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf, Lyon France (accessed 24.05.16.); Krewski, D., Pringsheim, T., Tremlett, H., Barakat-Haddad, C., van Lieshout, P., Martino, R., Walsh, S.J., Little, J., Determinants of neurological disease: synthesis of systematic reviews (2017) Neurotoxicology, 61, pp. 266-289; Little, J., Barakat-Haddad, C., Martino, R., Pringsheim, T., Tremlett, H., McKay, K., van Lieshout, P., Krewski, D., Genetic variation associated with the occurrence and progression of neurological disorders (2017) Neurotoxicology, 61, pp. 243-264; Moher, D., Tsertvadze, A., Systematic reviews: when an update is an update? (2006) Lancet, 367, pp. 881-882; National Research Council (NRC), Review of EPA's Integrated Risk Information System (2014), National Academy Press Washington, D.C; www.phac-aspc.gc.ca/publicat/ebic-femc/2005-2008/index-eng.php, Public Health Agency of Canada (PHAC), 2014a. Economic burden of illness in Canada, 2005–2008. March 2014, 111 pages. (accessed 18.12.15.); Quach, P., El Sherif, R., Gomes, J., Krewski, D., A systematic review of the risk factors associated with the onset and progression of primary brain tumours (2017) Neurotoxicology, 61, pp. 214-232; www.phac-aspc.gc.ca/publicat/cd-mc/mc-ec/index-eng.php, Public Health Agency of Canada (PHAC), 2014b. Mapping connections: an understanding of neurological conditions in Canada. September 2014, 110 pages. (accessed 18.12.15.); Rhomberg, L.R., Goodman, J.E., Bailey, L.A., Prueitt, R.L., Beck, N.B., Bevan, C., Honeycutt, M., Becker, R.A., A survey of frameworks for best practices in weight-of-evidence analyses (2013) Crit. Rev. Toxicol., 43, pp. 753-784; Shaikh, N., Badgett, R.G., Pi, M., Wilczynski, N.L., McKibbon, K.A., Ketchum, A.M., Haynes, R.B., Development and validation of filters for the retrieval of studies of clinical examination from Medline (2011) J. Med. Internet Res., 13 (4), p. e82; Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews (2009) J. Clin. Epidemiol., 62, pp. 1013-1020; Wang, M.-D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., A meta-analyses of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis (ALS) (2014) J Occup Environ. Med., 56, pp. 1235-1242; Wang, M.-D., Gomes, J., Cashman, N.R., Little, J., Krewski, D., Intermediate CAG repeats extension in the AXTN2 gene is a unique genetic risk factor for ALS (2014) PLoS One, 9, p. e105534; White, C.M., Stanley, I.P., McPheeters, M., Using existing systematic reviews to replace de novo process in conditional Comparative Effectiveness Reviews (2009), In Agency for Health Care Research and Quality Methods Guide for Comparative Effective Reviews, Rochville, MD; Whitlock, E.P., Lin, J.S., Chou, R., Using existing reviews in complex systematic reviews (2008) Ann. Intern. Med., 148, pp. 776-782; Wigle, D.T., Arbuckle, T.E., Turner, M.C., Bérubé, A., Yang, Q., Liu, S., Krewski, D., Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants (2008) J. Toxicol. Environ. Health B, 11, pp. 373-517; Wigle, D.T., Turner, M.C., Krewski, D., A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure (2009) Environ. Health Perspect., 117, pp. 1505-1513; Yetley, E.A., MacFarlane, A.J., Green-Finestone, L.S., Garza, B.G., DRI Chronic Disease Working Group (2016), Options for consideration of chronic disease endpoints for Dietary Reference Intakes (DRIs): summary report from a joint US/Canadian-sponsored expert panel. submitted for publication; Young, M.M., Stevens, A., Porath-Waller, A., Pirie, T., Garritty, C., Skidmore, B., Turner, L., Moher, D., Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol (2012) Syst. Rev., 1, p. 22},
correspondence_address1={Hersi, M.; McLaughlin Centre for Population Health Risk Assessment, Canada},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={27377856},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Mentis2010725,
author={Mentis, A.-F.A. and Kararizou, E.},
title={Does ageing originate in utero?},
journal={Biogerontology},
year={2010},
volume={11},
number={6},
pages={725-729},
doi={10.1007/s10522-010-9293-4},
note={cited By 15},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-78049235966&doi=10.1007%2fs10522-010-9293-4&partnerID=40&md5=2c91676086505f4b3f21e935ccdbd7b7},
affiliation={Athens University, Medical School, 75 Mikras Asias Street, 11527 Goudi, Greece; Neurologic Clinic, Aeginition Hospital, Athens University Medical School, 72-74, Vass. Sofias Ave., 11528 Athens, Greece},
abstract={Ageing still remains a conundrum on the cellular and molecular level, while environmental factors and interactions further increase the complexity of the ageing process. On the other hand is cancer, for which 20 years ago, it was proposed by Trichopoulos that it might have intrauterine origin. We herein discuss the idea that parameters such as the influence of insulin-like growth factor (IGF) signalling, of hormones and of the number of stem cells, as well as the effect of foetal and early life nutrition on ageing may also commence in utero and we provide epidemiological and biological data to advocate for this hypothesis. Finally, we analyse the public health implication of this hypothesis based on the World Health Organization (WHO) report that the burden of diseases, including ageing, may be due to impaired foetal development. © 2010 Springer Science+Business Media B.V.},
author_keywords={Ageing;  Epigenetics;  In utero;  Intrauterine environment;  Medical hypothesis},
keywords={hormone;  somatomedin, aging;  attitude to aging;  birth weight;  fetus development;  human;  note;  nutrition;  priority journal;  signal transduction;  stem cell, Aging;  Animals;  Female;  Humans;  Pregnancy;  Prenatal Exposure Delayed Effects;  Uterus},
references={Baik, I., Devito, W.J., Ballen, K., Becker, P.S., Okulicz, W., Liu, Q., Association of fetal hormone levels with stem cell potential: Evidence for early life roots of human cancer (2005) Cancer Res, 65 (1), pp. 358-363. , 1:CAS:528:DC%2BD2MXhvFaltg%3D%3D 15665314; Barker, D.J., Osmond, C., Simmonds, S.J., Wield, G.A., The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life (1993) BMJ, 306 (6875), pp. 422-426. , 1:STN:280:DyaK3s3hsVCgtA%3D%3D 10.1136/bmj.306.6875.422 8461722; Bateson, P., Barker, D., Clutton-Brock, T., Deb, D., D'Udine, B., Foley, R.A., Gluckman, P., Sultan, S.E., Developmental plasticity and human health (2004) Nature, 430 (6998), pp. 419-421. , DOI 10.1038/nature02725; Buss, C., Davis, E.P., Muftuler, L.T., Head, K., Sandman, C.A., High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-9-year-old children (2010) Psychoneuroendocrinology, 35 (1), pp. 141-153. , 10.1016/j.psyneuen.2009.07.010 19674845; Calvanese, V., Lara, E., Kahn, A., Fraga, M.F., The role of epigenetics in aging and age-related diseases (2009) Ageing Res Rev, 8 (4), pp. 268-276. , 1:CAS:528:DC%2BD1MXht1GntLrI 10.1016/j.arr.2009.03.004 19716530; Chen, J.H., Martin-Gronert, M.S., Tarry-Adkins, J., Ozanne, S.E., Maternal protein restriction affects postnatal growth and the expression of key proteins involved in lifespan regulation in mice (2009) PLoS One, 4 (3), p. 4950. , 10.1371/journal.pone.0004950 19308256; Cohen, E., Paulsson, J.F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Reduced IGF-1 signaling delays age-associated proteotoxicity in mice (2009) Cell, 139 (6), pp. 1157-1169. , 1:CAS:528:DC%2BC3cXhslartrk%3D 10.1016/j.cell.2009.11.014 20005808; Dolinoy, D.C., Weidman, J.R., Jirtle, R.L., Epigenetic gene regulation: Linking early developmental environment to adult disease (2007) Reproductive Toxicology, 23 (3), pp. 297-307. , DOI 10.1016/j.reprotox.2006.08.012, PII S0890623806001973; Domínguez-Gerpe, L., Araújo-Vilar, D., Prematurely aged children: Molecular alterations leading to Hutchinson-Gilford progeria and Werner syndromes (2008) Curr Aging Sci, 1 (3), pp. 202-212. , 10.2174/1874609810801030202 20021393; Fernandez-Capetillo, O., Intrauterine programming of ageing (2010) EMBO Rep, 11, pp. 32-36. , 1:CAS:528:DC%2BD1MXhsFChtbbM 10.1038/embor.2009.262 20010800; Fontana, L., Partridge, L., Longo, V.D., Extending healthy life span-from yeast to humans (2010) Science, 328 (5976), pp. 321-326. , 1:CAS:528:DC%2BC3cXks1Snsro%3D 10.1126/science.1172539 20395504; Fraga, M.F., Esteller, M., Epigenetics and aging: the targets and the marks (2007) Trends in Genetics, 23 (8), pp. 413-418. , DOI 10.1016/j.tig.2007.05.008, PII S0168952507001862; Fu, Q., Yu, X., Callaway, C.W., Lane, R.H., McKnight, R.A., Epigenetics: Intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene (2009) FASEB J, 23 (8), pp. 2438-2449. , 1:CAS:528:DC%2BD1MXpvFOltr0%3D 10.1096/fj.08-124768 19364764; Gavrilov, L.A., Gavrilova, N.S., Early-life factors modulating lifespan (2003) Modulating Aging and Longevity, pp. 5-27. , S.I.S. Rattan (eds). Kluwer Academic Publishers Dordrecht, The Netherlands; Gavrilov, L.A., Gavrilova, N.S., Early-life programming of aging and longevity: The idea of high initial damage load (the HIDL hypothesis) (2004) Annals of the New York Academy of Sciences, 1019, pp. 496-501. , DOI 10.1196/annals.1297.091; Gavrilova, N.S., Gavrilov, L.A., Evdokushkina, G.N., Semyonova, V.G., Early-life predictors of human longevity: Analysis of the 19th Century birth cohorts (2003) Annales de Demographie Historique, 2, pp. 177-198; Gluckman, P.D., Hanson, M.A., The developmental origins of the metabolic syndrome (2004) Trends in Endocrinology and Metabolism, 15 (4), pp. 183-187. , DOI 10.1016/j.tem.2004.03.002, PII S1043276004000578; Gluckman, P.D., Hanson, M.A., Cooper, C., Thornburg, K.L., Effect of in utero and early-life conditions on adult health and disease (2008) New England Journal of Medicine, 359 (1), pp. 61-73+6. , http://content.nejm.org/cgi/reprint/359/1/61.pdf, DOI 10.1056/NEJMra0708473; Godfrey, K.M., Lillycrop, K.A., Burdge, G.C., Gluckman, P.D., Hanson, M.A., Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease (2007) Pediatric Research, 61 (PART 2), pp. 5R-10R. , DOI 10.1203/pdr.0b013e318045bedb; Gravina, S., Vijg, J., Epigenetic factors in aging and longevity (2010) Pflugers Arch, 459 (2), pp. 247-258. , 1:CAS:528:DC%2BC3cXisVSkuw%3D%3D 10.1007/s00424-009-0730-7 19768466; Heijmans, B.T., Tobi, E.W., Lumey, L.H., Slagboom, P.E., The epigenome: Archive of the prenatal environment (2009) Epigenetics, 4 (8), pp. 526-531. , 1:CAS:528:DC%2BC3cXms1ajtrg%3D 10.4161/epi.4.8.10265 19923908; Kararizou, E., Manta, P., Kalfakis, N., Vassilopoulos, D., Morphometric study of the human muscle spindle (2005) Anal Quant Cytol Histol, 27 (1), pp. 1-4. , 15794446; Kararizou, E., Manta, P., Kalfakis, N., Vassilopoulos, D., Karyometric changes of intrafusal muscle fibers in neuromuscular diseases (2008) Anal Quant Cytol Histol, 30 (6), pp. 346-348. , 19160704; Kararizou, E., Manta, P., Kalfakis, N., Vassilopoulos, D., Age-related morphometric characteristics of human skeletal muscle in male subjects (2009) Pol J Pathol, 60 (4), pp. 186-188. , 20072953; Lagiou, P., Trichopoulos, D., Birth size and the pathogenesis of breast cancer (2008) PLoS Med, 5 (9), p. 194. , 10.1371/journal.pmed.0050194 18828668; Liotto, N., Miozzo, M., Giannì, M.L., Taroni, F., Morlacchi, L., Piemontese, P., Early nutrition: The role of genetics and epigenetics (2009) Pediatr Med Chir, 31 (2), pp. 65-71. , 1:STN:280:DC%2BD1Mritl2rsA%3D%3D 19642498; Murga, M., Bunting, S., Montaña, M.F., Soria, R., Mulero, F., Cañamero, M., A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging (2009) Nat Genet, 41 (8), pp. 891-898. , 1:CAS:528:DC%2BD1MXoslymur4%3D 10.1038/ng.420 19620979; Nafe, R., Glienke, W., Hattingen, E., Schlote, W., Lanfermann, H., Zanella, F., Correlation between amplification of the gene for the epidermal growth factor receptor (EGFR), data from preoperative proton-MR-spectroscopy (1HMRS) and histomorphometric data of glioblastomas (2007) Anal Quant Cytol Histol, 29 (4), pp. 199-207. , 17879627; Parrella, E., Longo, V.D., Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: From yeast to the mammalian brain (2010) Sci World J, 10, pp. 161-177. , 1:CAS:528:DC%2BC3cXht1WiurrJ; Pazhanisamy, S.K., Stem cells, DNA damage, ageing and cancer (2009) Hematol Oncol Stem Cell Ther, 2 (3), pp. 375-384. , 1:CAS:528:DC%2BC3cXht1ehsbc%3D 20139050; Savarese, T.M., Strohsnitter, W.C., Low, H.P., Liu, Q., Baik, I., Okulicz, W., Chelmow, D.P., Hsieh, C.-C., Correlation of umbilical cord blood hormones and growth factors with stem cell potential: Implications for the prenatal origin of breast cancer hypothesis (2007) Breast Cancer Research, 9 (3), pp. R29. , DOI 10.1186/bcr1674; Sayer, A.A., Cooper, C., Early diet and growth: Impact on ageing (2002) Proc Nutr Soc, 61 (1), pp. 79-85. , 12002798; Sayer, A.A., Cooper, C., Evans, J.R., Rauf, A., Wormald, R.P.L., Osmond, C., Barker, D.J.P., Are rates of ageing determined in utero? (1998) Age and Ageing, 27 (5), pp. 579-583. , DOI 10.1093/ageing/27.5.579; Skalkidou, A., Petridou, E., Papathoma, E., Salvanos, H., Trichopoulos, D., Growth velocity during the first postnatal week of life is linked to a spurt of IGF-I effect (2003) Paediatric and Perinatal Epidemiology, 17 (3), pp. 281-286. , DOI 10.1046/j.1365-3016.2003.00494.x; Strohsnitter, W.C., Savarese, T.M., Low, H.P., Chelmow, D.P., Lagiou, P., Lambe, M., Edmiston, K., Hsieh, C.-C., Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: Implications for a prenatal influence on cancer risk (2008) British Journal of Cancer, 98 (3), pp. 660-663. , DOI 10.1038/sj.bjc.6604183, PII 6604183; Tamimi, R.M., Lagiou, P., Czene, K., Liu, J., Ekbom, A., Hsieh, C.C., Birth weight, breast cancer susceptibility loci, and breast cancer risk (2010) Cancer Causes Control, 21 (5), pp. 689-696. , 10.1007/s10552-009-9496-7 20054709; Thompson, R.F., Einstein, F.H., Epigenetic basis for fetal origins of age-related disease (2010) J Womens Health (Larchmt), 19 (3), pp. 581-587. , 10.1089/jwh.2009.1408; Trichopoulos, D., Hypothesis: Does breast cancer originate in utero? (1990) Lancet, 335 (8695), pp. 939-940. , DOI 10.1016/0140-6736(90)91000-Z; Vaiserman, A.M., Voitenko, V.P., Early programming of adult longevity: Demographic and experimental studies (2003) J Anti Aging Med, 6 (1), pp. 11-20. , 10.1089/109454503765361542 12941179; Vassilopoulos, D., Emery, A.E., Muscle nuclear changes in fetuses at risk for Duchenne muscular dystrophy (1977) J Med Genet, 14, pp. 13-15. , 1:STN:280:DyaE2s7itFWhtg%3D%3D 10.1136/jmg.14.1.13 839493; Waterland, R.A., Is epigenetics an important link between early life events and adult disease? (2009) Horm Res, 71 (SUPPL. 1), pp. 13-16. , 1:CAS:528:DC%2BD1MXntVGrtg%3D%3D 10.1159/000178030 19153498; Willems, M., Geneviève, D., Borck, G., Baumann, C., Baujat, G., Bieth, E., Molecular analysis of Pericentrin gene (PCNT) in a series of 24 Seckel/MOPD II families (2009) J Med Genet, , in press; Zwaan, B.J., Linking development and aging (2003) Sci Aging Knowledge Environ, 47, pp. pe32},
correspondence_address1={Kararizou, E.; Neurologic Clinic, 72-74, Vass. Sofias Ave., 11528 Athens, Greece; email: ekarariz@med.uoa.gr},
issn={13895729},
coden={BIOGC},
pubmed_id={20607402},
language={English},
abbrev_source_title={Biogerontology},
document_type={Note},
source={Scopus},
}

@ARTICLE{Harper2019840,
author={Harper, S.},
title={A future for observational epidemiology: Clarity, credibility, transparency},
journal={American Journal of Epidemiology},
year={2019},
volume={188},
number={5},
pages={840-845},
doi={10.1093/aje/kwy280},
note={cited By 13},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065538152&doi=10.1093%2faje%2fkwy280&partnerID=40&md5=9b1c4f076600dde9dd2e2cddf2ed27d6},
affiliation={Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, QC  H3A1A2, Canada; Institute for Health and Social Policy, McGill University, Montreal, QC, Canada},
abstract={Observational studies are ambiguous, difficult, and necessary for epidemiology. Presently, there are concerns that the evidence produced by most observational studies in epidemiology is not credible and contributes to research waste. I argue that observational epidemiology could be improved by focusing greater attention on 1) defining questions that make clear whether the inferential goal is descriptive or causal; 2) greater utilization of quantitative bias analysis and alternative research designs that aim to decrease the strength of assumptions needed to estimate causal effects; and 3) promoting, experimenting with, and perhaps institutionalizing both reproducible research standards and replication studies to evaluate the fragility of study findings in epidemiology. Greater clarity, credibility, and transparency in observational epidemiology will help to provide reliable evidence that can serve as a basis for making decisions about clinical or population-health interventions. © 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved.},
author_keywords={causal inference;  observational studies;  quantitative bias analysis;  quasi-experiments;  reproducible research;  research reporting;  transparency},
keywords={epidemiology;  experimental study;  observational method;  public health;  quantitative analysis;  research work;  standard (regulation), attention;  observational study;  population health;  quantitative analysis;  replication study;  review;  causality;  epidemiology;  human;  organization and management;  procedures;  reproducibility;  statistical bias, Bias;  Causality;  Epidemiologic Methods;  Epidemiology;  Humans;  Observational Studies as Topic;  Reproducibility of Results},
references={Fisher, R.A., Cancer and smoking (1958) Nature, 182 (4635), p. 596; Byar, D.P., Why data bases should not replace randomized clinical trials (1980) Biometrics, 36 (2), pp. 337-342; Feinstein, A.R., Scientific standards in epidemiologic studies of the menace of daily life (1988) Science, 242 (4883), pp. 1257-1263; Savitz, D.A., Greenland, S., Stolley, P.D., Scientific standards of criticism: A reaction to scientific standards in epidemiologic studies of the menace of daily life by A.R. Feinstein (1990) Epidemiology, 1 (1), pp. 78-83; Kunz, R., Oxman, A.D., The unpredictability paradox: Review of empirical comparisons of randomised and non-randomised clinical trials (1998) BMJ, 317 (7167), pp. 1185-1190; Lawlor, D.A., Davey Smith, G., Kundu, D., Those confounded vitamins: What can we learn from the differences between observational versus randomised trial evidence (2004) Lancet, 363 (9422), pp. 1724-1727; Davey Smith, G., Ebrahim, S., Epidemiology-is it time to call it a day (2001) Int J Epidemiol, 30 (1), pp. 1-11; Taubes, G., (2007) Do We Really Know What Makes Us Healthy New York Times, 52. , https://www.nytimes.com/2007/09/16/magazine/16epidemiology-t.html, September 16, Magazine, Accessed November 16, 2018; Hernán, M.A., Alonso, A., Logan, R., Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease (2008) Epidemiology, 19 (6), pp. 766-779; Hernán, M.A., Sauer, B.C., Hernández-Diáz, S., Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses (2016) J Clin Epidemiol, 79, pp. 70-75; Jones, D., Molitor, D., Reif, J., (2018) What Do Workplace Wellness Programs Do Evidence from the Illinois Workplace Wellness Study, , http://www.nber.org/papers/w24229, Cambridge MA: National Bureau of EconomicResearch, Accessed November 16, 2018; Bowen, A., Casadevall, A., Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research (2015) Proc Natl Acad Sci USA, 112 (36), pp. 11335-11340; Ioannidis, J.P.A., The mass production of redundant, misleading, conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94 (3), pp. 485-514; Silberzahn, R., Uhlmann, E.L., Martin, D.P., Many analysts, one data set: Making transparent how variations in analytic choices affect results (2018) Adv Methods Pract Psychol Sci, 1 (3), pp. 337-356; Madigan, D., Ryan, P.B., Schuemie, M., Does design matter Systematic evaluation of the impact of analytical choices on effect estimates in observational studies (2013) Ther Adv Drug Saf, 4 (2), pp. 53-62; Patel, C.J., Burford, B., Ioannidis, J.P., Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations (2015) J Clin Epidemiol, 68 (9), pp. 1046-1058; Ioannidis, J.P., Greenland, S., Hlatky, M.A., Increasing value and reducing waste in research design, conduct, analysis (2014) Lancet, 383 (9912), pp. 166-175; Hernán, M.A., The c-word: Scientific euphemisms do not improve causal inference from observational data (2018) Am J Public Health, 108 (5), pp. 616-619; Kaufman, J.S., Statistics, adjusted statistics, maladjusted statistics (2017) Am J Law Med, 43 (2-3), pp. 193-208; Krieger, N., Davey Smith, G., The tale wagged by the dag: Broadening the scope of causal inference and explanation for epidemiology (2016) Int J Epidemiol, 45 (6), pp. 1787-1808; Vandenbroucke, J.P., Broadbent, A., Pearce, N., Causality and causal inference in epidemiology: The need for a pluralistic approach (2016) Int J Epidemiol, 45 (6), pp. 1776-1786; Fingerhut, L.A., Cox, C.S., Poisoning mortality 1985-1995 (1998) Public Health Rep, 113 (3), pp. 218-233; King, N.B., Fraser, V., Boikos, C., Determinants of increased opioid-related mortality in the United States and Canada 1990-2013: A systematic review (2014) Am J Public Health, 104 (8), pp. e32-e42; Alexander, M.J., Kiang, M.V., Barbieri, M., Trends in black and white opioid mortality in the United States 1979-2015 (2018) Epidemiology, 29 (5), pp. 707-715; Unintentional and undetermined poisoning deaths-11 states 1990-2001 (2004) MMWR Morb Mortal Wkly Rep, 53 (11), pp. 233-238. , Centers for Disease Control and Prevention; Franklin, G.M., Mai, J., Wickizer, T., Opioid dosing trends and mortality in Washington State workers' compensation 1996-2002 (2005) Am J Ind Med, 48 (2), pp. 91-99; Shah, N., Lathrop, S.L., Landen, M.G., Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance 1998-2002 (2005) Addiction, 100 (2), pp. 176-188; Felton, R., Flint residents raise concerns over discolored water Detroit Metro Times, , https://www.metrotimes.com/detroit/flint-residents-raise-concerns-over-discolored-water/Contentoid=2231724, Published August 13, 2014. Accessed November 16, 2018; Hanna-Attisha, M., LaChance, J., Sadler, R.C., Elevated blood lead levels in children associated with the flint drinking water crisis: A spatial analysis of risk and public health response (2016) Am J Public Health, 106 (2), pp. 283-290; Kennedy, C., Yard, E., Dignam, T., Blood lead levels among children aged 6 years-Flint, Michigan, 2013-2016 (2016) MMWR Morb Mortal Wkly Rep, 65 (25), pp. 650-654; Lieberson, S., (1987) Making It Count: The Improvement of Social Research and Theory, , Berkeley, CA: Univ of California Press; Lawlor, D.A., Tilling, K., Davey Smith, G., Triangulation in aetiological epidemiology (2016) Int J Epidemiol, 45 (6), pp. 1866-1886; Klinenberg, E., Denaturalizing disaster: A social autopsy of the 1995 chicago heat wave (1999) Theory Soc, 28 (2), pp. 239-295; Leon, D.A., Chenet, L., Shkolnikov, V.M., Huge variation in Russian mortality rates 1984-94 Artefact, alcohol, or what (1997) Lancet, 350 (9075), pp. 383-388; Venero Fernández, S.J., Medina, R.S., Britton, J., The association between living through a prolonged economic depression and the Male: Female birth ratio- A longitudinal study from Cuba 1960-2008 (2011) Am J Epidemiol, 174 (12), pp. 1327-1331; Jayachandran, S., Pandi, R., Why are indian children so short the role of birth order and son preference (2017) Am Econ Rev, 107 (9), pp. 2600-2629; Loudon, I., Maternal mortality in the past and its relevance to developing countries today (2000) Am J Clin Nutr, 72 (1), pp. 241S-246S; Susser, M., Stein, Z., Commentary: Civilization and peptic ulcer 40 years on (2002) Int J Epidemiol, 31 (1), pp. 18-21; Fang, J., Madhavan, S., Alderman, M.H., The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City (1996) N Engl J Med, 335 (21), pp. 1545-1551; Razum, O., Twardella, D., Time travel with oliver twist-towards an explanation foa a paradoxically low mortality among recent immigrants (2002) Trop Med Int Health, 7 (1), pp. 4-10; Tversky, A., Kahneman, D., Judgment under uncertainty: Heuristics and biases (1974) Science, 185 (4157), pp. 1124-1131; Lash, T.L., Heuristic thinking and inference from observational epidemiology (2007) Epidemiology, 18 (1), pp. 67-72; Greenland, S., Basic methods for sensitivity analysis of biases (1996) Int J Epidemiol, 25 (6), pp. 1107-1116; Lash, T.L., Fox, M.P., MacLehose, R.F., Good practices for quantitative bias analysis (2014) Int J Epidemiol, 43 (6), pp. 1969-1985; Brakenhoff, T.B., Mitroiu, M., Keogh, R.H., Measurement error is often neglected in medical literature: A systematic review (2018) J Clin Epidemiol, 98, pp. 89-97; Greenland, S., Multiple-bias modelling for analysis of observational data (2005) J R Stat Soc ser A Stat Soc, 168 (2), pp. 267-306; Shadish, W.R., Cook, T.D., Campbell, D.T., (2001) Experimental and Quasi-Experimental Designs for Generalized Causal Inference, , Boston MA Houghton Mifflin; Craig, P., Katikireddi, S.V., Leyland, A., Natural experiments: An overview of methods, approaches, contributions to public health intervention research (2017) Annu Rev Public Health, 38, pp. 39-56; Bernal, J.L., Cummins, S., Gasparrini, A., Interrupted time series regression for the evaluation of public health interventions: A tutorial (2017) Int J Epidemiol, 46 (1), pp. 348-355; Ryan, A.M., Burgess, J.F., Jr., Dimick, J.B., Why we should not be indifferent to specification choices for difference-in-differences (2015) Health Serv Res, 50 (4), pp. 1211-1235; Rehkopf, D.H., Basu, S., A new tool for case studies in epidemiology-the synthetic control method (2018) Epidemiology, 29 (4), pp. 503-505; Hernán, M.A., Robins, J.M., Instruments for causal inference: An epidemiologist's dream (2006) Epidemiology, 17 (4), pp. 360-372; Bor, J., Moscoe, E., Mutevedzi, P., Regression discontinuity designs in epidemiology: Causal inference without randomized trials (2014) Epidemiology, 25 (5), pp. 729-73754; Pletscher, M., The effects of organized screening programs on the demand for mammography in switzerland (2017) Eur J Health Econ, 18 (5), pp. 649-665; Cullati, S., Von Arx, M., Courvoisier, D.S., Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study (2018) Prev Med, 116, pp. 19-26; Feynman, R.P., Cargo cult science (1974) Engineering and Science, 37 (7), pp. 10-13; Kahneman, D., (2011) Thinking Fast Slow, , New York NY: Farrar Straus & Giroux; EQUATOR Network Reporting Guideline Manual, , https://www.equator-network.org/library/equator-network-reporting-guideline-manual/, Equator Network, Accessed December 17, 2018; Munafò, M.R., Nosek, B.A., Bishop, D.V., A manifesto for reproducible science (2017) Nat Hum Behav, 1, p. 0021; Chalmers, I., Bracken, M.B., Djulbegovic, B., How to increase value and reduce waste when research priorities are set (2014) Lancet, 383 (9912), pp. 156-165; Estimating the reproducibility of psychological science (2015) Science, 349 (6251), p. 4716; Ioannidis, J.P., Allison, D.B., Ball, C.A., Repeatability of published microarray gene expression analyses (2009) Nat Genet, 41 (2), pp. 149-155; Errington, T.M., Iorns, E., Gunn, W., Science forum: An open investigation of the reproducibility of cancer biology research (2014) ELife, (3), p. e04333; Button, K.S., Ioannidis, J.P., Mokrysz, C., Power failure: Why small sample size undermines the reliability of neuro science (2013) Nat Rev Neurosci, 14 (5), pp. 365-376; Camerer, C.F., Dreber, A., Forsell, E., Evaluating replicability of laboratory experiments in economics (2016) Science, 351 (6280), pp. 1433-1436; Lash, T.L., Collin, L.J., Van Dyke, M.E., The replication crisis in epidemiology: Snowball, snow job, or winter solstice (2018) Curr Epidemiol Rep, 5 (2), pp. 175-183; Zwaan, R.A., Etz, A., Lucas, R.E., Making replication mainstream (2017) Behav Brain Sci, pp. 1-50; Weuve, J., Sagiv, S.K., Fox, M.P., Quantitative bias analysis for collaborative science (2018) Epidemiology, 29 (5), pp. 627-630; Aiken, A.M., Davey, C., Hargreaves, J.R., Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: A pure replication (2015) Int J Epidemiol, 44 (5), pp. 1572-1580; Hicks, J.H., Kremer, M., Miguel, E., Commentary: Deworming externalities and schooling impacts in Kenya: A comment (2015) Int J Epidemiol, 44 (5), pp. 1593-1596. , Aiken et al. (2015) and Davey et al. 2015; Regnerus, M., Is structural stigma's effect on the mortality of sexual minorities robust A failure to replicate the results of a published study (2017) Soc Sci Med, 188, pp. 157-165; Hatzenbuehler, M.L., Bellatorre, A., Lee, Y., Structural stigma and all-cause mortality in sexual minority populations (2014) Soc Sci Med, 103, pp. 33-41; Ebrahim, S., Sohani, Z.N., Montoya, L., Reanalyses of randomized clinical trial data (2014) JAMA, 312 (10), pp. 1024-1032; Brown, A.N., Wood, B.D., Replication studies of development impact evaluations (2019) J Dev Stud, 55 (5), pp. 917-924; Nosek, B.A., Lakens, D., Registered reports: A method to increase the credibility of published results (2014) Soc Psychol, 45 (3), pp. 137-141; Franco, A., Malhotra, N., Simonovits, G., Social science. Publication bias in the social sciences: Unlocking the file drawer (2014) Science, 345 (6203), pp. 1502-1505; Lawlor, D.A., Quality in epidemiological research Should we be submitting papers before we have the results and submitting more hypothesis-generating research (2007) Int J Epidemiol, 36 (5), pp. 940-943; Fox, M.P., Lash, T.L., On the need for quantitative bias analysis in the peer-review process (2017) Am J Epidemiol, 185 (10), pp. 865-868; Allen, C.P., Mehler, D.M., (2018) Open Science Challenges, Benefits and Tips in Early Career and Beyond-manuscript, , PsyArXiv Preprint, Accessed November 16, 2018; Chavalarias, D., Wallach, J.D., Li, A.H., Evolution of reporting p values in the biomedical literature 1990-2015 (2016) JAMA, 315 (11), pp. 1141-1148; Lash, T.L., The harm done to reproducibility by the culture of null hypothesis significance testing (2017) Am J Epidemiol, 186 (6), pp. 627-635; Kaplan, R.M., Irvin, V.L., Likelihood of null effects of large NHLBI clinical trials has increased over time (2015) PLoS One, 10 (8), p. e0132382; Gertler, P., Galiani, S., Romero, M., How to make replication the norm (2018) Nature, 554 (7693), pp. 417-419; Ioannidis, J.P., How to make more published research true (2014) PLoS Med, 11 (10), p. e1001747},
correspondence_address1={Harper, S.; Department of Epidemiology, 1020 Pine Avenue West, Canada; email: sam.harper@mcgill.ca},
publisher={Oxford University Press},
issn={00029262},
coden={AJEPA},
pubmed_id={30877294},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Goldman20201,
author={Goldman, J.S.},
title={Predictive genetic counseling for neurodegenerative diseases: Past, present, and future},
journal={Cold Spring Harbor Perspectives in Medicine},
year={2020},
volume={10},
number={7},
pages={1-15},
doi={10.1101/cshperspect.a036525},
art_number={a036525},
note={cited By 12},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080992269&doi=10.1101%2fcshperspect.a036525&partnerID=40&md5=27a880fab81226486605a3343a22dc62},
affiliation={Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology, Columbia University Vagelos College of Medicine, New York, NY  10032, United States},
abstract={Predictive genetic counseling for neurodegenerative diseases commenced with Huntington’s disease (HD). Because the psychological issues and outcomes have been best studied in HD, the HD genetic counseling and testing protocol is still accepted as the gold standard for genetic counseling for these diseases. Yet, advances in genomic technology have produced an abundance of new information about the genetics of diseases such as Alzheimer’s disease, frontotemporal dementia, amyotrophic lateral sclerosis, and Parkinson’s disease. The resulting expansion of genetic tests together with the availability of direct-to-consumer testing and clinical trials for treatment of these diseases present new ethical and practical issues requiring modifications to the protocol for HD counseling and new demands on both physicians and genetic counselors. This work reviews the history of genetic counseling for neurodegenerative diseases, its current practice, and the future direction of genetic counseling for these conditions. © 2020 Cold Spring Harbor Laboratory Press; all rights reserved;.},
keywords={Alzheimer disease;  amyotrophic lateral sclerosis;  Article;  degenerative disease;  frontotemporal dementia;  genetic counseling;  genetic risk score;  genetic screening;  genetic variability;  human;  Huntington chorea;  mental health;  outcome assessment;  Parkinson disease;  prediction;  Alzheimer disease;  amyotrophic lateral sclerosis;  ethics;  frontotemporal dementia;  genetic counseling;  genetics;  Huntington chorea;  Parkinson disease;  procedures, Alzheimer Disease;  Amyotrophic Lateral Sclerosis;  Frontotemporal Dementia;  Genetic Counseling;  Genetic Testing;  Humans;  Huntington Disease;  Parkinson Disease},
references={Ahn, TB, Kim, SY, Kim, JY, Park, SS, Lee, DS, Min, HJ, Kim, YK, Kim, HJ, α-Synuclein gene duplication is present in sporadic Parkinson disease (2008) Neurology, 70, pp. 43-49; Alcalay, RN, Dinur, T, Quinn, T, Sakanaka, K, Levy, O, Waters, C, Fahn, S, Pauciulo, M, Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes (2014) JAMA Neurol, 71, pp. 752-757; Almqvist, EW, Bloch, M, Brinkman, R, Craufurd, D, Hayden, MR., A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease (1999) Am J Hum Genet, 64, pp. 1293-1304; Almqvist, EW, Brinkman, RR, Wiggins, S, Hayden, MR, Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Hun-tington’s disease (2003) Clin Genet, 64, pp. 300-309. , Canadian Collaborative Study of Predictive Testing; Statement on use of apolipoprotein E testing for Alzheimer disease (1995) J Am Med Assoc, 274, pp. 1627-1629. , American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease; Axelrud, LK, Santoro, ML, Pine, DS, Talarico, F, Gadelha, A, Manfro, GG, Pan, PM, Brietzke, E, Polygenic risk score for Alzheimer’s disease: implications for memory performance and hippocampal volumes in early life (2018) Am J Psychiatry, 175, pp. 555-563; Baig, SS, Strong, M, Rosser, E, Taverner, NV, Glew, R, Miedzy-brodzka, Z, Clarke, A, Quarrell, OW., 22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium (2016) Eur J Hum Genet, 24, pp. 1396-1402. , UK Huntington’s Disease Prediction Consortium; Barette, J, Marsden, CD., Attitudes of families to some aspects of Huntington’s chorea (1979) Psychol Med, 9, pp. 327-336; Bateman, RJ, Xiong, C, Benzinger, TL, Fagan, AM, Goate, A, Fox, NC, Marcus, DS, Blazey, TM, Clinical and biomarker changes in dominantly inherited Alzheimer’s disease (2012) N Engl J Med, 367, pp. 795-804; Bateman, RJ, Benzinger, TL, Berry, S, Clifford, DB, Duggan, C, Fagan, AM, Fanning, K, McDade, EM, The DIAN-TU Next Generation Alzheimer’s Prevention trial: adaptive design and disease progression model (2017) Alzheimers Dement, 13, pp. 8-19; Benatar, M, Stanislaw, C, Reyes, E, Hussain, S, Cooley, A, Fernandez, MC, Dauphin, DD, Wuu, J., Presymptomatic ALS genetic counseling and testing: experience and recommendations (2016) Neurology, 86, pp. 2295-2302; Bird, SJ., Presymptomatic testing for Huntington’s disease (1985) J Am Med Assoc, 253, pp. 3286-3291; Bloch, M, Hayden, MR, Opitz, JM., Preclinical testing in Huntington disease (1987) Am J Med Genet, 27, pp. 733-734; Brüggemann, N, Klein, C., Will genotype drive treatment options? (2019) Mov Disord; Cassidy, MR, Roberts, JS, Bird, TD, Steinbart, EJ, Cupples, LA, Chen, CA, Linnenbringer, E, Green, RC., Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer’s disease (2008) Alzheimers De-ment, 4, pp. 406-413; Chao, S, Roberts, JS, Marteau, TM, Silliman, R, Cupples, LA, Green, RC., Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study (2008) Alzheimer Dis Assoc Disord, 22, pp. 94-97; Christensen, KD, Roberts, JS, Whitehouse, PJ, Royal, CD, Obi-sesan, TO, Cupples, LA, Vernarelli, JA, Butson, MB, Disclosing pleiotropic effects during genetic risk assessment for Alzheimer dis-ease: a randomized trial (2016) Ann Intern Med, 164, pp. 155-163; Corder, EH, Saunders, AM, Strittmatter, WJ, Schmechel, DE, Gaskell, PC, Small, GW, Roses, AD, Pericak-Vance, MA., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families (1993) Science, 261, pp. 921-923; Craufurd, DI, Harris, R., Ethics of predictive testing for Huntington’s chorea: the need for more information (1986) Br Med J (Clin Res Ed), 293, pp. 249-251; Crook, A, Williams, K, Adams, L, Blair, I, Rowe, DB., Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling con-siderations (2017) Amyotroph Lateral Scler Frontotemporal De-gener, 18, pp. 475-485; Crozier, S, Robertson, N, Dale, M., The psychological impact of predictive genetic testing for Huntington’s dis-ease: a systematic review of the literature (2015) J Genet Couns, 24, pp. 29-39; Cruchaga, C, Del-Aguila, JL, Saef, B, Black, K, Fernandez, MV, Budde, J, Ibanez, L, Tosto, G, Polygenic risk score of sporadic late-onset Alz-heimer’s disease reveals a shared architecture with the familial and early-onset forms (2018) Alzheimers Dement, 14, pp. 205-214; Decruyenaere, M, Evers-Kiebooms, G, Cloostermans, T, Boo-gaerts, A, Demyttenaere, K, Dom, R, Fryns, JP., Predictive testing for Huntington’s disease: relationship with partners after testing (2004) Clin Genet, 65, pp. 24-31; Domingo, A, Klein, C., Genetics of Parkinson disease (2018) Handb Clin Neurol, 147, pp. 211-227; Escott-Price, V, Sims, R, Bannister, C, Harold, D, Vronskaya, M, Majounie, E, Badarinarayan, N, Passmore, P, Common polygenic variation enhances risk prediction for Alz-heimer’s disease (2015) Brain, 138, pp. 3673-3684. , GERAD/PERADES; IGAP consortia; Fanos, JH, Gronka, S, Wuu, J, Stanislaw, C, Andersen, PM, Benatar, M., Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis (2011) Genet Med, 13, pp. 342-348; Farrer, LA, Opitz, JM, Reynolds, JF., Suicide and attempt-ed suicide in Huntington disease: implications for pre-clinical testing of persons at risk (1986) Am J Med Genet, 24, pp. 305-311; Farrer, LA, Cupples, A, Haines, JL, Hyman, B, Kukull, WA, Mayeux, R, Myers, RH, van Duijn, CM., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease (1997) J Am Med Assoc, 278, pp. 1349-1356; Gargiulo, M, Lejeune, S, Tanguy, ML, Lahlou-Laforêt, K, Fau-det, A, Cohen, D, Feingold, J, Durr, A., Long-term outcome of presymptomatic testing in Huntington dis-ease (2009) Eur J Hum Genet, 17, pp. 165-171; Giannoccaro, MP, Bartoletti-Stella, A, Piras, S, Pession, A, De Massis, P, Oppi, F, Stanzani-Maserati, M, Avoni, P, Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observa-tions on their oligogenic nature (2017) J Neurol, 264, pp. 1426-1433; Goldman, JS, Hahn, SE, Catania, JW, LaRusse-Eckert, S, But-son, MB, Rumbaugh, M, Strecker, MN, Mayeux, R, Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors (2011) Genet Med, 13, pp. 597-605; Gooding, HC, Linnenbringer, EL, Burack, J, Roberts, JS, Green, RC, Biesecker, BB., Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk (2006) Patient Educ Couns, 64, pp. 259-267; Green, RC, Roberts, JS, Cupples, LA, Relkin, NR, Whitehouse, PJ, Brown, T, Eckert, SL, Quaid, KA, Disclosure of APOE genotype for risk of Alzheimer’s disease (2009) N Engl J Med, 361, pp. 245-254; Grill, JD, Bateman, RJ, Buckles, V, Oliver, A, Morris, JC, Mas-ters, CL, Klunk, WE, Ringman, JM, A survey of attitudes toward clinical trials and genetic disclosure in autosomal domi-nant Alzheimer’s disease (2015) Alzheimers Res Ther, 7, p. 50. , Dominantly Inherited Alzheimer’s Network; Groves, M., The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist’s role in assessment and counseling (2017) Handb Clin Neurol, 144, pp. 99-105; Hellmuth, J, Rabinovici, GD, Miller, BL., The rise of pseudomedicine for dementia and brain health (2019) JAm Med Assoc, 321, pp. 543-544; Huggins, M, Bloch, M, Kanani, S, Quarrell, OW, Theilman, J, Hedrick, A, Dickens, B, Hayden, M., Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington dis-ease (1990) Am J Hum Genet, 47, pp. 4-12; A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromo-somes (1993) Cell, 72, pp. 971-983. , Huntington’s Disease Collaborative Research Group; (1994) Guidelines for predictive testing for Huntington’s disease, , Huntington’s Disease Society of America. Hunting-ton’s Disease Society of America, New York; (2016) Genetic testing protocol for Huntington’s disease, , Huntington’s Disease Society of America. Huntington’s Disease Society of America, New York; Ibisler, A, Ocklenburg, S, Stemmler, S, Arning, L, Epplen, JT, Saft, C, Hoffjan, S., Prospective evaluation of predictive DNA testing for Huntington’s disease in a large Ger-man center (2017) J Genet Couns, 26, pp. 1029-1040; Guidelines for the molecular genetics predictive test in Huntington’s disease (1994) J Med Genet, 31, pp. 555-559. , International Huntington Association and the World Federation of Neurology Research Group on Huntington’s Chorea; Kessler, S., Psychiatric implications of presymptomatic testing for Huntington’s disease (1987) Am J Orthopsychiatry, 57, pp. 212-219; Kessler, S, Field, T, Worth, L, Mosbarger, H, Opitz, JM, Reynolds, JF., Attitudes of persons at risk for Huntington disease toward predictive testing (1987) Am J Med Genet, 26, pp. 259-270; Kolata, G., Genetic screening raises questions for em-ployers and insurers (1986) Science, 232, pp. 317-319; Lamport, AT, Opitz, JM, Shaw, MW., Presymptomatic testing for Huntington chorea: ethical and legal issues (1987) Am J Med Genet, 26, pp. 307-314; Lannfelt, L, Axelman, K, Lilius, L, Basun, H., Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation (1995) Am J Hum Genet, 56, pp. 332-335; Larsson, MU, Luszcz, MA, Bui, TH, Wahlin, TB., Depres-sion and suicidal ideation after predictive testing for Hun-tington’s disease: a two-year follow-up study (2006) J Genet Couns, 15, pp. 361-374; Lawson, K, Wiggins, S, Green, T, Adam, S, Bloch, M, Hayden, MR., Adverse psychological events occurring in the first year after predictive testing for Huntington’s disease. The Canadian Collaborative Study Predictive Testing (1996) J Med Genet, 33, pp. 856-862; Lennox, A, Karlinsky, H, Meschino, W, Buchanan, JA, Percy, ME, Berg, JM., Molecular genetic predictive testing for Alzheimer’s disease: deliberations and preliminary recommendations (1994) Alzheimer Dis Assoc Disord, 8, pp. 126-147; Lill, CM., Genetics of Parkinson’s disease (2016) Mol Cell Probes, 30, pp. 386-396; Lineweaver, TT, Bondi, MW, Galasko, D, Salmon, DP., Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults (2014) Am J Psychiatry, 171, pp. 201-208; Linnenbringer, E, Roberts, JS, Hiraki, S, Cupples, LA, Green, RC., I know what you told me, but this is what I think:” perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate (2010) Genet Med, 12, pp. 219-227; Lopez Lopez, C, Tariot, PN, Caputo, A, Langbaum, JB, Liu, F, Riviere, ME, Langlois, C, Hendrix, S, The Alzheimer’s Prevention Initiative Generation Program: study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer’s disease (2019) Alzheimers Dement (N Y), 5, pp. 216-227; MacLeod, R, Tibben, A, Frontali, M, Evers-Kiebooms, G, Jones, A, Martinez-Descales, A, Roos, RA, Recommendations for the predictive genetic test in Huntington’s disease (2013) Clin Genet, 83, pp. 221-231. , Editorial Committee and Working Group ‘Genetic Testing Counselling of the European Huntington Disease Network; Majounie, E, Renton, AE, Mok, K, Dopper, EG, Waite, A, Roll-inson, S, Chiò, A, Simon-Sanchez, J, Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study (2012) Lancet Neurol, 11, pp. 323-330; Mandich, P, Mantero, V, Verdiani, S, Gotta, F, Caponnetto, C, Bellone, E, Ferrandes, G, Origone, P., Complexities of genetic counseling for ALS: a case of two siblings with discordant genetic test results (2015) J Genet Couns, 24, pp. 553-557; Mandich, P, Lamp, M, Gotta, F, Gulli, R, Iacometti, A, Marchese, R, Bellone, E, Ferrandes, G., 1993– 2014: two decades of predictive testing for Huntington’s disease at the Medical Genetics Unit of the University of Genoa (2017) Mol Genet Genomic Med, 5, pp. 473-480; Marshe, VS, Gorbovskaya, I, Kanji, S, Kish, M, Müller, DJ., Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literature (2019) J Neural Transm, 126, pp. 65-85; Marteau, TM, Roberts, S, LaRusse, S, Green, RC., Predictive genetic testing for Alzheimer’s disease: impact upon risk perception (2005) Risk Anal, 25, pp. 397-404; Mayeux, R, Schupf, N., Apolipoprotein E and Alz-heimer’s disease: the implications of progress in molecular medicine (1995) Am J Public Health, 85, pp. 1280-1284; Molinuevo, JL, Pintor, L, Peri, JM, Lleó, A, Oliva, R, Marcos, T, Blesa, R., Emotional reactions to predictive testing in Alzheimer’s disease and other inherited dementias (2005) Am J Alzheimers Dis Other Demen, 20, pp. 233-238; Morrison, PJ, Harding-Lester, S, Bradley, A., Uptake of Huntington disease predictive testing in a complete pop-ulation (2011) Clin Genet, 80, pp. 281-286; Nicholson, AM, Rademakers, R., What we know about TMEM106B in neurodegeneration (2016) Acta Neuropathol, 132, pp. 639-651; Post, SG, Whitehouse, PJ, Binstock, RH, Bird, TD, Eckert, SK, Farrer, LA, Fleck, LM, Karlinsky, H, The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective (1997) J Am Med Assoc, 277, pp. 832-836; Qian, J, Wolters, FJ, Beiser, A, Haan, M, Ikram, MA, Karlawish, J, Langbaum, JB, Roberts, JS, APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts (2017) PLoS Med, 14, p. e1002254; Quaid, KA, Brandt, J, Folstein, SE., The decision to be tested for Huntington’s disease (1987) J Am Med Assoc, 257, p. 3362; Quaid, KA, Eberly, SW, Kayson-Rubin, E, Oakes, D, Shoulson, I, Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS) (2017) Clin Genet, 91, pp. 824-831. , Huntington Study Group PHAROS Investigators and Coordinators; Relkin, NR, Kwon, YJ, Tsai, J, Gandy, S., The National Institute on Aging/Alzheimer’s Association recommendations on the application of apolipoprotein E genotyping to Alzheimer’s disease (1996) Ann NY Acad Sci, 802, pp. 149-176; Richards, F, Williams, K., Impact on couple relation-ships of predictive testing for Huntington disease: a longitudinal study (2004) Am J Med Genet A, 126A, pp. 161-169; Roberts, JS, LaRusse, SA, Katzen, H, Whitehouse, PJ, Barber, M, Post, SG, Relkin, N, Cupples, LA, Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease (2003) Alzheimer Dis Assoc Disord, 17, pp. 86-93; Roberts, JS, Barber, M, Brown, TM, Cupples, LA, Farrer, LA, LaRusse, SA, Post, SG, Relkin, NR, Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial (2004) Genet Med, 6, pp. 197-203; Rosenfeld, A., At risk for Huntington’s disease: who should know what and when? (1984) Hastings Cent Rep, 14, pp. 5-8; Saunders, AM, Strittmatter, WJ, Schmechel, D, George-Hys-lop, PH, Pericak-Vance, MA, Joo, SH, Rosi, BL, Alberts, MJ, Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease (1993) Neurology, 43, pp. 1467-1472; Schneider, SA, Alcalay, RN., Neuropathology of genetic synucleinopathies with parkinsonism: review of the liter-ature (2017) Mov Disord, 32, pp. 1504-1523; Steinbart, EJ, Smith, CO, Poorkaj, P, Bird, TD., Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia (2001) Arch Neurol, 58, pp. 1828-1831; Suter, S., Legal challenges in genetics, including duty to warn, duty to recontact, and genetic discriminations (2019) Cold Spring Harb Perspect Med; Tan, CH, Hyman, BT, Tan, JJX, Hess, CP, Dillon, WP, Schellen-berg, GD, Besser, LM, McEvoy, LK, Polygenic hazard scores in preclinical Alzheimer disease (2017) Ann Neurol, 82, pp. 484-488; Tibben, A., Predictive testing for Huntington’s disease (2007) Brain Res Bull, 72, pp. 165-171; Tibben, A, Vegter-vd Vlis, M, vd Niermeijer, MF, Kamp, JJ, Roos, RA, Rooijmans, HG, Frets, PG, Verhage, F., Testing for Huntington’s disease with support for all par-ties (1990) Lancet, 335, p. 553; Tibben, A, Stevens, M, de Wert, GM, Niermeijer, MF, van Duijn, CM, van Swieten, JC., Preparing for presymp-tomatic DNA testing for early onset Alzheimer’s disease/ cerebral haemorrhage and hereditary Pick disease (1997) J Med Genet, 34, pp. 63-72; Tosto, G, Bird, TD, Tsuang, D, Bennett, DA, Boeve, BF, Cruchaga, C, Faber, K, Goate, AM, Polygenic risk scores in familial Alzheimer disease (2017) Neurology, 88, pp. 1180-1186; Turner, MR, Al-Chalabi, A, Chio, A, Hardiman, O, Kiernan, MC, Rohrer, JD, Rowe, J, Talbot, K., Genetic screening in sporadic ALS and FTD (2017) J Neurol Neurosurg Psychiatry, 88, pp. 1042-1044; Tyler, A, Harper, PS., Attitudes of subjects at risk and their relatives towards genetic counselling in Hunting-ton’s chorea (1983) J Med Genet, 20, pp. 179-188; van Blitterswijk, M, DeJesus-Hernandez, M, Rademakers, R., How do C9ORF72 repeat expansions cause amyo-trophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disor-ders? (2012) Curr Opin Neurol, 25, pp. 689-700; Vernarelli, JA, Roberts, JS, Hiraki, S, Chen, CA, Cupples, LA, Green, RC., Effect of Alzheimer disease genetic risk disclosure on dietary supplement use (2010) Am J Clin Nutr, 91, pp. 1402-1407; Wagner, KN, Nagaraja, HN, Allain, DC, Quick, A, Kolb, SJ, Roggenbuck, J., Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic test-ing (2018) Mol Genet Genomic Med, 6, pp. 224-229; Wild, EJ, Tabrizi, SJ., Therapies targeting DNA and RNA in Huntington’s disease (2017) Lancet Neurol, 16, pp. 837-847; Ethical issues policy statement on Huntington’s disease molecular genetics predictive test (1990) J Med Genet, 27, pp. 34-38. , World Federation of Neurology Research Group on Hun-tington’s Disease; Xiao, E, Chen, Q, Goldman, AL, Tan, HY, Healy, K, Zoltick, B, Das, S, Dickinson, D, Late-onset Alzheimer’s disease polygenic risk profile score predicts hippocampal function (2017) Biol Psychiatry Cogn Neurosci Neuroimaging, 2, pp. 673-679; Zallen, DT., Well, good luck with that”: reactions to learning of increased genetic risk for Alzheimer disease (2018) Genet Med, 20, pp. 1462-1467; Zick, CD, Mathews, CJ, Roberts, JS, Cook-Deegan, R, Pokorski, RJ, Green, RC., Genetic testing for Alzheimer’s disease and its impact on insurance purchasing behavior (2005) Health Aff (Millwood), 24, pp. 483-490},
correspondence_address1={Goldman, J.S.; Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, United States; email: jg2673@cumc.columbia.edu},
publisher={Cold Spring Harbor Laboratory Press},
issn={21571422},
pubmed_id={31548223},
language={English},
abbrev_source_title={Cold Spring Harbor Perspect. Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Adam2019196,
author={Adam, D.},
title={The gene-based hack that is revolutionizing epidemiology},
journal={Nature},
year={2019},
volume={576},
number={7786},
pages={196-199},
doi={10.1038/d41586-019-03754-3},
note={cited By 12},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076337381&doi=10.1038%2fd41586-019-03754-3&partnerID=40&md5=598e9ef729a49104afd08393b06f96e9},
author_keywords={Epidemiology;  Genetics;  Genomics},
keywords={epidemiology;  genetic predisposition;  genetic variation;  genetics;  human;  neoplasm;  risk factor, Epidemiologic Methods;  Epidemiology;  Genetic Predisposition to Disease;  Genetic Variation;  Humans;  Neoplasms;  Risk Factors},
publisher={NLM (Medline)},
issn={14764687},
pubmed_id={31822846},
language={English},
abbrev_source_title={Nature},
document_type={Article},
source={Scopus},
}

@ARTICLE{Sergentanis20191978,
author={Sergentanis, T.N. and Ntanasis-Stathopoulos, I. and Tzanninis, I.-G. and Gavriatopoulou, M. and Sergentanis, I.N. and Dimopoulos, M.A. and Psaltopoulou, T.},
title={Meat, fish, dairy products and risk of hematological malignancies in adults–a systematic review and meta-analysis of prospective studies},
journal={Leukemia and Lymphoma},
year={2019},
volume={60},
number={8},
pages={1978-1990},
doi={10.1080/10428194.2018.1563693},
note={cited By 12},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069442282&doi=10.1080%2f10428194.2018.1563693&partnerID=40&md5=d89e09b99fa72fbc8b946891f0fa50ee},
affiliation={Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Hôpital de Psychiatrie Hôpitaux, Universitaires de Genève, Geneva, Switzerland},
abstract={This systematic review and meta-analysis of cohort studies examine the association of meat, fish, and dairy product consumption with the risk of hematological neoplasms in adults. Thirteen studies encompassing 1,480,986 participants and 10,442 incident cases were included. Red or processed meat consumption was not associated with the risk of leukemia, acute myeloid leukemia, non-Hodgkin lymphoma (NHL) and small lymphocytic lymphoma/chronic lymphocytic leukemia (CLL/SLL). Poultry consumption did not seem to affect the risk of leukemia, NHL, CLL/SLL, and multiple myeloma (MM). Fish consumption was not associated with leukemia, NHL, CLL/SLL, and MM risk. Interestingly though, fish consumption was positively associated with myeloid leukemia risk (pooled RR = 1.74, 95% CI: 1.22–2.47, random effects, highest vs. lowest category). Milk and dairy product consumption was not associated with NHL and leukemia risk. In conclusion, methodologically strict prospective studies are mandatory, in order to extract reliable conclusions concerning the role of these dietary factors in hematological malignancies. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.},
author_keywords={dairy product;  fish;  Hematological cancer;  meat;  meta-analysis},
keywords={acute leukemia;  cancer risk;  chronic lymphatic leukemia;  dairy product;  fish meat;  food intake;  hematologic malignancy;  human;  lymphocytic lymphoma;  milk;  multiple myeloma;  myeloid leukemia;  nonhodgkin lymphoma;  poultry meat;  priority journal;  processed meat;  red meat;  Review;  systematic review;  animal;  disease predisposition;  feeding behavior;  female;  fish product;  hematologic disease;  male;  meat;  meta analysis;  odds ratio;  risk assessment;  risk factor, Animals;  Dairy Products;  Disease Susceptibility;  Feeding Behavior;  Female;  Fish Products;  Hematologic Neoplasms;  Humans;  Male;  Meat;  Odds Ratio;  Risk Assessment;  Risk Factors},
funding_details={World Cancer Research FundWorld Cancer Research Fund, WCRF},
funding_details={Wereld Kanker Onderzoek FondsWereld Kanker Onderzoek Fonds, WKOF, 2013/995},
funding_text 1={We are extremely thankful to and acknowledge the World Cancer Research Fund (WCRF), for the grant named ‘Identifying the role of nutrition, physical activity and body size in hematological malignancies through systematic reviews and meta-analyses’ funded by Wereld Kanker Onderzoek Fonds (WCRF NL) and administered by WCRF International as part of the WCRF International program [Grant number: 2013/995].},
references={Campo, E., Swerdlow, S.H., Harris, N.L., The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications (2011) Blood, 117, pp. 5019-5032; Arber, D.A., Orazi, A., Hasserjian, R., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (2016) Blood, 127, pp. 2391-2405; Swerdlow, S.H., Campo, E., Pileri, S.A., The 2016 revision of the World Health Organization classification of lymphoid neoplasms (2016) Blood, 127, pp. 2375-2390; Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016 (2016) CA Cancer J Clin, 66, pp. 7-30; Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 (2013) Eur J Cancer, 49, pp. 1374-1403; Liu, P., Holman, C.D., Jin, J., Diet and risk of adult leukemia: a multicenter case-control study in China (2015) Cancer Causes Control, 26, pp. 1141-1151; Bradbury, K.E., Appleby, P.N., Key, T.J., Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC) (2014) Am J Clin Nutr, 100, pp. 394S-398S; Bagnardi, V., Rota, M., Botteri, E., Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis (2015) Br J Cancer, 112, pp. 580-593; Sergentanis, T.N., Psaltopoulou, T., Ntanasis-Stathopoulos, I., Consumption of fruits, vegetables, and risk of hematological malignancies: a systematic review and meta-analysis of prospective studies (2018) Leuk Lymphoma, 59, pp. 434-447; Psaltopoulou, T., Sergentanis, T.N., Ntanasis-Stathopoulos, I., Alcohol consumption and risk of hematological malignancies: a meta-analysis of prospective studies (2018) Int J Cancer, 143, pp. 486-495; Psaltopoulou, T., Ntanasis-Stathopoulos, I., Tsilimigras, D.I., Micronutrient intake and risk of hematological malignancies in adults: a systematic review and meta-analysis of cohort studies (2018) Nutr Cancer, , 70(6):821–839; Abid, Z., Cross, A.J., Sinha, R., Meat, dairy, and cancer (2014) Am J Clin Nutr, 100, pp. 386S-393S; Lippi, G., Mattiuzzi, C., Cervellin, G., Meat consumption and cancer risk: a critical review of published meta-analyses (2016) Crit Rev Oncol Hematol, 97, pp. 1-14; Carr, P.R., Walter, V., Brenner, H., Meat subtypes and their association with colorectal cancer: systematic review and meta-analysis (2016) Int J Cancer, 138, pp. 293-302; Boada, L.D., Henríquez-Hernández, L.A., Luzardo, O.P., The impact of red and processed meat consumption on cancer and other health outcomes: epidemiological evidences (2016) Food Chem Toxicol, 92, pp. 236-244; Bandera, E.V., Kushi, L.H., Moore, D.F., Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis (2007) Cancer Causes Control, 18, pp. 967-988; Kolahdooz, F., van der Pols, J.C., Bain, C.J., Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis (2010) Am J Clin Nutr, 91, pp. 1752-1763; Luo, J., Yang, Y., Liu, J., Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma (2014) Aliment Pharmacol Ther, 39, pp. 913-922; Yu, X.F., Zou, J., Dong, J., Fish consumption and risk of gastrointestinal cancers: a meta-analysis of cohort studies (2014) World J Gastroenterol, 20, pp. 15398-15412; Song, J., Su, H., Wang, B.L., Fish consumption and lung cancer risk: systematic review and meta-analysis (2014) Nutr Cancer, 66, pp. 539-549; (2018), http://dietandcancerreport.org, Diet, nutrition, physical activity and cancer: a global perspective. Continuous update project expert report. London: World Cancer Research Fund/American Institute for Cancer Research;,. Available from; Chagas, C.E., Rogero, M.M., Martini, L.A., Evaluating the links between intake of milk/dairy products and cancer (2012) Nutr Rev, 70, pp. 294-300; Huth, P.J., Park, K.M., Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence (2012) Adv Nutr, 3, pp. 266-285; Astrup, A., Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies (2014) Am J Clin Nutr, 99, pp. 1235S-1242S; Caroli, A., Poli, A., Ricotta, D., Invited review: dairy intake and bone health: a viewpoint from the state of the art (2011) J Dairy Sci, 94, pp. 5249-5262; Rozenberg, S., Body, J.J., Bruyere, O., Effects of dairy products consumption on health: benefits and beliefs–a commentary from the Belgian bone club and the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (2016) Calcif Tissue Int, 98, pp. 1-17; Stroup, D.F., Berlin, J.A., Morton, S.C., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group (2000) JAMA, 283, pp. 2008-2012; Song, J.W., Chung, K.C., Observational studies: cohort and case-control studies (2010) Plast Reconstr Surg, 126, pp. 2234-2242; Psaltopoulou, T., Ntanasis-Stathopoulos, I., Tzanninis, I.G., Physical activity and gastric cancer risk: a systematic review and meta-analysis (2016) Clin J Sport Med, 26, pp. 445-464; Petridou, E.T., Sergentanis, T.N., Perlepe, C., Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis (2015) Ann Oncol, 26, pp. 589-597; Gialamas, S.P., Sergentanis, T.N., Antonopoulos, C.N., Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis (2013) Cancer Causes Control, 24, pp. 2129-2141; Sergentanis, T.N., Tsivgoulis, G., Perlepe, C., Obesity and risk for brain/CNS tumors, gliomas and meningiomas: a meta-analysis (2015) PLoS One, 10; Higgins, J.P.T., Green, S., (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011, , http://www.cochrane-handbook.org, London: The Cochrane Collaboration,. Available from; Wells, G.A., Shea, B., O’Connell, D., The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses (2011) Department of epidemiology and community medicine, , http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm, Ottawa, Canada: University of Ottawa,. Available from:, [cited 2016 Aug 31]; Aschebrook-Kilfoy, B., Ollberding, N.J., Kolar, C., Meat intake and risk of non-Hodgkin lymphoma (2012) Cancer Causes Control, 23, pp. 1681-1692; Hosgood, H.D., 3rd, Baris, D., Zahm, S.H., Diet and risk of multiple myeloma in Connecticut women (2007) Cancer Causes Control, 18, pp. 1065-1076; Erber, E., Maskarinec, G., Gill, J.K., Dietary patterns and the risk of non-Hodgkin lymphoma: the multiethnic cohort (2009) Leuk Lymphoma, 50, pp. 1269-1275; Ursin, G., Bjelke, E., Heuch, I., Milk consumption and cancer incidence: a Norwegian prospective study (1990) Br J Cancer, 61, pp. 454-459; Hagmar, L., Linden, K., Nilsson, A., Cancer incidence and mortality among Swedish Baltic Sea fishermen (1992) Scand J Work Environ Health, 18, pp. 217-224; Key, T.J., Appleby, P.N., Crowe, F.L., Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans (2014) Am J Clin Nutr, 100, pp. 378S-385S; Iso, H., Kubota, Y., Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) (2007) Asian Pac J Cancer Prev, 8, pp. 35-80; Ross, J.A., Kasum, C.M., Davies, S.M., Diet and risk of leukemia in the Iowa Women’s Health Study (2002) Cancer Epidemiol Biomarkers Prev, 11, pp. 777-781; Daniel, C.R., Cross, A.J., Graubard, B.I., Prospective investigation of poultry and fish intake in relation to cancer risk (2011) Cancer Prev Res (Phila), 4, pp. 1903-1911; Park, Y., Leitzmann, M.F., Subar, A.F., Dairy food, calcium, and risk of cancer in the NIH-AARP diet and health study (2009) Arch Intern Med, 169, pp. 391-401; Cross, A.J., Leitzmann, M.F., Gail, M.H., A prospective study of red and processed meat intake in relation to cancer risk (2007) PLoS Med, 4, p. e325; Chang, E.T., Canchola, A.J., Cockburn, M., Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study (2011) Blood, 118, pp. 1591-1599; Chiu, B.C., Cerhan, J.R., Folsom, A.R., Diet and risk of non-Hodgkin lymphoma in older women (1996) JAMA, 275, pp. 1315-1321; Daniel, C.R., Sinha, R., Park, Y., Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women (2012) J Nutr, 142, pp. 1074-1080; Ma, X., Park, Y., Mayne, S.T., Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort (2010) Am J Epidemiol, 171, pp. 312-322; Rohrmann, S., Linseisen, J., Jakobsen, M.U., Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition (2011) Int J Cancer, 128, pp. 623-634; Saberi Hosnijeh, F., Peeters, P., Romieu, I., Dietary intakes and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC) (2014) Nutr Cancer, 66, pp. 14-28; Tsai, H.T., Cross, A.J., Graubard, B.I., Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies (2010) Cancer Epidemiol Biomarkers Prev, 19, pp. 2680-2684; Zhang, S., Hunter, D.J., Rosner, B.A., Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women (1999) J Natl Cancer Inst, 91, pp. 1751-1758; Bosch, A.C., O’Neill, B., Sigge, G.O., Heavy metals in marine fish meat and consumer health: a review (2016) J Sci Food Agric, 96, pp. 32-48; Zhou, Q., Gu, Y., Yue, X., Combined toxicity and underlying mechanisms of a mixture of eight heavy metals (2016) Mol Med Rep, 15, pp. 859-866; Henry, T.B., Ecotoxicology of polychlorinated biphenyls in fish-a critical review (2015) Crit Rev Toxicol, 45, pp. 643-661; Donat-Vargas, C., Berglund, M., Glynn, A., Dietary polychlorinated biphenyls, long-chain n-3 polyunsaturated fatty acids and incidence of malignant melanoma (2017) Eur J Cancer, 72, pp. 137-143; Zhang, Q., Yang, L., Wang, W.X., Bioaccumulation and trophic transfer of dioxins in marine copepods and fish (2011) Environ Pollut, 159, pp. 3390-3397; Bertazzi, P.A., Consonni, D., Bachetti, S., Health effects of dioxin exposure: a 20-year mortality study (2001) Am J Epidemiol, 153, pp. 1031-1044; Chemical agents and related occupations (2012) IARC Monogr Eval Carcinog Risks Hum, 100, pp. 9-562; Domingo, J.L., Nadal, M., Carcinogenicity of consumption of red and processed meat: what about environmental contaminants? (2016) Environ Res, 145, pp. 109-115; Yang, L., Dong, J., Jiang, S., Red and processed meat consumption increases risk for non-Hodgkin lymphoma: a PRISMA-compliant meta-analysis of observational studies (2015) Medicine (Baltimore), 94, p. e1729; Fallahzadeh, H., Cheraghi, M., Amoori, N., Red meat intake and risk of non-Hodgkin lymphoma: a meta-analysis (2014) Asian Pac J Cancer Prev, 15, pp. 10421-10425; Caini, S., Masala, G., Gnagnarella, P., Food of animal origin and risk of non-Hodgkin lymphoma and multiple myeloma: a review of the literature and meta-analysis (2016) Crit Rev Oncol Hematol, 100, pp. 16-24; Solimini, A.G., Lombardi, A.M., Palazzo, C., Meat intake and non-Hodgkin lymphoma: a meta-analysis of observational studies (2016) Cancer Causes Control, 27, pp. 595-606; Yang, L., Shi, W.Y., Xu, X.H., Fish consumption and risk of non-Hodgkin lymphoma: a meta-analysis of observational studies (2014) Hematology; Wang, J., Li, X., Zhang, D., Dairy product consumption and risk of Non-Hodgkin lymphoma: a meta-analysis (2016) Nutrients, 8, p. 120; Klurfeld, D.M., Research gaps in evaluating the relationship of meat and health (2015) Meat Sci, 109, pp. 86-95; Boeing, H., Nutritional epidemiology: new perspectives for understanding the diet-disease relationship? (2013) Eur J Clin Nutr, 67, pp. 424-429},
correspondence_address1={Psaltopoulou, T.; Department of Hygiene, 75, M. Asias Str, Greece; email: tpsaltop@med.uoa.gr},
publisher={Taylor and Francis Ltd},
issn={10428194},
coden={LELYE},
pubmed_id={30912696},
language={English},
abbrev_source_title={Leuk. Lymphoma},
document_type={Review},
source={Scopus},
}

@ARTICLE{Gillett2020,
author={Gillett, G. and Tomlinson, A. and Efthimiou, O. and Cipriani, A.},
title={Predicting treatment effects in unipolar depression: A meta-review},
journal={Pharmacology and Therapeutics},
year={2020},
volume={212},
doi={10.1016/j.pharmthera.2020.107557},
art_number={107557},
note={cited By 11},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084415659&doi=10.1016%2fj.pharmthera.2020.107557&partnerID=40&md5=6d80915e0e379f0c3d22f64a34a4456f},
affiliation={Oxford University Clinical Academic Graduate School, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, United Kingdom; Institute of Social and Preventive Medicine, University of Bern, Switzerland; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, OX3 7JX, United Kingdom},
abstract={There is increasing interest in clinical prediction models in psychiatry, which focus on developing multivariate algorithms to guide personalized diagnostic or management decisions. The main target of these models is the prediction of treatment response to different antidepressant therapies. This is because the ability to predict response based on patients' personal data may allow clinicians to make improved treatment decisions, and to provide more efficacious or more tolerable medications to the right patient. We searched the literature for systematic reviews about treatment prediction in the context of existing treatment modalities for adult unipolar depression, until July 2019. Treatment effect is defined broadly to include efficacy, safety, tolerability and acceptability outcomes. We first focused on the identification of individual predictor variables that might predict treatment response, and second, we considered multivariate clinical prediction models. Our meta-review included a total of 10 systematic reviews; seven (from 2014 to 2018) focusing on individual predictor variables and three focusing on clinical prediction models. These identified a number of sociodemographic, phenomenological, clinical, neuroimaging, remote monitoring, genetic and serum marker variables as possible predictor variables for treatment response, alongside statistical and machine-learning approaches to clinical prediction model development. Effect sizes for individual predictor variables were generally small and clinical prediction models had generally not been validated in external populations. There is a need for rigorous model validation in large external data-sets to prove the clinical utility of models. We also discuss potential future avenues in the field of personalized psychiatry, particularly the combination of multiple sources of data and the emerging field of artificial intelligence and digital mental health to identify new individual predictor variables. © 2020 Elsevier Inc.},
author_keywords={Antidepressant drugs;  Clinical prediction model;  Personalized medicine;  Precision psychiatry;  Prediction;  Treatment response;  Unipolar depression},
keywords={antidepressant agent;  biological marker;  brain derived neurotrophic factor;  sertraline;  venlafaxine, A Measurement Tool to Assess Systematic Reviews;  Beck Depression Inventory;  cognitive behavioral therapy;  demography;  electroconvulsive therapy;  electroencephalography;  functional magnetic resonance imaging;  genetic variability;  Hamilton Depression Rating Scale;  human;  machine learning;  major depression;  meta analysis;  Montgomery Asberg Depression Rating Scale;  neuroimaging;  neuromodulation;  nuclear magnetic resonance imaging;  patient safety;  personalized medicine;  phenomenology;  predictor variable;  priority journal;  prognosis;  psychotherapy;  remote sensing;  Review;  systematic review;  transcranial direct current stimulation;  transcranial magnetic stimulation;  treatment outcome;  treatment response;  artificial intelligence;  depression, Artificial Intelligence;  Depressive Disorder;  Humans;  Precision Medicine},
chemicals_cas={brain derived neurotrophic factor, 218441-99-7; sertraline, 79617-96-2; venlafaxine, 93413-69-5, 99300-78-4},
funding_details={180083},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR, RP-2017-08-ST2-006},
funding_details={Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF},
funding_details={NIHR Oxford Biomedical Research CentreNIHR Oxford Biomedical Research Centre, OxBRC, BRC-1215-20005},
funding_text 1={The study was funded by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (grant BRC-1215-20005). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.OE was supported by project grant No. 180083 from the Swiss National Science Foundation (SNSF). AC is supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017-08-ST2-006) and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215-20005). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.},
funding_text 2={OE was supported by project grant No. 180083 from the Swiss National Science Foundation (SNSF) . AC is supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility , by an NIHR Research Professorship (grant RP-2017-08-ST2-006 ) and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215-20005 ). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.},
funding_text 3={The study was funded by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (grant BRC-1215-20005 ). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.},
references={Al-Kaysi, A.M., Al-Ani, A., Loo, C.K., Powell, T.Y., Martin, D.M., Breakspear, M., Predicting tDCS treatment outcomes of patients with major depressive disorder using automated EEG classification (2017) Journal of Affective Disorders, 208, pp. 597-603; Allan, C.L., Herrmann, L.L., Ebmeier, K.P., Transcranial magnetic stimulation in the management of mood disorders (2011) Neuropsychobiology, 64 (3), pp. 163-169; Azuaje, F., Computational models for predicting drug responses in cancer research (2017) Briefings in Bioinformatics, 18, pp. 820-829; Bailey, N.W., Hoy, K.E., Rogasch, N.C., Thomson, R.H., McQueen, S., Elliot, D., Responders to rTMS for depression show increased fronto-midline theta and theta connectivity compared to non-responders (2018) Brain Stimulation, 11 (1), pp. 190-203; Belzeaux, R., Lin, C.W., Ding, Y., Bergon, A., Ibrahim, E.C., Turecki, G., Predisposition to treatment response in major depressive episode: A per-ipheral blood gene coexpression network analysis (2016) Journal of Psychiatric Research, 81, pp. 119-126; Berwian, I.M., Walter, H., Seifritz, E., Huys, Q.J., Predicting relapse after antidepressant withdrawal - a systematic review (2017) Psychological Medicine, 47, pp. 426-437; Bloomgren, G., Richman, S., Hotermans, C., Subramanyam, M., Goelz, S., Natarajan, A., Risk of natalizumab-associated progressive multifocal leukoencephalopathy (2012) The New England Journal of Medicine, 366, pp. 1870-1880; Borrione, L., Moffa, A.H., Martin, D., Loo, C.K., Brunoni, A.R., Transcranial direct current stimulation in the acute depressive episode: A systematic review of current knowledge (2018) The Journal of ECT, 34 (3), pp. 153-163; Bos, F.M., Schoevers, R.A., aan het Rot, M., Experience sampling and ecological momentary assessment studies in psychopharmacology: A systematic review (2015) European Neuropsychopharmacology, 25, pp. 1853-1864; Brennan, F.X., Gardner, K.R., Lombard, J., Perlis, R.H., Fava, M., Harris, H.W., A naturalistic study of the effectiveness of pharmacogenomic testing to guide treatment in psychiatric patients with mood and anxiety disorders. (2015) (2015) Primary Care Companion for CNS Disorders, p. 17(2); Bzdok, D., Meyer-Lindenberg, A., Machine learning for precision psychiatry: opportunities and challenges (2018) Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 3, pp. 223-230; Chekroud, A.M., Gueorguieva, R., Krumholz, H.M., Trivedi, M.H., Krystal, J.H., McCarthy, G., Reevaluating the efficacy and predictability of antidepressant treatments: A symptom clustering approach (2017) JAMA Psychiatry, 74 (4), pp. 370-378; Chen, L.W., Chen, M.Y., Lian, Z.P., Lin, H.S., Chien, C.C., Yin, H.L., Amitriptyline and sexual function: A systematic review updated for sexual health practice (2018) American Journal of Men's Health, 12, pp. 370-379; Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis (2018) Lancet, 391, pp. 1357-1366; Cipriani, A., Tomlinson, A., Providing the most appropriate care to our individual patients (2019) Evidence-Based Mental Health, 22 (1), pp. 1-2; Cohen, J., Statistical power analysis for the behavioral sciences (1988), 2nd ed. Lawrence Earlbaum Associates Hillsdale, NJ; Cohen, Z.D., DeRubeis, R.J., Treatment selection in depression (2018) Annual Review of Clinical Psychology, 14, pp. 209-236; Cooper, A.A., Conklin, L.R., Dropout from individual psychotherapy for major depression: A meta-analysis of randomized clinical trials (2015) Clinical Psychology Review, 40, pp. 57-65; Cowen, P., Anderson, I., New approaches to treating resistant depression (2015) BJPsych Advances, 21 (5), pp. 315-323; Cuijpers, P., de Wit, L., Weitz, E., Andersson, G., Huibers, M.J.H., The combination of psychotherapy and pharmacotherapy in the treatment of adult depression: A comprehensive meta-analysis. [references] (2015) Journal of Evidence Based Psychotherapies, 15, pp. 147-168; Cuijpers, P., Ebert, D.D., Acarturk, C., Andersson, G., Cristea, I.A., Personalized psychotherapy for adult depression: A meta-analytic review (2016) Behavior Therapy, 47, pp. 966-980; Cuijpers, P., Noma, H., Karyotaki, E., Cipriani, A., Furukawa, T.A., Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: A network meta-analysis [published correction appears in JAMA psychiatry. 2019 Jul 17;:] (2019) JAMA Psychiatry, 76 (7), pp. 700-707; Cuijpers, P., Noma, H., Karyotaki, E., Vinkers, C.H., Cipriani, A., Furukawa, T.A., A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression (2020) World Psychiatry, 19 (1), pp. 92-107; Cuijpers, P., Reynolds, C.F., 3rd, Donker, T., Li, J., Andersson, G., Beekman, A., Personalized treatment of adult depression: Medication, psychotherapy, or both? A systematic review (2012) Depression and Anxiety, 29, pp. 855-864; Cuijpers, P., Weitz, E., Lamers, F., Penninx, B.W., Twisk, J., DeRubeis, R.J., Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression (2017) Depression and Anxiety, 34, pp. 246-256; Cuijpers, P., Weitz, E., Twisk, J., Kuehner, C., Cristea, I., David, D., Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: An “individual patient data” meta-analysis (2014) Depression and Anxiety, 31, pp. 941-951; Dreimüller, N., Schlicht, K.F., Wagner, S., Peetz, D., Borysenko, L., Hiemke, C., Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with major depression (2012) Neuropharmacology, 62 (1), pp. 264-269; Drysdale, A.T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Resting-state connectivity biomarkersdefine neurophysiological subtypes of depression (2017) Nature Medicine, 23 (1), pp. 28-38; Ebert, D.D., Donkin, L., Andersson, G., Andrews, G., Berger, T., Carlbring, P., Does internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials (2016) Psychological Medicine, 46, pp. 2679-2693; Fischer, S., Strawbridge, R., Vives, A.H., Cleare, A.J., Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis (2017) British Journal of Psychiatry, 210, pp. 105-109; Fornaro, M., Giosuè, P., Current nosology of treatment resistant depression: A controversy resistant to revision (2010) Clinical Practice and Epidemiology in Mental Health, 6, pp. 20-24; Fried, E.I., Nesse, R.M., Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study (2015) Journal of Affective Disorders, 172, pp. 96-102; Furukawa, T.A., Efthimiou, O., Weitz, E.S., Cipriani, A., Keller, M.B., Kocsis, J.H., Cognitive-behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: Personalizing the treatment choice using individual participant data network metaregression (2018) Psychotherapy and Psychosomatics, 87, pp. 140-153; Geschwind, N., Nicolson, N.A., Peeters, F., van Os, J., Barge-Schaapveld, D., Wichers, M., Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy (2011) European Neuropsychopharmacology, 21, pp. 241-247; Gibiino, S., Marsano, A., Serretti, A., Specificity profile of venlafaxine and sertraline in major depression: Metaregression of double-blind, randomized clinical trials (2014) The International Journal of Neuropsychopharmacology, 17, pp. 1-8; Gillett, G., Saunders, K.E.A., Remote monitoring for understanding mechanisms and prediction in psychiatry (2019) Current Behavioral Neuroscience Reports, 6 (2), pp. 51-56; Glue, P., Donovan, M.R., Kolluri, S., Emir, B., Meta-analysis of relapse prevention antidepressant trials in depressive disorders (2010) The Australian and New Zealand Journal of Psychiatry, 44 (8), pp. 697-705; Gómez-Carrillo, A., Langlois-Therien, T., Kirmayer, L.J., Precision psychiatry-yes, but precisely what? (2018) JAMA Psychiatry, 75, pp. 1302-1303; Guilloux, J.-P., Bassi, S., Ding, Y., Walsh, C., Turecki, G., Tseng, G., Sibille, E., Testing the predictive value of peripheral gene expression fornonremission following citalopram treatment for major depression (2015) Neuropsychopharmacology, 40 (3), pp. 701-710; Hall-Flavin, D.K., Winner, J.G., Allen, J.D., Carhart, J.M., Proctor, B., Snyder, K.A., Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting (2013) Pharmacogenetics and Genomics, 23 (10), pp. 535-548; Hall-Flavin, D.K., Winner, J.G., Allen, J.D., Jordan, J.J., Nesheim, R.S., Snyder, K.A., Using a pharmacogenomic algorithm to guide the treatment of depression (2012) Translational Psychiatry, 2; Hallgren, K.A., Bauer, A.M., Atkins, D.C., Digital technology and clinical decision making in depression treatment: Current findings and future opportunities (2017) Depression and Anxiety, 34, pp. 494-501; Head, M.L., Holman, L., Lanfear, R., Kahn, A.T., Jennions, M.D., The extent and consequences of p-hacking in science (2015) PLoS Biology, 13 (3). , (e1002106); Hoo, Z.H., Candlish, J., Teare, D., What is an ROC curve? (2017) Emergency Medicine Journal, 34 (6), pp. 357-359; Huang, M., Shen, A., Ding, J., Geng, M., Molecularly targeted cancer therapy: Some lessons from the past decade (2014) Trends in Pharmacological Sciences, 35, pp. 41-50; Iniesta, R., Malki, K., Maier, W., Rietschel, M., Mors, O., Hauser, J., Combining clinical variables to optimize prediction of antidepressant treatment outcomes (2016) Journal of Psychiatric Research, 78, pp. 94-102; Iwakami, N., Nagai, T., Furukawa, T.A., Tajika, A., Onishi, A., Nishimura, K., Optimal sampling in derivation studies was associated with improved discrimination in external validation for heart failure prognostic models (2020) Journal of Clinical Epidemiology, 121, pp. 71-80; Jang, I.S., Neto, E.C., Guinney, J., Friend, S.H., Margolin, A.A., Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data (2014) Pacific Symposium on Biocomputing, pp. 63-74; Jauhar, S., Morrison, P., Esketamine for treatment resistant depression (2019) BMJ, 366, p. l5572; Johnsen, T.J., Friborg, O., The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: A meta-analysis (2015) Psychological Bulletin, 141, pp. 747-768; Kalincik, T., Manouchehrinia, A., Sobisek, L., Jokubaitis, V., Spelman, T., Horakova, D., Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response (2017) Brain, 140, pp. 2426-2443; Karyotaki, E., Kleiboer, A., Smit, F., Turner, D.T., Pastor, A.M., Andersson, G., Predictors of treatment dropout in self-guided web-based interventions for depression: An “individual patient data” meta-analysis (2015) Psychological Medicine, 45, pp. 2717-2726; Kautzky, A., Baldinger, P., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Kasper, S., The combined effect of genetic polymorphismsand clinical parameters on treatment outcome in treatment-resistant depression (2015) European Neuropsychopharmacology, 25 (4), pp. 441-453; Kautzky, A., Dold, M., Bartova, L., Spies, M., Vanicek, T., Souery, D., Refining prediction in treatment-resistant depression: Results of machine learning analyses in the TRD III sample (2017) The Journal of Clinical Psychiatry, 79 (1); Kedzior, K.K., Reitz, S.K., Azorina, V., Loo, C., Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) in the absence of maintenance treatment in major depression: A systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials (2015) Depression and Anxiety, 32, pp. 193-203; Kelloff, G.J., Sigman, C.C., Cancer biomarkers: Selecting the right drug for the right patient (2012) Nature Reviews. Drug Discovery, 11, pp. 201-214; Kernot, C., Tomlinson, A., Chevance, A., Cipriani, A., One step closer to personalised prescribing of antidepressants: Using real-world data together with patients and clinicians’ preferences (2019) Evidence-Based Mental Health, 22 (3), pp. 91-92; Khodayari-Rostamabad, A., Reilly, J.P., Hasey, G.M., de Bruin, H., Maccrimmon, D.J., A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder (2013) Clinical Neurophysiology, 124 (10), pp. 1975-1985; Korgaonkar, M.S., Rekshan, W., Gordon, E., Rush, A.J., Williams, L.M., Blasey, C., Magnetic resonance imaging measures of brain structure to predict antidepressant treatment outcome in major depressive disorder (2015) EBioMedicine, 2 (1), pp. 37-45; Lee, Y., Ragguett, R.M., Mansur, R.B., Boutilier, J.J., Rosenblat, J.D., Trevizol, A., Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review (2018) Journal of Affective Disorders, 241, pp. 519-532; van der Leeuw, J., Ridker, P.M., van der Graaf, Y., Visseren, F.L., Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects (2014) European Heart Journal, 35, pp. 837-843; Lewis, C.C., Boyd, M., Puspitasari, A., Navarro, E., Howard, J., Kassab, H., Implementing measurement-based care in behavioral health: A review (2019) JAMA Psychiatry, 76, pp. 324-335; Liu, F., Guo, W., Yu, D., Gao, Q., Gao, K., Xue, Z., Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans (2012) PLoS One, 7 (7); Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., Lyu, J., Changes in the global burden of depression from 1990 to 2017: Findings from the global burden of disease study (2019) Journal of Psychiatric Research, , (pii: S0022-3956(19)30738-1); Łojko, D., Rybakowski, J.K., Atypical depression: Current perspectives (2017) Neuropsychiatric Disease and Treatment, 13, pp. 2447-2456; Lv, H., Zhao, Y.H., Chen, J.G., Wang, D.Y., Chen, H., Vagus nerve stimulation for depression: A systematic review (2019) Frontiers in Psychology, 10, p. 64; Maslej, M., Furukawa, T., Cipriani, A., Andrews, P., Mulsant, B., Individual differences in response to antidepressants: A meta-analysis of placebo-controlled randomized clinical trials (2020) JAMA Psychiatry; Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2009) PLoS Medicine, 6; Moons, K.G., de Groot, J.A., Bouwmeester, W., Vergouwe, Y., Mallett, S., Altman, D.G., Critical appraisal and data extraction for systematic reviews of prediction modelling studies: The CHARMS checklist (2014) PLoS Medicine, 11; Nanni, V., Uher, R., Danese, A., Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: A meta-analysis (2012) The American Journal of Psychiatry, 169, pp. 141-151; Palpacuer, C., Gallet, L., Drapier, D., Reymann, J.-M., Falissard, B., Naudet, F., Specific and non-specific effects of psychotherapeutic interventions for depression: Results from a meta-analysis of 84 studies (2017) Journal of Psychiatric Research, 87, pp. 95-104; Penninx, B.W., Nolen, W.A., Lamers, F., Zitman, F.G., Smit, J.H., Spinhoven, P., Two-year course of depressive and anxiety disorders: Results from the Netherlands study of depression and anxiety (NESDA) (2011) Journal of Affective Disorders, 133, pp. 76-85; Perlman, K., Benrimoh, D., Israel, S., Rollins, C., Brown, E., Tunteng, J.F., A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder (2019) Journal of Affective Disorders, 243, pp. 503-515; Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., Schroeter, M.L., BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis (2015) Journal of Affective Disorders, 174, pp. 432-440; Popovici, V., Chen, W., Gallas, B.G., Hatzis, C., Shi, W., Samuelson, F.W., Effect of training-sample size and classification difficulty on the accuracy of genomic predictors (2010) Breast Cancer Research, 12, p. R5; Redlich, R., Opel, N., Grotegerd, D., Dohm, K., Zaremba, D., Bürger, C., Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data (2016) JAMA Psychiatry, 73 (6), pp. 557-564; Rosenblat, J.D., Lee, Y., McIntyre, R.S., Does pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost-effectiveness studies (2017) The Journal of Clinical Psychiatry, 78, pp. 720-729; Serretti, A., Smeraldi, E., Neural network analysis in pharmacogenetics of mood disorders (2004) BMC Medical Genetics, 5, p. 27; Serretti, A., Zanardi, R., Mandelli, L., Smeraldi, E., Colombo, C., A neural network model for combining clinical predictors of antidepressant response in mood disorders (2007) Journal of Affective Disorders, 98 (3), pp. 239-245; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) Bmj, 358, p. j4008; Shinohara, K., Efthimiou, O., Ostinelli, E.G., Tomlinson, A., Geddes, J.R., Nierenberg, A.A., Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: Protocol for a systematic review and networkmeta-analysis (2019) BMJ Open, 9 (5); Shinohara, K., Tanaka, S., Imai, H., Noma, H., Maruo, K., Cipriani, A., Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: A pooled analysis of individual patient data (2019) Evidence-Based Mental Health, 22 (1), pp. 10-16; Shiozawa, P., Fregni, F., Bensenor, I.M., Lotufo, P.A., Berlim, M.T., Daskalakis, J.Z., Transcranial direct current stimulation for major depression: An updated systematic review and meta-analysis (2014) The International Journal of Neuropsychopharmacology, 17, pp. 1443-1452; Simon, G.E., Perlis, R.H., Personalized medicine for depression: Can we match patients with treatments? (2010) The American Journal of Psychiatry, 167, pp. 1445-1455; Singh, T., Williams, K., Atypical depression (2006) Psychiatry (Edgmont), 3 (4), pp. 33-39; Singh, A.B., Improved antidepressant remission in major depression via a pharmacokinetic pathway polygene pharmacogenetic report (2015) Clinical Psychopharmacology and Neuroscience, 13 (2), pp. 150-156; Stern, S., Linker, S., Vadodaria, K.C., Marchetto, M.C., Gage, F.H., Prediction of response to drug therapy in psychiatric disorders (2018) Open Biology, 8; Steyerberg, E.W., Harrell, F.E., Jr., Prediction models need appropriate internal, internal-external, and external validation (2016) Journal of Clinical Epidemiology, 69, pp. 245-247; Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., Cleare, A.J., Inflammation and clinical response to treatment in depression: A meta-analysis (2015) European Neuropsychopharmacology, 25, pp. 1532-1543; The UK ECT Review Group, Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis (2003) The Lancet, 361 (9360), pp. 799-808; Tomlinson, A., Boaden, K., Cipriani, A., Withdrawal, dependence and adverse events of antidepressants: Lessons from patients and data (2019) Evidence-Based Mental Health, 22 (4), pp. 137-138; Tomlinson, A., Furukawa, T.A., Efthimiou, O., Salanti, G., De Crescenzo, F., Singh, I., Cipriani, A., Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): Rationale and protocol (2019) Evidence-Based Mental Health, , Published Online First: 23 October 2019; Torous, J., Staples, P., Barnett, I., Sandoval, L.R., Keshavan, M., Onnela, J.P., Characterizing the clinical relevance of digital phenotyping data quality with applications to a cohort with schizophrenia (2018) NPJ Digital Medicine, 1, p. 15; Tunvirachaisakul, C., Gould, R.L., Coulson, M.C., Ward, E.V., Reynolds, G., Gathercole, R.L., Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis (2018) Journal of Affective Disorders, 227, pp. 164-182; Vaci, N., Liu, Q., Kormilitzin, A., De Crescenzo, F., Kurtulmus, A., Harvey, J., O'Dell, B., Natural language processing for structuring clinical text data on depression using UK-CRIS (2020) Evidence-Based Mental Health, 23 (1), pp. 21-26; Vázquez, G.H., Tondo, L., Undurraga, J., Zaratiegui, R., Selle, V., Baldessarini, R.J., Pharmacological treatment of bipolar depression (2014) Advances in Psychiatric Treatment, 20 (3), pp. 193-201; van Waarde, J.A., Scholte, H.S., van Oudheusden, L.J.B., Verwey, B., Denys, D., van Wingen, G.A., A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression (2014) Molecular Psychiatry, 20, p. 609; Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimuller, N., Muller, M.B., Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with major depressive disorder: Systematic review and meta-analysis (2017) Journal of Psychiatric Research, 94, pp. 96-106; Wan, Q., Pal, R., An ensemble based top performing approach for NCI-DREAM drug sensitivity prediction challenge (2014) PLoS One, 9 (6); Wessler, B.S., Lai Yh, L., Kramer, W., Cangelosi, M., Raman, G., Lutz, J.S., Clinical prediction models for cardiovascular disease: Tufts predictive analytics and comparative effectiveness clinical prediction model database (2015) Circulation. Cardiovascular Quality and Outcomes, 8, pp. 368-375; Widge, A.S., Bilge, M.T., Montana, R., Chang, W., Rodriguez, C.I., Deckersbach, T., Electroencephalographic biomarkers for treatment response prediction in major depressive illness: A meta-analysis (2019) The American Journal of Psychiatry, 176, pp. 44-56; Winner, J.G., Carhart, J.M., Altar, C.A., Allen, J.D., Dechairo, B.M., A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder (2013) Discovery Medicine, 16 (89), pp. 219-227; Zhang, N., Wang, H., Fang, Y., Wang, J., Zheng, X., Liu, X.S., Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model (2015) PLoS Computational Biology, 11},
correspondence_address1={Tomlinson, A.; Department of Psychiatry, United Kingdom; email: anneka.tomlinson@psych.ox.ac.uk},
publisher={Elsevier Inc.},
issn={01637258},
coden={PHTHD},
pubmed_id={32437828},
language={English},
abbrev_source_title={Pharmacol. Ther.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Belbasis20151,
author={Belbasis, L. and Panagiotou, O.A. and Dosis, V. and Evangelou, E.},
title={A systematic appraisal of field synopses in genetic epidemiology: A HuGE review},
journal={American Journal of Epidemiology},
year={2015},
volume={181},
number={1},
pages={1-16},
doi={10.1093/aje/kwu249},
note={cited By 11},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922473314&doi=10.1093%2faje%2fkwu249&partnerID=40&md5=6d0806b75892a7c1ddcde8992c4a68cf},
affiliation={Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, 45110, Greece; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom},
abstract={Evidence from genetic association studies is accumulating rapidly. Field synopses have recently arisen as an unbiased way of systematically synthesizing this evidence. We performed a systematic review and appraisal of published field synopses in genetic epidemiology and assessed their main findings and methodological characteristics. We identified 61 eligible field synopses, published between January 1, 2007, and October 31, 2013, on 52 outcomes reporting 734 significant associations at the P < 0.05 level. The median odds ratio for these associations was 1.25 (interquartile range, 1.15-1.43). Egger's test was the most common method (n = 30 synopses) of assessing publication bias. Only 12 synopses (20%) used the Venice criteria to evaluate the epidemiologic credibility of their findings (n = 449 variants). Eleven synopses (18%) were accompanied by an online database that has been regularly updated. These synopses received more citations (P = 0.01) and needed a larger research team (P = 0.02) than synopses without an online database. Overall, field synopses are becoming a valuable tool for the identification of common genetic variants, especially when researchers follow relevant methodological guidelines. Our work provides a summary of the current status of the field synopses published to date and may help interested readers efficiently identify the online resources containing the relevant genetic evidence. © 2014 The Author.},
author_keywords={Epidemiologic methods;  Field synopsis;  Genetic associations;  Genetic epidemiology;  Genome, human;  Meta-analysis},
keywords={database;  epidemiology;  genetic analysis;  methodology, bibliographic database;  citation analysis;  field synopsis;  genetic association;  genetic epidemiology;  genetic identification;  genetic variability;  human;  medical genetics;  medical literature;  medical research;  methodology;  practice guideline;  Review;  systematic review;  bibliometrics;  epidemiology;  genetic polymorphism;  genetic predisposition;  molecular epidemiology;  publishing;  risk;  statistics and numerical data, Bibliometrics;  Epidemiologic Methods;  Genetic Association Studies;  Genetic Predisposition to Disease;  Humans;  Molecular Epidemiology;  Odds Ratio;  Polymorphism, Genetic;  Publication Bias},
references={Ioannidis, J.P., Expectations, validity, and reality in omics (2010) J Clin Epidemiol., 63 (9), pp. 945-949; Lin, B.K., Clyne, M., Walsh, M., Tracking the epidemiology of human genes in the literature: The HuGE Published Literature database (2006) Am J Epidemiol., 164 (1), pp. 1-4; Yu, W., Gwinn, M., Clyne, M., A navigator for human genome epidemiology (2008) Nat Genet., 40 (2), pp. 124-125; Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A., Replication validity of genetic association studies (2001) Nat Genet., 29 (3), pp. 306-309; Panagiotou, O.A., Ioannidis, J.P., What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations (2012) Int J Epidemiol., 41 (1), pp. 273-286; Khoury, M.J., Gwinn, M., Ioannidis, J.P., The emergence of translational epidemiology: From scientific discovery to population health impact (2010) Am J Epidemiol., 172 (5), pp. 517-524; Khoury, M.J., Bertram, L., Boffetta, P., Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases (2009) Am J Epidemiol., 170 (3), pp. 269-279; Ioannidis, J.P., Gwinn, M., Little, J., A road map for efficient and reliable human genome epidemiology (2006) Nat Genet., 38 (1), pp. 3-5; Ariyaratnam, R., Casas, J.P., Whittaker, J., Genetics of ischaemic stroke among persons of non-European descent: A meta-analysis of eight genes involving approximately 32, 500 individuals (2007) PLoS Med., 4 (4), p. e131; Bertram, L., McQueen, M.B., Mullin, K., Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database (2007) Nat Genet., 39 (1), pp. 17-23; Kitsios, G., Zintzaras, E., Genetic variation associated with ischemic heart failure: A HuGE review and meta-analysis (2007) Am J Epidemiol., 166 (6), pp. 619-633; Tüttelmann, F., Rajpert-De Meyts, E., Nieschlag, E., Gene polymorphisms and male infertility-a meta-analysis and literature review (2007) Reprod Biomed Online., 15 (6), pp. 643-658; Allen, N.C., Bagade, S., McQueen, M.B., Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database (2008) Nat Genet., 40 (7), pp. 827-834; Lill, C.M., Roehr, J.T., McQueen, M.B., Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database (2012) PLoS Genet., 8 (3), p. e1002548; Ioannidis, J.P., Boffetta, P., Little, J., Assessment of cumulative evidence on genetic associations: Interim guidelines (2008) Int J Epidemiol., 37 (1), pp. 120-132; Attia, J., Ioannidis, J.P., Thakkinstian, A., How to use an article about genetic association: B: Are the results of the study valid? (2009) JAMA., 301 (2), pp. 191-197; Hindorff, L.A., Sethupathy, P., Junkins, H.A., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits (2009) Proc Natl Acad Sci USA., 106 (23), pp. 9362-9367; Paternoster, L., Martinez-Gonzalez, N.A., Charleton, R., Genetic effects on carotid intima-media thickness: Systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects (2010) Circ Cardiovasc Genet., 3 (1), pp. 15-21; Paternoster, L., Chen, W., Sudlow, C.L., Genetic determinants of white matter hyperintensities on brain scans: A systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19, 000 subjects (2009) Stroke., 40 (6), pp. 2020-2026; Rannikmäe, K., Samarasekera, N., Martînez-Gonzâlez, N.A., Genetics of cerebral amyloid angiopathy: Systematic review and meta-analysis (2013) J Neurol Neurosurg Psychiatry., 84 (8), pp. 901-908; Brouwer, M.C., De Gans, J., Heckenberg, S.G., Host genetic susceptibility to pneumococcal and meningococcal disease: A systematic review and meta-analysis (2009) Lancet Infect Dis., 9 (1), pp. 31-44; Taylor, S., Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies (2013) Mol Psychiatry., 18 (7), pp. 799-805; Staines-Urias, E., Paez, M.C., Doyle, P., Genetic association studies in pre-eclampsia: Systematic meta-analyses and field synopsis (2012) Int J Epidemiol., 41 (6), pp. 1764-1775; Seifuddin, F., Mahon, P.B., Judy, J., Meta-analysis of genetic association studies on bipolar disorder (2012) Am J Med Genet B Neuropsychiatr Genet., 159 B (5), pp. 508-518; Ma, X., Zhang, B., Zheng, W., Genetic variants associated with colorectal cancer risk: Comprehensive research synopsis, meta-analysis, and epidemiological evidence (2014) Gut., 63 (2), pp. 326-336; Theodoratou, E., Montazeri, Z., Hawken, S., Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer (2012) J Natl Cancer Inst., 104 (19), pp. 1433-1457; Chatzinasiou, F., Lill, C.M., Kypreou, K., Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma (2011) J Natl Cancer Inst., 103 (16), pp. 1227-1235; Alg, V.S., Sofat, R., Houlden, H., Genetic risk factors for intracranial aneurysms: A meta-analysis in more than 116, 000 individuals (2013) Neurology., 80 (23), pp. 2154-2165; Jiang, Y., Zhang, R., Zheng, J., Meta-analysis of 125 rheumatoid arthritis-related single nucleotide polymorphisms studied in the past two decades (2012) PLoS One., 7 (12), p. e51571; Egger, M., Davey Smith, G., Schneider, M., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ., 315 (7109), pp. 629-634; Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias (1994) Biometrics., 50 (4), pp. 1088-1101; Harbord, R.M., Egger, M., Sterne, J.A., A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints (2006) Stat Med., 25 (20), pp. 3443-3457; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials., 4 (3), pp. 245-253; Rosenthal, R., The file drawer problem and tolerance for null results (1979) Psychol Bull., 86 (3), pp. 638-641; Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis (2000) Biometrics., 56 (2), pp. 455-463; Goodman, S.N., Toward evidence-based medical statistics. 2: The Bayes factor (1999) Ann Intern Med., 130 (12), pp. 1005-1013; Wacholder, S., Chanock, S., Garcia-Closas, M., Assessing the probability that a positive report is false: An approach for molecular epidemiology studies (2004) J Natl Cancer Inst., 96 (6), pp. 434-442; Wakefield, J., A Bayesian measure of the probability of false discovery in genetic epidemiology studies (2007) Am J Hum Genet., 81 (2), pp. 208-227; Calati, R., Gressier, F., Balestri, M., Genetic modulation of borderline personality disorder: Systematic review and meta-analysis (2013) J Psychiatr Res., 47 (10), pp. 1275-1287; He, X., Yu, C., Zhao, P., The genetics of Henoch-Schönlein purpura: A systematic review and meta-analysis (2013) Rheumatol Int., 33 (6), pp. 1387-1395; Xin, X.Y., Song, Y.Y., Ma, J.F., Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis (2009) Thromb Res., 124 (5), pp. 619-624; Maxwell, S.S., Jackson, C.A., Paternoster, L., Genetic associations with brain microbleeds: Systematic review and meta-analyses (2011) Neurology., 77 (2), pp. 158-167; Zaffanello, M., Tardivo, S., Cataldi, L., Genetic susceptibility to renal scar formation after urinary tract infection: A systematic review and meta-analysis of candidate gene polymorphisms (2011) Pediatr Nephrol., 26 (7), pp. 1017-1029; Little, J., Higgins, J.P., Ioannidis, J.P., STrengthening the REporting of Genetic Association Studies (STREGA): An extension of the STROBE Statement (2009) PLoS Med., 6 (2), p. e22; Zintzaras, E., Kitsios, G.D., Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: The CUMAGAS-CLL information system (2009) Am J Epidemiol., 170 (6), pp. 671-678; Zintzaras, E., Kitsios, G.D., Ziogas, D.C., Field synopsis and synthesis of genetic association studies in osteoarthritis: The CUMAGAS-OSTEO information system (2010) Am J Epidemiol., 171 (8), pp. 851-858; Zintzaras, E., Zdoukopoulos, N., A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database (2009) Am J Epidemiol., 170 (1), pp. 1-11; Sava, G.P., Speedy, H.E., Houlston, R.S., Candidate gene association studies and risk of chronic lymphocytic leukemia: A systematic review and meta-analysis (2014) Leuk Lymphoma., 55 (1), pp. 160-167; Vassos, E., Collier, D.A., Fazel, S., Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression (2014) Mol Psychiatry., 19 (4), pp. 471-477; Ioannidis, J.P., Tarone, R., McLaughlin, J.K., The false-positive to false-negative ratio in epidemiologic studies (2011) Epidemiology., 22 (4), pp. 450-456; Evangelou, E., Ioannidis, J.P., Meta-analysis methods for genome-wide association studies and beyond (2013) Nat Rev Genet., 14 (6), pp. 379-389; Panagiotou, O.A., Willer, C.J., Hirschhorn, J.N., The power of meta-analysis in genome-wide association studies (2013) Annu Rev Genomics Hum Genet., 14, pp. 441-465; Vineis, P., Manuguerra, M., Kavvoura, F.K., A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility (2009) J Natl Cancer Inst., 101 (1), pp. 24-36; Gao, J., Pan, Z., Jiao, Z., TPH2 gene polymorphisms and major depression-a meta-analysis (2012) PLoS One., 7 (5), p. e36721; Lill, C.M., Abel, O., Bertram, L., Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases (2011) Amyotroph Lateral Scler., 12 (4), pp. 238-249; Liu, H., Liu, W., Liao, Y., CADgene: A comprehensive database for coronary artery disease genes (2011) Nucleic Acids Res., 39, pp. D991-D996. , database issue; Dong, L.M., Potter, J.D., White, E., Genetic susceptibility to cancer: The role of polymorphisms in candidate genes (2008) JAMA., 299 (20), pp. 2423-2436; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) CMAJ., 181 (8), pp. 488-493; Abhary, S., Hewitt, A.W., Burdon, K.P., A systematic meta-analysis of genetic association studies for diabetic retinopathy (2009) Diabetes., 58 (9), pp. 2137-2147; Brouwer, M.C., Read, R.C., Van De Beek, D., Host genetics and outcome in meningococcal disease: A systematic review and meta-analysis (2010) Lancet Infect Dis., 10 (4), pp. 262-274; Buurma, A.J., Turner, R.J., Driessen, J.H., Genetic variants in pre-eclampsia: A meta-analysis (2013) Hum Reprod Update., 19 (3), pp. 289-303; Castaldi, P.J., Cho, M.H., Cohn, M., The COPD genetic association compendium: A comprehensive online database of COPD genetic associations (2010) Hum Mol Genet., 19 (3), pp. 526-534; Chen, H., Liu, K., Chen, L.J., Genetic associations in polypoidal choroidal vasculopathy: A systematic review and meta-analysis (2012) Mol Vis., 18, pp. 816-829; Debette, S., Markus, H.S., The genetics of cervical artery dissection: A systematic review (2009) Stroke., 40 (6), pp. e459-e466; Dolan, S.M., Hollegaard, M.V., Merialdi, M., Synopsis of preterm birth genetic association studies: The Preterm Birth Genetics Knowledge Base (PTBGene) (2010) Public Health Genomics., 13 (7-8), pp. 514-523; Dwyer, R., Skrobot, O.A., Dwyer, J., Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment (2013) J Alzheimers Dis., 34 (1), pp. 145-154; Gizer, I.R., Ficks, C., Waldman, I.D., Candidate gene studies of ADHD: A meta-analytic review (2009) Hum Genet., 126 (1), pp. 51-90; Gohil, R., Peck, G., Sharma, P., The genetics of venous thromboembolism. A meta-analysis involving approximately 120, 000 cases and 180, 000 controls (2009) Thromb Haemost., 102 (2), pp. 360-370; Hamzi, K., Tazzite, A., Nadifi, S., Large-scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152, 797 individuals (2011) Indian J Hum Genet., 17 (3), pp. 212-217; Jin, F., Xiong, W.J., Jing, J.C., Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: A systematic review (2011) J Cancer Res Clin Oncol., 137 (7), pp. 1095-1104; Lee, Y.H., Choi, S.J., Ji, J.D., Candidate gene studies of fibromyalgia: A systematic review and meta-analysis (2012) Rheumatol Int., 32 (2), pp. 417-426; Li, X., Zhang, Y., Zhang, J., Asthma susceptible genes in Chinese population: A meta-analysis (2010) Respir Res., 11, pp. 129-150; Loh, M., Koh, K.X., Yeo, B.H., Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race (2009) Eur J Cancer., 45 (14), pp. 2562-2568; López-León, S., Janssens, A.C., González-Zuloeta Ladd, A.M., Meta-analyses of genetic studies on major depressive disorder (2008) Mol Psychiatry., 13 (8), pp. 772-785; Marjot, T., Yadav, S., Hasan, N., Genes associated with adult cerebral venous thrombosis (2011) Stroke., 42 (4), pp. 913-918; Mazaki, T., Masuda, H., Takayama, T., Polymorphisms and pancreatic cancer risk: A meta-analysis (2011) Eur J Cancer Prev., 20 (3), pp. 169-183; McColgan, P., Thant, K.Z., Sharma, P., The genetics of sporadic ruptured and unruptured intracranial aneurysms: A genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20, 000 individuals (2010) J Neurosurg., 112 (4), pp. 714-721; Mooyaart, A.L., Valk, E.J., Van Es, L.A., Genetic associations in diabetic nephropathy: A meta-analysis (2011) Diabetologia., 54 (3), pp. 544-553; Peck, G., Smeeth, L., Whittaker, J., The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults (2008) PLoS One., 3 (11), p. e3691; Povel, C.M., Boer, J.M., Reiling, E., Genetic variants and the metabolic syndrome: A systematic review (2011) Obes Rev., 12 (11), pp. 952-967; Rao, R., Tah, V., Casas, J.P., Ischaemic stroke subtypes and their genetic basis: A comprehensive meta-analysis of small and large vessel stroke (2009) Eur Neurol., 61 (2), pp. 76-86; Romero-Gomez, M., Eslam, M., Ruiz, A., Genes and hepatitis C: Susceptibility, fibrosis progression and response to treatment (2011) Liver Int., 31 (4), pp. 443-460; Schild, A.H., Pietschnig, J., Tran, U.S., Genetic association studies between SNPs and suicidal behavior: A meta-analytical field synopsis (2013) Prog Neuropsychopharmacol Biol Psychiatry., 46, pp. 36-42; Smolonska, J., Wijmenga, C., Postma, D.S., Meta-analyses on suspected chronic obstructive pulmonary disease genes: A summary of 20 years' research (2009) Am J Respir Crit Care Med., 180 (7), pp. 618-631; Srivastava, K., Srivastava, A., Sharma, K.L., Candidate gene studies in gallbladder cancer: A systematic review and meta-analysis (2011) Mutat Res., 728 (1-2), pp. 67-79; Varvarigou, V., Dahabreh, I.J., Malhotra, A., A review of genetic association studies of obstructive sleep apnea: Field synopsis and meta-analysis (2011) Sleep., 34 (11), pp. 1461-1468; Wu, D., Zou, Y.F., Xu, X.Y., The association of genetic polymorphisms with cerebral palsy: A meta-analysis (2011) Dev Med Child Neurol., 53 (3), pp. 217-225; Yadav, S., Hasan, N., Marjot, T., Detailed analysis of gene polymorphisms associated with ischemic stroke in South Asians (2013) PLoS One., 8 (3), p. e57305; Zdoukopoulos, N., Zintzaras, E., Genetic risk factors for placental abruption: A HuGE review and meta-analysis (2008) Epidemiology., 19 (2), pp. 309-323; Zhang, C., Bao, W., Rong, Y., Genetic variants and the risk of gestational diabetes mellitus: A systematic review (2013) Hum Reprod Update., 19 (4), pp. 376-390; Zhang, B., Beeghly-Fadiel, A., Long, J., Genetic variants associated with breast-cancer risk: Comprehensive research synopsis, meta-analysis, and epidemiological evidence (2011) Lancet Oncol., 12 (5), pp. 477-488},
correspondence_address1={Evangelou, E.; Department of Hygiene and Epidemiology, University of Ioannina Medical SchoolGreece},
publisher={Oxford University Press},
issn={00029262},
coden={AJEPA},
pubmed_id={25504025},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Faggion201970,
author={Faggion, C.M., Jr. and Diaz, K.T.},
title={Overview authors rarely defined systematic reviews that are included in their overviews},
journal={Journal of Clinical Epidemiology},
year={2019},
volume={109},
pages={70-79},
doi={10.1016/j.jclinepi.2019.01.004},
note={cited By 10},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061833973&doi=10.1016%2fj.jclinepi.2019.01.004&partnerID=40&md5=0ef1a8f2341041b518cb77b04e17f94d},
affiliation={Department of Periodontology and Operative Dentistry, Faculty of Dentistry, University of Münster, Münster, Germany; Graduate School, Faculty of Dentistry, Universidad de Chile, Santiago, Chile, Chile; Graduate School, Faculty of Dentistry, Universidad Privada San Juan Bautista, Lima, Peru},
abstract={Objectives: To report systematic review definitions that are published in overviews of reviews and to propose a new classification of systematic reviews. Study Design and Setting: In this review of overviews, we searched PubMed for systematic review definitions that were reported in overviews of reviews that were published in the medical literature between November 2017 and May 2018. Two independent authors extracted and descriptively reported the systematic review definitions from the overviews. The definitions were evaluated regarding whether the concepts of comprehensiveness and reproducibility were incorporated into them, as suggested by some published systematic review definitions. Results: Initially, 138 documents were retrieved, and 111 overviews and protocols of overviews were included. Eight (8%) overviews explicitly reported a systematic review definition, whereas 25 (24%) overviews reported heterogeneous information about the criteria that were used to include systematic reviews in the overviews. Seventy-two (68%) overviews did not report any definition/criteria for including a systematic review. Two (2%) overviews reported a definition based on reproducibility, and none of the overviews reported the need to search for grey and unpublished literature for a review to be considered systematic. Conclusion: Overview authors rarely define systematic reviews that are included in their overviews and the few that do include a definition that provides heterogeneous criteria. © 2019 Elsevier Inc.},
author_keywords={Bias;  Meta-analysis;  Methods;  Overview;  Research design;  Review;  Systematic review},
keywords={article;  human;  medical literature;  Medline;  reproducibility;  systematic review;  adult;  female;  male;  medical research;  middle aged;  personnel;  publication;  research;  selection bias, Adult;  Biomedical Research;  Female;  Humans;  Male;  Middle Aged;  Publications;  Reproducibility of Results;  Research Personnel;  Research Report;  Selection Bias;  Systematic Reviews as Topic},
references={PubMed health (2018), https://www.ncbi.nlm.nih.gov/pubmedhealth/what-is-a-systematic-review/, Available at (Accessed 18 June 2018); Haddaway, N.R., Land, M., Macura, B., “A little learning is a dangerous thing”: a call for better understanding of the term 'systematic review’ (2017) Environ Int, 99, pp. 356-360; Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015) Syst Rev, 4, p. 1; Cochrane glossary http://community.cochrane.org/glossary, Available at (Accessed 4 September 2017); Faggion, C.M., Jr., Bakas, N.P., Wasiak, J., A survey of prevalence of narrative and systematic reviews in five major medical journals (2017) BMC Med Res Methodol, 17, p. 176; Cochrane community. Glossary (2018), http://community.cochrane.org/glossary#letter-R, Available at (Accessed 2 July 2018); Berg, J., Progress on reproducibility (2018) Science, 359, p. 9; Hutson, M., Artificial intelligence faces reproducibility crisis (2018) Science, 359, pp. 725-726; Simons, D.J., The value of direct replication (2014) Perspect Psychol Sci, 9 (1), pp. 76-80; Cipriani, A., Geddes, J., Comparison of systematic and narrative reviews: the example of the atypical antipsychotics (2003) Epidemiol Psichiatr Soc, 12 (3), pp. 146-153; Page, M.J., Altman, D.G., Shamseer, L., McKenzie, J.E., Ahmadzai, N., Wolfe, D., Reproducible research practices are underused in systematic reviews of biomedical interventions (2018) J Clin Epidemiol, 94, pp. 8-18; Faggion, C.M., Jr., Huivin, R., Aranda, L., Pandis, N., Alarcon, M., The search and selection for primary studies in systematic reviews published in dental journals indexed in MEDLINE was not fully reproducible (2018) J Clin Epidemiol, 98, pp. 53-61; Savovic, J., Turner, R.M., Mawdsley, D., Jones, H.E., Beynon, R., Higgins, J.P.T., Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study (2018) Am J Epidemiol, 187, pp. 1113-1122; Easterbrook, P.J., Berlin, J.A., Gopalan, R., Matthews, D.R., Publication bias in clinical research (1991) Lancet, 337, pp. 867-872; Bramer, W.M., Rethlefsen, M.L., Kleijnen, J., Franco, O.H., Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study (2017) Syst Rev, 6 (1), p. 245; Lefebvre, C., Manheimer, E., Glanville, J., Chapter 6: searching for studies (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011), , www.handbook.cochrane.org, J.P.T. Higgins S. Green The Cochrane Collaboration Available at (Accessed 12 February 2019); McAuley, L., Pham, B., Tugwell, P., Moher, D., Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? (2000) Lancet, 356, pp. 1228-1231; Pieper, D., Pollock, M., Fernandes, R.M., Büchter, R.B., Hartling, L., Epidemiology and reporting characteristics of overviews of reviews of healthcare interventions published 2012-2016: protocol for a systematic review (2017) Syst Rev, 6 (1), p. 73; Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009) PLoS Med, 6 (7), p. e1000100; Cohen, J., A coefficient of agreement for nominal scales (1960) Educ Psychol Meas, 20 (1), pp. 37-46; Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008; Higgins, J.P.T., Sterne, J.A.C., Savović, J., Page, M.J., Hróbjartsson, A., Boutron, I., A revised tool for assessing risk of bias in randomized trials (2016) Cochrane methods. Cochrane database of systematic reviews, 10. , J. Chandler J. McKenzie I. Boutron V. Welch (Suppl 1); Whiting, P., Savović, J., Higgins, J.P., Caldwell, D.M., Reeves, B.C., Shea, B., ROBIS: a new tool to assess risk of bias in systematic reviews was developed (2016) J Clin Epidemiol, 69, pp. 225-234; PRISMA http://prisma-statement.org/News, Available at (Accessed 19 June 2018); Goodman, S.N., Fanelli, D., Ioannidis, J.P., What does research reproducibility mean? (2016) Sci Transl Med, 8 (341), p. 341ps12; Casadevall, A., Fang, F.C., Reproducible science (2010) Infect Immun, 78, pp. 4972-4975; Hopewell, S., McDonald, S., Clarke, M., Egger, M., Grey literature in meta-analyses of randomized trials of health care interventions (2007) Cochrane Database Syst Rev, p. MR000010; Faggion, C.M., Jr., Comment on Greenhalgh et al. 2018 (2018) Eur J Clin Invest, 48, p. e12947; Greenhalgh, T., Thorne, S., Malterud, K., Response to Faggion (2018) Eur J Clin Invest, 48, p. e12946; Wong, G., Greenhalgh, T., Westhorp, G., Buckingham, J., Pawson, R., RAMESES publication standards: meta-narrative reviews (2013) BMC Med, 11, p. 20; Otte-Trojel, T., Wong, G., Going beyond systematic reviews: realist and meta-narrative reviews (2016) Stud Health Technol Inform, 222, pp. 275-287; Mandrioli, D., Kearns, C.E., Bero, L.A., Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: a systematic review of reviews (2016) PLoS One, 11, p. e0162198; Munn, Z., Stern, C., Aromataris, E., Lockwood, C., Jordan, Z., What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences (2018) BMC Med Res Methodol, 18, p. 5; Munn, Z., Jordan, Z., The patient experience of high technology medical imaging: a systematic review of the qualitative evidence (2011) JBI Libr Syst Rev, 9 (19), pp. 631-678; Burdett, S., Stewart, L.A., Tierney, J.F., Publication bias and meta-analyses: a practical example (2003) Int J Technol Assess Health Care, 19 (1), pp. 129-134; Sham, E., Smith, T., Publication bias in studies of an applied behavior-analytic intervention: an initial analysis (2014) J Appl Behav Anal, 47 (3), pp. 663-678; Avenell, A., Handoll, H.H., Grant, A.M., Lessons for search strategies from a systematic review, in the Cochrane Library, of nutritional supplementation trials in patients after hip fracture (2001) Am J Clin Nutr, 73, pp. 505-510; Crumley, E.T., Wiebe, N., Cramer, K., Klassen, T.P., Hartling, L., Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review (2005) BMC Med Res Methodol, 5, p. 24; Oxford Dictionary https://en.oxforddictionaries.com/definition/systematic, Available at (Accessed 19 November 2018); Merriam-Webster dictionary https://www.merriam-webster.com/dictionary/systematic, Available at (Accessed 19 November 2018)},
correspondence_address1={Faggion, C.M.; Faculty of Dentistry, Waldeyerstrasse 30, Germany; email: clovisfaggion@yahoo.com},
publisher={Elsevier USA},
issn={08954356},
coden={JCEPE},
pubmed_id={30684566},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Tsivgoulis20153,
author={Tsivgoulis, G. and Faissner, S. and Voumvourakis, K. and Katsanos, A.H. and Triantafyllou, N. and Grigoriadis, N. and Gold, R. and Krogias, C.},
title={"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: The truth will set you free},
journal={Brain and Behavior},
year={2015},
volume={5},
number={1},
pages={3-12},
doi={10.1002/brb3.297},
note={cited By 10},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922645933&doi=10.1002%2fbrb3.297&partnerID=40&md5=018cf542067a9da44a82bc0357eadb9f},
affiliation={Second Department of Neurology, Attikon Hospital, School of Medicine, University of Athens, Athens, Greece; International Clinical Research Center, Department of Neurology, St. Anne's University Hospital, Brno, Czech Republic; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States; Department of Neurology, St. Josef-Hospital, Ruhr University, Bochum, Germany; Department of Neurology, School of Medicine, University of Ioannina, Ioannina, Greece; First Department of Neurology, Eginition Hospital, School of Medicine, University of Athens, Athens, Greece; Department of Neurology, Laboratory of Experimental Neurology and Neuroimmunology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece},
abstract={Background: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been introduced as a chronic state of impaired cerebral or cervical venous drainage that may be causally implicated in multiple sclerosis (MS) pathogenesis. Moreover, percutaneous transluminal angioplasty of extracranial veins termed "Liberation treatment" has been proposed (based on nonrandomized data) as an alternative therapy for MS. Methods: A comprehensive literature search was conducted to identify available published, peer-reviewed, clinical studies evaluating (1) the association of CCSVI with MS, (2) the reproducibility of proposed ultrasound criteria for CCSVI detection (3) the safety and efficacy of "Liberation treatment" in open-label and randomized-controlled trial (RCT) settings. Results: There is substantial heterogeneity between ultrasound case-control studies investigating the association of CCSVI and MS. The majority of independent investigators failed to reproduce the initially reported high prevalence rates of CCSVI in MS. The prevalence of extracranial venous stenoses evaluated by other neuroimaging modalities (contrast or MR venography) is similarly low in MS patients and healthy individuals. One small RCT failed to document any benefit in MS patients with CCSVI receiving "Liberation treatment", while an exacerbation of disease activity was observed. "Liberation treatment" has been complicated by serious adverse events (SAEs) in open-label studies (e.g., stroke, internal jugular vein thrombosis, stent migration, hydrocephalus). Conclusion: CCSVI appears to be a poorly reproducible and clinically irrelevant sonographic construct. "Liberation treatment" has no proven efficacy, may exacerbate underlying disease activity and has been complicated with SAEs. "Liberation treatment" should stop being offered to MS patients even in the settings of RCTs. CCSVI appears to be a poorly reproducible and clinically irrelevant sonographic construct. "Liberation treatment" has no proven efficacy, may exacerbate underlying disease activity and has been complicated with SAEs. "Liberation treatment" should stop being offered to MS patients even in the settings of RCTs. © 2014 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.},
author_keywords={"Liberation" treatment;  Chronic cerebro-spinal venous insufficiency;  Iron;  Multiple sclerosis;  Transcranial sonography;  Ultrasound;  Venous angioplasty},
keywords={Article;  bibliographic database;  case control study;  chronic cerebrospinal venous insufficiency;  disability severity;  disease association;  Doppler echography;  functional neuroimaging;  human;  inflammation;  magnetic resonance venography;  multicenter study (topic);  multiple sclerosis;  nuclear magnetic resonance imaging;  open study;  pathogenesis;  percutaneous transluminal angioplasty;  phlebography;  plethysmography;  priority journal;  randomized controlled trial (topic);  sensitivity and specificity;  surgical drainage;  systematic review;  angioplasty;  cerebrospinal fluid;  chronic disease;  complication;  echography;  multiple sclerosis;  reproducibility;  treatment outcome;  Venous Insufficiency, Angioplasty;  Chronic Disease;  Humans;  Multiple Sclerosis;  Randomized Controlled Trials as Topic;  Reproducibility of Results;  Treatment Outcome;  Venous Insufficiency},
references={Ackermann, Z., Seidenbaum, M., Loewenthal, E., Rubinow, A., Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease (1988) Arch. Dermatol., 124, pp. 1376-1378; Adams, C.W., Poston, R.N., Buk, S., Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis (1989) J. Neurol. Sci., 92, pp. 291-306; Al-Omari, M.H., Rousan, L.A., Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis (2010) Int. Angiol., 29, pp. 115-120; Alroughani, R., Lamdhade, S., Thussu, A., Endovascular treatment of chronic cerebrospinal venous insufficiency in multiple sclerosis: a retrospective study (2013) Int. J. Neurosci., 123, pp. 324-328; Baracchini, C., Perini, P., Calabrese, M., Causin, F., Rinaldi, F., Gallo, P., No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset (2011) Ann. Neurol., 69, pp. 90-99; Barbato, L., Scalise, F., Grasso, M.A., Spagnolo, S., Iron man: extreme endovascular treatment for chronic cerebrospinal venous insufficiency (2014) Eur. J. Cardiothorac. Surg., , ez294, [Epub ahead of print]; Barkhof, F., Wattjes, M.P., Multiple sclerosis: CCSVI deconstructed and discarded (2013) Nat. Rev. Neurol., 9, pp. 661-662; Blinkenberg, M., Akeson, P., Sillesen, H., Lövgaard, S., Sellebjerg, F., Paulson, O.B., Siebner, H.R., Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis (2012) Acta Neurol. Scand., 126, pp. 421-427; Brod, S.A., Kramer, L.A., Cohen, A.M., Barreto, A.D., Bui, T.T., Jemelka, J.R., Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment (2013) Mult. Scler., 19, pp. 1499-1507; Burton, J.M., Alikhani, K., Goyal, M., Costello, F., White, C., Patry, D., Complications in MS patients after CCSVI procedures abroad (Calgary, AB) (2011) Can. J. Neurol. Sci., 38, pp. 741-746; Chafe, R., Born, K.B., Slutsky, A.S., Laupacis, A., The rise of people power (2011) Nature, 472, pp. 410-411; Colleridge-Smith, P.D., Thomas, P., Scurr, J.H., Dormandy, J.A., Causes of venous ulceration: a new hypothesis (1988) BMJ, 296, pp. 1726-1727; Comi, G., Battaglia, M.A., Bertolotto, A., Del Sette, M., Ghezzi, A., Malferrari, G., Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in mulitple sclerosis: results from the CoSMo study (2013) Mult Scler, 19, pp. 1508-1517; Costello, F., Modi, J., Lautner, D., Bhayana, D., Scott, J.N., Davenport, W.J., Validity of the diagnostic criteria for chronic cerebrospinal venous insufficiency and association with multiple sclerosis (2014) CMAJ, 186, pp. E418-E426; Doepp, F., Paul, F., Valdueza, J.M., Schmierer, K., Schreiber, S.J., No cerebrocervical venous congestion in patients with multiple sclerosis (2010) Ann. Neurol., 68, pp. 173-183; Doležal, O., Horáková, D., Gdovinová, Z., Szilasiová, J., Serious complication of percutaneous angioplasty with stent implantation in so called "chronic cerebrospinal venous insufficiency" in multiple sclerosis patient (2012) Prague. Med. Rep., 113, pp. 289-293; Dolic, K., Marr, K., Valnarov, V., Dwyer, M.G., Carl, E., Hagemeier, J., Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis (2011) Funct. Neurol., 26, pp. 205-214; Dolic, K., Marr, K., Valnarov, V., Dwyer, M.G., Carl, E., Karmon, Y., Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques (2012) AJNR Am. J. Neuroradiol., 33, pp. 16-23; Filippi, M., Rocca, M.A., Barkhof, F., Bakshi, R., Fazekas, F., Khan, O., Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective (2011) AJNR Am. J. Neuroradiol., 32, pp. 424-427; Ghezzi, A., Annovazzi, P., Amato, M.P., Capello, E., Cavalla, P., Cocco, E., Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis (2013) Mult. Scler., 19, pp. 961-963; Ghezzi, A., Annovazzi, P., Cocco, E., Coarelli, G., Lugaresi, A., Rovaris, M., Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases (2013) Neurol. Sci., 34, pp. 1633-1637; Gold, R., Linington, C., Lassmann, H., Understanding pahtogenesis and theray of multiple sclerosis via animal models: 70 years of merits and culprits in experimantal autoimmune encephalomyelitis research (2006) Brain, 129, pp. 1953-1971; Hojnacki, D., Zamboni, P., Lopez-Soriano, A., Galleotti, R., Menegatti, E., Weinstock-Guttman, B., Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls (2010) Int. Angiol., 29, pp. 127-139; Hubbard, D., Ponec, D., Gooding, J., Saxon, R., Sauder, H., Haacke, M., Clinical improvement after extracranial venoplasty in multiple sclerosis (2012) J. Vasc. Interv. Radiol., 23, pp. 1302-1308; Jurkiewicz, E., Kotulska, K., Nowak, K., Chelstowska, S., Armata, M., Chmielewski, D., Bilska, M., MR venography in children and adolescents with multiple sclerosis does not show increased prevalence of extracranial veins anomalies (2014) Eur. J. Paediatr. Neurol., 18, pp. 218-222; Krogias, C., Schröder, A., Wiendl, H., Hohlfeld, R., Gold, R., "Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients (2010) Nervenarzt, 81, pp. 740-746; Krogias, C., Tsivgoulis, G., Grond, M., Hartung, H.P., Hemmer, B., Oertel, W., Review and analysis of international Case-Control Studies on CCSVI and multiple sclerosis (2013) Akt. Neurol., 40, pp. 445-451; Laupacis, A., Lillie, E., Dueck, A., Straus, S., Perrier, L., Burton, J.M., Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis (2011) CMAJ, 183, pp. E1203-E1212; Ludyga, T., Kazibudzki, M., Simka, M., Hartel, M., Swierad, M., Piegza, J., Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? (2010) Phlebology, 25, pp. 286-295; Mandato, K.D., Hegener, P.F., Siskin, G.P., Haskal, Z.J., Englander, M.J., Garla, S., Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis (2012) J. Vasc. Interv. Radiol., 23, pp. 55-59; Mayer, C.A., Pfeilschifter, W., Lorenz, M.W., Nedelmann, M., Bechmann, I., Steinmetz, H., Ziemann, U., The perfect crime? CCSVI not leaving a trace in MS (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 436-440; Menegetti, E., Genova, V., Tessari, M., Malagoni, A.M., Bartolomei, I., Zuolo, M., The reproducibility of colour Doppler in chronic cerebrospinal venous insufficiency associated with multiple sclerosis (2010) Int. Angiol., 29, pp. 121-126; Nicolaides, A.N., Morovic, S., Menegetti, E., Viselner, G., Zamboni, P., Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound: recommendations for a protocol (2011) Funct. Neurol., 26, pp. 229-248; Petrov, I., Grozdinski, L., Kaninski, G., Iliev, N., Iloska, M., Radev, A., Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (2011) J. Endovasc. Ther., 18, pp. 314-323; Pullman, D., Zarzeczny, A., Picard, A., Media, politics and science policy: MS and evidence from the CCSVI Trenches (2013) BMC Med. Ethics, 14, p. 6; Rodger, I.W., Dilar, D., Dwyer, J., Bienenstock, J., Coret, A., Coret-Simon, J., Evidence against the involvement of chronic cerebrospinal venous abnormalities in multiple sclerosis. A case-control study (2013) PLoS ONE, 8, p. e72495; Samson, K., Experimental multiple sclerosis vascular shunting procedure halted at Stanford (2010) Ann. Neurol., 67, pp. A13-A15; Siddiqui, A.H., Zivadinov, R., Benedict, R., Karmon, Y., Yu, J., Hartney, M.L., Prospective randomized trial for venous angioplasty in MS (2014) Neurology, 83, pp. 441-449; Simka, M., Ludyga, T., Kazibudzki, M., Latacz, P., Swierad, M., Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography (2012) JRSM Short Rep., 3, p. 56; Singh, A.V., Zamboni, P., Anomalous venous blood flow and iron deposition in multiple sclerosis (2009) J. Cereb. Blood Flow Metab., 29, pp. 1867-1878; Sundström, P., Wåhlin, A., Ambarki, K., Birgander, R., Eklund, A., Malm, J., Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study (2010) Ann. Neurol., 68, pp. 255-259; Takase, S., Pascarella, L., lerond, L., Bergan, J.J., Schmid-Schönbein, G.W., Venous hypertension, inflammation and valve remodelling (2004) Eur. J. Vasc. Endovasc. Surg., 28, pp. 484-493; Thapar, A., Lane, T.R., Pandey, V., Shalhoub, J., Malik, O., Ellis, M., Internal jugular thrombosis post venoplasty for chronic cerebrospinal venous insufficiency (2011) Phlebology, 26, pp. 254-256; Traboulsee, A.L., Knox, K.B., Machan, L., Zhao, Y., Yee, I., Rauscher, A., Prevalence of extracranial venous narrowing on catheter venography in people with multile sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study (2014) Lancet, 383, pp. 138-145; Tsivgoulis, G., Mantatzis, M., Bogiatzi, C., Vadikolias, K., Voumvourakis, K., Prassopoulos, P., Extracranial venous hemodynamics in multiple sclerosis: a case-control study (2011) Neurology, 77, pp. 1241-1245; Tsivgoulis, G., Sergentanis, T.N., Chan, A., Voumvourakis, K., Triantafyllou, N.N., Psaltopoulou, T., Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies (2014) Ther. Adv. Neurol. Disord., 7, pp. 114-136; Valdueza, J.M., Doepp, F., Schreiber, S.J., van Oosten, B.W., Schmierer, K., Paul, F., Wattjes, M.P., What went wrong? The flawed concept of cerebrospinal venous insufficiency (2013) J. Cereb. Blood Flow Metab., 33, pp. 657-668; Wattjes, M.P., van Oosten, B.W., de Graaf, W.L., Seewann, A., Bot, J.C., van den Berg, R., No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study (2011) J. Neurol. Neurosurg. Psychiatry, 82, pp. 429-435; Weilbach, F.X., Chan, A., Toyka, K.V., Gold, R., The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis (2004) Clin. Exp. Immunol., 135, pp. 49-55; Wilkinson, L.S., Bunker, C., Edwards, J.C., Scurr, J.H., Smith, P.D., Leukocytes: their role in the etiopathogenesis of skin damage in venous disease (1993) J. Vasc. Surg., 17, pp. 669-675; Yamout, B., Herlopian, A., Issa, Z., Habib, R.H., Fawaz, A., Salame, J., Extracranial venous stenosis is an unlikely cause of multiple sclerosis (2010) Mult. Scler., 16, pp. 1341-1348; Zamboni, P., The Big Idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis (2006) J. R. Soc. Med., 99, pp. 589-593; Zamboni, P., Galeotti, R., Menegetti, E., Malagoni, A.M., Tacconi, G., Dall'Ara, S., Bartolomei, I., Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (2009) J. Neurol. Neurosurg. Psychiatry, 80, pp. 392-399; Zamboni, P., Menegetti, E., Galeotti, R., Malagoni, A.M., Tacconi, G., Dall'Ara, S., The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis (2009) J. Neurol. Sci., 282, pp. 21-27; Zamboni, P., Galeotti, R., Menegetti, E., Malagoni, A.M., Gianesini, S., Bartolomei, I., A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency (2009) J. Vasc. Surg., 50, pp. 1348-1358; Zamboni, P., Galeotti, R., Weinstock-Guttman, B., Kennedy, C., Salvi, F., Zivadinov, R., Venous angioplasty in patients with multiple sclerosis: results of a pilot study (2012) Eur. J. Vasc. Endovasc. Surg., 43, pp. 116-122; Zaniewski, M., Kostecki, J., Kuczmik, W., Ziaja, D., Opala, G., Swiat, M., Neck duplex Doppler ultrasound evaluation for assessing chronic cerebrospinal venous insufficiency in multiple sclerosis patients (2013) Phlebology, 28, pp. 24-31; Zivadinov, R., Marr, K., Cutter, G., Ramanathan, M., Benedict, R.H., Kennedy, C., Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS (2011) Neurology, 77, pp. 138-144; Zivadinov, R., Cutter, G., Marr, K., Ramanathan, M., Benedict, R.H., Bergsland, N., No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis (2012) AJNR Am. J. Neuroradiol., 33, pp. 1913-1917; Zivadinov, R., Karmon, Y., Dolic, K., Hagemeier, J., Marr, K., Valnarov, V., Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study (2013) BMC Neurol., 13, p. 151; Zwischenberger, B.A., Beasley, M.M., Davenport, D.L., Xenos, E.S., Meta-analysis of the correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis (2013) Vasc. Endovasc. Surg., 47, pp. 620-624},
correspondence_address1={Tsivgoulis, G.; Second Department of Neurology, University of Athens, School of Medicine, Iras 39Greece},
publisher={John Wiley and Sons Ltd},
issn={21623279},
pubmed_id={25722945},
language={English},
abbrev_source_title={Brain Behav.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Macdonald2020m2925,
author={Macdonald, H. and Loder, E. and Abbasi, K.},
title={Living systematic reviews at The BMJ},
journal={BMJ (Clinical research ed.)},
year={2020},
volume={370},
pages={m2925},
doi={10.1136/bmj.m2925},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088884513&doi=10.1136%2fbmj.m2925&partnerID=40&md5=577e029e18e0b71aab9403ed7ee64256},
affiliation={BMJ, London, United Kingdom},
keywords={human;  medical research;  medicine;  publication, Biomedical Research;  Humans;  Medicine;  Periodicals as Topic;  Systematic Reviews as Topic},
publisher={NLM (Medline)},
issn={17561833},
pubmed_id={32732314},
language={English},
abbrev_source_title={BMJ},
document_type={Editorial},
source={Scopus},
}

@ARTICLE{Grabovac20201809,
author={Grabovac, I. and Veronese, N. and Stefanac, S. and Haider, S. and Jackson, S.E. and Koyanagi, A. and Meilinger, M. and Stubbs, B. and Firth, J. and Soysal, P. and Gennaro, F.D. and Demurtas, J. and McDermott, D.T. and Abbs, A.D. and Yang, L. and Smith, L.},
title={Human immunodeficiency virus infection and diverse physical health outcomes: An umbrella review of meta-analyses of observational studies},
journal={Clinical Infectious Diseases},
year={2020},
volume={70},
number={9},
pages={1809-1815},
doi={10.1093/cid/ciz539},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083546372&doi=10.1093%2fcid%2fciz539&partnerID=40&md5=f9cc8525a23089dcd07a29537f679218},
affiliation={Department of Social and Preventive Medicine, Center for Public Health, Medical University of Vienna, Austria; National Research Council, Aging Branch, Neuroscience Institute, Padua, Italy; Institute of Outcomes Research, Center for Medical Statistics, Medical University of Vienna, Informatics and Intelligent Systems, Austria; Department of Behavioural Science and Health, University College London, United Kingdom; Centro de Investigació N Biomé Dica en Red de Salud Mental, Parc Sanitari Sant Joan de Deú, Universitat de Barcelona, Fundació Sant Joan de Deú, Spain; Department of Respiratory and Critical Care, Otto Wagner Hospital, Vienna, Austria; Physiotherapy Department, South London and Maudsley National Health Service Foundation Trust, London, United Kingdom; National Institute of Complementary Medicine Health Research Institute, Western Sydney University, Westmead, Australia; Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey; Clinic of Infectious Diseases University of Bari, Italy; Primary Care Department, Azienda Usl Toscana Sud Est, Grosseto, Italy; School of Psychology and Sport Science, Anglia Ruskin University, Cambridge, United Kingdom; Pennine Acute Hospitals, Nhs Trust, United Kingdom; Department of Cancer Epidemiology and Prevention Research, Holy Cross Centre, Alberta Health Services, Canada; Cumming School of Medicine, University of Calgary, Preventive Oncology & Community Health Sciences, Canada; Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, United Kingdom},
abstract={Background. Our aim was to assess both the credibility and strength of evidence arising from systematic reviews with metaanalyses of observational studies and physical health outcomes associated with human immunodeficiency virus (HIV) but not acquired immunodeficiency syndrome. Methods. We performed an umbrella review of observational studies. Evidence was graded as convincing, highly suggestive, suggestive, weak, or nonsignificant. Results. From 3413 studies returned, 20 were included, covering 55 health outcomes. Median number of participants was 18 743 (range 403-225 000 000). Overall, 45 (81.8%) of the 55 unique outcomes reported nominally significant summary results (P < .05). Only 5 outcomes (9.0% higher likelihood of presence of breathlessness, higher chronic obstructive pulmonary disease [COPD] prevalence, maternal sepsis, higher risk of anemia, and higher risk of all fractures among people living with HIV [PLWHIV]) showed suggestive evidence, with P values < 10-3 only 3 (5.5% higher prevalence of cough in cross-sectional studies, higher incidence of pregnancy-related mortality, and higher incidence of ischemic heart disease among PLWHIV in cohort studies) outcomes showed stronger evidence using a stringent P value (< 10-6). None of the unique outcomes presented convincing evidence (Class I), yet 3 outcomes presented highly suggestive evidence, 5 outcomes presented suggestive evidence, and 37 outcomes presented weak evidence. Conclusions. Results show highly suggestive and suggestive evidence for HIV and the presence of a cough, COPD, ischemic heart disease, pregnancy-related mortality, maternal sepsis, and bone fractures. Public health policies should reflect and accommodate these changes, especially in light of the increases in the life expectancy and the incidence of comorbidities in this population. © The Author(s) 2019.},
author_keywords={Comorbid;  Health outcomes;  HIV;  Human immunodeficiency virus;  Umbrella review},
keywords={anemia;  chronic obstructive lung disease;  coughing;  dyspnea;  fracture;  health behavior;  health status;  human;  Human immunodeficiency virus infection;  ischemic heart disease;  mortality;  nonhuman;  outcome assessment;  priority journal;  Review;  sepsis;  chronic obstructive lung disease;  complication;  cross-sectional study;  female;  Human immunodeficiency virus infection;  incidence;  preeclampsia;  pregnancy, Cross-Sectional Studies;  Female;  HIV Infections;  Humans;  Incidence;  Pre-Eclampsia;  Pregnancy;  Pulmonary Disease, Chronic Obstructive},
references={(2017) Unaids Data 2017, , Joint United Nations Programme on HIV/AIDS (UNAIDS). Geneva, Switzerland: UNAIDS; HIV/AIDS Fact Sheet 2017, , http://www.who.int/mediacentre/factsheets/fs360/en/, World Health Organization. Accessed 06 July 2019; Smith, C.J., Ryom, L., Weber, R., Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration (2014) Lancet, 384, pp. 241-248; Weber, R., Ruppik, M., Rickenbach, M., Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study (2013) HIV Med, 14, pp. 195-207. , Swiss Human Immunodeficiency Virus Cohort Study (SHCS; High, K.P., Brennan-Ing, M., Clifford, D.B., HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) J Acquir Immune Defic Syndr, 60, pp. S1-18. , NIH Office of AIDS Research Working Group on Human Immunodeficiency Virus and Aging., (Suppl 1; Kuller, L.H., Tracy, R., Belloso, W., Inflammatory and coagulation biomarkers and mortality in patients with HIV infection (2008) Plos Med, 5, p. e203. , INSIGHT SMART Study Group; Friis-Moller, N., Reiss, P., Sabin, C.A., Class of antiretroviral drugs and the risk of myocardial infarction (2007) N Engl J Med, 356, pp. 1723-1735. , Data Collection on Adverse Events of Anti-HIV Drugs Study Group; Sabin, C.A., Worm, S.W., Weber, R., Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multi-cohort collaboration (2008) Lancet, 371, pp. 1417-1426. , Data Collection on Adverse Events of Anti-HIV Drugs Study Group; Brath, H., Grabovac, I., Schalk, H., Degen, O., Dorner, T.E., Prevalence and correlates of smoking and readiness to quit smoking in people living with HIV in Austria and Germany (2016) Plos One, 11, p. e0150553; Grabovac, I., Meilinger, M., Schalk, H., Leichsenring, B., Dorner, T.E., Prevalence and associations of illicit drug and polydrug use in people living with HIV in Vienna (2018) Sci Rep, 8, p. 8046; Ioannidis, J.P., Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) Cmaj, 181, pp. 488-493; Aromataris, E., Fernandez, R., Godfrey, C.M., Holly, C., Khalil, H., Tungpunkom, P., Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach (2015) Int J Evid Based Healthc, 13, pp. 132-140; Shea, B.J., Reeves, B.C., Wells, G., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) Bmj, 358, p. j4008; Lau, J., Ioannidis, J.P., Schmid, C.H., Quantitative synthesis in systematic reviews (1997) Ann Intern Med, 127, pp. 820-826; Chinn, S., A simple method for converting an odds ratio to effect size for use in meta-analysis (2000) Stat Med, 19, pp. 3127-3131; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc ser a Stat Soc, 172, pp. 137-159; IntHout, J., Ioannidis, J.P., Rovers, M.M., Goeman, J.J., Plea for routinely presenting prediction intervals in meta-analysis (2016) Bmj Open, 6, p. e010247; Serghiou, S., Goodman, S.N., Random-effects meta-analysis: Summarizing evidence with caveats (2018) Jama, 321, pp. 301-302; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21, pp. 1539-1558; Ioannidis, J.P., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses (2007) Bmj, 335, pp. 914-916; Egger, M., Smith, G.D., Schneider, M., Bias in meta-analysis detected by a simple, graphical test (1997) Bmj, 315, pp. 629-634; Carvalho, A.F., Kohler, C.A., Brunoni, A.R., Bias in peripheral depression biomarkers (2016) Psychother Psychosom, 85, pp. 81-90; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: Umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) Bmj, 357, p. j2376; Brown, J., Roy, A., Harris, R., Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: A systematic review and meta-analysis (2017) Thorax, 72, pp. 355-366; Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies (2017) Lancet HIV, 4, pp. e349-e356. , Antiretroviral Therapy Cohort C; Samji, H., Cescon, A., Hogg, R.S., Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada (2013) PLoS One, 8, p. e81355. , North American Acquired Immunodeficiency Syndrome Cohort Collaboration on Research and Design (NA-ACCORD) of International Epidemiology Database to Evaluate Aids; Shiau, S., Arpadi, S.M., Yin, M.T., Martins, S.S., Patterns of drug use and HIV infection among adults in a nationally representative sample (2017) Addict Behav, 68, pp. 39-44; Tron, L., Lert, F., Spire, B., Dray-Spira, R., Tobacco smoking in HIV-infected versus general population in France: Heterogeneity across the various groups of people living with HIV (2014) Plos One, 9, p. e107451. , ANRS-Vespa2 study group; Raposeiras-Roubin, S., Abu-Assi, E., Iniguez-Romo, A., Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV (2017) Curr Opin HIV AIDS, 12, pp. 523-527; Vachiat, A., McCutcheon, K., Tsabedze, N., Zachariah, D., Manga, P., HIV and ischemic heart disease (2017) J Am Coll Cardiol, 69, pp. 73-82; Shah, A.S.V., Stelzle, D., Lee, K.K., Global burden of atherosclerotic cardiovascular disease in people living with HIV (2018) Circulation, 138, pp. 1100-1112; Mary-Krause, M., Cotte, L., Simon, A., Partisani, M., Costagliola, D., Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men (2003) AIDS, 170, pp. 2479-2486. , Clinical Epidemiology Group from the French Hospital Database; Wang, X., Chai, H., Yao, Q., Chen, C., Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction (2007) J Acquir Immune Defic Syndr, 44, pp. 493-499; Fougere, B., Boulanger, E., Nourhashemi, F., Guyonnet, S., Cesari, M., Chronic inflammation: Accelerator of biological aging (2017) J Gerontol a Biol Sci Med Sci, 72, pp. 1218-1225; Fulop, T., Herbein, G., Cossarizza, A., Cellular senescence, immunosenescence and HIV (2017) Interdiscip Top Gerontol Geriatr, 42, pp. 28-46; Nasi, M., De Biasi, S., Gibellini, L., Ageing and inflammation in patients with HIV infection (2017) Clin Exp Immunol, 187, pp. 44-52; Salvioli, S., Capri, M., Valensin, S., Inflamm-aging, cytokines and aging: State of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology (2006) Curr Pharm des, 12, pp. 3161-3171; Sokoya, T., Steel, H.C., Nieuwoudt, M., Rossouw, T.M., HIV as a cause of immune activation and immunosenescence (2017) Mediators Inflamm, 2017, p. 6825493; Kovacs, E.J., Boe, D.M., Boule, L.A., Curtis, B.J., Inflammaging and the lung (2017) Clin Geriatr Med, 33, pp. 459-471; Leroy, V., Ladner, J., Nyiraziraje, M., Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group (1998) AIDS, 12, pp. 643-650; Mattar, R., Amed, A.M., Lindsey, P.C., Sass, N., Daher, S., Preeclampsia and HIV infection (2004) Eur J Obstet Gynecol Reprod Biol, 117, pp. 240-241; Glantz, J.C., Roberts, D.J., Pregnancy complicated by thrombocytopenia secondary to human immunodeficiency virus infection (1994) Obstet Gynecol, 83, pp. 825-827; Sebitloane, H.M., Thrombocytopenia during pregnancy in women with HIV infection receiving no treatment (2016) S Afr Med J, 106, pp. 210-213; Turan, J.M., Bukusi, E.A., Cohen, C.R., Sande, J., Miller, S., Effects of HIV/AIDS on maternity care providers in Kenya (2008) J Obstet Gynecol Neonatal Nurs, 37, pp. 588-595; Graham, W., Hussein, J., (2003) Measuring and Estimating Maternal Mortality in the Era of HIV/AIDS, , New York, New York: Population Division, Department of Economic and Social Affairs, United Nations Secretariat; (2012) Saving Mothers 2008-2012: Fifth Report on the Confidential Enquiries into Maternal Deaths in South Africa, , National Committee for Confidential Enquiry into Maternal Deaths. South Africa: Department Health Republic of South Africa; Van Dillen, J., Zwart, J., Schutte, J., Van, R.J., Maternal sepsis: Epidemiology, etiology and outcome (2010) Curr Opin Infect Dis, 23, pp. 249-254; Gibellini, D., Clo, A., Morini, S., Miserocchi, A., Ponti, C., Re, M.C., Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages (2013) World J Virol, 2, pp. 91-101; Shiau, S., Broun, E.C., Arpadi, S.M., Yin, M.T., Incident fractures in HIV-infected individuals: A systematic review and meta-analysis (2013) AIDS, 27, pp. 1949-1957; Pedrana, A.E., Hellard, M.E., Guy, R., Wilson, K., Stoove, M., The difference in selfreported and biological measured HIV prevalence: Implications for HIV prevention (2012) AIDS Behav, 16, pp. 1454-1463; Ioannidis, J.P., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses (2016) Milbank Q, 94, pp. 485-514},
correspondence_address1={Smith, L.; Cambridge Centre for Sport and Exercise Sciences, United Kingdom; email: lee.smith@anglia.ac.uk},
publisher={Oxford University Press},
issn={10584838},
coden={CIDIE},
pubmed_id={31401650},
language={English},
abbrev_source_title={Clin. Infect. Dis.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Kamoen202091,
author={Kamoen, O. and Maqueda, V. and Yperzeele, L. and Pottel, H. and Cras, P. and Vanhooren, G. and Vanacker, P.},
title={Stroke coach: a pilot study of a personal digital coaching program for patients after ischemic stroke},
journal={Acta Neurologica Belgica},
year={2020},
volume={120},
number={1},
pages={91-97},
doi={10.1007/s13760-019-01218-z},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074836100&doi=10.1007%2fs13760-019-01218-z&partnerID=40&md5=fb619d112cb97b0f59fff8429fdb3e26},
affiliation={Department of Neurology, Antwerp University Hospital, Edegem, Antwerp, Belgium; Department of Neurology, Sint-Lucas Hospital, Brugge, Belgium; Department of Neurology, Neurovascular Reference Center, Antwerp University Hospital, Edegem, Antwerp, Belgium; Born Bunge Institute, Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Public Health and Primary Care, KU Leuven Kulak, Kortrijk, Belgium; Department of Neurology, Sint-Jan Hospital, Brugge, Belgium; Department of Neurology, Groeninge Hospital, Kortrijk, Belgium},
abstract={Despite recent advances in acute stroke care, the risk of recurrent stroke remains high. On behalf of the Belgian Stroke Council (BSC), a nurse-led self-management program was developed, using a personal coach and digital platform with the aim of improving cardiovascular risk factor control in patients after ischemic stroke. The program was implemented in four Belgian hospitals. The stroke coach provided one educational session during hospitalization. After discharge, the patient received tips and tricks concerning a healthy lifestyle through the customized platform. The stroke coach set up video appointments through the platform at regular intervals. Primary endpoint of our study was the change in SCORE (Systematic COronary Risk Evaluation: High and Low cardiovascular Risk Charts) risk at baseline and 6 months compared with a historical control group who received standard care. A total of 147 patients were included for a follow-up period of 6 months. The mean SCORE in the intervention group showed a statistically significant reduction of 3.2 (p < 0.001) at 6 months. However, comparison between control and intervention groups was non-significant (p = 0.55). Secondary endpoints are promising with a medication adherence of 96%. Reported quality of life also improved (p < 0.001). No significant improvement in the modified Rankin scale (mRS) was observed (p = 0.720). Five percent of patients suffered a recurrent stroke. Our project consisting of a coached lifestyle intervention and digital platform shows promise in improving stroke recurrence rates, therapeutic adherence and quality of life in a Belgian healthcare setting. © 2019, Belgian Neurological Society.},
author_keywords={Digital platform;  Personal coach;  Secondary prevention;  Telemedicine},
keywords={adult;  aged;  Article;  brain ischemia;  cardiovascular risk;  cerebrovascular accident;  cohort analysis;  comparative study;  controlled study;  female;  follow up;  healthy lifestyle;  hospitalization;  human;  intervention study;  male;  multicenter study;  National Institutes of Health Stroke Scale;  outcome assessment;  patient satisfaction;  pilot study;  prospective study;  quality of life;  Rankin scale;  recurrence risk;  risk assessment;  stroke patient;  treatment outcome;  aftercare;  Belgium;  brain ischemia;  cerebrovascular accident;  healthy lifestyle;  middle aged;  procedures;  stroke rehabilitation;  telemedicine;  very elderly, Aftercare;  Aged;  Aged, 80 and over;  Belgium;  Brain Ischemia;  Female;  Follow-Up Studies;  Healthy Lifestyle;  Humans;  Male;  Middle Aged;  Outcome Assessment, Health Care;  Pilot Projects;  Stroke;  Stroke Rehabilitation;  Telemedicine},
funding_text 1={We thank the stroke coaches, Delphine Mahieu, Delphine Standaert, Julie Derous and Anja Lorrez for their hard work and dedication to the project. We thank Trendhuis and Zebra Academy for the help and technical support with the platform and VOKA, Wit-Gele Kruis West-Vlaanderen, Lokaal Multidisciplinair Netwerk Brugge-Houtland-Oostende and Bluehealth Innovation Center (MIC) for their input and financial aid. This project was supported by a project funding (mHealth) of the Belgian National Institute for Health and Disability Insurance and the Belgian Stroke Council.},
references={Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., (2017) European cardiovascular disease statistics 2017, , European Heart Network, Brussels; Mohan, K.M., Wolfe, C.D., Rudd, A.G., Heuschmann, P.U., Kolominsky- Rabas, P.L., Grieve, A.P., Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis (2011) Stroke, 42, pp. 1489-1494; Feigin, V.L., Roth, G.A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2016) Lancet Neurol, 15, pp. 913-924; Wissel, J., Olver, J., Sunnerhagen, K.S., Navigating the poststroke continuum of care (2013) J Stroke Cerebrovasc Dis, 22 (1), pp. 1-8; Jie Chen, J., Mullins, C.D., Novak, P., Thomas, S.B., Personalized strategies to activate and empower patients in health care and reduce health disparities (2016) Health Educ Behav, 43 (1), pp. 25-34; Mora, K., Dorrejo, X.M., Carreon, K.M., Butt, S., Nurse practitioner-led transitional care interventions: an integrative review (2017) J Am Assoc Nurse Pract, 29 (12), pp. 773-790. , PID: 28845555; Arts, M.L., Kwa, V.I., Dahmen, R., High satisfaction with an individualised stroke care programme after hospitalisation of patients with a TIA or minor stroke: a pilot study (2008) Cerebrovasc Dis, 25 (6), pp. 566-571; Vanacker, P., Standaert, D., Libbrecht, N., Vansteenkiste, I., Bernard, D., Yperzeele, L., An individualized coaching program for patients with acute ischemic stroke: feasibility study (2017) Clin Neurol Neurosurg, 154, pp. 89-93. , COI: 1:STN:280:DC%2BC1c3it1ehug%3D%3D; Bushnell, C., Arnan, M., Han, S., A new model for secondary prevention of stroke: transition coaching for stroke (2014) Front Neurol, 5 (219), pp. 1-6; Sides, E.G., Zimmer, L.O., Wilson, L., Pan, W., Olson, D.M., Peterson, E.D., Medication coaching program for patients with minor stroke or TIA: a pilot study (2012) BMC Public Health, 12, p. 549; Condon, C., Lycan, S., Duncan, P., Bushnell, C., Reducing readmissions after stroke with a structured nurse practitioner/registered nurse transitional stroke program (2016) Stroke, 47 (6), pp. 1599-1604; Hofstad, H., Gjelsvik, B.E., Naess, H., Eide, G.E., Skouen, J.S., Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual (2014) BMC Neurol, 14, p. 239; Leistner, S., Benik, S., Laumeier, I., Ziegler, A., Nieweler, G., Nolte, C.H., Secondary prevention after minor stroke and TIA-usual care and development of a support program (2012) PLoS One, 7 (12). , COI: 1:CAS:528:DC%2BC3sXht1Kgtw%3D%3D; Wan, L.H., Zhang, X.P., Mo, M.M., Xiong, X.N., Ou, C.L., You, L.M., Effectiveness of goal-setting telephone follow-up on health behaviors of patients with ischemic stroke: a randomized controlled trial (2016) J Stroke Cerebrovasc Dis, 25 (9), pp. 2259-2270; Ögren, J., Irewall, A., Söderström, L., Mooe, T., Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial (2018) BMC Neurol, 18, p. 153; Bridgwood, B., Lager, K.E., Mistri, A.K., Khunti, K., Wilson, A.D., Modi, P., Interventions for improving modifiable risk factor control in the secondary prevention of stroke (2018) Cochrane Database Syst Rev, 5, p. CD009103; Vanacker, P., Couvreur, T., Vanhooren, G., Can we improve cerebrovascular risk reduction in real-life? A single centre’s experience (2011) Cerebrovasc Dis, 31, p. 289; Philp, I., Brainin, M., Walker, M.F., Development of a poststroke checklist to standardize follow-up care for stroke survivors (2013) J Stroke Cerebrovasc Dis, 22, pp. 173-180; Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., European guidelines on CVD prevention in clinical practice (2012) Eur Heart J, 33, pp. 1635-1701. , COI: 1:CAS:528:DC%2BC38XhtVeitr3P; Banks, J.L., Marotta, C.A., Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials. A literature review and synthesis (2007) Stroke, 38, pp. 1091-1096; Brooks, R., Rabin, R., de Charro, F., (2003) The measurement and valuation of health status using EQ-5D: a European perspective, , (eds), Kluwer Academic Publishers, Dordrecht; Adams, H.P., Jr., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment (1993) Stroke, 24, pp. 35-41; Brott, T., Adams, H.P., Olinger, C.P., Marler, J.R., Barsan, W.G., Biller, J., Measurements of acute cerebral infarction: a clinical examination scale (1989) Stroke, 20, pp. 864-870. , COI: 1:STN:280:DyaL1MzhvVequg%3D%3D; Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences (2013) Eur Heart J, 34 (38), pp. 2940-2948. , COI: 1:CAS:528:DC%2BC3sXhsF2ltrnF; Bushnell, C.D., Olson, D.M., Zhao, X., Pan, W., Zimmer, L.O., Goldstein, L.B., Secondary preventive medication persistence and adherence 1 year after stroke (2011) Neurology, 77 (12), pp. 1182-1190. , COI: 1:STN:280:DC%2BC3MbjsF2qtQ%3D%3D; Benjamin, E.J., Virani, S.S., Callaway, C.W., Chamberlain, A.M., Chang, A.R., Cheng, S., Heart disease and stroke statistics—2018 update: a report from the American Heart Association (2018) Circulation, 137, pp. e67-e492},
correspondence_address1={Kamoen, O.; Department of Neurology, Belgium; email: oliviakamoen@gmail.be},
publisher={Springer},
issn={03009009},
coden={ANUBB},
pubmed_id={31701472},
language={English},
abbrev_source_title={Acta Neurol. Belg.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Prasad2020451,
author={Prasad, V.},
title={Our best weapons against cancer are not magic bullets},
journal={Nature},
year={2020},
volume={577},
number={7791},
pages={451},
doi={10.1038/d41586-020-00116-2},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078212770&doi=10.1038%2fd41586-020-00116-2&partnerID=40&md5=5d6d4e972828fddb20959d744a0edafa},
abstract={Better health and social policy would save more lives than sophisticated drugs. © 2020, Nature.},
author_keywords={Cancer;  Epidemiology;  Health care},
keywords={cancer incidence;  cancer mortality;  human;  life expectancy;  malignant neoplasm;  mortality rate;  Note;  priority journal;  risk factor;  health care delivery;  neoplasm;  weapon, Delivery of Health Care;  Humans;  Neoplasms;  Weapons},
references={Seigel, R.L., (2020) CA Cancer J. Clin., 70, pp. 7-30. , PID: 31912902; Marquart, J., (2018) JAMA Oncol., 4, pp. 1093-1098. , PID: 29710180; Singal, G., (2019) J. Am. Med. Assoc., 321, pp. 1391-1399; Siegel, R.L., (2018) CA Cancer J. Clin., 68, pp. 329-339. , PID: 30191964},
correspondence_address1={Prasad, V.email: prasad@ohsu.edu},
publisher={Nature Research},
issn={00280836},
coden={NATUA},
pubmed_id={31965108},
language={English},
abbrev_source_title={Nature},
document_type={Note},
source={Scopus},
}

@ARTICLE{Qi2019,
author={Qi, X. and Wang, S. and Zhang, L. and Liu, L. and Wen, Y. and Ma, M. and Cheng, S. and Li, P. and Cheng, B. and Du, Y. and Liang, X. and Zhao, Y. and Ding, M. and Zhang, F.},
title={An integrative analysis of transcriptome-wide association study and mRNA expression profile identified candidate genes for attention-deficit/hyperactivity disorder},
journal={Psychiatry Research},
year={2019},
volume={282},
doi={10.1016/j.psychres.2019.112639},
art_number={112639},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074505732&doi=10.1016%2fj.psychres.2019.112639&partnerID=40&md5=699144a68d2e41b900fab7331628073f},
affiliation={School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, China},
abstract={Background: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, but the genetic mechanism of ADHD remains elusive now. Methods: Tissue specific transcriptome-wide association study (TWAS) of ADHD was performed by FUSION utilizing a genome-wide association study (GWAS) dataset of ADHD (including 20,183 ADHD cases and 35,191 healthy controls) and gene expression reference from brain and blood. Furthermore, the genes identified by TWAS were compared with the differently expressed genes detected by mRNA expression profiles of ADHD rat model and autism spectrum disorders (ASD) patients. Functional enrichment and annotation analysis of the identified genes were performed by DAVID and FUMAGWAS tool. Results: For brain tissue, TWAS identified 148 genes with P value &lt; 0.05, such as TDO2 (PTWAS=4.01×10−2), CHD1L (PTWAS=9.64×10−3) and KIAA0319L (PTWAS=4.05×10−4). Further 11 common genes were examined in the mRNA expression datasets, such as ACSM5 (PTWAS=3.62×10−2, PmRNA=0.005), CCDC24 (PTWAS=1.49×10−2, PmRNA=2.35×10−3) and MVP (PTWAS=5.55×10−3, PmRNA=5.40×10−3). Pathway enrichment analysis of the genes identified by TWAS detected 3 pathways for ADHD, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041). Conclusions: Through integrating GWAS and mRNA expression data, we identified a group of ADHD-associated genes and pathways, providing novel clues for understanding the genetic mechanism of ADHD. © 2019 Elsevier B.V.},
author_keywords={Attention-deficit/hyperactivity disorder (ADHD);  Gene ontology (GO);  Genome-wide association study (GWAS);  Pathway;  Transcriptome-wide association study (TWAS)},
keywords={glycan;  messenger RNA;  messenger RNA, animal experiment;  animal model;  animal tissue;  Article;  attention deficit disorder;  autism;  brain tissue;  CCDC24 gene;  CHD1L gene;  controlled study;  endocytosis;  gene;  gene expression;  genetic association;  genetic association study;  genome;  genome-wide association study;  genotype;  human;  major clinical study;  MVP gene;  myocarditis;  nonhuman;  priority journal;  protein degradation;  rat;  single nucleotide polymorphism;  TDO2 gene;  transcriptome wide association study;  Wistar Kyoto rat;  animal;  attention deficit disorder;  blood;  brain;  disease model;  gene expression profiling;  genetics;  meta analysis;  metabolism, Animals;  Attention Deficit Disorder with Hyperactivity;  Autism Spectrum Disorder;  Blood;  Brain;  Disease Models, Animal;  Gene Expression Profiling;  Genetic Association Studies;  Humans;  Rats;  RNA, Messenger},
chemicals_cas={RNA, Messenger},
funding_details={Research and DevelopmentResearch and Development},
funding_details={National Natural Science Foundation of ChinaNational Natural Science Foundation of China, NSFC, 81472925, 81673112},
funding_details={Agriculture Department of Shaanxi ProvinceAgriculture Department of Shaanxi Province, 2013KJXX-51},
funding_details={Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities},
funding_details={Program for Jiangsu Excellent Scientific and Technological Innovation TeamProgram for Jiangsu Excellent Scientific and Technological Innovation Team, 2016YFE0119100},
funding_text 1={This study was funded by the National Natural Scientific Foundation of China(grants number 81472925 and 81673112), the Key projects of international cooperation among governments in Scientific And Technological Innovation (grant number 2016YFE0119100), the Technology Research and Development Program of in Shaanxi Province of China(grant number 2013KJXX-51), and the Fundamental Research Funds for the Central Universities.},
funding_text 2={This study was funded by the National Natural Scientific Foundation of China (grants number 81472925 and 81673112 ), the Key projects of international cooperation among governments in Scientific And Technological Innovation (grant number 2016YFE0119100 ), the Technology Research and Development Program of in Shaanxi Province of China (grant number 2013KJXX-51 ), and the Fundamental Research Funds for the Central Universities .},
references={Ahel, D., Horejsi, Z., Wiechens, N., Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1 (2009) Science, 325 (5945), pp. 1240-1243; Anttila, V., Bulik-Sullivan, B., Finucane, H.K., Analysis of shared heritability in common disorders of the brain (2018) Science, 360 (6395). , eaap8757; Barfield, R., Feng, H., Gusev, A., Transcriptome-wide association studies accounting for co-localization using Egger regression (2017), pp. 1-35; Brem, R.B., Kruglyak, L., The landscape of genetic complexity across 5,700 gene expression traits in yeast (2005) Proc. Natl. Acad. Sci., 102 (5), pp. 1572-1577; Comings, D.E., Muhleman, D., Dietz, G., Sequence of human tryptophan 2,3-Dioxygenase (TDO2) presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat (1995) Genomics, pp. 390-396; Demontis, D., Walters, R.K., Martin, J., Discovery of the first genome-wide significant risk loci for ADHD (2017) Nat. Genet., pp. 1-43; Dennis, G., Jr., Sherman, B.T., Hosack, D.A., DAVID: database for annotation, visualization, and integrated discovery (2003) Genome. Biol., 4 (9). , p. R60-R60; Eriksen, J., Bjorn-Yoshimoto, W.E., Jorgensen, T.N., Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons (2010) J. Biol. Chem., 285 (35), pp. 27289-27301; Faraone, S.V., Asherson, P., Banaschewski, T., Attention-deficit/hyperactivity disorder (2015) Nat. Rev. Dis. Primers, 1, pp. 1-22; Faraone, S.V., Perlis, R.H., Doyle, A.E., Molecular genetics of attention-deficit/hyperactivity disorder (2005) Biol. Psychiatry, 57 (11), pp. 1313-1323; Gupta, S., Ellis S, E., Ashar, F.N., Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism (2014) Nat. Commun., 5, p. 5748; Gusev, A., Ko, A., Shi, H., Integrative approaches for large-scale transcriptome-wide association studies (2016) Nat. Genet., 48 (3), pp. 245-252; Gusev, A., Mancuso, N., Won, H., Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights (2018) Nat. Genet., 50 (4), pp. 538-548; Gwynn, M.D., Amara, S.G., Regulated trafficking of the human dopamine transporter (1999) J. Biol. Chem., 274 (50). , p. 35794-35801; Haley, E.M., Buckley, K.M., Membrane trafficking regulates the activity of the human dopamine transporter (1999) J. Neurosci., 19 (18), pp. 7699-7710; Hoogman, M., Onnink, M., Cools, R., The dopamine transporter haplotype and reward-related striatal responses in adult ADHD (2013) Eur. Neuropsychopharmacol., 23 (6), pp. 469-478; Huang, D.W., Sherman, B.T., Tan, Q., DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists (2007) Nucleic Acids Res., 35, pp. W169-W175. , Web Server issue; Huang, D.W., Sherman, B.T., Tan, Q., The David gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists (2007) Genome Biol., 8 (9). , p. R183-R183; da Huang, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using David bioinformatics resources (2009) Nat. Protoc., 4 (1), pp. 44-57; Jansen, R.C., Nap, J.-P., Genetical genomics:the added value from segregation (2001) TRENDS Genetics, 17 (7), pp. 388-391; Jiang, T., Wang, Y., Zhu, M., Transcriptome-wide association study revealed two novel genes associated with nonobstructive azoospermia in a Chinese population (2017) Fertil. Steril., 108 (6). , p. 1056-1062 e4; Kim, D.S., Burt, A.A., Ranchalis, J.E., Sequencing of sporadic attention-deficit hyperactivity disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder (2017) Am. J. Med. Genet. B Neuropsychiatr. Genet., 174 (4), pp. 381-389; Larsson, H., Chang, Z., D'Onofrio, B.M., The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan (2014) Psychol. Med., 44 (10), pp. 2223-2229; Li, Y., Roy, B.D., Wang, W., Identification of two functionally distinct endosomal recycling pathways for dopamine D(2) receptor (2012) J. Neurosci., 32 (21), pp. 7178-7190; Neale, B.M., Medland, S., Ripke, S., Case-control genome-wide association study of attention-deficit/hyperactivity disorder (2010) J. Am. Acad. Child Adolesc. Psychiatry, 49 (9), pp. 906-920; Park, Y., Sarkar, A.K., Bhutani, K., Multi-tissue polygenic models for transcriptome-wide association studies (2017), pp. 1-34; Pierpont, E.I., Hudock, R.L., Foy, A.M., Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1 (2018) J. Neurodev. Disord., (1), p. 21; Pierpont, E.I., Tworog-Dube, E., Roberts, A.E., Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings (2015) Dev. Med. Child Neurol., 57 (4), pp. 385-392; Ribases, M., Bosch, R., Hervas, A., Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder (2009) Biol. Psychiatry, 66 (10), pp. 926-934; Rommelse, N.N., Franke, B., Geurts, H.M., Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder (2010) Eur. Child Adolesc. Psychiatry, 19 (3), pp. 281-295; Ronald, A., Simonoff, E., Kuntsi, J., Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample (2008) J. Child Psychol. Psychiatry, 49 (5), pp. 535-542; Sakrikar, D., Mazei-Robison, M.S., Mergy, M.A., Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation (2012) J. Neurosci., 32 (16), pp. 5385-5397; Samuels, I.S., Saitta, S.C., Landreth, G.E., MAP'ing CNS development and cognition: an ERKsome process (2009) Neuron, 61 (2), pp. 160-167; Sanchez-Mora, C., Ramos-Quiroga, J.A., Bosch, R., Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder (2015) Neuropsychopharmacology, 40 (4), pp. 915-926; Shilyansky, C., Karlsgodt, K.H., Cummings, D.M., Neurofibromin regulates corticostriatal inhibitory networks during working memory performance (2010) Proc. Natl. Acad. Sci. U S A, 107 (29), pp. 13141-13146; Sorkina, T., Hoover, B.R., Zahniser, N.R., Constitutive and protein Kinase C-Induced internalization of the dopamine transporter is mediated by a Clathrin-dependent mechanism (2005) Traffic, 6, pp. 157-170; Too, L.K., Li, K.M., Suarna, C., Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function (2016) Behav. Brain Res., 312, pp. 102-117; Veturi, Y., Ritchie, M.D., How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures? (2018) Pac. Symp. Biocomput., 23, pp. 228-239; Weber, H., Scholz, C.J., Jacob, C.P., SPOCK3, a risk gene for adult ADHD and personality disorders (2014) Eur. Arch. Psychiatry Clin. Neurosci., 264 (5), pp. 409-421; Yoshida, M., Watanabe, Y., Yamanishi, K., Analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: gene expression profiles in the brain (2014) Int. J. Mol. Med., 33 (4), pp. 887-896; Zhou, X., Carbonetto, P., Stephens, M., Polygenic modeling with bayesian sparse linear mixed models (2013) PLoS Genet., 9 (2). , e1003264-e1003264},
correspondence_address1={Zhang, F.; School of Public Health, China; email: fzhxjtu@mail.xjtu.edu.cn},
publisher={Elsevier Ireland Ltd},
issn={01651781},
coden={PSRSD},
pubmed_id={31685286},
language={English},
abbrev_source_title={Psychiatry Res.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Visser2019854,
author={Visser, A.E. and D'Ovidio, F. and Peters, S. and Vermeulen, R.C.H. and Beghi, E. and Chiò, A. and Veldink, J.H. and Logroscino, G. and Hardiman, O. and Van Den Berg, L.H.},
title={Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk},
journal={Journal of Neurology, Neurosurgery and Psychiatry},
year={2019},
volume={90},
number={8},
pages={854-860},
doi={10.1136/jnnp-2018-319779},
note={cited By 9},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062668382&doi=10.1136%2fjnnp-2018-319779&partnerID=40&md5=ee28765ae7ce15d6ddee845c488eb245},
affiliation={Department of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, 3584CX, Netherlands; Rita Levi Montalcini Department of Neuroscience, University of Torino, Torino, Italy; Division of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, Netherlands; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Unit of Neurodegenerative Diseases, Department of Clinical Research in Neurology, University of Bari 'Aldo Moro', Pia Fondazione Cardinale G Panico, Lecce, Italy; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy; Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland},
abstract={Objective To investigate whether exposure to particulates and combustion products may explain the association between certain occupations and amyotrophic lateral sclerosis (ALS) risk in a large, multicentre, population-based, case-control study, based on full job histories, using job-exposure matrices, with detailed information on possible confounders. Methods Population-based patients with ALS and controls were recruited from five registries in the Netherlands, Ireland and Italy. Demographics and data regarding educational level, smoking, alcohol habits and lifetime occupational history were obtained using a validated questionnaire. Using job-exposure matrices, we assessed occupational exposure to silica, asbestos, organic dust, contact with animals or fresh animal products, endotoxins, polycyclic aromatic hydrocarbons and diesel motor exhaust. Multivariate logistic regression models adjusting for confounding factors were used to determine the association between these exposures and ALS risk. Results We included 1557 patients and 2922 controls. Associations were positive for all seven occupational exposures (ORs ranging from 1.13 to 1.73 for high vs never exposed), and significant on the continuous scale for silica, organic dust and diesel motor exhaust (p values for trend ≤0.03). Additional analyses, adding an exposure (one at a time) to the model in the single exposure analysis, revealed a stable OR for silica. We found similar results when patients with a C9orf72 mutation were excluded. Conclusion In a large, multicentre study, using harmonised methodology to objectively quantify occupational exposure to particulates and combustion products, we found an association between ALS risk and exposure to silica, independent of the other occupational exposures studied. © 2019 Author(s).},
author_keywords={Davide Bertuzzo;  Enrica Bersano},
keywords={asbestos;  diesel fuel;  endotoxin;  guanine nucleotide exchange C9orf72;  polycyclic aromatic hydrocarbon;  silicon dioxide;  silicon dioxide, adult;  aged;  alcohol consumption;  amyotrophic lateral sclerosis;  Article;  C9orf72 gene;  case control study;  combustion;  combustion product;  controlled study;  disease association;  disease predisposition;  educational status;  employment status;  exhaust gas;  female;  gene mutation;  human;  Ireland;  Italy;  major clinical study;  male;  multicenter study;  Netherlands;  occupational exposure;  organic dust;  particulate matter;  population research;  priority journal;  questionnaire;  risk assessment;  adverse event;  air pollutant;  amyotrophic lateral sclerosis;  clinical trial;  middle aged;  occupational exposure;  particulate matter;  risk factor;  smoking, Aged;  Air Pollutants, Occupational;  Amyotrophic Lateral Sclerosis;  Case-Control Studies;  Female;  Humans;  Male;  Middle Aged;  Occupational Exposure;  Particulate Matter;  Risk Factors;  Silicon Dioxide;  Smoking;  Traffic-Related Pollution},
chemicals_cas={asbestos, 1332-21-4; diesel fuel, 68334-30-5; silicon dioxide, 10279-57-9, 14464-46-1, 14808-60-7, 15468-32-3, 60676-86-0, 7631-86-9; Air Pollutants, Occupational; Particulate Matter; Silicon Dioxide},
funding_details={BiogenBiogen},
funding_details={Fondation Thierry LatranFondation Thierry Latran},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7, 259867},
funding_details={EU Joint Programme – Neurodegenerative Disease ResearchEU Joint Programme – Neurodegenerative Disease Research, JPND},
funding_details={European CommissionEuropean Commission, EC},
funding_details={ZonMwZonMw},
funding_details={Ministero della SaluteMinistero della Salute},
funding_details={Seventh Framework ProgrammeSeventh Framework Programme, FP7},
funding_details={Stichting ALS NederlandStichting ALS Nederland, ALS},
funding_text 1={Competing interests eB reports grants from UcB-pharma, shire, eIsaI; personal fees from Viropharma; grants from the Italian Ministry of health, the european Union and Fondazione Borgonovo; grants from associazione IDIc 15, outside the submitted work. ac reports personal fees from Biogen Idec and cytokinetics; grants from Italfarmaco; personal fees from Mitsubishi, outside the submitted work. Oh reports grants from Framework 7 eUROMOTOR project, health Research Board Ireland and science Foundation Ireland, during the conduct of the study; personal fees from aLs FTD Journal, outside the submitted work. JhV reports other from Vertex pharmaceuticals, outside the submitted work. LhvdB reports grants from Netherlands aLs Foundation and the Netherlands Organization for health Research and Development, during the conduct of the study; grants from Baxalta, prinses Beatrix spierfonds, european community’s health seventh Framework programme, outside the submitted work; and LhvdB serves on scientific advisory boards for the prinses Beatrix spierfonds, Thierry Latran Foundation, Biogen and cytokinetics. serves on the editorial board of amyotrophic Lateral sclerosis and Frontotemporal Degeneration and The Journal of Neurology, Neurosurgery, and psychiatry. aeV, FD, sMp, RchV and GL report no disclosures.},
funding_text 2={Funding This work was supported by the european community’s health seventh Framework programme (Fp7/2007-2013) (grant agreement number 259867); the Netherlands aLs Foundation; and the Netherlands Organization for health Research and Development (Vici scheme, JpND (sTReNGTh)).},
funding_text 3={This work was supported by the European Community's Health Seventh Framework Programme (FP7/2007-2013) (grant agreement number 259867); the Netherlands ALS Foundation; and the Netherlands Organization for Health Research and Development (Vici Scheme, JPND (STRENGTH)).},
references={Al-Chalabi, A., Hardiman, O., The epidemiology of ALS: A conspiracy of genes, environment and time (2013) Nat Rev Neurol, 9, pp. 617-628; Al-Chalabi, A., Calvo, A., Chio, A., Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study (2014) Lancet Neurol, 13, pp. 1108-1113; Sutedja, N.A., Fischer, K., Veldink, J.H., What we truly know about occupation as a risk factor for ALS: A critical and systematic review (2009) Amyotroph Lateral Scler, 10, pp. 295-301; Kang, H., Cha, E.S., Choi, G.J., Amyotrophic lateral sclerosis and agricultural environments: A systematic review (2014) J Korean Med Sci, 29, pp. 1610-1617; Park, R.M., Schulte, P.A., Bowman, J.D., Potential occupational risks for neurodegenerative diseases (2005) Am J Ind Med, 48, pp. 63-77; Vanacore, N., Cocco, P., Fadda, D., Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study (2010) Amyotroph Lateral Scler, 11, pp. 430-434; Pinkerton, L.E., Hein, M.J., Grajewski, B., Mortality from neurodegenerative diseases in a cohort of US flight attendants (2016) Am J Ind Med, 59, pp. 532-537; Pamphlett, R., Rikard-Bell, A., Different occupations associated with amyotrophic lateral sclerosis: Is diesel exhaust the link (2013) PLoS One, 8, p. e80993; Rooney, J., Vajda, A., Heverin, M., No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland (2016) Environ Res, 147, pp. 102-107; Malek, A.M., Barchowsky, A., Bowser, R., Environmental and occupational risk factors for amyotrophic lateral sclerosis: A case-control study (2014) Neurodegener Dis, 14, pp. 31-38; Fang, F., Quinlan, P., Ye, W., Workplace exposures and the risk of amyotrophic lateral sclerosis (2009) Environ Health Perspect, 117, pp. 1387-1392; Sutedja, N.A., Veldink, J.H., Fischer, K., Lifetime occupation, education, smoking, and risk of ALS (2007) Neurology, 69, pp. 1508-1514; Weisskopf, M.G., McCullough, M.L., Morozova, N., Prospective study of occupation and amyotrophic lateral sclerosis mortality (2005) Am J Epidemiol, 162, pp. 1146-1152; Brooks, B.R., Miller, R.G., Swash, M., El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp. 293-299; D'Ovidio, F., Jpk, R., Visser, A.E., Critical issues in ALS case-control studies: The case of the Euro-MOTOR study (2017) Amyotroph Lateral Scler Frontotemporal Degener, 18, pp. 411-418; (2012) International Standard Classification of Education: ISCED 2011, , http://uis.unesco.org/sites/default/files/documents/international-standardclassification-of-education-isced-2011-en.pdf, UNESCO [Accessed 11 Jun 2018]; (1968) International Standard Classification of Occupations, , International Labour Office Geneva, Switzerland: International Labour Office; Peters, S., Vermeulen, R., Cassidy, A., Comparison of exposure assessment methods for occupational carcinogens in a multi-centre lung cancer case-control study (2011) Occup Environ Med, 68, pp. 148-153; Peters, S., Kromhout, H., Olsson, A.C., Occupational exposure to organic dust increases lung cancer risk in the general population (2012) Thorax, 67, pp. 111-116; Huoi, C., Olsson, A., Lightfoot, T., Parental occupational exposure and risk of childhood central nervous system tumors: A pooled analysis of case-control studies from Germany (2014) Cancer Causes Control, 25, pp. 1603-1613. , France, and the UK; DeJesus-Hernandez, M., MacKenzie, I.R., Boeve, B.F., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9orf72 causes chromosome 9p-linked FTD and ALS (2011) Neuron, 72, pp. 245-256; Renton, A.E., Majounie, E., Waite, A., A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD (2011) Neuron, 72, pp. 257-268; Dickerson, A.S., Hansen, J., Kioumourtzoglou, M.A., Study of occupation and amyotrophic lateral sclerosis in a Danish cohort (2018) Occup Environ Med, 75, pp. 630-638; Andrew, A.S., Caller, T.A., Tandan, R., Environmental and occupational exposures and amyotrophic lateral sclerosis in New England (2017) Neurodegener Dis, 17, pp. 110-116; Teschke, K., Olshan, A.F., Daniels, J.L., Occupational exposure assessment in casecontrol studies: Opportunities for improvement (2002) Occup Environ Med, 59, pp. 575-594; Hazard Prevention and Control in the Work Environment: Airborne Dust [Internet], , http://www.who.int/occupationalhealth/publications/en/oehairbornedust3.pdf, World Health Organization [Accessed 23 Nov 2018]; Block, M.L., Elder, A., Auten, R.L., The outdoor air pollution and brain health workshop (2012) Neurotoxicology, 33, pp. 972-984; Kenna, K.P., McLaughlin, R.L., Byrne, S., Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing (2013) J Med Genet, 50, pp. 776-783; Van Es, M.A., Dahlberg, C., Birve, A., Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis (2010) J Neurol Neurosurg Psychiatry, 81, pp. 562-566; Van Blitterswijk, M., Van Es, M.A., Hennekam, E.A., Evidence for an oligogenic basis of amyotrophic lateral sclerosis (2012) Hum Mol Genet, 21, pp. 3776-3784},
correspondence_address1={Van Den Berg, L.H.; Department of Neurology, Netherlands; email: L.H.vandenBerg@umcutrecht.nl},
publisher={BMJ Publishing Group},
issn={00223050},
coden={JNNPA},
pubmed_id={30850472},
language={English},
abbrev_source_title={J. Neurol. Neurosurg. Psychiatry},
document_type={Article},
source={Scopus},
}

@ARTICLE{Cooper2004,
author={Cooper, J.},
title={Disorders are different from diseases},
journal={World Psychiatry},
year={2004},
volume={3},
number={1},
note={cited By 9},
source={Scopus},
}

@ARTICLE{Silberholz2019535,
author={Silberholz, J. and Bertsimas, D. and Vahdat, L.},
title={Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis},
journal={Breast Cancer Research and Treatment},
year={2019},
volume={176},
number={3},
pages={535-543},
doi={10.1007/s10549-019-05208-w},
note={cited By 8},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065980147&doi=10.1007%2fs10549-019-05208-w&partnerID=40&md5=0c23e77f0ca5a5cb756393c0665a42be},
affiliation={Ross School of Business, University of Michigan, 701 Tappan Street R5468, Ann Arbor, MI  48109, United States; Sloan School of Management, MIT, Operations Research Center, E40-111, Massachusetts Institute of Technology, Cambridge, MA  02139, United States; Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 8th Floor, New York, NY  10065, United States},
abstract={Purpose: Oncologists, clinical trialists, and guideline developers need tools that enable them to efficiently review the settings and results of previous studies testing metastatic breast cancer (MBC) drug therapies. Methods: We searched the literature to identify clinical trials testing MBC drug therapies. Key eligibility criteria included at least 90% of patients enrolled in the trial having MBC, therapeutic clinical trials, and Phase II–III studies. Studies were stratified based on patients’ tumor receptor statuses and prior exposure to therapy. Survival and toxicity of each drug therapy were estimated from randomized controlled trials using network meta-analysis and from all studies using meta-analysis. These results, along with estimated drug costs, are presented in a web-based visualization tool. Results: We included 1865 studies containing 2676 treatment arms and 184,563 patients in the tool (http://www.cancertrials.info). Meta-analysis-based efficacy and toxicity estimates are available for 85 HER-2-directed therapies, 84 hormonal therapies, and 442 undirected therapies. Network meta-analysis-based estimates are available for 16 HER-2-directed therapies, 26 hormonal therapies, and 131 undirected therapies. Conclusions: In this era of increasing choices of MBC therapeutic agents and no superior approach to choosing a treatment regimen, the ability to compare multiple therapies based on survival, toxicity and cost would enable treating physicians to optimize therapeutic choices for patients. For investigators, it can point them in research directions that were previously non-obvious and for guideline designers, enable them to efficiently review the MBC clinical trial literature and visualize how regimens compare in the key dimensions of clinical benefit, toxicity, and cost. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.},
author_keywords={Dose-limiting toxicity;  Metastatic breast cancer;  Network meta-analysis;  Overall survival},
keywords={antineoplastic agent, cancer chemotherapy;  cancer survival;  drug choice;  drug cost;  drug efficacy;  drug safety;  hormonal therapy;  human;  meta analysis;  metastatic breast cancer;  outcome assessment;  palliative therapy;  phase 2 clinical trial (topic);  phase 3 clinical trial (topic);  practice guideline;  priority journal;  progression free survival;  randomized controlled trial (topic);  Review;  risk benefit analysis;  systematic review;  web browser;  adverse event;  breast tumor;  cancer staging;  clinical trial (topic);  disease management;  economics;  female;  health care cost;  metastasis;  mortality;  multimodality cancer therapy;  pathology;  procedures, Breast Neoplasms;  Clinical Trials as Topic;  Combined Modality Therapy;  Disease Management;  Female;  Health Care Costs;  Humans;  Neoplasm Metastasis;  Neoplasm Staging;  Outcome Assessment, Health Care},
references={Schnipper, L., Davidson, N., Wollins, D., Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received (2016) J Clin Oncol, 34 (24), pp. 2925-2934; (2016) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with NCCN Evidence Blocks™, , https://www.nccn.org/EvidenceBlocks/, Accessed 28 December 2016; Ge, L., Tang, Y., Zhang, Q., A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer (2017) Oncotarget, 8 (35), pp. 59539-59551; Wilson, F., Varu, A., Mitra, D., Cameron, C., Iyer, S., Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer (2017) Breast Cancer Res Treat, 166 (1), pp. 167-177; Leung, H.W.C., Leung, J.H., Chan, A.L.F., Efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis (2018) Expert Opin Drug Saf, 17 (1), pp. 1-7; Trotti, A., Colevas, A.D., Setser, A., CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment (2003) Semin Radiat Oncol, 13 (3), pp. 176-181; Parmar, M.K., Torri, V., Stewart, L., Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints (1998) Stat Med, 17 (24), pp. 2815-2834; Silberholz, J., (2015) Analytics for Improved Cancer Screening and Treatment, , Dissertation, MIT; Bertsimas, D., O’Hair, A., Relyea, S., Silberholz, J., An analytics approach to designing combination chemotherapy regimens for cancer (2016) Manage Sci, 62 (5), pp. 1511-1531; (2016) NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, , version 2.2016; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Higgins, J., Thompson, S., Deeks, J., Altman, D., Measuring inconsistency in meta-analyses (2003) BMJ, 327 (7414), pp. 557-560; Tibshirani, R., Regression shrinkage and selection via the lasso (1996) J R Statist Soc B, 58 (1), pp. 267-288; Rücker, G., Schwarzer, G., Reduce dimension or reduce weights? Comparing two approaches to multi-arm studies in network meta-analysis (2014) Stat Med, 33 (25), pp. 4353-4369; Schmid, P., Adams, S., Rugo, H.S., Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer (2018) N Engl J Med, 379 (22), pp. 2108-2121; Masuda, N., Nishimura, R., Takahashi, M., Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study (2018) Cancer Sci, 109 (3), pp. 803-813; Finn, R., Crown, J., Lang, I., The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study (2015) Lancet Oncol, 16 (1), pp. 25-35; Finn, R., Martin, M., Rugo, H., Palbociclib and letrozole in advanced breast cancer (2016) N Engl J Med, 375 (20), pp. 1925-1936; Hess, D., Köberle, D., Thürlimann, B., Capecitabine and vinorelbine as first-line treatment in elderly patients (≥ 65 years) with metastatic breast cancer: a phase II trial (SAKK 25/99) (2007) Oncology, 73 (3-4), pp. 228-237; Smorenburg, C.H., de Groot, S.M., van Leeuwen-Stok, A.E., A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG (2014) Ann Oncol, 25 (3), pp. 599-605; Easterbrook, P.J., Gopalan, R., Berlin, J.A., Matthews, D.R., Publication bias in clinical research (1991) Lancet, 337 (8746), pp. 867-872},
correspondence_address1={Silberholz, J.; Ross School of Business, 701 Tappan Street R5468, United States; email: josilber@umich.edu},
publisher={Springer New York LLC},
issn={01676806},
coden={BCTRD},
pubmed_id={31089928},
language={English},
abbrev_source_title={Breast Cancer Res. Treat.},
document_type={Review},
source={Scopus},
}

@ARTICLE{García-Rudolp2019,
author={García-Rudolp, A. and Sánchez-Pinsac, D. and Salleras, E.O. and Tormos, J.M.},
title={Subacute stroke physical rehabilitation evidence in activities of daily living outcomes},
journal={Medicine (United States)},
year={2019},
volume={98},
number={8},
doi={10.1097/MD.0000000000014501},
art_number={e14501},
note={cited By 8},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062759675&doi=10.1097%2fMD.0000000000014501&partnerID=40&md5=445d48f8e95ced423655fab02eeefa39},
affiliation={Department of Research and Innovation, Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit A la UAB, Badalona, Barcelona, Spain; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola Del Vallès), Spain; Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Barcelona, Spain},
abstract={Background: Stroke is a leading cause of disabilities worldwide. One of the key disciplines in stroke rehabilitation is physical therapy which is primarily aimed at restoring and maintaining activities of daily living (ADL). Several meta-analyses have found different interventions improving functional capacity and reducing disability. Objectives: To systematically evaluate existing evidence, from published systematic reviews of meta-analyses, of subacute physical rehabilitation interventions in (ADLs) for stroke patients. Methods:Umbrella review on meta-analyses of RCTs ADLs in MEDLINE, Web of Science, Scopus, Cochrane, and Google Scholar up to April 2018. Two reviewers independently applied inclusion criteria to select potential systematic reviews of meta-analyses of randomized controlled trials (RCTs) of physical rehabilitation interventions (during subacute phase) reporting results in ADLs. Two reviewers independently extracted name of the 1st author, year of publication, physical intervention, outcome(s), total number of participants, and number of studies from each eligible meta-analysis. The number of subjects (intervention and control), ADL outcome, and effect sizes were extracted from each study. Results: Fifty-five meta-analyses on 21 subacute rehabilitation interventions presented in 30 different publications involving a total of 314 RCTs for 13,787 subjects were identified. Standardized mean differences (SMDs), 95% confidence intervals (fixed and random effects models), 95% prediction intervals, and statistical heterogeneity (I2 and Q test) were calculated. Virtual reality, constraintinduced movement, augmented exercises therapy, and transcranial direct current stimulation interventions resulted statistically significant (P<.05) with moderate improvements (0.5≤SMD≤0.8) and no heterogeneity (I2=0%). Moxibustion, Tai Chi, and acupuncture presented best improvements (SMD>0.8) but with considerable heterogeneity (I2>75%). Only acupuncture reached "suggestive"level of evidence. Conclusion: Despite the range of interventions available for stroke rehabilitation in subacute phase, there is lack of high-quality evidence in meta-analyses, highlighting the need of further research reporting ADL outcomes. Copyright © 2019 the Author(s).},
author_keywords={Activities of daily living;  meta-analysis;  rehabilitation;  stroke;  subacute interventions;  umbrella review},
keywords={cerebrovascular accident;  convalescence;  daily life activity;  human;  kinesiotherapy;  meta analysis;  pathophysiology;  physiology;  procedures;  randomized controlled trial (topic);  stroke rehabilitation, Activities of Daily Living;  Exercise Therapy;  Humans;  Randomized Controlled Trials as Topic;  Recovery of Function;  Stroke;  Stroke Rehabilitation},
funding_details={Horizon 2020 Framework ProgrammeHorizon 2020 Framework Programme, H2020, 777107},
funding_text 1={This research was partially funded by EU H2020 PRECISE4Q - Personalized Medicine by Predictive Modeling in Stroke for better Quality of Life (Grant Agreement 777107 - Research and Innovation Action).},
funding_text 2={Editor: Weimin Guo. This research was partially funded by EU H2020 PRECISE4Q - Personalized Medicine by Predictive Modeling in Stroke for better Quality of Life (Grant Agreement 777107 – Research and Innovation Action). The authors have no conflicts of interest to disclose.},
references={Veerbeek, J.M., Langbroek-Amersfoort, A.C., Van Wegen, E.E., Effects of robot-assisted therapy for the upper limb after stroke (2017) Neurorehabil Neural Repair, 31, pp. 107-121; Wattchow, K.A., McDonnell, M.N., Hillier, S.L., Rehabilitation interventions for upper limb function in the first four weeks following stroke: A systematic review and meta-analysis of the evidence (2018) Arch Phys Med Rehabil, 99, pp. 367-382; (2017) The Burden of Stroke in Europe Report. Overview of Stroke Burden and Care in Each EU and SAFE Member Country, , Stroke Alliance for Europe -Stroke Association House 240 City Road, London; Benjamin, E., Heart disease and stroke statistics-2017 update a report from the American Heart Association (2017) Circulation, 135, pp. e146-e603; Langhorne, P., Legg, L., Evidence behind stroke rehabilitation (2003) J Neurol Neurosurg Psychiatry, 74, pp. iv18-iv21; Langhorne, P., Bernhardt, J., Kwakkel, G., Stroke rehabilitation (2011) Lancet, 377, pp. 1693-1702; Lee, S.H., (2011) Stroke Revisited: Diagnosis and Treatment of Ischemic Stroke, Stroke Revisited, , Rehabilitation in Sub-acute and Chronic Stage After Stroke Han-Young Jung; Pasanen, T., Tolvanen, S., Heinonen, A., Exercise therapy for functional capacity in chronic diseases: An overview of meta-analyses of randomised controlled trials (2017) Br J Sports Med, 51, pp. 1459-1465; Veerbeek, J.M., Van Wegen, E., Van Peppen, R., What is the evidence for physical therapy poststroke? A systematic review and meta-analysis (2014) PLoS One, 9; Elsner, B., Kugler, J., Pohl, M., Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke (2016) Cochrane Database of Syst Rev, (3). , CD009645 pub3; Momosaki, R., Yamada, N., Ota, E., Repetitive peripheral magnetic stimulation for activities of daily living and functional ability in people after stroke (2017) Cochrane Database of Syst Rev, (6); De Simoni, M.G., Milia, P., Barba, M., The inflammatory response in cerebral ischemia: Focus on cytokines in stroke patients (2002) Clin Exp Hypertens, 24, pp. 535-542; Hedley, C.A., Emsley, Pippa, J., Tyrrell Inflammation and Infection in Clinical Stroke (2002) Journal of Cerebral Blood Flow &metabolism, 22, pp. 1399-1419. , The International Society for Cerebral Blood Flow and Metabolism; Tuttolomondo, A., Di Sciacca, R., Di Raimondo, D., Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: A retrospective chart review from the GIFA study (2011) Int J Cardiol, 151, pp. 318-322; Emsley, H.C., Hopkins, S.J., Acute ischaemic stroke and infection: Recent and emerging concepts (2008) Lancet Neurol, 7, pp. 341-353; McColl, B.W., Allan, S.M., Rothwell, N.J., Systemic infection, inflammation and acute ischemic stroke (2009) Neuroscience, 158, pp. 1049-1061; Di Raimondo, D., Tuttolomondo, A., Buttà, C., Effects of ACEinhibitors and angiotensin receptor blockers on inflammation (2012) Curr Pharm des, 18, pp. 4385-4413; Elkind, M.S., Cheng, J., Rundek, T., Leukocyte count predicts outcome after ischemic stroke: The Northern Manhattan Stroke Study (2004) J Stroke Cerebrovasc Dis, 13, pp. 220-227; Aromataris, E., Fernandez, R., Godfrey, C., Methodology for JBI umbrella reviews (2014) Joanna Briggs Institute Reviewers' Manual, , edition/Supplement (1-34). Australia: The Joanna Briggs Institute; Hamilton, B.B., Laughlin, J.A., Fiedler, R.C., Interrater reliability of the 7-level functional independence measure (FIM) (1994) Scand J Rehabil Med, 26, pp. 115-119; Wade, D.T., Hewer, R.L., Functional abilities after stroke: Measurement, natural history and prognosis (1987) J Neurol Neurosurg Psychiatry, 50, pp. 177-182; Bonita, R., Beaglehole, R., Modification of Rankin scale: Recovery of motor function after stroke (1988) Stroke, 19, pp. 1497-1500; Schuling, J., De Haan, R., Limburg, M., The Frenchay activities index: Assessment of functional status in stroke patients (1993) Stroke, 24, pp. 1173-1177; Whiting, S., Lincoln, N., An ADL assessment for stroke patients (1980) Br JOccup Ther, 43, pp. 44-46; Hartigan, I., A comparative review of the Katz ADL and the Barthel Index in assessing the activities of daily living of older people (2007) Int JOlder People Nurs, 2, pp. 204-212; Uswatte, G., Taub, E., Morris, D., Reliability and validity of the upperextremity motor activity log14 for measuring real-world arm use (2005) Stroke, 36, pp. 2493-2496; Shah, S., Vanclay, F., Cooper, B., Improving the sensitivity of the Barthel Index for stroke rehabilitation (1989) J Clin Epidemiol, 42, pp. 703-709; Higgins, J.P.T., Green, S., (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, , www.handbook.cochrane.org, [updated March 2011], Accessed April 2018; Hatano, S., Experience from a multicentre stroke register: A preliminary report (1976) Bull World Health Organ, 54, pp. 541-553; Peurala, S.H., Karttunen, A.H., Sjögren, T., Evidence for the effectiveness of walking training on walking and self-care after stroke: A systematic review and meta-analysis of randomized controlled trials (2014) J Rehabil Med, 46, pp. 387-399; Shea, B.J., Bouter, L.M., Peterson, J., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS One, 2, pp. 1-5; Dersimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Cochran, W.G., The combination of estimates from different experiments (1954) Biometrics, 10, pp. 101-129; Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Measuring inconsistency in meta-analyses (2003) Br Med J, 327, pp. 557-560; Riley, R.D., Higgins, J.P., Deeks, J.J., Interpretation of random effects metaanalyses (2011) BMJ, 342, p. d549; Cohen, J., (1988) Statistical Power Analysis for the Behavioral Sciences, , London: Academic Press; Mlinarić, A., Horvat, M., Supak Smolčić, V., Dealing with the positive publication bias: Why you should really publish your negative results (2017) Biochem Med, 27; Mehrholz, J., Pohl, M., Platz, T., Electromechanical and robot-assisted armtraining for improving activities of daily living, armfunction, and armmuscle strength after stroke (2015) Cochrane Database of Systematic Reviews, (11). , CD006876.pub4; Norouzi-Gheidari, N., Archambault, P.S., Fung, J., Effects of robot-assisted therapy on stroke rehabilitation in upper limbs: Systematic review and meta-analysis of the literature (2012) J Rehabil Res Dev, 49, pp. 479-496; Chen, L., Chen, J., Peng, Q., Effect of sling exercise training on balance in patients with stroke: A meta-analysis (2016) PLoS One, 11; Cheok, G., Tan, D.M., Low, A., Is nintendo wii an effective intervention for individuals with stroke? A systematic review and meta-analysis (2015) Journal of the American Medical Directors Association, 1611, pp. 923-932; Tedesco Triccas, L., Burridge, J.H., Hughes, A.M., Multiple sessions of transcranial direct current stimulation and upper extremity rehabilitation in stroke: A review and meta-analysis (2016) Clin Neurophysiol, 127, pp. 946-955; Banchetti, P.A., Marini, C., Efficacy of transcranial direct current stimulation as support for neurorehabilitation therapy: A metaanalysis of available studies (2017) Int J Phys Med Rehabil, 5, p. 417; Han, C.-H., Ma, J.N., An, N., Moxibustion for stroke: Systematic review, meta-analysis, and GRADE-based recommendations (2018) Eur J Integrative Med, 20, pp. 115-125; Lee, S.-J., Shina, B.-C., Lee, M.S., Scalp acupuncture for stroke recovery: A systematic review and meta-analysis of randomized controlled trials (2012) Eur J Integr Med, 5, pp. 87-99; Li, L., Zhang, H., S-Q, M., An updated meta-analysis of the efficacy and safety of acupuncture treatment for cerebral infarction (2014) PLoS One, 9; Yang, A., Wu, H.M., Tang, J.L., Acupuncture for stroke rehabilitation (2016) Cochrane Database of Systematic Reviews, (8); Peng, L., Zhang, C., Zhou, L., Traditional manual acupuncture combined with rehabilitation therapy for shoulder hand syndrome after stroke within the Chinese healthcare system: A systematic review and meta-analysis (2018) Clin Rehabil, 32, pp. 429-439; Corbetta, D., Sirtori, V., Moja, L., Constraint-induced movement therapy in stroke patients: Systematic review and meta-analysis (2010) Eur J Phys Rehabil Med, 46, pp. 537-544; Peurala, S.H., Kantanen, M.P., Sjögren, T., Effectiveness of constraintinduced movement therapy on activity and participation after stroke: A systematic review and meta-analysis of randomized controlled trials (2012) Clin Rehabil, 26, pp. 209-223; Shi, Y.X., Tian, J.H., Yang, K.H., Modified constraint-induced movement therapy versus traditional rehabilitation in patients with upper-extremity dysfunction after stroke: A systematic review and metaanalysis (2011) Arch Phys Med Rehabil, 92, pp. 972-982; Laver, K., George, S., Thomas, S., Cochrane review: Virtual reality for stroke rehabilitation (2012) Eur J Phys Rehabil Med, 48, pp. 523-530; Laver, K.E., George, S., Thomas, S., Virtual reality for stroke rehabilitation (2015) Cochrane Database of Systematic Reviews, (2); Eraifej, J., Clark, W., France, B., Effectiveness of upper limb functional electrical stimulation after stroke for the improvement of activities of daily living and motor function: A systematic review and meta-analysis (2017) Syst Rev, 6, p. 40; French, B., Thomas, L.H., Leathley, M., Does repetitive task training improve functional activity after stroke? A Cochrane systematic review and meta-analysis (2010) J Rehabilit Med, 42, pp. 9-14; French, B., Thomas, L.H., Coupe, J., Repetitive task training for improving functional ability after stroke (2016) Cochrane Database of Systematic Reviews, (11); Lee, Y., Kim, M.Y., Park, J.H., Comparison of the effects of bilateral and unilateral training after stroke: A meta-analysis (2017) NeuroRehabilitation, 40, pp. 301-313; Veerbeek, J.M., Koolstra, M., Ket, J.C., Effects of augmented exercise therapy on outcome of gait and gait-related activities in the first 6months after stroke: A meta-analysis (2011) Stroke, 42, pp. 3311-3315; Fernandez Guerra, Z., Lucchetti, A.L.G., Lucchetti, G., Motor imagery training after stroke: A systematic review and meta-analysis of randomized controlled trials (2017) J Neurol Phys Ther, 41, pp. 205-214; Cai, Zhang, C.S., Liu, S., Electroacupuncture for poststroke spasticity: A systematic review andmeta-analysis (2017) Arch PhysMed Rehabil., 98 (12), pp. 2578-2578e4. , Epub 2017 Apr 25; Lyu, D., Lyu, X., Zhang, Y., Tai Chi for stroke rehabilitation: A systematic review and meta-analysis of randomized controlled trials (2018) Front Physiol, 9, p. 983; Mehrholz, J., Kugler, J., Pohl, M., Water-based exercises for improving activities of daily living after stroke (2011) Cochrane Database of Systematic Reviews, (1); Thieme, H., Morkisch, N., Mehrholz, J., Pohl, M., Behrens, J., Borgetto, B., Dohle, C., Mirror therapy for improving motor function after stroke (2018) Cochrane Database of Systematic Reviews, (7); Hao, Z., Wang, D., Zeng, Y., Liu, M., Repetitive transcranial magnetic stimulation for improving function after stroke (2013) Cochrane Database of Systematic Reviews, (5); English, C., Hillier, S.L., Lynch, E.A., Circuit class therapy for improving mobility after stroke (2017) Cochrane Database of Systematic Reviews, (6); Gordon, M., Lumley, T., Advanced Forest Plot Using 'Grid' Graphics, , https://cran.r-project.org/web/packages/forestplot/forestplot.pdf, Accessed August 20, 2018; Schwarzer, G., Meta: An R Package for Meta-Analysis, , https://cran.rproject.org/web/packages/meta/meta.pdf, Accessed August 20, 2018; O'Sullivan, J.W., Muntinga, T., Grigg, S., Prevalence and outcomes of incidental imaging findings: Umbrella review (2018) BMJ, 361, p. k2387; Inthout, J., Jpa, J., Rovers, M.M., Plea for routinely presenting prediction intervals in meta-analysis (2016) BMJ Open, 6, p. e010247; Bellou, V., Belbasis, L., Tzoulaki, I., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Pearson-Fuhrhop, K.M., Burke, E., Cramer, S.C., The influence of genetic factors on brain plasticity and recovery after neural injury (2012) Curr Opin Neurol, 25, pp. 682-688; Feldt-Rasmussen, U., Fabry disease and early stroke (2011) Stroke Res Treat, 2011, p. 615218; Tuttolomondo, A., Pecoraro, R., Simonetta, I., Neurological complications of Anderson-Fabry disease (2013) Curr Pharm des, 19, pp. 6014-6030. , Review; Tuttolomondo, A., Pecoraro, R., Simonetta, I., Anderson-Fabry disease: A multiorgan disease (2013) Curr Pharm des, 19, pp. 5974-5996; Dinu, M., Pagliai, G., Casini, A., Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomised trials (2018) Eur J Clin Nutr, 72, pp. 30-43; Gu, J., Wang, Q., Wang, X.G., Assessment of registration information on methodological design of acupuncture RCTs: A review of 453 registration records retrieved from WHO International Clinical Trials Registry Platform (2014) Evid Based Complement Alternat Med, 2014, p. 614850; Ioannidis, J.P., Trikalinos, T.A., An exploratory test for an excess of significant findings (2007) Clin Trials, 4, pp. 245-253},
correspondence_address1={García-Rudolp, A.; Department of Research and Innovation, Cami Can Ruti s/n, Badalona, Spain; email: agarciar@guttmann.com},
publisher={Lippincott Williams and Wilkins},
issn={00257974},
coden={MEDIA},
pubmed_id={30813152},
language={English},
abbrev_source_title={Medicine},
document_type={Review},
source={Scopus},
}

@ARTICLE{Tanner2015238,
author={Tanner, C.M. and Comella, C.L.},
title={When brawn benefits brain: Physical activity and Parkinson's disease risk},
journal={Brain},
year={2015},
volume={138},
number={2},
pages={238-239},
doi={10.1093/brain/awu351},
note={cited By 8},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922357670&doi=10.1093%2fbrain%2fawu351&partnerID=40&md5=0e4f7f49b970ff75debeb366401e3e4a},
affiliation={Department of Neurology, Parkinson's Disease Research Education and Clinical Centre, University of California, San Francisco, United States; Rush Medical Centre, Neurological Sciences, Chicago, IL, United States},
keywords={human;  Note;  Parkinson disease;  physical activity;  priority journal;  female;  male;  motor activity;  Parkinson disease, Female;  Humans;  Male;  Motor Activity;  Parkinson Disease},
funding_details={National Institutes of HealthNational Institutes of Health, NIH},
funding_details={U.S. Department of DefenseU.S. Department of Defense, DOD},
funding_details={National Institute of Neurological Disorders and StrokeNational Institute of Neurological Disorders and Stroke, NINDS, R01NS074343, U54NS065701},
funding_details={Michael J. Fox Foundation for Parkinson's ResearchMichael J. Fox Foundation for Parkinson's Research, MJFF},
funding_details={Parkinson's Disease FoundationParkinson's Disease Foundation, PDF},
funding_details={Dystonia Medical Research FoundationDystonia Medical Research Foundation, DMRF},
funding_details={National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences, NCATS, U54TR001456},
funding_details={AllerganAllergan},
funding_text 1={C.M.T. receives grant support from the Michael J. Fox Foundation, the Parkinson’s Disease Foundation, the Department of Defense and the National Institutes of Health. C.L.C. receives research support from the NIH R01NS074343, U54NS065701, Dystonia Medical Research Foundation, Allergan Inc. Ipsen Biopharmaceuticals, Inc and Merz Pharmaceutical; and receives research support from the Parkinson’s Disease Foundation.},
references={Ahlskog, J.E., Does vigorous exercise have a neuroprotective effect in parkinson disease (2011) Neurology., 77, pp. 288-294; Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G., Kieburtz, K., Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 (2007) Neurology., 68, pp. 384-386; Henderson, G.C., Sexual dimorphism in the effects of exercise on metabolism of lipids to support resting metabolism (2014) Front Endocrinol (Lausanne)., 5, p. 162; Johnson, N.B., Hayes, L.D., Brown, K., Hoo, E.C., Ethier, K.A., CDC national health report: Leading causes of morbidity and mortality and associated behavioral risk and protective factors-united states, 2005-2013 (2014) MMWR Surveill Summ., 63, pp. 3-27; Mattson, M.P., Interventions that improve body and brain bioenergetics for parkinson's disease risk reduction and therapy (2014) J Parkinsons Dis., 4, pp. 1-13; Palma, J.A., Kaufmann, H., Autonomic disorders predicting parkinson's disease (2014) Parkinsonism Relat Disord., 20, pp. S94-S98; Peterson, A.L., A review of vitamin d and parkinson's disease (2014) Maturitas., 78, pp. 40-44; Santiago, J.A., Potashkin, J.A., System-based approaches to decode the molecular links in parkinson's disease and diabetes (2014) Neurobiol Dis., , Advance Access published on April 6, 2014; Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., Physical activities and future risk of parkinson disease (2010) Neurology., 75, pp. 341-348; Yang, F., Lagerros, Y.T., Bellocco, R., Adami, H.O., Fang, F., Pedersen, N.L., Physical activity and risk of parkinson's disease in the swedish national march cohort (2015) Brain., 138, pp. 269-275},
correspondence_address1={Tanner, C.M.; Department of Neurology, United States; email: caroline.tanner@ucsf.edu},
publisher={Oxford University Press},
issn={00068950},
coden={BRAIA},
pubmed_id={25627233},
language={English},
abbrev_source_title={Brain},
document_type={Note},
source={Scopus},
}

@ARTICLE{Biondi-Zoccai20201744,
author={Biondi-Zoccai, G. and Versaci, F. and Iskandrian, A.E. and Schillaci, O. and Nudi, A. and Frati, G. and Nudi, F.},
title={Umbrella review and multivariate meta-analysis of diagnostic test accuracy studies on hybrid non-invasive imaging for coronary artery disease},
journal={Journal of Nuclear Cardiology},
year={2020},
volume={27},
number={5},
pages={1744-1755},
doi={10.1007/s12350-018-01487-w},
note={cited By 7},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056000344&doi=10.1007%2fs12350-018-01487-w&partnerID=40&md5=f7a66ceb06b1efd9497d546f409c56d1},
affiliation={Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; IRCCS NEUROMED, Pozzilli, Italy; Division of Cardiology, S. Maria Goretti Hospital, Latina, Italy; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, United States; Department of Nuclear Medicine, Tor Vergata University, Rome, Italy; Replycare, Viale Africa 36, Rome, 00144, Italy; Service of Nuclear Cardiology, Madonna della Fiducia Clinic, Rome, Italy; Service of Nuclear Cardiology, Ostia Radiologica, Rome, Italy},
abstract={Background: The diagnosis of coronary artery disease (CAD) remains challenging. It is uncertain whether hybrid imaging can improve diagnostic accuracy for CAD. Methods: This is a systematic review and multivariate meta-analysis. We searched PubMed and The Cochrane Library for recent (≥ 2010) systematic reviews of diagnostic test accuracy studies on non-invasive imaging for CAD. Study-level data were extracted from them, and pooled with pairwise and multivariate meta-analytic methods, using invasive coronary angiography (ICA) or invasive fractional flow reserve (FFR) as reference standards, focusing on sensitivity and specificity. Results: Details from 661 original studies (71,823 patients) were pooled. Pairwise meta-analysis using ICA as reference showed that anatomic imaging was associated with the best diagnostic accuracy (sensitivity = 0.95 [95% confidence interval 0.94-0.96], specificity = 0.83 [0.81-0.85]), whereas using FFR as reference identified hybrid imaging as the best test (sensitivity = 0.87 [0.83-0.90], specificity = 0.82 [0.76-0.87]). Multivariate meta-analysis confirmed the superiority of anatomic imaging using ICA as reference (sensitivity = 0.96, specificity = 0.83), and hybrid imaging using FFR as reference (sensitivity = 0.88 [0.86-0.91], specificity = 0.82 [0.77-0.87]). Conclusions: Non-invasive hybrid imaging tests appear superior to anatomic or functional only tests to diagnose ischemia-provoking coronary lesions, whereas anatomic imaging is best to diagnose and/or rule out angiographically significant CAD. Systematic review registration: PROSPERO Registry Number CRD42018088528. © 2018, American Society of Nuclear Cardiology.},
author_keywords={Coronary artery disease;  Diagnosis;  Imaging;  Multivariate meta-analysis;  Umbrella review},
keywords={Article;  cardiovascular magnetic resonance;  Cochrane Library;  computed tomographic angiography;  coronary angiography;  coronary artery disease;  diagnostic test accuracy study;  fractional flow reserve;  human;  image processing;  information retrieval;  major clinical study;  Medline;  meta analysis (topic);  positron emission tomography;  priority journal;  sensitivity and specificity;  single photon emission computed tomography;  systematic review;  cardiac imaging;  coronary artery disease;  diagnostic imaging;  meta analysis, Cardiac Imaging Techniques;  Coronary Artery Disease;  Humans;  Sensitivity and Specificity},
funding_details={BayerBayer},
funding_details={Australian Education International, Australian GovernmentAustralian Education International, Australian Government, AEI},
funding_details={Abbott VascularAbbott Vascular},
funding_text 1={Prof. Biondi-Zoccai has consulted for Abbott Vascular and Bayer. Prof. Versaci, Prof. Iskandrian, Prof. Schillaci, Dr. A. Nudi, Prof. Frati and Dr. F. Nudi have nothing to disclose. GZB and FN designed the study, interpreted the results and drafted the manuscript. GBZ, AN, and GF performed searches, extracted data, and appraised them. FV and AEI provided critical input on study design, data analysis, and interpretation. All authors finally approved the manuscript before submission. FN acts as guarantor. All data used to generate the analyses reported in this work are attached as an online supplement.},
references={Benjamin, E.J., Blaha, M.J., Chiuve, S.E., Cushman, M., Das, S.R., Deo, R., de Ferranti, S.D., Muntner, P., Heart Disease and Stroke Statistics—2017 Update: A Report from the American Heart Association (2017) Circulation, 135, pp. e146-e603; Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016 (2017) Lancet, 390, pp. 1151-1210; Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) Lancet, 390, pp. 1211-1259; Mann, D.L., Zipes, D.P., Libby, P., Bonow, R.O., (2014) Braunwald’s heart disease: A textbook of cardiovascular medicine, , (eds), Saunders, Philadelphia; Fuster, V., Harrington, R.A., (2017) Hurst’s the heart, , (eds), McGraw-Hill, New York; Froelicher, V.F., Myers, J., (2006) Manual of exercise testing, , Mosby, St. Louis; Picano, E., (2016) Stress echocardiography, , Springer International Publishing, Cham; Heller, G.V., Hendel, R.C., (2017) Nuclear cardiology: Practical applications, , (eds), McGraw-Hill, New York; Schindler, T.H., George, R.T., Lima, J.A.C., (2015) Molecular and multimodality imaging in cardiovascular disease, , (eds), Springer, Cham; Budoff, M.J., Shinbane, J.S., (2016) Cardiac CT imaging: Diagnosis of cardiovascular disease, , (eds), Springer, Cham; Bogaert, J., Dymarkowski, S., Taylor, A.M., Muthurangu, V., (2012) Clinical cardiac MRI, , (eds), Springer, Cham; Branch, K.R., Haley, R.D., Bittencourt, M.S., Patel, A.R., Hulten, E., Blankstein, R., Myocardial computed tomography perfusion (2017) Cardiovasc Diagn Ther, 7, pp. 452-462; Tesche, C., Vliegenthart, R., Duguay, T.M., De Cecco, C.N., Albrecht, M.H., De Santis, D., Langenbach, M.C., Schoepf, U.J., Coronary computed tomographic angiography-derived fractional flow reserve for therapeutic decision making (2017) Am J Cardiol, 120, pp. 2121-2127; Rizvi, A., Han, D., Danad, I., Ó Hartaigh, B., Lee, J.H., Gransar, H., Stuijfzand, W.J., Peña, J.M., Diagnostic performance of hybrid cardiac imaging methods for assessment of obstructive coronary artery disease compared with stand-alone coronary computed tomography angiography: A meta-analysis (2018) JACC Cardiovasc Imaging, 11, pp. 589-599; Biondi-Zoccai, G., (2016) Umbrella reviews: Evidence synthesis with overviews of reviews and meta-epidemiologic studies, , (ed), Springer, Cham; Biondi-Zoccai, G., (2018) Diagnostic meta-analysis: A useful tool for clinical decision making, , (ed), Springer, Cham; Biondi-Zoccai, G., (2014) Network meta-analysis: Evidence synthesis with mixed treatment comparison, , (ed), Nova Science Publishers, Hauppauge, NY; http://cochrane.org, (last accessed on August 22, 2018); International Prospective Register of Systematic Reviews, , https://www.crd.york.ac.uk/prospero/, (last accessed on August 22, 2018); McInnes, M.D.F., Moher, D., Thombs, B.D., McGrath, T.A., Bossuyt, P.M., Clifford, T., Cohen, J.F., Willis, B.H., Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: The PRISMA-DTA statement (2018) JAMA, 319, pp. 388-396; Chen, L., Wang, X., Bao, J., Geng, C., Xia, Y., Wang, J., Direct comparison of cardiovascular magnetic resonance and single-photon emission computed tomography for detection of coronary artery disease: A meta-analysis (2014) PLoS ONE, 9; Dai, N., Zhang, X., Zhang, Y., Hou, L., Li, W., Fan, B., Zhang, T., Xu, Y., Enhanced diagnostic utility achieved by myocardial blood analysis: A meta-analysis of noninvasive cardiac imaging in the detection of functional coronary artery disease (2016) Int J Cardiol, 221, pp. 665-673; Danad, I., Szymonifka, J., Twisk, J.W.R., Norgaard, B.L., Zarins, C.K., Knaapen, P., Min, J.K., Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: A meta-analysis (2017) Eur Heart J, 38, pp. 991-998; de Jong, M.C., Genders, T.S., van Geuns, R.J., Moelker, A., Hunink, M.G., Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: A systematic review and meta-analysis (2012) Eur Radiol, 22, pp. 1881-1895; Ding, A., Qiu, G., Lin, W., Hu, L., Lu, G., Long, X., Hong, X., Deng, D., Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in ischemia-causing coronary stenosis: A meta-analysis (2016) Jpn J Radiol, 34, pp. 795-808. , COI: 1:CAS:528:DC%2BC28Xhslylsb%2FJ; Dolor, R.J., Patel, M.R., Melloni, C., Chatterjee, R., McBroom, A.J., Musty, M.D., Wing, L., Sanders, G.D., (2012) Noninvasive Technologies for the diagnosis of coronary artery disease in women, , Agency for Healthcare Research and Quality (US), Rockville (MD; Gonzalez, J.A., Lipinski, M.J., Flors, L., Shaw, P.W., Kramer, C.M., Salerno, M., Meta-analysis of diagnostic performance of coronary computed tomography angiography, computed tomography perfusion, and computed tomography-fractional flow reserve in functional myocardial ischemia assessment versus invasive fractional flow reserve (2015) Am J Cardiol, 116, pp. 1469-1478; Huang, J.Y., Huang, C.K., Yen, R.F., Wu, H.Y., Tu, Y.K., Cheng, M.F., Lu, C.C., Wu, Y.W., Diagnostic performance of attenuation-corrected myocardial perfusion imaging for coronary artery disease: A systematic review and meta-analysis (2016) J Nucl Med, 57, pp. 1893-1898; Kiaos, A., Tziatzios, I., Hadjimiltiades, S., Karvounis, C., Karamitsos, T.D., Diagnostic performance of stress perfusion cardiac magnetic resonance for the detection of coronary artery disease: A systematic review and meta-analysis (2018) Int J Cardiol, 252, pp. 229-233; Jaarsma, C., Leiner, T., Bekkers, S.C., Crijns, H.J., Wildberger, J.E., Nagel, E., Nelemans, P.J., Schalla, S., Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis (2012) J Am Coll Cardiol, 59, pp. 1719-1728; Li, M., Du, X.M., Jin, Z.T., Peng, Z.H., Ding, J., Li, L., The diagnostic performance of coronary artery angiography with 64-MSCT and post 64-MSCT: Systematic review and meta-analysis (2014) PLoS ONE, 9; Goodacre, S., Thokala, P., Carroll, C., Stevens, J.W., Leaviss, J., Al Khalaf, M., Collinson, P., Wang, J., Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome (2013) Health Technol Assess, 17, pp. 1-188; Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: A summary of evidence-based analyses (2010) Ont Health Technol Assess Ser, 10, pp. 1-40; National Institute for Health and Care Excellence., , https://www.nice.org.uk/guidance/cg95, (last accessed on August 22, 2018); Nielsen, L.H., Ortner, N., Nørgaard, B.L., Achenbach, S., Leipsic, J., Abdulla, J., The diagnostic accuracy and outcomes after coronary computed tomography angiography vs. conventional functional testing in patients with stable angina pectoris: A systematic review and meta-analysis (2014) Eur Heart J Cardiovasc Imaging, 15, pp. 961-971; Nudi, F., Iskandrian, A.E., Schillaci, O., Peruzzi, M., Frati, G., Biondi-Zoccai, G., Diagnostic accuracy of myocardial perfusion imaging with CZT technology: systemic review and meta-analysis of comparison with invasive coronary angiography (2017) JACC Cardiovasc Imaging, 10, pp. 787-794; Parker, M.W., Iskandar, A., Limone, B., Perugini, A., Kim, H., Jones, C., Calamari, B., Heller, G.V., Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: A bivariate meta-analysis (2012) Circ Cardiovasc Imaging, 5, pp. 700-707; Sethi, P., Panchal, H.B., Veeranki, S.P., Ur Rahman, Z., Mamudu, H., Paul, T.K., Diagnostic value of noninvasive computed tomography perfusion imaging and coronary computed tomography angiography for assessing hemodynamically significant native coronary artery lesions (2017) Am J Med Sci, 354, pp. 291-298; Sørgaard, M.H., Kofoed, K.F., Linde, J.J., George, R.T., Rochitte, C.E., Feuchtner, G., Lima, J.A., Abdulla, J., Diagnostic accuracy of static CT perfusion for the detection of myocardial ischemia. A systematic review and meta-analysis (2016) J Cardiovasc Comput Tomogr, 10, pp. 450-457; Tan, X.W., Zheng, Q., Shi, L., Gao, F., Allen, J.C., Jr., Coenen, A., Baumann, S., Zhong, L., Combined diagnostic performance of coronary computed tomography angiography and computed tomography derived fractional flow reserve for the evaluation of myocardial ischemia: A meta-analysis (2017) Int J Cardiol, 236, pp. 100-106; Zhou, T., Yang, L.F., Zhai, J.L., Li, J., Wang, Q.M., Zhang, R.J., Wang, S., Sun, G., SPECT myocardial perfusion versus fractional flow reserve for evaluation of functional ischemia: a meta analysis (2014) Eur J Radiol, 83, pp. 951-956; Garrone, P., Biondi-Zoccai, G., Salvetti, I., Sina, N., Sheiban, I., Stella, P.R., Agostoni, P., Quantitative coronary angiography in the current era: principles and applications (2009) J Interv Cardiol, 22, pp. 527-536; Pijls, N.H., Tanaka, N., Fearon, W.F., Functional assessment of coronary stenoses: can we live without it? (2013) Eur Heart J, 34, pp. 1335-1344; Archbold, R.A., Comparison between National Institute for Health and Care Excellence (NICE) and European Society of Cardiology (ESC) guidelines for the diagnosis and management of stable angina: Implications for clinical practice (2016) Open Heart, 3},
correspondence_address1={Biondi-Zoccai, G.; Department of Medico-Surgical Sciences and Biotechnologies, Italy; email: giuseppe.biondizoccai@uniroma1.it},
publisher={Springer},
issn={10713581},
coden={JNCAE},
pubmed_id={30374848},
language={English},
abbrev_source_title={J. Nucl. Cardiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Kelly2020555,
author={Kelly, M.M. and Griffith, P.B.},
title={The Influence of preterm birth beyond infancy: Umbrella review of outcomes of adolescents and adults born preterm},
journal={Journal of the American Association of Nurse Practitioners},
year={2020},
volume={32},
number={8},
pages={555-562},
doi={10.1097/JXX.0000000000000248},
note={cited By 7},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087815741&doi=10.1097%2fJXX.0000000000000248&partnerID=40&md5=7f265d524530de58842572dae2d2ab31},
affiliation={M. Louise Fitzpatrick College of Nursing, Pediatric Nurse Practitioner Program, Villanova University, Villanova, PA, Italy; Adult Gerontology Acute Care Nurse Practitioner Program, University of Pennsylvania School of Nursing, Philadelphia, PA, United States},
abstract={BACKGROUND AND PURPOSE: In recent decades, increased neonatal survival has enabled research of long-term outcomes of those born preterm. The purpose of this article is to present the findings of an umbrella review, an examination of published systematic reviews and meta-analyses, to examine the outcomes of adolescents and adults born preterm. METHODS: The research was guided by the Joanna Briggs Institute methodology for umbrella reviews. A systematic search of PubMed, CINAHL, and PsycINFO databases with the search years 2010 through September 2018 yielded 16 reviews for inclusion. CONCLUSIONS: The 16 reviews included in this umbrella review represent five clinical outcomes: neurodevelopmental (3 reviews), mental/behavioral health (5 reviews), cardiovascular (4 reviews), pulmonary (3 reviews), and life experience outcomes (4 reviews). One review included data for multiple clinical outcomes. This umbrella review highlights the adolescent and adult risks related to cognitive scores, executive function, anxiety, depression, attention-deficit hyperactivity disorder, long-term effects on systolic blood pressure, low-density lipoproteins and cholesterol levels, pulmonary symptoms, including asthma, pulmonary function, radiographic changes in the lungs, sports and leisure participation, and educational attainment and employment. IMPLICATIONS FOR PRACTICE: There is a preponderance of evidence that supports targeted screening for a history of preterm birth by all health care providers. This screening should facilitate the promotion of healthy lifestyles and improving psychosocial and neurodevelopmental difficulties through early and continued support services. Curricular and practice standards are advocated to support this change.},
keywords={adolescent;  adult;  adverse drug reaction;  female;  growth, development and aging;  human;  male;  pathophysiology;  physiology;  prematurity, Adolescent;  Adult;  Female;  Humans;  Infant, Premature;  Long Term Adverse Effects;  Male;  Outcome Assessment, Health Care},
publisher={NLM (Medline)},
issn={23276924},
pubmed_id={31651585},
language={English},
abbrev_source_title={J Am Assoc Nurse Pract},
document_type={Article},
source={Scopus},
}

@ARTICLE{Paquette2019,
author={Paquette, M. and Alotaibi, A.M. and Nieuwlaat, R. and Santesso, N. and Mbuagbaw, L.},
title={A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation},
journal={Systematic Reviews},
year={2019},
volume={8},
number={1},
doi={10.1186/s13643-019-1152-z},
art_number={241},
note={cited By 7},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074127130&doi=10.1186%2fs13643-019-1152-z&partnerID=40&md5=93326905eed20bec92f74c9366070e4e},
affiliation={Department of Health Research Methods Evidence, and Impact, McMaster University, Hamilton, ON  L8S 4K1, Canada; Medical Department, Boehringer Ingelheim Ltd., Burlington, ON, Canada; Pediatric Endocrinology Department, King Abdullah Bin Abdulaziz University Hospital, Princess Noura University, Riyadh, Saudi Arabia; Biostatistics Unit, Father Sean o'Sullivan Research Centre, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada; Centre for the Development of Best Practices in Health, Yaoundé, Cameroon},
abstract={Background: Information on subgroup assessments in systematic reviews (SR) of atrial fibrillation (AF) is limited. This review aims to describe subgroup analyses in AF SRs to inform the design of SRs and randomized trials as well as clinical practice. Methods: We conducted a cross sectional meta-epidemiological study of Cochrane AF reviews by searching AF (including variants) in the title, abstract, or keyword field without date or language restrictions (Issue 9; September 2018). Two reviewers independently extracted study characteristics to summarize frequency of subgroups pre-specified and conducted and report credibility of subgroup effects claimed. Results: Of 39 Cochrane reviews identified, 17 met inclusion criteria (including 168 reports of 127 randomized trials) and the majority (16; 94.1%) conducted meta-analysis of outcomes. Most (13; 76.5%) planned pre-specified subgroup analyses; 7 of which (41.2%) conducted subgroups. In these 7 reviews, 56 subgroups were planned, 17 (30.4%) conducted and 6 (10.7%) yielded subgroup effects. Variables such as co-morbid disease, stroke risk factors, prior stroke/transient ischemic attack, age, race, and sex represented 44% (24 subgroups) of all planned subgroups (8 conducted; 14.3%); however, information on covariate selection was lacking. Overall, more subgroups were planned than conducted (mean difference (95% CI) 2.3 (1.2-3.5, p < 0.001)). Of all subgroups conducted, anticoagulant characteristics comprised a third of all subgroup effects (n = 5, 35.7%). The credibility of subgroups identified (n = 14) was assessed and less than half (43%) represented one of a small number of pre-specified hypothesis and rarely were effects seen within studies (7%). Of 5 reviews that reported subgroup effects, only 3 discussed subgroup effects as part of the overall conclusions; none discussed credibility of subgroup effects. Conclusions: This meta-epidemiological review of a subset of Cochrane AF reviews suggests that planning and reporting of subgroup analyses in AF reviews can be improved to better inform clinical management. Most pre-specified subgroup analyses were not performed, important variables (such as stroke, bleeding risk, and other comorbidities) were rarely examined and credibility of subgroup effects claimed was low. Future reviews should aim to identify important subgroups in their protocols and use recommended approaches to test subgroup effects in order to better support clinical decision-making. © 2019 The Author(s).},
author_keywords={Atrial fibrillation;  Meta-epidemiological review;  Subgroup analyses},
keywords={anticoagulant agent;  anticoagulant agent, age;  atrial fibrillation;  cerebrovascular accident;  chronic kidney failure;  clinical practice;  Cochrane Library;  cross-sectional study;  diabetes mellitus;  heart failure;  heart left ventricle failure;  human;  priority journal;  quality control;  race difference;  randomized controlled trial (topic);  Review;  risk factor;  sex difference;  study design;  systematic review (topic);  transient ischemic attack;  atrial fibrillation;  meta analysis (topic), Anticoagulants;  Atrial Fibrillation;  Epidemiologic Studies;  Humans;  Meta-Analysis as Topic;  Randomized Controlled Trials as Topic},
chemicals_cas={Anticoagulants},
funding_details={National Health and Medical Research CouncilNational Health and Medical Research Council, NHMRC, 1002028},
references={Sackett, D.L., Rosenberg, W.M., Gray, J.A., Haynes, R.B., Richardson, W.S., Evidence based medicine: What it is and what it isn't (1996) BMJ, 312 (7023), pp. 71-72. , 1:STN:280:DyaK287ktF2itw%3D%3D; Deeks, J.J.H.J., Altman, D.J., Chapter 9: Analysing data and undertaking meta-analyses (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, , www.handbook.cochrane.org, [updated March 2011]. The Cochrane Collaboration; Gagnier, J.J., Morgenstern, H., Altman, D.G., Berlin, J., Chang, S., McCulloch, P., Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews (2013) BMC Med Res Methodol, 13, p. 106; Gagnier, J.J., Moher, D., Boon, H., Beyene, J., Bombardier, C., Investigating clinical heterogeneity in systematic reviews: A methodologic review of guidance in the literature (2012) BMC Med Res Methodol, 12, p. 111; Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis (2002) Stat Med, 21 (11), pp. 1539-1558; Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., GRADE guidelines: 7. Rating the quality of evidence - Inconsistency (2011) J Clin Epidemiol, 64 (12), pp. 1294-1302; Thompson, S.G., Higgins, J.P.T., How should meta-regression analyses be undertaken and interpreted? (2002) Stat Med, 21 (11), pp. 1559-1573; Higgins, J., Thompson, S., Deeks, J., Altman, D., Statistical heterogeneity in systematic reviews of clinical trials: A critical appraisal of guidelines and practice (2002) J Health Serv Res Policy, 7 (1), pp. 51-61; Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., GRADE: An emerging consensus on rating quality of evidence and strength of recommendations (2008) BMJ, 336 (7650), pp. 924-926; Sun, X., Ioannidis, J.P.A., Agoritsas, T., Alba, A.C., Guyatt, G., How to Use a Subgroup Analysis (2014) JAMA, 311 (4), p. 405. , 1:CAS:528:DC%2BC2cXitlOru70%3D; Page, M.J., Altman, D.G., McKenzie, J.E., Shamseer, L., Ahmadzai, N., Wolfe, D., Flaws in the application and interpretation of statistical analyses in systematic reviews of therapeutic interventions were common: A cross-sectional analysis (2018) J Clini Epidemiol, 95, pp. 7-18; Donegan, S., Williams, L., Dias, S., Tudur-Smith, C., Welton, N., Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: A review of recent practice (2015) PLoS ONE, 10 (6), p. e0128804; Riley, R.D., Gates, S., Neilson, J., Alfirevic, Z., Statistical methods can be improved within Cochrane pregnancy and childbirth reviews (2011) J Clin Epidemiol, 64 (6), pp. 608-618; Nieuwlaat, R., Capucci, A., Camm, A.J., Olsson, S.B., Andresen, D., Davies, D.W., Atrial fibrillation management: A prospective survey in ESC member countries: The Euro Heart Survey on Atrial Fibrillation (2005) Eur Heart J, 26 (22), pp. 2422-2434; Hart, R.G., Pearce, L.A., McBride, R., Rothbart, R.M., Asinger, R.W., Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators (1999) Stroke, 30 (6), pp. 1223-1229. , 1:STN:280:DyaK1M3osVOguw%3D%3D; Lip, G.Y., Nieuwlaat, R., Pisters, R., Lane, D.A., Crijns, H.J., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation (2010) Chest, 137 (2), pp. 263-272; Wolf, P.A., Abbott, R.D., Kannel, W.B., Atrial fibrillation as an independent risk factor for stroke: The Framingham Study (1991) Stroke, 22 (8), pp. 983-988. , 1:STN:280:DyaK3Mzislektg%3D%3D; Marinigh, R., Lip, G.Y., Fiotti, N., Giansante, C., Lane, D.A., Age as a risk factor for stroke in atrial fibrillation patients: Implications for thromboprophylaxis (2010) J Am Coll Cardiol, 56 (11), pp. 827-837; Agarwal, M., Apostolakis, S., Lane, D.A., Lip, G.Y., The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: A systematic review (2014) Clin Ther, 36 (9), pp. 1135-1144; Lip, G.Y., Banerjee, A., Lagrenade, I., Lane, D.A., Taillandier, S., Fauchier, L., Assessing the risk of bleeding in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation project (2012) Circ Arrhythm Electrophysiol, 5 (5), pp. 941-948; Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017) BMJ, 358, p. j4008; Murad, M.H., Wang, Z., Guidelines for reporting meta-epidemiological methodology research (2017) Evid Based Med, 22 (4), pp. 139-142; Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M., PROSPERO at one year: An evaluation of its utility (2013) Syst Rev, 2, p. 4; Aguilar, M.I., Hart, R., Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (2005) Cochrane Database Syst Rev., p. 3; Aguilar, M.I., Hart, R., Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (2005) Cochrane Database Syst Rev., p. 4; Aguilar, M.I., Hart, R., Pearce, L.A., Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks (2007) Cochrane Database Syst Rev., p. 3; Saxena, R., Koudstaal, P.J., Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack (2004) Cochrane Database Syst Rev., p. 2; Saxena, R., Koudstaal, P.J., Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack (2004) Cochrane Database Syst Rev., p. 4; Kimachi, M., Furukawa, T.A., Kimachi, K., Goto, Y., Fukuma, S., Fukuhara, S., Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease (2017) Cochrane Database Syst Rev., (11); Lafuente-Lafuente, C., Valembois, L., Bergmann, J.F., Belmin, J., Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation (2015) Cochrane Database Syst Rev., (3); Salazar, C.A., Del Aguila, D., Cordova, E.G., Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation (2014) Cochrane Database Syst Rev, (3); Nyong, J., Amit, G., Adler, A.J., Owolabi, O.O., Perel, P., Prieto-Merino, D., Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation (2016) Cochrane Database Syst Rev., (11); Huffman, M.D., Karmali, K.N., Ma, B., Andrei, A.C., Kruse, J., McCarthy, P.M., Concomitant atrial fibrillation surgery for people undergoing cardiac surgery (2016) Cochrane Database Syst Rev., (8); Risom, S.S., Zwisler, A.D., Johansen, P.P., Sibilitz, K.L., Lindschou, J., Gluud, C., Exercise-based cardiac rehabilitation for adults with atrial fibrillation (2017) Cochrane Database Syst Rev., (2); Slot Kmh, B., Berge, E., Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation (2018) Cochrane Database Syst Rev., (3); De, C., Pattison, H.M., Khaing, P.H., Lane, D.A., Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation (2017) Cochrane Database Syst Rev., (4); Chen, H.S., Wen, J.M., Wu, S.N., Liu, J.P., Catheter ablation for paroxysmal and persistent atrial fibrillation (2012) Cochrane Database Syst Rev., p. 4; Heneghan, C.J., Garcia-Alamino, J.M., Spencer, E.A., Ward, A.M., Perera, R., Bankhead, C., Self-monitoring and self-management of oral anticoagulation (2016) Cochrane Database Syst Rev., (7); Moran, P.S., Teljeur, C., Ryan, M., Smith, S.M., Systematic screening for the detection of atrial fibrillation (2016) Cochrane Database Syst Rev., (6); Mead, G.E., Elder, A., Flapan, A.D., Cordina, J., Electrical cardioversion for atrial fibrillation and flutter (2017) Cochrane Database Syst Rev., (11); Bahiru, E., De Cates, A.N., Mrb, F., Jarvis, M.C., Palla, M., Rees, K., Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases (2017) Cochrane Database Syst Rev., (3); Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W., Radford, M.J., Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation (2001) JAMA, 285 (22), pp. 2864-2870. , 1:STN:280:DC%2BD3MzntFKgsQ%3D%3D; Higgins, J.P.T., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., Savovic, J., Sterne, J.A.C., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011) BMJ, 343 (OCT18 2), pp. d5928-d5928; Mbuagbaw, L., Morgano, G.P., Lawson, D.O., Nyambi, A., Youssef, M., Olaiya, O., Subgroup analyses are seldom possible and subgroup effects are rare in Cochrane HIV systematic reviews (2018) J Clin Epidemiol, 104, pp. 143-144; Oxman, A.D., Subgroup analyses (2012) BMJ, 344 (MAR15 1), pp. e2022-e2022; Groenwold, R.H.H., Donders, A.R.T., Van Der Heijden, G.J.M.G., Hoes, A.W., Rovers, M.M., Confounding of subgroup analyses in randomized data (2009) Arch Intern Med, 169 (16), pp. 1532-1534; Higgins, J.P.T., A revised tool for assessing risk of bias in randomized trials (2016) Cochrane Database Syst Rev, (10), p. 2016. , Chandler J, McKenzie J, Boutron I, Welch V (editors); Page, M.J., Shamseer, L., Altman, D.G., Tetzlaff, J., Sampson, M., Tricco, A.C., Epidemiology and reporting characteristics of systematic reviews of biomedical research: A cross-sectional study (2016) PLoS Med, 13 (5), p. e1002028},
correspondence_address1={Paquette, M.; Department of Health Research Methods Evidence, Canada; email: miney.paquette@boehringer-ingelheim.com},
publisher={BioMed Central Ltd.},
issn={20464053},
pubmed_id={31653275},
language={English},
abbrev_source_title={Syst. Rev.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Laaser2016,
author={Laaser, U. and Dorey, S. and Nurse, J.},
title={A plea for global health action bottom-up},
journal={Frontiers in Public Health},
year={2016},
volume={4},
number={OCT},
doi={10.3389/FPUBH.2016.00241},
art_number={241},
note={cited By 7},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015313985&doi=10.3389%2fFPUBH.2016.00241&partnerID=40&md5=84cdadcf33bed81867f0d8996d15ff92},
affiliation={Section of International Public Health (S-IPH), Faculty of Health Sciences, University of Bielefeld, Bielefeld, Germany; Commonwealth Secretariat Health and Education Unit, London, United Kingdom},
abstract={This opinion piece focuses on global health action by hands-on bottom-up practice: initiation of an organizational framework and securing financial efficiency are - however - essential, both clearly a domain of well-trained public health professionals. Examples of action are cited in the four main areas of global threats: planetary climate change, global divides and inequity, global insecurity and violent conflicts, and global instability and financial crises. In conclusion, a stable health systems policy framework would greatly enhance success. However, such organizational framework dries out if not linked to public debates channeling fresh thoughts and controversial proposals: the structural stabilization is essential but has to serve not to dominate bottom-up activities. In other words, a horizontal management is required, a balanced equilibrium between bottom-up initiative and top-down support. Last but not least, rewarding voluntary and charity work by public acknowledgment is essential. © 2016 Laaser, Dorey and Nurse.},
author_keywords={Bottom-up initiatives;  Global health action;  Global threats;  Public health professionals},
references={Laaser, U., A plea for good global governance (2015) Front Public Health, 3, p. 46; Horton, R., (2016) Public Health in the Arab World (PHAW) Listserv Hosted by the Faculty of Health Sciences, , https://lists.aub.edu.lb/wws/arc/phaw/2016-03/msg00051.html, Lebanon: American University of Beirut; Donev, D., Laaser, U., Levett, J., Skopje declaration on public health, peace & human rights, December 2001 (2002) Croat Med J, 43 (2), pp. 105-106; (2016) ASPHER 2020, , http://www.aspher.org/aspher-2020.html; (1998) Die Deutsche Herz-Kreislauf-Praeventionsstudie, , Bern, Switzerland: Hans Huber Publishing Company; Regions for Health Network, , http://www.euro.who.int/en/about-us/networks/regions-for-health-network-rhn; Laaser, U., (2001) Horizontal Health Services Development in the Northrhine-Westphalian Ruhrgebiet of Germany, pp. 58-72. , Japan: WHO Kobe Centre: Cities and Health, Management of Priority Health Issues. WHO; State Health Conference, , http://www.mgepa.nrw.de/gesundheit/landesgesundheitskonferenz/index.php; Jakovljevic, M.B., Resource allocation strategies in Southeastern European health policy (2013) Eur J Health Econ, 14 (2), pp. 153-159; (2015) Transforming Our World: The 2030 Agenda for Sustainable Development, , http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E, Resolution A/RES/70/1 Adopted by the General Assembly on 25 September 2015; Raworth, K., (2012) A Safe and Just Space for Humanity: Can We Live within the Doughnut? Oxfam, , http://policy-practice.oxfam.org.uk/publications/a-safe-and-just-space-for-humanity-can-we-live-within-the-doughnut-210490; Rogers, D.S., Duraiappah, A.K., Antons, D.C., Munoz, P., Bai, X., Fragkias, M., A vision for human well-being: transition to social sustainability (2012) Curr Opin Environ Sustain, 4 (1); (2015) Climate Change and Health Policy, , http://www.wfpha.org/images/news/WFPHA-Global-Climate-Health-Policy-Survey.FINAL.pdf, The Survey Report Coordinated by the Climate and Health Alliance, Australia; Lueddeke, G., (2014) Towards an Integrative Post-2015 Sustainable Development Goal Framework: Focusing on Global Justice-Peace, Security and Basic Human Rights, , http://www.seejph.com/index.php/seejph/article/view/42/36; Piketty, T., (2014) Capital in the Twenty-First Century, , Cambridge, MA: Harvard University Press; Churchman, C.W., Guest editorial: wicked problems (1967) Manage Sci, 14 (4), pp. B141-B142; www.spendenparlament.de; Laaser, U., Bjegovic-Mikanovic, V., Lueddeke, G., Chapter 10: together with the members of the Think Tank on Global Health. Epilogue: Global Health, Governance, and Education (2015) Global Population Health and Well-Being in the 21st Century-Towards New Paradigms, Policy, and Practice, , Lueddeke G, editor. New York: Springer; Rose, G., Day, S., The population mean predicts the number of deviant individuals (1990) BMJ, 301, pp. 1031-1034; Laaser, U., Donev, D., Bjegovic, V., Sarolli, Y., Public health and peace (2002) Croat Med J, 43 (2), pp. 107-113; (2016) Genocide, , https://en.wikipedia.org/wiki/Genocide#Stages_of_genocide.2C_influences_leading_to_genocide.2C_and_efforts_to_prevent_it; Pankau, J.G., (1997) Rhetorik im Nationalsozialismus (Rhetorics in Nationalsocialism), , Tuebingen: Niemeyer; Laaser, U., Epstein, L., Threats to global health and opportunities for change: a new global health (2010) Public Health Rev, 32 (1), pp. 54-89; Vassall, A., Shotton, J., Klein-Reshetnyk, O., Hasanaj-Goossens, L., Weil, O., Vohra, J., Andre: tracking aid flows for Development Assistance for Health (2014) Glob Health Action, 7, p. 23510; Bjegovic-Mikanovic, V., Jovic-Vranes, A., Czabanowska, K., Otok, R., Education for public health in Europe and its global outreach (2014) Glob Health Action, 7; (2016) A Health Systems Policy Framework for the Commonwealth to Support the Sustainable Delivery of Universal Health Coverage (UHC), , London, UK: Commonwealth Secretariat, Health and Education Unit; Laaser, U., Schröder-Bäck, P., Towards a code of conduct for the European public health profession! (2016) SEEJPH, p. 5},
correspondence_address1={Laaser, U.; Section of International Public Health (S-IPH), Germany; email: ulrich.laaser@uni-bielefeld.de},
publisher={Frontiers Media S. A},
issn={22962565},
language={English},
abbrev_source_title={Front. Public Health},
document_type={Article},
source={Scopus},
}

@ARTICLE{Baron2015658,
author={Baron, R. and Ferriero, D.M. and Frisoni, G.B. and Bettegowda, C. and Gokaslan, Z.L. and Kessler, J.A. and Vezzani, A. and Waxman, S.G. and Jarius, S. and Wildemann, B. and Weller, M.},
title={Neurology - The next 10 years},
journal={Nature Reviews Neurology},
year={2015},
volume={11},
number={11},
pages={658-664},
doi={10.1038/nrneurol.2015.196},
note={cited By 7},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947043563&doi=10.1038%2fnrneurol.2015.196&partnerID=40&md5=3cae8bcace9efddc618b3636930965e3},
affiliation={Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, Kiel, 24105, Germany; Department of Pediatrics, University of California, 550 16th Street, San Francisco, CA  94158-2549, United States; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Chemin du Petit Bel-Air 2 (Bâtiment Voirons), Chêne-Bourg, Genève, CH-1225, Switzerland; Johns Hopkins University School of Medicine, Department of Neurosurgery, 600 North Wolfe Street, Baltimore, MD  21287, United States; Rhode Island Hospital, Department of Neurosurgery, Norman Prince Neurosciences Institute, 593 Eddy Street, Providence, RI  02903, United States; Department of Neurology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL  60611, United States; Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, Milan, 20156, Italy; Department of Neurology, Yale University School of Medicine, PO Box 208018, New Haven, CT  06520, United States; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg, 69120, Germany; Department of Neurology, University Hospital, University of Zurich, Frauenklinikstrasse 26, Zurich, 8091, Switzerland},
abstract={Since the launch of our journal as Nature Clinical Practice Neurology in 2005, we have seen remarkable progress in many areas of neurology research, but what does the future hold? Will advances in basic research be translated into effective disease-modifying therapies, and will personalized medicine finally become a reality? For this special Viewpoint article, we invited a panel of Advisory Board members and other journal contributors to outline their research priorities and predictions in neurology for the next 10 years.},
keywords={Alzheimer disease;  analgesia;  autoimmune disease;  basic research;  channelopathy;  epilepsy;  human;  measurement precision;  medical education;  medical research;  neurology;  nociception;  oncology;  pain;  pain intensity;  patient care;  personalized medicine;  prediction;  priority journal;  Review;  Alzheimer disease;  animal;  Central Nervous System Neoplasms;  Channelopathies;  child;  Demyelinating Autoimmune Diseases, CNS;  epilepsy;  forecasting;  genetics;  metabolism;  nerve regeneration;  neurology;  pathology;  pathophysiology;  pediatrics;  physiology;  trends, autoantibody, Alzheimer Disease;  Animals;  Autoantibodies;  Central Nervous System Neoplasms;  Channelopathies;  Child;  Demyelinating Autoimmune Diseases, CNS;  Epilepsy;  Forecasting;  Humans;  Nerve Regeneration;  Neurology;  Pediatrics},
chemicals_cas={Autoantibodies},
references={Baron, R., Förster, M., Binder, A., Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: A first step to a stratified treatment approach (2012) Lancet Neurol., 11, pp. 999-1005; Demant, D.T., The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study (2014) Pain, 155, pp. 2263-2273; Mainka, T., Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain Eur. J. Pain, , http//dx.doi.org/10.1002/ejp.703; Jacobs, S.E., Cooling for newborns with hypoxic ischaemic encephalopathy Cochrane Database of Systematic Reviews, 1. , http//dx.doi.org/10.1002/14651858.CD003311.pub3; Benders, M.J., Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke (2014) J. Pediatr, 164, pp. 481-486e2; Donega, V., Van Velthoven, C.T., Nijboer, C.H., Kavelaars, A., Heijnen, C.J., The endogenous regenerative capacity of the damaged newborn brain: Boosting neurogenesis with mesenchymal stem cell treatment (2013) J. Cereb. Blood Flow Metab, 33, pp. 625-634; Phinney, D.G., Isakova, I.A., Mesenchymal stem cells as cellular vectors for pediatric neurological disorders (2014) Brain Res., 1573, pp. 92-107; McMichael, G., Rare copy number variation in cerebral palsy (2014) Eur. J. Hum. Genet, 22, pp. 40-45; Oskoui, M., Clinically relevant copy number variations detected in cerebral palsy (2015) Nat Commun, 6, p. 7949; De novo mutations in epileptic encephalopathies (2013) Nature, 501, pp. 217-221. , Epi4K Consortium & Epilepsy Phenome/Genome Project; Ceyhan-Birsoy, O., Whole exome sequencing reveals DYSF, FKTN, and ISPD mutations in congenital muscular dystrophy without brain or eye involvement (2015) J. Neuromuscul. Dis., 2, pp. 87-92; Soden, S.E., Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders (2014) Sci. Transl. Med., 6, p. 265ra168; Iossifov, I., The contribution of de novo coding mutations to autism spectrum disorder (2014) Nature, 515, pp. 216-221; Orgogozo, J.M., Subacute meningoencephalitis in a subset of patients with AD after A?42 immunization (2003) Neurology, 61, pp. 46-54; Frisoni, G.B., Fox, N.C., Jack, C.R., Jr., Scheltens, P., Thompson, P.M., The clinical use of structural MRI in Alzheimer disease (2010) Nat. Rev. Neurol., 6, pp. 67-77; Johnson, K.A., Appropriate use criteria for amyloid pet: A report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the Alzheimer's association (2013) Alzheimers Dement, 9, pp. E1-E16; Liu-Seifert, H., Start analyses of up to 3.5 years in the phase,3 solanezumab expedition program in mild Alzheimer's disease [poster p07.108] (2015) Presented at the Alzheimer's Association International Conference; Sevigny, J., Aducanumab (BIIB037), an anti-amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double-blind, placebo-controlled, phase 1b study (2015) Presented in Emerging Science Session 001 at the Alzheimer's Association International Conference; Sperling, R.A., The A4 study: Stopping AD before symptoms begin (2014) Sci. Transl. Med, 19, pp. 228-313; Thambisetty, M., Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease (2010) Arch.Gen. Psychiatry, 67, pp. 739-748; Mapstone, M., Plasma phospholipids identify antecedent memory impairment in older adults (2014) Nat. Med, 20, pp. 415-418; Ray, S., Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (2007) Nat. Med., 13, pp. 1359-1362; Ngandu, T., A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial (2015) Lancet, 385, pp. 2255-2263; Lakka, T.A., Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction (1994) N. Engl. J. Med., 330, pp. 1549-1554; Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas (2015) N. Engl. J. Med., 372, pp. 2481-2498. , The Cancer Genome Atlas Research Network; Gajjar, A., Pfister, S.M., Taylor, M.D., Gilbertson, R.J., Molecular insights into pediatric brain tumors have the potential to transform therapy (2014) Clin. Cancer Res., 20, pp. 5630-5640; Hyman, D.M., Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations (2015) N. Engl. J. Med., 373, pp. 726-736; Doudna, J.A., Charpentier, E., The new frontier of genome engineering with CRISPR-Cas9 (2014) Science, 346, p. 1258096. , Genome editing; Gupta, R.M., Musunuru, K., Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9 (2014) J Clin Invest, 124, pp. 4154-4161; Steinbeck, J.A., Studer, L., Moving stem cells to the clinic: Potential and limitations for brain repair (2015) Neuron, 86, pp. 187-206; (2015) ClinicalTrials.gov, , https//clinicaltrials.gov/, US National Library of Medicine; Yin, H., Non-viral vectors for gene-based therapy (2014) Nat. Rev. Genet, 15, pp. 541-555; Kay, M.A., State-of-the-art gene-based therapies: The road ahead (2011) Nat. Rev. Genet, 12, pp. 316-328; (2015), https//www.gemcris.od.nih.gov, GeMCRIS; Tam, R.Y., Fuehrmann, T., Mitrousis, N., Shoichet, M.S., Regenerative therapies for central nervous system diseases: A biomaterials approach (2014) Neuropsychopharmacology, 39, pp. 169-188; Srikanth, M., Kessler, J.A., Nanotechnology in the development of novel CNS therapeutics (2012) Nat.Rev. Neurol., 8, pp. 307-318; Haussecker, D., Kay, M.A., RNA interference,drugging RNAI (2015) Science, 347, pp. 1069-1070; Pitkänen, A., Lukasiuk, K., Mechanisms of epileptogenesis and potential treatment targets (2011) Lancet Neurol., 10, pp. 173-186; Vezzani, A., Anti-inflammatory drugs in epilepsy: Does it impact epileptogenesis (2015) Expert Opin.Drug Saf., 14, pp. 583-592; Perucca, E., French, J., Bialer, M., Development of new antiepileptic drugs: Challenges, incentives, and recent advances (2007) Lancet Neurol., 6, pp. 793-804; Kwan, P., Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ilae commission on therapeutic strategies (2010) Epilepsia, 51, pp. 1069-1077; Pitkänen, A., Engel, J., Jr., Past and present definitions of epileptogenesis and its biomarkers (2014) Neurotherapeutics, 11, pp. 231-241; Vezzani, A., Friedman, A., Brain inflammation as a biomarker in epilepsy (2011) Biomark. Med., 5, pp. 607-614; Brooks-Kayal, A.R., Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy (2013) Epilepsia, 54, pp. 44-60; Simonato, M., The challenge and promise of anti-epileptic therapy development in animal models (2014) Lancet Neurol., 13, pp. 949-960; Grone, B.P., Baraban, S.C., Animal models in epilepsy research: Legacies and new directions (2015) Nat. Neurosci., 18, pp. 339-343; Parent, J.M., Anderson, S.A., Reprogramming patient-derived cells to study the epilepsies (2015) Nat. Neurosci., 18, pp. 360-366; Ritter, L.M., WONOEP appraisal: Optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis (2014) Epilepsia, 55, pp. 1693-1702; Gadhoumi, K., Lina, J.M., Mormann, F., Gotman, J., Seizure prediction for therapeutic devices: A review J. Neurosci. Methods, , http//dx.doi.org/10.1016/j.jneumeth.2015.06.010; Ludvig, N., Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: The subdural hybrid neuroprosthesis (2010) Epilepsy Res. Treat, 2010, p. 725696; Shultz, S.R., O'Brien, T.J., Stefanidou, M., Kuzniecky, R.I., Neuroimaging the epileptogenic process (2014) Neurotherapeutics, 11, pp. 347-357; Rossignol, E., WONOEP appraisal: New genetic approaches to study epilepsy (2014) Epilepsia, 55, pp. 1170-1186; Loeb, J.A., Identifying targets for preventing epilepsy using systems biology (2011) Neurosci. Lett., 497, pp. 205-212; Steinlein, O.K., Mechanisms underlying epilepsies associated with sodium channel mutations (2014) Prog. Brain Res., 213, pp. 97-111; Catterall, W.A., Sodium channels, inherited epilepsy, and antiepileptic drugs (2014) Annu. Rev. Pharmacol. Toxicol., 54, pp. 317-338; Kahlig, K.M., Divergent sodium channel defects in familial hemiplegic migraine (2008) Proc. Natl Acad. Sci. USA, 105, pp. 9799-9804; Veeramah, K.R., De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP (2012) Am. J. Hum. Genet, 90, pp. 502-510; Faber, C.G., Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy (2012) Ann. Neurol., 71, pp. 26-39; Dib-Hajj, S.D., Yang, Y., Black, J.A., Waxman, S.G., The NaV1.7 sodium channel: From molecule to man (2013) Nat. Rev. Neurosci., 14, pp. 49-62; Zuliani, V., Rapalli, A., Patel, M.K., Rivara, M., Sodium channel blockers: A patent review (2010-2014) (2015) Expert Opin. Ther. Pat., 25, pp. 279-290; Yang, Y., Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1 (2012) 7 Mutant Channel. Nat. Commun., 3, p. 1186; Black, J.A., Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis (2000) Proc. Natl Acad. Sci. USA, 97, pp. 11598-11602; Shields, S.D., A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis (2012) Ann.Neurol., 71, pp. 186-194; Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S., Hinson, S.R., IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel (2005) J. Exp. Med., 202, pp. 473-477; Dalmau, J., Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma (2007) Ann. Neurol., 61, pp. 25-36; Jarius, S., Mechanisms of disease: Aquaporin-4 antibodies in neuromyelitis optica (2008) Nat. Clin. Pract. Neurol., 4, pp. 202-214; Jarius, S., Wildemann, B., AQP4 antibodies in neuromyelitis optica: Diagnostic and pathogenetic relevance (2010) Nat. Rev. Neurol., 6, pp. 383-392; Jarius, S., Wildemann, B., Medusa-head ataxia': The expanding spectrum of purkinje cell antibodies in autoimmune cerebellar ataxia.part 1: Anti-mglur1, anti-homer-3, anti-sj/itpr1, anti-carp VIII (2015) J. Neuroinflammation, 12, p. 166; Jarius, S., Wildemann, B., Medusa-head ataxia': The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia.Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC (2015) J. Neuroinflammation, 12, p. 167; Jarius, S., Wildemann, B., Medusa-head ataxia': The expanding spectrum of purkinje cell antibodies in autoimmune cerebellar ataxia.part 3: Anti-yo/cdr2, anti-nb/ap3b2, PCA-2, anti-tr/dner, other antibodies, diagnostic pitfalls, summary and outlook (2015) J. Neuroinflammation, 12, p. 168; Reindl, M., Di Pauli, F., Rostasy, K., Berger, T., The spectrum of MOG autoantibody-associated demyelinating diseases (2013) Nat. Rev. Neurol., 9, pp. 455-461; Jarius, S., Wildemann, B., Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: A critical review of the literature (2013) Brain Pathol., 23, pp. 661-683; Kalia, L.V., Lang, A.E., Parkinson's disease (2015) Lancet, 386, pp. 896-912; Dendrou, C.A., Fugger, L., Friese, M.A., Immunopathology of multiple sclerosis (2015) Nat. Rev. Immunol., 15, pp. 545-558; Pollock, A., Baer, G., Campbell, P., Choo, P.L., Forster, A., Morris, J., Pomeroy, V.M., Langhorne, P., Physical rehabilitation approaches for the recovery of function and mobility following stroke Cochrane Database of Systematic Reviews, 4. , http//dx.doi.org/10.1002/14651858.CD001920.pub3; Prabhakaran, S., Ruff, I., Bernstein, R.A., Acute stroke intervention. A systematic review (2015) JAMA, 313, pp. 1451-1462; Bettens, K., Sleegers, K., Van Broeckhoven, C., Genetic insights in Alzheimer's disease (2013) Lancet Neurol., 12, pp. 92-104; Weller, M., (2015) Glioma.Nat. Rev. Dis. Primers, 1, p. 15017. , http//dx.doi.org/10.1038/nrdp.2015.17},
publisher={Nature Publishing Group},
issn={17594758},
pubmed_id={26503922},
language={English},
abbrev_source_title={Nat. Rev. Neurol.},
document_type={Review},
source={Scopus},
}

@ARTICLE{Mentis2015357,
author={Mentis, A.-F.A.},
title={To What Extent Are Greek Children Exposed to the Risk of a Lifelong, Intergenerationally Transmitted Poverty?},
journal={Poverty & Public Policy},
year={2015},
volume={7},
number={4},
pages={357-381},
note={cited By 7},
source={Scopus},
}

@ARTICLE{Zhang20204823,
author={Zhang, X. and Gill, D. and He, Y. and Yang, T. and Li, X. and Monori, G. and Campbell, H. and Dunlop, M. and Tsilidis, K.K. and Timofeeva, M. and Theodoratou, E.},
title={Non-genetic biomarkers and colorectal cancer risk: Umbrella review and evidence triangulation},
journal={Cancer Medicine},
year={2020},
volume={9},
number={13},
pages={4823-4835},
doi={10.1002/cam4.3051},
note={cited By 6},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084481699&doi=10.1002%2fcam4.3051&partnerID=40&md5=75091614c0f8726c9fd70a6173c82832},
affiliation={Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Danish Institute for Advanced Study, Department of Public Health, University of Southern Denmark, Odense C, Denmark},
abstract={Several associations between non-genetic biomarkers and colorectal cancer (CRC) risk have been detected, but the strength of evidence and the direction of associations are not confirmed. We aimed to evaluate the evidence of these associations and integrate results from different approaches to assess causal inference. We searched Medline and Embase for meta-analyses of observational studies, meta-analyses of randomized clinical trials (RCTs), and Mendelian randomization (MR) studies measuring the associations between non-genetic biomarkers and CRC risk and meta-analyses of RCTs on supplementary micronutrients. We repeated the meta-analyses using random-effects models and categorized the evidence based on predefined criteria. We described each MR study and evaluated their credibility. Seventy-two meta-analyses of observational studies and 18 MR studies on non-genetic biomarkers and six meta-analyses of RCTs on micronutrient intake and CRC risk considering 65, 42, and five unique associations, respectively, were identified. No meta-analyses of RCTs on blood level biomarkers have been found. None of the associations were classified as convincing or highly suggestive, three were classified as suggestive, and 26 were classified as weak. For three biomarkers explored in MR studies, there was evidence of causality and seven were classified as likely noncausal. For the first time, results from both observational and MR studies were integrated by triangulating the evidence for a wide variety of non-genetic biomarkers and CRC risk. At blood level, lower vitamin D, higher homeostatic model assessment-insulin resistance, and human papillomavirus infection were associated with higher CRC risk while increased linoleic acid and oleic acid and decreased arachidonic acid were likely causally associated with lower CRC risk. No association was found convincing in both study types. © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.},
author_keywords={biomarkers;  cancer risk factors;  colorectal cancer;  epidemiology and prevention},
keywords={antiinfective agent;  arachidonic acid;  biological marker;  C peptide;  C reactive protein;  connective tissue growth factor;  ferritin;  folic acid;  glucose;  hemoglobin;  high density lipoprotein cholesterol;  insulin;  interleukin 6;  leptin;  linoleic acid;  low density lipoprotein cholesterol;  oleic acid;  pyridoxine;  riboflavin;  selenium;  somatomedin C receptor;  toll like receptor 4;  triacylglycerol;  zinc;  arachidonic acid;  linoleic acid;  oleic acid;  trace element;  tumor marker;  vitamin D, Article;  blood group;  cancer risk;  cancer staging;  colorectal cancer;  disease association;  homeostasis model assessment;  human;  insulin resistance;  micronutrient intake;  observational study;  papillomavirus infection;  priority journal;  triangulation;  vitamin blood level;  blood;  colorectal tumor;  complication;  Helicobacter infection;  Helicobacter pylori;  Mendelian randomization analysis;  meta analysis (topic);  randomized controlled trial (topic);  risk;  virology, Arachidonic Acid;  Biomarkers, Tumor;  Colorectal Neoplasms;  Helicobacter Infections;  Helicobacter pylori;  Humans;  Insulin Resistance;  Linoleic Acid;  Mendelian Randomization Analysis;  Meta-Analysis as Topic;  Micronutrients;  Observational Studies as Topic;  Oleic Acid;  Papillomavirus Infections;  Randomized Controlled Trials as Topic;  Risk;  Vitamin D},
chemicals_cas={arachidonic acid, 506-32-1, 6610-25-9, 7771-44-0; C peptide, 59112-80-0; C reactive protein, 9007-41-4; ferritin, 9007-73-2; folic acid, 59-30-3, 6484-89-5; glucose, 50-99-7, 84778-64-3; hemoglobin, 9008-02-0; insulin, 9004-10-8; linoleic acid, 1509-85-9, 2197-37-7, 60-33-3, 822-17-3; oleic acid, 112-80-1, 115-06-0; pyridoxine, 12001-77-3, 58-56-0, 65-23-6, 8059-24-3; riboflavin, 83-88-5; selenium, 7782-49-2; toll like receptor 4, 203811-83-0; zinc, 7440-66-6, 14378-32-6; Arachidonic Acid; Biomarkers, Tumor; Linoleic Acid; Micronutrients; Oleic Acid; Vitamin D},
funding_details={Cancer Research UKCancer Research UK, CRUK, C31250/A22804},
funding_details={University of EdinburghUniversity of Edinburgh},
funding_text 1={This work was supported by The Darwin Trust of Edinburgh which is a PhD studentship for XZ and Cancer Research UK which is a career development fellowship for ET [C31250/A22804]. We would like to express our gratitude to the support from Edinburgh CRUK Cancer Research Centre as well as support from all trustees of the Darwin Trust of Edinburgh. We would like to thank Dr Areti Angeliki Veroniki for her assistance with the selection of the analysis methods of between-study variance in meta-analysis. We would like to thank Marshall Dozier for her assistance with the refinement of the search strategy. We would like to thank all the library staffs from The University of Edinburgh for their assistance with the article searching. Finally, we would like to thank the editors and reviewers for their comments that greatly improved the manuscript.},
funding_text 2={This work was supported by The Darwin Trust of Edinburgh which is a PhD studentship for XZ and Cancer Research UK which is a career development fellowship for ET [C31250/A22804].},
funding_text 3={We would like to express our gratitude to the support from Edinburgh CRUK Cancer Research Centre as well as support from all trustees of the Darwin Trust of Edinburgh. We would like to thank Dr Areti Angeliki Veroniki for her assistance with the selection of the analysis methods of between‐study variance in meta‐analysis. We would like to thank Marshall Dozier for her assistance with the refinement of the search strategy. We would like to thank all the library staffs from The University of Edinburgh for their assistance with the article searching. Finally, we would like to thank the editors and reviewers for their comments that greatly improved the manuscript.},
references={Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2018) CA Cancer J Clin, 68, pp. 394-424; Arnold, M., Sierra, M.S., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F., Global patterns and trends in colorectal cancer incidence and mortality (2017) Gut, 66, pp. 683-691; Siegel, R.L., Torre, L.A., Soerjomataram, I., Global patterns and trends in colorectal cancer incidence in young adults (2019) Gut, 68, pp. 2179-2185; Maffei, F., Angelini, S., Cantelli Forti, G., Hrelia, P., Blood biomarkers linked to oxidative stress and chronic inflammation for risk assessment of colorectal neoplasia (2013) Curr Colorectal Cancer Rep, 9, pp. 85-94; Kuipers, E.J., Grady, W.M., Lieberman, D., Colorectal cancer (2015) Nat Rev Dis Primers, 1, p. 15065; Ma, X., Zhang, B., Zheng, W., Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence (2014) Gut, 63, pp. 326-336; Montazeri, Z., Li, X., Nyiraneza, C., Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer (2019) Gut, pp. gutjnl-2019. , http://dx.doi.org/10.1136/gutjnl-2019-319313; Law, P.J., Timofeeva, M., Fernandez-Rozadilla, C., Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) Nat Commun, 10, p. 2154; Huyghe, J.R., Bien, S.A., Harrison, T.A., Discovery of common and rare genetic risk variants for colorectal cancer (2019) Nat Genet, 51, pp. 76-87; Tsilidis, K.K., Papatheodorou, S.I., Evangelou, E., Ioannidis, J.P., Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk (2012) J Natl Cancer Inst, 104, pp. 1867-1878; Cornell, J.E., Mulrow, C.D., Localio, R., Random-effects meta-analysis of inconsistent effects: a time for change (2014) Ann Intern Med, 160, pp. 267-270; IntHout, J., Ioannidis, J.P., Borm, G.F., The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method (2014) BMC Med Res Methodol, 14, p. 25; Veroniki, A.A., Jackson, D., Viechtbauer, W., Methods to estimate the between-study variance and its uncertainty in meta-analysis (2016) Res Synth Methods, 7, pp. 55-79; DerSimonian, R., Laird, N., Meta-analysis in clinical trials (1986) Control Clin Trials, 7, pp. 177-188; Paule, R.C., Mandel, J., Consensus values, regressions, and weighting factors (1989) J Res Natl Inst Stand Technol, 94, pp. 197-203; Higgins, J.P., Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified (2008) Int J Epidemiol, 37, pp. 1158-1160; Higgins, J.P., Thompson, S.G., Spiegelhalter, D.J., A re-evaluation of random-effects meta-analysis (2009) J R Stat Soc Ser A Stat Soc, 172, pp. 137-159; Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test (1997) BMJ, 315, pp. 629-634; Ioannidis, J.P., Excess significance bias in the literature on brain volume abnormalities (2011) Arch Gen Psychiatry, 68, pp. 773-780; Viechtbauer, W., Conducting meta-analyses in R with the metafor package (2010) J Stat Softw, 36, pp. 1-48; Abbasi, A., Sahlqvist, A.-S., Lotta, L., A systematic review of biomarkers and risk of incident type 2 diabetes: an overview of epidemiological, prediction and aetiological research literature (2016) PLoS ONE, 11; Munafò, M.R., Smith, G.D., Robust research needs many lines of evidence (2018) Nature, 553 (7689), pp. 399-401. , https://doi.org/10.1038/d41586-018-01023-3; Giannakou, K., Evangelou, E., Papatheodorou, S.I., Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies (2018) Ultrasound Obstet Gynecol, 51, pp. 720-730; Theodoratou, E., Palmer, T., Zgaga, L., Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis (2012) PLoS ONE, 7; He, Y., Timofeeva, M., Farrington, S.M., Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study (2018) BMC Med, 16, p. 142; Dou, R., Ng, K., Giovannucci, E.L., Manson, J.E., Qian, Z.R., Ogino, S., Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence (2016) Br J Nutr, 115, pp. 1643-1660; Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Ntzani, E.E., Ioannidis, J.P., Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies (2015) BMJ, 350, p. g7607; Sciacca, L., Vigneri, R., Tumminia, A., Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients (2013) Nutr Metab Cardiovasc Dis, 23, pp. 808-815; Du, X., Stockklauser-Färber, K., Rösen, P., Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? (1999) Free Radic Biol Med, 27, pp. 752-763; Esposito, K., Nappo, F., Marfella, R., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress (2002) Circulation, 106, pp. 2067-2072; Terzić, J., Grivennikov, S., Karin, E., Karin, M., Inflammation and colon cancer (2010) Gastroenterology, 138 (2101-14); Liu, F., Yan, L., Wang, Z., Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis (2017) Oncotarget, 8, pp. 16017-16026; Bzhalava, D., Guan, P., Franceschi, S., Dillner, J., Clifford, G., A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types (2013) Virology, 445, pp. 224-231; Human papillomaviruses (2007) IARC Monogr Eval Carcinog Risks Hum, 90, pp. 1-636. , https://monographs.iarc.fr/wpcontent/uploads/2018/06/mono90.pdf, Accessed November 13, 2019; Cheng, J., Sheu, L., Meng, C., Lee, W., Lin, J., Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction (1995) Gut, 37, pp. 87-90; Salepci, T., Yazici, H., Dane, F., Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients (2009) J BUON, 14, pp. 495-499; Damin, D.D.C., Caetano, M.B., Rosito, M.A., Evidence for an association of human papillomavirus infection and colorectal cancer (2007) Eur J Surg Oncol, 33, pp. 569-574; Lorenzon, L., Mazzetta, F., Pilozzi, E., French DJWJoGW. Human papillomavirus does not have a causal role in colorectal carcinogenesis (2015) World J Gastroenterol, 21, p. 342; Dommels, Y.E., Alink, G.M., van Bladeren, P.J., van Ommen, B., Dietary n-6 and n-3 polyunsaturated fatty acids and colorectal carcinogenesis: results from cultured colon cells, animal models and human studies (2002) Environ Toxicol Pharmacol, 11, pp. 297-308; Manson, J.E., Cook, N.R., Lee, I.-M., Marine n−3 fatty acids and prevention of cardiovascular disease and cancer (2019) N Engl J Med, 380, pp. 23-32; Watson, H., Mitra, S., Croden, F.C., A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota (2018) Gut, 67, pp. 1974-1983; Cathcart, M.-C., Lysaght, J., Pidgeon, G.P., Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention (2011) Cancer Metastasis Rev, 30, pp. 363-385; Borzì, A.M., Biondi, A., Basile, F., Luca, S., Vicari, E.S.D., Vacante, M., Olive oil effects on colorectal cancer (2019) Nutrients, 11, p. 32; Jones, P., Cade, J.E., Evans, C.E., Hancock, N., Greenwood, D.C., The Mediterranean diet and risk of colorectal cancer in the UK Women’s Cohort Study (2017) Int J Epidemiol, 46, pp. 1786-1796; Lawlor, D.A., Tilling, K., Davey, S.G., Triangulation in aetiological epidemiology (2016) Int J Epidemiol, 45, pp. 1866-1886; He, Y., Li, X., Gasevic, D., Statins and multiple noncardiovascular outcomes: umbrella review of meta-analyses of observational studies and randomized controlled trials (2018) Ann Intern Med, 169, pp. 543-553; Li, X., Meng, X., Timofeeva, M., Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies (2017) BMJ, 357, p. j2376; Theodoratou, E., Tzoulaki, I., Zgaga, L., Ioannidis, J.P., Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) BMJ, 348, p. g2035; Yang, T., Li, X., Montazeri, Z., Gene–environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies (2018) Int J Cancer, 145, pp. 2315-2329; Mori, N., Sawada, N., Iwasaki, M., Circulating sex hormone levels and colorectal cancer risk in Japanese postmenopausal women: The JPHC nested case-control study (2019) Int J Cancer, 145, pp. 1238-1244; Chen, H., Chen, X.Z., Waterboer, T., Castro, F.A., Brenner, H., Viral infections and colorectal cancer: a systematic review of epidemiological studies (2015) Int J Cancer, 137, pp. 12-24; Murphy, N., Ward, H.A., Jenab, M., Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study (2019) Clin Gastroenterol Hepatol, 17, pp. 1323-1331; Lu, W., Huang, Z., Li, N., Liu, H., Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis (2018) Onco Targets Ther, 11, pp. 2519-2531; Lo, C.K.-L., Mertz, D., Loeb, M., Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments (2014) BMC Med Res Methodol, 14, p. 45},
correspondence_address1={Theodoratou, E.; Centre for Global Health, United Kingdom; email: e.theodoratou@ed.ac.uk},
publisher={Blackwell Publishing Ltd},
issn={20457634},
pubmed_id={32400092},
language={English},
abbrev_source_title={Cancer Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Rasooly20191563,
author={Rasooly, D. and Ioannidis, J.P.A. and Khoury, M.J. and Patel, C.J.},
title={Family History-Wide Association Study to Identify Clinical and Environmental Risk Factors for Common Chronic Diseases},
journal={American Journal of Epidemiology},
year={2019},
volume={188},
number={8},
pages={1563-1568},
doi={10.1093/aje/kwz125},
note={cited By 6},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072687346&doi=10.1093%2faje%2fkwz125&partnerID=40&md5=68aaca22433eeb5e1a882d4e4883860f},
affiliation={Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA  02115, United States; Meta-Research Innovation Center, Stanford, United States; Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA, United States},
abstract={Family history is a strong risk factor for many common chronic diseases and summarizes shared environmental and genetic risk, but how this increased risk is mediated is unknown. We developed a "family history-wide association study" (FamWAS) to systematically and comprehensively test clinical and environmental quantitative traits (CEQTs) for their association with family history of disease. We implemented our method on 457 CEQTs for association with family history of diabetes, asthma, and coronary heart disease (CHD) in 42,940 adults spanning 8 waves of the 1999-2014 US National Health and Nutrition Examination Survey. We conducted pooled analyses of the 8 survey waves and analyzed trait associations using survey-weighted logistic regression. We identified 172 (37.6% of total), 32 (7.0%), and 78 (17.1%) CEQTs associated with family history of diabetes, asthma, and CHD, respectively, in subcohorts of individuals without the respective disease. Twenty associated CEQTs were shared across family history of diabetes, asthma, and CHD, far more than expected by chance. FamWAS can examine traits not previously studied in association with family history and uncover trait overlap, highlighting a putative shared mechanism by which family history influences disease risk. © 2019 The Author(s). Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.},
author_keywords={chronic disease;  family history;  family history-wide association study;  NHANES},
keywords={asthma;  cardiovascular disease;  diabetes;  health risk;  health survey;  public health;  risk factor, adult;  Article;  asthma;  chronic disease;  clinical evaluation;  clinical feature;  cohort analysis;  cross-sectional study;  diabetes mellitus;  disease association;  disease risk assessment;  environmental factor;  family history;  female;  genetic association;  genetic risk;  genotype;  human;  ischemic heart disease;  major clinical study;  male;  middle aged;  nutritional assessment;  public health;  quantitative trait;  risk factor;  chronic disease;  coronary artery disease;  genetic predisposition;  genetics;  nutrition;  phenotype;  risk factor;  United States, United States, Adult;  Asthma;  Chronic Disease;  Coronary Disease;  Cross-Sectional Studies;  Diabetes Mellitus;  Female;  Genetic Predisposition to Disease;  Humans;  Male;  Middle Aged;  Nutrition Surveys;  Phenotype;  Risk Factors;  United States},
funding_details={National Science FoundationNational Science Foundation, NSF, DGE1745303},
funding_details={National Institute of Allergy and Infectious DiseasesNational Institute of Allergy and Infectious Diseases, NIAID, R01AI127250},
funding_details={National Institute of Environmental Health SciencesNational Institute of Environmental Health Sciences, NIEHS, R00ES023504, R21ES025052},
funding_text 1={This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program (grant DGE1745303).},
references={Denny, J.C., Ritchie, M.D., Basford, M.A., PheWAS: Demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations (2010) Bioinformatics., 26 (9), pp. 1205-1210; Visscher, P.M., Wray, N.R., Zhang, Q., 10 years of GWAS discovery: Biology, function, and translation (2017) Am J Hum Genet., 101 (1), pp. 5-22; National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2014, , https://www.cdc.gov/nchs/nhanes/, Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS). Updated January 7, 2019. Accessed February 12, 2019; Diagnosis and classification of diabetes mellitus (2011) Diabetes Care., 34, pp. S62-S69. , American Diabetes Association; Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2017 Report: GOLD executive summary (2017) Am J Respir Crit Care Med., 195 (5), pp. 557-582; Lumley, T., Analysis of complex survey samples (2004) J Stat Softw., 9 (1), pp. 1-19; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing (1995) J R Stat Soc Series B Stat Methodol., 57 (1), pp. 289-300; Viechtbauer, W., Conducting meta-analyses in R with the metafor package (2010) J Stat Softw., 36 (3), pp. 1-48; Meigs, J.B., Cupples, L.A., Wilson, P.W., Parental transmission of type 2 diabetes: The Framingham Offspring Study (2000) Diabetes., 49 (12), pp. 2201-2207; Harrison, T.A., Hindorff, L.A., Kim, H., Family history of diabetes as a potential public health tool (2003) Am J Prev Med., 24 (2), pp. 152-159; Hariri, S., Yoon, P.W., Qureshi, N., Family history of type 2 diabetes: A population-based screening tool for prevention? (2006) Genet Med., 8 (2), pp. 102-108; Bulik-Sullivan, B., Finucane, H.K., Anttila, V., An atlas of genetic correlations across human diseases and traits (2015) Nat Genet., 47 (11), pp. 1236-1241; Eliassen, B.M., Melhus, M., Tell, G.S., Validity of selfreported myocardial infarction and stroke in regions with Sami and Norwegian populations: The SAMINOR 1 survey and the CVDNOR project (2016) BMJ Open., 6 (11), p. e012717; Oksanen, T., Kivimäki, M., Pentti, J., Self-report as an indicator of incident disease (2010) Ann Epidemiol., 20 (7), pp. 547-554; Janssens, A.C., Henneman, L., Detmar, S.B., Accuracy of selfreported family history is strongly influenced by the accuracy of self-reported personal health status of relatives (2012) J Clin Epidemiol., 65 (1), pp. 82-89; Bensen, J.T., Liese, A.D., Rushing, J.T., Accuracy of proband reported family history: The NHLBI Family Heart Study (FHS) (1999) Genet Epidemiol., 17 (2), pp. 141-150; Valdez, R., Yoon, P.W., Qureshi, N., Family history in public health practice: A genomic tool for disease prevention and health promotion (2010) Annu Rev Public Health., 31, pp. 69-87; Liu, J.Z., Erlich, Y., Pickrell, J.K., Case-control association mapping by proxy using family history of disease (2017) Nat Genet., 49 (3), pp. 325-331; Scott, R.A., Langenberg, C., The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: The EPIC-InterAct study (2013) Diabetologia., 56 (1), pp. 60-69. , InterAct Consortium; Raghavan, S., Porneala, B., McKeown, N., Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study (2015) Diabetologia., 58 (5), pp. 988-996},
correspondence_address1={Patel, C.J.; Department of Biomedical Informatics, 10 Shattuck Street, United States; email: Chirag_Patel@hms.harvard.edu},
publisher={Oxford University Press},
issn={00029262},
coden={AJEPA},
pubmed_id={31172187},
language={English},
abbrev_source_title={Am. J. Epidemiol.},
document_type={Article},
source={Scopus},
}

@ARTICLE{McKay2015237,
author={McKay, K.A. and Tremlett, H.},
title={The systematic search for risk factors in multiple sclerosis},
journal={The Lancet Neurology},
year={2015},
volume={14},
number={3},
pages={237-238},
doi={10.1016/S1474-4422(15)70015-3},
note={cited By 6},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923304191&doi=10.1016%2fS1474-4422%2815%2970015-3&partnerID=40&md5=7777f72d4951e7773625376378c5b42a},
affiliation={Faculty of Medicine (Neurology), University of British Columbia, Vancouver, V6T 2B5, Canada},
keywords={Epstein Barr virus antigen;  vitamin D, Article;  control;  environmental exposure;  environmental factor;  Epstein Barr virus;  family counseling;  geography;  human;  meta analysis (topic);  multiple sclerosis;  priority journal;  risk factor;  smoking;  systematic review (topic);  adverse effects;  literature;  meta analysis (topic);  multiple sclerosis, Environmental Exposure;  Humans;  Meta-Analysis as Topic;  Multiple Sclerosis;  Review Literature as Topic},
references={Killestein, J., Rudick, R.A., Polman, C.H., Oral treatment for multiple sclerosis (2011) Lancet Neurol, 10, pp. 1026-1034; Sawcer, S., Franklin, R.J.M., Ban, M., Multiple sclerosis genetics (2014) Lancet Neurol, 13, pp. 700-709; Atlas of MS 2013: mapping multiple sclerosis around the world, , http://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf, (accessed Jan 27, 2015); Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P.A., Tzoulaki, I., Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, , http://dx.doi.org/10.1016/S1474-4422(14)70267-4, published online Feb 4; Cohen, J.I., Epstein-Barr virus infection (2000) N Engl J Med, 343, pp. 481-492; Cohen, J.I., Mocarski, E.S., Raab-Traub, N., Corey, L., Nabel, G.J., The need and challenges for development of an Epstein-Barr virus vaccine (2013) Vaccine, 31, pp. B194-B196; Warner, K.E., The effects of the anti-smoking campaign on cigarette consumption (1977) Am J Public Health, 67, pp. 645-650; Duan, S., Lv, Z., Fan, X., Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis (2014) Neurosci Lett, 570, pp. 108-113; Ebers, G.C., Environmental factors and multiple sclerosis (2008) Lancet Neurol, 7, pp. 268-277; Munger, K.L., Bentzen, J., Laursen, B., Childhood body mass index and multiple sclerosis risk: a long-term cohort study (2013) Mult Scler J, 19, pp. 1323-1329},
correspondence_address1={Tremlett, H.; Faculty of Medicine (Neurology), Canada; email: helen.tremlett@ubc.ca},
publisher={Lancet Publishing Group},
issn={14744422},
coden={LNAEA},
pubmed_id={25662899},
language={English},
abbrev_source_title={Lancet Neurol.},
document_type={Note},
source={Scopus},
}

@ARTICLE{Puljak201935,
author={Puljak, L. and Pieper, D.},
title={Registration of methodological studies, that is, “research-on-research” studies—should it be mandatory?},
journal={Journal of Clinical Epidemiology},
year={2019},
volume={115},
pages={35-36},
doi={10.1016/j.jclinepi.2019.06.017},
note={cited By 5},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069734212&doi=10.1016%2fj.jclinepi.2019.06.017&partnerID=40&md5=1b5fcfcd8e1ccc1cd30def8b4f7ed1d7},
affiliation={Centre for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Ilica 242, Zagreb, 10000, Croatia; Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Ostmerheimer Str. 200, building 38, Cologne, 51109, Germany},
keywords={clinical trial (topic);  clinical trial protocol;  consensus;  evidence based medicine;  Letter;  medical education;  medical research;  Medline;  methodology;  outcome reporting bias;  priority journal;  publication bias;  registration;  clinical trial (topic);  human;  publishing;  register;  time factor, Clinical Trials as Topic;  Evidence-Based Medicine;  Humans;  Publishing;  Registries;  Time Factors},
references={Goldacre, B., DeVito, N.J., Heneghan, C., Irving, F., Bacon, S., Fleminger, J., Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource (2018) BMJ, 362, p. k3218; Allers, K., Hoffmann, F., Mathes, T., Pieper, D., Systematic reviews with published protocols compared to those without: more effort, older search (2018) J Clin Epidemiol, 95, pp. 102-110; Open science framework https://osf.io/, Available at (Accessed 20 July 2019); PROSPERO https://www.crd.york.ac.uk/prospero/, Available at (Accessed 20 July 2019)},
correspondence_address1={Puljak, L.; Centre for Evidence-Based Medicine and Health Care, Ilica 242, Croatia; email: livia.puljak@gmail.com},
publisher={Elsevier USA},
issn={08954356},
coden={JCEPE},
pubmed_id={31279727},
language={English},
abbrev_source_title={J. Clin. Epidemiol.},
document_type={Letter},
source={Scopus},
}

@ARTICLE{Giovannoni2019,
author={Giovannoni, G. and Noyce, A.J. and Scheltens, P.},
journal={Time matters. A call to prioritize brain health},
year={2019},
note={cited By 5},
source={Scopus},
}

@ARTICLE{Benedict2013,
author={Benedict, R.H.B. and Weinstock-Guttmam, B. and Marr, K. and Valnarov, V. and Kennedy, C. and Carl, E. and Brooks, C. and Hojnacki, D. and Zivadinov, R.},
title={Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis},
journal={BMC Medicine},
year={2013},
volume={11},
number={1},
doi={10.1186/1741-7015-11-167},
art_number={167},
note={cited By 5},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880182242&doi=10.1186%2f1741-7015-11-167&partnerID=40&md5=722322c6e85346ef43351fe17346af0b},
affiliation={Department of Neurology, State University of New York at Buffalo, 100 High St, Buffalo, NY 14203, United States; Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York at Buffalo, 100 High St, Buffalo, NY 14203, United States; Department of Neurology, School of Medicine and Biomedical Sciences, 100 High St, Buffalo, NY 14203, United States},
abstract={Background: Chronic cerebrospinal venous insufficiency (CCSVI) has been reported in multiple sclerosis (MS) yet its significance in relation to cognitive function is undetermined.This study measured the association between the presence and severity of CCSVI and cognitive impairment in patients with MS.Methods: CCSVI was assessed using extra-cranial and trans-cranial Doppler sonography in 109 MS patients (79 with relapsing-remitting, 23 with secondary-progressive and 7 with primary-progressive disease subtype). A subject was considered CCSVI-positive if ≥2 venous hemodynamic criteria were fulfilled. The Minimal Assessment of Cognitive Function in MS (MACFIMS) battery was administered assessing the full spectrum of cognitive domains known to be affected by MS. Depression was quantified using the Beck Depression Inventory Fast Screen (BDIFS). Partial correlations, analysis of variance (or covariance) and linear regression were used to examine the hypothesis that CCSVI status is related to cognition or depression after controlling for education and gender.Results: There were 64 (58.7%) patients who were considered CCSVI-positive. The regression models predicting venous hemodynamic insufficiency severity score were not statistically significant for any of the MACFIMS predictor variables. The analysis of variance tests showed a significant effect of CCSVI-positive diagnosis on cognitive ability in only one of the 10 MACFIMS outcomes, and that one was in the opposite direction of the tested hypothesis. There was no correspondence between CCSVI diagnosis and depression, as measured by the BDIFS.Conclusions: We find no evidence of an association between the presence and severity of CCSVI with cognitive impairment and depression in patients with MS. © 2013 Benedict et al.; licensee BioMed Central Ltd.},
author_keywords={CCSVI;  Cognition;  Multiple sclerosis},
keywords={adult;  aged;  analysis of variance;  article;  Beck Depression Inventory;  beck depression inventory fast screen;  chronic cerebrospinal venous insufficiency;  cognition;  cognitive defect;  controlled study;  decision making;  depression;  disease association;  disease duration;  disease severity;  Doppler echography;  education;  female;  gender;  hemodynamics;  human;  hypothesis;  learning;  major clinical study;  male;  multiple sclerosis;  predictor variable;  recall, Adult;  Aged;  Cerebrovascular Circulation;  Chronic Disease;  Cognition Disorders;  Cross-Sectional Studies;  Female;  Humans;  Male;  Middle Aged;  Multiple Sclerosis;  Single-Blind Method;  Spinal Cord;  Ultrasonography, Doppler, Transcranial;  Venous Insufficiency},
funding_details={Biogen IdecBiogen Idec},
funding_details={Toa PharmaceuticalToa Pharmaceutical, Toa},
funding_text 1={RHBB receives royalties from Psychological Assessment Resources that are in part associated with the Brief Visuospatial Memory Test Revised. RHBB has acted as a consultant or scientific advisory board member for Bayer, Biogen Idec, Actelion, and Novartis. He has received financial support for research activities from Shire Pharmaceuticals, Accorda and Biogen Idec. BW-G has participated in speaker’s bureaus and served as a consultant for Biogen Idec, Teva Neurosciences, EMD Serono, Pfizer, Novartis, Genzyme, and Acorda. She also has received grant/research support from the agencies listed above as well as ITN, Questcor and Shire. No other industry financial relationships exist. DH has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceutical Industries Ltd., EMD Serono, Pfizer Inc, and Genzyme. RZ has received financial support for research activities from Biogen Idec, Teva Pharmaceutical and Teva Neuroscience, EMD Serono, Genzyme-Sanofi, Novartis, Greatbatch, Bracco and Questcor. He also received personal compensation from Teva Pharmaceutical, Biogen Idec, Novartis, Genzyme-Sanofi, EMD Serono, Bayer, Novartis and General Electric for speaking and consultant services. KM, VV, CK, EC and CB declare that they have no competing interests.},
funding_text 2={The data used for this study were collected prospectively (between May 2010 and January 2011), as part of a self-referred, fee-for-service program in MS patients. Participants underwent clinical and imaging tests and were evaluated for the presence of CCSVI. All patients provided signed informed consent for entry of their test results in a central research database. The database registry included MRI of the brain and neck, Doppler examination of the brain and neck, neurological examination, neuropsychological testing and blood draw for genetic testing. The current study on cognition and CCSVI was funded by internal resources of the Buffalo Neuroimaging Analysis Center and Baird MS Center, the Jacobs Neurological Institute, University of Buffalo, as well as from the Direct MS Foundation and the Jacquemin Family Foundation.},
references={Hauser, S.L., Oksenberg, J.R., Hauser, S.L., Oksenberg, J.R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration (2006) Neuron, 52, pp. 61-76. , 10.1016/j.neuron.2006.09.011, 17015227; Trapp, B.D., Nave, K.A., Multiple sclerosis: an immune or neurodegenerative disorder? (2008) Annu Rev Neurosci, 31, pp. 247-269. , 10.1146/annurev.neuro.30.051606.094313, 18558855; Rao, S.M., Leo, G.J., Bernardin, L., Unverzagt, F., Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction (1991) Neurology, 41, pp. 685-691. , 10.1212/WNL.41.5.685, 2027484; Benedict, R.H.B., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., Weinstock-Guttman, B., Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) (2006) J Int Neuropsychol Soc, 12, pp. 549-558; Patti, F., Amato, M., Trojano, M., Bastianello, S., Tola, M., Goretti, B., Caniatti, L., Luccichenti, G., Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study (2009) Mult Scler, 15, pp. 779-788. , 10.1177/1352458509105544, 19542262, COGIMUS Study Group; Glanz, B.I., Holland, C.M., Gauthier, S.A., Amunwa, E.L., Liptak, Z., Houtchens, M.K., Sperling, R.A., Weiner, H.L., Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis (2007) Mult Scler, 13, pp. 1004-1010. , 10.1177/1352458507077943, 17623735; Houtchens, M.K., Benedict, R.H.B., Killiany, R., Sharma, J., Jaisani, Z., Singh, B., Weinstock-Guttman, B., Bakshi, R., Thalamic atrophy and cognition in multiple sclerosis (2007) Neurology, 69, pp. 113-123; Roosendaal, S.D., Bendfeldt, K., Vrenken, H., Polman, C.H., Borgwardt, S., Radue, E.W., Kappos, L., Geurts, J.J., Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability (2011) Mult Scler, 17, pp. 1098-1106. , 10.1177/1352458511404916, 21586487; Fisher, E., Lee, J.C., Nakamura, K., Rudick, R.A., Gray matter atrophy in multiple sclerosis: a longitudinal study (2008) Ann Neurol, 64, pp. 255-265. , 10.1002/ana.21436, 18661561; Zamboni, P., Galeotti, R., Menegatti, E., Malagoni, A.M., Tacconi, G., Dall'Ara, S., Bartolomei, I., Salvi, F., Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (2009) J Neurol Neurosurg Psychiatry, 80, pp. 392-399. , 2647682, 19060024; Khan, O., Filippi, M., Freedman, M.S., Barkhof, F., Dore-Duffy, P., Lassmann, H., Trapp, B., Lisak, R., Chronic cerebrospinal venous insufficiency and multiple sclerosis (2010) Ann Neurol, 67, pp. 286-290. , 10.1002/ana.22001, 20373339; Zivadinov, R., Ramanathan, M., Dolic, K., Marr, K., Karmon, Y., Siddiqui, A.H., Benedict, R.H., Weinstock-Guttman, B., Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives (2011) Expert Rev Neurother, 11, pp. 1277-1294. , 10.1586/ern.11.117, 21864074; Rudick, R.A., Multiple sclerosis: is multiple sclerosis caused by venous insufficiency? (2010) Nat Rev Neurol, 6, pp. 472-474. , 10.1038/nrneurol.2010.117, 20811464; Zamboni, P., Menegatti, E., Galeotti, R., Malagoni, A.M., Tacconi, G., Dall'Ara, S., Bartolomei, I., Salvi, F., The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis (2009) J Neurol Sci, 282, pp. 21-27. , 10.1016/j.jns.2008.11.027, 19144359; Zivadinov, R., Funding CCSVI research is/was a waste of valuable time, money and intellectual energy (2013) No. Mult Scler, 19, pp. 858-860; Baracchini, C., Perini, P., Causin, F., Calabrese, M., Rinaldi, F., Gallo, P., Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency (2011) Neurology, 77, pp. 844-850. , 10.1212/WNL.0b013e31822c6208, 21849656; Batista, S., Teter, B., Sequeira, K., Josyula, S., Hoogs, M., Ramanathan, M., Benedict, R.H., Weinstock-Guttman, B., Cognitive impairment is associated with reduced bone mass in multiple sclerosis (2012) Mult Scler, 18, pp. 1459-1465. , 10.1177/1352458512440206, 22419674; Doepp, F., Paul, F., Valdueza, J.M., Schmierer, K., Schreiber, S.J., No cerebrocervical venous congestion in patients with multiple sclerosis (2010) Ann Neurol, 68, pp. 173-183; Baracchini, C., Perini, P., Calabrese, M., Causin, F., Rinaldi, F., Gallo, P., No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset (2011) Ann Neurol, 69, pp. 90-99. , 10.1002/ana.22228, 21280079; Centonze, D., Floris, R., Stefanini, M., Rossi, S., Fabiano, S., Castelli, M., Marziali, S., Simonetti, G., Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity (2011) Ann Neurol, 70, pp. 51-58; Tsivgoulis, G., Mantatzis, M., Bogiatzi, C., Vadikolias, K., Voumvourakis, K., Prassopoulos, P., Piperidou, C., Heliopoulos, I., Extracranial venous hemodynamics in multiple sclerosis: a case-control study (2011) Neurology, 77, pp. 1241-1245. , 10.1212/WNL.0b013e318230a149, 21849653; Mayer, C.A., Pfeilschifter, W., Lorenz, M.W., Nedelmann, M., Bechmann, I., Steinmetz, H., Ziemann, U., The perfect crime? CCSVI not leaving a trace in MS (2011) J Neurol Neurosurg Psychiatry, 82, pp. 436-440. , 10.1136/jnnp.2010.231613, 3061048, 21296899; Zivadinov, R., Marr, K., Cutter, G., Ramanathan, M., Benedict, R.H., Kennedy, C., Elfadil, M., Weinstock-Guttman, B., Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS (2011) Neurology, 77, pp. 138-144. , 10.1212/WNL.0b013e318212a901, 21490322; Weinstock-Guttman, B., Ramanathan, M., Marr, K., Hojnack, D., Benedict, R.H., Morgan, C., Yeh, E.A., Zivadinov, R., Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis (2012) BMC Neurol, 12, p. 26. , 10.1186/1471-2377-12-26, 3462121, 22587224; Dolic, K., Marr, K., Valnarov, V., Dwyer, M.G., Carl, E., Hagemeier, J., Kennedy, C., Zivadinov, R., Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis (2011) Funct Neurol, 26, pp. 205-214; Bastianello, S., Romani, A., Viselner, G., Tibaldi, E.C., Giugni, E., Altieri, M., Cecconi, P., Bergamaschi, R., Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study (2011) BMC Neurol, 11, p. 132. , 10.1186/1471-2377-11-132, 3221625, 22029656; Zivadinov, R., Cutter, G., Marr, K., Ramanathan, M., Benedict, R.H., Bergsland, N., Morgan, C., Weinstock-Guttman, B., No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis (2012) AJNR Am J Neuroradiol, 33, pp. 1913-1917. , 10.3174/ajnr.A3112, 22576891; Kurtzke, J.F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) (1983) Ann Neurol, 13, pp. 227-231. , 10.1002/ana.410130302, 6847134; Lublin, F.D., Reingold, S.C., Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. [see comment] (1996) Neurology, 46, pp. 907-911. , 10.1212/WNL.46.4.907, 8780061; Beck, A.T., Steer, R.A., Brown, G.K., (2000) BDI-Fast Screen for Medical Patients: Manual, , San Antonio, TX: Psychological Corporation; Benedict, R.H.B., Fishman, I., McClellan, M.M., Bakshi, R., Weinstock-Guttman, B., Validity of the beck depression inventory - fast screen in multiple sclerosis (2003) Mult Scler, 9, pp. 393-396. , 10.1191/1352458503ms902oa, 12926845; Benedict, R.H.B., Fischer, J.S., Archibald, C.J., Arnett, P.A., Beatty, W.W., Bobholz, J., Chelune, G., Munschauer, F., Minimal neuropsychological assessment of MS patients: a consensus approach (2002) Clin Neuropsychol, 16, pp. 381-397. , 10.1076/clin.16.3.381.13859, 12607150; Parmenter, B.A., Testa, S.M., Schretlen, D.J., Weinstock-Guttman, B., Benedict, R.H.B., The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) (2010) J Int Neuropsychol Soc, 16, pp. 6-16. , 10.1017/S1355617709990750, 19796441; Benedict, R.H.B., Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis (2005) J Int Neuropsychol Soc, 11, pp. 727-736; Benedict, R., Ramasamy, D., Munschauer, F.E., Weinstock-Guttman, B., Zivadinov, R., Memory impairment in multiple sclerosis: correlation with deep gray matter and mesial temporal atrophy (2008) Mult Scler, 14, pp. S252; Tekok-Kilic, A., Benedict, R.H.B., Weinstock-Guttman, B., Dwyer, M.G., Carone, D., Srinivasaraghavan, B., Yella, V., Zivadinov, R., Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis (2007) NeuroImage, 36, pp. 1294-1300. , 10.1016/j.neuroimage.2007.04.017, 17524670; Smith, A., (1982) Symbol Digit Modalities Test: Manual, , Los Angeles: Western Psychological Services; Gronwall, D., Paced auditory serial addition task: A measure of recovery from concussion (1977) Percept Mot Skills, 44, pp. 367-373. , 10.2466/pms.1977.44.2.367, 866038; Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., (2000) Califorina Verbal Learning Test, , San Antonio, TX: The Psychological Corporation, 2; Benedict, R.H.B., Schretlen, D., Groninger, L., Dobraski, M., Shpritz, B., Revision of the Brief Visuospatial Memory Test: studies of normal performance, reliability, and validity (1996) Psychol Assess, 8, pp. 145-153; Benton, A.L., Hamsher, K.S., (1989) Multilingual Aphasia Examination, , Iowa City: IA: AJA Associates; Benton, A.L., Sivan, A.B., Hamsher, K., Varney, N.R., Spreen, O., (1994) Contributions to Neuropsychological Assessment, , New York: Oxford University Press, 2; Delis, D.C., Kaplan, E., Kramer, J.H., (2001) Delis-Kaplan Executive Function System, , San Antonio, TX: The Psychological Corporation; Zamboni, P., Menegatti, E., Weinstock-Guttman, B., Schirda, C., Cox, J.L., Malagoni, A.M., Hojanacki, D., Zivadinov, R., The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics (2009) Funct Neurol, 24, pp. 133-138; Batista, S., Zivadinov, R., Hoogs, M., Bergsland, N., Heininen-Brown, M., Dwyer, M.G., Weinstock-Guttman, B., Benedict, R.H., Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis (2012) J Neurol, 259, pp. 139-146. , 10.1007/s00415-011-6147-1, 21720932; Eshaghi, A., Riyahi-Alam, S., Roostaei, T., Haeri, G., Aghsaei, A., Aidi, M.R., Pouretemad, H.R., Sahraian, M.A., Validity and reliability of a Persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) (2012) Clin Neuropsychol, 26, pp. 975-984. , 10.1080/13854046.2012.694912, 22681459; Parmenter, B.A., Zivadinov, R., Kerenyi, L., Gavett, R., Weinstock-Guttman, B., Dwyer, M., Garg, N., Benedict, R.H.B., Validity of the Wisconsin card sorting and Delis-Kaplan executive function system (DKEFS) sorting tests in multiple sclerosis (2007) J Clin Exp Neuropsychol, 29, pp. 215-223. , 10.1080/13803390600672163, 17365256; Zivadinov, R., Galeotti, R., Hojnacki, D., Menegatti, E., Dwyer, M.G., Schirda, C., Malagoni, A.M., Zamboni, P., Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study (2011) AJNR Am J Neuroradiol, 32, pp. 938-946. , 10.3174/ajnr.A2386, 21474626; Hojnacki, D., Zamboni, P., Lopez-Soriano, A., Galleotti, R., Menegatti, E., Weinstock-Guttman, B., Schirda, C., Zivadinov, R., Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls (2010) Int Angiol, 29, pp. 127-139; Benedict, R.H., Zivadinov, R., Risk factors for and management of cognitive dysfunction in multiple sclerosis (2011) Nat Rev Neurol, 7, pp. 332-342. , 10.1038/nrneurol.2011.61, 21556031; Filippi, M., Rocca, M.A., Benedict, R.H., DeLuca, J., Geurts, J.J., Rombouts, S.A., Ron, M., Comi, G., The contribution of MRI in assessing cognitive impairment in multiple sclerosis (2010) Neurology, 75, pp. 2121-2128. , 10.1212/WNL.0b013e318200d768, 3385423, 21135387},
correspondence_address1={Benedict, R.H.B.; Department of Neurology, 100 High St, Buffalo, NY 14203, United States; email: benedict@buffalo.edu},
issn={17417015},
pubmed_id={23866161},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Lumley1995576,
author={Lumley, T. and Keech, A.},
title={Meta-meta-analysis with confidence [9]},
journal={Lancet},
year={1995},
volume={346},
number={8974},
pages={576-577},
doi={10.1016/S0140-6736(95)91413-7},
note={cited By 4},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029114082&doi=10.1016%2fS0140-6736%2895%2991413-7&partnerID=40&md5=396da46cebc1526915af0e3cac8eafd7},
affiliation={NHMRC Clinical Trials Centre, Edward Ford Building, University of Sydney, NSW 2006, Australia},
keywords={analytical error;  letter;  meta analysis;  prediction;  priority journal;  risk;  statistical analysis},
correspondence_address1={Lumley, T.; NHMRC Clinical Trials Centre, , NSW 2006, Australia},
publisher={Elsevier B.V.},
issn={01406736},
coden={LANCA},
pubmed_id={7658800},
language={English},
abbrev_source_title={LANCET},
document_type={Letter},
source={Scopus},
}

@ARTICLE{Chalkias2019,
author={Chalkias, A. and Ioannidis, J.P.A.},
title={Interventions to improve cardiopulmonary resuscitation: A review of meta-analyses and future agenda},
journal={Critical Care},
year={2019},
volume={23},
number={1},
doi={10.1186/s13054-019-2495-5},
art_number={210},
note={cited By 3},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066944108&doi=10.1186%2fs13054-019-2495-5&partnerID=40&md5=16b6b5f711c516f5dc51203670835468},
affiliation={Department of Anesthesiology, University of Thessaly, Larisa, Greece; Hellenic Society of Cardiopulmonary Resuscitation, Athens, Greece; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA  94305, United States; Department of Medicine, Stanford University, Stanford, CA  94305, United States; Department of Health Research and Policy, Stanford University, Stanford, CA  94305, United States; Department of Biomedical Data Science, Stanford University, Stanford, CA  94305, United States; Department of Statistics, Stanford University, Stanford, CA  94305, United States},
keywords={clinical outcome;  confidence interval;  data base;  defibrillation;  follow up;  heart arrest;  hospital discharge;  human;  intensive care;  meta analysis;  neurologic disease;  out of hospital cardiac arrest;  patient care;  practice guideline;  priority journal;  randomized controlled trial (topic);  resuscitation;  Review;  sample size;  survival rate;  health care quality;  meta analysis (topic);  procedures;  resuscitation, Cardiopulmonary Resuscitation;  Humans;  Meta-Analysis as Topic;  Quality of Health Care;  Randomized Controlled Trials as Topic},
references={Meier, P., Baker, P., Jost, D., Jacobs, I., Henzi, B., Knapp, G., Sasson, C., Chest compressions before defibrillation for out-of-hospital cardiac arrest: A meta-analysis of randomized controlled clinical trials (2010) BMC Med, 8, p. 52; Brooks, S.C., Bigham, B.L., Morrison, L.J., Mechanical versus manual chest compressions for cardiac arrest (2011) Cochrane Database Syst Rev, 1, p. CD007260; Brooks, S.C., Hassan, N., Bigham, B.L., Morrison, L.J., Mechanical versus manual chest compressions for cardiac arrest (2014) Cochrane Database Syst Rev, 2, p. CD007260; Gates, S., Quinn, T., Deakin, C.D., Blair, L., Couper, K., Perkins, G.D., Mechanical chest compression for out of hospital cardiac arrest: Systematic review and meta-analysis (2015) Resuscitation., 94, pp. 91-97; Tang, L., Gu, W.J., Wang, F., Mechanical versus manual chest compressions for out-of-hospital cardiac arrest: A meta-analysis of randomized controlled trials (2015) Sci Rep, 5, p. 15635. , 1:CAS:528:DC%2BC2MXhslCns7bI; Li, H., Wang, D., Yu, Y., Zhao, X., Jing, X., Mechanical versus manual chest compressions for cardiac arrest: A systematic review and meta-analysis (2016) Scand J Trauma Resusc Emerg Med, 24, p. 10. , 1:CAS:528:DC%2BC28XmvV2qu7k%3D; Zhan, L., Yang, L.J., Huang, Y., He, Q., Liu, G.J., Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation of non-asphyxial out-of-hospital cardiac arrest (2017) Cochrane Database Syst Rev, 3, p. CD010134. , 28349529; Lin, S., Callaway, C.W., Shah, P.S., Wagner, J.D., Beyene, J., Ziegler, C.P., Morrison, L.J., Adrenaline for out-of-hospital cardiac arrest resuscitation: A systematic review and meta-analysis of randomized controlled trials (2014) Resuscitation., 85 (6), pp. 732-740. , 1:CAS:528:DC%2BC2cXlsF2ksL8%3D; Kempton, H., Vlok, R., Thang, C., Melhuish, T., White, L., Standard dose epinephrine versus placebo in out of hospital cardiac arrest: A systematic review and meta-analysis (2019) Am J Emerg Med, 37 (3), pp. 511-517; Finn, J., Jacobs, I., Williams, T.A., Gates, S., Perkins, G.D., Adrenaline and vasopressin for cardiac arrest (2019) Cochrane Database Syst Rev, 1, p. CD003179. , 30653257; Vargas, M., Buonanno, P., Iacovazzo, C., Servillo, G., Epinephrine for out of hospital cardiac arrest: A systematic review and meta-analysis of randomized controlled trials (2019) Resuscitation., 136, pp. 54-60; White, L., Melhuish, T., Holyoak, R., Ryan, T., Kempton, H., Vlok, R., Advanced airway management in out of hospital cardiac arrest: A systematic review and meta-analysis (2018) Am J Emerg Med, 36 (12), pp. 2298-2306; Newell, C., Grier, S., Soar, J., Airway and ventilation management during cardiopulmonary resuscitation and after successful resuscitation (2018) Crit Care, 22 (1), p. 190; Andersen, L.W., Granfeldt, A., Callaway, C.W., Bradley, S.M., Soar, J., Nolan, J.P., Kurth, T., Donnino, M.W., Association between tracheal intubation during adult in-hospital cardiac arrest and survival (2017) JAMA., 317 (5), pp. 494-506; Perkins, G.D., Ji, C., Deakin, C.D., Quinn, T., Nolan, J.P., Scomparin, C., Regan, S., Lall, R., A randomized trial of epinephrine in out-of-hospital cardiac arrest (2018) N Engl J Med, 379 (8), pp. 711-721. , PARAMEDIC2 collaborators 1:CAS:528:DC%2BC1cXhs1eqs77J},
correspondence_address1={Ioannidis, J.P.A.; Meta-Research Innovation Center at Stanford (METRICS), United States; email: jioannid@stanford.edu},
publisher={BioMed Central Ltd.},
issn={13648535},
coden={CRCAF},
pubmed_id={31174581},
language={English},
abbrev_source_title={Crit. Care},
document_type={Review},
source={Scopus},
}

@ARTICLE{Mentis20186408,
author={Mentis, A.-F.A. and Papavassiliou, A.G.},
title={Correcting “insertion-deletion mutations” in medical terminology},
journal={Journal of Cellular and Molecular Medicine},
year={2018},
volume={22},
number={12},
pages={6408-6409},
doi={10.1111/jcmm.13875},
note={cited By 3},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052927035&doi=10.1111%2fjcmm.13875&partnerID=40&md5=058db15f97be1d2d2c1e751e79a0e6c4},
affiliation={Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece},
keywords={algorithm;  Brucella melitensis;  castration resistant prostate cancer;  complex regional pain syndrome type I;  disease surveillance;  DNA sequence;  electronic medical record;  epidemic;  genetic disorder;  global health;  health care system;  human;  human genome;  indel mutation;  Letter;  leukemia;  machine learning;  medical terminology;  nomenclature;  personalized medicine;  phenotype;  pneumonia;  posttraumatic stress disorder;  priority journal;  psychosis;  RNA analysis;  schizophrenia;  social media;  Spanish influenza;  spelling;  sympathectomy;  syphilis;  biology;  genetics;  indel mutation;  nomenclature;  peer review, Computational Biology;  Genome, Human;  Humans;  INDEL Mutation;  Peer Review, Research;  Terminology as Topic},
references={Lata, S., Marasa, M., Li, Y., Whole-exome sequencing in adults with chronic kidney disease: a pilot study (2018) Ann Intern Med, 168, pp. 100-109; Probert, P., (2006) Ancient Greek accentuation: synchronic patterns, frequency effects, and prehistory, , Oxford, UK, Oxford University Press; Honigsbaum, M., Spanish influenza redux: revisiting the mother of all pandemics (2018) Lancet, 391, pp. 2492-2495; Coderre, T.J., Complex regional pain syndrome: what's in a name? (2011) J Pain, 12, pp. 2-12; Pezaro, C.J., Omlin, A., Mastris, K., Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from ‘castration-resistant’ prostate cancer (2017) Ann Oncol, 28, pp. 1692-1694; van Os, J., “Schizophrenia” does not exist (2016) BMJ, 352, p. i375; Vasilevsky, N.A., Foster, E.D., Engelstad, M.E., Plain-language medical vocabulary for precision diagnosis (2018) Nat Genet, 50, pp. 474-476; Torous, J., Onnela, J.P., Keshavan, M., New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices (2017) Transl Psychiatry, 7; Hadfield, J., Retief, J., A profusion of confusion in NGS methods naming (2018) Nat Methods, 15, pp. 7-8; Lanera, C., Minto, C., Sharma, A., Extending PubMed searches to ClinicalTrials.gov through a machine learning approach for systematic reviews (2018) J Clin Epidemiol, , https://doi.org/10.1016/j.jclinepi.2018.06.015},
correspondence_address1={Papavassiliou, A.G.; Department of Biological Chemistry, Greece; email: papavas@med.uoa.gr},
publisher={Blackwell Publishing Inc.},
issn={15821838},
pubmed_id={30187998},
language={English},
abbrev_source_title={J. Cell. Mol. Med.},
document_type={Letter},
source={Scopus},
}

@ARTICLE{Donnan2017234,
author={Donnan, J. and Walsh, S. and Fortin, Y. and Gaskin, J. and Sikora, L. and Morrissey, A. and Collins, K. and MacDonald, D.},
title={Factors associated with the onset and progression of neurotrauma: A systematic review of systematic reviews and meta-analyses},
journal={NeuroToxicology},
year={2017},
volume={61},
pages={234-241},
doi={10.1016/j.neuro.2016.03.006},
note={cited By 3},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975515841&doi=10.1016%2fj.neuro.2016.03.006&partnerID=40&md5=39f54a3516a61e7817dc253f8583f88e},
affiliation={School of Pharmacy, Memorial University of Newfoundland, Health Science Centre, St. John's, NL, Canada; Newfoundland and Labrador Centre for Health Information, St. John's, NL, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada; Health Sciences Library, University of Ottawa, Ottawa, ON, Canada},
abstract={Neurotrauma, including traumatic brain injury (TBI) and spinal cord injury (SCI), is a preventable condition that imposes an important burden on the Canadian society. In this study, the current evidence on risk factors for the onset and progression of neurotrauma is systematically reviewed and synthesized. Searches of the Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (DARE), Medline and Medline in Process (via OVID), EMBASE and PsycINFO from inception to February 2013 were conducted to identify relevant systematic reviews and meta-analyses published in English or French. Two referees screened and assessed the quality of the studies using the AMSTAR tool. Thirty-two studies examined at least one risk factor for the onset of neurotrauma. Thirteen studies passed the quality assessment and the majority evaluated the impact of protective equipment in sports. Helmets effectively reduce TBI from bicycling, skiing, snowboarding, ice hockey and motorcycling. There was no evidence of a protective effect of helmets for SCI. No studies contributed evidence on risk factors for the onset of SCI. Of two studies examining risk factors for the progression of neurotrauma, only injury severity was found to be associated with poorer post-injury outcomes. Substantial evidence supports the use of helmets for the prevention of TBI in sports and motorcycling and face shields in ice hockey. Addressing bicycle helmet legislation across Canada may be an effective option for reducing TBI caused by bicycle accidents. Limited evidence on relevant risk factors for spinal cord injuries and neurotrauma progression was available. © 2016},
author_keywords={Aetiology;  Concussion;  Post-concussion syndrome;  Traumatic brain injury;  Traumatic spinal cord injury},
keywords={Article;  Canada;  cohort analysis;  cycling;  disease course;  disease severity;  human;  ice hockey;  law;  longitudinal study;  mortality;  motorcycle;  observational study;  priority journal;  quality control;  risk factor;  skiing;  spinal cord injury;  systematic review;  traffic accident;  traumatic brain injury;  disease exacerbation;  meta analysis;  onset age;  spinal cord injury;  traumatic brain injury, Age of Onset;  Brain Injuries, Traumatic;  Canada;  Disease Progression;  Humans;  Risk Factors;  Spinal Cord Injuries},
funding_details={University of OttawaUniversity of Ottawa, U of O},
funding_details={Public Health Agency of CanadaPublic Health Agency of Canada, PHAC},
funding_text 1={This study was funded by the Public Health Agency of Canada in association with Neurological Health Charities Canada under a contribution agreement administered through the University of Ottawa. We would like to thank to Dr. Shawn Marshall for helpful comments on an earlier draft of this article. Our thanks also go to Dr. Shalu Darshan for editorial support in finalizing this manuscript.},
references={Attewell, R.G., Glase, K., McFadden, M., Bicycle helmet efficacy: a meta-analysis (2001) Accid. Anal. Prev., 33, pp. 345-352; Barlow, K.M., Chapter 95—traumatic brain injury. Handbook of clinical neurology (2013) Pediatric Neurology Part II, Elsevier Handbook of Clinical Neurology, 112, pp. 891-903. , M.L. Olivier Dulac M. Lassonde H.B.S. Harveymat Elsevier B.V; Benson, B.W., Hamilton, G.M., Meeuwisse, W.H., McCrory, P., Dvorak, J., Is protective equipment useful in preventing concussion? A systematic review of the literature (2009) Br. J. Sports Med., 43, pp. i56-i67; Binder, H., Traumatic spinal cord injury (2013) Neurological Rehabilitation: Handbook of Clinical Neurology, 110, pp. 411-426. , M.P. Barnes D.C. Good Elsevier B.V; Borich, M.R., Cheung, K.L., Jones, P., Khramova, V., Gavrailoff, L., Boyd, L.A., Virji-Babul, N., Concussion: current concepts in diagnosis and management (2013) J. Neurol. Phys. Ther., 37, pp. 133-139; (2007), The burden of neurological diseases, disorders and injuries in Canada. Edited by Canadian Institute for Health Information: CIHI; Cappa, K.A., Conger, J.C., Conger, A.J., Injury severity and outcome: a meta-analysis of prospective studies on TBI outcome (2011) Health Psychol., 30, p. 542; Cassidy, J.D., Carroll, L., Peloso, P., Borg, J., von Holst, H., Holm, L., Kraus, J., Coronado, V., Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury (2004) J. Rehabil. Med., 36, pp. 28-60; Chen, Y., Huang, W., Non-impact, blast-induced mild TBI and PTSD: concepts and caveats (2011) Brain Inj., 25, pp. 641-650; Cusimano, M.D., Nassiri, F., Chang, Y., The effectiveness of interventions to reduce neurological injuries in rugby union: a systematic review (2010) Neurosurgery, 67, pp. 1404-1418; Dick, R.W., Is there a gender difference in concussion incidence and outcomes? (2009) Br. J. Sports Med., 43, pp. i46-i50; Emery, C.A., Hagel, B., Decloe, M., McKay, C., Risk factors for injury and severe injury in youth ice hockey: a systematic review of the literature (2010) Inj. Preven., 16, pp. 113-118; Farace, E., Alves, W.M., Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome (2000) J. Neurosurg., 93, pp. 539-545; Faul, M., Xu, L., Wald, M.M., Coronado, V.G., Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002–2006 (2010), Centers for Disease Control and Prevention : National Center for Injury Prevention and Control Atlanta, GA; Gean, A.D., Fischbein, N.J., Head trauma (2010) Neuroimaging Clin. N. Am., 2, pp. 527-556; Gelalis, I.D., Karageorgos, A., Arnaoutoglou, C., Gartzonikas, D., Politis, A., Georgakopoulos, N., Petsanas, A.P., Xenakis, T., Traumatic pneumorrhachis: etiology, pathomechanism, diagnosis, treatment (2011) Spine J., 11, pp. 153-157; Hersi, M., Quach, P., Wang, M.-D., Gomes, J., Gaskin, J., Krewski, D., Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview (2017) Neurotoxicology, 61, pp. 12-18; Howard, A.W., Children, automobile restraints and injuries (2000) Paediatr. Child Health, 5, p. 24; Hung, R., Carroll, L.J., Cancelliere, C., Côté, P., Rumney, P., Keightley, M., Donovan, J., Cassidy, J.D., Systematic review of the clinical course, natural history, prognosis for pediatric mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis (2014) Arch. Phys. Med. Rehabil., 95, pp. S174-S191; Khangura, S., Konnyu, K., Cushman, R., Grimshaw, J., Moher, D., Evidence summaries: the evolution of a rapid review approach (2012) Syst. Rev., 1, pp. 1-9; Knapik, J.J., Marshall, S.W., Lee, R.B., Darakjy, S.S., Jones, S.B., Mitchener, T.A., dela Cruz, G.G., Jones, B.H., Mouthguards in sport activities history, physical properties and injury prevention effectiveness (2007) Sports Med., 37, pp. 117-144; Koh, J.O., Cassidy, J.D., Watkinson, E.J., Incidence of concussion in contact sports: a systematic review of the evidence (2003) Brain Inj., 17, pp. 901-917; Langlois, J.A., Rutland-Brown, W., Wald, M.M., The epidemiology and impact of traumatic brain injury: a brief overview (2006) J. Head Trauma Rehabil., 21, pp. 375-378; Lastennet, F., Sizun, J., Dobrzynski, M., de Parscau, L., Bicycle helmet effectiveness in children: qualitative analysis of the literature (2001) Arch. Pediatr., 8, pp. 1246-1250; Lee, R.S., Hagel, B.E., Karkhaneh, M., Rowe, B.H., A systematic review of correct bicycle helmet use: how varying definitions and study quality influence the results (2009) Inj. Prev., 15, pp. 125-131; Liu, B.C., Ivers, R., Norton, R., Boufous, S., Blows, S., Lo, S.K., Helmets for preventing injury in motorcycle riders (2008) Cochrane Database of Systematic Reviews, Issue 1. , Art. No.: CD004333; Loosemore, M., Knowles, C.H., Whyte, G.P., Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies (2007) BMJ, 335, p. 809; Marshall, S., Bayley, M., McCullagh, S., Velikonja, D., Berrigan, L., Clinical practice guidelines for mild traumatic brain injury and persistent symptoms (2012) Can. Fam. Phys., 58, pp. 257-267; McGuine, T., Sports injuries in high school athletes: a review of injury-risk and injury-prevention research (2006) Clin. J. Sport Med., 1, pp. 488-499; Parkinson, G.W., Hike, K.E., Bicycle helmet assessment during well visits reveals severe shortcomings in condition and fit (2003) Pediatrics, 112, pp. 320-323; Parry-Jones, B.L., Vaughan, F.L., Cox, W.M., Traumatic brain injury and substance misuse: a systematic review of prevalence and outcomes research (1994–2004) (2006) Neuropsychol. Rehabil., 16, pp. 537-560; Petchprapai, N., Winkelman, C., Mild traumatic brain injury: determinants and subsequent quality of life. A review of the literature (2007) J. Neurosci. Nurs., 39, pp. 260-272; Reilly, P.L., Current evaluation of TBI epidemiology in an ageing society with improved preventive measures (2012) Traumatic Brain and Spinal Cord Injury: Challenges and Developments, pp. 1-10. , C. Morganti-Kossmann R. Raghupathi A. Maas Cambridge University Press Cambridge, MA; Russell, K., Christie, J., Hagel, B.E., The effect of helmets on the risk of head and neck injuries among skiers and snowboarders: a meta-analysis (2010) CMAJ, 182, pp. 333-340; Ryu, W.H.A., Feinstein, A., Colantonio, A., Streiner, D., Dawson, L., Early identification and incidence of mild TBI in Ontario (2009) Can. J. Neurol. Sci., 36, pp. 429-435; Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., Porter, A.C., Bouter, L.M., Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007) BMC Med. Res. Methodol., 7, p. 10; Slewa-Younan, S., van Den Berg, S., Baguley, I.J., Nott, M., Cameron, I.D., Towards an understanding of sex differences in functional outcome following moderate to severe traumatic brain injury: a systematic review (2008) J. Neurol. Neurosurg. Psychiatry, 79, pp. 1197-1201; Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., Kraus, J., A systematic review of brain injury epidemiology in Europe (2006) Acta Neurochir. (Wien), 148, pp. 255-268; Thompson, D.C., Rivara, F., Thompson, R., Helmets for preventing head and facial injuries in bicyclists (1999) Cochrane Database of Systematic Reviews, Issue 4. , Art. No.: CD001855; Toth, C., McNeil, S., Feasby, T., Central nervous system injuries in sport and recreation (2005) Sports Med., 35, pp. 685-715; Neurological Disorders: Public Health Challenges (2006), WHO press, World Health Organization Geneva, CH},
correspondence_address1={Donnan, J.; School of Pharmacy, Canada; email: jennifer.donnan@mun.ca},
publisher={Elsevier B.V.},
issn={0161813X},
coden={NRTXD},
pubmed_id={27006002},
language={English},
abbrev_source_title={NeuroToxicology},
document_type={Article},
source={Scopus},
}

@ARTICLE{Armon2019189,
author={Armon, C. and Traynor, B.J.},
title={High BMI is associated with low ALS risk: What does it mean?},
journal={Neurology},
year={2019},
volume={93},
number={5},
pages={189-191},
doi={10.1212/WNL.0000000000007852},
note={cited By 2},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070790440&doi=10.1212%2fWNL.0000000000007852&partnerID=40&md5=28a454361221d16952f8385d4b0d290e},
affiliation={Department of Neurology, Tel Aviv University, Sackler School of Medicine, Israel; Shamir (Assaf Harofeh) Medical Center, Israel; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, United States; Neurology Department, Johns Hopkins University, Baltimore, MD, United States},
keywords={apolipoprotein E;  cholesterol;  triacylglycerol, age;  allele;  Alzheimer disease;  amyotrophic lateral sclerosis;  APOE gene;  body mass;  follow up;  human;  incidence;  low risk population;  Parkinson disease;  phenotype;  physical activity;  priority journal;  race;  Review;  risk assessment;  risk factor;  sex;  smoking;  body mass;  methodology;  risk, Amyotrophic Lateral Sclerosis;  Body Mass Index;  Humans;  Research Design;  Risk},
chemicals_cas={cholesterol, 57-88-5},
references={Armon, C., From snow to Hill to ALS: An epidemiological odyssey in search of ALS causation (2018) J Neurol Sci, 391, pp. 134-140; Hudson, A.J., Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: A review (1981) Brain, 104, pp. 217-247; Brown, R.H., Al-Chalabi, A., Amyotrophic lateral sclerosis (2017) N Engl J Med, 377, pp. 162-172; Armon, C., An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis (2003) Neuroepidemiology, 22, pp. 217-228; Armon, C., Smoking may be considered an established risk factor for sporadic ALS (2009) Neurology, 73, pp. 1693-1698; Zhan, Y., Fang, F., Smoking and amyotrophic lateral sclerosis: A Mendelian randomization study (2019) Ann Neurol, 85, pp. 482-484; Armon, C., Smoking is a cause of amyotrophic lateral sclerosis: High low-density lipoprotein cholesterol levels? Unsure (2019) Ann Neurol, 85, pp. 465-469; Chen, X., Yazdani, S., Piehl, F., Magnusson, P.K.E., Fang, F., Polygenic link between blood lipids and amyotrophic lateral sclerosis (2018) Neurobiol Aging, 67, pp. 202.e1–202.e6; Zeng, P., Zhou, X., Causal effects of blood lipids on amyotrophic lateral sclerosis: A Mendelian randomization study (2019) Hum Mol Genet, 28, pp. 688-697; Bandres-Ciga, S., Noyce, A.J., Hemani, G., Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis (2019) Ann Neurol, 85, pp. 470-481; Nakken, O., Meyer, H.E., Stigum, H., Holmøy, T., High BMI is associated with low ALS risk: A population-based study (2019) Neurology, 93, pp. e424-e432; Mehta, P., Kaye, W., Raymond, J., Prevalence of amyotrophic lateral sclerosis: United States, 2015 (2018) MMWR Morb Mortal Wkly Rep, 67, pp. 1285-1289; Alzheimer’s disease facts and figures (2018) Alzheimers Dement, 14, pp. 367-429. , Alzheimer’s Association. 2018; (2017) The Incidence and Prevalence of Parkinson’S in the UK: Results from the Clinical Practice Research Datalink: Reference Report, , parkinsons.org.uk/sites/default/files/2018-01/Prevalence%20%20Incidence%20Report%20Latest_Public_2.pdf, Accessed March 30, 2019; Roberts, R.O., Geda, Y.E., Knopman, D.S., The incidence of MCI differs by subtype and is higher in men: The Mayo clinic study of aging (2012) Neurology, 78, pp. 342-351; Mielke, M.M., Vemuri, P., Rocca, W.A., Clinical epidemiology of Alzheimer’s disease: Assessing sex and gender differences (2014) Clin Epidemiol, 6, pp. 37-48; Moisan, F., Kab, S., Mohamed, F., Parkinson disease Male-to-female ratios increase with age: French nationwide study and metaanalysis (2016) J Neurol Neurosurg Psychiatry, 87, pp. 952-957; Durazzo, T.C., Mattsson, N., Weiner, M.W., Smoking and increased Alzheimer’s disease risk: A review of potential mechanisms (2014) Alzheimers Dement, 10, pp. S122-S145. , for the Alzheimer’s Disease Neuroimaging Initiative; Wang, Y.L., Wang, Y.T., Li, J.F., Zhang, Y.Z., Yin, H.L., Han, B., Body mass index and risk of Parkinson’s disease: A dose-response meta-analysis of prospective studies (2015) PLoS One, 10; Noyce, A.J., Kia, D.A., Hemani, G., Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study (2017) PLoS Med, 14; Chiò, A., Brunetti, M., Barberis, M., The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis (2016) JAMA Neurol, 73, pp. 425-430; Federoff, M., Jimenez-Rolando, B., Nalls, M.A., Singletonca, A.B., A large study reveals no association between APOE and Parkinson’s disease (2012) Neurobiol Dis, 46, pp. 389-392; Pang, S., Li, J., Zhang, Y., Chen, J., Meta-analysis of the relationship between the APOE gene and the onset of Parkinson’s disease dementia (2018) Hindawi Parkinson Dis, 2018, p. 12; van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity (2003) Am J Epidemiol, 157, pp. 1015-1022; Podcasy, J.L., Epperson, C.N., Considering sex and gender in Alzheimer disease and other dementias (2016) Dialogues Clin Neurosci, 18, pp. 437-446},
correspondence_address1={Armon, C.; Department of Neurology, Israel; email: carmon@asaf.health.gov.il},
publisher={Lippincott Williams and Wilkins},
issn={00283878},
coden={NEURA},
pubmed_id={31243070},
language={English},
abbrev_source_title={Neurology},
document_type={Review},
source={Scopus},
}

@ARTICLE{Wang2016271,
author={Wang, M.-D. and Little, J.},
title={How Credible Are Meta-Analyses of Risk Factors Based on Observational Studies for Amyotrophic Lateral Sclerosis? A New Insight from an Umbrella Review},
journal={Neuroepidemiology},
year={2016},
volume={46},
number={4},
pages={271-272},
doi={10.1159/000445389},
note={cited By 2},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963517860&doi=10.1159%2f000445389&partnerID=40&md5=38b61537334023f3a80c28469d67233a},
affiliation={School of Life Science, Changchun Normal University, Changchun , Jilin, 130032, China; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON  K1G 5Z3, Canada},
keywords={biological marker;  pesticide, agricultural worker;  amyotrophic lateral sclerosis;  diet;  electromagnetic field;  human;  Note;  observational study;  occupational exposure;  practice guideline;  risk factor;  smoking;  amyotrophic lateral sclerosis;  meta analysis (topic);  reproducibility, Amyotrophic Lateral Sclerosis;  Humans;  Meta-Analysis as Topic;  Observational Studies as Topic;  Reproducibility of Results;  Risk Factors},
references={Al-Chalabi, A., Fang, F., Hanby, M.F., Leigh, P.N., Shaw, C.E., Ye, W., Rijsdijk, F., An estimate of amyotrophic lateral sclerosis heritability using twin data (2010) J Neurol Neurosurg Psychiatry, 81, pp. 1324-1326; Wingo, T.S., Cutler, D.J., Yarab, N., Kelly, C.M., Glass, J.D., The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry (2011) PLoS One, 6, p. e27985; Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Thacker, S.B., Meta-analysis of observational studies in epidemiology: A proposal for reporting (2000) JAMA, 283, pp. 2008-2012. , Meta-analysis of observational studies in epidemiology (MOOSE) group; Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Clarke, M., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration (2009) J Clin Epidemiol, 62, pp. e1-e34; Shea, B.J., Bouter, L.M., Peterson, J., Boers, M., Andersson, N., Ortiz, Z., Ramsay, T., Grimshaw, J.M., External validation of a measurement tool to assess systematic reviews (AMSTAR) (2007) PLoS One, 2, p. e1350; Khoury, M.J., Bertram, L., Boffetta, P., Butterworth, A.S., Chanock, S.J., Dolan, S.M., Fortier, I., Ioannidis, J.P., Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases (2009) Am J Epidemiol, 170, pp. 269-279; Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J.P., Tzoulaki, I., Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses (2015) Lancet Neurol, 14, pp. 263-273; Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., Ioannidis, J.P., Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses (2016) Parkinsonism Relat Disord, 23, pp. 1-9; Belbasis, L., Bellou, V., Evangelou, E., Environmental risk factors and amyotrophic lateral sclerosis: An umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies (2016) Neuroepidemiology, 46, pp. 96-105; Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions (1998) J Epidemiol Community Health, 52, pp. 377-384; Armon, C., An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis (2003) Neuroepidemiology, 22, pp. 217-228},
publisher={S. Karger AG},
issn={02515350},
coden={NEEPD},
pubmed_id={27064494},
language={English},
abbrev_source_title={Neuroepidemiology},
document_type={Note},
source={Scopus},
}

@ARTICLE{Lawlor2019,
author={Lawlor, D.A.},
title={Fifteen years of epidemiology in BMC Medicine},
journal={BMC Medicine},
year={2019},
volume={17},
number={1},
doi={10.1186/s12916-019-1407-5},
art_number={177},
note={cited By 1},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072569318&doi=10.1186%2fs12916-019-1407-5&partnerID=40&md5=780fb8bd227443a77a60e647fcd2a946},
affiliation={MRC Integrative Epidemiology Unit at the University of Bristol, Population Health Science, Bristol Medical School, Bristol NIHR Biomedical Research Centre, Bristol, United Kingdom},
abstract={BMC Medicine was launched in November 2003 as an open access, open peer-reviewed general medical journal that has a broad remit to publish "outstanding and influential research in all areas of clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities". Here, I discuss the last 15 years of epidemiological research published by BMC Medicine, with a specific focus on how this reflects changes occurring in the field of epidemiology over this period; the impact of 'Big Data'; the reinvigoration of debates about causality; and, as we increasingly work across and with many diverse disciplines, the use of the name 'population health science'. Reviewing all publications from the first volume to the end of 2018, I show that most BMC Medicine papers are epidemiological in nature, and the majority of them are applied epidemiology, with few methodological papers. Good research must address important translational questions that should not be driven by the increasing availability of data, but should take appropriate advantage of it. Over the next 15 years it would be good to see more publications that integrate results from several different methods, each with different sources of bias, in a triangulation framework. © 2019 The Author(s).},
author_keywords={Big data;  Causality;  Epidemiology},
keywords={article;  big data;  causality;  population health},
funding_details={MC_UU_00011/6},
funding_details={MedtronicMedtronic},
funding_details={National Institute for Health ResearchNational Institute for Health Research, NIHR},
funding_details={British Heart FoundationBritish Heart Foundation, BHF},
funding_details={European Research CouncilEuropean Research Council, ERC},
funding_details={University of BristolUniversity of Bristol},
funding_text 1={DAL works in a unit that receives support from the University of Bristol and UK Medical Research Council (grant number MC-UU-00011/6). The views presented in this paper are those of the author and not necessarily any acknowledged funding body or person. Professor George Davey Smith (University of Bristol) and Professor Neil Pearce (London School of Hygiene &pical Medicine) provided useful comments on an earlier draft of this editorial.},
funding_text 2={DAL works in a unit that receives support from the University of Bristol and UK Medical Research Council (grant number MC_UU_00011/6). The views presented in this paper are those of the author and not necessarily any acknowledged funding body or person.},
funding_text 3={DAL receives or has received during the last 10 years) support from the UK National Institute for Health Research, British Heart Foundation, European Research Council, US National Institute of Health, Medtronic Ltd. and Roche Diagnostics for research that is unrelated to this article.},
references={Saracci, R., Epidemiology in wonderland: Big data and precision medicine (2018) Eur J Epidemiol, 33 (3), pp. 245-257; Davey Smith, G., Post-Modern Epidemiology: When Methods Meet Matter (2019) American Journal of Epidemiology, 188 (8), pp. 1410-1419; Pearce, N., Vandenbroucke, J.P., Lawlor, D.A., Causal inference in environmental epidemiology: Old and new approaches (2019) Epidemiology, 30 (3), pp. 311-316; Keyes, K.M., Galea, S., Setting the agenda for a new discipline: Population health science (2016) Am J Public Health, 106 (4), pp. 633-634; Saracci, R., Epidemiology, the international epidemiological association and the international journal of epidemiology: A personal chronicle (2016) Int J Epidemiol, 45 (6), pp. 1727-1732. , 27940485; Zhang, J., Mikolajczyk, R., Lei, X., Sun, L., Yu, H., Cheng, W., An adjustable fetal weight standard for twins: A statistical modeling study (2015) BMC Med, 13, p. 159; Ndila, C., Bauni, E., Nyirongo, V., Mochamah, G., Makazi, A., Kosgei, P., Verbal autopsy as a tool for identifying children dying of sickle cell disease: A validation study conducted in Kilifi district, Kenya (2014) BMC Med, 12, p. 65; Pearce, N., Lawlor, D.A., Causal inference - So much more than statistics (2016) Int J Epidemiol, 45 (6), pp. 1895-1903; (2019) BMC Med., , https://bmcmedicine.biomedcentral.com/articles/collections/bigdata, Beyond Big Data to new biomedical and health data science: moving to next century precision health. Accessed 15 May 2019; Agardh, E., Lundstig, A., Perfilyev, A., Volkov, P., Freiburghaus, T., Lindholm, E., Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy (2015) BMC Med, 13, p. 182; Lin, X., Lim, I.Y., Wu, Y., Teh, A.L., Chen, L., Aris, I.M., Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome (2017) BMC Med, 15 (1), p. 50; Maitre, L., Fthenou, E., Athersuch, T., Coen, M., Toledano, M.B., Holmes, E., Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study (2014) BMC Med, 12, p. 110; Wang, Q., Ferreira, D.L.S., Nelson, S.M., Sattar, N., Ala-Korpela, M., Lawlor, D.A., Metabolic characterization of menopause: Cross-sectional and longitudinal evidence (2018) BMC Med, 16 (1), p. 17; Lau, C.E., Siskos, A.P., Maitre, L., Robinson, O., Athersuch, T.J., Want, E.J., Determinants of the urinary and serum metabolome in children from six European populations (2018) BMC Med, 16 (1), p. 202. , 1:CAS:528:DC%2BC1MXhtFWit7nK; Felix, J.F., Joubert, B.R., Baccarelli, A.A., Sharp, G.C., Almqvist, C., Annesi-Maesano, I., Cohort Profile: Pregnancy and Childhood Epigenetics (PACE) Consortium (2018) Int J Epidemiol, 47 (1), pp. 22-23u; Santos Ferreira, D.L., Williams, D.M., Kangas, A.J., Soininen, P., Ala-Korpela, M., Smith, G.D., Association of pre-pregnancy body mass index with offspring metabolic profile: Analyses of 3 European prospective birth cohorts (2017) PLoS Med, 14 (8). , e1002376; Millard, L.A.C., Tilling, K., Lawlor, D.A., Flach, P.A., Gaunt, T.R., Physical activity phenotyping with activity bigrams, and their association with BMI (2017) Int J Epidemiol, 46, pp. 1857-1870; Davey Smith, G., Ebrahim, S., Mendelian randomisation": Can genetic epidemiology contribute to understanding environmental determinants of disease? (2003) Int J Epidemiol, 32, pp. 1-22; Davey, S.G., Capitalising on Mendelian randomization to assess the effects of treatments (2006) JLL Bulletin: Commentaries on the history of treatment evaluation, , https://www.jameslindlibrary.org/articles/capitalising-on-mendelian-randomization-to-assess-the-effects-of-treatments/; Borges, M.C., Barros, A.J.D., Ferreira, D.L.S., Casas, J.P., Horta, B.L., Kivimaki, M., Metabolic profiling of adiponectin levels in adults: Mendelian randomization analysis (2017) Circ Cardiovasc Genet, 10 (6). , e001837 1:CAS:528:DC%2BC1cXhtF2ms74%3D; Borges, M.C., Lawlor, D.A., De Oliveira, C., White, J., Horta, B.L., Barros, A.J.D., The role of adiponectin in coronary heart disease risk: A Mendelian randomization study (2016) Circ Res, 119, pp. 491-499. , 1:CAS:528:DC%2BC28Xht1WntLrP; Carter, A.R., Borges, M.C., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Nordestgaard, B.G., Combined association of body mass index and alcohol consumption with biomarkers for liver injury and incidence of liver disease: A Mendelian randomization study (2019) JAMA Netw Open, 2 (3). , e190305; Freathy, R.M., Kazeem, G.R., Morris, R.W., Johnson, P.C., Paternoster, L., Ebrahim, S., Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index (2011) Int J Epidemiol, 40 (6), pp. 1617-1628; Tyrrell, J., Richmond, R.C., Palmer, T.M., Feenstra, B., Rangarajan, J., Metrustry, S., Genetic evidence for causal relationships between maternal obesity-related traits and birth weight (2016) JAMA, 315 (11), pp. 1129-1140. , 1:CAS:528:DC%2BC28XhtlGrtrnF; Bowden, J., Davey Smith, G., Haycock, P.C., Burgess, S., Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator (2016) Genet Epidemiol, 40 (4), pp. 304-314; Bowden, J., Del Greco, M.F., Minelli, C., Davey Smith, G., Sheehan, N.A., Thompson, J.R., Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-egger regression: The role of the I2 statistic (2016) Int J Epidemiol, 45 (6), pp. 1961-1974. , 27616674 5446088; Bowden, J., Del Greco, M.F., Minelli, C., Zhao, Q., Lawlor, D.A., Sheehan, N.A., Thompson, J., Davey Smith, G., Improving the accuracy of two-sample summary-data Mendelian randomization: Moving beyond the NOME assumption (2018) International Journal of Epidemiology, 48 (3), pp. 728-742; Hartwig, F.P., Davies, N.M., Hemani, G., Davey, S.G., Two-sample Mendelian randomization: Avoiding the downsides of a powerful, widely applicable but potentially fallible technique (2016) Int J Epidemiol, 45 (6), pp. 1717-1726; Lawlor, D.A., Two-sample Mendelian randomization: Opportunities and challenges (2016) Int J Epidemiol, 45 (3), pp. 908-915; Slichter, D., (2014) Testing Instrument Validity and Identification with Invalid Instruments. Society of Labor Economics Journal of Labor Economics, , University of Chicago Press Chicago, IL http://www.sole-jole.org/14436.pdf. Accessed 15 May 2019; Spiller, W., Slichter, D., Bowden, J., Davey, S.G., Detecting and correcting for bias in Mendelian randomization analyses using gene-by-environment interactions (2018) Int J Epidemiol, , https://doi.org/10.1093/ije/dyy204; Guo, Z., Kang, H., Cai, T.T., Small, D.S., (2017) Confidence intervals for causal effects with invalid instruments using two-stage hard thresholding with voting, , [math.ST]; Kang, H., Zhang, A., Cai, T.T., Small, D.S., Instrumental variables estimation with some invalid instruments and its application to Mendelian randomization (2016) J Am Stat Assoc, 111, pp. 132-142. , 1:CAS:528:DC%2BC28XnsV2jsro%3D; Van Kippersluis, H., Rietveld, C.A., Pleiotropy-robust Mendelian randomization (2018) Int J Epidemiol, 47 (4), pp. 1279-1288; Hemani, G., Zheng, J., Elsworth, B., Wade, K.H., Haberland, V., Baird, D., The MR-base platform supports systematic causal inference across the human phenome (2018) Elife, 7. , e34408; Lea, R.A., Ovcaric, M., Sundholm, J., Macmillan, J., Griffiths, L.R., The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura (2004) BMC Med, 2, p. 3; Disney-Hogg, L., Cornish, A.J., Sud, A., Law, P.J., Kinnersley, B., Jacobs, D.I., Impact of atopy on risk of glioma: A Mendelian randomisation study (2018) BMC Med, 16 (1), p. 42; Lai, F.Y., Nath, M., Hamby, S.E., Thompson, J.R., Nelson, C.P., Samani, N.J., Adult height and risk of 50 diseases: A combined epidemiological and genetic analysis (2018) BMC Med, 16 (1), p. 187. , 1:CAS:528:DC%2BC1MXhtFWitrbF; He, Y., Timofeeva, M., Farrington, S.M., Vaughan-Shaw, P., Svinti, V., Walker, M., Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: A large Mendelian randomisation study (2018) BMC Med, 16 (1), p. 142; Larsson, S.C., Burgess, S., Michaelsson, K., Serum magnesium levels and risk of coronary artery disease: Mendelian randomisation study (2018) BMC Med, 16 (1), p. 68; Mocellin, S., Tropea, S., Benna, C., Rossi, C.R., Circadian pathway genetic variation and cancer risk: Evidence from genome-wide association studies (2018) BMC Med, 16 (1), p. 20; Nordestgaard, L.T., Tybjaerg-Hansen, A., Rasmussen, K.L., Nordestgaard, B.G., Frikke-Schmidt, R., Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: Cohort studies and meta-analyses of 362,338 individuals (2018) BMC Med, 16 (1), p. 39; Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Retraction: A significant causal association between C-reactive protein levels and schizophrenia (2018) Sci Rep, 8, p. 46947; Lawlor, D.A., Tilling, K., Davey, S.G., Triangulation in aetiological epidemiology (2016) Int J Epidemiol, 45 (6), pp. 1866-1886. , 28108528; Barbui, C., Sharing all types of clinical data and harmonizing journal standards (2016) BMC Med, 14, p. 63; Lawlor, D.A., Quality in epidemiological research: Should we be submitting papers before we have the results and submitting more hypothesis-generating research? (2007) Int J Epidemiol, 36 (5), pp. 940-943; Allen, N.E., Sudlow, C., Peakman, T., Collins, R., Biobank, U.K., UK biobank data: Come and get it (2014) Sci Transl Med, 6 (224), p. 224ed224; Lawlor, D.A., Lewcock, M., Rena-Jones, L., Rollings, C., Yip, V., Smith, D., The second generation of the Avon longitudinal study of parents and children (ALSPAC-G2): A cohort profile (2019) Wellcome Open Res, 4, p. 36. , 10.12688/wellcomeopenres.15087.1; (2019) Nature, 567, p. 283. , It's time to talk about ditching statistical significance. Looking beyond a much used and abused measure would make science harder, but better},
correspondence_address1={Lawlor, D.A.; MRC Integrative Epidemiology Unit at the University of Bristol, United Kingdom; email: d.a.lawlor@bristol.ac.uk},
publisher={BioMed Central Ltd.},
issn={17417015},
pubmed_id={31543077},
language={English},
abbrev_source_title={BMC Med.},
document_type={Article},
source={Scopus},
}

@ARTICLE{Mentis2017,
author={Mentis, A.-F.},
journal={Social Determinants of Tobacco Use: Towards an Equity Lens Approach Tob Prev Cessation},
year={2017},
volume={3},
number={7},
note={cited By 1},
source={Scopus},
}

@ARTICLE{Smith2001,
author={Smith, G.D. and Ebrahim, S.},
title={Epidemiologyis it time to call it a day?},
journal={Epidemiology—is It Time to Call It a Day?},
year={2001},
note={cited By 1},
source={Scopus},
}
